PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bradley, AS; Baharoglu, Z; Niewiarowski, A; Michel, B; Tsaneva, IR				Bradley, Alison S.; Baharoglu, Zeynep; Niewiarowski, Andrew; Michel, Benedicte; Tsaneva, Irina R.			Formation of a Stable RuvA Protein Double Tetramer Is Required for Efficient Branch Migration in Vitro and for Replication Fork Reversal in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION RESOLVASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DNA-REPAIR; SCHIZOSACCHAROMYCES-POMBE; OCTAMERIC RUVA; COMPLEX; RECOMBINATION; RESOLUTION; ENDONUCLEASE	In bacteria, RuvABC is required for the resolution of Holliday junctions (HJ) made during homologous recombination. The RuvAB complex catalyzes HJ branch migration and replication fork reversal (RFR). During RFR, a stalled fork is reversed to form a HJ adjacent to a DNA double strand end, a reaction that requires RuvAB in certain Escherichia coli replication mutants. The exact structure of active RuvAB complexes remains elusive as it is still unknown whether one or two tetramers of RuvA support RuvB during branch migration and during RFR. We designed an E. coli RuvA mutant, RuvA2(KaP), specifically impaired for RuvA tetramer-tetramer interactions. As expected, the mutant protein is impaired for complex II (two tetramers) formation on HJs, although the binding efficiency of complex I (a single tetramer) is as wild type. We show that although RuvA complex II formation is required for efficient HJ branch migration in vitro, RuvA2(KaP) is fully active for homologous recombination in vivo. RuvA2(KaP) is also deficient at forming complex II on synthetic replication forks, and the binding affinity of RuvA2(KaP) for forks is decreased compared with wildtype. Accordingly, RuvA2(KaP) is inefficient at processing forks in vitro and in vivo. These data indicate that RuvA2(KaP) is a separation-of-function mutant, capable of homologous recombination but impaired for RFR. RuvA2(KaP) is defective for stimulation of RuvB activity and stability of HJ.RuvA.RuvB tripartite complexes. This work demonstrates that the need for RuvA tetramer-tetramer interactions for full RuvAB activity in vitro causes specifically an RFR defect in vivo.	[Baharoglu, Zeynep; Michel, Benedicte] CNRS, Ctr Genet Mol, UPR3404, F-91198 Gif Sur Yvette, France; [Baharoglu, Zeynep; Michel, Benedicte] Univ Paris 11, F-91405 Orsay, France; [Bradley, Alison S.; Niewiarowski, Andrew; Tsaneva, Irina R.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London	Michel, B (corresponding author), CNRS, Ctr Genet Mol, UPR3404, F-91198 Gif Sur Yvette, France.	benedicte.michel@cgm.cnrs-gif.fr; i.tsaneva@biochem.ucl.ac.uk	Zeynep, Baharoglu/O-3135-2013	Zeynep, Baharoglu/0000-0003-3477-2685	Biotechnology and Biological Sciences Research Council; Department of Structural Molecular Biology, University College London [ANR-05-BLAN-0204-01, ANR-BLAN08-3_309268]; Bettencourt-Shueller Foundation; Action Concertee Incitative "Biologie Cellulaire Molecularie et Structurale" [04 5 481]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Structural Molecular Biology, University College London; Bettencourt-Shueller Foundation; Action Concertee Incitative "Biologie Cellulaire Molecularie et Structurale"	This work was supported in part by the Biotechnology and Biological Sciences Research Council, the Department of Structural Molecular Biology, University College London, by Grants ANR-05-BLAN-0204-01 and ANR-BLAN08-3_309268, and by a "Prix Coup d'Elan" from the Bettencourt-Shueller Foundation (to the B. M. laboratory).; Supported by the Action Concertee Incitative "Biologie Cellulaire Molecularie et Structurale" Grant 04 5 481. Present address: Institut Pasteur, Unite Plasticite du Genome Bacterien, Departement Genomes et Genetique, Paris, France.	Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Chamberlain D, 1998, J MOL BIOL, V284, P385, DOI 10.1006/jmbi.1998.2177; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Davies AA, 1998, CURR BIOL, V8, P725, DOI 10.1016/S0960-9822(98)70282-9; Dickman MJ, 2002, EUR J BIOCHEM, V269, P5492, DOI 10.1046/j.1432-1033.2002.03250.x; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; DUNDERDALE HJ, 1994, J BIOL CHEM, V269, P5187; Fujiwara Y, 2008, BIOCHEM BIOPH RES CO, V366, P426, DOI 10.1016/j.bbrc.2007.11.149; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; IWASAKI H, 1989, J BACTERIOL, V171, P5276, DOI 10.1128/jb.171.10.5276-5280.1989; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; Le Masson M, 2008, MOL MICROBIOL, V70, P537, DOI 10.1111/j.1365-2958.2008.06431.x; Mahdi AA, 1996, J MOL BIOL, V257, P561, DOI 10.1006/jmbi.1996.0185; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; Mayanagi K, 2008, BIOCHEM BIOPH RES CO, V365, P273, DOI 10.1016/j.bbrc.2007.10.165; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Oram M, 1998, NUCLEIC ACIDS RES, V26, P594, DOI 10.1093/nar/26.2.594; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Privezentzev CV, 2005, J BIOL CHEM, V280, P3365, DOI 10.1074/jbc.M409256200; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SHARPLES GJ, 1994, EMBO J, V13, P6133, DOI 10.1002/j.1460-2075.1994.tb06960.x; TSANEVA IR, 1992, MOL GEN GENET, V235, P1, DOI 10.1007/BF00286175; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; van Gool AJ, 1999, GENE DEV, V13, P1861, DOI 10.1101/gad.13.14.1861; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; Whitby MC, 1998, J BIOL CHEM, V273, P35063, DOI 10.1074/jbc.273.52.35063; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X; Yu X, 1997, J MOL BIOL, V266, P217, DOI 10.1006/jmbi.1996.0799	35	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22372	22383		10.1074/jbc.M111.233908	http://dx.doi.org/10.1074/jbc.M111.233908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531731	hybrid, Green Published			2022-12-25	WOS:000291719900047
J	Matsuura, T; Hosoda, K; Ichihashi, N; Kazuta, Y; Yomo, T				Matsuura, Tomoaki; Hosoda, Kazufumi; Ichihashi, Norikazu; Kazuta, Yasuaki; Yomo, Tetsuya			Kinetic Analysis of beta-Galactosidase and beta-Glucuronidase Tetramerization Coupled with Protein Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EXPRESSION SYSTEMS; FUSION PROTEINS; IN-VIVO; RIBOSOME; CELL; COMPONENTS; PROMOTERS; EVOLUTION; PLATFORM	Both beta-galactosidase (GAL) and beta-glucuronidase (GUS) are tetrameric enzymes used widely as reporter proteins. However, little is known about the folding and assembly of these enzymes. Although the refolding kinetics of GAL from a denatured enzyme have been reported, it is not known how the kinetics differ when coupled with a protein translation reaction. Elucidating the assembly kinetics of GAL and GUS when coupled with protein translation will illustrate the differences between these two reporter proteins and also the assembly process under conditions more relevant to those in vivo. In this study, we used an in vitro translation/transcription system to synthesize GAL and GUS, measured the time development of the activity and oligomerization state of these enzymes, and determined the rate constants of the monomer to tetramer assembly process. We found that at similar concentrations, GAL assembles into tetramers faster than GUS. The rate constant of monomer to dimer assembly of GAL was 50-fold faster when coupled with protein translation than that of refolding from the denatured state. Furthermore, GAL synthesis was found to lack the rate-limiting step in the assembly process, whereas GUS has two rate-limiting steps: monomer to dimer assembly and dimer to tetramer assembly. The consequence of these differences when used as reporter proteins is discussed.	[Matsuura, Tomoaki; Hosoda, Kazufumi; Ichihashi, Norikazu; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Matsuura, Tomoaki] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Matsuura, Tomoaki; Ichihashi, Norikazu; Kazuta, Yasuaki; Yomo, Tetsuya] Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yomo, T (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp	Matsuura, Tomoaki/W-6086-2019; Ichihashi, Norikazu/AAY-6897-2020; matsuura, tomoaki/O-7368-2018	Matsuura, Tomoaki/0000-0003-1015-6781; matsuura, tomoaki/0000-0003-1015-6781	Global Centers of Excellence Program; Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Global Centers of Excellence Program and the Special Coordination Funds for Promoting Science and Technology: Yuragi Project from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	BLANCO C, 1987, BIOCHIMIE, V69, P157, DOI 10.1016/0300-9084(87)90248-3; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; COWIE DB, 1961, P NATL ACAD SCI USA, V47, P114, DOI 10.1073/pnas.47.1.114; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Fedorov AN, 1999, J MOL BIOL, V294, P579, DOI 10.1006/jmbi.1999.3281; Gronemeyer T, 2005, CURR OPIN BIOTECH, V16, P453, DOI 10.1016/j.copbio.2005.06.001; HAMLIN J, 1972, P NATL ACAD SCI USA, V69, P412, DOI 10.1073/pnas.69.2.412; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hosoda K, 2008, LANGMUIR, V24, P13540, DOI 10.1021/la802432f; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Jain VK, 1996, METHOD ENZYMOL, V273, P319; JEFFERSON RA, 1986, P NATL ACAD SCI USA, V83, P8447, DOI 10.1073/pnas.83.22.8447; Kazuta Y, 2008, MOL CELL PROTEOMICS, V7, P1530, DOI 10.1074/mcp.M800051-MCP200; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kiernan JA, 2007, BIOTECH HISTOCHEM, V82, P73, DOI 10.1080/10520290701375278; KIHO Y, 1964, P NATL ACAD SCI USA, V51, P111, DOI 10.1073/pnas.51.1.111; Kolb VA, 2000, J BIOL CHEM, V275, P16597, DOI 10.1074/jbc.M002030200; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kuthan H, 2001, PROG BIOPHYS MOL BIO, V75, P1, DOI 10.1016/S0079-6107(00)00023-7; LIS JT, 1983, CELL, V35, P403, DOI 10.1016/0092-8674(83)90173-3; Matsumura I, 1999, NAT BIOTECHNOL, V17, P696, DOI 10.1038/10910; Matsuura T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.50; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Naleway JJ, 1992, GUS PROTOCOLS USING, P61; Nichtl A, 1998, J MOL BIOL, V282, P1083, DOI 10.1006/jmbi.1998.2075; Olsen SN, 2007, COMP BIOCHEM PHYS A, V148, P339, DOI 10.1016/j.cbpa.2007.05.009; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h; Yokoyama S, 2003, CURR OPIN CHEM BIOL, V7, P39, DOI 10.1016/S1367-5931(02)00019-4; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	33	26	27	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22028	22034		10.1074/jbc.M111.240168	http://dx.doi.org/10.1074/jbc.M111.240168			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531724	Green Published, hybrid			2022-12-25	WOS:000291719900009
J	Geng, HQ; Xu, GF; Ran, YL; Lopez, JA; Peng, YD				Geng, Hongquan; Xu, Guofeng; Ran, Yali; Lopez, Jose A.; Peng, Yuandong			Platelet Glycoprotein Ib beta/IX Mediates Glycoprotein Ib alpha Localization to Membrane Lipid Domain Critical for von Willebrand Factor Interaction at High Shear	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IX-V COMPLEX; PROTEIN-DISULFIDE-ISOMERASE; BERNARD-SOULIER-SYNDROME; GPIB-ALPHA; INTEGRIN ALPHA(IIB)BETA(3); TRANSMEMBRANE DOMAIN; MONOCLONAL-ANTIBODY; PHYSICAL PROXIMITY; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE	The localization of the platelet glycoprotein GP Ib-IX complex (GP Ib alpha, GP Ib beta, and GP IX) to membrane lipid domain, also known as glycosphingolipid-enriched membranes (GEMs or raft) lipid domain, is essential for the GP Ib-IX complex mediated platelet adhesion to von Willebrand factor (vWf) and subsequent platelet activation. To date, the mechanism for the complex association with the GEMs remains unclear. Although the palmitate modifications of GP Ib beta and GP IX were thought to be critical for the complex presence in the GEMs, we found that the removal of the putative palmitoylation sites of GP Ib beta and GP IX had no effects on the localization of the GP Ib-IX complex to the GEMs. Instead, the disruption of GP Ib alpha disulfide linkage with GP Ib beta markedly decreased the amount of the GEM-associated GP Ib alpha without altering the GEM association of GP Ib beta and GP IX. Furthermore, partial dissociation with the GEMs greatly inhibited GP Ib alpha interaction with vWf at high shear instead of in static condition or under low shear stress. Thus, for the first time, we demonstrated that GP Ib beta/GP IX mediates the disulfide-linked GP Ib alpha localization to the GEMs, which is critical for vWf interaction at high shear.	[Geng, Hongquan; Xu, Guofeng] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Shanghai 200092, Peoples R China; [Lopez, Jose A.] Univ Washington, Puget Sound Blood Ctr, Div Hematol, Dept Med, Seattle, WA 98104 USA; [Peng, Yuandong] Baylor Coll Med, Thrombosis Div, Cardiovasc Sci Res Sect, Dept Med, Houston, TX 77030 USA	Shanghai Jiao Tong University; Puget Sound Blood Center; University of Washington; University of Washington Seattle; Baylor College of Medicine	Peng, YD (corresponding author), 1 Baylor Plaza,Alkek N1317-06, Houston, TX 77030 USA.	yuandong@bcm.tmc.edu			National Institutes of Health [HL095676]; American Heart Association [0635155N]; Alkek Endowment Fund; Fondren Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Alkek Endowment Fund; Fondren Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL095676 (to Y.P.). This work was also supported by the American Heart Association Scientist Development Grant 0635155N (to Y.P.), the Alkek Endowment Fund (to Y.P.), and the Fondren Foundation.	Andrews RK, 2003, INT J BIOCHEM CELL B, V35, P1170, DOI 10.1016/S1357-2725(02)00280-7; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Bodnar RJ, 2002, J BIOL CHEM, V277, P47080, DOI 10.1074/jbc.M208329200; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Burgess JK, 2000, J BIOL CHEM, V275, P9758, DOI 10.1074/jbc.275.13.9758; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Cranmer SL, 1999, J BIOL CHEM, V274, P6097, DOI 10.1074/jbc.274.10.6097; DU XP, 1987, BLOOD, V69, P1524; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Essex DW, 2004, ANTIOXID REDOX SIGN, V6, P736, DOI 10.1089/1523086041361622; Essex DW, 2001, BIOCHEMISTRY-US, V40, P6070, DOI 10.1021/bi002454e; Fredrickson BJ, 1998, BLOOD, V92, P3684, DOI 10.1182/blood.V92.10.3684.422k39_3684_3693; Gosse JA, 2005, J IMMUNOL, V175, P2123, DOI 10.4049/jimmunol.175.4.2123; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jin W, 2007, J THROMB HAEMOST, V5, P1034, DOI 10.1111/j.1538-7836.2007.02476.x; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Kanaji T, 2002, BLOOD, V100, P2102, DOI 10.1182/blood-2002-03-0997; Kasirer-Friede A, 2002, J BIOL CHEM, V277, P11949, DOI 10.1074/jbc.M108727200; KATAGIRI Y, 1990, THROMB HAEMOSTASIS, V63, P122; Koziak K, 2000, J BIOL CHEM, V275, P2057, DOI 10.1074/jbc.275.3.2057; Lin PJC, 2007, CELL SIGNAL, V19, P978, DOI 10.1016/j.cellsig.2006.11.006; Lopez JA, 2005, J THROMB HAEMOST, V3, P1737, DOI 10.1111/j.1538-7836.2005.01463.x; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; LOPEZ JA, 1994, J BIOL CHEM, V269, P23716; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Marchese P, 1999, P NATL ACAD SCI USA, V96, P7837, DOI 10.1073/pnas.96.14.7837; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Michal P, 2009, EUR J PHARMACOL, V606, P50, DOI 10.1016/j.ejphar.2009.01.028; Mo X, 2008, J THROMB HAEMOST, V6, P1789, DOI 10.1111/j.1538-7836.2008.03088.x; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUSZBEK L, 1989, J BIOL CHEM, V264, P9716; NEZIL FA, 1992, BIOPHYS J, V61, P1176, DOI 10.1016/S0006-3495(92)81926-4; Peng YD, 2004, BLOOD, V104, P3971, DOI 10.1182/blood-2004-07-2544; Perrault C, 2001, THROMB HAEMOSTASIS, V86, P1238, DOI 10.1055/s-0037-1616057; PERSCHL A, 1995, J CELL SCI, V108, P1033; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Shrimpton CN, 2002, J EXP MED, V196, P1057, DOI 10.1084/jem.20020143; Sullam PM, 1998, J BIOL CHEM, V273, P5331, DOI 10.1074/jbc.273.9.5331; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; Wu GX, 1996, BLOOD, V87, P2782, DOI 10.1182/blood.V87.7.2782.bloodjournal8772782	50	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21315	21323		10.1074/jbc.M110.202549	http://dx.doi.org/10.1074/jbc.M110.202549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507943	Green Published, hybrid			2022-12-25	WOS:000291464700030
J	Kraepiel, Y; Pedron, J; Patrit, O; Simond-Cote, E; Hermand, V; Van Gijsegem, F				Kraepiel, Yvan; Pedron, Jacques; Patrit, Oriane; Simond-Cote, Elizabeth; Hermand, Victor; Van Gijsegem, Frederique			Analysis of the Plant bos1 Mutant Highlights Necrosis as an Efficient Defence Mechanism during D. dadantii/Arabidospis thaliana Interaction	PLOS ONE			English	Article							WALL-DEGRADING ENZYMES; ERWINIA-CHRYSANTHEMI STRAIN-3937; CAROTOVORA SUBSP CAROTOVORA; SOFT-ROT PATHOGENESIS; ARABIDOPSIS-THALIANA; CELL-DEATH; HYPERSENSITIVE RESPONSE; BOTRYTIS-CINEREA; TRANSCRIPTION FACTOR; VIRULENCE FACTORS	Dickeya dadantii is a broad host range phytopathogenic bacterium provoking soft rot disease on many plants including Arabidopsis. We showed that, after D. dadantii infection, the expression of the Arabidopsis BOS1 gene was specifically induced by the production of the bacterial PelB/C pectinases able to degrade pectin. This prompted us to analyze the interaction between the bos1 mutant and D. dadantii. The phenotype of the infected bos1 mutant is complex. Indeed, maceration symptoms occurred more rapidly in the bos1 mutant than in the wild type parent but at a later stage of infection, a necrosis developed around the inoculation site that provoked a halt in the progression of the maceration. This necrosis became systemic and spread throughout the whole plant, a phenotype reminiscent of that observed in some lesion mimic mutants. In accordance with the progression of maceration symptoms, bacterial population began to grow more rapidly in the bos1 mutant than in the wild type plant but, when necrosis appeared in the bos1 mutant, a reduction in bacterial population was observed. From the plant side, this complex interaction between D. dadantii and its host includes an early plant defence response that comprises reactive oxygen species (ROS) production accompanied by the reinforcement of the plant cell wall by protein cross-linking. At later timepoints, another plant defence is raised by the death of the plant cells surrounding the inoculation site. This plant cell death appears to constitute an efficient defence mechanism induced by D. dadantii during Arabidopsis infection.	[Kraepiel, Yvan; Pedron, Jacques; Patrit, Oriane; Simond-Cote, Elizabeth; Hermand, Victor; Van Gijsegem, Frederique] INRA, UMR217, Paris, France; [Kraepiel, Yvan; Pedron, Jacques; Patrit, Oriane; Simond-Cote, Elizabeth; Hermand, Victor; Van Gijsegem, Frederique] Univ Paris 06, UMR217, Paris, France; [Kraepiel, Yvan; Pedron, Jacques; Patrit, Oriane; Simond-Cote, Elizabeth; Hermand, Victor; Van Gijsegem, Frederique] AgroParisTech, UMR217, Paris, France	INRAE; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech	Kraepiel, Y (corresponding author), INRA, UMR217, Paris, France.	vangijse@agroparistech.fr	Kraepiel, Yvan/D-5056-2017; Hermand, Victor/AAD-4414-2022; Van Gijsegem, Frederique/D-1103-2017	Kraepiel, Yvan/0000-0003-4043-5896; 	INRA (Institut National de la REcherche Agronomique); UPMC (Universite Pierre et Marie Curie)	INRA (Institut National de la REcherche Agronomique); UPMC (Universite Pierre et Marie Curie)	INRA (Institut National de la REcherche Agronomique) and UPMC (Universite Pierre et Marie Curie) supported the cost of the complete project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRO T, 1984, J BACTERIOL, V160, P1199, DOI 10.1128/JB.160.3.1199-1203.1984; Asselbergh B, 2008, MOL PLANT PATHOL, V9, P11, DOI [10.1111/J.1364-3703.2007.00437.X, 10.1111/j.1364-3703.2007.00437.x]; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; BAUER DW, 1994, MOL PLANT MICROBE IN, V7, P573, DOI 10.1094/MPMI-7-0573; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; BEAULIEU C, 1993, MOL PLANT MICROBE IN, V6, P197, DOI 10.1094/MPMI-6-197; BOCCARA M, 1988, PHYSIOL MOL PLANT P, V33, P95, DOI 10.1016/0885-5765(88)90046-X; COLLMER A, 1986, ANNU REV PHYTOPATHOL, V24, P383, DOI 10.1146/annurev.py.24.090186.002123; CONDEMINE G, 1995, MOL PLANT MICROBE IN, V8, P632, DOI 10.1094/MPMI-8-0632; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Degrave A, 2008, MOL PLANT MICROBE IN, V21, P1076, DOI 10.1094/MPMI-21-8-1076; Dellagi A, 2005, PLANT J, V43, P262, DOI 10.1111/j.1365-313X.2005.02451.x; Dellagi A, 2009, PLANT PHYSIOL, V150, P1687, DOI 10.1104/pp.109.138636; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; DIOLEZ A, 1986, SYMBIOSIS, V2, P323; El Hassouni M, 1999, P NATL ACAD SCI USA, V96, P887, DOI 10.1073/pnas.96.3.887; Expert D, 1999, ANNU REV PHYTOPATHOL, V37, P307, DOI 10.1146/annurev.phyto.37.1.307; Fagard M, 2007, MOL PLANT MICROBE IN, V20, P794, DOI 10.1094/MPMI-20-7-0794; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hommais F, 2008, J BACTERIOL, V190, P7508, DOI 10.1128/JB.00553-08; Hugouvieux-Cotte-Pattat N., 1996, ANNU REV MICROBIOL, V50, P213; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kariola T, 2003, MOL PLANT MICROBE IN, V16, P179, DOI 10.1094/MPMI.2003.16.3.179; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lebeau A, 2008, ENVIRON MICROBIOL, V10, P545, DOI 10.1111/j.1462-2920.2007.01473.x; LETOFFE S, 1990, EMBO J, V9, P1375, DOI 10.1002/j.1460-2075.1990.tb08252.x; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYON GD, 1989, PLANT PATHOL, V38, P20; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; MAUCHMANI B, 1994, MOL PLANT MICROBE IN, V7, P378, DOI 10.1094/MPMI-7-0378; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Miguel E, 2000, MOL PLANT MICROBE IN, V13, P421, DOI 10.1094/MPMI.2000.13.4.421; Norman C, 1999, MOL PLANT MICROBE IN, V12, P640, DOI 10.1094/MPMI.1999.12.7.640; Norman-Setterblad C, 2000, MOL PLANT MICROBE IN, V13, P430, DOI 10.1094/MPMI.2000.13.4.430; PALVA TK, 1994, MOL PLANT MICROBE IN, V7, P356, DOI 10.1094/MPMI-7-0356; PEROMBELON M C M, 1975, Potato Research, V18, P64, DOI 10.1007/BF02361776; PEROMBELON MCM, 1980, ANNU REV PHYTOPATHOL, V18, P361, DOI 10.1146/annurev.py.18.090180.002045; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; REIGNAULT P, 1994, MICROBIOL-SGM, V140, P3249, DOI 10.1099/13500872-140-12-3249; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Roy C, 1999, J BACTERIOL, V181, P3705, DOI 10.1128/JB.181.12.3705-3709.1999; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; Segond D, 2009, PLANT J, V58, P195, DOI 10.1111/j.1365-313X.2008.03775.x; Sepulchre JA, 2007, J THEOR BIOL, V244, P239, DOI 10.1016/j.jtbi.2006.08.010; Soulie MC, 2003, FUNGAL GENET BIOL, V40, P38, DOI 10.1016/S1087-1845(03)00065-3; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; VANGIJSEGEM F, 1995, EUR J PLANT PATHOL, V101, P549, DOI 10.1007/BF01874480; Veronese P, 2004, PLANT J, V40, P558, DOI 10.1111/j.1365-313X.2004.02232.x; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; Yang CH, 2002, MOL PLANT MICROBE IN, V15, P472, DOI 10.1094/MPMI.2002.15.5.472; Zhang C, 2004, MOL PLANT MICROBE IN, V17, P357, DOI 10.1094/MPMI.2004.17.4.357	58	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18991	10.1371/journal.pone.0018991	http://dx.doi.org/10.1371/journal.pone.0018991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533045	Green Published, Green Submitted, gold			2022-12-25	WOS:000290014500018
J	Groenheit, R; Ghebremichael, S; Svensson, J; Rabna, P; Colombatti, R; Riccardi, F; Couvin, D; Hill, V; Rastogi, N; Koivula, T; Kallenius, G				Groenheit, Ramona; Ghebremichael, Solomon; Svensson, Jenny; Rabna, Paulo; Colombatti, Raffaella; Riccardi, Fabio; Couvin, David; Hill, Veronique; Rastogi, Nalin; Koivula, Tuija; Kallenius, Gunilla			The Guinea-Bissau Family of Mycobacterium tuberculosis Complex Revisited	PLOS ONE			English	Article							NITRATE REDUCTASE NARGHJI; PULMONARY TUBERCULOSIS; POLYMORPHIC NUCLEOTIDE; BURKINA-FASO; AFRICANUM; STRAINS; EPIDEMIOLOGY; PREDOMINANCE; RESISTANCE; PHYLOGENY	The Guinea-Bissau family of strains is a unique group of the Mycobacterium tuberculosis complex that, although genotypically closely related, phenotypically demonstrates considerable heterogeneity. We have investigated 414 M. tuberculosis complex strains collected in Guinea-Bissau between 1989 and 2008 in order to further characterize the Guinea-Bissau family of strains. To determine the strain lineages present in the study sample, binary outcomes of spoligotyping were compared with spoligotypes existing in the international database SITVIT2. The major circulating M. tuberculosis clades ranked in the following order: AFRI (n = 195, 47.10%), Latin-American-Mediterranean (LAM) (n = 75, 18.12%), ill-defined T clade (n = 53, 12.8%), Haarlem (n = 37, 8.85%), East-African-Indian (EAI) (n = 25, 6.04%), Unknown (n = 12, 2.87%), Beijing (n = 7, 1.68%), X clade (n = 4, 0.96%), Manu (n = 4, 0.97%), CAS (n = 2, 0.48%). Two strains of the LAM clade isolated in 2007 belonged to the Cameroon family (SIT61). All AFRI isolates except one belonged to the Guinea-Bissau family, i.e. they have an AFRI_1 spoligotype pattern, they have a distinct RFLP pattern with low numbers of IS6110 insertions, and they lack the regions of difference RD7, RD8, RD9 and RD10, RD701 and RD702. This profile classifies the Guinea-Bissau family, irrespective of phenotypic biovar, as part of the M. africanum West African 2 lineage, or the AFRI_1 sublineage according to the spoligtyping nomenclature. Guinea-Bissau family strains display a variation of biochemical traits classically used to differentiate M. tuberculosis from M. bovis. Yet, the differential expression of these biochemical traits was not related to any genes so far investigated (narGHJI and pncA). Guinea-Bissau has the highest prevalence of M. africanum recorded in the African continent, and the Guinea-Bissau family shows a high phylogeographical specificity for Western Africa, with Guinea-Bissau being the epicenter. Trends over time however indicate that this family of strains is waning in most parts of Western Africa, including Guinea-Bissau (p = 0.048).	[Groenheit, Ramona; Ghebremichael, Solomon; Svensson, Jenny; Koivula, Tuija] Swedish Inst Infect Dis Control, Dept Preparedness, Solna, Sweden; [Groenheit, Ramona] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Rabna, Paulo] Lab Nacl Saude Publ, Bissau, Guinea Bissau; [Rabna, Paulo] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Colombatti, Raffaella] Hosp Raoul Follereau, Bissau, Guinea Bissau; [Colombatti, Raffaella] Azienda Osped Univ Padova, Dept Pediat, Padua, Italy; [Riccardi, Fabio] Univ Roma Tor Vergata, Dept Publ Hlth, Rome, Italy; [Koivula, Tuija; Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Rome Tor Vergata; Karolinska Institutet	Groenheit, R (corresponding author), Swedish Inst Infect Dis Control, Dept Preparedness, Solna, Sweden.	gunilla.kallenius@ki.se	Colombatti, Raffaella/D-2910-2017; RASTOGI, NALIN/AAP-1958-2020; Källenius, Gunilla/AGZ-3956-2022	Colombatti, Raffaella/0000-0001-9797-0457; RASTOGI, NALIN/0000-0002-7199-7747; Groenheit, Ramona/0000-0003-2696-437X; Couvin, David/0000-0002-7897-9023; RICCARDI, Fabio/0000-0003-4523-3556; Kallenius, Gunilla/0000-0002-8921-0551	Swedish International Development Cooperation Agency; Swedish Heart-Lung Foundation; Swedish Research Council; Regional Council of Guadeloupe [CR/08-1612]; United States National Institutes of Health [R01LM009731]; NATIONAL LIBRARY OF MEDICINE [R01LM009731] Funding Source: NIH RePORTER	Swedish International Development Cooperation Agency; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Regional Council of Guadeloupe; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by grants from the Swedish International Development Cooperation Agency, the Swedish Heart-Lung Foundation, and the Swedish Research Council. The SITVIT2 database project benefited from research grants from the Regional Council of Guadeloupe (grant CR/08-1612), and by United States National Institutes of Health (grant R01LM009731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; Al-Hajoj SAM, 2007, J CLIN MICROBIOL, V45, P2467, DOI 10.1128/JCM.02293-06; Asiimwe BB, 2008, INT J TUBERC LUNG D, V12, P386; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; de Jong BC, 2007, INT J TUBERC LUNG D, V11, P450; de Jong BC, 2006, J INFECT DIS, V193, P1279, DOI 10.1086/502977; de Jong BC, 2005, AIDS, V19, P1714, DOI 10.1097/01.aids.0000185991.54595.41; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; DIAS F, 1993, TUBERCLE LUNG DIS, V74, P129, DOI 10.1016/0962-8479(93)90040-5; Ferdinand Severine, 2005, Infection Genetics and Evolution, V5, P340, DOI 10.1016/j.meegid.2004.10.002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06; Goh KS, 2005, J CLIN MICROBIOL, V43, P4010, DOI 10.1128/JCM.43.8.4010-4014.2005; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Haas WH, 1997, J CLIN MICROBIOL, V35, P663, DOI 10.1128/JCM.35.3.663-666.1997; Helal ZH, 2009, J CLIN MICROBIOL, V47, P2794, DOI 10.1128/JCM.00360-09; HOFFNER SE, 1993, J CLIN MICROBIOL, V31, P2215, DOI 10.1128/JCM.31.8.2215-2217.1993; Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103; Huard RC, 2006, J BACTERIOL, V188, P4271, DOI 10.1128/JB.01783-05; HUET M, 1971, Revue de Tuberculose et de Pneumologie, V35, P413; Kallenius G, 1999, J CLIN MICROBIOL, V37, P3872; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Koivula T, 2004, MICROBES INFECT, V6, P272, DOI 10.1016/j.micinf.2003.12.006; Ledru S, 1996, TUBERCLE LUNG DIS, V77, P429, DOI 10.1016/S0962-8479(96)90116-1; Meyer CG, 2008, TUBERCULOSIS, V88, P482, DOI 10.1016/j.tube.2008.05.004; MOLINATORRES CA, J CLIN MICROBIOL, V48, P448; Mostowy S, 2004, J CLIN MICROBIOL, V42, P3594, DOI 10.1128/jcm.42.8.3594-3599.2004; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Namouchi A, 2008, J MED MICROBIOL, V57, P864, DOI 10.1099/jmm.0.47483-0; Naucler A, 1996, TUBERCLE LUNG DIS, V77, P226, DOI 10.1016/S0962-8479(96)90005-2; Niemann S, 2004, J CLIN MICROBIOL, V42, P3958, DOI 10.1128/JCM.42.9.3958-3962.2004; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Rey J L, 1979, Med Trop (Mars), V39, P149; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stermann M, 2003, J CLIN MICROBIOL, V41, P3252, DOI 10.1128/JCM.41.7.3252-3259.2003; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; VIEGAS SO, BMC MICROBIOL, V10, P195	44	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18601	10.1371/journal.pone.0018601	http://dx.doi.org/10.1371/journal.pone.0018601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533101	Green Published, Green Submitted, gold			2022-12-25	WOS:000289719400015
J	Kothapalli, NR; Norton, DD; Fugmann, SD				Kothapalli, Naga Rama; Norton, Darrell D.; Fugmann, Sebastian D.			Classical Mus musculus Ig kappa Enhancers Support Transcription but not High Level Somatic Hypermutation from a V-Lambda Promoter in Chicken DT40 Cells	PLOS ONE			English	Article							IMMUNOGLOBULIN GENE CONVERSION; CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; LOCUS; DNA; DOWNSTREAM; TARGETS; DIVERSIFICATION; ELEMENTS; REGION	Somatic hypermutation (SHM) of immunoglobulin genes is initiated by activation-induced cytidine deaminase (AID) in activated B cells. This process is strictly dependent on transcription. Hence, cis-acting transcriptional control elements have been proposed to target SHM to immunoglobulin loci. The Mus musculus Ig kappa locus is regulated by the intronic enhancer (iE/MAR) and the 3' enhancer (3'E), and multiple studies using transgenic and knock-out approaches in mice and cell lines have reported somewhat contradictory results about the function of these enhancers in AID-mediated sequence diversification. Here we show that the M. musculus iE/MAR and 3'E elements are active solely as transcriptional enhancer when placed in the context of the IGL locus in Gallus gallus DT40 cells, but they are very inefficient in targeting AID-mediated mutation events to this locus. This suggests that either key components of the cis-regulatory targeting elements reside outside the murine Igk transcriptional enhancer sequences, or that the targeting of AID activity to Ig loci occurs by largely species-specific mechanisms.	[Kothapalli, Naga Rama; Norton, Darrell D.; Fugmann, Sebastian D.] NIA, Lab Mol Biol & Immunol, Mol Immunol Unit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kothapalli, NR (corresponding author), NIA, Lab Mol Biol & Immunol, Mol Immunol Unit, NIH, Baltimore, MD 21224 USA.	fugmanns@grc.nia.nih.gov	Kothapalli, Naga Rama/E-5229-2017	Kothapalli, Naga Rama/0000-0001-7993-8525	National Institute on Aging/National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000387] Funding Source: NIH RePORTER	National Institute on Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was entirely funded by the intramural program of the National Institute on Aging/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2004, PLOS BIOL, V2, P967, DOI 10.1371/journal.pbio.0020179; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Blagodatski A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000332; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Diaz M, 2001, PHILOS T R SOC B, V356, P67, DOI 10.1098/rstb.2000.0750; Gopal AAR, 2008, MOL IMMUNOL, V45, P2062, DOI 10.1016/j.molimm.2007.10.017; Inlay M, 2002, NAT IMMUNOL, V3, P463, DOI 10.1038/ni790; Inlay MA, 2006, J IMMUNOL, V177, P1146, DOI 10.4049/jimmunol.177.2.1146; Kim Y, 2009, MOL IMMUNOL, V46, P3283, DOI 10.1016/j.molimm.2009.07.027; Kothapalli N, 2008, J IMMUNOL, V180, P2019, DOI 10.4049/jimmunol.180.4.2019; Larson ED, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-211; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu ZM, 2002, J BIOL CHEM, V277, P32640, DOI 10.1074/jbc.M204065200; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Saribasak H, 2009, PHILOS T R SOC B, V364, P605, DOI 10.1098/rstb.2008.0188; Tanaka A, 2010, J EXP MED, V207, P405, DOI 10.1084/jem.20090821; Xiang YG, 2008, J IMMUNOL, V180, P6725, DOI 10.4049/jimmunol.180.10.6725; Yang Shu Yuan, 2007, Adv Immunol, V94, P109, DOI 10.1016/S0065-2776(06)94004-8	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18955	10.1371/journal.pone.0018955	http://dx.doi.org/10.1371/journal.pone.0018955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533098	Green Submitted, gold, Green Published			2022-12-25	WOS:000289719400038
J	Swenson, JJ; Carter, CE; Domec, JC; Delgado, CI				Swenson, Jennifer J.; Carter, Catherine E.; Domec, Jean-Christophe; Delgado, Cesar I.			Gold Mining in the Peruvian Amazon: Global Prices, Deforestation, and Mercury Imports	PLOS ONE			English	Article							BRAZILIAN AMAZON; CONSERVATION	Many factors such as poverty, ineffective institutions and environmental regulations may prevent developing countries from managing how natural resources are extracted to meet a strong market demand. Extraction for some resources has reached such proportions that evidence is measurable from space. We present recent evidence of the global demand for a single commodity and the ecosystem destruction resulting from commodity extraction, recorded by satellites for one of the most biodiverse areas of the world. We find that since 2003, recent mining deforestation in Madre de Dios, Peru is increasing nonlinearly alongside a constant annual rate of increase in international gold price (similar to 18%/yr). We detect that the new pattern of mining deforestation (1915 ha/year, 2006-2009) is outpacing that of nearby settlement deforestation. We show that gold price is linked with exponential increases in Peruvian national mercury imports over time (R-2 = 0.93, p = 0.04, 2003-2009). Given the past rates of increase we predict that mercury imports may more than double for 2011 (similar to 500 t/year). Virtually all of Peru's mercury imports are used in artisanal gold mining. Much of the mining increase is unregulated/artisanal in nature, lacking environmental impact analysis or miner education. As a result, large quantities of mercury are being released into the atmosphere, sediments and waterways. Other developing countries endowed with gold deposits are likely experiencing similar environmental destruction in response to recent record high gold prices. The increasing availability of satellite imagery ought to evoke further studies linking economic variables with land use and cover changes on the ground.	[Swenson, Jennifer J.; Carter, Catherine E.; Domec, Jean-Christophe] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Domec, Jean-Christophe] Ecole Natl Ingenieurs Travaux Agr Bordeaux, Unite Mixte Rech Transfert & Cycle Elements Miner, Gradignan, France; [Delgado, Cesar I.] CESEL SA, Environm Affairs Off, Lima, Peru	Duke University	Swenson, JJ (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	jswenson@duke.edu	domec, jean-christophe/P-9251-2019; Domec, Jean-Christophe/AFV-5999-2022	domec, jean-christophe/0000-0003-0478-2559; Domec, Jean-Christophe/0000-0003-0478-2559; Swenson, Jennifer J./0000-0002-2069-667X	Duke University	Duke University	J. Swenson and J.C. Domec are supported by Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBACETE C, 2007, PARKSWATCH DATABASE; Alvarez NL, 2003, AMBIO, V32, P269, DOI 10.1639/0044-7447(2003)032[0269:LNAPTD]2.0.CO;2; ASTER GDEM, 2009, ASTER GLOB DIG EL MO; Behrens A, 2007, ECOL ECON, V64, P444, DOI 10.1016/j.ecolecon.2007.02.034; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks WE, 2007, 20071252 US GEOL SUR; BUTLER R, 2009, HIGH GOLD PRICES ARM; BUTLER R, 2006, ILLEGAL MINING THREA; Cleary David, 1990, ANATOMY AMAZON GOLD; *COM, 2009, SUB PREC OR IMP MIN; *COM, 2009, SEP MERC; Crompton P, 2002, ENVIRON RES, V90, P69, DOI 10.1006/enrs.2002.4358; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; DELGADO CI, 2008, IS INTEROCEANIC HIGH; Dudley N., 1999, CONVERSION PAPER PAR; Fernandes CC, 2004, SCIENCE, V305, P1960, DOI 10.1126/science.1101240; Fraser B, 2009, ENVIRON SCI TECHNOL, V43, P7162, DOI 10.1021/es902347z; Friedli HR, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P193, DOI 10.1007/978-0-387-93958-2_8; Graham D, 2006, WORLD DEV, V34, P868, DOI 10.1016/j.worlddev.2005.04.022; Harvard Law School, 2007, ALL GLITT GOLD MIN G; *IIRSA, 2009, IND TERR PLANN IIRSA; IUCN, 2008, GLOB AMPH ASS; *IUCN, 2008, GLOB MAMM ASS; Keane L, 2009, RISING PRICES SPARK; Killeen TJ, 2007, PERFECT STORM AMAZON; Kirkby CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013015; Kumah A, 2006, J CLEAN PROD, V14, P315, DOI 10.1016/j.jclepro.2004.08.007; LARMER B, 2009, NAT GEO          JAN; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Pachas V., 2009, ESTUDIO DIAGNOSTICO; *PER MIN ENV, 2009, MIN INF MADR DIOS; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Shrum P., 2009, THESIS CLEMSON U CLE; Sousa RN, 2009, AMBIO, V38, P40, DOI 10.1579/0044-7447-38.1.40; Telmer KM, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P131, DOI 10.1007/978-0-387-93958-2_6; TORRES C, 2007, MINERIA ARTISANAL GR; *UN ENV PROGR, 2009, HIST TREAT TACKL TOX; Veiga M.M., 1997, INTRO NEW TECHNOLOGI; Veiga MM, 2006, J CLEAN PROD, V14, P436, DOI 10.1016/j.jclepro.2004.08.010; Vieira R, 2006, J CLEAN PROD, V14, P448, DOI 10.1016/j.jclepro.2004.09.007; Wessendorf K., 2008, INDIGENOUS WORLD 200; WHO, 1989, ENV HLTH CRIT 86 MER; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; Yu DW, 2010, BIOTROPICA, V42, P569, DOI 10.1111/j.1744-7429.2010.00680.x; 2010, PERU POISED BECOME 5	46	196	204	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18875	10.1371/journal.pone.0018875	http://dx.doi.org/10.1371/journal.pone.0018875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526143	Green Published, gold			2022-12-25	WOS:000289671100033
J	Zhao, L; Tang, YL; You, ZR; Wang, QX; Liang, SW; Han, XF; Qiu, DK; Wei, J; Liu, Y; Shen, L; Chen, XY; Peng, YS; Li, ZP; Ma, X				Zhao, Li; Tang, Yanli; You, Zhengrui; Wang, Qixia; Liang, Shuwen; Han, Xiaofeng; Qiu, Dekai; Wei, Jue; Liu, Yuan; Shen, Lei; Chen, Xiaoyu; Peng, Yanshen; Li, Zhiping; Ma, Xiong			Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression	PLOS ONE			English	Article							REGULATORY T-CELLS; SUPPRESSION; GENERATION; INDUCTION; T(H)17; IL-17	T helper cells that produce IL-17 (Th17 cells) have recently been identified as the third distinct subset of effector T cells. Emerging data suggests that Th17 cells play an important role in the pathogenesis of many liver diseases by regulating innate immunity, adaptive immunity, and autoimmunity. In this study, we examine the role and mechanism of Th17 cells in the pathogenesis of autoimmune hepatitis (AIH). The serum levels of IL-17 and IL-23, as well as the frequency of IL-17+ cells in the liver, were significantly elevated in patients with AIH, compared to other chronic hepatitis and healthy controls. The hepatic expressions of IL-17, IL-23, ROR-gamma t, IL-6 and IL-1 beta in patients with AIH were also significantly increased and were associated with increased inflammation and fibrosis. IL-17 induces IL-6 expression via the MAPK signaling pathway in hepatocytes, which, in turn, may further stimulate Th17 cells and forms a positive feedback loop. In conclusion, Th17 cells are key effector T cells that regulate the pathogenesis of AIH, via induction of MAPK dependent hepatic IL-6 expression. Blocking the signaling pathway and interrupting the positive feedback loop are potential therapeutic targets for autoimmune hepatitis.	[Zhao, Li; Tang, Yanli; You, Zhengrui; Wang, Qixia; Han, Xiaofeng; Qiu, Dekai; Wei, Jue; Liu, Yuan; Shen, Lei; Chen, Xiaoyu; Peng, Yanshen; Ma, Xiong] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Dept Gastroenterol,Renji Hosp, Shanghai 200030, Peoples R China; [Liang, Shuwen; Li, Zhiping] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Shanghai Jiao Tong University; Johns Hopkins University	Zhao, L (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Dept Gastroenterol,Renji Hosp, Shanghai 200030, Peoples R China.	zhipingli@jhmi.edu; maxiongmd@hotmail.com		Ma, Xiong/0000-0001-9616-4672	National Natural Science Foundation of China [30770963, 30972751]; Shanghai Pujiang program; Shanghai Municipal Education Commission; NIH/NIDDK [R01DK075990]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075990] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang program(Shanghai Pujiang Program); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Awards from National Natural Science Foundation of China (#30770963, 30972751, XM), Shanghai Pujiang program, Program for Innovative Research Team of Shanghai Municipal Education Commission (XM), and a research grant from NIH/NIDDK R01DK075990 (ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bertolino Patrick, 2008, Hepatology, V47, P345, DOI 10.1002/hep.22154; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; Dai JS, 2004, TOXICOLOGY, V203, P199, DOI 10.1016/j.tox.2004.06.009; Fisher NC, 1999, GUT, V45, P416, DOI 10.1136/gut.45.3.416; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jiang SP, 2003, AM J TRANSPLANT, V3, P516, DOI 10.1034/j.1600-6143.2003.00124.x; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Lafdil F, 2009, GASTROENTEROLOGY, V137, P2125, DOI 10.1053/j.gastro.2009.08.004; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Longhi MS, 2008, HEPATOLOGY, V47, P581, DOI 10.1002/hep.22071; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; SENALDI G, 1992, ARCH DIS CHILD, V67, P1447, DOI 10.1136/adc.67.12.1447; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Vergani D, 2007, SEMIN LIVER DIS, V27, P140, DOI 10.1055/s-2007-979467; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	30	136	153	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18909	10.1371/journal.pone.0018909	http://dx.doi.org/10.1371/journal.pone.0018909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526159	Green Submitted, Green Published, gold			2022-12-25	WOS:000289671100036
J	Guellai, B; Streri, A				Guellai, Bahia; Streri, Arlette			Cues for Early Social Skills: Direct Gaze Modulates Newborns' Recognition of Talking Faces	PLOS ONE			English	Article							EYE-CONTACT; NATIVE-LANGUAGE; YOUNG INFANTS; MOTHERS FACE; 4-MONTH-OLD INFANTS; VISUAL-ATTENTION; MATERNAL SPEECH; RACE FACES; PREFERENCE; PERCEPTION	Previous studies showed that, from birth, speech and eye gaze are two important cues in guiding early face processing and social cognition. These studies tested the role of each cue independently; however, infants normally perceive speech and eye gaze together. Using a familiarization-test procedure, we first familiarized newborn infants (n = 24) with videos of unfamiliar talking faces with either direct gaze or averted gaze. Newborns were then tested with photographs of the previously seen face and of a new one. The newborns looked longer at the face that previously talked to them, but only in the direct gaze condition. These results highlight the importance of both speech and eye gaze as socio-communicative cues by which infants identify others. They suggest that gaze and infant-directed speech, experienced together, are powerful cues for the development of early social skills.	[Guellai, Bahia] Univ Paris 05, Paris, France; Ctr Biomed St Peres, CNRS, Lab Psychol Percept, Unite Mixte Rech 8158, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Guellai, B (corresponding author), Univ Paris 05, Paris, France.	bahia.guellai@gmail.com			Institut Universitaire de France (I.U.F.); French Ministry of Research	Institut Universitaire de France (I.U.F.); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	The work was supported by grants from the Institut Universitaire de France (I.U.F.) and the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Argyle M., 1976, GAZE MUTUAL GAZE; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Baron-Cohen Simon, 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1994, CAH PSYCHOL COGN, V13, P513; Batki A, 2000, INFANT BEHAV DEV, V23, P223, DOI 10.1016/S0163-6383(01)00037-6; BEIER JS, CHILD DEV IN PRESS; Best CT, 2009, PSYCHOL SCI, V20, P539, DOI 10.1111/j.1467-9280.2009.02327.x; Bosch L, 1997, COGNITION, V65, P33, DOI 10.1016/S0010-0277(97)00040-1; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BRUCE V, 1987, APPL COGNITIVE PSYCH, V1, P109, DOI 10.1002/acp.2350010204; Bruce V., 1998, EYE BEHOLDER SCI FAC; Bulf H, 2010, VIS COGN, V18, P504, DOI 10.1080/13506280903272037; Burnham D, 2002, SCIENCE, V296, P1435, DOI 10.1126/science.1069587; BURNHAM D, 1993, PERCEPTION, V22, P1133, DOI 10.1068/p221133; BUSHNELL IWR, 1989, BRIT J DEV PSYCHOL, V7, P3, DOI 10.1111/j.2044-835X.1989.tb00784.x; COULON M, INT J BEHAV IN PRESS; de Heering A, 2008, COGNITION, V106, P444, DOI 10.1016/j.cognition.2006.12.012; DECASPER AJ, 1986, INFANT BEHAV DEV, V9, P133, DOI 10.1016/0163-6383(86)90025-1; DECASPER AJ, 1994, INFANT BEHAV DEV, V17, P159, DOI 10.1016/0163-6383(94)90051-5; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; EKMAN P, 1992, PSYCHOL SCI, V3, P34, DOI 10.1111/j.1467-9280.1992.tb00253.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, COGNITION, V102, P396, DOI 10.1016/j.cognition.2006.01.007; FERNALD A, 1985, INFANT BEHAV DEV, V8, P181, DOI 10.1016/S0163-6383(85)80005-9; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gava L, 2008, DEVELOPMENTAL SCI, V11, P563, DOI 10.1111/j.1467-7687.2008.00702.x; George N, 2008, NEUROPHYSIOL CLIN, V38, P197, DOI 10.1016/j.neucli.2008.03.001; Gliga T, 2007, PROG BRAIN RES, V164, P323, DOI 10.1016/S0079-6123(07)64018-7; Gredeback G, 2010, DEVELOPMENTAL SCI, V13, P839, DOI 10.1111/j.1467-7687.2009.00945.x; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Hood BM, 1998, PSYCHOL SCI, V9, P131, DOI 10.1111/1467-9280.00024; Hood BM, 2003, DEVELOPMENTAL SCI, V6, P67, DOI 10.1111/1467-7687.00256; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Kinzler KD, 2007, PROG BRAIN RES, V164, P257, DOI 10.1016/S0079-6123(07)64014-X; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Panneton-Cooper R. P., 1990, CHILD DEV, V61, P1584, DOI 10.2307/1130766; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; PASCALIS O, 1994, NEUROREPORT, V5, P1721, DOI 10.1097/00001756-199409080-00008; PEGG JE, 1992, INFANT BEHAV DEV, V15, P325, DOI 10.1016/0163-6383(92)80003-D; Quinn PC, 2010, INFANT BEHAV DEV, V33, P357, DOI 10.1016/j.infbeh.2010.03.001; Quinn PC, 2008, J NEUROPSYCHOL, V2, P15, DOI 10.1348/174866407X231029; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; Sai FZ, 2005, INFANT CHILD DEV, V14, P29, DOI 10.1002/icd.376; Sanefuji W, 2006, INFANT BEHAV DEV, V29, P584, DOI 10.1016/j.infbeh.2006.07.007; Soderstrom M, 2007, DEV REV, V27, P501, DOI 10.1016/j.dr.2007.06.002; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Vouloumanos A, 2010, CHILD DEV, V81, P517, DOI 10.1111/j.1467-8624.2009.01412.x; WALTON GE, 1992, INFANT BEHAV DEV, V15, P265, DOI 10.1016/0163-6383(92)80027-R; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686	59	36	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18610	10.1371/journal.pone.0018610	http://dx.doi.org/10.1371/journal.pone.0018610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750WK	21525972	Green Submitted, Green Published, gold			2022-12-25	WOS:000289578600017
J	Wang, Y; Romigh, T; He, X; Tan, MH; Orloff, MS; Silverman, RH; Heston, WD; Eng, C				Wang, Y.; Romigh, T.; He, X.; Tan, M-H; Orloff, M. S.; Silverman, R. H.; Heston, W. D.; Eng, C.			Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers	ONCOGENE			English	Article						androgen receptor; PTEN; prostate cancer; breast cancer; Cowden syndrome	TUMOR-SUPPRESSOR; PHOSPHOINOSITOL-3-KINASE/AKT PATHWAY; TRANSCRIPTIONAL ACTIVITY; 3-KINASE/AKT PATHWAY; PROMOTER MUTATIONS; CELL-PROLIFERATION; COWDEN-DISEASE; GENE; AKT; COACTIVATOR	Prostate cancer and breast cancer are the most common malignancies in the western world. Androgen receptor (AR) and PTEN both have been well documented to have important roles in prostate carcinogenesis. In contrast, AR and PTEN in breast carcinogenesis have not been well studied. Furthermore, the crosstalk and connection between those two pathways remain unclear. Increased AR expression in prostate cancers, combined with decreased PTEN expression, portends a poor clinical outcome. Paradoxically, both high AR and high PTEN levels, detected by immunohistochemistry, in primary breast carcinomas have been associated with better disease-free survival. Here, we performed in silico analysis of publicly available microarray data sets from prostate or breast carcinomas. We found an inverse correlation between AR and PTEN transcript expression in prostate cancer tissues in contrast to the positive correlation in breast cancer. These data led us to hypothesize that AR may directly affect PTEN transcriptional regulation in prostate and breast cancer cells. Here, we show for the first time that AR inhibits PTEN transcription in prostate cancer cells, whereas AR upregulates PTEN transcription in breast cancer cells, which mechanistically explains both the immunohistochemical PTEN-AR expressional data noted in clinical trials and in our in silico analysis of the transcriptomes of breast and prostate cancers. In addition, we have fine-mapped the AR-binding motif within the PTEN promoter. Here we show that, in patients with Cowden syndrome, an inherited cancer syndrome caused by germline mutations scattered throughout PTEN, point variants affecting the 30 end of the AR-binding motif result in abrogation of androgen-mediated transcriptional regulation of PTEN expression. We may speculate that the differential AR effect on PTEN may begin to explain organ-specific and perhaps sex-specific neoplasia predisposition in Cowden syndrome, as well as why only a fraction of women with germline PTEN mutations develop breast cancer, depending on the androgen steroid milieu and levels. Oncogene (2011) 30, 4327-4338; doi: 10.1038/onc.2011.144; published online 2 May 2011	[Wang, Y.; Romigh, T.; He, X.; Tan, M-H; Orloff, M. S.; Eng, C.] Cleveland Clin, Genom Med Inst, Lerner Res Inst, Cleveland, OH 44195 USA; [Orloff, M. S.; Silverman, R. H.; Heston, W. D.; Eng, C.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [Silverman, R. H.; Heston, W. D.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Silverman, R. H.; Heston, W. D.; Eng, C.] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH USA; [Eng, C.] Cleveland Clin, Stanley Shalom Zielony Inst Nursing Excellence, Cleveland, OH 44195 USA; [Eng, C.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, Lerner Res Inst, 9500 Euclid Ave,Mailcode NE-50, Cleveland, OH 44195 USA.	engc@ccf.org	Tan, Min Han/D-9205-2014; he, xin/C-3122-2011; WANG, YU/E-4655-2013	Tan, Min Han/0000-0002-0644-3457; Eng, Charis/0000-0002-3693-5145	William Randolph Hearst Foundations; Susan G Komen for the Cure Breast Cancer Research Foundation; FM Kirby Foundation	William Randolph Hearst Foundations; Susan G Komen for the Cure Breast Cancer Research Foundation(Susan G. Komen Breast Cancer Foundation); FM Kirby Foundation	We are grateful to Dr George Stark for critical review of manuscript drafts and for helpful discussions. This work was supported, in part, by the William Randolph Hearst Foundations and Susan G Komen for the Cure Breast Cancer Research Foundation. CE is the Sondra J and Stephen R Hardis Chair of Cancer Genomic Medicine at the Cleveland Clinic, was a Doris Duke Distinguished Clinical Scientist and is an American Cancer Society Clinical Research Professor, generously funded, in part, by the FM Kirby Foundation.	Agoff SN, 2003, AM J CLIN PATHOL, V120, P725, DOI 10.1309/42F00D0DJD0J5EDT; Agrawal S, 2005, HUM MOL GENET, V14, P2459, DOI 10.1093/hmg/ddi246; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bedolla R, 2007, CLIN CANCER RES, V13, P3860, DOI 10.1158/1078-0432.CCR-07-0091; BIRRELL SN, 1995, J STEROID BIOCHEM, V52, P459, DOI 10.1016/0960-0760(95)00005-K; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Ihaka S., 1996, J COMPUT GRAPH STAT, V5, P299; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lin HK, 2004, MOL ENDOCRINOL, V18, P2409, DOI 10.1210/me.2004-0117; Manin M, 2002, BIOCHEM J, V366, P729, DOI 10.1042/BJ20020585; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Mikhailova M, 2008, ADV EXP MED BIOL, V617, P397, DOI 10.1007/978-0-387-69080-3_38; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Nan B, 2003, J MOL ENDOCRINOL, V31, P169, DOI 10.1677/jme.0.0310169; Ogawa Y, 2008, INT J CLIN ONCOL, V13, P431, DOI 10.1007/s10147-008-0770-6; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Teresi RE, 2008, HUM MOL GENET, V17, P919, DOI 10.1093/hmg/ddm364; Teresi RE, 2007, AM J HUM GENET, V81, P756, DOI 10.1086/521051; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang Y, 2008, ONCOGENE, V27, P7106, DOI 10.1038/onc.2008.318; Wang Y, 2007, CURR CANCER DRUG TAR, V7, P591, DOI 10.2174/156800907781662248; Wen Y, 2000, CANCER RES, V60, P6841; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037; Zhou XP, 2003, AM J HUM GENET, V73, P1191, DOI 10.1086/379382; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109	36	70	71	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	42					4327	4338		10.1038/onc.2011.144	http://dx.doi.org/10.1038/onc.2011.144			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HP	21532617				2022-12-25	WOS:000296356400004
J	Chin, KT; Kang, GX; Qu, JX; Gardner, LB; Coetzee, WA; Zito, E; Fishman, GI; Ron, D				Chin, King-Tung; Kang, Guoxin; Qu, Jiaxiang; Gardner, Lawrence B.; Coetzee, William A.; Zito, Ester; Fishman, Glenn I.; Ron, David			The sarcoplasmic reticulum luminal thiol oxidase ERO1 regulates cardiomyocyte excitation-coupled calcium release and response to hemodynamic load	FASEB JOURNAL			English	Article						disulfide bonds; endoplasmic reticulum; heart failure	OXIDATIVE STRESS; PROTEIN; GENE; HOMEOSTASIS; MECHANISMS; PATHWAYS; HYPOXIA; CELLS; HEART; SERCA	Two related ER oxidation 1 (ERO1) proteins, ERO1 alpha and ERO1 beta, dynamically regulate the redox environment in the mammalian endoplasmic reticulum (ER). Redox changes in cysteine residues on intralumenal loops of calcium release and reuptake channels have been implicated in altered calcium release and reuptake. These findings led us to hypothesize that altered ERO1 activity may affect cardiac functions that are dependent on intracellular calcium flux. We established mouse lines with loss of function insertion mutations in Ero1l and Ero1lb encoding ERO1 alpha and ERO1 beta. The peak amplitude of calcium transients in homozygous Ero1 alpha mutant adult cardiomyocytes was reduced to 42.0 +/- 2.2% (n = 10, P <= 0.01) of values recorded in wild-type cardiomyocytes. Decreased ERO1 activity blunted cardiomyocyte inotropic response to adrenergic stimulation and sensitized mice to adrenergic blockade. Whereas all 12 wild-type mice survived challenge with 4 mg/kg esmolol, 6 of 8 compound Ero1l and Ero1lb mutant mice succumbed to this level of beta adrenergic blockade (P <= 0.01). In addition, mice lacking ERO1 alpha were partially protected against progressive heart failure in a transaortic constriction model [at 10 wk postprocedure, fractional shortening was 0.31 +/- 0.02 in the mutant (n = 20) vs. 0.23 +/- 0.03 in the wild type (n = 18); P <= 0.01]. These findings establish a role for ERO1 in calcium homeostasis and suggest that modifying the lumenal redox environment may affect the progression of heart failure.Chin, K. T., Kang, G., Qu, J., Gardner, L. B., Coetzee, W. A., Zito, E., Fishman, G. I., Ron, R. The sarcoplasmic reticulum luminal thiol oxidase ERO1 regulates cardiomyocyte excitation-coupled calcium release and response to hemodynamic load. FASEB J. 25, 2583-2591 (2011). www.fasebj.org	[Kang, Guoxin] NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med, New York, NY 10016 USA; [Chin, King-Tung; Zito, Ester; Ron, David] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Ron, David] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Coetzee, William A.] NYU, Sch Med, Dept Pediat, New York, NY 10016 USA; [Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge, England	New York University; New York University; New York University; New York University; University of Cambridge	Fishman, GI (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med, 522 1st Ave,Smilow 801, New York, NY 10016 USA.	glenn.fishman@med.nyu.edu; dr360@medschl.cam.ac.uk	Zito, Ester/ABB-9687-2020; Zito, Ester/AAA-7246-2020	Coetzee, William/0000-0003-1522-8326; Ron, David/0000-0002-3014-5636; Gardner, Lawrence/0000-0003-0191-0172; Fishman, Glenn/0000-0002-2366-8527	U.S. National Institutes of Health [ES08681, DK47119, DK075311, R01HL82727, R01HL081336, S10RR026881]; EMBO [ALTF649-2008]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081336, T32HL007151, R01HL082727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081641, R01DK075311, R01DK047119, R29DK047119, R37DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; Medical Research Council [G0600717B] Funding Source: researchfish	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank S. James Remington (University of Oregon, Eugene, OR, USA) for the roGFP_iE. This study was supported by U.S. National Institutes of Health grants ES08681, DK47119, and DK075311 to D.R. and R01HL82727, R01HL081336, and S10RR026881 to G.I.F., and EMBO long-term fellowship ALTF649-2008 to E.Z. D.R. is a Wellcome Trust Principal Research Fellow.	Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blais JD, 2010, J BIOL CHEM, V285, P20993, DOI 10.1074/jbc.M110.126599; Dibb KM, 2007, CELL CALCIUM, V42, P503, DOI 10.1016/j.ceca.2007.04.002; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Hamada H, 2004, MOL CELL BIOL, V24, P8007, DOI 10.1128/MCB.24.18.8007-8017.2004; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Kang GX, 2010, CIRC RES, V107, P512, DOI 10.1161/CIRCRESAHA.110.221481; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; LOMPRE AM, 1994, J MOL CELL CARDIOL, V26, P1109, DOI 10.1006/jmcc.1994.1130; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; May D, 2005, ONCOGENE, V24, P1011, DOI 10.1038/sj.onc.1208325; Meyers MB, 2003, J BIOL CHEM, V278, P28865, DOI 10.1074/jbc.M302009200; Nass RD, 2008, NAT CLIN PRACT CARD, V5, P196, DOI 10.1038/ncpcardio1130; O'Neill SC, 2004, J PHYSIOL-LONDON, V559, P121, DOI 10.1113/jphysiol.2003.058917; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Qu JX, 2009, CIRC RES, V104, P365, DOI 10.1161/CIRCRESAHA.108.184044; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	33	41	41	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2583	2591		10.1096/fj.11-184622	http://dx.doi.org/10.1096/fj.11-184622			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21507899	Green Published, Green Submitted			2022-12-25	WOS:000293337800009
J	Sarkar, A; Zhang, M; Liu, SH; Sarkar, S; Brunicardi, FC; Berger, DH; Belaguli, NS				Sarkar, Aloke; Zhang, Mao; Liu, Shi-He; Sarkar, Swapna; Brunicardi, F. Charles; Berger, David H.; Belaguli, Narasimhaswamy S.			Serum response factor expression is enriched in pancreatic beta cells and regulates insulin gene expression	FASEB JOURNAL			English	Article						Pdx-1; knock-in; LacZ	TRANSCRIPTION FACTOR; FACTOR-BINDING; E-BOX; ACTIVATION; ELEMENT; SRF; CARG; PROLIFERATION; PROTEINS; PROMOTER	Serum response factor (SRF) is an essential regulator of myogenic and neurogenic genes and the ubiquitously expressed immediate-early genes. The purpose of this study is to determine SRF expression pattern in murine pancreas and examine the role of SRF in pancreatic gene expression. Immunohistochemical analysis of wild-type pancreas and LacZ staining of pancreas from SRF LacZ knock-in animals showed that SRF expression is restricted to beta cells. SRF bound to the rat insulin promoter II (RIP II) serum response element, an element conserved in both rat I and murine I and II insulin promoters. SRF activated RIP II, and SRF binding to RIP II and the exon 5-encoded 64-aa subdomain of SRF was required for this activation. Transient or stable knockdown of SRF leads to down-regulation of insulin gene expression, suggesting that SRF is required for insulin gene expression. Further, SRF physically interacted with the pancreas and duodenum homeobox-1 (Pdx-1) and synergistically activated RIP II. Elevated glucose concentration down-regulated SRF binding to RIP II SRE, and this down-regulation was associated with decreased RIP II activity and increased SRF phosphorylation on serine 103. Together, our results demonstrate that SRF is a glucose concentration-sensitive regulator of insulin gene expression.-Sarkar, A., Zhang, M., Liu, S.-H., Sarkar, S., Brunicardi, F. C., Berger, D. H., Belaguli, N. S. Serum response factor expression is enriched in pancreatic beta cells and regulates insulin gene expression. FASEB J. 25, 2592-2603 (2011). www.fasebj.org	[Belaguli, Narasimhaswamy S.] Baylor Coll Med, Michael E DeBakey Dept Surg, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Belaguli, NS (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd, Houston, TX 77030 USA.	elaguli@bcm.edu			American Diabetes Association [1-06-RA-10]	American Diabetes Association(American Diabetes Association)	The authors thank Dr. Christopher Newgard (Duke University, Durham, NC, USA) for the generous gift of INS-1 823/13 cells. Thanks to Dr. Patricia Castro for help with quantitative PCR and Dr. Pradip Saha for islet isolation. This work was supported by the American Diabetes Association (research award 1-06-RA-10 to N.S.B).	Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Baker DL, 1998, NUCLEIC ACIDS RES, V26, P1092, DOI 10.1093/nar/26.4.1092; Barron MR, 2005, J BIOL CHEM, V280, P11816, DOI 10.1074/jbc.M412408200; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Belaguli NS, 1999, MOL CELL BIOL, V19, P4582; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Bernal-Mizrachi E, 2000, J BIOL CHEM, V275, P25681, DOI 10.1074/jbc.M003424200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chen CY, 1996, MOL CELL BIOL, V16, P6372; CHEN YR, 1995, MOL CELL BIOL, V15, P4631; Cheng GM, 1999, J BIOL CHEM, V274, P12819, DOI 10.1074/jbc.274.18.12819; Contreras JL, 2001, TRANSPLANTATION, V71, P1015, DOI 10.1097/00007890-200104270-00001; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; CROWE DT, 1989, MOL CELL BIOL, V9, P1784, DOI 10.1128/MCB.9.4.1784; Escalante R, 2003, EUKARYOT CELL, V2, P1327, DOI 10.1128/EC.2.6.1327-1335.2003; Groisman R, 1996, J BIOL CHEM, V271, P5258; Gurzov EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003030; Hautmann MB, 1998, J BIOL CHEM, V273, P8398, DOI 10.1074/jbc.273.14.8398; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; JOHANSEN FE, 1993, MOL CELL BIOL, V13, P4640, DOI 10.1128/MCB.13.8.4640; Kaneto H, 2008, ENDOCR J, V55, P235, DOI 10.1507/endocrj.K07E-041; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; LIU SH, 1993, J BIOL CHEM, V268, P21147; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2006, LAB INVEST, V86, P1020, DOI 10.1038/labinvest.3700457; Nilsson M, 2007, NUCLEIC ACIDS RES, V35, P4858, DOI 10.1093/nar/gkm492; Niu Z, 2005, J BIOL CHEM, V280, P32531, DOI 10.1074/jbc.M501372200; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Pino MF, 2005, MOL ENDOCRINOL, V19, P1343, DOI 10.1210/me.2003-0493; Rene C, 2005, NUCLEIC ACIDS RES, V33, P5271, DOI 10.1093/nar/gki837; Schratt G, 2004, EMBO J, V23, P1834, DOI 10.1038/sj.emboj.7600188; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Sun K, 2009, HEPATOLOGY, V49, P1645, DOI 10.1002/hep.22834; TAYLOR M, 1989, DEVELOPMENT, V106, P67; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; Treisman R, 1992, CURR OPIN GENET DEV, V2, P221, DOI 10.1016/S0959-437X(05)80277-1; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Zhang SX, 2005, J BIOL CHEM, V280, P19115, DOI 10.1074/jbc.M413793200	50	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2592	2603		10.1096/fj.10-173757	http://dx.doi.org/10.1096/fj.10-173757			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21525490				2022-12-25	WOS:000293337800010
J	Choi, ES; Stralfors, A; Castillo, AG; Durand-Dubief, M; Ekwall, K; Allshire, RC				Choi, Eun Shik; Stralfors, Annelie; Castillo, Araceli G.; Durand-Dubief, Mickael; Ekwall, Karl; Allshire, Robin C.			Identification of Noncoding Transcripts from within CENP-A Chromatin at Fission Yeast Centromeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPREHENSIVE ANALYSIS; EPIGENETIC REGULATION; RNA; HETEROCHROMATIN; PROTEIN; GENE; KINETOCHORES; COMPONENTS; TURNOVER; DYNAMICS	The histone H3 variant CENP-A is the most favored candidate for an epigenetic mark that specifies the centromere. In fission yeast, adjacent heterochromatin can direct CENP-A(Cnp1) chromatin establishment, but the underlying features governing where CENP-A(Cnp1) chromatin assembles are unknown. We show that, in addition to centromeric regions, a low level of CENP-A(Cnp1) associates with gene promoters where histone H3 is depleted by the activity of the Hrp1(Chd1) chromatin-remodeling factor. Moreover, we demonstrate that noncoding RNAs are transcribed by RNA polymerase II (RNAPII) from CENP-A(Cnp1) chromatin at centromeres. These analyses reveal a similarity between centromeres and a subset of RNAPII genes and suggest a role for remodeling at RNAPII promoters within centromeres that influences the replacement of histone H3 with CENP-A(Cnp1).	[Stralfors, Annelie; Durand-Dubief, Mickael; Ekwall, Karl] Karolinska Inst, Novum, Dept Biosci & Nutr, Ctr Biosci, S-14157 Huddinge, Sweden; [Choi, Eun Shik; Castillo, Araceli G.; Allshire, Robin C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Choi, Eun Shik; Castillo, Araceli G.; Allshire, Robin C.] Univ Edinburgh, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Karolinska Institutet; University of Edinburgh; University of Edinburgh	Ekwall, K (corresponding author), Karolinska Inst, Novum, Dept Biosci & Nutr, Ctr Biosci, S-14157 Huddinge, Sweden.	karl.ekwall@ki.se; robin.allshire@ed.ac.uk	Castillo, Araceli G/C-5158-2013; Durand-Dubief, Mickael/O-2315-2019	Castillo, Araceli G/0000-0003-3990-5475; Durand-Dubief, Mickael/0000-0002-8556-4459; Ekwall, Karl/0000-0002-3029-4041; Choi, Eun Shik/0000-0002-2306-2103; Allshire, Robin/0000-0002-8005-3625	European Molecular Biology Organization; Wellcome Trust [065061/Z]; Swedish Research Council (VR); Gorans Gustafsson Foundation for Research in Natural Sciences and Medicine; Cancer Society (CF)	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council (VR)(Swedish Research Council); Gorans Gustafsson Foundation for Research in Natural Sciences and Medicine; Cancer Society (CF)	This work was supported by a European Molecular Biology Organization long-term fellowship (to E. S. C.), Wellcome Trust Programme Grant (065061/Z (to R. C. A.), the Swedish Research Council (VR; to K. E.), the Gorans Gustafsson Foundation for Research in Natural Sciences and Medicine (to K. E.), and the Cancer Society (CF; to K. E.).	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cam HP, 2009, CELL, V136, P610, DOI 10.1016/j.cell.2009.02.004; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Durand-Dubief Mickael, 2009, V529, P279, DOI 10.1007/978-1-59745-538-1_18; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2000, P NATL ACAD SCI USA, V97, P12583, DOI 10.1073/pnas.97.23.12583; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Okada M, 2009, MOL BIOL CELL, V20, P3986, DOI 10.1091/mbc.E09-01-0065; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; RIEDER CL, 1979, J CELL BIOL, V80, P1, DOI 10.1083/jcb.80.1.1; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Shobuike T, 2001, NUCLEIC ACIDS RES, V29, P1326, DOI 10.1093/nar/29.6.1326; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Walfridsson J, 2007, EMBO J, V26, P2868, DOI 10.1038/sj.emboj.7601728; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; Wang SW, 2005, MOL CELL BIOL, V25, P2288, DOI 10.1128/MCB.25.6.2288-2296.2005; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807	42	90	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23600	23607		10.1074/jbc.M111.228510	http://dx.doi.org/10.1074/jbc.M111.228510			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531710	Green Published, hybrid			2022-12-25	WOS:000292025000090
J	Lintner, NG; Kerou, M; Brumfield, SK; Graham, S; Liu, HT; Naismith, JH; Sdano, M; Peng, N; She, QX; Copie, V; Young, MJ; White, MF; Lawrence, CM				Lintner, Nathanael G.; Kerou, Melina; Brumfield, Susan K.; Graham, Shirley; Liu, Huanting; Naismith, James H.; Sdano, Matthew; Peng, Nan; She, Qunxin; Copie, Valerie; Young, Mark J.; White, Malcolm F.; Lawrence, C. Martin			Structural and Functional Characterization of an Archaeal Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated Complex for Antiviral Defense (CASCADE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROVIDES ACQUIRED-RESISTANCE; RNA RECOGNITION MOTIF; PROTEIN-STRUCTURE; SULFOLOBUS-SOLFATARICUS; IMMUNE-SYSTEM; CRISPR; BACTERIA; GENUS; ALIGNMENT; SEQUENCE	In response to viral infection, many prokaryotes incorporate fragments of virus-derived DNA into loci called clustered regularly interspaced short palindromic repeats (CRISPRs). The loci are then transcribed, and the processed CRISPR transcripts are used to target invading viral DNA and RNA. The Escherichia coli "CRISPR-associated complex for antiviral defense" (CASCADE) is central in targeting invading DNA. Here we report the structural and functional characterization of an archaeal CASCADE (aCASCADE) from Sulfolobus solfataricus. Tagged Csa2 (Cas7) expressed in S. solfataricus co-purifies with Cas5a-, Cas6-, Csa5-, and Cas6-processed CRISPR-RNA (crRNA). Csa2, the dominant protein in aCASCADE, forms a stable complex with Cas5a. Transmission electron microscopy reveals a helical complex of variable length, perhaps due to substoichiometric amounts of other CASCADE components. A recombinant Csa2-Cas5a complex is sufficient to bind crRNA and complementary ssDNA. The structure of Csa2 reveals a crescent-shaped structure unexpectedly composed of a modified RNA-recognition motif and two additional domains present as insertions in the RNA-recognition motif. Conserved residues indicate potential crRNA- and target DNA-binding sites, and the H160A variant shows significantly reduced affinity for crRNA. We propose a general subunit architecture for CASCADE in other bacteria and Archaea.	[Kerou, Melina; Graham, Shirley; Liu, Huanting; Naismith, James H.; White, Malcolm F.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Lintner, Nathanael G.; Brumfield, Susan K.; Sdano, Matthew; Copie, Valerie; Young, Mark J.; Lawrence, C. Martin] Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA; [Lintner, Nathanael G.; Sdano, Matthew; Copie, Valerie; Lawrence, C. Martin] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Brumfield, Susan K.; Young, Mark J.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Peng, Nan; She, Qunxin] Univ Copenhagen, Dept Biol, Archaea Ctr, DK-2200 Copenhagen N, Denmark	University of St Andrews; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Copenhagen	White, MF (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	mfw2@st-and.ac.uk; lawrence@chemistry.montana.edu	White, Malcolm F/A-6055-2010; Naismith, James Henderson/AAB-8614-2020; She, Qunxin/E-4311-2012; Kerou, Melina/V-7485-2019; Lawrence, C. Martin/AAH-3420-2020; Copie, Valerie/GPW-9767-2022; Naismith, James Henderson/H-3408-2012; Peng, Nan/K-3819-2016	White, Malcolm F/0000-0003-1543-9342; Naismith, James Henderson/0000-0001-6744-5061; She, Qunxin/0000-0002-4448-6669; Kerou, Melina/0000-0003-1657-3041; Lawrence, C. Martin/0000-0002-5398-466X; Copie, Valerie/0000-0002-2778-1463; Naismith, James Henderson/0000-0001-6744-5061; Peng, Nan/0000-0002-1637-6729; Graham, Shirley/0000-0002-2608-3815	National Science Foundation [MCB-0628732, MCB-0920312]; Biotechnology and Biological Sciences Research Council [BB/G011400/1]; Molecular Biosciences Program; National Science Foundation; Montana State University [DGE 0654336]; Danish Council for Independent Research [09-062932/FTP]; Murdock Foundation; BBSRC [BB/G011400/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/14426] Funding Source: researchfish; Direct For Biological Sciences [0920312] Funding Source: National Science Foundation; Emerging Frontiers [0802200] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Molecular Biosciences Program; National Science Foundation(National Science Foundation (NSF)); Montana State University; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Murdock Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grants MCB-0628732 and MCB-0920312 and Biotechnology and Biological Sciences Research Council Grant BB/G011400/1.; Supported by fellowships from the Molecular Biosciences Program and the National Science Foundation Integrated Graduate Education and Research Training Program in Geobiological Systems Grant DGE 0654336 from the Montana State University.; Supported by the Danish Council for Independent Research Grant 09-062932/FTP.; We thank Paul Talbot and Donald L. Alsbury for technical assistance and Dr. Christophe Rouillon and Dr. Jing Zhang for scientific discussion. Portions of this work were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. The Macromolecular Diffraction Laboratory at Montana State University was supported, in part, by a grant from the Murdock Foundation. We thank the Mass Spectrometry facility in St. Andrews supported by the Wellcome Trust.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Botting CH, 2010, ARCHAEA, V2010, DOI 10.1155/2010/106341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han D, 2009, FEBS LETT, V583, P1928, DOI 10.1016/j.febslet.2009.04.047; Han D, 2009, FEBS LETT, V583, P771, DOI 10.1016/j.febslet.2009.01.024; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hugler M, 2003, EUR J BIOCHEM, V270, P736, DOI 10.1046/j.1432-1033.2003.03434.x; JORE MJ, 2011, NAT STRUCT IN PRESS; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kraft P, 2004, J VIROL, V78, P7438, DOI 10.1128/JVI.78.14.7438-7442.2004; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lawrence CM, 2011, STRUCTURE, V19, P142, DOI 10.1016/j.str.2011.01.003; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maaty WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006964; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Manica A, 2011, MOL MICROBIOL, V80, P481, DOI 10.1111/j.1365-2958.2011.07586.x; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martusewitsch E, 2000, J BACTERIOL, V182, P2574, DOI 10.1128/JB.182.9.2574-2581.2000; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Peng N, 2009, MOL MICROBIOL, V74, P928, DOI 10.1111/j.1365-2958.2009.06908.x; Peng X, 2003, J BACTERIOL, V185, P2410, DOI 10.1128/JB.185.8.2410-2417.2003; Perez-Rodriguez R, 2011, MOL MICROBIOL, V79, P584, DOI 10.1111/j.1365-2958.2010.07482.x; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014	65	159	183	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21643	21656		10.1074/jbc.M111.238485	http://dx.doi.org/10.1074/jbc.M111.238485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507944	Green Published, hybrid			2022-12-25	WOS:000291464700061
J	Refaat, A; Zhou, Y; Suzuki, S; Takasaki, I; Koizumi, K; Yamaoka, S; Tabuchi, Y; Saiki, I; Sakurai, H				Refaat, Alaa; Zhou, Yue; Suzuki, Shunsuke; Takasaki, Ichiro; Koizumi, Keiichi; Yamaoka, Shoji; Tabuchi, Yoshiaki; Saiki, Ikuo; Sakurai, Hiroaki			Distinct Roles of Transforming Growth Factor-beta-activated Kinase 1 (TAK1)-c-Rel and Interferon Regulatory Factor 4 (IRF4) Pathways in Human T Cell Lymphotropic Virus 1-transformed T helper 17 Cells Producing Interleukin-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; HTLV-1 TAX; TRANSCRIPTION FACTOR; SPASTIC PARAPARESIS; SIGNALING PATHWAY; ARSENIC TRIOXIDE; GENE-EXPRESSION; LEUKEMIA; LEUKEMIA/LYMPHOMA	Investigation of helper T cell markers in HTLV-1-transformed cell lines demonstrated that HuT-102 has an IL-9-producing Th17 phenotype. We confirmed the vital role of retinoic acid-related orphan receptor C, a Th17 transcription factor, in the expression of IL-17. Interferon regulatory factor 4 (IRF4), a transcription factor overexpressed in all HTLV-1-infected cells, regulated IL-17 and IL-9 concomitantly. We further demonstrated a novel pathway for the regulation of Tax-induced cytokines, IL-9 and IL-6, through TAK1-mediated nuclear accumulation of c-Rel. A microarray analysis for IRF4 knocked down HuT-102 cells showed a significant up-regulation in the set of genes related to Th1, mainly IFN-gamma and several transcription factors. T-bet and IRF1, but not STAT1 and IRF9, participated in counteracting the inhibitory effect of IRF4 on the production of IFN-gamma. Finally, suppression of both IRF4 and c-Rel resulted in the reduced proliferation. Collectively, these findings indicate that TAK1-c-Rel and IRF4 pathways play distinct roles in the maintenance of IL-9-producing Th17 phenotype of HTLV-1-transformed cells.	[Refaat, Alaa; Zhou, Yue; Suzuki, Shunsuke; Koizumi, Keiichi; Tabuchi, Yoshiaki; Saiki, Ikuo; Sakurai, Hiroaki] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan; [Takasaki, Ichiro] Toyama Univ, Life Sci Res Ctr, Div Mol Genet Res, Toyama 9300194, Japan; [Yamaoka, Shoji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Virol, Tokyo 1138519, Japan	University of Toyama; University of Toyama; Tokyo Medical & Dental University (TMDU)	Sakurai, H (corresponding author), Toyama Univ, Inst Nat Med, Div Pathogen Biochem, 2630 Sugitani, Toyama 9300194, Japan.	hsakurai@inm.u-toyama.ac.jp	Koizumi, Keiichi/AAG-6915-2019; Sakurai, Hiroaki/AAE-4294-2019; Refaat, Alaa/F-3596-2018	Refaat, Alaa/0000-0002-7821-2500; Zhou, Yue/0000-0002-1335-5703; Tabuchi, Yoshiaki/0000-0002-6007-6176; Sakurai, Hiroaki/0000-0003-0657-9570	Ministry of Education, Culture, Sports, Science, and Technology (Japan) [19590063, 20890078]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-aid for Scientific Research (C) 19590063 and Young Scientist Start-up 20890078 from the Ministry of Education, Culture, Sports, Science, and Technology (Japan) and a grant from the Takeda Science Foundation.	Bazarbachi A, 2004, LANCET ONCOL, V5, P664, DOI 10.1016/S1470-2045(04)01608-0; Bazarbachi A, 1999, BLOOD, V93, P278, DOI 10.1182/blood.V93.1.278.401k22_278_283; Bazarbachi A, 2000, LEUKEMIA, V14, P716, DOI 10.1038/sj.leu.2401742; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chen J, 2008, BLOOD, V111, P5163, DOI 10.1182/blood-2007-09-113654; Dodon MD, 2004, J GEN VIROL, V85, P1921, DOI 10.1099/vir.0.79921-0; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; GESSAIN A, 1985, LANCET, V2, P407; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; HARA H, 1994, J EXP MED, V180, P831, DOI 10.1084/jem.180.3.831; Hermine O, 2004, HEMATOL J, V5, P130, DOI 10.1038/sj.thj.6200374; HINUMA Y, 1982, INT J CANCER, V29, P631, DOI 10.1002/ijc.2910290606; Honma K, 2008, P NATL ACAD SCI USA, V105, P15890, DOI 10.1073/pnas.0803171105; Inagaki A, 2006, INT J CANCER, V118, P3054, DOI 10.1002/ijc.21688; Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Karube K, 2004, BRIT J HAEMATOL, V126, P81, DOI 10.1111/j.1365-2141.2004.04999.x; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Mitra-Kaushik S, 2004, BLOOD, V104, P3305, DOI 10.1182/blood-2004-01-0266; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Morinobu A, 2004, J BIOL CHEM, V279, P40640, DOI 10.1074/jbc.M407576200; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; OSAME M, 1986, LANCET, V2, P104; Ramos JC, 2007, BLOOD, V109, P3060, DOI 10.1182/blood-2006-07-036368; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; Suzuki S, 2007, J BIOL CHEM, V282, P25177, DOI 10.1074/jbc.C700065200; Suzuki S, 2010, J BIOL CHEM, V285, P4441, DOI 10.1074/jbc.M109.031476; SUZUKI T, 1994, ONCOGENE, V9, P3099; Takasaki I, 2007, J CELL BIOCHEM, V102, P1472, DOI 10.1002/jcb.21369; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; YAMASHITA I, 1994, BLOOD, V84, P1573; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9	41	22	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21092	21099		10.1074/jbc.M110.200907	http://dx.doi.org/10.1074/jbc.M110.200907			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498517	hybrid, Green Published			2022-12-25	WOS:000291464700008
J	Lindsey-Boltz, LA; Sancar, A				Lindsey-Boltz, Laura A.; Sancar, Aziz			Tethering DNA Damage Checkpoint Mediator Proteins Topoisomerase II beta-binding Protein 1 (TopBP1) and Claspin to DNA Activates Ataxia-Telangiectasia Mutated and RAD3-related (ATR) Phosphorylation of Checkpoint Kinase 1 (Chk1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEATED PHOSPHOPEPTIDE MOTIFS; EXCISION-REPAIR; ABSENCE; RECONSTITUTION; SYSTEM; BREAKS; CELLS	The ataxia-telangiectasia mutated and RAD3-related (ATR) kinase initiates DNA damage signaling pathways in human cells after DNA damage such as that induced upon exposure to ultraviolet light by phosphorylating many effector proteins including the checkpoint kinase Chk1. The conventional view of ATR activation involves a universal signal consisting of genomic regions of replication protein A-covered single-stranded DNA. However, there are some indications that the ATR-mediated checkpoint can be activated by other mechanisms. Here, using the well defined Escherichia coli lac repressor/operator system, we have found that directly tethering the ATR activator topoisomerase II beta-binding protein 1 (TopBP1) to DNA is sufficient to induce ATR phosphorylation of Chk1 in an in vitro system as well as in vivo in mammalian cells. In addition, we find synergistic activation of ATR phosphorylation of Chk1 when the mediator protein Claspin is also tethered to the DNA with TopBP1. Together, these findings indicate that crowding of checkpoint mediator proteins on DNA is sufficient to activate the ATR kinase.	[Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833( to A. S.).	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; RIGGS AD, 1970, J MOL BIOL, V51, P303, DOI 10.1016/0022-2836(70)90144-0; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	33	29	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19229	19236		10.1074/jbc.M111.237958	http://dx.doi.org/10.1074/jbc.M111.237958			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21502314	hybrid, Green Published			2022-12-25	WOS:000291027700005
J	Yadav, AK; Bachhawat, AK				Yadav, Amit Kumar; Bachhawat, Anand Kumar			CgCYN1, a Plasma Membrane Cystine-specific Transporter of Candida glabrata with Orthologues Prevalent among Pathogenic Yeast and Fungi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATIN DECOMPOSITION; GENE DISRUPTION; ACID; GLUTATHIONE; DERMATOPHYTES; BIOSYNTHESIS; EXPRESSION; EVOLUTION; EXCHANGE; SEQUENCE	We describe a novel plasma membrane cystine transporter, CgCYN1, from Candida glabrata, the first such transporter to be described from yeast and fungi. C. glabrata met15 Delta strains, organic sulfur auxotrophs, were observed to utilize cystine as a sulfur source, and this phenotype was exploited in the discovery of CgCYN1. Heterologous expression of CgCYN1 in Saccharomyces cerevisiae met15 Delta strains conferred the ability of S. cerevisiae strains to grow on cystine. Deletion of the CgCYN1 ORF (CAGL0M00154g) in C. glabrata met15 Delta strains caused abrogation of growth on cystine with growth being restored when CgCYN1 was reintroduced. The CgCYN1 protein belongs to the amino acid permease family of transporters, with no similarity to known plasma membrane cystine transporters of bacteria and humans, or lysosomal cystine transporters of humans/yeast. Kinetic studies revealed a K-m of 18 +/- 5 mu M for cystine. Cystine uptake was inhibited by cystine, but not by other amino acids, including cysteine. The structurally similar cystathionine, lanthionine, and selenocystine alone inhibited transport, confirming that the transporter was specific for cystine. CgCYN1 localized to the plasma membrane and transport was energy-dependent. Functional orthologues could be demonstrated from other pathogenic yeast like Candida albicans and Histoplasma capsulatum, but were absent in Schizosaccharomyces pombe and S. cerevisiae.	[Bachhawat, Anand Kumar] Indian Inst Sci Educ & Res IISER Mohali, Chandigarh 160019, India; [Yadav, Amit Kumar; Bachhawat, Anand Kumar] CSIR, Inst Microbial Technol, Sector 39 A, Chandigarh 160036, India	Indian Institute of Science Education & Research (IISER) - Mohali; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Bachhawat, AK (corresponding author), Indian Inst Sci Educ & Res, Sector 26, Mohali Transit Campus,MGSIPAP Complex, Chandigarh 160019, India.	anand@iisermohali.ac.in			Departments of Science and Technology; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Departments of Science and Technology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was in part supported by a grant-in-aid project from the Departments of Science and Technology and the Department of Biotechnology, Government of India (to A. K. B.).; Recipient of a research fellowship from the Council of Scientific and Industrial Research, Government of India.	BANNAI S, 1986, J BIOL CHEM, V261, P2256; BAPTIST EW, 1977, J BACTERIOL, V131, P111, DOI 10.1128/JB.131.1.111-118.1977; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; BUTLER JD, 1993, LIFE SCI, V52, P1209, DOI 10.1016/0024-3205(93)90103-A; De Hertogh B, 2006, GENETICS, V172, P771, DOI 10.1534/genetics.105.046813; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Earley MC, 1996, GENE, V169, P111, DOI 10.1016/0378-1119(95)00805-5; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fujita Y, 2004, BIOSCI BIOTECH BIOCH, V68, P306, DOI 10.1271/bbb.68.306; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GILBERT B E, 1970, Infection and Immunity, V2, P139; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Kaur J, 2009, J BIOL CHEM, V284, P23872, DOI 10.1074/jbc.M109.029728; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; KUNERT J, 1976, Z ALLG MIKROBIOL, V16, P97, DOI 10.1002/jobm.3630160203; KUNERT J, 1972, EXPERIENTIA, V28, P1025, DOI 10.1007/BF01918649; Rajan DP, 2000, J BIOL CHEM, V275, P14331, DOI 10.1074/jbc.275.19.14331; Rajan DP, 1999, J BIOL CHEM, V274, P29005, DOI 10.1074/jbc.274.41.29005; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; STAHL WH, 1949, ARCH BIOCHEM, V20, P422; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner MS, 1999, J BACTERIOL, V181, P2192, DOI 10.1128/JB.181.7.2192-2198.1999; Viaene J, 2000, YEAST, V16, P1205, DOI 10.1002/1097-0061(20000930)16:13&lt;1205::AID-YEA615&gt;3.0.CO;2-C; Yadav AK, 2011, MICROBIOL-SGM, V157, P484, DOI 10.1099/mic.0.045054-0	28	12	15	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19714	19723		10.1074/jbc.M111.240648	http://dx.doi.org/10.1074/jbc.M111.240648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21507960	Green Published, hybrid			2022-12-25	WOS:000291027700054
J	Rossi, C; Doumiati, S; Lazzarelli, C; Davi, M; Meddar, F; Ladant, D; Chopineau, J				Rossi, Claire; Doumiati, Samah; Lazzarelli, Clarine; Davi, Marilyne; Meddar, Fetta; Ladant, Daniel; Chopineau, Joel			A Tethered Bilayer Assembled on Top of Immobilized Calmodulin to Mimic Cellular Compartmentalization	PLOS ONE			English	Article							PERTUSSIS ADENYLATE-CYCLASE; SUPPORTED MEMBRANES; BINDING; SURFACE	Background: Biomimetic membrane models tethered on solid supports are important tools for membrane protein biochemistry and biotechnology. The supported membrane systems described up to now are composed of a lipid bilayer tethered or not to a surface separating two compartments: a ''trans'' side, one to a few nanometer thick, located between the supporting surface and the membrane; and a "cis'' side, above the synthetic membrane, exposed to the bulk medium. We describe here a novel biomimetic design composed of a tethered bilayer membrane that is assembled over a surface derivatized with a specific intracellular protein marker. This multilayered biomimetic assembly exhibits the fundamental characteristics of an authentic biological membrane in creating a continuous yet fluid phospholipidic barrier between two distinct compartments: a "cis'' side corresponding to the extracellular milieu and a "trans'' side marked by a key cytosolic signaling protein, calmodulin. Methodology/Principal Findings: We established and validated the experimental conditions to construct a multilayered structure consisting in a planar tethered bilayer assembled over a surface derivatized with calmodulin. We demonstrated the following: (i) the grafted calmodulin molecules (in trans side) were fully functional in binding and activating a calmodulin-dependent enzyme, the adenylate cyclase from Bordetella pertussis; and (ii) the assembled bilayer formed a continuous, protein-impermeable boundary that fully separated the underlying calmodulin (trans side) from the above medium (cis side). Conclusions: The simplicity and robustness of the tethered bilayer structure described here should facilitate the elaboration of biomimetic membrane models incorporating membrane embedded proteins and key cytoplasmic constituents. Such biomimetic structures will also be an attractive tool to study translocation across biological membranes of proteins or other macromolecules.	[Rossi, Claire; Doumiati, Samah; Meddar, Fetta] Univ Technol Compiegne, CNRS, UMR 6022, F-60206 Compiegne, France; [Lazzarelli, Clarine; Chopineau, Joel] Univ Nimes, Nimes, France; [Davi, Marilyne; Ladant, Daniel] Inst Pasteur, Unite Biochim Interact Macromol, CNRS, URA 2185, Paris, France; [Chopineau, Joel] Ecole Natl Super Chim, Inst Charles Gerhardt Montpellier, UMR 5253, CNRS ENSCM UM2 UM1, Montpellier, France	Picardie Universites; Universite de Technologie de Compiegne; Centre National de la Recherche Scientifique (CNRS); Universite de Nimes; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Rossi, C (corresponding author), Univ Technol Compiegne, CNRS, UMR 6022, F-60206 Compiegne, France.	daniel.ladant@pasteur.fr; joel.chopineau@unimes.fr	chopineau, joel/J-6674-2015	chopineau, joel/0000-0001-8307-0167; LADANT, Daniel/0000-0003-1955-548X	CNRS; Pasteur Institute; European Union	CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute; European Union(European Commission)	This work was funded by CNRS and by Pasteur Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank A. Chenal and S. Ouellette for critical reading of the manuscript, and the European Union for co-funding of equipment within the CPER 2007-2013.	Carton I, 2010, ANAL CHEM, V82, P9275, DOI 10.1021/ac102495q; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Csucs G, 1998, BBA-BIOMEMBRANES, V1369, P304, DOI 10.1016/S0005-2736(97)00233-2; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; Fang Y, 2002, J AM CHEM SOC, V124, P2394, DOI 10.1021/ja017346+; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Jelinek R, 2009, MOL BIOSYST, V5, P811, DOI 10.1039/b907223n; Kiesslling V., 2008, WILEY ENCY CHEM BIOL, V4, P411; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1986, J BIOL CHEM, V261, P6264; Laine E, 2010, P NATL ACAD SCI USA, V107, P11277, DOI 10.1073/pnas.0914611107; Leroueil PR, 2008, NANO LETT, V8, P420, DOI 10.1021/nl0722929; Loose M, 2009, J STRUCT BIOL, V168, P143, DOI 10.1016/j.jsb.2009.03.016; Rossi C, 2003, BIOCHEMISTRY-US, V42, P15273, DOI 10.1021/bi035336a; Rossi C, 2007, EUR BIOPHYS J BIOPHY, V36, P955, DOI 10.1007/s00249-007-0202-y; Rossi C, 2007, J PHYS CHEM B, V111, P7567, DOI 10.1021/jp0686792; Tamm LK, 2009, J STRUCT BIOL, V168, P1, DOI 10.1016/j.jsb.2009.07.016; Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164; Vougier S, 2004, J BIOL CHEM, V279, P30210, DOI 10.1074/jbc.M400604200; Yu CH, 2010, MED BIOL ENG COMPUT, V48, P955, DOI 10.1007/s11517-010-0634-x	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19101	10.1371/journal.pone.0019101	http://dx.doi.org/10.1371/journal.pone.0019101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533059	Green Published, gold			2022-12-25	WOS:000289719400058
J	Bazzini, S; Udine, C; Sass, A; Pasca, MR; Longo, F; Emiliani, G; Fondi, M; Perrin, E; Decorosi, F; Viti, C; Giovannetti, L; Leoni, L; Fani, R; Riccardi, G; Mahenthiralingam, E; Buroni, S				Bazzini, Silvia; Udine, Claudia; Sass, Andrea; Pasca, Maria Rosalia; Longo, Francesca; Emiliani, Giovanni; Fondi, Marco; Perrin, Elena; Decorosi, Francesca; Viti, Carlo; Giovannetti, Luciana; Leoni, Livia; Fani, Renato; Riccardi, Giovanna; Mahenthiralingam, Eshwar; Buroni, Silvia			Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; MULTIDRUG EFFLUX; MEMBRANE PROTEIN; CYSTIC-FIBROSIS; FLAGELLIN; MICROBIOLOGY; EXPRESSION; RESISTANCE; INFECTION	Burkholderia cenocepacia J2315 is representative of a highly problematic group of cystic fibrosis (CF) pathogens. Eradication of B. cenocepacia is very difficult with the antimicrobial therapy being ineffective due to its high resistance to clinically relevant antimicrobial agents and disinfectants. RND (Resistance-Nodulation-Cell Division) efflux pumps are known to be among the mediators of multidrug resistance in Gram-negative bacteria. Since the significance of the 16 RND efflux systems present in B. cenocepacia (named RND-1 to -16) has been only partially determined, the aim of this work was to analyze mutants of B. cenocepacia strain J2315 impaired in RND-4 and RND-9 efflux systems, and assess their role in the efflux of toxic compounds. The transcriptomes of mutants deleted individually in RND-4 and RND-9 (named D4 and D9), and a double-mutant in both efflux pumps (named D4-D9), were compared to that of the wild-type B. cenocepacia using microarray analysis. Microarray data were confirmed by qRT-PCR, phenotypic experiments, and by Phenotype MicroArray analysis. The data revealed that RND-4 made a significant contribution to the antibiotic resistance of B. cenocepacia, whereas RND-9 was only marginally involved in this process. Moreover, the double mutant D4-D9 showed a phenotype and an expression profile similar to D4. The microarray data showed that motility and chemotaxis-related genes appeared to be up-regulated in both D4 and D4-D9 strains. In contrast, these gene sets were down-regulated or expressed at levels similar to J2315 in the D9 mutant. Biofilm production was enhanced in all mutants. Overall, these results indicate that in B. cenocepacia RND pumps play a wider role than just in drug resistance, influencing additional phenotypic traits important for pathogenesis.	[Bazzini, Silvia; Udine, Claudia; Pasca, Maria Rosalia; Riccardi, Giovanna; Buroni, Silvia] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Sass, Andrea; Mahenthiralingam, Eshwar] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Longo, Francesca; Leoni, Livia] Univ Roma Tre, Dipartimento Biol, Rome, Italy; [Emiliani, Giovanni] CNR, Trees & Timber Inst, San Michele All Adige, Italy; [Fondi, Marco; Perrin, Elena; Fani, Renato] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Decorosi, Francesca; Viti, Carlo; Giovannetti, Luciana] Univ Florence, Dipartimento Biotecnol Agr, Florence, Italy	University of Pavia; Cardiff University; Roma Tre University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR); University of Florence; University of Florence	Bazzini, S (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	silvia.buroni@unipv.it	riccardi, gabriele/A-9269-2012; Mahenthiralingam, Eshwar/D-3333-2009; Leoni, Livia/F-2919-2013; Perrin, Elena/AAX-2762-2020; Emiliani, Giovanni/G-5023-2016; Sass, Andrea Michaela/G-6537-2014; Pasca, Maria Rosalia/J-8752-2016; Buroni, Silvia/AAX-5454-2020	Mahenthiralingam, Eshwar/0000-0001-9014-3790; Emiliani, Giovanni/0000-0002-1264-8002; Sass, Andrea Michaela/0000-0001-9396-7648; Pasca, Maria Rosalia/0000-0002-8906-4937; Fondi, Marco/0000-0001-9291-5467; RICCARDI, Giovanna/0000-0003-3295-0070; VITI, CARLO/0000-0001-7188-549X; Buroni, Silvia/0000-0002-6979-2275; Longo, Francesca/0000-0002-8733-5959; Perrin, Elena/0000-0001-5148-3178	Italian Cystic Fibrosis Research Foundation (FFC) [15/2009, 14/2010]; US Cystic Fibrosis Therapeutics [MAHENT06V0]	Italian Cystic Fibrosis Research Foundation (FFC)(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); US Cystic Fibrosis Therapeutics	This research was supported by grants from the Italian Cystic Fibrosis Research Foundation (FFC) to G.R. (Project FFC#15/2009, adopted by Pastificio Rana S.p.A.) and to L.L. (Project FFC#14/2010). A.S. and E.M. acknowledge support for the microarray analysis by the US Cystic Fibrosis Therapeutics program (grant number MAHENT06V0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Bochner BR, 2008, MOL MICROBIOL, V70, P274, DOI 10.1111/j.1365-2958.2008.06383.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; COENYE T, 2011, ANTIMICROB IN PRESS; Coenye T, 2010, FEMS IMMUNOL MED MIC, V59, P239, DOI 10.1111/j.1574-695X.2010.00682.x; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunha LG, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-4; Drevinek P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-121; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Foweraker J, 2009, BRIT MED BULL, V89, P93, DOI 10.1093/bmb/ldn050; Guglierame P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-66; Hales BA, 1998, J BACTERIOL, V180, P1110, DOI 10.1128/JB.180.5.1110-1118.1998; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Leungsakul T, 2005, APPL MICROBIOL BIOT, V69, P321, DOI 10.1007/s00253-005-1983-5; Liaudet L, 2003, SHOCK, V19, P131, DOI 10.1097/00024382-200302000-00008; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; MONTIE TC, 1983, J CLIN MICROBIOL, V18, P452, DOI 10.1128/JCM.18.3.452-456.1983; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; NIKAIDO H, 2009, BIOCHIM BIOPHYS ACTA, V179, P769; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Perrin E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-164; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Rampioni G, 2009, FEMS MICROBIOL LETT, V301, P210, DOI 10.1111/j.1574-6968.2009.01817.x; Rose H, 2009, J ANTIMICROB CHEMOTH, V63, P502, DOI 10.1093/jac/dkn540; Saiman L, 2003, INFECT CONT HOSP EP, V24, pS6, DOI 10.1086/503485; Sambrook J, 2001, MOL CLONING LAB MANU; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09	47	54	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18902	10.1371/journal.pone.0018902	http://dx.doi.org/10.1371/journal.pone.0018902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526150	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100035
J	Cornelissen, A; Ceyssens, PJ; T'Syen, J; Van Praet, H; Noben, JP; Shaburova, OV; Krylov, VN; Volckaert, G; Lavigne, R				Cornelissen, Anneleen; Ceyssens, Pieter-Jan; T'Syen, Jeroen; Van Praet, Helena; Noben, Jean-Paul; Shaburova, Olga V.; Krylov, Victor N.; Volckaert, Guido; Lavigne, Rob			The T7-Related Pseudomonas putida Phage phi 15 Displays Virion-Associated Biofilm Degradation Properties	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ESCHERICHIA-COLI; BACTERIAL BIOFILMS; POLYSACCHARIDE DEPOLYMERASE; CAPSULAR POLYSACCHARIDE; BACTERIOPHAGE INFECTION; AERUGINOSA; RESISTANT; ENZYME; VIM-2	Formation of a protected biofilm environment is recognized as one of the major causes of the increasing antibiotic resistance development and emphasizes the need to develop alternative antibacterial strategies, like phage therapy. This study investigates the in vitro degradation of single-species Pseudomonas putida biofilms, PpG1 and RD5PR2, by the novel phage phi 15, a 'T7-like virus' with a virion-associated exopolysaccharide (EPS) depolymerase. Phage phi 15 forms plaques surrounded by growing opaque halo zones, indicative for EPS degradation, on seven out of 53 P. putida strains. The absence of haloes on infection resistant strains suggests that the EPS probably act as a primary bacterial receptor for phage infection. Independent of bacterial strain or biofilm age, a time and dose dependent response of phi 15-mediated biofilm degradation was observed with generally a maximum biofilm degradation 8 h after addition of the higher phage doses (10(4) and 10(6) pfu) and resistance development after 24 h. Biofilm age, an in vivo very variable parameter, reduced markedly phage-mediated degradation of PpG1 biofilms, while degradation of RD5PR2 biofilms and phi 15 amplification were unaffected. Killing of the planktonic culture occurred in parallel with but was always more pronounced than biofilm degradation, accentuating the need for evaluating phages for therapeutic purposes in biofilm conditions. EPS degrading activity of recombinantly expressed viral tail spike was confirmed by capsule staining. These data suggests that the addition of high initial titers of specifically selected phages with a proper EPS depolymerase are crucial criteria in the development of phage therapy.	[Cornelissen, Anneleen; Ceyssens, Pieter-Jan; T'Syen, Jeroen; Van Praet, Helena; Volckaert, Guido; Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Louvain, Belgium; [Noben, Jean-Paul] Hasselt Univ, Sch Life Sci, Biomed Res Inst, Diepenbeek, Belgium; [Noben, Jean-Paul] Hasselt Univ, Transnat Univ Limburg, Diepenbeek, Belgium; [Shaburova, Olga V.; Krylov, Victor N.] State Inst Genet Ind Microorganisms, Moscow, Russia	KU Leuven; Hasselt University; Hasselt University	Cornelissen, A (corresponding author), Katholieke Univ Leuven, Lab Gene Technol, Louvain, Belgium.	rob.lavigne@biw.kuleuven.be	Shaburova, Olga/AAK-2332-2021; Noben, Jean-Paul/E-8066-2011	Noben, Jean-Paul/0000-0003-3368-5686; Ceyssens, Pieter-Jan/0000-0001-7735-8316; , Olga/0000-0003-0368-3794; Lavigne, Rob/0000-0001-7377-1314	K.U. Leuven [STRT1/10/021TBA]; 'Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen' (I.W.T., Belgium)	K.U. Leuven(KU Leuven); 'Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen' (I.W.T., Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was partially supported by the K.U. Leuven (STRT1/10/021TBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The authors thank Prof. M. Vaneechoutte (Laboratory Bacteriology, Ghent University Hospital, Belgium), Prof. R. De Mot (Centre of Microbial and Plant Genetics, K.U.Leuven, Belgium) and Prof. D. Springael (Division Soil and Water Management, K.U.Leuven, Belgium) for providing bacteria for this study. The authors are also grateful to Dr. Hans-W. Ackermann (Laval University, Quebec, Canada) for expert electron microscopy and to Dr. Y. Briers and Y. Born for providing information on the capsule staining assay (Institute of Food Science and Nutrition, ETH Zurich, Switzerland). Anneleen Cornelissen holds a predoctoral fellowship of the 'Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen' (I.W.T., Belgium). Pieter-Jan Ceyssens is a postdoctoral fellow of the 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen, Belgium).	ADAMS MH, 1959, BACTERIOPHAGES, P19; ANAISSIE E, 1987, AM J MED, V82, P1191, DOI 10.1016/0002-9343(87)90223-3; BARTELL PF, 1966, J BACTERIOL, V92, P56, DOI 10.1128/JB.92.1.56-62.1966; BARTELL PF, 1968, J BIOL CHEM, V243, P2077; BAYER ME, 1979, VIROLOGY, V94, P95, DOI 10.1016/0042-6822(79)90441-0; Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P291, DOI 10.1111/j.1574-6976.1997.tb00315.x; Bogaerts P, 2008, J ANTIMICROB CHEMOTH, V61, P749, DOI 10.1093/jac/dkm529; Bouallegue O, 2004, J HOSP INFECT, V57, P88, DOI 10.1016/j.jhin.2004.01.024; Briers Y, 2006, CELL MOL LIFE SCI, V63, P1899, DOI 10.1007/s00018-006-6183-7; Bull JJ, 2010, VIROLOGY, V398, P79, DOI 10.1016/j.virol.2009.11.040; Carson L, 2010, FEMS IMMUNOL MED MIC, V59, P447, DOI 10.1111/j.1574-695X.2010.00696.x; CASTILLO FJ, 1974, J VIROL, V14, P904, DOI 10.1128/JVI.14.4.904-909.1974; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Ceyssens PJ, 2008, J BACTERIOL, V190, P1429, DOI 10.1128/JB.01441-07; Clark JR, 2006, TRENDS BIOTECHNOL, V24, P212, DOI 10.1016/j.tibtech.2006.03.003; Corbin BD, 2001, CAN J MICROBIOL, V47, P680, DOI 10.1139/cjm-47-7-680; COSTERTON JW, 1995, J IND MICROBIOL, V15, P137, DOI 10.1007/BF01569816; CRAIG BA, 2006, TRENDS MICROBIOL, V14, P176; Doolittle MM, 1996, J IND MICROBIOL, V16, P331, DOI 10.1007/BF01570111; EKLUND C, 1962, J BACTERIOL, V84, P1209, DOI 10.1128/JB.84.6.1209-1215.1962; Francis T, 1934, J EXP MED, V59, P641, DOI 10.1084/jem.59.5.641; GEYER H, 1983, PURE APPL CHEM, V55, P637, DOI 10.1351/pac198855040637; Glonti T, 2010, J APPL MICROBIOL, V108, P695, DOI 10.1111/j.1365-2672.2009.04469.x; GOODNER KENNETH, 1932, JOUR EXP MED, V55, P393, DOI 10.1084/jem.55.3.393; Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kovalyova IV, 2003, VIROLOGY, V311, P305, DOI 10.1016/S0042-6822(03)00124-7; Lacqua A, 2006, APPL ENVIRON MICROB, V72, P956, DOI 10.1128/AEM.72.1.956-959.2006; Ladhani S, 1998, EUR J CLIN MICROBIOL, V17, P642, DOI 10.1007/s100960050148; Lee K, 2009, YONSEI MED J, V50, P335, DOI 10.3349/ymj.2009.50.3.335; LENSKI RE, 1988, ADV MICROB ECOL, P1; Linnerborg M, 2001, CARBOHYD RES, V333, P263, DOI 10.1016/S0008-6215(01)00159-8; Lombardi G, 2002, J CLIN MICROBIOL, V40, P4051, DOI 10.1128/JCM.40.11.4051-4055.2002; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Maneval WE, 1941, STAIN TECHNOL, V16, P13, DOI 10.3109/10520294109106189; Martino R, 1996, EUR J CLIN MICROBIOL, V15, P610, DOI 10.1007/BF01709374; MOLLINEUX IJ, 2006, BACTERIOPHAGES, P277; Monzon M, 2002, DIAGN MICR INFEC DIS, V44, P319, DOI 10.1016/S0732-8893(02)00464-9; NIMMICH W, 1994, J CLIN MICROBIOL, V32, P2843, DOI 10.1128/JCM.32.11.2843-2845.1994; Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74; Pearl S, 2008, PLOS BIOL, V6, P957, DOI 10.1371/journal.pbio.0060120; PELKONEN S, 1992, J BACTERIOL, V174, P7757, DOI 10.1128/JB.174.23.7757-7761.1992; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; PREHM P, 1976, J MOL BIOL, V101, P277, DOI 10.1016/0022-2836(76)90377-6; Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; Senda K, 1996, J CLIN MICROBIOL, V34, P2909, DOI 10.1128/JCM.34.12.2909-2913.1996; Shaburova OV, 2009, RUSS J GENET+, V45, P161, DOI 10.1134/S1022795409020057; Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-79; Steindler L, 2008, FEMS MICROBIOL LETT, V288, P102, DOI 10.1111/j.1574-6968.2008.01344.x; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Sutherland IW, 1999, CARBOHYD POLYM, V38, P319, DOI 10.1016/S0144-8617(98)00114-3; SUTHERLAND IW, 1995, FEMS MICROBIOL REV, V16, P323, DOI 10.1016/0168-6445(95)00020-D; Sutherland IW, 1977, SURFACE CARBOHYDRATE, P209; TOMLINSON S, 1985, J VIROL, V55, P374, DOI 10.1128/JVI.55.2.374-378.1985; von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003; Yan JJ, 2001, ANTIMICROB AGENTS CH, V45, P2224, DOI 10.1128/AAC.45.8.2224-2228.2001	61	119	123	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18597	10.1371/journal.pone.0018597	http://dx.doi.org/10.1371/journal.pone.0018597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526174	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100010
J	Guilini, K; Soltwedel, T; van Oevelen, D; Vanreusel, A				Guilini, Katja; Soltwedel, Thomas; van Oevelen, Dick; Vanreusel, Ann			Deep-Sea Nematodes Actively Colonise Sediments, Irrespective of the Presence of a Pulse of Organic Matter: Results from an In-Situ Experiment	PLOS ONE			English	Article							LIVING MARINE NEMATODES; MEIOFAUNAL COLONIZATION; VERTICAL-DISTRIBUTION; BENTHIC RESPONSE; ANTARCTIC SHELF; SOUTHERN BIGHT; DISTURBANCE; PHYTODETRITUS; MEIOBENTHOS; MARGIN	A colonisation experiment was performed in situ at 2500 m water depth at the Arctic deep-sea long-term observatory HAUSGARTEN to determine the response of deep-sea nematodes to disturbed, newly available patches, enriched with organic matter. Cylindrical tubes, laterally covered with a 500 mm mesh, were filled with azoic deep-sea sediment and C-13-labelled food sources (diatoms and bacteria). After 10 days of incubation the tubes were analysed for nematode response in terms of colonisation and uptake. Nematodes actively colonised the tubes, however with densities that only accounted for a maximum of 2.13% (51 ind. 10 cm(-2)) of the ambient nematode assemblages. Densities did not differ according to the presence or absence of organic matter, nor according to the type of organic matter added. The fact that the organic matter did not function as an attractant to nematodes was confirmed by the absence of notable C-13 assimilation by the colonising nematodes. Overall, colonisationappears to be a process that yields reproducible abundance and diversity patterns, with certain taxa showing more efficiency. Together with the high variability between the colonising nematode assemblages, this lends experimental support to the existence of a spatio-temporal mosaic that emerges from highly localised, partially stochastic community dynamics.	[Guilini, Katja; Vanreusel, Ann] Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium; [Soltwedel, Thomas] Alfred Wegener Inst, Dept Deep Sea Ecol & Technol, Bremerhaven, Germany; [van Oevelen, Dick] Netherlands Inst Ecol NIOO KNAW, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands	Ghent University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Guilini, K (corresponding author), Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium.	Katja.Guilini@UGent.be	Soltwedel, Thomas/P-1852-2016	Soltwedel, Thomas/0000-0002-8214-5937	European Community [GOCE-CT-2005- 511234, 226354]; Flanders Fund for Scientific Research (FWO) [3G0346]; FUNDEEP [01J14909]	European Community(European Commission); Flanders Fund for Scientific Research (FWO)(FWO); FUNDEEP	The research leading to the results presented in this manuscript received funding from the European Community's Sixth Framework Program under the Hotspot Ecosystem Research on the Margins of European Seas project (HERMES, http://www.eu-hermes.net), contract number GOCE-CT-2005- 511234, from the European Community's Seventh Framework Program under the Hotspot Ecosystem Research and Man's Impact on European Seas project (HERMIONE, http://www.eu-hermione.net), grant agreement number 226354, and from the Flanders Fund for Scientific Research (FWO, project number 3G0346, http://www.fwo.be) and Special Research Fund (BOF, the relation between function and biodiversity of Nematoda in the deep sea [FUNDEEP], project number 01J14909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONGI DM, 1983, MAR BIOL, V72, P325, DOI 10.1007/BF00396839; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Bauerfeind E, 2009, DEEP-SEA RES PT I, V56, P1471, DOI 10.1016/j.dsr.2009.04.011; Beaulieu SE, 2002, OCEANOGR MAR BIOL, V40, P171; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; BILLHEIMER LE, 1988, ESTUAR COAST SHELF S, V27, P335, DOI 10.1016/0272-7714(88)90060-1; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; CHANDLER GT, 1983, J EXP MAR BIOL ECOL, V69, P175, DOI 10.1016/0022-0981(83)90066-7; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clarke K.R., 2001, PRIMER V5 PLYMOUTH R, P91; DEBOVEE F, 1993, MAR ECOL-P S Z N I, V14, P159; Forest A, 2010, POLAR BIOL, V33, P1733, DOI 10.1007/s00300-010-0855-3; Franco MA, 2008, MAR ECOL PROG SER, V358, P51, DOI 10.3354/meps07361; GAGE JD, 1991, REV AQUAT SCI, V5, P49; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Giere, 2009, MEIOBENTHOLOGY THE M; Gooday AJ, 2002, J OCEANOGR, V58, P305, DOI 10.1023/A:1015865826379; Gooday AJ, 1996, J MAR BIOL ASSOC UK, V76, P297, DOI 10.1017/S0025315400030563; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; GRASSLE JF, 1987, DEEP-SEA RES, V34, P1911, DOI 10.1016/0198-0149(87)90091-4; GRASSLE JF, 1973, DEEP-SEA RES, V20, P643; Guilini K, 2010, LIMNOL OCEANOGR, V55, P1977, DOI 10.4319/lo.2010.55.5.1977; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HENDELBERG M, 1993, OPHELIA, V37, P83, DOI 10.1080/00785326.1993.10429909; Hockelmann C, 2004, LIMNOL OCEANOGR, V49, P1809, DOI 10.4319/lo.2004.49.5.1809; HORN HS, 1981, THEORETICAL ECOLOGY, P253; HOSTE E, 2006, THESIS GHENT U; Hoste E, 2007, DEEP-SEA RES PT I, V54, P109, DOI 10.1016/j.dsr.2006.09.007; Ingels J, 2011, J EXP MAR BIOL ECOL, V396, P185, DOI 10.1016/j.jembe.2010.10.018; Ingels J, 2010, MAR ECOL PROG SER, V406, P121, DOI 10.3354/meps08535; JOHNSON RG, 1970, AM NAT, V104, P285, DOI 10.1086/282662; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAMBSHEAD PJD, 1993, OCEANIS S D, V19, P5; LAMPITT RS, 1985, DEEP-SEA RES, V32, P885, DOI 10.1016/0198-0149(85)90034-2; LEE JJ, 1977, HELGOLAND WISS MEER, V30, P272, DOI 10.1007/BF02207841; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levin LA, 1999, MAR ECOL PROG SER, V182, P37, DOI 10.3354/meps182037; Menot L, 2009, DEEP-SEA RES PT II, V56, P2313, DOI 10.1016/j.dsr2.2009.04.012; Mincks SL, 2005, MAR ECOL PROG SER, V300, P3, DOI 10.3354/meps300003; Moens T, 2007, POLAR BIOL, V31, P1, DOI 10.1007/s00300-007-0323-x; Moodley L, 2002, MAR ECOL PROG SER, V236, P23, DOI 10.3354/meps236023; Nedwell DB, 1999, FEMS MICROBIOL ECOL, V30, P101; Neira C, 2001, DEEP-SEA RES PT I, V48, P2453, DOI 10.1016/S0967-0637(01)00018-8; Nomaki H, 2005, LIMNOL OCEANOGR, V50, P134, DOI 10.4319/lo.2005.50.1.0134; OLAFSSON E, 1990, MAR ECOL PROG SER, V65, P241, DOI 10.3354/meps065241; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Quijon PA, 2008, J EXP MAR BIOL ECOL, V366, P134, DOI 10.1016/j.jembe.2008.07.017; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Riemann F., 1974, MIKROFAUNA MEERESBOD, V40, P1; Ruhl HA, 2008, P NATL ACAD SCI USA, V105, P17006, DOI 10.1073/pnas.0803898105; Sachs O, 2009, DEEP-SEA RES PT I, V56, P1319, DOI 10.1016/j.dsr.2009.02.003; Sauter EJ, 2001, DEEP-SEA RES PT I, V48, P529, DOI 10.1016/S0967-0637(00)00061-3; SAVIDGE WB, 1988, J EXP MAR BIOL ECOL, V115, P137, DOI 10.1016/0022-0981(88)90099-8; Schewe I, 2003, POLAR BIOL, V26, P610, DOI 10.1007/s00300-003-0526-8; Schratzberger M, 2004, MAR BIOL, V145, P69, DOI 10.1007/s00227-004-1302-1; Seinhorst J. W., 1959, Nematologica, V4, P67; SHERMAN KM, 1980, J EXP MAR BIOL ECOL, V46, P59, DOI 10.1016/0022-0981(80)90091-X; SHERMAN KM, 1983, MAR ECOL PROG SER, V11, P23, DOI 10.3354/meps011023; SMITH CR, 1989, LIMNOL OCEANOGR, V34, P1263, DOI 10.4319/lo.1989.34.7.1263; SMITH CR, 1986, J MAR RES, V44, P567, DOI 10.1357/002224086788403015; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; SNELGROVE PVR, 1992, LIMNOL OCEANOGR, V37, P1543, DOI 10.4319/lo.1992.37.7.1543; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; Soltwedel T, 1997, OCEANOL ACTA, V20, P871; Soltwedel T., 2005, OCEANOGRAPHY, V18, P46, DOI [10.5670/oceanog.2005.24, DOI 10.5670/0CEAN0G.2005.24]; *STATSOFT INC, 2010, EL STAT TXB; Sweetman AK, 2008, MAR ECOL PROG SER, V355, P73, DOI 10.3354/meps07240; THISTLE D, 1981, MAR ECOL PROG SER, V6, P223, DOI 10.3354/meps006223; Tita G, 1999, J MAR BIOL ASSOC UK, V79, P1007, DOI 10.1017/S0025315499001241; Ullberg J, 2003, MAR ECOL PROG SER, V260, P141, DOI 10.3354/meps260141; Ullberg J, 2003, MAR BIOL, V143, P867, DOI 10.1007/s00227-003-1139-z; VANREUSEL A, 1990, CAH BIOL MAR, V31, P439; VINCX M, 1990, CAH BIOL MAR, V31, P107; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; WIDBOM B, 1983, OCEANOL ACTA SPEC, V213; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799; Zhou H, 2001, J EXP MAR BIOL ECOL, V256, P99, DOI 10.1016/S0022-0981(00)00310-5	80	35	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18912	10.1371/journal.pone.0018912	http://dx.doi.org/10.1371/journal.pone.0018912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526147	Green Published, gold			2022-12-25	WOS:000289671100037
J	Hoogerhout, P; Kamphuis, W; Brugghe, HF; Sluijs, JA; Timmermans, HAM; Westdijk, J; Zomer, G; Boog, CJP; Hol, EM; van den Dobbelsteen, GPJM				Hoogerhout, Peter; Kamphuis, Willem; Brugghe, Humphrey F.; Sluijs, Jacqueline A.; Timmermans, Hans A. M.; Westdijk, Janny; Zomer, Gijsbert; Boog, Claire J. P.; Hol, Elly M.; van den Dobbelsteen, Germie P. J. M.			A Cyclic Undecamer Peptide Mimics a Turn in Folded Alzheimer Amyloid beta and Elicits Antibodies against Oligomeric and Fibrillar Amyloid and Plaques	PLOS ONE			English	Article							DISEASE; IMMUNIZATION; VACCINATION; AD; IMMUNOTHERAPY; ASSEMBLIES; GENERATION; VACCINES; LESSONS; PROTEIN	The 39- to 42-residue amyloid beta (A beta) peptide is deposited in extracellular fibrillar plaques in the brain of patients suffering from Alzheimer's Disease (AD). Vaccination with these peptides seems to be a promising approach to reduce the plaque load but results in a dominant antibody response directed against the N-terminus. Antibodies against the N-terminus will capture A beta immediately after normal physiological processing of the amyloid precursor protein and therefore will also reduce the levels of non-misfolded A beta, which might have a physiologically relevant function. Therefore, we have targeted an immune response on a conformational neo-epitope in misfolded amyloid that is formed in advance of A beta-aggregation. A tetanus toxoid-conjugate of the 11-meric cyclic peptide A beta(22-28)-YNGK' elicited specific antibodies in Balb/c mice. These antibodies bound strongly to the homologous cyclic peptide-bovine serum albumin conjugate, but not to the homologous linear peptide-conjugate, as detected in vitro by enzyme-linked immunosorbent assay. The antibodies also bound-although more weakly-to A beta(1-42) oligomers as well as fibrils in this assay. Finally, the antibodies recognized A beta deposits in AD mouse and human brain tissue as established by immunohistological staining. We propose that the cyclic peptide conjugate might provide a lead towards a vaccine that could be administered before the onset of AD symptoms. Further investigation of this hypothesis requires immunization of transgenic AD model mice.	[Hoogerhout, Peter; Brugghe, Humphrey F.; Timmermans, Hans A. M.; Westdijk, Janny; Zomer, Gijsbert; Boog, Claire J. P.; van den Dobbelsteen, Germie P. J. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Dept Vaccinol, Bilthoven, Netherlands; [Kamphuis, Willem; Sluijs, Jacqueline A.; Hol, Elly M.] Royal Netherlands Acad Arts & Sci, NIN, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Hoogerhout, P (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Dept Vaccinol, Bilthoven, Netherlands.	Peter.Hoogerhout@rivm.nl	Hol, Elly/J-2025-2019; Hol, Elly M/F-1891-2013	Hol, Elly/0000-0001-5604-2603; Hol, Elly M/0000-0001-5604-2603				Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; BRUGGHE HF, 1994, INT J PEPT PROT RES, V43, P166; Cao CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-25; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; Drijfhout JW, 2000, PRACT APPROACH SER, V222, P229; Foster JK, 2009, MOL PSYCHIATR, V14, P239, DOI 10.1038/mp.2008.115; Ghochikyan A, 2006, VACCINE, V24, P2275, DOI 10.1016/j.vaccine.2005.11.039; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hawkes Cheryl A, 2007, Expert Rev Neurother, V7, P1535, DOI 10.1586/14737175.7.11.1535; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Huitinga I, 2008, J NEURAL TRANSM, V115, P1715; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lee M, 2005, ANN NEUROL, V58, P430, DOI 10.1002/ana.20592; Lemere CA, 2006, REJUV RES, V9, P77, DOI 10.1089/rej.2006.9.77; Lemere CA, 2004, AM J PATHOL, V165, P283, DOI 10.1016/S0002-9440(10)63296-8; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lemere CA, 2009, PROG BRAIN RES, V175, P83, DOI 10.1016/S0079-6123(09)17506-4; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Oomen CJ, 2005, J MOL BIOL, V351, P1070, DOI 10.1016/j.jmb.2005.06.061; Oomen CJ, 2003, J MOL BIOL, V328, P1083, DOI 10.1016/S0022-2836(03)00377-2; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pride M, 2008, NEURODEGENER DIS, V5, P194, DOI 10.1159/000113700; SARRIA AJ, 1994, J CELL SCI, V107, P1593; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schneeberger A, 2009, J NUTR HEALTH AGING, V13, P264, DOI 10.1007/s12603-009-0070-5; Solomon B, 2008, REJUV RES, V11, P349, DOI 10.1089/rej.2008.0689; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Vasilevko V, 2010, NEUROBIOL DIS, V39, P301, DOI 10.1016/j.nbd.2010.04.014; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Westdijk J, 1997, J IMMUNOASSAY, V18, P267, DOI 10.1080/01971529708005819; Wisniewski T, 2009, CNS NEUROL DISORD-DR, V8, P160, DOI 10.2174/187152709787847289; Woodhouse A, 2007, DRUG AGING, V24, P107, DOI 10.2165/00002512-200724020-00003; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zeng H, 2001, BIOL PSYCHIAT, V49, P248, DOI 10.1016/S0006-3223(00)01111-2; Zomer G, 2009, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P287, DOI 10.1142/9789812839589_0066	43	11	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19110	10.1371/journal.pone.0019110	http://dx.doi.org/10.1371/journal.pone.0019110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526148	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100053
J	Jeong, HW; Cui, W; Yang, YY; Lu, JY; He, J; Li, AL; Song, D; Guo, Y; Liu, BH; Chai, L				Jeong, Ha-Won; Cui, Wei; Yang, Youyang; Lu, Jiayun; He, Jie; Li, Ailing; Song, David; Guo, Ye; Liu, Bee H.; Chai, Li			SALL4, a Stem Cell Factor, Affects the Side Population by Regulation of the ATP-Binding Cassette Drug Transport Genes	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HUMAN TUMOR-CELLS; SLAM FAMILY RECEPTORS; HEMATOPOIETIC STEM; MULTIDRUG-RESISTANCE; EFFLUX CAPACITY; IN-VIVO; EXPRESSION; MARKER; SEQUESTRATION	Our previous work shows that the stem cell factor SALL4 plays a central role in embryonic and leukemic stem cells. In this study, we report that SALL4 expression was higher in drug resistant primary acute myeloid leukemic patients than those from drug-responsive cases. In addition, while overexpression of SALL4 led to drug resistance in cell lines, cells with decreased SALL4 expression were more sensitive to drug treatments than the parental cells. This led to our investigation of the implication of SALL4 in drug resistance and its role in side population (SP) cancer stem cells. SALL4 expression was higher in SP cells compared to non-SP cells by 2-4 fold in various malignant hematopoietic cell lines. Knocking down of SALL4 in isolated SP cells resulted in a reduction of SP cells, indicating that SALL4 is required for their self-renewal. The SP phenotype is known to be mediated by members of the ATP-binding cassette (ABC) drug transport protein family, such as ABCG2 and ABCA3. Using chromatin-immunoprecipitation (ChIP), quantitative reverse transcription polymerase chain reaction (qRT-PCR) and electrophoretic mobility shift assay(EMSA), we demonstrated that SALL4 was able to bind to the promoter region of ABCA3 and activate its expression while regulating the expression of ABCG2 indirectly. Furthermore, SALL4 expression was positively correlated to those of ABCG2 and ABCA3 in primary leukemic patient samples. Taken together, our results suggest a novel role for SALL4 in drug sensitivity, at least in part through the maintenance of SP cells, and therefore may be responsible for drug-resistance in leukemia. We are the first to demonstrate a direct link between stem cell factor SALL4, SP and drug resistance in leukemia.	[Jeong, Ha-Won; Yang, Youyang; Lu, Jiayun; He, Jie; Li, Ailing; Song, David; Chai, Li] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA; [Cui, Wei; Guo, Ye] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100037, Peoples R China; [Liu, Bee H.] Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, Singapore 117548, Singapore	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; National University of Singapore	Jeong, HW (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA.	lchai@partners.org		Chai, Li/0000-0003-1937-4750	National Institutes of Health [RO1HL092437, RO1HL092437-A1S1, PO1 DK080665, PO1HL095489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092437, P01HL095489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK080665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part through National Institutes of Health grants RO1HL092437, RO1HL092437-A1S1, PO1 DK080665 and PO1HL095489 (to Dr. Li Chai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cao DF, 2009, CANCER-AM CANCER SOC, V115, P2640, DOI 10.1002/cncr.24308; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chapuy B, 2008, LEUKEMIA, V22, P1576, DOI 10.1038/leu.2008.103; Chapuy B, 2009, HAEMATOL-HEMATOL J, V94, P1528, DOI 10.3324/haematol.2009.008631; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; Gillet JP, 2004, CANCER RES, V64, P8987, DOI 10.1158/0008-5472.CAN-04-1978; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goodell Margaret A, 2005, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0918s34; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hirschmann-Jax C, 2005, CELL CYCLE, V4, P203; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Huntly BJP, 2004, CANCER CELL, V6, P199, DOI 10.1016/j.ccr.2004.09.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Lin KK, 2006, METHOD ENZYMOL, V420, P255, DOI 10.1016/S0076-6879(06)20011-9; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Norwood K, 2004, LEUKEMIA RES, V28, P295, DOI 10.1016/j.leukres.2003.08.006; Steinbach D, 2002, LEUKEMIA, V16, P1443, DOI 10.1038/sj.leu.2402541; Steinbach D, 2007, LEUKEMIA, V21, P1172, DOI 10.1038/sj.leu.2404692; Steinbach D, 2006, CLIN CANCER RES, V12, P4357, DOI 10.1158/1078-0432.CCR-05-2587; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; Uchida N, 1996, EXP HEMATOL, V24, P649; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	38	60	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18372	10.1371/journal.pone.0018372	http://dx.doi.org/10.1371/journal.pone.0018372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526180	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100003
J	Perera, TD; Dwork, AJ; Keegan, KA; Thirumangalakudi, L; Lipira, CM; Joyce, N; Lange, C; Higley, JD; Rosoklija, G; Hen, R; Sackeim, HA; Coplan, JD				Perera, Tarique D.; Dwork, Andrew J.; Keegan, Kathryn A.; Thirumangalakudi, Lakshmi; Lipira, Cecilia M.; Joyce, Niamh; Lange, Christopher; Higley, J. Dee; Rosoklija, Gorazd; Hen, Rene; Sackeim, Harold A.; Coplan, Jeremy D.			Necessity of Hippocampal Neurogenesis for the Therapeutic Action of Antidepressants in Adult Nonhuman Primates	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; CHRONIC MILD STRESS; RAT DENTATE GYRUS; CHRONIC FLUOXETINE; RHESUS-MONKEYS; SYNAPTIC PLASTICITY; CELL-PROLIFERATION; DECLARATIVE MEMORY; MACAQUE MONKEYS; GRANULE CELLS	Background: Rodent studies show that neurogenesis is necessary for mediating the salutary effects of antidepressants. Nonhuman primate (NHP) studies may bridge important rodent findings to the clinical realm since NHP-depression shares significant homology with human depression and kinetics of primate neurogenesis differ from those in rodents. After demonstrating that antidepressants can stimulate neurogenesis in NHPs, our present study examines whether neurogenesis is required for antidepressant efficacy in NHPs. Materials/Methodology: Adult female bonnets were randomized to three social pens (N = 6 each). Pen-1 subjects were exposed to control-conditions for 15 weeks with half receiving the antidepressant fluoxetine and the rest receiving saline-placebo. Pen-2 subjects were exposed to 15 weeks of separation-stress with half receiving fluoxetine and half receiving placebo. Pen-3 subjects 2 weeks of irradiation (N = 4) or sham-irradiation (N = 2) and then exposed to 15 weeks of stress and fluoxetine. Dependent measures were weekly behavioral observations and postmortem neurogenesis levels. Results: Exposing NHPs to repeated separation stress resulted in depression-like behaviors (anhedonia and subordinance) accompanied by reduced hippocampal neurogenesis. Treatment with fluoxetine stimulated neurogenesis and prevented the emergence of depression-like behaviors. Ablation of neurogenesis with irradiation abolished the therapeutic effects of fluoxetine. Non-stressed controls had normative behaviors although the fluoxetine-treated controls had higher neurogenesis rates. Across all groups, depression-like behaviors were associated with decreased rates of neurogenesis but this inverse correlation was only significant for new neurons in the anterior dentate gyrus that were at the threshold of completing maturation. Conclusion: We provide evidence that induction of neurogenesis is integral to the therapeutic effects of fluoxetine in NHPs. Given the similarity between monkeys and humans, hippocampal neurogenesis likely plays a similar role in the treatment of clinical depression. Future studies will examine several outstanding questions such as whether neuro-suppression is sufficient for producing depression and whether therapeutic neuroplastic effects of fluoxetine are specific to antidepressants.	[Perera, Tarique D.; Dwork, Andrew J.; Keegan, Kathryn A.; Thirumangalakudi, Lakshmi; Lipira, Cecilia M.; Joyce, Niamh; Rosoklija, Gorazd; Hen, Rene; Sackeim, Harold A.] Columbia Univ, Dept Psychiat, Coll Phys & Surg, Med Ctr, New York, NY 10027 USA; [Perera, Tarique D.; Dwork, Andrew J.; Keegan, Kathryn A.; Thirumangalakudi, Lakshmi; Lipira, Cecilia M.; Joyce, Niamh; Rosoklija, Gorazd; Hen, Rene; Sackeim, Harold A.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Lange, Christopher] SUNY Brooklyn, Dept Radiol, Brooklyn, NY USA; [Coplan, Jeremy D.] SUNY Brooklyn, Dept Psychiat, Brooklyn, NY USA; [Higley, J. Dee] Brigham Young Univ, Provo, UT 84602 USA; [Dwork, Andrew J.; Rosoklija, Gorazd] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, Med Ctr, New York, NY USA; [Rosoklija, Gorazd] Macedonian Acad Sci & Arts, Skopje, Macedonia	Columbia University; New York State Psychiatry Institute; State University of New York (SUNY) System; State University of New York (SUNY) System; Brigham Young University; Columbia University	Perera, TD (corresponding author), Columbia Univ, Dept Psychiat, Coll Phys & Surg, Med Ctr, New York, NY 10027 USA.	tp119@columbia.edu			National Institute of Mental Health (NIMH) [KO8 MH70954, RO1MH59990]; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064168, K08MH070954, R01MH059990] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided to Dr. Perera from the National Institute of Mental Health (NIMH) (KO8 MH70954) and NARSAD (Young Investigator Award) and to Dr. Coplan from NIMH (RO1MH59990). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bremner JD, 2004, AM J PSYCHIAT, V161, P637, DOI 10.1176/appi.ajp.161.4.637; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Clewell T, 2004, J AM PSYCHOANAL ASS, V52, P43, DOI 10.1177/00030651040520010601; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Deuschle M, 2004, PHARMACOPSYCHIATRY, V37, P147, DOI 10.1055/s-2004-827168; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gu L, 1999, Chem Immunol, V72, P7, DOI 10.1159/000058723; Higley J, 1998, NEUROPSYCHOPHARMACOL, V18, P431; HOEHNSARIC R, 1990, J CLIN PSYCHOPHARM, V10, P343; Hoffman GE, 2002, J NEUROENDOCRINOL, V14, P259, DOI 10.1046/j.1365-2826.2002.00775.x; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Jayatissa MN, 2008, NEUROPHARMACOLOGY, V54, P530, DOI 10.1016/j.neuropharm.2007.11.009; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Koketsu D, 2003, J NEUROSCI, V23, P937; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Lee KJ, 2006, EXP MOL MED, V38, P44, DOI 10.1038/emm.2006.6; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Ngwenya LB, 2006, J COMP NEUROL, V498, P204, DOI 10.1002/cne.21045; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Perera TD, 2008, NEUROSCIENTIST, V14, P326, DOI 10.1177/1073858408317242; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Roche M, 2007, NEUROPSYCHOPHARMACOL, V32, P1312, DOI 10.1038/sj.npp.1301253; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosenblum LA, 2001, DEV PSYCHOBIOL, V39, P40, DOI 10.1002/dev.1026; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schindler MK, 2002, BIOL PSYCHIAT, V51, P827, DOI 10.1016/S0006-3223(01)01341-5; SEGMAN RH, 1995, PSYCHOPHARMACOLOGY, V119, P440, DOI 10.1007/BF02245860; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shively CA, 2005, BIOL PSYCHOL, V69, P67, DOI 10.1016/j.biopsycho.2004.11.006; Shors TJ, 2007, BIOL PSYCHIAT, V62, P487, DOI 10.1016/j.biopsych.2006.10.033; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; STEELE VE, 1976, RADIAT RES, V67, P21, DOI 10.2307/3574492; SUOMI SJ, 1991, CIBA F SYMP, V156, P171; Tonchev AB, 2003, MOL CELL NEUROSCI, V23, P292, DOI 10.1016/S1044-7431(03)00058-7; Trivedi Madhukar H, 2009, J Clin Psychiatry, V70, pe01; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Verwer RWH, 2007, BRAIN, V130, P3321, DOI 10.1093/brain/awm264; Vollmayr B, 2003, BIOL PSYCHIAT, V54, P1035, DOI 10.1016/S0006-3223(03)00527-4; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167	62	171	177	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e17600	10.1371/journal.pone.0017600	http://dx.doi.org/10.1371/journal.pone.0017600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525974	Green Published, Green Submitted, gold			2022-12-25	WOS:000289578600006
J	Wang, P; Lu, YL; Zheng, MM; Rong, TZ; Tang, QL				Wang, Pei; Lu, Yanli; Zheng, Mingmin; Rong, Tingzhao; Tang, Qilin			RAPD and Internal Transcribed Spacer Sequence Analyses Reveal Zea nicaraguensis as a Section Luxuriantes Species Close to Zea luxurians	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; PHYLOGENETIC-RELATIONSHIPS; GENETIC DIVERSITY; TEOSINTE; MAIZE; IDENTIFICATION; TAXONOMY; POACEAE; HYBRIDIZATION; SYSTEMATICS	Genetic relationship of a newly discovered teosinte from Nicaragua, Zea nicaraguensis with waterlogging tolerance, was determined based on randomly amplified polymorphic DNA (RAPD) markers and the internal transcribed spacer (ITS) sequences of nuclear ribosomal DNA using 14 accessions from Zea species. RAPD analysis showed that a total of 5,303 fragments were produced by 136 random decamer primers, of which 84.86% bands were polymorphic. RAPD-based UPGMA analysis demonstrated that the genus Zea can be divided into section Luxuriantes including Zea diploperennis, Zea luxurians, Zea perennis and Zea nicaraguensis, and section Zea including Zea mays ssp. mexicana, Zea mays ssp. parviglumis, Zea mays ssp. huehuetenangensis and Zea mays ssp. mays. ITS sequence analysis showed the lengths of the entire ITS region of the 14 taxa in Zea varied from 597 to 605 bp. The average GC content was 67.8%. In addition to the insertion/deletions, 78 variable sites were recorded in the total ITS region with 47 in ITS1, 5 in 5.8S, and 26 in ITS2. Sequences of these taxa were analyzed with neighbor-joining (NJ) and maximum parsimony (MP) methods to construct the phylogenetic trees, selecting Tripsacum dactyloides L. as the outgroup. The phylogenetic relationships of Zea species inferred from the ITS sequences are highly concordant with the RAPD evidence that resolved two major subgenus clades. Both RAPD and ITS sequence analyses indicate that Zea nicaraguensis is more closely related to Zea luxurians than the other teosintes and cultivated maize, which should be regarded as a section Luxuriantes species.	[Wang, Pei; Lu, Yanli; Zheng, Mingmin; Rong, Tingzhao; Tang, Qilin] Sichuan Agr Univ, Maize Res Inst, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University	Wang, P (corresponding author), Sichuan Agr Univ, Maize Res Inst, Yaan, Sichuan, Peoples R China.	tangql@sicau.edu.cn			National Program on Key Basic Research Project of China (973 Program) [2007CB108900]; National Natural Science Foundation of China [31071432]; Science and Technology Foundation for Youths of Sichuan Province [2007Q14-032]; Forage Breeding Project of Sichuan Province	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation for Youths of Sichuan Province; Forage Breeding Project of Sichuan Province	This work was supported by National Program on Key Basic Research Project of China (973 Program) (2007CB108900), National Natural Science Foundation of China (31071432), Science and Technology Foundation for Youths of Sichuan Province (2007Q14-032), and Forage Breeding Project of Sichuan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN BG, 1993, AM J BOT, V80, P222, DOI 10.2307/2445043; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Baltazar BM, 2005, THEOR APPL GENET, V110, P519, DOI 10.1007/s00122-004-1859-6; Baral J, 2002, J AM SOC HORTIC SCI, V127, P318, DOI 10.21273/JASHS.127.3.318; BEADLE G. W., 1932, Zeitschrift fur induktive Abstammungs- und Vererbungslehre, V62, P291, DOI 10.1007/BF01948608; Buckler ES, 1996, MOL BIOL EVOL, V13, P612, DOI 10.1093/oxfordjournals.molbev.a025621; Conti E, 1999, MOL PHYLOGENET EVOL, V13, P536, DOI 10.1006/mpev.1999.0673; DOEBLEY J, 1990, MAYDICA, V35, P143; DOEBLEY J, 1987, GENETICS, V117, P139; DOEBLEY JF, 1980, AM J BOT, V67, P982, DOI 10.2307/2442441; DOEBLEY JF, 1984, SYST BOT, V9, P203, DOI 10.2307/2418824; Dyer GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005734; Ellstrand NC, 2007, J HERED, V98, P183, DOI 10.1093/jhered/esm002; Fukunaga K, 2005, GENETICS, V169, P2241, DOI 10.1534/genetics.104.031393; Gaut BS, 2000, PLANT SYST EVOL, V224, P33, DOI 10.1007/BF00985265; Holderegger R, 2003, AM J BOT, V90, P931, DOI 10.3732/ajb.90.6.931; HSIAO C, 1994, GENOME, V37, P112, DOI 10.1139/g94-014; HSIAO C, 1995, THEOR APPL GENET, V90, P389, DOI 10.1007/BF00221981; Iltis HH, 2000, NOVON, V10, P382, DOI 10.2307/3392992; ILTIS HH, 1980, AM J BOT, V67, P994, DOI 10.2307/2442442; Jorgensen JL, 2003, AM J BOT, V90, P1470, DOI 10.3732/ajb.90.10.1470; Kermicle JL, 2006, MAYDICA, V51, P219; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lausser A, 2010, J EXP BOT, V61, P673, DOI 10.1093/jxb/erp330; Li YG, 1999, ANN BOT-LONDON, V84, P695, DOI 10.1006/anbo.1999.0973; Mano Y, 2006, PLANT SOIL, V281, P269, DOI 10.1007/s11104-005-4268-y; Mano Y, 2008, MOL BREEDING, V21, P327, DOI 10.1007/s11032-007-9132-8; Orr AR, 2004, AM J BOT, V91, P165, DOI 10.3732/ajb.91.2.165; PERNILLA ES, 2007, HEREDITAS, V144, P96; Rasul MG, 2007, SCI HORTIC-AMSTERDAM, V111, P271, DOI 10.1016/j.scienta.2006.10.023; ROHLF FJ, 1998, APPL BIOSTATISTICS; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Tang QiLin, 2000, Scientia Agricultura Sinica, V33, P62; Tang QiLin, 2006, Acta Agronomica Sinica, V32, P144; Tang QL, 2005, CROP SCI, V45, P717, DOI 10.2135/cropsci2005.0717; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vollbrecht E, 2005, BIOCHEM SOC T, V33, P1502, DOI 10.1042/BST20051502; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wilkes H.G., 1967, TEOSINTE CLOSEST REL; Wilson CA, 2003, SYST BOT, V28, P39; Zhang LB, 2001, AM J BOT, V88, P2331, DOI 10.2307/3558393	42	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e16728	10.1371/journal.pone.0016728	http://dx.doi.org/10.1371/journal.pone.0016728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525982	gold, Green Submitted, Green Published			2022-12-25	WOS:000289578600003
J	Lee, YH; Judge, AD; Seo, D; Kitade, M; Gomez-Quiroz, LE; Ishikawa, T; Andersen, JB; Kim, BK; Marquardt, JU; Raggi, C; Avital, I; Conner, EA; MacLachlan, I; Factor, VM; Thorgeirsson, SS				Lee, Y-H; Judge, A. D.; Seo, D.; Kitade, M.; Gomez-Quiroz, L. E.; Ishikawa, T.; Andersen, J. B.; Kim, B-K; Marquardt, J. U.; Raggi, C.; Avital, I.; Conner, E. A.; MacLachlan, I.; Factor, V. M.; Thorgeirsson, S. S.			Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response	ONCOGENE			English	Article						hepatocellular carcinoma; CSN5; targeted siRNA therapeutics; SNALP	BINDING PROTEIN-1 EXPRESSION; CYCLE INHIBITOR P27(KIP1); COP9 SIGNALOSOME; RNA INTERFERENCE; BREAST-CANCER; IN-VIVO; PANCREATIC-CANCER; SYNTHETIC SIRNA; GENE-EXPRESSION; C-MYC	Development of targeted therapy for hepatocellular carcinoma (HCC) remains a major challenge. We have recently identified an elevated expression of the fifth subunit of COP9 signalosome (CSN5) in early HCC as compared with dysplastic stage. In the present study, we explored the possibility of CSN5 being a potential therapeutic target for HCC. Our results show that CSN5 knockdown by small-interfering (si) RNA caused a strong induction of apoptosis and inhibition of cell-cycle progression in HCC cells in vitro. The down-regulation of CSN5 was sufficient to interfere with CSN function as evidenced by the accumulation of neddylated Cullin 1 and changes in the protein levels of CSN-controlled substrates SKP2, p53, p27 and nuclear factor-kappa B, albeit to a different degree depending on the HCC cell line, which could account for the CSN5 knockdown phenotype. The transcriptomic analysis of CSN5 knockdown signature showed that the anti-proliferative effect was driven by a common subset of molecular alterations including down-regulation of cyclin-dependent kinase 6 (CDK6) and integrin beta 1 (ITGB1), which were functionally interconnected with key oncogenic regulators MYC and TGF beta 1 involved in the control of proliferation, apoptotic cell death and HCC progression. Consistent with microarray analysis, western blotting revealed that CSN5 depletion increased phosphorylation of Smad 2/3, key mediators of TGF beta 1 signaling, decreased the protein levels of ITGB1, CDK6 and cyclin D1 and caused reduced expression of anti-apoptotic Bcl-2, while elevating the levels of proapoptotic Bak. A chemically modified variant of CSN5 siRNA was then selected for in vivo application based on the growth inhibitory effect and minimal induction of unwanted immune response. Systemic delivery of the CSN5 3/8 variant by stable-nucleic-acid-lipid particles significantly suppressed the tumor growth in Huh7-luc(+) orthotopic xenograft model. Taken together, these results indicate that CSN5 has a pivotal role in HCC pathogenesis and maybe an attractive molecular target for systemic HCC therapy. Oncogene (2011) 30, 4175-4184; doi:10.1038/onc.2011.126; published online 18 April 2011	[Lee, Y-H; Seo, D.; Kitade, M.; Gomez-Quiroz, L. E.; Ishikawa, T.; Andersen, J. B.; Kim, B-K; Marquardt, J. U.; Raggi, C.; Conner, E. A.; Factor, V. M.; Thorgeirsson, S. S.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Judge, A. D.; MacLachlan, I.] Tekmira Pharmaceut Corp, Burnaby, BC, Canada; [Avital, I.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Thorgeirsson, SS (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, 37 Convent Dr Dr MSC,Room 4146A, Bethesda, MD 20892 USA.	snorri_thorgeirsson@nih.gov	RAGGI, Chiara/U-3081-2017; Gomez-Quiroz, Luis/L-8415-2013	RAGGI, Chiara/0000-0003-2473-3535; Marquardt, Jens/0000-0002-8314-2682; Andersen, Jesper B/0000-0003-1760-5244; Gomez-Quiroz, Luis Enrique/0000-0002-5704-5985	Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE [ZIABC011175] Funding Source: NIH RePORTER	Center for Cancer Research, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Intramural Research Program of the Center for Cancer Research, NCI.	Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Arsura M, 2005, CANCER LETT, V229, P157, DOI 10.1016/j.canlet.2005.07.008; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Berasain C, 2003, HEPATOLOGY, V38, P148, DOI 10.1053/jhep.2003.50269; Brasse D, 2010, INT J CANCER, V127, P1347, DOI 10.1002/ijc.25309; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Chamovitz DA, 2009, EMBO REP, V10, P352, DOI 10.1038/embor.2009.33; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esteva FJ, 2003, CLIN CANCER RES, V9, P5652; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukumoto A, 2004, ONCOL REP, V11, P277; Fukumoto A, 2006, FEBS LETT, V580, P5836, DOI 10.1016/j.febslet.2006.09.042; Goto A, 2004, PATHOL INT, V54, P675, DOI 10.1111/j.1440-1827.2004.01679.x; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hokaiwado N, 2008, IDRUGS, V11, P274; Ito Y, 2003, ANTICANCER RES, V23, P4121; Ivan D, 2004, MODERN PATHOL, V17, P811, DOI 10.1038/modpathol.3800123; Jeffs LB, 2005, PHARM RES-DORDR, V22, P362, DOI 10.1007/s11095-004-1873-z; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Kashiwakura Y, 2008, CANCER RES, V68, P8333, DOI 10.1158/0008-5472.CAN-08-0080; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Kouvaraki MA, 2003, CANCER RES, V63, P2977; Lee JS, 2004, GASTROENTEROLOGY, V127, pS51, DOI 10.1053/j.gastro.2004.09.015; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Morrissey DV, 2005, HEPATOLOGY, V41, P1349, DOI 10.1002/hep.20702; Okabe H, 2001, CANCER RES, V61, P2129; Pai SI, 2006, GENE THER, V13, P464, DOI 10.1038/sj.gt.3302694; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roberts LR, 2005, SEMIN LIVER DIS, V25, P212, DOI 10.1055/s-2005-871200; Rossi JJ, 2006, GENE THER, V13, P583, DOI 10.1038/sj.gt.3302661; Rust C, 2000, AM J MED, V108, P567, DOI 10.1016/S0002-9343(00)00370-3; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sui L, 2001, CLIN CANCER RES, V7, P4130; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tsubari M, 1999, MOL CELL BIOL, V19, P3654; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Zamore PD, 2001, NAT STRUCT BIOL, V8, P746, DOI 10.1038/nsb0901-746; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	53	57	59	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	40					4175	4184		10.1038/onc.2011.126	http://dx.doi.org/10.1038/onc.2011.126			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	833ZK	21499307	Green Accepted			2022-12-25	WOS:000295924600004
J	Kubota, H; Wu, X; Goodyear, SM; Avarbock, MR; Brinster, RL				Kubota, Hiroshi; Wu, Xin; Goodyear, Shaun M.; Avarbock, Mary R.; Brinster, Ralph L.			Glial cell line-derived neurotrophic factor and endothelial cells promote self-renewal of rabbit germ cells with spermatogonial stem cell properties	FASEB JOURNAL			English	Article						spermatogenesis; testis; growth factors	IN-VITRO; MOUSE TESTES; UNDIFFERENTIATED SPERMATOGONIA; LENTIVIRAL VECTOR; TRANSPLANTATION; CULTURE; MICE; RAT; EXPRESSION; FATE	Previous studies suggest that exogenous factors crucial for spermatogonial stem cell (SSC) self-renewal are conserved among several mammalian species. Since glial cell line-derived neurotrophic factor (GDNF) and fibroblast growth factor 2 (FGF2) are critical for rodent SSC self-renewal, we hypothesized that they might promote self-renewal of nonrodent SSCs. Therefore, we cultured testicular germ cells from prepubertal rabbits in the presence of GDNF and FGF2 and found they proliferated indefinitely as cellular clumps that displayed characteristics previously identified for rodent SSCs. The rabbit germ cells could not be maintained on mouse embryonic fibroblast (STO) feeders that support rodent SSC self-renewal in vitro but were rather supported on mouse yolk sac-derived endothelial cell (C166) feeder layers. Proliferation of rabbit germ cells was dependent on GDNF. Of critical importance was that clump-forming rabbit germ cells colonized seminiferous tubules of immunodeficient mice, proliferated for at least 6 mo, while retaining an SSC phenotype in the testes of recipient mice, indicating that they were rabbit SSCs. This study demonstrates that GDNF is a mitogenic factor promoting self-renewal that is conserved between rodent and rabbit SSCs; with an evolutionary separation of similar to 60 million years. These findings provide a foundation to study the mechanisms governing SSC self-renewal in nonrodent species.-Kubota, H., Wu, X., Goodyear, S. M., Avarbock, M. R., Brinster, R. L. Glial cell line-derived neurotrophic factor and endothelial cells promote self-renewal of rabbit germ cells with spermatogonial stem cell properties. FASEB J. 25, 2604-2614 (2011). www.fasebj.org	[Kubota, Hiroshi; Wu, Xin; Goodyear, Shaun M.; Avarbock, Mary R.; Brinster, Ralph L.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Brinster, RL (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3850 Baltimore Ave, Philadelphia, PA 19104 USA.	cpope@vet.upenn.edu	wu, xin/A-3010-2011; KUBOTA, Hiroshi/N-7832-2019	Brinster, Ralph/0000-0003-1408-7656; Goodyear, Shaun/0000-0003-0217-0890; wu, xin/0000-0001-7938-9407	U.S. National Institute of Child Health and Human Development [HD 052728]; Robert J. Kleberg, Jr., and Helen C. Kleberg Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052728] Funding Source: NIH RePORTER	U.S. National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Robert J. Kleberg, Jr., and Helen C. Kleberg Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Dr. Zhiyv Niu for helpful comments on the manuscript, Drs. L. Wang and J. Johnston for construction and production of lentivirus vectors at the Penn Vector Core, C. Freeman and R. Naroznowski for assistance with animal maintenance and experimentation, and J. Hayden for photography. Financial support for the research was from the U.S. National Institute of Child Health and Human Development (HD 052728) and the Robert J. Kleberg, Jr., and Helen C. Kleberg Foundation.	Aponte PM, 2008, REPRODUCTION, V136, P543, DOI 10.1530/REP-07-0419; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; De Rooij DG, 2000, J ANDROL, V21, P776; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Hermann BP, 2009, HUM REPROD, V24, P1704, DOI 10.1093/humrep/dep073; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kobinger GP, 2001, NAT BIOTECHNOL, V19, P225, DOI 10.1038/85664; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Kubota H, 2008, METHOD CELL BIOL, V86, P59, DOI 10.1016/S0091-679X(08)00004-6; Kubota H, 2009, BIOL REPROD, V81, P293, DOI 10.1095/biolreprod.109.075960; Lu LS, 1996, P NATL ACAD SCI USA, V93, P14782, DOI 10.1073/pnas.93.25.14782; Matzuk MM, 2004, P NATL ACAD SCI USA, V101, P16395, DOI 10.1073/pnas.0407344101; McKenna MC, 1997, CLASSIFICATION MAMMA; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Nagano M, 2001, P NATL ACAD SCI USA, V98, P13090, DOI 10.1073/pnas.231473498; Nagano M, 2002, FERTIL STERIL, V78, P1225, DOI 10.1016/S0015-0282(02)04345-5; Nagano M, 2001, BIOL REPROD, V64, P1409, DOI 10.1095/biolreprod64.5.1409; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Reding SC, 2010, REPRODUCTION, V139, P893, DOI 10.1530/REP-09-0513; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Spinnler K, 2010, HUM REPROD, V25, P2181, DOI 10.1093/humrep/deq170; Viglietto G, 2000, INT J ONCOL, V16, P689; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	50	47	54	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2604	2614		10.1096/fj.10-175802	http://dx.doi.org/10.1096/fj.10-175802			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21525489	Green Published			2022-12-25	WOS:000293337800011
J	Li, ZJ; Burns, AR; Miller, SB; Smith, CW				Li, Zhijie; Burns, Alan R.; Miller, Sarah Byeseda; Smith, C. Wayne			CCL20, gamma delta T cells, and IL-22 in corneal epithelial healing	FASEB JOURNAL			English	Article						ICAM-1; IL-17A; IL-23R; neutrophils; platelets	ENDOTHELIAL GROWTH-FACTOR; STIMULATES AXONAL OUTGROWTH; SPINAL-CORD-INJURY; MHC CLASS-II; CHEMOKINE RECEPTOR; NEUROTROPHIC KERATOPATHY; ANTIMICROBIAL PEPTIDES; INTRACELLULAR POOL; HUMAN NEUTROPHILS; DENDRITIC CELLS	After corneal epithelial abrasion, leukocytes and platelets rapidly enter the corneal stroma, and CCR6(+) IL-17(+) gamma delta T cells migrate into the epithelium. gamma delta T-cell-deficient (TCR delta(-/-)) mice have significantly reduced inflammation and epithelial wound healing. Epithelial CCL20 mRNA increased 19-fold at 3 h, and protein increased similar to 16-fold at 6 h after injury. Systemic or topical treatment of wild-type C57BL/6 mice with anti-CCL20 reduced gamma delta T-cell accumulation in the cornea by > 50% with a concomitant decrease in epithelial healing and stromal inflammation. In addition to CCR6 and IL-17, corneal gamma delta T cells stained positively for ROR gamma t, IL-23R, and IL-22. Anti-IL-22 reduced peak cell division of the healing epithelium by 52%. Treatment of TCR delta(-/-) mice with rIL-22 significantly promoted wound closure, with peak epithelial cell division increased > 3-fold. In addition, rIL-22 restored neutrophil and platelet influx in the TCR delta(-/-) mice to wildtype levels and increased CXCL1 production by wounded corneal explants > 2-fold. These results indicate that an important aspect of the healing response to corneal epithelial abrasion includes CCL20-dependent influx of CCR6(+) IL-17(+) IL-22(+) gamma delta T cells and that IL-22 contributes to the inflammatory response and promotes epithelial healing.-Li, Z., Burns, A. R., Byeseda Miller, S., Smith, C. W. CCL20, gamma delta T cells, and IL-22 in corneal epithelial healing. FASEB J. 25, 2659-2668 (2011). www.fasebj.org	[Smith, C. Wayne] Baylor Coll Med, Dept Pediat, Sect Leukocyte Biol, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Smith, C. Wayne] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Li, Zhijie] Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Li, Zhijie] Jinan Univ, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Jinan University; Jinan University; University of Houston System; University of Houston	Smith, CW (corresponding author), Baylor Coll Med, Dept Pediat, Sect Leukocyte Biol, Childrens Nutr Res Ctr, 1100 Bates,Rm 6014, Houston, TX 77030 USA.	cwsmith@bcm.tmc.edu			U.S. National Institutes of Health [EY-018239, EY-00751, EY-017120]; National Natural Science Foundation of China [39970250, 30772387, 81070703]; NATIONAL EYE INSTITUTE [P30EY007551, R01EY017120, R01EY018239] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health grants EY-018239, EY-00751, and EY-017120 and National Natural Science Foundation of China grants 39970250, 30772387, and 81070703.	ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Byeseda SE, 2009, AM J PATHOL, V175, P571, DOI 10.2353/ajpath.2009.090112; Chinnery HR, 2007, INVEST OPHTH VIS SCI, V48, P1568, DOI 10.1167/iovs.06-0746; Cole N, 2000, IMMUNOL CELL BIOL, V78, P1, DOI 10.1046/j.1440-1711.2000.00860.x; Cooper D, 2003, AM J PHYSIOL-GASTR L, V284, pG1027, DOI 10.1152/ajpgi.00457.2002; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; FERRARI G, 2010, INVEST OPHTHALMOL VI; Gagen D, 2010, EXP EYE RES, V91, P676, DOI 10.1016/j.exer.2010.08.007; Gan L, 1999, INVEST OPHTH VIS SCI, V40, P575; Gaudry M, 1997, BLOOD, V90, P4153, DOI 10.1182/blood.V90.10.4153; Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hamrah P, 2003, J LEUKOCYTE BIOL, V74, P172, DOI 10.1189/jlb.1102544; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; HELDIN CH, 1981, BIOCHEM J, V193, P907, DOI 10.1042/bj1930907; Huang LC, 2007, CURR EYE RES, V32, P595, DOI 10.1080/02713680701446653; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin YP, 2007, MOL VIS, V13, P626; KAREY KP, 1989, BLOOD, V74, P1093; Knickelbein JE, 2009, OPHTHALMOL EYE DIS, V1, P45; Laurence A, 2008, NAT MED, V14, P247, DOI 10.1038/nm0308-247; Lee EJ, 2010, INVEST OPHTH VIS SCI, V51, P2101, DOI 10.1167/iovs.08-2213; Li Z, 2007, AM J PATHOL, V171, P838, DOI 10.2353/ajpath.2007.070008; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P4794, DOI 10.1167/iovs.06-0381; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Li ZJ, 2004, J APPL PHYSIOL, V97, P641, DOI 10.1152/japplphysiol.00200.2004; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Nagano T, 2003, INVEST OPHTH VIS SCI, V44, P3810, DOI 10.1167/iovs.03-0189; Nishida T, 2009, CURR OPIN OPHTHALMOL, V20, P276, DOI 10.1097/ICU.0b013e32832b758f; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Ouyang WJ, 2010, CYTOKINE GROWTH F R, V21, P435, DOI 10.1016/j.cytogfr.2010.10.007; Pereira HA, 2004, INVEST OPHTH VIS SCI, V45, P4284, DOI 10.1167/iovs.03-1052; Petrescu MS, 2007, INVEST OPHTH VIS SCI, V48, P5023, DOI 10.1167/iovs.07-0562; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Robker RL, 2004, OBES RES, V12, P936, DOI 10.1038/oby.2004.114; Rollin S, 2004, BLOOD, V103, P3789, DOI 10.1182/blood-2003-07-2272; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Scapini P, 2004, J IMMUNOL, V172, P5034, DOI 10.4049/jimmunol.172.8.5034; Scapini P, 1999, J IMMUNOL METHODS, V232, P121, DOI 10.1016/S0022-1759(99)00170-2; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shirane J, 2004, CURR EYE RES, V28, P297, DOI 10.1076/ceyr.28.5.297.28682; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Taichman NS, 1997, J LEUKOCYTE BIOL, V62, P397, DOI 10.1002/jlb.62.3.397; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Valeri CR, 2006, TRANSFUSION, V46, P225, DOI 10.1111/j.1537-2995.2006.00705.x; von Vietinghoff S, 2009, J IMMUNOL, V183, P865, DOI 10.4049/jimmunol.0804080; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698; Yamagami S, 2005, INVEST OPHTH VIS SCI, V46, P1201, DOI 10.1167/iovs.04-0658; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yin ZN, 2002, J IMMUNOL, V168, P1566, DOI 10.4049/jimmunol.168.4.1566; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com	67	77	82	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2659	2668		10.1096/fj.11-184804	http://dx.doi.org/10.1096/fj.11-184804			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21518851	Green Published			2022-12-25	WOS:000293337800016
J	Tae, HS; Cui, YF; Karunasekara, Y; Board, PG; Dulhunty, AF; Casarotto, MG				Tae, Han-Shen; Cui, Yanfang; Karunasekara, Yamuna; Board, Philip G.; Dulhunty, Angela F.; Casarotto, Marco G.			Cyclization of the Intrinsically Disordered alpha(1S) Dihydropyridine Receptor II-III Loop Enhances Secondary Structure and in Vitro Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL RYANODINE RECEPTORS; RELEASE CHANNELS; CYTOPLASMIC LOOP; MINI-INTEINS; SPRY DOMAIN; C-REGION; MUSCLE; CONTRACTION; SEQUENCE; CALSEQUESTRIN	A key component of excitation contraction (EC) coupling in skeletal muscle is the cytoplasmic linker (II-III loop) between the second and third transmembrane repeats of the alpha(1S) subunit of the dihydropyridine receptor (DHPR). The II-III loop has been previously examined in vitro using a linear II-III loop with unrestrained N- and C-terminal ends. To better reproduce the loop structure in its native environment (tethered to the DHPR transmembrane domains), we have joined the N- and C termini using intein-mediated technology. Circular dichroism and NMR spectroscopy revealed a structural shift in the cyclized loop toward a protein with increased alpha-helical and beta-strand structure in a region of the loop implicated in its in vitro function and also in a critical region for EC coupling. The affinity of binding of the II-III loop binding to the SPRY2 domain of the skeletal ryanodine receptor (RyR1) increased 4-fold, and its ability to activate RyR1 channels in lipid bilayers was enhanced 3-fold by cyclization. These functional changes were predicted consequences of the structural enhancement. We suggest that tethering the N- and C termini stabilized secondary structural elements in the DHPR II-III loop and may reflect structural and dynamic characteristics of the loop that are inherent in EC coupling.	[Tae, Han-Shen; Cui, Yanfang; Karunasekara, Yamuna; Board, Philip G.; Dulhunty, Angela F.; Casarotto, Marco G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Casarotto, MG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Marco.Casarotto@anu.edu.au	Dulhunty, Angela/AAO-5421-2020; Tae, Han-Shen/AAA-1904-2020; Casarotto, Marco/D-8704-2011	Tae, Han-Shen/0000-0001-8961-7194; Dulhunty, Angela/0000-0001-9493-4944; Casarotto, Marco/0000-0002-0571-7671; Cui, Yanfang/0000-0002-1041-9097	National Health and Medical Research Council [471418]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Grant 471418.	Ahern CA, 2001, BIOPHYS J, V81, P3294, DOI 10.1016/S0006-3495(01)75963-2; Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Beard NA, 2008, CELL CALCIUM, V44, P363, DOI 10.1016/j.ceca.2008.01.005; Carbonneau L, 2005, BIOPHYS J, V89, P243, DOI 10.1529/biophysj.104.056218; Casarotto MG, 2000, J BIOL CHEM, V275, P11631, DOI 10.1074/jbc.275.16.11631; Casarotto MG, 2001, BIOPHYS J, V80, P2715, DOI 10.1016/S0006-3495(01)76240-6; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Copello JA, 1997, BIOPHYS J, V73, P141, DOI 10.1016/S0006-3495(97)78055-X; Cui YF, 2009, INT J BIOCHEM CELL B, V41, P677, DOI 10.1016/j.biocel.2008.08.004; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; Dulhunty AF, 2005, FRONT BIOSCI, V10, P1368, DOI 10.2741/1626; Dulhunty AF, 2005, BIOCHEM J, V385, P803, DOI 10.1042/BJ20041152; Dulhunty AF, 2002, PROG BIOPHYS MOL BIO, V79, P45, DOI 10.1016/S0079-6107(02)00013-5; ELHAYEK R, 1995, J BIOL CHEM, V270, P22116, DOI 10.1074/jbc.270.38.22116; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Green D, 2003, BIOCHEM J, V370, P517, DOI 10.1042/BJ20021488; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; Kugler G, 2004, ARCH BIOCHEM BIOPHYS, V427, P91, DOI 10.1016/j.abb.2004.04.007; Kugler G, 2004, J BIOL CHEM, V279, P4721, DOI 10.1074/jbc.M307538200; Leong P, 1998, J BIOL CHEM, V273, P7791, DOI 10.1074/jbc.273.14.7791; LU XY, 1994, J BIOL CHEM, V269, P6511; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Oddoux S, 2009, J BIOL CHEM, V284, P34918, DOI 10.1074/jbc.M109.022442; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Shrivastava IH, 2004, BIOPHYS J, V87, P2255, DOI 10.1529/biophysj.104.040592; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Stange M, 2001, BIOPHYS J, V81, P1419, DOI 10.1016/S0006-3495(01)75797-9; Tae HS, 2009, CLIN EXP PHARMACOL P, V36, P346, DOI 10.1111/j.1440-1681.2008.05130.x; Tae H, 2009, EUR BIOPHYS J BIOPHY, V39, P51, DOI 10.1007/s00249-009-0455-8; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Wei L, 2006, BIOPHYS J, V91, P1288, DOI 10.1529/biophysj.106.082610; Wei L, 2009, INT J BIOCHEM CELL B, V41, P2214, DOI 10.1016/j.biocel.2009.04.017; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilkens CM, 2001, P NATL ACAD SCI USA, V98, P5892, DOI 10.1073/pnas.101618098; Williams NK, 2005, J MOL BIOL, V346, P1095, DOI 10.1016/j.jmb.2004.12.037; Williams NK, 2002, J BIOL CHEM, V277, P7790, DOI 10.1074/jbc.M110303200; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5	49	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22589	22599		10.1074/jbc.M110.205476	http://dx.doi.org/10.1074/jbc.M110.205476			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525002	Green Published, hybrid			2022-12-25	WOS:000291719900066
J	Talfournier, F; Stines-Chaumeil, C; Branlant, G				Talfournier, Francois; Stines-Chaumeil, Claire; Branlant, Guy			Methylmalonate-semialdehyde Dehydrogenase from Bacillus subtilis SUBSTRATE SPECIFICITY AND COENZYME A BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; SITE-DIRECTED MUTAGENESIS; STREPTOCOCCUS-MUTANS; PSEUDOMONAS-AERUGINOSA; CATALYTIC MECHANISM; STEADY-STATE; ACTIVE-SITE; RAT-LIVER; DEFICIENCY	Methylmalonate-semialdehyde dehydrogenase (MSDH) belongs to the CoA-dependent aldehyde dehydrogenase subfamily. It catalyzes the NAD-dependent oxidation of methylmalonate semialdehyde (MMSA) to propionyl-CoA via the acylation and deacylation steps. MSDH is the only member of the aldehyde dehydrogenase superfamily that catalyzes a beta-decarboxylation process in the deacylation step. Recently, we demonstrated that the beta-decarboxylation is rate-limiting and occurs before CoA attack on the thiopropionyl enzyme intermediate. Thus, this prevented determination of the transthioesterification kinetic parameters. Here, we have addressed two key aspects of the mechanism as follows: 1) the molecular basis for recognition of the carboxylate of MMSA; and 2) how CoA binding modulates its reactivity. We substituted two invariant arginines, Arg-124 and Arg-301, by Leu. The second-order rate constant for the acylation step for both mutants was decreased by at least 50-fold, indicating that both arginines are essential for efficient MMSA binding through interactions with the carboxylate group. To gain insight into the transthioesterification, we substituted MMSA with propionaldehyde, as both substrates lead to the same thiopropionyl enzyme intermediate. This allowed us to show the following: 1) the pK(app) of CoA decreases by similar to 3 units upon binding to MSDH in the deacylation step; and 2) the catalytic efficiency of the transthioesterification is increased by at least 10(4)-fold relative to a chemical model. Moreover, we observed binding of CoA to the acylation complex, supporting a CoA-binding site distinct from that of NAD(H).	[Talfournier, Francois; Stines-Chaumeil, Claire; Branlant, Guy] Nancy Univ, Fac Sci & Technol, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Unite Mixte Rech CNRS,Univ Henri Poincare AREMS 7, F-54506 Vandoeuvre Les Nancy, France	Universite de Lorraine	Talfournier, F (corresponding author), Nancy Univ, Fac Sci & Technol, ARN RNP Struct Fonct Maturat Enzymol Mol & Struct, Unite Mixte Rech CNRS,Univ Henri Poincare AREMS 7, Bd Aiguillettes,BP 70239, F-54506 Vandoeuvre Les Nancy, France.	francois.talfournier@maem.uhp-nancy.fr; guy.branlant@maem.uhp-nancy.fr			CNRS; University of Nancy I; Institut Federatif de Recherche 111 Bioingenierie; Region Lorraine; French Research Ministry	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nancy I; Institut Federatif de Recherche 111 Bioingenierie; Region Lorraine(Region Grand-Est); French Research Ministry(Ministry of Research, France)	This work was supported in part by the CNRS, the University of Nancy I, the Institut Federatif de Recherche 111 Bioingenierie, and local funds from the Region Lorraine.; Supported by the French Research Ministry.	BANNERJEE D, 1970, J BIOL CHEM, V245, P1828; BRADBURY SL, 1971, J BIOL CHEM, V246, P1834; Chambliss KL, 2000, J INHERIT METAB DIS, V23, P497, DOI 10.1023/A:1005616315087; CHASE JFA, 1966, BIOCHEM BIOPH RES CO, V23, P208, DOI 10.1016/0006-291X(66)90529-8; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Fry J, 2001, MOL PLANT MICROBE IN, V14, P1016, DOI 10.1094/MPMI.2001.14.8.1016; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; GRAY RGF, 1987, BIOCHEM MED METAB B, V38, P121, DOI 10.1016/0885-4505(87)90069-7; HUPE DJ, 1977, J AM CHEM SOC, V99, P451, DOI 10.1021/ja00444a023; JOCELYN PC, 1972, BIOCH SH GROUP; Kim YG, 2009, EMBO J, V28, P959, DOI 10.1038/emboj.2009.40; KUPIECKI FP, 1960, BIOCH PREP, V7, P69; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; MACGIBBON AKH, 1977, BIOCHEM J, V167, P469, DOI 10.1042/bj1670469; Marchal S, 2002, J BIOL CHEM, V277, P39235, DOI 10.1074/jbc.M205633200; Marchal S, 2000, BIOCHEMISTRY-US, V39, P3327, DOI 10.1021/bi9914208; Roe CR, 1998, MOL GENET METAB, V65, P35, DOI 10.1006/mgme.1998.2737; SHONE CC, 1981, BIOCHEMISTRY-US, V20, P7494, DOI 10.1021/bi00529a026; SOHLING B, 1993, EUR J BIOCHEM, V212, P121, DOI 10.1111/j.1432-1033.1993.tb17641.x; STEELE MI, 1992, J BIOL CHEM, V267, P13585; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Stines-Chaumeil C, 2006, BIOCHEM J, V395, P107, DOI 10.1042/BJ20051525; Talfournier F, 2009, CHEM-BIOL INTERACT, V178, P79, DOI 10.1016/j.cbi.2008.10.045; Tanaka N, 2005, J PROTEOME RES, V4, P1575, DOI 10.1021/pr050114f; VALLARI RC, 1981, ARCH BIOCHEM BIOPHYS, V212, P9, DOI 10.1016/0003-9861(81)90338-6; Vedadi M, 1997, EUR J BIOCHEM, V246, P698, DOI 10.1111/j.1432-1033.1997.t01-1-00698.x; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; Yoshida KI, 1997, J BACTERIOL, V179, P4591, DOI 10.1128/jb.179.14.4591-4598.1997; Zhang YX, 1996, J BACTERIOL, V178, P490, DOI 10.1128/jb.178.2.490-495.1996	31	24	26	5	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21971	21981		10.1074/jbc.M110.213280	http://dx.doi.org/10.1074/jbc.M110.213280			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515690	Green Published, hybrid			2022-12-25	WOS:000291719900004
J	Guzik-Lendrum, S; Nagy, A; Takagi, Y; Houdusse, A; Sellers, JR				Guzik-Lendrum, Stephanie; Nagy, Attila; Takagi, Yasuharu; Houdusse, Anne; Sellers, James R.			Drosophila melanogaster Myosin-18 Represents a Highly Divergent Motor with Actin Tethering Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM-DISCOIDEUM MYOSIN; TUMOR-SUPPRESSOR GENE; SKELETAL-MUSCLE MYOSIN; KINETIC MECHANISM; ADENOSINE-TRIPHOSPHATASE; HEAVY-MEROMYOSIN; BINDING DOMAIN; SMOOTH-MUSCLE; IN-VITRO; ACTOMYOSIN	The gene encoding Drosophila myosin-18 is complex and can potentially yield six alternatively spliced mRNAs. One of the major features of this myosin is an N-terminal PDZ domain that is included in some of the predicted alternatively spliced products. To explore the biochemical properties of this protein, we engineered two minimal motor domain (MMD)-like constructs, one that contains the N-terminal PDZ (myosin-18 M-PDZ) domain and one that does not (myosin-18 M-Delta PDZ). These two constructs were expressed in the baculovirus/Sf9 system. The results suggest that Drosophila myosin-18 is highly divergent from most other myosins in the superfamily. Neither of the MMD constructs had an actin-activated MgATPase activity, nor did they even bind ATP. Both myosin-18 M-PDZ and M-Delta PDZ proteins bound to actin with K-d values of 2.61 and 1.04 mu M, respectively, but only about 50-75% of the protein bound to actin even at high actin concentrations. Unbound proteins from these actin binding assays reiterated the 60% saturation maximum, suggesting an equilibrium between actin-binding and non-actin-binding conformations of Drosophila myosin-18 in vitro. Neither the binding affinity nor the substoichiometric binding was significantly affected by ATP. Optical trapping of single molecules in three-bead assays showed short lived interactions of the myosin-18 motors with actin filaments. Combined, these data suggest that this highly divergent motor may function as an actin tethering protein.	[Guzik-Lendrum, Stephanie; Nagy, Attila; Takagi, Yasuharu; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Guzik-Lendrum, Stephanie] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Houdusse, Anne] Inst Curie CNRS, UMR144, F-75248 Paris 05, France	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov			NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004232] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health intramural funds from the NHLBI.	Ajima R, 2007, BIOCHEM BIOPH RES CO, V356, P851, DOI 10.1016/j.bbrc.2007.03.060; Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; BATTERS C, 2004, J BIOL CHEM, V359, P1895; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Harlow E., 2006, COLD SPRING HARB PRO, V2006; HARRIS DE, 1994, J MUSCLE RES CELL M, V15, P11, DOI 10.1007/BF00123828; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; HEMMINGS L, 1996, P NATL ACAD SCI USA, V109, P2715; HOMSHER E, 1992, J AM PHYSL, V262, pC714; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; JANSON LW, 1992, CELL MOTIL CYTOSKEL, V22, P274, DOI 10.1002/cm.970220407; Kempler K, 2007, BIOCHEMISTRY-US, V46, P4280, DOI 10.1021/bi062112u; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kuhlman PA, 1998, J MUSCLE RES CELL M, V19, P491, DOI 10.1023/A:1005304408812; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Nakano T, 2005, GENE CHROMOSOME CANC, V43, P162, DOI 10.1002/gcc.20180; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Nishioka M, 2002, P NATL ACAD SCI USA, V99, P12269, DOI 10.1073/pnas.192445899; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Onishi H, 1997, BIOCHEMISTRY-US, V36, P3767, DOI 10.1021/bi9630772; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rio D. C., 2010, COLD SPRING HARB PRO; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Ruppel KM, 1996, MOL BIOL CELL, V7, P1123, DOI 10.1091/mbc.7.7.1123; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sellers J. R., 1999, MYOSINS; Sellers JR, 1996, J MUSCLE RES CELL M, V17, P7, DOI 10.1007/BF00140320; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Vanzi F, 2005, BIOPHYS J, V89, P1909, DOI 10.1529/biophysj.104.056283; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; WINDER SJ, 1995, J CELL SCI, V108, P63; Woodward SKA, 1995, BIOCHEMISTRY-US, V34, P16056, DOI 10.1021/bi00049a020; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Yanaihara N, 2004, INT J CANCER, V112, P150, DOI 10.1002/ijc.20339; Zolkiewski M, 1996, BIOPHYS CHEM, V59, P365, DOI 10.1016/0301-4622(95)00129-8	55	25	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21755	21766		10.1074/jbc.M111.218669	http://dx.doi.org/10.1074/jbc.M111.218669			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498886	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000291464700071
J	Luoto, HH; Belogurov, GA; Baykov, AA; Lahti, R; Malinen, AM				Luoto, Heidi H.; Belogurov, Georgiy A.; Baykov, Alexander A.; Lahti, Reijo; Malinen, Anssi M.			Na+-translocating Membrane Pyrophosphatases Are Widespread in the Microbial World and Evolutionarily Precede H+-translocating Pyrophosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC PYROPHOSPHATASE; RHODOSPIRILLUM-RUBRUM; PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; SEQUENCE; EXPRESSION; SODIUM; PPASE; ARABIDOPSIS; GENE	Membrane pyrophosphatases (PPases), divided into K+-dependent and K+-independent subfamilies, were believed to pump H+ across cell membranes until a recent demonstration that some K+-dependent PPases function as Na+ pumps. Here, we have expressed seven evolutionarily important putative PPases in Escherichia coli and estimated their hydrolytic, Na+ transport, and H+ transport activities as well as their K+ and Na+ requirements in inner membrane vesicles. Four of these enzymes (from Anaerostipes caccae, Chlorobium limicola, Clostridium tetani, and Desulfuromonas acetoxidans) were identified as K+-dependent Na+ transporters. Phylogenetic analysis led to the identification of a monophyletic clade comprising characterized and predicted Na+-transporting PPases (Na+-PPases) within the K+-dependent subfamily. H+-transporting PPases (H+-PPases) are more heterogeneous and form at least three independent clades in both subfamilies. These results suggest that rather than being a curious rarity, Na+-PPases predominantly constitute the K+-dependent subfamily. Furthermore, Na+-PPases possibly preceded H+-PPases in evolution, and transition from Na+ to H+ transport may have occurred in several independent enzyme lineages. Site-directed mutagenesis studies facilitated the identification of a specific Glu residue that appears to be central in the transport mechanism. This residue is located in the cytoplasm-membrane interface of transmembrane helix 6 in Na+-PPases but shifted to within the membrane or helix 5 in H+-PPases. These results contribute to the prediction of the transport specificity and K+ dependence for a particular membrane PPase sequence based on its position in the phylogenetic tree, identity of residues in the K+ dependence signature, and position of the membrane-located Glu residue.	[Luoto, Heidi H.; Belogurov, Georgiy A.; Lahti, Reijo; Malinen, Anssi M.] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland; [Baykov, Alexander A.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	University of Turku; Lomonosov Moscow State University	Malinen, AM (corresponding author), Univ Turku, Dept Biochem & Food Chem, Vatselankatu 2, FIN-20014 Turku, Finland.	anssi.malinen@utu.fi	Baykov, Alexander/AAH-5301-2021; Baykov, Alexander A/C-7981-2012	Belogurov, Georgiy/0000-0002-3070-6843; Malinen, Anssi/0000-0003-2987-2649; Baykov, Alexander/0000-0002-2495-8200	Academy of Finland [114706, 130581, 139031]; Ministry of Education of Finland; Russian Foundation for Basic Research [09-04-00869]	Academy of Finland(Academy of Finland); Ministry of Education of Finland; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The work was supported by Academy of Finland Grants 114706, 130581, and 139031; a grant from the Ministry of Education of Finland (for the National Graduate School in Informational and Structural Biology); and Russian Foundation for Basic Research Grant 09-04-00869.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; BALTSCHEFFSKY M, 1967, NATURE, V216, P241, DOI 10.1038/216241a0; Baumer Sebastian, 2002, Archaea, V1, P1, DOI 10.1155/2002/371325; BAYKOV AA, 1981, ANAL BIOCHEM, V116, P1, DOI 10.1016/0003-2697(81)90313-4; BAYKOV AA, 1993, FEBS LETT, V327, P199, DOI 10.1016/0014-5793(93)80169-U; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Belogurov GA, 2005, BIOCHEMISTRY-US, V44, P2088, DOI 10.1021/bi048429g; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Belogurov GA, 2002, J BIOL CHEM, V277, P22209, DOI 10.1074/jbc.M202951200; Biegel E, 2011, J BIOL CHEM, V286, P6080, DOI 10.1074/jbc.M110.192823; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRITTEN CJ, 1992, J BIOL CHEM, V267, P21850; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Docampo R, 2008, CURR PHARM DESIGN, V14, P882, DOI 10.2174/138161208784041079; Drozdowicz YM, 1999, FEBS LETT, V460, P505, DOI 10.1016/S0014-5793(99)01404-0; Drozdowicz YM, 2003, J BIOL CHEM, V278, P1075, DOI 10.1074/jbc.M209436200; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fukuda A, 2006, PLANT PHYSIOL BIOCH, V44, P351, DOI 10.1016/j.plaphy.2006.06.012; Garcia-Contreras R, 2004, J BACTERIOL, V186, P6651, DOI 10.1128/JB.186.19.6651-6655.2004; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; Holm NG, 2011, ORIGINS LIFE EVOL B, V41, P483, DOI 10.1007/s11084-011-9235-4; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Li B, 2008, PLANT BIOTECHNOL J, V6, P146, DOI 10.1111/j.1467-7652.2007.00301.x; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Lopez-Marques RL, 2004, J BACTERIOL, V186, P5418, DOI 10.1128/JB.186.16.5418-5426.2004; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; Lv S, 2008, PLANT CELL PHYSIOL, V49, P1150, DOI 10.1093/pcp/pcn090; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; Malinen AM, 2008, BIOCHEMISTRY-US, V47, P13447, DOI 10.1021/bi801803b; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; MOYLE J, 1972, FEBS LETT, V23, P233, DOI 10.1016/0014-5793(72)80349-1; Mulkidjanian AY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-13; Mulkidjanian AY, 2008, BBA-BIOENERGETICS, V1777, P985, DOI 10.1016/j.bbabio.2008.04.028; Mulkidjanian AY, 2009, TRENDS BIOCHEM SCI, V34, P206, DOI 10.1016/j.tibs.2009.01.005; Pan YJ, 2011, BBA-BIOENERGETICS, V1807, P59, DOI 10.1016/j.bbabio.2010.10.006; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pirovano W, 2006, NUCLEIC ACIDS RES, V34, P6540, DOI 10.1093/nar/gkl901; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Serrano A, 2007, IUBMB LIFE, V59, P76, DOI 10.1080/15216540701258132; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JA, 2011, PLANT PHYSIOL BIOCH, V49, P33, DOI 10.1016/j.plaphy.2010.09.014; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340	53	42	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21633	21642		10.1074/jbc.M111.244483	http://dx.doi.org/10.1074/jbc.M111.244483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527638	Green Published, hybrid			2022-12-25	WOS:000291464700060
J	Masuho, I; Wakasugi-Masuho, H; Posokhova, EN; Patton, JR; Martemyanov, KA				Masuho, Ikuo; Wakasugi-Masuho, Hideko; Posokhova, Ekaterina N.; Patton, Joseph R.; Martemyanov, Kirill A.			Type 5 G Protein beta Subunit (G beta 5) Controls the Interaction of Regulator of G Protein Signaling 9 (RGS9) with Membrane Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE ACCELERATING PROTEIN; DEP DOMAIN; PROTEOLYTIC STABILITY; MICE LACKING; EXPRESSION; R7BP; COMPLEX; R9AP; LOCALIZATION; RECEPTOR	The R7 family of regulators of G protein signaling (RGS) proteins, comprising RGS6, RGS7, RGS9, and RGS11, regulate neuronal G protein signaling pathways. All members of the R7 RGS form trimeric complexes with the atypical G protein beta subunit, G beta 5, and membrane anchor R7BP or R9AP. Association with G beta 5 and membrane anchors has been shown to be critical for maintaining proteolytic stability of the R7 RGS proteins. However, despite its functional importance, the mechanism of how R7 RGS forms complexes with G beta 5 and membrane anchors remains poorly understood. Here, we used protein-protein interaction, co-localization, and protein stability assays to show that association of RGS9 with membrane anchors requires G beta 5. We further establish that the recruitment of R7BP to the complex requires an intact interface between the N-terminal lobe of RGS9 and protein interaction surface of G beta 5. Site-directed mutational analysis reveals that distinct molecular determinants in the interface between G beta 5 and N-terminal Dishevelled, EGL-10, Pleckstrin/DEP Helical Extension (DEP/DHEY) domains are differentially involved in R7BP binding and proteolytic stabilization. On the basis of these findings, we conclude that G beta 5 contributes to the formation of the binding site to the membrane anchors and thus is playing a central role in the assembly of the proteolytically stable trimeric complex and its correct localization in the cell.	[Masuho, Ikuo; Wakasugi-Masuho, Hideko; Posokhova, Ekaterina N.; Patton, Joseph R.; Martemyanov, Kirill A.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Martemyanov, KA (corresponding author), Scripps Res Inst, Dept Sci, 130 Scripps Way,3C2, Jupiter, FL 33458 USA.	kirill@scripps.edu	Masuho, Ikuo/J-6115-2014		National Institutes of Health [EY018139, DA026405, DA021743]; NATIONAL EYE INSTITUTE [R01EY018139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021743, K02DA026405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants EY018139 (to K. A. M.), DA026405 (to K. A. M.), and DA021743 (to K. A. M.).	Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Cabrera-Vera TM, 2004, P NATL ACAD SCI USA, V101, P16339, DOI 10.1073/pnas.0407416101; Cao Y, 2010, J NEUROSCI, V30, P13784, DOI 10.1523/JNEUROSCI.1191-10.2010; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Howlett AC, 2009, J BIOL CHEM, V284, P16386, DOI 10.1074/jbc.M900800200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Kehrl JH, 2006, IMMUNOL RES, V34, P211, DOI 10.1385/IR:34:3:211; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Keresztes G, 2003, MOL CELL NEUROSCI, V24, P687, DOI 10.1016/S1044-7431(03)00231-8; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Martemyanov KA, 2009, PROG MOL BIOL TRANSL, V86, P205, DOI 10.1016/S1877-1173(09)86007-9; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Patikoglou GA, 2002, J BIOL CHEM, V277, P47004, DOI 10.1074/jbc.M208186200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Porter MY, 2010, J BIOL CHEM, V285, P41100, DOI 10.1074/jbc.M110.163600; Posokhova E, 2010, J PROTEOME RES, V9, P1510, DOI 10.1021/pr901022m; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Slepak VZ, 2009, PROG MOL BIOL TRANSL, V86, P157, DOI 10.1016/S1877-1173(09)86006-7; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Thomas EA, 1998, J NEUROSCI RES, V52, P118, DOI 10.1002/(SICI)1097-4547(19980401)52:1<118::AID-JNR11>3.0.CO;2-6; Traynor JR, 2009, TRENDS PHARMACOL SCI, V30, P105, DOI 10.1016/j.tips.2008.11.006; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; Wieland T, 2007, CURR OPIN PHARMACOL, V7, P201, DOI 10.1016/j.coph.2006.11.007; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang K, 1999, GENE, V240, P23, DOI 10.1016/S0378-1119(99)00393-5	47	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21806	21813		10.1074/jbc.M111.241513	http://dx.doi.org/10.1074/jbc.M111.241513			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21511947	hybrid, Green Published			2022-12-25	WOS:000291464700075
J	Hamouda, AK; Stewart, DS; Husain, SS; Cohen, JB				Hamouda, Ayman K.; Stewart, Deirdre S.; Husain, S. Shaukat; Cohen, Jonathan B.			Multiple Transmembrane Binding Sites for p-Trifluoromethyldiazirinyl-etomidate, a Photoreactive Torpedo Nicotinic Acetylcholine Receptor Allosteric Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; NONCOMPETITIVE ANTAGONISTS; MOLECULAR-MECHANISMS; ANESTHETIC ETOMIDATE; OPEN-STATE; IDENTIFICATION; AGONIST; TIME; SUBUNIT; PROTON	Photoreactive derivatives of the general anesthetic etomidate have been developed to identify their binding sites in gamma-aminobutyric acid, type A and nicotinic acetylcholine receptors. One such drug, [H-3]TDBzl-etomidate (4-[3-(trifluoromethyl)3H-diazirin-3-yl]benzyl-[H-3]1-(1-phenylethyl)-1H-imidazole-5- carboxylate), acts as a positive allosteric potentiator of Torpedo nACh receptor (nAChR) and binds to a novel site in the transmembrane domain at the gamma-alpha subunit interface. To extend our understanding of the locations of allosteric modulator binding sites in the nAChR, we now characterize the interactions of a second aryl diazirine etomidate derivative, TFD-etomidate (ethyl-1-(1-(4-(3-trifluoromethyl)-3H-diazirin-3-yl)phenylethyl)1H-imidazole-5-carboxylate). TFD-etomidate inhibited acetylcholine-induced currents with an IC50 = 4 mu M, whereas it inhibited the binding of [H-3]phencyclidine to the Torpedo nAChR ion channel in the resting and desensitized states with IC50 values of 2.5 and 0.7 mM, respectively. Similar to [H-3] TDBzl-etomidate, [H-3]TFD-etomidate bound to a site at the gamma-alpha subunit interface, photolabeling alpha M2-10 (alpha Ser-252) and gamma Met-295 and gamma Met-299 within gamma M3, and to a site in the ion channel, photolabeling amino acids within each subunit M2 helix that line the lumen of the ion channel. In addition, [H-3]TFD-etomidate photolabeled in an agonist-dependent manner amino acids within the delta subunit M2-M3 loop (delta Ile-288) and the delta subunit transmembrane helix bundle (delta Phe-232 and delta Cys-236 within delta M1). The fact that TFD-etomidate does not compete with ion channel blockers at concentrations that inhibit acetylcholine responses indicates that binding to sites at the gamma-alpha subunit interface and/or within delta subunit helix bundle mediates the TFD-etomidate inhibitory effect. These results also suggest that the gamma-alpha subunit interface is a binding site for Torpedo nAChR negative allosteric modulators (TFD-etomidate) and for positive modulators (TDBzl-etomidate).	[Hamouda, Ayman K.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Stewart, Deirdre S.; Husain, S. Shaukat] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	Jonathan_Cohen@hms.harvard.edu		Hamouda, Ayman/0000-0001-7819-3074	United States Public Health Service [GM-58448]; Howard Hughes Biomedical Research Support Program for Medical Schools; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Howard Hughes Biomedical Research Support Program for Medical Schools; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States Public Health Service Grant GM-58448 (to J. B. C., Stuart Forman, and Keith W. Miller) and by an award to Harvard Medical School from the Howard Hughes Biomedical Research Support Program for Medical Schools.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Arias HR, 2010, ADV PROTEIN CHEM STR, V80, P153, DOI [10.1016/S1876-1623(10)80005-7, 10.1016/B978-0-12-381264-3.00005-9]; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Chiara DC, 2009, MOL PHARMACOL, V75, P1084, DOI 10.1124/mol.108.054353; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Garcia G, 2007, BIOCHEMISTRY-US, V46, P10296, DOI 10.1021/bi7008163; Hamouda AK, 2008, BIOCHEMISTRY-US, V47, P12787, DOI 10.1021/bi801476j; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Husain SS, 2010, J MED CHEM, V53, P6432, DOI 10.1021/jm100498u; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; Middleton RE, 1999, MOL PHARMACOL, V56, P290, DOI 10.1124/mol.56.2.290; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; OSWALD RE, 1983, BIOCHEMISTRY-US, V22, P3128, DOI 10.1021/bi00282a015; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sigel E, 2005, MED CHEM REV ONLINE, V2, P251, DOI [10.2174/1567203054065673, DOI 10.2174/1567203054065673]; SIGRIST H, 1990, J PHOTOCH PHOTOBIO B, V7, P277, DOI 10.1016/1011-1344(90)85162-P; Sullivan DA, 2000, J BIOL CHEM, V275, P12651, DOI 10.1074/jbc.275.17.12651; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wells GB, 2008, FRONT BIOSCI-LANDMRK, V13, P5479, DOI 10.2741/3094; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	43	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20466	20477		10.1074/jbc.M111.219071	http://dx.doi.org/10.1074/jbc.M111.219071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498509	Green Published, hybrid			2022-12-25	WOS:000291267600034
J	Han, Y; Noam, Y; Lewis, AS; Gallagher, JJ; Wadman, WJ; Baram, TZ; Chetkovich, DM				Han, Ye; Noam, Yoav; Lewis, Alan S.; Gallagher, Johnie J.; Wadman, Wytse J.; Baram, Tallie Z.; Chetkovich, Dane M.			Trafficking and Gating of Hyperpolarization-activated Cyclic Nucleotide-gated Channels Are Regulated by Interaction with Tetratricopeptide Repeat-containing Rab8b-interacting Protein (TRIP8b) and Cyclic AMP at Distinct Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HCN PACEMAKER CHANNELS; IMPORT RECEPTOR PEX5P; SURFACE EXPRESSION; CAMP MODULATION; SUBUNITS	Ion channel trafficking and gating are often influenced by interactions with auxiliary subunits. Tetratricopeptide repeat-containing Rab8b-interacting protein (TRIP8b) is an auxiliary subunit for neuronal hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. TRIP8b interacts directly with two distinct sites of HCN channel pore-forming subunits to control channel trafficking and gating. Here we use mutagenesis combined with electrophysiological studies to define and distinguish the functional importance of the HCN/TRIP8b interaction sites. Interaction with the last three amino acids of the HCN1 C terminus governed the effect of TRIP8b on channel trafficking, whereas TRIP8b interaction with the HCN1 cyclic nucleotide binding domain (CNBD) affected trafficking and gating. Biochemical studies revealed that direct interaction between TRIP8b and the HCN1 CNBD was disrupted by cAMP and that TRIP8b binding to the CNBD required an arginine residue also necessary for cAMP binding. In accord, increasing cAMP levels in cells antagonized the up-regulation of HCN1 channels mediated by a TRIP8b construct binding the CNBD exclusively. These data illustrate the distinct roles of the two TRIP8b-HCN interaction domains and suggest that TRIP8b and cAMP may directly compete for binding the HCN CNBD to control HCN channel gating, kinetics, and trafficking.	[Han, Ye; Lewis, Alan S.; Gallagher, Johnie J.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Noam, Yoav; Baram, Tallie Z.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Noam, Yoav; Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Noam, Yoav; Wadman, Wytse J.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Amsterdam	Chetkovich, DM (corresponding author), 303 E Chicago Ave,Ward Bldg,Room 10-201, Chicago, IL 60611 USA.	d-chetkovich@northwestern.edu	Baram, Tallie Z/J-6447-2014; Lewis, Alan/AAV-9582-2021; Chetkovich, Dane/AAV-5457-2021	Lewis, Alan/0000-0002-7165-5376; 	National Institutes of Health [NS05595, NS059934, NS064757, NS35439]; Brain Research Foundation; Dutch Epilepsy Fund (NEF) [08-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934, R37NS035439, F30NS064757, R01NS035439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation; Dutch Epilepsy Fund (NEF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS05595 and NS059934 (to D. M. C.), NS064757 (to A. S. L.), and NS35439 (to T. Z. B. and Y. N.). This work was also supported by the Brain Research Foundation (to D. M. C.) and the Dutch Epilepsy Fund (NEF #08-01; to W. J. W. and Y. N.).	Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Cuadra AE, 2004, J NEUROSCI, V24, P7491, DOI 10.1523/JNEUROSCI.1255-04.2004; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Klein ATJ, 2001, J BIOL CHEM, V276, P15034, DOI 10.1074/jbc.M010776200; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Noam Y, 2008, J PHYSIOL-LONDON, V586, P3629, DOI 10.1113/jphysiol.2008.153486; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Shimozawa N, 1999, BIOCHEM BIOPH RES CO, V262, P504, DOI 10.1006/bbrc.1999.1232; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Stanley WA, 2006, BBA-MOL CELL RES, V1763, P1592, DOI 10.1016/j.bbamcr.2006.10.015; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	23	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20823	20834		10.1074/jbc.M111.236125	http://dx.doi.org/10.1074/jbc.M111.236125			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21504900	Green Published, hybrid			2022-12-25	WOS:000291267600067
J	Hong, SK; Dawid, IB				Hong, Sung-Kook; Dawid, Igor B.			The Transcriptional Mediator Component Med12 Is Required for Hindbrain Boundary Formation	PLOS ONE			English	Article							ZEBRAFISH HINDBRAIN; GENE-EXPRESSION; NEURAL CREST; RHOMBOMERE BOUNDARIES; RETINOIC ACID; COMPLEX; SEGMENTATION; VERTEBRATE; MOUSE; NOTCH	Background: Rhombomere boundaries form during hindbrain segmentation and are critical for maintaining segmental integrity and regulating migration in the hindbrain. Some genetic models affecting hindbrain boundary formation have been described, but involvement of components of the transcriptional mediator complex in boundary formation has not reported so far. Principal Findings: The kto/med12 mutant zebrafish, which affects the Mediator component Med12, causes specific loss of rhombomere boundary cells even though segmentation of the hindbrain takes place at least in part. In kto mutant embryos, cells forming rhombomere boundaries were largely absent as indicated by the use of several marker genes. While no obvious increase in cell death was observed, we found a notable reduction of cell proliferation in the hindbrain of kto mutant zebrafish. Conclusions: The kto/med12 mutation results in specific defects of boundary cell formation in the zebrafish hindbrain.	[Hong, Sung-Kook; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child & Human De, Mol Genet Lab, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Hong, Sung-Kook] NHGRI, Mol Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Hong, SK (corresponding author), Eunice Kennedy Shriver Natl Inst Child & Human De, Mol Genet Lab, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov			Division of Intramural Research of the National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded in its entirety by the Division of Intramural Research of the National Institute of Child Health and Human Development. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; BIERKAMP C, 1993, MECH DEVELOP, V43, P87, DOI 10.1016/0925-4773(93)90027-U; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Blair SS, 2004, CURR BIOL, V14, pR570, DOI 10.1016/j.cub.2004.07.015; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Cooke JE, 2002, TRENDS NEUROSCI, V25, P260, DOI 10.1016/S0166-2236(02)02134-3; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; KELLY GM, 1995, MECH DEVELOP, V53, P261, DOI 10.1016/0925-4773(95)00442-4; Kemp HA, 2009, DEV BIOL, V327, P313, DOI 10.1016/j.ydbio.2008.12.010; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Lecaudey V, 2004, DEVELOPMENT, V131, P3121, DOI 10.1242/dev.01190; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; McClintock JM, 2002, DEVELOPMENT, V129, P2339; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; Moens CB, 1998, DEVELOPMENT, V125, P381; Moens CB, 1996, DEVELOPMENT, V122, P3981; Nittenberg R, 1997, DEVELOPMENT, V124, P2297; Philiber RA, 2007, PHARMACOGENOMICS, V8, P909, DOI 10.2217/14622416.8.8.909; Picker A, 2002, DEVELOPMENT, V129, P3227; Qiu XH, 2009, DEV GENES EVOL, V219, P339, DOI 10.1007/s00427-009-0296-6; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Riley BB, 2004, DEV DYNAM, V231, P278, DOI 10.1002/dvdy.20133; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Sassa T, 2007, DEV DYNAM, V236, P706, DOI 10.1002/dvdy.21084; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Shin CH, 2008, DEV BIOL, V317, P467, DOI 10.1016/j.ydbio.2008.02.031; Thisse B., 2001, EXPRESSION ZEBRAFISH; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	46	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19076	10.1371/journal.pone.0019076	http://dx.doi.org/10.1371/journal.pone.0019076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533047	Green Submitted, gold, Green Published			2022-12-25	WOS:000290014500022
J	Agapakis, CM; Niederholtmeyer, H; Noche, RR; Lieberman, TD; Megason, SG; Way, JC; Silver, PA				Agapakis, Christina M.; Niederholtmeyer, Henrike; Noche, Ramil R.; Lieberman, Tami D.; Megason, Sean G.; Way, Jeffrey C.; Silver, Pamela A.			Towards a Synthetic Chloroplast	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; AMBYSTOMA-MACULATUM; BACTERIA; VIRULENCE; GROWTH; METABOLISM; SYMBIOSES; DYNAMICS; PROTEIN; SYSTEM	Background: The evolution of eukaryotic cells is widely agreed to have proceeded through a series of endosymbiotic events between larger cells and proteobacteria or cyanobacteria, leading to the formation of mitochondria or chloroplasts, respectively. Engineered endosymbiotic relationships between different species of cells are a valuable tool for synthetic biology, where engineered pathways based on two species could take advantage of the unique abilities of each mutualistic partner. Results: We explored the possibility of using the photosynthetic bacterium Synechococcus elongatus PCC 7942 as a platform for studying evolutionary dynamics and for designing two-species synthetic biological systems. We observed that the cyanobacteria were relatively harmless to eukaryotic host cells compared to Escherichia coli when injected into the embryos of zebrafish, Danio rerio, or taken up by mammalian macrophages. In addition, when engineered with invasin from Yersinia pestis and listeriolysin O from Listeria monocytogenes, S. elongatus was able to invade cultured mammalian cells and divide inside macrophages. Conclusion: Our results show that it is possible to engineer photosynthetic bacteria to invade the cytoplasm of mammalian cells for further engineering and applications in synthetic biology. Engineered invasive but non-pathogenic or immunogenic photosynthetic bacteria have great potential as synthetic biological devices.	[Agapakis, Christina M.; Niederholtmeyer, Henrike; Noche, Ramil R.; Lieberman, Tami D.; Megason, Sean G.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Way, Jeffrey C.; Silver, Pamela A.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Agapakis, CM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu		Niederholtmeyer, Henrike/0000-0002-1375-0287; Noche, Ramil R./0000-0002-4894-5682; /0000-0001-5430-3937	Wyss Institute for Biologically Inspired Engineering; National Science Foundation; Synthetic Biology Engineering Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177] Funding Source: NIH RePORTER	Wyss Institute for Biologically Inspired Engineering; National Science Foundation(National Science Foundation (NSF)); Synthetic Biology Engineering Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by grants from the Wyss Institute for Biologically Inspired Engineering, the National Science Foundation, and the Synthetic Biology Engineering Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Bermudes D, 2002, CURR OPIN DRUG DISC, V5, P194; BIELECKI J, 1990, NATURE, V345, P175, DOI 10.1038/345175a0; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; BUCHSBAUM RALPH, 1934, SCIENCE, V80, P408, DOI 10.1126/science.80.2079.408; BUCHSBAUM RALPH, 1937, PHYSIOL ZOOL, V10, P373; Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899; Chin JW, 2006, NAT CHEM BIOL, V2, P304, DOI 10.1038/nchembio789; Cirillo JD, 1999, TRENDS MICROBIOL, V7, P96, DOI 10.1016/S0966-842X(99)01456-0; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; FORBES NS, 2010, NAT REV CANCER, P1; Gilbert PW, 1944, ECOLOGY, V25, P366, DOI 10.2307/1931284; Goetz M, 2001, P NATL ACAD SCI USA, V98, P12221, DOI 10.1073/pnas.211106398; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Howe CJ, 2008, PHILOS T R SOC B, V363, P2675, DOI 10.1098/rstb.2008.0050; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; JEON KW, 1987, ANN NY ACAD SCI, V503, P359, DOI 10.1111/j.1749-6632.1987.tb40622.x; Kenny B, 2009, CURR OPIN MICROBIOL, V12, P1, DOI 10.1016/j.mib.2009.01.002; Kerney R, 2011, P NATL ACAD SCI USA, V108, P6497, DOI 10.1073/pnas.1018259108; Kleine T, 2009, ANNU REV PLANT BIOL, V60, P115, DOI 10.1146/annurev.arplant.043008.092119; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; MARGULIS L, 1990, BIOSCIENCE, V40, P673, DOI 10.2307/1311435; Markmann K, 2009, TRENDS PLANT SCI, V14, P77, DOI 10.1016/j.tplants.2008.11.009; MARQUIS H, 1993, INFECT IMMUN, V61, P3756, DOI 10.1128/IAI.61.9.3756-3760.1993; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; NIEDERHOLTMEYER H, 2010, APPL ENVIRON MICROB, P1; Pelz O, 1999, ENVIRON MICROBIOL, V1, P167, DOI 10.1046/j.1462-2920.1999.00023.x; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; SIZEMORE DR, 1995, SCIENCE, V270, P299, DOI 10.1126/science.270.5234.299; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Stritzker J, 2004, INFECT IMMUN, V72, P5622, DOI 10.1128/IAI.72.10.5622-5629.2004; Tattersall GJ, 2008, CAN J ZOOL, V86, P1289, DOI 10.1139/Z08-115; TAYLOR DL, 1978, J PROTOZOOL, V25, P77, DOI 10.1111/j.1550-7408.1978.tb03871.x; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Waks Z, 2009, APPL ENVIRON MICROB, V75, P1867, DOI 10.1128/AEM.02009-08; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt1211	47	47	53	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18877	10.1371/journal.pone.0018877	http://dx.doi.org/10.1371/journal.pone.0018877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533097	Green Submitted, gold, Green Published			2022-12-25	WOS:000289719400032
J	Penny, RH; Montgomery, BR; Delph, LF				Penny, Rebecca H.; Montgomery, Benjamin R.; Delph, Lynda F.			X Linkage of AP3A, a Homolog of the Y-Linked MADS-Box Gene AP3Y in Silene latifolia and S-dioica	PLOS ONE			English	Article							SEX-CHROMOSOMES; EVOLUTION; REARRANGEMENTS	Background: The duplication of autosomal genes onto the Y chromosome may be an important element in the evolution of sexual dimorphism. A previous cytological study reported on a putative example of such a duplication event in a dioecious tribe of Silene (Caryophyllaceae): it was inferred that the Y-linked MADS-box gene AP3Y originated from a duplication of the reportedly autosomal orthologAP3A. However, a recent study, also using cytological methods, indicated that AP3A is X-linked in Silenelatifolia. Methodology/Principal Findings: In this study, we hybridized S. latifolia and S. dioicato investigate whether the pattern of X linkage is consistent among distinct populations, occurs in both species, and is robust to genetic methods. We found inheritance patterns indicative of X linkage of AP3A in widely distributed populations of both species. Conclusions/Significance: X linkage ofAP3A and Y linkage of AP3Yin both species indicates that the genes' ancestral progenitor resided on the autosomes that gave rise to the sex chromosomesand that neither gene has moved between chromosomes since species divergence. Consequently, our results do not support the contention that inter-chromosomal gene transfer occurred in the evolution of SlAP3Y from SlAP3A.	[Penny, Rebecca H.; Montgomery, Benjamin R.; Delph, Lynda F.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Penny, RH (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	rhpenny@indiana.edu	Montgomery, Benjamin/G-5851-2013		National Science Foundation [0813766]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant 0813766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergero R, 2008, GENETICS, V178, P2045, DOI 10.1534/genetics.107.084566; BROSSEAU GE, 1960, GENETICS, V45, P257; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Cegan R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-180; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Fairbairn DJ, 2006, HEREDITY, V97, P319, DOI 10.1038/sj.hdy.6800895; Filatov DA, 2005, GENETICS, V170, P975, DOI 10.1534/genetics.104.037069; Filatov DA, 2005, METHOD ENZYMOL, V395, P418, DOI 10.1016/S0076-6879(05)95023-4; Hobza R, 2007, MOL GENET GENOMICS, V278, P633, DOI 10.1007/s00438-007-0279-0; Kaiser VB, 2009, MOL BIOL EVOL, V26, P2343, DOI 10.1093/molbev/msp141; Matsunaga S, 2003, MOL BIOL EVOL, V20, P1062, DOI 10.1093/molbev/msg114; Matsunaga S, 2006, GENES GENET SYST, V81, P219, DOI 10.1266/ggs.81.219; Montgomery BR, 2010, ANN BOT-LONDON, V105, P595, DOI 10.1093/aob/mcq013	14	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18972	10.1371/journal.pone.0018972	http://dx.doi.org/10.1371/journal.pone.0018972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533056	gold, Green Submitted, Green Published			2022-12-25	WOS:000289719400042
J	Li, L; Sun, JH				Li, Li; Sun, Jianghua			Host Suitability of a Gregarious Parasitoid on Beetle Hosts: Flexibility between Fitness of Adult and Offspring	PLOS ONE			English	Article							STEPHANODERIS BETREM HYMENOPTERA; STAGE SELECTION; SIZE; BETHYLIDAE; PREFERENCE; EVOLUTION; GROWTH; WASPS; TEMPERATURE; PERFORMANCE	Behavioral tactics play a crucial role in the evolution of species and are likely to be found in host-parasitoid interactions where host quality may differ between host developmental stages. We investigated foraging decisions, parasitism and related fitness in a gregarious ectoparasitoid, Sclerodermus harmandi in relation to two distinct host developmental stages: larvae and pupae. Two colonies of parasitoids were reared on larvae of Monochamus alternatus and Saperda populnea (Cerambycidae: Lamiinae). Paired-choice and non-choice experiments were used to evaluate the preference and performance of S. harmandi on larvae and pupae of the two species. Foraging decisions and offspring fitness-related consequences of S. harmandi led to the selection of the most profitable host stage for parasitoid development. Adult females from the two colonies oviposited more quickly on pupae as compared to larvae of M. alternatus. Subsequently, their offspring development time was faster and they gained higher body weight on the pupal hosts. This study demonstrates optimal foraging of intraspecific detente that can occur during host-parasitoid interactions, of which the quality of the parasitism (highest fitness benefit and profitability) is related to the host developmental stage utilized. We conclude that S. harmandi is able to perfectly discriminate among host species or stages in a manner that maximizes its offspring fitness. The results indicated that foraging potential of adults may not be driven by its maternal effects, also induced flexibly with encountering prior host quality.	[Li, Li; Sun, Jianghua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Li, Li] Guizhou Normal Univ, Sch Life Sci, Guiyang, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Guizhou Normal University	Li, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	sunjh@ioz.ac.cn		sun, jianghua/0000-0002-9465-3672	National Nature Science Foundation of China [30730074, 30921063]; National Basic Research Program [2009CB119200]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	The research was supported by the National Nature Science Foundation of China (30730074 and 30921063) and the National Basic Research Program (2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARNOV EL, 1984, FLA ENTOMOL, V67, P5, DOI 10.2307/3494101; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chau A, 2001, CAN ENTOMOL, V133, P549, DOI 10.4039/Ent133549-4; Chong JH, 2006, ENVIRON ENTOMOL, V35, P1188, DOI 10.1603/0046-225X(2006)35[1188:IOTAMS]2.0.CO;2; Chong JH, 2006, ENTOMOL EXP APPL, V121, P39, DOI 10.1111/j.1570-8703.2006.00460.x; Colinet H, 2005, ECOL ENTOMOL, V30, P473, DOI 10.1111/j.0307-6946.2005.00716.x; Ding Y, 2001, CHIN J APPL ECOL, V12, P351; EVANS HOWARD E., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V132, P1; Gauld Ian D., 1995, P464; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Henry LM, 2005, ENTOMOL EXP APPL, V116, P167, DOI 10.1111/j.1570-7458.2005.00318.x; KING BH, 1989, OECOLOGIA, V78, P420, DOI 10.1007/BF00379119; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Lauziere I, 2000, ANN ENTOMOL SOC AM, V93, P103, DOI 10.1603/0013-8746(2000)093[0103:EOFBSA]2.0.CO;2; Lauziere I, 2000, J INSECT BEHAV, V13, P375, DOI 10.1023/A:1007762202679; Lauziere I, 2001, BIOL CONTROL, V21, P128, DOI 10.1006/bcon.2000.0909; Li BP, 2004, ENTOMOL EXP APPL, V110, P249, DOI 10.1111/j.0013-8703.2004.00144.x; Li L, 2010, BIOCONTROL, V55, P465, DOI 10.1007/s10526-010-9270-5; Li L, 2009, ECOL ENTOMOL, V34, P725, DOI 10.1111/j.1365-2311.2009.01120.x; Mackauer M., 1997, Ecological Studies, V130, P191; Mackauer M., 1993, P1; Nofemela RS, 2008, ENTOMOL EXP APPL, V126, P9, DOI 10.1111/j.1570-7458.2007.00632.x; Ode PJ, 2002, BIOL CONTROL, V24, P31, DOI 10.1016/S1049-9644(02)00003-8; Otto M, 1998, OECOLOGIA, V117, P353, DOI 10.1007/s004420050668; Stephens D.W., 1986, pi; STRAND MR, 1983, ENVIRON ENTOMOL, V12, P1114, DOI 10.1093/ee/12.4.1114; Strand MR, 2000, PARASITOID POPULATION BIOLOGY, P139; Waage JK., 1986, INSECT PARASITOIDS, P63; ZHANG WG, 2004, THESIS U SHANDONG AG	31	14	20	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18563	10.1371/journal.pone.0018563	http://dx.doi.org/10.1371/journal.pone.0018563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526176	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100008
J	Saunders, SE; Yuan, Q; Bartz, JC; Bartelt-Hunt, S				Saunders, Samuel E.; Yuan, Qi; Bartz, Jason C.; Bartelt-Hunt, Shannon			Effects of Solution Chemistry and Aging Time on Prion Protein Adsorption and Replication of Soil-Bound Prions	PLOS ONE			English	Article							ENVIRONMENTAL SOURCES; FATE; SCRAPIE; PRPSC; TRANSMISSION; INFECTIVITY; EXTRACTION; DIGESTION; KINETICS; SURVIVAL	Prion interactions with soil may play an important role in the transmission of chronic wasting disease (CWD) and scrapie. Prions are known to bind to a wide range of soil surfaces, but the effects of adsorption solution chemistry and long-term soil binding on prion fate and transmission risk are unknown. We investigated HY TME prion protein (PrPSc) adsorption to soil minerals in aqueous solutions of phosphate buffered saline (PBS), sodium chloride, calcium chloride, and deionized water using western blotting. The replication efficiency of bound prions following adsorption in these solutions was also evaluated by protein misfolding cyclic amplification (PMCA). Aging studies investigated PrPSc desorption and replication efficiency up to one year following adsorption in PBS or DI water. Results indicate that adsorption solution chemistry can affect subsequent prion replication or desorption ability, especially after incubation periods of 30 d or longer. Observed effects were minor over the short-term (7 d or less). Results of long-term aging experiments demonstrate that unbound prions or prions bound to a diverse range of soil surfaces can readily replicate after one year. Our results suggest that while prion-soil interactions can vary with solution chemistry, prions bound to soil could remain a risk for transmitting prion diseases after months in the environment.	[Saunders, Samuel E.; Yuan, Qi; Bartelt-Hunt, Shannon] Univ Nebraska Lincoln, Dept Civil Engn, Peter Kiewit Inst, Omaha, NE USA; [Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Lincoln; Creighton University	Saunders, SE (corresponding author), Univ Nebraska Lincoln, Dept Civil Engn, Peter Kiewit Inst, Omaha, NE USA.	sbartelt2@unl.edu		Bartz, Jason/0000-0003-4081-7886	University of Nebraska-Lincoln; Creighton University; National Center for Research Resources [P20 RR0115635-6, C06 RR17417-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417] Funding Source: NIH RePORTER	University of Nebraska-Lincoln; Creighton University; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported in part by the University of Nebraska-Lincoln, Creighton University, and the National Center for Research Resources (P20 RR0115635-6 and C06 RR17417-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Bartz JC, 2007, J VIROL, V81, P689, DOI 10.1128/JVI.01751-06; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Cooke CM, 2007, ENVIRON SCI TECHNOL, V41, P811, DOI 10.1021/es0618189; Czajkowsky DM, 2003, J MICROSC-OXFORD, V211, P1, DOI 10.1046/j.1365-2818.2003.01208.x; de Motes CM, 2008, WATER RES, V42, P2465, DOI 10.1016/j.watres.2008.01.031; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Genovesi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001069; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Khare N, 2006, J COLLOID INTERF SCI, V303, P404, DOI 10.1016/j.jcis.2006.07.070; Kramer ML, 2009, PRION, V3, P44, DOI 10.4161/pri.3.1.8442; Kurrat R, 1997, J COLLOID INTERF SCI, V185, P1, DOI 10.1006/jcis.1996.4528; Lee L, 2003, APPL ENVIRON MICROB, V69, P4111, DOI 10.1128/AEM.69.7.4111-4115.2003; Ma X, 2007, ENVIRON SCI TECHNOL, V41, P2324, DOI 10.1021/es062122i; Maddison BC, 2010, ENVIRON SCI TECHNOL, V44, P8503, DOI 10.1021/es101591a; Maddison BC, 2010, J VIROL, V84, P11560, DOI 10.1128/JVI.01133-10; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; Prusiner Stanley B., 2004, VVolume 41, P1; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Saunders SE, 2008, ENVIRON SCI TECHNOL, V42, P6573, DOI 10.1021/es800590k; Saunders SE, 2010, ENVIRON SCI TECHNOL, V44, P4129, DOI 10.1021/es903520d; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P7728, DOI 10.1021/es901385t; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P5242, DOI 10.1021/es900502f; Saunders SE, 2008, PRION, V2, P162, DOI 10.4161/pri.2.4.7951; SAUNDERS SE, 2011, J VIROLOGY IN PRESS; Scherbel C, 2007, ZOONOSES PUBLIC HLTH, V54, P185, DOI 10.1111/j.1863-2378.2007.01040.x; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Szabo G, 2006, RADIOCHIM ACTA, V94, P553, DOI 10.1524/ract.2006.94.9.553; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Vasina EN, 2005, BIOMACROMOLECULES, V6, P3425, DOI 10.1021/bm050492d; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wei T, 2009, J PHYS CHEM C, V113, P2053, DOI 10.1021/jp806586n	39	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18752	10.1371/journal.pone.0018752	http://dx.doi.org/10.1371/journal.pone.0018752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526178	Green Published, gold			2022-12-25	WOS:000289671100018
J	Amaratunga, C; Lopera-Mesa, TM; Brittain, NJ; Cholera, R; Arie, T; Fujioka, H; Keefer, JR; Fairhurst, RM				Amaratunga, Chanaki; Lopera-Mesa, Tatiana M.; Brittain, Nathaniel J.; Cholera, Rushina; Arie, Takayuki; Fujioka, Hisashi; Keefer, Jeffrey R.; Fairhurst, Rick M.			A Role for Fetal Hemoglobin and Maternal Immune IgG in Infant Resistance to Plasmodium falciparum Malaria	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INFECTED ERYTHROCYTES; CEREBRAL MALARIA; ACQUIRED-IMMUNITY; RED-CELLS; SEQUESTRATION; SURFACE; PROTECTION; ANTIBODIES; CHILDREN	Background: In Africa, infant susceptibility to Plasmodium falciparum malaria increases substantially as fetal hemoglobin (HbF) and maternal immune IgG disappear from circulation. During the first few months of life, however, resistance to malaria is evidenced by extremely low parasitemias, the absence of fever, and the almost complete lack of severe disease. This resistance has previously been attributed in part to poor parasite growth in HbF-containing red blood cells (RBCs). A specific role for maternal immune IgG in infant resistance to malaria has been hypothesized but not yet identified. Methods and Findings: We found that P. falciparum parasites invade and develop normally in fetal (cord blood, CB) RBCs, which contain up to 95% HbF. However, these parasitized CB RBCs are impaired in their binding to human microvascular endothelial cells (MVECs), monocytes, and nonparasitized RBCs -cytoadherence interactions that have been implicated in the development of high parasite densities and the symptoms of malaria. Abnormal display of the parasite's cytoadherence antigen P. falciparum erythrocyte membrane protein-1 (PfEMP-1) on CB RBCs accounts for these findings and is reminiscent of that on HbC and HbS RBCs. IgG purified from the plasma of immune Malian adults almost completely abolishes the adherence of parasitized CB RBCs to MVECs. Conclusions: Our data suggest a model of malaria protection in which HbF and maternal IgG act cooperatively to impair the cytoadherence of parasitized RBCs in the first few months of life. In highly malarious areas of Africa, an infant's contemporaneous expression of HbC or HbS and development of an immune IgG repertoire may effectively reconstitute the waning protective effects of HbF and maternal immune IgG, thereby extending the malaria resistance of infancy into early childhood.	[Amaratunga, Chanaki; Lopera-Mesa, Tatiana M.; Brittain, Nathaniel J.; Cholera, Rushina; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Arie, Takayuki] Osaka Prefecture Univ, Sch Engn, Dept Phys & Elect, Osaka, Japan; [Fujioka, Hisashi] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Keefer, Jeffrey R.] Johns Hopkins Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Osaka Metropolitan University; Case Western Reserve University; Johns Hopkins University; Johns Hopkins Medicine	Amaratunga, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rfairhurst@niaid.nih.gov			National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001066, ZIAAI001000] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	ADVANI R, 1992, PEDIATR RES, V32, P165, DOI 10.1203/00006450-199208000-00008; Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Brittain NJ, 2007, BRIT J HAEMATOL, V136, P491, DOI 10.1111/j.1365-2141.2006.06446.x; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; COLOMBO B, 1976, BRIT J HAEMATOL, V32, P79, DOI 10.1111/j.1365-2141.1976.tb01877.x; Covell Sir G., 1950, Tropical Diseases Bulletin, V47, P1147; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; FRIEDMAN MJ, 1979, NATURE, V280, P245, DOI 10.1038/280245a0; Glikman D, 2007, PEDIATRICS, V120, pE745, DOI 10.1542/peds.2007-0041; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; Hviid L, 2004, TRENDS PARASITOL, V20, P66, DOI 10.1016/j.pt.2003.11.009; Khattab A, 2007, PARASITOL RES, V101, P767, DOI 10.1007/s00436-007-0548-1; LANGRETH SG, 1985, INFECT IMMUN, V47, P760, DOI 10.1128/IAI.47.3.760-766.1985; Le Scanf C, 2008, MICROBES INFECT, V10, P447, DOI 10.1016/j.micinf.2007.12.012; LOGIE DE, 1973, B WORLD HEALTH ORGAN, V49, P547; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Nagao T, 1996, AM J TROP MED HYG, V55, P562, DOI 10.4269/ajtmh.1996.55.562; OCKENHOUSE CF, 1989, J CLIN INVEST, V84, P468, DOI 10.1172/JCI114188; PASVOL G, 1977, NATURE, V270, P171, DOI 10.1038/270171a0; PASVOL G, 1976, LANCET, V1, P1269; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Safeukui I, 2008, BLOOD, V112, P2520, DOI 10.1182/blood-2008-03-146779; Shear HL, 1998, BLOOD, V92, P2520, DOI 10.1182/blood.V92.7.2520.2520_2520_2526; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tena-Tomas C, 2007, PARASITOL RES, V101, P1045, DOI 10.1007/s00436-007-0585-9; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Weinberg JB, 2008, CURR OPIN INFECT DIS, V21, P468, DOI 10.1097/QCO.0b013e32830ef5cf; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; WILSON RJM, 1977, B WORLD HEALTH ORGAN, V55, P179	47	56	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e14798	10.1371/journal.pone.0014798	http://dx.doi.org/10.1371/journal.pone.0014798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532754	gold, Green Published, Green Submitted			2022-12-25	WOS:000289404700003
J	Burkhalter, RJ; Symowicz, J; Hudson, LG; Gottardi, CJ; Stack, MS				Burkhalter, Rebecca J.; Symowicz, Jaime; Hudson, Laurie G.; Gottardi, Cara J.; Stack, M. Sharon			Integrin Regulation of beta-Catenin Signaling in Ovarian Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; E-CADHERIN; CELL-ADHESION; PLASMINOGEN-ACTIVATOR; LYSOPHOSPHATIDIC ACID; EPITHELIAL TUMORS; WNT PATHWAY; MICROENVIRONMENTAL REGULATION; PHENOTYPIC PLASTICITY; EXPRESSION	Reversible modulation of integrin-regulated cell-matrix adhesion and epithelial (E)-cadherin-mediated cell-cell adhesion plays a critical role in the establishment of ovarian cancer metastases. In contrast to most epithelial cell-derived tumors that down-regulate E-cadherin expression during progression, acquisition of E-cadherin expression accompanies malignant transformation of the ovarian surface epithelium and is maintained in peritoneal metastases. Metastatic epithelial ovarian cancer cells are disseminated intraperitoneally and preferentially adhere via integrins to interstitial collagens in the peritoneal cavity. This study was undertaken to determine whether integrin engagement influences E-cadherin and beta-catenin localization and function. The data demonstrate that multivalent integrin engagement results in increased internalization of E-cadherin, inhibition of GSK-3 beta, elevated levels of nuclear beta-catenin, increased beta-catenin-regulated promoter activation, and transcriptional activation of Wnt/beta-catenin target genes. Blocking beta-catenin transcriptional control with inhibitor of beta-catenin and Tcf-4 reduces cellular invasion, suggesting a key role for beta-catenin nuclear signaling in EOC invasion and metastasis. These studies support a model wherein cell-matrix engagement regulates the functional integrity of cell-cell contacts, leading to increased beta-catenin nuclear signaling and enhanced cellular invasive activity. Furthermore, these results provide a mechanism for activation of Wnt/beta-catenin signaling in the absence of activating mutations in this pathway.	[Burkhalter, Rebecca J.; Stack, M. Sharon] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Burkhalter, Rebecca J.; Stack, M. Sharon] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Symowicz, Jaime] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Med Sch, Chicago, IL 60612 USA; [Gottardi, Cara J.] Northwestern Univ, Dept Med, Feinberg Med Sch, Div Pulm & Crit Care, Chicago, IL 60612 USA; [Hudson, Laurie G.] Univ New Mexico, Dept Pharmaceut Sci, Coll Pharm, Albuquerque, NM 87131 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of New Mexico	Stack, MS (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Harper Canc Res Inst, 1234 Notre Dame Ave,A200D Harper Hall, Notre Dame, IN 46617 USA.	Sharon.Stack.11@nd.edu	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617	National Institutes of Health [T32CA09560, RO1 CA086984, RO1 CA109545, RO1 CA90492, RO1 GM076561, 3RO1CA086984-11S1]; University of Missouri; NATIONAL CANCER INSTITUTE [R01CA090492, R01CA086984, T32CA009560, R01CA109545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32CA09560 (training grant to J. S.), RO1 CA086984 (to M. S. S.), RO1 CA109545 (to M. S. S.), RO1 CA90492 (to L. G. H.), and RO1 GM076561 (to C. J. G.), and Research Supplement 3RO1CA086984-11S1 to Promote Diversity (to R. J. B.). This work was also supported by a Life Sciences Fellowship from the University of Missouri (to R. J. B.).	Ahmed N, 2005, BRIT J CANCER, V92, P1475, DOI 10.1038/sj.bjc.6602495; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; AUERSPERG N, 1994, LAB INVEST, V71, P510; Badiglian L, 2009, ONCOL REP, V21, P313, DOI 10.3892/or_00000223; Barbolina M. V., 2011, BIOCH J IN PRESS; Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Barbolina MV, 2009, INT J CANCER, V125, P816, DOI 10.1002/ijc.24347; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Casey RC, 2000, CLIN EXP METASTAS, V18, P67, DOI 10.1023/A:1026519016213; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Cho EY, 2006, PATHOL INT, V56, P62, DOI 10.1111/j.1440-1827.2006.01925.x; Choudhury M, 2008, ALCOHOL CLIN EXP RES, V32, P829, DOI 10.1111/j.1530-0277.2008.00630.x; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Danielson KG, 1995, J BIOL CHEM, V270, P31225, DOI 10.1074/jbc.270.52.31225; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Davies BR, 1998, HISTOPATHOLOGY, V32, P69; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; Ellerbroek SM, 1999, CANCER RES, V59, P1635; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Ferrandina G, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-182; Fishman DA, 2001, CANCER RES, V61, P3194; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Fujioka T, 2001, ONCOL REP, V8, P249; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Ghosh S, 2006, J BIOL CHEM, V281, P13021, DOI 10.1074/jbc.M508526200; GOODE N, 1992, J BIOL CHEM, V267, P16878; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Huang LW, 2000, GYNECOL ONCOL, V77, P369, DOI 10.1006/gyno.2000.5806; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jin HY, 2010, INT J CANCER, V126, P2102, DOI 10.1002/ijc.24901; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Karbova E, 2002, INT J SURG PATHOL, V10, P175, DOI 10.1177/106689690201000302; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Lee CM, 2003, GYNECOL ONCOL, V88, P363, DOI 10.1016/S0090-8258(02)00015-X; Lessan K, 1999, AM J PATHOL, V154, P1525, DOI 10.1016/S0002-9440(10)65406-5; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Menczer J, 2009, EUR J GYNAECOL ONCOL, V30, P531; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NIEDBALA MJ, 1987, CANCER RES, V47, P4634; Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Sagae S, 1999, JPN J CANCER RES, V90, P510, DOI 10.1111/j.1349-7006.1999.tb00777.x; Sakata K, 2000, INT J ONCOL, V17, P673; Santala M, 1998, BRIT J CANCER, V77, P1825, DOI 10.1038/bjc.1998.303; Skubitz Amy P N, 2002, Cancer Treat Res, V107, P305; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Symowicz J, 2005, CANCER RES, V65, P2234, DOI 10.1158/0008.5472.CAN-04-2781; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Tago K, 2000, GENE DEV, V14, P1741; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Tuhkanen H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-289; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; Voutilainen KA, 2006, J CLIN PATHOL, V59, P460, DOI 10.1136/jcp.2005.029876; Wang L, 2009, GYNECOL ONCOL, V114, P265, DOI 10.1016/j.ygyno.2009.04.031; Wang Y, 2006, BRIT J CANCER, V94, P686, DOI 10.1038/sj.bjc.6602988; Wright K, 1999, INT J CANCER, V82, P625, DOI 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2; Wu R, 2001, CANCER RES, V61, P8247; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; Young TN, 1996, GYNECOL ONCOL, V62, P89, DOI 10.1006/gyno.1996.0195; YOUNG TN, 1994, AM J OBSTET GYNECOL, V170, P1285; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	78	43	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23467	23475		10.1074/jbc.M110.199539	http://dx.doi.org/10.1074/jbc.M110.199539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21518759	Green Published, hybrid			2022-12-25	WOS:000292025000077
J	Mekler, V; Minakhin, L; Severinov, K				Mekler, Vladimir; Minakhin, Leonid; Severinov, Konstantin			A Critical Role of Downstream RNA Polymerase-Promoter Interactions in the Formation of Initiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-R PROMOTER; CONFORMATIONAL-CHANGES; TRANSCRIPTION INITIATION; SIGMA(70) SUBUNIT; ANGSTROM RESOLUTION; NONTEMPLATE STRAND; STRUCTURAL BASIS; DNA-BINDING; START SITE; HOLOENZYME	Nucleation of promoter melting in bacteria is coupled with RNA polymerase (RNAP) binding to a conserved - 10 promoter element located at the upstream edge of the transcription bubble. The mechanism of downstream propagation of the transcription bubble to include the transcription start site is unclear. Here we introduce new model downstream fork junction promoter fragments that specifically bind RNAP and mimic the downstream segment of promoter complexes. We demonstrate that RNAP binding to downstream fork junctions is coupled with DNA melting around the transcription start point. Consequently, certain downstream fork junction probes can serve as transcription templates. Using a protein beacon fluorescent method, we identify structural determinants of affinity and transcription activity of RNAP-downstream fork junction complexes. Measurements of RNAP interaction with double-stranded promoter fragments reveal that the strength of RNAP interactions with downstream DNA plays a critical role in promoter opening and that the length of the downstream duplex must exceed a critical length for efficient formation of transcription competent open promoter complex.	[Mekler, Vladimir; Minakhin, Leonid; Severinov, Konstantin] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Rutgers State Univ, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 119334, Russia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences	Mekler, V (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA.	mekler@waksman.rutgers.edu; severik@waksman.rutgers.edu	Severinov, Konstantin/C-8545-2016		National Institutes of Health [R01 GM64530]; Russian Academy of Sciences Presidium; Federal Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia" [02.740.11.0771]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Academy of Sciences Presidium(Russian Academy of Sciences); Federal Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64530. This work was also supported by a Molecular and Cell Biology Program grant from the Russian Academy of Sciences Presidium and Federal Program "Scientific and Scientific-Pedagogical Personnel of Innovative Russia 2009-2013," State Contract 02.740.11.0771 (to K. S.).	Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; Camara B, 2010, P NATL ACAD SCI USA, V107, P2247, DOI 10.1073/pnas.0907908107; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; Colland F, 1998, MOL MICROBIOL, V27, P819, DOI 10.1046/j.1365-2958.1998.00729.x; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; DEDRICK RL, 1985, BIOCHEMISTRY-US, V24, P2245, DOI 10.1021/bi00330a019; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Ederth J, 2002, MOL GENET GENOMICS, V267, P587, DOI 10.1007/s00438-002-0689-y; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Fenton MS, 2003, J BIOL CHEM, V278, P39669, DOI 10.1074/jbc.M307412200; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Guo YL, 2000, GENE DEV, V14, P2242, DOI 10.1101/gad.794800; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; HESSELBACH BA, 1975, NATURE, V258, P354, DOI 10.1038/258354a0; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KIRKEGAARD K, 1983, P NATL ACAD SCI-BIOL, V80, P2544, DOI 10.1073/pnas.80.9.2544; Kontur WS, 2008, J MOL BIOL, V376, P1034, DOI 10.1016/j.jmb.2007.11.064; Kontur WS, 2006, BIOCHEMISTRY-US, V45, P2161, DOI 10.1021/bi051835v; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; McCullagh M, 2008, J PHYS CHEM B, V112, P11415, DOI 10.1021/jp802378a; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mekler V, 2011, J BIOL CHEM, V286, P270, DOI 10.1074/jbc.M110.174102; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nechaev S, 1999, J MOL BIOL, V289, P815, DOI 10.1006/jmbi.1999.2782; PFEFFER SR, 1977, J BIOL CHEM, V252, P5403; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Roberts CW, 1996, CELL, V86, P495; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; Schroder O, 2003, P NATL ACAD SCI USA, V100, P934, DOI 10.1073/pnas.242735699; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Sclavi Bianca, 2009, P38, DOI 10.1039/9781847559982-00038; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Tsujikawa L, 2002, P NATL ACAD SCI USA, V99, P3493, DOI 10.1073/pnas.062487299; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wigneshweraraj SR, 2005, J BIOL CHEM, V280, P36176, DOI 10.1074/jbc.M506416200; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Zenkin N, 2004, P NATL ACAD SCI USA, V101, P4396, DOI 10.1073/pnas.0400886101	52	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22600	22608		10.1074/jbc.M111.247080	http://dx.doi.org/10.1074/jbc.M111.247080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525530	Green Published, hybrid			2022-12-25	WOS:000291719900067
J	Zweytick, D; Deutsch, G; Andra, J; Blondelle, SE; Vollmer, E; Jerala, R; Lohner, K				Zweytick, Dagmar; Deutsch, Guenter; Andra, Joerg; Blondelle, Sylvie E.; Vollmer, Ekkehard; Jerala, Roman; Lohner, Karl			Studies on Lactoferricin-derived Escherichia coli Membrane-active Peptides Reveal Differences in the Mechanism of N-Acylated Versus Nonacylated Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-BINDING PROTEIN; X-RAY; ENDOTOXIN NEUTRALIZATION; ANTIMICROBIAL PEPTIDES; PHASE; ANTIBIOTICS; DERIVATIVES; BACTERIA; DESIGN	To improve the low antimicrobial activity of LF11, an 11-mer peptide derived from human lactoferricin, mutant sequences were designed based on the defined structure of LF11 in the lipidic environment. Thus, deletion of noncharged polar residues and strengthening of the hydrophobic N-terminal part upon adding a bulky hydrophobic amino acid or N-acylation resulted in enhanced antimicrobial activity against Escherichia coli, which correlated with the peptides' degree of perturbation of bacterial membrane mimics. Nonacylated and N-acylated peptides exhibited different effects at a molecular level. Nonacylated peptides induced segregation of peptide-enriched and peptide-poor lipid domains in negatively charged bilayers, although N-acylated peptides formed small heterogeneous domains resulting in a higher degree of packing defects. Additionally, only N-acylated peptides perturbed the lateral packing of neutral lipids and exhibited increased permeability of E. coli lipid vesicles. The latter did not correlate with the extent of improvement of the antimicrobial activity, which could be explained by the fact that elevated binding of N-acylated peptides to lipopolysaccharides of the outer membrane of Gram-negative bacteria seems to counteract the elevated membrane permeabilization, reflected in the respective minimal inhibitory concentration for E. coli. The antimicrobial activity of the peptides correlated with an increase of membrane curvature stress and hence bilayer instability. Transmission electron microscopy revealed that only the N-acylated peptides induced tubular protrusions from the outer membrane, whereas all peptides caused detachment of the outer and inner membrane of E. coli bacteria. Viability tests demonstrated that these bacteria were dead before onset of visible cell lysis.	[Zweytick, Dagmar; Deutsch, Guenter; Lohner, Karl] Austrian Acad Sci, Inst Biophys & Nanosyst Res, A-8042 Graz, Austria; [Andra, Joerg] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, D-23845 Borstel, Germany; [Blondelle, Sylvie E.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Vollmer, Ekkehard] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Clin & Expt Pathol, D-23845 Borstel, Germany; [Jerala, Roman] Univ Ljubljana, EN FIST Ctr Excellence, Natl Inst Chem, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Austrian Academy of Sciences; Forschungszentrum Borstel; Torrey Pines Institute for Molecular Studies, California; Forschungszentrum Borstel; National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana	Lohner, K (corresponding author), Austrian Acad Sci, Inst Biophys & Nanosyst Res, Schmiedlstr 6, A-8042 Graz, Austria.	karl.lohner@oeaw.ac.at	; Jerala, Roman/H-9850-2015	Zweytick, Dagmar/0000-0002-4766-7713; Jerala, Roman/0000-0002-6337-5251	EC [QLK2-CT-2002-01001]; German Science Foundation [AN301/5-1]; Slovenian Research Agency; EN-FIST Centre of Excellence	EC(European CommissionEuropean Commission Joint Research Centre); German Science Foundation(German Research Foundation (DFG)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence	This work was supported in part by EC-specific RTD Programme Grant QLK2-CT-2002-01001, "Antimicrobial Endotoxin Neutralizing Peptides to Combat Infectious Diseases."; Supported by German Science Foundation Grant AN301/5-1.; Supported by the Slovenian Research Agency and EN-FIST Centre of Excellence.	Andra J, 2005, BIOCHEM J, V385, P135, DOI 10.1042/BJ20041270; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; Blondelle SE, 2000, BIOPOLYMERS, V55, P74, DOI 10.1002/1097-0282(2000)55:1&lt;74::AID-BIP70&gt;3.0.CO;2-S; Blondelle SE, 2005, Peptides 2004, Proceedings, P81; Blondelle SE, 2004, PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, P877; Brandenburg K, 2002, EUR J BIOCHEM, V269, P5972, DOI 10.1046/j.1432-1033.2002.03333.x; Brandenburg Klaus, 2010, Anti-Infective Agents in Medicinal Chemistry, V9, P9; DEUTSCH G, 2006, THESIS GRAZ U TECHNO; DEUTSCH G, 2006, BIOPHYS J, V90; EKLUND KK, 1989, CHEM PHYS LIPIDS, V50, P71, DOI 10.1016/0009-3084(89)90028-5; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GRIFFITH OH, 1972, P NATL ACAD SCI USA, V69, P561, DOI 10.1073/pnas.69.3.561; HAHN F L, 1956, Pharm Zentralhalle Dtschl, V95, P309; Hickel A, 2008, BBA-BIOMEMBRANES, V1778, P2325, DOI 10.1016/j.bbamem.2008.05.014; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; Japelj B, 2007, J AM CHEM SOC, V129, P1022, DOI 10.1021/ja067419v; Jurgens G, 2002, J ENDOTOXIN RES, V8, P115, DOI 10.1179/096805102125000263; Latal A, 1997, EUR J BIOCHEM, V248, P938, DOI 10.1111/j.1432-1033.1997.00938.x; Lockwood NA, 2004, BIOCHEM J, V378, P93, DOI 10.1042/BJ20031393; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Lohner K, 2009, GEN PHYSIOL BIOPHYS, V28, P105, DOI 10.4149/gpb_2009_02_105; MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0; MASSON PL, 1969, J EXP MED, V130, P643, DOI 10.1084/jem.130.3.643; OFEK I, 1994, ANTIMICROB AGENTS CH, V38, P374, DOI 10.1128/AAC.38.2.374; Pabst G, 2000, PHYS REV E, V62, P4000, DOI 10.1103/PhysRevE.62.4000; Pabst G, 2003, J APPL CRYSTALLOGR, V36, P1378, DOI 10.1107/S0021889803017527; Rappolt M, 2003, BIOPHYS J, V84, P3111, DOI 10.1016/S0006-3495(03)70036-8; Sanchez-Gomez S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-196; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; SORENSEN MARGRETHE, 1939, Comptes rendus des Travaux du Laboratoire Carlsberg, V23, P55; Staudegger E, 2000, BBA-BIOMEMBRANES, V1468, P213, DOI 10.1016/S0005-2736(00)00260-1; Strom MB, 2002, BIOCHEM CELL BIOL, V80, P65, DOI 10.1139/o01-236; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Wakabayashi H, 1999, ANTIMICROB AGENTS CH, V43, P1267, DOI 10.1128/AAC.43.5.1267; Wakabayashi H, 2003, CURR PHARM DESIGN, V9, P1277, DOI 10.2174/1381612033454829; WHITE DA, 1972, J BACTERIOL, V109, P686, DOI 10.1128/JB.109.2.686-690.1972; Wilkinson S.G., 1988, MICROBIAL LIPIDS, V1, P299; Willumeit R, 2005, BBA-BIOMEMBRANES, V1669, P125, DOI 10.1016/j.bbamem.2005.01.011; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Yang N, 2004, J PEPT SCI, V10, P37, DOI 10.1002/psc.470; Zorko M, 2009, BBA-BIOMEMBRANES, V1788, P314, DOI 10.1016/j.bbamem.2008.10.015; Zweytick D, 2008, BIOCHEM BIOPH RES CO, V369, P395, DOI 10.1016/j.bbrc.2008.01.176; Zweytick D, 2006, BBA-BIOMEMBRANES, V1758, P1426, DOI 10.1016/j.bbamem.2006.02.032	44	50	55	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21266	21276		10.1074/jbc.M110.195412	http://dx.doi.org/10.1074/jbc.M110.195412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515687	Green Published, hybrid			2022-12-25	WOS:000291464700025
J	Cheng, L; Yung, A; Covarrubias, M; Radice, GL				Cheng, Lan; Yung, Aaron; Covarrubias, Manuel; Radice, Glenn L.			Cortactin Is Required for N-cadherin Regulation of Kv1.5 Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE VENTRICULAR MYOCYTES; POTASSIUM CHANNEL; K+ CURRENTS; HETEROGENEOUS EXPRESSION; TARGETED DELETION; SODIUM-CHANNELS; UNEXPECTED ROLE; HEART-FAILURE; SUDDEN-DEATH; LONG QT	The intercalated disc serves as an organizing center for various cell surface components at the termini of the cardiomyocyte, thus ensuring proper mechanoelectrical coupling throughout the myocardium. The cell adhesion molecule, N-cadherin, is an essential component of the intercalated disc. Cardiac-specific deletion of N-cadherin leads to abnormal electrical conduction and sudden arrhythmic death in mice. The mechanisms linking the loss of N-cadherin in the heart and spontaneous malignant ventricular arrhythmias are poorly understood. To investigate whether ion channel remodeling contributes to arrhythmogenesis in N-cadherin conditional knock-out (N-cad CKO) mice, cardiac myocyte excitability and voltage-gated potassium channel ( Kv), as well as inwardly rectifying K+ channel remodeling, were investigated in N-cad CKO cardiomyocytes by whole cell patch clamp recordings. Action potential duration was prolonged in N-cad CKO ventricle myocytes compared with wild type. Relative to wild type, I-K,I-slow density was significantly reduced consistent with decreased expression of Kv1.5 and Kv accessory protein, Kcne2, in the N-cad CKO myocytes. The decreased Kv1.5/Kcne2 expression correlated with disruption of the actin cytoskeleton and reduced cortactin at the sarcolemma. Biochemical experiments revealed that cortactin co-immunoprecipitates with Kv1.5. Finally, cortactin was required for N-cadherin-mediated enhancement of Kv1.5 channel activity in a heterologous expression system. Our results demonstrate a novel mechanistic link among the cell adhesion molecule, N-cadherin, the actin-binding scaffold protein, cortactin, and Kv channel remodeling in the heart. These data suggest that in addition to gap junction remodeling, aberrant Kv1.5 channel function contributes to the arrhythmogenic phenotype in N-cad CKO mice.	[Cheng, Lan; Yung, Aaron; Radice, Glenn L.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA; [Covarrubias, Manuel] Thomas Jefferson Univ, Dept Neurosci, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Radice, GL (corresponding author), Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Rm 309,Coll Bldg,1025 Walnut St, Philadelphia, PA 19107 USA.	glenn.radice@jefferson.edu		Covarrubias, Manuel/0000-0002-0881-4143; CHENG, LAN/0000-0002-3620-3366	National Institutes of Health [HL081569]; National Institutes of Health Cancer Center [5 P30 CA-56036]; American Heart Association [0440114N]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL081569 (to G. L. R.). This work was also supported in part by National Institutes of Health Cancer Center Core Grant 5 P30 CA-56036 (to the Kimmel Cancer Center) and American Heart Association Established Investigator Grant 0440114N (to G. L. R.).	Ackerman MJ, 2010, CIRC RES, V107, P457, DOI 10.1161/CIRCRESAHA.110.224592; Akar FG, 2003, CIRC RES, V93, P638, DOI 10.1161/01.RES.0000092248.59479.AE; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Brunner M, 2003, AM J PHYSIOL-HEART C, V285, pH194, DOI 10.1152/ajpheart.00971.2002; Choi WS, 2005, CIRC RES, V97, P363, DOI 10.1161/01.RES.0000179535.06458.f8; Cunha SR, 2008, CIRC RES, V103, P779, DOI 10.1161/CIRCRESAHA.108.186460; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; El Sayegh TY, 2005, MOL BIOL CELL, V16, P5514, DOI 10.1091/mcbE05-05-0410; El Sayegh TY, 2004, J CELL SCI, V117, P5117, DOI 10.1242/jcs.01385; Eldstrom J, 2006, FEBS LETT, V580, P6039, DOI 10.1016/j.febslet.2006.09.069; Fedida D, 2003, CIRC RES, V93, P744, DOI 10.1161/01.RES.0000096362.60730.AE; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jeron A, 2000, AM J PHYSIOL-HEART C, V278, pH1891, DOI 10.1152/ajpheart.2000.278.6.H1891; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Koutsouki E, 2007, BIOCHEM BIOPH RES CO, V363, P18, DOI 10.1016/j.bbrc.2007.07.181; Kucera JP, 2002, CIRC RES, V91, P1176, DOI 10.1161/01.RES.0000046237.54156.0A; Leonard M, 2011, DEV BIOL, V349, P363, DOI 10.1016/j.ydbio.2010.10.009; Li HL, 2004, AM J PHYSIOL-HEART C, V286, pH319, DOI 10.1152/ajpheart.00665.2003; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Li JF, 2008, J MOL CELL CARDIOL, V44, P597, DOI 10.1016/j.yjmcc.2007.11.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; Maier SKG, 2002, P NATL ACAD SCI USA, V99, P4073, DOI 10.1073/pnas.261705699; Marionneau C, 2008, J MOL CELL CARDIOL, V44, P1002, DOI 10.1016/j.yjmcc.2008.03.023; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Maruoka ND, 2000, FEBS LETT, V473, P188, DOI 10.1016/S0014-5793(00)01521-0; Mathur R, 2006, BIOCHEM BIOPH RES CO, V342, P1, DOI 10.1016/j.bbrc.2006.01.110; MAYS DJ, 1995, J CLIN INVEST, V96, P282, DOI 10.1172/JCI118032; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Murata M, 2001, AM J PHYSIOL-HEART C, V281, pH2575, DOI 10.1152/ajpheart.2001.281.6.H2575; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nerbonne JM, 2002, J CARDIOVASC ELECTR, V13, P406, DOI 10.1046/j.1540-8167.2002.00406.x; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Saffitz JE, 2006, J CARDIOVASC ELECTR, V17, P225, DOI 10.1111/j.1540-8167.2006.00365.x; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Shahidullah M, 2003, BIOCHEMISTRY-US, V42, P11243, DOI 10.1021/bi034738f; Shimoni Y, 1999, J PHYSIOL-LONDON, V514, P735, DOI 10.1111/j.1469-7793.1999.735ad.x; Steele DF, 2007, J PHYSIOL-LONDON, V582, P17, DOI 10.1113/jphysiol.2007.130245; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; UNDROVINAS AI, 1995, AM J PHYSIOL-HEART C, V269, pH203, DOI 10.1152/ajpheart.1995.269.1.H203; VanWagoner DR, 1997, CIRC RES, V80, P772; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yang XJ, 2002, J PHYSIOL-LONDON, V541, P411, DOI 10.1113/jphysiol.2002.019562; Yu D, 2010, EXP CELL RES, V316, P848, DOI 10.1016/j.yexcr.2009.11.018; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	53	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20478	20489		10.1074/jbc.M111.218560	http://dx.doi.org/10.1074/jbc.M111.218560			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507952	Green Published, hybrid			2022-12-25	WOS:000291267600035
J	Jaschke, PR; Hardjasa, A; Digby, EL; Hunter, CN; Beatty, JT				Jaschke, Paul R.; Hardjasa, Amelia; Digby, Elizabeth L.; Hunter, C. Neil; Beatty, J. Thomas			A bchD (Magnesium Chelatase) Mutant of Rhodobacter sphaeroides Synthesizes Zinc Bacteriochlorophyll through Novel Zinc-containing Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM ACIDIPHILIUM-RUBRUM; CHLOROPHYLL ISOCYCLIC RING; DELTA-AMINOLEVULINIC ACID; RHODOPSEUDOMONAS-SPHEROIDES; ESCHERICHIA-COLI; PROTOPORPHYRIN CHELATASE; EARLY EVOLUTION; MG-CHELATASE; BIOSYNTHESIS; PHOTOSYNTHESIS	Heme and bacteriochlorophyll a (BChl) biosyntheses share the same pathway to protoporphyrin IX, which then branches as follows. Fe2+ chelation into the macrocycle by ferrochelatase results in heme formation, and Mg2+ addition by Mg-chelatase commits the porphyrin to BChl synthesis. It was recently discovered that a bchD (Mg-chelatase) mutant of Rhodobacter sphaeroides produces an alternative BChl in which Mg2+ is substituted by Zn2+. Zn-BChl has been found in only one other organism before, the acidophilic Acidiphilium rubrum. Our objectives in this work on the bchD mutant were to 1) elucidate the Zn-BChl biosynthetic pathway in this organism and 2) understand causes for the low amounts of Zn-BChl produced. The bchD mutant was found to contain a Zn-protoporphyrin IX pool, analogous to the Mg-protoporphyrin IX pool found in the wild type strain. Inhibition of ferrochelatase with N-methylprotoporphyrin IX caused Zn-protoporphyrin IX and Zn-BChl levels to decline by 80-90% in the bchD mutant, whereas in the wild type strain, Mg-protoporphyrin IX and Mg-BChl levels increased by 170-240%. Two early metabolites of the Zn-BChl pathway were isolated from the bchD mutant and identified as Zn-protoporphyrin IX monomethyl ester and divinyl-Zn-protochlorophyllide. Our data support a model in which ferrochelatase synthesizes Zn-protoporphyrin IX, and this metabolite is acted on by enzymes of the BChl pathway to produce Zn-BChl. Finally, the low amounts of Zn-BChl in the bchD mutant may be due, at least in part, to a bottleneck upstream of the step where divinyl-Zn-protochlorophyllide is converted to monovinyl-Zn-protochlorophyllide.	[Jaschke, Paul R.; Hardjasa, Amelia; Digby, Elizabeth L.; Beatty, J. Thomas] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of British Columbia; University of Sheffield	Beatty, JT (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	j.beatty@ubc.ca	Jaschke, Paul R/D-7244-2017	Jaschke, Paul R/0000-0003-2359-1301; Digby, Elizabeth/0000-0002-9799-0498	University of British Columbia; Pacific Century Graduate Fellowship; John Richard Turner Fellowship in Microbiology; Natural Sciences and Engineering Research Council; Killam Research Fellowship; Biotechnology and Biological Sciences Research Council (United Kingdom); Biotechnology and Biological Sciences Research Council [BB/G021546/1] Funding Source: researchfish	University of British Columbia; Pacific Century Graduate Fellowship; John Richard Turner Fellowship in Microbiology; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Research Fellowship; Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a University of British Columbia Graduate Fellowship, a Pacific Century Graduate Fellowship, and the John Richard Turner Fellowship in Microbiology (to P.R.J.); a Biodiversity Research: Integrative Training and Education scholarship (to A.H.) from the University of British Columbia; a Natural Sciences and Engineering Research Council Discovery Grant and a Killam Research Fellowship (to J.T.B.); and funding from the Biotechnology and Biological Sciences Research Council (United Kingdom) (to C.N.H.).	BARRETT J, 1978, BIOCHEM J, V174, P277, DOI 10.1042/bj1740277; Bauer Carl E., 2009, V28, P707; Beck Richard, 1997, Biochemical Society Transactions, V25, p77S; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Braatsch S, 2002, MOL MICROBIOL, V45, P827, DOI 10.1046/j.1365-2958.2002.03058.x; BURNHAM BF, 1963, BIOCHEM J, V87, P462, DOI 10.1042/bj0870462; Chekounova E, 2001, MOL GENET GENOMICS, V266, P363, DOI 10.1007/s004380100574; COOMBER SA, 1990, MOL MICROBIOL, V4, P977, DOI 10.1111/j.1365-2958.1990.tb00670.x; DAILEY HA, 1982, J BIOL CHEM, V257, P4714; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; GIBSON LCD, 1994, FEBS LETT, V352, P127, DOI 10.1016/0014-5793(94)00934-1; Gomelsky L, 2008, J BACTERIOL, V190, P8106, DOI 10.1128/JB.01094-08; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; Hartwich G, 1998, J AM CHEM SOC, V120, P3675, DOI 10.1021/ja970874u; Ikegami I, 2005, PLANT CELL PHYSIOL, V46, P729, DOI 10.1093/pcp/pci079; Jacobs JM, 1998, TOXICOLOGY, V125, P95, DOI 10.1016/S0300-483X(97)00164-9; Jaschke PR, 2007, BIOCHEMISTRY-US, V46, P12491, DOI 10.1021/bi701407k; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; JONES MS, 1970, BIOCHEM J, V119, P453, DOI 10.1042/bj1190453; Kanazireva E, 1996, GENE, V170, P149, DOI 10.1016/0378-1119(96)00845-1; Kannangara CG, 1997, MOL GEN GENET, V254, P85, DOI 10.1007/s004380050394; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; KIKUCHI G, 1958, BIOCHIM BIOPHYS ACTA, V28, P219, DOI 10.1016/0006-3002(58)90461-X; Labbe RF, 1999, CLIN CHEM, V45, P2060; LASCELLES J, 1960, J GEN MICROBIOL, V23, P487, DOI 10.1099/00221287-23-3-487; Lascelles J, 1968, Biochem Soc Symp, V28, P49; Lazcano A, 1996, CELL, V85, P793, DOI 10.1016/S0092-8674(00)81263-5; Lide D. R., 2009, CRC HDB CHEM PHYS, V90th, P8; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Lundqvist J, 2009, J STRUCT BIOL, V167, P227, DOI 10.1016/j.jsb.2009.06.013; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Masuda T, 1999, J BIOL CHEM, V274, P33594, DOI 10.1074/jbc.274.47.33594; Masuda T, 2006, ANAL BIOCHEM, V355, P307, DOI 10.1016/j.ab.2006.04.008; MAZANOWSKA AM, 1966, BIOCHEM J, V98, P117, DOI 10.1042/bj0980117; MOODY MD, 1985, J BACTERIOL, V161, P1074, DOI 10.1128/JB.161.3.1074-1079.1985; NASRULHAQBOYCE A, 1987, BIOCHEM J, V243, P23, DOI 10.1042/bj2430023; NEIDLE EL, 1993, J BACTERIOL, V175, P2304, DOI 10.1128/JB.175.8.2304-2313.1993; NIEDERMAN RA, 1976, BIOCHIM BIOPHYS ACTA, V440, P429, DOI 10.1016/0005-2728(76)90076-1; NISBET EG, 1995, NATURE, V373, P479, DOI 10.1038/373479a0; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Pappas CT, 2004, J BACTERIOL, V186, P4748, DOI 10.1128/JB.186.14.4748-4758.2004; PRETLOW TP, 1967, BIOCHIM BIOPHYS ACTA, V148, P629, DOI 10.1016/0304-4165(67)90036-0; Rebeiz CA, 2002, HEME CHLOROPHYLL BIL, P111; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Rudiger W, 2005, BIOCHEMISTRY-US, V44, P10864, DOI 10.1021/bi0504198; Sambrook J., 2002, MOL CLONING LAB MANU; Sawicki A, 2008, J BIOL CHEM, V283, P31294, DOI 10.1074/jbc.M805792200; Scheumann V, 1996, EUR J BIOCHEM, V242, P163, DOI 10.1111/j.1432-1033.1996.0163r.x; Scheumann V, 1996, Z NATURFORSCH C, V51, P185; SHIOI Y, 1988, ARCH BIOCHEM BIOPHYS, V267, P69, DOI 10.1016/0003-9861(88)90009-4; STILLMAN LC, 1978, ANAL BIOCHEM, V91, P166, DOI 10.1016/0003-2697(78)90827-8; TUBOI S, 1970, ARCH BIOCHEM BIOPHYS, V138, P155, DOI 10.1016/0003-9861(70)90294-8; WACKER WEC, 1965, BIOCHEMISTRY-US, V4, P940, DOI 10.1021/bi00881a021; Wakao N, 1996, PLANT CELL PHYSIOL, V37, P889, DOI 10.1093/oxfordjournals.pcp.a029029; Weissman KJ, 2007, TRENDS BIOTECHNOL, V25, P139, DOI 10.1016/j.tibtech.2007.02.004; Williams RJP, 1997, CELL MOL LIFE SCI, V53, P816, DOI 10.1007/s000180050102; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n; Willows Robert D., 2009, V28, P57; Wohlleben W, 2002, CHEM BIOL, V9, P1163, DOI 10.1016/S1074-5521(02)00267-3; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Xiong J, 2002, J MOL BIOL, V322, P1025, DOI 10.1016/S0022-2836(02)00822-7; YANG ZM, 1990, J BACTERIOL, V172, P5001, DOI 10.1128/jb.172.9.5001-5010.1990; YUBISUI T, 1972, ARCH BIOCHEM BIOPHYS, V150, P77, DOI 10.1016/0003-9861(72)90012-4; ZEILSTRARYALLS JH, 1995, J BACTERIOL, V177, P6422, DOI 10.1128/jb.177.22.6422-6431.1995	67	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20313	20322		10.1074/jbc.M110.212605	http://dx.doi.org/10.1074/jbc.M110.212605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502322	Green Published, hybrid			2022-12-25	WOS:000291267600019
J	Qi, XF; Jiang, JJ; Zhu, MQ; Wu, QY				Qi, Xiaofei; Jiang, Jingjing; Zhu, Mingqing; Wu, Qingyu			Human Corin Isoforms with Different Cytoplasmic Tails That Alter Cell Surface Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE PROTEASES; PROATRIAL NATRIURETIC PEPTIDE; PLASMA SOLUBLE CORIN; ZYMOGEN ACTIVATION; MOLECULAR-CLONING; CARDIAC-MUSCLE; HEART-FAILURE; EXPRESSION; GENE; HYPERTENSION	Corin is a cardiac serine protease that activates natriuretic peptides. It consists of an N-terminal cytoplasmic tail, a transmembrane domain, and an extracellular region with a C-terminal trypsin-like protease domain. The transmembrane domain anchors corin on the surface of cardiomyocytes. To date, the function of the corin cytoplasmic tail remains unknown. By examining the difference between human and mouse corin cytoplasmic tails, analyzing their gene sequences, and verifying mRNA expression in hearts, we show that both human and mouse corin genes have alternative exons encoding different cytoplasmic tails. Human corin isoforms E1 and E1a have 45 and 15 amino acids, respectively, in their cytoplasmic tails. In transfected HEK 293 cells and HL-1 cardiomyocytes, corin isoforms E1 and E1a were expressed at similar levels. Compared with isoform E1a, however, isoform E1 was more active in processing natriuretic peptides. By cell surface labeling, glycosidase digestion, Western blotting, and flow cytometry, we found that corin isoform E1 was activated more readily as a result of more efficient cell surface targeting. By mutagenesis, we identified a DDNN motif in the cytoplasmic tail of isoform E1 (which is absent in isoform E1a) that promotes corin surface targeting in both HEK 293 and HL-1 cells. Our data indicate that the sequence in the cytoplasmic tail plays an important role in corin cell surface targeting and zymogen activation.	[Wu, Qingyu] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Qi, Xiaofei; Jiang, Jingjing; Wu, Qingyu] Cleveland Clin, Dept Nephrol, Cleveland, OH 44195 USA; [Qi, Xiaofei; Jiang, Jingjing; Wu, Qingyu] Cleveland Clin, Dept Hypertens, Cleveland, OH 44195 USA; [Qi, Xiaofei; Zhu, Mingqing; Wu, Qingyu] Soochow Univ, Cyrus Tang Hematol Ctr, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou 215123, Peoples R China	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Soochow University - China	Wu, QY (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org		Wu, Qingyu/0000-0003-0561-9315	National Institutes of Health [HL089298, HL089298-S1, HD064634]; Ralph Wilson Medical Foundation; Bakken Heart-Brain Institute; Jiangsu Higher Education Institutions; National Natural Science Foundation of China [31070716, 30811130467]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph Wilson Medical Foundation; Bakken Heart-Brain Institute; Jiangsu Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089298, HL089298-S1, and HD064634. This work was also supported by grants from the Ralph Wilson Medical Foundation, the Bakken Heart-Brain Institute, and the Priority Academic Program Development of Jiangsu Higher Education Institutions and by National Natural Science Foundation of China Grants 31070716 and 30811130467.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brown D, 2000, KIDNEY INT, V57, P816, DOI 10.1046/j.1523-1755.2000.00920.x; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chen SH, 2010, AM J PHYSIOL-HEART C, V299, pH1687, DOI 10.1152/ajpheart.00399.2010; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dong NZ, 2010, CLIN CHIM ACTA, V411, P1998, DOI 10.1016/j.cca.2010.08.021; Dong NZ, 2010, CIRC-HEART FAIL, V3, P207, DOI 10.1161/CIRCHEARTFAILURE.109.903849; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Gladysheva IP, 2008, BIOCHEM BIOPH RES CO, V373, P130, DOI 10.1016/j.bbrc.2008.05.181; Gladysheva IP, 2008, J MOL CELL CARDIOL, V44, P131, DOI 10.1016/j.yjmcc.2007.10.002; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Ibebuogu UN, 2011, CIRC-HEART FAIL, V4, P114, DOI 10.1161/CIRCHEARTFAILURE.109.895581; Ichiki T, 2011, CLIN CHEM, V57, P40, DOI 10.1373/clinchem.2010.153908; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Jiang W, 2005, EUR J PHARMACOL, V507, P153, DOI 10.1016/j.ejphar.2004.11.023; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Knappe S, 2004, J BIOL CHEM, V279, P34464, DOI 10.1074/jbc.M405041200; Knappe S, 2003, J BIOL CHEM, V278, P52363, DOI 10.1074/jbc.M309991200; Langenickel TH, 2004, AM J PHYSIOL-HEART C, V287, pH1516, DOI 10.1152/ajpheart.00947.2003; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; McCormick SD, 2006, GEN COMP ENDOCR, V147, P3, DOI 10.1016/j.ygcen.2005.12.009; Mikosch M, 2009, CURR OPIN PLANT BIOL, V12, P685, DOI 10.1016/j.pbi.2009.09.020; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Pan JL, 2002, J BIOL CHEM, V277, P38390, DOI 10.1074/jbc.M205686200; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Peleg A, 2009, CLIN CHIM ACTA, V409, P85, DOI 10.1016/j.cca.2009.09.004; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; Rame JE, 2009, CIRC-HEART FAIL, V2, P541, DOI 10.1161/CIRCHEARTFAILURE.109.866822; Shrestha K, 2010, J CARD FAIL, V16, P621, DOI 10.1016/j.cardfail.2010.03.010; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tran KL, 2004, AM J PHYSIOL-HEART C, V287, pH1625, DOI 10.1152/ajpheart.00298.2004; Tsukada T, 2006, GEN COMP ENDOCR, V147, P31, DOI 10.1016/j.ygcen.2005.09.009; Wang W, 2008, CIRC RES, V103, P502, DOI 10.1161/CIRCRESAHA.108.177352; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P4179, DOI 10.2741/2379; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yamaguchi N, 2002, J BIOL CHEM, V277, P6806, DOI 10.1074/jbc.M103645200; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926	46	30	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20963	20969		10.1074/jbc.M110.217570	http://dx.doi.org/10.1074/jbc.M110.217570			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518754	hybrid, Green Published			2022-12-25	WOS:000291267600080
J	Bae, JS; Cheong, HS; Kim, JH; Park, BL; Kim, JH; Park, TJ; Kim, JY; Pasaje, CFA; Lee, JS; Park, YJ; Park, M; Park, C; Koh, I; Chung, YJ; Lee, JY; Shin, HD				Bae, Joon Seol; Cheong, Hyun Sub; Kim, Ji-Hong; Park, Byung Lae; Kim, Jeong-Hyun; Park, Tae Joon; Kim, Jason Yongha; Pasaje, Charisse Flerida A.; Lee, Jin Sol; Park, Yun-Ju; Park, Miey; Park, Chan; Koh, InSong; Chung, Yeun-Jun; Lee, Jong-Young; Shin, Hyoung Doo			The Genetic Effect of Copy Number Variations on the Risk of Type 2 Diabetes in a Korean Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFICATION; VARIANTS; CNVS	Background: Unlike Caucasian populations, genetic factors contributing to the risk of type 2 diabetes mellitus (T2DM) are not well studied in Asian populations. In light of this, and the fact that copy number variation (CNV) is emerging as a new way to understand human genomic variation, the objective of this study was to identify type 2 diabetes-associated CNV in a Korean cohort. Methodology/Principal Findings: Using the Illumina HumanHap300 BeadChip (317,503 markers), genome-wide genotyping was performed to obtain signal and allelic intensities from 275 patients with type 2 diabetes mellitus (T2DM) and 496 nondiabetic subjects (Total n = 771). To increase the sensitivity of CNV identification, we incorporated multiple factors using PennCNV, a program that is based on the hidden Markov model (HMM). To assess the genetic effect of CNV on T2DM, a multivariate logistic regression model controlling for age and gender was used. We identified a total of 7,478 CNVs (average of 9.7 CNVs per individual) and 2,554 CNV regions (CNVRs; 164 common CNVRs for frequency>1%) in this study. Although we failed to demonstrate robust associations between CNVs and the risk of T2DM, our results revealed a putative association between several CNVRs including chr15:45994758-45999227 (P = 8.6E-04, P-corr = 0.01) and the risk of T2DM. The identified CNVs in this study were validated using overlapping analysis with the Database of Genomic Variants (DGV; 71.7% overlap), and quantitative PCR (qPCR). The identified variations, which encompassed functional genes, were significantly enriched in the cellular part, in the membrane-bound organelle, in the development process, in cell communication, in signal transduction, and in biological regulation. Conclusion/Significance: We expect that the methods and findings in this study will contribute in particular to genome studies of Asian populations.	[Bae, Joon Seol; Kim, Jeong-Hyun; Park, Tae Joon; Kim, Jason Yongha; Pasaje, Charisse Flerida A.; Lee, Jin Sol; Shin, Hyoung Doo] Sogang Univ, Lab Genom Divers, Dept Life Sci, Seoul, South Korea; [Cheong, Hyun Sub; Park, Byung Lae; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Cheong, Hyun Sub] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Kim, Ji-Hong; Chung, Yeun-Jun] Catholic Univ Korea, Integrated Res Ctr Genome Polymorphism, Sch Med, Seoul, South Korea; [Kim, Ji-Hong; Chung, Yeun-Jun] Catholic Univ Korea, Dept Hosp Pathol, Seoul St Marys Hosp, Sch Med, Seoul, South Korea; [Park, Yun-Ju; Park, Miey; Lee, Jong-Young] NIH, Ctr Genome Sci, Osong, South Korea; [Park, Chan] NIH, Ctr Immunol & Pathol, Osong, South Korea; [Koh, InSong] Hanyang Univ, Dept Physiol, Coll Med, Seoul 133791, South Korea	Sogang University; SNP Genetics; Seoul National University (SNU); Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Hanyang University	Bae, JS (corresponding author), Sogang Univ, Lab Genom Divers, Dept Life Sci, Seoul, South Korea.	leejy63@nih.go.kr; hdshin@sogang.ac.kr	Lee, Jong-Young/M-6319-2013; Pasaje, Charisse Flerida A./J-7990-2014; Pasaje, Charisse Flerida A./AAY-8793-2020	Lee, Jong-Young/0000-0002-0092-9958; Pasaje, Charisse Flerida A./0000-0002-9780-3680; Pasaje, Charisse Flerida A./0000-0002-9780-3680	Korea government (MEST) [2009-0080157, 2010-0011206]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Korea Science and Engineering Foundation (KOSEF) funded by the Korea government (MEST) (No. 2009-0080157), and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2010-0011206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLQVIST E, 2011, CLIN CHEM, P57; Bae JS, 2008, BIOCHEM BIOPH RES CO, V373, P593, DOI 10.1016/j.bbrc.2008.06.083; Bae JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011417; Bae JS, 2010, OPHTHALMOLOGY, V117, P1306, DOI 10.1016/j.ophtha.2009.11.021; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; BAE JS, 2010, J HUM GENET; Barroso I, 2005, DIABETIC MED, V22, P517, DOI 10.1111/j.1464-5491.2005.01550.x; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Beissbarth T, 2006, METHOD ENZYMOL, V411, P340, DOI 10.1016/S0076-6879(06)11018-6; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Bridges CB, 1936, SCIENCE, V83, P210, DOI 10.1126/science.83.2148.210; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Elbein SC, 2002, ENDOCRINOLOGY, V143, P2012, DOI 10.1210/en.143.6.2012; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Groop LC, 1997, ANN MED, V29, P37, DOI 10.3109/07853899708998742; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jeon JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-426; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KWAK SH, 2010, HORM RES PAEDIAT; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rong R, 2009, DIABETES, V58, P478, DOI 10.2337/db08-0877; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shtir Corina, 2009, BMC Proc, V3 Suppl 7, pS133; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	40	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19091	10.1371/journal.pone.0019091	http://dx.doi.org/10.1371/journal.pone.0019091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526130	gold, Green Published, Green Submitted			2022-12-25	WOS:000290015800039
J	Narayanaswamy, BE; Bett, BJ				Narayanaswamy, Bhavani E.; Bett, Brian J.			Macrobenthic Biomass Relations in the Faroe-Shetland Channel: An Arctic-Atlantic Boundary Environment	PLOS ONE			English	Article							DEEP-SEA MEIOBENTHOS; NORTHEAST ATLANTIC; SIZE STRUCTURE; BODY-SIZE; OCEAN; WATER; MARGIN; SLOPE; DIVERSITY; PACIFIC	The Faroe-Shetland Channel, located in the NE Atlantic, ranges in depth from 0-1700 m and is an unusual deep-sea environment because of its complex and dynamic hydrographic regime, as well as having numerous different seafloor habitats. Macrofaunal samples have been collected on a 0.5 mm mesh sieve from over 300 stations in a wide area survey and on nested 0.5 and 0.25 mm mesh sieves along a specific depth transect. Contrary to general expectation, macrofauanl biomass in the Channel did not decline with increasing depth. When examined at phylum level, two main biomass patterns with depth were apparent: (a) polychaetes showed little change in biomass on the upper slope then increased markedly below 500 m to a depth of 1100 m before declining; and (b) other phyla showed enhanced biomass between 300-500 m. The polychaete response may be linked with a seafloor environment change to relatively quiescent hydrodynamic conditions and an increasing sediment mud content that occurs at c. 500 m. In contrast, the mid-slope enhancement of other phyla biomass may reflect the hydrodynamically active interface between the warm and cold water masses present in the Channel at c. 300-500 m. Again contrary to expectation, mean macrofaunal body size did not decline with depth, and the relative contribution of smaller (>0.25 mm <0.5 mm) to total (>0.25 mm) macrobenthos did not increase with depth. Overall our total biomass and average individual biomass estimates appear to be greater than those predicted from global analyses. It is clear that global models of benthic biomass distribution may mask significant variations at the local and regional scale.	[Narayanaswamy, Bhavani E.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Bett, Brian J.] Natl Oceanog Ctr, Southampton, Hants, England	UHI Millennium Institute; NERC National Oceanography Centre	Narayanaswamy, BE (corresponding author), Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	Bhavani.Narayanaswamy@sams.ac.uk		Narayanaswamy, Bhavani/0000-0002-5810-9127	Atlantic Frontier Environmental Network (AFEN); Natural Environmental Research Council [NER/D/S/2001/00659]; NERC [noc010004, noc010009, dml010004] Funding Source: UKRI; Natural Environment Research Council [noc010004, noc010009, dml010004] Funding Source: researchfish	Atlantic Frontier Environmental Network (AFEN); Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors would like to thank the Atlantic Frontier Environmental Network (AFEN) and the Natural Environmental Research Council (Grant No: NER/D/S/2001/00659) for funding this study. AFEN comprised: AGIP (UK) Ltd., Amerada Hess Ltd., BG E&P Ltd., BP Amoco, Chevron UK Ltd., Conoco (UK) Ltd., Enterprise Oil plc., Marathon Oil UK Ltd., Phillips Petroleum Company UK Ltd., Shell UK Exploration and Production Ltd., Statoil Ltd., Texaco North Sea UK Company, TotalFina, Veba Oil and Gas UK Ltd., Department of Trade and Industry, Joint Nature Conservation Committee and the Scottish Executive's Environment and Rural Affairs Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berelson WM, 2001, DEEP-SEA RES PT II, V49, P237, DOI 10.1016/S0967-0645(01)00102-3; BETT BJ, 1994, MAR ECOL PROG SER, V104, P197, DOI 10.3354/meps104197; Bett BJ, 2001, CONT SHELF RES, V21, P917, DOI 10.1016/S0278-4343(00)00119-9; Blake JA, 2004, DEEP-SEA RES PT II, V51, P1797, DOI 10.1016/j.dsr2.2004.07.014; Brandt Angelika, 2003, Berichte zur Polar- und Meeresforschung, V470, P45; Bullough LW, 1998, FISH RES, V39, P33, DOI 10.1016/S0165-7836(98)00170-2; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Castellan NJ, 1988, NONPARAMETRIC STAT B; CLARKE ARTHUR H., 1960, NAT HIST PAPERS, V7, P1; Dooley H. D., 1981, DTSCH HYDROGR Z, V34, P41, DOI DOI 10.1007/BF02226585; Gage J.D., 2005, P273, DOI 10.1002/9780470995129.ch7; Gage JD, 2002, MAR ECOL PROG SER, V225, P97, DOI 10.3354/meps225097; GAGE JD, 1977, BIOL BENTHIC ORGANIS, P247; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; HANSEN B, 1985, RIT FISKIDEILDAR, V9, P110; HESSLER RR, 1974, DEEP-SEA RES, V21, P185, DOI 10.1016/0011-7471(74)90058-8; HESSLER RR, 1972, SCIENCE, V175, P636, DOI 10.1126/science.175.4022.636; Hosegood P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019544; Hosegood P, 2004, DEEP-SEA RES PT II, V51, P2943, DOI 10.1016/j.dsr2.2004.09.016; Hughes DJ, 2004, PROG OCEANOGR, V63, P29, DOI 10.1016/j.pocean.2004.09.002; Kaariainen JI, 2006, J MAR BIOL ASSOC UK, V86, P1339, DOI 10.1017/S0025315406014366; Masson DG, 2010, MAR GEOL, V268, P85, DOI 10.1016/j.margeo.2009.10.014; Masson DG, 2004, SEDIMENTOLOGY, V51, P1207, DOI 10.1111/j.1365-3091.2004.00668.x; Masson DG, 2001, CONT SHELF RES, V21, P825, DOI 10.1016/S0278-4343(00)00115-1; McIntyre AD, 1984, METHODS STUDY MARINE, P217; Narayanaswamy BE, 2010, MAR ECOL-EVOL PERSP, V31, P237, DOI 10.1111/j.1439-0485.2010.00360.x; Rex MA, 2005, AM NAT, V165, P163, DOI 10.1086/427226; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Rowe G.T., 1979, AMBIO SPEC REP, P19; Rowe GT, 2003, AM FISH S S, V36, P225; Sherwin T., 1991, TIDAL HYDRODYNAMICS, P469; SOETAERT K, 1989, DEEP-SEA RES, V36, P93, DOI 10.1016/0198-0149(89)90020-4; Soltwedel T, 1996, J MAR BIOL ASSOC UK, V76, P327, DOI 10.1017/S0025315400030587; Steel RGD, 1981, PRINCIPLES PROCEDURE; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Thiel H., 1979, Ambio Special Report, P25; Thiel H, 1975, INT REV GES HYDROBIO, V60, P576; THURSTON MH, 1979, MAR BIOL, V51, P55, DOI 10.1007/BF00389031; TIETJEN JH, 1989, DEEP-SEA RES, V36, P1579, DOI 10.1016/0198-0149(89)90059-9; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; Turrell WR, 1999, DEEP-SEA RES PT I, V46, P1, DOI 10.1016/S0967-0637(98)00067-3; TYLER P, 1978, ESTUAR COAST MAR SCI, V6, P439, DOI 10.1016/0302-3524(78)90134-2; VELLEMAN PF, 1977, P NATL ACAD SCI USA, V74, P434, DOI 10.1073/pnas.74.2.434; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Wolff T., 1962, Galathea Report, V6, P1; Wynn RB, 2002, MAR GEOL, V192, P309, DOI 10.1016/S0025-3227(02)00561-3; Zar J.H., 1999, BIOSTAT ANAL, V4th; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	53	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18602	10.1371/journal.pone.0018602	http://dx.doi.org/10.1371/journal.pone.0018602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526171	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000290015800010
J	Yamazaki, S; Okada, K; Maruyama, A; Matsumoto, M; Yagita, H; Seya, T				Yamazaki, Sayuri; Okada, Kohei; Maruyama, Akira; Matsumoto, Misako; Yagita, Hideo; Seya, Tsukasa			TLR2-Dependent Induction of IL-10 and Foxp3(+)CD25(+)CD4(+) Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo	PLOS ONE			English	Article							MACROPHAGE-ACTIVATING LIPOPEPTIDE-2; BACILLUS-CALMETTE-GUERIN; NATURAL-KILLER-CELLS; TOLL-LIKE RECEPTOR-2; GROWTH-FACTOR-BETA; DENDRITIC CELLS; TGF-BETA; WALL SKELETON; NK CELLS; INTERLEUKIN-10	16 S-[2,3-bis(palmitoyl)propyl] cysteine (Pam2) lipopeptides act as toll-like receptor (TLR)2/6 ligands and activate natural killer (NK) cells and dendritic cells (DCs) to produce inflammatory cytokines and cytotoxic NK activity in vitro. However, in this study, we found that systemic injection of Pam2 lipopeptides was not effective for the suppression of NK-sensitive B16 melanomas in vivo. When we investigated the immune suppressive mechanisms, systemic injection of Pam2 lipopeptides induced IL-10 in a TLR2-dependent manner. The Pam2 lipopeptides increased the frequencies of Foxp3(+)CD4(+) regulatory T (T reg) cells in a TLR2- and IL-10-dependent manner. The T reg cells from Pam2-lipopeptide injected mice maintained suppressor activity. Pam2 lipopeptides, plus the depletion of T reg with an anti-CD25 monoclonal antibody, improved tumor growth compared with Pam2 lipopeptides alone. In conclusion, our data suggested that systemic treatment of Pam2 lipopeptides promoted IL-10 production and T reg function, which suppressed the effective induction of anti-tumor immunity in vivo. It is necessary to develop an adjuvant that does not promote IL-10 and T reg function in vivo for the future establishment of an anti-cancer vaccine.	[Yamazaki, Sayuri; Okada, Kohei; Maruyama, Akira; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Hokkaido University; Juntendo University	Yamazaki, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.	yamazas@med.hokudai.ac.jp; seya-tu@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Seya, Tsukasa/A-4336-2012		Japan Society for The Promotion of Science; Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Yakult Foundation; Waxman Foundation; Grants-in-Aid for Scientific Research [23390088, 23590558, 22114008] Funding Source: KAKEN	Japan Society for The Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Yakult Foundation; Waxman Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grant for challenging exploratory research, Japan Society for The Promotion of Science Challenging Grand (SY), Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research) and the Ministry of Health, Labor, and Welfare of Japan, the Mochida Memorial Foundation for Medical and Pharmaceutical Research (SY), the Yakult Foundation, and the Waxman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Akazawa T, 2010, CANCER SCI, V101, P1596, DOI 10.1111/j.1349-7006.2010.01583.x; Alter G, 2010, J CLIN INVEST, V120, P1905, DOI 10.1172/JCI40913; Aramaki O, 2005, TRANSPLANTATION, V79, P568, DOI 10.1097/01.TP.0000153151.16350.53; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Azuma I, 2001, INT IMMUNOPHARMACOL, V1, P1249, DOI 10.1016/S1567-5769(01)00055-8; Azuma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012550; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; Brooks MN, 2011, CELL MICROBIOL, V13, P402, DOI 10.1111/j.1462-5822.2010.01544.x; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Giroux M, 2007, J IMMUNOL, V179, P4492, DOI 10.4049/jimmunol.179.7.4492; Klages K, 2010, CANCER RES, V70, P7788, DOI 10.1158/0008-5472.CAN-10-1736; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Li XR, 2010, EUR J IMMUNOL, V40, P3325, DOI 10.1002/eji.201041093; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; Mehrotra PT, 1998, J IMMUNOL, V160, P2637; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murata M, 2008, CANCER SCI, V99, P1435, DOI 10.1111/j.1349-7006.2008.00832.x; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Onizuka S, 1999, CANCER RES, V59, P3128; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schmidt J, 2007, BRIT J CANCER, V97, P598, DOI 10.1038/sj.bjc.6603903; Schulz U, 2010, SCAND J IMMUNOL, V72, P319, DOI 10.1111/j.1365-3083.2010.02435.x; Seya T, 2009, CANCER IMMUNOL IMMUN, V58, P1175, DOI 10.1007/s00262-008-0652-9; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shingu K, 2003, AM J RESP CELL MOL, V28, P316, DOI 10.1165/rcmb.2002-0106OC; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Teng MWL, 2010, CANCER RES, V70, P2665, DOI 10.1158/0008-5472.CAN-09-1574; Terme M, 2008, J IMMUNOL, V180, P4679, DOI 10.4049/jimmunol.180.7.4679; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Uehori J, 2003, INFECT IMMUN, V71, P4238, DOI 10.1128/IAI.71.8.4238-4249.2003; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831	55	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18833	10.1371/journal.pone.0018833	http://dx.doi.org/10.1371/journal.pone.0018833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533081	gold, Green Submitted, Green Published			2022-12-25	WOS:000289719400029
J	Lau, T; Zochowski, M				Lau, Troy; Zochowski, Michal			The Resonance Frequency Shift, Pattern Formation, and Dynamical Network Reorganization via Sub-Threshold Input	PLOS ONE			English	Article							GAMMA-OSCILLATIONS; THETA-OSCILLATIONS; NEURONS; MEMORY; HIPPOCAMPUS; PERFORMANCE; MECHANISMS; RESPONSES; RHYTHM; ALPHA	We describe a novel mechanism that mediates the rapid and selective pattern formation of neuronal network activity in response to changing correlations of sub-threshold level input. The mechanism is based on the classical resonance and experimentally observed phenomena that the resonance frequency of a neuron shifts as a function of membrane depolarization. As the neurons receive varying sub-threshold input, their natural frequency is shifted in and out of its resonance range. In response, the neuron fires a sequence of action potentials, corresponding to the specific values of signal currents, in a highly organized manner. We show that this mechanism provides for the selective activation and phase locking of the cells in the network, underlying input-correlated spatio-temporal pattern formation, and could be the basis for reliable spike-timing dependent plasticity. We compare the selectivity and efficiency of this pattern formation to a supra-threshold network activation and a non-resonating network/neuron model to demonstrate that the resonance mechanism is the most effective. Finally we show that this process might be the basis of the phase precession phenomenon observed during firing of hippocampal place cells, and that it may underlie the active switching of neuronal networks to locking at various frequencies.	[Lau, Troy; Zochowski, Michal] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Zochowski, Michal] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lau, T (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.	michalz@umich.edu		Zochowski, Michal/0000-0002-1722-986X	NIH [EB008163]; NSF [CMMI1029388]; Molecular Biophysics training grant [T32GM008270]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Molecular Biophysics training grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH EB008163(MZ), NSF CMMI1029388 (MZ) and Molecular Biophysics training grant T32GM008270 (TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Clemens Z, 2009, NEUROSCIENCE, V163, P388, DOI 10.1016/j.neuroscience.2009.06.044; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Feng HF, 2001, NEURAL NETWORKS, V14, P955, DOI 10.1016/S0893-6080(01)00074-0; Fernandez T, 1998, NEUROREPORT, V9, P3681; FLORIAN M, 2000, PHYSICA D, V144, P358; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lee S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000602; Mathes B, 2010, NEUROSCI LETT, V478, P14, DOI 10.1016/j.neulet.2010.04.057; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Miura K, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021914; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Pikovsky A, 1997, CHAOS, V7, P680, DOI 10.1063/1.166265; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sanhueza M, 2005, EUR J NEUROSCI, V22, P1618, DOI 10.1111/j.1460-9568.2005.04341.x; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sun MK, 2001, J NEUROPHYSIOL, V85, P269, DOI 10.1152/jn.2001.85.1.269; Wu NP, 2001, J NEUROSCI, V21, P3729, DOI 10.1523/JNEUROSCI.21-11-03729.2001	26	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18983	10.1371/journal.pone.0018983	http://dx.doi.org/10.1371/journal.pone.0018983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526162	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100044
J	Strother, L; Mathuranath, PS; Aldcroft, A; Lavell, C; Goodale, MA; Vilis, T				Strother, Lars; Mathuranath, Pavagada S.; Aldcroft, Adrian; Lavell, Cheryl; Goodale, Melvyn A.; Vilis, Tutis			Face Inversion Reduces the Persistence of Global Form and Its Neural Correlates	PLOS ONE			English	Article							HUMAN OCCIPITOTEMPORAL CORTEX; LATERAL OCCIPITAL COMPLEX; HUMAN BRAIN; PERCEPTUAL PERSISTENCE; FUSIFORM GYRUS; INVERTED FACES; VISUAL AREAS; RECOGNITION; SELECTIVITY; NETWORK	Face inversion produces a detrimental effect on face recognition. The extent to which the inversion of faces and other kinds of objects influences the perceptual binding of visual information into global forms is not known. We used a behavioral method and functional MRI (fMRI) to measure the effect of face inversion on visual persistence, a type of perceptual memory that reflects sustained awareness of global form. We found that upright faces persisted longer than inverted versions of the same images; we observed a similar effect of inversion on the persistence of animal stimuli. This effect of inversion on persistence was evident in sustained fMRI activity throughout the ventral visual hierarchy, including the lateral occipital area (LO), two face-selective visual areas-the fusiform face area (FFA) and the occipital face area (OFA)-and several early visual areas. V1 showed the same initial fMRI activation to upright and inverted forms but this activation lasted longer for upright stimuli. The inversion effect on persistence-related fMRI activity in V1 and other retinotopic visual areas demonstrates that higher-tier visual areas influence early visual processing via feedback. This feedback effect on figure-ground processing is sensitive to the orientation of the figure.	[Strother, Lars; Mathuranath, Pavagada S.; Aldcroft, Adrian; Lavell, Cheryl; Goodale, Melvyn A.; Vilis, Tutis] Univ Western Ontario, Ctr Brain & Mind, London, ON, Canada; [Strother, Lars; Lavell, Cheryl; Vilis, Tutis] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Goodale, Melvyn A.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Mathuranath, Pavagada S.] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum, Kerala, India	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Strother, L (corresponding author), Univ Western Ontario, Ctr Brain & Mind, London, ON, Canada.	lstroth@uwo.ca	Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561; Aldcroft, Adrian/0000-0003-0106-720X; Mathuranath, P S/0000-0002-3055-9134	Canadian Institutes of Health Research (CIHR) [9335, 36036]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants 9335 to T. Vilis and 36036 to M. A. Goodale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Caldara R, 2006, NEUROIMAGE, V31, P313, DOI 10.1016/j.neuroimage.2005.12.011; Caldara R, 2009, HUM BRAIN MAPP, V30, P1615, DOI 10.1002/hbm.20626; Chen CC, 2007, CEREB CORTEX, V17, P1423, DOI 10.1093/cercor/bhl054; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.4.2; de Heering A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002317; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Ferber S, 2005, NEUROPSYCHOLOGIA, V43, P41, DOI 10.1016/j.neuropsychologia.2004.06.020; Ferber S, 2003, CEREB CORTEX, V13, P716, DOI 10.1093/cercor/13.7.716; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Garrido L, 2008, J NEUROPSYCHOL, V2, P119, DOI 10.1348/174866407X246843; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Goffaux V, 2009, J NEUROPSYCHOL, V3, P45, DOI 10.1348/174866408X292670; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Hsieh PJ, 2010, J NEUROPHYSIOL, V103, P1501, DOI 10.1152/jn.00812.2009; Jacques C, 2007, NEUROIMAGE, V36, P863, DOI 10.1016/j.neuroimage.2007.04.016; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Large ME, 2005, J NEUROPHYSIOL, V93, P3453, DOI 10.1152/jn.00934.2004; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Liu J, 2010, J COGNITIVE NEUROSCI, V22, P203, DOI 10.1162/jocn.2009.21203; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Mazard A, 2006, NEUROPSYCHOLOGIA, V44, P912, DOI 10.1016/j.neuropsychologia.2005.08.015; Meeren HKM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003503; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; RAMSAY JO, 2005, FUNCTIONAL DATA ANAL, pR19; REGAN D, 1986, Spatial Vision, V1, P305, DOI 10.1163/156856886X00106; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Rosburg T, 2010, PSYCHOPHYSIOLOGY, V47, P147, DOI 10.1111/j.1469-8986.2009.00881.x; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Schwarzkopf DS, 2008, CURR BIOL, V18, P1162, DOI 10.1016/j.cub.2008.06.072; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Strother L, 2010, J NEUROPHYSIOL, V104, P2075, DOI 10.1152/jn.00462.2010; SUNG YW, 2010, BRAIN RES; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Van Belle G, 2010, J VISION, V10, DOI 10.1167/10.5.10; Wong YJ, 2009, J NEUROPHYSIOL, V102, P3461, DOI 10.1152/jn.00243.2009; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2005, J COGNITIVE NEUROSCI, P112; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Zhang JX, 2010, P NATL ACAD SCI USA, V107, P13503, DOI 10.1073/pnas.1002506107	54	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18705	10.1371/journal.pone.0018705	http://dx.doi.org/10.1371/journal.pone.0018705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750WK	21525978	Green Submitted, Green Published, gold			2022-12-25	WOS:000289578600023
J	Rouse, MN; Saleh, AA; Seck, A; Keeler, KH; Travers, SE; Hulbert, SH; Garrett, KA				Rouse, Matthew N.; Saleh, Amgad A.; Seck, Amadou; Keeler, Kathleen H.; Travers, Steven E.; Hulbert, Scot H.; Garrett, Karen A.			Genomic and Resistance Gene Homolog Diversity of the Dominant Tallgrass Prairie Species across the US Great Plains Precipitation Gradient	PLOS ONE			English	Article							BLUESTEM ANDROPOGON-GERARDII; DISEASE RESISTANCE; BIG BLUESTEM; DROSOPHILA-MELANOGASTER; POLYPLOID VARIATION; PLANT-DISEASE; RED QUEEN; POPULATIONS; SELECTION; PATTERNS	Background: Environmental variables such as moisture availability are often important in determining species prevalence and intraspecific diversity. The population genetic structure of dominant plant species in response to a cline of these variables has rarely been addressed. We evaluated the spatial genetic structure and diversity of Andropogon gerardii populations across the U.S. Great Plains precipitation gradient, ranging from approximately 48 cm/year to 105 cm/year. Methodology/Principal Findings: Genomic diversity was evaluated with AFLP markers and diversity of a disease resistance gene homolog was evaluated by PCR-amplification and digestion with restriction enzymes. We determined the degree of spatial genetic structure using Mantel tests. Genomic and resistance gene homolog diversity were evaluated across prairies using Shannon's index and by averaging haplotype dissimilarity. Trends in diversity across prairies were determined using linear regression of diversity on average precipitation for each prairie. We identified significant spatial genetic structure, with genomic similarity decreasing as a function of distance between samples. However, our data indicated that genome-wide diversity did not vary consistently across the precipitation gradient. In contrast, we found that disease resistance gene homolog diversity was positively correlated with precipitation. Significance: Prairie remnants differ in the genetic resources they maintain. Selection and evolution in this disease resistance homolog is environmentally dependent. Overall, we found that, though this environmental gradient may not predict genomic diversity, individual traits such as disease resistance genes may vary significantly.	[Rouse, Matthew N.; Saleh, Amgad A.; Seck, Amadou; Travers, Steven E.; Hulbert, Scot H.; Garrett, Karen A.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Keeler, Kathleen H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	Kansas State University; University of Nebraska System; University of Nebraska Lincoln	Rouse, MN (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA.	kgarrett@ksu.edu	Saleh, Amgad A/B-4783-2015; Saleh, Amgad/A-8697-2012; Rouse, Matthew N/G-5474-2011	Saleh, Amgad A/0000-0002-2354-0144; Saleh, Amgad/0000-0002-2354-0144; 	Land Institute; Ecological Genomics Institute at Kansas State University; US National Science Foundation [EF-0525712]; NSF [DEB-0516046]; Kansas Agricultural Experiment Station; Direct For Biological Sciences [0823341] Funding Source: National Science Foundation	Land Institute; Ecological Genomics Institute at Kansas State University; US National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Kansas Agricultural Experiment Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors appreciate the support provided by The Land Institute (http://www.landinstitute.org/), The Ecological Genomics Institute at Kansas State University, the US National Science Foundation under Grants EF-0525712 (as part of the joint NSF-NIH Ecology of Infectious Disease program) and NSF DEB-0516046, and the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HM, 2007, J ECOL, V95, P446, DOI 10.1111/j.1365-2745.2007.01228.x; [Anonymous], 2010, R LANG ENV STAT COMP; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Burdon JJ, 1999, AM NAT, V153, pS15, DOI 10.1086/303209; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P17444, DOI 10.1073/pnas.0407899101; Caicedo AL, 2008, AM J BOT, V95, P393, DOI 10.3732/ajb.95.3.393; Cheatham MR, 2009, PHYTOPATHOLOGY, V99, P1228, DOI 10.1094/PHYTO-99-11-1228; Clay K, 1996, ANNU REV PHYTOPATHOL, V34, P29, DOI 10.1146/annurev.phyto.34.1.29; Collinge JE, 2006, J EVOLUTION BIOL, V19, P473, DOI 10.1111/j.1420-9101.2005.01016.x; COX TS, 1992, PLANT DIS, V76, P1061, DOI 10.1094/PD-76-1061; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Duan YP, 2009, PLANT DIS, V93, P607, DOI 10.1094/PDIS-93-6-0607; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Garrett KA, 2009, ECOL APPL, V19, P1868, DOI 10.1890/08-0942.1; Garrett KA, 1999, PHYTOPATHOLOGY, V89, P984, DOI 10.1094/PHYTO.1999.89.11.984; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Green DM, 1996, EVOLUTION, V50, P374, DOI 10.1111/j.1558-5646.1996.tb04500.x; Gustafson DJ, 2004, J APPL ECOL, V41, P389, DOI 10.1111/j.0021-8901.2004.00904.x; Gustafson DJ, 1999, MOL ECOL, V8, P1693, DOI 10.1046/j.1365-294x.1999.00756.x; Hammerli A, 2003, HEREDITY, V91, P448, DOI 10.1038/sj.hdy.6800310; HUBER L, 1992, ANNU REV PHYTOPATHOL, V30, P553, DOI 10.1146/annurev.py.30.090192.003005; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kane NC, 2007, GENETICS, V175, P1823, DOI 10.1534/genetics.106.067728; KEELER KH, 1992, AM J BOT, V79, P1229, DOI 10.2307/2445049; Keeler KH, 2004, AM MIDL NAT, V152, P63, DOI 10.1674/0003-0031(2004)152[0063:IOIPIA]2.0.CO;2; Keeler KH, 2002, AM MIDL NAT, V147, P295, DOI 10.1674/0003-0031(2002)147[0295:CSOAGV]2.0.CO;2; KEELER KH, 1990, GENOME, V33, P95, DOI 10.1139/g90-015; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Laine AL, 2011, J ECOL, V99, P96, DOI 10.1111/j.1365-2745.2010.01738.x; Lane DR, 2000, J VEG SCI, V11, P359, DOI 10.2307/3236628; LEONARD KJ, 1969, PHYTOPATHOLOGY, V59, P1858; LEONARD KJ, 1977, ANN NY ACAD SCI, V287, P207, DOI 10.1111/j.1749-6632.1977.tb34240.x; LEONARD KJ, 1980, ANNU REV PHYTOPATHOL, V18, P237, DOI 10.1146/annurev.py.18.090180.001321; LEONARD KJ, 1994, PHYTOPATHOLOGY, V84, P70, DOI 10.1094/Phyto-84-70; Lythgoe KA, 1998, TRENDS ECOL EVOL, V13, P473, DOI 10.1016/S0169-5347(98)01486-4; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Muriithi LM, 1997, EUPHYTICA, V98, P129, DOI 10.1023/A:1003025624950; NEVO E, 1984, PLANT SYST EVOL, V145, P79, DOI 10.1007/BF00984032; Norrmann GA, 2003, BOT J LINN SOC, V141, P95, DOI 10.1046/j.1095-8339.2003.00116.x; Norrmann GA, 1997, AM J BOT, V84, P201, DOI 10.2307/2446081; Nuismer SL, 2000, EVOLUTION, V54, P1102; Ouborg NJ, 2010, CONSERV GENET, V11, P643, DOI 10.1007/s10592-009-0016-9; Randolph LF, 1932, P NATL ACAD SCI USA, V18, P222, DOI 10.1073/pnas.18.3.222; Richards CL, 2004, ECOL LETT, V7, P1155, DOI 10.1111/j.1461-0248.2004.00674.x; Rose LE, 2007, GENETICS, V175, P1307, DOI 10.1534/genetics.106.063602; Saleh AA, 2010, MOL ECOL, V19, P79, DOI 10.1111/j.1365-294X.2009.04433.x; SORK VL, 1993, AM NAT, V142, P928, DOI 10.1086/285581; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Travers SE, 2007, FRONT ECOL ENVIRON, V5, P19, DOI 10.1890/1540-9295(2007)5[19:EGMTLF]2.0.CO;2; Travers SE, 2010, J ECOL, V98, P374, DOI 10.1111/j.1365-2745.2009.01618.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Weeks AR, 2002, ECOL LETT, V5, P756, DOI 10.1046/j.1461-0248.2002.00380.x; Wright S, 1943, GENETICS, V28, P114; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e17641	10.1371/journal.pone.0017641	http://dx.doi.org/10.1371/journal.pone.0017641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532756	Green Published, gold			2022-12-25	WOS:000289404700005
J	Pfueller, CF; Brandt, AU; Schubert, F; Bock, M; Walaszek, B; Waiczies, H; Schwenteck, T; Dorr, J; Bellmann-Strobl, J; Mohr, C; Weinges-Evers, N; Ittermann, B; Wuerfel, JT; Paul, F				Pfueller, Caspar F.; Brandt, Alexander U.; Schubert, Florian; Bock, Markus; Walaszek, Bernadeta; Waiczies, Helmar; Schwenteck, Thomas; Doerr, Jan; Bellmann-Strobl, Judith; Mohr, Christian; Weinges-Evers, Nicholetta; Ittermann, Bernd; Wuerfel, Jens T.; Paul, Friedemann			Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MAGNETIC-RESONANCE-SPECTROSCOPY; APPEARING WHITE-MATTER; BRAIN ATROPHY; CLINICAL-RELEVANCE; IMPAIRMENT; ROBUST; DISABILITY; ACCURATE; LESIONS	Objective: To investigate the damage to the retinal nerve fiber layer as part of the anterior visual pathway as well as an impairment of the neuronal and axonal integrity in the visual cortex as part of the posterior visual pathway with complementary neuroimaging techniques, and to correlate our results to patients' clinical symptoms concerning the visual pathway. Design, Subjects and Methods: Survey of 86 patients with relapsing-remitting multiple sclerosis that were subjected to retinal nerve fiber layer thickness (RNFLT) measurement by optical coherence tomography, to a routine MRI scan including the calculation of the brain parenchymal fraction (BPF), and to magnetic resonance spectroscopy at 3 tesla, quantifying N-acetyl aspartate (NAA) concentrations in the visual cortex and normal-appearing white matter. Results: RNFLT correlated significantly with BPF and visual cortex NAA, but not with normal-appearing white matter NAA. This was connected with the patients' history of a previous optic neuritis. In a combined model, both BPF and visual cortex NAA were independently associated with RNFLT. Conclusions: Our data suggest the existence of functional pathway-specific damage patterns exceeding global neurodegeneration. They suggest a strong interrelationship between damage to the anterior and the posterior visual pathway.	[Pfueller, Caspar F.; Brandt, Alexander U.; Bock, Markus; Doerr, Jan; Weinges-Evers, Nicholetta; Wuerfel, Jens T.; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Brandt, Alexander U.] Gfnmediber GmbH, Berlin, Germany; [Mohr, Christian; Wuerfel, Jens T.] Univ Lubeck, Inst Neuroradiol, Lubeck, Germany; [Schubert, Florian; Walaszek, Bernadeta; Waiczies, Helmar; Schwenteck, Thomas; Ittermann, Bernd] Phys Tech Bundesanstalt, D-3300 Braunschweig, Germany; [Schubert, Florian; Walaszek, Bernadeta; Waiczies, Helmar; Schwenteck, Thomas; Ittermann, Bernd] Phys Tech Bundesanstalt, Berlin, Germany; [Waiczies, Helmar; Bellmann-Strobl, Judith; Paul, Friedemann] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Waiczies, Helmar; Bellmann-Strobl, Judith; Paul, Friedemann] Max Delbrueck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; Physikalisch-Technische Bundesanstalt (PTB); Physikalisch-Technische Bundesanstalt (PTB); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Pfueller, CF (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	caspar.pfueller@charite.de	Paul, Friedemann/ABF-9415-2020	Wuerfel, Jens/0000-0002-0034-8053; Waiczies, Helmar/0000-0001-6651-4790; paul, friedemann/0000-0002-6378-0070; Bellmann-Strobl, Judith/0000-0003-2615-1643	German Research Foundation; German Ministry of Economics [KF2286101FO9]; gfnmediber; gfnmediber GmbH, Berlin, Germany	German Research Foundation(German Research Foundation (DFG)); German Ministry of Economics; gfnmediber; gfnmediber GmbH, Berlin, Germany	This work was supported by grants from the Excellence Cluster 257 of the German Research Foundation to NeuroCure Clinical Research Center and the grant KF2286101FO9 from the German Ministry of Economics awarded both to NeuroCure Clinical Research Center and gfnmediber, a company co-managed by Alexander U Brandt, who is also a guest scientist in the NeuroCure Clinical Research Center. Therefore the authors mention gfnmediber as a funder of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Alexander U Brandt is the deputy CEO of gfnmediber and a guest scientist in the NeuroCure Clinical Research Center (NCRC). There is no conflict of gfnmediber's company interests with the current study; Alexander U Brandt contributed to the study merely in his role of a guest scientist in the NCRC. As the grant KF2286101FO9 from the German Ministry of Economics was awarded both to NeuroCure Clinical Research Center and gfnmediber and gfnmediber is employing Alexander U Brandt, the authors include gfnmediber GmbH, Berlin, Germany as a funding source. This does not alter their adherence to all the PLoS ONE policies on sharing data and materials.	Audoin B, 2006, BRAIN, V129, P1031, DOI 10.1093/brain/awl039; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Barnes GR, 2010, INVEST OPHTH VIS SCI, V51, P1432, DOI 10.1167/iovs.09-3931; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Bock M, 2010, MULT SCLER J, V16, P893, DOI 10.1177/1352458510365156; CHARCOT JM, 1968, GAZETTE HOPITAUX, V141, P554; Cheung CYL, 2008, OPHTHALMOLOGY, V115, P1347, DOI 10.1016/j.ophtha.2007.11.027; Costello F, 2009, J NEUROL SCI, V281, P74, DOI 10.1016/j.jns.2009.02.354; De Stefano N, 2007, J NEUROIMAGING, V17, p31S, DOI 10.1111/j.1552-6569.2007.00134.x; Elster C, 2005, MAGN RESON MED, V53, P1288, DOI 10.1002/mrm.20500; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Fink F, 2010, MULT SCLER J, V16, P332, DOI 10.1177/1352458509356367; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Grazioli E, 2008, J NEUROL SCI, V268, P12, DOI 10.1016/j.jns.2007.10.020; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gupta N, 2003, EUR J OPHTHALMOL, V13, pS32; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; HUSTED CA, 1994, ANN NEUROL, V36, P157, DOI 10.1002/ana.410360207; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Parisi V, 1999, INVEST OPHTH VIS SCI, V40, P2520; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reich DS, 2009, ARCH NEUROL-CHICAGO, V66, P998, DOI 10.1001/archneurol.2009.107; Ropper A.H. a.B., 2005, ADAMS VICTORS PRINCI; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Schubert F, 2004, NEUROIMAGE, V21, P1762, DOI 10.1016/j.neuroimage.2003.11.014; Schubert F, 2002, MAGN RESON MATER PHY, V14, P213, DOI 10.1007/BF02668215; Sepulcre J, 2009, ARCH NEUROL-CHICAGO, V66, P173, DOI 10.1001/archneurol.2008.562; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	47	66	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18019	10.1371/journal.pone.0018019	http://dx.doi.org/10.1371/journal.pone.0018019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494672	Green Published, Green Accepted, gold			2022-12-25	WOS:000289192400006
J	Gerstel, D; Wegwitz, F; Jannasch, K; Ludewig, P; Scheike, K; Alves, F; Beauchemin, N; Deppert, W; Wagener, C; Horst, AK				Gerstel, D.; Wegwitz, F.; Jannasch, K.; Ludewig, P.; Scheike, K.; Alves, F.; Beauchemin, N.; Deppert, W.; Wagener, C.; Horst, A. K.			CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation	ONCOGENE			English	Article						CEACAM1; angiogenesis; tumor microenvironments; vessel maturation; MMP9-expressing leukocytes	CELL-ADHESION MOLECULE-1; VOLUME COMPUTED-TOMOGRAPHY; VASCULAR MORPHOGENESIS; BLOOD-VESSELS; MOUSE MODEL; IN-VIVO; CANCER; EXPRESSION; GROWTH; CARCINOGENESIS	We have studied the effects of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) on tumor angiogenesis in murine ductal mammary adenocarcinomas. We crossed transgenic mice with whey acidic protein promoter-driven large T-antigen expression (WAP-T mice) with oncogene-induced mammary carcinogenesis with CEA-CAM1null mice, and with Tie2-Ceacam1 transgenics, in which the Tie2 promoter drives endothelial overexpression of CEACAM1 (WAP-T x CEACAM1(endo+) mice), and analyzed tumor vascularization, angiogenesis and vessel maturation in these mice. Using flat-panel volume computed tomography (fpVCT) and histology, we found that WAP-T x CEACAM1(endo+) mice exhibited enhanced tumoral vascularization owing to CEACAM1(+) vessels in the tumor periphery, and increased intratumoral angiogenesis compared with controls. In contrast, vascularization of CEACAM1null/WAP-T-derived tumors was poor, and tumor vessels were dilated, leaky and showed poor pericyte coverage. Consequently, the tumoral vasculature could not be visualized in CEACAM1null/WAP-T mice by fpVCT, and we observed poor organization of the perivascular extracellular matrix (ECM), accompanied by the accumulation of collagen IV-degrading matrix metalloproteinase 9(+) (MMP9(+)) leukocytes and stromal cells. Vascular instability and alterations in ECM structure were accompanied by a significant increase in pulmonary metastases in CEACAM1null/WAP-T mice, whereas only occasional metastases were observed in CEACAM1(+) hosts. In CEACAM1(+) hosts, intratumoral vessels did not express CEACAM1, but they were intact, extensively covered with pericytes and framed by a well-organized perivascular ECM. MMP9(+) accessory cells were largely absent. Orthotopic transplantation of primary WAP-T- and CEACAM1null/WAP-T tumors into all three mouse lines confirmed that a CEACAM1(+) host environment is a prerequisite for productive angiogenic remodeling of the tumor microenvironment. Hence, CEACAM1 expression in the tumor periphery determines the vascular phenotype in a tumor, whereas systemic absence of CEACAM1 interferes with the formation of an organized tumor matrix and intratumoral vessel maturation. Oncogene (2011) 30, 4275-4288; doi: 10.1038/onc.2011.146; published online 2 May 2011	[Gerstel, D.; Ludewig, P.; Scheike, K.; Wagener, C.; Horst, A. K.] Univ Med Ctr Hamburg Eppendorf, Ctr Diagnost, Inst Clin Chem, D-20246 Hamburg, Germany; [Wegwitz, F.; Deppert, W.] Heinrich Pette Inst, Dept Tumor Virol, Hamburg, Germany; [Jannasch, K.; Alves, F.] Univ Gottingen, Dept Hematol & Oncol, Univ Med Ctr Gottingen, Gottingen, Germany; [Beauchemin, N.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Gottingen; McGill University	Horst, AK (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Diagnost, Inst Clin Chem, CAMPUS Res Bldg N27,02-089,52 Martinistr, D-20246 Hamburg, Germany.	ahorst@uke.de			German Research Foundation [SPP1190]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation, Priority Program SPP1190: the tumor vessel interface to WD, CW, AKH and FA.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Ahn GO, 2009, ANGIOGENESIS, V12, P159, DOI 10.1007/s10456-009-9135-7; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Betsholtz C, 2005, EXP SUPPL, V94, P115; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Fathers KE, 2005, AM J PATHOL, V167, P1753, DOI 10.1016/S0002-9440(10)61256-4; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Heinlein C, 2008, INT J CANCER, V122, P1701, DOI 10.1002/ijc.23317; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Horst AK, 2004, HANDB EXP PHARM, V165, P283, DOI 10.1007/978-3-540-68170-0_10; Horst AK, 2009, BLOOD, V113, P6726, DOI 10.1182/blood-2008-10-184556; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jannasch K, 2009, INT J CANCER, V125, P62, DOI 10.1002/ijc.24332; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kilic N, 2007, BLOOD, V110, P4223, DOI 10.1182/blood-2007-06-097592; Kirshner J, 2004, J MOL HISTOL, V35, P287, DOI 10.1023/B:HIJO.0000032360.01976.81; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kohler S, 2010, BRIT J CANCER, V102, P602, DOI 10.1038/sj.bjc.6605492; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Li CX, 2009, EXP CELL RES, V315, P1225, DOI 10.1016/j.yexcr.2008.12.015; Missbach-Guentner J, 2007, NEOPLASIA, V9, P755, DOI 10.1593/neo.07466; Nouvion AL, 2010, J CELL SCI, V123, P4221, DOI 10.1242/jcs.073635; Oliveira-Ferrer L, 2004, CANCER RES, V64, P8932, DOI 10.1158/0008-5472.CAN-04-0505; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; SAWA H, 1994, DEV BRAIN RES, V78, P35, DOI 10.1016/0165-3806(94)90006-X; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schulze-Garg C, 2000, ONCOGENE, V19, P1028, DOI 10.1038/sj.onc.1203281; Seandel M, 2008, CANCER CELL, V13, P181, DOI 10.1016/j.ccr.2008.02.016; Tilki D, 2006, ONCOGENE, V25, P4965, DOI 10.1038/sj.onc.1209514; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wegwitz F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012103	42	42	43	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	41					4275	4288		10.1038/onc.2011.146	http://dx.doi.org/10.1038/onc.2011.146			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HO	21532628				2022-12-25	WOS:000296356300005
J	Yang, L; Wu, X; Wang, Y; Zhang, K; Wu, J; Yuan, YC; Deng, X; Chen, L; Kim, CCH; Lau, S; Somlo, G; Yen, Y				Yang, L.; Wu, X.; Wang, Y.; Zhang, K.; Wu, J.; Yuan, Y-C; Deng, X.; Chen, L.; Kim, C. C. H.; Lau, S.; Somlo, G.; Yen, Y.			FZD7 has a critical role in cell proliferation in triple negative breast cancer	ONCOGENE			English	Article						FZD7; TNBC; Wnt canonical signaling pathway; proliferation; potential therapeutic target	MAMMARY-GLAND DEVELOPMENT; STEM-CELLS; WNT; THERAPY; RECEPTOR; FAMILY; MEMBER; TUMORS; LRP6; MICE	Breast cancer is genetically and clinically heterogeneous. Triple negative breast cancer (TNBC) is a subtype of breast cancer that is usually associated with poor outcome and lack of benefit from targeted therapy. We used microarray analysis to perform a pathway analysis of TNBC compared with non-triple negative breast cancer (non-TNBC). Overexpression of several Wnt pathway genes, such as frizzled homolog 7 (FZD7), low density lipoprotein receptor-related protein 6 and transcription factor 7 (TCF7) was observed in TNBC, and we directed our focus to the Wnt pathway receptor, FZD7. To validate the function of FZD7, FZD7shRNA was used to knock down FZD7 expression. Notably, reduced cell proliferation and suppressed invasiveness and colony formation were observed in TNBC MDA-MB-231 and BT-20 cells. Study of the possible mechanism indicated that these effects occurred through silencing of the canonical Wnt signaling pathway, as evidenced by loss of nuclear accumulation of beta-catenin and decreased transcriptional activity of TCF7. In vivo studies revealed that FZD7shRNA significantly suppressed tumor formation, through reduced cell proliferation, in mice bearing xenografts without FZD7 expression. Our findings suggest that FZD7-involved canonical Wnt signaling pathway is essential for tumorigenesis of TNBC, and thus, FZD7 shows promise as a biomarker and a potential therapeutic target for TNBC. Oncogene (2011) 30, 4437-4446; doi:10.1038/onc.2011.145; published online 2 May 2011	[Yang, L.; Kim, C. C. H.; Yen, Y.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Wu, X.; Yuan, Y-C; Deng, X.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Wang, Y.; Zhang, K.; Chen, L.] City Hope Natl Med Ctr, Beckman Res Inst, Translat Res Lab, Duarte, CA 91010 USA; [Wu, J.] City Hope Natl Med Ctr, Beckman Res Inst, Div Comparat Med, Duarte, CA 91010 USA; [Lau, S.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Pathol, Duarte, CA 91010 USA; [Somlo, G.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Med Oncol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Yen, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Beckman Bldg,Room 4117,1500 E Duarte Rd, Duarte, CA 91010 USA.	yyen@coh.org	Yen, Yun/H-9591-2016; Zhang, Keqiang/P-7082-2019		City of Hope National Medical Center for Translational Research	City of Hope National Medical Center for Translational Research	We thank Mariko Lee in the Light Microscopy and Digital Imaging Core for assistance with immunofluorescence and immunohistochemical microscopy, Arthur Li in the Division of Information Science for statistical analysis and Yan Wang in the Division of Comparative Medicine for tumor inoculation, tumor measurement and tumor collection. We thank Dr Keely Walker and Mansze Kong for critical editing of the manuscript. Grant Support was received from City of Hope National Medical Center for Translational Research.	Amir E, 2010, NAT REV CLIN ONCOL, V7, P79, DOI 10.1038/nrclinonc.2009.231; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Brown AMC, 2001, BREAST CANCER RES, V3, P351, DOI 10.1186/bcr321; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Jones KA, 2008, GENE DEV, V22, P3077, DOI 10.1101/gad.1741008; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Komiya Yuko, 2008, Organogenesis, V4, P68; LEE FS, 1995, P NATL ACAD SCI USA, V92, P2268, DOI 10.1073/pnas.92.6.2268; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Perez EA, 2010, BREAST CANCER RES TR, V120, P285, DOI 10.1007/s10549-010-0736-z; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Rahman M, 2009, ADV CANCER RES, V103, P43, DOI 10.1016/S0065-230X(09)03003-6; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192	33	194	207	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	43					4437	4446		10.1038/onc.2011.145	http://dx.doi.org/10.1038/onc.2011.145			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HQ	21532620	hybrid			2022-12-25	WOS:000296356500006
J	Hsu, CY; Henry, J; Raymond, AA; Mechin, MC; Pendaries, V; Nassar, D; Hansmann, B; Balica, S; Burlet-Schiltz, O; Schmitt, AM; Takahara, H; Paul, C; Serre, G; Simon, M				Hsu, Chiung-Yueh; Henry, Julie; Raymond, Anne-Aurelie; Mechin, Marie-Claire; Pendaries, Valerie; Nassar, Dany; Hansmann, Britta; Balica, Stefana; Burlet-Schiltz, Odile; Schmitt, Anne-Marie; Takahara, Hidenari; Paul, Carle; Serre, Guy; Simon, Michel			Deimination of Human Filaggrin-2 Promotes Its Proteolysis by Calpain 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATIONS; STRATUM-CORNEUM MOISTURIZATION; CALCIUM-BINDING PROTEINS; N-TERMINAL DOMAIN; CORNIFIED ENVELOPE; PEPTIDYLARGININE DEIMINASE; EPIDERMAL DIFFERENTIATION; BARRIER FUNCTION; IMMUNOHISTOCHEMICAL LOCALIZATION; STRUCTURAL PROTEINS	Filaggrin-2 (FLG2), a member of the S100-fused type protein family, shares numerous features with filaggrin (FLG), a key protein implicated in the epidermal barrier functions. Both display a related structural organization, an identical pattern of expression and localization in human epidermis, and proteolytic processing of a large precursor. Here, we tested whether FLG2 was a substrate of calpain 1, a calcium-dependent protease directly involved in FLG catabolism. In addition, deimination being critical for FLG degradation, we analyzed whether FLG2 deimination interfered with its proteolytic processing. With this aim, we first produced a recombinant form of FLG2 corresponding to subunits B7 to B10 fused to a COOH-terminal His tag. Incubation with calpain 1 in the presence of calcium induced a rapid degradation of the recombinant protein and the production of several peptides, as shown by Coomassie Blue-stained gels and Western blotting with anti-FLG2 or anti-His antibodies. MALDI-TOF mass spectrometry confirmed this result and further evidenced the production of non-immunoreactive smaller peptides. The degradation was not observed when a calpain 1-specific inhibitor was added. The calpain cleavage sites identified by Edman degradation were regularly present in the B-type repeats of FLG2. Moreover, immunohistochemical analysis of normal human skin revealed colocalization of FLG2 and calpain 1 in the upper epidermis. Finally, the FLG2 deiminated by human peptidylarginine deiminases was shown to be more susceptible to calpain 1 than the unmodified protein. Altogether, these data demonstrate that calpain 1 is essential for the proteolytic processing of FLG2 and that deimination accelerates this process.	[Simon, Michel] CHU Purpan, CNRS, UMR5165, UPS, F-31059 Toulouse 9, France; [Hsu, Chiung-Yueh; Henry, Julie; Raymond, Anne-Aurelie; Mechin, Marie-Claire; Pendaries, Valerie; Burlet-Schiltz, Odile; Paul, Carle; Serre, Guy; Simon, Michel] Univ Toulouse, UPS, F-31000 Toulouse, France; [Raymond, Anne-Aurelie; Burlet-Schiltz, Odile] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Nassar, Dany] St Antoine Res Ctr, INSERM, U938, Paris, France; [Balica, Stefana; Paul, Carle] Larrey Hosp, Dept Dermatol, F-31059 Toulouse, France; [Schmitt, Anne-Marie] Pierre Fabre Dermocosmet, Ctr Europeen Rech Peau & Epitheliums Revetement, F-31025 Toulouse, France; [Hansmann, Britta] Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Takahara, Hidenari] Ibaraki Univ, Sch Agr, Ibaraki 30003, Japan	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; University of Kiel; Schleswig Holstein University Hospital; Ibaraki University	Simon, M (corresponding author), CHU Purpan, CNRS, UMR5165, UPS, Pl Dr Baylac TSA40031, F-31059 Toulouse 9, France.	michel.simon@udear.cnrs.fr	Simon, Michel/B-7308-2011	Simon, Michel/0000-0003-3655-6329; Schiltz, Odile/0000-0002-3606-2356; HSU, Chiung-Yueh/0000-0002-4671-0919; RAYMOND, Anne-Aurelie/0000-0003-2697-9352; Takahara, Hidenari/0000-0003-2373-8588; Nassar, Dany/0000-0001-6780-0721; Paul, Carle/0000-0003-0165-5263	CNRS; INSERM; Toulouse III University; Toulouse University Hospital; Region Midi-Pyrenees; Pierre Fabre Dermo-Cosmetique; French Society for Dermatological Research (SRD)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Toulouse III University; Toulouse University Hospital; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Pierre Fabre Dermo-Cosmetique; French Society for Dermatological Research (SRD)	This work was supported by CNRS, INSERM, Toulouse III University, Toulouse University Hospital, the "Region Midi-Pyrenees," Pierre Fabre Dermo-Cosmetique and the French Society for Dermatological Research (SRD).	Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; D'Souza CA, 2006, NEUROCHEM RES, V31, P1045, DOI 10.1007/s11064-006-9116-9; DALE BA, 1985, AM J DERMATOPATH, V7, P65; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Elias PM, 2004, J INVEST DERMATOL, V122, pXXXVI, DOI 10.1046/j.0022-202X.2004.22233.x; Garach-Jehoshua O, 1998, BRIT J DERMATOL, V139, P950; HARDING CR, 1983, J MOL BIOL, V170, P651, DOI 10.1016/S0022-2836(83)80126-0; Henry J, 2011, FASEB J, V25, P1567, DOI 10.1096/fj.10-168658; Ishida-Yamamoto A, 1998, LAB INVEST, V78, P1245; Ishida-Yamamoto A, 2002, J INVEST DERMATOL, V118, P282, DOI 10.1046/j.0022-202x.2001.01671.x; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kezic S, 2008, J INVEST DERMATOL, V128, P2117, DOI 10.1038/jid.2008.29; Krieg P, 1997, GENOMICS, V43, P339, DOI 10.1006/geno.1997.4818; LEE SC, 1993, J INVEST DERMATOL, V100, P65, DOI 10.1111/1523-1747.ep12354504; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Listwan P, 2004, METHOD CELL BIOL, V78, P817; MACK JW, 1993, J MOL BIOL, V232, P50, DOI 10.1006/jmbi.1993.1369; Makino T, 2001, J BIOL CHEM, V276, P47445, DOI 10.1074/jbc.M107512200; MANABE M, 1991, DIFFERENTIATION, V48, P43, DOI 10.1111/j.1432-0436.1991.tb00241.x; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 2006, BBA-MOL CELL RES, V1763, P1282, DOI 10.1016/j.bbamcr.2006.07.013; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; MIYACHI Y, 1986, J INVEST DERMATOL, V86, P346, DOI 10.1111/1523-1747.ep12285556; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; Pearton DJ, 2001, EXP DERMATOL, V10, P193, DOI 10.1034/j.1600-0625.2001.010003193.x; Peltier J, 2006, J AM SOC NEPHROL, V17, P3415, DOI 10.1681/ASN.2006050542; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5374, DOI 10.1021/bi9925569; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Rawlings AV, 2005, J INVEST DERMATOL, V124, P1099, DOI 10.1111/j.1523-1747.2005.23726.x; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; RESING KA, 1995, J BIOL CHEM, V270, P28193; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; SENSHU T, 1995, J INVEST DERMATOL, V105, P163, DOI 10.1111/1523-1747.ep12317070; SIMON M, 1995, J INVEST DERMATOL, V105, P432, DOI 10.1111/1523-1747.ep12321148; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Stemmler S, 2007, J INVEST DERMATOL, V127, P722, DOI 10.1038/sj.jid.5700579; Takaishi M, 2005, J BIOL CHEM, V280, P4696, DOI 10.1074/jbc.M409026200; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Wu ZH, 2009, J INVEST DERMATOL, V129, P1446, DOI 10.1038/jid.2008.370; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227; Yamazaki M, 1997, BIOCHEM BIOPH RES CO, V235, P652, DOI 10.1006/bbrc.1997.6809; Zhang D, 2002, J INVEST DERMATOL, V119, P905, DOI 10.1046/j.1523-1747.2002.00133.x	59	55	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23222	23233		10.1074/jbc.M110.197400	http://dx.doi.org/10.1074/jbc.M110.197400			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531719	hybrid, Green Published			2022-12-25	WOS:000292025000056
J	Dreaden, TM; Chen, J; Rexroth, S; Barry, BA				Dreaden, Tina M.; Chen, Jun; Rexroth, Sascha; Barry, Bridgette A.			N-Formylkynurenine as a Marker of High Light Stress in Photosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLVING PHOTOSYSTEM-II; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; SITE-DIRECTED MUTAGENESIS; SINGLET OXYGEN; TRYPTOPHAN OXIDATION; CRYSTAL-STRUCTURE; D1 PROTEIN; CHLORIDE REQUIREMENT; RAMAN-SPECTROSCOPY	Photosystem II (PSII) is the membrane protein complex that catalyzes the photo-induced oxidation of water at a manganese-calcium active site. Light-dependent damage and repair occur in PSII under conditions of high light stress. The core reaction center complex is composed of the D1, D2, CP43, and CP47 intrinsic polypeptides. In this study, a new chromophore formed from the oxidative post-translational modification of tryptophan is identified in the CP43 subunit. Tandem mass spectrometry peptide sequencing is consistent with the oxidation of the CP43 tryptophan side chain, Trp-365, to produce N-formylkynurenine (NFK). Characterization with ultraviolet visible absorption and ultraviolet resonance Raman spectroscopy supports this assignment. An optical assay suggests that the yield of NFK increases 2-fold (2.2 +/- 0.5) under high light illumination. A concomitant 2.4 +/- 0.5-fold decrease is observed in the steady-state rate of oxygen evolution under the high light conditions. NFK is the product formed from reaction of tryptophan with singlet oxygen, which can be produced under high light stress in PSII. Reactive oxygen species reactions lead to oxidative damage of the reaction center, D1 protein turnover, and inhibition of electron transfer. Our results are consistent with a role for the CP43 NFK modification in photoinhibition.	Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Barry, BA (corresponding author), 901 Atlantic Dr NW, Atlanta, GA 30332 USA.	bridgette.barry@chemistry.gatech.edu	Chen, Jun/K-2332-2015; Chen, Jun/M-9608-2016; Rexroth, Sascha/H-3702-2011	Chen, Jun/0000-0002-4114-3046; Rexroth, Sascha/0000-0003-3819-2127	National Science Foundation [MCB 08-42246]; Div Of Molecular and Cellular Bioscience [0842246] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by Grant MCB 08-42246 from the National Science Foundation (to B. A. B.).	Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Anderson LB, 2004, J AM CHEM SOC, V126, P8399, DOI 10.1021/ja0478781; Anderson LB, 2000, J BIOL CHEM, V275, P4920, DOI 10.1074/jbc.275.7.4920; Anderson LB, 2002, P NATL ACAD SCI USA, V99, P14676, DOI 10.1073/pnas.232591599; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; ASHER SA, 1993, ANAL CHEM, V65, pA59, DOI 10.1021/ac00052a715; BARRY BA, 1995, METHOD ENZYMOL, V258, P303; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; BIEKER L, 1979, FEBS LETT, V106, P268, DOI 10.1016/0014-5793(79)80511-6; BOWYER JR, 1992, J BIOL CHEM, V267, P5424; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; CALDWELL CR, 1993, PLANT PHYSIOL, V101, P947, DOI 10.1104/pp.101.3.947; CHALAPATHI VV, 1968, J MOL SPECTROSC, V26, P444, DOI 10.1016/S0022-2852(68)80058-X; Chen J, 2008, PHOTOCHEM PHOTOBIOL, V84, P815, DOI 10.1111/j.1751-1097.2008.00298.x; Chen J, 2009, J PHYS CHEM B, V113, P11367, DOI 10.1021/jp906491r; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eilstein J, 2006, CHEM RES TOXICOL, V19, P1248, DOI 10.1021/tx0601408; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fedorova M, 2010, PROTEOMICS, V10, P2692, DOI 10.1002/pmic.201000147; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; FUJIMORI E, 1981, FEBS LETT, V135, P257, DOI 10.1016/0014-5793(81)80795-8; Galetskiy D, 2011, RAPID COMMUN MASS SP, V25, P184, DOI 10.1002/rcm.4855; GHANOTAKIS DF, 1984, FEBS LETT, V170, P169, DOI 10.1016/0014-5793(84)81393-9; Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HAM JS, 1952, J CHEM PHYS, V20, P335, DOI 10.1063/1.1700403; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; HIDEG E, 1994, BBA-BIOENERGETICS, V1186, P143, DOI 10.1016/0005-2728(94)90173-2; HUANG HV, 1983, METHOD ENZYMOL, V91, P318; Hunzinger C, 2006, J PROTEOME RES, V5, P625, DOI 10.1021/pr050377+; JACOBSON KB, 1978, ARCH BIOCHEM BIOPHYS, V186, P84, DOI 10.1016/0003-9861(78)90466-6; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Keren N, 1997, P NATL ACAD SCI USA, V94, P1579, DOI 10.1073/pnas.94.4.1579; Knoepfle N, 1999, BIOCHEMISTRY-US, V38, P1582, DOI 10.1021/bi9821418; KNOX JP, 1985, PHYTOCHEMISTRY, V24, P889, DOI 10.1016/S0031-9422(00)83147-7; Krieger A, 1998, BIOCHEMISTRY-US, V37, P16262, DOI 10.1021/bi981243v; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MACDONALD GM, 1994, BIOCHEMISTRY-US, V33, P4393, DOI 10.1021/bi00180a037; Mamedov F, 2002, PHOTOSYNTH RES, V74, P61, DOI 10.1023/A:1020835822266; MEHLER AH, 1950, J BIOL CHEM, V187, P431; MISHRA NP, 1994, BBA-BIOENERGETICS, V1186, P81, DOI 10.1016/0005-2728(94)90138-4; MIYAO M, 1989, BIOCHIM BIOPHYS ACTA, V977, P315, DOI 10.1016/S0005-2728(89)80086-6; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nishiyama Y, 2004, BIOCHEMISTRY-US, V43, P11321, DOI 10.1021/bi036178q; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Ouellette AJA, 1998, P NATL ACAD SCI USA, V95, P2204, DOI 10.1073/pnas.95.5.2204; Patzlaff JS, 1996, BIOCHEMISTRY-US, V35, P7802, DOI 10.1021/bi960056z; PIRIE A, 1971, BIOCHEM J, V125, P203, DOI 10.1042/bj1250203; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; PREVIERO A, 1967, J MOL BIOL, V24, P261, DOI 10.1016/0022-2836(67)90331-2; PURANIK PG, 1959, J MOL SPECTROSC, V3, P486, DOI 10.1016/0022-2852(59)90043-8; Rexroth S, 2007, J BIOL CHEM, V282, P27802, DOI 10.1074/jbc.M704394200; Rhee KH, 1998, NATURE, V396, P283, DOI 10.1038/24421; Rinalducci S, 2005, J PROTEOME RES, V4, P2327, DOI 10.1021/pr0502368; Rokos H, 2008, J RAMAN SPECTROSC, V39, P1214, DOI 10.1002/jrs.1968; Ronsein GE, 2008, CHEM RES TOXICOL, V21, P1271, DOI 10.1021/tx800026g; Rosenberg C, 1999, BIOCHEMISTRY-US, V38, P15994, DOI 10.1021/bi991326r; SANDUSKY PO, 1984, BIOCHIM BIOPHYS ACTA, V766, P603, DOI 10.1016/0005-2728(84)90121-X; SANDUSKY PO, 1986, BIOCHIM BIOPHYS ACTA, V849, P85, DOI 10.1016/0005-2728(86)90099-X; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sharma J, 1997, J BIOL CHEM, V272, P33158, DOI 10.1074/jbc.272.52.33158; SIMAT T, 1994, J CHROMATOGR A, V661, P93, DOI 10.1016/0021-9673(94)85180-8; STADTMAN ER, 1990, BIOCHEMISTRY-US, V29, P6323, DOI 10.1021/bi00479a001; TELFER A, 1994, J BIOL CHEM, V269, P13244; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vener AV, 2001, J BIOL CHEM, V276, P6959, DOI 10.1074/jbc.M009394200; VIRGIN I, 1988, FEBS LETT, V233, P408, DOI 10.1016/0014-5793(88)80472-1; Whitelegge JP, 1998, PROTEIN SCI, V7, P1423, DOI 10.1002/pro.5560070619; Whitelegge JP, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P4381; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0; YAMAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P9038, DOI 10.1021/bi00028a012; Yang CY, 1999, BIOCHEMISTRY-US, V38, P15903, DOI 10.1021/bi991464g; Yang CY, 1997, FREE RADICAL BIO MED, V23, P82, DOI 10.1016/S0891-5849(96)00624-7; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zhao H, 2009, J BIOL CHEM, V284, P23344, DOI 10.1074/jbc.M109.022517; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	90	49	49	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22632	22641		10.1074/jbc.M110.212928	http://dx.doi.org/10.1074/jbc.M110.212928			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21527632	Green Published, hybrid			2022-12-25	WOS:000291719900070
J	Kleinau, G; Mueller, S; Jaeschke, H; Grzesik, P; Neumann, S; Diehl, A; Paschke, R; Krause, G				Kleinau, Gunnar; Mueller, Sandra; Jaeschke, Holger; Grzesik, Paul; Neumann, Susanne; Diehl, Anne; Paschke, Ralf; Krause, Gerd			Defining Structural and Functional Dimensions of the Extracellular Thyrotropin Receptor Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE-RECEPTOR; THYROID-STIMULATING HORMONE; LEUCINE-RICH DOMAIN; HUMAN TSH RECEPTOR; HINGE REGION; CONSTITUTIVE ACTIVITY; TRANSMEMBRANE DOMAIN; INVERSE AGONIST; GONADOTROPIN RECEPTORS; SIGNAL-TRANSDUCTION	The extracellular region of the thyrotropin receptor (TSHR) can be subdivided into the leucine-rich repeat domain (LRRD) and the hinge region. Both the LRRD and the hinge region interact with thyrotropin (TSH) or autoantibodies. Structural data for the TSHR LRRD were previously determined by crystallization (amino acids Glu(30)-Thr(257), 10 repeats), but the structure of the hinge region is still undefined. Of note, the amino acid sequence (Trp(258)-Tyr(279)) following the crystallized LRRD comprises a pattern typical for leucine-rich repeats with conserved hydrophobic side chains stabilizing the repeat fold. Moreover, functional data for amino acids between the LRRD and the transmembrane domain were fragmentary. We therefore investigated systematically these TSHR regions by mutagenesis to reveal insights into their functional contribution and potential structural features. We found that mutations of conserved hydrophobic residues between Thr(257) and Tyr(279) cause TSHR misfold, which supports a structural fold of this peptide, probably as an additional leucine-rich repeat. Furthermore, we identified several new mutations of hydrophilic amino acids in the entire hinge region leading to partial TSHR inactivation, indicating that these positions are important for intramolecular signal transduction. In summary, we provide new information regarding the structural features and functionalities of extracellular TSHR regions. Based on these insights and in context with previous results, we suggest an extracellular activation mechanism that supports an intramolecular agonistic unit as a central switch for activating effects at the extracellular region toward the serpentine domain.	[Kleinau, Gunnar; Grzesik, Paul; Diehl, Anne; Krause, Gerd] Leibniz Inst Mol Pharmacol, Dept Biol Struct, D-13125 Berlin, Germany; [Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany; [Mueller, Sandra; Jaeschke, Holger; Paschke, Ralf] Univ Leipzig, Dept Internal Med Neurol & Dermatol, D-04103 Leipzig, Germany; [Neumann, Susanne] NIDDK, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Krause, G (corresponding author), Leibniz Inst Mol Pharmacol, Dept Biol Struct, D-13125 Berlin, Germany.	gkrause@FMP-Berlin.de	Kleinau, Gunnar/GPX-6330-2022	Diehl, Anne/0000-0001-7295-9972	National Institutes of Health, NIDDK; Medical Faculty, University of Leipzig [NBL Formel.1-108]; Deutsche Forschungsgemeinschaft [KL2334/2-1, KR1273/1-2,3, Pa 423/15-1,2]	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Faculty, University of Leipzig; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by the National Institutes of Health, NIDDK, Intramural Research Program. This work was also supported by Medical Faculty, University of Leipzig, Grant NBL Formel.1-108 and by Deutsche Forschungsgemeinschaft Grants KL2334/2-1, KR1273/1-2,3, and Pa 423/15-1,2.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Bernard MP, 1998, BIOCHEM J, V335, P611, DOI 10.1042/bj3350611; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Bozon W, 2002, PROTEIN EXPRES PURIF, V25, P114, DOI 10.1006/prep.2002.1617; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; Chen CR, 2011, J BIOL CHEM, V286, P6219, DOI 10.1074/jbc.M110.211003; Chen CR, 2010, ENDOCRINOLOGY, V151, P1940, DOI 10.1210/en.2009-1430; Chen CR, 2009, ENDOCRINOLOGY, V150, P3401, DOI 10.1210/en.2008-1800; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Couet J, 1996, J BIOL CHEM, V271, P4545; Dias JA, 2005, NATURE, V433, P203, DOI 10.1038/433203a; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fan QR, 2008, PROTEINS, V72, P393, DOI 10.1002/prot.21937; Fan QR, 2007, MOL CELL ENDOCRINOL, V260, P73, DOI 10.1016/j.mce.2005.12.055; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Hamidi S, 2011, MOL ENDOCRINOL, V25, P184, DOI 10.1210/me.2010-0401; Ho SC, 2005, MOL CELL ENDOCRINOL, V245, P158, DOI 10.1016/j.mce.2005.11.008; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Ho SC, 2008, THYROID, V18, P1313, DOI 10.1089/thy.2008.0240; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jaschke H, 2006, J BIOL CHEM, V281, P9841, DOI 10.1074/jbc.C600014200; Kaezur V, 2007, J MOL RECOGNIT, V20, P392, DOI 10.1002/jmr.851; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kajava AV, 2001, J STRUCT BIOL, V134, P132, DOI 10.1006/jsbi.2000.4328; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2008, FASEB J, V22, P2798, DOI 10.1096/fj.07-104711; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Kleinau G, 2010, HUM MUTAT, V31, pE1519, DOI 10.1002/humu.21265; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Latif R, 2009, ENDOCRIN METAB CLIN, V38, P319, DOI 10.1016/j.ecl.2009.01.006; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Mueller S, 2009, J BIOL CHEM, V284, P16317, DOI 10.1074/jbc.M109.005710; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1990, BIOCHEM BIOPH RES CO, V173, P1150, DOI 10.1016/S0006-291X(05)80906-4; NAGAYAMA Y, 1992, ENDOCRINOLOGY, V131, P548, DOI 10.1210/en.131.2.548; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Nakabayashi K, 2003, MOL CELL ENDOCRINOL, V202, P139, DOI 10.1016/S0303-7207(03)00075-3; Neumann S, 2005, EUR J ENDOCRINOL, V152, P625, DOI 10.1530/eje.1.01891; NUNEZ MR, 2004, THYROID, V14, P991; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders J, 2006, THYROID, V16, P1195, DOI 10.1089/thy.2006.16.1195; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797; Zhang R, 1996, J BIOL CHEM, V271, P5755, DOI 10.1074/jbc.271.10.5755	62	21	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22622	22631		10.1074/jbc.M110.211193	http://dx.doi.org/10.1074/jbc.M110.211193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525003	hybrid, Green Published			2022-12-25	WOS:000291719900069
J	Manzano, M; Reichert, ED; Polo, S; Falgout, B; Kasprzak, W; Shapiro, BA; Padmanabhan, R				Manzano, Mark; Reichert, Erin D.; Polo, Stephanie; Falgout, Barry; Kasprzak, Wojciech; Shapiro, Bruce A.; Padmanabhan, Radhakrishnan			Identification of Cis-Acting Elements in the 3 '-Untranslated Region of the Dengue Virus Type 2 RNA That Modulate Translation and Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; PARALLEL GENETIC ALGORITHM; SECONDARY STRUCTURE-ANALYSIS; CAP-DEPENDENT TRANSLATION; 3 UNTRANSLATED REGION; STEM-LOOP STRUCTURE; DE-NOVO SYNTHESIS; CYCLIZATION SEQUENCES; VIRAL REPLICATION; FLAVIVIRUS RNA	Using the massively parallel genetic algorithm for RNA folding, we show that the core region of the 3'-untranslated region of the dengue virus (DENV) RNA can form two dumbbell structures (5' - and 3' -DBs) of unequal frequencies of occurrence. These structures have the propensity to form two potential pseudoknots between identical five-nucleotide terminal loops 1 and 2 (TL1 and TL2) and their complementary pseudoknot motifs, PK2 and PK1. Mutagenesis using a DENV2 replicon RNA encoding the Renilla luciferase reporter indicated that all four motifs and the conserved sequence 2 (CS2) element within the 3' -DB are important for replication. However, for translation, mutation of TL1 alone does not have any effect; TL2 mutation has only a modest effect in translation, but translation is reduced by similar to 60% in the TL1/TL2 double mutant, indicating that TL1 exhibits a cooperative synergy with TL2 in translation. Despite the variable contributions of individual TL and PK motifs in translation, WT levels are achieved when the complementarity between TL1/PK2 and TL2/PK1 is maintained even under conditions of inhibition of the translation initiation factor 4E function mediated by LY294002 via a noncanonical pathway. Taken together, our results indicate that the cis-acting RNA elements in the core region of DENV2 RNA that include two DB structures are required not only for RNA replication but also for optimal translation.	[Shapiro, Bruce A.] NCI, Ctr Canc Res Nanobiol Program, NIH, Ft Detrick, MD 21702 USA; [Manzano, Mark; Reichert, Erin D.; Padmanabhan, Radhakrishnan] Georgetown Univ Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA; [Polo, Stephanie; Falgout, Barry] US FDA, Ctr Biol Evaluat & Review, Bethesda, MD 20892 USA; [Kasprzak, Wojciech] SAIC Frederick Inc, Basic Sci Program, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University; US Food & Drug Administration (FDA); Science Applications International Corporation (SAIC); SAIC-Frederick	Shapiro, BA (corresponding author), NCI, Ctr Canc Res Nanobiol Program, NIH, Ft Detrick, MD 21702 USA.	shapirbr@mail.nih.gov; rp55@georgetown.edu	Manzano, Mark/AAV-4057-2020		National Institutes of Health (NIH) [AI 57705, AI 70791]; NCI, NIH [NO1-CO-12400, HHSN261200800001E]; NCI, NIH, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC008382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI057705, R01AI070791] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, NIH, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants AI 57705 and AI 70791 (to R. P.); by NCI, NIH, Contracts NO1-CO-12400 and HHSN261200800001E (to W. K.); and by the Intramural Research Program of the NCI, NIH, Center for Cancer Research. This work constitutes a partial fulfillment of the requirements for the degree of Doctor of Philosophy at Georgetown University School of Medicine for E. R. and M. M.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7; BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0; CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052; Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034; Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289; Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10; Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09; Gee AH, 2006, J BIOMOL STRUCT DYN, V23, P417, DOI 10.1080/07391102.2006.10531236; Gould EA, 2001, ADV VIRUS RES, V57, P71, DOI 10.1016/S0065-3527(01)57001-3; Gritsun TS, 2006, J GEN VIROL, V87, P3297, DOI 10.1099/vir.0.82235-0; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kasprzak W, 1999, BIOINFORMATICS, V15, P16, DOI 10.1093/bioinformatics/15.1.16; Kasprzak W, 2005, NUCLEIC ACIDS RES, V33, P7151, DOI 10.1093/nar/gki1015; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Linnstaedt SD, 2006, RNA, V12, P1521, DOI 10.1261/rna.89306; Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; MOHAN PM, 1991, GENE, V108, P185, DOI 10.1016/0378-1119(91)90433-C; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Olsthoorn RCL, 2001, RNA, V7, P1370; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0; Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194; RIBAS JC, 1992, P NATL ACAD SCI USA, V89, P2185, DOI 10.1073/pnas.89.6.2185; Romero TA, 2006, J GEN VIROL, V87, P3291, DOI 10.1099/vir.0.82182-0; Shapiro BA, 1996, J MOL GRAPH MODEL, V14, P194, DOI 10.1016/S0263-7855(96)00063-X; Shapiro BA, 1996, COMPUT APPL BIOSCI, V12, P171; SHAPIRO BA, 1994, J SUPERCOMPUT, V8, P195, DOI 10.1007/BF01204728; Shapiro BA, 2001, J MOL BIOL, V312, P27, DOI 10.1006/jmbi.2001.4931; Shapiro BA, 2001, BIOINFORMATICS, V17, P137, DOI 10.1093/bioinformatics/17.2.137; Shapiro BA, 2006, J MOL GRAPH MODEL, V25, P514, DOI 10.1016/j.jmgm.2006.04.004; Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748; Stupina VA, 2008, RNA, V14, P2379, DOI 10.1261/rna.1227808; Suzuki R, 2008, J VIROL, V82, P6942, DOI 10.1128/JVI.00662-08; Tortorici MA, 2006, RNA, V12, P133, DOI 10.1261/rna.2122606; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2; Westaway EG, 2002, CURR TOP MICROBIOL, V267, P323; Wu JC, 1999, J BIOMOL STRUCT DYN, V17, P581, DOI 10.1080/07391102.1999.10508388; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998; Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016; Zhang JC, 2006, J VIROL, V80, P9181, DOI 10.1128/JVI.00295-06; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	88	75	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22521	22534		10.1074/jbc.M111.234302	http://dx.doi.org/10.1074/jbc.M111.234302			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515677	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000291719900060
J	Wu, ZY; Yu, DJ; Soong, TW; Dawe, GS; Bian, JS				Wu, Zhi-Yuan; Yu, De-Jie; Soong, Tuck Wah; Dawe, Gavin S.; Bian, Jin-Song			Progesterone Impairs Human Ether-a-go-go-related Gene (HERG) Trafficking by Disruption of Intracellular Cholesterol Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; CARDIAC TIME INTERVALS; INFANT-DEATH-SYNDROME; MENSTRUAL-CYCLE; ENDOPLASMIC-RETICULUM; GOLGI TRANSPORT; PREGNANCY; PROTEIN; PROLONGATION; ARRHYTHMIAS	The prolongation of QT intervals in both mothers and fetuses during the later period of pregnancy implies that higher levels of progesterone may regulate the function of the human ether-ago- go-related gene (HERG) potassium channel, a key ion channel responsible for controlling the length of QT intervals. Here, we studied the effect of progesterone on the expression, trafficking, and function of HERG channels and the underlying mechanism. Treatment with progesterone for 24 h decreased the abundance of the fully glycosylated form of the HERG channel in rat neonatal cardiac myocytes and HERG-HEK293 cells, a cell line stably expressing HERG channels. Progesterone also concentration-dependently decreased HERG current density, but had no effect on voltage-gated L-type Ca2+ and K+ channels. Immunofluorescence microscopy and Western blot analysis show that progesterone preferentially decreased HERG channel protein abundance in the plasma membrane, induced protein accumulation in the dilated endoplasmic reticulum (ER), and increased the protein expression of C/EBP homologous protein, a hallmark of ER stress. Application of 2-hydroxypropyl-beta-cyclodextrin (a sterol-binding agent) or overexpression of Rab9 rescued the progesterone-induced HERG trafficking defect and ER stress. Disruption of intracellular cholesterol homeostasis with simvastatin, imipramine, or exogenous application of cholesterol mimicked the effect of progesterone on HERG channel trafficking. Progesterone may impair HERG channel folding in the ER and/or block its trafficking to the Golgi complex by disrupting intracellular cholesterol homeostasis. Our findings may reveal a novel molecular mechanism to explain the QT prolongation and high risk of developing arrhythmias during late pregnancy.	[Wu, Zhi-Yuan; Dawe, Gavin S.; Bian, Jin-Song] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Yu, De-Jie; Soong, Tuck Wah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Bian, JS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore.	phcbjs@nus.edu.sg		Dawe, Gavin/0000-0001-6119-701X; Bian, Jinsong/0000-0002-7741-598X	National Medical Research Council [NMRC0881/2004]; Biomedical Research Council [BMRC 04/1/21/19/335]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by National Medical Research Council Research Grant NMRC0881/2004 (to J.-S. B.) and Biomedical Research Council Research Grant BMRC 04/1/21/19/335 (to J.-S. B.).	Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; AISIEN AO, 1994, INT J GYNECOL OBSTET, V47, P27, DOI 10.1016/0020-7292(94)90457-X; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Beinder E, 2003, PRENATAL DIAG, V23, P1097, DOI 10.1002/pd.702; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bhuiyan ZA, 2008, HEART RHYTHM, V5, P553, DOI 10.1016/j.hrthm.2008.01.020; Burke JH, 1997, AM J CARDIOL, V79, P178, DOI 10.1016/S0002-9149(96)00707-2; Chia EL, 2005, PRENATAL DIAG, V25, P546, DOI 10.1002/pd.1184; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Dijkema R, 1998, J STEROID BIOCHEM, V64, P147, DOI 10.1016/S0960-0760(97)00160-X; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gowda RM, 2003, INT J CARDIOL, V88, P129, DOI 10.1016/S0167-5273(02)00601-0; Hulot JS, 2003, EUR HEART J, V24, P1663, DOI 10.1016/S0195-668X(03)00436-6; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Kahler C, 2002, PRENATAL DIAG, V22, P408, DOI 10.1002/pd.322; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Lechmanova M., 2002, Archives of Gynecology and Obstetrics, V266, P145, DOI 10.1007/s00404-001-0254-7; Lechmanova M, 2002, PHYSIOL RES, V51, P121; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Nakagawa M, 2006, PACE, V29, P607, DOI 10.1111/j.1540-8159.2006.00407.x; Nakamura H, 2007, CIRCULATION, V116, P2913, DOI 10.1161/CIRCULATIONAHA.107.702407; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Rashba EJ, 1998, CIRCULATION, V97, P451; Ridsdale A, 2006, MOL BIOL CELL, V17, P1593, DOI 10.1091/mbc.E05-02-0100; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; Runz H, 2006, EMBO J, V25, P2953, DOI 10.1038/sj.emboj.7601205; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; Seth R, 2007, J AM COLL CARDIOL, V49, P1092, DOI 10.1016/j.jacc.2006.09.054; SHEN BQ, 1995, J BIOL CHEM, V270, P25102, DOI 10.1074/jbc.270.42.25102; SNART RS, 1967, NATURE, V215, P964, DOI 10.1038/215964a0; Teng GQ, 2008, CIRC RES, V103, P1483, DOI 10.1161/CIRCRESAHA.108.177055; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; Wible Barbara A., 2005, Journal of Pharmacological and Toxicological Methods, V52, P136, DOI 10.1016/j.vascn.2005.03.008; Wolbrette D, 2002, CLIN CARDIOL, V25, P49, DOI 10.1002/clc.4950250203; Wu ZY, 2008, ENDOCRINOLOGY, V149, P5061, DOI 10.1210/en.2007-1802; Xu K, 2009, ATHEROSCLEROSIS, V207, P123, DOI 10.1016/j.atherosclerosis.2009.04.019; CENT PROG ASS MAN	38	29	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22186	22194		10.1074/jbc.M110.198853	http://dx.doi.org/10.1074/jbc.M110.198853			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525004	Green Published, hybrid			2022-12-25	WOS:000291719900025
J	Iwasa, H; Meshitsuka, S; Hongo, K; Mizobata, T; Kawata, Y				Iwasa, Hisanori; Meshitsuka, Shunsuke; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi			Covalent Structural Changes in Unfolded GroES That Lead to Amyloid Fibril Formation Detected by NMR INSIGHT INTO INTRINSICALLY DISORDERED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CO-CHAPERONIN GROES; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PRION PROTEIN; ISOASPARTATE FORMATION; PARKINSONS-DISEASE; ASPARTYL RESIDUES; BETA OLIGOMERS; HUMAN LENS; DEAMIDATION	Co-chaperonin GroES from Escherichia coli works with chaperonin GroEL to mediate the folding reactions of various proteins. However, under specific conditions, i.e. the completely disordered state in guanidine hydrochloride, this molecular chaperone forms amyloid fibrils similar to those observed in various neurodegenerative diseases. Thus, this is a good model system to understand the amyloid fibril formation mechanism of intrinsically disordered proteins. Here, we identified a critical intermediate of GroES in the early stages of this fibril formation using NMR and mass spectroscopy measurements. A covalent rearrangement of the polypeptide bond at Asn(45)-Gly(46) and/or Asn(51)-Gly(52) that eventually yield beta-aspartic acids via deamidation of asparagine was observed to precede fibril formation. Mutation of these asparagines to alanines resulted in delayed nucleus formation. Our results indicate that peptide bond rearrangement at Asn-Gly enhances the formation of GroES amyloid fibrils. The finding provides a novel insight into the structural process of amyloid fibril formation from a disordered state, which may be applicable to intrinsically disordered proteins in general.	[Kawata, Yasushi] Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, Tottori 6808552, Japan; [Meshitsuka, Shunsuke; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori 6808552, Japan	Tottori University; Tottori University	Kawata, Y (corresponding author), Tottori Univ, Dept Chem & Biotechnol, Grad Sch Engn, Tottori 6808552, Japan.	kawata@bio.tottori-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; Mizobata, Tomohiro/V-6672-2019	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Global COE Program; Organization for Regional Industrial Academic Cooperation of Tottori University; Grants-in-Aid for Scientific Research [21570113] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Organization for Regional Industrial Academic Cooperation of Tottori University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Global COE Program, and a grant from the Organization for Regional Industrial Academic Cooperation of Tottori University. Mass spectrometry measurements were performed using the facilities of the Research Center for Bioscience and Technology (Venture Business Laboratory) of Tottori University.	Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Bhak G, 2009, BMB REP, V42, P541, DOI 10.5483/BMBRep.2009.42.9.541; BISCHOFF R, 1994, J CHROMATOGR B, V662, P261, DOI 10.1016/0378-4347(94)00203-7; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; CHOU FCH, 1976, J BIOL CHEM, V251, P2671; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; FABIAN H, 1994, EUR J BIOCHEM, V221, P959, DOI 10.1111/j.1432-1033.1994.tb18811.x; Fiaux J, 2004, J BIOMOL NMR, V29, P289, DOI 10.1023/B:JNMR.0000032523.00554.38; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Fujii N, 2007, AMINO ACIDS, V32, P87, DOI 10.1007/s00726-006-0303-4; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; GEIGER T, 1987, J BIOL CHEM, V262, P785; Goddard T. D., 2008, SPARKY 3; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Higurashi T, 2005, J MOL BIOL, V351, P1057, DOI 10.1016/j.jmb.2005.07.006; Higurashi T, 2003, J MOL BIOL, V333, P605, DOI 10.1016/j.jmb.2003.08.056; Higurashi T, 1999, J MOL BIOL, V291, P703, DOI 10.1006/jmbi.1999.2994; Horst R, 2006, P NATL ACAD SCI USA, V103, P15445, DOI 10.1073/pnas.0607141103; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; JOHNSON BA, 1989, ARCH BIOCHEM BIOPHYS, V268, P276, DOI 10.1016/0003-9861(89)90589-4; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kitamura A, 2010, FEBS J, V277, P1369, DOI 10.1111/j.1742-4658.2010.07570.x; Koradi R, 1996, J MOL GRAPHICS, V14, P29; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Makio T, 1999, J MOL BIOL, V293, P125, DOI 10.1006/jmbi.1999.3142; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Naiki H, 2009, J BIOCHEM, V146, P751, DOI 10.1093/jb/mvp119; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Robinson NE, 2009, PROTEIN SCI, V18, P1766, DOI 10.1002/pro.183; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Sandmeier E, 1999, BIOCHEM BIOPH RES CO, V261, P578, DOI 10.1006/bbrc.1999.1056; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shewmaker F, 2001, J BIOL CHEM, V276, P31257, DOI 10.1074/jbc.M102765200; Shimizu T, 2000, ARCH BIOCHEM BIOPHYS, V381, P225, DOI 10.1006/abbi.2000.1955; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tashiro M, 2008, BIOCHEM BIOPH RES CO, V369, P910, DOI 10.1016/j.bbrc.2008.02.127; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Watanabe A, 1999, J BIOL CHEM, V274, P7368, DOI 10.1074/jbc.274.11.7368; Weber DJ, 1998, BIOCHEM BIOPH RES CO, V246, P606, DOI 10.1006/bbrc.1998.8672; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yagi H, 2008, J MOL BIOL, V377, P1593, DOI 10.1016/j.jmb.2008.02.012; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9	60	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21796	21805		10.1074/jbc.M111.228445	http://dx.doi.org/10.1074/jbc.M111.228445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507961	hybrid, Green Published			2022-12-25	WOS:000291464700074
J	Lokappa, SB; Ulmer, TS				Lokappa, Sowmya Bekshe; Ulmer, Tobias S.			alpha-Synuclein Populates Both Elongated and Broken Helix States on Small Unilamellar Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; EXTENDED HELIX; PROTEIN; MEMBRANE; BINDING; MUTATION; PHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; ARRANGEMENT	The misfolding of the protein alpha-synuclein (alpha S) has been implicated in the molecular chain of events leading to Parkinson disease. Physiologically, alpha S undergoes a transition from a random coil to helical conformation upon encountering synaptic vesicle membranes. On analogous small unilamellar vesicles (SUVs), the conformation of alpha S is dominated by a single elongated alpha S helix. However, alternative broken helix states have been postulated, mandating experimental clarification. Here, the upper limit for the free energy difference between elongated and broken helix conformations on SUVs resembling synaptic vesicles was determined to be 1.2 +/- 0.4 kcal/mol, which amounts to a population ratio of 7.6:1 between both states (12% broken helices). In response to helix breaks at different positions, alpha S rearranged in an opportunistic manner, thereby minimizing helix abrogations to as little as one to two turns. Enthalpy and entropy measurements of gel state SUV-alpha S interactions indicated that broken helix states retain the ability to relieve membrane-packing stress. Thus, broken helix states are a distinct physiological feature of the vesicle-bound alpha S state, making it a "checkered" protein of multiple parallel conformations. A continuous interconversion between structural states may contribute to pathological alpha S misfolding.	[Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Ulmer, TS (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, ZNI 111,1501 San Pablo St, Los Angeles, CA 90033 USA.	tulmer@usc.edu			John Douglas French Alzheimer's Foundation; National Institutes of Health [HL089726]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089726] Funding Source: NIH RePORTER	John Douglas French Alzheimer's Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by The John Douglas French Alzheimer's Foundation, National Institutes of Health Grant HL089726, and the American Heart Association. To whom correspondence should be addressed: University of Southern California, ZNI 111, 1501 San Pablo St., Los Angeles, CA 90033. Tel.: 323-442-4326; Fax: 323-442-4404; E-mail: tulmer@usc.edu.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; EGERDIE B, 1982, CHEM PHYS LIPIDS, V31, P75, DOI 10.1016/0009-3084(82)90020-2; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; MANNING MC, 1991, BIOPOLYMERS, V31, P569, DOI 10.1002/bip.360310511; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; PARENTE RA, 1984, BIOCHEMISTRY-US, V23, P2353, DOI 10.1021/bi00306a005; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; Rao JN, 2009, J MOL BIOL, V390, P516, DOI 10.1016/j.jmb.2009.05.058; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Suk JE, 2010, BIOCHEMISTRY-US, V49, P1533, DOI 10.1021/bi901753h; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TAMM LK, 1991, BIOCHIM BIOPHYS ACTA, V1071, P123, DOI 10.1016/0304-4157(91)90021-N; TENCHOV BG, 1985, BIOCHIM BIOPHYS ACTA, V816, P122, DOI 10.1016/0005-2736(85)90400-6; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	48	72	74	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21450	21457		10.1074/jbc.M111.224055	http://dx.doi.org/10.1074/jbc.M111.224055			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21524999	hybrid, Green Published			2022-12-25	WOS:000291464700043
J	Lu, CY; Yeh, SR				Lu, Changyuan; Yeh, Syun-Ru			Ferryl Derivatives of Human Indoleamine 2,3-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; CYTOCHROME-C PEROXIDASE; HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; TRYPTOPHAN 2,3-DIOXYGENASE; SUBSTRATE-BINDING; NITRIC-OXIDE; COMPOUND-II; MECHANISM; INTERMEDIATE	The critical role of the ferryl intermediate in catalyzing the oxygen chemistry of monooxygenases, oxidases, or peroxidases has been known for decades. In contrast, its involvement in heme-based dioxygenases, such as human indoleamine 2,3-dioxygenase (hIDO), was not recognized until recently. In this study, H2O2 was used as a surrogate to generate the ferryl intermediate of hIDO. Spectroscopic data demonstrate that the ferryl species is capable of oxidizing azinobis(3-ethylbenzothiazoline-6-sulfonic acid) but not L-Trp. Kinetic studies reveal that the conversion of the ferric enzyme to the ferryl intermediate facilitates the L-Trp binding rate by >400-fold; conversely, L-Trp binding to the enzyme retards the peroxide reaction rate by similar to 9-fold, because of the significant elevation of the entropic barrier. The unfavorable entropic factor for the peroxide reaction highlights the scenario that the structure of hIDO is not optimized for utilizing H2O2 as a co-substrate for oxidizing L-Trp. Titration studies show that the ferryl intermediate possesses two substrate-binding sites with a K-d of 0.3 and 440 mu M and that the electronic properties of the ferryl moiety are sensitive to the occupancy of the two substrate-binding sites. The implications of the data are discussed in the context of the structural and functional relationships of the enzyme.	[Lu, Changyuan; Yeh, Syun-Ru] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Yeh, SR (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.	syun-ru.yeh@einstein.yu.edu		Yeh, Syun-Ru/0000-0002-9858-386X	National Institutes of Health [GM086482]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086482] Funding Source: NIH RePORTER; Division Of Chemistry [1026788] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM086482 (to S.-R. Y.).	BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BALNY C, 1987, FEBS LETT, V221, P349, DOI 10.1016/0014-5793(87)80954-7; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; BRUNORI M, 1971, BIOCHEMISTRY-US, V10, P1604, DOI 10.1021/bi00785a016; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Capece L, 2010, J BIOL INORG CHEM, V15, P811, DOI 10.1007/s00775-010-0646-x; Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; CHUANG WJ, 1992, J BIOL CHEM, V267, P13293; DALEYYATES PT, 1988, TOXICOL APPL PHARM, V96, P222, DOI 10.1016/0041-008X(88)90082-8; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; DOLMAN D, 1975, CAN J BIOCHEM CELL B, V53, P495, DOI 10.1139/o75-069; DUNFORD HB, 1976, COORDIN CHEM REV, V19, P187, DOI 10.1016/S0010-8545(00)80316-1; Efimov I, 2007, BIOCHEMISTRY-US, V46, P8017, DOI 10.1021/bi7006492; Ferry G, 2005, BIOCHEM J, V388, P205, DOI 10.1042/BJ20042075; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Gennis RB, 2004, FRONT BIOSCI, V9, P581, DOI 10.2741/1237; GREENGARD O, 1962, J BIOL CHEM, V237, P1903; Groves J. T., 2004, CYTOCHROME P450 STRU, P1; Han S, 2000, J BIOL CHEM, V275, P1910, DOI 10.1074/jbc.275.3.1910; HARBURY HA, 1957, J BIOL CHEM, V225, P1009; HAREL S, 1988, FREE RADICAL RES COM, V5, P21, DOI 10.3109/10715768809068555; HEWSON WD, 1975, CAN J CHEM, V53, P1928, DOI 10.1139/v75-268; ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593; Kakkar T, 1999, DRUG METAB DISPOS, V27, P756; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Khan KK, 1998, EUR J BIOCHEM, V257, P547, DOI 10.1046/j.1432-1327.1998.2570547.x; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; LOO S, 1975, BIOCHEMISTRY-US, V14, P3467, DOI 10.1021/bi00686a027; Lu CY, 2008, METHOD ENZYMOL, V437, P255, DOI 10.1016/S0076-6879(07)37014-6; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2010, BIOCHEMISTRY-US, V49, P5028, DOI 10.1021/bi1005078; Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768; Makris TM, 2006, J INORG BIOCHEM, V100, P507, DOI 10.1016/j.jinorgbio.2006.01.025; McCormick CG, 2000, BIOCHEM J, V350, P709, DOI 10.1042/0264-6021:3500709; MORISHIMA I, 1978, BIOCHEM BIOPH RES CO, V83, P946, DOI 10.1016/0006-291X(78)91487-0; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Nickel E, 2009, J BIOL CHEM, V284, P31548, DOI 10.1074/jbc.M109.039859; Ogura T, 2004, BBA-BIOENERGETICS, V1655, P290, DOI 10.1016/j.bbabio.2003.10.013; PAENG KJ, 1988, J AM CHEM SOC, V110, P7913, DOI 10.1021/ja00231a073; PALANIAPPAN V, 1989, J BIOL CHEM, V264, P16046; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; POULOS TL, 1980, J BIOL CHEM, V255, P8199; Prasad S, 2002, BBA-PROTEIN STRUCT M, V1596, P63, DOI 10.1016/S0167-4838(02)00205-4; Rodriguez-Lopez JN, 2000, BIOCHEMISTRY-US, V39, P13201, DOI 10.1021/bi001150p; RUBIN BY, 1988, J INTERFERON RES, V8, P691, DOI 10.1089/jir.1988.8.691; Samelson-Jones BJ, 2006, BIOCHEMISTRY-US, V45, P8527, DOI 10.1021/bi060143j; SATO K, 1995, BBA-PROTEIN STRUCT M, V1253, P94, DOI 10.1016/0167-4838(95)00144-J; SCHUTZ G, 1972, J BIOL CHEM, V247, P5333; SITTER AJ, 1985, J BIOL CHEM, V260, P7515; SMITH AT, 1992, EUR J BIOCHEM, V207, P507, DOI 10.1111/j.1432-1033.1992.tb17077.x; SONO M, 1989, J BIOL CHEM, V264, P1616; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; TAKIKAWA O, 1983, J BIOL CHEM, V258, P6808; Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200; Terner J, 2006, J INORG BIOCHEM, V100, P480, DOI 10.1016/j.jinorgbio.2006.01.008; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; Torres MI, 2007, CLIN EXP IMMUNOL, V148, P419, DOI 10.1111/j.1365-2249.2007.03365.x; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Yanagisawa S, 2010, CHEM LETT, V39, P36, DOI 10.1246/cl.2010.36; YIM MB, 1993, J BIOL CHEM, V268, P4099	63	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21220	21230		10.1074/jbc.M111.221507	http://dx.doi.org/10.1074/jbc.M111.221507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21502325	Green Published, hybrid			2022-12-25	WOS:000291464700021
J	Matta, H; Gopalakrishnan, R; Punj, V; Yi, H; Suo, YL; Chaudhary, PM				Matta, Hittu; Gopalakrishnan, Ramakrishnan; Punj, Vasu; Yi, Han; Suo, Yulan; Chaudhary, Preet M.			A20 Is Induced by Kaposi Sarcoma-associated Herpesvirus-encoded Viral FLICE Inhibitory Protein (vFLIP) K13 and Blocks K13-induced Nuclear Factor-kappa B in a Negative Feedback Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; GENE; EXPRESSION; ACTIVATION; DEATH; INDUCTION; LYMPHOMA; TNF	Expression of A20, a negative regulator of the NF-kappa B pathway, is frequently lost in several subtypes of Hodgkin and non-Hodgkin lymphoma. We report that A20 is expressed in Kaposi sarcoma-associated herpesvirus (KSHV)-infected primary effusion lymphoma cell lines, and its expression correlates closely with the expression of KSHV-encoded viral FLICE inhibitory protein K13. Ectopic expression of K13 induced A20 expression through NF-kappa B-mediated activation of A20 promoter. In turn, A20 blocked K13-induced NF-kappa B activity and up-regulation of pro-inflammatory cytokines CCL20 and IL-8 in a negative feedback fashion. Both the N-terminal deubiquitinating domain and the C-terminal zinc finger domain of A20 were involved in the inhibition of K13-induced NF-kappa B activity. Overexpression of A20 blocked K13-induced I kappa B alpha phosphorylation, NF-kappa B nuclear translocation, and cellular transformation. Consistent with the above, K13-induced I kappa B alpha phosphorylation and NF-kappa B transcriptional activation were enhanced in A20-deficient cells. Finally, A20 was found to interact physically with K13. Taken collectively, these results demonstrate that K13 is a key determinant of A20 expression in KSHV-infected cells, and A20 is a key negative regulator of K13-induced NF-kappa B activity. A20 might serve to control the inflammatory response to KSHV infection and protect KSHV-infected cells from apoptosis.	[Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Jane Ann Nohl Div Hematol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Ctr Study Blood Dis, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Chaudhary, PM (corresponding author), Univ So Calif, Keck Sch Med, Jane Ann Nohl Div Hematol, Los Angeles, CA 90033 USA.	preet.chaudhary@med.usc.edu	Chaudhary, Preet/E-1970-2018; Gopalakrishnan, Ramakrishnan/N-3454-2015	Gopalakrishnan, Ramakrishnan/0000-0002-5068-6886	National Institutes of Health [CA85177, CA124621, DE019811]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA085177, R01CA124621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA85177, CA124621, and DE019811. This work was also supported by the Leukemia and Lymphoma Society.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Amir-Zilberstein L, 2008, J BIOL CHEM, V283, P1317, DOI 10.1074/jbc.M706767200; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chaudhary PM, 1999, J BIOL CHEM, V274, P19211, DOI 10.1074/jbc.274.27.19211; Chaudhary Preet M., 2008, V1, P186, DOI 10.1159/000141519; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Jaattela M, 1996, J IMMUNOL, V156, P1166; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Keller SA, 2000, BLOOD, V96, P2537; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; LAHERTY CD, 1993, J BIOL CHEM, V268, P5032; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Matta H, 2008, ONCOGENE, V27, P5243, DOI 10.1038/onc.2008.150; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; PAINE E, 1995, J VIROL, V69, P4572, DOI 10.1128/JVI.69.7.4572-4576.1995; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Punj V, 2009, BLOOD, V113, P5660, DOI 10.1182/blood-2008-10-186403; Sakakibara S, 2009, J VIROL, V83, P2140, DOI 10.1128/JVI.01871-08; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sturzl M, 1999, J NATL CANCER I, V91, P1725, DOI 10.1093/jnci/91.20.1725; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu YY, 2007, J GEN VIROL, V88, P46, DOI 10.1099/vir.0.82375-0; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067	47	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21555	21564		10.1074/jbc.M111.224048	http://dx.doi.org/10.1074/jbc.M111.224048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531730	Green Published, hybrid			2022-12-25	WOS:000291464700053
J	Shiozaki, K; Yamaguchi, K; Takahashi, K; Moriya, S; Miyagi, T				Shiozaki, Kazuhiro; Yamaguchi, Kazunori; Takahashi, Kohta; Moriya, Setsuko; Miyagi, Taeko			Regulation of Sialyl Lewis Antigen Expression in Colon Cancer Cells by Sialidase NEU4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; HUMAN COLORECTAL-CANCER; CARCINOMA CELLS; E-SELECTIN; APOPTOSIS SUPPRESSION; UP-REGULATION; HYPOXIA; TUMOR; GLYCOSYLATION; PROGRESSION	Sialyl Lewis antigens, sialyl Lewis a and sialyl Lewis x, are utilized as tumor markers, and their increase in cancer is associated with tumor progression by enhancement of cancer cell adhesion to endothelial E-selectin. However, regulation mechanisms are not fully understood. We previously demonstrated that NEU4 is the only sialidase efficiently acting on mucins and it is down-regulated in colon cancer. To elucidate the significance of NEU4 down-regulation, we investigated sialyl Lewis antigens as endogenous substrates for the sialidase. NEU4 was found to hydrolyze the antigens in vitro and decrease cell surface levels much more effectively than other sialidases. Western blot, thin layer chromatography, and metabolic inhibition studies of desialylation products revealed NEU4 to preferentially catalyze sialyl Lewis antigens expressed on O-glycans. Cell adhesion to and motility and growth on E-selectin were significantly reduced by NEU4. E-selectin stimulation of colon cancer cells enhanced cell motility through activation of the p38/Hsp27/actin reorganization pathway, whereas NEU4 attenuated the signaling. On immunocytochemical analysis, some NEU4 molecules were localized at cell surfaces. Under hypoxia conditions whereby the antigens were increased concomitantly with several sialyl-and fucosyltransferases, NEU4 expression was markedly decreased. These results suggest that NEU4 plays an important role in control of sialyl Lewis antigen expression and its impairment in colon cancer.	[Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Marine Biochem Lab, Kagoshima 8900056, Japan; [Yamaguchi, Kazunori] Miyagi Canc Ctr, Res Inst, Div Biochem, Natori, Miyagi 9811293, Japan; [Takahashi, Kohta; Moriya, Setsuko; Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Canc Glycosylat Res, Sendai, Miyagi 9818558, Japan	Kagoshima University; Miyagi Cancer Center; Tohoku Medical & Pharmaceutical University	Miyagi, T (corresponding author), 4-4-1 Komatsushima,Aobu Ku, Sendai, Miyagi 9818558, Japan.	tmiyagi@tohoku-pharm.ac.jp		Shiozaki, Kazuhiro/0000-0002-0523-838X	Ministry of Education, Culture, Sports, Science and Technology of Japan [20013047]; Grants-in-Aid for Scientific Research [21570122] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research on Priority Areas in Cancer (20013047) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bardoni A, 1999, FEBS LETT, V451, P75, DOI 10.1016/S0014-5793(99)00547-5; BERG EL, 1991, J BIOL CHEM, V266, P14869; Bigi A, 2010, GLYCOBIOLOGY, V20, P148, DOI 10.1093/glycob/cwp156; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Gadhoum SZ, 2008, NAT CHEM BIOL, V4, P751, DOI 10.1038/nchembio.116; Gout S, 2006, CANCER RES, V66, P9117, DOI 10.1158/0008-5472.CAN-05-4605; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Inata J, 2007, INT J CANCER, V120, P2643, DOI 10.1002/ijc.22613; Izawa M, 2000, CANCER RES, V60, P1410; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kannagi R, 2010, CANCER SCI, V101, P586, DOI 10.1111/j.1349-7006.2009.01455.x; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kobayashi M, 2007, J HISTOCHEM CYTOCHEM, V55, P263, DOI 10.1369/jhc.6A7097.2006; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Kudo T, 1998, LAB INVEST, V78, P797; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; Laferriere J, 2002, ANN NY ACAD SCI, V973, P562, DOI 10.1111/j.1749-6632.2002.tb04702.x; Lafferriere J, 2004, CLIN EXP METASTAS, V21, P257, DOI 10.1023/B:CLIN.0000037708.09420.9a; Miyagi T, 2008, PROTEOMICS, V8, P3303, DOI 10.1002/pmic.200800248; Miyagi T, 2008, P JPN ACAD B-PHYS, V84, P407, DOI 10.2183/pjab.84.407; Miyazaki K, 2004, CANCER RES, V64, P4498, DOI 10.1158/0008-5472.CAN-03-3614; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Nakagoe T, 2002, J CLIN GASTROENTEROL, V34, P408, DOI 10.1097/00004836-200204000-00005; Ouchi K, 1996, CANCER, V78, P2313, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2313::AID-CNCR7>3.0.CO;2-N; SAUL R, 1983, ARCH BIOCHEM BIOPHYS, V221, P593, DOI 10.1016/0003-9861(83)90181-9; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; Srinivas U, 1996, SCAND J IMMUNOL, V44, P197, DOI 10.1046/j.1365-3083.1996.d01-302.x; Steplewska-Mazur K, 2000, HYBRIDOMA, V19, P129, DOI 10.1089/02724570050031167; Tsuchida A, 2003, J BIOL CHEM, V278, P22787, DOI 10.1074/jbc.M211034200; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Yamanami H, 2007, CANCER SCI, V98, P299, DOI 10.1111/j.1349-7006.2007.00403.x; Yang WQ, 2004, CHEM BIOL, V11, P439, DOI 10.1016/j.chembiol.2004.03.021; Yusa A, 2010, CANCER RES, V70, P4064, DOI 10.1158/0008-5472.CAN-09-2383	45	53	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21052	21061		10.1074/jbc.M111.231191	http://dx.doi.org/10.1074/jbc.M111.231191			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521691	Green Published, hybrid			2022-12-25	WOS:000291464700004
J	Garg, R; Peddada, N; Sagar, A; Nihalani, D; Ashish				Garg, Renu; Peddada, Nagesh; Sagar, Amin; Nihalani, Deepak; Ashish			Visual Insight into How Low pH Alone Can Induce Actin-severing Ability in Gelsolin under Calcium-free Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; RAY SOLUTION SCATTERING; ILL SURGICAL-PATIENTS; PLASMA GELSOLIN; REGULATORY PROTEIN; TERMINAL HALF; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CYTOSOLIC ACIDIFICATION; INTRACELLULAR PH; ACTIVATION	Gelsolin is a key actin cytoskeleton-modulating protein primarily regulated by calcium and phosphoinositides. In addition, low pH has also been suggested to activate gelsolin in the absence of Ca2+ ions, although no structural insight on this pathway is available except for a reported decrement in its diffusion coefficient at low pH. We also observed similar to 1.6-fold decrease in the molecular mobility of recombinant gelsolin when buffer pH was lowered from 9 to 5. Analysis of the small angle x-ray scattering data collected over the same pH range indicated that the radius of gyration and maximum linear dimension of gelsolin molecules increased from 30.3 to 34.1 angstrom and from 100 to 125 angstrom, respectively. Models generated for each dataset indicated that similar to the Ca2+ -induced process, low pH also promotes unwinding of this six-domain protein but only partially. It appeared that pH is able to induce extension of the G1 domain from the rest of the five domains, whereas the Ca2+ sensitive latch between G2 and G6 domains remains closed. Interestingly, increasing the free Ca2+ level to merely similar to 40 nM, the partially open pH 5 shape "sprung open" to a shape seen earlier for this protein at pH 8 and 1 mM free Ca2+. Also, pH alone could induce a shape where the g3-g4 linker of gelsolin was open when we truncated the C-tail latch from this protein. Our results provide insight into how under physiological conditions, a drop in pH can fully activate the F-actin-severing shape of gelsolin with micromolar levels of Ca2+ available.	[Garg, Renu; Peddada, Nagesh; Sagar, Amin; Ashish] CSIR, Inst Microbial Technol, Chandigarh 160036, India; [Nihalani, Deepak] Univ Penn, Renal Elect & Hypertens Div, Philadelphia, PA 19104 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Pennsylvania	Garg, R (corresponding author), CSIR, Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	rgarg@imtech.res.in; ashgang@imtech.res.in	Sagar, Amin/AAF-4044-2021; nihalani, deepak/AAK-9453-2020; Peddada, Nagesh/L-6760-2019	Sagar, Amin/0000-0002-6207-9557; Peddada, Nagesh/0000-0003-4033-7305	National Institutes of Health through the NIDDK [K01 DK072047-03, 5K01DK072047-04, RO1 1R01DK087956]; Department of Science and Technology [SR/WOS-A/LS-106/2009]; CSIR, India; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK072047, R01DK087956] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; Department of Science and Technology(Department of Science & Technology (India)); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health Grants K01 DK072047-03 and 5K01DK072047-04 and RO1 1R01DK087956 through the NIDDK.; Recipient of a Department of Science and Technology, Women Scientist Scheme A (SR/WOS-A/LS-106/2009) award.; Recipients of Junior Research Fellowships from CSIR, India.; Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886. Travel support to the synchrotron was provided by CSIR-INDIA (SIP10 and FAC-03). We acknowledge the consistent support from the faculty and staff of the Institute of Microbial Technology.	Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; Azuma T, 2000, J BIOL CHEM, V275, P3761, DOI 10.1074/jbc.275.6.3761; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Glatter O., 1982, SMALL ANGLE X RAY SC; Hirko AC, 2007, MOL THER, V15, P1623, DOI 10.1038/sj.mt.6300253; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Kiselar JG, 2003, P NATL ACAD SCI USA, V100, P3942, DOI 10.1073/pnas.0736004100; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; KWIATKOWSKI DJ, 1988, J CELL BIOL, V106, P375, DOI 10.1083/jcb.106.2.375; Lagarrigue E, 2003, EUR J BIOCHEM, V270, P4105, DOI 10.1046/j.1432-1033.2003.03803.x; Lagarrigue E, 2003, EUR J BIOCHEM, V270, P2236, DOI 10.1046/j.1432-1033.2003.03591.x; LAMB JA, 1993, J BIOL CHEM, V268, P8999; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lin KM, 1997, J BIOL CHEM, V272, P20443, DOI 10.1074/jbc.272.33.20443; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Narayan K, 2003, FEBS LETT, V552, P82, DOI 10.1016/S0014-5793(03)00933-5; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; Ohtsu M, 1997, EMBO J, V16, P4650, DOI 10.1093/emboj/16.15.4650; Pope BJ, 1997, BIOCHEMISTRY-US, V36, P15848, DOI 10.1021/bi972192p; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; SELVE N, 1987, EUR J BIOCHEM, V168, P111, DOI 10.1111/j.1432-1033.1987.tb13394.x; Spies CD, 1997, ALCOHOL CLIN EXP RES, V21, P1653, DOI 10.1097/00000374-199712000-00015; Steed PM, 1996, BIOCHEMISTRY-US, V35, P5229, DOI 10.1021/bi952370j; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TSUNODA Y, 1991, EXP CELL RES, V193, P356, DOI 10.1016/0014-4827(91)90107-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; Xu YS, 2000, J BIOL CHEM, V275, P24645, DOI 10.1074/jbc.M001159200; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409; Zhang Y, 2006, EMBO J, V25, P4458, DOI 10.1038/sj.emboj.7601323	43	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20387	20397		10.1074/jbc.M111.236943	http://dx.doi.org/10.1074/jbc.M111.236943			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498516	hybrid, Green Published			2022-12-25	WOS:000291267600026
J	Islam, ST; Gold, AC; Taylor, VL; Anderson, EM; Ford, RC; Lam, JS				Islam, Salim T.; Gold, Alexander C.; Taylor, Veronique L.; Anderson, Erin M.; Ford, Robert C.; Lam, Joseph S.			Dual Conserved Periplasmic Loops Possess Essential Charge Characteristics That Support a Catch-and-Release Mechanism of O-antigen Polymerization by Wzy in Pseudomonas aeruginosa PAO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER-MEMBRANE-PROTEINS; LIPID-A-CORE; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; CHAIN-LENGTH; POLYSACCHARIDE; BINDING; LIPOPOLYSACCHARIDE; POLYMERASE; TOPOLOGY	Heteropolymeric B-band lipopolysaccharide in Pseudomonas aeruginosa PAO1 is synthesized via the so-called Wzy-dependent pathway, requiring a functional Wzy for polymerization of O-antigen repeat units in the periplasm. Wzy is an integral inner membrane protein for which the detailed topology has been mapped in a recent investigation (Islam, S. T., Taylor, V. L., Qi, M., and Lam, J. S. (2010) mBio 1, e00189-10), revealing two principal periplasmic loops (PL), PL3 and PL5, each containing an RX(10)G motif. Despite considerable sequence conservation between the two loops, the isoelectric point for each peptide displayed marked differences, with PL3 exhibiting a net-positive charge and PL5 showing a net-negative charge. Data from site-directed mutagenesis of amino acids in each PL have led to the identification of several key Arg residues within the two RX(10)G motifs that are important for Wzy function, of which Arg(176), Arg(290), and Arg(291) could not be functionally substituted with Lys. These observations support the proposed role of each PL in a catch-and-release mechanism for Wzy-mediated O-antigen polymerization.	[Islam, Salim T.; Gold, Alexander C.; Taylor, Veronique L.; Anderson, Erin M.; Lam, Joseph S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Ford, Robert C.] Univ Manchester, Fac Life Sci, Manchester M60 1QD, Lancs, England	University of Guelph; University of Manchester	Lam, JS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jlam@uoguelph.ca	Islam, Salim/P-1323-2019; Islam, Salim/G-8608-2011	Islam, Salim/0000-0001-6853-8446; Islam, Salim/0000-0001-6853-8446; Ford, Robert/0000-0002-0958-1505	Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR) [MOP-14687]	Cystic Fibrosis Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants from Cystic Fibrosis Canada and the Canadian Institutes of Health Research (CIHR) (Grant MOP-14687).	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Abeyrathne PD, 2007, MOL MICROBIOL, V65, P1345, DOI 10.1111/j.1365-2958.2007.05875.x; Abeyrathne PD, 2007, CAN J MICROBIOL, V53, P526, DOI 10.1139/W07-007; Augustin DK, 2007, J BACTERIOL, V189, P2203, DOI 10.1128/JB.01839-06; BASTIN DA, 1993, MOL MICROBIOL, V7, P725, DOI 10.1111/j.1365-2958.1993.tb01163.x; Burrows LL, 1999, J BACTERIOL, V181, P973, DOI 10.1128/JB.181.3.973-980.1999; Coyne MJ, 1995, GENE, V167, P81, DOI 10.1016/0378-1119(95)00595-1; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; Daniels C, 2002, ENVIRON MICROBIOL, V4, P883, DOI 10.1046/j.1462-2920.2002.00288.x; DEKIEVIT TR, 1995, MOL MICROBIOL, V16, P565; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Elumalai P, 2010, PROTOPLASMA, V247, P13, DOI 10.1007/s00709-010-0132-x; Ernst RK, 2003, J ENDOTOXIN RES, V9, P395, DOI 10.1179/096805103225002764; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Islam ST, 2010, MBIO, V1, DOI 10.1128/mBio.00189-10; Kim TH, 2010, J BIOL CHEM, V285, P27839, DOI 10.1074/jbc.M110.143859; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; LAM JS, 1987, INFECT IMMUN, V55, P1051, DOI 10.1128/IAI.55.5.1051-1057.1987; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Malik A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-1; Mazur A, 2003, J BACTERIOL, V185, P2503, DOI 10.1128/JB.185.8.2503-2511.2003; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schild S, 2005, J BIOL CHEM, V280, P25936, DOI 10.1074/jbc.M501259200; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351	33	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20600	20605		10.1074/jbc.C110.204651	http://dx.doi.org/10.1074/jbc.C110.204651			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498511	Green Published, hybrid			2022-12-25	WOS:000291267600046
J	Liu, ZM; Yang, A; Wang, ZQ; Bunting, KD; Davuluri, G; Green, MR; Devireddy, LR				Liu, Zhuoming; Yang, Amy; Wang, Zhengqi; Bunting, Kevin D.; Davuluri, Gangarao; Green, Michael R.; Devireddy, Laxminarayana R.			Multiple Apoptotic Defects in Hematopoietic Cells from Mice Lacking Lipocalin 24p3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FAMILY; C-KIT; MOUSE; THYMOCYTES; IL-3; SUPPRESSION; EXPRESSION; INFECTION; LIGAND; GENE	The lipocalin mouse 24p3 has been implicated in diverse physiological processes, including apoptosis, iron trafficking, development and innate immunity. Studies from our laboratory as well as others demonstrated the proapoptotic activity of 24p3 in a variety of cultured models. However, a general role for the lipocalin 24p3 in the hematopoietic system has not been tested in vivo. To study the role of 24p3, we derived 24p3 null mice and back-crossed them onto C57BL/6 and 129/SVE backgrounds. Homozygous 24p3(-/-) mice developed a progressive accumulation of lymphoid, myeloid, and erythroid cells, which was not due to enhanced hematopoiesis because competitive repopulation and recovery from myelosuppression were the same as for wild type. Instead, apoptotic defects were unique to many mature hematopoietic cell types, including neutrophils, cytokine-dependent mast cells, thymocytes, and erythroid cells. Thymocytes isolated from 24p3 null mice also displayed resistance to apoptosis-induced by dexamethasone. Bim response to various apoptotic stimuli was attenuated in 24p3(-/-) cells, thus explaining their resistance to the ensuing cell death. The results of these studies, in conjunction with those of previous studies, reveal 24p3 as a regulator of the hematopoietic compartment with important roles in normal physiology and disease progression. Interestingly, these functions are limited to relatively mature blood cell compartments.	[Yang, Amy; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; [Yang, Amy; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; [Liu, Zhuoming; Davuluri, Gangarao; Devireddy, Laxminarayana R.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Liu, Zhuoming; Davuluri, Gangarao; Devireddy, Laxminarayana R.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Dept Pediat, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Blood Disorders Serv, Atlanta, GA 30322 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Case Western Reserve University; Case Western Reserve University; Emory University; Emory University	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA.	michael.green@umassmed.edu; LXD59@case.edu	Liu, Zhuoming/I-6950-2013	Liu, Zhuoming/0000-0002-8466-3199	National Institutes of Health [R01DK059380, K01CA113838, R01DK081395, R01CA115817]; Case Western Reserve University; March of Dimes; American Society of Hematology; NATIONAL CANCER INSTITUTE [K01CA113838, R01CA115817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059380, R01DK081395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; March of Dimes(March of Dimes); American Society of Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK059380 (to K. D. B.), K01CA113838 and R01DK081395 (to L. R. D.), and R01CA115817 (to M. R. G.). This work was also supported by Case Western Reserve University start up funds (to L. R. D.).; Recipient of career developmental awards from March of Dimes and the American Society of Hematology.	Agulnik AI, 1999, MAMM GENOME, V10, P926, DOI 10.1007/s003359901116; Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Leng X, 2008, ONCOGENE, V27, P6110, DOI 10.1038/onc.2008.209; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; MEKORI YA, 1993, J IMMUNOL, V151, P3775; Metcalfe D D, 1995, Exp Dermatol, V4, P227, DOI 10.1111/j.1600-0625.1995.tb00250.x; Miharada K, 2008, J CELL PHYSIOL, V215, P526, DOI 10.1002/jcp.21334; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Park S, 2009, J BIOL CHEM, V284, P2187, DOI 10.1074/jbc.M806131200; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; RODRIGUEZTARDUCHY G, 1990, EMBO J, V9, P2997, DOI 10.1002/j.1460-2075.1990.tb07492.x; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sheng Z, 2009, EMBO J, V28, P866, DOI 10.1038/emboj.2009.35; TISO M, 1995, AM J PATHOL, V147, P434; TSUJI K, 1991, J CELL PHYSIOL, V148, P362, DOI 10.1002/jcp.1041480306; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang J, 2000, J IMMUNOL, V165, P2970, DOI 10.4049/jimmunol.165.6.2970	30	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20606	20614		10.1074/jbc.M110.216549	http://dx.doi.org/10.1074/jbc.M110.216549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507940	Green Published, hybrid			2022-12-25	WOS:000291267600047
J	Lim, TP; Tan, TY; Lee, W; Sasikala, S; Tan, TT; Hsu, LY; Kwa, AL				Lim, Tze-Peng; Tan, Thean-Yen; Lee, Winnie; Sasikala, S.; Tan, Thuan-Tong; Hsu, Li-Yang; Kwa, Andrea L.			In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PSEUDOMONAS-AERUGINOSA; COLISTIN; STRAINS; HETERORESISTANCE; INFECTIONS; PNEUMONIA; IMIPENEM; FEATURES; THERAPY	Objective: Carbapenem-resistant Acinetobacter baumannii (CR-AB) is an emerging cause of nosocomial infections worldwide. Combination therapy may be the only viable option until new antibiotics become available. The objective of this study is to identify potential antimicrobial combinations against CR-AB isolated from our local hospitals. Methods: AB isolates from all public hospitals in Singapore were systematically collected between 2006 and 2007. MICs were determined according to CLSI guidelines. All CR-AB isolates were genotyped using a PCR-based method. Clonal relationship was elucidated. Time-kill studies (TKS) were conducted with polymyxin B, rifampicin and tigecycline alone and in combination using clinically relevant (achievable) unbound concentrations. Results: 31 CR AB isolates were identified. They are multidrug-resistant, but are susceptible to polymyxin B. From clonal typing, 8 clonal groups were identified and 11 isolates exhibited clonal diversity. In single TKS, polymyxin B, rifampicin and tigecycline alone did not exhibit bactericidal activity at 24 hours. In combination TKS, polymyxin plus rifampicin, polymyxin B plus tigecycline and tigecycline plus rifampicin exhibited bactericidal killing in 13/31, 9/31 and 7/31 isolates respectively at 24 hours. Within a clonal group, there may be no consensus with the types of antibiotics combinations that could still kill effectively. Conclusion: Monotherapy with polymyxin B may not be adequate against polymyxin B susceptible AB isolates. These findings demonstrate that in-vitro synergy of antibiotic combinations in CR AB may be strain dependant. It may guide us in choosing a pre-emptive therapy for CR AB infections and warrants further investigations.	[Lim, Tze-Peng; Lee, Winnie; Kwa, Andrea L.] Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore; [Tan, Thean-Yen; Sasikala, S.] Changi Gen Hosp, Dept Microbiol, Singapore, Singapore; [Lim, Tze-Peng; Hsu, Li-Yang] Natl Univ Singapore, Yong Loo Lin Sch Med, Div Infect Dis, Dept Med, Singapore 117595, Singapore	Singapore General Hospital; Changi General Hospital; National University of Singapore	Lim, TP (corresponding author), Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore.	andrea.kwa.l.h@sgh.com.sg		Hsu, Li Yang/0000-0002-0396-066X; Tan, Thean Yen/0000-0003-4358-1098	National Medical Research Council, Singapore [NMRC 06May038]; SingHealth Foundation [SHF/FG385S/2008, SHF/FG355P/2007]; Wyeth Pharmaceuticals; Pfizer; Janssen-Cilag; Merck Sharp & Dohme (I.A.) Corp.	National Medical Research Council, Singapore(National Medical Research Council, Singapore); SingHealth Foundation(SingHealth); Wyeth Pharmaceuticals(Wyeth); Pfizer(Pfizer); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Sharp & Dohme (I.A.) Corp.(Merck & Company)	This study was supported by National Medical Research Council, Singapore (NMRC 06May038), and SingHealth Foundation (SHF/FG385S/2008, SHF/FG355P/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; Transparency Declaration: on other occasions TTY and HLY have received funding for research from, and have been an invited as speakers for Wyeth Pharmaceuticals and Pfizer. ALK, WL and LTP have received funding for research from Janssen-Cilag and Merck Sharp & Dohme (I.A.) Corp. None of these companies provided any funding for this particular study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chen TL, 2007, CLIN MICROBIOL INFEC, V13, P801, DOI 10.1111/j.1469-0691.2007.01744.x; Clinical and Laboratory Standards Institute, 1999, METH DET BACT ACT AN; Grundmann HJ, 1997, J CLIN MICROBIOL, V35, P3071, DOI 10.1128/JCM.35.12.3071-3077.1997; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Hawley JS, 2008, ANTIMICROB AGENTS CH, V52, P351, DOI 10.1128/AAC.00766-07; Hogg GM, 1998, J ANTIMICROB CHEMOTH, V41, P494, DOI 10.1093/jac/41.4.494; KUNIN CM, 1973, ANN NY ACAD SCI, V226, P214, DOI 10.1111/j.1749-6632.1973.tb20483.x; Kuo LC, 2007, CLIN MICROBIOL INFEC, V13, P196, DOI 10.1111/j.1469-0691.2006.01601.x; Kwa ALH, 2007, DIAGN MICR INFEC DIS, V58, P99, DOI 10.1016/j.diagmicrobio.2006.11.014; Li J, 2006, ANTIMICROB AGENTS CH, V50, P2946, DOI 10.1128/AAC.00103-06; LIM TP, 2009, J ANTIBIOT TOKYO; Lolans K, 2006, ANTIMICROB AGENTS CH, V50, P2941, DOI 10.1128/AAC.00116-06; Mendes RE, 2008, CLIN INFECT DIS, V46, P1324, DOI 10.1086/533476; Montero A, 2004, J ANTIMICROB CHEMOTH, V54, P1085, DOI 10.1093/jac/dkh485; Pachon-Ibanez ME, 2004, ANTIMICROB AGENTS CH, V48, P4479, DOI 10.1128/AAC.48.11.4479-4481.2004; Pantopoulou A, 2007, INT J ANTIMICROB AG, V29, P51, DOI 10.1016/j.ijantimicag.2006.09.009; Paterson DL, 2007, CLIN INFECT DIS, V45, P1179, DOI 10.1086/522287; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Rodvold KA, 2006, J ANTIMICROB CHEMOTH, V58, P1221, DOI 10.1093/jac/dkl403; Song JY, 2007, J ANTIMICROB CHEMOTH, V60, P317, DOI 10.1093/jac/dkm136; Sopirala MM, 2010, ANTIMICROB AGENTS CH, V54, P4678, DOI 10.1128/AAC.00497-10; TAN LW, 2008, CHARACTERIZATION RES; Tascini C, 1998, J ANTIMICROB CHEMOTH, V42, P270, DOI 10.1093/jac/42.2.270; Timurkaynak F, 2006, INT J ANTIMICROB AG, V27, P224, DOI 10.1016/j.ijantimicag.2005.10.012; Tygacil (tigecycline) prescribing information, 2010, TYG TIG PRESCR INF; Villegas MV, 2007, ANTIMICROB AGENTS CH, V51, P2001, DOI 10.1128/AAC.00226-07; Yoon J, 2004, ANTIMICROB AGENTS CH, V48, P753, DOI 10.1128/AAC.48.3.753-757.2004; Zavascki AP, 2008, CLIN INFECT DIS, V47, P1298, DOI 10.1086/592577	32	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18485	10.1371/journal.pone.0018485	http://dx.doi.org/10.1371/journal.pone.0018485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533030	gold, Green Published, Green Submitted			2022-12-25	WOS:000290014500004
J	Subramanian, SV; Ozaltin, E; Finlay, JE				Subramanian, S. V.; Oezaltin, Emre; Finlay, Jocelyn E.			Height of Nations: A Socioeconomic Analysis of Cohort Differences and Patterns among Women in 54 Low- to Middle-Income Countries	PLOS ONE			English	Article							ADULT HEIGHT; SECULAR TREND; ASSOCIATION; MORTALITY; MEN; STATURE; RISK	Background: Adult height is a useful biological measure of long term population health and well being. We examined the cohort differences and socioeconomic patterning in adult height in low-to middle-income countries. Methods/Findings: We analyzed cross-sectional, representative samples of 364538 women aged 25-49 years drawn from 54 Demographic and Health Surveys (DHS) conducted between 1994 and 2008. Linear multilevel regression models included year of birth, household wealth, education, and area of residence, and accounted for clustering by primary sampling units and countries. Attained height was measured using an adjustable measuring board. A yearly change in birth cohorts starting with those born in 1945 was associated with a 0.0138 cm (95% CI 0.0107, 0.0169) increase in height. Increases in heights in more recent birth year cohorts were largely concentrated in women from the richer wealth quintiles. 35 of the 54 countries experienced a decline (14) or stagnation (21) in height. The decline in heights was largely concentrated among the poorest wealth quintiles. There was a strong positive association between height and household wealth; those in two richest quintiles of household wealth were 1.988 cm (95% CI 1.886, 2.090) and 1.018 cm (95% CI 0.916, 1.120) taller, compared to those in the poorest wealth quintile. The strength of the association between wealth and height was positive (0.05 to 1.16) in 96% (52/54) countries. Conclusions: Socioeconomic inequalities in height remain persistent. Height has stagnated or declined over the last decades in low-to middle-income countries, particularly in Africa, suggesting worsening nutritional and environmental circumstances during childhood.	[Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Oezaltin, Emre; Finlay, Jocelyn E.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu	Finlay, Jocelyn/AAS-9588-2021	Finlay, Jocelyn/0000-0002-3077-5515	National Institutes of Health [NHLBI K25 HL081275]; Robert Wood Johnson Investigator Award in Health Policy Research; Harvard Center for Population and Development Studies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Investigator Award in Health Policy Research; Harvard Center for Population and Development Studies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Subramanian is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275) and the Robert Wood Johnson Investigator Award in Health Policy Research. The authors also acknowledge the support of Harvard Center for Population and Development Studies for research assistance for a related work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akachi Y, 2010, ECON HUM BIOL, V8, P273, DOI 10.1016/j.ehb.2010.05.015; Baynouna LM, 2009, ECON HUM BIOL, V7, P405, DOI 10.1016/j.ehb.2009.07.004; Bozzoli C, 2009, DEMOGRAPHY, V46, P647; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Croft T, 1991, DEMOGRAPHIC HLTH SUR, VII, P1337; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; DHS, 2009, DEM HLTH SURV; Ethiopia CSA, 2006, DEMOGRAPHIC HLTH SUR; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Garcia J, 2007, ECON HUM BIOL, V5, P340, DOI 10.1016/j.ehb.2007.02.002; Goldstein H., 2003, MULTILEVEL STAT MODE; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Haghdoost AA, 2008, IRAN J PUBLIC HEALTH, V37, P1; Hatton TJ, 2010, ECON HUM BIOL, V8, P405, DOI 10.1016/j.ehb.2010.03.001; Komlos J, 2004, SOC SCI HIST, V28, P191, DOI 10.1215/01455532-28-2-191; KOMLOS J, 2009, RECENT TRENDS HEIGHT; Komlos J, 2010, ECON HUM BIOL, V8, P58, DOI 10.1016/j.ehb.2009.12.004; Kues AB, 2010, ECON HUM BIOL, V8, P67, DOI 10.1016/j.ehb.2009.09.002; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Ozer BK, 2008, ANTHROPOL SCI, V116, P191, DOI 10.1537/ase.061213; Perkins JM, 2011, ECON HUM BIOL, V9, P184, DOI 10.1016/j.ehb.2010.10.001; Pullum T. W., 2006, ASSESSMENT AGE DATE; Pullum TW, 2008, ASSESSMENT QUALITY D; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Rutstein SO, 2004, DHS WEALTH ASSET IND, V6; Rutstein SO, 2003, GUIDE DHS STAT; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Singh-Manoux A, 2010, ECON HUM BIOL, V8, P396, DOI 10.1016/j.ehb.2010.03.002; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Smith GD, 2002, WESTERN J MED, V176, P209, DOI 10.1136/ewjm.176.3.209; Sorkin JD, 1999, EPIDEMIOL REV, V21, P247, DOI 10.1093/oxfordjournals.epirev.a018000; *STATACORP, 2008, STAT SOFTW REL 10SE; Steckel RH, 2009, EXPLOR ECON HIST, V46, P1, DOI 10.1016/j.eeh.2008.12.001; Strauss J, 2008, HBK ECON, V9, P3375, DOI 10.1016/S1573-4471(07)04054-5; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; *SURV DAH, 1996, SAMPL MAN; SUSSER M, 1994, AM J PUBLIC HEALTH, V84, P825, DOI 10.2105/AJPH.84.5.825; Tucker-Seeley RD, 2011, ECON HUM BIOL, V9, P194, DOI 10.1016/j.ehb.2010.11.002; VAESSEN M, 1996, DEMOGRAPHIC EVALUATI; Webb EA, 2008, ECON HUM BIOL, V6, P228, DOI 10.1016/j.ehb.2008.03.001; Wirth M., 2006, MONITORING HLTH EQUI	46	93	97	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18962	10.1371/journal.pone.0018962	http://dx.doi.org/10.1371/journal.pone.0018962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533104	Green Published, gold			2022-12-25	WOS:000289719400040
J	Coltri, P; Effenberger, K; Chalkley, RJ; Burlingame, AL; Jurica, MS				Coltri, Patricia; Effenberger, Kerstin; Chalkley, Robert J.; Burlingame, A. L.; Jurica, Melissa S.			Breaking Up the C Complex Spliceosome Shows Stable Association of Proteins with the Lariat Intron Intermediate	PLOS ONE			English	Article							PRE-MESSENGER-RNA; U2 SNRNP; MASS-SPECTROMETRY; BRANCH SITE; ACTIVATION; REARRANGEMENT; FIDELITY; RELEASE; BINDING; STEPS	Spliceosome assembly requires several structural rearrangements to position the components of the catalytic core. Many of these rearrangements involve successive strengthening and weakening of different RNA: RNA and RNA: proteins interactions within the complex. To gain insight into the organization of the catalytic core of the spliceosome arrested between the two steps of splicing chemistry (C complex), we investigated the effects of exposing C complex to low concentrations of urea. We find that in the presence of 3M urea C complex separates into at least three sub-complexes. One sub-complex contains the 5`exon, another contains the intron-lariat intermediate, and U2/U5/U6 snRNAs likely comprise a third sub-complex. We purified the intron-lariat intermediate sub-complex and identified several proteins, including U2 snRNP and PRP19 complex (NTC) components. The data from our study indicate that U2 snRNP proteins in C complex are more stably associated with the lariat-intron intermediate than the U2 snRNA. The results also suggest a set of candidate proteins that hold the lariat-intron intermediate together in C complex. This information is critical for further interpreting the complex architecture of the mammalian spliceosome.	[Coltri, Patricia; Effenberger, Kerstin; Jurica, Melissa S.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Coltri, Patricia; Effenberger, Kerstin; Jurica, Melissa S.] Univ Calif Santa Cruz, Ctr Mol Biol, RNA, Santa Cruz, CA 95064 USA; [Chalkley, Robert J.; Burlingame, A. L.] Univ Calif Santa Cruz, Dept Pharmaceut Chem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Coltri, P (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	jurica@biology.ucsc.edu	Coltri, Patricia P./E-6294-2014	Coltri, Patricia P./0000-0001-8447-7516; Chalkley, Robert/0000-0002-9757-7302	National Institutes of Health [5R01GM72649]; National Center for Research Resources [RR001614, RR015804, RR019934]; CAPES; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019934, S10RR015804, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072649, P41GM103481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant 5R01GM72649 to MSJ. RJC and ALB were supported by National Center for Research Resources grants RR001614, RR015804, and RR019934. PPC was supported by a CAPES fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; Dybkov O, 2006, MOL CELL BIOL, V26, P2803, DOI 10.1128/MCB.26.7.2803-2816.2006; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hirose T, 2006, MOL CELL, V23, P673, DOI 10.1016/j.molcel.2006.07.011; Hogg R, 2010, BIOCHEM SOC T, V38, P1110, DOI 10.1042/BST0381110; Jurica MS, 2004, NAT STRUCT MOL BIOL, V11, P265, DOI 10.1038/nsmb728; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; Smith DJ, 2009, MOL CELL, V34, P333, DOI 10.1016/j.molcel.2009.03.012; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Tseng CK, 2008, SCIENCE, V320, P1782, DOI 10.1126/science.1158993; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; WU J, 1991, NATURE, V352, P818, DOI 10.1038/352818a0; Yan D, 1996, MOL CELL BIOL, V16, P818	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19061	10.1371/journal.pone.0019061	http://dx.doi.org/10.1371/journal.pone.0019061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526149	Green Published, gold			2022-12-25	WOS:000289671100047
J	Errington, AC; Gibson, KM; Crunelli, V; Cope, DW				Errington, Adam C.; Gibson, K. Michael; Crunelli, Vincenzo; Cope, David W.			Aberrant GABA(A) Receptor-Mediated Inhibition in Cortico-Thalamic Networks of Succinic Semialdehyde Dehydrogenase Deficient Mice	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; SSADH DEFICIENCY; GENETIC MODEL; WAVE DISCHARGES; SEIZURES; NEURONS; NUCLEUS; RATS; MECHANISMS; SPIKE	Aberrant gamma-aminobutyric acid type A (GABA(A)) receptor-mediated inhibition in cortico-thalamic networks remains an attractive mechanism for typical absence seizure genesis. Using the whole-cell patch clamp technique we examined 'phasic' and 'tonic' GABA(A) inhibition in thalamocortical neurons of somatosensory (ventrobasal, VB) thalamus, nucleus reticularis thalami (NRT) neurons, and layer 5/6 pyramidal neurons of the somatosensory (barrel) cortex of succinic semialdehyde dehydrogenase (SSADH) knock-out (SSADH(-/-)) mice that replicate human SSADH deficiency and exhibit typical absence seizures. We found increased sIPSC frequency in both VB and NRT neurons and larger sIPSC amplitude in VB neurons of SSADH(-/-) mice compared to wild-type animals, demonstrating an increase in total phasic inhibition in thalamus of SSADH(-/-) mice. mIPSCs in both VB and NRT neurons were no different between genotypes, although there remained a trend toward more events in SSADH(-/-) mice. In cortical layer 5/6 pyramidal neurons, sIPSCs were fewer but larger in SSADH(-/-) mice, a feature retained by mIPSCs. Tonic currents were larger in both thalamocortical neurons and layer 5/6 pyramidal neurons from SSADH(-/-) mice compared to WTs. These data show that enhanced, rather than compromised, GABAA receptor-mediated inhibition occurs in cortico-thalamic networks of SSADH(-/-) mice. In agreement with previous studies, GABAA receptor-mediated inhibitory gain-of-function may be a common feature in models of typical absence seizures, and could be of pathological importance in patients with SSADH deficiency.	[Errington, Adam C.; Crunelli, Vincenzo; Cope, David W.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Gibson, K. Michael] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Cardiff University; Michigan Technological University	Errington, AC (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	erringtonac@cf.ac.uk	Errington, Adam/D-1678-2011	Errington, Adam/0000-0002-2171-389X; Crunelli, Vincenzo/0000-0001-7154-9752	Wellcome Trust [091882]; NIH [NS40270-09, HD58553-02/02S2/03]; Pediatric Neurotransmitter Disease Association; Epilepsy Research U.K. [P0802]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040270] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Neurotransmitter Disease Association; Epilepsy Research U.K.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Wellcome Trust (grant 091882 to V.C.), NIH (grants NS40270-09 and HD58553-02/02S2/03 to K.M.G.), and a grant from the Pediatric Neurotransmitter Disease Association (to K.M.G.). D.W.C. was a research fellow of Epilepsy Research U.K. (grant P0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bessaih T, 2006, J NEUROPHYSIOL, V96, P3074, DOI 10.1152/jn.00682.2006; Blumenfeld H, 2005, EPILEPSIA, V46, P21, DOI 10.1111/j.1528-1167.2005.00311.x; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Cortez MA, 2004, PHARMACOL BIOCHEM BE, V79, P547, DOI 10.1016/j.pbb.2004.09.008; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Dosa Z, 2010, EPILEPSY RES, V90, P39, DOI 10.1016/j.eplepsyres.2010.03.005; Drasbek K, 2008, J INHERIT METAB DIS, V31, P662, DOI 10.1007/s10545-008-0941-7; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gibson KM, 2003, BIOL PSYCHIAT, V54, P763, DOI 10.1016/S0006-3223(03)00113-6; Gibson KM, 1997, PEDIATRICS, V99, P567, DOI 10.1542/peds.99.4.567; Gupta M, 2004, NEUROBIOL DIS, V16, P556, DOI 10.1016/j.nbd.2004.04.008; HARRIS RM, 1987, NEUROSCIENCE, V21, P229, DOI 10.1016/0306-4522(87)90335-6; Hogema BM, 2001, NAT GENET, V29, P212, DOI 10.1038/ng727; Hosford DA, 1997, EPILEPSY RES, V27, P55, DOI 10.1016/S0920-1211(97)01023-1; Huntsman MM, 2000, J NEUROPHYSIOL, V83, P350, DOI 10.1152/jn.2000.83.1.350; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Nylen K, 2008, EXP NEUROL, V210, P449, DOI 10.1016/j.expneurol.2007.11.015; Payne HL, 2006, J NEUROSCI, V26, P8600, DOI 10.1523/JNEUROSCI.1088-06.2006; Pearl PL, 2009, J INHERIT METAB DIS, V32, P343, DOI 10.1007/s10545-009-1034-y; Pearl PL, 2003, ANN NEUROL, V54, pS73, DOI 10.1002/ana.10629; Pearl PL, 2003, NEUROLOGY, V60, P1413, DOI 10.1212/01.WNL.0000059549.70717.80; PEETERS BWMM, 1989, LIFE SCI, V45, P1171, DOI 10.1016/0024-3205(89)90505-5; Pinault D, 1997, J NEUROSCI, V17, P3215; PINAULT D, 1995, EUR J NEUROSCI, V7, P31, DOI 10.1111/j.1460-9568.1995.tb01017.x; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Polack PO, 2009, CEREB CORTEX, V19, P2078, DOI 10.1093/cercor/bhn237; Sohal VS, 2003, J NEUROSCI, V23, P3649; SPREAFICO R, 1991, J COMP NEUROL, V304, P478, DOI 10.1002/cne.903040311; Stewart LS, 2008, EPILEPSY BEHAV, V13, P290, DOI 10.1016/j.yebeh.2008.04.012; Tanaka M, 2008, AM J HUM GENET, V82, P1249, DOI 10.1016/j.ajhg.2008.04.020; Toth TI, 2007, EUR J NEUROSCI, V26, P1832, DOI 10.1111/j.1460-9568.2007.05800.x; VERGNES M, 1984, NEUROSCI LETT, V44, P91, DOI 10.1016/0304-3940(84)90226-X; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wu Y, 2006, ANN NEUROL, V59, P42, DOI 10.1002/ana.20686; WU Y, 2008, SOC NEUR ABS	43	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19021	10.1371/journal.pone.0019021	http://dx.doi.org/10.1371/journal.pone.0019021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526163	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000289671100046
J	Taylor, M; Banerjee, T; Navarro-Garcia, F; Huerta, J; Massey, S; Burlingame, M; Pande, AH; Tatulian, SA; Teter, K				Taylor, Michael; Banerjee, Tuhina; Navarro-Garcia, Fernando; Huerta, Jazmin; Massey, Shane; Burlingame, Mansfield; Pande, Abhay H.; Tatulian, Suren A.; Teter, Ken			A Therapeutic Chemical Chaperone Inhibits Cholera Intoxication and Unfolding/Translocation of the Cholera Toxin A1 Subunit	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; AMYOTROPHIC-LATERAL-SCLEROSIS; CHO-CELLS RESISTANT; ENDOPLASMIC-RETICULUM; INTRACELLULAR TRAFFICKING; THERMAL-STABILITY; EPITHELIAL-CELLS; MAMMALIAN-CELLS; PROTEIN TOXINS; CYTOSOL	Cholera toxin (CT) travels as an intact AB(5) protein toxin from the cell surface to the endoplasmic reticulum (ER) of an intoxicated cell. In the ER, the catalytic A1 subunit dissociates from the rest of the toxin. Translocation of CTA1 from the ER to the cytosol is then facilitated by the quality control mechanism of ER-associated degradation (ERAD). Thermal instability in the isolated CTA1 subunit generates an unfolded toxin conformation that acts as the trigger for ERAD-mediated translocation to the cytosol. In this work, we show by circular dichroism and fluorescence spectroscopy that exposure to 4-phenylbutyric acid (PBA) inhibited the thermal unfolding of CTA1. This, in turn, blocked the ER-to-cytosol export of CTA1 and productive intoxication of either cultured cells or rat ileal loops. In cell culture studies PBA did not affect CT trafficking to the ER, CTA1 dissociation from the holotoxin, or functioning of the ERAD system. PBA is currently used as a therapeutic agent to treat urea cycle disorders. Our data suggest PBA could also be used in a new application to prevent or possibly treat cholera.	[Taylor, Michael; Banerjee, Tuhina; Massey, Shane; Burlingame, Mansfield; Pande, Abhay H.; Teter, Ken] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Navarro-Garcia, Fernando; Huerta, Jazmin] IPN CINVESTAV Zacatenco, Dept Cell Biol, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico; [Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; State University System of Florida; University of Central Florida	Taylor, M (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	kteter@mail.ucf.edu	Navarro-Garcia, Fernando/A-3980-2011	Teter, Ken/0000-0003-4176-9361	National Institutes of Health [R03 AI067987, R01 AI073783]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI067987, R01AI073783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov/) grants R03 AI067987 and R01 AI073783 to K. Teter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; BECH E, 1994, CLIN CHEM, V40, P1331; Bonapace G, 2004, P NATL ACAD SCI USA, V101, P12300, DOI 10.1073/pnas.0404764101; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; CHANG FH, 1989, J BIOL CHEM, V264, P5352; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; GOINS B, 1988, BIOCHEMISTRY-US, V27, P2046, DOI 10.1021/bi00406a035; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hilger H, 2009, INFECT IMMUN, V77, P5593, DOI 10.1128/IAI.00710-09; Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0; Kato J, 2007, MOL CELL BIOL, V27, P5534, DOI 10.1128/MCB.00302-07; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; Lin Liang-Ping, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P61, DOI 10.2174/1568008053174697; Loffing J, 1999, AM J PHYSIOL-LUNG C, V277, pL700, DOI 10.1152/ajplung.1999.277.4.L700; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Paton JC, 2006, KIDNEY INT, V70, P2049, DOI 10.1038/sj.ki.5001954; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Petri S, 2006, NEUROBIOL DIS, V22, P40, DOI 10.1016/j.nbd.2005.09.013; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; SUREWICZ WK, 1990, BIOCHEMISTRY-US, V29, P8106, DOI 10.1021/bi00487a017; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Teckman JH, 2004, J PEDIATR GASTR NUTR, V39, P34, DOI 10.1097/00005176-200407000-00007; Teter K, 2006, INFECT IMMUN, V74, P2259, DOI 10.1128/IAI.74.4.2259-2267.2006; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Vilatoba M, 2005, SURGERY, V138, P342, DOI 10.1016/j.surg.2005.04.019; Watson P, 2006, ADV DRUG DELIVER REV, V58, P1581, DOI 10.1016/j.addr.2006.09.016; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Wernick NLB, 2010, J BIOL CHEM, V285, P6145, DOI 10.1074/jbc.M109.062067; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06	50	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18825	10.1371/journal.pone.0018825	http://dx.doi.org/10.1371/journal.pone.0018825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526142	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100025
J	Wang, A; Zocchi, G				Wang, Andrew; Zocchi, Giovanni			Artificial Modulation of the Gating Behavior of a K+ Channel in a KvAP-DNA Chimera	PLOS ONE			English	Article							VOLTAGE; RECONSTITUTION; CHEMISTRY	We present experiments where the gating behavior of a voltage-gated ion channel is modulated by artificial ligand binding. We construct a channel-DNA chimera with the KvAP potassium channel reconstituted in an artificial membrane. The channel is functional and the single channel ion conductivity unperturbed by the presence of the DNA. However, the channel opening probability vs. bias voltage, i.e., the gating, can be shifted considerably by the electrostatic force between the charges on the DNA and the voltage sensing domain of the protein. Different hybridization states of the chimera DNA thus lead to different response curves of the channel.	[Wang, Andrew; Zocchi, Giovanni] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, A (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	zocchi@physics.ucla.edu			University of California; National Science Foundation [DMR-1006162]	University of California(University of California System); National Science Foundation(National Science Foundation (NSF))	This work was supported by the University of California Lab Research Program and by National Science Foundation grant DMR-1006162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Choi B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.078102; Choi B, 2006, J AM CHEM SOC, V128, P8541, DOI 10.1021/ja060903d; COHEN FS, 1989, J GEN PHYSIOL, V93, P201, DOI 10.1085/jgp.93.2.201; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Fadool DA, 1997, J NEUROPHYSIOL, V78, P1563, DOI 10.1152/jn.1997.78.3.1563; Godfraind T., 2004, MIL DRUG TH; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Jackson J. D, 1998, CLASSICAL ELECTRODYN, VThird; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; Kocer A, 2005, SCIENCE, V309, P755, DOI 10.1126/science.1114760; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Ohndorf UM, 2005, J MOL BIOL, V350, P857, DOI 10.1016/j.jmb.2005.05.050; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PEROZO E, 1990, NEURON, V5, P685, DOI 10.1016/0896-6273(90)90222-2; Rant U, 2006, ORG BIOMOL CHEM, V4, P3448, DOI 10.1039/b605712h; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; RAUDINO A, 1986, BIOPHYS J, V50, P441, DOI 10.1016/S0006-3495(86)83480-4; Rigaud JL, 1998, EUR BIOPHYS J BIOPHY, V27, P305, DOI 10.1007/s002490050138; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Treptow W, 2006, BIOPHYS J, V90, pL64, DOI 10.1529/biophysj.106.080754; Tseng CY, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/18005; VEREECKE, 1995, POTASSIUM CHANNELS N; WONDERLIN WF, 1990, BIOPHYS J, V58, P289, DOI 10.1016/S0006-3495(90)82376-6; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zocchi G, 2009, ANNU REV BIOPHYS, V38, P75, DOI 10.1146/annurev.biophys.050708.133637	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18598	10.1371/journal.pone.0018598	http://dx.doi.org/10.1371/journal.pone.0018598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526187	gold, Green Submitted, Green Published			2022-12-25	WOS:000289671100011
J	Claro, T; Widaa, A; O'Seaghdha, M; Miajlovic, H; Foster, TJ; O'Brien, FJ; Kerrigan, SW				Claro, Tania; Widaa, Amro; O'Seaghdha, Maghnus; Miajlovic, Helen; Foster, Timothy J.; O'Brien, Fergal J.; Kerrigan, Steven W.			Staphylococcus aureus Protein A Binds to Osteoblasts and Triggers Signals That Weaken Bone in Osteomyelitis	PLOS ONE			English	Article							APOPTOSIS; EXPRESSION; INTERNALIZATION; INTERLEUKIN-6; INFECTION; DOMAIN; MOUSE; HOST; TNF	Osteomyelitis is a debilitating infectious disease of the bone. It is predominantly caused by S. aureus and is associated with significant morbidity and mortality. It is characterised by weakened bones associated with progressive bone loss. Currently the mechanism through which either bone loss or bone destruction occurs in osteomyelitis patients is poorly understood. We describe here for the first time that the major virulence factor of S. aureus, protein A (SpA) binds directly to osteoblasts. This interaction prevents proliferation, induces apoptosis and inhibits mineralisation of cultured osteoblasts. Infected osteoblasts also increase the expression of RANKL, a key protein involved in initiating bone resorption. None of these effects was seen in a mutant of S. aureus lacking SpA. Complementing the SpA-defective mutant with a plasmid expressing spa or using purified protein A resulted in attachment to osteoblasts, inhibited proliferation and induced apoptosis to a similar extent as wildtype S. aureus. These events demonstrate mechanisms through which loss of bone formation and bone weakening may occur in osteomyelitis patients. This new information may pave the way for the development of new and improved therapeutic agents to treat this disease.	[Claro, Tania; Widaa, Amro; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland; [O'Seaghdha, Maghnus; Miajlovic, Helen; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dublin, Ireland; [O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Kerrigan, Steven W.] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland	Claro, T (corresponding author), Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland.	skerrigan@rcsi.ie	O'Brien, Fergal/F-9485-2011; Kerrigan, Steven/C-3922-2012	O'Brien, Fergal/0000-0003-2030-8005; Miajlovic, Helen/0000-0001-8854-4309; O'Seaghdha, Maghnus/0000-0002-0232-0556	Science Foundation of Ireland [BMT/2008/1709]; Health Research Board of Ireland [RP/2006/2]; Royal College of Surgeons in Ireland	Science Foundation of Ireland(Science Foundation Ireland); Health Research Board of Ireland; Royal College of Surgeons in Ireland	This work was supported by a grant from the Science Foundation of Ireland Research Frontiers Programme awarded to SWK (no. BMT/2008/1709), a Health Research Board of Ireland project grant RP/2006/2 to TJF and the Royal College of Surgeons in Ireland Alumni Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Alexander EH, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-5; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bost KL, 1999, J INFECT DIS, V180, P1912, DOI 10.1086/315138; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Bu RF, 2003, BONE, V33, P760, DOI 10.1016/j.bone.2003.07.006; Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413; CEDERGREN L, 1993, PROTEIN ENG, V6, P441, DOI 10.1093/protein/6.4.441; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gomez MI, 2006, J BIOL CHEM, V281, P20190, DOI 10.1074/jbc.M601956200; GOUDA H, 1992, BIOCHEMISTRY-US, V31, P9665, DOI 10.1021/bi00155a020; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Have KLV, 2009, J PEDIATR ORTHOPED, V29, P927, DOI 10.1097/BPO.0b013e3181bd1e0c; Hill P A, 1998, Br J Orthod, V25, P101; Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075; Kahl BC, 2000, INFECT IMMUN, V68, P5385, DOI 10.1128/IAI.68.9.5385-5392.2000; Klosterhalfen B, 1996, J TRAUMA, V40, P372, DOI 10.1097/00005373-199603000-00008; Kudo O, 2002, J PATHOL, V198, P220, DOI 10.1002/path.1190; Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luong TT, 2002, INFECT IMMUN, V70, P3389, DOI 10.1128/IAI.70.7.3389-3395.2002; Marriott I, 2004, AM J PATHOL, V164, P1399, DOI 10.1016/S0002-9440(10)63226-9; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Nilsson IM, 1997, INFECT IMMUN, V65, P4216, DOI 10.1128/IAI.65.10.4216-4221.1997; O'Seaghdha M, 2006, FEBS J, V273, P4831, DOI 10.1111/j.1742-4658.2006.05482.x; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Plunkett NA, 2010, TISSUE ENG PT A, V16, P943, DOI 10.1089/ten.TEA.2009.0345; Reilly SS, 2000, BONE, V26, P63, DOI 10.1016/S8756-3282(99)00239-2; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Somayaji SN, 2008, INFECT IMMUN, V76, P5120, DOI 10.1128/IAI.00228-08; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207; Tucker KA, 2000, FEMS MICROBIOL LETT, V186, P151, DOI 10.1016/S0378-1097(00)00125-7; UHLEN M, 1984, J BACTERIOL, V159, P713; Viau M, 2005, MOL IMMUNOL, V42, P849, DOI 10.1016/j.molimm.2004.07.047; vonEiff C, 1997, CLIN INFECT DIS, V25, P1250, DOI 10.1086/516962; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003	44	113	121	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18748	10.1371/journal.pone.0018748	http://dx.doi.org/10.1371/journal.pone.0018748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525984	Green Published, gold, Green Submitted			2022-12-25	WOS:000289578600028
J	Gleicher, N; Weghofer, A; Lee, IH; Barad, DH				Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.			Association of FMR1 Genotypes with In Vitro Fertilization (IVF) Outcomes Based on Ethnicity/Race	PLOS ONE			English	Article							ASIAN ETHNICITY; PREGNANCY; WOMEN; REPEAT; GENE; DISPARITY; REGION; COHORT	The FMR1 gene, mapping to an area of the X chromosome closely associated with autoimmunity also affects ovarian reserve, with specific genotypes associated with distinct ovarian aging patterns. They, therefore, could also be associated with differences of in vitro fertilization (IVF) outcomes, reported between races/ethnicities. We analyzed 339 consecutive IVF patients, 232 Caucasian, 59 African and 48 Asian, for FMR1 genotypes, and tested by multiple logistic regressions for associations between race/ethnicity, FMR1 genotype, autoimmunity and pregnancy chances with IVF. FMR1 genotypes were predictive of pregnancy (P = 0.046), het-norm/low most significantly and with decreasing chance in comparison to norm genotypes (OR 0.44; 95% CI 0.23-0.85; P = 0.014). Race/ethnicity was, overall, independently associated (P = 0.03), African demonstrating decreased odds in comparison to Caucasian (OR 0.33. 95% CI 0.13-0.79; P = 0.014). Autoimmunity did not differ but interaction of autoimmunity with FMR1 genotype almost reached significance (P = 0.07). Logistic regression with race/ethnicity and interaction between FMR1 genotype and autoimmunity in the model, demonstrated 2.5-times the odds of being associated with autoimmune positivity (OR 2.5, 1.34-4.55; P = 0.004). FMR1 genotypes offer a possible explanation for differences in IVF outcomes between races/ethnicities.	[Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.] CHR, New York, NY USA; [Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.] Fdn Reprod Med, New York, NY USA; [Gleicher, Norbert] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Weghofer, Andrea] Univ Vienna, Sch Med, Dept Gynecol Endocrinol & Reprod Med, Vienna, Austria; [Barad, David H.] Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10467 USA; [Barad, David H.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA	Yale University; University of Vienna; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gleicher, N (corresponding author), CHR, New York, NY USA.	ngleicher@thechr.com; dbarad@thechr.com	Barad, David/AAF-4332-2021		Foundation for Reproductive Medicine; Center for Human Reproduction (CHR)	Foundation for Reproductive Medicine; Center for Human Reproduction (CHR)	This work was supported by the Foundation for Reproductive Medicine, a not-for-profit research foundation, and intramural funds from the Center for Human Reproduction (CHR). CHR's principal contribution to the here reported (and other research efforts) is two-fold: It supplies clinical materials (patients, laboratory results, etc.) and it supplies financial support, both in way of facilities, staff and also in assuming outright expenses for many studies, which are not funded via extramural funds. As owner of CHR and as one of its principal investigators, NG is ultimately responsible for all economic decisions made at CHR.	Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7; Barad D, 2007, J ASSIST REPROD GEN, V24, P629, DOI 10.1007/s10815-007-9178-x; Barad DH, 2007, OBSTET GYNECOL, V109, P1404, DOI 10.1097/01.AOG.0000264065.37661.a0; BARAD DH, 2010, HUM REPROD S1, V25, P82; Barad DH, 2009, FERTIL STERIL, V92, pS105; Bodega B, 2006, HUM REPROD, V21, P952, DOI 10.1093/humrep/dei432; Bretherick KL, 2005, HUM GENET, V117, P376, DOI 10.1007/s00439-005-1326-8; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Dayal MB, 2009, FERTIL STERIL, V91, P2414, DOI 10.1016/j.fertnstert.2008.03.055; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Fujimoto VY, 2010, FERTIL STERIL, V93, P382, DOI 10.1016/j.fertnstert.2008.10.061; Gleicher N, 2002, HUM REPROD, V17, P539, DOI 10.1093/humrep/17.3.539; GLEICHER N, 2010, FERTIL STERIL   0602; GLEICHER N, 2010, PLOS ONE IN PRESS; Gleicher N, 2007, HUM REPROD, V22, P2879, DOI 10.1093/humrep/dem289; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Gleicher N, 2009, REPROD BIOMED ONLINE, V19, P385, DOI 10.1016/S1472-6483(10)60173-3; Gleicher N, 2009, HUM REPROD, V24, P2395, DOI 10.1093/humrep/dep256; Gleicher N, 2009, FERTIL STERIL, V91, P1707, DOI 10.1016/j.fertnstert.2008.01.099; Grainger DA, 2004, FERTIL STERIL, V82, pS37, DOI 10.1016/j.fertnstert.2004.07.098; Hagerman RJ, 2008, JAMA-J AM MED ASSOC, V300, P2419, DOI 10.1001/jama.2008.684; Huddleston HG, 2010, FERTIL STERIL, V94, P2059, DOI 10.1016/j.fertnstert.2009.11.019; Lamb JD, 2009, REPROD BIOMED ONLINE, V19, P252, DOI 10.1016/S1472-6483(10)60081-8; Langen ES, 2010, OBSTET GYNECOL, V115, P591, DOI 10.1097/AOG.0b013e3181cf45c1; Legro RS, 2006, FERTIL STERIL, V86, P914, DOI 10.1016/j.fertnstert.2006.03.037; Luborsky JL, 2003, HUM REPROD, V18, P199, DOI 10.1093/humrep/deg005; Marozzi A, 2000, HUM GENET, V107, P304, DOI 10.1007/s004390000364; Persani L, 2009, J AUTOIMMUN, V33, P35, DOI 10.1016/j.jaut.2009.03.004; Purcell K, 2007, FERTIL STERIL, V87, P297, DOI 10.1016/j.fertnstert.2006.06.031; Purcell KJ, 2004, FERTIL STERIL, V82, pS40, DOI 10.1016/j.fertnstert.2004.07.103; Seifer DB, 2008, FERTIL STERIL, V90, P1701, DOI 10.1016/j.fertnstert.2007.08.024; Seifer DB, 2010, FERTIL STERIL, V93, P626, DOI 10.1016/j.fertnstert.2009.02.084; Shahine LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007599; Wellons MF, 2008, FERTIL STERIL, V90, P1640, DOI 10.1016/j.fertnstert.2007.09.056; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004	36	52	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18781	10.1371/journal.pone.0018781	http://dx.doi.org/10.1371/journal.pone.0018781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526209	Green Published, Green Submitted, gold			2022-12-25	WOS:000289578600032
J	Lengyel, C; Orosz, A; Hegyi, P; Komka, Z; Udvardy, A; Bosnyak, E; Trajer, E; Pavlik, G; Toth, M; Wittmann, T; Papp, JG; Varro, A; Baczko, I				Lengyel, Csaba; Orosz, Andrea; Hegyi, Peter; Komka, Zsolt; Udvardy, Anna; Bosnyak, Edit; Trajer, Emese; Pavlik, Gabor; Toth, Miklos; Wittmann, Tibor; Papp, Julius Gy; Varro, Andras; Baczko, Istvan			Increased Short-Term Variability of the QT Interval in Professional Soccer Players: Possible Implications for Arrhythmia Prediction	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; TO-BEAT VARIABILITY; TORSADES-DE-POINTES; HEART-FAILURE; VENTRICULAR-ARRHYTHMIAS; CELLULAR BASIS; I-KS; REPOLARIZATION; BLOCK; DOGS	Background: Sudden cardiac death in competitive athletes is rare but it is significantly more frequent than in the normal population. The exact cause is seldom established and is mostly attributed to ventricular fibrillation. Myocardial hypertrophy and slow heart rate, both characteristic changes in top athletes in response to physical conditioning, could be associated with increased propensity for ventricular arrhythmias. We investigated conventional ECG parameters and temporal shortterm beat-to-beat variability of repolarization (STVQT), a presumptive novel parameter for arrhythmia prediction, in professional soccer players. Methods: Five-minute 12-lead electrocardiograms were recorded from professional soccer players (n = 76, all males, age 22.0 +/- 0.61 years) and age-matched healthy volunteers who do not participate in competitive sports (n = 76, all males, age 22.0 +/- 0.54 years). The ECGs were digitized and evaluated off-line. The temporal instability of beat-to-beat heart rate and repolarization were characterized by the calculation of short-term variability of the RR and QT intervals. Results: Heart rate was significantly lower in professional soccer players at rest (61 +/- 1.2 vs. 72 +/- 1.5/min in controls). The QT interval was prolonged in players at rest (419 +/- 3.1 vs. 390 +/- 3.6 in controls, p<0.001). QTc was significantly longer in players compared to controls calculated with Fridericia and Hodges correction formulas. Importantly, STVQT was significantly higher in players both at rest and immediately after the game compared to controls (4.8 +/- 0.14 and 4.3 +/- 0.14 vs. 3.5 +/- 0.10 ms, both p<0.001, respectively). Conclusions: STVQT is significantly higher in professional soccer players compared to age-matched controls, however, further studies are needed to relate this finding to increased arrhythmia propensity in this population.	[Lengyel, Csaba; Hegyi, Peter; Wittmann, Tibor] Univ Szeged, Fac Med, Dept Internal Med 1, Szeged, Hungary; [Orosz, Andrea; Papp, Julius Gy; Varro, Andras; Baczko, Istvan] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary; [Komka, Zsolt; Udvardy, Anna; Bosnyak, Edit; Trajer, Emese; Pavlik, Gabor; Toth, Miklos] Semmelweis Univ, Fac Phys Educ & Sports Sci, Dept Hlth Sci & Sports Med, Budapest, Hungary; [Papp, Julius Gy; Varro, Andras] Hungarian Acad Sci, Div Cardiovasc Pharmacol, Szeged, Hungary	Szeged University; Szeged University; Semmelweis University; Hungarian Academy of Sciences	Lengyel, C (corresponding author), Univ Szeged, Fac Med, Dept Internal Med 1, Szeged, Hungary.	ibaczko@phcol.szote.u-szeged.hu	Udvardy, Andor/AAA-1473-2022; Varro, Andras/M-2647-2016; Baczko, István/I-7752-2019	Baczko, István/0000-0002-9588-0797; Bosnyak, Edit/0000-0003-0632-4279; Orosz, Andrea/0000-0002-0750-4741	National Office for Research and Technology [NKTH CARDIO 08]; Hungarian Academy of Sciences; Hungarian Scientific Research Fund (OTKA) [CNK-77855]; European Commission [EUGeneHeart-LSHM-CT-2005-118833, preDiCT - DG-INFSO - 224381]	National Office for Research and Technology(National Office for Research and Technology); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the National Office for Research and Technology (NKTH CARDIO 08), Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to I. B. and Cs.L.), Hungarian Scientific Research Fund (OTKA CNK-77855) and by the European Commission grants (EUGeneHeart-LSHM-CT-2005-118833 and preDiCT - DG-INFSO - 224381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy WB, 2003, J AM COLL CARDIOL, V41, P280, DOI 10.1016/S0735-1097(02)02633-5; Abi-Gerges N, 2010, BRIT J PHARMACOL, V159, P77, DOI 10.1111/j.1476-5381.2009.00338.x; Akar FG, 2003, CIRC RES, V93, P638, DOI 10.1161/01.RES.0000092248.59479.AE; Atchley AE, 2007, CARDIOL CLIN, V25, P371, DOI 10.1016/j.ccl.2007.06.009; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Biffi A, 2004, J AM COLL CARDIOL, V44, P1053, DOI 10.1016/j.jacc.2004.05.065; CONSTABLE PD, 1994, J APPL PHYSIOL, V76, P433, DOI 10.1152/jappl.1994.76.1.433; Constable PD, 2000, AM J VET RES, V61, P582, DOI 10.2460/ajvr.2000.61.582; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2007, CARDIOL CLIN, V25, P391, DOI 10.1016/j.ccl.2007.07.008; Corrado D, 2008, J AM COLL CARDIOL, V52, P1981, DOI 10.1016/j.jacc.2008.06.053; DiFrancesco D, 2007, DRUGS, V67, P15, DOI 10.2165/00003495-200767002-00003; Fridericia LS, 1920, ACTA MED SCAND, V53, P489; Frolov RV, 2008, J BIOL CHEM, V283, P1518, DOI 10.1074/jbc.M708100200; Haigney MC, 2004, J AM COLL CARDIOL, V44, P1481, DOI 10.1016/j.jacc.2004.06.063; Hanton G., 2008, Journal of Pharmacological and Toxicological Methods, V57, P194, DOI 10.1016/j.vascn.2008.03.001; Hart G, 2003, EXP PHYSIOL, V88, P639, DOI 10.1113/eph8802619; Hinterseer M, 2008, EUR HEART J, V29, P185, DOI 10.1093/eurheartj/ehm586; Hinterseer M, 2010, AM J CARDIOL, V106, P216, DOI 10.1016/j.amjcard.2010.02.033; Hinterseer M, 2009, AM J CARDIOL, V103, P1244, DOI 10.1016/j.amjcard.2009.01.011; Indik JH, 2006, HEART RHYTHM, V3, P1003, DOI 10.1016/j.hrthm.2006.05.023; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Jost N, 2007, ANN NONINVAS ELECTRO, V12, P64, DOI 10.1111/j.1542-474X.2007.00140.x; Kavazis AN, 2009, SPORTS MED, V39, P923, DOI 10.2165/11317870-000000000-00000; Lengyel C, 2007, BRIT J PHARMACOL, V151, P941, DOI 10.1038/sj.bjp.0707297; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; Madias C, 2007, J CARDIOVASC ELECTR, V18, P115, DOI 10.1111/j.1540-8167.2006.00684.x; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; MARON BJ, 1980, CIRCULATION, V62, P218, DOI 10.1161/01.CIR.62.2.218; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nuss HB, 1999, AM J PHYSIOL-HEART C, V277, pH80, DOI 10.1152/ajpheart.1999.277.1.H80; PAOLO FM, 2007, CARDIOL CLIN, V25, P383; Parratt J, 1997, HEART, V78, P423, DOI 10.1136/hrt.78.5.423; Paylik G, 1996, Acta Physiol Hung, V84, P171; Pigozzi F, 2008, CLIN SPORT MED, V27, P153, DOI 10.1016/j.csm.2007.09.004; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Roden DM, 2005, CIRCULATION, V112, P1376, DOI 10.1161/CIRCULATIONAHA.105.562777; Rose J, 2005, AM J PHYSIOL-HEART C, V288, pH2077, DOI 10.1152/ajpheart.00526.2003; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; SHAPIRO LM, 1984, BRIT HEART J, V52, P130; So PS, 2008, BRIT J PHARMACOL, V155, P1185, DOI 10.1038/bjp.2008.354; Sperelakis N, 1996, MOL CELL BIOCHEM, V164, P85, DOI 10.1007/BF00408644; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Thomsen MB, 2004, CIRCULATION, V110, P2453, DOI 10.1161/01.CIR.0000145162.64183.C8; Thomsen MB, 2005, BASIC RES CARDIOL, V100, P279, DOI 10.1007/s00395-005-0519-6; Thomsen MB, 2007, CARDIOVASC RES, V73, P521, DOI 10.1016/j.cardiores.2006.11.025; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Vago H, 2010, CIRCULATION, V121, P2456, DOI 10.1161/CIRCULATIONAHA.109.917724; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Varro A, 2006, CARDIOVASC RES, V70, P404, DOI 10.1016/j.cardiores.2006.04.006; Varro A, 2010, PFLUG ARCH EUR J PHY, V460, P31, DOI 10.1007/s00424-010-0798-0; Volders PGA, 1999, CIRCULATION, V100, P2455, DOI 10.1161/01.CIR.100.24.2455; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Zitron E, 2005, CIRCULATION, V111, P835, DOI 10.1161/01.CIR.0000155617.54749.09; MOTHERWELL CAPTAIN O; BENFICA STRIKER DIES; CAM STAR FOE DIES CA	60	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18751	10.1371/journal.pone.0018751	http://dx.doi.org/10.1371/journal.pone.0018751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526208	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000289578600030
J	Papasergi, S; Brega, S; Mistou, MY; Firon, A; Oxaran, V; Dover, R; Teti, G; Shai, Y; Trieu-Cuot, P; Dramsi, S				Papasergi, Salvatore; Brega, Sara; Mistou, Michel-Yves; Firon, Arnaud; Oxaran, Virginie; Dover, Ron; Teti, Giuseppe; Shai, Yechiel; Trieu-Cuot, Patrick; Dramsi, Shaynoor			The GBS PI-2a Pilus Is Required for Virulence in Mice Neonates	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; STREPTOCOCCUS-AGALACTIAE; PROTEIN; SURFACE; SUSCEPTIBILITY; TRANSLOCATION; CONTRIBUTES; INVOLVEMENT; INFECTIONS; EXPRESSION	Background: Streptococcus agalactiae (Group B Streptococcus) is a leading cause of sepsis and meningitis in newborns. Most bacterial pathogens, including gram-positive bacteria, have long filamentous structures known as pili extending from their surface. Although pili are described as adhesive organelles, they have been also implicated in many other functions including thwarting the host immune responses. We previously characterized the pilus-encoding operon PI-2a (gbs14791474) in strain NEM316. This pilus is composed of three structural subunit proteins: PilA (Gbs1478), PilB (Gbs1477), and PilC (Gbs1474), and its assembly involves two class C sortases (SrtC3 and SrtC4). PilB, the bona fide pilin, is the major component whereas PilA, the pilus associated adhesin, and PilC the pilus anchor are both accessory proteins incorporated into the pilus backbone. Methodology/Principal Findings: In this study, the role of the major pilin subunit PilB was tested in systemic virulence using 6-weeks old and newborn mice. Notably, the non-piliated Delta pilB mutant was less virulent than its wild-type counterpart in the newborn mice model. Next, we investigated the possible role(s) of PilB in resistance to innate immune host defenses, i.e. resistance to macrophage killing and to antimicrobial peptides. Phagocytosis and survival of wild-type NEM316 and its isogenic Delta pilB mutant in immortalized RAW 264.7 murine macrophages were not significantly different whereas the isogenic Delta sodA mutant was more susceptible to killing. These results were confirmed using primary peritoneal macrophages. We also tested the activities of five cationic antimicrobial peptides (AMP-1D, LL-37, colistin, polymyxin B, and mCRAMP) and found no significant difference between WT and Delta pilB strains whereas the isogenic dltA mutant showed increased sensitivity. Conclusions/Significance: These results question the previously described role of PilB pilus in resistance to the host immune defenses. Interestingly, PilB was found to be important for virulence in the neonatal context.	[Papasergi, Salvatore; Brega, Sara; Mistou, Michel-Yves; Firon, Arnaud; Trieu-Cuot, Patrick; Dramsi, Shaynoor] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France; [Papasergi, Salvatore; Brega, Sara; Mistou, Michel-Yves; Firon, Arnaud; Trieu-Cuot, Patrick; Dramsi, Shaynoor] CNRS, URA 2172, Paris, France; [Papasergi, Salvatore; Teti, Giuseppe] Univ Messina, Elie Metchnikoff Dept, Messina, Italy; [Mistou, Michel-Yves] INRA, MICALIS, UMR 1319, Equipe Paroi, Jouy En Josas, France; [Oxaran, Virginie] INRA, MICALIS, UMR1319, Equipe Prot Surface Utiles, Jouy En Josas, France; [Dover, Ron; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Messina; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Weizmann Institute of Science	Papasergi, S (corresponding author), Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France.	shaynoor.dramsi@pasteur.fr	Mistou, Michel-Yves/AAY-2688-2021; papasergi, salvatore/AAE-8818-2021; Dover, Ron Saar/ABC-4574-2020	Brega, Sara/0000-0001-6378-842X; Oxaran, Virginie/0000-0001-6766-6497; Mistou, Michel-Yves/0000-0001-9732-3970; FIRON, Arnaud/0000-0002-5323-5212; TRIEU-CUOT, Patrick/0000-0002-2768-9587	Agence Nationale de la Recherche "ERA-NET PathoGenoMics" [ANR-06-PATHO-001-01]; Network of Excellence "Europathogenomics" [LSHB-CT-2005-512061]; WIS [720047]; National Institute of Health (NIH) [R01 AI052455-06A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052455] Funding Source: NIH RePORTER	Agence Nationale de la Recherche "ERA-NET PathoGenoMics"(French National Research Agency (ANR)); Network of Excellence "Europathogenomics"; WIS; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants ANR-06-PATHO-001-01 from the Agence Nationale de la Recherche "ERA-NET PathoGenoMics" (to P. T.-C.), LSHB-CT-2005-512061 from the Network of Excellence "Europathogenomics" (to P. T.-C. and S. P), and WIS Project Number 720047 from Pasteur-Weizmann (to P. T.-C. and Y. S). This work was also supported in part by funding from the *National Institute of Health (NIH) Grant R01 AI052455-06A1* to P. T.-C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Burns-Guydish SM, 2005, PEDIATR RES, V58, P153, DOI 10.1203/01.PDR.0000157725.44213.C4; Costakos Dennis T, 2009, WMJ, V108, P176; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Eichenbaum Z, 1998, APPL ENVIRON MICROB, V64, P2763; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; KREIKEMEYER B, 2010, INT J MED MICROBIOL; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Piard JC, 1997, J BACTERIOL, V179, P3068, DOI 10.1128/jb.179.9.3068-3072.1997; Poyart C, 2003, MOL MICROBIOL, V49, P1615, DOI 10.1046/j.1365-2958.2003.03655.x; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Poyart C, 2008, EMERG INFECT DIS, V14, P1647, DOI 10.3201/eid1410.080185; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rinaudo CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009216; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Sambrook J, 1989, MOL CLONING LABORATO; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Sillanpaa J, 2009, J CLIN MICROBIOL, V47, P896, DOI 10.1128/JCM.02283-08; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Urao M, 1996, J PEDIATR SURG, V31, P1482, DOI 10.1016/S0022-3468(96)90160-8; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987	42	23	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18747	10.1371/journal.pone.0018747	http://dx.doi.org/10.1371/journal.pone.0018747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525979	Green Published, gold, Green Submitted			2022-12-25	WOS:000289578600027
J	Huang, TT; Liu, FG; Wei, CF; Lu, CC; Chen, CC; Lin, HC; Ojcius, DM; Lai, HC				Huang, Tsung-Teng; Liu, Fu-Guo; Wei, Chia-Fong; Lu, Chia-Chen; Chen, Chang-Chieh; Lin, Hung-Chi; Ojcius, David M.; Lai, Hsin-Chih			Activation of Multiple Apoptotic Pathways in Human Nasopharyngeal Carcinoma Cells by the Prenylated Isoflavone, Osajin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MACLURA-POMIFERA; CANCER; DEATH; BCL-2; TUMOR; FLAVONOIDS; INDUCTION; LINES; BAX	Osajin is a prenylated isoflavone showing antitumor activity in different tumor cell lines. The underlying mechanism of osajin-induced cancer cell death is not clearly understood. In the present study, the mechanisms of osajin-induced cell death of human nasopharyngeal carcinoma (NPC) cells were explored. Osajin was found to significantly induce apoptosis of NPC cells in a dose-and time-dependent manner. Multiple molecular effects were observed during osajin treatment including a significant loss of mitochondrial transmembrane potential, release of cytochrome c into the cytosol, enhanced expression of Fas ligand (FasL), suppression of glucose-regulated protein 78 kDa (GRP78), and activation of caspases-9, -8, -4 and -3. In addition, up-regulation of proapoptotic Bax protein and down-regulation of antiapoptotic Bcl-2 protein were also observed. Taken together, osajin induces apoptosis in human NPC cells through multiple apoptotic pathways, including the extrinsic death receptor pathway, and intrinsic pathways relying on mitochondria and endoplasmic reticulum stress. Thus, osajin could be developed as a new effective and chemopreventive compound for human NPC.	[Huang, Tsung-Teng; Liu, Fu-Guo] Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan; [Wei, Chia-Fong; Chen, Chang-Chieh; Lin, Hung-Chi; Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.; Lai, Hsin-Chih] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan	National Central University; Chang Gung University; Fu Jen Catholic University; University of California System; University of California Merced; University of California System; University of California Merced; Chang Gung University	Huang, TT (corresponding author), Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan.	liur@cc.ncu.edu.tw; dojcius@ucmerced.edu; hclai@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council [NSC96-2628-B-033-MY3]; Chang Gung Memorial Hospital [CMRPD160273]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council (NSC96-2628-B-033-MY3) and Chang Gung Memorial Hospital (CMRPD160273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bellosillo B, 2002, BLOOD, V100, P1810, DOI 10.1182/blood-2001-12-0327; Breitschopf K, 2000, J BIOL CHEM, V275, P21648, DOI 10.1074/jbc.M001083200; CHANG YS, 1989, CANCER RES, V49, P6752; Chen GG, 2002, CLIN EXP METASTAS, V19, P457, DOI 10.1023/A:1016336724463; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Erkal HS, 2001, RADIOTHER ONCOL, V61, P247, DOI 10.1016/S0167-8140(01)00448-0; Fadeel B, 1997, INT IMMUNOL, V9, P201, DOI 10.1093/intimm/9.2.201; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Florian Tomas, 2006, Biomedical Papers (Olomouc), V150, P93; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Konopleva M, 2002, LEUKEMIA, V16, P1713, DOI 10.1038/sj.leu.2402608; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Licitra L, 2003, CRIT REV ONCOL HEMAT, V45, P199, DOI 10.1016/S1040-8428(01)00210-4; LIN CT, 1990, LAB INVEST, V62, P713; LIN CT, 1993, LAB INVEST, V68, P716; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; METHA U, 2002, GEN PHYSL BIOPHYS, V21, P15; Michels G, 2005, TOXICOLOGY, V206, P337, DOI 10.1016/j.tox.2004.07.022; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nishino H, 2004, BIOFACTORS, V22, P57, DOI 10.1002/biof.5520220110; O'Sullivan B, 2007, INT J RADIAT ONCOL, V69, pS118, DOI 10.1016/j.ijrobp.2007.04.085; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Roy S, 2000, J EXP MED, V192, pF21, DOI 10.1084/jem.192.8.F21; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Son IH, 2007, BIOORG MED CHEM LETT, V17, P4753, DOI 10.1016/j.bmcl.2007.06.060; Spano JP, 2003, EUR J CANCER, V39, P2121, DOI 10.1016/S0959-8049(03)00367-8; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tombal B, 2000, PROSTATE, V43, P303; Tsao R, 2003, J AGR FOOD CHEM, V51, P6445, DOI 10.1021/jf0342369; Van Hoorn DEC, 2002, EUR J PHARMACOL, V451, P111, DOI 10.1016/S0014-2999(02)02192-1; Vesela D, 2004, FITOTERAPIA, V75, P209, DOI 10.1016/j.fitote.2003.12.005; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451	52	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18308	10.1371/journal.pone.0018308	http://dx.doi.org/10.1371/journal.pone.0018308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532751	Green Published, gold, Green Submitted			2022-12-25	WOS:000289404700010
J	Wang, GZ; Lercher, MJ				Wang, Guang-Zhong; Lercher, Martin J.			The Effects of Network Neighbours on Protein Evolution	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SIMPLE DEPENDENCE; NUMBER; COEVOLUTION; EXPRESSION	Interacting proteins may often experience similar selection pressures. Thus, we may expect that neighbouring proteins in biological interaction networks evolve at similar rates. This has been previously shown for protein-protein interaction networks. Similarly, we find correlated rates of evolution of neighbours in networks based on co-expression, metabolism, and synthetic lethal genetic interactions. While the correlations are statistically significant, their magnitude is small, with network effects explaining only between 2% and 7% of the variation. The strongest known predictor of the rate of protein evolution remains expression level. We confirmed the previous observation that similar expression levels of neighbours indeed explain their similar evolution rates in protein-protein networks, and showed that the same is true for metabolic networks. In co-expression and synthetic lethal genetic interaction networks, however, neighbouring genes still show somewhat similar evolutionary rates even after simultaneously controlling for expression level, gene essentiality and gene length. Thus, similar expression levels and related functions (as inferred from co-expression and synthetic lethal interactions) seem to explain correlated evolutionary rates of network neighbours across all currently available types of biological networks.	[Wang, Guang-Zhong; Lercher, Martin J.] Univ Dusseldorf, Inst Comp Sci, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Wang, GZ (corresponding author), Univ Dusseldorf, Inst Comp Sci, Dusseldorf, Germany.	lercher@cs.uni-duesseldorf.de	Lercher, Martin/K-7939-2013	Lercher, Martin/0000-0003-3940-1621				Agrafioti I, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-23; [Anonymous], 2010, R LANG ENV STAT COMP; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Batada NN, 2007, PLOS BIOL, V5, P1202, DOI 10.1371/journal.pbio.0050154; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bloom JD, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-14; Bloom JD, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-21; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Jovelin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r35; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Juan D, 2008, FEBS LETT, V582, P1225, DOI 10.1016/j.febslet.2008.02.017; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Lin YS, 2007, MOL BIOL EVOL, V24, P1005, DOI 10.1093/molbev/msm019; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; Madaoui H, 2008, P NATL ACAD SCI USA, V105, P7708, DOI 10.1073/pnas.0707032105; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Pal C, 2001, GENETICS, V158, P927; Saeed R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-128; Tillier ERM, 2009, GENOME RES, V19, P1861, DOI 10.1101/gr.092452.109; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; [No title captured]	42	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18288	10.1371/journal.pone.0018288	http://dx.doi.org/10.1371/journal.pone.0018288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532755	gold, Green Submitted, Green Published			2022-12-25	WOS:000289404700009
J	Almendinger, J; Doukoumetzidis, K; Kinchen, JM; Kaech, A; Ravichandran, KS; Hengartner, MO				Almendinger, Johann; Doukoumetzidis, Kimon; Kinchen, Jason M.; Kaech, Andres; Ravichandran, Kodi S.; Hengartner, Michael O.			A Conserved Role for SNX9-Family Members in the Regulation of Phagosome Maturation during Engulfment of Apoptotic Cells	PLOS ONE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; DEGRADATION; REMOVAL; PROMOTES; MUTATION; RECEPTOR; DOMAINS; PATHWAY; NEUROPATHY	Clearance of apoptotic cells is of key importance during development, tissue homeostasis and wound healing in multicellular animals. Genetic studies in the nematode Caenorhabditis elegans have identified a set of genes involved in the early steps of cell clearance, in particular the recognition and internalization of apoptotic cells. A pathway that orchestrates the maturation of phagosomes containing ingested apoptotic cells in the worm has recently been described. However, many steps in this pathway remain elusive. Here we show that the C. elegans SNX9-family member LST-4 (lateral signaling target) and its closest mammalian orthologue SNX33 play an evolutionary conserved role during apoptotic cell corpse clearance. In lst-4 deficient worms, internalized apoptotic cells accumulated within non-acidified, DYN-1-positive but RAB-5-negative phagosomes. Genetically, we show that LST-4 functions at the same step as DYN-1 during corpse removal, upstream of the GTPase RAB-5. We further show that mammalian SNX33 rescue C. elegans lst-4 mutants and that overexpression of truncated SNX33 fragments interfered with phagosome maturation in a mammalian cell system. Taken together, our genetic and cell biological analyses suggest that LST-4 is recruited through a combined activity of DYN-1 and VPS-34 to the early phagosome membrane, where it cooperates with DYN-1 to promote recruitment/retention of RAB-5 on the early phagosomal membrane during cell corpse clearance. The functional conservation between LST-4 and SNX33 indicate that these early steps of apoptotic phagosome maturation are likely conserved through evolution.	[Almendinger, Johann; Doukoumetzidis, Kimon; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA USA; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Kaech, Andres] Univ Zurich, Ctr Microscopy & Image Anal, Zurich, Switzerland; [Almendinger, Johann] UZH ETHZ, Life Sci Zurich Grad Sch, Mol Life Sci PhD Program, Zurich, Switzerland	University of Zurich; University of Virginia; University of Virginia; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Almendinger, J (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	johann.almendinger@imls.uzh.ch	Kinchen, Jason/ABC-5663-2021; Hengartner, Michael O/E-6235-2011	Hengartner, Michael/0000-0002-7584-596X; Kinchen, Jason/0000-0001-8430-2265; Ravichandran, Kodi/0000-0001-9049-1410	Kanton of Zurich; Swiss National Science Foundation; Ernst Hadorn Foundation; National Institutes of Health; American Heart Association	Kanton of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ernst Hadorn Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the Kanton of Zurich, the Swiss National Science Foundation and the Ernst Hadorn Foundation (MOH), grants from the National Institutes of Health (KSR) and a Scientist Development Grant from the American Heart Association (JMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieri T, 2007, NUCLEIC ACIDS RES, V35, pD506, DOI 10.1093/nar/gkl818; BRENNER S, 1974, GENETICS, V77, P71; Cabello J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000297; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; He B, 2010, MOL BIOL CELL, V21, P610, DOI 10.1091/mbc.E09-05-0440; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Houlden H, 2004, ANN NEUROL, V56, P586, DOI 10.1002/ana.20281; Hurwitz ME, 2009, PLOS BIOL, V7, P876, DOI 10.1371/journal.pbio.1000099; Huynh KK, 2008, CURR BIOL, V18, pR563, DOI 10.1016/j.cub.2008.05.032; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; KINCHEN JM, 2010, NATURE; KINCHEN JM, 2010, APOPTOSIS; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Lettre G, 2004, CELL DEATH DIFFER, V11, P1198, DOI 10.1038/sj.cdd.4401488; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; LU N, 2010, MOL BIOL CELL; Lu Q, 2008, DEVELOPMENT, V135, P1069, DOI 10.1242/dev.016063; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; Meggouh F, 2006, NEUROLOGY, V67, P1476, DOI 10.1212/01.wnl.0000240068.21499.f5; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Neukomm LJ, 2011, NAT CELL BIOL, V13, P79, DOI 10.1038/ncb2138; Nieto C, 2010, J CELL SCI, V123, P2000, DOI 10.1242/jcs.062331; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Peplowska K, 2008, NAT CELL BIOL, V10, P759, DOI 10.1038/ncb0708-759; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Yarar D, 2008, TRAFFIC, V9, P133, DOI 10.1111/j.1600-0854.2007.00675.x; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zhou Z, 2008, TRENDS CELL BIOL, V18, P474, DOI 10.1016/j.tcb.2008.08.002	49	24	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18325	10.1371/journal.pone.0018325	http://dx.doi.org/10.1371/journal.pone.0018325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494661	Green Published, Green Submitted, gold			2022-12-25	WOS:000289292800009
J	Varcoe, TJ; Wight, N; Voultsios, A; Salkeld, MD; Kennaway, DJ				Varcoe, Tamara J.; Wight, Nicole; Voultsios, Athena; Salkeld, Mark D.; Kennaway, David J.			Chronic Phase Shifts of the Photoperiod throughout Pregnancy Programs Glucose Intolerance and Insulin Resistance in the Rat	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; PITUITARY-ADRENAL AXIS; PRENATAL STRESS; BODY-WEIGHT; ADULT RATS; GLUCOCORTICOID EXPOSURE; BEHAVIORAL ALTERATIONS; LATE-GESTATION; DIABETIC-RATS; BIRTH-WEIGHT	Shift work during pregnancy is associated with an increased risk for preterm birth and low birth weight. However, the impact upon the long term health of the children is currently unknown. In this study, we used an animal model to determine the consequences of maternal shift work exposure on the health of the adult offspring. Pregnant rats were exposed to chronic phase shifts (CPS) in their photoperiod every 3-4 days throughout gestation and the first week after birth. Adult offspring were assessed for a range of metabolic, endocrine, circadian and neurobehavioural parameters. At 3 months of age, male pups exposed to the CPS schedule in utero had increased adiposity (+29%) and hyperleptinaemia (+99% at 0700h). By 12 months of age, both male and female rats displayed hyperleptinaemia (+26% and +41% respectively) and hyperinsulinaemia (+110% and +83% respectively). 12 month old female CPS rats displayed poor glucose tolerance (+18%) and increased insulin secretion (+29%) in response to an intraperitoneal glucose tolerance test. In CPS males the glucose response was unaltered, but the insulin response was reduced by 35%. The glucose response to an insulin tolerance test was decreased by 21% in CPS females but unaltered in males. Disruption of circadian rhythmicity during gestation resulted in gender dependent metabolic consequences for the adult offspring. These results highlight the need for a thorough analysis of shift work exposure in utero on the health of the adult offspring in humans.	[Varcoe, Tamara J.; Wight, Nicole; Voultsios, Athena; Salkeld, Mark D.; Kennaway, David J.] Univ Adelaide, Res Ctr Reprod Hlth, Robinson Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Varcoe, TJ (corresponding author), Univ Adelaide, Res Ctr Reprod Hlth, Robinson Inst, Adelaide, SA, Australia.	tamara.varcoe@adelaide.edu.au	Kennaway, David J/B-8955-2009; Varcoe, Tamara/H-2785-2014	Kennaway, David J/0000-0002-5864-3514; Varcoe, Tamara/0000-0002-9462-1830	Women's and Children's Hospital Foundation	Women's and Children's Hospital Foundation	This project was funded through a project grant to TJV from the Women's and Children's Hospital Foundation (http://www.wchfoundation.org.au/Contentaspx?p=120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2007, NEUROSCI RES, V59, P145, DOI 10.1016/j.neures.2007.06.1465; Aerts L, 1997, DIABETES RES CLIN PR, V38, P9, DOI 10.1016/S0168-8227(97)00080-6; Ain R, 2005, J ENDOCRINOL, V185, P253, DOI 10.1677/joe.1.06039; Cabrera RJ, 1999, BRAZ J MED BIOL RES, V32, P1229, DOI 10.1590/S0100-879X1999001000009; Carrapato MRG, 2003, J PERINAT MED, V31, P5, DOI 10.1515/JPM.2003.001; Choi GY, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.024; D'mello AP, 2006, PSYCHONEUROENDOCRINO, V31, P395, DOI 10.1016/j.psyneuen.2005.10.003; Desai M, 1997, AM J PHYSIOL-GASTR L, V273, pG899, DOI 10.1152/ajpgi.1997.273.4.G899; Drago F, 1999, EUR NEUROPSYCHOPHARM, V9, P239, DOI 10.1016/S0924-977X(98)00032-7; Dumont M, 2001, J BIOL RHYTHM, V16, P502, DOI 10.1177/074873001129002178; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Estanislau C, 2005, BEHAV BRAIN RES, V163, P70, DOI 10.1016/j.bbr.2005.04.003; Ferguson SA, 2000, NEUROREPORT, V11, P1539, DOI 10.1097/00001756-200005150-00034; GAUGUIER D, 1990, DIABETES, V39, P734, DOI 10.2337/diabetes.39.6.734; Gerardin DCC, 2005, PHYSIOL BEHAV, V84, P97, DOI 10.1016/j.physbeh.2004.10.014; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; HOLEMANS K, 1991, DIABETOLOGIA, V34, P81, DOI 10.1007/BF00500377; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P221, DOI 10.1016/0892-0362(92)90020-B; Jin LZ, 2004, J OCCUP ENVIRON MED, V46, P1144, DOI 10.1097/01.jom.0000145168.21614.21; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Joseph V, 2002, J PHYSIOL-LONDON, V543, P387, DOI 10.1113/jphysiol.2002.022236; Kennaway DJ, 2001, J PINEAL RES, V30, P188, DOI 10.1034/j.1600-079X.2001.300308.x; Kiss ACI, 2009, DIABETOL METAB SYNDR, V1, DOI 10.1186/1758-5996-1-21; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Koehl M, 1999, J NEUROBIOL, V40, P302, DOI 10.1002/(SICI)1097-4695(19990905)40:3<302::AID-NEU3>3.0.CO;2-7; Kofman O, 2002, NEUROSCI BIOBEHAV R, V26, P457, DOI 10.1016/S0149-7634(02)00015-5; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Lawson CC, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.006; Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291; LETURQUE A, 1984, AM J PHYSIOL, V246, pE25, DOI 10.1152/ajpendo.1984.246.1.E25; MCDONALD AD, 1988, BRIT J IND MED, V45, P56; Merzouk H, 2001, J LIPID RES, V42, P1152; MUNOZ C, 1995, BIOL NEONATE, V68, P282, DOI 10.1159/000244248; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; OH W, 1988, METABOLISM, V37, P1146, DOI 10.1016/0026-0495(88)90192-8; OROZCOSOLIS R, 2010, INT J OBES LOND; Patin V, 2002, DEV BRAIN RES, V139, P1, DOI 10.1016/S0165-3806(02)00491-1; Saito FH, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-26; Soulimane-Mokhtari NA, 2005, CLIN SCI, V109, P287, DOI 10.1042/CS20050028; Sugden MC, 2002, J ENDOCRINOL, V175, P757, DOI 10.1677/joe.0.1750757; Sutton GM, 2010, ENDOCRINOLOGY, V151, P1570, DOI 10.1210/en.2009-1133; SZANTOOVA K, 2010, MOL CELL BIOCH; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Thompson BL, 2009, NAT REV NEUROSCI, V10, P303, DOI 10.1038/nrn2598; Tsai LL, 2005, AM J PHYSIOL-ENDOC M, V289, pE212, DOI 10.1152/ajpendo.00603.2004; Whelan EA, 2007, EPIDEMIOLOGY, V18, P350, DOI 10.1097/01.ede.0000259988.77314.a4; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhu JL, 2004, AM J OBSTET GYNECOL, V191, P285, DOI 10.1016/j.ajog.2003.12.002; 2006, AUSTR BUREAU STAT, P6342	50	76	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18504	10.1371/journal.pone.0018504	http://dx.doi.org/10.1371/journal.pone.0018504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494686	Green Published, Green Submitted, gold			2022-12-25	WOS:000289192400033
J	Zhou, L; Opalinska, J; Sohal, D; Yu, YT; Mo, YK; Bhagat, T; Abdel-Wahab, O; Fazzari, M; Figueroa, M; Alencar, C; Zhang, JH; Kambhampati, S; Parmar, S; Nischal, S; Hueck, C; Suzuki, M; Freidman, E; Pellagatti, A; Boultwood, J; Steidl, U; Sauthararajah, Y; Yajnik, V; Mcmahon, C; Gore, SD; Platanias, LC; Levine, R; Melnick, A; Wickrema, A; Greally, JM; Vermaa, A				Zhou, Li; Opalinska, Joanna; Sohal, Davendra; Yu, Yiting; Mo, Yongkai; Bhagat, Tushar; Abdel-Wahab, Omar; Fazzari, Melissa; Figueroa, Maria; Alencar, Cristina; Zhang, Jinghang; Kambhampati, Suman; Parmar, Simrit; Nischal, Sangeeta; Hueck, Christoph; Suzuki, Masako; Freidman, Ellen; Pellagatti, Andrea; Boultwood, Jacqueline; Steidl, Ulrich; Sauthararajah, Yogen; Yajnik, Vijay; Mcmahon, Christine; Gore, Steven D.; Platanias, Leonidas C.; Levine, Ross; Melnick, Ari; Wickrema, Amittha; Greally, John M.; Vermaa, Amit			Aberrant Epigenetic and Genetic Marks Are Seen in Myelodysplastic Leukocytes and Reveal Dock4 as a Candidate Pathogenic Gene on Chromosome 7q	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; CYTOSINE METHYLATION; EXPRESSION PROFILES; POOR-PROGNOSIS; CD34(+) CELLS; LEUKEMIA; KINASE; HYPERMETHYLATION; PREDICTS; CANCER	Myelodysplastic syndromes (MDS) are characterized by abnormal and dysplastic maturation of all blood lineages. Even though epigenetic alterations have been seen in MDS marrow progenitors, very little is known about the molecular alterations in dysplastic peripheral blood cells. We analyzed the methylome of MDS leukocytes by the HELP assay and determined that it was globally distinct from age-matched controls and was characterized by numerous novel, aberrant hypermethylated marks that were located mainly outside of CpG islands and preferentially affected GTPase regulators and other cancer-related pathways. Additionally, array comparative genomic hybridization revealed that novel as well as previously characterized deletions and amplifications could also be visualized in peripheral blood leukocytes, thus potentially reducing the need for bone marrow samples for future studies. Using integrative analysis, potentially pathogenic genes silenced by genetic deletions and aberrant hypermethylation in different patients were identified. DOCK4, a GTPase regulator located in the commonly deleted 7q31 region, was identified by this unbiased approach. Significant hypermethylation and reduced expression of DOCK4 in MDS bone marrow stem cells was observed in two large independent datasets, providing further validation of our findings. Finally, DOCK4 knockdown in primary marrow CD34(+) stem cells led to decreased erythroid colony formation and increased apoptosis, thus recapitulating the bone marrow failure seen in MDS. These findings reveal widespread novel epigenetic alterations in myelodysplastic leukocytes and implicate DOCK4 as a pathogenic gene located on the 7q chromosomal region.	[Zhou, Li; Opalinska, Joanna; Sohal, Davendra; Yu, Yiting; Mo, Yongkai; Bhagat, Tushar; Fazzari, Melissa; Alencar, Cristina; Zhang, Jinghang; Nischal, Sangeeta; Hueck, Christoph; Suzuki, Masako; Freidman, Ellen; Steidl, Ulrich; Mcmahon, Christine; Greally, John M.; Vermaa, Amit] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Abdel-Wahab, Omar; Levine, Ross] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Figueroa, Maria; Melnick, Ari] Weill Cornell Med Sch, New York, NY 10065 USA; [Kambhampati, Suman] Kansas City Vet Affairs Med Ctr, Kansas City, MO 64128 USA; [Parmar, Simrit] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Pellagatti, Andrea; Boultwood, Jacqueline] John Radcliffe Hosp, Oxford OX3 9DU, England; [Wickrema, Amittha] Univ Chicago, Sch Med, Chicago, IL 60637 USA; [Sauthararajah, Yogen] Cleveland Clin, Cleveland, OH 44195 USA; [Yajnik, Vijay] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Gore, Steven D.] Johns Hopkins Univ Hosp, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA	Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Texas System; UTMD Anderson Cancer Center; University of Oxford; University of Chicago; Cleveland Clinic Foundation; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Greally, JM (corresponding author), Albert Einstein Coll Med, Bronx, NY 10461 USA.	john.greally@einstein.yu.edu; amit.verma@einstein.yu.edu	Greally, John/AAF-9540-2019; Suzuki, Masako/ABF-6497-2020; Melnick, Ari/AAA-5763-2020; levine, ross/AAE-7658-2019; Figueroa, Maria/AAE-8662-2019	Greally, John/0000-0001-6069-7960; Suzuki, Masako/0000-0003-0605-9225; Fazzari, Melissa/0000-0002-5674-3589; Pellagatti, Andrea/0000-0002-6122-0221; Boultwood, Jacqueline/0000-0002-4330-2928; Abdel-Wahab, Omar/0000-0002-3907-6171; Figueroa, Maria Eugenia/0000-0003-4887-4981	National Institutes of Health [RO1HL082846, RO1AG02913801, CA009173]; American Cancer Society; Gabrielle Angel Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Gabrielle Angel Foundation	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL082846, RO1AG02913801, and CA009173. This work was also supported by American Cancer Society, Partnership for Cures grant and the Gabrielle Angel Foundation.	Aggerholm A, 2006, EUR J HAEMATOL, V76, P23, DOI 10.1111/j.1600-0609.2005.00559.x; Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Breit S, 2004, BRIT J HAEMATOL, V126, P231, DOI 10.1111/j.1365-2141.2004.05017.x; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Christiansen DH, 2003, LEUKEMIA, V17, P1813, DOI 10.1038/sj.leu.2403054; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Figueroa ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001882; Gondek LP, 2008, BLOOD, V111, P1534, DOI 10.1182/blood-2007-05-092304; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Li YZ, 2004, J BIOL CHEM, V279, P970, DOI 10.1074/jbc.M309927200; Liang H, 2005, CANCER GENET CYTOGEN, V162, P151, DOI 10.1016/j.cancergencyto.2005.03.019; Mohamedali A, 2007, BLOOD, V110, P3365, DOI 10.1182/blood-2007-03-079673; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oswald J, 2006, STEM CELLS, V24, P494, DOI 10.1634/stemcells.2005-0276; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Soderholm J, 1997, LEUKEMIA, V11, P352, DOI 10.1038/sj.leu.2400584; Sohal D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002965; Starczynowski DT, 2008, BLOOD, V112, P3412, DOI 10.1182/blood-2007-11-122028; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Zhou L, 2008, BLOOD, V112, P3434, DOI 10.1182/blood-2008-02-139824	44	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25211	25223		10.1074/jbc.M111.235028	http://dx.doi.org/10.1074/jbc.M111.235028			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21532034	Green Published, hybrid			2022-12-25	WOS:000292547900067
J	Nelson, O; Supnet, C; Tolia, A; Horre, K; De Strooper, B; Bezprozvanny, I				Nelson, Omar; Supnet, Charlene; Tolia, Alexandra; Horre, Katrien; De Strooper, Bart; Bezprozvanny, Ilya			Mutagenesis Mapping of the Presenilin 1 Calcium Leak Conductance Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; AMYLOID PRECURSOR PROTEIN; DISEASE-LINKED MUTATIONS; ALZHEIMERS-DISEASE; CATALYTIC PORE; IN-VIVO; COMPLEX; SITE; ENDOPROTEOLYSIS; RECONSTITUTION	Missense mutations in presenilin 1 (PS1) and presenilin 2 (PS2) proteins are a major cause of familial Alzheimer disease. Presenilins are proteins with nine transmembrane (TM) domains that function as catalytic subunits of the gamma-secretase complex responsible for the cleavage of the amyloid precursor protein and other type I transmembrane proteins. The water-filled cavity within presenilin is necessary to mediate the intramembrane proteolysis reaction. Consistent with this idea, cysteine-scanning mutagenesis and NMR studies revealed a number of water-accessible residues within TM7 and TM9 of mouse PS1. In addition to gamma-secretase function, presenilins also demonstrate a low conductance endoplasmic reticulum Ca2+ leak function, and many familial Alzheimer disease presenilin mutations impair this function. To map the potential Ca2+ conductance pore in PS1, we systematically evaluated endoplasmic reticulum Ca2+ leak activity supported by a series of cysteine point mutants in TM6, TM7, and TM9 of mouse PS1. The results indicate that TM7 and TM9, but not TM6, could play an important role in forming the conductance pore of PS1. These results are consistent with previous cysteine-scanning mutagenesis and NMR analyses of PS1 and provide further support for our hypothesis that the hydrophilic catalytic cavity of presenilins may also constitute a Ca2+ conductance pore.	[Nelson, Omar; Supnet, Charlene; Bezprozvanny, Ilya] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Tolia, Alexandra; Horre, Katrien; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Tolia, Alexandra; Horre, Katrien; De Strooper, Bart] VIB, Dept Mol & Dev Genet, B-3000 Leuven, Belgium	University of Texas System; University of Texas Southwestern Medical Center Dallas; KU Leuven; Flanders Institute for Biotechnology (VIB)	Bezprozvanny, I (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, ND12-200AA, Dallas, TX 75390 USA.	ilya.bezprozvanny@utsouthwestern.edu	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; Supnet, Charlene/0000-0001-6917-770X; Horre, Katrien/0000-0002-6801-3137	National Institutes of Health [R01AG030746, F31]; King Foundation; McKnight Brain Disorders award; Flemish Government; Katholieke Universiteit Leuven; Fund for Scientific Research (Flanders, Belgium); Federal Office for Scientific Affairs (Belgium) [IUAP P6/43]; Division of Basic Science; NATIONAL INSTITUTE ON AGING [R01AG030746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King Foundation; McKnight Brain Disorders award; Flemish Government(European Commission); Katholieke Universiteit Leuven(KU Leuven); Fund for Scientific Research (Flanders, Belgium)(FWO); Federal Office for Scientific Affairs (Belgium); Division of Basic Science; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG030746 (to I. B.). This work was also supported by a King Foundation award and a McKnight Brain Disorders award (to I. B.), a Methusalem grant from the Flemish Government and the Katholieke Universiteit Leuven, the Fund for Scientific Research (Flanders, Belgium), and the Federal Office for Scientific Affairs (IUAP P6/43, Belgium).; Supported by a Division of Basic Science training grant and a National Institutes of Health predoctoral fellowship award for minority students (F31). Present address: Dept. of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136.	Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Cervantes S, 2001, FEBS LETT, V505, P81, DOI 10.1016/S0014-5793(01)02785-5; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Hebert SS, 2003, BIOCHEM BIOPH RES CO, V301, P119, DOI 10.1016/S0006-291X(02)02984-4; Herl L, 2006, BIOCHEM BIOPH RES CO, V340, P668, DOI 10.1016/j.bbrc.2005.12.063; Hofer AM, 1999, METH MOL B, V114, P249; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; Khandelwal A, 2007, P NATL ACAD SCI USA, V104, P13337, DOI 10.1073/pnas.0702038104; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nelson O, 2010, J ALZHEIMERS DIS, V21, P781, DOI 10.3233/JAD-2010-100159; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010	43	56	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22339	22347		10.1074/jbc.M111.243063	http://dx.doi.org/10.1074/jbc.M111.243063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531718	hybrid, Green Published			2022-12-25	WOS:000291719900043
J	Van Montfort, T; Melchers, M; Isik, G; Menis, S; Huang, PS; Matthews, K; Michael, E; Berkhout, B; Schief, WR; Moore, JP; Sanders, RW				Van Montfort, Thijs; Melchers, Mark; Isik, Goezde; Menis, Sergey; Huang, Po-Ssu; Matthews, Katie; Michael, Elizabeth; Berkhout, Ben; Schief, William R.; Moore, John P.; Sanders, Rogier W.			A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODIES; DNA VACCINE; IMMUNE-RESPONSES; MONOCLONAL-ANTIBODIES; MACAQUE MONKEYS; MOUTH-DISEASE; DOUBLE-BLIND; TNF-ALPHA; GP120	An effective HIV-1 vaccine should ideally induce strong humoral and cellular immune responses that provide sterilizing immunity over a prolonged period. Current HIV-1 vaccines have failed in inducing such immunity. The viral envelope glycoprotein complex (Env) can be targeted by neutralizing antibodies to block infection, but several Env properties limit the ability to induce an antibody response of sufficient quantity and quality. We hypothesized that Env immunogenicity could be improved by embedding an immunostimulatory protein domain within its sequence. A stabilized Env trimer was therefore engineered with the granulocyte-macrophage colony-stimulating factor (GM-CSF) inserted into the V1V2 domain of gp120. Probing with neutralizing antibodies showed that both the Env and GM-CSF components of the chimeric protein were folded correctly. Furthermore, the embedded GM-CSF domain was functional as a cytokine in vitro. Mouse immunization studies demonstrated that chimeric Env(GM-CSF) enhanced Env-specific antibody and T cell responses compared with wild-type Env. Collectively, these results show that targeting and activation of immune cells using engineered cytokine domains within the protein can improve the immunogenicity of Env subunit vaccines.	[Van Montfort, Thijs; Melchers, Mark; Isik, Goezde; Berkhout, Ben; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Menis, Sergey; Huang, Po-Ssu; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Matthews, Katie; Michael, Elizabeth; Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Washington; University of Washington Seattle; Cornell University	Sanders, RW (corresponding author), Meibergdreef 15, NL-1100 DE Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl	Schief, William/ABF-3645-2020	Schief, William/0000-0002-1120-0150; Isik, Gozde/0000-0002-1329-6782; Huang, Possu/0000-0002-7948-2895	National Institutes of Health [AI36082, AI45463]; AIDS Fund (Amsterdam) [2008013, 2009012, 2005021]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045463, R37AI036082, R01AI036082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Fund (Amsterdam); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI36082 and AI45463 (to J. P. M.). This work was also supported by Grants 2008013 and 2009012 (to R. W. S.) and 2005021 (to B. B.) from the AIDS Fund (Amsterdam) and by the International AIDS Vaccine Initiative.	ALMOND N, 1995, LANCET, V345, P1342, DOI 10.1016/S0140-6736(95)92540-6; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2002, J IMMUNOL, V168, P562, DOI 10.4049/jimmunol.168.2.562; Binley JM, 2010, J VIROL, V84, P5637, DOI 10.1128/JVI.00105-10; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BOGERS WM, 1995, AIDS, V9, P13; Bontjer I, 2010, J BIOL CHEM, V285, P36456, DOI 10.1074/jbc.M110.156588; Bontjer I, 2009, J VIROL, V83, P368, DOI 10.1128/JVI.01404-08; Bower JF, 2004, J VIROL, V78, P4710, DOI 10.1128/JVI.78.9.4710-4719.2004; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chakrabarti R, 2004, VACCINE, V22, P1199, DOI 10.1016/j.vaccine.2003.09.023; Deresinski SC, 1999, AIDS, V13, P633, DOI 10.1097/00002030-199904160-00003; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Foresman L, 1998, AIDS RES HUM RETROV, V14, P1035, DOI 10.1089/aid.1998.14.1035; Fujiwara Y, 2010, PROTEIN EXPRES PURIF, V72, P125, DOI 10.1016/j.pep.2010.02.008; FURMAN WL, 1991, J CLIN ONCOL, V9, P1022, DOI 10.1200/JCO.1991.9.6.1022; Ghirelli C, 2010, BLOOD, V115, P5037, DOI 10.1182/blood-2010-01-266932; GIBELLINI D, 1994, MICROBIOLOGICA, V17, P85; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Hu XD, 2010, VACCINE, V28, P2408, DOI 10.1016/j.vaccine.2009.12.076; Kim JJ, 1998, J INTERF CYTOK RES, V18, P537, DOI 10.1089/jir.1998.18.537; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; Koch M, 2005, VIROLOGY, V340, P277, DOI 10.1016/j.virol.2005.06.034; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kusakabe K, 2000, J IMMUNOL, V164, P3102, DOI 10.4049/jimmunol.164.6.3102; LING P, 1995, J IMMUNOL, V154, P116; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; MOORE JP, 1995, J VIROL, V69, P101, DOI 10.1128/JVI.69.1.101-109.1995; Nimal S, 2006, VACCINE, V24, P3298, DOI 10.1016/j.vaccine.2006.01.020; Nimal S, 2007, VACCINE, V25, P2306, DOI 10.1016/j.vaccine.2006.11.059; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Reddy KS, 2010, FEMS IMMUNOL MED MIC, V60, P261, DOI 10.1111/j.1574-695X.2010.00739.x; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 2006, VIROLOGY, V352, P285, DOI 10.1016/j.virol.2006.02.011; Rozwarski DA, 1996, PROTEINS, V26, P304, DOI 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D; Sailaja G, 2003, J IMMUNOL, V170, P2496, DOI 10.4049/jimmunol.170.5.2496; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shibata R, 1997, J VIROL, V71, P8141, DOI 10.1128/JVI.71.11.8141-8148.1997; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Song RJ, 2006, J INTERF CYTOK RES, V26, P380, DOI 10.1089/jir.2006.26.380; Spearman P, 2009, VACCINE, V27, P243, DOI 10.1016/j.vaccine.2008.10.051; STUTE N, 1995, J PHARM SCI-US, V84, P824, DOI 10.1002/jps.2600840708; Su BW, 2008, VACCINE, V26, P5111, DOI 10.1016/j.vaccine.2008.03.089; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; WALTER MR, 1992, J MOL BIOL, V224, P1075, DOI 10.1016/0022-2836(92)90470-5; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103; Zhang C, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-7; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	70	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22250	22261		10.1074/jbc.M111.229625	http://dx.doi.org/10.1074/jbc.M111.229625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515681	Green Published, hybrid			2022-12-25	WOS:000291719900033
J	Agarwal, V; Metlitskaya, A; Severinov, K; Nair, SK				Agarwal, Vinayak; Metlitskaya, Anastasiya; Severinov, Konstantin; Nair, Satish K.			Structural Basis for Microcin C7 Inactivation by the MccE Acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; CAP-BINDING; MACROMOLECULAR STRUCTURES; PLASMID GENES; PROTEIN; REFINEMENT; RECOGNITION; SUPERFAMILY; MATURATION; ENZYME	The antibiotic microcin C7 (McC) acts as a bacteriocide by inhibiting aspartyl-tRNA synthetase and stalling the protein translation machinery. McC is synthesized as a heptapeptide-nucleotide conjugate, which is processed by cellular peptidases within target strains to yield the biologically active compound. As unwanted processing of intact McC can result in self-toxicity, producing strains utilize multiple mechanisms for autoimmunity against processed McC. We have shown previously that the mccE gene within the biosynthetic cluster can inactivate processed McC by acetylating the antibiotic. Here, we present the characterization of this acetylation mechanism through biochemical and structural biological studies of the MccE acetyltransferase domain (MccE(AcTase)). We have also determined five crystal structures of the MccE-acetyl-CoA complex with bound substrates, inhibitor, and reaction product. The structural data reveal an unexpected mode of substrate recognition through pi-stacking interactions similar to those found in cap-binding proteins and nucleotidyltransferases. These studies provide a rationale for the observation that MccE(AcTase) can detoxify a range of aminoacylnucleotides, including those that are structurally distinct from microcin C7.	[Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Severinov, Konstantin] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Metlitskaya, Anastasiya; Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 11934, Russia; [Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 11934, Russia	Rutgers State University New Brunswick; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Rutgers State University New Brunswick; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu; snair@illinois.edu	Severinov, Konstantin/C-8545-2016; Nair, Satish/AAY-2510-2021; Agarwal, Vinayak/L-5688-2017		Rutgers University; Russian Academy of Sciences; Russian Foundation for Basic Research [06-04-48865]	Rutgers University; Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by a Technology Commercialization Fund grant from Rutgers University (to K.S.) and a Molecular and Cell Biology Program grant from the Russian Academy of Sciences. A.M. was supported by Grant 06-04-48865 from the Russian Foundation for Basic Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunzelle JS, 2004, PROTEINS, V57, P850, DOI 10.1002/prot.10601; Destoumieux-Garzon D, 2002, BIOCHIMIE, V84, P511, DOI 10.1016/S0300-9084(02)01411-6; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Fomenko DE, 2003, ANTIMICROB AGENTS CH, V47, P2868, DOI 10.1128/AAC.47.9.2868-2874.2003; GONZALEZPASTOR JE, 1995, J BACTERIOL, V177, P7131, DOI 10.1128/jb.177.24.7131-7140.1995; GONZALEZPASTOR JE, 1994, NATURE, V369, P281, DOI 10.1038/369281a0; GUIJARRO JI, 1995, J BIOL CHEM, V270, P23520, DOI 10.1074/jbc.270.40.23520; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Ho CK, 2004, STRUCTURE, V12, P327, DOI 10.1016/j.str.2004.01.011; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Hurdle JG, 2005, ANTIMICROB AGENTS CH, V49, P4821, DOI 10.1128/AAC.49.12.4821-4833.2005; Kazakov T, 2008, J BACTERIOL, V190, P2607, DOI 10.1128/JB.01956-07; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Metlitskaya A, 2006, J BIOL CHEM, V281, P18033, DOI 10.1074/jbc.M513174200; Metlitskaya A, 2009, J BACTERIOL, V191, P2380, DOI 10.1128/JB.00999-08; METLITSKAYA AZ, 1995, FEBS LETT, V357, P235, DOI 10.1016/0014-5793(94)01345-2; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novikova M, 2007, J BACTERIOL, V189, P8361, DOI 10.1128/JB.01028-07; Novikova M, 2010, J BIOL CHEM, V285, P12662, DOI 10.1074/jbc.M109.080192; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pohlmann J., 2004, Current Drug Targets - Infectious Disorders, V4, P261, DOI 10.2174/1568005043340515; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Stefanska AL, 2000, J ANTIBIOT, V53, P1346, DOI 10.7164/antibiotics.53.1346; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Zeng Y, 2009, ANTIMICROB AGENTS CH, V53, P4619, DOI 10.1128/AAC.00782-09	40	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21295	21303		10.1074/jbc.M111.226282	http://dx.doi.org/10.1074/jbc.M111.226282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507941	hybrid, Green Published			2022-12-25	WOS:000291464700028
J	Mescam, M; Vinnakota, KC; Beard, DA				Mescam, Muriel; Vinnakota, Kalyan C.; Beard, Daniel A.			Identification of the Catalytic Mechanism and Estimation of Kinetic Parameters for Fumarase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG-HEART FUMARASE; ISO-MECHANISMS; PRODUCT INHIBITION; ENZYMES; CYCLE; SITE	The enzyme fumarase catalyzes the reversible hydration of fumarate to malate. The reaction catalyzed by fumarase is critical for cellular energetics as a part of the tricarboxylic acid cycle, which produces reducing equivalents to drive oxidative ATP synthesis. A catalytic mechanism for the fumarase reaction that can account for the kinetic behavior of the enzyme observed in both isotope exchange studies and initial velocity studies has not yet been identified. In the present study, we develop an 11-state kinetic model of the enzyme based on the current consensus on its catalytic mechanism and design a series of experiments to estimate the model parameters and identify the major flux routes through the mechanism. The 11-state mechanism accounts for competitive binding of inhibitors and activation by different anions, including phosphate and fumarate. The model is identified from experimental time courses of the hydration of fumarate to malate obtained over a wide range of buffer and substrate concentrations. Further, the 11-state model is found to effectively reduce to a five-state model by lumping certain successive steps together to yield a mathematically less complex representation that is able to match the data. Analysis suggests the primary reaction route of the catalytic mechanism, with fumarate binding to the free unprotonated enzyme and a proton addition prior to malate release in the fumarate hydration reaction. In the reverse direction (malate dehydration), malate binds the protonated form of the enzyme, and a proton is generated before fumarate is released from the active site.	Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Beard, DA (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	dbeard@mcw.edu	Mescam, Muriel/F-5855-2013; Vinnakota, Kalyan/G-4706-2010	Vinnakota, Kalyan/0000-0003-2185-2213	National Institutes of Health [HL094317]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL094317.	ALBERTY RA, 1954, J AM CHEM SOC, V76, P2485, DOI 10.1021/ja01638a053; ALBERTY RA, 2003, THERMODYNAMICS BIOCH, P47; ALBERTY RA, 1959, ENZYMES; BEARD DA, 2008, CHEM BIOPHYSICS QUAN, P36; Beeckmans S, 1998, J BIOL CHEM, V273, P31661, DOI 10.1074/jbc.273.48.31661; CORNISHBOWDEN A, 1994, BIOCHEM J, V301, P621, DOI 10.1042/bj3010621; HANSEN JN, 1969, J BIOL CHEM, V244, P6270; HASINOFF BB, 1986, BIOCHEM J, V235, P891, DOI 10.1042/bj2350891; HILL RL, 1971, ENZYMES, P552; Li X, 2010, J PHYS CHEM B, V114, P16068, DOI 10.1021/jp911381p; MASSEY V, 1953, BIOCHEM J, V53, P67, DOI 10.1042/bj0530067; MASSEY V, 1953, BIOCHEM J, V55, P172, DOI 10.1042/bj0550172; NORTHROP DB, 1994, ANAL BIOCHEM, V216, P285, DOI 10.1006/abio.1994.1043; Northrop DB, 1997, ARCH BIOCHEM BIOPHYS, V342, P317, DOI 10.1006/abbi.1997.0131; REBHOLZ KL, 1994, ARCH BIOCHEM BIOPHYS, V312, P227, DOI 10.1006/abbi.1994.1303; REBHOLZ KL, 1993, BIOCHEM J, V296, P355, DOI 10.1042/bj2960355; ROSE IA, 1992, BIOCHEMISTRY-US, V31, P9993, DOI 10.1021/bi00156a019; Rose IA, 1997, BIOCHEMISTRY-US, V36, P12346, DOI 10.1021/bi971258d; ROSE IA, 1993, BIOCHEMISTRY-US, V32, P8504, DOI 10.1021/bi00084a016; Rose IA, 2004, P NATL ACAD SCI USA, V101, P3393, DOI 10.1073/pnas.0307524101; Rose IA, 1998, BIOCHEMISTRY-US, V37, P17651, DOI 10.1021/bi9821521; Tian ZM, 2009, HYPERTENSION, V54, P255, DOI 10.1161/HYPERTENSIONAHA.109.129528; Vinnakota KC, 2009, METHOD ENZYMOL, V454, P29, DOI 10.1016/S0076-6879(08)03802-0	23	21	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21100	21109		10.1074/jbc.M110.214452	http://dx.doi.org/10.1074/jbc.M110.214452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498518	Green Published, hybrid			2022-12-25	WOS:000291464700009
J	Park, SJ; Kleffmann, T; Hessian, PA				Park, Sun Jin; Kleffmann, Torsten; Hessian, Paul A.			The G82S Polymorphism Promotes Glycosylation of the Receptor for Advanced Glycation End Products (RAGE) at Asparagine 81 COMPARISON OF WILD-TYPE RAGE WITH THE G82S POLYMORPHIC VARIANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYLATED N-GLYCANS; CELL-SURFACE RECEPTOR; AMYLOID-BETA PEPTIDE; ENDOTHELIAL-CELLS; INFLAMMATORY RESPONSE; PATTERN-RECOGNITION; ALZHEIMERS-DISEASE; CIRCULATING LEVELS; NEURITE OUTGROWTH; MASS-SPECTROMETRY	Interaction between the receptor for advanced glycation end products (RAGE) and its ligands amplifies the proinflammatory response. N-Linked glycosylation of RAGE plays an important role in the regulation of ligand binding. Two potential sites for N-linked glycosylation, at Asn(25) and Asn(81), are implicated, one of which is potentially influenced by a naturally occurring polymorphism that substitutes Gly(82) with Ser. This G82S polymorphic RAGE variant displays increased ligand binding and downstream signaling. We hypothesized that the G82S polymorphism affects RAGE glycosylation and thereby affects ligand binding. WT or various mutant forms of RAGE protein, including N25Q, N81Q, N25Q/G82S, and N25Q/N81Q, were produced by transfecting HEK293 cells. The glycosylation patterns of expressed proteins were compared. Enzymatic deglycosylation showed that WT RAGE and the G82S polymorphic variant are glycosylated to the same extent. Our data also revealed N-linked glycosylation of N25Q and N81Q mutants, suggesting that both Asn(25) and Asn(81) can be utilized for N-linked glycosylation. Using mass spectrometry analysis, we found that Asn(81) may or may not be glycosylated in WT RAGE, whereas in G82S RAGE, Asn(81) is always glycosylated. Furthermore, RAGE binding to S100B ligand is affected by Asn(81) glycosylation, with consequences for NF-kappa B activation. Therefore, the G82S polymorphism promotes N-linked glycosylation of Asn(81), which has implications for the structure of the ligand binding region of RAGE and might explain the enhanced function associated with the G82S polymorphic RAGE variant.	[Hessian, Paul A.] Univ Otago, Leukocyte Inflammat Res Lab, Dept Physiol, Dunedin Sch Med Sci, Dunedin 9054, New Zealand; [Kleffmann, Torsten] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	University of Otago; University of Otago	Hessian, PA (corresponding author), Univ Otago, Leukocyte Inflammat Res Lab, Dept Physiol, Dunedin Sch Med Sci, Wellcome Bldg,POB 913, Dunedin 9054, New Zealand.	paul.hessian@stonebow.otago.ac.nz		Kleffmann, Torsten/0000-0001-9305-5980	Arthritis New Zealand; Health Research Council of New Zealand	Arthritis New Zealand; Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by Arthritis New Zealand and the Health Research Council of New Zealand.	Chavakis T, 2004, MICROBES INFECT, V6, P1219, DOI 10.1016/j.micinf.2004.08.004; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; GONZALEZ J, 1992, ANAL BIOCHEM, V205, P151, DOI 10.1016/0003-2697(92)90592-U; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 1998, DIABETES, V47, P1155, DOI 10.2337/diabetes.47.7.1155; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Huttunen HJ, 2002, CANCER RES, V62, P4805; Jang Y, 2007, METABOLISM, V56, P199, DOI 10.1016/j.metabol.2006.09.013; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Kuster B, 1999, ANAL CHEM, V71, P1431, DOI 10.1021/ac981012u; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li KS, 2010, J NEURAL TRANSM, V117, P97, DOI 10.1007/s00702-009-0334-6; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Ostendorp T, 2006, BIOCHEM BIOPH RES CO, V347, P4, DOI 10.1016/j.bbrc.2006.04.077; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Peng WH, 2009, ARCH MED RES, V40, P393, DOI 10.1016/j.arcmed.2009.06.008; Pullerits R, 2005, ARTHRITIS RES THER, V7, pR817, DOI 10.1186/ar1749; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; Schmidt AM, 2000, SEMIN THROMB HEMOST, V26, P485, DOI 10.1055/s-2000-13204; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; Srikrishna G, 2005, J IMMUNOL, V175, P5412, DOI 10.4049/jimmunol.175.8.5412; Srikrishna G, 2005, BIOCHEM BIOPH RES CO, V332, P1020, DOI 10.1016/j.bbrc.2005.05.056; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Srikrishna G, 2001, J IMMUNOL, V166, P624, DOI 10.4049/jimmunol.166.1.624; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1997, NATURE, V389, P689; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371	43	38	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21384	21392		10.1074/jbc.M111.241281	http://dx.doi.org/10.1074/jbc.M111.241281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21511948	hybrid, Green Published			2022-12-25	WOS:000291464700037
J	Charvet, C; Liao, WL; Heo, GY; Laird, J; Salomon, RG; Turko, IV; Pikuleva, IA				Charvet, Casey; Liao, Wei-Li; Heo, Gun-Young; Laird, James; Salomon, Robert G.; Turko, Illarion V.; Pikuleva, Irina A.			Isolevuglandins and Mitochondrial Enzymes in the Retina MASS SPECTROMETRY DETECTION OF POST-TRANSLATIONAL MODIFICATION OF STEROL-METABOLIZING CYP27A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450C27 CYP27; PROTEIN ADDUCTS; CEREBROTENDINOUS-XANTHOMATOSIS; MACULAR DEGENERATION; DENSITY-LIPOPROTEIN; ISOPROSTANE PATHWAY; LIPID-PEROXIDATION; LEVUGLANDIN E(2); 27-HYDROXYLASE; CHOLESTEROL	We report the first peptide mapping and sequencing of an in vivo isolevuglandin-modified protein. Mitochondrial cytochrome P450 27A1 (CYP27A1) is a ubiquitous multifunctional sterol C27-hydroxylase that eliminates cholesterol and likely 7-ketocholesterol from the retina and many other tissues. We investigated the post-translational modification of this protein with isolevuglandins, arachidonate oxidation products. Treatment of purified recombinant CYP27A1 with authentic iso[4]levuglandin E-2 (iso[4]LGE(2)) in vitro diminished enzyme activity in a time-and phospholipid-dependent manner. A multiple reaction monitoring protocol was then developed to identify the sites and extent of iso[4]LGE2 adduction. CYP27A1 exhibited only three Lys residues, Lys(134), Lys(358), and Lys(476), that readily interact with iso[4]LGE(2) in vitro. Such selective modification enabled the generation of an internal standard, N-15-labeled CYP27A1 modified with iso[4]LGE(2), for the subsequent analysis of a human retinal sample. Two multiple reaction monitoring transitions arising from the peptide AVLK(358)(-C20H26O3)ETLR in the retinal sample were observed that co-eluted with the corresponding two N-15 transitions from the supplemented standard. These data demonstrate that modified CYP27A1 is present in the retina. We suggest that such protein modification impairs sterol elimination and likely has other pathological sequelae. We also propose that the post-translational modifications identified in CYP27A1 exemplify a general mechanism whereby oxidative stress and inflammation deleteriously affect protein function, contributing, for example, to cholesterol-rich lesions associated with age-related macular degeneration and cardiovascular disease. The proteomic protocols developed in this study are generally applicable to characterization of lipid-derived oxidative protein modifications occurring in vivo, including proteins bound to membranes.	[Turko, Illarion V.] Natl Inst Stand & Technol, Div Analyt Chem, Gaithersburg, MD 20899 USA; [Liao, Wei-Li; Turko, Illarion V.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Laird, James; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Charvet, Casey; Heo, Gun-Young; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	National Institute of Standards & Technology (NIST) - USA; Case Western Reserve University; Case Western Reserve University	Pikuleva, IA (corresponding author), 2085 Adelbert Rd,Rm 303, Cleveland, OH 44106 USA.	iap8@case.edu	Salomon, Robert G/C-3463-2008	Pikuleva, Irina/0000-0001-9742-6232; Salomon, Robert/0000-0001-9456-3557	National Institutes of Health [EY018383, AG024336, GM21249, T32 EY007157, P30 EY11373]; NATIONAL EYE INSTITUTE [R01EY018383, T32EY007157, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018383 and AG024336 (to I. A. P.), GM21249 (to R. G. S.), Fellowship T32 EY007157 (to C. C.), and Core Grant P30 EY11373 (to Case Visual Sciences Research Center).	*AV POL LIP, 2010, PREP LIP; Babiker A, 1997, J BIOL CHEM, V272, P26253, DOI 10.1074/jbc.272.42.26253; BENGA G, 1978, EUR J BIOCHEM, V84, P625, DOI 10.1111/j.1432-1033.1978.tb12205.x; BJORKHEM I, 1994, SCAND J GASTROENTERO, V29, P68, DOI 10.3109/00365529409103629; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; BRODY TM, 1952, J BIOL CHEM, V195, P685; Brown AJ, 2000, J BIOL CHEM, V275, P27627; Davies SS, 2007, NAT PROTOC, V2, P2079, DOI 10.1038/nprot.2007.298; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; DIFRANCO E, 1995, CHEM RES TOXICOL, V8, P61, DOI 10.1021/tx00043a008; Dotti MT, 2001, J INHERIT METAB DIS, V24, P696, DOI 10.1023/A:1012981019336; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUJIYAMA J, 1991, CLIN CHIM ACTA, V200, P1, DOI 10.1016/0009-8981(91)90328-A; Govindarajan B, 2008, BIOCHEMISTRY-US, V47, P817, DOI 10.1021/bi701517m; Griffiths JR, 2007, J AM SOC MASS SPECTR, V18, P1423, DOI 10.1016/j.jasms.2007.04.021; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; GULCAN HG, 1993, INVEST OPHTH VIS SCI, V34, P3187; HAMILTON JG, 1988, LIPIDS, V23, P1146, DOI 10.1007/BF02535281; HEO GY, 2011, J LIPID RES, V10, P241; Hollyfield JG, 2003, ADV EXP MED BIOL, V533, P83; Hulsmeier AJ, 2007, MOL CELL PROTEOMICS, V6, P2132, DOI 10.1074/mcp.M700361-MCP200; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kitteringham NR, 2009, J CHROMATOGR B, V877, P1229, DOI 10.1016/j.jchromb.2008.11.013; KOBIERSKI ME, 1994, J ORG CHEM, V59, P6044, DOI 10.1021/jo00099a040; Lee JW, 2006, EXP EYE RES, V83, P465, DOI 10.1016/j.exer.2005.11.018; Li CM, 2007, EXP EYE RES, V85, P192, DOI 10.1016/j.exer.2007.04.002; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; Liao WL, 2010, ANAL CHEM, V82, P5760, DOI 10.1021/ac100811x; Lyons MA, 2001, LIPIDS, V36, P701, DOI 10.1007/s11745-001-0775-8; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Mollah S, 2007, RAPID COMMUN MASS SP, V21, P3357, DOI 10.1002/rcm.3227; MORGAN SJ, 1989, BRIT J OPHTHALMOL, V73, P1011, DOI 10.1136/bjo.73.12.1011; Murtazina D, 2002, J BIOL CHEM, V277, P37582, DOI 10.1074/jbc.M204909200; OMURA T, 1964, J BIOL CHEM, V239, P2379; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Pikuleva IA, 1998, J BIOL CHEM, V273, P18153, DOI 10.1074/jbc.273.29.18153; Pikuleva IA, 1997, ARCH BIOCHEM BIOPHYS, V343, P123, DOI 10.1006/abbi.1997.0142; Pikuleva IA, 1999, J BIOL CHEM, V274, P2045, DOI 10.1074/jbc.274.4.2045; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; Poliakov E, 2004, CHEM RES TOXICOL, V17, P613, DOI 10.1021/tx034185+; Reiss AB, 1997, J LIPID RES, V38, P1254; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Salomon R G, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P323; Salomon RG, 2005, ANTIOXID REDOX SIGN, V7, P185, DOI 10.1089/ars.2005.7.185; Salomon RG, 1999, J BIOL CHEM, V274, P20271, DOI 10.1074/jbc.274.29.20271; Subbanagounder G, 1997, J ORG CHEM, V62, P7658, DOI 10.1021/jo970858f; Sullivan CB, 2010, J LIPID RES, V51, P999, DOI 10.1194/jlr.M001040; Szapacs ME, 2008, J PROTEOME RES, V7, P4237, DOI 10.1021/pr8001222; Tallman KA, 2007, CHEM RES TOXICOL, V20, P227, DOI 10.1021/tx600331s; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6	53	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20413	20422		10.1074/jbc.M111.232546	http://dx.doi.org/10.1074/jbc.M111.232546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498512	Green Published, hybrid			2022-12-25	WOS:000291267600029
J	Hozoji-Inada, M; Munehira, Y; Nagao, K; Kioka, N; Ueda, K				Hozoji-Inada, Masako; Munehira, Youichi; Nagao, Kohjiro; Kioka, Noriyuki; Ueda, Kazumitsu			Liver X Receptor beta (LXR beta) Interacts Directly with ATP-binding Cassette A1 (ABCA1) to Promote High Density Lipoprotein Formation during Acute Cholesterol Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER A1; TANGIER-DISEASE; CELLULAR CHOLESTEROL; EXTRACELLULAR DOMAIN; APOA-I; EFFLUX; MUTATIONS; ALPHA; GENE; LOCALIZATION	Cells have evolved multiple mechanisms for maintaining cholesterol homeostasis, and, among these, ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux is highly regulated at the transcriptional level through the activity of the nuclear receptor liver X receptor (LXR). Here, we show that in addition to its well defined role in transcription, LXR beta directly binds to the C-terminal region ((LTSFL2251)-L-2247) of ABCA1 to mediate its post-translational regulation. In the absence of cholesterol accumulation in the macrophage-like cell line THP-1, the ABCA1-LXR beta complex stably localizes to the plasma membrane, but apolipoprotein A-I (apoA-I) binding or cholesterol efflux does not occur. Exogenously added LXR ligands, which mimic cholesterol accumulation, cause LXR beta to dissociate from ABCA1, thus freeing ABCA1 for apoA-I binding and subsequent cholesterol efflux. Photoaffinity labeling experiments with 8-azido-[alpha-P-32] ATP showed that the interaction of LXR beta with ABCA1 inhibits ATP binding by ABCA1. This is the first study to show that a protein-protein interaction with the endogenous protein suppresses the function of ABC proteins by inhibiting ATP binding. LXR beta can cause a post-translational response by binding directly to ABCA1, as well as a transcriptional response, to maintain cholesterol homeostasis.	[Hozoji-Inada, Masako; Nagao, Kohjiro; Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068502, Japan; [Munehira, Youichi; Kioka, Noriyuki; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Cellular Biochem, Kyoto 6068502, Japan	Kyoto University; Kyoto University	Ueda, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	uedak@kais.kyoto-u.ac.jp		Kioka, Noriyuki/0000-0002-2708-537X; Ueda, Kazumitsu/0000-0003-2980-6078	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) of Japan; Takeda Scientific Foundation; World Premier International Research Center Initiative, MEXT, Japan; Grants-in-Aid for Scientific Research [20228001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) of Japan; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); World Premier International Research Center Initiative, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (S) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) of Japan, by a grant from the Takeda Scientific Foundation, and by the World Premier International Research Center Initiative, MEXT, Japan.	Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Azuma Y, 2009, GENES CELLS, V14, P191, DOI 10.1111/j.1365-2443.2008.01261.x; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Costet P, 2000, J BIOL CHEM, V275, P28240; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Hashimoto K, 2002, HEPATOLOGY, V36, P1236, DOI 10.1053/jhep.2002.36368; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Hirata T, 2009, BIOSCI BIOTECH BIOCH, V73, P619, DOI 10.1271/bbb.80694; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Hozoji M, 2009, J BIOL CHEM, V284, P11293, DOI 10.1074/jbc.M900580200; Kaneko E, 2003, J BIOL CHEM, V278, P36091, DOI 10.1074/jbc.M304153200; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Nagao K, 2009, J LIPID RES, V50, P1165, DOI 10.1194/jlr.M800597-JLR200; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Prufer K, 2007, J CELL BIOCHEM, V100, P69, DOI 10.1002/jcb.21006; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Szakacs G, 2001, BIOCHEM BIOPH RES CO, V288, P1258, DOI 10.1006/bbrc.2001.5905; Taguchi Y, 1997, FEBS LETT, V401, P11, DOI 10.1016/S0014-5793(96)01421-4; Takeda Y, 1998, BBA-BIOMEMBRANES, V1373, P131, DOI 10.1016/S0005-2736(98)00099-6; Tanaka AR, 2001, BIOCHEM BIOPH RES CO, V283, P1019, DOI 10.1006/bbrc.2001.4891; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; Wellington CL, 2002, J LIPID RES, V43, P1939, DOI 10.1194/jlr.M200277-JLR200; Yokoyama S, 2000, BBA-MOL CELL BIOL L, V1529, P231, DOI 10.1016/S1388-1981(00)00152-9	37	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20117	20124		10.1074/jbc.M111.235846	http://dx.doi.org/10.1074/jbc.M111.235846			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21507939	hybrid, Green Published			2022-12-25	WOS:000291027700088
J	Merhi, A; Gerard, N; Lauwers, E; Prevost, M; Andre, B				Merhi, Ahmad; Gerard, Nicolas; Lauwers, Elsa; Prevost, Martine; Andre, Bruno			Systematic Mutational Analysis of the Intracellular Regions of Yeast Gap1 Permease	PLOS ONE			English	Article							AMINO-ACID PERMEASE; NITROGEN CATABOLITE REPRESSION; MULTIVESICULAR BODY PATHWAY; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; SHUTTLE VECTORS; PROTEIN; UBIQUITIN; GENE; TRANSPORTERS	Background: The yeast general amino acid permease Gap1 is a convenient model for studying the intracellular trafficking of membrane proteins. Present at the plasma membrane when the nitrogen source is poor, it undergoes ubiquitin-dependent endocytosis and degradation upon addition of a good nitrogen source, e. g., ammonium. It comprises 12 transmembrane domains (TM) flanked by cytosol-facing N- and C-terminal tails (NT, CT). The NT of Gap1 contains the acceptor lysines for ubiquitylation and its CT includes a sequence essential to exit from the endoplasmic reticulum (ER). Principal Findings: We used alanine-scanning mutagenesis to isolate 64 mutant Gap1 proteins altered in the NT, the CT, or one of the five TM-connecting intracellular loops (L2, -4, -6, -8 and -10). We found 17 mutations (in L2, L8, L10 and CT) impairing Gap1 exit from the ER. Of the 47 mutant proteins reaching the plasma membrane normally, two are unstable and rapidly down-regulated even when the nitrogen source is poor. Six others are totally inactive and another four, altered in a 16-amino-acid sequence in the NT, are resistant to ammonium-induced down-regulation. Finally, a mutation in L6 causes missorting of Gap1 from the secretory pathway to the vacuole. Interestingly, this direct vacuolar sorting seems to be independent of Gap1 ubiquitylation. Conclusions: This study illustrates the importance of multiple intracellular regions of Gap1 in its secretion, transport activity, and down-regulation.	[Merhi, Ahmad; Gerard, Nicolas; Lauwers, Elsa; Andre, Bruno] Univ Libre Bruxelles, Gosselies, Belgium; [Prevost, Martine] Univ Libre Bruxelles, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Merhi, A (corresponding author), Univ Libre Bruxelles, Gosselies, Belgium.	bran@ulb.ac.be	André, Bruno/D-1725-2010	Lauwers, Elsa/0000-0002-0283-1911; Merhi, Ahmad/0000-0001-7046-2508	Fonds de la Recherche Scientifique Medicale [3.4.592.08.F]; Region Wallonne [716760]; Communaute Francaise de Belgique; FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture)	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Region Wallonne; Communaute Francaise de Belgique(Australian Research Council); FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by a "Fonds de la Recherche Scientifique Medicale" grant (3.4.592.08.F), a "Region Wallonne" grant 716760, and an "Actions de Recherche Concertee" grant of the Communaute Francaise de Belgique. A. M. is a recipient of a FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Diallinas G, 2008, SCIENCE, V322, P1644, DOI 10.1126/science.1168107; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gilstring CF, 2000, J BIOL CHEM, V275, P31488, DOI 10.1074/jbc.M005047200; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LASKO PF, 1981, J BACTERIOL, V148, P241, DOI 10.1128/JB.148.1.241-247.1981; Lauwers E, 2007, MOL BIOL CELL, V18, P3068, DOI 10.1091/mbc.E07-03-0196; Lauwers E, 2006, TRAFFIC, V7, P1045, DOI 10.1111/j.1600-0854.2006.00445.x; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E; Lowe M, 2007, NAT REV MOL CELL BIO, V8, P429, DOI 10.1038/nrm2179; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Nikko E, 2003, J BIOL CHEM, V278, P50732, DOI 10.1074/jbc.M306953200; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; SIKORSKI RS, 1989, GENETICS, V122, P19; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Springael JY, 1999, J CELL SCI, V112, P1375; Van Belle D, 2001, CURR OPIN CELL BIOL, V13, P389, DOI 10.1016/S0955-0674(00)00226-X; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X	47	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18457	10.1371/journal.pone.0018457	http://dx.doi.org/10.1371/journal.pone.0018457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526172	Green Submitted, Green Published, gold			2022-12-25	WOS:000289671100004
J	Palkovacs, EP; Wasserman, BA; Kinnison, MT				Palkovacs, Eric P.; Wasserman, Ben A.; Kinnison, Michael T.			Eco-Evolutionary Trophic Dynamics: Loss of Top Predators Drives Trophic Evolution and Ecology of Prey	PLOS ONE			English	Article							GUPPIES POECILIA-RETICULATA; LIFE-HISTORY EVOLUTION; RAPID EVOLUTION; TRADE-OFF; FOOD-WEB; SWIMMING PERFORMANCE; FISH COMMUNITIES; GAMBUSIA-AFFINIS; SHAPE; SELECTION	Ecosystems are being altered on a global scale by the extirpation of top predators. The ecological effects of predator removal have been investigated widely; however, predator removal can also change natural selection acting on prey, resulting in contemporary evolution. Here we tested the role of predator removal on the contemporary evolution of trophic traits in prey. We utilized a historical introduction experiment where Trinidadian guppies (Poecilia reticulata) were relocated from a site with predatory fishes to a site lacking predators. To assess the trophic consequences of predator release, we linked individual morphology (cranial, jaw, and body) to foraging performance. Our results show that predator release caused an increase in guppy density and a "sharpening" of guppy trophic traits, which enhanced food consumption rates. Predator release appears to have shifted natural selection away from predator escape ability and towards resource acquisition ability. Related diet and mesocosm studies suggest that this shift enhances the impact of guppies on lower trophic levels in a fashion nuanced by the omnivorous feeding ecology of the species. We conclude that extirpation of top predators may commonly select for enhanced feeding performance in prey, with important cascading consequences for communities and ecosystems.	[Palkovacs, Eric P.; Wasserman, Ben A.] Duke Univ, Marine Lab, Beaufort, NC 28516 USA; [Palkovacs, Eric P.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Wasserman, Ben A.; Kinnison, Michael T.] Univ Maine, Sch Biol & Ecol, Orono, ME USA	Duke University; Duke University; University of Maine System; University of Maine Orono	Palkovacs, EP (corresponding author), Duke Univ, Marine Lab, Beaufort, NC 28516 USA.	eric.palkovacs@duke.edu	Wasserman, Ben/AAD-5957-2019	Kinnison, Michael/0000-0003-4211-2118; Wasserman, Ben/0000-0002-9997-4934	U.S.A. National Science Foundation [EF 0623632]; Maine Agricultural and Forest Experiment Station [3172]; Duke University Marine Laboratory McCurdy Endowment	U.S.A. National Science Foundation(National Science Foundation (NSF)); Maine Agricultural and Forest Experiment Station; Duke University Marine Laboratory McCurdy Endowment	Funding was provided by the U.S.A. National Science Foundation (EF 0623632), the Maine Agricultural and Forest Experiment Station (contribution 3172), and the Duke University Marine Laboratory McCurdy Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Adams DC, 1999, EVOL ECOL RES, V1, P959; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Arendt JD, 2005, P ROY SOC B-BIOL SCI, V272, P333, DOI 10.1098/rspb.2004.2899; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Becks L, 2010, ECOL LETT, V13, P989, DOI 10.1111/j.1461-0248.2010.01490.x; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bookstein F.L., 1996, ADV MORPHOMETRICS, V284, P131; Burns JG, 2009, J FISH BIOL, V75, P1144, DOI 10.1111/j.1095-8649.2009.02314.x; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; DELURY DB, 1947, BIOMETRICS, V3, P145, DOI 10.2307/3001390; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Dunlop ES, 2009, EVOL APPL, V2, P246, DOI 10.1111/j.1752-4571.2009.00087.x; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Fischer-Rousseau L, 2010, J EXP ZOOL PART B, V314B, P67, DOI 10.1002/jez.b.21311; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Ghalambor CK, 2003, INTEGR COMP BIOL, V43, P431, DOI 10.1093/icb/43.3.431; Grether GF, 2001, ECOLOGY, V82, P1546, DOI 10.1890/0012-9658(2001)082[1546:RFCCRA]2.0.CO;2; Grunbaum T, 2007, J EXP ZOOL PART B, V308B, P396, DOI 10.1002/jez.b.21163; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; Jones LE, 2009, PHILOS T R SOC B, V364, P1579, DOI 10.1098/rstb.2009.0004; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; KLINGENBERG CP, 1996, ADV MORPHOMETRICS, V284, P23; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; O'Steen S, 2002, EVOLUTION, V56, P776, DOI 10.1554/0014-3820(2002)056[0776:REOEAI]2.0.CO;2; Palkovacs EP, 2009, PHILOS T R SOC B, V364, P1617, DOI 10.1098/rstb.2009.0016; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Relyea RA, 2002, ECOLOGY, V83, P1953, DOI 10.2307/3071778; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 2008, MOL ECOL, V17, P97, DOI 10.1111/j.1365-294X.2007.03474.x; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Reznick DN, 2005, CAN J FISH AQUAT SCI, V62, P791, DOI 10.1139/F05-079; ROBINSON BW, 1995, COPEIA, P294; Rohlf F.J., 2009, TPSDIG VERSION 214; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ., 2008, TPSRELW VERSION 146; Rohlf FJ, 2009, TPSUTIL VERSION 1 44; Rohlf FJ, 2004, TPSSPLINE VERSION 1; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Strong DR, 2010, ANNU REV ENV RESOUR, V35, P1, DOI 10.1146/annurev-environ-031809-133103; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Van Buskirk J, 1998, OIKOS, V82, P20; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; Ward P, 2005, ECOLOGY, V86, P835, DOI 10.1890/03-0746; WASSERSUG RJ, 1976, STAIN TECHNOL, V51, P131, DOI 10.3109/10520297609116684; Yoshida T, 2004, P ROY SOC B-BIOL SCI, V271, P1947, DOI 10.1098/rspb.2004.2818; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	63	61	61	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18879	10.1371/journal.pone.0018879	http://dx.doi.org/10.1371/journal.pone.0018879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526156	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100034
J	Varkuti, B; Cavusoglu, M; Kullik, A; Schiffler, B; Veit, R; Yilmaz, O; Rosenstiel, W; Braun, C; Uludag, K; Birbaumer, N; Sitaram, R				Varkuti, Balint; Cavusoglu, Mustafa; Kullik, Alexander; Schiffler, Bjoern; Veit, Ralf; Yilmaz, Oezge; Rosenstiel, Wolfgang; Braun, Christoph; Uludag, Kamil; Birbaumer, Niels; Sitaram, Ranganatha			Quantifying the Link between Anatomical Connectivity, Gray Matter Volume and Regional Cerebral Blood Flow: An Integrative MRI Study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HUMAN BRAIN; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; ALZHEIMERS-DISEASE; STRUCTURAL CONNECTIVITY; CORTICAL THICKNESS; DEFAULT MODE; WHITE-MATTER; PERFUSION	Background: In the graph theoretical analysis of anatomical brain connectivity, the white matter connections between regions of the brain are identified and serve as basis for the assessment of regional connectivity profiles, for example, to locate the hubs of the brain. But regions of the brain can be characterised further with respect to their gray matter volume or resting state perfusion. Local anatomical connectivity, gray matter volume and perfusion are traits of each brain region that are likely to be interdependent, however, particular patterns of systematic covariation have not yet been identified. Methodology/Principal Findings: We quantified the covariation of these traits by conducting an integrative MRI study on 23 subjects, utilising a combination of Diffusion Tensor Imaging, Arterial Spin Labeling and anatomical imaging. Based on our hypothesis that local connectivity, gray matter volume and perfusion are linked, we correlated these measures and particularly isolated the covariation of connectivity and perfusion by statistically controlling for gray matter volume. We found significant levels of covariation on the group-and regionwise level, particularly in regions of the Default Brain Mode Network. Conclusions/Significance: Connectivity and perfusion are systematically linked throughout a number of brain regions, thus we discuss these results as a starting point for further research on the role of homology in the formation of functional connectivity networks and on how structure/function relationships can manifest in the form of such trait interdependency.	[Varkuti, Balint; Veit, Ralf; Yilmaz, Oezge; Braun, Christoph; Birbaumer, Niels; Sitaram, Ranganatha] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Baden Wurttembe, Germany; [Cavusoglu, Mustafa; Uludag, Kamil] Max Planck Inst Biol Cybernet, Tubingen, Baden Wurttembe, Germany; [Varkuti, Balint] Int Max Planck Res Sch, Grad Training Ctr Neurosci, Tubingen, Baden Wurttembe, Germany; [Kullik, Alexander; Rosenstiel, Wolfgang] Univ Tubingen, Wilhelm Schickard Inst Comp Engn, Tubingen, Baden Wurttembe, Germany; [Schiffler, Bjoern] Univ Freiburg, Inst Psychol, Freiburg, Baden Wurttembe, Germany; [Braun, Christoph] CIMeC Ctr Interdipartimentale Mente Cervello, Rovereto, Trento, Italy; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venice, Veneto, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Max Planck Society; Eberhard Karls University of Tubingen; University of Freiburg	Varkuti, B (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Baden Wurttembe, Germany.	balint.varkuti@medizin.uni-tuebingen.de	Braun, Christoph/E-4561-2010; Veit, Ralf/F-8907-2012; yilmaz, ozge/B-3866-2014; Braun, Christoph/J-4160-2014	Braun, Christoph/0000-0002-7836-4010; Veit, Ralf/0000-0001-9860-642X; Braun, Christoph/0000-0002-7836-4010; Schiffler, Bjorn/0000-0003-2347-4965; Sitaram, Ranganatha/0000-0002-8577-8035; Uludag, Kamil/0000-0002-2813-5930; Birbaumer, Niels/0000-0002-6786-5127	Werner Reichardt Centre for Integrative Neuroscience [PP: 2009-15]; Deutsche Forschungsgemeinschaft (DFG) [BI 195/59-1]; European Union [HUMOUR 231724]	Werner Reichardt Centre for Integrative Neuroscience; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission)	This work was partially funded by the Werner Reichardt Centre for Integrative Neuroscience (Poolproject: Implementation of an Integrative Connectivity Toolbox for Investigation of Cortical Plasticity and Reorganization after Stroke, PP: 2009-15), the Deutsche Forschungsgemeinschaft (DFG BI 195/59-1) and the European Union (HUMOUR 231724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Arthurs OJ, 2002, TRENDS NEUROSCI, V25, P27, DOI 10.1016/S0166-2236(00)01995-0; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Barab?si AL., 2002, AM J PHYS, V71, P409, DOI [10.1119/1.1538577, DOI 10.1119/1.1538577]; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun V. D., 2003, P INT WORKSH IND COM, DOI 10.1.1.3.7473; Cammoun L., 2009, NEUROIMAGE, V47, pS157, DOI [10.1016/S1053-8119(09)71653-2, DOI 10.1016/S1053-8119(09)71653-2]; Cavusoglu M, 2009, MAGN RESON IMAGING, V27, P1039, DOI 10.1016/j.mri.2009.04.002; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; GJEDDE A, 1985, J CEREBR BLOOD F MET, V5, P282, DOI 10.1038/jcbfm.1985.36; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GREICIUS MD, 2008, CEREBRAL CORTEX; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jahng GH, 2007, IFMBE PROC, V14, P1380; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; KAWAMURA J, 1993, J NEUROL NEUROSUR PS, V56, P182, DOI 10.1136/jnnp.56.2.182; KLEIN B, 1986, AM J PHYSIOL, V251, pH1333, DOI 10.1152/ajpheart.1986.251.6.H1333; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; KUSCHINSKY W, 1991, NEUROSURG REV, V14, P163, DOI 10.1007/BF00310651; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Nordberg A, 2010, NEURODEGENER DIS, V7, P136, DOI 10.1159/000289223; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RUBINOV M, 2009, NEUROIMAGE; Schuff N, 2007, BRIT J RADIOL, V80, pS109, DOI 10.1259/bjr/63830887; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sotiropoulos SN, 2010, NEUROIMAGE, V49, P2444, DOI 10.1016/j.neuroimage.2009.10.001; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X	52	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e14801	10.1371/journal.pone.0014801	http://dx.doi.org/10.1371/journal.pone.0014801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525993	gold, Green Submitted, Green Published			2022-12-25	WOS:000289578600002
J	Wu, Z; Zheng, S; Li, Z; Tan, J; Yu, Q				Wu, Z.; Zheng, S.; Li, Z.; Tan, J.; Yu, Q.			E2F1 suppresses Wnt/beta-catenin activity through transactivation of beta-catenin interacting protein ICAT	ONCOGENE			English	Article						E2F1; Wnt/beta-catenin; ICAT; cancer cells	WNT; PATHWAY; TRANSCRIPTION; TARGET; APOPTOSIS; CANCER; LIFE	Deregulation of the pRb/E2F or Wnt/beta-catenin pathway occurs frequently in human cancers, which is often associated with inappropriate cell proliferation. Although the oncogenic roles of pRb/E2F1 and Wnt/beta-catenin pathways have been well studied, the functional interaction between the two pathways has only recently been characterized. In particular, E2F1 has been recently reported to negatively regulate Wnt/beta-catenin activity in human colorectal cancers, though the mechanism underlying this regulation is not fully understood. Here we provide evidence that beta-catenin interacting protein 1 (CTNNBIP1), also known as ICAT (inhibitor of beta-catenin and TCF4), functions as a crucial node to mediate the cross talk between E2F1 and beta-catenin signaling. We show that ICAT is a direct transcriptional target of E2F1, and that activation of ICAT by E2F1 is required for E2F1 to inhibit beta-catenin activity. This study provides a mechanistic insight into the antagonistic interaction between E2F1 and beta-catenin signaling. Oncogene (2011) 30, 3979-3984; doi:10.1038/onc.2011.129; published online 2 May 2011	[Wu, Z.; Zheng, S.; Li, Z.; Tan, J.; Yu, Q.] ASTAR, Dept Canc Biol & Pharmacol, Genome Inst Singapore, Singapore 138672, Singapore; [Yu, Q.] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Yu, Q (corresponding author), ASTAR, Dept Canc Biol & Pharmacol, Genome Inst Singapore, Genome 02-01,60 Biopolis St, Singapore 138672, Singapore.	yuq@gis.a-star.edu.sg		Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology and Research of Singapore	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	We thank Dr Kristian Helin (European Institute of Oncology, Milan) for the ER-E2F1 plasmids and Dr Claudio Brancolini for providing the IMR90/E1A cells. This work was supported by the Agency for Science, Technology and Research of Singapore.	Bernards R, 2008, NATURE, V455, P479, DOI 10.1038/455479a; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bramis J, 2004, ANTICANCER RES, V24, P3041; Cadigan KM, 2008, CURR BIOL, V18, pR943, DOI 10.1016/j.cub.2008.08.017; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kim SM, 2009, EXP CELL RES, V315, P943, DOI 10.1016/j.yexcr.2009.01.013; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Tago K, 2000, GENE DEV, V14, P1741; Tan J, 2006, J BIOL CHEM, V281, P10508, DOI 10.1074/jbc.M512719200; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Xie W, 2009, J CELL MOL MED, V13, P1719, DOI 10.1111/j.1582-4934.2008.00423.x; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102	23	32	33	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	37					3979	3984		10.1038/onc.2011.129	http://dx.doi.org/10.1038/onc.2011.129			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	820FG	21532622				2022-12-25	WOS:000294890400007
J	Harris, NC; Paavonen, K; Davydova, N; Roufail, S; Sato, T; Zhang, YF; Karnezis, T; Stacker, SA; Achen, MG				Harris, Nicole C.; Paavonen, Karri; Davydova, Natalia; Roufail, Sally; Sato, Teruhiko; Zhang, You-Fang; Karnezis, Tara; Stacker, Steven A.; Achen, Marc G.			Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer	FASEB JOURNAL			English	Article						VEGF-D; metastasis; lymphangiogenesis; angiogenesis; neuropilin	VEGF-D; PROPROTEIN CONVERTASES; FACTOR-C; TUMOR LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MOLECULAR CONTROL; FACTOR RECEPTOR-3; BREAST-CANCER; IN-VIVO; CELLS	VEGF-D is a mitogen for endothelial cells that promotes tumor growth and metastatic spread in animal models, and expression of which correlates with lymph node metastasis in some human cancers. It is secreted from the cell as a full-length form with propeptides flanking a central region containing binding sites for VEGFR-2 and VEGFR-3, receptors that signal for angiogenesis and lymphangiogenesis. The propeptides can be cleaved from VEGF-D, enhancing affinity for VEGFR-2 and VEGFR-3 in vitro; however, the importance of this processing in cancer is unclear. To explore the necessity of processing for the effects of VEGF-D in cancer, we use a mutant full-length form that cannot be processed, and show that, in contrast to full-length VEGF-D that is processed, this mutant does not promote tumor growth and lymph node metastasis in a mouse tumor model. Processing of VEGF-D is required for tumor angiogenesis, lymphangiogenesis, and recruitment of tumor-associated macrophages. These observations may be explained by the requirement of processing for VEGF-D to bind neuropilin receptors and activate VEGFR-2. Our results indicate that proteolytic processing is necessary for VEGF-D to promote the growth and spread of cancer, and suggest that enzymes catalyzing this processing could be targets for antimetastatic therapeutics.-Harris, N. C., Paavonen, K., Davydova, N., Roufail, S., Sato, T., Zhang, Y. -F., Karnezis, T., Stacker, S. A., Achen, M. G. Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer. FASEB J. 25, 2615-2625 (2011). www.fasebj.org	[Harris, Nicole C.; Davydova, Natalia; Roufail, Sally; Zhang, You-Fang; Karnezis, Tara; Stacker, Steven A.; Achen, Marc G.] Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia; [Harris, Nicole C.] Univ Melbourne, Dept Surg, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Harris, Nicole C.; Paavonen, Karri; Davydova, Natalia; Roufail, Sally; Sato, Teruhiko; Zhang, You-Fang; Karnezis, Tara; Stacker, Steven A.; Achen, Marc G.] Univ Melbourne, Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic, Australia	Peter Maccallum Cancer Center; Royal Melbourne Hospital; University of Melbourne; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Melbourne	Achen, MG (corresponding author), Peter MacCallum Canc Ctr, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.	marc.achen@petermac.org		Achen, Marc/0000-0002-3791-803X; Stacker, Steven/0000-0003-4096-9273	National Health and Medical Research Council of Australia; Melbourne Research Scholarship; Victorian Government, Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Research Scholarship; Victorian Government, Australia	This work was supported by a Program Grant and Research Fellowships (to M.G.A. and S.A.S.) from the National Health and Medical Research Council of Australia, a Melbourne Research Scholarship (to N.C.H.), and funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. M.G.A. and S.A.S. are consultants to Vegenics Ltd., a company developing anticancer therapeutics.	Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Achen MG, 2006, INT J CANCER, V119, P1755, DOI 10.1002/ijc.21899; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Baldwin ME, 2002, BIOESSAYS, V24, P1030, DOI 10.1002/bies.10173; Baldwin ME, 2001, J BIOL CHEM, V276, P44307, DOI 10.1074/jbc.M106188200; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bassi DE, 2010, NEOPLASIA, V12, P516, DOI 10.1593/neo.92030; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bhardwaj S, 2003, HUM GENE THER, V14, P1451, DOI 10.1089/104303403769211664; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Byzova TV, 2002, BLOOD, V99, P4434, DOI 10.1182/blood.V99.12.4434; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Erber R, 2003, FASEB J, V17, P338, DOI 10.1096/fj.03-0271fje; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Haiko P, 2008, MOL CELL BIOL, V28, P4843, DOI 10.1128/MCB.02214-07; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Karpanen T, 2001, CANCER RES, V61, P1786; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kopfstein L, 2007, AM J PATHOL, V170, P1348, DOI 10.2353/ajpath.2007.060835; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rutanen J, 2003, CARDIOVASC RES, V59, P971, DOI 10.1016/S0008-6363(03)00518-2; Rutanen J, 2004, CIRCULATION, V109, P1029, DOI 10.1161/01.CIR.0000115519.03688.A2; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Shojaei F, 2007, LAB INVEST, V87, P227, DOI 10.1038/labinvest.3700526; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tuttle TM, 2004, AM SURGEON, V70, P407; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Von Marschall Z, 2005, INT J ONCOL, V27, P669; WARREN RS, 1995, J CLIN INVEST, V95, P1789, DOI 10.1172/JCI117857; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Wise LM, 2003, J BIOL CHEM, V278, P38004, DOI 10.1074/jbc.M301194200; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137	50	30	32	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2615	2625		10.1096/fj.10-179788	http://dx.doi.org/10.1096/fj.10-179788			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21515745				2022-12-25	WOS:000293337800012
J	Benjdia, A; Martens, EC; Gordon, JI; Berteau, O				Benjdia, Alhosna; Martens, Eric C.; Gordon, Jeffrey I.; Berteau, Olivier			Sulfatases and a Radical S-Adenosyl-L-methionine (AdoMet) Enzyme Are Key for Mucosal Foraging and Fitness of the Prominent Human Gut Symbiont, Bacteroides thetaiotaomicron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYLGLYCINE-GENERATING ENZYME; IN-VIVO; MATURATING ENZYMES; BACTERIAL SYMBIONT; MICROBIOMES; PROKARYOTES; INTESTINE; COLITIS; SYSTEM; TWINS	The large-scale application of genomic and metagenomic sequencing technologies has yielded a number of insights about the metabolic potential of symbiotic human gut microbes. Nevertheless, the molecular basis of the interactions between commensal bacteria and their host remained to be investigated. Bacteria colonizing the mucosal layer that overlies the gut epithelium are exposed to highly sulfated glycans (i.e. mucin and glycosaminoglycans). These polymers can serve as potential nutrient sources, but their high sulfate content usually prevents their degradation. Commensal bacteria such as Bacteroides thetaiotaomicron possess more predicted sulfatase genes than in the human genome, the physiological functions of which are largely unknown. To be active, sulfatases must undergo a critical post-translational modification catalyzed in anaerobic bacteria by the radical AdoMet enzyme anaerobic sulfatase-maturating enzyme (anSME). In the present study, we have tested the role of this pathway in Bacteroides thetaiotaomicron which, in addition to 28 predicted sulfatases, possesses a single predicted anSME. In vitro studies revealed that deletion of the gene encoding its anSME (BT0238) results in loss of sulfatase activity and impaired ability to use sulfated polysaccharides as carbon sources. Co-colonization of formerly germ-free mice with both isogenic strains (i.e. wild-type or Delta anSME), or invasion experiments involving introduction of one followed by the other strain established that anSME activity and the sulfatases activated via this pathway, are important fitness factors for B. thetaiotaomicron, especially when mice are fed a simple sugar diet that requires this saccharolytic bacterium to adaptively forage on host glycans as nutrients. Whole genome transcriptional profiling of wild-type and the anSME mutant in vivo revealed that loss of this enzyme alters expression of genes involved in mucin utilization and that this disrupted ability to access mucosal glycans likely underlies the observed pronounced colonization defect. Comparative genomic analysis reveals that 100% of 46 fully sequenced human gut Bacteroidetes contain homologs of BT0238 and genes encoding sulfatases, suggesting that this is an important and evolutionarily conserved feature for bacterial adaptation to life in this habitat.	[Benjdia, Alhosna; Berteau, Olivier] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Martens, Eric C.; Gordon, Jeffrey I.] Washington Univ Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Martens, Eric C.] Univ Michigan Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Washington University (WUSTL); University of Michigan System; University of Michigan	Berteau, O (corresponding author), INRA, Micalis UMR1319, F-78352 Jouy En Josas, France.	Olivier.Berteau@jouy.inra.fr	Berteau, Olivier/AAF-9080-2019; Benjdia, Alhosna/AAM-7415-2021	Berteau, Olivier/0000-0002-3434-5168; Benjdia, Alhosna/0000-0002-3544-2541	Agence Nationale de la Recherche [ANR-08-BLAN-0224-02]; INRA department AlimH [ANSSD-2008]; National Institutes of Health [DK30292, DK084214]; Crohn's and Colitis Foundation of America; Region Ile-de-France; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084214, R01DK070977, R01DK030292, R37DK030292] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA department AlimH; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Region Ile-de-France(Region Ile-de-France); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from Agence Nationale de la Recherche (ANR-08-BLAN-0224-02), ANSSD-2008 from INRA department AlimH, the National Institutes of Health (DK30292 and DK084214), and the Crohn's and Colitis Foundation of America.; Recipient of a PhD grant from the Region Ile-de-France.	Benjdia A, 2008, J BIOL CHEM, V283, P17815, DOI 10.1074/jbc.M710074200; Benjdia A, 2007, J AM CHEM SOC, V129, P3462, DOI 10.1021/ja067175e; Benjdia A, 2007, FEBS LETT, V581, P1009, DOI 10.1016/j.febslet.2007.01.076; Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x; Benjdia A, 2009, J AM CHEM SOC, V131, P8348, DOI 10.1021/ja901571p; Berteau O, 2006, J BIOL CHEM, V281, P22464, DOI 10.1074/jbc.M602504200; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Carlson BL, 2008, J BIOL CHEM, V283, P20117, DOI 10.1074/jbc.M800217200; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lee JK, 2003, GLYCOBIOLOGY, V13, P245, DOI 10.1093/glycob/cwg018; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Osteras M, 1998, P NATL ACAD SCI USA, V95, P11394, DOI 10.1073/pnas.95.19.11394; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; SALYERS AA, 1988, APPL ENVIRON MICROB, V54, P1970, DOI 10.1128/AEM.54.8.1970-1976.1988; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; TSAI HH, 1995, GUT, V36, P570, DOI 10.1136/gut.36.4.570; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	31	102	105	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25973	25982		10.1074/jbc.M111.228841	http://dx.doi.org/10.1074/jbc.M111.228841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21507958	Green Published, hybrid			2022-12-25	WOS:000293073000056
J	Safavi-Hemami, H; Siero, WA; Kuang, ZH; Williamson, NA; Karas, JA; Page, LR; MacMillan, D; Callaghan, B; Kompella, SN; Adams, DJ; Norton, RS; Purcell, AW				Safavi-Hemami, Helena; Siero, William A.; Kuang, Zhihe; Williamson, Nicholas A.; Karas, John A.; Page, Louise R.; MacMillan, David; Callaghan, Brid; Kompella, Shiva Nag; Adams, David J.; Norton, Raymond S.; Purcell, Anthony W.			Embryonic Toxin Expression in the Cone Snail Conus victoriae PRIMED TO KILL OR DIVERGENT FUNCTION?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; PERFORMANCE LIQUID-CHROMATOGRAPHY; ALPHA-CONOTOXINS VC1.1; TORSION ANGLE DYNAMICS; ROOT GANGLION NEURONS; MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; STRUCTURAL-CHARACTERIZATION; PROTEIN STRUCTURES; CALCIUM-CHANNELS	Predatory marine cone snails (genus Conus) utilize complex venoms mainly composed of small peptide toxins that target voltage-and ligand-gated ion channels in their prey. Although the venoms of a number of cone snail species have been intensively profiled and functionally characterized, nothing is known about the initiation of venom expression at an early developmental stage. Here, we report on the expression of venom mRNA in embryos of Conus victoriae and the identification of novel alpha- and O-conotoxin sequences. Embryonic toxin mRNA expression is initiated well before differentiation of the venom gland, the organ of venom biosynthesis. Structural and functional studies revealed that the embryonic alpha-conotoxins exhibit the same basic three-dimensional structure as the most abundant adult toxin but significantly differ in their neurological targets. Based on these findings, we postulate that the venom repertoire of cone snails undergoes ontogenetic changes most likely reflecting differences in the biotic interactions of these animals with their prey, predators, or competitors. To our knowledge, this is the first study to show toxin mRNA transcripts in embryos, a finding that extends our understanding of the early onset of venom expression in animals and may suggest alternative functions of peptide toxins during development.	[Safavi-Hemami, Helena; Williamson, Nicholas A.; Karas, John A.; Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Safavi-Hemami, Helena; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Siero, William A.; MacMillan, David; Norton, Raymond S.] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia; [Kuang, Zhihe] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Page, Louise R.] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; [Callaghan, Brid; Kompella, Shiva Nag; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; University of Victoria; Royal Melbourne Institute of Technology (RMIT); Monash University	Purcell, AW (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Melbourne, Vic 3010, Australia.	apurcell@unimelb.edu.au	Williamson, Nicholas A/O-9812-2016; Adams, David John/K-3578-2019; Adams, David/J-9125-2014; Callaghan, Brid/N-1764-2019; Karas, John/AAE-9729-2019; Purcell, Anthony/AAH-1942-2019; Safavi-Hemami, Helena/E-7624-2015	Williamson, Nicholas A/0000-0002-2173-3452; Adams, David John/0000-0002-7030-2288; Adams, David/0000-0002-7030-2288; Callaghan, Brid/0000-0001-7251-8851; Karas, John/0000-0002-3800-5152; Purcell, Anthony/0000-0003-0532-8331; Safavi-Hemami, Helena/0000-0002-1984-2721; Kompella, Shiva/0000-0001-5625-2491; Norton, Raymond/0000-0001-8893-0584	Australian Research Council [DP110101331]; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian Research Council Grant DP110101331 (to A. W. P. and N. A. W.).; Recipient of a National Health and Medical Research Council of Australia principal research fellowship.	Arredondo J, 2002, J CELL BIOL, V159, P325, DOI 10.1083/jcb.200206096; BALL AD, 1999, SEAGRASS FLORA FAUNA, P137; Ball Alexander D., 2002, Bollettino Malacologico, V38, P51; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Brandhorst B P, 1985, Dev Biol (N Y 1985), V1, P525; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; COLL JC, 1995, MAR BIOL, V123, P1432; Cowart JD, 2000, MAR BIOL, V136, P993, DOI 10.1007/s002270000271; Craig AG, 2001, TOXICON, V39, P809, DOI 10.1016/S0041-0101(00)00211-7; Cummins SF, 2010, PEPTIDES, V31, P394, DOI 10.1016/j.peptides.2009.10.010; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DEGNAN BM, 1995, ROUX ARCH DEV BIOL, V205, P97, DOI 10.1007/BF00188848; Drago J, 2003, CELL MOL LIFE SCI, V60, P1267, DOI 10.1007/s00018-003-2259-9; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Escoubas P, 2002, RAPID COMMUN MASS SP, V16, P403, DOI 10.1002/rcm.595; Faghih Ramin, 2007, Recent Pat CNS Drug Discov, V2, P99; FEIN A, 1971, DEV BIOL, V24, P520, DOI 10.1016/0012-1606(71)90062-5; FRANC A, 1943, THESIS FS U ALGER, P1; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gatton ML, 2006, AM J TROP MED HYG, V75, P212, DOI 10.4269/ajtmh.2006.75.212; Genikhovich G, 2006, DEV BIOL, V289, P466, DOI 10.1016/j.ydbio.2005.10.028; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haberberger RV, 2004, AUTON NEUROSCI-BASIC, V113, P32, DOI 10.1016/j.autneu.2004.05.008; Halai R, 2009, NAT PROD REP, V26, P526, DOI 10.1039/b819311h; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Heinemann SH, 2007, CELL MOL LIFE SCI, V64, P1329, DOI 10.1007/s00018-007-6565-5; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hone AJ, 2009, J NEUROCHEM, V111, P80, DOI 10.1111/j.1471-4159.2009.06299.x; HOWDEN ME, 1974, CROWN OF THORNS STAR; HOWELL AM, 1987, J MOL EVOL, V25, P29, DOI 10.1007/BF02100038; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Jakubowski JA, 2005, J EXP BIOL, V208, P2873, DOI 10.1242/jeb.01713; Jakubowski JA, 2004, J MASS SPECTROM, V39, P548, DOI 10.1002/jms.624; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; Jones A, 1996, RAPID COMMUN MASS SP, V10, P138, DOI 10.1002/(SICI)1097-0231(19960115)10:1<138::AID-RCM442>3.0.CO;2-3; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P67, DOI 10.1007/s10158-006-0039-6; Kaplan N, 2007, J MOL BIOL, V369, P553, DOI 10.1016/j.jmb.2007.02.106; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KOHN AJ, 1972, SCIENCE, V176, P49, DOI 10.1126/science.176.4030.49; KOHN AJ, 1994, J MAR BIOL ASSOC UK, V74, P744; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kurzen H, 2005, EXP DERMATOL, V14, P155, DOI 10.1111/j.0906-6705.2005.0266i.x; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Gall F, 1999, TOXICON, V37, P985, DOI 10.1016/S0041-0101(98)00227-X; LINDQUIST N, 1991, EXPERIENTIA, V47, P504, DOI 10.1007/BF01959957; LINDQUIST N, 1992, ECOL MONOGR, V62, P547, DOI 10.2307/2937316; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lips KS, 2002, NEUROSCIENCE, V115, P1, DOI 10.1016/S0306-4522(02)00274-9; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Lopez-Vera E, 2007, FEBS J, V274, P3972, DOI 10.1111/j.1742-4658.2007.05931.x; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Loughnan ML, 2004, J MED CHEM, V47, P1234, DOI 10.1021/jm031010o; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo S, 2006, J PEPT SCI, V12, P693, DOI 10.1002/psc.781; Marshall J, 2002, BIOL BULL, V203, P27, DOI 10.2307/1543455; Mastrangeli R, 2003, EUR J DERMATOL, V13, P560; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Moran Y, 2008, J MOL BIOL, V380, P437, DOI 10.1016/j.jmb.2008.05.011; Moran Y, 2009, J MOL EVOL, V69, P115, DOI 10.1007/s00239-009-9258-x; NASH MA, 1987, J CELL BIOL, V104, P1133, DOI 10.1083/jcb.104.5.1133; Nevin ST, 2007, MOL PHARMACOL, V72, P1406, DOI 10.1124/mol.107.040568; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; NYBAKKEN J, 1988, MAR BIOL, V98, P239, DOI 10.1007/BF00391200; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Olivera BM, 2002, ANNU REV ECOL SYST, V33, P25, DOI 10.1146/annurev.ecolsys.33.010802.150424; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; Pantin C. F. A., 1946, NOTES MICROSCOPICAL; Peng HS, 2004, LIFE SCI, V76, P263, DOI 10.1016/j.lfs.2004.05.031; PERRON FE, 1981, MAR BIOL, V61, P215, DOI 10.1007/BF00386662; PERRON FE, 1980, J EXP MAR BIOL ECOL, V42, P27, DOI 10.1016/0022-0981(80)90164-1; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; Safavi-Hemami H, 2010, J BIOL CHEM, V285, P12735, DOI 10.1074/jbc.M109.078691; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Slattery M, 1999, CORAL REEFS, V18, P75, DOI 10.1007/s003380050158; Stock DW, 1996, GENOMICS, V37, P234, DOI 10.1006/geno.1996.0548; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Townsend A, 2009, INT J PEPT RES THER, V15, P195, DOI 10.1007/s10989-009-9173-4; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; VREUGDENHIL E, 1988, J NEUROSCI, V8, P4184; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; Zhangsun D, 2006, CHEM BIOL DRUG DES, V68, P256, DOI 10.1111/j.1747-0285.2006.00443.x	90	26	40	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22546	22557		10.1074/jbc.M110.217703	http://dx.doi.org/10.1074/jbc.M110.217703			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21504902	hybrid, Green Published			2022-12-25	WOS:000291719900062
J	Voordeckers, K; Kimpe, M; Haesendonckx, S; Louwet, W; Versele, M; Thevelein, JM				Voordeckers, Karin; Kimpe, Marlies; Haesendonckx, Steven; Louwet, Wendy; Versele, Matthias; Thevelein, Johan M.			Yeast 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) Orthologs Pkh1-3 Differentially Regulate Phosphorylation of Protein Kinase A (PKA) and the Protein Kinase B (PKB)/S6K Ortholog Sch9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; ADENYLATE-CYCLASE; CRYSTAL-STRUCTURE; BINDING POCKET; RAS PROTEINS; DOCKING SITE; AGC KINASES; IN-VIVO	Pkh1, -2, and -3 are the yeast orthologs of mammalian 3-phosphoinositide- dependent protein kinase-1 (PDK1). Although essential for viability, their functioning remains poorly understood. Sch9, the yeast protein kinase B and/or S6K ortholog, has been identified as one of their targets. We now have shown that in vitro interaction of Pkh1 and Sch9 depends on the hydrophobic PDK1-interacting fragment pocket in Pkh1 and requires the complementary hydrophobic motif in Sch9. We demonstrated that Pkh1 phosphorylates Sch9 both in vitro and in vivo on its PDK1 site and that this phosphorylation is essential for a wild type cell size. In vivo phosphorylation on this site disappeared during nitrogen deprivation and rapidly increased again upon nitrogen resupplementation. In addition, we have shown here for the first time that the PDK1 site in protein kinase A is phosphorylated by Pkh1 in vitro, that this phosphorylation is Pkh-dependent in vivo and occurs during or shortly after synthesis of the protein kinase A catalytic subunits. Mutagenesis of the PDK1 site in Tpk1 abolished binding of the regulatory subunit and cAMP dependence. As opposed to PDK1 site phosphorylation of Sch9, phosphorylation of the PDK1 site in Tpk1 was not regulated by nitrogen availability. These results bring new insight into the control and prevalence of PDK1 site phosphorylation in yeast by Pkh protein kinases.	[Thevelein, Johan M.] VIB, Dept Mol Microbiol, B-3001 Louvain, Flanders, Belgium; Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Flanders, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Thevelein, JM (corresponding author), VIB, Dept Mol Microbiol, Kasteelpk Arenberg 31, B-3001 Louvain, Flanders, Belgium.	Johan.Thevelein@mmbio.vib-kuleuven.be	Thevelein, Johan M./AAK-4203-2021; Thevelein, Johan M./A-7897-2013	Thevelein, Johan M./0000-0002-2626-0180	Fund for Scientific Research-Flanders (FWO); Agency for Innovation by Science and Technology (IWT-Flanders); Belgian Federal Science Policy Office; Interuniversity Attraction Poles Network [P5/30, P6/14]; KULeuven	Fund for Scientific Research-Flanders (FWO)(FWO); Agency for Innovation by Science and Technology (IWT-Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Interuniversity Attraction Poles Network(Belgian Federal Science Policy Office); KULeuven(KU Leuven)	This work was supported by a Ph.D. fellowship from the Fund for Scientific Research-Flanders (FWO) (to K. V. and M. K.), a fellowship from the Agency for Innovation by Science and Technology (IWT-Flanders) (to S. H.), a return grant from the Belgian Federal Science Policy Office (to M. V.), and grants from the Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network P5/30 and P6/14 and the Research Fund of the KULeuven (Concerted Research Actions) (to J. M. T.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Crauwels M, 1997, MICROBIOL-UK, V143, P2627, DOI 10.1099/00221287-143-8-2627; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; DURNEZ P, 1994, YEAST, V10, P1049, DOI 10.1002/yea.320100807; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Geyskens I, 2000, NATO SCI S A LIF SCI, V316, P117; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; LEVIN LR, 1988, SCIENCE, V240, P68, DOI 10.1126/science.2832943; LEVIN LR, 1990, MOL CELL BIOL, V10, P1066, DOI 10.1128/MCB.10.3.1066; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peeters T, 2006, P NATL ACAD SCI USA, V103, P13034, DOI 10.1073/pnas.0509644103; Portela P, 2006, CELL SIGNAL, V18, P1072, DOI 10.1016/j.cellsig.2005.09.001; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; SHOJI S, 1979, J BIOL CHEM, V254, P6211; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Tang Y, 2004, GENETICS, V168, P1843, DOI 10.1534/genetics.104.032466; TODA T, 1988, GENE DEV, V2, P517, DOI 10.1101/gad.2.5.517; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TONERWEBB J, 1992, J BIOL CHEM, V267, P25174; Trott A, 2005, GENETICS, V170, P1009, DOI 10.1534/genetics.105.043109; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; YONEMOTO W, 1993, J BIOL CHEM, V268, P18626	53	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22017	22027		10.1074/jbc.M110.200071	http://dx.doi.org/10.1074/jbc.M110.200071			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531713	Green Published, hybrid			2022-12-25	WOS:000291719900008
J	Hammani, K; des Francs-Small, CC; Takenaka, M; Tanz, SK; Okuda, K; Shikanai, T; Brennicke, A; Small, I				Hammani, Kamel; des Francs-Small, Catherine Colas; Takenaka, Mizuki; Tanz, Sandra K.; Okuda, Kenji; Shikanai, Toshiharu; Brennicke, Axel; Small, Ian			The Pentatricopeptide Repeat Protein OTP87 Is Essential for RNA Editing of nad7 and atp1 Transcripts in Arabidopsis Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-ACTING ELEMENTS; PPR PROTEIN; CHLOROPLAST TRANSCRIPTS; COMPARATIVE GENOMICS; ELECTRON-TRANSPORT; MULTIPLE SITES; MESSENGER-RNA; DYW PROTEIN; IDENTIFICATION; RECOGNITION	In plant organelles, RNA editing is a post-transcriptional mechanism that converts specific cytidines to uridines in RNA of both mitochondria and plastids, altering the information encoded by the gene. The cytidine to be edited is determined by a cis-element surrounding the editing site that is specifically recognized and bound by a trans-acting factor. All the trans-acting editing factors identified so far in plant organelles are members of a large protein family, the pentatricopeptide repeat (PPR) proteins. We have identified the Organelle Transcript Processing 87 (OTP87) gene, which is required for RNA editing of the nad7-C24 and atp1-C1178 sites in Arabidopsis mitochondria. OTP87 encodes an E-subclass PPR protein with an unusually short E-domain. The recombinant protein expressed in Escherichia coli specifically binds to RNAs comprising 30 nucleotides upstream and 10 nucleotides downstream of the nad7-C24 and atp1-C1178 editing sites. The loss-of-function of OTP87 results in small plants with growth and developmental delays. In the otp87 mutant, the amount of assembled respiratory complex V (ATP synthase) is highly reduced compared with the wild type suggesting that the amino acid alteration in ATP1 caused by loss of editing at the atp1-C1178 site affects complex V assembly in mitochondria.	[Hammani, Kamel; des Francs-Small, Catherine Colas; Tanz, Sandra K.; Small, Ian] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Hammani, Kamel] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Okuda, Kenji; Shikanai, Toshiharu] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan; [Takenaka, Mizuki; Brennicke, Axel] Univ Ulm, D-89069 Ulm, Germany	University of Western Australia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kyoto University; Ulm University	Hammani, K (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	khammani@uoregon.edu	Francs-Small, Catherine Colas des/N-2992-2019; Takenaka, Mizuki/AAK-9884-2020; Takenaka, Mizuki/B-2636-2013; Small, Ian D/C-1168-2008; Small, Ian/AAR-5506-2021; Tanz, Sandra K/C-2686-2011; Francs-Small, Catherine C Colas des/E-6279-2011; Shikanai, Toshiharu/AAK-9112-2020	Francs-Small, Catherine Colas des/0000-0002-6386-5672; Takenaka, Mizuki/0000-0002-3242-5092; Takenaka, Mizuki/0000-0002-3242-5092; Small, Ian D/0000-0001-5300-1216; Small, Ian/0000-0001-5300-1216; Francs-Small, Catherine C Colas des/0000-0002-6386-5672; Tanz, Sandra/0000-0002-0632-4095; Hammani, Kamel/0000-0001-5759-5955	Australian Research Council [CE0561495]; Australian Government Department of Innovation, Industry, Science and Research [CG120098]; Centre National de la Recherche Scientifique; Deutsche Forschungsgeminschaft; Region of Alsace; University of Western Australia; Ministry of Education, Culture, Sport, Science, and Technology of Japan [17GS0316, 16085206]; Genomics for Agricultural Innovation, Ministry of Agriculture, Forestry, and Fishers of Japan [GPN0008]; Grants-in-Aid for Scientific Research [23657032] Funding Source: KAKEN	Australian Research Council(Australian Research Council); Australian Government Department of Innovation, Industry, Science and Research(Australian GovernmentDepartment of Industry, Innovation and Science); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Deutsche Forschungsgeminschaft(German Research Foundation (DFG)); Region of Alsace(Region Grand-Est); University of Western Australia; Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Genomics for Agricultural Innovation, Ministry of Agriculture, Forestry, and Fishers of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded through the Australian Research Council Centres of Excellence scheme (CE0561495), an International Science Linkages Grant (CG120098) from the Australian Government Department of Innovation, Industry, Science and Research, the Centre National de la Recherche Scientifique, the Deutsche Forschungsgeminschaft and scholarships from the Region of Alsace and the University of Western Australia.; Supported by Grants-in-aid (17GS0316 and 16085206) from the Ministry of Education, Culture, Sport, Science, and Technology of Japan and by Genomics for Agricultural Innovation (GPN0008) from the Ministry of Agriculture, Forestry, and Fishers of Japan.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; Bentolila S, 2010, PLANT PHYSIOL, V154, P1966, DOI 10.1104/pp.110.165969; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; DEPAEPE R, 1993, P NATL ACAD SCI USA, V90, P5934, DOI 10.1073/pnas.90.13.5934; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; HERNOULD M, 1993, P NATL ACAD SCI USA, V90, P2370, DOI 10.1073/pnas.90.6.2370; Hirose Tetsuro, 2004, Methods Mol Biol, V265, P333; Kobayashi Y, 2008, NUCLEIC ACIDS RES, V36, P311, DOI 10.1093/nar/gkm1026; Koprivova A, 2010, J BIOL CHEM, V285, P32192, DOI 10.1074/jbc.M110.147603; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Kuzmin EV, 2004, J BIOL CHEM, V279, P20672, DOI 10.1074/jbc.M400640200; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Meyer EH, 2009, PLANT PHYSIOL, V151, P603, DOI 10.1104/pp.109.141770; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Munshi MK, 2005, PLANT J, V44, P1036, DOI [10.1111/j.1365-313X.2005.02604, 10.1111/j.1365-313X.2005.02604.x]; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2008, MOL BIOL EVOL, V25, P1405, DOI 10.1093/molbev/msn084; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sung TY, 2010, PLANT J, V63, P499, DOI 10.1111/j.1365-313X.2010.04258.x; Takenaka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn975; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tang JW, 2010, PLANT J, V61, P456, DOI 10.1111/j.1365-313X.2009.04082.x; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Merwe JA, 2006, FEBS LETT, V580, P268, DOI 10.1016/j.febslet.2005.12.011; Verbitskiy D, 2011, FEBS LETT, V585, P700, DOI 10.1016/j.febslet.2011.01.037; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Walker NS, 2007, NUCLEIC ACIDS RES, V35, pD852, DOI 10.1093/nar/gkl795; WARMKE HE, 1978, SCIENCE, V200, P561, DOI 10.1126/science.200.4341.561; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	65	67	72	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21361	21371		10.1074/jbc.M111.230516	http://dx.doi.org/10.1074/jbc.M111.230516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21504904	Green Published, hybrid			2022-12-25	WOS:000291464700035
J	Larson, MR; Rajashankar, KR; Crowley, PJ; Kelly, C; Mitchell, TJ; Brady, LJ; Deivanayagam, C				Larson, Matthew R.; Rajashankar, Kanagalaghatta R.; Crowley, Paula J.; Kelly, Charles; Mitchell, Tim J.; Brady, L. Jeannine; Deivanayagam, Champion			Crystal Structure of the C-terminal Region of Streptococcus mutans Antigen I/II and Characterization of Salivary Agglutinin Adherence Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS; STAPHYLOCOCCUS-AUREUS; STABILIZING ISOPEPTIDE; ORAL STREPTOCOCCI; BINDING DOMAIN; SEROTYPE-C; PROTEIN; ADHESIN; IDENTIFICATION; RECEPTOR	The Streptococcus mutans antigen I/II (AgI/II) is a cell surface-localized protein that adheres to salivary components and extracellular matrix molecules. Here we report the 2.5 angstrom resolution crystal structure of the complete C-terminal region of AgI/II. The C-terminal region is comprised of three major domains: C-1, C-2, and C-3. Each domain adopts a DE-variant IgG fold, with two beta-sheets whose A and F strands are linked through an intramolecular isopeptide bond. The adherence of the C-terminal AgI/II fragments to the putative tooth surface receptor salivary agglutinin (SAG), as monitored by surface plasmon resonance, indicated that the minimal region of binding was contained within the first and second DE-variant-IgG domains (C1 and C2) of the C terminus. The minimal C-terminal region that could inhibit S. mutans adherence to SAG was also confirmed to be within the C-1 and C-2 domains. Competition experiments demonstrated that the C-and N-terminal regions of AgI/II adhere to distinct sites on SAG. A cleft formed at the intersection between these C-1 and C-2 domains bound glucose molecules from the cryo-protectant solution, revealing a putative binding site for its highly glycosylated receptor SAG. Finally, electron microscopy images confirmed the elongated structure of AgI/II and enabled building a composite tertiary model that encompasses its two distinct binding regions.	[Larson, Matthew R.; Deivanayagam, Champion] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Larson, Matthew R.; Deivanayagam, Champion] Univ Alabama, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Deivanayagam, Champion] Univ Alabama, Dept Vis Sci, Birmingham, AL 35294 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, NE Collaborat Access Team, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Crowley, Paula J.; Brady, L. Jeannine] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Kelly, Charles] Kings Coll London, Guys Hosp, Inst Dent, London SE1 9RT, England; [Mitchell, Tim J.] Univ Glasgow, Div Infect & Immun, Glasgow G12 8TA, Lanark, Scotland	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; State University System of Florida; University of Florida; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Glasgow	Deivanayagam, C (corresponding author), Univ Alabama, Dept Physiol & Biophys, 1025 18th St S,CBSE 100, Birmingham, AL 35294 USA.	champy@cbse.uab.edu	Brady, L. Jeannine/P-5059-2019	Deivanayagam, Champion/0000-0003-2972-1824; Mitchell, Timothy/0000-0002-8309-5556	National Institutes of Health [RO1 DE017737]; NIDCR [NIDCR T-32 DE0176707]; National Center for Research Resources [RR-15301]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DE017737 (to C. D.) through the Dental Academic Research Training grant NIDCR Training Grant NIDCR T-32 DE0176707 (to M. R. L.); We thank Shaan Khaled and Manisha Patel for help with the purification AgI/II fragments. M. R. L. and C. D. also thank the University of Alabama Comprehensive Cancer Center X-Ray Core. We thank the North Eastern Collaborative Access Team facility at the Advanced Photon Source/Argonne National Laboratory, which is supported by National Center for Research Resources Award RR-15301 and United States Department of Energy under Contract DE-AC02-06CH11357.	Brady LJ, 2010, MOL MICROBIOL, V77, P276, DOI 10.1111/j.1365-2958.2010.07212.x; BRADY LJ, 1992, INFECT IMMUN, V60, P1008, DOI 10.1128/IAI.60.3.1008-1017.1992; Brady LJ, 1998, INFECT IMMUN, V66, P4274; BRADY LJ, 1991, INFECT IMMUN, V59, P1803, DOI 10.1128/IAI.59.5.1803-1810.1991; Brooks W, 1997, INFECT IMMUN, V65, P3753, DOI 10.1128/IAI.65.9.3753-3758.1997; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chung WO, 2000, INFECT IMMUN, V68, P6758, DOI 10.1128/IAI.68.12.6758-6762.2000; CROWLEY PJ, 1993, INFECT IMMUN, V61, P1547, DOI 10.1128/IAI.61.4.1547-1552.1993; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; DEMUTH DR, 1990, J BIOL CHEM, V265, P7120; Demuth DR, 2001, INFECT IMMUN, V69, P5736, DOI 10.1128/IAI.69.9.5736-5741.2001; DUAN Y, 1994, INFECT IMMUN, V62, P5220, DOI 10.1128/IAI.62.12.5220-5226.1994; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; HAJISHENGALLIS G, 1994, J DENT RES, V73, P1493, DOI 10.1177/00220345940730090301; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kelly CG, 1999, NAT BIOTECHNOL, V17, P42, DOI 10.1038/5213; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leahy DJ, 1997, ANNU REV CELL DEV BI, V13, P363, DOI 10.1146/annurev.cellbio.13.1.363; Ligtenberg AJM, 2007, BIOL CHEM, V388, P1275, DOI 10.1515/BC.2007.158; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Love RM, 2000, INFECT IMMUN, V68, P1359, DOI 10.1128/IAI.68.3.1359-1365.2000; MA JKC, 1991, INFECT IMMUN, V59, P2686, DOI 10.1128/IAI.59.8.2686-2694.1991; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; Matsumoto-Nakano M, 2009, ORAL MICROBIOL IMMUN, V24, P427, DOI 10.1111/j.1399-302X.2009.00521.x; MUNRO GH, 1993, INFECT IMMUN, V61, P4590, DOI 10.1128/IAI.61.11.4590-4598.1993; Nomura R, 2006, J MED MICROBIOL, V55, P1135, DOI 10.1099/jmm.0.46609-0; Nylander A, 2011, ACTA CRYSTALLOGR F, V67, P23, DOI 10.1107/S174430911004443X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pecharki D, 2005, ORAL MICROBIOL IMMUN, V20, P366, DOI 10.1111/j.1399-302X.2005.00244.x; RUSSELL MW, 1980, INFECT IMMUN, V28, P486; RUSSELL MW, 1978, ARCH ORAL BIOL, V23, P7, DOI 10.1016/0003-9969(78)90047-X; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zeituni AE, 2010, J BACTERIOL, V192, P4103, DOI 10.1128/JB.00275-10; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	43	46	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21657	21666		10.1074/jbc.M111.231100	http://dx.doi.org/10.1074/jbc.M111.231100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21505225	Green Published, hybrid			2022-12-25	WOS:000291464700062
J	Aoyagi, K; Minashi, K; Igaki, H; Tachimori, Y; Nishimura, T; Hokamura, N; Ashida, A; Daiko, H; Ochiai, A; Muto, M; Ohtsu, A; Yoshida, T; Sasaki, H				Aoyagi, Kazuhiko; Minashi, Keiko; Igaki, Hiroyasu; Tachimori, Yuji; Nishimura, Takao; Hokamura, Norikazu; Ashida, Akio; Daiko, Hiroyuki; Ochiai, Atsushi; Muto, Manabu; Ohtsu, Atsushi; Yoshida, Teruhiko; Sasaki, Hiroki			Artificially Induced Epithelial-Mesenchymal Transition in Surgical Subjects: Its Implications in Clinical and Basic Cancer Research	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NF-KAPPA-B; GASTRIC-CANCER; DEFINITIVE CHEMORADIOTHERAPY; PREOPERATIVE CHEMORADIATION; EXPRESSION PATTERNS; ESOPHAGEAL CANCER; METASTASIS; MICROARRAYS; HEDGEHOG	Background: Surgical samples have long been used as important subjects for cancer research. In accordance with an increase of neoadjuvant therapy, biopsy samples have recently become imperative for cancer transcriptome. On the other hand, both biopsy and surgical samples are available for expression profiling for predicting clinical outcome by adjuvant therapy; however, it is still unclear whether surgical sample expression profiles are useful for prediction via biopsy samples, because little has been done about comparative gene expression profiling between the two kinds of samples. Methodology and Findings: A total of 166 samples (77 biopsy and 89 surgical) of normal and malignant lesions of the esophagus were analyzed by microarrays. Gene expression profiles were compared between biopsy and surgical samples. Artificially induced epithelial-mesenchymal transition (aiEMT) was found in the surgical samples, and also occurred in mouse esophageal epithelial cell layers under an ischemic condition. Identification of clinically significant subgroups was thought to be disrupted by the disorder of the expression profile through this aiEMT. Conclusion and Significance: This study will evoke the fundamental misinterpretation including underestimation of the prognostic evaluation power of markers by overestimation of EMT in past cancer research, and will furnish some advice for the near future as follows: 1) Understanding how long the tissues were under an ischemic condition. 2) Prevalence of biopsy samples for in vivo expression profiling with low biases on basic and clinical research. 3) Checking cancer cell contents and normal- or necrotic-tissue contamination in biopsy samples for prevalence.	[Aoyagi, Kazuhiko; Nishimura, Takao; Ashida, Akio; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Div Integrat Omics & Bioinformat, Chuo Ku, Tokyo 104, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Chuo Ku, Tokyo 104, Japan; [Igaki, Hiroyasu; Tachimori, Yuji; Hokamura, Norikazu] Natl Canc Ctr, Dept Surg, Chuo Ku, Tokyo, Japan; [Daiko, Hiroyuki] Natl Canc Ctr Hosp E, Dept Surg, Chiba, Japan; [Ochiai, Atsushi] Natl Canc Ctr Hosp E, Dept Pathol, Chiba, Japan; [Ohtsu, Atsushi] Natl Canc Ctr Hosp E, Dept Endoscopy, Chiba, Japan; [Muto, Manabu] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Sakyo Ku, Kyoto, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Kyoto University	Aoyagi, K (corresponding author), Natl Canc Ctr, Res Inst, Div Integrat Omics & Bioinformat, Chuo Ku, Tokyo 104, Japan.	hksasaki@ncc.go.jp			National Institute of Biomedical Innovation; Ministry of Health, Labour and Welfare of Japan; Princess Takamatsu Cancer Research Fund; Foundation for Promotion of Cancer Research	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Princess Takamatsu Cancer Research Fund; Foundation for Promotion of Cancer Research	This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; a Grant-in-Aid for the Third Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan; Princess Takamatsu Cancer Research Fund, and Foundation for Promotion of Cancer Research (RR: T.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aoyagi K, 2003, BIOCHEM BIOPH RES CO, V300, P915, DOI 10.1016/S0006-291X(02)02967-4; Ashida A, 2006, INT J ONCOL, V28, P1345; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Chengyin M., 2008, J CELL BIOCHEM, V104, P733; Cormac T.T., 2009, ANN NY ACAD SCI, V1177, P178; DeRisi J, 1996, NAT GENET, V14, P457; Duong C, 2007, ANN SURG ONCOL, V14, P3602, DOI 10.1245/s10434-007-9550-1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eoin P.C., 2006, P NATL ACAD SCI USA, V103, P18154; FORDOR SPA, 1991, SCIENCE, V251, P767; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Isohata N, 2009, INT J CANCER, V125, P1212, DOI 10.1002/ijc.24400; Izzo JG, 2009, DIS ESOPHAGUS, V22, P127, DOI 10.1111/j.1442-2050.2008.00884.x; Katoh M, 2009, INT J ONCOL, V34, P1737, DOI 10.3892/ijo_00000304; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Luthra R, 2006, J CLIN ONCOL, V24, P259, DOI 10.1200/JCO.2005.03.3688; Maher SG, 2009, ANN SURG, V250, P729, DOI 10.1097/SLA.0b013e3181bce7e1; Nakamura N, 2006, ONCOGENE, V25, P4245, DOI 10.1038/sj.onc.1209442; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Sano M, 2010, INT J ONCOL, V36, P321, DOI 10.3892/ijo_00000503; Tachimori Y, 2009, J THORAC CARDIOV SUR, V137, P49, DOI 10.1016/j.jtcvs.2008.05.016; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	29	19	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18196	10.1371/journal.pone.0018196	http://dx.doi.org/10.1371/journal.pone.0018196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533028	Green Published, Green Submitted, gold			2022-12-25	WOS:000290014500002
J	Scrosati, RA; Patten, RD; Lauff, RF				Scrosati, Ricardo A.; Patten, Ruth D.; Lauff, Randolph F.			Positive Interspecific Relationship between Temporal Occurrence and Abundance in Insects	PLOS ONE			English	Article							-3/2 POWER RULE; OCCUPANCY RELATIONSHIPS; MACROINVERTEBRATES	One of the most studied macroecological patterns is the interspecific abundance-occupancy relationship, which relates species distribution and abundance across space. Interspecific relationships between temporal distribution and abundance, however, remain largely unexplored. Using data for a natural assemblage of tabanid flies measured daily during spring and summer in Nova Scotia, we found that temporal occurrence (proportion of sampling dates in which a species occurred in an experimental trap) was positively related to temporal mean abundance (number of individuals collected for a species during the study period divided by the total number of sampling dates). Moreover, two models that often describe spatial abundance-occupancy relationships well, the He-Gaston and negative binomial models, explained a high amount of the variation in our temporal data. As for the spatial abundance-occupancy relationship, the (temporal) aggregation parameter, k, emerged as an important component of the hereby named interspecific temporal abundance-occurrence relationship. This may be another case in which a macroecological pattern shows similarities across space and time, and it deserves further research because it may improve our ability to forecast colonization dynamics and biological impacts.	[Scrosati, Ricardo A.; Patten, Ruth D.; Lauff, Randolph F.] St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada	Saint Francis Xavier University - Canada	Scrosati, RA (corresponding author), St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada.	rscrosat@stfx.ca	Scrosati, Ricardo A/K-6172-2016	Scrosati, Ricardo A/0000-0002-3050-132X; Patten, Ruth/0000-0002-2593-1296	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Canada Research Chairs program (CRC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs program (CRC)(Canada Research ChairsAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding was provided through grants to RAS from the Natural Sciences and Engineering Research Council of Canada (NSERC, www.nserc-crsng.gc.ca), the Canada Foundation for Innovation (CFI, www.innovation.ca), and the Canada Research Chairs program (CRC, www.chairs-chaires.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Buckley HL, 2010, J ECOL, V98, P645, DOI 10.1111/j.1365-2745.2010.01650.x; Foggo A, 2007, J ANIM ECOL, V76, P695, DOI 10.1111/j.1365-2656.2007.01245.x; FRENCH FE, 1995, J MED ENTOMOL, V32, P197, DOI 10.1093/jmedent/32.2.197; Guo QF, 2000, J ECOL, V88, P551, DOI 10.1046/j.1365-2745.2000.00466.x; He FL, 2000, AM NAT, V156, P553, DOI 10.1086/303403; Holt AR, 2002, BASIC APPL ECOL, V3, P1, DOI 10.1078/1439-1791-00083; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Lampinen R, 1996, ATLAS FLORAE EUROPAE; Mullen G. R., 2009, MED VET ENTOMOLOGY; Quinn GP, 2003, EXPT DESIGN DATA ANA; TESKEY HJ, 1990, INSECTS ARACHNIDS CA, V16; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Webb TJ, 2009, MAR ECOL PROG SER, V396, P293, DOI 10.3354/meps08253; WELLER DE, 1989, AM NAT, V133, P20, DOI 10.1086/284899; WELLER DE, 1987, ECOL MONOGR, V57, P23, DOI 10.2307/1942637; Wilson PD, 2011, GLOBAL ECOL BIOGEOGR, V20, P193, DOI 10.1111/j.1466-8238.2010.00569.x	18	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18982	10.1371/journal.pone.0018982	http://dx.doi.org/10.1371/journal.pone.0018982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533057	Green Published, gold			2022-12-25	WOS:000289719400045
J	Hofmann, RW; Jahufer, MZZ				Hofmann, Rainer W.; Jahufer, M. Z. Zulfiqhar			Tradeoff between Biomass and Flavonoid Accumulation in White Clover Reflects Contrasting Plant Strategies	PLOS ONE			English	Article							TRIFOLIUM-REPENS L.; UV-B RADIATION; WATER AVAILABILITY; RESPONSES; PRODUCTIVITY; CULTIVARS; STRESS; ROLES	An outdoor study was conducted to examine relationships between plant productivity and stress-protective phenolic plant metabolites. Twenty-two populations of the pasture legume white clover were grown for 4 1/2 months during spring and summer in Palmerston North, New Zealand. The major phenolic compounds identified and quantified by HPLC analysis were glycosides of the flavonoids quercetin and kaempferol. Multivariate analysis revealed a trade-off between flavonoid accumulation and plant productivity attributes. White clover populations with high biomass production, large leaves and thick tap roots showed low levels of quercetin glycoside accumulation and low quercetin: kaempferol ratios, while the opposite was true for less productive populations. The latter included stress-resistant ecotypes from Turkey and China, and the analysis also identified highly significant positive relationships of quercetin glycoside accumulation with plant morphology (root: shoot ratio). Importantly, a high degree of genetic variation was detected for most of the measured traits. These findings suggest merit for considering flavonoids such as quercetin as potential selection criteria in the genetic improvement of white clover and other crops.	[Hofmann, Rainer W.] Lincoln Univ, Fac Agr & Life Sci, Lincoln, New Zealand; [Hofmann, Rainer W.; Jahufer, M. Z. Zulfiqhar] AgResearch, Grasslands Res Ctr, Palmerston North, New Zealand	Lincoln University - New Zealand; AgResearch - New Zealand	Hofmann, RW (corresponding author), Lincoln Univ, Fac Agr & Life Sci, Lincoln, New Zealand.	Rainer.Hofmann@lincoln.ac.nz	Hofmann, Rainer W/D-2686-2018	Hofmann, Rainer W/0000-0002-1804-2319	Agricultural and Marketing Research and Development Trust (AGMARDT) of New Zealand [20390]	Agricultural and Marketing Research and Development Trust (AGMARDT) of New Zealand	Funding is acknowledged from the Agricultural and Marketing Research and Development Trust (AGMARDT) of New Zealand, grant number 20390, http://www.agmardt.org.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2010, NEW PHYTOL, V186, P786, DOI 10.1111/j.1469-8137.2010.03269.x; Agati G, 2009, ANN BOT-LONDON, V104, P853, DOI 10.1093/aob/mcp177; Albert A, 2009, OECOLOGIA, V160, P1, DOI 10.1007/s00442-009-1277-1; Andrews M, 2007, ANN APPL BIOL, V151, P11, DOI 10.1111/j.1744-7348.2007.00137.x; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Caradus JR, 1996, CROP SCI, V36, P900, DOI 10.2135/cropsci1996.0011183X0036000400014x; Carlsen SCK, 2008, CHEMOECOLOGY, V18, P129, DOI 10.1007/s00049-008-0402-7; Falconer D. S, 1996, INTRO QUANTITATIVE G; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Genstat, 2003, GENST WIND REL 7 1 R; Grime J. P., 2001, PLANT STRATEGIES VEG; Hofmann RW, 2011, PLANT BIOLOGY, V13, P896, DOI 10.1111/j.1438-8677.2011.00458.x; Hofmann RW, 2003, PLANT CELL ENVIRON, V26, P603, DOI 10.1046/j.1365-3040.2003.00996.x; Hofmann RW, 2003, GLOBAL CHANGE BIOL, V9, P473, DOI 10.1046/j.1365-2486.2003.00578.x; Hofmann RW, 2001, PLANT CELL ENVIRON, V24, P917, DOI 10.1046/j.1365-3040.2001.00749.x; Hofmann RW, 2000, ANN BOT-LONDON, V86, P527, DOI 10.1006/anbo.2000.1216; Jahufer MZZ, 2009, NEW ZEAL J AGR RES, V52, P407, DOI 10.1080/00288230909510523; KROONENBERG PM, 1994, COMPUT STAT DATA AN, V18, P73, DOI 10.1016/0167-9473(94)90133-3; LUKE J, 1968, NZ SOIL BUREAU B 3, V26; Maggio A, 2007, ENVIRON EXP BOT, V59, P276, DOI 10.1016/j.envexpbot.2006.02.002; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Smith GJ, 1998, J PHOTOCH PHOTOBIO A, V118, P99, DOI 10.1016/S1010-6030(98)00354-2; Watson SL., 1995, GEBEIL ANAL PACKAGE; Wery J, 2005, AUST J AGR RES, V56, P1201, DOI 10.1071/AR05066; White T. L., 1989, PREDICTING BREEDING, V1st; Wittenmyer L, 2005, J PLANT NUTR SOIL SC, V168, P531, DOI 10.1002/jpln.200520507; Woodfield D. R., 2001, Proceedings of the New Zealand Grassland Association, V63, P103	27	35	36	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18949	10.1371/journal.pone.0018949	http://dx.doi.org/10.1371/journal.pone.0018949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526153	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100039
J	Eifuku, S; De Souza, WC; Nakata, R; Ono, T; Tamura, R				Eifuku, Satoshi; De Souza, Wania C.; Nakata, Ryuzaburo; Ono, Taketoshi; Tamura, Ryoi			Neural Representations of Personally Familiar and Unfamiliar Faces in the Anterior Inferior Temporal Cortex of Monkeys	PLOS ONE			English	Article							RECOGNITION MEMORY; PERIRHINAL NEURONS; RESPONSES; ACTIVATION; IDENTITY; SYSTEM; CELLS; AREA; TERM	To investigate the neural representations of faces in primates, particularly in relation to their personal familiarity or unfamiliarity, neuronal activities were chronically recorded from the ventral portion of the anterior inferior temporal cortex (AITv) of macaque monkeys during the performance of a facial identification task using either personally familiar or unfamiliar faces as stimuli. By calculating the correlation coefficients between neuronal responses to the faces for all possible pairs of faces given in the task and then using the coefficients as neuronal population-based similarity measures between the faces in pairs, we analyzed the similarity/dissimilarity relationship between the faces, which were potentially represented by the activities of a population of the face-responsive neurons recorded in the area AITv. The results showed that, for personally familiar faces, different identities were represented by different patterns of activities of the population of AITv neurons irrespective of the view (e. g., front, 90 degrees left, etc.), while different views were not represented independently of their facial identities, which was consistent with our previous report. In the case of personally unfamiliar faces, the faces possessing different identities but presented in the same frontal view were represented as similar, which contrasts with the results for personally familiar faces. These results, taken together, outline the neuronal representations of personally familiar and unfamiliar faces in the AITv neuronal population.	[Eifuku, Satoshi; De Souza, Wania C.; Nakata, Ryuzaburo; Tamura, Ryoi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Integrat Neurosci, Toyama 930, Japan; [Ono, Taketoshi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Judo Neurophysiotherapy, Toyama 930, Japan	University of Toyama; University of Toyama	Eifuku, S (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Integrat Neurosci, Toyama 930, Japan.	se@med.u-toyama.ac.jp; rtamura@med.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Sports, Science and Technology, Japan [19500348, 18020012, 20119006]	Ministry of Education, Culture, Sports, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research (C) (19500348), Grant-in-Aid for Scientific Research on Priority Areas, "System study on higher-order brain functions", (18020012), and Grant-in-Aid for Scientific Research on Innovative Areas, "Face perception and recognition", (20119006) from the Ministry of Education, Culture, Sports, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi T, 2003, NEUROSCI RES, V47, P255, DOI 10.1016/S0168-0102(03)00202-5; Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Balas B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001223; Balas Benjamin J, 2010, Front Hum Neurosci, V4, P1, DOI 10.3389/neuro.09.001.2010; BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BRUCE V, 1986, PERCEPTION, V15, P387, DOI 10.1068/p150387; Bruce V, 1988, RECOGNISING FACES; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; De Souza WC, 2005, J NEUROPHYSIOL, V94, P1252, DOI 10.1152/jn.00949.2004; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Eifuku S, 2004, J NEUROPHYSIOL, V91, P358, DOI 10.1152/jn.00198.2003; Eifuku S, 2010, J NEUROSCI, V30, P15085, DOI 10.1523/JNEUROSCI.0471-10.2010; Ellis HD, 1997, P ROY SOC B-BIOL SCI, V264, P1085, DOI 10.1098/rspb.1997.0150; ELLIS HD, 1990, BRIT J PSYCHIAT, V157, P239, DOI 10.1192/bjp.157.2.239; Erickson CA, 1999, J NEUROSCI, V19, P10404; Erickson CA, 2000, NAT NEUROSCI, V3, P1143, DOI 10.1038/80664; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hays AV, 1982, WESCON C P, V2, P1; Herzmann G, 2004, PSYCHOPHYSIOLOGY, V41, P688, DOI 10.1111/j.1469-8986.2004.00196.x; Hirstein W, 1997, P ROY SOC B-BIOL SCI, V264, P437, DOI 10.1098/rspb.1997.0062; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kloth N, 2006, EUR J NEUROSCI, V24, P3317, DOI 10.1111/j.1460-9568.2006.05211.x; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MACPHERSON JM, 1979, BRAIN RES, V175, P183, DOI 10.1016/0006-8993(79)90530-4; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Sugiura M, 2001, NEUROIMAGE, V13, P877, DOI 10.1006/nimg.2001.0747; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	53	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18913	10.1371/journal.pone.0018913	http://dx.doi.org/10.1371/journal.pone.0018913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526206	gold, Green Published, Green Submitted			2022-12-25	WOS:000289578600037
J	Fu, G; Peng, C				Fu, G.; Peng, C.			Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells	ONCOGENE			English	Article						Nodal; ALK7; cyclin G2; FoxO3a; Smad; ovarian cancer	VERTEBRATE DEVELOPMENT; PHOSPHOINOSITIDE 3-KINASE; PROMOTES TUMORIGENESIS; DEPENDENT REGULATION; TUMOR SUPPRESSION; UP-REGULATION; FORKHEAD; APOPTOSIS; EXPRESSION; GROWTH	Nodal, a member of the transforming growth factor-beta superfamily, has been recently shown to suppress cell proliferation and to stimulate the expression of cyclin G2 (CCNG2) in human epithelial ovarian cancer cells. However, the precise mechanisms underlying these events are not fully understood. In this study, we investigated the transcriptional regulation of CCNG2 by the Nodal signaling pathway. In ovarian cancer cells, overexpression of Nodal or its receptors, activin receptor-like kinase 7 (ALK7) or ALK4, resulted in an increase in the CCNG2 promoter activity. Several putative Forkhead box class O (FoxO)3a-binding sites are present in the human CCNG2 promoter and overexpression of FoxO3a enhanced the CCNG2 promoter activity. The functional FoxO3a-binding element (FBE) was mapped to a proximal region located between -398 and -380 bp (FBE1) through deletion and mutation analyses, as well as chromatin immunoprecipitation (IP) assay. Interestingly, mutation of the FBE1 not only abolished the effect of FoxO3a, but also blocked Nodal-induced CCNG2 transcription. Nodal stimulated FoxO3a mRNA and protein expression through the canonical Smad pathway and suppressed FoxO3a inactivation by inhibiting AKT activity. Silencing of FoxO3a using small interfering RNA significantly reduced the effect of Nodal on the CCNG2 promoter activity. On the other hand, overexpression of Smad2 and Smad3 enhanced the FoxO3a-induced CCNG2 promoter activity whereas knockdown of Smad4 blocked the activity of FoxO3a. Furthermore, IP assays revealed that FoxO3a formed complexes with Smad proteins and that Nodal enhanced the binding of FoxO3a to the CCNG2 promoter. Finally, silencing of FoxO3a reversed the inhibitory effect of Nodal on cell proliferation. Taken together, these findings demonstrated that Nodal signaling promotes CCNG2 transcription by upregulating FoxO3a expression, inhibiting FoxO3a phosphorylation and enhancing its synergistic interaction with Smads. These results also suggest that FoxO3a is an important mediator of Nodal signaling in ovarian cancer cells. Oncogene (2011) 30, 3953-3966; doi:10.1038/onc.2011.127; published online 2 May 2011	[Fu, G.; Peng, C.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	York University - Canada	Peng, C (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	cpeng@yorku.ca	Fu, Guodong/AGF-1991-2022		CIHR [MOP-89931]; CIHR/OWHC	CIHR(Canadian Institutes of Health Research (CIHR)); CIHR/OWHC(Canadian Institutes of Health Research (CIHR))	This work was supported by a CIHR grant (MOP-89931) and a CIHR/OWHC Mid-Career Award to CP.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Baker K, 2008, P NATL ACAD SCI USA, V105, P13924, DOI 10.1073/pnas.0802159105; Bates S, 1996, ONCOGENE, V13, P1103; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; Cornforth AN, 2008, ONCOGENE, V27, P4422, DOI 10.1038/onc.2008.80; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Fei M, 2009, CANCER INVEST, V27, P52, DOI 10.1080/07357900802146204; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Hauck L, 2007, CIRC RES, V100, P50, DOI 10.1161/01.RES.0000254704.92532.b9; Horne MC, 1997, J BIOL CHEM, V272, P12650, DOI 10.1074/jbc.272.19.12650; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Katayama K, 2008, ONCOGENE, V27, P1677, DOI 10.1038/sj.onc.1210813; Kenney NJ, 2004, J MAMMARY GLAND BIOL, V9, P133, DOI 10.1023/B:JOMG.0000037158.91940.1c; Kim Y, 2004, CANCER RES, V64, P8980, DOI 10.1158/0008-5472.CAN-04-1926; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Li YW, 2007, J BIOL CHEM, V282, P21542, DOI 10.1074/jbc.M701978200; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Matsuyama S, 2003, CANCER RES, V63, P7791; Munir S, 2004, J BIOL CHEM, V279, P31277, DOI 10.1074/jbc.M400641200; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Papageorgiou I, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-122; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Strizzi Luigi, 2008, Breast Dis, V29, P91; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tian J, 2008, DEVELOPMENT, V135, P2649, DOI 10.1242/dev.019794; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Wang H, 2006, MOL ENDOCRINOL, V20, P2469, DOI 10.1210/me.2005-0446; Weidinger C, 2008, ENDOCR-RELAT CANCER, V15, P917, DOI 10.1677/ERC-08-0153; Xu GX, 2008, MOL BIOL CELL, V19, P4968, DOI 10.1091/mbc.E08-03-0259; Xu GX, 2006, MOL CANCER RES, V4, P235, DOI 10.1158/1541-7786.MCR-05-0174; Xu GX, 2004, J CLIN ENDOCR METAB, V89, P5523, DOI 10.1210/jc.2004-0893; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2010, CANCER RES, V70, P4709, DOI 10.1158/0008-5472.CAN-09-4524; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Zhang N, 2006, DIABETOLOGIA, V49, P506, DOI 10.1007/s00125-005-0095-1; Zhang YQ, 2008, DEV DYNAM, V237, P1255, DOI 10.1002/dvdy.21527	62	54	57	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	37					3953	3966		10.1038/onc.2011.127	http://dx.doi.org/10.1038/onc.2011.127			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	820FG	21532621				2022-12-25	WOS:000294890400005
J	Fujii, S; Tokita, K; Wada, N; Ito, K; Yamauchi, C; Ito, Y; Ochiai, A				Fujii, S.; Tokita, K.; Wada, N.; Ito, K.; Yamauchi, C.; Ito, Y.; Ochiai, A.			MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes	ONCOGENE			English	Article						EZH2/MEK-ERK pathway; histone; triple negative; breast cancer; ERBB2-overexpressing breast cancer	H3 LYSINE-27 METHYLATION; GENE-EXPRESSION; GASTRIC-CANCER; POLYCOMB; CELLS; CARCINOMAS; HER-2/NEU; PHENOTYPE; PROSTATE; ENHANCER	EZH2 overexpression occurs in various malignancies and is associated with a poor outcome. We have so far demonstrated that EZH2 downregulates the important genes such as E-cadherin and RUNX3 by increasing histone H3K27 trimethylation. However, the mechanism of EZH2 overexpression in various cancer cells remains unclear. In this study we carried out a promoter analysis of the EZH2 gene and investigated whether a survival signal that is upregulated in cancer cells is related to overexpression at the transcription level. We also explored the clinical relevance of the signaling pathway that leads to EZH2 overexpression in breast cancer and demonstrated that MEK-ERK1/2-Elk-1 pathway leads to EZH2 overexpression. The triple-negative and ERBB2-overexpressing subtypes of breast cancer are known to contain more rapidly proliferating breast cancer cells. The signaling pathway connected to EZH2 overexpression was associated with both aggressive subtypes of breast cancer. We show the significance that overexpression of histone modifier protein EZH2 in cancer cells and our study could pave the way for EZH2 inhibition to become an efficient treatment for more aggressive breast cancers. Oncogene (2011) 30, 4118-4128; doi:10.1038/onc.2011.118; published online 18 April 2011	[Fujii, S.; Tokita, K.; Yamauchi, C.; Ochiai, A.] Natl Canc Ctr Kashiwa, Div Pathol, Res Ctr Innovat Oncol, Chiba 2778577, Japan; [Wada, N.] Natl Canc Ctr Hosp E, Breast Surg Div, Chiba, Japan; [Ito, K.] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Ito, Y.] Canc Sci Inst Singapore, Proteos, Singapore	National Cancer Center - Japan; National Cancer Center - Japan; Nagasaki University	Ochiai, A (corresponding author), Natl Canc Ctr Kashiwa, Div Pathol, Res Ctr Innovat Oncol, 6-5-1 Kashiwanoha, Chiba 2778577, Japan.	aochiai@east.ncc.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21590453]; Grants-in-Aid for Scientific Research [21590453] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We wish to acknowledge the assistance of Ms Hiroko Hashimoto for cell culture support and the assistance of Mr Shinya Yanagi for making paraffin-embedded thin sections for immunohistochemistry. The research described in this report has been funded by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (21590453), to SF. Individual contributions of each author; Study concept and design; SF, AO, Acquisition of data; SF, KT, Analysis and interpretation of data; SF, KT, NW, Drafting the manuscript; SF, Critical revision of the manuscript for important intellectual content; SF, KI, YI, AO. Statistical analysis; SF, KT, NW Obtained funding; SF, Material support; NW, KI, YI, CY, Study supervision; SF.	Arai A, 2002, ONCOGENE, V21, P2641, DOI 10.1038/sj.onc.1205346; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Fujii S, 2003, HUM MOL GENET, V12, P1791, DOI 10.1093/hmg/ddg204; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Fujii S, 2008, CANCER SCI, V99, P738, DOI 10.1111/j.1349-7006.2008.00743.x; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Konecny G, 2003, J NATL CANCER I, V95, P142, DOI 10.1093/jnci/95.2.142; Korsching E, 2008, J CLIN PATHOL, V61, P553, DOI 10.1136/jcp.2008.055475; Morris DP, 2005, J BIOL CHEM, V280, P31368, DOI 10.1074/jbc.M501546200; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Raaphorst FM, 2000, AM J PATHOL, V157, P709, DOI 10.1016/S0002-9440(10)64583-X; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395	28	94	99	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	39					4118	4128		10.1038/onc.2011.118	http://dx.doi.org/10.1038/onc.2011.118			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	826ME	21499305				2022-12-25	WOS:000295357500007
J	Ko, JK; Choi, KH; Zhao, XL; Komazaki, S; Pan, Z; Weisleder, N; Ma, JJ				Ko, Jae-Kyun; Choi, Kyoung-Han; Zhao, Xiaoli; Komazaki, Shinji; Pan, Zui; Weisleder, Noah; Ma, Jianjie			A versatile single-plasmid system for tissue-specific and inducible control of gene expression in transgenic mice	FASEB JOURNAL			English	Article						cre; doxycycline; junctophilin; muscle; shRNA	OPERATED CA2+ ENTRY; RNA-INTERFERENCE; MAMMALIAN-CELLS; SKELETAL-MUSCLE; JUNCTOPHILIN TYPE-1; CHANNEL FUNCTION; U6 PROMOTER; DEFICIENCY; TRANSLATION; EFFICIENCY	We describe a novel transgenic system for tissue-specific and inducible control of gene expression in mice. The system employs a tetracycline-responsive CMV promoter that controls transcription of a short-hairpin RNA (shRNA) that remains nonfunctional until an interrupting reporter cassette is excised by Cre recombinase. Insertion of Dicer and Drosha RNase processing sites within the shRNA allows generation of siRNA to knock down a target gene efficiently. Tissue-specific shRNA expression is achieved through the use of appropriate inducer mice with tissue-specific expression of Cre. We applied this system to regulate expression of junctophilins (JPs), genes essential for maintenance of membrane ultrastructure and Ca(2+) signaling in muscle. Transgenic mice with skeletal muscle-specific expression of shRNA against JP mRNAs displayed no basal change of JP expression before treatment with doxycycline (Dox), while inducible and reversible knockdown of JPs was achieved by feeding mice with Dox-containing water. Dox-induced knockdown of JPs led to abnormal junctional membrane structure and Ca(2+) signaling in adult muscle fibers, consistent with essential roles of JPs in muscle development and function. This transgenic approach can be applied for inducible and reversible gene knockdown or gene overexpression in many different tissues, thus providing a versatile system for elucidating the physiological gene function in viable animal models.- Ko, J. -K., Choi, K. -H., Zhao, X., Komazaki, S., Pan, Z., Weisleder, N., Ma, J. A versatile single-plasmid system for tissue-specific and inducible control of gene expression in transgenic mice. FASEB J. 25, 2638 -2649 (2011). www.fasebj.org	[Ko, Jae-Kyun; Choi, Kyoung-Han; Zhao, Xiaoli; Pan, Zui; Weisleder, Noah; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Komazaki, Shinji] Saitama Med Sch, Dept Anat, Saitama, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Saitama Medical University	Ma, JJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	maj2@umdnj.edu	Weisleder, Noah L/A-7098-2013	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088; Pan, Zui/0000-0003-4105-901X	U.S. National Institutes of Health [RO1-HL069000, RO1-AG028614, K99/R00-AR054793, AHA 10SDG2630086]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR054793, R00AR054793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by U.S. National Institutes of Health grants RO1-HL069000 and RO1-AG028614 to J.M., K99/R00-AR054793 to N.W., and AHA 10SDG2630086 to X. Z.	Chang HS, 2004, AM J PATHOL, V165, P1535, DOI 10.1016/S0002-9440(10)63411-6; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ferrer-Martinez A, 2006, GENE, V384, P145, DOI 10.1016/j.gene.2006.07.042; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Freundlieb S, 1999, J GENE MED, V1, P4, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Henriksen JR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm193; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Komazaki S, 2003, FEBS LETT, V542, P69, DOI 10.1016/S0014-5793(03)00340-5; Komazaki S, 2002, FEBS LETT, V524, P225, DOI 10.1016/S0014-5793(02)03042-9; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; LI H, 2010, J BIOL CHEM; Lin XY, 2004, FEBS LETT, V577, P376, DOI 10.1016/j.febslet.2004.10.033; Mao H, 1998, ANN BIOMED ENG, V26, P666, DOI 10.1114/1.124; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; RAYMOND F, BMC GENOMICS, V11, P125; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Silva J, 2004, ONCOGENE, V23, P8401, DOI 10.1038/sj.onc.1208176; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tiscornia G, 2004, P NATL ACAD SCI USA, V101, P7347, DOI 10.1073/pnas.0402107101; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Woo JS, 2010, BIOCHEM J, V427, P125, DOI 10.1042/BJ20091225; Zhao XL, 2008, AGING CELL, V7, P561, DOI 10.1111/j.1474-9726.2008.00408.x; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhu Z, 2002, SEMIN CELL DEV BIOL, V13, P121, DOI 10.1016/S1084-9521(02)00018-6; Zhu Z, 2001, J BIOL CHEM, V276, P25222, DOI 10.1074/jbc.M101512200	41	18	19	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2638	2649		10.1096/fj.11-181560	http://dx.doi.org/10.1096/fj.11-181560			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21518849	Green Published			2022-12-25	WOS:000293337800014
J	Keeling, CI; Madilao, LL; Zerbe, P; Dullat, HK; Bohlmann, J				Keeling, Christopher I.; Madilao, Lina L.; Zerbe, Philipp; Dullat, Harpreet K.; Bohlmann, Joerg			The Primary Diterpene Synthase Products of Picea abies Levopimaradiene/Abietadiene Synthase (PaLAS) Are Epimers of a Thermally Unstable Diterpenol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABIETADIENOL/ABIETADIENAL OXIDASE PTAO; RESIN ACID BIOSYNTHESIS; ENT-KAURENE SYNTHASE; PRE-STEADY-STATE; ABIETADIENE SYNTHASE; FUNCTIONAL-CHARACTERIZATION; INITIATED CYCLIZATION; PHYSCOMITRELLA-PATENS; MONOTERPENE SYNTHASE; MUTATIONAL ANALYSIS	The levopimaradiene/abietadiene synthase from Norway spruce (Picea abies; PaLAS) has previously been reported to produce a mixture of four diterpene hydrocarbons when incubated with geranylgeranyl diphosphate as the substrate: levopimaradiene, abietadiene, neoabietadiene, and palustradiene. However, variability in the assay products observed by GC-MS of this and orthologous conifer diterpene synthases over the past 15 years suggested that these diterpenes may not be the initial enzyme assay products but are rather the products of dehydration of an unstable alcohol. We have identified epimers of the thermally unstable allylic tertiary alcohol 13-hydroxy-8(14)-abietene as the products of PaLAS. The identification of these compounds, not previously described in conifers, as the initial products of PaLAS has considerable implications for our understanding of the complexity of the biosynthetic pathway of the structurally diverse diterpene resin acids of conifer defense.	[Keeling, Christopher I.; Madilao, Lina L.; Zerbe, Philipp; Dullat, Harpreet K.; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Bohlmann, J (corresponding author), Univ British Columbia, Michael Smith Labs, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada.	bohlmann@msl.ubc.ca	Zerbe, Philipp/H-8348-2015; Zerbe, Philipp/A-2590-2013; Keeling, Christopher I./I-3371-2012	Zerbe, Philipp/0000-0001-5163-9523; Keeling, Christopher I./0000-0001-7885-8558	Natural Sciences and Engineering Research Council of Canada (NSERC); Genome British Columbia; Government of Canada through Genome Canada; University of British Columbia; Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome British Columbia; Government of Canada through Genome Canada(Genome Canada); University of British Columbia; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC; to J. B.) and by Genome British Columbia and the Government of Canada through Genome Canada in support of the Treenomix Conifer Forest Health Project (to J. B.) and the Tria Project (to J. B. and C. I. K.).; Supported in part by the University of British Columbia Distinguished University Scholars Program and a Natural Sciences and Engineering Research Council Steacie Memorial Fellowship.	ANTHONSE.T, 1973, ACTA CHEM SCAND, V27, P1073, DOI 10.3891/acta.chem.scand.27-1073; Cane DE, 1997, BIOCHEMISTRY-US, V36, P8332, DOI 10.1021/bi963018o; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Gu Q, 2006, STEROIDS, V71, P96, DOI 10.1016/j.steroids.2005.08.008; Hamberger B, 2006, BIOCHEM SOC T, V34, P1209, DOI 10.1042/BST0341209; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hyatt DC, 2005, ARCH BIOCHEM BIOPHYS, V439, P222, DOI 10.1016/j.abb.2005.05.017; Jones CG, 2008, ARCH BIOCHEM BIOPHYS, V477, P121, DOI 10.1016/j.abb.2008.05.008; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Kawaide H, 2011, FEBS J, V278, P123, DOI 10.1111/j.1742-4658.2010.07938.x; Keeling CI, 2008, P NATL ACAD SCI USA, V105, P1085, DOI 10.1073/pnas.0709466105; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Keeling CI, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-43; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; Kollner TG, 2006, ARCH BIOCHEM BIOPHYS, V448, P83, DOI 10.1016/j.abb.2005.10.011; Kollner TG, 2004, PLANT CELL, V16, P1115, DOI 10.1105/tpc.019877; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Mathis JR, 1997, BIOCHEMISTRY-US, V36, P8340, DOI 10.1021/bi963019g; Miller B, 2005, PLANT PHYSIOL, V137, P369, DOI 10.1104/pp.104.050187; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2002, P NATL ACAD SCI USA, V99, P580, DOI 10.1073/pnas.022627099; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Ro DK, 2006, PHYTOCHEMISTRY, V67, P1572, DOI 10.1016/j.phytochem.2006.01.011; Ro DK, 2005, P NATL ACAD SCI USA, V102, P8060, DOI 10.1073/pnas.0500825102; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yang NY, 2010, PHYTOCHEMISTRY, V71, P1528, DOI 10.1016/j.phytochem.2010.06.008; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607; Zhang CL, 2005, CHINESE CHEM LETT, V16, P727; Zulak KG, 2009, PLANT J, V60, P1015, DOI 10.1111/j.1365-313X.2009.04020.x	38	43	47	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21145	21153		10.1074/jbc.M111.245951	http://dx.doi.org/10.1074/jbc.M111.245951			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518766	Green Published, hybrid			2022-12-25	WOS:000291464700014
J	Redmann, V; Oresic, K; Tortorella, LL; Cook, JP; Lord, M; Tortorella, D				Redmann, Veronika; Oresic, Kristina; Tortorella, Lori L.; Cook, Jonathan P.; Lord, Michael; Tortorella, Domenico			Dislocation of Ricin Toxin A Chains in Human Cells Utilizes Selective Cellular Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; A-CHAIN; SACCHAROMYCES-CEREVISIAE; B-CHAIN; RETRO-TRANSLOCATION; GOLGI TRANSPORT; PROTEIN TOXINS; CYTOSOL; ER	Ricin is a potent A-B toxin that is transported from the cell surface to the cytosol, where it inactivates ribosomes, leading to cell death. Ricin enters cells via endocytosis, where only a minute number of ricin molecules reach the endoplasmic reticulum (ER) lumen. Subsequently, the ricin A chain traverses the ER bilayer by a process referred to as dislocation or retrograde translocation to gain access to the cytosol. To study the molecular processes of ricin A chain dislocation, we have established, for the first time, a human cell system in which enzymatically attenuated ricin toxin A chains (RTA(E177D) and RTA(Delta 177-181)) are expressed in the cell and directed to the ER. Using this human cell-based system, we found that ricin A chains underwent a rapid dislocation event that was quite distinct from the dislocation of a canonical ER soluble misfolded protein, null Hong Kong variant of alpha(1)-antitrypsin. Remarkably, ricin A chain dislocation occurred via a membrane-integrated intermediate and utilized the ER protein SEL1L for transport across the ER bilayer to inhibit protein synthesis. The data support a model in which ricin A chain dislocation occurs via a novel strategy of utilizing the hydrophobic nature of the ER membrane and selective ER components to gain access to the cytosol.	[Redmann, Veronika; Oresic, Kristina; Tortorella, Lori L.; Tortorella, Domenico] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Cook, Jonathan P.; Lord, Michael] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Icahn School of Medicine at Mount Sinai; University of Warwick	Tortorella, D (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,POB 1124, New York, NY 10029 USA.	domenico.tortorella@mssm.edu	Cook, Jonathan/D-5704-2011	Cook, Jonathan/0000-0003-3690-555X; Tortorella, Domenico/0000-0003-0961-3535	National Institutes of Health [AI060905]; Defense Threat Reduction Agency [W81XWH-10-2-0048]; Irma T. Hirschl Trust; United States Public Health Service [AI07647]; Kadlec Medical Center Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Irma T. Hirschl Trust; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Kadlec Medical Center Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI060905. This work was also supported by Defense Threat Reduction Agency Contract W81XWH-10-2-0048 and the Irma T. Hirschl Trust.; Predoctoral trainee supported in part by United States Public Health Service Institutional Research Training Award AI07647 and the Kadlec Medical Center Foundation.	Allen SCH, 2007, FEBS J, V274, P5586, DOI 10.1111/j.1742-4658.2007.06080.x; Baker BM, 2007, J BIOL CHEM, V282, P26845, DOI 10.1074/jbc.M704315200; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; CHADDOCK JA, 1993, PROTEIN ENG, V6, P425, DOI 10.1093/protein/6.4.425; Day PJ, 2001, J BIOL CHEM, V276, P7202, DOI 10.1074/jbc.M009499200; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Di Cola A, 2005, PLANT PHYSIOL, V137, P287, DOI 10.1104/pp.104.055434; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; EIKLID K, 1980, EXP CELL RES, V126, P321, DOI 10.1016/0014-4827(80)90270-0; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; FRANKEL A, 1989, MOL CELL BIOL, V9, P415, DOI 10.1128/MCB.9.2.415; Grimmer S, 2000, MOL BIOL CELL, V11, P4205, DOI 10.1091/mbc.11.12.4205; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Iversen TG, 2001, MOL BIOL CELL, V12, P2099, DOI 10.1091/mbc.12.7.2099; LEHAR SM, 1994, PROTEIN ENG, V7, P1261, DOI 10.1093/protein/7.10.1261; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Li XP, 2007, INFECT IMMUN, V75, P417, DOI 10.1128/IAI.01295-06; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Llorente A, 1998, J CELL BIOL, V140, P553, DOI 10.1083/jcb.140.3.553; LONDON E, 1989, BIOCHEM BIOPH RES CO, V160, P333, DOI 10.1016/0006-291X(89)91660-4; LORD JM, 1994, FASEB J, V8, P201, DOI 10.1096/fasebj.8.2.8119491; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; OLSNES S, 1975, EUR J BIOCHEM, V60, P281, DOI 10.1111/j.1432-1033.1975.tb21001.x; Oresic K, 2006, J BIOL CHEM, V281, P19395, DOI 10.1074/jbc.M601026200; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; SCHLOSSMAN D, 1989, MOL CELL BIOL, V9, P5012, DOI 10.1128/MCB.9.11.5012; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Teckman JH, 1996, HEPATOLOGY, V24, P1504, DOI 10.1002/hep.510240635; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	47	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21231	21238		10.1074/jbc.M111.234708	http://dx.doi.org/10.1074/jbc.M111.234708			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527639	Green Published, hybrid			2022-12-25	WOS:000291464700022
J	Xu, Z; Xiao, SB; Xu, P; Xie, Q; Cao, L; Wang, D; Luo, R; Zhong, Y; Chen, HC; Fang, LR				Xu, Zheng; Xiao, Shao-Bo; Xu, Peng; Xie, Qian; Cao, Lu; Wang, Dang; Luo, Rui; Zhong, Yao; Chen, Huan-Chun; Fang, Liu-Rong			miR-365, a Novel Negative Regulator of Interleukin-6 Gene Expression, Is Cooperatively Regulated by Sp1 and NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION FACTOR; MICRORNA; ACTIVATION; PROMOTER; PROTEIN; LIPOPOLYSACCHARIDE; PHOSPHORYLATION; INDUCTION; TARGETS	Interleukin-6 (IL-6) is a pleiotropic cytokine that plays a central role in host defense. IL-6 expression can be regulated at both a transcriptional and a post-transcriptional level. We used a combination of bioinformatics and experimental techniques to demonstrate that the miR-365 is a direct negative regulator of IL-6. Overexpression of miR-365 mimics decreased activity of a luciferase reporter containing the IL-6 3'-UTR and led to repression of IL-6 protein. In contrast, ectopic expression of a miR-365 inhibitor elevated IL-6 expression. The negative regulation of miR-365 was strictly dependent on a microRNA binding element in the 3'-UTR of IL-6 mRNA. Deletion mutant analysis of the miR-365 promoter showed that two transcription factors, Sp1 and NF-kappa B, are essential for the transcriptional regulation of miR-365. We also demonstrate that the MAPK/ERK pathway contributes to the regulation of miR-365. Furthermore, miR-365 exhibited a greater negative regulatory effect on IL-6 than hsa-let-7a, a previously identified microRNA negatively regulating IL-6. Taken together, our results show that miR-365 is a novel negative regulator of IL-6.	[Xu, Zheng; Xiao, Shao-Bo; Xu, Peng; Xie, Qian; Cao, Lu; Wang, Dang; Luo, Rui; Zhong, Yao; Chen, Huan-Chun; Fang, Liu-Rong] Huazhong Agr Univ, Coll Vet Med, Div Anim Infect Dis, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Xiao, SB (corresponding author), Huazhong Agr Univ, Coll Vet Med, Lab Anim Virol, Wuhan 430070, Peoples R China.	vet@mail.hzau.edu.cn; fanglr@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188	New Century Excellent Talent Project [NCET-07-0347]; National Natural Sciences Foundation of China [30972189, 30871871]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0726]	New Century Excellent Talent Project(Program for New Century Excellent Talents in University (NCET)); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the New Century Excellent Talent Project (NCET-07-0347), the National Natural Sciences Foundation of China (30972189, 30871871), and the Program for Changjiang Scholars and Innovative Research Team in University (IRT0726).	AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Borghaei RC, 2009, BIOCHEM BIOPH RES CO, V382, P269, DOI 10.1016/j.bbrc.2009.03.002; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kim BH, 2006, EUR J PHARMACOL, V543, P158, DOI 10.1016/j.ejphar.2006.05.042; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Narayan VA, 1997, J BIOL CHEM, V272, P7801, DOI 10.1074/jbc.272.12.7801; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; RAMBALDI A, 1993, BRIT J HAEMATOL, V83, P204, DOI 10.1111/j.1365-2141.1993.tb08273.x; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; STADE BG, 1990, IMMUNOBIOLOGY, V182, P79, DOI 10.1016/S0171-2985(11)80585-1; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Wang TY, 2001, J IMMUNOL, V167, P6924, DOI 10.4049/jimmunol.167.12.6924; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056	59	97	106	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21401	21412		10.1074/jbc.M110.198630	http://dx.doi.org/10.1074/jbc.M110.198630			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518763	hybrid, Green Published			2022-12-25	WOS:000291464700039
J	Varley, ZK; Pizzarelli, R; Antonelli, R; Stancheva, SH; Kneussel, M; Cherubini, E; Zacchi, P				Varley, Zeynep Kasap; Pizzarelli, Rocco; Antonelli, Roberta; Stancheva, Stefka H.; Kneussel, Matthias; Cherubini, Enrico; Zacchi, Paola			Gephyrin Regulates GABAergic and Glutamatergic Synaptic Transmission in Hippocampal Cell Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY SYNAPSES; GABA(A) RECEPTOR; RELEASE PROBABILITY; ADHESION MOLECULES; GLYCINE RECEPTOR; NEUREXIN COMPLEX; DEFICIENT MICE; NEUROLIGIN; NEURONS; COLLYBISTIN	Gephyrin is a scaffold protein essential for stabilizing glycine and GABA(A) receptors at inhibitory synapses. Here, recombinant intrabodies against gephyrin (scFv-gephyrin) were used to assess whether this protein exerts a transynaptic action on GABA and glutamate release. Pair recordings from interconnected hippocampal cells in culture revealed a reduced probability of GABA release in scFv-gephyrin-transfected neurons compared with controls. This effect was associated with a significant decrease in VGAT, the vesicular GABA transporter, and in neuroligin 2 (NLG2), a protein that, interacting with neurexins, ensures the cross-talk between the post-and presynaptic sites. Interestingly, hampering gephyrin function also produced a significant reduction in VGLUT, the vesicular glutamate transporter, an effect accompanied by a significant decrease in frequency of miniature excitatory postsynaptic currents. Overexpressing NLG2 in gephyrin-deprived neurons rescued GABAergic but not glutamatergic innervation, suggesting that the observed changes in the latter were not due to a homeostatic compensatory mechanism. Pulldown experiments demonstrated that gephyrin interacts not only with NLG2 but also with NLG1, the isoform enriched at excitatory synapses. These results suggest a key role of gephyrin in regulating transynaptic signaling at both inhibitory and excitatory synapses.	[Varley, Zeynep Kasap; Pizzarelli, Rocco; Antonelli, Roberta; Stancheva, Stefka H.; Cherubini, Enrico; Zacchi, Paola] Int Sch Adv Studies SISSA, Dept Neurobiol, I-34136 Trieste, Italy; [Varley, Zeynep Kasap; Pizzarelli, Rocco; Antonelli, Roberta; Stancheva, Stefka H.; Cherubini, Enrico; Zacchi, Paola] Int Sch Adv Studies SISSA, Italian Inst Technol Unit, I-34136 Trieste, Italy; [Kneussel, Matthias] Univ Hamburg, Ctr Mol Neurobiol, Zentrum Mol Neurobiol, Sch Med, D-20251 Hamburg, Germany; [Zacchi, Paola] Cluster Biomed, I-34136 Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; University of Hamburg; University Medical Center Hamburg-Eppendorf	Zacchi, P (corresponding author), SISSA, Neurobiol Sector, Via Bonomea 265, I-34136 Trieste, Italy.	zacchi@sissa.it	antonelli, roberta/AAV-2890-2021	Kneussel, Matthias/0000-0003-4900-366X	Ministero Istruzione, Universita e Ricerca (MIUR)	Ministero Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from Ministero Istruzione, Universita e Ricerca (MIUR) (to E. C.).	Anderson TR, 2004, NEUROPHARMACOLOGY, V47, P694, DOI 10.1016/j.neuropharm.2004.07.023; Andjus PR, 1997, J PHYSIOL-LONDON, V504, P103, DOI 10.1111/j.1469-7793.1997.103bf.x; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Jones MV, 2001, BIOPHYS J, V81, P2660, DOI 10.1016/S0006-3495(01)75909-7; Katz B., 1969, RELEASE NEURAL TRANS; Kneussel M, 2005, EMBO REP, V6, P22, DOI 10.1038/sj.embor.7400319; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Levinson JN, 2010, NEUROSCIENCE, V165, P782, DOI 10.1016/j.neuroscience.2009.11.016; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maas C, 2009, P NATL ACAD SCI USA, V106, P8731, DOI 10.1073/pnas.0812391106; Marchionni I, 2009, NEUROSCIENCE, V164, P552, DOI 10.1016/j.neuroscience.2009.07.063; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Studler B, 2005, J COMP NEUROL, V484, P344, DOI 10.1002/cne.20472; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; YANG J, 1993, DEV BRAIN RES, V71, P19, DOI 10.1016/0165-3806(93)90100-O; Yu WD, 2008, J NEUROCHEM, V104, P830, DOI 10.1111/j.1471-4159.2007.05014.x; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Zacchi P, 2008, J MOL NEUROSCI, V34, P141, DOI 10.1007/s12031-007-9018-6; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	44	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20942	20951		10.1074/jbc.M111.234641	http://dx.doi.org/10.1074/jbc.M111.234641			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507951	Green Published, hybrid			2022-12-25	WOS:000291267600078
J	Kendall, RT; Strungs, EG; Rachidi, SM; Lee, MH; El-Shewy, HM; Luttrell, DK; Janech, MG; Luttrell, LM				Kendall, Ryan T.; Strungs, Erik G.; Rachidi, Saleh M.; Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Janech, Michael G.; Luttrell, Louis M.			The beta-Arrestin Pathway-selective Type 1A Angiotensin Receptor (AT(1A)) Agonist [Sar(1), Ile(4), Ile(8)] Angiotensin II Regulates a Robust G Protein-independent Signaling Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ACTIVATION; PHOSPHORYLATION; KINASE; SET; CYCLOOXYGENASE-1; BETA-ARRESTIN-2; STIMULATION; COMPLEXES; SYNTHASE	The angiotensin II peptide analog [Sar(1), Ile(4), Ile(8)] AngII (SII) is a biased AT(1A) receptor agonist that stimulates receptor phosphorylation, beta-arrestin recruitment, receptor internalization, and beta-arrestin-dependent ERK1/2 activation without activating heterotrimeric G-proteins. To determine the scope of G-protein- independent AT(1A) receptor signaling, we performed a gelbased phosphoproteomic analysis of AngII and SII-induced signaling in HEK cells stably expressing AT(1A) receptors. A total of 34 differentially phosphorylated proteins were detected, of which 16 were unique to SII and eight to AngII stimulation. MALDI-TOF/TOF mass fingerprinting was employed to identify 24 SII-sensitive phosphoprotein spots, of which three (two peptide inhibitors of protein phosphatase 2A (I1PP2A and I2PP2A) and prostaglandin E synthase 3 (PGES3)) were selected for validation and further study. We found that phosphorylation of I2PP2A was associated with rapid and transient inhibition of a beta-arrestin 2-associated pool of protein phosphatase 2A, leading to activation of Akt and increased phosphorylation of glycogen synthase kinase 3 beta in an arrestin signalsome complex. SII-stimulated PGES3 phosphorylation coincided with an increase in beta-arrestin 1-associated PGES3 and an arrestin-dependent increase in cyclooxygenase 1-dependent prostaglandin E-2 synthesis. These findings suggest that AT(1A) receptors regulate a robust G protein-independent signaling network that affects protein phosphorylation and autocrine/paracrine prostaglandin production and that these pathways can be selectively modulated by biased ligands that antagonize G protein activation.	[Kendall, Ryan T.; Strungs, Erik G.; Rachidi, Saleh M.; Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Louis M.] Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA; [Luttrell, Deirdre K.; Janech, Michael G.] Med Univ S Carolina, Dept Med, Div Nephrol, Charleston, SC 29425 USA; [Janech, Michael G.; Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Luttrell, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 96 Jonathan Lucas St,MSC 624, Charleston, SC 29425 USA.	luttrell@musc.edu	janech, michael/AAA-1011-2019	Luttrell, Louis/0000-0003-2805-6949; Janech, Michael/0000-0002-3202-4811	National Institutes of Health [R01 DK055524, T32 HL07260]; Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; Nephcure Young Investigator Award; Cancer Center [P30 CA138313]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000061, UL1TR000062] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; Nephcure Young Investigator Award; Cancer Center; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK055524 (to L. M. L.) and T32 HL07260 (to R. T. K.). This work was also supported by the Research Service of the Ralph H. Johnson Veterans Affairs Medical Center (to L. M. L. and M. G. J.) and the Nephcure Young Investigator and Department of Veterans Affairs Career Development Awards (to M. G. J.). Imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 (to the Hollings Cancer Center, Medical University of South Carolina).	ALEXANDER RW, 1976, P NATL ACAD SCI USA, V73, P1617, DOI 10.1073/pnas.73.5.1617; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; CHICZ RM, 1990, METHOD ENZYMOL, V182, P392; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; GIMBRONE MA, 1975, SCIENCE, V189, P219, DOI 10.1126/science.1138377; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; Kobayashi T, 2004, BIOCHEM J, V381, P59, DOI 10.1042/BJ20040118; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Liao Y, 2010, AM J TRANSL RES, V2, P19; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Lymperopoulos A, 2009, P NATL ACAD SCI USA, V106, P5825, DOI 10.1073/pnas.0811706106; Morinelli TA, 2009, J PHARMACOL EXP THER, V330, P118, DOI 10.1124/jpet.109.151829; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Schilling M, 2008, J PROTEOME RES, V7, P4164, DOI 10.1021/pr800120f; Simon V, 2006, J BIOL CHEM, V281, P40310, DOI 10.1074/jbc.M603858200; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yu LG, 2004, J BIOL CHEM, V279, P41377, DOI 10.1074/jbc.M400017200	33	50	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19880	19891		10.1074/jbc.M111.233080	http://dx.doi.org/10.1074/jbc.M111.233080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21502318	Green Published, hybrid			2022-12-25	WOS:000291027700068
J	Albinsson, S; Skoura, A; Yu, J; DiLorenzo, A; Fernandez-Hernando, C; Offermanns, S; Miano, JM; Sessa, WC				Albinsson, Sebastian; Skoura, Athanasia; Yu, Jun; DiLorenzo, Annarita; Fernandez-Hernando, Carlos; Offermanns, Stefan; Miano, Joseph M.; Sessa, William C.			Smooth Muscle miRNAs Are Critical for Post-Natal Regulation of Blood Pressure and Vascular Function	PLOS ONE			English	Article							NEOINTIMAL LESION FORMATION; STRETCH-DEPENDENT GROWTH; SERUM RESPONSE FACTOR; ACTIN POLYMERIZATION; CELL-SURVIVAL; DIFFERENTIATION; DICER; MICRORNAS; ANGIOGENESIS; CYTOSKELETON	Phenotypic modulation of smooth muscle cells (SMCs) plays a key role in vascular disease, including atherosclerosis. Several transcription factors have been suggested to regulate phenotypic modulation of SMCs but the decisive mechanisms remain unknown. Recent reports suggest that specific microRNAs (miRNAs) are involved in SMC differentiation and vascular disease but the global role of miRNAs in postnatal vascular SMC has not been elucidated. Thus, the objective of this study was to identify the role of Dicer-dependent miRNAs for blood pressure regulation and vascular SMC contractile function and differentiation in vivo. Tamoxifen-inducible and SMC specific deletion of Dicer was achieved by Cre-Lox recombination. Deletion of Dicer resulted in a global loss of miRNAs in aortic SMC. Furthermore, Dicer-deficient mice exhibited a dramatic reduction in blood pressure due to significant loss of vascular contractile function and SMC contractile differentiation as well as vascular remodeling. Several of these results are consistent with our previous observations in SM-Dicer deficient embryos. Therefore, miRNAs are essential for maintaining blood pressure and contractile function in resistance vessels. Although the phenotype of miR-143/145 deficient mice resembles the loss of Dicer, the phenotypes of SM-Dicer KO mice were far more severe suggesting that additional miRNAs are involved in maintaining postnatal SMC differentiation.	[Albinsson, Sebastian; Skoura, Athanasia; Yu, Jun; DiLorenzo, Annarita; Fernandez-Hernando, Carlos; Sessa, William C.] Yale Univ Sch Med, Dept Pharmacol, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Miano, Joseph M.] Univ Rochester Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY USA	Yale University; Max Planck Society; University of Rochester	Albinsson, S (corresponding author), Yale Univ Sch Med, Dept Pharmacol, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011; Albinsson, Sebastian/B-4105-2010; Offermanns, Stefan/L-3313-2017; Miano, Joseph/L-5634-2018	Sessa, William C/0000-0001-5759-1938; Albinsson, Sebastian/0000-0001-6936-3967; Di Lorenzo, Annarita/0000-0003-1239-4222; Offermanns, Stefan/0000-0001-8676-6805; Miano, Joseph/0000-0001-7522-3207	Swedish Research Council; Swedish Heart Lung Foundation;  [R01 HL64793];  [R01 HL61371];  [R01 HL081190];  [RO1 HL096670];  [P01 HL70295];  [HL-62572];  [HL-091168]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070295, R01HL064793, R01HL081190, R01HL061371, R01HL096670, R01HL091168, R01HL062572] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants R01 HL64793, R01 HL61371, R01 HL081190, RO1 HL096670, P01 HL70295 to W. C. Sessa; HL-62572 and HL-091168 to JMM; a post-doctoral fellowship from the Swedish Research Council and Swedish Heart Lung Foundation to S. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; ALBINSSON S, 2010, PHYSL GENOMICS; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Murphy RA, 2005, CAN J PHYSIOL PHARM, V83, P857, DOI 10.1139/Y05-090; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Small EM, CIRCULATION, V121, P1022; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	39	100	104	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18869	10.1371/journal.pone.0018869	http://dx.doi.org/10.1371/journal.pone.0018869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526127	Green Submitted, gold, Green Published			2022-12-25	WOS:000290015800017
J	Alagramam, KN; Goodyear, RJ; Geng, RS; Furness, DN; van Aken, AFJ; Marcotti, W; Kros, CJ; Richardson, GP				Alagramam, Kumar N.; Goodyear, Richard J.; Geng, Ruishuang; Furness, David N.; van Aken, Alexander F. J.; Marcotti, Walter; Kros, Corne J.; Richardson, Guy P.			Mutations in Protocadherin 15 and Cadherin 23 Affect Tip Links and Mechanotransduction in Mammalian Sensory Hair Cells	PLOS ONE			English	Article							MECHANOELECTRICAL TRANSDUCER CHANNELS; SYNDROME TYPE 1F; HEARING-LOSS; MOUSE COCHLEA; MYOSIN VIIA; FUNCTIONAL INTERACTION; ORGANOTYPIC CULTURES; STEREOCILIARY BUNDLE; ELECTRON-MICROSCOPY; KINOCILIAL LINKS	Immunocytochemical studies have shown that protocadherin-15 (PCDH15) and cadherin-23 (CDH23) are associated with tip links, structures thought to gate the mechanotransducer channels of hair cells in the sensory epithelia of the inner ear. The present report describes functional and structural analyses of hair cells from Pcdh15(av3J) (av3J), Pcdh15(av6J) (av6J) and Cdh23(v2J) (v2J) mice. The av3J and v2J mice carry point mutations that are predicted to introduce premature stop codons in the transcripts for Pcdh15 and Cdh23, respectively, and av6J mice have an in-frame deletion predicted to remove most of the 9th cadherin ectodomain from PCDH15. Severe disruption of hair-bundle morphology is observed throughout the early-postnatal cochlea in av3J/av3J and v2J/v2J mice. In contrast, only mild-to-moderate bundle disruption is evident in the av6J/av6J mice. Hair cells from av3J/av3J mice are unaffected by aminoglycosides and fail to load with [(3)H]-gentamicin or FM1-43, compounds that permeate the hair cell's mechanotransducer channels. In contrast, hair cells from av6J/av6J mice load with both FM1-43 and [(3)H]-gentamicin, and are aminoglycoside sensitive. Transducer currents can be recorded from hair cells of all three mutants but are reduced in amplitude in all mutants and have abnormal directional sensitivity in the av3J/av3J and v2J/v2J mutants. Scanning electron microscopy of early postnatal cochlear hair cells reveals tip-link like links in av6J/av6J mice, substantially reduced numbers of links in the av3J/av3J mice and virtually none in the v2J/v2J mice. Analysis of mature vestibular hair bundles reveals an absence of tip links in the av3J/av3J and v2J/v2J mice and a reduction in av6J/av6J mice. These results therefore provide genetic evidence consistent with PCDH15 and CDH23 being part of the tip-link complex and necessary for normal mechanotransduction.	[Alagramam, Kumar N.; Geng, Ruishuang] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Goodyear, Richard J.; van Aken, Alexander F. J.; Marcotti, Walter; Kros, Corne J.; Richardson, Guy P.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Furness, David N.] Keele Univ, Sch Life Sci, Inst Sci & Technol Med, Keele, Staffs, England; [Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Case Western Reserve University; Case Western Reserve University Hospital; University of Sussex; Keele University; University of Sheffield	Alagramam, KN (corresponding author), Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.	c.j.kros@sussex.ac.uk; g.p.richardson@sussex.ac.uk	Geng, Ruishuang/F-8255-2013		NIH [R01 DC05385]; Maniglia Endowed Chair; University Hospitals Case Medical Center; Wellcome Trust [087737]; Medical Research Council [ID 59565]; Henry Smith Charity; EU; MRC [G0100798] Funding Source: UKRI; Medical Research Council [G0100798] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010816, R01DC005385] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maniglia Endowed Chair; University Hospitals Case Medical Center; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Henry Smith Charity; EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by grants from the NIH (R01 DC05385 to KA) and funds from the Maniglia Endowed Chair, University Hospitals Case Medical Center (to KA), The Wellcome Trust (grant reference number 087737 to GPR), the Medical Research Council (grant ID 59565 to CJK), the Henry Smith Charity (to DNF) and the EU (FP6 Integrated Project EuroHear to GPR and CJK). WM is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Furness DN, 2008, NEUROSCIENCE, V154, P10, DOI 10.1016/j.neuroscience.2008.02.010; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; Furness DN, 1997, P ROY SOC B-BIOL SCI, V264, P45, DOI 10.1098/rspb.1997.0007; FURNESS DN, 1986, HEARING RES, V21, P243, DOI 10.1016/0378-5955(86)90222-4; FURNESS DN, 1989, HEARING RES, V38, P95, DOI 10.1016/0378-5955(89)90131-7; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Goodyear RJ, 2003, J NEUROSCI, V23, P4878; HACKNEY CM, 1991, SCANNING MICROSCOPY, V5, P741; HACKNEY CM, 1995, AM J PHYSIOL-CELL PH, V268, pC1, DOI 10.1152/ajpcell.1995.268.1.C1; HACKNEY CM, 1992, P ROY SOC B-BIOL SCI, V248, P215, DOI 10.1098/rspb.1992.0064; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Lelli A, 2010, J NEUROSCI, V30, P11259, DOI 10.1523/JNEUROSCI.1949-10.2010; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Pawlowski KS, 2006, JARO-J ASSOC RES OTO, V7, P83, DOI 10.1007/s10162-005-0024-5; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Richardson GP, 1997, J NEUROSCI, V17, P9506; RUSSELL IJ, 1987, HEARING RES, V31, P9, DOI 10.1016/0378-5955(87)90210-3; Rzadzinska AK, 2009, NEUROSCIENCE, V158, P365, DOI 10.1016/j.neuroscience.2008.10.012; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Stepanyan R, 2009, J NEUROSCI, V29, P4023, DOI 10.1523/JNEUROSCI.4566-08.2009; Tsuprun V, 2004, BIOPHYS J, V87, P4106, DOI 10.1529/biophysj.104.049031; Zheng QY, 2006, HEARING RES, V219, P110, DOI 10.1016/j.heares.2006.06.010	51	95	96	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19183	10.1371/journal.pone.0019183	http://dx.doi.org/10.1371/journal.pone.0019183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21532990	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000290014500024
J	Boufassa, F; Saez-Cirion, A; Lechenadec, J; Zucman, D; Avettand-Fenoel, V; Venet, A; Rouzioux, C; Delfraissy, JF; Lambotte, O; Meyer, L				Boufassa, Faroudy; Saez-Cirion, Asier; Lechenadec, Jerome; Zucman, David; Avettand-Fenoel, Veronique; Venet, Alain; Rouzioux, Christine; Delfraissy, Jean-Francois; Lambotte, Olivier; Meyer, Laurence		ANRS EP36 HIV Controllers Study Gr	CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory	PLOS ONE			English	Article							LONG-TERM NONPROGRESSORS; IMMUNODEFICIENCY-VIRUS TYPE-1; NATURAL-HISTORY; ANTIRETROVIRAL THERAPY; VIRAL LOAD; CELL COUNT; RNA LEVELS; PROGRESSION; INFECTION; SEROCONVERSION	Background: There are few large published studies of HIV controllers with long-term undetectable viral load (VL). We describe the characteristics and outcomes of 81 French HIV controllers. Methods and Results: HIV controllers were defined as asymptomatic, antiretroviral-naive persons infected >= 10 years previously, with HIV-RNA < 400 copies/mL in > 90% of plasma samples. All available CD4 and VL values were collected at enrolment. Mixed-effect linear models were used to analyze CD4 cell count slopes since diagnosis. HIV controllers represented 0.31% of all patients managed in French hospitals. Patients infected through intravenous drug use were overrepresented (31%) and homosexual men were under represented (26% of men) relative to the ANRS SEROCO cohort of subjects diagnosed during the same period. HIV controllers whose VL values were always below the detection limit of the assays were compared with those who had rare "blips" (< 50% of VL values above the detection limit) or frequent blips (< 50% of VL values above the detection limit). Estimated CD4 cell counts at HIV diagnosis were similar in the three groups. CD4 cell counts remained stable after HIV diagnosis in the "no blip" group, while they fell significantly in the two other groups (-0.26 root CD4 and -0.28 root CD4/mm(3)/year in the rare and frequent blip groups, respectively). No clinical, immunological or virological progression was observed in the no blip group, while 3 immunological and/or virological events and 4 cancers were observed in the blip subgroups. Conclusions: Viral blips in HIV controllers are associated with a significant decline in CD4 T cells and may be associated with an increased risk of pathological events, possibly owing to chronic inflammation/immune activation.	[Boufassa, Faroudy; Lechenadec, Jerome; Meyer, Laurence] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Epidemiol HIV & STI Team, F-94275 Le Kremlin Bicetre, France; [Boufassa, Faroudy; Lechenadec, Jerome; Meyer, Laurence] Univ Paris 11, UMRS 1018, Le Kremlin Bicetre, France; [Saez-Cirion, Asier] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Zucman, David] Hop Foch, AP HP, Serv Med Interne, Suresnes, France; [Avettand-Fenoel, Veronique; Rouzioux, Christine] Univ Paris 05, Hop Necker, AP HP, EA3620, Paris, France; [Venet, Alain] Univ Paris 11, INSERM, U1012, Le Kremlin Bicetre, France; [Delfraissy, Jean-Francois; Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France; [Meyer, Laurence] Hop Bicetre, AP HP, Serv Sante Publ, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Boufassa, F (corresponding author), INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Epidemiol HIV & STI Team, F-94275 Le Kremlin Bicetre, France.	faroudy.boufassa@inserm.fr	Lambotte, Olivier/GRT-0160-2022; Avettand-Fenoel, Véronique/O-6285-2017; Saez-Cirion, Asier/A-8640-2008	Avettand-Fenoel, Véronique/0000-0002-7022-2990; Saez-Cirion, Asier/0000-0003-2406-7536; ABEL, Sylvie/0000-0002-3351-0547; Scott-Algara, Daniel/0000-0003-1851-503X; Cabie, Andre/0000-0003-0117-3061	ANRS (Agence Nationale de Recherches sur le Sida et les hepatites virales)	ANRS (Agence Nationale de Recherches sur le Sida et les hepatites virales)(ANRSFrench National Research Agency (ANR))	This study was funded by ANRS (Agence Nationale de Recherches sur le Sida et les hepatites virales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avettand-Fenoel V, 2008, J CLIN VIROL, V42, P399, DOI 10.1016/j.jcv.2008.03.013; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Djomand G, 2006, JAIDS-J ACQ IMM DEF, V43, P401, DOI 10.1097/01.qai.0000243117.21788.90; EASTERBROOK PJ, 1994, AIDS, V8, P1179, DOI 10.1097/00002030-199408000-00023; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Hull M, 2010, 17 C RETR OPP INF SA; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Madec Y, 2005, CLIN INFECT DIS, V40, P1350, DOI 10.1086/429318; Madec Y, 2009, JAIDS-J ACQ IMM DEF, V50, P19, DOI 10.1097/QAI.0b013e31818ce709; NOVITSKY V, 2009, J ACQ IMMUN DEF SYND, V50, P60; O'Byrne KJ, 2001, BRIT J CANCER, V85, P473, DOI 10.1054/bjoc.2001.1943; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Rodes B, 2004, AIDS, V18, P1109, DOI [10.1097/00002030-200405210-00004, 10.1097/01.aids.0000125962.16506.f9]; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Sajadi MM, 2009, JAIDS-J ACQ IMM DEF, V50, P403, DOI 10.1097/QAI.0b013e3181945f1e; Seng R, 2008, JAIDS-J ACQ IMM DEF, V49, P251, DOI 10.1097/QAI.0b013e318189a739	31	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18726	10.1371/journal.pone.0018726	http://dx.doi.org/10.1371/journal.pone.0018726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533035	gold, Green Published, Green Submitted			2022-12-25	WOS:000290014500010
J	Yochum, GS				Yochum, Gregory S.			Multiple Wnt/beta-Catenin Responsive Enhancers Align with the MYC Promoter through Long-Range Chromatin Loops	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; RNA-POLYMERASE-II; BETA-CATENIN; C-MYC; GENE-EXPRESSION; TARGET GENES; HUMAN GENOME; TRANSCRIPTION; APC; ACTIVATION	Inappropriate activation of c-Myc (MYC) gene expression by the Wnt/beta-catenin signaling pathway is required for colorectal carcinogenesis. The elevated MYC levels in colon cancer cells are attributed in part to beta-catenin/TCF4 transcription complexes that are assembled at proximal Wnt/beta-catenin responsive enhancers (WREs). Recent studies suggest that additional WREs that control MYC expression reside far upstream of the MYC transcription start site. Here, I report the characterization of five novel WREs that localize to a region over 400 kb upstream from MYC. These WREs harbor nucleosomes with post-translational histone modifications that demarcate enhancer and gene promoter regions. Using quantitative chromatin conformation capture, I show that the distal WREs are aligned with the MYC promoter through large chromatin loops. The chromatin loops are not restricted to colon cancer cells, but are also found in kidney epithelial and lung fibroblast cell lines that lack de-regulated Wnt signaling and nuclear beta-catenin/TCF4 complexes. While each chromatin loop is detected in quiescent cells, the positioning of three of the five distal enhancers with the MYC promoter is induced by serum mitogens. These findings suggest that the architecture of the MYC promoter is comprised of distal elements that are juxtaposed through large chromatin loops and that beta-catenin/TCF4 complexes utilize this conformation to activate MYC expression in colon cancer cells.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yochum, GS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA.	gsy3@psu.edu			National Institutes of Health [R01DK080805]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by National Institutes of Health grant number R01DK080805 to GSY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KELLY K, 1985, J CLIN IMMUNOL, V5, P65, DOI 10.1007/BF00915003; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Polakis P, 2000, GENE DEV, V14, P1837; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Prochownik Edward V, 2004, Expert Rev Anticancer Ther, V4, P289, DOI 10.1586/14737140.4.2.289; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200; Yochum GS, 2010, P NATL ACAD SCI USA, V107, P145, DOI 10.1073/pnas.0912294107; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08	52	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18966	10.1371/journal.pone.0018966	http://dx.doi.org/10.1371/journal.pone.0018966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533051	gold, Green Published, Green Submitted			2022-12-25	WOS:000289719400041
J	Carrete, M; Tella, JL				Carrete, Martina; Tella, Jose L.			Inter-Individual Variability in Fear of Humans and Relative Brain Size of the Species Are Related to Contemporary Urban Invasion in Birds	PLOS ONE			English	Article							BEHAVIORAL FLEXIBILITY; ECOLOGY; SUCCESS; URBANIZATION; EVOLUTION; PREDICTS; HERITABILITY; INNOVATIONS	Background: Urbanization is the most prevailing cause of habitat transformation worldwide, differing from others by its intense levels of human activity. Despite its obvious impact on wildlife, it is still unclear why and how some species are able to adapt to urban settings. One possibility is that fear of humans and vehicles could preclude most species from invading cities. Species entering urban environments might be those that are more tolerant of human disturbance (i.e., tame species). Alternatively or in addition, urban invaders could be a fraction of variable species, with "tame" individuals invading urban habitats and other individuals remaining in rural areas. Methodology: Using the contemporary urban invasion by birds in a recently established South American city, we tested both hypotheses by relating interspecific differences in invasiveness to their flight initiation distances (i.e., the distances at which birds flee from approaching cars, FID), as well as to their relative brain size (RBS), a correlate of measures of behavioral flexibility. Principal Findings: Urban invasiveness was not significantly related to species' average rural FIDs but positively related to their RBS and inter-individual variability in FID. Moreover, FIDs were consistently lower in urban than in rural conspecifics, and the FIDs of urban individuals were within the lower-range distribution of their rural conspecifics. RBS indirectly influenced urban invasion through its positive effect on inter-individual variability in FID. Conclusions/Significance: Urban invaders do not appear to be individuals from apparently tame species, but rather tame individuals from species with a variable response regarding fear of people. Given the positive relationship between RBS and inter-individual variability in FID, our results suggest that behavioural flexibility should be regarded as a specific trait encompassing variability among individuals. Further research is needed to ascertain the neurophysiological mechanisms underlying the relationship between brain size and inter-individual variability in behavioural traits.	[Carrete, Martina; Tella, Jose L.] CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Carrete, Martina] Univ Pablo de Olavide, Dept Phys Chem & Nat Syst, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Pablo de Olavide	Carrete, M (corresponding author), CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	mcarrete@upo.es	Carrete, Martina/D-2618-2017; Carrete, Martina/A-6376-2009; Tella, José L/I-3707-2015	Carrete, Martina/0000-0002-0491-2950; Tella, José L/0000-0002-3038-7424	Canal Sur Television and Repsol-YPF Foundation; Junta de AndalucA-a [P07RNM 02918]	Canal Sur Television and Repsol-YPF Foundation; Junta de AndalucA-a	This study was partially supported by Canal Sur Television and Repsol-YPF Foundation. MC was supported by an Excellence post-doctoral contract (P07RNM 02918 Project, Junta de AndalucA-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman J.M., 1999, EVOLVING BRAINS; Araujo MS, 2009, J ANIM ECOL, V78, P848, DOI 10.1111/j.1365-2656.2009.01546.x; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Bouchard J, 2009, ECOL SOC, V14; Canevari M., 1991, NUEVA GUIA AVES ARGE, VII, P517; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Carrete M, 2009, BIOL CONSERV, V142, P2002, DOI 10.1016/j.biocon.2009.02.012; Carter AJ, 2010, BEHAV ECOL, V21, P655, DOI 10.1093/beheco/arq036; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; COOKE AS, 1980, BIOL CONSERV, V18, P85, DOI 10.1016/0006-3207(80)90072-5; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dearborn DC, 2010, CONSERV BIOL, V24, P432, DOI 10.1111/j.1523-1739.2009.01328.x; DIAMOND JM, 1986, NATURE, V324, P107, DOI 10.1038/324107a0; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P261, DOI 10.1016/j.tree.2010.01.008; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Dunning J.B., 2007, CRC HDB AVIAN BODY M; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; FAHRIG L, 2009, ECOL SOC, V14; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Greenberg Russell, 2003, P175; Ikuta LA, 2003, BIOL CONSERV, V112, P447, DOI 10.1016/S0006-3207(02)00324-5; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Rodriguez-Prieto I, 2009, BEHAV ECOL, V20, P371, DOI 10.1093/beheco/arn151; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; SALVADOR S A, 1988, Hornero, V13, P78; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Travaini A, 2004, ORNITOL NEOTROP, V15, P513; White C.M., 1994, NEW WORLD VULTURES G	49	142	147	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18859	10.1371/journal.pone.0018859	http://dx.doi.org/10.1371/journal.pone.0018859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526193	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100031
J	Colin, L; Vandenhoudt, N; de Walque, S; van Driessche, B; Bergamaschi, A; Martinelli, V; Cherrier, T; Vanhulle, C; Guiguen, A; David, A; Burny, A; Herbein, G; Pancino, G; Rohr, O; Van Lint, C				Colin, Laurence; Vandenhoudt, Nathalie; de Walque, Stephane; van Driessche, Benoit; Bergamaschi, Anna; Martinelli, Valerie; Cherrier, Thomas; Vanhulle, Caroline; Guiguen, Allan; David, Annie; Burny, Arsene; Herbein, Georges; Pancino, Gianfranco; Rohr, Olivier; Van Lint, Carine			The AP-1 Binding Sites Located in the pol Gene Intragenic Regulatory Region of HIV-1 Are Important for Viral Replication	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LONG TERMINAL REPEAT; TRANSCRIPTION FACTOR AP-1; SARCOMA-ASSOCIATED HERPESVIRUS; NF-KAPPA-B; T-LYMPHOCYTES; DNA-BINDING; C-JUN; TAT PROTEIN; ACTIVATION	Our laboratory has previously identified an important intragenic region in the human immunodeficiency virus type 1 (HIV-1) genome, whose complete functional unit is composed of the 5103 fragment, the DNaseI-hypersensitive site HS7 and the 5105 fragment. These fragments (5103 and 5105) both exhibit a phorbol 12-myristate 13-acetate (PMA)-inducible enhancer activity on the herpes simplex virus thymidine kinase promoter. Here, we characterized the three previously identified AP-1 binding sites of fragment 5103 by showing the PMA-inducible in vitro binding and in vivo recruitment of c-Fos, JunB and JunD to this fragment located at the end of the pol gene. Functional analyses demonstrated that the intragenic AP-1 binding sites are fully responsible for the PMA-dependent enhancer activity of fragment 5103. Moreover, infection of T-lymphoid Jurkat and promonocytic U937 cells with wild-type and mutant viruses demonstrated that mutations of the intragenic AP-1 sites individually or in combination altered HIV-1 replication. Importantly, mutations of the three intragenic AP-1 sites led to a decreased in vivo recruitment of RNA polymerase II to the viral promoter, strongly supporting that the deleterious effect of these mutations on viral replication occurs, at least partly, at the transcriptional level. Single-round infections of monocyte-derived macrophages confirmed the importance of intragenic AP-1 sites for HIV-1 infectivity.	[Colin, Laurence; Vandenhoudt, Nathalie; de Walque, Stephane; van Driessche, Benoit; Martinelli, Valerie; Vanhulle, Caroline; Guiguen, Allan; Burny, Arsene; Van Lint, Carine] ULB, IBMM, Mol Virol Lab, Gosselies, Belgium; [Bergamaschi, Anna; David, Annie; Pancino, Gianfranco] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Cherrier, Thomas; Rohr, Olivier] Univ Strasbourg, IUT Louis Pasteur de Schiltigheim, Schiltigheim, France; [Herbein, Georges] Univ Franche Comte, Hop St Jacques, EA3186, Dept Virol,IFR133, F-25030 Besancon, France	Universite Libre de Bruxelles; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Franche-Comte; CHU Besancon	Colin, L (corresponding author), ULB, IBMM, Mol Virol Lab, Gosselies, Belgium.	olivier.rohr@iutlpa.u-strasbg.fr; cvlint@ulb.ac.be	CHERRIER, Thomas/F-8727-2018	Colin, Laurence/0000-0002-8544-7746; ROHR, Olivier/0000-0001-8992-2025; CHERRIER, Thomas/0000-0002-0707-9204	FRS-FNRS, Belgium; Action de Recherche Concertee du Ministere de la Communaute Francaise (Universite Libre de Bruxelles, ARC) [04/09-309]; Programme d'Excellence "Cibles" of the Region Wallonne; Internationale Brachet Stiftung; Agence Nationale de Recherches sur le SIDA (ANRS); French Ministry of Research and "Sidaction"; Region Wallonne [WALEO2 616295]	FRS-FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); Action de Recherche Concertee du Ministere de la Communaute Francaise (Universite Libre de Bruxelles, ARC); Programme d'Excellence "Cibles" of the Region Wallonne; Internationale Brachet Stiftung; Agence Nationale de Recherches sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); French Ministry of Research and "Sidaction"; Region Wallonne	This work was supported by grants from the Belgian National Fund for Scientific Research (FRS-FNRS, Belgium), the Televie-Program of the FRS-FNRS, the Action de Recherche Concertee du Ministere de la Communaute Francaise (Universite Libre de Bruxelles, ARC [program no. 04/09-309]), the Programme d'Excellence "Cibles" of the Region Wallonne, the Internationale Brachet Stiftung, the Agence Nationale de Recherches sur le SIDA (ANRS), the French Ministry of Research and "Sidaction". L.C. is a Research fellow of the FRS-FNRS. N.V. was a fellow of the FRIA/FNRS. S.d.W. was supported by a post-doctoral fellowship from the Region Wallonne (Program WALEO2 616295). B.V.D and A.G are Postdoctoral fellows of the FRS-FNRS. C.V.L. is Research Director of the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calomme C, 2002, J BIOL CHEM, V277, P8775, DOI 10.1074/jbc.M107441200; CANONNEHERGAUX F, 1995, J VIROL, V69, P6634, DOI 10.1128/JVI.69.11.6634-6642.1995; Chen PF, 2000, J BIOL CHEM, V275, P20382, DOI 10.1074/jbc.M001149200; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Goffin W, 2005, NUCLEIC ACIDS RES, V33, P4285, DOI 10.1093/nar/gki720; HARRICH D, 1994, J VIROL, V68, P5899, DOI 10.1128/JVI.68.9.5899-5910.1994; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hidalgo-Estevez AM, 2006, J GEN VIROL, V87, P1603, DOI 10.1099/vir.0.81637-0; Inoshima Y, 1996, J VIROL, V70, P8518, DOI 10.1128/JVI.70.12.8518-8526.1996; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; KIM JYH, 1993, J VIROL, V67, P1658, DOI 10.1128/JVI.67.3.1658-1662.1993; Krylov D, 1997, P NATL ACAD SCI USA, V94, P12274, DOI 10.1073/pnas.94.23.12274; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Li YQ, 1999, IMMUNOLOGY, V96, P524; Liebermann DA, 1998, INT J ONCOL, V12, P685; Liu YZ, 1996, AIDS, V10, P1323, DOI 10.1097/00002030-199610000-00003; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Marcello A, 2001, IUBMB LIFE, V51, P175, DOI 10.1080/152165401753544241; Marks RE, 2003, BIOCHEM BIOPH RES CO, V312, P691, DOI 10.1016/j.bbrc.2003.10.168; MARODER M, 1993, MOL ENDOCRINOL, V7, P570, DOI 10.1210/me.7.4.570; MAURER B, 1991, J VIROL, V65, P6353, DOI 10.1128/JVI.65.11.6353-6357.1991; Meiering CD, 2001, J VIROL, V75, P6547, DOI 10.1128/JVI.75.14.6547-6557.2001; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Morse BA, 1999, J VIROL, V73, P37, DOI 10.1128/JVI.73.1.37-45.1999; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; Perez-Bercoff D, 2003, J VIROL, V77, P4081, DOI 10.1128/JVI.77.7.4081-4094.2003; Prusty BK, 2005, INT J CANCER, V113, P951, DOI 10.1002/ijc.20668; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; SMITH SD, 1984, CANCER RES, V44, P5657; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; THIERRY F, 1992, J VIROL, V66, P3740, DOI 10.1128/JVI.66.6.3740-3748.1992; Ueda K, 1996, VIROLOGY, V217, P413, DOI 10.1006/viro.1996.0133; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; VANLINT C, 1994, J VIROL, V68, P2632, DOI 10.1128/JVI.68.4.2632-2648.1994; VANLINT C, 1991, J VIROL, V65, P7066, DOI 10.1128/JVI.65.12.7066-7072.1991; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1990, P NATL ACAD SCI USA, V87, P4874, DOI 10.1073/pnas.87.12.4874; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Wei P, 2005, J BIOCHEM, V138, P399, DOI 10.1093/jb/mvi136; WEISS A, 1984, J IMMUNOL, V133, P123; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; ZEICHNER SL, 1991, GENE EXPRESSION, V1, P15	64	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19084	10.1371/journal.pone.0019084	http://dx.doi.org/10.1371/journal.pone.0019084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526160	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100049
J	Dong, X; Wang, YS; Dou, GR; Hou, HY; Shi, YY; Zhang, R; Ma, K; Wu, L; Yao, LB; Cai, Y; Zhang, J				Dong, Xiao; Wang, Yu-Sheng; Dou, Guo-Rui; Hou, Hui-Yuan; Shi, Yuan-Yuan; Zhang, Rui; Ma, Ke; Wu, Lin; Yao, Li-Bo; Cai, Yan; Zhang, Jian			Influence of Dll4 via HIF-1 alpha-VEGF Signaling on the Angiogenesis of Choroidal Neovascularization under Hypoxic Conditions	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; HUMAN RPE CELLS; TARGETING HIF-1-ALPHA; VASCULAR DEVELOPMENT; EMBRYONIC LETHALITY; TUMOR ANGIOGENESIS; VEGF EXPRESSION; TUBE FORMATION; UP-REGULATION	Choroidal neovascularization (CNV) is the common pathological basis of irreversible visual impairment encountered in a variety of chorioretinal diseases; the pathogenesis of its development is complicated and still imperfectly understood. Recent studies indicated that delta-like ligand 4 (Dll4), one of the Notch family ligands might participate in the HIF-1 alpha-VEGF pathway to regulate CNV angiogenesis. But little is known about the influence and potential mechanism of Dll4/Notch signals on CNV angiogenesis. Real-time RT-PCR, Western blotting were used to analyze the expression alteration of Dll4, VEGF and HIF-1 alpha in hypoxic RF/6A cells. Immunofluorescence staining, a laser-induced rat CNV model and intravitreal injection techniques were used to confirm the relationships among these molecules in vitro and in vivo. RPE-RF/6A cell co-culture systems were used to investigate the effects of Dll4/Notch signals on CNV angiogenesis. We found that the Dll4 was involved in hypoxia signaling in CNV angiogenesis. Results from the co-culture system showed that the enhancement of Dll4 expression in RF/6A cells led to the significantly faster proliferation and stronger tube forming ability, but inhibited cells migration and invasion across a monolayer of RPE cells in hypoxic environment, while siRNA-mediated Dll4 silencing caused the opposite effects. Pharmacological disruption of Notch signaling using gamma-secretase inhibitor (GSI) produced similar, but not identical effects, to that caused by the Dll4 siRNA. In addition, the expression of several key molecules involved in the angiogenesis of CNV was altered in RF/6A cells showing constitutively active Dll4 expression. These results suggest that Dll4 play an important role in CNV angiogenesis, which appears to be regulated by HIF-1 alpha and VEGF during the progression of CNV under hypoxic conditions. Targeting Dll4/Notch signaling may facilitate further understanding of the mechanisms that underlie CNV angiogenesis.	[Dong, Xiao; Wang, Yu-Sheng; Dou, Guo-Rui; Hou, Hui-Yuan; Shi, Yuan-Yuan; Ma, Ke; Cai, Yan] Fourth Mil Med Univ, Dept Ophthalmol, Xijing Hosp, Xian 710032, Peoples R China; [Zhang, Rui; Wu, Lin; Yao, Li-Bo; Zhang, Jian] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Dong, X (corresponding author), Fourth Mil Med Univ, Dept Ophthalmol, Xijing Hosp, Xian 710032, Peoples R China.	wangys003@126.com; biozhangj@yahoo.com.cn	Hou, Huiyuan/AAI-3718-2020	Hou, Huiyuan/0000-0003-0082-8353	National Natural Science Foundation of China [30872818]; National Basic Research Program of China (973 Program) [2011CB510200]; Alexander Von Humboldt Foundation in Germany [v-81551/02085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Alexander Von Humboldt Foundation in Germany(Alexander von Humboldt Foundation)	This work was supported by grants from the National Natural Science Foundation of China (No. 30872818) and National Basic Research Program of China (973 Program/2011CB510200). The project was sponsored partly by the equipment donation from the Alexander Von Humboldt Foundation in Germany (to Y.S.W., v-81551/02085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjamaa O, 2009, AGEING RES REV, V8, P349, DOI 10.1016/j.arr.2009.06.002; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Chen Lin, 2009, Zhonghua Yi Xue Za Zhi, V89, P3106; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Dou GR, 2008, FASEB J, V22, P1606, DOI 10.1096/fj.07-9998com; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Geisen P, 2006, EXP EYE RES, V82, P608, DOI 10.1016/j.exer.2005.08.021; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hartnett ME, 2003, EXP EYE RES, V77, P593, DOI 10.1016/S0014-4835(03)00189-1; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hofmann JJ, 2007, GENE EXPR PATTERNS, V7, P461, DOI 10.1016/j.modgep.2006.11.002; Hou HY, 2010, MOL THER, V18, P1837, DOI 10.1038/mt.2010.144; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Jubb AM, 2009, BRIT J CANCER, V101, P1749, DOI 10.1038/sj.bjc.6605368; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lu F, 2009, GRAEF ARCH CLIN EXP, V247, P171, DOI 10.1007/s00417-008-0936-y; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Noguera-Troise I, 2007, NOVART FDN SYMP, V283, P238; Noguera-Troise I, 2007, NOVART FDN SYMP, V283, P121; Noguera-Troise Irene, 2007, Novartis Found Symp, V283, P106; Ottino P, 2004, MOL VIS, V10, P341; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Peterson LJ, 2007, EXP EYE RES, V84, P737, DOI 10.1016/j.exer.2006.12.012; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; SAKAMOTO T, 1995, ARCH OPHTHALMOL-CHIC, V113, P512, DOI 10.1001/archopht.1995.01100040134039; Sancho-Tello M, 2009, OPHTHALMIC RES, V41, P28, DOI 10.1159/000162263; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shutter JR, 2000, GENE DEV, V14, P1313; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Wang YS, 2002, J OCUL PHARMACOL TH, V18, P377, DOI 10.1089/10807680260218542; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Yamanda S, 2009, BLOOD, V113, P3631, DOI 10.1182/blood-2008-07-170381; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Zhang P, 2007, OPHTHALMOLOGICA, V221, P411, DOI 10.1159/000107502; Zhang P, 2009, GRAEF ARCH CLIN EXP, V247, P633, DOI 10.1007/s00417-008-1031-0; Zhao W, 2008, GRAEF ARCH CLIN EXP, V246, P1413, DOI 10.1007/s00417-008-0858-8; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	54	49	54	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18481	10.1371/journal.pone.0018481	http://dx.doi.org/10.1371/journal.pone.0018481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526177	Green Submitted, Green Published, gold			2022-12-25	WOS:000289671100005
J	Roiz, D; Neteler, M; Castellani, C; Arnoldi, D; Rizzoli, A				Roiz, David; Neteler, Markus; Castellani, Cristina; Arnoldi, Daniele; Rizzoli, Annapaola			Climatic Factors Driving Invasion of the Tiger Mosquito (Aedes albopictus) into New Areas of Trentino, Northern Italy	PLOS ONE			English	Article							WEST-NILE-VIRUS; SEASONAL ACTIVITY; CULICIDAE; DIPTERA; TEMPERATURE; SPREAD; ESTABLISHMENT; PRECIPITATION; VARIABILITY; POPULATIONS	Background: The tiger mosquito (Aedes albopictus), vector of several emerging diseases, is expanding into more northerly latitudes as well as into higher altitudes in northern Italy. Changes in the pattern of distribution of the tiger mosquito may affect the potential spread of infectious diseases transmitted by this species in Europe. Therefore, predicting suitable areas of future establishment and spread is essential for planning early prevention and control strategies. Methodology/Principal Findings: To identify the areas currently most suitable for the occurrence of the tiger mosquito in the Province of Trento, we combined field entomological observations with analyses of satellite temperature data (MODIS Land Surface Temperature: LST) and human population data. We determine threshold conditions for the survival of overwintering eggs and for adult survival using both January mean temperatures and annual mean temperatures. We show that the 0 degrees C LST threshold for January mean temperatures and the 11 degrees C threshold for annual mean temperatures provide the best predictors for identifying the areas that could potentially support populations of this mosquito. In fact, human population density and distance to human settlements appear to be less important variables affecting mosquito distribution in this area. Finally, we evaluated the future establishment and spread of this species in relation to predicted climate warming by considering the A2 scenario for 2050 statistically downscaled at regional level in which winter and annual temperatures increase by 1.5 and 1 degrees C, respectively. Conclusions/Significance: MODIS satellite LST data are useful for accurately predicting potential areas of tiger mosquito distribution and for revealing the range limits of this species in mountainous areas, predictions which could be extended to an European scale. We show that the observed trend of increasing temperatures due to climate change could facilitate further invasion of Ae. albopictus into new areas.	[Roiz, David; Neteler, Markus; Castellani, Cristina; Arnoldi, Daniele; Rizzoli, Annapaola] Fdn Edmund Mach, Dept Biodivers & Mol Ecol, Res & Innovat Ctr, San Michele All Adige, Italy; [Roiz, David] CSIC, Wetland Ecol Dept, Donana Biol Stn, E-41080 Seville, Spain	Fondazione Edmund Mach; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Roiz, D (corresponding author), Fdn Edmund Mach, Dept Biodivers & Mol Ecol, Res & Innovat Ctr, San Michele All Adige, Italy.	davidroiz@gmail.com	Rizzoli, Annapaola/J-2439-2012; Rizzoli, Annapaola/B-8583-2011; Roiz, David/F-2082-2011; Neteler, Markus/C-6328-2008	Rizzoli, Annapaola/0000-0003-3997-6783; Roiz, David/0000-0002-5819-3648; Neteler, Markus/0000-0003-1916-1966	Autonomous Province of Trento	Autonomous Province of Trento(Autonomous Province of Trento)	This work was supported by The Autonomous Province of Trento, postdoctoral project Risktiger: Risk Assessment of New Arbovirus Diseases Transmitted by Aedes albopictus (Diptera: Culicidae) in the Autonomous Province of Trento, Principal Investigator and Researcher: David Roiz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Andreadis TG, 2009, J AM MOSQUITO CONTR, V25, P25, DOI 10.2987/08-5813.1; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bohm R, 2001, INT J CLIMATOL, V21, P1779, DOI 10.1002/joc.689; Brunetti M, 2006, INT J CLIMATOL, V26, P345, DOI 10.1002/joc.1251; Caffarra A, 2011, AUST J GRAPE WINE R, V17, P52, DOI 10.1111/j.1755-0238.2010.00118.x; Colombi A., 2007, EARSeL eProceedings, V6, P38; Eby M, 2009, J CLIMATE, V22, P2501, DOI 10.1175/2008JCLI2554.1; Eccel E, 2009, INT J BIOMETEOROL, V53, P273, DOI 10.1007/s00484-009-0213-8; Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6; *EUR CTR DIS PREV, 2009, DEV AED ALB RISK MAP; Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x; Ferrarese Uberto, 2004, Annali dei Musei Civici Rovereto, V19, P281; Fontenille D, 2007, ECOL CONT VECTOR-BOR, V1, P169; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; HANSON SM, 1995, J AM MOSQUITO CONTR, V11, P35; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Holick J, 2002, J AM MOSQUITO CONTR, V18, P131; Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177; Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4; Kutz FW, 2003, J AM MOSQUITO CONTR, V19, P190; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2; MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44; Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309; Neteler M., 2005, INT J GEOINFORMATICS, V1, P133; Neteler M, 2010, REMOTE SENS-BASEL, V2, P333, DOI 10.3390/rs1020333; POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589; R Core Team, 2022, R LANG ENV STAT COMP; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Richards SL, 2006, J MED ENTOMOL, V43, P976, DOI 10.1603/0022-2585(2006)43[976:SAOAAD]2.0.CO;2; Roiz D., 2007, Boletin de la SEA, V40, P523; Roiz D, 2008, J MED ENTOMOL, V45, P347, DOI 10.1603/0022-2585(2008)45[347:IDAOAA]2.0.CO;2; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2; Romi R., 2008, EUR INF DIS, V2, P98; SABATANI A, 1990, Parassitologia (Rome), V32, P301; Schaffner F, 2001, MOUSTIQUES EUROPE; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038; Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x; ZAMBURLINI R, 2003, DISINFESTAZIONE, V3, P8	46	89	92	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e14800	10.1371/journal.pone.0014800	http://dx.doi.org/10.1371/journal.pone.0014800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525991	gold, Green Published, Green Submitted			2022-12-25	WOS:000289578600001
J	Xu, B; Sun, ZL; Liu, ZJ; Guo, HY; Liu, QA; Jiang, HY; Zou, YX; Gong, YQ; Tischfield, JA; Shao, CS				Xu, Bing; Sun, Zhaoliang; Liu, Zhaojian; Guo, Haiyang; Liu, Qiao; Jiang, Haiyan; Zou, Yongxin; Gong, Yaoqin; Tischfield, Jay A.; Shao, Changshun			Replication Stress Induces Micronuclei Comprising of Aggregated DNA Double-Strand Breaks	PLOS ONE			English	Article							CELL-CYCLE PHASE; HISTONE H2AX; POLYMERASE-ALPHA; PROTEIN-A; IN-VIVO; REPAIR; APOPTOSIS; MICE; ATM; PHOSPHORYLATION	Background: Micronuclei (MN) in mammalian cells serve as a reliable biomarker of genomic instability and genotoxic exposure. Elevation of MN is commonly observed in cells bearing intrinsic genomic instability and in normal cells exposed to genotoxic agents. DNA double-strand breaks are marked by phosphorylation of H2AX at serine 139 (gamma-H2AX). One subclass of MN contains massive and uniform gamma-H2AX signals. This study tested whether this subclass of MN can be induced by replication stress. Principal Findings: We observed that a large proportion of MN, from 20% to nearly 50%, showed uniform staining by antibodies against gamma-H2AX, a marker of DNA double-strand breaks (DSBs). Such micronuclei were designated as MN-gamma-H2AX (+). We showed that such MN can be induced by chemicals that are known to cause DNA replication stress and S phase arrest. Hydroxyurea, aphidicolin and thymidine could all significantly induce MN-gamma-H2AX (+), which were formed during S phase and appeared to be derived from aggregation of DSBs. MN-gamma-H2AX (-), MN that were devoid of uniform gamma-H2AX signals, were induced to a lesser extent in terms of fold change. Paclitaxel, which inhibits the disassembly of microtubules, only induced MN-gamma-H2AX (-). The frequency of MN-gamma-H2AX (+), but not that of MN-gamma-H2AX (-), was also significantly increased in cells that experience S phase prolongation due to depletion of cell cycle regulator CUL4B. Depletion of replication protein A1 (RPA1) by RNA interference resulted in an elevation of both MN-gamma-H2AX (+) and MN-gamma-H2AX (-). Conclusions/Significance: A subclass of MN, MN-gamma-H2AX (+), can be preferentially induced by replication stress. Classification of MN according to their gamma-H2AX status may provide a more refined evaluation of intrinsic genomic instabilities and the various environmental genotoxicants.	[Xu, Bing; Sun, Zhaoliang; Liu, Zhaojian; Guo, Haiyang; Liu, Qiao; Jiang, Haiyan; Zou, Yongxin; Gong, Yaoqin; Shao, Changshun] Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Shandong, Peoples R China; [Xu, Bing; Sun, Zhaoliang; Liu, Zhaojian; Guo, Haiyang; Liu, Qiao; Jiang, Haiyan; Zou, Yongxin; Gong, Yaoqin; Shao, Changshun] Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Shandong, Peoples R China; [Tischfield, Jay A.; Shao, Changshun] Rutgers State Univ, Dept Genet, Piscataway, NJ USA	Shandong University; Shandong University; Rutgers State University New Brunswick	Xu, B (corresponding author), Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Shandong, Peoples R China.	changshun.shao@gmail.com	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342; Tischfield, Jay/0000-0003-3217-8287; guo, haiyang/0000-0001-5503-6922	National Natural Science Foundation of China [30771231, 30900804]; National Basic Research Program [2011CB966201]; National Natural Science Foundation of China for Innovative Research Group [81021001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China grants (30771231, 30900804), National Basic Research Program grant (2011CB966201) and State Program of National Natural Science Foundation of China for Innovative Research Group (81021001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Bonassi S, 2005, ENVIRON MOL MUTAGEN, V45, P258, DOI 10.1002/em.20115; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Decordier I, 2002, MUTAGENESIS, V17, P337, DOI 10.1093/mutage/17.4.337; Dmitrieva NI, 2004, P NATL ACAD SCI USA, V101, P2317, DOI 10.1073/pnas.0308463100; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; Fan T, 2003, CANCER RES, V63, P4677; Fauth E, 1999, MUTAT RES-GEN TOX EN, V440, P147, DOI 10.1016/S1383-5718(99)00021-2; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GRAWE J, 1992, CYTOMETRY, V13, P750, DOI 10.1002/cyto.990130711; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; HEDDLE JA, 1991, ENVIRON MOL MUTAGEN, V18, P277, DOI 10.1002/em.2850180414; HILL AB, 1985, CANCER RES, V45, P5050; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; ISHII Y, 1980, MUTAT RES, V79, P19, DOI 10.1016/0165-1218(80)90144-5; Kurose A, 2006, CYTOM PART A, V69A, P212, DOI 10.1002/cyto.a.20241; Kurose A, 2005, CYTOM PART A, V68A, P1, DOI 10.1002/cyto.a.20186; Liu ZJ, 2009, MUTAT RES-FUND MOL M, V662, P75, DOI 10.1016/j.mrfmmm.2008.12.009; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MARASCHIO P, 1992, ANN HUM GENET, V56, P273, DOI 10.1111/j.1469-1809.1992.tb01152.x; Meintieres S, 2001, MUTAGENESIS, V16, P243, DOI 10.1093/mutage/16.3.243; Norppa H, 2003, MUTAGENESIS, V18, P221, DOI 10.1093/mutage/18.3.221; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; ROSIN MP, 1985, HUM GENET, V71, P187, DOI 10.1007/BF00284570; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Shao CS, 1999, P NATL ACAD SCI USA, V96, P9230, DOI 10.1073/pnas.96.16.9230; Shima N, 2003, GENETICS, V163, P1031; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; SPEICHER LA, 1992, CANCER RES, V52, P4433; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; TIMSON J, 1975, MUTAT RES, V32, P115, DOI 10.1016/0165-1110(75)90002-0; TINWELL H, 1994, CARCINOGENESIS, V15, P1499, DOI 10.1093/carcin/15.8.1499; Turner JMA, 2001, J CELL SCI, V114, P3367; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; YANG SJ, 1966, EXP CELL RES, V42, P130, DOI 10.1016/0014-4827(66)90326-0; Yasui M, 2010, MUTAT RES-FUND MOL M, V692, P12, DOI 10.1016/j.mrfmmm.2010.07.009; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	45	62	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18618	10.1371/journal.pone.0018618	http://dx.doi.org/10.1371/journal.pone.0018618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525980	Green Submitted, Green Published, gold			2022-12-25	WOS:000289578600019
J	Barathi, VA; Weon, SR; Tan, QSW; Lin, KJ; Tong, L; Beuerman, RW				Barathi, V. A.; Weon, Sung R.; Tan, Queenie S. W.; Lin, Kwan J.; Tong, Louis; Beuerman, Roger W.			Transglutaminases (TGs) in Ocular and Periocular Tissues: Effect of Muscarinic Agents on TGs in Scleral Fibroblasts	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; CROSS-LINKING; RETINOIC ACID; EXTRACELLULAR-MATRIX; CELL-GROWTH; EXPRESSION; DIFFERENTIATION; FIBRONECTIN; HYPERPROLIFERATION; CONJUNCTIVA	Objective: To investigate the expression of transglutaminases (TGs) in the ocular surface, the eyelid margin and associated glands and to determine effect of muscarinic agents on TGs in scleral fibroblasts (SF). Materials and Methods: Primary SFs cultured from mouse and human sclera were treated with atropine and carbachol for 5 days. Lysed cell RNA was used for real-time PCR, protein was used for Western blot analysis and TG-2 transamidase activity was measured by ELISA. Immunohistochemistry was done to determine the expression of TGases. Results: Immunohistochemistry and western blot confirmed the expression of TGs-1, 2, 3 and 5 proteins in cultured SFs and eye tissues. Real time PCR showed TG-1, 2, 5 transcript levels to be down regulated 3 fold (p < 0.05) in cultured human and mouse SFs after incubation with atropine and this was reversed by carbachol. However, TG-3 expression was increased with atropine and decreased with carbachol at all concentrations. Atropine abrogated the carbachol-induced activation of SF in a dose-dependent manner. TGs-1, 3, 5 were localized in the entire mouse corneal epithelium, stroma and endothelium but TG-2 was present only in the corneal subepithelium and stroma. All TGs were localized in mouse Meibomian glands however TG-2 had a weak expression. Conclusions: Our results confirm that TGs-1, 2, 3 and 5 are expressed in human SF and murine ocular tissues, eyelid and associated Meibomian glands. Real-time PCR and Western blot results showed that muscarinic antagonist down-regulates TGs-1, 2 and 5 in both cultured human and mouse SFs and upregulates TG-3. Atropine abrogated the carbachol-induced activation of SF in a dose-dependent manner. These results suggest that manipulation of TGs by way of muscarinic receptor acting drugs may be a plausible method of intervention in wound healing and scleral remodeling.	[Barathi, V. A.; Weon, Sung R.; Tan, Queenie S. W.; Lin, Kwan J.; Tong, Louis; Beuerman, Roger W.] Singapore Eye Res Inst, Ocular Dis Model Res Grp, Singapore, Singapore; [Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Tong, Louis; Beuerman, Roger W.] DUKE NUS Grad Med Sch, SRP Neurosci & Behav Disorder, Singapore, Singapore; [Beuerman, Roger W.] Natl Univ Singapore Hosp, Natl Univ Hlth Sci, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117548, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore	Barathi, VA (corresponding author), Singapore Eye Res Inst, Ocular Dis Model Res Grp, Singapore, Singapore.	vabarathi97@mac.com		Tong, Louis/0000-0002-3986-6552	National Medical Research Council of Singapore [NIG/NMRC/003/2007, NIG/NMRC/1178/2008]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This study is supported by NIG/NMRC/003/2007 and NIG/NMRC/1178/2008 from the National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; Brink N, 2000, INFLAMM RES, V49, P290, DOI 10.1007/PL00000209; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Del Bino S, 2004, BRIT J DERMATOL, V150, P658, DOI 10.1111/j.0007-0963.2004.05886.x; ELALAOUI S, 1991, INT J CANCER, V48, P221; Fuchshofer R, 2005, INVEST OPHTH VIS SCI, V46, P568, DOI 10.1167/iovs.04-0649; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; JEON WM, 1989, ANAL BIOCHEM, V182, P170, DOI 10.1016/0003-2697(89)90737-9; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kantola AK, 2008, EXP CELL RES, V314, P2488, DOI 10.1016/j.yexcr.2008.05.010; Kim Y J, 1998, Korean J Ophthalmol, V12, P6; Lind GJ, 1998, INVEST OPHTH VIS SCI, V39, P2217; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; Nakamura T, 2001, INVEST OPHTH VIS SCI, V42, P549; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; Nishida K, 1999, AM J PATHOL, V154, P331, DOI 10.1016/S0002-9440(10)65279-0; Ohtake Y, 2006, BIOMED RES-TOKYO, V27, P75, DOI 10.2220/biomedres.27.75; Priglinger SG, 2003, INVEST OPHTH VIS SCI, V44, P355, DOI 10.1167/iovs.02-0224; Priglinger SG, 2006, INVEST OPHTH VIS SCI, V47, P4990, DOI 10.1167/iovs.06-0273; Priglinger SG, 2006, INVEST OPHTH VIS SCI, V47, P3835, DOI 10.1167/iovs.05-0960; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Raghunath M, 1999, INVEST OPHTH VIS SCI, V40, P2780; SAUNDERS NA, 1993, MOL ENDOCRINOL, V7, P387, DOI 10.1210/me.7.3.387; SAUNDERS NA, 1994, J BIOL CHEM, V269, P2016; Sohn J, 2003, J CLIN INVEST, V111, P121, DOI 10.1172/JCI200315937; Stephens P, 2004, J CELL SCI, V117, P3389, DOI 10.1242/jcs.01188; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P1938, DOI 10.1167/iovs.05-1129; Toshino A, 2005, CURR EYE RES, V30, P731, DOI 10.1080/02713680591005940; Tsubota K, 1999, INVEST OPHTH VIS SCI, V40, P28; Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zhang W, 2004, CURR EYE RES, V28, P37, DOI 10.1076/ceyr.28.1.37.23493	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18326	10.1371/journal.pone.0018326	http://dx.doi.org/10.1371/journal.pone.0018326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494676	Green Published, Green Submitted, gold			2022-12-25	WOS:000289192400019
J	Legros, S; Boxus, M; Gatot, JS; Van Lint, C; Kruys, V; Kettmann, R; Twizere, JC; Dequiedt, F				Legros, S.; Boxus, M.; Gatot, J. S.; Van Lint, C.; Kruys, V.; Kettmann, R.; Twizere, J. C.; Dequiedt, F.			The HTLV-1 Tax protein inhibits formation of stress granules by interacting with histone deacetylase 6	ONCOGENE			English	Article						HTLV-I; Tax; p-bodies; stress	VIRUS TYPE-1 TAX; NF-KAPPA-B; DNA-DAMAGE-RESPONSE; T-LYMPHOTROPIC-VIRUS; I TAX; MESSENGER-RNA; PROCESSING BODIES; EIF2-ALPHA PHOSPHORYLATION; GENE-EXPRESSION; ONCOPROTEIN	Human T cell leukemia virus type-1 (HTLV-1) is the causative agent of a fatal adult T-cell leukemia. Through deregulation of multiple cellular signaling pathways the viral Tax protein has a pivotal role in T-cell transformation. In response to stressful stimuli, cells mount a cellular stress response to limit the damage that environmental forces inflict on DNA or proteins. During stress response, cells postpone the translation of most cellular mRNAs, which are gathered into cytoplasmic mRNA-silencing foci called stress granules (SGs) and allocate their available resources towards the production of dedicated stress-management proteins. Here we demonstrate that Tax controls the formation of SGs and interferes with the cellular stress response pathway. In agreement with previous reports, we observed that Tax relocates from the nucleus to the cytoplasm in response to environmental stress. We found that the presence of Tax in the cytoplasm of stressed cells prevents the formation of SGs and counteracts the shutoff of specific host proteins. Unexpectedly, nuclear localization of Tax promotes spontaneous aggregation of SGs, even in the absence of stress. Mutant analysis revealed that the SG inhibitory capacity of Tax is independent of its transcriptional abilities but relies on its interaction with histone deacetylase 6, a critical component of SGs. Importantly, the stress-protective effect of Tax was also observed in the context of HTLV-1 infected cells, which were shown to be less prone to form SGs and undergo apoptosis under arsenite exposure. These observations identify Tax as the first virally encoded inhibitory component of SGs and unravel a new strategy developed by HTLV-1 to deregulate normal cell processes. We postulate that inhibition of the stress response pathway by Tax would favor cell survival under stressful conditions and may have an important role in HTLV-1-induced cellular transformation. Oncogene (2011) 30, 4050-4062; doi:10.1038/onc.2011.120; published online 2 May 2011	[Legros, S.; Boxus, M.; Kettmann, R.; Twizere, J. C.; Dequiedt, F.] Univ Liege ULg, Gembloux Agrobio Tech, Ctr Mol & Cellular Biol, Gembloux, Belgium; [Gatot, J. S.; Van Lint, C.] Free Univ Brussels ULB, IBMM, Ctr Mol Virol, Gosselies, Belgium; [Kruys, V.] Free Univ Brussels ULB, IBMM, Ctr Mol Biol Gene, Gosselies, Belgium; [Twizere, J. C.; Dequiedt, F.] Univ Liege ULg, GIGA Res, Lab Prot Signaling & Interact, Liege, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Liege	Dequiedt, F (corresponding author), Univ Liege ULg, Gembloux Agrobio Tech, Ctr Mol & Cellular Biol, 13 Av Marechal Juin,Bat92, B-5030 Namur, Belgium.	fdequiedt@ulg.ac.be	Twizere, Jean-Claude/AAG-3706-2019; Kruys, Veronique I/N-6613-2018	Dequiedt, Franck/0000-0003-1234-7477; TWIZERE, Jean-Claude/0000-0002-8683-705X; Kruys, Veronique/0000-0002-3144-5403	Belgian Foundation Against Cancer [IUAP-BELSPOPVI/28]	Belgian Foundation Against Cancer	We thank all members of the Dequiedt laboratory for helpful and stimulating discussions. This work was supported by the Belgian National Fund for Scientific Research, the Televie (7.4613.09), the Belgian Foundation Against Cancer, the Interuniversity Attraction Poles Program-Belgian Science Policy (IUAP-BELSPOPVI/28). FD and JCT are Research Associates, MB is a Postdoctoral Researcher, SL is a FRIA Fellow and R.K. is a Research Director of the Belgian National Fund for Scientific Research.	Alefantis T, 2005, J BIOMED SCI, V12, P961, DOI 10.1007/s11373-005-9026-x; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Asquith B, 2008, TRENDS IMMUNOL, V29, P4, DOI 10.1016/j.it.2007.09.006; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Bex F, 1997, J VIROL, V71, P3484, DOI 10.1128/JVI.71.5.3484-3497.1997; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chiari E, 2004, J VIROL, V78, P11823, DOI 10.1128/JVI.78.21.11823-11832.2004; Chun ACS, 2000, AIDS RES HUM RETROV, V16, P1689, DOI 10.1089/08892220050193155; Dunand-Sauthier I, 2002, MOL BIOL CELL, V13, P1626, DOI 10.1091/mbc.01-06-0301; Durkin SS, 2008, J BIOL CHEM, V283, P36311, DOI 10.1074/jbc.M804931200; Ego T, 2002, ONCOGENE, V21, P7241, DOI 10.1038/sj.onc.1205701; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Esclatine A, 2004, J VIROL, V78, P8582, DOI 10.1128/JVI.78.16.8582-8592.2004; Gatza ML, 2006, J VIROL, V80, P6657, DOI 10.1128/JVI.02270-05; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gupta SK, 2007, J BIOL CHEM, V282, P29431, DOI 10.1074/jbc.M704110200; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Kinjo T, 2010, J VIROL, V84, P5431, DOI 10.1128/JVI.02460-09; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Legros S, 2009, FRONT BIOSCI-LANDMRK, V14, P4138, DOI 10.2741/3518; Lodewick J, 2009, VIROLOGY, V386, P68, DOI 10.1016/j.virol.2008.12.043; Lu HX, 2004, J VIROL, V78, P6735, DOI 10.1128/JVI.78.13.6735-6743.2004; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; MIWA M, 1984, GANN, V75, P752; Montero H, 2008, J VIROL, V82, P1496, DOI 10.1128/JVI.01779-07; MYDLARSKI MB, 1993, BRAIN RES, V627, P113, DOI 10.1016/0006-8993(93)90754-B; Nasr R, 2005, ONCOGENE, V24, P419, DOI 10.1038/sj.onc.1208212; Nasr R, 2006, BLOOD, V107, P4021, DOI 10.1182/blood-2005-09-3572; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; Nicot C, 1998, J VIROL, V72, P6777, DOI 10.1128/JVI.72.8.6777-6784.1998; Peloponese JM, 2004, J VIROL, V78, P11686, DOI 10.1128/JVI.78.21.11686-11695.2004; Pothof J, 2009, CELL CYCLE, V8, P3462, DOI 10.4161/cc.8.21.9835; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Raaben M, 2007, CELL MICROBIOL, V9, P2218, DOI 10.1111/j.1462-5822.2007.00951.x; Schutz S, 2007, CELL HOST MICROBE, V2, P284, DOI 10.1016/j.chom.2007.10.009; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Semmes OJ, 1996, J VIROL, V70, P6347, DOI 10.1128/JVI.70.9.6347-6357.1996; SIVANANDHAM M, 1989, IMMUNOL LETT, V23, P149, DOI 10.1016/0165-2478(89)90128-4; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Tsuji T, 2007, J BIOL CHEM, V282, P13875, DOI 10.1074/jbc.M611629200; Twizere JC, 2003, J NATL CANCER I, V95, P1846, DOI 10.1093/jnci/djg118; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Villanueva R, 2006, ONCOL REP, V16, P581; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x	61	39	41	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	38					4050	4062		10.1038/onc.2011.120	http://dx.doi.org/10.1038/onc.2011.120			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	823KR	21532619	Green Published			2022-12-25	WOS:000295121600006
J	Lind, GE; Raiborg, C; Danielsen, SA; Rognum, TO; Thiis-Evensen, E; Hoff, G; Nesbakken, A; Stenmark, H; Lothe, RA				Lind, G. E.; Raiborg, C.; Danielsen, S. A.; Rognum, T. O.; Thiis-Evensen, E.; Hoff, G.; Nesbakken, A.; Stenmark, H.; Lothe, R. A.			SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis	ONCOGENE			English	Article						colorectal neoplasia; cytokinesis; early detection; methylation; Spartin; SPG20	HEREDITARY SPASTIC PARAPLEGIA; TROYER-SYNDROME; PROTEIN SPARTIN; HYPERMETHYLATED GENES; DNA METHYLATION; FECAL DNA; CELLS; IDENTIFICATION; TUMORIGENESIS; INTERACTS	Colorectal cancer is a common disease with high mortality. Suitable biomarkers for detection of tumors at an early curable stage would significantly improve patient survival. Here, we show that the SPG20 (spastic paraplegia-20) promoter, encoding the multifunctional Spartin protein, is hypermethylated in 89% of colorectal carcinomas, 78% of adenomas and only 1% of normal mucosa samples. SPG20 methylation was also present in a pilot series of stool samples and corresponding tumors from colorectal cancer patients. SPG20 promoter hypermethylation resulted in loss of mRNA expression in various cancer types and subsequent depletion of Spartin. We further showed that Spartin down-regulation in cancer cells resulted in cytokinesis arrest, which was reversed when SPG20 methylation was inhibited. The present study identifies SPG20 promoter hypermethylation as a biomarker suitable for non-invasive detection of colorectal cancer, and a possible mechanism for cytokinesis arrest in colorectal tumorigenesis. Oncogene (2011) 30, 3967-3978; doi:10.1038/onc.2011.109; published online 18 April 2011	[Lind, G. E.; Danielsen, S. A.; Lothe, R. A.] Oslo Univ Hosp, Dept Canc Prevent, Inst Canc Res, Radiumhosp, N-0310 Oslo, Norway; [Lind, G. E.; Raiborg, C.; Danielsen, S. A.; Nesbakken, A.; Stenmark, H.; Lothe, R. A.] Univ Oslo, Ctr Canc Biomed, Fac Med, Oslo, Norway; [Raiborg, C.; Stenmark, H.] Oslo Univ Hosp, Dept Biochem, Inst Canc Res, Radiumhosp, N-0310 Oslo, Norway; [Rognum, T. O.] Oslo Univ Hosp, Inst Forens Med, Rikshosp, N-0310 Oslo, Norway; [Thiis-Evensen, E.] Oslo Univ Hosp, Dept Med, Rikshosp, N-0310 Oslo, Norway; [Hoff, G.] Telemark Hosp, Dept Med, Div Gastroenterol, Skien, Norway; [Nesbakken, A.] Oslo Univ Hosp, Dept Surg, Aker Hosp, N-0310 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Telemark Hospital Trust; University of Oslo	Lothe, RA (corresponding author), Oslo Univ Hosp, Dept Canc Prevent, Inst Canc Res, Radiumhosp, N-0310 Oslo, Norway.	rlothe@rr-research.no	Stenmark, Harald/B-8868-2008	Lothe, Ragnhild A./0000-0002-1693-1032	Norwegian Cancer Society [PR-2008-0163, PR-2007-0063, PR-2006-0442, A95068]; European Research Council	Norwegian Cancer Society(Norwegian Cancer Society); European Research Council(European Research Council (ERC)European Commission)	We are grateful to Dr Hans Geir Eiken for providing expertise on stool DNA extraction and Hilde Honne, Mette Eknaes, Merete Hektoen and Kim Andresen for technical assistance. The breast cancer and pancreatic cancer cell lines were provided by Dr Anne Kallioniemi (Tampere University Hospital, Finland). The non-commercially available colon cancer cell lines were provided by Dr Richard Hamelin (INSERM, Paris, France). Financial support: This study is supported by grants from the Norwegian Cancer Society: GEL as a senior research fellow (PR-2008-0163), CR as a postdoctoral fellow (PR-2007-0063, HS) and SAD as a PhD student (PR-2006-0442, RAL), long-term grant (A95068, RAL). HS is supported by an Advanced Grant from the European Research Council.	Bakowska JC, 2005, BIOCHEM BIOPH RES CO, V334, P1042, DOI 10.1016/j.bbrc.2005.06.201; Bakowska JC, 2008, ARCH NEUROL-CHICAGO, V65, P520, DOI 10.1001/archneur.65.4.520; Bakowska JC, 2007, MOL BIOL CELL, V18, P1683, DOI 10.1091/mbc.E06-09-0833; Bu YQ, 2008, ONCOLOGY-BASEL, V74, P198, DOI 10.1159/000151367; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Goh L, 2007, BIOINFORMATICS, V23, P281, DOI 10.1093/bioinformatics/btl620; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hooper C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-72; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim MS, 2010, CANCER METAST REV, V29, P181, DOI 10.1007/s10555-010-9207-6; Kron K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004830; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lind GE, 2007, GASTROENTEROLOGY, V132, P1631, DOI 10.1053/j.gastro.2007.03.003; Lind GE, 2006, CELL ONCOL, V28, P259; Lu J, 2006, J NEUROCHEM, V98, P1908, DOI 10.1111/j.1471-4159.2006.04008.x; Milewska M, 2009, J NEUROCHEM, V111, P1022, DOI 10.1111/j.1471-4159.2009.06382.x; Muller HM, 2004, LANCET, V363, P1283, DOI 10.1016/S0140-6736(04)16002-9; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Pointis G, 2010, PHILOS T R SOC B, V365, P1607, DOI 10.1098/rstb.2009.0114; Proukakis C, 2004, J NEUROL, V251, P1105, DOI 10.1007/s00415-004-0491-3; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Robay D, 2006, EXP CELL RES, V312, P2764, DOI 10.1016/j.yexcr.2006.05.003; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Simonsen A, 1998, EUR J CELL BIOL, V75, P223, DOI 10.1016/S0171-9335(98)80116-7; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tsang HTH, 2009, HUM MOL GENET, V18, P3805, DOI 10.1093/hmg/ddp324; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Vidulescu C, 2004, J CELL MOL MED, V8, P388, DOI 10.1111/j.1582-4934.2004.tb00328.x; Zhang WP, 2007, SCI CHINA SER G, V50, P1, DOI 10.1007/s11433-007-0010-5; Zitt M, 2007, DIS MARKERS, V23, P51, DOI 10.1155/2007/891967	46	57	58	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	37					3967	3978		10.1038/onc.2011.109	http://dx.doi.org/10.1038/onc.2011.109			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	820FG	21499309	Green Published, hybrid			2022-12-25	WOS:000294890400006
J	Luo, QZ; Joubert, MK; Stevenson, R; Ketchem, RR; Narhi, LO; Wypych, J				Luo, Quanzhou; Joubert, Marisa K.; Stevenson, Riki; Ketchem, Randal R.; Narhi, Linda O.; Wypych, Jette			Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-CATALYZED OXIDATION; MONOCLONAL-ANTIBODY; METHIONINE OXIDATION; MASS-SPECTROMETRY; DEAMIDATION; BINDING; FORMULATION; STABILITY; HISTIDINE; PEPTIDES	In this study, we characterized the chemical modifications in the monoclonal antibody (IgG(2)) aggregates generated under various conditions, including mechanical, chemical, and thermal stress treatment, to provide insight into the mechanism of protein aggregation and the types of aggregate produced by the different stresses. In a separate study, additional biophysical characterization was performed to arrange these aggregates into a classification system (Joubert, M. K., Luo, Q., Nashed-Samuel, Y., Wypych, J., and Narhi, L. O. (2011) J. Biol. Chem. 286, 25118-25133). Here, we report that different aggregates possessed different types and levels of chemical modification. For chemically treated samples, metal-catalyzed oxidation using copper showed site-specific oxidation of Met(246), His(304), and His(427) in the Fc portion of the antibody, which might be attributed to a putative copper-binding site. For the hydrogen peroxide-treated sample, in contrast, four solvent-exposed Met residues in the Fc portion were completely oxidized. Met and/or Trp oxidation was observed in the mechanically stressed samples, which is in agreement with the proposed model of protein interaction at the air-liquid interface. Heat treatment resulted in significant deamidation but almost no oxidation, which is consistent with thermally induced aggregates being generated by a different pathway, primarily by perturbing conformational stability. These results demonstrate that chemical modifications are present in protein aggregates; furthermore, the type, locations, and severity of the modifications depend on the specific conditions that generated the aggregates.	[Luo, Quanzhou; Wypych, Jette] Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA; [Joubert, Marisa K.; Stevenson, Riki; Narhi, Linda O.] Amgen Inc, Dept Formulat & Analyt Resources, Thousand Oaks, CA 91320 USA; [Ketchem, Randal R.] Amgen Inc, Dept Prot Sci, Seattle, WA 98119 USA	Amgen; Amgen; Amgen	Luo, QZ (corresponding author), Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA.	qluo@amgen.com; jwypych@amgen.com	Ketchem, Randal R/K-2258-2017; Ketchem, Randal/AAB-4372-2020	Ketchem, Randal R/0000-0002-7821-2682; Ketchem, Randal/0000-0002-7821-2682				Baalp A., 2002, HYBRIDOMA HYBRIDOM, V21, P45; Bebbington C, 2008, CURR OPIN BIOTECH, V19, P613, DOI 10.1016/j.copbio.2008.10.002; Bee JS, 2009, J PHARM SCI-US, V98, P3290, DOI 10.1002/jps.21707; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Braun A, 1997, PHARMACEUT RES, V14, P1472, DOI 10.1023/A:1012193326789; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chi EY, 2003, PROTEIN SCI, V12, P903, DOI 10.1110/ps.0235703; Churnsae C, 2007, J CHROMATOGR B, V850, P285, DOI 10.1016/j.jchromb.2006.11.050; Cruickshank D. W., 1959, INT TABLES XRAY CRYS, V2, P331; Demeule B, 2006, EUR J PHARM BIOPHARM, V62, P121, DOI 10.1016/j.ejpb.2005.08.008; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; GEIGER T, 1987, J BIOL CHEM, V262, P785; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Hlavaty JJ, 1997, BIOCHEMISTRY-US, V36, P15514, DOI 10.1021/bi970574p; Huang LH, 2005, ANAL CHEM, V77, P1432, DOI 10.1021/ac0494174; Ji JA, 2009, J PHARM SCI-US, V98, P4485, DOI 10.1002/jps.21746; Jiang YJ, 2009, J PHARM SCI-US, V98, P4695, DOI 10.1002/jps.21778; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Kerwin BA, 2008, J PHARM SCI-US, V97, P2924, DOI 10.1002/jps.21190; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Kosky AA, 1999, PROTEIN SCI, V8, P2519; Lam XM, 1997, J PHARM SCI, V86, P1250, DOI 10.1021/js970143s; LI SH, 1995, BIOCHEMISTRY-US, V34, P5762, DOI 10.1021/bi00017a008; Lim J, 2003, ANAL CHEM, V75, P1164, DOI 10.1021/ac026206v; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Liu HC, 2006, J CHROMATOGR B, V837, P35, DOI 10.1016/j.jchromb.2006.03.053; Liu YD, 2009, BIOLOGICALS, V37, P313, DOI 10.1016/j.biologicals.2009.06.001; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; Mahler HC, 2005, EUR J PHARM BIOPHARM, V59, P407, DOI 10.1016/j.ejpb.2004.12.004; MARIA CS, 1995, FEBS LETT, V374, P85; Men L, 2007, J PROTEOME RES, V6, P216, DOI 10.1021/pr0603809; Nonaka Y, 2008, PROTEINS, V72, P313, DOI 10.1002/prot.21927; Pan H, 2009, PROTEIN SCI, V18, P424, DOI 10.1002/pro.45; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Ryan ME, 1996, CLIN PEDIATR, V35, P23, DOI 10.1177/000992289603500105; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schoneich C, 2000, J PHARMACEUT BIOMED, V21, P1093, DOI 10.1016/S0731-7085(99)00182-X; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Ueda EKM, 2003, J CHROMATOGR A, V988, P1, DOI 10.1016/S0021-9673(02)02057-5; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Zhang ZQ, 2009, MASS SPECTROM REV, V28, P147, DOI 10.1002/mas.20190; Zhao F, 1997, J BIOL CHEM, V272, P9019; Zheng ZQ, 2004, ANAL CHEM, V76, P6374, DOI 10.1021/ac0491206	48	144	148	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25134	25144		10.1074/jbc.M110.160440	http://dx.doi.org/10.1074/jbc.M110.160440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21518762	Green Published, hybrid			2022-12-25	WOS:000292547900061
J	Adler, LN; Gomez, TA; Clarke, SG; Linster, CL				Adler, Lital N.; Gomez, Tara A.; Clarke, Steven G.; Linster, Carole L.			A Novel GDP-D-glucose Phosphorylase Involved in Quality Control of the Nucleoside Diphosphate Sugar Pool in Caenorhabditis elegans and Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-GALACTOSE PHOSPHORYLASE; ASCORBATE BIOSYNTHESIS; VITAMIN-C; L-2-HYDROXYGLUTARIC ACIDURIA; MANNOSE PYROPHOSPHORYLASE; EXPRESSION; PURIFICATION; MANNAN; GUANYLTRANSFERASE; GLUCOMANNAN	The plant VTC2 gene encodes GDP-L-galactose phosphorylase, a rate-limiting enzyme in plant vitamin C biosynthesis. Genes encoding apparent orthologs of VTC2 exist in both mammals, which produce vitamin C by a distinct metabolic pathway, and in the nematode worm Caenorhabditis elegans where vitamin C biosynthesis has not been demonstrated. We have now expressed cDNAs of the human and worm VTC2 homolog genes (C15orf58 and C10F3.4, respectively) and found that the purified proteins also display GDP-hexose phosphorylase activity. However, as opposed to the plant enzyme, the major reaction catalyzed by these enzymes is the phosphorolysis of GDP-D-glucose to GDP and D-glucose 1-phosphate. We detected activities with similar substrate specificity in worm and mouse tissue extracts. The highest expression of GDP-D-glucose phosphorylase was found in the nervous and male reproductive systems. A C. elegans C10F3.4 deletion strain was found to totally lack GDP-D-glucose phosphorylase activity; this activity was also found to be decreased in human HEK293T cells transfected with siRNAs against the human C15orf58 gene. These observations confirm the identification of the worm C10F3.4 and the human C15orf58 gene expression products as the GDP-D-glucose phosphorylases of these organisms. Significantly, we found an accumulation of GDP-D-glucose in the C10F3.4 mutant worms, suggesting that the GDP-D-glucose phosphorylase may function to remove GDP-D-glucose formed by GDP-D-mannose pyrophosphorylase, an enzyme that has previously been shown to lack specificity for its physiological D-mannose 1-phosphate substrate. We propose that such removal may prevent the misincorporation of glucosyl residues for mannosyl residues into the glycoconjugates of worms and mammals.	[Adler, Lital N.; Gomez, Tara A.; Clarke, Steven G.; Linster, Carole L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Adler, Lital N.; Gomez, Tara A.; Clarke, Steven G.; Linster, Carole L.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Linster, Carole L.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universite Catholique Louvain	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu; carole.linster@uclouvain.be		Linster, Carole/0000-0001-7143-0719	National Institutes of Health [GM026020, AG032303]; Ellison Medical Foundation; UCLA; Fonds de la Recherche Scientifique (FNRS); European Union [FP7/2007-2013, 276814]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); UCLA; Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 and AG032303 (to S. G. C.). This work was also supported by a Senior Scholar in Aging Award from the Ellison Medical Foundation (to S. G. C.).; Supported by a UCLA Philip Whitcome Fellowship.; Supported by the Fonds de la Recherche Scientifique (FNRS) and by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 276814. To whom correspondence may be addressed: de Duve Inst., Universite catholique de Louvain, BCHM 7539, Ave. Hippocrate 75, B-1200 Brussels, Belgium. Tel.: 32-2-7647561; Fax: 32-2-7647598; E-mail: carole.linster@uclouvain.be.	BARBER GA, 1985, FEBS LETT, V183, P129, DOI 10.1016/0014-5793(85)80969-8; BEHRENS NH, 1968, J BIOL CHEM, V243, P502; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; BRENNER C, 2007, ENCY LIFE SCI, DOI DOI 10.1002/9780470015902.00020545; BRENNER S, 1974, GENETICS, V77, P71; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; CARLSON DM, 1962, J BIOL CHEM, V237, P1260; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; Coulier L, 2006, ANAL CHEM, V78, P6573, DOI 10.1021/ac0607616; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; ELBEIN AD, 1969, J BIOL CHEM, V244, P1608; Guranowski A, 2010, FEBS LETT, V584, P93, DOI 10.1016/j.febslet.2009.11.003; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; KAGAN RM, 1995, BIOCHEMISTRY-US, V34, P10794, DOI 10.1021/bi00034a012; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Liepman AH, 2005, P NATL ACAD SCI USA, V102, P2221, DOI 10.1073/pnas.0409179102; Linster CL, 2008, J BIOL CHEM, V283, P18483, DOI 10.1074/jbc.M802594200; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; MASSIE HR, 1991, EXP GERONTOL, V26, P487, DOI 10.1016/0531-5565(91)90037-M; Mori S, 2010, PROTEIN EXPRES PURIF, V69, P99, DOI 10.1016/j.pep.2009.09.010; Nihira T, 2007, ANAL BIOCHEM, V371, P259, DOI 10.1016/j.ab.2007.07.012; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; PIRO G, 1993, PLANTA, V190, P206, DOI 10.1007/BF00196613; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; SMITH MM, 1976, BIOCHIMIE, V58, P1195, DOI 10.1016/S0300-9084(76)80119-8; SMOOT JW, 1985, EUR J BIOCHEM, V148, P83, DOI 10.1111/j.1432-1033.1985.tb08810.x; SPIRO MJ, 1984, DIABETOLOGIA, V26, P70; Struwe WB, 2010, METHOD ENZYMOL, V480, P477, DOI 10.1016/S0076-6879(10)80021-7; Sulston J., 1988, NEMATODE CAENORHABDI, P587; SZUMILO T, 1993, J BIOL CHEM, V268, P17943; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; VARKI A, 2009, ESSENTIALS GLYCOBIOL, P50; VERACHTERT H, 1966, J BIOL CHEM, V241, P2007; Watanabe K, 2006, PHYTOCHEMISTRY, V67, P338, DOI 10.1016/j.phytochem.2005.12.003; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Zea CJ, 2005, BIOPOLYMERS, V79, P106, DOI 10.1002/bip.20338	43	24	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21511	21523		10.1074/jbc.M111.238774	http://dx.doi.org/10.1074/jbc.M111.238774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507950	Green Published, hybrid			2022-12-25	WOS:000291464700049
J	Gan, Q; Thiebaud, P; Theze, N; Jin, L; Xu, GF; Grant, P; Owens, GK				Gan, Qiong; Thiebaud, Pierre; Theze, Nadine; Jin, Li; Xu, Guofeng; Grant, Patrick; Owens, Gary K.			WD Repeat-containing Protein 5, a Ubiquitously Expressed Histone Methyltransferase Adaptor Protein, Regulates Smooth Muscle Cell-selective Gene Activation through Interaction with Pituitary Homeobox 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SERUM RESPONSE FACTOR; MOLECULAR REGULATION; H3K4 METHYLATION; TARGET GENES; DIFFERENTIATION; COMPLEX; RECRUITMENT; LYSINE-4; BINDING	WD repeat-containing protein 5 (WDR5) is a common component of mammalian mixed lineage leukemia methyltransferase family members and is important for histone H3 lysine 4 methylation (H3K4me), which has been implicated in control of activation of cell lineage genes during embryogenesis. However, WDR5 has not been considered to play a specific regulatory role in epigenetic programming of cell lineage because it is ubiquitously expressed. Previous work from our laboratory showed the appearance of histone H3K4me within smooth muscle cell (SMC)-marker gene promoters during the early stages of development of SMC from multipotential embryonic cells but did not elucidate the underlying mechanisms that mediate SMC-specific and locus-selective H3K4me. Results presented herein show that knockdown of WDR5 significantly decreased SMC-marker gene expression in cultured SMC differentiation systems and in Xenopus laevis embryos in vivo. In addition, we showed that WDR5 complexes within SMC progenitor cells contained H3K4 methyltransferase enzymatic activity and that knockdown of WDR5 selectively decreased H3K4me1 and H3K4me3 enrichment within SMC-marker gene promoter loci. Moreover, we present evidence that it is recruited to these gene promoter loci through interaction with a SMC-selective pituitary homeobox 2 (Pitx2). Taken together, studies provide evidence for a novel mechanism for epigenetic control of SMC-marker gene expression during development through interaction of WDR5, homeodomain proteins, and chromatin remodeling enzymes.	[Gan, Qiong; Jin, Li; Owens, Gary K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Xu, Guofeng] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Grant, Patrick] Univ Virginia, Dept Biochem, Charlottesville, VA 22908 USA; [Thiebaud, Pierre; Theze, Nadine] Univ Bordeaux 2, F-33076 Bordeaux, France	University of Virginia; University of Virginia; University of Virginia; UDICE-French Research Universities; Universite de Bordeaux	Owens, GK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	gko@virginia.edu	Xu, Guofeng/I-3063-2016	THIEBAUD, Pierre/0000-0003-1174-1616	National Institutes of Health [P01 HL19242, R01 HL57353, R01 HL 38854]; American Hearth Association [09POST2250363]; CNRS; University of Bordeaux 2; Association Francaise contre les Myopathies; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057353, R01HL038854, P01HL019242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearth Association(American Heart Association); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux 2; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL19242, R01 HL57353, and R01 HL 38854 (to G. K. O.). This work was also supported by American Hearth Association Grant 09POST2250363 (to Q. G.). Work in the laboratory of P. T. and N. T. was supported by the CNRS, the University of Bordeaux 2, and the Association Francaise contre les Myopathies.	Barillot W, 2008, DEV DYNAM, V237, P3373, DOI 10.1002/dvdy.21749; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Campione M, 1999, DEVELOPMENT, V126, P1225; Chang DF, 2007, P NATL ACAD SCI USA, V104, P157, DOI 10.1073/pnas.0605635103; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Huebert DJ, 2006, METHODS, V40, P365, DOI 10.1016/j.ymeth.2006.07.032; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nie ZQ, 2003, MOL CELL BIOL, V23, P2942, DOI 10.1128/MCB.23.8.2942-2952.2003; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rodenberg JM, 2010, AM J PHYSIOL-CELL PH, V299, pC1058, DOI 10.1152/ajpcell.00080.2010; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Stoller JZ, 2010, EXP BIOL MED, V235, P569, DOI 10.1258/ebm.2010.009318; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weiskirchen R, 2000, BIOCHEM BIOPH RES CO, V274, P655, DOI 10.1006/bbrc.2000.3187; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	52	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21853	21864		10.1074/jbc.M111.233098	http://dx.doi.org/10.1074/jbc.M111.233098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531708	Green Published, hybrid			2022-12-25	WOS:000291464700080
J	Phillips, NJ; Adin, DM; Stabb, EV; McFall-Ngai, MJ; Apicella, MA; Gibson, BW				Phillips, Nancy J.; Adin, Dawn M.; Stabb, Eric V.; McFall-Ngai, Margaret J.; Apicella, Michael A.; Gibson, Bradford W.			The Lipid A from Vibrio fischeri Lipopolysaccharide A UNIQUE STRUCTURE BEARING A PHOSPHOGLYCEROL MOIETY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; ASSISTED-LASER-DESORPTION/IONIZATION; O-SPECIFIC POLYSACCHARIDE; GRAM-NEGATIVE BACTERIA; ION-TRAP; FRANCISELLA-TULARENSIS; GLYCEROL PHOSPHATE; EUPRYMNA-SCOLOPES; LIGHT ORGAN; SYMBIOSIS	Vibrio fischeri, a bioluminescent marine bacterium, exists in an exclusive symbiotic relationship with the Hawaiian bobtail squid, Euprymna scolopes, whose light organ it colonizes. Previously, it has been shown that the lipopolysaccharide (LPS) or free lipid A of V. fischeri can trigger morphological changes in the juvenile squid's light organ that occur upon colonization. To investigate the structural features that might be responsible for this phenomenon, the lipid A from V. fischeri ES114 LPS was isolated and characterized by multistage mass spectrometry (MSn). A microheterogeneous mixture of mono- and diphosphorylated diglucosamine disaccharides was observed with variable states of acylation ranging from tetra- to octaacylated forms. All lipid A species, however, contained a set of conserved primary acyl chains consisting of an N-linked C14:0(3-OH) at the 2-position, an unusual N-linked C14:1(3-OH) at the 2'-position, and two O-linked C12:0(3-OH) fatty acids at the 3- and 3'-positions. The fatty acids found in secondary acylation were considerably more variable, with either a C12:0 or C16:1 at the 2-position, C14:0 or C14:0(3-OH) at the 2'-position, and C12:0 or no substituent at the 3'-position. Most surprising was the presence of an unusual set of modifications at the secondary acylation site of the 3-position consisting of phosphoglycerol (GroP), lysophosphatidic acid (GroP bearing C12:0, C16:0, or C16:1), or phosphatidic acid (GroP bearing either C16:0 + C12:0 or C16:0 + C16:1). Given their unusual nature, it is possible that these features of the V. fischeri lipid A may underlie the ability of E. scolopes to recognize its symbiotic partner.	[Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Phillips, Nancy J.; Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Adin, Dawn M.; Stabb, Eric V.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [McFall-Ngai, Margaret J.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Apicella, Michael A.] Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	Buck Institute for Research on Aging; University of California System; University of California San Francisco; University System of Georgia; University of Georgia; University of Wisconsin System; University of Wisconsin Madison; University of Iowa	Gibson, BW (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	bgibson@buckinstitute.org		Adin, Dawn/0000-0002-7341-3952	National Institutes of Health [AI-50661]; Sandler Family Foundation; Gordon and Betty Moore Foundation; National Institutes of Health, NCI, Cancer Center [P30 CA082103, DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024616, R01AI050661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health, NCI, Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-50661 (to M. J. M.-N.).; We are grateful to Dr. Haichuan Liu for acquisition of reflectron spectra on the 4800 TOF/TOF instrument. Mass spectrometry analysis on the LTQ XL and 4800 TOF/TOF instruments was performed at the University of California (San Francisco, CA) Sandler-Moore Mass Spectrometry Core Facility (supported by the Sandler Family Foundation, the Gordon and Betty Moore Foundation, National Institutes of Health, NCI, Cancer Center Support Grant P30 CA082103, and DE-AC02-05CH11231).	ADAMS J, 1986, J AM CHEM SOC, V108, P6915, DOI 10.1021/ja00282a014; Adin DA, 2008, APPL ENVIRON MICROB, V74, P633, DOI 10.1128/AEM.02138-07; Altura MA, 2011, CELL MICROBIOL, V13, P527, DOI 10.1111/j.1462-5822.2010.01552.x; ANDERSON R, 1985, J BIOL CHEM, V260, P2219; Apicella Michael A., 2008, V431, P3; Aussel L, 2000, RAPID COMMUN MASS SP, V14, P595, DOI 10.1002/(SICI)1097-0231(20000415)14:7<595::AID-RCM919>3.0.CO;2-4; Bedoux G, 2004, J MASS SPECTROM, V39, P505, DOI 10.1002/jms.611; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; Boue SM, 2000, J MASS SPECTROM, V35, P361, DOI 10.1002/(SICI)1096-9888(200003)35:3<361::AID-JMS943>3.0.CO;2-D; BROADY KW, 1981, EUR J BIOCHEM, V115, P463; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Corcoran AT, 2006, FEMS MICROBIOL LETT, V257, P228, DOI 10.1111/j.1574-6968.2006.00177.x; COSTELLO CE, 1990, METHOD ENZYMOL, V193, P738, DOI 10.1016/0076-6879(90)93448-T; Davidson SK, 2004, CELL MICROBIOL, V6, P1139, DOI 10.1111/j.1462-5822.2004.00429.x; El-Aneed A, 2005, RAPID COMMUN MASS SP, V19, P1683, DOI 10.1002/rcm.1971; Foster JS, 2000, DEV BIOL, V226, P242, DOI 10.1006/dbio.2000.9868; Hankins JV, 2009, J BIOL CHEM, V284, P25804, DOI 10.1074/jbc.M109.022772; Jachymek W, 1999, EUR J BIOCHEM, V266, P53, DOI 10.1046/j.1432-1327.1999.00813.x; Jeyaretnam B, 2002, J BIOL CHEM, V277, P41802, DOI 10.1074/jbc.M112140200; KOCHAROVA NA, 1994, EUR J BIOCHEM, V219, P653, DOI 10.1111/j.1432-1033.1994.tb19981.x; Kolodziejska K, 2006, FEMS IMMUNOL MED MIC, V47, P267, DOI 10.1111/j.1574-695X.2006.00084.x; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Krasikova IN, 2004, EUR J BIOCHEM, V271, P2895, DOI 10.1111/j.1432-1033.2004.04212.x; Kussak A, 2002, ANAL BIOCHEM, V307, P131, DOI 10.1016/S0003-2697(02)00004-0; Lee CS, 2004, J MASS SPECTROM, V39, P514, DOI 10.1002/jms.614; Mikhail I, 2005, ANAL BIOCHEM, V340, P303, DOI 10.1016/j.ab.2005.02.020; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Pupo E, 2004, ELECTROPHORESIS, V25, P2156, DOI 10.1002/elps.200405980; Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Schilling B, 2007, ANAL CHEM, V79, P1034, DOI 10.1021/ac061654e; Shaffer SA, 2007, J AM SOC MASS SPECTR, V18, P1080, DOI 10.1016/j.jasms.2007.03.008; Silipo A, 2008, J MASS SPECTROM, V43, P478, DOI 10.1002/jms.1333; Stabb EV, 2001, J BACTERIOL, V183, P309, DOI 10.1128/JB.183.1.309-317.2001; Vinogradov E, 2009, CARBOHYD RES, V344, P484, DOI 10.1016/j.carres.2008.12.017; Wang Z, 2008, CARBOHYD RES, V343, P483, DOI 10.1016/j.carres.2007.11.016; Weil K, 2002, LIPIDS, V37, P317, DOI 10.1007/s11745-002-0897-z; YAN H, 1989, J BIOL CHEM, V264, P18667; Yang YL, 2006, J LIPID RES, V47, P1823, DOI 10.1194/jlr.M600034-JLR200	44	26	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21203	21219		10.1074/jbc.M111.239475	http://dx.doi.org/10.1074/jbc.M111.239475			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498521	Green Published, hybrid			2022-12-25	WOS:000291464700020
J	von Rossum, A; Krall, R; Escalante, NK; Choy, JC				von Rossum, Anna; Krall, Randall; Escalante, Nichole K.; Choy, Jonathan C.			Inflammatory Cytokines Determine the Susceptibility of Human CD8 T Cells to Fas-mediated Activation-induced Cell Death through Modulation of FasL and c-FLIPS Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MULTIPLE-SCLEROSIS; CUTTING EDGE; ALLOGENEIC RESPONSES; RECEPTOR EXPRESSION; CARDIAC ALLOGRAFTS; UP-REGULATION; APOPTOSIS; DIFFERENTIATION; RESISTANCE	The nature of inflammatory signals determines the outcome of T cell responses. However, little is known about how inflammatory cytokines provided to human CD8 T cells during activation affects their susceptibility to post-activation cell death. We have examined and compared the effects of the inflammatory cytokine IL-12, as well as the combination of IL-1, IL-6, and IL-23 (IL-1/6/23) on the susceptibility of primary human CD8 T cells to post-activation cell death. Human CD8 T cells activated in the presence of IL-1/6/23 underwent significantly less cell death after activation as compared with those activated in IL-12. This was due to reduced susceptibility to Fas-mediated activation-induced cell death (AICD). Mechanistically, the reduced level of cell death in CD8 T cells activated in IL-1/6/23 was a result of a low level of FasL expression and high level of c-FLIPS expression. When the effect of IL-1, IL-6, and IL-23 individually was examined, IL-1 or IL-6 alone was sufficient to inhibit CD8 T cell death that occurs after activation in IL-12. IL-1, but not IL-6, inhibited expression of FasL, whereas IL-6, but not IL-1, increased c-FLIPS expression. Our findings show that the presence of IL-1 and/or IL-6 during activation of human CD8 T cells attenuates Fas-mediated AICD, whereas IL-12 increases the susceptibility of activated CD8 T cells to this form of cell death.	[von Rossum, Anna; Krall, Randall; Escalante, Nichole K.; Choy, Jonathan C.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Choy, JC (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	jonathan.choy@sfu.ca		Choy, Jonathan/0000-0003-1837-8514; Escalante, Nichole/0000-0003-4037-1634	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of British Columbia Yukon	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia Yukon	This work was supported, in whole or in part, by an operating grant from the Canadian Institutes of Health Research (CIHR, to J. C. C.) and a Grant-in-Aid from the Heart and Stroke Foundation of British Columbia & Yukon (to J. C. C.). J. C. C. is a recipient of a CIHR New Investigator Award.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; Choy JC, 2009, AM J TRANSPLANT, V9, P2281, DOI 10.1111/j.1600-6143.2009.02771.x; Choy JC, 2007, P NATL ACAD SCI USA, V104, P1313, DOI 10.1073/pnas.0607731104; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; CRUSIUS JBA, 1995, LANCET, V346, P979, DOI 10.1016/S0140-6736(95)91607-5; DESAI BB, 1992, J IMMUNOL, V148, P3125; Diaz JA, 2009, AM J TRANSPLANT, V9, P1773, DOI 10.1111/j.1600-6143.2009.02706.x; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; FONG TAT, 1990, J IMMUNOL, V144, P1744; FREI K, 1991, J NEUROIMMUNOL, V31, P147; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; HIRATA Y, 1989, J IMMUNOL, V143, P2900; Huber JP, 2010, J IMMUNOL, V185, P813, DOI 10.4049/jimmunol.1000469; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Husted TL, 2006, INFLAMM RES, V55, P177, DOI 10.1007/s00011-006-0073-1; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaser A, 1999, CYTOKINE, V11, P736, DOI 10.1006/cyto.1998.0484; Kilinc MO, 2009, J IMMUNOL, V183, P7656, DOI 10.4049/jimmunol.0902625; Kirchhoff S, 2000, J IMMUNOL, V165, P6293, DOI 10.4049/jimmunol.165.11.6293; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Lee SW, 2003, J IMMUNOL, V170, P2456, DOI 10.4049/jimmunol.170.5.2456; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; MIZUOCHI T, 1988, J IMMUNOL, V141, P1571; Monteleone I, 2006, GASTROENTEROLOGY, V130, P389, DOI 10.1053/j.gastro.2005.10.021; MORGAN CJ, 1993, TRANSPLANTATION, V55, P919, DOI 10.1097/00007890-199304000-00042; Perez LE, 2008, J IMMUNOL, V180, P1545, DOI 10.4049/jimmunol.180.3.1545; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Ramaswamy M, 2007, J IMMUNOL, V179, P6384, DOI 10.4049/jimmunol.179.10.6384; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Schenk AD, 2008, AM J TRANSPLANT, V8, P1652, DOI 10.1111/j.1600-6143.2008.02302.x; Semra YK, 2001, J NEUROIMMUNOL, V113, P268, DOI 10.1016/S0165-5728(00)00443-4; Shi GP, 2009, J IMMUNOL, V183, P7547, DOI 10.4049/jimmunol.0900519; SHIRAISHI M, 1995, J SURG RES, V58, P465, DOI 10.1006/jsre.1995.1073; Snoeijs MGJ, 2010, CURR OPIN ORGAN TRAN, V15, P190, DOI 10.1097/MOT.0b013e32833593eb; Syrjala SO, 2010, J HEART LUNG TRANSPL, V29, P1047, DOI 10.1016/j.healun.2010.04.012; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Vukmanovic-Stejic M, 2000, BLOOD, V95, P231; Wan S, 1996, J THORAC CARDIOV SUR, V111, P469, DOI 10.1016/S0022-5223(96)70458-0; Wang XJ, 1998, BLOOD, V91, P3308, DOI 10.1182/blood.V91.9.3308.3308_3308_3314; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yu Y, 2009, BLOOD, V114, P1026, DOI 10.1182/blood-2009-03-210153; Zhang YY, 2008, J IMMUNOL, V181, P190, DOI 10.4049/jimmunol.181.1.190	55	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21137	21144		10.1074/jbc.M110.197657	http://dx.doi.org/10.1074/jbc.M110.197657			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518761	Green Published, hybrid			2022-12-25	WOS:000291464700013
J	Chigaev, A; Smagley, Y; Zhang, YA; Waller, A; Haynes, MK; Amit, O; Wang, W; Larson, RS; Sklar, LA				Chigaev, Alexandre; Smagley, Yelena; Zhang, Yinan; Waller, Anna; Haynes, Mark K.; Amit, Or; Wang, Wei; Larson, Richard S.; Sklar, Larry A.			Real-time Analysis of the Inside-out Regulation of Lymphocyte Function-associated Antigen-1 Revealed Similarities to and Differences from Very Late Antigen-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ACUTE MYELOGENOUS LEUKEMIA; FORMYL PEPTIDE RECEPTOR; CELL-ADHESION; CONFORMATIONAL REGULATION; INTEGRIN ACTIVATION; BINDING-SITE; GUINEA-PIG; I-DOMAIN; ALPHA(4)BETA(1) INTEGRIN	Ten years ago, we introduced a fluorescent probe that shed light on the inside-out regulation of one of the major leukocyte integrins, very late antigen-4 (VLA-4, CD49d/CD29). Here we describe the regulation of another leukocyte integrin, lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18) using a novel small fluorescent probe in real time on live cells. We found that multiple signaling mechanisms regulate LFA-1 conformation in a manner analogous to VLA-4. LFA-1 can be rapidly activated by G alpha(i)-coupled G protein-coupled receptors (GPCRs) and deactivated by G alpha(s)-coupled GPCRs. The effects of G alpha(s)-coupled GPCR agonists can be reversed in real time by receptor-specific antagonists. The specificity of the fluorescent probe binding has been assessed in a competition assay using the natural LFA-1 ligand ICAM-1 and the LFA-1-specific alpha I allosteric antagonist BIRT0377. Similar to VLA-4 integrin, modulation of the ligand dissociation rate can be observed for different LFA-1 affinity states. However, we also found a striking difference in the binding of the small fluorescent ligand. In the absence of inside-out activation ligand, binding to LFA-1 is extremely slow, at least 10 times slower than expected for diffusion-limited binding. This implies that an additional structural mechanism prevents ligand binding to inactive LFA-1. We propose that such a mechanism explains the inability of LFA-1 to support cell rolling, where the absence of its rapid engagement by a counterstructure in the inactive state leads to a requirement for a selectin-mediated rolling step.	[Chigaev, Alexandre; Smagley, Yelena; Waller, Anna; Haynes, Mark K.; Amit, Or; Larson, Richard S.; Sklar, Larry A.] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [Chigaev, Alexandre; Smagley, Yelena; Waller, Anna; Haynes, Mark K.; Amit, Or; Larson, Richard S.; Sklar, Larry A.] Univ New Mexico, Hlth Sci Ctr, Ctr Canc, Albuquerque, NM 87131 USA; [Zhang, Yinan; Wang, Wei] Univ New Mexico, Hlth Sci Ctr, Dept Chem, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Chigaev, A (corresponding author), MSC08 4630,915 Camino Salud, Albuquerque, NM 87131 USA.	achigaev@salud.unm.edu; lsklar@salud.unm.edu	Zhang, Yinan/AAY-5941-2020; Chigaev, Alexandre/A-3103-2010; Zhang, Yinan/D-5769-2016	Zhang, Yinan/0000-0002-0362-1473; Chigaev, Alexandre/0000-0002-7726-638X; Zhang, Yinan/0000-0002-0362-1473; Waller, Anna/0000-0003-3676-2501	National Institutes of Health [U54 MH084690, HL081062]; Leukemia and Lymphoma Society [7388-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 MH084690 and HL081062. This work was also supported by Leukemia and Lymphoma Society Grant 7388-06.	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Alon R, 2009, MICROCIRCULATION, V16, P3, DOI 10.1080/10739680802026076; Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Benschop RJ, 1996, BRAIN BEHAV IMMUN, V10, P77, DOI 10.1006/brbi.1996.0009; BENSCHOP RJ, 1994, BRIT J PHARMACOL, V113, P1311, DOI 10.1111/j.1476-5381.1994.tb17141.x; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BOOZE RM, 1989, J PHARMACOL EXP THER, V249, P911; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; Chen LL, 1999, J BIOL CHEM, V274, P13167, DOI 10.1074/jbc.274.19.13167; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Chigaev A, 2007, J IMMUNOL, V178, P6828, DOI 10.4049/jimmunol.178.11.6828; Chigaev A, 2011, J BIOL CHEM, V286, P5455, DOI 10.1074/jbc.M110.162636; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; Chigaev A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-26; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Dimitrov S, 2010, J IMMUNOL, V184, P503, DOI 10.4049/jimmunol.0902189; Dimitrov S, 2009, BLOOD, V113, P5134, DOI 10.1182/blood-2008-11-190769; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Eniola AO, 2005, BIOPHYS J, V89, P3577, DOI 10.1529/biophysj.104.057729; Ezeamuzie CI, 2000, BRIT J PHARMACOL, V131, P482, DOI 10.1038/sj.bjp.0703556; Fabbri M, 1999, INFLAMM RES, V48, P239, DOI 10.1007/s000110050454; FOREMAN JC, 1986, BRIT J PHARMACOL, V87, P37, DOI 10.1111/j.1476-5381.1986.tb10154.x; FREER RJ, 1982, BIOCHEMISTRY-US, V21, P257, DOI 10.1021/bi00531a009; Gadek TR, 2002, SCIENCE, V295, P1086, DOI 10.1126/science.295.5557.1086; GREEN SA, 1993, J BIOL CHEM, V268, P23116; Huhtala M, 2005, MATRIX BIOL, V24, P83, DOI 10.1016/j.matbio.2005.01.003; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Hyduk SJ, 2009, MICROCIRCULATION, V16, P17, DOI 10.1080/10739680802425195; Hyun YM, 2009, IMMUNOL RES, V45, P195, DOI 10.1007/s12026-009-8101-1; Johnston B, 1996, J EXP MED, V183, P1995, DOI 10.1084/jem.183.5.1995; Keating SM, 2006, PROTEIN SCI, V15, P290, DOI 10.1110/ps.051583406; Kelly TA, 1999, J IMMUNOL, V163, P5173; Kew RR, 1997, J LEUKOCYTE BIOL, V61, P329, DOI 10.1002/jlb.61.3.329; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Larson RS, 2005, BIOCHEMISTRY-US, V44, P4322, DOI 10.1021/bi048187k; Last-Barney K, 2001, J AM CHEM SOC, V123, P5643, DOI 10.1021/ja0104249; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Laudanna C, 2005, NAT IMMUNOL, V6, P429, DOI 10.1038/ni0505-429; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LIGGETT SB, 1989, EUR J PHARMACOL, V163, P171, DOI 10.1016/0014-2999(89)90414-7; Lin KC, 1999, J MED CHEM, V42, P920, DOI 10.1021/jm980673g; Maestes DC, 1999, J BIOL CHEM, V274, P29791, DOI 10.1074/jbc.274.42.29791; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; MILLER LJ, 1986, J IMMUNOL, V137, P2891; Njus BH, 2009, ASSAY DRUG DEV TECHN, V7, P507, DOI 10.1089/adt.2009.0203; Prossnitz ER, 1997, J BIOL CHEM, V272, P15213, DOI 10.1074/jbc.272.24.15213; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Sarantos MR, 2005, J BIOL CHEM, V280, P28290, DOI 10.1074/jbc.M501662200; Schedlowski M, 1996, J IMMUNOL, V156, P93; Schmidmaier R, 2008, CURR MED CHEM, V15, P978, DOI 10.2174/092986708784049667; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shayo C, 1997, MOL PHARMACOL, V51, P983, DOI 10.1124/mol.51.6.983; Shimaoka M, 2004, CURR TOP MED CHEM, V4, P1485, DOI 10.2174/1568026043387575; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Stanley P, 1998, J BIOL CHEM, V273, P3358, DOI 10.1074/jbc.273.6.3358; STANLEY P, 1994, EMBO J, V13, P1790, DOI 10.1002/j.1460-2075.1994.tb06447.x; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Ueda H, 1997, J BIOL CHEM, V272, P24966, DOI 10.1074/jbc.272.40.24966; van der Goot H, 2000, EUR J MED CHEM, V35, P5, DOI 10.1016/S0223-5234(00)00101-X; VONANDRIAN UH, 1991, P NATL ACAD SCI USA, V88, P7538, DOI 10.1073/pnas.88.17.7538; Wang LL, 2002, J RES NATL INST STAN, V107, P339, DOI 10.6028/jres.107.027; Woska JR, 2001, J LEUKOCYTE BIOL, V70, P329; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104; ZHANG L, 1990, AM J PHYSIOL, V259, pG436, DOI 10.1152/ajpgi.1990.259.3.G436; Zhuang GQ, 2001, J BIOSCI BIOENG, V92, P330, DOI 10.1263/jbb.92.330; Zimmerman T, 2008, CURR PHARM DESIGN, V14, P2128, DOI 10.2174/138161208785740225; Zwartz G, 2004, BIOPHYS J, V86, P1243, DOI 10.1016/S0006-3495(04)74198-3; Zwartz GJ, 2004, J BIOL CHEM, V279, P38277, DOI 10.1074/jbc.M402944200	81	11	11	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20375	20386		10.1074/jbc.M110.206185	http://dx.doi.org/10.1074/jbc.M110.206185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515675	Green Published, hybrid			2022-12-25	WOS:000291267600025
J	Ying, Z; Wang, HF; Fan, HD; Wang, GH				Ying, Zheng; Wang, Hongfeng; Fan, Huadong; Wang, Guanghui			The Endoplasmic Reticulum (ER)-associated Degradation System Regulates Aggregation and Degradation of Mutant Neuroserpin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTILITY FACTOR-RECEPTOR; UBIQUITIN LIGASE; PRION PROTEIN; CUE DOMAIN; GP78; ERAD; TOXICITY; DEMENTIA; E3; RETROTRANSLOCATION	Familial encephalopathy with neuroserpin inclusion bodies is a neurodegenerative disorder characterized by the accumulation of neuroserpin polymers in the endoplasmic reticulum (ER) of cortical and subcortical neurons in the CNS because of neuroserpin point mutations. ER-associated degradation (ERAD) is involved in mutant neuroserpin degradation. In this study, we demonstrate that two ER-associated E3 ligases, Hrd1 and gp78, are involved in the ubiquitination and degradation of mutant neuroserpin. Overexpression of Hrd1 and gp78 decreases the mutant neuroserpin protein level, whereas Hrd1 and gp78 knockdown increases mutant neuroserpin stability. Moreover, ERAD impairment by mutant valosin-containing protein increases the mutant neuroserpin protein level and aggregate formation. Thus, these findings identify mutant neuroserpin as an ERAD target and show that Hrd1 and gp78 mediate mutant neuroserpin turnover through the ERAD pathway.	[Ying, Zheng; Wang, Hongfeng; Fan, Huadong; Wang, Guanghui] Univ Sci & Technol China, Chinese Acad Sci, Lab Mol Neuropathol, Key Lab Brain Funct & Dis,Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, HF (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Lab Mol Neuropathol, Hefei 230027, Anhui, Peoples R China.	hfwang4@mail.ustc.edu.cn; ghui@ustc.edu.cn	Wang, Guanghui/U-3979-2017; Fan, Huadong/AAD-2321-2019	Wang, Guanghui/0000-0001-8551-6468; Fan, Huadong/0000-0001-5282-4843	National Natural Sciences Foundation of China [30970921, 31000473]; National High-Tech Research and Development Program of China 973 Projects [2011CB504102]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China 973 Projects(National Basic Research Program of China)	This work was supported in part by National Natural Sciences Foundation of China Grants 30970921 and 31000473 and by National High-Tech Research and Development Program of China 973 Projects Grant 2011CB504102.	Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Osterwalder T, 1996, EMBO J, V15, P2944, DOI 10.1002/j.1460-2075.1996.tb00657.x; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; RON I, HUM MOL GENET, V19, P3771; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Ying Z, 2009, HUM MOL GENET, V18, P4268, DOI 10.1093/hmg/ddp380; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	38	36	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20835	20844		10.1074/jbc.M110.200808	http://dx.doi.org/10.1074/jbc.M110.200808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507957	Green Published, hybrid			2022-12-25	WOS:000291267600068
J	Bostrom, J; Haber, L; Koenig, P; Kelley, RF; Fuh, G				Bostrom, Jenny; Haber, Lauric; Koenig, Patrick; Kelley, Robert F.; Fuh, Germaine			High Affinity Antigen Recognition of the Dual Specific Variants of Herceptin Is Entropy-Driven in Spite of Structural Plasticity	PLOS ONE			English	Article							HIV-1 MONOCLONAL-ANTIBODY; MOLECULAR RECOGNITION; THERMODYNAMIC ANALYSIS; MUTATIONAL ANALYSIS; BINDING INTERFACES; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; PROTEIN DYNAMICS; RECEPTOR-BINDING; FAB	The antigen-binding site of Herceptin, an anti-human Epidermal Growth Factor Receptor 2 (HER2) antibody, was engineered to add a second specificity toward Vascular Endothelial Growth Factor (VEGF) to create a high affinity two-in-one antibody bH1. Crystal structures of bH1 in complex with either antigen showed that, in comparison to Herceptin, this antibody exhibited greater conformational variability, also called "structural plasticity''. Here, we analyzed the biophysical and thermodynamic properties of the dual specific variants of Herceptin to understand how a single antibody binds two unrelated protein antigens. We showed that while bH1 and the affinity-improved bH1-44, in particular, maintained many properties of Herceptin including binding affinity, kinetics and the use of residues for antigen recognition, they differed in the binding thermodynamics. The interactions of bH1 and its variants with both antigens were characterized by large favorable entropy changes whereas the Herceptin/HER2 interaction involved a large favorable enthalpy change. By dissecting the total entropy change and the energy barrier for dual interaction, we determined that the significant structural plasticity of the bH1 antibodies demanded by the dual specificity did not translate into the expected increase of entropic penalty relative to Herceptin. Clearly, dual antigen recognition of the Herceptin variants involves divergent antibody conformations of nearly equivalent energetic states. Hence, increasing the structural plasticity of an antigen-binding site without increasing the entropic cost may play a role for antibodies to evolve multi-specificity. Our report represents the first comprehensive biophysical analysis of a high affinity dual specific antibody binding two unrelated protein antigens, furthering our understanding of the thermodynamics that drive the vast antigen recognition capacity of the antibody repertoire.	[Bostrom, Jenny; Haber, Lauric; Koenig, Patrick; Kelley, Robert F.; Fuh, Germaine] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Bostrom, Jenny; Haber, Lauric; Koenig, Patrick; Kelley, Robert F.; Fuh, Germaine] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Bostrom, J (corresponding author), Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA.	gml@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Genentech, Inc. supported and funded the research described in the report. As a company, Genentech encourages publication and plays a role of determining and issuing the approval for the authors to release and submit the manuscript to journals. Besides this role, the company did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREVALO JH, 1993, NATURE, V365, P859, DOI 10.1038/365859a0; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; DallAcqua W, 1996, BIOCHEMISTRY-US, V35, P9667, DOI 10.1021/bi960819i; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; FASMAN GD, 1976, HDB BIOCH MOL BIOL; Fellouse FA, 2006, J MOL BIOL, V357, P100, DOI 10.1016/j.jmb.2005.11.092; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Foote J, 2003, SCIENCE, V299, P1327, DOI 10.1126/science.1082717; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.3.CO;2-F; Garber E, 2007, BIOCHEM BIOPH RES CO, V355, P751, DOI 10.1016/j.bbrc.2007.02.042; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jimenez R, 2003, P NATL ACAD SCI USA, V100, P92, DOI 10.1073/pnas.262411399; Jimenez R, 2004, P NATL ACAD SCI USA, V101, P3803, DOI 10.1073/pnas.0305745101; Keitel T, 1997, CELL, V91, P811, DOI 10.1016/S0092-8674(00)80469-9; KELLEY RF, 1992, BIOCHEMISTRY-US, V31, P5434, DOI 10.1021/bi00139a003; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kossiakoff AA, 2008, CURR OPIN STRUC BIOL, V18, P499, DOI 10.1016/j.sbi.2008.06.004; Kramer A, 1997, CELL, V91, P799, DOI 10.1016/S0092-8674(00)80468-7; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lee CV, 2006, BLOOD, V108, P3103, DOI 10.1182/blood-2006-03-011031; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Mohan S, 2009, BIOCHEMISTRY-US, V48, P1390, DOI 10.1021/bi801901d; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; MURPHY KP, 1995, PROTEINS, V21, P83, DOI 10.1002/prot.340210202; MURPHY KP, 1994, PROTEINS, V18, P63, DOI 10.1002/prot.340180108; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; PETRI V, 1995, BIOCHEMISTRY-US, V34, P9977, DOI 10.1021/bi00031a020; PRABHAKAR BS, 1984, J IMMUNOL, V133, P2815; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Trinh CH, 1997, STRUCTURE, V5, P937, DOI 10.1016/S0969-2126(97)00247-5; vanderMerwe PA, 1996, CURR OPIN IMMUNOL, V8, P257, DOI 10.1016/S0952-7915(96)80065-3; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; Winzor DJ, 2005, ANAL BIOCHEM, V337, P289, DOI 10.1016/j.ab.2004.10.049	55	61	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e17887	10.1371/journal.pone.0017887	http://dx.doi.org/10.1371/journal.pone.0017887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526167	gold, Green Submitted, Green Published			2022-12-25	WOS:000290015800004
J	McGrail, M; Hatler, JM; Kuang, XY; Liao, HK; Nannapaneni, K; Watt, KEN; Uhl, JD; Largaespada, DA; Vollbrecht, E; Scheetz, TE; Dupuy, AJ; Hostetter, JM; Essner, JJ				McGrail, Maura; Hatler, Julia M.; Kuang, Xianyan; Liao, Hsin-Kai; Nannapaneni, Kishore; Watt, Kristin E. Noack; Uhl, Juli D.; Largaespada, David A.; Vollbrecht, Erik; Scheetz, Todd E.; Dupuy, Adam J.; Hostetter, Jesse M.; Essner, Jeffrey J.			Somatic Mutagenesis with a Sleeping Beauty Transposon System Leads to Solid Tumor Formation in Zebrafish	PLOS ONE			English	Article							CANCER GENE DISCOVERY; T-CELL LEUKEMIA; COLORECTAL CANCERS; INSERTIONAL MUTAGENESIS; TRANSGENIC ZEBRAFISH; GENOMIC INSTABILITY; HUMAN BREAST; MOUSE; EXPRESSION; PATHWAYS	Large-scale sequencing of human cancer genomes and mouse transposon-induced tumors has identified a vast number of genes mutated in different cancers. One of the outstanding challenges in this field is to determine which genes, when mutated, contribute to cellular transformation and tumor progression. To identify new and conserved genes that drive tumorigenesis we have developed a novel cancer model in a distantly related vertebrate species, the zebrafish, Danio rerio. The Sleeping Beauty (SB) T2/Onc transposon system was adapted for somatic mutagenesis in zebrafish. The carp beta-actin promoter was cloned into T2/Onc to create T2/OncZ. Two transgenic zebrafish lines that contain large concatemers of T2/OncZ were isolated by injection of linear DNA into the zebrafish embryo. The T2/OncZ transposons were mobilized throughout the zebrafish genome from the transgene array by injecting SB11 transposase RNA at the 1-cell stage. Alternatively, the T2/OncZ zebrafish were crossed to a transgenic line that constitutively expresses SB11 transposase. T2/OncZ transposon integration sites were cloned by ligation-mediated PCR and sequenced on a Genome Analyzer II. Between 700-6800 unique integration events in individual fish were mapped to the zebrafish genome. The data show that introduction of transposase by transgene expression or RNA injection results in an even distribution of transposon reintegration events across the zebrafish genome. SB11 mRNA injection resulted in neoplasms in 10% of adult fish at similar to 10 months of age. T2/OncZ-induced zebrafish tumors contain many mutated genes in common with human and mouse cancer genes. These analyses validate our mutagenesis approach and provide additional support for the involvement of these genes in human cancers. The zebrafish T2/OncZ cancer model will be useful for identifying novel and conserved genetic drivers of human cancers.	[McGrail, Maura; Kuang, Xianyan; Liao, Hsin-Kai; Watt, Kristin E. Noack; Uhl, Juli D.; Vollbrecht, Erik; Essner, Jeffrey J.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Hatler, Julia M.; Largaespada, David A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Masonic Canc Ctr, Ctr Genome Engn, Minneapolis, MN USA; [Nannapaneni, Kishore; Scheetz, Todd E.] Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; [Nannapaneni, Kishore; Scheetz, Todd E.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Dupuy, Adam J.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Hostetter, Jesse M.] Iowa State Univ, Dept Vet Pathol, Ames, IA USA	Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Iowa; University of Iowa; Iowa State University	McGrail, M (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	mmcgrail@iastate.edu	Largaespada, David/C-9832-2014; McGrail, Maura/AAA-5610-2021; Liao, Hsin-Kai/H-9608-2015	McGrail, Maura/0000-0001-9308-6189; Scheetz, Todd/0000-0002-1965-5811; Dupuy, Adam/0000-0002-8561-4911; Essner, Jeffrey/0000-0001-8816-3848; Hostetter, Jesse/0000-0002-5555-5121; Nannapaneni, Kishore/0000-0002-5559-9378	Roy J. Carver Charitable Trust [07-2991]; NIH-NCRR [P40 RR012546]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER	Roy J. Carver Charitable Trust; NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Roy J. Carver Charitable Trust Grant #07-2991, https://www.carvertrust.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Jenny Groeltz of the Histopathology Laboratory (College of Veterinary Medicine, ISU) for histopathology slide preparations, and Ting Li and Justin Breitbach for technical assistance. Dr. Steve Ekker, Dr. Darius Balciunas and Dr. Chi-Bin Chien kindly provided constructs. Some strains of zebrafish used in this study were obtained from the Zebrafish International Resource Center, which is supported by grant P40 RR012546 from the NIH-NCRR.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Amatruda JF, 2008, INT REV CEL MOL BIO, V271, P1, DOI 10.1016/S1937-6448(08)01201-X; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Bender AM, 2010, CANCER RES, V70, P3557, DOI 10.1158/0008-5472.CAN-09-4674; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carlson CM, 2003, GENETICS, V165, P243; Chen J, 2007, LEUKEMIA, V21, P462, DOI 10.1038/sj.leu.2404546; Clark KJ, 2004, GENESIS, V39, P225, DOI 10.1002/gene.20049; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dupuy AJ, 2010, SEMIN CANCER BIOL, V20, P261, DOI 10.1016/j.semcancer.2010.05.003; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Geurts AM, 2006, PLOS GENET, V2, P1413, DOI 10.1371/journal.pgen.0020156; Geurts AM, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-30; Geurts AM, 2006, NUCLEIC ACIDS RES, V34, P2803, DOI 10.1093/nar/gkl301; Goessling W, 2007, J CLIN ONCOL, V25, P2473, DOI 10.1200/JCO.2006.08.9821; Grabher C, 2003, GENE, V322, P57, DOI 10.1016/j.gene.2003.09.009; Haramis APG, 2006, EMBO REP, V7, P444, DOI 10.1038/sj.embor.7400638; Hong WY, 2004, CANCER RES, V64, P7256, DOI 10.1158/0008-5472.CAN-04-0931; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kent ML, 2002, COMPARATIVE MED, V52, P354; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Langenau DM, 2003, SCIENCE, V299, P887, DOI 10.1126/science.1080280; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LIU ZJ, 1991, GENE, V108, P211, DOI 10.1016/0378-1119(91)90436-F; LIU ZJ, 1990, MOL CELL BIOL, V10, P3432, DOI 10.1128/MCB.10.7.3432; LIU ZJ, 1990, BIO-TECHNOL, V8, P1268, DOI 10.1038/nbt1290-1268; Matthews JL, 2004, METHOD CELL BIOL, V77, P617; Michailidou C, 2009, DIS MODEL MECH, V2, P399, DOI 10.1242/dmm.001149; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Preacher KJ, 2001, CALCULATION CHI SQUA; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smolowitz R, 2002, BIOL BULL, V203, P265, DOI 10.2307/1543433; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yergeau DA, 2009, DEV DYNAM, V238, P1727, DOI 10.1002/dvdy.21994	58	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18826	10.1371/journal.pone.0018826	http://dx.doi.org/10.1371/journal.pone.0018826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533036	Green Published, Green Submitted, gold			2022-12-25	WOS:000290014500012
J	Sun, CK; Ng, KT; Lim, ZX; Cheng, Q; Lo, CM; Poon, RT; Man, K; Wong, N; Fan, ST				Sun, Chris K.; Ng, Kevin T.; Lim, Zophia X.; Cheng, Qiao; Lo, Chung Mau; Poon, Ronnie T.; Man, Kwan; Wong, Nathalie; Fan, Sheung Tat			Proline-Rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma through Induction of Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							CADHERIN EXPRESSION; TUMOR PROGRESSION; SIGNAL TRANSDUCERS; CANCER; HIC-5; TRANSFORMATION; METASTASIS; INVASIVENESS; PROTEIN; TRANSCRIPTION	Aims: Proline-rich tyrosine kinase 2 (Pyk2), a non-receptor tyrosine kinase of the focal adhesion kinase (FAK) family, is up-regulated in more than 60% of the tumors of hepatocellular carcinoma (HCC) patients. Forced overexpression of Pyk2 can promote the proliferation and invasion of HCC cells. In this study, we aimed to explore the underlying molecular mechanism of Pyk2-mediated cell migration of HCC cells. Methodology/Principal Findings: We demonstrated that Pyk2 transformed the epithelial HCC cell line Hep3B into a mesenchymal phenotype via the induction of epithelial to mesenchymal transition (EMT), signified by the up-regulation of membrane ruffle formation, activation of Rac/Rho GTPases, down-regulation of epithelial genes E-cadherin and cytokeratin as well as promotion of cell motility in presence of lysophosphatidic acid (LPA). Suppression of Pyk2 by overexpression of dominant negative PRNK domain in the metastatic HCC cell line MHCC97L transformed its fibroblastoid phenotype to an epithelial phenotype with up-regulation of epithelial genes, down-regulation of mesenchymal genes N-cadherin and STAT5b, and reduction of LPA-induced membrane ruffle formation and cell motility. Moreover, overexpression of Pyk2 in Hep3B cells promoted the phosphorylation and localization of mesenchymal gene Hic-5 onto cell membrane while suppression of Pyk2 in MHCC97L cells attenuated its phosphorylation and localization. Conclusion: These data provided new evidence of the underlying mechanism of Pyk2 in controlling cell motility of HCC cells through regulation of genes associated with EMT.	[Sun, Chris K.; Ng, Kevin T.; Lim, Zophia X.; Cheng, Qiao; Lo, Chung Mau; Poon, Ronnie T.; Man, Kwan; Fan, Sheung Tat] Univ Hong Kong, Dept Surg, Ctr Canc Res, LKS Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wong, Nathalie] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong	Sun, CK (corresponding author), Univ Hong Kong, Dept Surg, Ctr Canc Res, LKS Fac Med, Pokfulam, Hong Kong, Peoples R China.	kwanman@hku.hk	NG, Kevin Tak-Pan/J-1510-2018	NG, Kevin Tak-Pan/0000-0001-9822-1335	Research Grant Council Hong Kong [7574/06M, HKU5/CRF/08]	Research Grant Council Hong Kong(Hong Kong Research Grants Council)	This study was supported by the General Research Fund (7574/06M) and Collaborative Research Fund (HKU5/CRF/08) of the Research Grant Council Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agiostratidou G, 2007, J MAMMARY GLAND BIOL, V12, P127, DOI 10.1007/s10911-007-9044-6; Avraamides C, 2007, AM J PHYSIOL-HEART C, V293, pH193, DOI 10.1152/ajpheart.00728.2006; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Boivin D, 1996, CAN J PHYSIOL PHARM, V74, P801, DOI 10.1139/cjpp-74-7-801; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; DEAKIN NO, 2010, MOL BIOL CELL; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Hay ED, 1995, ACTA ANAT, V154, P8; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ishino M, 2000, FEBS LETT, V474, P179, DOI 10.1016/S0014-5793(00)01597-0; KAWANO Y, 2008, EUR J SURG ONCOL; Klampfer L, 2008, FRONT BIOSCI-LANDMRK, V13, P2888, DOI 10.2741/2893; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Li X, 2011, ONCOGENE, V30, P167, DOI 10.1038/onc.2010.400; Liotta L A, 1985, Important Adv Oncol, P28; Mathurin P, 1998, ALIMENT PHARM THERAP, V12, P111; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nishiya N, 1998, NUCLEIC ACIDS RES, V26, P4267, DOI 10.1093/nar/26.18.4267; Niu RF, 2007, J EXP CLIN CANC RES, V26, P385; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Stracke M L, 1992, In Vivo, V6, P309; Sun CK, 2007, BRIT J CANCER, V97, P50, DOI 10.1038/sj.bjc.6603827; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Teng YQ, 2007, J CLIN INVEST, V117, P304, DOI 10.1172/JCI31200; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Tumbarello DA, 2005, J CELL SCI, V118, P4849, DOI 10.1242/jcs.02615; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M	37	29	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18878	10.1371/journal.pone.0018878	http://dx.doi.org/10.1371/journal.pone.0018878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533080	Green Published, Green Submitted, gold			2022-12-25	WOS:000289719400033
J	Sawyer, EB; Claessen, D; Haas, M; Hurgobin, B; Gras, SL				Sawyer, Elizabeth B.; Claessen, Dennis; Haas, Maria; Hurgobin, Bhavna; Gras, Sally L.			The Assembly of Individual Chaplin Peptides from Streptomyces coelicolor into Functional Amyloid Fibrils	PLOS ONE			English	Article							CELL-SURFACE PROTEINS; AERIAL HYPHAE; AGGREGATION; PREDICTION; DISEASE; SERVER; ICE	The self-association of proteins into amyloid fibrils offers an alternative to the natively folded state of many polypeptides. Although commonly associated with disease, amyloid fibrils represent the natural functional state of some proteins, such as the chaplins from the soil-dwelling bacterium Streptomyces coelicolor, which coat the aerial mycelium and spores rendering them hydrophobic. We have undertaken a biophysical characterisation of the five short chaplin peptides ChpD-H to probe the mechanism by which these peptides self-assemble in solution to form fibrils. Each of the five chaplin peptides produced synthetically or isolated from the cell wall is individually surface-active and capable of forming fibrils under a range of solution conditions in vitro. These fibrils contain a highly similar cross-beta core structure and a secondary structure that resembles fibrils formed in vivo on the spore and mycelium surface. They can also restore the growth of aerial hyphae to a chaplin mutant strain. We show that cysteine residues are not required for fibril formation in vitro and propose a role for the cysteine residues conserved in four of the five short chaplin peptides.	[Sawyer, Elizabeth B.; Haas, Maria; Hurgobin, Bhavna; Gras, Sally L.] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia; [Sawyer, Elizabeth B.; Haas, Maria; Hurgobin, Bhavna; Gras, Sally L.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Claessen, Dennis] Leiden Univ, Inst Biol, Dept Mol & Dev Genet, Leiden, Netherlands	University of Melbourne; University of Melbourne; Leiden University; Leiden University - Excl LUMC	Sawyer, EB (corresponding author), Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia.	sgras@unimelb.edu.au	Sawyer, Elizabeth/J-6962-2012; Hurgobin, Bhavna/AAZ-3428-2020; Gras, Sally L/G-2025-2014; Claessen, Dennis/J-1903-2014	Hurgobin, Bhavna/0000-0001-9603-2493; Gras, Sally L/0000-0002-4660-1245; Claessen, Dennis/0000-0002-0789-2633; Sawyer, Elizabeth/0000-0003-0389-2692	Endeavour Research Award (Austraining International); Marie Curie Reintegration Grant [FP7-PEOPLE-ERG-230944]	Endeavour Research Award (Austraining International); Marie Curie Reintegration Grant(European Commission)	EBS was supported by an Endeavour Research Award (Austraining International). DC was supported by a Marie Curie Reintegration Grant (FP7-PEOPLE-ERG-230944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Baumketner A, 2005, BIOPHYS J, V89, P1493, DOI 10.1529/biophysj.105.059196; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crilly JF, 2008, IND ENG CHEM RES, V47, P6362, DOI 10.1021/ie701773z; de Jong W, 2009, MOL MICROBIOL, V73, P1128, DOI 10.1111/j.1365-2958.2009.06838.x; Di Berardo C, 2008, J BACTERIOL, V190, P5879, DOI 10.1128/JB.00685-08; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Elliot MA, 2004, CURR OPIN MICROBIOL, V7, P594, DOI 10.1016/j.mib.2004.10.013; Elliot MA, 2003, GENE DEV, V17, P1727, DOI 10.1101/gad.264403; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028; Gras SL, 2007, AUST J CHEM, V60, P333, DOI 10.1071/CH06485; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; KEISER T, 2000, GEN INTRO ACTINOMYCE, P1; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Squires AM, 2006, J AM CHEM SOC, V128, P11738, DOI 10.1021/ja063751v; Stefani M, 2010, CURR PROTEIN PEPT SC, V11, P343, DOI 10.2174/138920310791330631; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; WESSELS JGH, 1991, PLANT CELL, V3, P793; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	36	47	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18839	10.1371/journal.pone.0018839	http://dx.doi.org/10.1371/journal.pone.0018839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526199	gold, Green Published, Green Accepted			2022-12-25	WOS:000289671100027
J	Ramgolam, K; Lauriol, J; Lalou, C; Lauden, L; Michel, L; de la Grange, P; Khatib, AM; Aoudjit, F; Charron, D; Alcaide-Loridan, C; Al-Daccak, R				Ramgolam, Kiran; Lauriol, Jessica; Lalou, Claude; Lauden, Laura; Michel, Laurence; de la Grange, Pierre; Khatib, Abdel-Majid; Aoudjit, Fawzi; Charron, Dominique; Alcaide-Loridan, Catherine; Al-Daccak, Reem			Melanoma Spheroids Grown Under Neural Crest Cell Conditions Are Highly Plastic Migratory/Invasive Tumor Cells Endowed with Immunomodulator Function	PLOS ONE			English	Article							CANCER STEM-CELLS; MHC CLASS-II; IN-VITRO; INITIATING CELLS; B-16 MELANOMA; EXPRESSION; METASTASIS; ACTIVATION; PHENOTYPE; LIGAND	Background: The aggressiveness of melanoma tumors is likely to rely on their well-recognized heterogeneity and plasticity. Melanoma comprises multi-subpopulations of cancer cells some of which may possess stem cell-like properties. Although useful, the sphere-formation assay to identify stem cell-like or tumor initiating cell subpopulations in melanoma has been challenged, and it is unclear if this model can predict a functional phenotype associated with aggressive tumor cells. Methodology/Principal Findings: We analyzed the molecular and functional phenotypes of melanoma spheroids formed in neural crest cell medium. Whether from metastatic or advanced primary tumors, spheroid cells expressed melanoma-associated markers. They displayed higher capacity to differentiate along mesenchymal lineages and enhanced expression of SOX2, NANOG, KLF4, and/or OCT4 transcription factors, but not enhanced self-renewal or tumorigenicity when compared to their adherent counterparts. Gene expression profiling attributed a neural crest cell signature to these spheroids and indicated that a migratory/invasive and immune-function modulating program could be associated with these cells. In vitro assays confirmed that spheroids display enhanced migratory/invasive capacities. In immune activation assays, spheroid cells elicited a poorer allogenic response from immune cells and inhibited mitogen-dependent T cells activation and proliferation more efficiently than their adherent counterparts. Our findings reveal a novel immune-modulator function of melanoma spheroids and suggest specific roles for spheroids in invasion and in evasion of antitumor immunity. Conclusion/Significance: The association of a more plastic, invasive and evasive, thus a more aggressive tumor phenotype with melanoma spheroids reveals a previously unrecognized aspect of tumor cells expanded as spheroid cultures. While of limited efficiency for melanoma initiating cell identification, our melanoma spheroid model predicted aggressive phenotype and suggested that aggressiveness and heterogeneity of melanoma tumors can be supported by subpopulations other than cancer stem cells. Therefore, it could be constructive to investigate melanoma aggressiveness, relevant to patients and clinical transferability.	[Ramgolam, Kiran; Lalou, Claude; Lauden, Laura; Khatib, Abdel-Majid; Charron, Dominique; Al-Daccak, Reem] Univ Paris 07, INSERM, Hop St Louis, Inst Univ Hematol,UMRS 940, Paris, France; [Lauriol, Jessica; Alcaide-Loridan, Catherine] Univ Paris 07, Inst Jacques Monod, UMRS 7592, CNRS, F-75251 Paris, France; [Michel, Laurence] Univ Paris 07, INSERM, Hop St Louis, UMRS976, Paris, France; [Aoudjit, Fawzi] Univ Laval, CRCHUQ, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1K 7P4, Canada; [Charron, Dominique] Hop St Louis, AP HP, CIB HOG, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Laval University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Ramgolam, K (corresponding author), Univ Paris 07, INSERM, Hop St Louis, Inst Univ Hematol,UMRS 940, Paris, France.	reem.al-daccak@inserm.fr	Al-Daccak, Reem/L-8804-2018; KHATIB, Abdel-Majid/A-9948-2015; Michel, Laurence/E-8605-2017	KHATIB, Abdel-Majid/0000-0001-6957-0384; de la Grange, Pierre/0000-0001-6361-1878; Al-Daccak, Reem/0000-0002-6146-2845; LALOU, Claude/0000-0002-5271-7439	Association de la Recherche sur le Cancer; Institut National du Cancer (Reseau des cellules souches) - France; La Ligue contre le Cancer, France; Conseil Regional d'Ile-de-France; Ministere de la Recherche	Association de la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer (Reseau des cellules souches) - France(Institut National du Cancer (INCA) France); La Ligue contre le Cancer, France; Conseil Regional d'Ile-de-France(Region Ile-de-France); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by grants to R. D. from Association de la Recherche sur le Cancer and Institut National du Cancer (Reseau des cellules souches) - France. K. R. is supported by a postdoctoral fellowship from La Ligue contre le Cancer, France. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Didier Auboeuf for microarray platform, Dr. Ryad Tamouza and Wahid Boukouaci (UMRS 940) for effective discussions, and Carine Deruyfellaere and Stephanie Ghislin (Institut Jacques Monod) for technical support. Particular thanks for Dr M. Pla (UMRS 940 and Departement d'experimentation animale, Hopital Saint-Louis) and Martine Chopin (Departement d'experimentation animale, Hopital Saint-Louis) for their help in conducting animal studies. We also thank the Imagery Department of the Institut Universitaire d'Hematologie. The imagery department is supported by grants from the Conseil Regional d'Ile-de-France and the Ministere de la Recherche.	Aoudjit F, 2004, EXP CELL RES, V299, P79, DOI 10.1016/j.yexcr.2004.05.011; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Banerjee SS, 2000, HISTOPATHOLOGY, V36, P387; Byrne SN, 2003, CANCER IMMUNOL IMMUN, V52, P396, DOI 10.1007/s00262-003-0380-0; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Coucke Paul H. A., 1994, In Vivo (Attiki), V8, P333; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Fukunaga-Kalabis M, 2010, ONCOGENE, V29, P6115, DOI 10.1038/onc.2010.350; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hofmann UB, 2000, INT J CANCER, V87, P12, DOI 10.1002/1097-0215(20000701)87:1<12::AID-IJC3>3.0.CO;2-A; Huls M, 2009, J PHARMACOL EXP THER, V328, P3, DOI 10.1124/jpet.107.132225; Jeffs AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008461; JIANG X, 2008, STEM CELLS DEV; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Klein WM, 2007, MODERN PATHOL, V20, P102, DOI 10.1038/modpathol.3800720; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; LEVENE A, 1980, J CLIN PATHOL, V33, P101, DOI 10.1136/jcp.33.2.101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunter PC, 2005, CANCER RES, V65, P8801, DOI 10.1158/0008-5472.CAN-05-0378; Martins I, 2007, EUR J IMMUNOL, V37, P788, DOI 10.1002/eji.200636620; Martins I, 2009, MELANOMA RES, V19, P226, DOI 10.1097/CMR.0b013e32832e0bc3; Matsumoto Y, 2009, BURNS, V35, P383, DOI 10.1016/j.burns.2008.06.017; McFadden C, 2007, J IMMUNOL, V179, P6439, DOI 10.4049/jimmunol.179.10.6439; Mills L, 2002, CANCER RES, V62, P5106; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Ostmeier H, 2001, BRIT J DERMATOL, V145, P203, DOI 10.1046/j.1365-2133.2001.04335.x; Palacios R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001222; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perego M, 2010, J INVEST DERMATOL, V130, P1877, DOI 10.1038/jid.2010.69; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Rappa G, 2008, EXP CELL RES, V314, P2110, DOI 10.1016/j.yexcr.2008.03.008; RAZ A, 1983, SCIENCE, V221, P1307, DOI 10.1126/science.6612347; REFAELI Y, 2009, EMBO REP; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x; Schatton T, 2010, J INVEST DERMATOL, V130, P1769, DOI 10.1038/jid.2010.135; Schatton T, 2010, CANCER RES, V70, P697, DOI 10.1158/0008-5472.CAN-09-1592; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; STACKPOLE CW, 1985, INT J CANCER, V35, P667, DOI 10.1002/ijc.2910350516; Strizzi L, 2008, CELL CYCLE, V7, P1931, DOI 10.4161/cc.7.13.6236; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Vigouroux S, 2003, J VIROL, V77, P10872, DOI 10.1128/JVI.77.20.10872-10880.2003; Wang HY, 2005, J IMMUNOL, V174, P2661, DOI 10.4049/jimmunol.174.5.2661; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; WIDERA D, 2009, STEM CELLS; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; Yu SC, 2009, STEM CELL REV REP, V5, P66, DOI 10.1007/s12015-008-9047-8	71	72	74	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18784	10.1371/journal.pone.0018784	http://dx.doi.org/10.1371/journal.pone.0018784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526207	Green Published, Green Submitted, gold			2022-12-25	WOS:000289578600033
J	Altrichter, S; Peter, HJ; Pisarevskaja, D; Metz, M; Martus, P; Maurer, M				Altrichter, Sabine; Peter, Hans-Juergen; Pisarevskaja, Dina; Metz, Martin; Martus, Peter; Maurer, Marcus			IgE Mediated Autoallergy against Thyroid Peroxidase - A Novel Pathomechanism of Chronic Spontaneous Urticaria?	PLOS ONE			English	Article							SERUM SKIN-TEST; FC-EPSILON-RI; ANTI-IGE; AUTOANTIBODIES; IDENTIFICATION; CLASSIFICATION; AUTOANTIGENS; ASSOCIATION; ALLERGEN	Background: Chronic spontaneous urticaria (csU), which is characterized by recurrent episodes of mast cell-driven wheal and flare-type skin reactions, is often associated with elevated total IgE levels and thyroid autoimmunity. We speculate that some csU patients express IgE autoantibodies against thyroid antigens such as thyroid peroxidase (TPO), which could bind to skin mast cells and induce their activation. Methods: We developed and used a site-directed human IgE capture ELISA to quantify IgE-anti-TPO. We used this assay and investigated csU patients (n = 478) and healthy control subjects (n = 127) for IgE-anti-TPO and then assessed IgE-anti-TPO-positive and -negative csU patients for clinical and serological differences. Principal Findings: CsU patients were found to express more than 2fold higher IgE-anti-TPO serum levels as compared to healthy control subjects (p < 0.001). 54% of csU patients had serum levels higher than the cut off (= 5 IU/ml). By distribution analyses we identified two distinct subpopulations of csU patients: 1) IgE-anti-TPOlow (= 39%, IgE-anti-TPO: median 2.17 interquartile range 0.86-5.44, = comparable to healthy controls) and 2) IgE-anti-TPOhigh (= 61%, IgE-anti-TPO: median 6.67, interquartile range 5.39-8.24). IgE-anti-TPO-positive and -negative csU patients had very similar distributions of age and gender as well as disease activity and duration. IgE-anti-TPO-positive csU patients exhibited significantly higher IgG-anti-TPO levels and lymphocyte counts as well as decreased C4 complement levels. Conclusion: Our findings show that a sizeable subgroup of csU patients expresses IgE antibodies against thyroid peroxidase. These autoantibodies could cause "autoallergic" mast cell activation, a novel pathomechanism of chronic spontaneous urticaria.	[Altrichter, Sabine; Peter, Hans-Juergen; Pisarevskaja, Dina; Metz, Martin; Maurer, Marcus] Charite, ECARF, Allergie Ctr Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany; [Martus, Peter] Charite, Dept Biometry & Clin Epidemiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Altrichter, S (corresponding author), Charite, ECARF, Allergie Ctr Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany.	marcus.maurer@charite.de	Metz, Martin/M-5237-2013; Metz, Martin/B-8799-2009; Maurer, Marcus/ABG-2174-2020	Metz, Martin/0000-0002-4070-9976; Metz, Martin/0000-0002-4070-9976; Maurer, Marcus/0000-0002-4121-481X; Altrichter, Sabine/0000-0001-9955-385X	Innovationsstiftung Rheinland-Pfalz; European Centre of Allergy Research Foundation (ECARF)	Innovationsstiftung Rheinland-Pfalz; European Centre of Allergy Research Foundation (ECARF)	This work was funded in part by grants from Innovationsstiftung Rheinland-Pfalz and the European Centre of Allergy Research Foundation (ECARF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller U, 1999, INT ARCH ALLERGY IMM, V118, P193, DOI 10.1159/000024064; Bar-Sela S, 1999, J ALLERGY CLIN IMMUN, V103, P1216, DOI 10.1016/S0091-6749(99)70204-6; Bohning D, 1998, BIOMETRICS, V54, P525, DOI 10.2307/3109760; Bunder R, 2004, J ALLERGY CLIN IMMUN, V114, P422, DOI 10.1016/j.jaci.2004.05.029; Dimson OG, 2003, J INVEST DERMATOL, V120, P784, DOI 10.1046/j.1523-1747.2003.12146.x; Dopp R, 2000, J AM ACAD DERMATOL, V42, P577, DOI 10.1067/mjd.2000.103986; Fairley JA, 2005, J INVEST DERMATOL, V125, P467, DOI 10.1111/j.0022-202X.2005.23853.x; Fiebiger E, 1995, J CLIN INVEST, V96, P2606, DOI 10.1172/JCI118325; Gangemi S, 2009, J ENDOCRINOL INVEST, V32, P107, DOI 10.1007/BF03345696; Grattan CEH, 2004, IMMUNOL ALLERGY CLIN, V24, P163, DOI 10.1016/j.iac.2004.01.003; GRATTAN CEH, 1991, CLIN EXP ALLERGY, V21, P695, DOI 10.1111/j.1365-2222.1991.tb03198.x; Greaves MW, 2003, CURR OPIN ALLERGY CL, V3, P363, DOI 10.1097/01.all.0000092607.76804.f1; Haapala AM, 1997, SCAND J IMMUNOL, V46, P78, DOI 10.1046/j.1365-3083.1997.d01-90.x; Kadooka Y, 2000, INT ARCH ALLERGY IMM, V122, P264, DOI 10.1159/000024408; Levy Y, 2003, ARCH DIS CHILD, V88, P517, DOI 10.1136/adc.88.6.517; LEZNOFF A, 1983, ARCH DERMATOL, V119, P636, DOI 10.1001/archderm.119.8.636; Mlynek A, 2008, CURR OPIN ALLERGY CL, V8, P433, DOI 10.1097/ACI.0b013e32830f9119; Natter S, 1998, FASEB J, V12, P1559, DOI 10.1096/fasebj.12.14.1559; PALMACARLOS AG, 2005, ALLERG IMMUNOL PARIS, V37, P143; Sabroe RA, 2002, J ALLERGY CLIN IMMUN, V110, P492, DOI 10.1067/mai.2002.126782; Sabroe RA, 1999, BRIT J DERMATOL, V140, P446; Staubach P, 2006, DERMATOLOGY, V212, P150, DOI 10.1159/000090656; Staubach P, 2009, MYCOSES, V52, P334, DOI 10.1111/j.1439-0507.2008.01601.x; Tedeschi A, 2001, J ALLERGY CLIN IMMUN, V108, P467; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Valenta R, 1998, J INVEST DERMATOL, V111, P1178, DOI 10.1046/j.1523-1747.1998.00413.x; Zauli D, 2001, ALLERGY ASTHMA PROC, V22, P93, DOI 10.2500/108854101778250625; Zuberbier T, 2009, ALLERGY, V64, P1417, DOI 10.1111/j.1398-9995.2009.02179.x	28	184	197	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e14794	10.1371/journal.pone.0014794	http://dx.doi.org/10.1371/journal.pone.0014794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532759	gold, Green Published, Green Submitted			2022-12-25	WOS:000289404700001
J	Farrell, ME; Briefer, E; McElligott, AG				Farrell, Mary E.; Briefer, Elodie; McElligott, Alan G.			Assortative Mating in Fallow Deer Reduces the Strength of Sexual Selection	PLOS ONE			English	Article							FEMALE MATE CHOICE; RED DEER; DAMA-DAMA; BUCKS; AGE; SUCCESS; QUALITY; COMPETITION; EXPERIENCE; MODELS	Background: Assortative mating can help explain how genetic variation for male quality is maintained even in highly polygynous species. Here, we present a longitudinal study examining how female and male ages, as well as male social dominance, affect assortative mating in fallow deer (Dama dama) over 10 years. Assortative mating could help explain the substantial proportion of females that do not mate with prime-aged, high ranking males, despite very high mating skew. We investigated the temporal pattern of female and male matings, and the relationship between female age and the age and dominance of their mates. Results: The peak of yearling female matings was four days later than the peak for older females. Younger females, and especially yearlings, mated with younger and lower-ranking males than older females. Similarly, young males and lower-ranking males mated with younger females than older males and higher-ranking males. Furthermore, the timing of matings by young males coincided with the peak of yearling female matings, whereas the timing of older male matings (irrespective of rank) coincided with the peak of older female matings. Conclusions: Assortative mating, through a combination of indirect and/or direct female mate choice, can help explain the persistence of genetic variation for male traits associated with reproductive success.	[Farrell, Mary E.] Univ W England, Hartpury Coll, Gloucester, England; [Briefer, Elodie; McElligott, Alan G.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of West England; University of London; Queen Mary University London	Farrell, ME (corresponding author), Univ W England, Hartpury Coll, Gloucester, England.	e.briefer@qmul.ac.uk; a.g.mcelligott@qmul.ac.uk	McElligott, Alan G./ABC-1179-2020; Briefer, Elodie/A-3584-2010	McElligott, Alan G./0000-0001-5770-4568; Farrell, Mary/0000-0002-6232-0654	Office of Public Works; Department of Education Ireland; Swiss National Science Foundation	Office of Public Works; Department of Education Ireland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors acknowledge the financial support of the Office of Public Works (http://www.opw.ie/), the Department of Education Ireland (http://www.education.ie/; M. E. Farrell) during some of the data collection and the Swiss National Science Foundation (http://www.snf.ch/; E. Briefer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Apollonio M, 2003, NATURWISSENSCHAFTEN, V90, P553, DOI 10.1007/s00114-003-0475-7; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; Bang A, 2010, ANIM BEHAV, V79, P631, DOI 10.1016/j.anbehav.2009.12.009; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Bebie N, 2006, MAMM BIOL, V71, P347, DOI 10.1016/j.mambio.2006.02.008; Birgersson B, 1997, BEHAV ECOL, V8, P493, DOI 10.1093/beheco/8.5.493; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carranza J, 2009, MOL ECOL, V18, P4964, DOI 10.1111/j.1365-294X.2009.04401.x; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Charlton BD, 2008, ETHOLOGY, V114, P1023, DOI 10.1111/j.1439-0310.2008.01539.x; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Ciuti S, 2011, ETHOLOGY, V117, P133, DOI 10.1111/j.1439-0310.2010.01862.x; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Darwin G., 1871, P423; Farrell M. E., 2001, THESIS U COLL DUBLIN; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Harty H. C., 2002, THESIS U COLL DUBLIN; Higginson AD, 2009, P ROY SOC B-BIOL SCI, V276, P1153, DOI 10.1098/rspb.2008.1592; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Hosken DJ, 2001, CURR BIOL, V11, P489, DOI 10.1016/S0960-9822(01)00146-4; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Iwasa Y, 1999, J THEOR BIOL, V200, P97, DOI 10.1006/jtbi.1999.0979; Jabbour HN, 1997, J ZOOL, V243, P461, DOI 10.1111/j.1469-7998.1997.tb02795.x; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Komers PE, 1999, AM NAT, V153, P431, DOI 10.1086/303185; Kotiaho JS, 2008, TRENDS ECOL EVOL, V23, P1, DOI 10.1016/j.tree.2007.09.012; Langbein Jochen, 1992, P293; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Mainguy J, 2009, P ROY SOC B-BIOL SCI, V276, P4067, DOI 10.1098/rspb.2009.1231; McElligott AG, 1999, ANIM BEHAV, V57, P1159, DOI 10.1006/anbe.1999.1076; McElligott AG, 1998, ETHOLOGY, V104, P789; McElligott AG, 2003, EVOL ECOL RES, V5, P1239; McElligott AG, 2002, P ROY SOC B-BIOL SCI, V269, P1129, DOI 10.1098/rspb.2002.1993; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; McElligott AG, 2000, BEHAV ECOL SOCIOBIOL, V48, P203, DOI 10.1007/s002650000234; MOORE NP, 1995, BEHAV ECOL SOCIOBIOL, V36, P91, DOI 10.1007/s002650050128; OCONNELL JM, 1993, THESIS U COLL DUBLIN; Petrie M, 2007, HEREDITY, V98, P198, DOI 10.1038/sj.hdy.6800921; Preston BT, 2005, P ROY SOC B-BIOL SCI, V272, P365, DOI 10.1098/rspb.2004.2977; R- Development-Core-Team, 2009, R FDN STAT COMP; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; Rossiter SJ, 2005, NATURE, V437, P408, DOI 10.1038/nature03965; San Jose C, 1999, CAN J ZOOL, V77, P1717, DOI 10.1139/cjz-77-11-1717; Say L, 2003, MOL ECOL, V12, P2793, DOI 10.1046/j.1365-294X.2003.01945.x; Tudor MS, 2009, ETHOLOGY, V115, P812, DOI 10.1111/j.1439-0310.2009.01676.x; Vannoni E, 2009, ANIM BEHAV, V78, P3, DOI 10.1016/j.anbehav.2009.03.015; Wiley RH, 1996, EVOLUTION, V50, P1371, DOI 10.1111/j.1558-5646.1996.tb03911.x; Wilson AJ, 2005, AM NAT, V166, pE177, DOI 10.1086/497441; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032	60	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18533	10.1371/journal.pone.0018533	http://dx.doi.org/10.1371/journal.pone.0018533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494678	Green Published, gold			2022-12-25	WOS:000289192400037
J	Kong, JP; Crissey, MA; Funakoshi, S; Kreindler, JL; Lynch, JP				Kong, Jianping; Crissey, Mary Ann; Funakoshi, Shinsuke; Kreindler, James L.; Lynch, John P.			Ectopic Cdx2 Expression in Murine Esophagus Models an Intermediate Stage in the Emergence of Barrett's Esophagus	PLOS ONE			English	Article							DILATED INTERCELLULAR SPACES; SCANNING-ELECTRON-MICROSCOPY; TRANSCRIPTION FACTORS CDX1; COLUMNAR-LINED ESOPHAGUS; IN-VITRO MODEL; INTESTINAL METAPLASIA; TRANSGENIC MICE; MULTILAYERED EPITHELIUM; GENE-EXPRESSION; DUODENOESOPHAGEAL REFLUX	Barrett's esophagus (BE) is an intestinal metaplasia that occurs in the setting of chronic acid and bile reflux and is associated with a risk for adenocarcinoma. Expression of intestine-specific transcription factors in the esophagus likely contributes to metaplasia development. Our objective was to explore the effects of an intestine-specific transcription factor when expressed in the mouse esophageal epithelium. Transgenic mice were derived in which the transcription factor Cdx2 is expressed in squamous epithelium using the murine Keratin-14 gene promoter. Effects of the transgene upon cell proliferation and differentiation, gene expression, and barrier integrity were explored. K14-Cdx2 mice express the Cdx2 transgene in esophageal squamous tissues. Cdx2 expression was associated with reduced basal epithelial cell proliferation and altered cell morphology. Ultrastructurally two changes were noted. Cdx2 expression was associated with dilated space between the basal cells and diminished cell-cell adhesion caused by reduced Desmocollin-3 mRNA and protein expression. This compromised epithelial barrier function, as the measured trans-epithelial electrical resistance (TEER) of the K14-Cdx2 epithelium was significantly reduced compared to controls (1189 Ohm* cm(2) +/- 343.5 to 508 Ohm* cm(2) +/- 92.48, p = 0.0532). Secondly, basal cells with features of a transitional cell type, intermediate between keratinocytes and columnar Barrett's epithelial cells, were observed. These cells had reduced keratin bundles and increased endoplasmic reticulum levels, suggesting the adoption of secretory-cell features. Moreover, at the ultrastructural level they resembled "Distinctive" cells associated with multilayered epithelium. Treatment of the K14-Cdx2 mice with 5'-Azacytidine elicited expression of BE-associated genes including Cdx1, Krt18, and Slc26a3/Dra, suggesting the phenotype could be advanced under certain conditions. We conclude that ectopic Cdx2 expression in keratinocytes alters cell proliferation, barrier function, and differentiation. These altered cells represent a transitional cell type between normal squamous and columnar BE cells. The K14-Cdx2 mice represent a useful model to study progression from squamous epithelium to BE.	[Kong, Jianping; Crissey, Mary Ann; Funakoshi, Shinsuke; Lynch, John P.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Kreindler, James L.] Childrens Hosp Philadelphia, Dept Pediat, Div Pulm Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Kong, JP (corresponding author), Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	lynchj@mail.med.upenn.edu		Crissey, Mary Ann/0000-0002-6952-5601	National Institutes of Health, NIDDK [DK068366]; NCI [P01 CA098101]; Morphology, Cell Culture, and Molecular Biology Core Facilities of the Center for Molecular Studies in Digestive and Liver Disease at the University of Pennsylvania [P30-DK50306]; NATIONAL CANCER INSTITUTE [P01CA098101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK068366] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Morphology, Cell Culture, and Molecular Biology Core Facilities of the Center for Molecular Studies in Digestive and Liver Disease at the University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by National Institutes of Health research awards including NIDDK Grant DK068366 (J. Lynch), an NCI Program Project P01 CA098101, and the Morphology, Cell Culture, and Molecular Biology Core Facilities of the Center for Molecular Studies in Digestive and Liver Disease at the University of Pennsylvania (P30-DK50306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch JA, 1997, GASTROENTEROLOGY, V112, P760, DOI 10.1053/gast.1997.v112.pm9041237; Chen XX, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-1; CLARK GWB, 1994, ANN SURG ONCOL, V1, P252, DOI 10.1007/BF02303531; Clement G, 2006, J PATHOL, V208, P100, DOI 10.1002/path.1884; Colleypriest BJ, 2009, TRENDS MOL MED, V15, P313, DOI 10.1016/j.molmed.2009.05.001; Eads CA, 2001, CANCER RES, V61, P3410; Eads CA, 2000, CANCER RES, V60, P5021; Eda A, 2003, J GASTROENTEROL, V38, P14, DOI 10.1007/s005350300001; Ezaki T, 2007, AM J PHYSIOL-GASTR L, V293, pG54, DOI 10.1152/ajpgi.00533.2006; Farre R, 2008, GUT, V57, P1366, DOI 10.1136/gut.2007.141804; Fitzgerald RC, 2006, GUT, V55, P1810, DOI 10.1136/gut.2005.089144; Fitzgerald RC, 1997, J CELL SCI, V110, P663; FUNAKOSHI S, 2010, AM J PHYSL IN PRESS; Funakoshi S, 2008, MOL CANCER RES, V6, P1478, DOI 10.1158/1541-7786.MCR-07-2161; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Groisman GM, 2004, MODERN PATHOL, V17, P1282, DOI 10.1038/modpathol.3800182; Guillem PG, 2005, DIGEST DIS SCI, V50, P415, DOI 10.1007/s10620-005-2451-x; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; Guo RJ, 2004, J BIOL CHEM, V279, P36865, DOI 10.1074/jbc.M405213200; Guo RJ, 2010, CARCINOGENESIS, V31, P159, DOI 10.1093/carcin/bgp213; Hao J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-59; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Ingravallo G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-108; Jaiswal KR, 2007, DIS ESOPHAGUS, V20, P256, DOI 10.1111/j.1442-2050.2007.00683.x; KALABIS J, 2008, J CLIN INVEST; Kazumori H, 2006, GUT, V55, P16, DOI 10.1136/gut.2005.066209; Keller MS, 2004, AM J PHYSIOL-GASTR L, V287, pG104, DOI 10.1152/ajpgi.00484.2003; Khan K, 2006, BRIT J CANCER, V95, P1367, DOI 10.1038/sj.bjc.6603453; Kong J, 2009, CARCINOGENESIS, V30, P122, DOI 10.1093/carcin/bgn227; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Lynch J, 2000, J BIOL CHEM, V275, P4499, DOI 10.1074/jbc.275.6.4499; Lynch JP, 2008, NEOPLASIA, V10, P8, DOI 10.1593/neo.07703; Marchetti M, 2003, J CELL SCI, V116, P1429, DOI 10.1242/jcs.00338; Moons LMG, 2004, J CLIN PATHOL, V57, P1063, DOI 10.1136/jcp.2003.015727; Morales CP, 2002, LANCET, V360, P1587, DOI 10.1016/S0140-6736(02)11569-8; Mutoh H, 2004, GUT, V53, P1416, DOI 10.1136/gut.2003.032482; Mutoh H, 2002, BIOCHEM BIOPH RES CO, V294, P470, DOI 10.1016/S0006-291X(02)00480-1; Nishijima K, 2004, ANN SURG, V240, P57, DOI 10.1097/01.sla.0000130850.31178.8c; Nozawa K, 2004, ARTHRITIS RES THER, V6, pR95, DOI 10.1186/ar1035; Palanca-Wessels MCA, 2003, CARCINOGENESIS, V24, P1183, DOI 10.1093/carcin/bgg076; Pera M, 2007, J GASTROINTEST SURG, V11, P869, DOI 10.1007/s11605-007-0162-7; Phillips RW, 2003, AM J SURG PATHOL, V27, P1442, DOI 10.1097/00000478-200311000-00006; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Sawhney RA, 1996, DIGEST DIS SCI, V41, P1088, DOI 10.1007/BF02088224; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shafa M, 2010, BIOESSAYS, V32, P791, DOI 10.1002/bies.201000033; SHIELDS HM, 1995, MICROSC RES TECHNIQ, V31, P248, DOI 10.1002/jemt.1070310308; Shields HM, 2001, AM J GASTROENTEROL, V96, P3268; SHIELDS HM, 1993, DIGEST DIS SCI, V38, P97, DOI 10.1007/BF01296780; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Souza RF, 2002, GASTROENTEROLOGY, V122, P299, DOI 10.1053/gast.2002.30993; Spechler SJ, 2010, GASTROENTEROLOGY, V138, P854, DOI 10.1053/j.gastro.2010.01.002; Stairs DB, 2010, PROG MOL BIOL TRANSL, V96, P231, DOI 10.1016/S1877-1173(10)96010-9; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Su YH, 2004, LAB INVEST, V84, P753, DOI 10.1038/labinvest.3700079; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; Theisen J, 2005, ANN SURG, V241, P63, DOI 10.1097/01.sla.0000150072.55037.e3; Tobey NA, 2004, AM J GASTROENTEROL, V99, P13, DOI 10.1046/j.1572-0241.2003.04018.x; Tobey NA, 1996, GASTROENTEROLOGY, V111, P1200, DOI 10.1053/gast.1996.v111.pm8898633; Troelsen JT, 1997, BIOCHEM J, V322, P833, DOI 10.1042/bj3220833; Upton MP, 2006, DIGEST DIS SCI, V51, P1783, DOI 10.1007/s10620-006-9243-9; Vaninetti N, 2009, MOL CARCINOGEN, V48, P965, DOI 10.1002/mc.20549; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Zou HZ, 2005, INT J CANCER, V116, P584, DOI 10.1002/ijc.21045	68	56	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18280	10.1371/journal.pone.0018280	http://dx.doi.org/10.1371/journal.pone.0018280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494671	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400015
J	Bu, W; Chen, J; Morrison, GD; Huang, S; Creighton, CJ; Huang, J; Chamness, GC; Hilsenbeck, SG; Roop, DR; Leavitt, AD; Li, Y				Bu, W.; Chen, J.; Morrison, G. D.; Huang, S.; Creighton, C. J.; Huang, J.; Chamness, G. C.; Hilsenbeck, S. G.; Roop, D. R.; Leavitt, A. D.; Li, Y.			Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer	ONCOGENE			English	Article						Keratin 6; TVA; RCAS; PyMT; mammary gland; normal-like breast cancer	STEM-CELLS; GENE-EXPRESSION; STEM/PROGENITOR CELLS; GLAND DEVELOPMENT; SELF-RENEWAL; MOUSE MODELS; TUMORIGENESIS; POPULATION; RECEPTOR; SYSTEM	Progenitor cells are considered an important cell of origin of human malignancies. However, there has not been any single gene that can define mammary bipotential progenitor cells, and as such it has not been possible to use genetic methods to introduce oncogenic alterations into these cells in vivo to study tumorigenesis from them. Keratin 6a is expressed in a subset of mammary luminal epithelial cells and body cells of terminal end buds. By generating transgenic mice using the Keratin 6a (K6a) gene promoter to express tumor virus A (tva), which encodes the receptor for avian leukosis virus subgroup A (ALV/A), we provide direct evidence that K6a(+) cells are bipotential progenitor cells, and the first demonstration of a non-basal location for some biopotential progenitor cells. These K6a(+) cells were readily induced to form mammary tumors by intraductal injection of RCAS (an ALV/A-derived vector) carrying the gene encoding the polyoma middle T antigen. Tumors in this K6a-tva line were papillary and resembled the normal breast-like subtype of human breast cancer. This is the first model of this subtype of human tumors and thus may be useful for preclinical testing of targeted therapy for patients with normal-like breast cancer. These observations also provide direct in vivo evidence for the hypothesis that the cell of origin affects mammary tumor phenotypes. Oncogene (2011) 30, 4399-4409; doi:10.1038/onc.2011.147; published online 2 May 2011	[Bu, W.; Morrison, G. D.; Huang, J.; Chamness, G. C.; Hilsenbeck, S. G.; Li, Y.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Chen, J.; Roop, D. R.; Li, Y.] Univ Colorado Denver, Dermatol & Charles C Gates Regenerat Med & Stem C, Aurora, CO USA; [Huang, S.; Li, Y.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Huang, S.; Creighton, C. J.; Hilsenbeck, S. G.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Leavitt, A. D.] Univ Calif San Francisco, Dept Lab Med & Med, San Francisco, CA 94143 USA	Baylor College of Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco	Li, Y (corresponding author), Baylor Coll Med, Breast Ctr, 1 Baylor Plaza,BCM 600, Houston, TX 77030 USA.	liyi@bcm.edu	Li, Yi/A-7635-2009	Li, Yi/0000-0002-9976-518X	USAMRMC [BC030755, BC073703]; National Institutes of Health [CA113869, CA124820]; MMHCC [U01 CA084243-07]; NCI [P50 CA058183]; NATIONAL CANCER INSTITUTE [P50CA058183, R01CA113869, U01CA084243, R01CA124820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM069234] Funding Source: NIH RePORTER	USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MMHCC; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tammy Tong, Amanda McGrath, Ekaterina Bogoslovskaia, Andrei Lazarev, Meghali Goswami and Yiqun Zhang for technical assistance, Drs Jeffrey Rosen and Michael Lewis for stimulating discussions and/or critical review of this manuscript, as well as Drs Robert D Cardiff and Barry Gusterson for advice on pathological comparisons. This work was supported in part by funds from USAMRMC BC030755 and BC073703 (to YL), National Institutes of Health CA113869 and CA124820 (to YL), Project 5 of MMHCC U01 CA084243-07 (to YL; U01 PI: Dr Jeffrey Rosen) and a developmental project of NCI P50 CA058183 (to YL; SPORE PI: Dr C Kent Osborne).	Andrechek ER, 2004, P NATL ACAD SCI USA, V101, P4984, DOI 10.1073/pnas.0306802101; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bai LX, 2010, GENE DEV, V24, P1882, DOI 10.1101/gad.1932810; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Grimm SL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1504; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hughes SH, 2004, FOLIA BIOL-PRAGUE, V50, P107; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Mollet M, 2008, BIOTECHNOL BIOENG, V100, P260, DOI 10.1002/bit.21762; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; SMITH GH, 1990, CELL GROWTH DIFFER, V1, P161; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Toneff MJ, 2010, NEOPLASIA, V12, P718, DOI 10.1593/neo.10516; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	35	35	35	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	43					4399	4409		10.1038/onc.2011.147	http://dx.doi.org/10.1038/onc.2011.147			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HQ	21532625	Green Submitted, Green Accepted			2022-12-25	WOS:000296356500003
J	Messina, S; Frati, L; Leonetti, C; Zuchegna, C; Di Zazzo, E; Calogero, A; Porcellini, A				Messina, S.; Frati, L.; Leonetti, C.; Zuchegna, C.; Di Zazzo, E.; Calogero, A.; Porcellini, A.			Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas	ONCOGENE			English	Article						glioblastoma; dual-specificity phosphatase; tumor promoting	CANCER-CELLS; LUNG-CANCER; MALIGNANT PHENOTYPE; DOWN-REGULATION; UP-REGULATION; GROWTH; EXPRESSION; MUTATIONS; RAS; DUSP6/MKP-3	Dual-specificity phosphatase 6 (DUSP6, mitogen-activated protein kinase (MAPK) phosphatase 3 or PYST1) dephosphorylates phosphotyrosine and phosphothreonine residues on extracellular signal-regulated kinase (ERK1/2; MAPK1/2) to inactivate the ERK1/2 kinase. DUSP6 is a critical regulator of the ERK signaling cascade and has been implicated as a tumor suppressor. We report here experimental evidences that DUSP6 is transcriptionally upregulated in primary and long-term cultures of human glioblastoma, as assayed by northern hybridization and real-time quantitative PCR, producing constitutive high level of protein expression. Functional assays were performed with adenovirus-mediated expression of DUSP6 in glioblastoma cultures. Protein overexpression inhibits growth by inducing G1-phase delay and increased mitogenic/anchorage dependence and clonogenic potential in vitro. Changes in cell morphology were associated with an increased tumor growth in vivo. Chemoresistance is a major cause of treatment failure and poor outcome in human glioblastomas. Importantly, DUSP6 overexpression increased resistance to cisplatin-mediated cell death in vitro and in vivo. Antisense-mediated depletion of DUSP6 acted in lowering the threshold to anticancer DNA-damaging drugs. We conclude that upregulation of DUSP6 exerts a tumor-promoting role in human glioblastomas exacerbating the malignant phenotype. Oncogene (2011) 30, 3813-3820; doi:10.1038/onc.2011.99; published online 18 April 2011	[Messina, S.; Frati, L.] IRCCS Neuromed, Dept Pathol, I-86077 Isernia, Italy; [Messina, S.] Univ Cassino, Dept Hlth & Motor Sci, I-03043 Cassino, Italy; [Leonetti, C.] Regina Elena Inst Canc Res, Dept Expt Chemotherapy, Rome, Italy; [Zuchegna, C.; Di Zazzo, E.] Univ Campobasso, Dept Hlth Sci, Campobasso, Italy; [Zuchegna, C.; Porcellini, A.] Univ Naples Federico 2, Dept Struct & Funct Biol, Naples, Italy; [Calogero, A.] Univ Roma La Sapienza, Dept Med & Surg Sci & Biotecnol, Rome, Italy	IRCCS Neuromed; University of Cassino; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Molise; University of Naples Federico II; Sapienza University Rome	Messina, S (corresponding author), IRCCS Neuromed, Dept Pathol, Via Atinense 18, I-86077 Isernia, Italy.	samantha.messina@uniroma1.it; Antonio.Porcellini@unina.it	Porcellini, Antonio/E-1900-2011; Di Zazzo, Erika/Z-5299-2019; calogero, antonella/U-5418-2019; Porcellini, Antonio/AAC-6097-2019; Frati, Luigi/ABI-7437-2020; Leonetti, Carlo/B-2860-2018	Porcellini, Antonio/0000-0001-6882-9518; Di Zazzo, Erika/0000-0001-7621-488X; Leonetti, Carlo/0000-0002-3526-7827; calogero, antonella/0000-0002-3322-2916; Zuchegna, Candida/0000-0002-8494-8602				Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Bermudez O, 2011, J CELL PHYSIOL, V226, P276, DOI 10.1002/jcp.22339; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cui YK, 2006, CANCER RES, V66, P5950, DOI 10.1158/0008-5472.CAN-05-3243; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Gozdz A, 2003, J BIOL CHEM, V278, P43663, DOI 10.1074/jbc.M301554200; Hong L, 2007, MED HYPOTHESES, V69, P1379, DOI 10.1016/j.mehy.2007.03.029; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Li YQ, 2008, CANCER RES, V68, P1723, DOI 10.1158/0008-5472.CAN-07-1963; Lucci MA, 2010, CELL ONCOL, V32, P361, DOI 10.3233/CLO-2010-0520; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Marchetti S, 2004, J CELL PHYSIOL, V199, P441, DOI 10.1002/jcp.10465; Mark JK, 2008, J BIOL CHEM, V283, P28574, DOI 10.1074/jbc.M801747200; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Messina S, 2004, BIOCHEM BIOPH RES CO, V320, P493, DOI 10.1016/j.bbrc.2004.06.003; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nagane M, 1996, CANCER RES, V56, P5079; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; PETALIDIS LP, 2008, MOL CANCER THER, V7, pOF1; Porcellini A, 1997, ONCOGENE, V15, P781, DOI 10.1038/sj.onc.1201240; Porcellini Antonio, 2004, Methods Mol Biol, V259, P155; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Silvani A, 2009, J NEURO-ONCOL, V94, P57, DOI 10.1007/s11060-009-9800-0; Tanuma N, 2009, ONCOGENE, V28, P752, DOI 10.1038/onc.2008.431; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Waha A, 2010, CANCER RES, V70, P1689, DOI 10.1158/0008-5472.CAN-09-3218; Warmka JK, 2004, J BIOL CHEM, V279, P33085, DOI 10.1074/jbc.M403120200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020	40	66	69	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	35					3813	3820		10.1038/onc.2011.99	http://dx.doi.org/10.1038/onc.2011.99			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	814TZ	21499306				2022-12-25	WOS:000294481400008
J	Xing, F; Okuda, H; Watabe, M; Kobayashi, A; Pai, SK; Liu, W; Pandey, PR; Fukuda, K; Hirota, S; Sugai, T; Wakabayshi, G; Koeda, K; Kashiwaba, M; Suzuki, K; Chiba, T; Endo, M; Mo, YY; Watabe, K				Xing, F.; Okuda, H.; Watabe, M.; Kobayashi, A.; Pai, S. K.; Liu, W.; Pandey, P. R.; Fukuda, K.; Hirota, S.; Sugai, T.; Wakabayshi, G.; Koeda, K.; Kashiwaba, M.; Suzuki, K.; Chiba, T.; Endo, M.; Mo, Y-Y; Watabe, K.			Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells	ONCOGENE			English	Article						Jagged2; Notch; breast cancer; hypoxia; cancer stem-like cells	INDUCIBLE-FACTOR 1-ALPHA; NOTCH LIGANDS; ACTIVATION; BONE; SURVIVAL; GENE; AKT; OVEREXPRESSION; ADENOCARCINOMA; PROLIFERATION	Notch signaling is often and aberrantly activated by hypoxia during tumor progression; however, the exact pathological role of hypoxia-induced Notch signaling in tumor metastasis is as yet poorly understood. In this study, we aimed to define the mechanism of Notch-ligand activation by hypoxia in both primary tumor and bone stromal cells in the metastatic niche and to clarify their roles in tumor progression. We have analyzed the expression profiles of various Notch ligands in 779 breast cancer patients in GEO database and found that the expression of Jagged2 among all five ligands is most significantly correlated with the overall-and metastasis-free survival of breast cancer patients. The results of our immunohistochemical (IHC) analysis for Jagged2 in 61 clinical samples also revealed that both Jagged2 and Notch signaling were strongly upregulated at the hypoxic invasive front. Activation of Jagged2 by hypoxia in tumor cells induced EMT and also promoted cell survival in vitro. Notably, a c-secretase inhibitor significantly blocked Notch-mediated invasion and survival under hypoxia by promoting expression of E-cadherin and inhibiting Akt phosphorylation. Importantly, Jagged2 was also found to be upregulated in bone marrow stroma under hypoxia and promoted the growth of cancer stem-like cells by activating their Notch signaling. Therefore, hypoxia-induced Jagged2 activation in both tumor invasive front and normal bone stroma has a critical role in tumor progression and metastasis, and Jagged2 is considered to be a valuable prognostic marker and may serve as a novel therapeutic target for metastatic breast cancer. Oncogene (2011) 30, 4075-4086; doi:10.1038/onc.2011.122; published online 18 April 2011	[Xing, F.; Okuda, H.; Watabe, M.; Kobayashi, A.; Pai, S. K.; Liu, W.; Pandey, P. R.; Fukuda, K.; Mo, Y-Y; Watabe, K.] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62702 USA; [Hirota, S.; Sugai, T.; Wakabayshi, G.; Koeda, K.; Kashiwaba, M.; Suzuki, K.; Chiba, T.; Endo, M.] Iwate Med Univ, Sch Med, Morioka, Iwate, Japan	Southern Illinois University System; Southern Illinois University; Iwate Medical University	Watabe, K (corresponding author), So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, 751 N Rutledge St,POB 19626, Springfield, IL 62702 USA.	kwatabe@siumed.edu	Kobayashi, Aya/AAA-2530-2020; Mo, Yin-Yuan/R-8255-2019	Chiba, Toshimi/0000-0001-7072-3157; Okuda, Hiroshi/0000-0002-5747-8086	NIH [R01CA124650, R01CA129000]; US Department of Defense [BC085424, BC085590]; Susan Komen Foundation [KG080477]; NATIONAL CANCER INSTITUTE [R01CA124650, R01CA129000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH (R01CA124650, R01CA129000 to KW), the US Department of Defense (BC085424, BC085590 to KW) and Susan Komen Foundation (KG080477 to KW).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Bertout JA, 2009, CANCER RES, V69, P3213, DOI 10.1158/0008-5472.CAN-08-4223; Cejudo-Martin P, 2005, DEV CELL, V9, P575, DOI 10.1016/j.devcel.2005.10.001; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Choi K, 2009, J BIOL CHEM, V284, P17766, DOI 10.1074/jbc.M109.003111; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Horree N, 2007, HUM PATHOL, V38, P1232, DOI 10.1016/j.humpath.2007.01.008; Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Kominsky SL, 2006, J CLIN ONCOL, V24, P2227, DOI 10.1200/JCO.2005.05.5319; Lambin P, 1998, ANAEROBE, V4, P183, DOI 10.1006/anae.1998.0161; Lee SH, 2007, APMIS, V115, P1357, DOI 10.1111/j.1600-0463.2007.00751.x; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nam DH, 2008, CLIN CANCER RES, V14, P4059, DOI 10.1158/1078-0432.CCR-07-4039; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Tomes L, 2003, BREAST CANCER RES TR, V81, P61, DOI 10.1023/A:1025476722493; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zhao NJ, 2010, ONCOL REP, V23, P1443, DOI 10.3892/or_00000782; Zhong H, 1999, CANCER RES, V59, P5830	41	159	166	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	39					4075	4086		10.1038/onc.2011.122	http://dx.doi.org/10.1038/onc.2011.122			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	826ME	21499308	Green Accepted			2022-12-25	WOS:000295357500003
J	Woo, KC; Kim, TD; Lee, KH; Kim, DY; Kim, S; Lee, HR; Kang, HJ; Chung, SJ; Senju, S; Nishimura, Y; Kim, KT				Woo, Kyung-Chul; Kim, Tae-Don; Lee, Kyung-Ha; Kim, Do-Yeon; Kim, Sangjune; Lee, Hwa-Rim; Kang, Hyo-Jin; Chung, Sang J.; Senju, Satoru; Nishimura, Yasuharu; Kim, Kyong-Tai			Modulation of exosome-mediated mRNA turnover by interaction of GTP-binding protein 1 (GTPBP1) with its target mRNAs	FASEB JOURNAL			English	Article						circadian rhythm; untranslated region	N-ACETYLTRANSFERASE; 3'-UNTRANSLATED REGION; QUALITY-CONTROL; SKI COMPLEX; MOUSE; DECAY; DEGRADATION; EXPRESSION; KSRP; IDENTIFICATION	Eukaryotic mRNA turnover is among most critical mechanisms that affect mRNA abundance and are regulated by mRNA-binding proteins and the cytoplasmic exosome. A functional protein, guanosinetriphosphate-binding protein 1 (GTPBP1), which associates with both the exosome and target mRNAs, was identified. The overexpression of GTPBP1 accelerated the target mRNA decay, whereas the reduction of the GTPBP1 expression with RNA interference stabilized the target mRNA. GTPBP1 has a putative guanosinetriphosphate (GTP)-binding domain, which is found in members of the G-protein family and Ski7p, a well-known core factor of the exosome-mediated mRNA turnover pathway in yeast. Analyses of protein interactions and mRNA decay demonstrated that GTPBP1 modulates mRNA degradation via GTP-binding-dependent target loading. Moreover, GTPBP1-knockout models displayed multiple mRNA decay defects, including elevated nocturnal levels of Aanat mRNA in pineal glands, and retarded degradation of TNF-alpha mRNA in lipopolysaccharide-treated splenocytes. The results of this study suggest that GTPBP1 is a regulator and adaptor of the exosome-mediated mRNA turnover pathway.-Woo, K.-C., Kim, T.-D., Lee, K.-H., Kim, D.-Y. Kim, S., Lee, H.-R., Kang, H.-J., Chung, S. J., Senju, S., Nishimura, Yasuharu, Kim, K.-T. Modulation of exosome-mediated mRNA turnover by interaction of GTP-binding protein 1 (GTPBP1) with its target mRNAs. FASEB J. 25, 2757-2769 (2011). www.fasebj.org	[Woo, Kyung-Chul; Lee, Kyung-Ha; Kim, Do-Yeon; Kim, Sangjune; Lee, Hwa-Rim; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea; [Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Kang, Hyo-Jin; Chung, Sang J.] Korea Res Inst Biosci & Biotechnol, BioNanotechnol Res Ctr, Taejon, South Korea; [Kim, Tae-Don] Korea Res Inst Biosci & Biotechnol, Cell Therapy Res Ctr, Taejon, South Korea; [Kang, Hyo-Jin; Chung, Sang J.] Korea Univ Sci & Technol, Nanobiotechnol Div, Taejon, South Korea; [Senju, Satoru; Nishimura, Yasuharu] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kumamoto University	Kim, KT (corresponding author), POSTECH, Dept Life Sci, San 31, Pohang 790784, South Korea.	ktk@postech.ac.kr	Lee, Kyung-Ha/GRY-2640-2022; Kim, Do-Yeon/B-1877-2009	Lee, Kyung-Ha/0000-0003-0515-7392; Kang, Hyo Jin/0000-0001-7104-8456; Kim, Sangjune/0000-0003-3052-3163; Kim, Tae-Don/0000-0002-5910-4264; KIM, KYONG-TAI/0000-0001-7292-2627	National Research Foundation of Korea [20100030004, 20100000250, 20100002146, 20100019706]; Brain Korea 21 program; World Class University [R31-10105]; Korean Ministry of Education, Science, and Technology; Pohang University of Science and Technology Biotechnology Research Center	National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); World Class University; Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Pohang University of Science and Technology Biotechnology Research Center	The authors thank Dr. C. S. Lee and Dr. S. H. Ha for critical comments, Dr. Kyung-Yeol Lee (Chonbuk National University, Jeanju, Korea) for the pCY2-TNF-alpha ARE, and Dr. K. J. Kim for the hnRNP Q437 purification. This work was supported by grants from the National Research Foundation of Korea (20100030004, 20100000250, 20100002146, and 20100019706), the Brain Korea 21 program, the World Class University program (R31-10105), and the Regional Core Research Program/Antiaging and Well-being Research Center funded by the Korean Ministry of Education, Science, and Technology. This work was also supported by Pohang University of Science and Technology Biotechnology Research Center.	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Benard L, 1999, J VIROL, V73, P2893, DOI 10.1128/JVI.73.4.2893-2900.1999; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Chae HD, 1999, NEUROCHEM INT, V35, P447, DOI 10.1016/S0197-0186(99)00086-8; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Coon SL, 2006, MOL CELL ENDOCRINOL, V252, P2, DOI 10.1016/j.mce.2006.03.039; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Fritz DT, 2004, CELL BIOCHEM BIOPHYS, V41, P265, DOI 10.1385/CBB:41:2:265; GAMBERUCCI A, 1994, J BIOL CHEM, V269, P23597; Garcia-Mayoral MF, 2008, NUCLEIC ACIDS RES, V36, P5290, DOI 10.1093/nar/gkn509; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; Hahm B, 1998, FEBS LETT, V425, P401, DOI 10.1016/S0014-5793(98)00269-5; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Kojima S, 2003, BIOCHEM BIOPH RES CO, V301, P1, DOI 10.1016/S0006-291X(02)02938-8; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kudo H, 2000, BIOCHEM BIOPH RES CO, V272, P456, DOI 10.1006/bbrc.2000.2763; Kwak E, 2006, J BIOL CHEM, V281, P19100, DOI 10.1074/jbc.M511927200; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Laroia G, 2002, NUCLEIC ACIDS RES, V30, P3052, DOI 10.1093/nar/gkf444; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Peng SSY, 1996, MOL CELL BIOL, V16, P1490; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roseboom PH, 1998, MOL BRAIN RES, V63, P189, DOI 10.1016/S0169-328X(98)00273-3; Rudoni S, 2001, BBA-MOL CELL RES, V1538, P181, DOI 10.1016/S0167-4889(01)00067-2; Ruggiero T, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-28; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Senju S, 1997, BIOCHEM BIOPH RES CO, V231, P360, DOI 10.1006/bbrc.1997.6103; Senju S, 2000, MOL CELL BIOL, V20, P6195, DOI 10.1128/MCB.20.17.6195-6200.2000; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Tucker M, 2000, ANNU REV BIOCHEM, V69, P571, DOI 10.1146/annurev.biochem.69.1.571; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; UKAITADENUMA M, 2008, NAT CELL BIOL; Vasudevan S, 2003, CURR OPIN CELL BIOL, V15, P332, DOI 10.1016/S0955-0674(03)00051-6; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; ZHU JH, 1995, J BIOL CHEM, V270, P4805, DOI 10.1074/jbc.270.9.4805	47	20	28	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2757	2769		10.1096/fj.10-178715	http://dx.doi.org/10.1096/fj.10-178715			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21515746				2022-12-25	WOS:000293337800024
J	Pantoom, S; Vetter, IR; Prinz, H; Suginta, W				Pantoom, Supansa; Vetter, Ingrid R.; Prinz, Heino; Suginta, Wipa			Potent Family-18 Chitinase Inhibitors X-RAY STRUCTURES, AFFINITIES, AND BINDING MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRODUCT CYCLOPENTAPEPTIDE INHIBITORS; ACIDIC MAMMALIAN CHITINASE; HIGH-RESOLUTION STRUCTURES; GLIOCLADIUM SP FTD-0668; SERRATIA-MARCESCENS; CRYSTAL-STRUCTURES; ARGIFIN; ALLOSAMIDIN; COMPLEX; SPECIFICITY	Six novel inhibitors of Vibrio harveyi chitinase A (VhChiA), a family-18 chitinase homolog, were identified by in vitro screening of a library of pharmacologically active compounds. Unlike the previously identified inhibitors that mimicked the reaction intermediates, crystallographic evidence from 14 VhChiA-inhibitor complexes showed that all of the inhibitor molecules occupied the outer part of the substrate-binding cleft at two hydrophobic areas. The interactions at the aglycone location are well defined and tightly associated with Trp-397 and Trp-275, whereas the interactions at the glycone location are patchy, indicating lower affinity and a loose interaction with two consensus residues, Trp-168 and Val-205. When Trp-275 was substituted with glycine (W275G), the binding affinity toward all of the inhibitors dramatically decreased, and in most structures two inhibitor molecules were found to stack against Trp-397 at the aglycone site. Such results indicate that hydrophobic interactions are important for binding of the newly identified inhibitors by the chitinase. X-ray data and isothermal microcalorimetry showed that the inhibitors occupied the active site of VhChiA in three different binding modes, including single-site binding, independent two-site binding, and sequential two-site binding. The inhibitory effect of dequalinium in the low nanomolar range makes this compound an extremely attractive lead compound for plausible development of therapeutics against human diseases involving chitinase-mediated pathologies.	[Pantoom, Supansa; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Chem, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Pantoom, Supansa; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Biochem, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Vetter, Ingrid R.; Prinz, Heino] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Suranaree University of Technology; Suranaree University of Technology; Max Planck Society	Vetter, IR (corresponding author), Otto Hahn Str 11, D-44227 Dortmund, Germany.	ingrid.vetter@mpi-dortmund.mpg.de; heino.prinz@mpi-dortmund.mpg.de; wipa@sut.ac.th		Pantoom, Supansa/0000-0001-9630-1999	Thailand Research Fund [PHD/0238/2549]	Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by the Thailand Research Fund through Royal Golden Jubilee Ph.D. Program Grant PHD/0238/2549.	Andersen OA, 2005, NAT PROD REP, V22, P563, DOI 10.1039/b416660b; Andersen OA, 2008, CHEM BIOL, V15, P295, DOI 10.1016/j.chembiol.2008.02.015; Arai N, 2000, J ANTIBIOT, V53, P609, DOI 10.7164/antibiotics.53.609; Arai N, 2000, CHEM PHARM BULL, V48, P1442, DOI 10.1248/cpb.48.1442; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOLLER T, 1988, METHOD ENZYMOL, V161, P430; Bortone K, 2002, J MOL BIOL, V320, P293, DOI 10.1016/S0022-2836(02)00444-8; Cederkvist FH, 2007, BIOCHEMISTRY-US, V46, P12347, DOI 10.1021/bi701029u; Dixon MJ, 2009, ORG BIOMOL CHEM, V7, P259, DOI 10.1039/b815077j; Dixon MJ, 2005, BIOORG MED CHEM LETT, V15, P4717, DOI 10.1016/j.bmcl.2005.07.068; Donnelly LE, 2004, TRENDS PHARMACOL SCI, V25, P509, DOI 10.1016/j.tips.2004.08.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukamizo T, 2000, CURR PROTEIN PEPT SC, V1, P105, DOI 10.2174/1389203003381450; Hirose T, 2010, P JPN ACAD B-PHYS, V86, P85, DOI 10.2183/pjab.86.85; Hollis T, 2000, PROTEIN SCI, V9, P544, DOI 10.1110/ps.9.3.544; Houston DR, 2004, J MED CHEM, V47, P5713, DOI 10.1021/jm049940a; Houston DR, 2002, P NATL ACAD SCI USA, V99, P9127, DOI 10.1073/pnas.132060599; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Kumar A, 2010, BBA-GEN SUBJECTS, V1800, P526, DOI 10.1016/j.bbagen.2010.01.014; Langer RC, 2001, TRENDS PARASITOL, V17, P269, DOI 10.1016/S1471-4922(01)01918-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Macdonald JM, 2010, ANGEW CHEM INT EDIT, V49, P2599, DOI 10.1002/anie.200906644; Olland AM, 2009, PROTEIN SCI, V18, P569, DOI 10.1002/pro.63; Omura S, 2000, J ANTIBIOT, V53, P603, DOI 10.7164/antibiotics.53.603; Pantoom Supansa, 2008, BMC Biochemistry, V9, P2, DOI 10.1186/1471-2091-9-2; Papanikolau Y, 2003, ACTA CRYSTALLOGR D, V59, P400, DOI 10.1107/S0907444902021923; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Petter C, 2008, J MOL RECOGNIT, V21, P401, DOI 10.1002/jmr.911; Prinz Heino, 2008, J Chem Biol, V1, P95, DOI 10.1007/s12154-008-0011-5; Rao FV, 2005, CHEM BIOL, V12, P973, DOI 10.1016/j.chembiol.2005.07.009; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; SAKUDA S, 1987, J ANTIBIOT, V40, P296, DOI 10.7164/antibiotics.40.296; Sakuda S, 1998, BIOORG MED CHEM LETT, V8, P2987, DOI 10.1016/S0960-894X(98)00542-3; SAKUDA S, 1986, TETRAHEDRON LETT, V27, P2475, DOI 10.1016/S0040-4039(00)84560-8; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P27278, DOI 10.1074/jbc.M604048200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Suginta W, 2007, BBA-GEN SUBJECTS, V1770, P1151, DOI 10.1016/j.bbagen.2007.03.012; Sunazuka T, 2009, BIOORGAN MED CHEM, V17, P2751, DOI 10.1016/j.bmc.2009.02.047; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; vanScheltinga ACT, 1996, J MOL BIOL, V262, P243, DOI 10.1006/jmbi.1996.0510; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	47	25	27	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24312	24323		10.1074/jbc.M110.183376	http://dx.doi.org/10.1074/jbc.M110.183376			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21531720	Green Published, hybrid			2022-12-25	WOS:000292294900072
J	Park, H; Valencia-Gallardo, C; Sharff, A; Guy, TVN; Izard, T				Park, HaJeung; Valencia-Gallardo, Cesar; Sharff, Andrew; Guy Tran Van Nhieu; Izard, Tina			Novel Vinculin Binding Site of the IpaA Invasin of Shigella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTININ; TALIN ROD; PROTEIN; ENTRY; ACTIVATION; IDENTIFICATION; ASSOCIATION; MUTAGENESIS; DYNAMICS; FLEXNERI	Internalization of Shigella into host epithelial cells, where the bacteria replicates and spreads to neighboring cells, requires a type 3 secretion system (T3SS) effector coined IpaA. IpaA binds directly to and activates the cytoskeletal protein vinculin after injection in the host cell cytosol, and this was previously thought to be directed by two amphipathic alpha-helical vinculin-binding sites (VBS) found in the C-terminal tail domain of IpaA. Here, we report a third VBS, IpaA-VBS3, that is located N-terminal to the other two VBSs of IpaA and show that one IpaA molecule can bind up to three vinculin molecules. Biochemical in vitro Shigella invasion assays and the 1.6 angstrom crystal structure of the vinculin.IpaA-VBS3 complex showed that IpaA-VBS3 is functionally redundant with the other two IpaA-VBSs in cell invasion and in activating the latent F-actin binding functions of vinculin. Multiple VBSs in IpaA are reminiscent of talin, which harbors 11 VBSs. However, most of the talin VBSs have low affinity and are buried in helix bundles, whereas all three of the VBSs of IpaA are high affinity, readily available, and in close proximity to each other in the IpaA structure. Although deletion of IpaA-VBS3 has no detectable effects on Shigella invasion of epithelial cells, deletion of all three VBSs impaired bacterial invasion to levels found in an ipaA null mutant strain. Thus, IpaA-directed mimicry of talin in activating vinculin occurs through three high affinity VBSs that are essential for Shigella pathogenesis.	[Park, HaJeung; Izard, Tina] Scripps Res Inst, Cell Adhes Lab, Dept Canc Biol, Jupiter, FL 33458 USA; [Valencia-Gallardo, Cesar; Guy Tran Van Nhieu] Coll France, INSERM, Unite Commun Intercellulaire & Infect Microbienne, U971, F-75005 Paris, France; [Sharff, Andrew] Global Phasing Ltd, Cambridge CB3 0AX, England	Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Global Phasing Limited	Izard, T (corresponding author), Scripps Res Inst, Cell Adhes Lab, Dept Canc Biol, Jupiter, FL 33458 USA.	mkernick@scripps.edu	Van Nhieu, Guy Tran/Y-6359-2018	Van Nhieu, Guy Tran/0000-0002-3901-2186	National Institutes of Health; State of Florida	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Florida	This work was supported, in whole or in part, by National Institutes of Health grants (to T. I.). This work was also supported by start-up funds provided to Scripps Florida from the State of Florida (to T. I.).	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Bricogne G., 2010, BUSTER VERSION 2 9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Huttelmaier S, 2001, J CELL BIOL, V155, P775, DOI 10.1083/jcb.200105044; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; LEE SW, 1992, J BIOL CHEM, V267, P16355; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MENARD R, 1993, J BACTERIOL, V175, P5899; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; Niebuhr K, 2000, MOL MICROBIOL, V38, P8, DOI 10.1046/j.1365-2958.2000.02041.x; Niyogi SK, 2005, J MICROBIOL, V43, P133; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Ramarao N, 2007, FEBS LETT, V581, P853, DOI 10.1016/j.febslet.2007.01.057; Rangarajan ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010679; Sansonetti PJ, 1998, ANTON LEEUW INT J G, V74, P191, DOI 10.1023/A:1001519806727; Smart O. S., 2008, ANN M AM CRYST ASS A; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Van Nhieu GT, 2007, EMBO J, V26, P4588; VanNhieu GT, 1997, EMBO J, V16, P2717, DOI 10.1093/emboj/16.10.2717; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Zamir E, 2001, J CELL SCI, V114, P3583; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	44	28	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23214	23221		10.1074/jbc.M110.184283	http://dx.doi.org/10.1074/jbc.M110.184283			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21525010	hybrid, Green Published			2022-12-25	WOS:000292025000055
J	De Franceschi, G; Frare, E; Pivato, M; Relini, A; Penco, A; Greggio, E; Bubacco, L; Fontana, A; de Laureto, PP				De Franceschi, Giorgia; Frare, Erica; Pivato, Micaela; Relini, Annalisa; Penco, Amanda; Greggio, Elisa; Bubacco, Luigi; Fontana, Angelo; de Laureto, Patrizia Polverino			Structural and Morphological Characterization of Aggregated Species of alpha-Synuclein Induced by Docosahexaenoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; SOLUTION NMR-SPECTROSCOPY; PARKINSONS-DISEASE; IN-VITRO; PHOSPHOLIPID-BINDING; METHIONINE OXIDATION; SECONDARY STRUCTURE; PROTEIN ADDUCTS; LEWY-BODY; BRAIN	The interaction of brain lipids with alpha-synuclein may play an important role in the pathogenesis of Parkinson disease (PD). Docosahexaenoic acid (DHA) is an abundant fatty acid of neuronal membranes, and it is presents at high levels in brain areas with alpha-synuclein inclusions of patients with PD. In animal models, an increase of DHA content in the brain induces alpha-synuclein oligomer formation in vivo. However, it is not clear whether these oligomeric species are the precursors of the larger aggregates found in Lewy bodies of post-mortem PD brains. To characterize these species and to define the role of fatty acids in amyloid formation, we investigated the aggregation process of alpha-synuclein in the presence of DHA. We found that DHA readily promotes alpha-synuclein aggregation and that the morphology of these aggregates is dependent on the ratio between the protein and DHA. In the presence of a molar ratio protein/DHA of 1:10, amyloid-like fibrils are formed. These fibrils are morphologically different from those formed by alpha-synuclein alone and have a less packed structure. At a protein/DHA molar ratio of 1:50, we observe the formation of stable oligomers. Moreover, chemical modifications, methionine oxidations, and protein-lipid adduct formations are induced by increasing concentrations of DHA. The extent of these modifications defines the structure and the stability of aggregates. We also show that alpha-synuclein oligomers are more toxic if generated in the presence of DHA in dopaminergic neuronal cell lines, suggesting that these species might be important in the neurodegenerative process associated with PD.	[De Franceschi, Giorgia; Frare, Erica; Pivato, Micaela; Fontana, Angelo; de Laureto, Patrizia Polverino] Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Ctr Biotechnol, I-35121 Padua, Italy; [Relini, Annalisa; Penco, Amanda] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Greggio, Elisa; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy	University of Padua; University of Genoa; University of Padua	de Laureto, PP (corresponding author), Univ Padua, Ctr Ric Interdipartimentale Biotecnol Innovat, Ctr Biotechnol, Viale G Colombo 3, I-35121 Padua, Italy.	patrizia.polverinodelaureto@unipd.it	Bubacco, Luigi/B-5602-2012; Relini, Annalisa/AHC-3105-2022; Fontana, Angelo/C-3354-2012; Greggio, Elisa/H-6119-2013	Bubacco, Luigi/0000-0001-7927-9208; Fontana, Angelo/0000-0002-5453-461X; Greggio, Elisa/0000-0002-8172-3598; RELINI, ANNALISA/0000-0002-4040-9279	Ministero dell'Istruzione, dell'Universita e della Ricerca; Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetti di Ricerca di Interesse Nazionale [2008SYP79]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetti di Ricerca di Interesse Nazionale	Supported by Ministero dell'Istruzione, dell'Universita e della Ricerca ("Rientro dei Cervelli" Program).; Supported by Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetti di Ricerca di Interesse Nazionale 2008 (Protocol 2008SYP79).	ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cole NB, 2005, J BIOL CHEM, V280, P9678, DOI 10.1074/jbc.M409946200; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; FRANKEL E N, 1980, Progress in Lipid Research, V19, P1, DOI 10.1016/0163-7827(80)90006-5; Frankel E.N., 2005, LIPID OXIDATION; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glaser CB, 2005, BBA-PROTEINS PROTEOM, V1703, P157, DOI 10.1016/j.bbapap.2004.10.008; Golovko MY, 2007, J NEUROCHEM, V101, P201, DOI 10.1111/j.1471-4159.2006.04357.x; Golovko MY, 2006, BIOCHEMISTRY-US, V45, P6956, DOI 10.1021/bi0600289; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kim KS, 2005, B KOREAN CHEM SOC, V26, P1255; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu W, 2007, BBA-PROTEINS PROTEOM, V1774, P258, DOI 10.1016/j.bbapap.2006.11.014; Liu Wei, 2008, Current Proteomics, V5, P62, DOI 10.2174/157016408783955119; Liu XB, 2008, J BIOL CHEM, V283, P34887, DOI 10.1074/jbc.M805682200; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Namani T, 2007, COLLOID SURFACE B, V54, P118, DOI 10.1016/j.colsurfb.2006.05.022; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qin ZJ, 2007, J BIOL CHEM, V282, P5862, DOI 10.1074/jbc.M608126200; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shibamoto T, 2006, J PHARMACEUT BIOMED, V41, P12, DOI 10.1016/j.jpba.2006.01.047; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Trostchansky A, 2007, AMINO ACIDS, V32, P517, DOI 10.1007/s00726-006-0426-7; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2006, BIOCHEMISTRY-US, V45, P8135, DOI 10.1021/bi052584t	49	77	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22262	22274		10.1074/jbc.M110.202937	http://dx.doi.org/10.1074/jbc.M110.202937			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21527634	hybrid, Green Published			2022-12-25	WOS:000291719900034
J	Huber, K; Doyon, G; Plaks, J; Fyne, E; Mellors, JW; Sluis-Cremer, N				Huber, Kelly; Doyon, Genevieve; Plaks, Joseph; Fyne, Elizabeth; Mellors, John W.; Sluis-Cremer, Nicolas			Inhibitors of Histone Deacetylases CORRELATION BETWEEN ISOFORM SPECIFICITY AND REACTIVATION OF HIV TYPE 1 (HIV- 1) FROM LATENTLY INFECTED CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; VALPROIC ACID; POSTINTEGRATION LATENCY; T-CELLS; EXPRESSION; RESERVOIR; RECRUITMENT; LINE; IDENTIFICATION	Deacetylation of histone proteins at the HIV type 1 (HIV-1) long terminal repeat (LTR) by histone deactylases (HDACs) can promote transcriptional repression and virus latency. As such, HDAC inhibitors (HDACI) could be used to deplete reservoirs of persistent, quiescent HIV-1 proviral infection. However, the development of HDACI to purge latent HIV-1 requires knowledge of the HDAC isoforms contributing to viral latency and the development of inhibitors specific to these isoforms. In this study, we identify the HDACs responsible for HIV-1 latency in Jurkat J89GFP cells using a chemical approach that correlates HDACI isoform specificity with their ability to reactivate latent HIV-1 expression. We demonstrate that potent inhibition or knockdown of HDAC1, an HDAC isoform reported to drive HIV-1 into latency, was not sufficient to de-repress the viral LTR. Instead, we found that inhibition of HDAC3 was necessary to activate latent HIV-1. Consistent with this finding, we identified HDAC3 at the HIV-1 LTR by chromatin immunoprecipitation. Interestingly, we show that valproic acid is a weak inhibitor of HDAC3 (IC50 = 5.5 mM) relative to HDAC1 (IC50 = 170 mu M). Because the total therapeutic concentration of valproic acid ranges from 275 to 700 mu M in adults, these data may explain why this inhibitor has no effect on the decay of latent HIV reservoirs in patients. Taken together, our study suggests an important role for HDAC3 in HIV-1 latency and, importantly, describes a chemical approach that can readily be used to identify the HDAC isoforms that contribute to HIV-1 latency in other cell types.	[Huber, Kelly; Doyon, Genevieve; Plaks, Joseph; Fyne, Elizabeth; Mellors, John W.; Sluis-Cremer, Nicolas] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sluis-Cremer, N (corresponding author), S817 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	nps2@pitt.edu	Huber, Kelly/AAE-3449-2020					ANTONI BA, 1994, VIROLOGY, V202, P684, DOI 10.1006/viro.1994.1390; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malcolm T, 2007, VIRUS GENES, V35, P215, DOI 10.1007/s11262-007-0109-9; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Margolis David M, 2010, Curr HIV/AIDS Rep, V7, P37, DOI 10.1007/s11904-009-0033-9; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495; Ying H, 2010, INT J MOL MED, V26, P265, DOI 10.3892/ijmm_00000461; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	38	110	114	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22211	22218		10.1074/jbc.M110.180224	http://dx.doi.org/10.1074/jbc.M110.180224			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531716	Green Published, hybrid			2022-12-25	WOS:000291719900028
J	Kumar, A; John, L; Maity, S; Manchanda, M; Sharma, A; Saini, N; Chakraborty, K; Sengupta, S				Kumar, Arun; John, Lijo; Maity, Shuvadeep; Manchanda, Mini; Sharma, Abhay; Saini, Neeru; Chakraborty, Kausik; Sengupta, Shantanu			Converging Evidence of Mitochondrial Dysfunction in a Yeast Model of Homocysteine Metabolism Imbalance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; CORONARY-ARTERY-DISEASE; SACCHAROMYCES-CEREVISIAE; ENDOTHELIAL DYSFUNCTION; S-ADENOSYLHOMOCYSTEINE; OXIDATIVE STRESS; GENE-EXPRESSION; REGULATORY ASSOCIATIONS; FLUORESCENT PROTEINS; INDUCED APOPTOSIS	An elevated level of homocysteine, a thiol amino acid, is associated with various complex disorders. The cellular effects of homocysteine and its precursors S-adenosylhomocysteine (AdoHcy) and S-adenosylmethionine (AdoMet) are, however, poorly understood. We used Saccharomyces cerevisiae as a model to understand the basis of pathogenicity induced by homocysteine and its precursors. Both homocysteine and AdoHcy but not AdoMet inhibited the growth of the str4 Delta strain (which lacks the enzyme that converts homocysteine to cystathionine-mimicking vascular cells). Addition of AdoMet abrogated the inhibitory effect of AdoHcy but not that of homocysteine indicating that an increase in the AdoMet/AdoHcy ratio is sufficient to overcome the AdoHcy-mediated growth defect but not that of homocysteine. Also, the transcriptomic profile of AdoHcy and homocysteine showed gross dissimilarity based on gene enrichment analysis. Furthermore, compared with homocysteine, AdoHcy treatment caused a higher level of oxidative stress in the cells. However, unlike a previously reported response in wild type (Kumar, A., John, L., Alam, M. M., Gupta, A., Sharma, G., Pillai, B., and Sengupta, S. (2006) Biochem. J. 396, 61-69), the str4 Delta strain did not exhibit an endoplasmic reticulum stress response. This suggests that homocysteine induces varied response depending on the flux of homocysteine metabolism. We also observed altered expression of mitochondrial genes, defective membrane potential, and fragmentation of the mitochondrial network together with the increased expression of fission genes indicating that the imbalance in homocysteine metabolism has a major effect on mitochondrial functions. Furthermore, treatment of cells with homocysteine or AdoHcy resulted in apoptosis as revealed by annexin V staining and TUNEL assay. Cumulatively, our results suggest that elevated levels of homocysteine lead to mitochondrial dysfunction, which could potentially initiate pro-apoptotic pathways, and this could be one of the mechanisms underlying homocysteine-induced pathogenicity.	[Kumar, Arun; John, Lijo; Maity, Shuvadeep; Manchanda, Mini; Sharma, Abhay; Saini, Neeru; Chakraborty, Kausik; Sengupta, Shantanu] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sengupta, S (corresponding author), CSIR, Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.	shantanus@igib.res.in	Maity, Shuvadeep/I-7846-2019; Chakraborty, Kausik/AAL-5748-2021	Maity, Shuvadeep/0000-0002-6031-4744; KUMAR, ARUN/0000-0001-8706-8558; Sharma, Abhay/0000-0003-1306-1497; chakraborty, kausik/0000-0001-6000-8379	Council of Scientific and Industrial Research, India [CMM 0018/NWP 0034]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Grant CMM 0018/NWP 0034 from the Council of Scientific and Industrial Research, India.	Applebaum J, 2004, J PSYCHIATR RES, V38, P413, DOI 10.1016/j.jpsychires.2004.01.003; Ara AI, 2008, HEPATOLOGY, V47, P1655, DOI 10.1002/hep.22231; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Brune B, 2005, ANTIOXID REDOX SIGN, V7, P497, DOI 10.1089/ars.2005.7.497; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Cavalca V, 2001, CLIN CHEM, V47, P887; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cheng WC, 2008, BBA-MOL CELL RES, V1783, P1272, DOI 10.1016/j.bbamcr.2008.04.012; Christopher SA, 2002, MOL GENET METAB, V75, P335, DOI 10.1016/S1096-7192(02)00003-3; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Dickhout JG, 2007, ANTIOXID REDOX SIGN, V9, P1863, DOI 10.1089/ars.2007.1780; Eberhardt RT, 2000, J CLIN INVEST, V106, P483, DOI 10.1172/JCI8342; Fujita Y, 2006, MICROBIOL-SGM, V152, P397, DOI 10.1099/mic.0.28398-0; Gauthier NP, 2010, NUCLEIC ACIDS RES, V38, pD699, DOI 10.1093/nar/gkp1044; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kanani PM, 1999, CIRCULATION, V100, P1161, DOI 10.1161/01.CIR.100.11.1161; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kissova I, 2006, J BIOL CHEM, V281, P36187, DOI 10.1074/jbc.M607444200; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Kumar A, 2001, NAT REV GENET, V2, P302, DOI 10.1038/35066084; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; Kumar J, 2009, CIRC-CARDIOVASC GENE, V2, P599, DOI 10.1161/CIRCGENETICS.108.841411; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lin HC, 2008, BIOFACTORS, V34, P81, DOI 10.1002/biof.5520340201; Lindquist S, 2001, PHILOS T ROY SOC B, V356, P169, DOI 10.1098/rstb.2000.0762; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Majors AK, 2002, ARTERIOSCL THROM VAS, V22, P1354, DOI 10.1161/01.ATV.0000023899.93940.7C; Malanovic N, 2008, J BIOL CHEM, V283, P23989, DOI 10.1074/jbc.M800830200; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Outinen PA, 1998, BIOCHEM J, V332, P213, DOI 10.1042/bj3320213; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; PALELLA TD, 1982, J LAB CLIN MED, V100, P269; Pereira C, 2008, BBA-MOL CELL RES, V1783, P1286, DOI 10.1016/j.bbamcr.2008.03.010; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Priault M, 2003, FEMS YEAST RES, V4, P15, DOI 10.1016/S1567-1356(03)00143-0; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rimon G, 1997, J NEUROSCI RES, V48, P563, DOI 10.1002/(SICI)1097-4547(19970615)48:6<563::AID-JNR9>3.0.CO;2-8; Rounds S, 1998, AM J PHYSIOL-LUNG C, V275, pL379, DOI 10.1152/ajplung.1998.275.2.L379; Sengupta S, 2001, J BIOL CHEM, V276, P46896, DOI 10.1074/jbc.M108451200; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; STARKEBAUM G, 1986, J CLIN INVEST, V77, P1370, DOI 10.1172/JCI112442; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Sundaramoorthy E, 2008, PROTEINS, V71, P1475, DOI 10.1002/prot.21846; Szabadkai G, 2009, APOPTOSIS, V14, P1405, DOI 10.1007/s10495-009-0363-5; Tanriverdi H, 2007, CARDIOLOGY, V107, P313, DOI 10.1159/000099068; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van Guldener C, 2003, CLIN CHEM LAB MED, V41, P1412; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; Vinci CR, 2007, J BIOL CHEM, V282, P8604, DOI 10.1074/jbc.M610029200; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Weiss N, 2003, CLIN CHEM LAB MED, V41, P1455, DOI 10.1515/CCLM.2003.223; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zinellu A, 2009, ATHEROSCLEROSIS, V206, P40, DOI 10.1016/j.atherosclerosis.2009.01.035	81	13	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21779	21795		10.1074/jbc.M111.228072	http://dx.doi.org/10.1074/jbc.M111.228072			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21504896	hybrid, Green Published			2022-12-25	WOS:000291464700073
J	Feng, Y; Wang, JX; Asher, S; Hoang, L; Guardiani, C; Ivanov, I; Zheng, YG				Feng, You; Wang, Juxian; Asher, Sabrina; Hoang, Linh; Guardiani, Carlo; Ivanov, Ivaylo; Zheng, Y. George			Histone H4 Acetylation Differentially Modulates Arginine Methylation by an in Cis Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; ACETYLTRANSFERASE ACTIVITY; CHROMATIN MODIFICATIONS; SUBSTRATE-SPECIFICITY; COACTIVATORS P300; MSL COMPLEX; TRANSCRIPTION; DNA	Histone H4 undergoes extensive post-translational modifications (PTMs) at its N-terminal tail. Many of these PTMs profoundly affect the on and off status of gene transcription. The molecular mechanism by which histone PTMs modulate genetic and epigenetic processes is not fully understood. In particular, how a PTM mark affects the presence and level of other histone modification marks needs to be addressed and is essential for better understanding the molecular basis of histone code hypothesis. To dissect the interplaying relationship between different histone modification marks, we investigated how individual lysine acetylations and their different combinations at the H4 tail affect Arg-3 methylation in cis. Our data reveal that the effect of lysine acetylation on arginine methylation depends on the site of acetylation and the type of methylation. Although certain acetylations present a repressive impact on PRMT1-mediated methylation (type I methylation), lysine acetylation generally is correlated with enhanced methylation by PRMT5 (type II dimethylation). In particular, Lys-5 acetylation decreases the activity of PRMT1 but increases that of PRMT5. Furthermore, circular dichroism study and computer simulation demonstrate that hyperacetylation increases the content of ordered secondary structures at the H4 tail region. These findings provide new insights into the regulatory mechanism of Arg-3 methylation by H4 acetylation and unravel the complex intercommunications that exist between different the PTM marks in cis. The divergent activities of PRMT1 and PRMT5 with respect to different acetyl-H4 substrates suggest that type I and type II protein-arginine methyltransferases use distinct molecular determinants for substrate recognition and catalysis.	[Zheng, Y. George] Georgia State Univ, Dept Chem, Program Mol Basis Dis, Atlanta, GA 30302 USA; Georgia State Univ, Dept Biol, Program Mol Basis Dis, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Zheng, YG (corresponding author), Georgia State Univ, Dept Chem, Program Mol Basis Dis, Atlanta, GA 30302 USA.	yzheng@gsu.edu	Ivanov, Ivaylo/A-7613-2013; Zheng, Yujun/H-9122-2012; Guardiani, Carlo/AHB-1217-2022; Zheng, Yujun/P-8975-2014	Ivanov, Ivaylo/0000-0002-5306-1005; Zheng, Yujun/0000-0001-7116-3067; Guardiani, Carlo/0000-0002-8914-9260; Feng, You/0000-0002-4710-7396	National Institutes of Health [R01GM086717]; American Heart Association [09BGIA2220207]; Georgia State University; Department of Energy [DE-AC05-00OR22725]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Georgia State University; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM086717 (to Y.G.Z.). This work was also supported by American Heart Association Grant 09BGIA2220207 (to Y.G.Z.) and by Georgia State University Molecular Basis of Disease Program (to S.A. and L.H.).; Computational resources were provided through an INCITE allocation (to I.I.) at the Oak Ridge Leadership Computing Facility, supported by the Department of Energy under Contract DE-AC05-00OR22725.	ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; Babin V., 2008, AMBER; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Cheung WL, 2005, CURR BIOL, V15, P656, DOI 10.1016/j.cub.2005.02.049; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; CUOMO A, 2010, AMINO ACIDS; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TURNER BM, 1989, EXP CELL RES, V182, P206, DOI 10.1016/0014-4827(89)90292-9; TURNER BM, 1995, SEMIN CELL BIOL, V6, P229, DOI 10.1006/scel.1995.0031; Utley RT, 2005, MOL CELL BIOL, V25, P8179, DOI 10.1128/MCB.25.18.8179-8190.2005; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Vyskot B, 1999, GENOME, V42, P343, DOI 10.1139/gen-42-2-343; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xie N, 2009, BIOCONJUGATE CHEM, V20, P360, DOI 10.1021/bc800467a; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zheng YG, 2008, MED RES REV, V28, P645, DOI 10.1002/med.20120	61	54	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20323	20334		10.1074/jbc.M110.207258	http://dx.doi.org/10.1074/jbc.M110.207258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502321	Green Published, hybrid			2022-12-25	WOS:000291267600020
J	Truschel, ST; Sengupta, D; Foote, A; Heroux, A; Macbeth, MR; Linstedt, AD				Truschel, Steven T.; Sengupta, Debrup; Foote, Adam; Heroux, Annie; Macbeth, Mark R.; Linstedt, Adam D.			Structure of the Membrane-tethering GRASP Domain Reveals a Unique PDZ Ligand Interaction That Mediates Golgi Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STACKING; PHOSPHORYLATION; GM130	Biogenesis of the ribbon-like membrane network of the mammalian Golgi requires membrane tethering by the conserved GRASP domain in GRASP65 and GRASP55, yet the tethering mechanism is not fully understood. Here, we report the crystal structure of the GRASP55 GRASP domain, which revealed an unusual arrangement of two tandem PDZ folds that more closely resemble prokaryotic PDZ domains. Biochemical and functional data indicated that the interaction between the ligand-binding pocket of PDZ1 and an internal ligand on PDZ2 mediates the GRASP self-interaction, and structural analyses suggest that this occurs via a unique mode of internal PDZ ligand recognition. Our data uncover the structural basis for ligand specificity and provide insight into the mechanism of GRASP-dependent membrane tethering of analogous Golgi cisternae.	[Truschel, Steven T.; Sengupta, Debrup; Foote, Adam; Macbeth, Mark R.; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Heroux, Annie] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA	Carnegie Mellon University; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory	Linstedt, AD (corresponding author), 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@andrew.cmu.edu		Truschel, Steven/0000-0003-3394-6006	National Institutes of Health [GM-56779]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; NCI, National Institutes of Health [P41RR012408]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-56779 (to A.D.L.).; We thank Collin Bachert and Somshuvra Mukhopadhyay for critical reading of the manuscript. Some data for this study were measured at beamline X25 at the National Synchrotron Light Source where financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from the NCI, National Institutes of Health, Grant P41RR012408.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Inaba K, 2008, J BIOL CHEM, V283, P35042, DOI 10.1074/jbc.M806603200; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Sengupta D, 2010, J BIOL CHEM, V285, P39994, DOI 10.1074/jbc.M110.189449; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132	23	47	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20125	20129		10.1074/jbc.C111.245324	http://dx.doi.org/10.1074/jbc.C111.245324			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515684	Green Published, hybrid			2022-12-25	WOS:000291267600001
J	Burghaus, R; Coboeken, K; Gaub, T; Kuepfer, L; Sensse, A; Siegmund, HU; Weiss, W; Mueck, W; Lippert, J				Burghaus, Rolf; Coboeken, Katrin; Gaub, Thomas; Kuepfer, Lars; Sensse, Anke; Siegmund, Hans-Ulrich; Weiss, Wolfgang; Mueck, Wolfgang; Lippert, Joerg			Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation	PLOS ONE			English	Article							FACTOR-XA INHIBITOR; ACTIVATED PROTEIN-C; DEEP-VEIN THROMBOSIS; TOTAL KNEE ARTHROPLASTY; TOTAL HIP-REPLACEMENT; VENOUS THROMBOEMBOLISM; PROTHROMBINASE COMPLEX; POTENT ANTICOAGULANT; FACTOR-VIII; PHARMACOKINETICS	Rivaroxaban is an oral, direct Factor Xa inhibitor approved in the European Union and several other countries for the prevention of venous thromboembolism in adult patients undergoing elective hip or knee replacement surgery and is in advanced clinical development for the treatment of thromboembolic disorders. Its mechanism of action is antithrombin independent and differs from that of other anticoagulants, such as warfarin (a vitamin K antagonist), enoxaparin (an indirect thrombin/Factor Xa inhibitor) and dabigatran (a direct thrombin inhibitor). A blood coagulation computer model has been developed, based on several published models and preclinical and clinical data. Unlike previous models, the current model takes into account both the intrinsic and extrinsic pathways of the coagulation cascade, and possesses some unique features, including a blood flow component and a portfolio of drug action mechanisms. This study aimed to use the model to compare the mechanism of action of rivaroxaban with that of warfarin, and to evaluate the efficacy and safety of different rivaroxaban doses with other anticoagulants included in the model. Rather than reproducing known standard clinical measurements, such as the prothrombin time and activated partial thromboplastin time clotting tests, the anticoagulant benchmarking was based on a simulation of physiologically plausible clotting scenarios. Compared with warfarin, rivaroxaban showed a favourable sensitivity for tissue factor concentration inducing clotting, and a steep concentration-effect relationship, rapidly flattening towards higher inhibitor concentrations, both suggesting a broad therapeutic window. The predicted dosing window is highly accordant with the final dose recommendation based upon extensive clinical studies.	[Burghaus, Rolf; Mueck, Wolfgang] Bayer Schering Pharma AG, Wuppertal, Germany; [Coboeken, Katrin; Gaub, Thomas; Kuepfer, Lars; Siegmund, Hans-Ulrich; Weiss, Wolfgang; Lippert, Joerg] Bayer Technol Serv GmbH, Leverkusen, Germany; [Sensse, Anke] Bayer Schering Pharma AG, Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer AG; Bayer Healthcare Pharmaceuticals	Burghaus, R (corresponding author), Bayer Schering Pharma AG, Wuppertal, Germany.	joerg.lippert@bayer.com	Kuepfer, Lars/F-5795-2012; Kuepfer, Lars/AAD-5884-2022; Kuepfer, Lars/A-5762-2012	Kuepfer, Lars/0000-0002-8741-7786; Burghaus, Rolf/0000-0001-7843-427X	Bayer Schering Pharma AG; Johnson & Johnson Pharmaceutical Research Development	Bayer Schering Pharma AG(Bayer AG); Johnson & Johnson Pharmaceutical Research Development(Johnson & JohnsonJohnson & Johnson USA)	The authors would like to acknowledge Chandrabala Shah who provided medical writing services with funding from Bayer Schering Pharma AG and Johnson & Johnson Pharmaceutical Research & Development.	Adams TE, 2003, J THROMB HAEMOST, V1, P1024, DOI 10.1046/j.1538-7836.2003.00127.x; Agnelli G, 2007, CIRCULATION, V116, P180, DOI 10.1161/CIRCULATIONAHA.106.668020; Alexander JH, 2005, J THROMB HAEMOST, V3, P439, DOI 10.1111/j.1538-7836.2004.01081.x; Anand M., 2003, J THEOR MED, V5, P183, DOI [10.1080/10273660412331317415, DOI 10.1080/10273660412331317415]; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; *BAY TECHN SER, 2009, MOBI; BEGUIN S, 1989, THROMB HAEMOSTASIS, V61, P397; Brufatto N, 2003, J THROMB HAEMOST, V1, P1258, DOI 10.1046/j.1538-7836.2003.00254.x; Buller HR, 2008, BLOOD, V112, P2242, DOI 10.1182/blood-2008-05-160143; Bungay SD, 2003, MATH MED BIOL, V20, P105, DOI 10.1093/imammb20.1.105; Cullberg M, 2005, CLIN PHARMACOL THER, V77, P279, DOI 10.1016/j.clpt.2004.11.001; Elisen MGLM, 1998, BLOOD, V91, P1542, DOI 10.1182/blood.V91.5.1542.1542_1542_1547; ELLIS V, 1982, BIOCHIM BIOPHYS ACTA, V701, P24; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2006, CIRCULATION, V114, P2374, DOI 10.1161/CIRCULATIONAHA.106.642074; Eriksson BI, 2006, J THROMB HAEMOST, V4, P121, DOI 10.1111/j.1538-7836.2005.01657.x; Eriksson UG, 2003, EUR J CLIN PHARMACOL, V59, P35, DOI 10.1007/s00228-003-0565-7; Ferreira CN, 2002, BLOOD COAGUL FIBRIN, V13, P129, DOI 10.1097/00001721-200203000-00008; *FISH DIAGN, 1999, THROMB CORR STUD; GILBERT GE, 1990, J BIOL CHEM, V265, P815; Gustafsson D, 2003, THROMB RES, V109, pS9, DOI 10.1016/S0049-3848(03)00249-4; Haas S, 2008, J THROMB THROMBOLYS, V25, P52, DOI 10.1007/s11239-007-0108-7; HARA T, 1994, THROMB HAEMOSTASIS, V71, P314; HEEB MJ, 1991, J BIOL CHEM, V266, P17606; HERMANS JM, 1993, BIOCHEM J, V295, P239, DOI 10.1042/bj2950239; Hirsh J, 2008, CHEST, V133, p71S, DOI 10.1378/chest.08-0693; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Ieko M, 2004, J THROMB HAEMOST, V2, P612, DOI 10.1111/j.1538-7933.2004.00649.x; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; KAPPERT G, 2002, VERGLEICHBARKEIT MET; Kubitza D, 2005, CLIN PHARMACOL THER, V78, P412, DOI 10.1016/j.clpt.2005.06.011; Kubitza D, 2006, EXPERT OPIN INV DRUG, V15, P843, DOI 10.1517/13543784.15.8.843; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mattsson C, 2001, THROMB HAEMOSTASIS, V86, P611; Mattsson Christer, 2005, Semin Vasc Med, V5, P235, DOI 10.1055/s-2005-916162; Mauray S, 1998, BBA-PROTEIN STRUCT M, V1387, P184, DOI 10.1016/S0167-4838(98)00120-4; *MEDS, 2010, CLEX CLEX FORT; Mueck W, 2008, CLIN PHARMACOKINET, V47, P203, DOI 10.2165/00003088-200847030-00006; Murayama N, 1999, CLIN PHARMACOL THER, V66, P258, DOI 10.1016/S0009-9236(99)70033-0; Nagashima H, 2002, J BIOL CHEM, V277, P50439, DOI 10.1074/jbc.M208222200; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Perzborn E, 2010, ARTERIOSCL THROM VAS, V30, P376, DOI 10.1161/ATVBAHA.110.202978; Rezaie AR, 2003, THROMB HAEMOSTASIS, V89, P112; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; *SAN, 2009, LOV EN SOD PRESCR IN; Stangier J, 2009, CLIN APPL THROMB-HEM, V15, p9S, DOI 10.1177/1076029609343004; Stevens WK, 1996, J BIOL CHEM, V271, P8062, DOI 10.1074/jbc.271.14.8062; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; Tobu M, 2003, CLIN APPL THROMB-HEM, V9, P1, DOI 10.1177/107602960300900101; Turpie AGG, 2005, J THROMB HAEMOST, V3, P2479, DOI 10.1111/j.1538-7836.2005.01602.x; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; VANDERMEER FJM, 1989, THROMB HAEMOSTASIS, V62, P756; Wittkowsky Ann K, 2003, Semin Vasc Med, V3, P221	55	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e17626	10.1371/journal.pone.0017626	http://dx.doi.org/10.1371/journal.pone.0017626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526168	gold, Green Published, Green Submitted			2022-12-25	WOS:000290015800002
J	ten Hove, CA; de Jong, M; Lapin, D; Andel, A; Sanchez-Perez, GF; Tarutani, Y; Suzuki, Y; Heidstra, R; van den Ackerveken, G				ten Hove, Colette A.; de Jong, Mark; Lapin, Dmitry; Andel, Annemiek; Sanchez-Perez, Gabino F.; Tarutani, Yoshiaki; Suzuki, Yoshihito; Heidstra, Renze; van den Ackerveken, Guido			Trans-Repression of Gene Activity Upstream of T-DNA Tagged RLK902 Links Arabidopsis Root Growth Inhibition and Downy Mildew Resistance	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; AGROBACTERIUM-MEDIATED TRANSFORMATION; ASYMMETRIC CELL-DIVISION; REVERSE GENETICS; PLANT TRANSFORMATION; FUNCTIONAL-ANALYSIS; THALIANA; MERISTEM; EXPRESSION; MICROARRAY	Receptor-like kinases (RLKs) constitute a large family of signal perception molecules in Arabidopsis. The largest group of RLKs is the leucine-rich repeat (LRR) class that has been described to function in development and defense. Of these, CLAVATA1 (CLV1) and ERECTA (ER) receptors function in maintaining shoot meristem homeostasis and organ growth, but LRR RLKs with similar function in the root remain unknown. For the interaction of Arabidopsis with the oomycete pathogen Hyaloperonospora arabidopsidis the involvement of LRR RLKs has not been demonstrated. A set of homozygous T-DNA insertion lines mutated in LRR RLKs was investigated to assess the potential role of these receptors in root meristem maintenance and compatibility. One mutant line, rlk902, was discovered that showed both reduced root growth and resistance to downy mildew in a recessive manner. The phenotypes of this mutated line could not be rescued by complementation, but are nevertheless linked to the T-DNA insertion. Microarray studies showed that gene expression spanning a region of approximately 84 kb upstream of the mutated gene was downregulated. The results suggest T-DNA mediated trans-repression of multiple genes upstream of the RLK902 locus links both phenotypes.	[ten Hove, Colette A.; de Jong, Mark; Lapin, Dmitry; Andel, Annemiek; Sanchez-Perez, Gabino F.; van den Ackerveken, Guido] Univ Utrecht, Utrecht, Netherlands; [de Jong, Mark] Swammerdam Inst Life Sci, Integrat Bioinformat Unit, Amsterdam, Netherlands; [de Jong, Mark] Swammerdam Inst Life Sci, MicroArray Dept, Amsterdam, Netherlands; [Sanchez-Perez, Gabino F.] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Tarutani, Yoshiaki; Suzuki, Yoshihito] Univ Tokyo, Dept Appl Biol Chem, Tokyo, Japan; [Tarutani, Yoshiaki] Natl Inst Genet, Dept Integrated Genet, Mishima, Shizuoka 411, Japan; [Suzuki, Yoshihito] Ibaraki Univ, Dept Bioresource Sci, Ibaraki, Japan	Utrecht University; University of Amsterdam; University of Amsterdam; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Ibaraki University	ten Hove, CA (corresponding author), Univ Utrecht, Utrecht, Netherlands.	r.heidstra@uu.nl	Sanchez-Perez, Gabino/E-3597-2010; Van den Ackerveken, Guido/B-8568-2011	Sanchez-Perez, Gabino/0000-0002-2692-9892; Van den Ackerveken, Guido/0000-0002-0183-8978; Lapin, Dmitry/0000-0001-9591-3950; Suzuki, Yoshihito/0000-0002-4574-9504	Centre for BioSystems Genomics (CBSG); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO); NWO	Centre for BioSystems Genomics (CBSG); Netherlands Consortium for Systems Biology (NCSB); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	This research was funded by the Centre for BioSystems Genomics (CBSG) (CAtH and RH) and the Netherlands Consortium for Systems Biology (NCSB) (GFSP), which are part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NGI/NWO), and by a VIDI innovational grant from NWO (GVdA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemeersch J, 2005, PLANT PHYSIOL, V137, P588, DOI 10.1104/pp.104.051300; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Bechtold N, 1998, METH MOL B, V82, P259; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Calhoun VC, 2003, P NATL ACAD SCI USA, V100, P9878, DOI 10.1073/pnas.1233791100; CLARK SE, 1993, DEVELOPMENT, V119, P397; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de Jong M, 2006, PLANT J, V46, P708, DOI 10.1111/j.1365-313X.2006.02724.x; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Hejatko J, 2006, NAT PROTOC, V1, P1939, DOI 10.1038/nprot.2006.333; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Merli C, 1996, GENE DEV, V10, P1260, DOI 10.1101/gad.10.10.1260; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Ohtake Y, 2000, PLANT CELL PHYSIOL, V41, P1038, DOI 10.1093/pcp/pcd028; Ren SX, 2004, PLANT CELL, V16, P2910, DOI 10.1105/tpc.104.025072; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Tarutani Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1935, DOI 10.1271/bbb.68.1935; Tor M, 2009, J EXP BOT, V60, P3645, DOI 10.1093/jxb/erp233; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; van Damme M, 2009, PLANT CELL, V21, P2179, DOI 10.1105/tpc.109.066811; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Willemsen V, 1998, DEVELOPMENT, V125, P521; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004	51	7	7	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19028	10.1371/journal.pone.0019028	http://dx.doi.org/10.1371/journal.pone.0019028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21532992	Green Submitted, gold, Green Published			2022-12-25	WOS:000290014500019
J	Sun, Y; Ran, HM; Liou, B; Quinn, B; Zamzow, M; Zhang, WJ; Bielawski, J; Kitatani, K; Setchell, KDR; Hannun, YA; Grabowski, GA				Sun, Ying; Ran, Huimin; Liou, Benjamin; Quinn, Brian; Zamzow, Matt; Zhang, Wujuan; Bielawski, Jacek; Kitatani, Kazuyuki; Setchell, Kenneth D. R.; Hannun, Yusuf A.; Grabowski, Gregory A.			Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease Mouse	PLOS ONE			English	Article							ACID BETA-GLUCOSIDASE; ENZYME REPLACEMENT THERAPY; SAPOSIN C DEFICIENCY; GLUCOSYLCERAMIDE SYNTHASE; NEUROLOGICAL DEFICITS; TYPE-1; MODELS; ACCUMULATION; INFLAMMATION; INHIBITION	The pharmacological chaperone, isofagomine (IFG), enhances acid beta-glucosidase (GCase) function by altering folding, trafficking, and activity in wild-type and Gaucher disease fibroblasts. The in vivo effects of IFG on GCase activity, its substrate levels, and phenotype were evaluated using a neuronopathic Gaucher disease mouse model, 4L;C* (V394L/V394L + saposin C-/-) that has CNS accumulation of glucosylceramide (GC) and glucosylsphingosine (GS) as well as progressive neurological deterioration. IFG administration to 4L;C* mice at 20 or 600 mg/kg/day resulted in life span extensions of 10 or 20 days, respectively, and increases in GCase activity and protein levels in the brain and visceral tissues. Cerebral cortical GC and GS levels showed no significant reductions with IFG treatment. Increases of GC or GS levels were detected in the visceral tissues of IFG treated (600 mg/kg/day) mice. The attenuations of brain proinflammatory responses in the treated mice were evidenced by reductions in astrogliosis and microglial cell activation, and decreased p38 phosphorylation and TNF alpha levels. Terminally, axonal degeneration was present in the brain and spinal cord from untreated and treated 4L;C* mice. These data demonstrate that IFG exerts in vivo effects by enhancing V394L GCase protein and activity levels, and in mediating suppression of proinflammation, which led to delayed onset of neurological disease and extension of the life span of 4L;C* mice. However, this was not correlated with a reduction in the accumulation of lipid substrates.	[Sun, Ying; Ran, Huimin; Liou, Benjamin; Quinn, Brian; Zamzow, Matt; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Div Human Genet, Cincinnati, OH 45221 USA; [Zhang, Wujuan; Setchell, Kenneth D. R.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH USA; [Sun, Ying; Ran, Huimin; Liou, Benjamin; Quinn, Brian; Zamzow, Matt; Zhang, Wujuan; Setchell, Kenneth D. R.; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Bielawski, Jacek; Kitatani, Kazuyuki; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Kitatani, Kazuyuki] Tottori Univ, Tottori Univ Hosp, Dept Clin Lab, Yonago, Tottori, Japan	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Medical University of South Carolina; Tottori University	Sun, Y (corresponding author), Univ Cincinnati, Coll Med, Div Human Genet, Cincinnati, OH 45221 USA.	Greg.Grabowski@cchmc.org	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135	Japan Society for the Promotion of Science [21890144];  [R01 NS/DK36681];  [R21 HD059823];  [CA087584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD059823] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to GAG (R01 NS/DK36681 and R21 HD059823) and YAH (CA087584), and to KK, the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists-Start-up, 21890144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrow TA, 2007, J PEDIATR-US, V150, P202, DOI 10.1016/j.jpeds.2006.10.062; Butters TD, 2005, GLYCOBIOLOGY, V15, pR43, DOI 10.1093/glycob/cwi076; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Grabowski GA, 2010, ONLINE METABOLIC MOL; Grabowski GA, 2009, GENET MED, V11, P92, DOI 10.1097/GIM.0b013e31818e2c19; GUPTA N, 2010, BLOOD CELLS MOL DIS; Jeyakumar M, 2004, ANN NEUROL, V56, P642, DOI 10.1002/ana.20242; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; KHANNA R, 2010, FEBS J; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Luzi P, 2009, BRAIN RES, V1300, P146, DOI 10.1016/j.brainres.2009.09.017; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Nishimura Y, 2009, J ANTIBIOT, V62, P407, DOI 10.1038/ja.2009.53; RADIN NS, 1994, MOL CHEM NEUROPATHOL, V21, P111, DOI 10.1007/BF02815346; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2003, J BIOL CHEM, V278, P31918, DOI 10.1074/jbc.M302752200; Sun Y, 2008, HUM MOL GENET, V17, P2345, DOI 10.1093/hmg/ddn135; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Sun Y, 2010, HUM MOL GENET, V19, P634, DOI 10.1093/hmg/ddp531; Weinreb NJ, 2005, AM J HEMATOL, V80, P223, DOI 10.1002/ajh.20504; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wenstrup RJ, 2007, J BONE MINER RES, V22, P119, DOI 10.1359/JBMR.061004; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 1996, PEDIATR RES, V39, P313, DOI 10.1203/00006450-199602000-00021; XU YH, 2008, MOL GENET METAB; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	38	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19037	10.1371/journal.pone.0019037	http://dx.doi.org/10.1371/journal.pone.0019037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533102	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400054
J	Desdevises, Y; Maillet, V; Fuentes, M; Escriva, H				Desdevises, Yves; Maillet, Vincent; Fuentes, Michael; Escriva, Hector			A Snapshot of the Population Structure of Branchiostoma lanceolatum in the Racou Beach, France, during Its Spawning Season	PLOS ONE			English	Article							LAGOS LAGOON; SECONDARY PRODUCTION; SEDIMENT DYNAMICS; FLORIDA LANCELET; LIFE-HISTORY; INNER-SHELF; AMPHIOXUS; ECOLOGY; GROWTH; TUNICATES	A methodology for inducing spawning in captivity of the lancelet Branchiostoma lanceolatum has been developed recently with animals collected at the Racou beach, in the southern coast of France. An increasing amount of laboratories around the world are now working on the evolution of developmental mechanisms (Evo-Devo) using amphioxus collected in this site. Thus, today, the development of new aquaculture techniques for keeping amphioxus in captivity is needed and the study of the natural conditions at which amphioxus is exposed in the Racou beach during their spawning season becomes necessary. We have investigated the amphioxus distribution, size frequency, and population structure in the Racou beach during its natural spawning season using multivariate methods (redundancy analysis and multiple regression). We found a clear preference of amphioxus for sandy sites, something that seems to be a general behaviour of different amphioxus species around the world. We have also estimated the amphioxus growth rate and we show how the animals are preferentially localized in shallow waters during April and June.	[Desdevises, Yves; Maillet, Vincent; Fuentes, Michael; Escriva, Hector] Univ Paris 06, CNRS, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Desdevises, Y (corresponding author), Univ Paris 06, CNRS, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France.	hector.escriva@obs-banyuls.fr	Desdevises, Yves/D-5528-2011; Escriva, Hector/K-8325-2013; Desdevises, Yves/H-5334-2019; Desdevises, Yves/AAH-2097-2019	Desdevises, Yves/0000-0001-9774-0336; Escriva, Hector/0000-0001-7577-5028; Desdevises, Yves/0000-0001-9774-0336	L'Agence Nationale de la Recherche (ANR) [BLAN 171601, BLAN 123402]; CNRS [SDV-D-2009-1926]	L'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was supported by L'Agence Nationale de la Recherche (ANR) BLAN 171601 and BLAN 123402 and by CNRS PEPS (Projet Exploratoire Premier Soutien) SDV-D-2009-1926 (http://www.cnrs.fr/insb/carrieresemplois/peps-2009.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand Stephanie, 2007, Journal de la Societe de Biologie, V201, P51, DOI 10.1051/jbio:2007006; BOSCHUNG HERBERT V., 1962, TULANE STUD ZOOL, V9, P245; CAILLEUX A, 1969, QUATERNARY PERIGLACI, P285; Chen Y, 2008, J EXP MAR BIOL ECOL, V357, P64, DOI 10.1016/j.jembe.2007.12.028; CHIN T. G., 1941, PHILADELPHIA JOUR SCI, V75, P369; CORY RL, 1967, LIMNOL OCEANOGR, V12, P650, DOI 10.4319/lo.1967.12.4.0650; Courtney W.A.M., 1975, Symposia Zool Soc Lond, VNo. 36, P213; da Silva LFB, 2008, REV BRAS ZOOL, V25, P617, DOI 10.1590/S0101-81752008000400006; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; EISMA D, 1970, Netherlands Journal of Sea Research, V5, P101, DOI 10.1016/0077-7579(70)90006-2; Ferre B, 2005, CONT SHELF RES, V25, P2410, DOI 10.1016/j.csr.2005.08.017; Folk R.L., 1957, J SEDIMENT RES, V27, P3, DOI [10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D, 10.1306/74d70646-2b21-11d7-8648000102c1865]; FRANKENBERG D, 1968, BIOSCIENCE, V18, P877, DOI 10.2307/1294155; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; FUENTES M, 2007, J EXP ZOOLOG B; FUTCH C R, 1977, Florida Marine Research Publications, V24, P1; GOSSELCK F, 1979, INT REV GES HYDROBIO, V64, P541, DOI 10.1002/iroh.19790640418; GOSSELCK F, 1975, Internationale Revue der Gesamten Hydrobiologie, V60, P199, DOI 10.1002/iroh.19750600204; GUENO Y, 1968, CAHIERS ORSTOM O, V6, P69; Guillen J, 2006, MAR GEOL, V234, P129, DOI 10.1016/j.margeo.2006.09.018; Holland LZ, 2004, METHOD CELL BIOL, V74, P195; Kubokawa K, 2003, ZOOL SCI, V20, P889, DOI 10.2108/zsj.20.889; Legendre P., 1998, NUMERICAL ECOLOGY, V24; MONNIOT F, 1962, VIE MILIEU, V13, P232; Nelson G. E., 1969, Quarterly Journal of the Florida Academy of Sciences, V31, P93; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Poss SG, 1996, ISRAEL J ZOOL, V42, pS13; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Somorjai IML, 2008, AQUACULTURE, V281, P145, DOI 10.1016/j.aquaculture.2008.05.023; Soto CG, 1995, AQUACULTURE, V136, P149, DOI 10.1016/0044-8486(95)01051-3; Stokes MD, 1996, ISRAEL J ZOOL, V42, pS67; Stokes MD, 1996, MAR ECOL PROG SER, V130, P71, DOI 10.3354/meps130071; Team RDC, 2008, COMP RFFS; THEODOSIOU M, 2011, J EXP ZOO B IN PRESS; Webb J.E., 1975, Symposia Zool Soc Lond, VNo. 36, P179; WEBB J. E., 1956, PROC ZOOL SOC LONDON, V127, P119; Webb J. E., 1971, Vie et Milieu, VNo. 22, P827; WEBB J. E., 1956, PROC ZOOL SOC LONDON, V127, P125; WEBB JE, 1958, PHILOS T ROY SOC B, V241, P335, DOI 10.1098/rstb.1958.0007; WEBB JE, 1958, PHILOS T ROY SOC B, V241, P355, DOI 10.1098/rstb.1958.0008; WEBB JE, 1958, PHILOS T ROY SOC B, V241, P393, DOI 10.1098/rstb.1958.0009; Wells M M, 1926, Science, V64, P187, DOI 10.1126/science.64.1651.187; Wu Xian-han, 2000, Chinese Journal of Oceanology and Limnology, V18, P334; Yasui K, 2007, ZOOL SCI, V24, P514, DOI 10.2108/zsj.24.514; Zhou Ren-jie, 2007, Journal of Oceanography in Taiwan Strait, V26, P121	47	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18520	10.1371/journal.pone.0018520	http://dx.doi.org/10.1371/journal.pone.0018520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525973	Green Published, gold, Green Submitted			2022-12-25	WOS:000289578600012
J	Drogemuller, C; Reichart, U; Seuberlich, T; Oevermann, A; Baumgartner, M; Boghenbor, KK; Stoffel, MH; Syring, C; Meylan, M; Muller, S; Muller, M; Gredler, B; Solkner, J; Leeb, T				Drogemuller, Cord; Reichart, Ursula; Seuberlich, Torsten; Oevermann, Anna; Baumgartner, Martin; Boghenbor, Kathrin Kuhni; Stoffel, Michael H.; Syring, Claudia; Meylan, Mireille; Mueller, Simone; Mueller, Mathias; Gredler, Birgit; Soelkner, Johann; Leeb, Tosso			An Unusual Splice Defect in the Mitofusin 2 Gene (MFN2) Is Associated with Degenerative Axonopathy in Tyrolean Grey Cattle	PLOS ONE			English	Article							MITOCHONDRIAL FUSION; MISSENSE MUTATION; EXONIC MUTATIONS; DISEASE; NEUROPATHY; ANIMALS; TYPE-2A; MODEL; MOTOR	Tyrolean Grey cattle represent a local breed with a population size of,5000 registered cows. In 2003, a previously unknown neurological disorder was recognized in Tyrolean Grey cattle. The clinical signs of the disorder are similar to those of bovine progressive degenerative myeloencephalopathy (weaver syndrome) in Brown Swiss cattle but occur much earlier in life. The neuropathological investigation of an affected calf showed axonal degeneration in the central nervous system (CNS) and femoral nerve. The pedigrees of the affected calves suggested a monogenic autosomal recessive inheritance. We localized the responsible mutation to a 1.9 Mb interval on chromosome 16 by genome-wide association and haplotype mapping. The MFN2 gene located in this interval encodes mitofusin 2, a mitochondrial membrane protein. A heritable human axonal neuropathy, Charcot-Marie-Tooth disease-2A2 (CMT2A2), is caused by MFN2 mutations. Therefore, we considered MFN2 a positional and functional candidate gene and performed mutation analysis in affected and control Tyrolean Grey cattle. We did not find any non-synonymous variants. However, we identified a perfectly associated silent SNP in the coding region of exon 20 of the MFN2 gene. This SNP is located within a putative exonic splice enhancer (ESE) and the variant allele leads to partial retention of the entire intron 19 and a premature stop codon in the aberrant MFN2 transcript. Thus we have identified a highly unusual splicing defect, where an exonic single base exchange leads to the retention of the preceding intron. This splicing defect represents a potential explanation for the observed degenerative axonopathy. Marker assisted selection can now be used to eliminate degenerative axonopathy from Tyrolean Grey cattle.	[Drogemuller, Cord; Leeb, Tosso] Univ Bern, Inst Genet, Bern, Switzerland; [Reichart, Ursula; Mueller, Simone; Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Seuberlich, Torsten; Oevermann, Anna] Univ Bern, Neuroctr, Div Expt Clin Res, Bern, Switzerland; [Baumgartner, Martin] Univ Bern, Div Mol Pathobiol, Bern, Switzerland; [Boghenbor, Kathrin Kuhni; Stoffel, Michael H.] Univ Bern, Div Vet Anat, Bern, Switzerland; [Syring, Claudia; Meylan, Mireille] Univ Bern, Clin Ruminants, Bern, Switzerland; [Gredler, Birgit; Soelkner, Johann] Univ Nat Resources & Appl Life Sci, Div Livestock Sci, Vienna, Austria	University of Bern; University of Veterinary Medicine Vienna; University of Bern; University of Bern; University of Bern; University of Bern; University of Natural Resources & Life Sciences, Vienna	Drogemuller, C (corresponding author), Univ Bern, Inst Genet, Bern, Switzerland.	Johann.Soelkner@boku.ac.at; Tosso.Leeb@itz.unibe.ch	Leeb, Tosso/G-3187-2014; Stoffel, Michael Hubert/I-6939-2015	Leeb, Tosso/0000-0003-0553-4880; Stoffel, Michael Hubert/0000-0002-4699-5125; Muller, Mathias/0000-0002-7879-3552; Drogemuller, Cord/0000-0001-9773-522X; Solkner, Johann/0000-0002-1517-5829; Baumgartner, Martin/0000-0001-9539-7204; Reichart, Ursula/0000-0001-9709-0919; Oevermann, Anna/0000-0002-3569-8547	ONGENE	ONGENE	This work was funded in part by ONGENE, the Austrian national body responsible for the conservation of endangered livestock breeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiott EA, 2008, EXP NEUROL, V211, P115, DOI 10.1016/j.expneurol.2008.01.010; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Calvo J, 2009, ARCH NEUROL-CHICAGO, V66, P1511, DOI 10.1001/archneurol.2009.284; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Defesche JC, 2008, CLIN GENET, V73, P573, DOI 10.1111/j.1399-0004.2008.00999.x; Detmer SA, 2008, HUM MOL GENET, V17, P367, DOI 10.1093/hmg/ddm314; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Drogemuller C, 2008, GENOMICS, V92, P474, DOI 10.1016/j.ygeno.2008.07.014; GEORGES M, 1993, P NATL ACAD SCI USA, V90, P1058, DOI 10.1073/pnas.90.3.1058; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Krebs S, 2007, P NATL ACAD SCI USA, V104, P6746, DOI 10.1073/pnas.0607721104; Maimaiti M, 2009, J HUM GENET, V54, P493, DOI 10.1038/jhg.2009.66; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Mozdy AD, 2003, NAT REV MOL CELL BIO, V4, P468, DOI 10.1038/nrm1125; PATTERSON DF, 1988, J AM VET MED ASSOC, V193, P1131; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2001, J CELL SCI, V114, P867; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Syring C, 2010, J VET INTERN MED, V24, P1519, DOI 10.1111/j.1939-1676.2010.0607.x; Thomsen B, 2010, NEUROGENETICS, V11, P175, DOI 10.1007/s10048-009-0214-0; Vallat JM, 2008, J NEUROPATH EXP NEUR, V67, P1097, DOI 10.1097/NEN.0b013e31818b6cbc; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Windsor PA, 2009, AUST VET J, V87, P193, DOI 10.1111/j.1751-0813.2009.00422.x; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	30	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18931	10.1371/journal.pone.0018931	http://dx.doi.org/10.1371/journal.pone.0018931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526202	Green Submitted, Green Published, gold			2022-12-25	WOS:000289578600040
J	Sun, SC; Wang, ZB; Xu, YN; Lee, SE; Cui, XS; Kim, NH				Sun, Shao-Chen; Wang, Zhen-Bo; Xu, Yong-Nan; Lee, Seung-Eun; Cui, Xiang-Shun; Kim, Nam-Hyung			Arp2/3 Complex Regulates Asymmetric Division and Cytokinesis in Mouse Oocytes	PLOS ONE			English	Article							POLAR BODY FORMATION; ACTIN-BASED MOTILITY; N-WASP; MEIOTIC SPINDLE; F-ACTIN; CORTACTIN; CDC42; POLYMERIZATION; ACTIVATION; NUCLEATOR	Mammalian oocyte meiotic maturation involves oocyte polarization and a unique asymmetric division, but until now, the underlying mechanisms have been poorly understood. Arp2/3 complex has been shown to regulate actin nucleation and is widely involved in a diverse range of processes such as cell locomotion, phagocytosis and the establishment of cell polarity. Whether Arp2/3 complex participates in oocyte polarization and asymmetric division is unknown. The present study investigated the expression and functions of Arp2/3 complex during mouse oocyte meiotic maturation. Immunofluorescent staining showed that the Arp2/3 complex was restricted to the cortex, with a thickened cap above the meiotic apparatus, and that this localization pattern was depended on actin. Disruption of Arp2/3 complex by a newly-found specific inhibitor CK666, as well as by Arpc2 and Arpc3 RNAi, resulted in a range of effects. These included the failure of asymmetric division, spindle migration, and the formation and completion of oocyte cytokinesis. The formation of the actin cap and cortical granule-free domain (CGFD) was also disrupted, which further confirmed the disruption of spindle migration. Our data suggest that the Arp2/3 complex probably regulates oocyte polarization through its effect on spindle migration, asymmetric division and cytokinesis during mouse oocyte meiotic maturation.	[Sun, Shao-Chen; Xu, Yong-Nan; Lee, Seung-Eun; Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Wang, Zhen-Bo] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Chungbuk National University; Chinese Academy of Sciences; Institute of Zoology, CAS	Sun, SC (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea.	nhkim@chungbuk.ac.kr			Biogreen 21 Program, RDA, Republic of Korea [PJ007124201005, PJ007076201004, PJ007076201005]	Biogreen 21 Program, RDA, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	The funding for this work was provided by Biogreen 21 Program (PJ007124201005, PJ007076201004 and PJ007076201005), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; BRUNET S, HUM REPROD UPDATE; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Dahl JP, 2003, J NEUROSCI, V23, P3343; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; Johnston SA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-65; Kutsuna H, 2004, AM J PHYSIOL-CELL PH, V286, pC55, DOI 10.1152/ajpcell.00131.2003; Lin Sheng-Li, 2010, Front Biosci (Elite Ed), V2, P1254; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Ma CQ, 2006, CURR BIOL, V16, P214, DOI 10.1016/j.cub.2005.11.067; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; Na J, 2006, CURR BIOL, V16, P1249, DOI 10.1016/j.cub.2006.05.023; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Schaerer-Brodbeck C, 2000, MOL BIOL CELL, V11, P1113, DOI 10.1091/mbc.11.4.1113; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; SUN SC, 2011, MOL HUM REP IN PRESS; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yu D, 2010, EXP CELL RES, V316, P848, DOI 10.1016/j.yexcr.2009.11.018; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	45	142	145	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18392	10.1371/journal.pone.0018392	http://dx.doi.org/10.1371/journal.pone.0018392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494665	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800012
J	Levary, DA; Parthasarathy, R; Boder, ET; Ackerman, ME				Levary, David A.; Parthasarathy, Ranganath; Boder, Eric T.; Ackerman, Margaret E.			Protein-Protein Fusion Catalyzed by Sortase A	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; SURFACE-PROTEINS; LIGATION; TRANSPEPTIDASE; ACIDS	Chimeric proteins boast widespread use in areas ranging from cell biology to drug delivery. Post-translational protein fusion using the bacterial transpeptidase sortase A provides an attractive alternative when traditional gene fusion fails. We describe use of this enzyme for in vitro protein ligation and report the successful fusion of 10 pairs of protein domains with preserved functionality - demonstrating the robust and facile nature of this reaction.	[Levary, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Ackerman, Margaret E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Parthasarathy, Ranganath; Boder, Eric T.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA; [Parthasarathy, Ranganath; Boder, Eric T.] Univ Tennessee, Dept Biomol Engn, Knoxville, TN USA	Harvard University; Dartmouth College; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Levary, DA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	Margaret.E.Ackerman@Dartmouth.edu	Boder, Eric T./E-9635-2015; Ackerman, Margaret/B-5944-2012	Boder, Eric T./0000-0003-4095-5680; 	MIT Portugal Program; Harvard University PRISE; Herchel Smith Fellowships	MIT Portugal Program; Harvard University PRISE; Herchel Smith Fellowships	The authors wish to acknowledge funding from the MIT Portugal Program, Harvard University PRISE and Herchel Smith Fellowships and laboratory materials and space kindly provided by Dr. K. Dane Wittrup. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Ayers B, 1999, BIOPOLYMERS, V51, P343, DOI 10.1002/(SICI)1097-0282(1999)51:5<343::AID-BIP4>3.0.CO;2-W; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Blaschke UK, 2000, METHOD ENZYMOL, V328, P478, DOI 10.1016/S0076-6879(00)28414-0; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Hackel BJ, 2010, J MOL BIOL, V401, P84, DOI 10.1016/j.jmb.2010.06.004; JACKSON DY, 1994, SCIENCE, V266, P243, DOI 10.1126/science.7939659; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Orcutt KD, 2010, PROTEIN ENG DES SEL, V23, P221, DOI 10.1093/protein/gzp077; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; POPP MW, 2011, P NATL ACAD SCI US; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Pritz S, 2009, ADV EXP MED BIOL, V611, P107, DOI 10.1007/978-0-387-73657-0_47; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Refaei MA, 2011, J BIOMOL NMR, V49, P3, DOI 10.1007/s10858-010-9464-2; SAKAMOTO T, 2010, BIOCONJUG CHEM; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773; SIKORSKI RS, 1989, GENETICS, V122, P19; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Wu S, 2010, BIOTECHNOL LETT, V32, P1713, DOI 10.1007/s10529-010-0349-y; Wu ZM, 2010, J AM CHEM SOC, V132, P1567, DOI 10.1021/ja906611x	28	73	111	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18342	10.1371/journal.pone.0018342	http://dx.doi.org/10.1371/journal.pone.0018342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494692	Green Submitted, gold, Green Published			2022-12-25	WOS:000289192400022
J	Musumeci, M; Coppola, V; Addario, A; Patrizii, M; Maugeri-Sacca, M; Memeo, L; Colarossi, C; Francescangeli, F; Biffoni, M; Collura, D; Giacobbe, A; D'Urso, L; Falchi, M; Venneri, MA; Muto, G; De Maria, R; Bonci, D				Musumeci, M.; Coppola, V.; Addario, A.; Patrizii, M.; Maugeri-Sacca, M.; Memeo, L.; Colarossi, C.; Francescangeli, F.; Biffoni, M.; Collura, D.; Giacobbe, A.; D'Urso, L.; Falchi, M.; Venneri, M. A.; Muto, G.; De Maria, R.; Bonci, D.			Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer	ONCOGENE			English	Article						miRNA; microenvironment; cancer progression	FIBROBLAST-GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITIONS; CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL-LINES; STROMA INTERACTIONS; MICRORNA TARGETS; MULTIPLE-MYELOMA; REACTIVE STROMA; FACTOR-2 FGF-2; FACTOR BFGF	The interaction between cancer cells and microenvironment has a critical role in tumor development and progression. Although microRNAs regulate all the major biological mechanisms, their influence on tumor microenvironment is largely unexplored. Here, we investigate the role of microRNAs in the tumor-supportive capacity of stromal cells. We demonstrated that miR-15 and miR-16 are downregulated in fibroblasts surrounding the prostate tumors of the majority of 23 patients analyzed. Such downregulation of miR-15 and miR-16 in cancer-associated fibroblasts (CAFs) promoted tumor growth and progression through the reduced post-transcriptional repression of Fgf-2 and its receptor Fgfr1, which act on both stromal and tumor cells to enhance cancer cell survival, proliferation and migration. Moreover, reconstitution of miR-15 and miR-16 impaired considerably the tumor-supportive capability of stromal cells in vitro and in vivo. Our data suggest a molecular circuitry in which miR-15 and miR-16 and their correlated targets cooperate to promote tumor expansion and invasiveness through the concurrent activity on stromal and cancer cells, thus providing further support to the development of therapies aimed at reconstituting miR-15 and miR-16 in advanced prostate cancer. Oncogene (2011) 30, 4231-4242; doi: 10.1038/onc.2011.140; published online 2 May 2011	[Musumeci, M.; Coppola, V.; Addario, A.; Patrizii, M.; Maugeri-Sacca, M.; Francescangeli, F.; Biffoni, M.; Venneri, M. A.; De Maria, R.; Bonci, D.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Memeo, L.; Colarossi, C.; De Maria, R.] Mediterranean Inst Oncol, Dept Expt Oncol, Catania, Italy; [Collura, D.; Giacobbe, A.; D'Urso, L.; Muto, G.] S Giovanni Bosco Hosp, Dept Urol, Turin, Italy; [Falchi, M.] Ist Super Sanita, AIDS Natl Ctr, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Mediterranean Institute of Oncology; Istituto Superiore di Sanita (ISS)	De Maria, R (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	ruggero.demaria@iss.it; desiree.bonci@iss.it	Bonci, Desiree/K-6488-2016; Coppola, Valeria/K-5120-2016; Addario, Antonio/AAC-4707-2022; Biffoni, Mauro/J-8318-2016; Francescangeli, Federica/K-6500-2016; Giacobbe, alessandro/AAC-6802-2022; De Maria, Ruggero/S-6385-2019; Maugeri-Saccà, Marcello/K-2350-2014	Bonci, Desiree/0000-0002-2472-5140; Coppola, Valeria/0000-0002-5745-2572; Addario, Antonio/0000-0001-8527-8738; Biffoni, Mauro/0000-0002-1304-9060; Francescangeli, Federica/0000-0002-1086-5265; De Maria, Ruggero/0000-0003-2255-0583; Maugeri-Saccà, Marcello/0000-0003-2287-9581; Memeo, Lorenzo/0000-0003-4251-7203; Falchi, Mario/0000-0002-8290-5406; Colarossi, Cristina/0000-0001-5395-8608; collura, devis/0000-0002-8964-5248; Musumeci, Maria/0000-0001-6680-8158; Muto, Giovanni/0000-0003-3593-6450; VENNERI, MARY ANNA/0000-0002-0687-8135	Italian Health Ministry; Italian Association for Cancer Research (AIRC)	Italian Health Ministry(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	We thank Giuseppe Loreto and Maria Rita Pulvirenti for technical assistance. This work was supported by the Italian Health Ministry with 'Under forty researchers 2007' and Italy-USA programs and by the Italian Association for Cancer Research (AIRC).	Acevedo VD, 2009, CELL CYCLE, V8, P580, DOI 10.4161/cc.8.4.7657; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; CHUNG LWK, 1989, INT J CANCER, V43, P1179, DOI 10.1002/ijc.2910430636; CHUNG LWK, 1983, PROSTATE, V4, P503, DOI 10.1002/pros.2990040509; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cronauer MV, 1997, PROSTATE, V31, P223; CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Efstathiou E, 2010, CLIN CANCER RES, V16, P1100, DOI 10.1158/1078-0432.CCR-09-1215; Giri D, 1999, CLIN CANCER RES, V5, P1063; Hayward SW, 2001, CANCER RES, V61, P8135; He QM, 2003, J BIOL CHEM, V278, P21831, DOI 10.1074/jbc.M300880200; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Josson S, 2010, SEMIN CELL DEV BIOL, V21, P26, DOI 10.1016/j.semcdb.2009.11.016; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaminski A, 2006, INT J MOL MED, V18, P941; Karaa ZS, 2009, RNA, V15, P249, DOI 10.1261/rna.1301109; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Konig A, 1997, LEUKEMIA, V11, P258, DOI 10.1038/sj.leu.2400556; Kwabi-Addo B, 2004, ENDOCR-RELAT CANCER, V11, P709, DOI 10.1677/erc.1.00535; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Menzel T, 1996, BLOOD, V87, P1056, DOI 10.1182/blood.V87.3.1056.bloodjournal8731056; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; NAKAMOTO T, 1992, CANCER RES, V52, P571; Navarro A, 2011, J SURG ONCOL, V103, P411, DOI 10.1002/jso.21847; Polnaszek N, 2003, CANCER RES, V63, P5754; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Risbridger GP, 2008, ENDOCRINOLOGY, V149, P4303, DOI 10.1210/en.2008-0465; Roccaro AM, 2009, BLOOD, V113, P6669, DOI 10.1182/blood-2009-01-198408; Sahni A, 2008, J THROMB HAEMOST, V6, P176; Sezer O, 2001, EUR J HAEMATOL, V66, P83, DOI 10.1034/j.1600-0609.2001.00348.x; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; Smith JA, 2001, BIOCHEM PHARMACOL, V62, P469, DOI 10.1016/S0006-2952(01)00690-6; Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; van Moorselaar RJA, 2002, MOL CELL ENDOCRINOL, V197, P239, DOI 10.1016/S0303-7207(02)00262-9; Wernert Nicolas, 2007, V382, P223, DOI 10.1007/978-1-59745-304-2_14; Winter SF, 2007, ONCOGENE, V26, P4897, DOI 10.1038/sj.onc.1210288; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Yang F, 2008, ONCOGENE, V27, P450, DOI 10.1038/sj.onc.1210663; Zhang YL, 2001, J PHARMACOL EXP THER, V299, P426	54	187	200	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	41					4231	4242		10.1038/onc.2011.140	http://dx.doi.org/10.1038/onc.2011.140			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HO	21532615				2022-12-25	WOS:000296356300002
J	Rexer, BN; Ham, AJL; Rinehart, C; Hill, S; Granja-Ingram, ND; Gonzalez-Angulo, AM; Mills, GB; Dave, B; Chang, JC; Liebler, DC; Arteaga, CL				Rexer, B. N.; Ham, A-J L.; Rinehart, C.; Hill, S.; Granja-Ingram, N. de Matos; Gonzalez-Angulo, A. M.; Mills, G. B.; Dave, B.; Chang, J. C.; Liebler, D. C.; Arteaga, C. L.			Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition	ONCOGENE			English	Article						breast cancer; HER2; lapatinib; Src kinases; tyrosine phosphorylation	GROWTH-FACTOR RECEPTOR; BREAST-CANCER; TRASTUZUMAB RESISTANCE; LAPATINIB GW572016; CYCLIN D1; PHOSPHORYLATION; ACTIVATION; IDENTIFICATION; DASATINIB; ERBB2	Despite the initial effectiveness of the tyrosine kinase inhibitor lapatinib against HER2 gene-amplified breast cancers, most patients eventually relapse after treatment, implying that tumors acquire mechanisms of drug resistance. To discover these mechanisms, we generated six lapatinib-resistant HER2-overexpressing human breast cancer cell lines. In cells that grew in the presence of lapatinib, HER2 autophosphorylation was undetectable, whereas active phosphoinositide-3 kinase (PI3K)-Akt and mitogen-activated protein kinase (MAPK) were maintained. To identify networks maintaining these signaling pathways, we profiled the tyrosine phosphoproteome of sensitive and resistant cells using an immunoaffinity-enriched mass spectrometry method. We found increased phosphorylation of Src family kinases (SFKs) and putative Src substrates in several resistant cell lines. Treatment of these resistant cells with Src kinase inhibitors partially blocked PI3K-Akt signaling and restored lapatinib sensitivity. Further, SFK mRNA expression was upregulated in primary HER2+ tumors treated with lapatinib. Finally, the combination of lapatinib and the Src inhibitor AZD0530 was more effective than lapatinib alone at inhibiting pAkt and growth of established HER2-positive BT-474 xenografts in athymic mice. These data suggest that increased Src kinase activity is a mechanism of lapatinib resistance and support the combination of HER2 antagonists with Src inhibitors early in the treatment of HER2+ breast cancers in order to prevent or overcome resistance to HER2 inhibitors. Oncogene (2011) 30, 4163-4174; doi:10.1038/onc.2011.130; published online 18 April 2011	[Rexer, B. N.; Rinehart, C.; Arteaga, C. L.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Ham, A-J L.; Hill, S.; Liebler, D. C.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Ham, A-J L.; Liebler, D. C.] Vanderbilt Univ, Sch Med, Ayers Inst Precancer Detect & Diag, Nashville, TN 37212 USA; [Granja-Ingram, N. de Matos] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA; [Gonzalez-Angulo, A. M.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Gonzalez-Angulo, A. M.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Med Oncol, Houston, TX 77030 USA; [Dave, B.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Chang, J. C.] Methodist Hosp, Dept Med, Houston, TX 77030 USA; [Arteaga, C. L.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Arteaga, C. L.] Vanderbilt Ingram Canc Ctr, Dept Breast Canc Res Program, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Vanderbilt University; Vanderbilt University	Arteaga, CL (corresponding author), VUMC, Div Oncol, 2220 Pierce Ave,777 PRB, Nashville, TN 37232 USA.	carlos.arteaga@vanderbilt.edu	Dave, Bhuvanesh/ABF-8334-2020	Dave, Bhuvanesh/0000-0001-6741-1363; Liebler, Daniel/0000-0002-7873-3031	NIH [R01 CA80195]; Dinah Armstrong Kukes Fund/Phi Mu foundation; Department of Defense [BC087465]; ASCO; Kleberg Center for Molecular Markers at MD Anderson Cancer Center; NCI [1K23CA121994-01]; Susan G Komen Foundation [FAS0703849]; ACS [CRP-07-234]; Lee Jeans Translational Breast Cancer Research Program; Breast Cancer SPORE [P50 CA98131]; Vanderbilt-Ingram Cancer Center [P30 CA68485];  [T32 CA119910]; NATIONAL CANCER INSTITUTE [K23CA121994, R01CA080195, P30CA068485, K08CA143153, T32CA119910, P50CA098131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dinah Armstrong Kukes Fund/Phi Mu foundation; Department of Defense(United States Department of Defense); ASCO; Kleberg Center for Molecular Markers at MD Anderson Cancer Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); ACS(American Cancer Society); Lee Jeans Translational Breast Cancer Research Program; Breast Cancer SPORE; Vanderbilt-Ingram Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01 CA80195 (CLA), Dinah Armstrong Kukes Fund/Phi Mu foundation (BNR), T32 CA119910 (BNR), Department of Defense BC087465 Post-Doctoral Fellowship (BNR), ASCO Young Investigator Award (BNR), Kleberg Center for Molecular Markers at MD Anderson Cancer Center, ASCO Career Development Award (AMG), NCI 1K23CA121994-01 (AMG), Susan G Komen Foundation FAS0703849 (AMG, GBM), ACS Clinical Research Professorship CRP-07-234 (CLA), Lee Jeans Translational Breast Cancer Research Program (CLA), Breast Cancer SPORE P50 CA98131 and Vanderbilt-Ingram Cancer Center Support Grant P30 CA68485.	Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Erlichman C, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B56; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Jones RJ, 2009, BREAST CANCER RES TR, V114, P211, DOI 10.1007/s10549-008-9997-1; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lenferink AEG, 2001, CANCER RES, V61, P6583; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Moasser MM, 2007, ONCOGENE, V26, P6577, DOI 10.1038/sj.onc.1210478; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sheffield LG, 1998, BIOCHEM BIOPH RES CO, V250, P27, DOI 10.1006/bbrc.1998.9214; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Vadlamudi RK, 2003, FEBS LETT, V543, P76, DOI 10.1016/S0014-5793(03)00404-6; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Xu WP, 2007, MOL CELL BIOL, V27, P220, DOI 10.1128/MCB.00899-06; Yakes FM, 2002, CANCER RES, V62, P4132; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zhang HT, 1998, ONCOGENE, V16, P2835, DOI 10.1038/sj.onc.1201820	53	105	111	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	40					4163	4174		10.1038/onc.2011.130	http://dx.doi.org/10.1038/onc.2011.130			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	833ZK	21499296	Green Accepted			2022-12-25	WOS:000295924600003
J	Willecke, M; Toggweiler, J; Basler, K				Willecke, M.; Toggweiler, J.; Basler, K.			Loss of PI3K blocks cell-cycle progression in a Drosophila tumor model	ONCOGENE			English	Article						cell cycle; Drosophila; PI3K; tumor	PHOSPHOINOSITIDE 3-KINASE; IMAGINAL DISC; GENETIC SCREEN; S-PHASE; PATHWAY; GROWTH; RAS; KINASE; PROLIFERATION; CANCER	Tumorigenesis is a complex process, which requires alterations in several tumor suppressor or oncogenes. Here, we use a Drosophila tumor model to identify genes, which are specifically required for tumor growth. We found that reduction of phosphoinositide 3-kinase (PI3K) activity resulted in very small tumors while only slightly affecting growth of wild-type tissue. The observed inhibition on tumor growth occurred at the level of cell-cycle progression. We conclude that tumor cells become dependent on PI3K function and that reduction of PI3K activity synthetically interferes with tumor growth. The results presented here broaden our insights into the intricate mechanisms underling tumorigenesis and illustrate the power of Drosophila genetics in revealing weak points of tumor progression. Oncogene (2011) 30, 4067-4074; doi:10.1038/onc.2011.125; published online 25 April 2011	[Willecke, M.; Toggweiler, J.; Basler, K.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@imls.uzh.ch		Basler, Konrad/0000-0003-3534-1529	FEBS; Swiss National Science Foundation; Kanton of Zurich	FEBS; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton of Zurich	We would like to thank G Hausmann and J Zartman for comments on the manuscript; A Smith for help with experiments; and H Stocker, the Bloomington Stock Center, the National Institute of Genetics (NIG) and the Vienna Drosophila RNAi Center (VDRC) for fly strains. This work was supported by an FEBS Long-term Fellowship to MW, the Swiss National Science Foundation and the Kanton of Zurich.	Bach EA, 2003, GENETICS, V165, P1149; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Cleary JM, 2010, CURR ONCOL REP, V12, P87, DOI 10.1007/s11912-010-0091-6; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Halfar K, 2001, DEVELOPMENT, V128, P1687; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Newsome TP, 2000, DEVELOPMENT, V127, P851; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; STEWART M, 1972, DEV BIOL, V27, P71, DOI 10.1016/0012-1606(72)90113-3; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702	32	35	36	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	39					4067	4074		10.1038/onc.2011.125	http://dx.doi.org/10.1038/onc.2011.125			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	826ME	21516128				2022-12-25	WOS:000295357500002
J	Zhao, YJ; Zhang, HM; Lam, CMC; Hao, Q; Lee, HC				Zhao, Yong Juan; Zhang, Hong Min; Lam, Connie Mo Ching; Hao, Quan; Lee, Hon Cheung			Cytosolic CD38 Protein Forms Intact Disulfides and Is Active in Elevating Intracellular Cyclic ADP-ribose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID; LENTIVIRAL-VECTORS; CALCIUM-RELEASE; BOND FORMATION; PRION PROTEIN; CA2+ STORES; TRANSMEMBRANE; HYDROLYSIS; EXPRESSION; NAD(+)	CD38 catalyzes the synthesis of cyclic ADP-ribose (cADPR), a Ca2+ messenger responsible for regulating a wide range of physiological functions. It is generally regarded as an ectoenzyme, but its intracellular localization has also been well documented. It is not known if internal CD38 is enzymatically active and contributes to the Ca2+ signaling function. In this study, we engineered a novel soluble form of CD38 that can be efficiently expressed in the cytosol and use cytosolic NAD as a substrate to produce cADPR intracellularly. The activity of the engineered CD38 could be decreased by mutating the catalytic residue Glu-226 and increased by the double mutation E146A/T221F, which increased its cADPR synthesis activity by > 11-fold. Remarkably, the engineered CD38 exhibited the ability to form the critical disulfide linkages required for its enzymatic activity. This was verified by using a monoclonal antibody generated against a critical disulfide, Cys-254-Cys-275. The specificity of the antibody was established by x-ray crystallography and site-directed mutagenesis. The engineered CD38 is thus a novel example challenging the general belief that cytosolic proteins do not possess disulfides. As a further refinement of this approach, the engineered CD38 was placed under the control of tetracycline using an autoregulated construct. This study has set the stage for in vivo manipulation of cADPR metabolism.	[Zhao, Yong Juan; Zhang, Hong Min; Lam, Connie Mo Ching; Hao, Quan; Lee, Hon Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lee, HC (corresponding author), Univ Hong Kong, Dept Physiol, 4-F Lab Block,Fac Med Bldg,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	leehc@hku.hk	Zhao, Yongjuan/AAS-9919-2021; Zhang, Hongmin/C-4503-2009; Hao, Quan/C-4304-2009; Lee, Hon Cheung/C-4329-2009; Zhang, Hongmin/S-9953-2017	Zhang, Hongmin/0000-0001-6357-4106; Zhang, Hongmin/0000-0003-4356-3615; Hao, Quan/0000-0002-9642-0514; Zhao, Yong Juan/0000-0003-4564-1912	Hong Kong General Research Fund [769107, 768408, 769309, 770610, 765909, 766510, 785110]; National Natural Science Foundation of China/Research Grants Council [N_HKU 722/08]	Hong Kong General Research Fund; National Natural Science Foundation of China/Research Grants Council(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC))	This work was supported by Hong Kong General Research Fund Grants 769107, 768408, 769309, and 770610 (to H. C. L.), 765909 and 766510 (to Q. H.), and 785110 (to H. M. Z.) and National Natural Science Foundation of China/Research Grants Council Joint Research Scheme Grant N_HKU 722/08 (to H. C. L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Bruzzone S, 2001, FASEB J, V15, P10; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; Centlivre M, 2010, GENE THER, V17, P14, DOI 10.1038/gt.2009.109; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Franco L, 2001, J BIOL CHEM, V276, P21642, DOI 10.1074/jbc.M010536200; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2001, J BIOL CHEM, V276, P12169, DOI 10.1074/jbc.M011299200; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Hegde RS, 1998, MOL CELL, V2, P85, DOI 10.1016/S1097-2765(00)80116-1; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Khoo KM, 2000, J BIOL CHEM, V275, P24807, DOI 10.1074/jbc.M908231199; Kou W, 2009, J NEUROSCI RES, V87, P2326, DOI 10.1002/jnr.22060; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LEE HC, 2002, CYCLIC ADP RIBOSE NA; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Markusic D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni062; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Robinson LC, 2008, BIOCHEM BIOPH RES CO, V368, P593, DOI 10.1016/j.bbrc.2008.01.127; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Stewart RS, 2003, J BIOL CHEM, V278, P45960, DOI 10.1074/jbc.M307833200; Tate CG, 2010, SCIENCE, V328, P1644, DOI 10.1126/science.1193065; TOHGO A, 1994, J BIOL CHEM, V269, P28555; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Yalcintepe L, 2005, EXP CELL RES, V303, P14, DOI 10.1016/j.yexcr.2004.09.010; Yamada M, 1997, BRAIN RES, V756, P52, DOI 10.1016/S0006-8993(97)00117-0; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zocchi E, 2001, FASEB J, V15, P1610, DOI 10.1096/fj.00-0803fje; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	54	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22170	22177		10.1074/jbc.M111.228379	http://dx.doi.org/10.1074/jbc.M111.228379			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21524995	Green Published, hybrid			2022-12-25	WOS:000291719900023
J	Kamani, M; Mylvaganam, M; Tian, R; Rigat, B; Binnington, B; Lingwood, C				Kamani, Mustafa; Mylvaganam, Murugesapillai; Tian, Robert; Rigat, Brigitte; Binnington, Beth; Lingwood, Clifford			Adamantyl Glycosphingolipids Provide a New Approach to the Selective Regulation of Cellular Glycosphingolipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ALPHA-GALACTOSIDASE; GROWTH-FACTOR RECEPTOR; ACID BETA-GLUCOSIDASE; GAUCHER-DISEASE; GLUCOSYLCERAMIDE SYNTHASE; STORAGE DISEASES; GLYCOLIPID CONFORMATION; GLOBOTRIAOSYL CERAMIDE; MONOCLONAL-ANTIBODY; IMPROVED INHIBITORS	Mammalian glycosphingolipid (GSL) precursor monohexosylceramides are either glucosyl-or galactosylceramide (GlcCer or GalCer). Most GSLs derive from GlcCer. Substitution of the GSL fatty acid with adamantane generates amphipathic mimics of increased water solubility, retaining receptor function. We have synthesized adamantyl GlcCer (adaGlcCer) and adamantyl GalCer (adaGalCer). AdaGlcCer and adaGalCer partition into cells to alter GSL metabolism. At low dose, adaGlcCer increased cellular GSLs by inhibition of glucocerebrosidase (GCC). Recombinant GCC was inhibited at pH 7 but not pH 5. In contrast, adaGalCer stimulated GCC at pH 5 but not pH 7 and, like adaGlcCer, corrected N370S mutant GCC traffic from the endoplasmic reticulum to lysosomes. AdaGalCer reduced GlcCer levels in normal and lysosomal storage disease (LSD) cells. At 40 mu M adaGlcCer, lactosylceramide (LacCer) synthase inhibition depleted LacCer (and more complex GSLs), such that only GlcCer remained. In Vero cell microsomes, 40 mu M adaGlcCer was converted to adaLacCer, and LacCer synthesis was inhibited. AdaGlcCer is the first cell LacCer synthase inhibitor. At 40 mu M adaGalCer, cell synthesis of only Gb(3) and Gb(4) was significantly reduced, and a novel product, adamantyl digalactosylceramide (adaGb(2)), was generated, indicating substrate competition for Gb(3) synthase. AdaGalCer also inhibited cell sulfatide synthesis. Microsomal Gb(3) synthesis was inhibited by adaGalCer. Metabolic labeling of Gb(3) in Fabry LSD cells was selectively reduced by adaGalCer, and adaGb(2) was produced. AdaGb(2) in cells was 10-fold more effectively shed into the medium than the more polar Gb(3), providing an easily eliminated "safety valve" alternative to Gb(3) accumulation. Adamantyl monohexosyl ceramides thus provide new tools to selectively manipulate normal cellular GSL metabolism and reduce GSL accumulation in cells from LSD patients.	[Kamani, Mustafa; Lingwood, Clifford] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Lingwood, Clifford] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Kamani, Mustafa; Mylvaganam, Murugesapillai; Tian, Robert; Binnington, Beth; Lingwood, Clifford] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Rigat, Brigitte] Hosp Sick Children, Res Inst, Div Genet & Genome Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Lingwood, C (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cling@sickkids.ca	Tian, Rui/E-5637-2011		Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics	Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research team grant in Lysosomal Storage Disease Pharmaco-therapeutics.	ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; Asano N, 2000, EUR J BIOCHEM, V267, P4179, DOI 10.1046/j.1432-1327.2000.01457.x; BAILLY P, 1986, BIOCHEM BIOPH RES CO, V141, P84, DOI 10.1016/S0006-291X(86)80338-2; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Bieberich E, 2004, GLYCOCONJUGATE J, V21, P315, DOI 10.1023/B:GLYC.0000046274.35732.47; Bietrix F, 2010, ARTERIOSCL THROM VAS, V30, P931, DOI 10.1161/ATVBAHA.109.201673; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Burrow TA, 2007, CURR OPIN PEDIATR, V19, P628, DOI 10.1097/MOP.0b013e3282f161f2; Butters TD, 2005, GLYCOBIOLOGY, V15, pR43, DOI 10.1093/glycob/cwi076; Chatterjee S, 2008, CURR DRUG TARGETS, V9, P272, DOI 10.2174/138945008783954952; Chen CS, 1999, LANCET, V354, P901, DOI 10.1016/S0140-6736(98)10034-X; Colsch B, 2008, J NEUROIMMUNOL, V193, P52, DOI 10.1016/j.jneuroim.2007.10.008; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; De Rosa MF, 2008, J BIOL CHEM, V283, P4501, DOI 10.1074/jbc.M705473200; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; FREDMAN P, 1988, BIOCHEM J, V251, P17, DOI 10.1042/bj2510017; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; GRABOWSKI GA, 1986, J BIOL CHEM, V261, P8263; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Heese BA, 2008, SEMIN PEDIATR NEUROL, V15, P119, DOI 10.1016/j.spen.2008.05.005; Hoffmann B, 2005, NEUROPEDIATRICS, V36, P285, DOI 10.1055/s-2005-872810; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Lingwood Clifford, 2006, V347, P305; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lloyd DH, 2007, VET DERMATOL, V18, P197, DOI 10.1111/j.1365-3164.2007.00594.x; Lund N, 2006, AIDS, V20, P333, DOI 10.1097/01.aids.0000206499.78664.58; Mahfoud R, 2002, J LIPID RES, V43, P1670, DOI 10.1194/jlr.M200165-JLR200; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; Mamelak D, 2001, CARBOHYD RES, V335, P91, DOI 10.1016/S0008-6215(01)00209-9; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Mylvaganam M, 1999, BIOCHEM BIOPH RES CO, V257, P391, DOI 10.1006/bbrc.1999.0474; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Nishio M, 2004, J BIOL CHEM, V279, P33368, DOI 10.1074/jbc.M403816200; Norez C, 2009, AM J RESP CELL MOL, V41, P217, DOI 10.1165/rcmb.2008-0285OC; Nutikka Anita, 2003, Methods Mol Med, V73, P197; Park HJ, 2009, CHEM BIOL, V16, P461, DOI 10.1016/j.chembiol.2009.02.014; Pastores GM, 2002, J AM SOC NEPHROL, V13, pS130, DOI 10.1097/01.ASN.0000015236.70757.C4; RADIN NS, 1993, ADV LIPID RES, V26, P183; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Rigat B, 2009, MOL GENET METAB, V96, P225, DOI 10.1016/j.ymgme.2008.12.008; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sillence DJ, 2007, INT REV CYTOL, V262, P151, DOI 10.1016/S0074-7696(07)62003-8; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; VANDERPLOEG AT, 1991, J CLIN INVEST, V87, P513, DOI 10.1172/JCI115025; Velayati A, 2010, CURR NEUROL NEUROSCI, V10, P190, DOI 10.1007/s11910-010-0102-x; Whetstone H, 2003, BIOCHEMISTRY-US, V42, P1611, DOI 10.1021/bi026735t; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; Yew NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011239; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103	63	12	12	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21413	21426		10.1074/jbc.M110.207670	http://dx.doi.org/10.1074/jbc.M110.207670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518770	hybrid, Green Published			2022-12-25	WOS:000291464700040
J	Kasamatsu, A; Nakao, M; Smith, BC; Comstock, LR; Ono, T; Kato, J; Denu, JM; Moss, J				Kasamatsu, Atsushi; Nakao, Motoyuki; Smith, Brian C.; Comstock, Lindsay R.; Ono, Tohru; Kato, Jiro; Denu, John M.; Moss, Joel			Hydrolysis of O-Acetyl-ADP-ribose Isomers by ADP-ribosylhydrolase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							39-KDA POLY(ADP-RIBOSE) GLYCOHYDROLASE; NAD(+)-DEPENDENT DEACETYLASES; RIBOSYLARGININE HYDROLASES; TURKEY ERYTHROCYTES; SIR2 FAMILY; RIBOSYLTRANSFERASES; IDENTIFICATION; RIBOSYLATION; METABOLITE; PRODUCT	O-Acetyl-ADP-ribose (OAADPr), produced by the Sir2-catalyzed NAD(+)-dependent histone/protein deacetylase reaction, regulates diverse biological processes. Interconversion between two OAADPr isomers with acetyl attached to the C-2 '' and C-3 '' hydroxyl of ADP-ribose (ADPr) is rapid. We reported earlier that ADP-ribosylhydrolase 3 (ARH3), one of three ARH proteins sharing structural similarities, hydrolyzed OAADPr to ADPr and acetate, and poly(ADPr) to ADPr monomers. ARH1 also hydrolyzed OAADPr and poly(ADPr) as well as ADP-ribose-arginine, with arginine in alpha-anomeric linkage to C-1 '' of ADP-ribose. Because both ARH3- and ARH1-catalyzed reactions involve nucleophilic attacks at the C-1 '' position, it was perplexing that the ARH3 catalytic site would cleave OAADPr at either the 2 ''- or 3 ''-position, and we postulated the existence of a third isomer, 1 ''-OAADPr, in equilibrium with 2 ''- and 3 ''-isomers. A third isomer, consistent with 1 ''-OAADPr, was identified at pH 9.0. Further, ARH3 OAADPr hydrolase activity was greater at pH 9.0 than at neutral pH where 3 ''-OAADPr predominated. Consistent with our hypothesis, IC50 values for ARH3 inhibition by 2 ''- and 3 ''-N-acetyl-ADPr analogs of OAADPr were significantly higher than that for ADPr. ARH1 also hydrolyzed OAADPr more rapidly at alkaline pH, but cleavage of ADP-ribose-arginine was faster at neutral pH than pH 9.0. ARH3-catalyzed hydrolysis of OAADPr in H-2 O-18 resulted in incorporation of one O-18 into ADP-ribose by mass spectrometric analysis, consistent with cleavage at the C-1 '' position. Together, these data suggest that ARH family members, ARH1 and ARH3, catalyze hydrolysis of the 1 ''-O linkage in their structurally diverse substrates.	[Kasamatsu, Atsushi; Nakao, Motoyuki; Ono, Tohru; Kato, Jiro; Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Smith, Brian C.; Comstock, Lindsay R.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Wisconsin System; University of Wisconsin Madison	Moss, J (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, Rm 6D05,Bldg 10,MSC 1590, Bethesda, MD 20892 USA.	mossj@nhlbi.nih.gov	Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768; Comstock, Lindsay/0000-0003-0764-7344	National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Intramural Research Program, National Institutes of Health, NHLBI.	Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Comstock LR, 2007, ORG BIOMOL CHEM, V5, P3087, DOI 10.1039/b710231c; Diefenbach J, 2005, CELL MOL LIFE SCI, V62, P721, DOI 10.1007/s00018-004-4503-3; FERRO AM, 1978, P NATL ACAD SCI USA, V75, P809, DOI 10.1073/pnas.75.2.809; FISHMAN PH, 1990, ADP RIBOSYLATING TOX, P127; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Kato J, 2007, MOL CELL BIOL, V27, P5534, DOI 10.1128/MCB.00302-07; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Masutani M, 2005, CELL MOL LIFE SCI, V62, P769, DOI 10.1007/s00018-004-4509-x; MIWA M, 1981, J BIOL CHEM, V256, P2916; MOSS J, 1988, BIOCHEMISTRY-US, V27, P5819, DOI 10.1021/bi00415a063; MOSS J, 1986, BIOCHEMISTRY-US, V25, P5408, DOI 10.1021/bi00367a010; Moss J, 1997, ADV EXP MED BIOL, V419, P25; MOSS J, 1992, J BIOL CHEM, V267, P10481; MOSS J, 1985, P NATL ACAD SCI USA, V82, P5603, DOI 10.1073/pnas.82.17.5603; Nguewa PA, 2005, PROG BIOPHYS MOL BIO, V88, P143, DOI 10.1016/j.pbiomolbio.2004.01.001; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; Williamson KC, 1990, ADP RIBOSYLATING TOX, P493	27	35	37	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21110	21117		10.1074/jbc.M111.237636	http://dx.doi.org/10.1074/jbc.M111.237636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498885	hybrid, Green Published			2022-12-25	WOS:000291464700010
J	Ryu, SY; Beutner, G; Kinnally, KW; Dirksen, RT; Sheu, SS				Ryu, Shin-Young; Beutner, Gisela; Kinnally, Kathleen W.; Dirksen, Robert T.; Sheu, Shey-Shing			Single Channel Characterization of the Mitochondrial Ryanodine Receptor in Heart Mitoplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE CONDUCTANCE CHANNEL; INNER MEMBRANE; K+ CHANNELS; CA2+ UPTAKE; RAT-HEART; INTRACELLULAR CALCIUM; VENTRICULAR MYOCYTES; POTASSIUM CHANNELS; RELEASE CHANNEL; ATP SYNTHASE	Heart mitochondria utilize multiple Ca2+ transport mechanisms. Among them, the mitochondrial ryanodine receptor provides a fast Ca2+ uptake pathway across the inner membrane to control "excitation and metabolism coupling." In the present study, we identified a novel ryanodine-sensitive channel in the native inner membrane of heart mitochondria and characterized its pharmacological and biophysical properties by directly patch clamping mitoplasts. Four distinct channel conductances of similar to 100, similar to 225, similar to 700, and similar to 1,000 picosiemens (pS) in symmetrical 150 mM CsCl were observed. The 225 pS cation-selective channel exhibited multiple subconductance states and was blocked by high concentrations of ryanodine and ruthenium red, known inhibitors of ryanodine receptors. Ryanodine exhibited a concentration-dependent modulation of this channel, with low concentrations stabilizing a subconductance state and high concentrations abolishing activity. The 100, 700, and 1,000 pS conductances exhibited different channel characteristics and were not inhibited by ryanodine. Taken together, these findings identified a novel 225 pS channel as the native mitochondrial ryanodine receptor channel activity in heart mitoplasts with biophysical and pharmacological properties that distinguish it from previously identified mitochondrial ion channels.	[Ryu, Shin-Young; Beutner, Gisela; Dirksen, Robert T.; Sheu, Shey-Shing] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Ryu, Shin-Young; Kinnally, Kathleen W.] NYU, Dept Basic Sci, New York, NY 10010 USA; [Sheu, Shey-Shing] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	University of Rochester; New York University; Jefferson University	Sheu, SS (corresponding author), 1025 Walnut St, Philadelphia, PA 19107 USA.	shey-shing.sheu@jefferson.edu	Sheu, Shey-Shing/Y-4009-2019	Sheu, Shey-Shing/0000-0003-3838-3601	National Institutes of Health [HL-033333, HL-093671, AR-44657, GM57249]; American Heart Association [0525951T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033333, R01HL093671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044657, R29AR044657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-033333 and HL-093671 (to S.-S.S.), AR-44657 (to R.T.D.), and GM57249 (to K.W.K.) and American Heart Association Postdoctoral Fellowship Grant 0525951T to S.-Y.R.	Ahern GP, 1997, BIOPHYS J, V72, P146, DOI 10.1016/S0006-3495(97)78654-5; Altschafl BA, 2007, BBA-BIOMEMBRANES, V1768, P1784, DOI 10.1016/j.bbamem.2007.04.011; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Beavis AD, 1996, J BIOENERG BIOMEMBR, V28, P207, DOI 10.1007/BF02110652; Bednarezyk P, 2005, FEBS LETT, V579, P1625, DOI 10.1016/j.febslet.2005.01.077; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; DAS AM, 1990, BIOCHEM SOC T, V18, P554, DOI 10.1042/bst0180554; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Er F, 2004, CIRCULATION, V110, P3100, DOI 10.1161/01.CIR.0000146900.84943.E0; FENG L, 1992, CELL CALCIUM, V13, P79, DOI 10.1016/0143-4160(92)90001-9; FILL M, 1990, BIOPHYS J, V57, P471, DOI 10.1016/S0006-3495(90)82563-7; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9; Grigoriev SM, 2004, INT REV CYTOL, V238, P227, DOI 10.1016/S0074-7696(04)38005-8; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; KINNALLY KW, 1991, BIOCHEM BIOPH RES CO, V176, P1183, DOI 10.1016/0006-291X(91)90410-9; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kushnareva YE, 1999, ARCH BIOCHEM BIOPHYS, V366, P107, DOI 10.1006/abbi.1999.1190; Lin L, 2007, PFLUG ARCH EUR J PHY, V454, P395, DOI 10.1007/s00424-007-0257-8; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Lohret TA, 1997, J CELL BIOL, V137, P377, DOI 10.1083/jcb.137.2.377; Maack C, 2007, BASIC RES CARDIOL, V102, P369, DOI 10.1007/s00395-007-0666-z; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; MCCORMACK JG, 1993, DEV NEUROSCI-BASEL, V15, P165, DOI 10.1159/000111332; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Muro C, 2003, BIOPHYS J, V84, P2981, DOI 10.1016/S0006-3495(03)70024-1; Murphy RC, 1998, FEBS LETT, V425, P259, DOI 10.1016/S0014-5793(98)00245-2; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; ONO K, 1992, J PHYSIOL-LONDON, V454, P673, DOI 10.1113/jphysiol.1992.sp019286; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pickel VM, 1997, J COMP NEUROL, V386, P625, DOI 10.1002/(SICI)1096-9861(19971006)386:4<625::AID-CNE8>3.0.CO;2-4; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Ryu SY, 2010, FEBS LETT, V584, P1948, DOI 10.1016/j.febslet.2010.01.032; Ryu SY, 2005, J MOL CELL CARDIOL, V39, P874, DOI 10.1016/j.yjmcc.2005.08.011; Sun L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0705com; SZABO I, 1991, J BIOL CHEM, V266, P3376; Szewczyk A, 2006, BBA-BIOENERGETICS, V1757, P715, DOI 10.1016/j.bbabio.2006.05.002; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Uehara K, 2004, CELL TISSUE RES, V317, P137, DOI 10.1007/s00441-004-0904-8; Xu JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1717, DOI 10.1152/ajpcell.00105.2004; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; ZIMANYI I, 1992, MOL PHARMACOL, V42, P1049; ZOROV DB, 1992, BIOCHIM BIOPHYS ACTA, V1105, P263, DOI 10.1016/0005-2736(92)90203-X	54	39	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21324	21329		10.1074/jbc.C111.245597	http://dx.doi.org/10.1074/jbc.C111.245597			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21524998	Green Published, hybrid			2022-12-25	WOS:000291464700031
J	Siemens, N; Patenge, N; Otto, J; Fiedler, T; Kreikemeyer, B				Siemens, Nikolai; Patenge, Nadja; Otto, Juliane; Fiedler, Tomas; Kreikemeyer, Bernd			Streptococcus pyogenes M49 Plasminogen/Plasmin Binding Facilitates Keratinocyte Invasion via Integrin-Integrin-linked Kinase (ILK) Pathways and Protects from Macrophage Killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; HYALURONIC-ACID CAPSULE; FIBRONECTIN-BINDING; EPITHELIAL-CELLS; PLASMIN RECEPTOR; VIRULENCE FACTOR; SKIN INFECTION; SEROTYPE M49; HOST-CELLS; ADHERENCE	The entry into epithelial cells and the prevention of primary immune responses are a prerequisite for a successful colonization and subsequent infection of the human host by Streptococcus pyogenes (group A streptococci, GAS). Here, we demonstrate that interaction of GAS with plasminogen promotes an integrin-mediated internalization of the bacteria into keratinocytes, which is independent from the serine protease activity of potentially generated plasmin. alpha(1)beta(1)- and alpha(5)beta(1)-integrins were identified as the major keratinocyte receptors involved in this process. Inhibition of integrin-linked kinase (ILK) expression by siRNA silencing or blocking of PI3K and Akt with specific inhibitors, reduced the GAS M49-plasminogen/plasmin-mediated invasion of keratinocytes. In addition, blocking of actin polymerization significantly reduced GAS internalization into keratinocytes. Altogether, these results provide a first model of plasminogen-mediated GAS invasion into keratinocytes. Furthermore, we demonstrate that plasminogen binding protects the bacteria against macrophage killing.	[Siemens, Nikolai; Patenge, Nadja; Otto, Juliane; Fiedler, Tomas; Kreikemeyer, Bernd] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany	University of Rostock	Kreikemeyer, B (corresponding author), Univ Hosp, Inst Med Microbiol Virol & Hyg, Schillingallee 70, D-18057 Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de		Fiedler, Tomas/0000-0001-6717-1865; Kreikemeyer, Bernd/0000-0001-9527-5098; Siemens, Nikolai/0000-0003-0657-3822	Medical Faculty of the University of Rostock; BMBF (German Federal Ministry of Education and Research)	Medical Faculty of the University of Rostock; BMBF (German Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Medical Faculty of the University of Rostock in the framework of the FORUN program 2010 and by grants from the BMBF (German Federal Ministry of Education and Research) in the framework of the ERANet PathoGenoMics II and SysMO II programs (to B. K.).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; BRODER CC, 1991, J BIOL CHEM, V266, P4922; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Chavakis T, 2005, Hamostaseologie, V25, P33; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cue D, 2001, MICROB PATHOGENESIS, V31, P231, DOI 10.1006/mpat.2001.0467; Cue DR, 1998, INFECT IMMUN, V66, P4577; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Darmstadt GL, 2000, INFECT IMMUN, V68, P1215, DOI 10.1128/IAI.68.3.1215-1221.2000; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Edwards ML, 2004, MICROBES INFECT, V6, P1156, DOI 10.1016/j.micinf.2004.06.007; Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104; Goldmann O, 2007, INFECT IMMUN, V75, P4148, DOI 10.1128/IAI.00181-07; Goldmann O, 2009, CELL MICROBIOL, V11, P138, DOI 10.1111/j.1462-5822.2008.01245.x; GRECO R, 1995, RES MICROBIOL, V146, P551, DOI 10.1016/0923-2508(96)80561-4; Hampton MB, 1999, J IMMUNOL METHODS, V232, P15, DOI 10.1016/S0022-1759(99)00147-7; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Jadoun J, 1998, J INFECT DIS, V178, P147, DOI 10.1086/515589; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; KULISEK ES, 1989, ANAL BIOCHEM, V177, P78, DOI 10.1016/0003-2697(89)90017-1; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Lishko VK, 2004, BLOOD, V104, P719, DOI 10.1182/blood-2003-09-3016; LOTTENBERG R, 1992, J BACTERIOL, V174, P5204, DOI 10.1128/JB.174.16.5204-5210.1992; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; OKADA N, 1994, J CLIN INVEST, V94, P965, DOI 10.1172/JCI117463; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Oliver SL, 2007, J CLIN MICROBIOL, V45, P3050, DOI 10.1128/JCM.02015-06; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; POONKING R, 1993, J EXP MED, V178, P759, DOI 10.1084/jem.178.2.759; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; Serrano RL, 1996, BIOCHEM J, V313, P171, DOI 10.1042/bj3130171; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Wang BN, 2007, CELL MICROBIOL, V9, P1519, DOI 10.1111/j.1462-5822.2007.00889.x; Wang BN, 2006, CELL MICROBIOL, V8, P257, DOI 10.1111/j.1462-5822.2005.00618.x; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x	64	48	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21612	21622		10.1074/jbc.M110.202671	http://dx.doi.org/10.1074/jbc.M110.202671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521694	hybrid, Green Published			2022-12-25	WOS:000291464700058
J	Zhang, XP; Dong, CM; Wu, QJ; Balch, WE; Wu, GY				Zhang, Xiaoping; Dong, Chunmin; Wu, Qiong J.; Balch, William E.; Wu, Guangyu			Di-acidic Motifs in the Membrane-distal C Termini Modulate the Transport of Angiotensin II Receptors from the Endoplasmic Reticulum to the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ER EXPORT; TYPE-2 RECEPTOR; COPII COAT; CARBOXYL-TERMINUS; CARDIAC MYOCYTES; SELECTIVE EXPORT; STRUCTURAL BASIS; RAB1 GTPASE; TRAFFICKING	The molecular mechanisms underlying the endoplasmic reticulum (ER) export and cell surface transport of nascent G protein-coupled receptors (GPCRs) have just begun to be revealed and previous studies have shown that hydrophobic motifs in the putative amphipathic 8th alpha-helical region within the membrane-proximal C termini play an important role. In this study, we demonstrate that di-acidic motifs in the membrane-distal, nonstructural C-terminal portions are required for the exit from the ER and transport to the plasma membrane of angiotensin II receptors, but not adrenergic receptors. More interestingly, distinct di-acidic motifs dictate optimal export trafficking of different angiotensin II receptors and export ability of each acidic residue in the di-acidic motifs cannot be fully substituted by other acidic residue. Moreover, the function of the di-acidic motifs is likely mediated through facilitating the recruitment of the receptors onto the ER-derived COPII transport vesicles. Therefore, the di-acidic motifs located in the membrane-distal C termini may represent the first linear motifs which recruit selective GPCRs onto the COPII vesicles to control their export from the ER.	[Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Zhang, Xiaoping; Dong, Chunmin; Wu, Qiong J.; Wu, Guangyu] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University System of Georgia; Augusta University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Scripps Research Institute	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@georgiahealth.edu			National Institutes of Health [R01GM076167]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033301, R01GM076167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM076167 (to G. W.).	Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Fan J, 2005, MOL ENDOCRINOL, V19, P2579, DOI 10.1210/me.2004-0301; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gallinat S, 2000, AM J PHYSIOL-ENDOC M, V278, pE357, DOI 10.1152/ajpendo.2000.278.3.E357; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Heymann JAW, 1997, P NATL ACAD SCI USA, V94, P4966, DOI 10.1073/pnas.94.10.4966; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Matsubara H, 1998, CIRC RES, V83, P1182, DOI 10.1161/01.RES.83.12.1182; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mizrachi D, 2004, MOL ENDOCRINOL, V18, P1768, DOI 10.1210/me.2003-0406; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 2002, P NATL ACAD SCI USA, V99, P6755, DOI 10.1073/pnas.092150699; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Nufer O, 2002, J CELL SCI, V115, P619; Olivares-Reyes JA, 2001, J BIOL CHEM, V276, P37761; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Zhang XP, 2009, J PHARMACOL EXP THER, V330, P109, DOI 10.1124/jpet.109.153460; Zhou FG, 2006, CELL SIGNAL, V18, P318, DOI 10.1016/j.cellsig.2005.05.014; Zhuang XL, 2010, BIOCHEM BIOPH RES CO, V396, P874, DOI 10.1016/j.bbrc.2010.05.014; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	56	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20525	20535		10.1074/jbc.M111.222034	http://dx.doi.org/10.1074/jbc.M111.222034			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507945	Green Published, hybrid			2022-12-25	WOS:000291267600039
J	Vouldoukis, I; Mazier, D; Moynet, D; Thiolat, D; Malvy, D; Mossalayi, MD				Vouldoukis, Ioannis; Mazier, Dominique; Moynet, Daniel; Thiolat, Denis; Malvy, Denis; Mossalayi, M. Djavad			IgE Mediates Killing of Intracellular Toxoplasma gondii by Human Macrophages through CD23-Dependent, Interleukin-10 Sensitive Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; IMMUNOGLOBULIN-E; IFN-GAMMA; LEISHMANIA-MAJOR; IMMUNE-RESPONSE; HUMAN MONOCYTES; CYCLIC-AMP; ACTIVATION; INFECTION; CELLS	BACKGROUND: In addition to helminthic infections, elevated serum IgE levels were observed in many protozoal infections, while their contribution during immune response to these pathogens remained unclear. As IgE/antigen immune complexes (IgE-IC) bind to human cells through FceRI or FceRII/CD23 surface molecules, the present study aimed to identify which functional receptor may be involved in IgE-IC interaction with human macrophages, the major effector cell during parasite infection. METHODOLOGY/PRINCIPAL FINDINGS: Human monocyte-derived macrophages were infected with Toxoplasma gondii before being incubated with IgE-IC. IgE receptors were then identified using appropriate blocking antibodies. The activation of cells and parasiticidal activity were evaluated by mediator quantification and direct counting of infected macrophages. RNAs were extracted and cell supernatants were also collected for their content in tumor necrosis factor (TNF)-alpha, interleukin-10 (IL-10) and nitrites. Sera from symptomatic infected atients were also tested for their content of IgE, IL-10 and nitrites, and compared to values found in healthy donors. Results showed that IgE-IC induced intracellular elimination of parasites by human macrophages. IgE-mediated effect was FceRI-independent, but required cross-linking of surface FceRII/CD23, cell activation and the generation of nitric oxide (NO). Although TNF-alpha was shown to be produced during cell activation, this cytokine had minor contribution in this phenomenon while endogenous and exogenous IL-10 down-regulated parasite killing. Inverse relationship was found between IL-10 and NO expression by infected human macrophages at both mRNA and mediator levels. The relationship between these in vitro data and in vivo levels of various factors in T. gondii infected patients supports the involvement of CD23 antigen and IL-10 expression in disease control. CONCLUSION: Thus, IgE may be considered as immune mediator during antiprotozoal activity of human macrophages through its ability to trigger CD23 signaling. Increased cell activation by IgE-IC may also account for chronic inflammatory diseases observed in some patients.	[Vouldoukis, Ioannis; Mazier, Dominique] Univ Paris 06, Inserm U511, Paris, France; [Moynet, Daniel; Thiolat, Denis; Malvy, Denis; Mossalayi, M. Djavad] Univ Bordeaux, UFR Sci Pharmaceut, Inserm U1035, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Vouldoukis, I (corresponding author), Univ Paris 06, Inserm U511, Paris, France.	djavad.mossalayi@imparph.u-bordeaux2.fr	MALVY, Denis/T-7930-2019					Ahn HJ, 2009, PARASITOL RES, V105, P1445, DOI 10.1007/s00436-009-1577-8; Alexander J, 1998, CHEM IMMUNOL, V70, P81; Alexander J, 1997, PHILOS T ROY SOC B, V352, P1355, DOI 10.1098/rstb.1997.0120; ALONSO A, 1995, J IMMUNOL, V154, P6475; AROCK M, 1994, BIOCHEM BIOPH RES CO, V203, P265, DOI 10.1006/bbrc.1994.2177; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; Bahia-Oliveira LMG, 2009, MEM I OSWALDO CRUZ, V104, P273, DOI 10.1590/S0074-02762009000200021; BECHEREL PA, 1994, J CLIN INVEST, V93, P2275, DOI 10.1172/JCI117227; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Coura-Vital W, 2008, EXP PARASITOL, V120, P269, DOI 10.1016/j.exppara.2008.08.001; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dunay IR, 2010, CURR OPIN IMMUNOL, V22, P461, DOI 10.1016/j.coi.2010.04.008; Ege MJ, 2008, ALLERGY, V63, P1505, DOI 10.1111/j.1398-9995.2008.01793.x; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Finkelman FD, 2001, J ALLERGY CLIN IMMUN, V107, P772, DOI 10.1067/mai.2001.114989; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hibbert RG, 2005, J EXP MED, V202, P751, DOI 10.1084/jem.20050811; Kim L, 2004, J IMMUNOL, V172, P3003, DOI 10.4049/jimmunol.172.5.3003; KOLB JP, 1994, J BIOL CHEM, V269, P9811; LECOANETHENCHOZ S, 1995, IMMUNITY, V3, P119, DOI 10.1016/1074-7613(95)90164-7; Leng J, 2009, J IMMUNOL, V182, P489, DOI 10.4049/jimmunol.182.1.489; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Marshall LA, 1998, J IMMUNOL, V161, P6005; Mossalayi M D, 1997, Int Rev Immunol, V16, P129, DOI 10.3109/08830189709045706; Mossalayi MD, 2009, INFECT IMMUN, V77, P5537, DOI 10.1128/IAI.01457-08; Nacher M, 2004, CLIN REV ALLERG IMMU, V26, P85, DOI 10.1007/s12016-004-0003-3; OUAAZ F, 1994, BLOOD, V84, P3095; Perlmann P, 1997, INFECT IMMUN, V65, P116, DOI 10.1128/IAI.65.1.116-121.1997; Prandota Joseph, 2007, Am J Ther, V14, P63, DOI 10.1097/01.mjt.0000208272.42379.aa; Rambert J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004834; Safeukui I, 2008, MICROBES INFECT, V10, P1411, DOI 10.1016/j.micinf.2008.07.033; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Sousa-Atta MLB, 2002, CLIN DIAGN LAB IMMUN, V9, P101, DOI 10.1128/CDLI.9.1.101-104.2002; Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; WANG AM, 1985, SCIENCE, V228, P149, DOI 10.1126/science.3856324; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Yarovinsky F, 2008, IMMUNOL LETT, V119, P17, DOI 10.1016/j.imlet.2008.05.007	43	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18289	10.1371/journal.pone.0018289	http://dx.doi.org/10.1371/journal.pone.0018289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526166	Green Submitted, Green Published, gold			2022-12-25	WOS:000290015800006
J	Yasukochi, Y; Miura, N; Nakano, R; Sahara, K; Ishikawa, Y				Yasukochi, Yuji; Miura, Nami; Nakano, Ryo; Sahara, Ken; Ishikawa, Yukio			Sex-Linked Pheromone Receptor Genes of the European Corn Borer, Ostrinia nubilalis, Are in Tandem Arrays	PLOS ONE			English	Article							SILKMOTH BOMBYX-MORI; ADZUKI BEAN BORER; MOLECULAR EVOLUTION; LEPIDOPTERA; ODORANT; MOTHS; INSECT; BIOSYNTHESIS; SCAPULALIS; CRAMBIDAE	BACKGROUND: Tuning of the olfactory system of male moths to conspecific female sex pheromones is crucial for correct species recognition; however, little is known about the genetic changes that drive speciation in this system. Moths of the genus Ostrinia are good models to elucidate this question, since significant differences in pheromone blends are observed within and among species. Odorant receptors (ORs) play a critical role in recognition of female sex pheromones; eight types of OR genes expressed in male antennae were previously reported in Ostrinia moths. METHODOLOGY/PRINCIPAL FINDINGS: We screened an O. nubilalis bacterial artificial chromosome (BAC) library by PCR, and constructed three contigs from isolated clones containing the reported OR genes. Fluorescence in situ hybridization (FISH) analysis using these clones as probes demonstrated that the largest contig, which contained eight OR genes, was located on the Z chromosome; two others harboring two and one OR genes were found on two autosomes. Sequence determination of BAC clones revealed the Z-linked OR genes were closely related and tandemly arrayed; moreover, four of them shared 181-bp direct repeats spanning exon 7 and intron 7. CONCLUSIONS/SIGNIFICANCE: This is the first report of tandemly arrayed sex pheromone receptor genes in Lepidoptera. The localization of an OR gene cluster on the Z chromosome agrees with previous findings for a Z-linked locus responsible for O. nubilalis male behavioral response to sex pheromone. The 181-bp direct repeats might enhance gene duplications by unequal crossovers. An autosomal locus responsible for male response to sex pheromone in Heliothis virescens and H. subflexa was recently reported to contain at least four OR genes. Taken together, these findings support the hypothesis that generation of additional copies of OR genes can increase the potential for male moths to acquire altered specificity for pheromone components, and accordingly, facilitate differentiation of sex pheromones.	[Yasukochi, Yuji] Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki, Japan; [Miura, Nami; Nakano, Ryo; Ishikawa, Yukio] Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Sahara, Ken] Hokkaido Univ, Lab Appl Mol Entomol, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido, Japan	National Institute of Agrobiological Sciences - Japan; University of Tokyo; Hokkaido University	Yasukochi, Y (corresponding author), Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki, Japan.	yaskoch@affrc.go.jp	Ishikawa, Yukio/J-5676-2019; Sahara, Ken/A-4266-2012	Ishikawa, Yukio/0000-0003-3067-2513; 	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science (JSPS) [22380040/19208005]	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) and grants 22380040/19208005 from Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Carde RT, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P283, DOI 10.1017/CBO9780511542664.009; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P1063, DOI 10.1016/j.jinsphys.2007.05.013; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P488, DOI 10.1016/j.jinsphys.2007.01.009; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; FELSENSTEIN J, 2006, PHYLIP PHYLOGENY INF; Fukuzawa M, 2006, J INSECT PHYSIOL, V52, P430, DOI 10.1016/j.jinsphys.2005.11.004; Gould F, 2010, P NATL ACAD SCI USA, V107, P8660, DOI 10.1073/pnas.0910945107; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Heckel DG, 2010, P NATL ACAD SCI USA, V107, P9481, DOI 10.1073/pnas.1004511107; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang YP, 2002, J CHEM ECOL, V28, P533, DOI 10.1023/A:1014540011854; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Kim CG, 1999, APPL ENTOMOL ZOOL, V34, P405, DOI 10.1303/aez.34.405; Krieger J, 2005, EUR J NEUROSCI, V21, P2167, DOI 10.1111/j.1460-9568.2005.04058.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Linn CE, 2007, J CHEM ECOL, V33, P199, DOI 10.1007/s10886-006-9204-y; Linn C, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.15; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Miura N, 2009, INT J BIOL SCI, V5, P319; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Olsson SB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-285; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; ROELOFS WL, 1985, J CHEM ECOL, V11, P829, DOI 10.1007/BF01012071; Sakai R, 2009, INSECT BIOCHEM MOLEC, V39, P62, DOI 10.1016/j.ibmb.2008.10.001; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Tabata F, 2005, J CHEM ECOL, V31, P1111, DOI 10.1007/s10886-005-4251-3; Takanashi T, 2005, BIOL J LINN SOC, V84, P143, DOI 10.1111/j.1095-8312.2005.00421.x; Takanashi T, 2000, CHEMOECOLOGY, V10, P143, DOI 10.1007/PL00001816; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104; Yasukochi Y, 1999, MOL GEN GENET, V261, P796, DOI 10.1007/s004380050023; Yasukochi Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/165894; Yasukochi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007465	51	34	38	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18843	10.1371/journal.pone.0018843	http://dx.doi.org/10.1371/journal.pone.0018843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526121	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800016
J	Hamazaki, T; Leung, WY; Cain, BD; Ostrov, DA; Thorsness, PE; Terada, N				Hamazaki, Takashi; Leung, Wai-Yee; Cain, Brian D.; Ostrov, David A.; Thorsness, Peter E.; Terada, Naohiro			Functional Expression of Human Adenine Nucleotide Translocase 4 in Saccharomyces Cerevisiae	PLOS ONE			English	Article							MITOCHONDRIAL ADP/ATP CARRIER; N-TERMINAL REGION; YEAST MITOCHONDRIA; GERM-CELLS; PROTEINS; GENE; IDENTIFICATION; TRANSPORT; SYSTEM	The adenine nucleotide translocase (ANT) mediates the exchange of ADP and ATP across the inner mitochondrial membrane. The human genome encodes multiple ANT isoforms that are expressed in a tissue-specific manner. Recently a novel germ cell-specific member of the ANT family, ANT4 (SLC25A31) was identified. Although it is known that targeted depletion of ANT4 in mice resulted in male infertility, the functional biochemical differences between ANT4 and other somatic ANT isoforms remain undetermined. To gain insight into ANT4, we expressed human ANT4 (hANT4) in yeast mitochondria. Unlike the somatic ANT proteins, expression of hANT4 failed to complement an AAC-deficient yeast strain for growth on media requiring mitochondrial respiration. Moreover, overexpression of hANT4 from a multi-copy plasmid interfered with optimal yeast growth. However, mutation of specific amino acids of hANT4 improved yeast mitochondrial expression and supported growth of the AAC-deficient yeast on non-fermentable carbon sources. The mutations affected amino acids predicted to interact with phospholipids, suggesting the importance of lipid interactions for function of this protein. Each mutant hANT4 and the somatic hANTs exhibited similar ADP/ATP exchange kinetics. These data define common and distinct biochemical characteristics of ANT4 in comparison to ANT1, 2 and 3 providing a basis for study of its unique adaptation to germ cells.	[Hamazaki, Takashi; Leung, Wai-Yee; Ostrov, David A.; Terada, Naohiro] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; [Cain, Brian D.] Univ Florida, Dept Biochem, Gainesville, FL USA; [Thorsness, Peter E.] Univ Wyoming, Coll Agr, Dept Mol Biol, Laramie, WY 82071 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Wyoming	Hamazaki, T (corresponding author), Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA.	hamazaki@pathology.ufl.edu			National Institutes of Health (NIH) [UO1 HD060474]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060474] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health (NIH) grants UO1 HD060474 to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; BETINA S, 1995, EUR J BIOCHEM, V229, P651, DOI 10.1111/j.1432-1033.1995.tb20510.x; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRANDOLIN G, 1980, BIOCHIM BIOPHYS ACTA, V592, P592, DOI 10.1016/0005-2728(80)90103-6; Brower JV, 2007, J BIOL CHEM, V282, P29658, DOI 10.1074/jbc.M704386200; Brower JV, 2009, REPRODUCTION, V138, P463, DOI 10.1530/REP-09-0201; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dolce V, 2005, FEBS LETT, V579, P633, DOI 10.1016/j.febslet.2004.12.034; DURBIN RM, 2010, NATURE ENGLAND, P1061; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; Hatanaka T, 2001, BIOL PHARM BULL, V24, P595, DOI 10.1248/bpb.24.595; Hatanaka T, 2001, J BIOL CHEM, V276, P28881, DOI 10.1074/jbc.M102535200; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kim YH, 2007, DEV BIOL, V302, P463, DOI 10.1016/j.ydbio.2006.10.004; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KU CS, 2010, J HUM GENET JAPAN, P403; Kucejova B, 2008, MOL GENET GENOMICS, V280, P25, DOI 10.1007/s00438-008-0342-5; Lousa CD, 2005, BIOCHEMISTRY-US, V44, P4342, DOI 10.1021/bi0475370; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; RO DK, 2006, NATURE ENGLAND, P940; Rodic N, 2005, STEM CELLS, V23, P1314, DOI 10.1634/stemcells.2005-0119; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Smith CP, 2008, GENETICS, V179, P1285, DOI 10.1534/genetics.108.087700; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Trezeguet V, 2008, J BIOENERG BIOMEMBR, V40, P435, DOI 10.1007/s10863-008-9178-2; WOLDEGIORGIS G, 1985, J BIOL CHEM, V260, P7585; YAFFE MP, 1991, METHOD ENZYMOL, V194, P627	31	13	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19250	10.1371/journal.pone.0019250	http://dx.doi.org/10.1371/journal.pone.0019250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21532989	gold, Green Published, Green Submitted			2022-12-25	WOS:000290014500026
J	Schneider, KL; Marrero, G; Alvarez, AM; Presting, GG				Schneider, Kevin L.; Marrero, Glorimar; Alvarez, Anne M.; Presting, Gernot G.			Classification of Plant Associated Bacteria Using RIF, a Computationally Derived DNA Marker	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; 16S RIBOSOMAL-RNA; COMB-NOV; GENOME SEQUENCE; RECLASSIFICATION; PECTOBACTERIUM; IDENTIFICATION; PATHOGENICITY; CHRYSANTHEMI; ALIGNMENT	A DNA marker that distinguishes plant associated bacteria at the species level and below was derived by comparing six sequenced genomes of Xanthomonas, a genus that contains many important phytopathogens. This DNA marker comprises a portion of the dnaA replication initiation factor (RIF). Unlike the rRNA genes, dnaA is a single copy gene in the vast majority of sequenced bacterial genomes, and amplification of RIF requires genus-specific primers. In silico analysis revealed that RIF has equal or greater ability to differentiate closely related species of Xanthomonas than the widely used ribosomal intergenic spacer region (ITS). Furthermore, in a set of 263 Xanthomonas, Ralstonia and Clavibacter strains, the RIF marker was directly sequenced in both directions with a success rate approximately 16% higher than that for ITS. RIF frameworks for Xanthomonas, Ralstonia and Clavibacter were constructed using 682 reference strains representing different species, subspecies, pathovars, races, hosts and geographic regions, and contain a total of 109 different RIF sequences. RIF sequences showed subspecific groupings but did not place strains of X. campestris or X. axonopodis into currently named pathovars nor R. solanacearum strains into their respective races, confirming previous conclusions that pathovar and race designations do not necessarily reflect genetic relationships. The RIF marker also was sequenced for 24 reference strains from three genera in the Enterobacteriaceae: Pectobacterium, Pantoea and Dickeya. RIF sequences of 70 previously uncharacterized strains of Ralstonia, Clavibacter, Pectobacterium and Dickeya matched, or were similar to, those of known reference strains, illustrating the utility of the frameworks to classify bacteria below the species level and rapidly match unknown isolates to reference strains. The RIF sequence frameworks are available at the online RIF database, RIFdb, and can be queried for diagnostic purposes with RIF sequences obtained from unknown strains in both chromatogram and FASTA format.	[Schneider, Kevin L.; Marrero, Glorimar; Alvarez, Anne M.; Presting, Gernot G.] Univ Hawaii Manoa, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Schneider, KL (corresponding author), Univ Hawaii Manoa, Honolulu, HI 96822 USA.	gernot@hawaii.edu			USDA [2008-34135-19370, 2005-34135-15972]	USDA(United States Department of Agriculture (USDA))	This work was funded by USDA grants 2008-34135-19370 and 2005-34135-15972. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Bakker PAHM, 2007, PHYTOPATHOLOGY, V97, P239, DOI 10.1094/PHYTO-97-2-0239; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; BUDDENHAGEN IVAN, 1964, ANN REV PHYTOPATHOL, V2, P203, DOI 10.1146/annurev.py.02.090164.001223; Castillo JA, 2007, APPL ENVIRON MICROB, V73, P1225, DOI 10.1128/AEM.01253-06; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y; Denny TP, 2006, PLANT-ASSOCIATED BACTERIA, P573; EICHENLAUB R, 2006, PLANT ASS BACTERIA, P131; EWING A, 2008, THESIS U HAWAII MANO; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Fegan M, 1998, BACTERIAL WILT DISEASE, P19; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Garcia-Martinez J, 1999, J MICROBIOL METH, V36, P55, DOI 10.1016/S0167-7012(99)00011-1; GAVINI F, 1989, INT J SYST BACTERIOL, V39, P337, DOI 10.1099/00207713-39-3-337; Gottwald TR, 2001, PHYTOPATHOLOGY, V91, P30, DOI 10.1094/PHYTO.2001.91.1.30; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hauben L, 1998, SYST APPL MICROBIOL, V21, P384, DOI 10.1016/S0723-2020(98)80048-9; HAWKS B, 2005, FED REGISTER, V70, P13241; Hayward A. C., 1993, Xanthomonas., P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; IMHOFF JF, 2005, BERGEYS MANUAL SYSTE, V2, P1, DOI DOI 10.1099/00207713-34-3-338; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kang YJ, 2010, MICROBIOLOGY+, V79, P655, DOI 10.1134/S0026261710050103; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Nassar A, 1996, APPL ENVIRON MICROB, V62, P2228, DOI 10.1128/AEM.62.7.2228-2235.1996; NORMAND P, 1996, MOL MICROBIAL ECOLOG, P1; Parkinson N, 2007, INT J SYST EVOL MICR, V57, P2881, DOI 10.1099/ijs.0.65220-0; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P2388, DOI 10.1099/ijs.0.009258-0; Pascual J, 2010, INT J SYST EVOL MICR, V60, P154, DOI 10.1099/ijs.0.010702-0; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Prior P, 2005, ACTA HORTIC, P127, DOI 10.17660/ActaHortic.2005.695.14; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x; Schaad Norman W, 2006, Syst Appl Microbiol, V29, P690, DOI 10.1016/j.syapm.2006.08.001; Sherwood AR, 2008, MOL ECOL RESOUR, V8, P1011, DOI 10.1111/j.1755-0998.2008.02138.x; Sherwood AR, 2007, J PHYCOL, V43, P605, DOI 10.1111/j.1529-8817.2007.00341.x; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vitorino L, 2007, MICROBIOL-SGM, V153, P160, DOI 10.1099/mic.0.2006/001149-0; Wang N, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-117; Wilton SD, 1997, BIOTECHNIQUES, V22, P642, DOI 10.2144/97224bm14; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Young JM, 2007, SYST APPL MICROBIOL, V30, P343, DOI 10.1016/j.syapm.2007.03.002; YOUNG JM, 2001, COMMITTEE TAXONOMY P; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	61	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18496	10.1371/journal.pone.0018496	http://dx.doi.org/10.1371/journal.pone.0018496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533033	Green Published, Green Submitted, gold			2022-12-25	WOS:000290014500005
J	Wang, Z; Nilsson, RH; Lopez-Giraldez, F; Zhuang, WY; Dai, YC; Johnston, PR; Townsend, JP				Wang, Zheng; Nilsson, R. Henrik; Lopez-Giraldez, Francesc; Zhuang, Wen-ying; Dai, Yu-cheng; Johnston, Peter R.; Townsend, Jeffrey P.			Tasting Soil Fungal Diversity with Earth Tongues: Phylogenetic Test of SATe Alignments for Environmental ITS Data	PLOS ONE			English	Article							ASCOMYCOTA TREE; SEQUENCE; EVOLUTION; CLASSIFICATION; IDENTIFICATION; DATABASES; PROGRESS; ECOLOGY; SEARCH; LIFE	An abundance of novel fungal lineages have been indicated by DNA sequencing of the nuclear ribosomal ITS region from environmental samples such as soil and wood. Although phylogenetic analysis of these novel lineages is a key component of unveiling the structure and diversity of complex communities, such analyses are rare for environmental ITS data due to the difficulties of aligning this locus across significantly divergent taxa. One potential approach to this issue is simultaneous alignment and tree estimation. We targeted divergent ITS sequences of the earth tongue fungi (Geoglossomycetes), a basal class in the Ascomycota, to assess the performance of SATe, recent software that combines progressive alignment and tree building. We found that SATe performed well in generating high-quality alignments and in accurately estimating the phylogeny of earth tongue fungi. Drawing from a data set of 300 sequences of earth tongues and progressively more distant fungal lineages, 30 insufficiently identified ITS sequences from the public sequence databases were assigned to the Geoglossomycetes. The association between earth tongues and plants has been hypothesized for a long time, but hard evidence is yet to be collected. The ITS phylogeny showed that four ectomycorrhizal isolates shared a clade with Geoglossum but not with Trichoglossum earth tongues, pointing to the significant potential inherent to ecological data mining of environmental samples. Environmental sampling holds the key to many focal questions in mycology, and simultaneous alignment and tree estimation, as performed by SATe, can be a highly efficient companion in that pursuit.	[Wang, Zheng; Lopez-Giraldez, Francesc; Townsend, Jeffrey P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Nilsson, R. Henrik] Gothenburg Univ, Dept Plant & Environm Sci, Gothenburg, Sweden; [Nilsson, R. Henrik] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia; [Zhuang, Wen-ying] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Dai, Yu-cheng] Beijing Forestry Univ, Inst Microbiol, Beijing, Peoples R China; [Johnston, Peter R.] Landcare Res, Herbarium PDD, Auckland, New Zealand	Yale University; University of Gothenburg; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Beijing Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Landcare Research - New Zealand	Wang, Z (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	wang.zheng@yale.edu	Nilsson, R. Henrik/A-6062-2009; Wang, Zheng/A-2318-2011; López-Giráldez, Francesc/A-5251-2011; Johnston, Peter/AAP-6300-2021; Johnston, Peter/GZL-2513-2022; Townsend, Jeffrey/H-2747-2019; Dai, Yu-Cheng/A-6589-2015	Nilsson, R. Henrik/0000-0002-8052-0107; Wang, Zheng/0000-0002-8849-8549; López-Giráldez, Francesc/0000-0001-7476-9822; Johnston, Peter/0000-0003-0761-9116; Townsend, Jeffrey/0000-0002-9890-3907; 	Yale University	Yale University	ZW was supported by a Yale University internal postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; BIDARTONDO MI, 2005, FUNGAL COMMUNITY, P215; Blair C, 2011, J HERED, V102, P130, DOI 10.1093/jhered/esq092; Brock PM, 2009, NEW PHYTOL, V181, P719, DOI 10.1111/j.1469-8137.2008.02703.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Eberhardt U, 2010, NEW PHYTOL, V187, P266, DOI 10.1111/j.1469-8137.2010.03329.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hartmann M, 2009, ENVIRON MICROBIOL, V11, P3045, DOI 10.1111/j.1462-2920.2009.02008.x; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kirk PM, 2008, DICT FUNGI; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Loytynoja A, 2009, SCIENCE, V324, P1528, DOI 10.1126/science.1175949; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; MADDISON DR, 2000, MACCLADE VERSION 4; Morris MH, 2008, MYCORRHIZA, V18, P375, DOI 10.1007/s00572-008-0186-1; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Napoli C, 2010, NEW PHYTOL, V185, P237, DOI 10.1111/j.1469-8137.2009.03053.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2011, MYCOSCIENCE, V52, P278, DOI 10.1007/s10267-010-0086-z; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nilsson RH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-178; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Ohenoja E, 2010, MYCOLOGIA, V102, P1089, DOI 10.3852/09-317; Peay KG, 2008, BIOSCIENCE, V58, P799, DOI 10.1641/B580907; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schoch CL, 2009, PERSOONIA, V22, P129, DOI 10.3767/003158509X461486; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; SEAVER FJ, 1951, N AM CUP FUNGI IN OP; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shenoy BD, 2007, FUNGAL DIVERS, V26, P1; Taylor DL, 2007, ENVIRON MICROBIOL, V9, P1329, DOI 10.1111/j.1462-2920.2007.01253.x; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waldrop MP, 2006, ECOL LETT, V9, P1127, DOI 10.1111/j.1461-0248.2006.00965.x; Wang Z, 2006, MYCOLOGIA, V98, P1065, DOI 10.3852/mycologia.98.6.1065; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031; White T., 1990, PCR PROTOCOLS GUIDE, P315; ZHUANG WY, 1998, FLORA FUNGORUM SINIC, V8	50	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19039	10.1371/journal.pone.0019039	http://dx.doi.org/10.1371/journal.pone.0019039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533038	gold, Green Published			2022-12-25	WOS:000290014500020
J	Roegner, GC; Needoba, JA; Baptista, AM				Roegner, G. Curtis; Needoba, Joseph A.; Baptista, Antonio M.			Coastal Upwelling Supplies Oxygen-Depleted Water to the Columbia River Estuary	PLOS ONE			English	Article							JUVENILE CHINOOK SALMON; PASSIVE INTEGRATED TRANSPONDERS; LOW DISSOLVED-OXYGEN; CALIFORNIA CURRENT; ONCORHYNCHUS-TSHAWYTSCHA; CANCER-MAGISTER; DUNGENESS CRAB; AVIAN PREDATION; COLD HALOCLINE; WILLAPA BAY	Low dissolved oxygen (DO) is a common feature of many estuarine and shallow-water environments, and is often attributed to anthropogenic nutrient enrichment from terrestrial-fluvial pathways. However, recent events in the U. S. Pacific Northwest have highlighted that wind-forced upwelling can cause naturally occurring low DO water to move onto the continental shelf, leading to mortalities of benthic fish and invertebrates. Coastal estuaries in the Pacific Northwest are strongly linked to ocean forcings, and here we report observations on the spatial and temporal patterns of oxygen concentration in the Columbia River estuary. Hydrographic measurements were made from transect (spatial survey) or anchor station (temporal survey) deployments over a variety of wind stresses and tidal states during the upwelling seasons of 2006 through 2008. During this period, biologically stressful levels of dissolved oxygen were observed to enter the Columbia River estuary from oceanic sources, with minimum values close to the hypoxic threshold of 2.0 mg L-1. Riverine water was consistently normoxic. Upwelling wind stress controlled the timing and magnitude of low DO events, while tidal-modulated estuarine circulation patterns influenced the spatial extent and duration of exposure to low DO water. Strong upwelling during neap tides produced the largest impact on the estuary. The observed oxygen concentrations likely had deleterious behavioral and physiological consequences for migrating juvenile salmon and benthic crabs. Based on a wind-forced supply mechanism, low DO events are probably common to the Columbia River and other regional estuaries and if conditions on the shelf deteriorate further, as observations and models predict, Pacific Northwest estuarine habitats could experience a decrease in environmental quality.	[Roegner, G. Curtis] NOAA Fisheries, NW Fisheries Sci Ctr, Point Adams Res Stn, Hammond, OR USA; [Needoba, Joseph A.; Baptista, Antonio M.] Oregon Hlth & Sci Univ, Sci & Technol Ctr Coastal Margin Observat & Predi, Beaverton, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon Health & Science University	Roegner, GC (corresponding author), NOAA Fisheries, NW Fisheries Sci Ctr, Point Adams Res Stn, Hammond, OR USA.	curtis.roegner@noaa.gov	Roegner, G. Curtis/D-8964-2011	Roegner, G. Curtis/0000-0003-0621-343X; Baptista, Antonio/0000-0002-7641-5937	Bonneville Power Association; National Science Foundation through the Science and Technology Center for Coastal Margin Observation and Prediction [OCE-0424602]	Bonneville Power Association; National Science Foundation through the Science and Technology Center for Coastal Margin Observation and Prediction(National Science Foundation (NSF))	Funding was provided by the Bonneville Power Association (GCR) and the National Science Foundation (JN and AMB) through the Science and Technology Center for Coastal Margin Observation and Prediction (OCE-0424602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALABASTER JS, 1988, J FISH BIOL, V32, P635, DOI 10.1111/j.1095-8649.1988.tb05402.x; Armstrong DA, 2003, ESTUARIES, V26, P1174, DOI 10.1007/BF02803372; Banas NS, 2007, MAR ECOL PROG SER, V341, P123, DOI 10.3354/meps341123; Beeman JW, 2006, T AM FISH SOC, V135, P584, DOI 10.1577/T05-193.1; Bernatis JL, 2007, MAR BIOL, V150, P941, DOI 10.1007/s00227-006-0392-3; BIRTWELL IK, 1989, HYDROBIOLOGIA, V188, P543, DOI 10.1007/BF00027822; BIRTWELL IK, 1989, CAN TECH REP FISH AQ, V1695; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Breitburg DL, 1997, ECOL MONOGR, V67, P489, DOI 10.1890/0012-9615(1997)067[0489:VEOLDO]2.0.CO;2; Bricker S, 2007, NOAA COASTAL OCEAN P, V26; Bricker SB, 2003, ECOL MODEL, V169, P39, DOI 10.1016/S0304-3800(03)00199-6; Bruland KW, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004702; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Colbert D, 2003, ESTUARIES, V26, P1205, DOI 10.1007/BF02803625; Collis K, 2001, T AM FISH SOC, V130, P385, DOI 10.1577/1548-8659(2001)130<0385:CWPOJS>2.0.CO;2; Curtis DL, 2010, MAR BIOL, V157, P603, DOI 10.1007/s00227-009-1345-4; DAHLBERG ML, 1968, J FISH RES BOARD CAN, V25, P49, DOI 10.1139/f68-005; DAUBLE DD, 1989, FISH B-NOAA, V87, P775; DAVIS GERALD E., 1963, TRANS AMER FISH SOC, V92, P111, DOI 10.1577/1548-8659(1963)92[111:TIOOCO]2.0.CO;2; DAVIS JC, 1975, J FISH RES BOARD CAN, V32, P2295, DOI 10.1139/f75-268; DEANGELIS MA, 1985, ESTUAR COAST SHELF S, V20, P375, DOI 10.1016/0272-7714(85)90082-4; Deutsch C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023190; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Diaz RJ, 2009, FISH PHYSIOL, V27, P1, DOI 10.1016/S1546-5098(08)00001-0; *ENV PROT AG, 1986, 440586003 EPA; *ENV PROT AG, 2000, EPA822R00012; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Freeland HJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016663; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; HAERTEL L, 1969, ECOLOGY, V50, P962, DOI 10.2307/1936889; Hales B, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002517; Hauri C, 2009, OCEANOGRAPHY, V22, P60, DOI 10.5670/oceanog.2009.97; Hazen EL, 2009, MAR ECOL PROG SER, V375, P195, DOI 10.3354/meps07791; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Herfort L, 2011, AQUAT MICROB ECOL, V62, P85, DOI 10.3354/ame01460; Hickey B. M., 1989, COASTAL OCEANOGRAPHY, P41, DOI DOI 10.1016/S0422-9894(08)70346-5; Hickey BM, 2003, ESTUARIES, V26, P1010, DOI 10.1007/BF02803360; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; JARVI T, 1989, ENVIRON BIOL FISH, V26, P149, DOI 10.1007/BF00001031; JAY DA, 1990, PROG OCEANOGR, V25, P81, DOI 10.1016/0079-6611(90)90004-L; Kaplan DM, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005382; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Kennedy BM, 2007, CAN J FISH AQUAT SCI, V64, P1506, DOI 10.1139/F07-117; KRAMER DL, 1987, ENVIRON BIOL FISH, V18, P81, DOI 10.1007/BF00002597; Lohan MC, 2008, ENVIRON SCI TECHNOL, V42, P6462, DOI 10.1021/es800144j; Ludsin SA, 2009, J EXP MAR BIOL ECOL, V381, pS121, DOI 10.1016/j.jembe.2009.07.016; Mcgaw IJ, 1999, BIOL BULL-US, V196, P163, DOI 10.2307/1542562; MESA MG, 1994, T AM FISH SOC, V123, P786, DOI 10.1577/1548-8659(1994)123<0786:EOMASO>2.3.CO;2; Nezlin NP, 2009, ESTUAR COAST SHELF S, V82, P139, DOI 10.1016/j.ecss.2009.01.004; PAULMIER A, 2009, PROG OCEANOGR, V80, P113, DOI DOI 10.1016/J.POCEAN.2008.08.001; Prahl FG, 1998, HYDROBIOLOGIA, V361, P37; Price CS, 2003, CAN J FISH AQUAT SCI, V60, P910, DOI [10.1139/f03-080, 10.1139/F03-080]; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Roby DD, 2003, CAN J ZOOL, V81, P250, DOI 10.1139/Z02-242; Roegner GC, 2007, MAR ECOL PROG SER, V351, P177, DOI 10.3354/meps07130; Roegner GC, 2003, ESTUARIES, V26, P1058; Roegner GC, 2002, LIMNOL OCEANOGR, V47, P1033; Roegner GC, 2001, ESTUARIES, V24, P244, DOI 10.2307/1352948; ROEGNER GC, 2010, ESTUAR COASTS; Ryan BA, 2003, T AM FISH SOC, V132, P275, DOI 10.1577/1548-8659(2003)132<0275:RVTAPO>2.0.CO;2; Seitz RD, 2003, MAR ECOL PROG SER, V257, P179, DOI 10.3354/meps257179; Sigleo AC, 2005, ESTUAR COAST SHELF S, V64, P211, DOI 10.1016/j.ecss.2005.02.018; Stone RP, 2001, MAR ECOL PROG SER, V214, P167, DOI 10.3354/meps214167; STRAMMA L, 2010, DEEP SEA RES 1; SUGARMAN PC, 1983, ESTUARIES, V6, P380, DOI 10.2307/1351397; Sullivan BE, 2001, GEOCHIM COSMOCHIM AC, V65, P1125, DOI 10.1016/S0016-7037(00)00565-2; Takahashi T, 2009, J OCEANOGR, V65, P113, DOI 10.1007/s10872-009-0011-2; Tyler RM, 2007, MAR ECOL PROG SER, V333, P257, DOI 10.3354/meps333257; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; VARGO SL, 1977, MAR BIOL, V40, P165, DOI 10.1007/BF00396263; WARREN CE, 1973, EPAR373019; *WASH STAT DEP EC, 2006, PUBL WASH STAT DEP E; Webster SJ, 2007, J FISH BIOL, V71, P842, DOI 10.1111/j.1095-8649.2007.01553.x; Wheeler PA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017395; WHITMORE CECIL M., 1960, TRANS AMER FISH SOC, V89, P17, DOI 10.1577/1548-8659(1960)89[17:AROSAC]2.0.CO;2; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007	78	46	46	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18672	10.1371/journal.pone.0018672	http://dx.doi.org/10.1371/journal.pone.0018672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533083	Green Published, Green Submitted, gold			2022-12-25	WOS:000289719400018
J	Schlatter, R; Schmich, K; Lutz, A; Trefzger, J; Sawodny, O; Ederer, M; Merfort, I				Schlatter, Rebekka; Schmich, Kathrin; Lutz, Anna; Trefzger, Judith; Sawodny, Oliver; Ederer, Michael; Merfort, Irmgard			Modeling the TNF alpha-Induced Apoptosis Pathway in Hepatocytes	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; JNK ACTIVATION; CELL-DEATH; MEDIATED APOPTOSIS; SYSTEMS BIOLOGY; LIVER-INJURY; CASPASE-8 ACTIVATION; MATHEMATICAL-MODEL; SIGNALING PATHWAY	The proinflammatory cytokine TNF alpha fails to provoke cell death in isolated hepatocytes but has been implicated in hepatocyte apoptosis during liver diseases associated with chronic inflammation. Recently, we showed that TNF alpha is able to sensitize primary murine hepatocytes cultured on collagen to Fas ligand-induced apoptosis and presented a mathematical model of the sensitizing effect. Here, we analyze how TNF alpha induces apoptosis in combination with the transcriptional inhibitor actinomycin D (ActD). Accumulation of reactive oxygen species ( ROS) in response to TNFR activation turns out to be critical for sustained activation of JNK which then triggers mitochondrial pathway-dependent apoptosis. In addition, the amount of JNK is strongly upregulated in a ROS-dependent way. In contrast to TNF alpha plus cycloheximide no cFLIP degradation is observed suggesting a different apoptosis pathway in which the Itch-mediated cFLIP degradation and predominantly caspase-8 activation is not involved. Time-resolved data of the respective pro-and antiapoptotic factors are obtained and subjected to mathematical modeling. On the basis of these data we developed a mathematical model which reproduces the complex interplay regulating the phosphorylation status of JNK and generation of ROS. This model was fully integrated with our model of TNF alpha/Fas ligand sensitizing as well as with a published NF-kappa B-model. The resulting comprehensive model delivers insight in the dynamical interplay between the TNF alpha and FasL pathways, NF-kappa B and ROS and gives an example for successful model integration.	[Schlatter, Rebekka; Sawodny, Oliver; Ederer, Michael] Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany; [Schmich, Kathrin; Lutz, Anna; Trefzger, Judith; Merfort, Irmgard] Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, Freiburg, Germany	University of Stuttgart; University of Freiburg	Schlatter, R (corresponding author), Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany.	michael.ederer@isys.uni-stuttgart.de; irmgard.merfort@pharmazie.uni-freiburg.de			BMBF	BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the BMBF (http://www.bmbf.de/) research grant Virtual Liver (RS, KS, AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen XY, 2007, MOL CELL BIOL, V27, P541, DOI 10.1128/MCB.01166-06; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cho KH, 2003, GENOME RES, V13, P2413, DOI 10.1101/gr.1195703; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dussmann H, 2010, CELL DEATH DIFFER, V17, P278, DOI 10.1038/cdd.2009.123; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Harrington HA, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-26; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kiessling MK, 2010, FEBS LETT, V584, P4679, DOI 10.1016/j.febslet.2010.10.047; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Krause F, 2010, BIOINFORMATICS, V26, P421, DOI 10.1093/bioinformatics/btp642; Lavrik IN, 2010, CURR OPIN BIOTECH, V21, P551, DOI 10.1016/j.copbio.2010.07.001; Lavrik IN, 2009, MOL BIOSYST, V5, P1105, DOI 10.1039/b905129p; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; OYAMA Y, 1994, BRAIN RES, V635, P113, DOI 10.1016/0006-8993(94)91429-X; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Papa S, 2009, BIOL CHEM, V390, P965, DOI 10.1515/BC.2009.111; Park SG, 2006, FEBS LETT, V580, P822, DOI 10.1016/j.febslet.2006.01.004; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Rangamani P, 2007, BIOTECHNOL BIOENG, V97, P1216, DOI 10.1002/bit.21307; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schmich K, 2011, HEPATOLOGY, V53, P282, DOI 10.1002/hep.23987; Schmidt C, 2009, J ETHNOPHARMACOL, V122, P523, DOI 10.1016/j.jep.2009.01.022; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Stucki JW, 2005, J THEOR BIOL, V234, P123, DOI 10.1016/j.jtbi.2004.11.011; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; TRAYNER ID, 1995, J IMMUNOL METHODS, V186, P275, DOI 10.1016/0022-1759(95)00152-Z; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walter D, 2008, HEPATOLOGY, V48, P1942, DOI 10.1002/hep.22541; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Witt J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-71; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Yan H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-50; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou LF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000657	63	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18646	10.1371/journal.pone.0018646	http://dx.doi.org/10.1371/journal.pone.0018646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533085	Green Submitted, gold, Green Published			2022-12-25	WOS:000289719400017
J	Chen, ZH; Zhu, YZ; Ren, YL; Tong, YM; Hua, X; Zhu, FH; Huang, LB; Liu, Y; Luo, Y; Lu, W; Zhao, P; Qi, ZT				Chen, Zhihui; Zhu, Yongzhe; Ren, Yanli; Tong, Yimin; Hua, Xian; Zhu, Fenghui; Huang, Libin; Liu, Yuan; Luo, Yuan; Lu, Wei; Zhao, Ping; Qi, Zhongtian			Hepatitis C Virus Protects Human B Lymphocytes from Fas-Mediated Apoptosis via E2-CD81 Engagement	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; MIXED CRYOGLOBULINEMIA; T-CELLS; COSTIMULATORY SIGNAL; IMMUNOGLOBULIN GENE; INFECTED PATIENTS; E2 GLYCOPROTEIN; HCV INFECTION; VIRAL ENTRY; KAPPA-B	HCV infection is often associated with B-cell regulatory control disturbance and delayed appearance of neutralizing antibodies. CD81 is a cellular receptor for HCV and can bind to HCV envelope protein 2 (E2). CD81 also participates to form a B cell costimulatory complex. To investigate whether HCV influences B cell activation and immune function through E2 CD81 engagement, here, human Burkitt's lymphoma cell line Raji cells and primary human B lymphocytes (PHB) were treated with HCV E2 protein and cell culture produced HCV particles (HCVcc), and then the related cell phenotypes were assayed. The results showed that both E2 and HCVcc triggered phosphorylation of IkBa, enhanced the expression of antiapoptosis Bcl-2 family proteins, and protected Raji cells and PHB cells from Fas-mediated death. In addition, both E2 protein and HCVcc increased the expression of costimulatory molecules CD80, CD86 and CD81 itself, and decreased the expression of complement receptor CD21. The effects were dependent on E2-CD81 interaction on the cell surface, since CD81-silenced Raji cells did not respond to both treatments; and an E2 mutant that lose the CD81 binding activity, could not trigger the responses of both Raji cells and PHB cells. The effects were not associated with HCV replication in cells, for HCV pseudoparticle (HCVpp) and HCVcc failed to infect Raji cells. Hence, E2-CD81 engagement may contribute to HCV-associated B cell lymphoproliferative disorders and insufficient neutralizing antibody production.	[Chen, Zhihui; Zhu, Yongzhe; Ren, Yanli; Tong, Yimin; Hua, Xian; Zhu, Fenghui; Huang, Libin; Liu, Yuan; Luo, Yuan; Zhao, Ping; Qi, Zhongtian] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China; [Chen, Zhihui] Second Mil Med Univ, Affiliated Changhai Hosp, Dept Infect Dis, Shanghai, Peoples R China; [Lu, Wei] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Chen, ZH (corresponding author), Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China.	pnzhao@163.com; qizt@smmu.edu.cn			973 Programme of China [2009CB522501, 2009CB522503]; Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases [2008ZX10002-013]; Natural Science Foundation of China [81071364, 30901348]; New Drugs Creation Special Projects of China [2009ZX09103-688]; Shanghai LAD [B901]	973 Programme of China(National Basic Research Program of China); Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Drugs Creation Special Projects of China; Shanghai LAD	This work was supported by research grants from 973 Programme of China (2009CB522501 and 2009CB522503), Important National Science and Technology Special Projects for Prevention and Treatment of Major Infectious Diseases (2008ZX10002-013), Natural Science Foundation of China (81071364, 30901348) and New Drugs Creation Special Projects of China (2009ZX09103-688), and Shanghai LAD Project (B901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2002, ARCH IMMUNOL THER EX, V50, P307; Bando M, 2003, J BIOL CHEM, V278, P5786, DOI 10.1074/jbc.M204178200; Bare P, 2005, J GEN VIROL, V86, P1717, DOI 10.1099/vir.0.80882-0; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bernardin F, 2008, HEPATOLOGY, V47, P1446, DOI 10.1002/hep.22184; Bukh J, 2008, J VIROL, V82, P8183, DOI 10.1128/JVI.00142-08; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Casato M, 2002, BLOOD, V99, P2259, DOI 10.1182/blood.V99.6.2259; Chang LL, 2007, ANTIVIR RES, V75, P43, DOI 10.1016/j.antiviral.2006.11.009; Cheng WC, 2006, ONCOGENE, V25, P4697, DOI 10.1038/sj.onc.1209596; Cocquerel L, 2003, J VIROL, V77, P10677, DOI 10.1128/JVI.77.19.10677-10683.2003; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; Crotta S, 2006, EUR J IMMUNOL, V36, P919, DOI 10.1002/eji.200535527; Ding H, 2008, HEPAT MON, V8, P267; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Flint M, 2000, J VIROL, V74, P702, DOI 10.1128/JVI.74.2.702-709.2000; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Haberstroh A, 2008, GASTROENTEROLOGY, V135, P1719, DOI 10.1053/j.gastro.2008.07.018; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Hinshaw JA, 2003, EUR J IMMUNOL, V33, P2490, DOI 10.1002/eji.200323194; Hu Y, 2003, AM J CLIN PATHOL, V119, P95, DOI 10.1309/33TAJLB748KLMXVG; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Komurian-Pradel F, 2004, J VIROL METHODS, V116, P103, DOI 10.1016/j.jviromet.2003.10.004; Kondo Y, 2009, J INFECT DIS, V199, P726, DOI 10.1086/596739; Laporte J, 2003, BLOOD, V101, P52, DOI 10.1182/blood-2002-03-0818; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Lucas M, 2003, J GEN VIROL, V84, P545, DOI 10.1099/vir.0.18775-0; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Masilamani M, 2003, EUR J IMMUNOL, V33, P2391, DOI 10.1002/eji.200323843; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Mizuochi T, 2011, VIRUS RES, V155, P349, DOI 10.1016/j.virusres.2010.09.017; Mongini PKA, 2003, J IMMUNOL, V171, P5244, DOI 10.4049/jimmunol.171.10.5244; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Saadoun D, 2006, ARTHRITIS RHEUM-US, V54, P3696, DOI 10.1002/art.22168; Sansonno D, 2007, CLIN EXP IMMUNOL, V147, P241, DOI 10.1111/j.1365-2249.2006.03272.x; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simula MP, 2007, ANN NY ACAD SCI, V1110, P121, DOI 10.1196/annals.1423.014; Soldaini E, 2003, EUR J IMMUNOL, V33, P455, DOI 10.1002/immu.200310021; Stamataki Z, 2008, CLIN LIVER DIS, V12, P693, DOI 10.1016/j.cld.2008.03.008; Sugalski JM, 2010, J IMMUNOL, V185, P3019, DOI 10.4049/jimmunol.1000879; Sung VMH, 2003, J VIROL, V77, P2134, DOI 10.1128/JVI.77.3.2134-2146.2003; Tardif MR, 2005, J VIROL, V79, P4316, DOI 10.1128/JVI.79.7.4316-4328.2005; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Wack A, 2001, EUR J IMMUNOL, V31, P166, DOI 10.1002/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO;2-L; Weng WK, 2003, LEUKEMIA LYMPHOMA, V44, P1113, DOI 10.1080/1042819031000076972; Zehender G, 1997, J INFECT DIS, V176, P1209, DOI 10.1086/514114; Zignego AL, 2002, ANN INTERN MED, V137, P571, DOI 10.7326/0003-4819-137-7-200210010-00008; Zuckerman E, 2001, BRIT J HAEMATOL, V112, P364, DOI 10.1046/j.1365-2141.2001.02573.x; Zuckerman E, 2002, CLIN EXP IMMUNOL, V128, P353, DOI 10.1046/j.1365-2249.2002.01844.x	59	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18933	10.1371/journal.pone.0018933	http://dx.doi.org/10.1371/journal.pone.0018933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526201	gold, Green Submitted, Green Published			2022-12-25	WOS:000289671100038
J	Lu, TZ; Feng, ZP				Lu, Tom Z.; Feng, Zhong-Ping			A Sodium Leak Current Regulates Pacemaker Activity of Adult Central Pattern Generator Neurons in Lymnaea Stagnalis	PLOS ONE			English	Article							RESPIRATORY RHYTHM GENERATION; PRE-BOTZINGER COMPLEX; IN-VITRO; SMALL-CONDUCTANCE; CALCIUM-CHANNELS; PERSISTENT NA+; IONIC CURRENTS; MODULATION; BEHAVIOR; NETWORK	The resting membrane potential of the pacemaker neurons is one of the essential mechanisms underlying rhythm generation. In this study, we described the biophysical properties of an uncharacterized channel (U-type channel) and investigated the role of the channel in the rhythmic activity of a respiratory pacemaker neuron and the respiratory behaviour in adult freshwater snail Lymnaea stagnalis. Our results show that the channel conducts an inward leak current carried by Na(+) (I(Leak-Na)). The I(Leak-Na) contributed to the resting membrane potential and was required for maintaining rhythmic action potential bursting activity of the identified pacemaker RPeD1 neurons. Partial knockdown of the U-type channel suppressed the aerial respiratory behaviour of the adult snail in vivo. These findings identified the Na(+) leak conductance via the U-type channel, likely a NALCN-like channel, as one of the fundamental mechanisms regulating rhythm activity of pacemaker neurons and respiratory behaviour in adult animals.	[Lu, Tom Z.; Feng, Zhong-Ping] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Lu, TZ (corresponding author), Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada.	zp.feng@utoronto.ca			National Sciences and Engineering Research Council of Canada [NSERC-249962-09]; Heart and Stroke Foundation of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The work was supported by an operating grant to ZPF from the National Sciences and Engineering Research Council of Canada (NSERC-249962-09). TZL is a recipient of a Graduate Studentship of Natural Sciences and Engineering Research Council of Canada; ZPF holds a New Investigator Award from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Coumoul X, 2006, BIOCHIMIE, V88, P637, DOI 10.1016/j.biochi.2005.11.010; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; Dickinson PS, 2006, CURR OPIN NEUROBIOL, V16, P604, DOI 10.1016/j.conb.2006.10.007; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Fei GH, 2007, J NEUROCHEM, V100, P50, DOI 10.1111/j.1471-4159.2006.04194.x; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Feng ZP, 1997, J NEUROSCI, V17, P7839; Feng ZP, 2002, J PHYSIOL-LONDON, V539, P53, DOI 10.1113/jphysiol.2001.013125; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Guo CH, 2010, BEHAV GENET, V40, P680, DOI 10.1007/s10519-010-9374-9; Hallworth NE, 2003, J NEUROSCI, V23, P7525; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; HODGKIN AL, 1947, J PHYSIOL-LONDON, V106, P341, DOI 10.1113/jphysiol.1947.sp004216; Hui K, 2007, DEVELOPMENT, V134, P4479, DOI 10.1242/dev.008979; JONES JD, 1961, COMP BIOCHEM PHYSIOL, V4, P1, DOI 10.1016/0010-406X(61)90042-1; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; KANDEL E. R., 1977, CELLULAR BASIS BEHAV; KEYNES RD, 1951, J PHYSIOL-LONDON, V114, P119, DOI 10.1113/jphysiol.1951.sp004608; Koizumi H, 2008, J NEUROSCI, V28, P1773, DOI 10.1523/JNEUROSCI.3916-07.2008; Korneev SA, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0003.2002; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; LU TZ, 2009, SOC NEUR 39 ANN M; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Onimaru H, 1997, JPN J PHYSIOL, V47, P385, DOI 10.2170/jjphysiol.47.385; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Raman IM, 2000, J NEUROSCI, V20, P9004; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Sipila ST, 2006, EUR J NEUROSCI, V23, P2330, DOI 10.1111/j.1460-9568.2006.04757.x; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Spencer GE, 1999, J NEUROSCI, V19, P1836; Staras K, 2002, EUR J NEUROSCI, V15, P109, DOI 10.1046/j.0953-816x.2001.01845.x; Swayne LA, 2009, EMBO REP, V10, P873, DOI 10.1038/embor.2009.125; SYED NI, 1991, J COMP PHYSIOL A, V169, P541; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Taylor BE, 2000, RESP PHYSIOL, V122, P197, DOI 10.1016/S0034-5687(00)00159-6; Tazerart S, 2008, J NEUROSCI, V28, P8577, DOI 10.1523/JNEUROSCI.1437-08.2008; Thoby-Brisson M, 2000, J NEUROSCI, V20, P5858, DOI 10.1523/JNEUROSCI.20-15-05858.2000; Tryba AK, 2004, J NEUROBIOL, V60, P481, DOI 10.1002/neu.20050; van Diepen MT, 2005, MOL CELL NEUROSCI, V29, P74, DOI 10.1016/j.mcn.2005.01.005; VANDEN TM, 2003, J PHYSL, V549, P809; WINLOW W, 1992, ACTA BIOL HUNG, V43, P399; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Yeh E, 2008, PLOS BIOL, V6, P552, DOI 10.1371/journal.pbio.0060055; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644	53	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18745	10.1371/journal.pone.0018745	http://dx.doi.org/10.1371/journal.pone.0018745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526173	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100016
J	Pettingill, LN; Wise, AK; Geaney, MS; Shepherd, RK				Pettingill, Lisa N.; Wise, Andrew K.; Geaney, Marilyn S.; Shepherd, Robert K.			Enhanced Auditory Neuron Survival Following Cell-Based BDNF Treatment in the Deaf Guinea Pig	PLOS ONE			English	Article							SPIRAL-GANGLION NEURONS; SENSORINEURAL HEARING-LOSS; ROUND WINDOW MEMBRANE; NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; RAT INNER-EAR; NEUROTROPHIC FACTOR; SCHWANN-CELLS; ELECTRICAL-STIMULATION; DRUG-DELIVERY	Exogenous neurotrophin delivery to the deaf cochlea can prevent deafness-induced auditory neuron degeneration, however, we have previously reported that these survival effects are rapidly lost if the treatment stops. In addition, there are concerns that current experimental techniques are not safe enough to be used clinically. Therefore, for such treatments to be clinically transferable, methods of neurotrophin treatment that are safe, biocompatible and can support long-term auditory neuron survival are necessary. Cell transplantation and gene transfer, combined with encapsulation technologies, have the potential to address these issues. This study investigated the survival-promoting effects of encapsulated BDNF over-expressing Schwann cells on auditory neurons in the deaf guinea pig. In comparison to control (empty) capsules, there was significantly greater auditory neuron survival following the cell-based BDNF treatment. Concurrent use of a cochlear implant is expected to result in even greater auditory neuron survival, and provide a clinically relevant method to support auditory neuron survival that may lead to improved speech perception and language outcomes for cochlear implant patients.	[Pettingill, Lisa N.; Wise, Andrew K.; Shepherd, Robert K.] Bion Ear Inst, Melbourne, Vic, Australia; [Wise, Andrew K.; Shepherd, Robert K.] Univ Melbourne, Dept Otolaryngol, Parkville, Vic 3052, Australia; [Geaney, Marilyn S.] Living Cell Technol Ltd, Auckland, New Zealand	University of Melbourne	Pettingill, LN (corresponding author), Bion Ear Inst, Melbourne, Vic, Australia.	lpettingill@bionicear.org	Wise, Andrew/B-5943-2014; Shepherd, Robert/I-6276-2012; Shepherd, Robert/G-1332-2013	Wise, Andrew/0000-0001-9715-8784; Shepherd, Robert/0000-0002-4239-3362	The Macquarie Bank Foundation; Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council of Australia; State Government of Victoria Operational Infrastructure Program; National Institutes of Health [HHS-N-263-2007-00053-C]; Living Cell Technologies, Limited (LCT)	The Macquarie Bank Foundation; Garnett Passe and Rodney Williams Memorial Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); State Government of Victoria Operational Infrastructure Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Living Cell Technologies, Limited (LCT)	Funding for this research was provided by: The Macquarie Bank Foundation, The Garnett Passe and Rodney Williams Memorial Foundation, The National Health and Medical Research Council of Australia, The State Government of Victoria Operational Infrastructure Program, The National Institutes of Health (HHS-N-263-2007-00053-C) and Living Cell Technologies, Limited (LCT). MSG is employed by LCT and played a role in the cell encapsulation aspects of the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Blesch A, 2003, J COMP NEUROL, V467, P403, DOI 10.1002/cne.10934; Blits B, 2005, RESTOR NEUROL NEUROS, V23, P313; Brigadski T, 2005, J NEUROSCI, V25, P7601, DOI 10.1523/JNEUROSCI.1776-05.2005; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chen ZQ, 2005, J CONTROL RELEASE, V110, P1, DOI 10.1016/j.jconrel.2005.09.003; Chikar JA, 2008, HEARING RES, V245, P24, DOI 10.1016/j.heares.2008.08.005; Coleman B, 2006, CELL TRANSPLANT, V15, P369, DOI 10.3727/000000006783981819; Cureoglu S, 2005, ACTA OTO-LARYNGOL, V125, P9, DOI 10.1080/00016480410022534; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; Ernfors P, 1996, NAT MED, V2, P463, DOI 10.1038/nm0496-463; Fiering J, 2009, BIOMED MICRODEVICES, V11, P571, DOI 10.1007/s10544-008-9265-5; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Gillespie LN, 2004, NEUROREPORT, V15, P1121, DOI 10.1097/00001756-200405190-00008; Gillespie LN, 2005, EUR J NEUROSCI, V22, P2123, DOI 10.1111/j.1460-9568.2005.04430.x; Girard C, 2005, J NEUROSCI, V25, P7924, DOI 10.1523/JNEUROSCI.4890-04.2005; Golden KL, 2007, EXP NEUROL, V207, P203, DOI 10.1016/j.expneurol.2007.06.023; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Haubensak W, 1998, J CELL SCI, V111, P1483; Hu Y, 2005, MOL THER, V11, P906, DOI 10.1016/j.ymthe.2005.01.016; Kanzaki S, 2002, J COMP NEUROL, V454, P350, DOI 10.1002/cne.10480; Lalwani AK, 1997, HEARING RES, V114, P139, DOI 10.1016/S0378-5955(97)00151-2; Makar TK, 2009, J NEUROIMMUNOL, V210, P40, DOI 10.1016/j.jneuroim.2009.02.017; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50; Miller JM, 1997, INT J DEV NEUROSCI, V15, P631, DOI 10.1016/S0736-5748(96)00117-7; MONTERO CN, 1988, J NEUROSCI, V8, P2986; Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010; Nakaizumi T, 2004, AUDIOL NEURO-OTOL, V9, P135, DOI 10.1159/000077264; Noushi F, 2005, OTOL NEUROTOL, V26, P528, DOI 10.1097/01.mao.0000169780.84588.a5; Pettingill LN, 2008, NEUROSCIENCE, V152, P821, DOI 10.1016/j.neuroscience.2007.11.057; Pettingill LN, 2007, IEEE T BIO-MED ENG, V54, P1138, DOI 10.1109/TBME.2007.895375; PIRVOLA U, 1994, HEARING RES, V75, P131, DOI 10.1016/0378-5955(94)90064-7; Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010; Richardson RT, 2008, EXPERT OPIN DRUG DEL, V5, P1059, DOI 10.1517/17425247.5.10.1059 ; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; SAIJO S, 1984, ACTA OTO-LARYNGOL, V97, P593, DOI 10.3109/00016488409132937; Salt AN, 2001, HEARING RES, V154, P88, DOI 10.1016/S0378-5955(01)00223-4; SALT AN, 2010, COCHLEAR FLUIDS VOLU; SCHECTERSON LC, 1994, HEARING RES, V73, P92, DOI 10.1016/0378-5955(94)90286-0; Shepherd RK, 2005, J COMP NEUROL, V486, P145, DOI 10.1002/cne.20564; Shepherd RK, 2008, HEARING RES, V242, P100, DOI 10.1016/j.heares.2007.12.005; Shinohara T, 2002, P NATL ACAD SCI USA, V99, P1657, DOI 10.1073/pnas.032677999; Skinner SJM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065001; Staecker H, 1996, NEUROREPORT, V7, P889, DOI 10.1097/00001756-199603220-00011; Staecker H, 1998, OTOLARYNG HEAD NECK, V119, P7, DOI 10.1016/S0194-5998(98)70194-9; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Stover T, 2000, GENE THER, V7, P377, DOI 10.1038/sj.gt.3301108; Tan J, 2006, AM J PATHOL, V169, P528, DOI 10.2353/ajpath.2006.060122; Thanos Christopher G, 2008, Recent Pat Drug Deliv Formul, V2, P19, DOI 10.2174/187221108783331384; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138; Winn SR, 1996, EXP NEUROL, V140, P126, DOI 10.1006/exnr.1996.0123; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; Yagi M, 2000, JARO-J ASSOC RES OTO, V1, P315, DOI 10.1007/s101620010011; Yamagata T, 2004, J NEUROSCI RES, V78, P75, DOI 10.1002/jnr.20239; YLIKOSKI J, 1993, HEARING RES, V65, P69, DOI 10.1016/0378-5955(93)90202-C; Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1	62	61	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18733	10.1371/journal.pone.0018733	http://dx.doi.org/10.1371/journal.pone.0018733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525998	Green Published, gold, Green Submitted			2022-12-25	WOS:000289578600025
J	Shan, TL; Lan, DL; Li, LL; Wang, CM; Cui, L; Zhang, W; Hua, XG; Zhu, CX; Zhao, W; Delwart, E				Shan, Tongling; Lan, Daoliang; Li, Linlin; Wang, Chunmei; Cui, Li; Zhang, Wen; Hua, Xiuguo; Zhu, Caixia; Zhao, Wei; Delwart, Eric			Genomic Characterization and High Prevalence of Bocaviruses in Swine	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; INFECTION; IDENTIFICATION; PARVOVIRUS; VIRUS; CARDIOVIRUSES; PICORNAVIRUS; DISCOVERY; DIVERSE; CLONING	Using random PCR amplification followed by plasmid subcloning and DNA sequencing, we detected bocavirus related sequences in 9 out of 17 porcine stool samples. Using primer walking, we sequenced the nearly complete genomes of two highly divergent bocaviruses we provisionally named porcine bocavirus 1 isolate H18 (PBoV1-H18) and porcine bocavirus 2 isolate A6 (PBoV2-A6) which differed by 51.8% in their NS1 protein. Phylogenetic analysis indicated that PBoV1-H18 was very closely related to a similar to 2 Kb central region of a porcine bocavirus-like virus (PBo-LikeV) from Sweden described in 2009. PBoV2-A6 was very closely related to the porcine bocavirus genomes PBoV-1 and PBoV2 from China described in 2010. Among 340 fecal samples collected from different age, asymptomatic swine in five Chinese provinces, the prevalence of PBoV1-H18 and PBoV2-A6 related viruses were 45-75% and 55-70% respectively, with 30-47% of pigs co-infected. PBoV1-A6 related strains were highly conserved, while PBoV2-H18 related strains were more diverse, grouping into two genotypes corresponding to the previously described PBoV1 and PBoV2. Together with the recently described partial bocavirus genomes labeled V6 and V7, a total of three major porcine bocavirus clades have therefore been described to date. Further studies will be required to elucidate the possible pathogenic impact of these diverse bocaviruses either alone or in combination with other porcine viruses.	[Shan, Tongling; Lan, Daoliang; Cui, Li; Hua, Xiuguo; Zhu, Caixia; Zhao, Wei] Shanghai Jiao Tong Univ, Zoonosis & Comparat Med Grp, Shanghai 200030, Peoples R China; [Shan, Tongling; Li, Linlin; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Shan, Tongling; Li, Linlin; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Wang, Chunmei] Huazhong Agr Univ, Coll Vet Med, Wuhan, Huibei, Peoples R China; [Zhang, Wen] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Huazhong Agricultural University; Jiangsu University	Shan, TL (corresponding author), Shanghai Jiao Tong Univ, Zoonosis & Comparat Med Grp, Shanghai 200030, Peoples R China.	hxg@sjtu.edu.cn	Shan, Tongling/AFG-8328-2022; Li, Linlin/E-3335-2010	Shan, Tongling/0000-0002-5329-6349; Delwart, Eric/0000-0002-6296-4484	Shanghai Science and Technology Committee of China [063919121]	Shanghai Science and Technology Committee of China(Shanghai Science & Technology Committee)	This work was supported by Key Project of Shanghai Science and Technology Committee of China under Grant No. 063919121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque MCM, 2007, EMERG INFECT DIS, V13, P1756, DOI 10.3201/eid1311.070671; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2007, J CLIN MICROBIOL, V45, P610, DOI 10.1128/JCM.01044-06; BINN L N, 1970, Infection and Immunity, V1, P503; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Campe H, 2008, J CLIN VIROL, V43, P340, DOI 10.1016/j.jcv.2008.07.014; Catalano-Pons C, 2007, PEDIATR INFECT DIS J, V26, P959, DOI 10.1097/INF.0b013e3181256583; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; CHEN KC, 1986, J VIROL, V60, P1085, DOI 10.1128/JVI.60.3.1085-1097.1986; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; Claude M., 2004, VIRUS TAXONOMY; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de Vries JJC, 2009, J CLIN MICROBIOL, V47, P1241, DOI 10.1128/JCM.01703-08; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gagliardi TB, 2009, EPIDEMIOL INFECT, V137, P1032, DOI 10.1017/S0950268808001842; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Holtz LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Li LL, 2009, EMERG INFECT DIS, V15, P288, DOI 10.3201/eid1502.080341; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Lipkin WI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000002; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Shan TL, 2009, J CLIN VIROL, V46, P196, DOI 10.1016/j.jcv.2009.07.012; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Zhai SL, 2010, ARCH VIROL, V155, P1313, DOI 10.1007/s00705-010-0698-9; Ziegler S, 2008, J CLIN VIROL, V43, P349, DOI 10.1016/j.jcv.2008.07.006	59	57	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e17292	10.1371/journal.pone.0017292	http://dx.doi.org/10.1371/journal.pone.0017292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525999	Green Published, gold, Green Submitted			2022-12-25	WOS:000289578600005
J	Braunstein, SL; Nash, D; Kim, AA; Ford, K; Mwambarangwe, L; Ingabire, CM; Vyankandondera, J; van de Wijgert, JHHM				Braunstein, Sarah L.; Nash, Denis; Kim, Andrea A.; Ford, Ken; Mwambarangwe, Lambert; Ingabire, Chantal M.; Vyankandondera, Joseph; van de Wijgert, Janneke H. H. M.			Dual Testing Algorithm of BED-CEIA and AxSYM Avidity Index Assays Performs Best in Identifying Recent HIV Infection in a Sample of Rwandan Sex Workers	PLOS ONE			English	Article							CAPTURE ENZYME-IMMUNOASSAY; SEROCONVERSION; SURVEILLANCE	Background: To assess the performance of BED-CEIA (BED) and AxSYM Avidity Index (Ax-AI) assays in estimating HIV incidence among female sex workers (FSW) in Kigali, Rwanda. Methodology and Findings: Eight hundred FSW of unknown HIV status were HIV tested; HIV-positive women had BED and Ax-AI testing at baseline and >= 12 months later to estimate assay false-recent rates (FRR). STARHS-based HIV incidence was estimated using the McWalter/Welte formula, and adjusted with locally derived FRR and CD4 results. HIV incidence and local assay window periods were estimated from a prospective cohort of FSW. At baseline, 190 HIV-positive women were BED and Ax-AI tested; 23 were classified as recent infection (RI). Assay FRR with 95% confidence intervals were: 3.6% (1.2-8.1) (BED); 10.6% (6.1-17.0) (Ax-AI); and 2.1% (0.4-6.1) (BED/Ax-AI combined). After FRR-adjustment, incidence estimates by BED, Ax-AI, and BED/Ax-AI were: 5.5/100 person-years (95% CI 2.2-8.7); 7.7 (3.2-12.3); and 4.4 (1.4-7.3). After CD4-adjustment, BED, Ax-AI, and BED/Ax-AI incidence estimates were: 5.6 (2.6-8.6); 9.7 (5.0-14.4); and 4.7 (2.0-7.5). HIV incidence rates in the first and second 6 months of the cohort were 4.6 (1.6-7.7) and 2.2 (0.1-4.4). Conclusions: Adjusted incidence estimates by BED/Ax-AI combined were similar to incidence in the first 6 months of the cohort. Furthermore, false-recent rate on the combined BED/Ax-AI algorithm was low and substantially lower than for either assay alone. Improved assay specificity with time since seroconversion suggests that specificity would be higher in population-based testing where more individuals have long-term infection.	[Braunstein, Sarah L.; Nash, Denis] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Kim, Andrea A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Ford, Ken; Mwambarangwe, Lambert; Ingabire, Chantal M.; Vyankandondera, Joseph; van de Wijgert, Janneke H. H. M.] Projet Ubuzima, Kigali, Rwanda; [Vyankandondera, Joseph] Belgian Dev Agcy, Kigali, Rwanda; [van de Wijgert, Janneke H. H. M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [van de Wijgert, Janneke H. H. M.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	Columbia University; Centers for Disease Control & Prevention - USA; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Braunstein, SL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.	braunstein.sarah@gmail.com	Nash, Denis/AFI-7485-2022	van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Nash, Denis/0000-0002-3280-5386	International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP); United States Centers for Disease Control and Prevention; US National Institutes of Health	International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP); United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by International Partnership for Microbicides, Inc.; European and Developing Countries Clinical Trials Partnership (EDCTP); United States Centers for Disease Control and Prevention; and US National Institutes of Health-Institutional Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Blackwelder W C, 2004, J Dent Res, V83 Spec No C, pC113; Brookmeyer R, 2009, AIDS, V23, P2066, DOI 10.1097/QAD.0b013e32832f3dbb; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Calypte Biomedical Corporation, 2005, CAL HIV 1 BED INC EI; CDC, 2006, INT REC US BED CAPT; Chawla A, 2007, J CLIN MICROBIOL, V45, P415, DOI 10.1128/JCM.01879-06; Constantine NT, 2003, JAIDS-J ACQ IMM DEF, V32, P94, DOI 10.1097/00126334-200301010-00014; Dieltjens T, 2009, AIDS RES HUM RETROV, V25, P1165, DOI 10.1089/aid.2008.0161; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hargrove JW, 2009, AIDS, V23, P2061, DOI 10.1097/QAD.0b013e32832f3d8b; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Martro E, 2005, J CLIN MICROBIOL, V43, P6197, DOI 10.1128/JCM.43.12.6197-6199.2005; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McDougal JS, 2009, AIDS, V23, P2064, DOI 10.1097/QAD.0b013e32832eff6e; McDougal JS, 2005, AIDS, V19, pS25, DOI 10.1097/01.aids.0000172874.90133.7a; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; MURPHY G, 2004, INT AIDS C; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parekh BS, 2001, AIDS REV, V3, P183; PAREKH BS, 2010, AIDS RES HUM RETROVI; Rutherford GW, 2000, J ACQ IMMUN DEF SYND, V25, pS115, DOI 10.1097/00126334-200012152-00005; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; *UNAIDS, 2008, EP FACT SHEET RWAND; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Welte A, 2009, AIDS, V23, P2062, DOI 10.1097/QAD.0b013e32832eff59; *WHO, 2009, P M DEV ASS EST HIV; Yang OO, 2005, J VIROL, V79, P860, DOI 10.1128/JVI.79.2.860-868.2005	35	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18402	10.1371/journal.pone.0018402	http://dx.doi.org/10.1371/journal.pone.0018402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532753	Green Published, gold			2022-12-25	WOS:000289404700012
J	Martin, R; Moran, GP; Jacobsen, ID; Heyken, A; Domey, J; Sullivan, DJ; Kurzai, O; Hube, B				Martin, Ronny; Moran, Gary P.; Jacobsen, Ilse D.; Heyken, Antje; Domey, Jenny; Sullivan, Derek J.; Kurzai, Oliver; Hube, Bernhard			The Candida albicans-Specific Gene EED1 Encodes a Key Regulator of Hyphal Extension	PLOS ONE			English	Article							FILAMENTOUS GROWTH; TRANSCRIPTIONAL REGULATOR; MORPHOGENESIS; EXPRESSION; PHOSPHORYLATION; CYCLIN; YEAST; EFG1; UME6; INTERNALIZATION	The extension of germ tubes into elongated hyphae by Candida albicans is essential for damage of host cells. The C. albicans-specific gene EED1 plays a crucial role in this extension and maintenance of filamentous growth. eed1 Delta cells failed to extend germ tubes into long filaments and switched back to yeast growth after 3 h of incubation during growth on plastic surfaces. Expression of EED1 is regulated by the transcription factor Efg1 and ectopic overexpression of EED1 restored filamentation in efg1 Delta. Transcriptional profiling of eed1 Delta during infection of oral tissue revealed down-regulation of hyphal associated genes including UME6, encoding another key transcriptional factor. Ectopic overexpression of EED1 or UME6 rescued filamentation and damage potential in eed1 Delta. Transcriptional profiling during overexpression of UME6 identified subsets of genes regulated by Eed1 or Ume6. These data suggest that Eed1 and Ume6 act in a pathway regulating maintenance of hyphal growth thereby repressing hyphal-to-yeast transition and permitting dissemination of C. albicans within epithelial tissues.	[Martin, Ronny; Jacobsen, Ilse D.; Heyken, Antje; Domey, Jenny; Hube, Bernhard] Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Dept Microbial Pathogenic Mech, Jena, Germany; [Martin, Ronny; Kurzai, Oliver] Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Grp Fungal Sept, Ctr Innovat Competence Sept, Jena, Germany; [Martin, Ronny; Kurzai, Oliver; Hube, Bernhard] Univ Jena, Jena, Germany; [Moran, Gary P.; Sullivan, Derek J.] Univ Dublin, Microbiol Res Unit, Div Oral Biosci, Sch Dent Sci, Dublin, Ireland; [Moran, Gary P.; Sullivan, Derek J.] Univ Dublin, Dublin Dent Univ Hosp, Trin Coll Dublin, Dublin, Ireland	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Trinity College Dublin; Trinity College Dublin	Martin, R (corresponding author), Hans Knoell Inst HKI, Leibniz Inst Nat Product Res & Infect Biol, Dept Microbial Pathogenic Mech, Jena, Germany.	bernhard.hube@hki-jena.de	Jacobsen, Ilse/B-3155-2011; Moran, Gary/F-3116-2012; Sullivan, Derek/A-8269-2008	Jacobsen, Ilse/0000-0002-6033-9984; Moran, Gary/0000-0003-0469-1788; Kurzai, Oliver/0000-0002-7277-2646; Hube, Bernhard/0000-0002-6028-0425; Sullivan, Derek/0000-0003-0195-9697	Deutsche Forschungsgemeinschaft [Hu528/10]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was partially supported by the Deutsche Forschungsgemeinschaft Hu528/10 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Argimon S, 2007, EUKARYOT CELL, V6, P682, DOI 10.1128/EC.00340-06; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Berman J, 2006, CURR OPIN MICROBIOL, V9, P595, DOI 10.1016/j.mib.2006.10.007; Bishop A, 2010, EMBO J, V29, P2930, DOI 10.1038/emboj.2010.158; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Braun BR, 2000, GENETICS, V155, P57; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Carlisle PL, 2010, EUKARYOT CELL, V9, P1320, DOI 10.1128/EC.00046-10; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kumamoto CA, 2005, ANNU REV MICROBIOL, V59, P113, DOI 10.1146/annurev.micro.59.030804.121034; Leng P, 2001, J BACTERIOL, V183, P4090, DOI 10.1128/JB.183.13.4090-4093.2001; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Loeb JDJ, 1999, MOL CELL BIOL, V19, P4019; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Moreno-Ruiz E, 2009, CELL MICROBIOL, V11, P1179, DOI 10.1111/j.1462-5822.2009.01319.x; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Shen JQ, 2008, P NATL ACAD SCI USA, V105, P20918, DOI 10.1073/pnas.0809147105; Skrzypek MS, 2010, NUCLEIC ACIDS RES, V38, pD428, DOI 10.1093/nar/gkp836; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wang A, 2009, MOL CELL BIOL, V29, P4406, DOI 10.1128/MCB.01502-08; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195; Zheng XD, 2007, EMBO J, V26, P3760, DOI 10.1038/sj.emboj.7601814; ZHU W, 2009, CELL MICROBIOL	56	64	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18394	10.1371/journal.pone.0018394	http://dx.doi.org/10.1371/journal.pone.0018394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21512583	Green Published, Green Submitted, gold			2022-12-25	WOS:000289238700010
J	Banerjee, R; Mani, RS; Russo, N; Scanlon, CS; Tsodikov, A; Jing, X; Cao, Q; Palanisamy, N; Metwally, T; Inglehart, RC; Tomlins, S; Bradford, C; Carey, T; Wolf, G; Kalyana-Sundaram, S; Chinnaiyan, AM; Varambally, S; D'Silva, NJ				Banerjee, R.; Mani, R-S; Russo, N.; Scanlon, C. S.; Tsodikov, A.; Jing, X.; Cao, Q.; Palanisamy, N.; Metwally, T.; Inglehart, R. C.; Tomlins, S.; Bradford, C.; Carey, T.; Wolf, G.; Kalyana-Sundaram, S.; Chinnaiyan, A. M.; Varambally, S.; D'Silva, N. J.			The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma	ONCOGENE			English	Article						miR-101; EZH2; rap1GAP; rap1; promoter hypermethylation	GROUP PROTEIN EZH2; HISTONE METHYLTRANSFERASE; DOWN-REGULATION; E-CADHERIN; SOMATIC MUTATIONS; MOLECULAR-BIOLOGY; PROMOTES INVASION; HIGH EXPRESSION; NECK-CANCER; POLYCOMB	Rap1GAP is a critical tumor suppressor gene that is downregulated in multiple aggressive cancers, such as head and neck squamous cell carcinoma, melanoma and pancreatic cancer. However, the mechanistic basis of rap1GAP downregulation in cancers is poorly understood. By employing an integrative approach, we demonstrate polycomb-mediated repression of rap1GAP that involves Enhancer of Zeste Homolog 2 (EZH2), a histone methyltransferase in head and neck cancers. We further demonstrate that the loss of miR-101 expression correlates with EZH2 upregulation, and the concomitant downregulation of rap1GAP in head and neck cancers. EZH2 represses rap1GAP by facilitating the trimethylation of histone 3 at lysine 27, a mark of gene repression, and also hypermethylation of rap1GAP promoter. These results provide a conceptual framework involving a microRNA-oncogene-tumor suppressor axis to understand head and neck cancer progression. Oncogene (2011) 30, 4339-4349; doi: 10.1038/onc.2011.141; published online 2 May 2011	[D'Silva, N. J.] Univ Michigan, Sch Dent, Sch Med, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Mani, R-S; Jing, X.; Palanisamy, N.; Tomlins, S.; Kalyana-Sundaram, S.; Chinnaiyan, A. M.; Varambally, S.; D'Silva, N. J.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Mani, R-S; Jing, X.; Cao, Q.; Palanisamy, N.; Tomlins, S.; Kalyana-Sundaram, S.; Chinnaiyan, A. M.; Varambally, S.; D'Silva, N. J.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Tsodikov, A.] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; [Bradford, C.; Carey, T.; Wolf, G.] Univ Michigan, Sch Med, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Kalyana-Sundaram, S.] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli, Tamil Nadu, India; [Chinnaiyan, A. M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Bharathidasan University; University of Michigan System; University of Michigan	D'Silva, NJ (corresponding author), Univ Michigan, Sch Dent, Sch Med, Dept Periodont & Oral Med, 1011 N Univ Ave,Room 5217, Ann Arbor, MI 48109 USA.	njdsilva@umich.edu	Palanisamy, Nallasivam/ABC-8844-2020; D'Silva, Nisha J/B-4734-2013; Kalyana-Sundaram, Shanker/F-6860-2012; Cao, Qi/A-5517-2010	Palanisamy, Nallasivam/0000-0002-0633-9772; Cao, Qi/0000-0002-5140-3681; Varambally, Sooryanarayana/0000-0002-2277-1127; Carey, Thomas/0000-0002-5202-7518; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Mani, Ram/0000-0003-3552-7905	Prostate Cancer Foundation; NIDCR [DE16920-01, DE018512-01]; University of Michigan; National Institutes of Health through the University of Michigan's Cancer Center Support [5 P30 CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K02DE019513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE016920, R01DE018512] Funding Source: NIH RePORTER	Prostate Cancer Foundation; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Michigan(University of Michigan System); National Institutes of Health through the University of Michigan's Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr T Giardano for tissue, and Dr Khalid Suleman and Vineeta Sharma for technical assistance for the FISH and methylation studies, respectively. R-SM is the recipient of StewartRahr-PCF Young Investigator Award from the Prostate Cancer Foundation. This work was supported by NIDCR DE16920-01, DE018512-01 grants and funding from University of Michigan Head and Neck Specialized Program of Research Excellence (SPORE) (NJD). This research was made possible, in part, by the use of the Cancer Center Flow Cytometry Core, which was supported (in part) by the National Institutes of Health through the University of Michigan's Cancer Center Support Grant (5 P30 CA46592).	Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chin D, 2006, EXPERT REV ANTICANC, V6, P1111, DOI 10.1586/14737140.6.7.1111; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Glazer CA, 2009, ORAL ONCOL, V45, P440, DOI 10.1016/j.oraloncology.2008.05.013; He LR, 2010, INT J CANCER, V127, P138, DOI 10.1002/ijc.25031; Herceg Z, 2007, MUTAGENESIS, V22, P91, DOI 10.1093/mutage/gel068; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Kidani K, 2009, ORAL ONCOL, V45, P39, DOI 10.1016/j.oraloncology.2008.03.016; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Martinez-Garcia E, 2010, NAT GENET, V42, P100, DOI 10.1038/ng0210-100; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Mitra RS, 2008, CANCER RES, V68, P3959, DOI 10.1158/0008-5472.CAN-07-2755; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Su L, 2003, J BIOL CHEM, V278, P15232, DOI 10.1074/jbc.M211888200; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Thomas GJ, 2001, CRIT REV ORAL BIOL M, V12, P479, DOI 10.1177/10454411010120060301; Todd R, 1997, J ORAL MAXIL SURG, V55, P613, DOI 10.1016/S0278-2391(97)90495-X; Tsygankova OA, 2007, MOL CELL BIOL, V27, P6647, DOI 10.1128/MCB.00155-07; Tsygankova OM, 2010, MOL CELL BIOL, V30, P3262, DOI 10.1128/MCB.01345-09; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Yarbrough WG, 2006, HEAD NECK-J SCI SPEC, V28, P549, DOI 10.1002/hed.20357; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang LZ, 2006, CANCER RES, V66, P898, DOI 10.1158/0008-5472.CAN-05-3025; Zhang ZC, 2006, AM J PATHOL, V168, P585, DOI 10.2353/ajpath.2006.050132; Zheng H, 2009, CANCER RES, V69, P449, DOI 10.1158/0008-5472.CAN-08-2399; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	46	79	82	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	42					4339	4349		10.1038/onc.2011.141	http://dx.doi.org/10.1038/onc.2011.141			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HP	21532618	Green Accepted			2022-12-25	WOS:000296356400005
J	Zheng, R; Bailey, E; Nguyen, B; Yang, X; Piloto, O; Levis, M; Small, D				Zheng, R.; Bailey, E.; Nguyen, B.; Yang, X.; Piloto, O.; Levis, M.; Small, D.			Further activation of FLT3 mutants by FLT3 ligand	ONCOGENE			English	Article						FLT3; tyrosine kinase receptor; FLT3 ligand; internal tandem duplication mutation; point mutation	ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; TYROSINE KINASE RECEPTOR; CONSTITUTIVE ACTIVATION; HEMATOPOIETIC-CELLS; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; C-KIT; EXPRESSION; GENE	Somatic mutations of FLT3 involving internal tandem duplication (ITD) of the juxtamembrane domain or point mutations in the tyrosine kinase domain (TKD) appear to activate FLT3 in a FLT3 ligand (FL)-independent manner. To determine whether or not FLT3 mutants respond to FL for their activation, a FL-deficient (FL-/-) murine embryo fibroblast (MEF) cell line was established. Expression of FLT3/ITD and FLT3/TKD mutations in FL-/- MEF cells resulted in low levels of constitutive phosphorylation of FLT3. However, a more than fourfold increase of FLT3 autophosphorylation was induced by exogenous FL. Rescue of endogenous FL expression in FL-/- MEF cells expressing FLT3 mutants led to more than a threefold increase of FLT3 phosphorylation. FL addition led to further activation of the FLT3 receptors and enhanced survival and/or decreased apoptosis in leukemia-derived cell lines and primary leukemic cells expressing FLT3 mutations. Functional studies revealed that exogenous FL promoted the colony-forming and recloning abilities of FLT3 mutant transduced primary bone marrow cells derived from FL-/- mice. Endogenous FL contributes in vivo to functional signaling through FLT3 as noted by the decreased survival of FL+/+ ITD+/+ mice compared with FL-/- ITD+/+ mice. These data suggest that FL leads to further activation of FLT3 mutants and is especially important in light of recent findings of elevated FL levels in acute myeloid leukemia patients in response to chemotherapy. Oncogene (2011) 30, 4004-4014; doi:10.1038/onc.2011.110; published online 25 April 2011	[Zheng, R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; [Bailey, E.; Nguyen, B.; Yang, X.; Piloto, O.; Levis, M.; Small, D.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Small, D.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Small, D (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Pediat Oncol, CRB 251,1650 Orleans St, Baltimore, MD 21231 USA.	donsmall@jhmi.edu			Giant Food Pediatric Cancer Research Fund; NIH [CA90668, CA70970, CA095600-01]; Leukemia and Lymphoma Society; NCI (NCI Leukemia SPORE) [P50 CA100632-06, R01 CA128864]; American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE [R01CA128864, R01CA090668, K08CA095600, P50CA100632] Funding Source: NIH RePORTER	Giant Food Pediatric Cancer Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NCI (NCI Leukemia SPORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Katharine A Whartenby, Alan Friedman and Linzhao Cheng for their gift of reagents. DS is also supported by the Kyle Haydock Professorship in Oncology and the Giant Food Pediatric Cancer Research Fund. This work was supported by grants from the NIH (CA90668, CA70970 and CA095600-01) and the Leukemia and Lymphoma Society (DS). It was also supported by grants from the NCI (NCI Leukemia SPORE P50 CA100632-06, R01 CA128864) and the American Society of Clinical Oncology (ML). ML is a Clinical Scholar of the Leukemia and Lymphoma Society.	Abu-Duhier FM, 2001, BRIT J HAEMATOL, V113, P1076, DOI 10.1046/j.1365-2141.2001.02821.x; Bellamy WT, 2001, BLOOD, V97, P1427, DOI 10.1182/blood.V97.5.1427; BIRG F, 1992, BLOOD, V80, P2584; BRASEL K, 1995, LEUKEMIA, V9, P1212; Carow CE, 1996, BLOOD, V87, P1089, DOI 10.1182/blood.V87.3.1089.bloodjournal8731089; DOSIL M, 1993, MOL CELL BIOL, V13, P6572, DOI 10.1128/MCB.13.10.6572; Drexler HG, 1996, LEUKEMIA, V10, P588; Fenski R, 2000, BRIT J HAEMATOL, V108, P322; FREEDMAN MH, 1993, BLOOD, V81, P3068; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Horiike S, 1997, LEUKEMIA, V11, P1442, DOI 10.1038/sj.leu.2400770; Iwai T, 1999, LEUKEMIA, V13, P38, DOI 10.1038/sj.leu.2401241; Kiyoi H, 1997, LEUKEMIA, V11, P1447, DOI 10.1038/sj.leu.2400756; Kiyoi H, 1999, BLOOD, V93, P3074; Kiyoi H, 1998, LEUKEMIA, V12, P1333, DOI 10.1038/sj.leu.2401130; Lavagna-Sevenier C, 1998, J BIOL CHEM, V273, P14962, DOI 10.1074/jbc.273.24.14962; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Li L, 2008, BLOOD, V111, P3849, DOI 10.1182/blood-2007-08-109942; Li YW, 2004, BLOOD, V104, P1137, DOI 10.1182/blood-2003-07-2585; Lisovsky M, 1996, BLOOD, V88, P3987, DOI 10.1182/blood.V88.10.3987.bloodjournal88103987; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; Marchetto S, 1999, LEUKEMIA, V13, P1374, DOI 10.1038/sj.leu.2401527; MEIERHOFF G, 1995, LEUKEMIA, V9, P1368; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Nakao M, 1996, LEUKEMIA, V10, P1911; Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; PIETSCH T, 1993, NOUV REV FR HEMATOL, V35, P285; Piloto O, 2005, CANCER RES, V65, P1514, DOI 10.1158/0008-5472.CAN-04-3081; ROGERS SY, 1994, EXP HEMATOL, V22, P593; Rosnet O, 1996, ACTA HAEMATOL-BASEL, V95, P218; Sato T, 2011, BLOOD, V117, P3286, DOI 10.1182/blood-2010-01-266742; Stirewalt DL, 2001, BLOOD, V97, P3589, DOI 10.1182/blood.V97.11.3589; Tse KF, 2000, LEUKEMIA, V14, P1766, DOI 10.1038/sj.leu.2401905; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yokota S, 1997, LEUKEMIA, V11, P1605, DOI 10.1038/sj.leu.2400812; Zhang SL, 2000, BIOCHEM BIOPH RES CO, V277, P195, DOI 10.1006/bbrc.2000.3662; Zhang SL, 2000, J EXP MED, V192, P719, DOI 10.1084/jem.192.5.719; Zhang SL, 1999, J LEUKOCYTE BIOL, V65, P372, DOI 10.1002/jlb.65.3.372; Zheng R, 2004, BLOOD, V103, P267, DOI 10.1182/blood-2003-06-1969; Zheng R, 2002, BLOOD, V100, P4154, DOI 10.1182/blood-2002-03-0936	41	34	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	38					4004	4014		10.1038/onc.2011.110	http://dx.doi.org/10.1038/onc.2011.110			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	823KR	21516120	Green Accepted			2022-12-25	WOS:000295121600002
J	Muthurajan, UM; McBryant, SJ; Lu, X; Hansen, JC; Luger, K				Muthurajan, Uma M.; McBryant, Steven J.; Lu, Xu; Hansen, Jeffrey C.; Luger, Karolin			The Linker Region of MacroH2A Promotes Self-association of Nucleosomal Arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; AMINO-ACID-COMPOSITION; STRUCTURAL-CHARACTERIZATION; HISTONE VARIANTS; CHROMATIN FIBER; IN-VITRO; DOMAIN; DYNAMICS; BINDING	MacroH2A is a histone variant found in higher eukaryotes localized at the inactive X chromosome and is known to maintain heterochromatic regions in the genome. MacroH2A consists of a conserved histone domain and a macro domain connected by a linker region. To understand the contributions of the three domains to chromatin condensation, we incorporated various constructs of macroH2A into defined nucleosomal arrays and analyzed their impact on in vitro chromatin compaction. The folding and oligomerization properties of arrays containing full-length macroH2A (macroH2A(FL)), macroH2A(1-161) (encompassing the histone domain and linker region), and macroH2A(1-122) (histone domain only) were compared with major-type H2A arrays. Analytical ultracentrifugation and atomic force microscope imaging indicate that macroH2A(1-161)-containing arrays favor condensation under conditions where major-type arrays are nearly fully extended. In contrast, arrays with macroH2A(FL) exhibit behavior similar to that of major-type arrays. This suggests that the linker region of macroH2A facilitates array condensation and that this behavior is inhibited by the macro domain. Furthermore, chimeric major-type H2A arrays containing the macroH2A linker domain (H2A(ML)) exhibited the same condensation properties as macroH2A(1-161) arrays, thus emphasizing the intriguing behavior of the macroH2A linker region.	[Muthurajan, Uma M.; Hansen, Jeffrey C.; Luger, Karolin] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; [McBryant, Steven J.] Gevo Inc, Englewood, CO 80112 USA; [Lu, Xu] Univ Findlay, Findlay, OH 45840 USA	Colorado State University; Colorado State University; Howard Hughes Medical Institute; University of Findlay	Luger, K (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	karolin.luger@colostate.edu		SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	National Institutes of Health [GM061909, P01GM088409, GM45916]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088409, R01GM045916, R01GM061909, R29GM045916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061909 and P01GM088409 (to K. L.) and GM45916 (to J. C. H.).; Supported by the Howard Hughes Medical Institute. To whom correspondence should be addressed. Tel.: 970-491-6405; Fax: 970-491-5113; E-mail: karolin.luger@colostate.edu.	Abbott DW, 2004, BIOCHEMISTRY-US, V43, P1352, DOI 10.1021/bi035859i; Baker AM, 2009, NUCLEIC ACIDS RES, V37, P5019, DOI 10.1093/nar/gkp515; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cano S, 2006, EUR BIOPHYS J BIOPHY, V35, P495, DOI 10.1007/s00249-006-0057-7; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Chakravarthy S, 2004, COLD SPRING HARB SYM, V69, P227, DOI 10.1101/sqb.2004.69.227; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Chakravarthy S, 2006, J BIOL CHEM, V281, P25522, DOI 10.1074/jbc.M602258200; Changolkar LN, 2006, MOL CELL BIOL, V26, P4410, DOI 10.1128/MCB.02258-05; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; EICKBUSH TH, 1976, CELL, V9, P785, DOI 10.1016/0092-8674(76)90141-0; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Filenko NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016299; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; HANSEN JC, 1994, BIOCHEMISTRY-US, V33, P13155, DOI 10.1021/bi00249a001; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Ladurner AG, 2003, MOL CELL, V12, P1, DOI 10.1016/S1097-2765(03)00284-3; Lohr Dennis, 2008, V464, P123; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Lu X, 2006, BIOCHEM CELL BIOL, V84, P411, DOI 10.1139/O06-068; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; Montel F, 2009, BIOPHYS J, V97, P544, DOI 10.1016/j.bpj.2009.04.042; Nusinow DA, 2007, J MOL BIOL, V371, P11, DOI 10.1016/j.jmb.2007.05.063; OLINS DE, 1972, J CELL BIOL, V53, P715, DOI 10.1083/jcb.53.3.715; Qian R L, 1997, Cell Res, V7, P143; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Shlyakhtenko LS, 2009, BIOCHEMISTRY-US, V48, P7842, DOI 10.1021/bi900977t; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; Tse C, 1998, P NATL ACAD SCI USA, V95, P12169, DOI 10.1073/pnas.95.21.12169	41	37	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23852	23864		10.1074/jbc.M111.244871	http://dx.doi.org/10.1074/jbc.M111.244871			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21532035	Green Published, hybrid			2022-12-25	WOS:000292294900028
J	Zhao, X; Kuja-Panula, J; Rouhiainen, A; Chen, YC; Panula, P; Rauvala, H				Zhao, Xiang; Kuja-Panula, Juha; Rouhiainen, Ari; Chen, Yu-chia; Panula, Pertti; Rauvala, Heikki			High Mobility Group Box-1 (HMGB1; Amphoterin) Is Required for Zebrafish Brain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; CATECHOLAMINERGIC NEURONS; NERVOUS-SYSTEM; FOREBRAIN; PROTEIN; EXPRESSION; GENE; ACTIVATION; CELLS; PAX6	Hmgb1 (high mobility group box-1; amphoterin) is highly expressed in brain during early development of vertebrate and nonvertebrate species. However, its role in brain development remains elusive. Here we have cloned the zebrafish Hmgb1 and specifically manipulated Hmgb1 expression using injection of morpholino antisense oligonucleotides or Hmgb1 cRNA. The HMGB1 knockdown morphants produced by injection of three different morpholino oligonucleotides display a characteristic phenotype with smaller size, smaller brain width, and shorter distance between the eyes. Closer examination of the phenotype reveals severe defects in the development of the forebrain that largely lacks catecholaminergic neural networks. The HMGB1 morphant is deficient in survival and proliferation of neural progenitors and displays fewer cell groups expressing the transcription factor Pax6a in the forebrain and aberrant Wnt8 signaling. The mechanism of HMGB1-dependent progenitor survival involves the neuronal transmembrane protein AMIGO (amphoterin-induced gene and orf), the expression of which is regulated by HMGB1 in vivo. Our data demonstrate that HMGB1 is a critical factor for brain development, enabling survival and proliferation of neural progenitors that will form the forebrain structures.	[Zhao, Xiang; Kuja-Panula, Juha; Rouhiainen, Ari; Chen, Yu-chia; Panula, Pertti; Rauvala, Heikki] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; [Chen, Yu-chia; Panula, Pertti] Univ Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Rauvala, H (corresponding author), Univ Helsinki, Ctr Neurosci, POB 56,Viikinkaari 4, FIN-00014 Helsinki, Finland.	heikki.rauvala@helsinki.fi	Zhao, Xiang/AAK-9641-2020	Zhao, Xiang/0000-0002-3339-4806; Rouhiainen, Ari/0000-0003-2492-4788; Panula, Pertti/0000-0002-1189-5132; Rauvala, Heikki/0000-0001-7809-9811	Academy of Finland; Sigrid Juselius Foundation; Helsinki Graduate School in Biotechnology and Molecular Biology	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki Graduate School in Biotechnology and Molecular Biology	This work was supported by the Academy of Finland and the Sigrid Juselius Foundation.; Supported by the Helsinki Graduate School in Biotechnology and Molecular Biology.	Appel B, 2000, DEV DYNAM, V219, P155, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1052>3.3.CO;2-B; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fink M, 2006, DEV DYNAM, V235, P3370, DOI 10.1002/dvdy.20995; Guerin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005374; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Huang XW, 2005, INT J DEV BIOL, V49, P49, DOI 10.1387/ijdb.041915xh; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Kim JD, 2009, BIOCHEM BIOPH RES CO, V381, P717, DOI 10.1016/j.bbrc.2009.02.135; KINOSHITA M, 1994, FEBS LETT, V352, P191, DOI 10.1016/0014-5793(94)00909-0; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Manuel M, 2005, BRAIN RES BULL, V66, P387, DOI 10.1016/j.brainresbull.2005.02.006; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Mueller T., 2005, ATLAS EARLY ZEBRAFIS, P29; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Ono T, 2003, J NEUROSCI, V23, P5887; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; PARKKINEN J, 1993, J BIOL CHEM, V268, P19726; RAUVALA H, 1988, J CELL BIOL, V107, P2293, DOI 10.1083/jcb.107.6.2293; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Thisse C, 2005, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wullimann MF, 2004, J COMP NEUROL, V475, P143, DOI 10.1002/cne.20183; Wullimann MF, 2002, BRAIN RES BULL, V57, P363, DOI 10.1016/S0361-9230(01)00666-9; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512	45	43	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23200	23213		10.1074/jbc.M111.223834	http://dx.doi.org/10.1074/jbc.M111.223834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21527633	hybrid, Green Published			2022-12-25	WOS:000292025000054
J	Ho, CW; Chen, HT; Hwang, J				Ho, Chia-Wen; Chen, Hung-Ta; Hwang, Jaulang			UBC9 Autosumoylation Negatively Regulates Sumoylation of Septins in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SUMOYLATION; SUMO-1 MODIFICATION; CELL-CYCLE; UBIQUITIN; COMPLEX; BINDING; CONJUGATION; RANGAP1; CHAIN; AUTOUBIQUITINATION	Sumoylation regulates a wide range of cellular processes. However, little is known about the regulation of the SUMO machinery. In this study, we demonstrate that two lysine residues (Lys-153 and Lys-157) in the C-terminal region of the yeast E2-conjugating enzyme Ubc9 are the major and minor autosumoylation sites, respectively. Surprisingly, mutation of Lys-157 (ubc9(K157R)) significantly stimulates the level of Ubc9 autosumoylation at Lys-153. The functional role of Ubc9 autosumoylation is exemplified in our findings that cell cycle-dependent sumoylation of cytoskeletal septin proteins is inversely correlated with the Ubc9 autosumoylation level and that mutation of the Ubc9 autosumoylation sites results in aberrant cell morphology. Our study elucidates a regulatory mechanism that utilizes automodification of the E2 enzyme of the sumoylation machinery to control substrate sumoylation.	[Ho, Chia-Wen; Chen, Hung-Ta; Hwang, Jaulang] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Ho, Chia-Wen; Hwang, Jaulang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Chen, HT (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	htchen@imb.sinica.edu.tw; jaulangh@imb.sinica.edu.tw	Chen, Hung-Ta/ABC-8094-2021	Chen, Hung-Ta/0000-0003-1192-0382	National Science Council in Taiwan [NSC98-2311-B-001-008-MY3]; Institute of Molecular Biology, Academia Sinica	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Institute of Molecular Biology, Academia Sinica(Academia Sinica - Taiwan)	This work was supported by National Science Council in Taiwan Grant NSC98-2311-B-001-008-MY3 and by the Institute of Molecular Biology, Academia Sinica.	ARNOLD JE, 1990, BIOCHEM J, V267, P751, DOI 10.1042/bj2670751; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jacquiau HR, 2005, J BIOL CHEM, V280, P23566, DOI 10.1074/jbc.M500947200; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Knop AE, 1999, GENE THER, V6, P373, DOI 10.1038/sj.gt.3300822; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	48	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21826	21834		10.1074/jbc.M111.234914	http://dx.doi.org/10.1074/jbc.M111.234914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518767	hybrid, Green Published			2022-12-25	WOS:000291464700077
J	Li, H; Solomon, E; Muggy, SD; Sun, DQ; Zolkiewska, A				Li, Hui; Solomon, Emilia; Muggy, Sara Duhachek; Sun, Danqiong; Zolkiewska, Anna			Metalloprotease-Disintegrin ADAM12 Expression Is Regulated by Notch Signaling via MicroRNA-29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN BREAST; INTRACELLULAR DOMAIN; EXTRACELLULAR-MATRIX; FAMILY-MEMBERS; CROSS-TALK; ACTIVATION; PATHWAY; CANCER; CELLS	Metalloprotease-disintegrin ADAM12 is overexpressed and frequently mutated in breast cancer. We report here that ADAM12 expression in cultured mammalian cells is up-regulated by Notch signals. Expression of a constitutively active form of Notch1 in murine fibroblasts, myoblasts, or mammary epithelial cells or activation of the endogenous Notch signaling by co-culture with ligand-expressing cells increases ADAM12 protein and mRNA levels. Up-regulation of ADAM12 expression by Notch requires new transcription, is activated in a CSL-dependent manner, and is abolished upon inhibition of I kappa B kinase. Expression of a constitutively active Notch1 in NIH3T3 cells increases the stability of Adam12 mRNA. We further show that the microRNA-29 family, which has a predicted conserved site in the 3'-untranslated region of mouse Adam12, plays a critical role in mediating the stimulatory effect of Notch on ADAM12 expression. In human cells, Notch up-regulates the expression of the long form, but not the short form, of ADAM12 containing a divergent 3'-untranslated mRNA region. These studies uncover a novel paradigm in Notch signaling and establish Adam12 as a Notch-related gene.	[Li, Hui; Solomon, Emilia; Muggy, Sara Duhachek; Sun, Danqiong; Zolkiewska, Anna] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Zolkiewska, A (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	zolkiea@ksu.edu	LI, HUI/G-1227-2011; Solomon, Emilia/AAH-9319-2021	LI, HUI/0000-0002-4114-8349; Solomon, Emilia/0000-0003-0265-9792	National Institutes of Health [CA151065]; Terry C. Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CANCER INSTITUTE [R15CA151065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Center for Basic Cancer Research at Kansas State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA151065 (to A. Z.). This work was also supported by an Innovative Research Award from Terry C. Johnson Center for Basic Cancer Research at Kansas State University.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Aifantis I, 2007, CELL CYCLE, V6, P403, DOI 10.4161/cc.6.4.3858; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barter MJ, 2010, MATRIX BIOL, V29, P602, DOI 10.1016/j.matbio.2010.05.002; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bornemann A, 2000, J MUSCLE RES CELL M, V21, P475, DOI 10.1023/A:1005657607591; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Cao Y, 2003, MOL CELL BIOL, V23, P6725, DOI 10.1128/MCB.23.19.6725-6738.2003; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Conigliaro A, 2008, CELL DEATH DIFFER, V15, P123, DOI 10.1038/sj.cdd.4402236; Dieguez-Acuna F, 2010, INT J BIOCHEM CELL B, V42, P1651, DOI 10.1016/j.biocel.2009.12.001; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Eyholzer M, 2010, BRIT J CANCER, V103, P275, DOI 10.1038/sj.bjc.6605751; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fu YX, 2009, J BIOL CHEM, V284, P19452, DOI 10.1074/jbc.M109.011833; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Hao L, 2010, ONCOGENE, V29, P201, DOI 10.1038/onc.2009.323; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Keating DT, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-114; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2007, CURR OPIN STRUC BIOL, V17, P117, DOI 10.1016/j.sbi.2006.11.004; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lendeckel U, 2005, J CANCER RES CLIN, V131, P41, DOI 10.1007/s00432-004-0619-y; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Luna C, 2009, MOL VIS, V15, P2488; Mareddy S, 2010, TISSUE ENG PT A, V16, P749, DOI [10.1089/ten.tea.2009.0307, 10.1089/ten.TEA.2009.0307]; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; O'Dea E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000216; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Pierfelice TJ, 2008, COLD SH Q B, V73, P367, DOI 10.1101/sqb.2008.73.013; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Ray A, 2010, MOL CANCER RES, V8, P1261, DOI 10.1158/1541-7786.MCR-10-0212; Ray BK, 2011, P NATL ACAD SCI USA, V108, P103, DOI 10.1073/pnas.1008831108; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Sun DQ, 2008, J CELL SCI, V121, P3815, DOI 10.1242/jcs.035493; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhao P, 2004, DEV DYNAM, V229, P380, DOI 10.1002/dvdy.10457	75	33	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21500	21510		10.1074/jbc.M110.207951	http://dx.doi.org/10.1074/jbc.M110.207951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518768	Green Published, hybrid			2022-12-25	WOS:000291464700048
J	Marek, M; Milles, S; Schreiber, G; Daleke, DL; Dittmar, G; Herrmann, A; Muller, P; Pomorski, TG				Marek, Magdalena; Milles, Sigrid; Schreiber, Gabriele; Daleke, David L.; Dittmar, Gunnar; Herrmann, Andreas; Mueller, Peter; Pomorski, Thomas Guenther			The Yeast Plasma Membrane ATP Binding Cassette (ABC) Transporter Aus1 PURIFICATION, CHARACTERIZATION, AND THE EFFECT OF LIPIDS ON ITS ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN; DIETARY-CHOLESTEROL; STEROL UPTAKE; PROTEIN; HYDROLYSIS; GENE; OVEREXPRESSION; TRANSLOCATION; OPTIMIZATION; SUPERFAMILY	The ATP binding cassette (ABC) transporter Aus1 is expressed under anaerobic growth conditions at the plasma membrane of the yeast Saccharomyces cerevisiae and is required for sterol uptake. These observations suggest that Aus1 promotes the translocation of sterols across membranes, but the precise transport mechanism has yet to be identified. In this study, an extraction and purification procedure was developed to characterize the Aus1 transporter. The detergent-solubilized protein was able to bind and hydrolyze ATP. Mutagenesis of the conserved lysine to methionine in the Walker A motif abolished ATP hydrolysis. Likewise, ATP hydrolysis was inhibited by classical inhibitors of ABC transporters. Upon reconstitution into proteoliposomes, the ATPase activity of Aus1 was specifically stimulated by phosphatidylserine (PS) in a stereoselective manner. We also found that Aus1-dependent sterol uptake, but not Aus1 expression and trafficking to the plasma membrane, was affected by changes in cellular PS levels. These results suggest a direct interaction between Aus1 and PS that is critical for the activity of the transporter.	[Marek, Magdalena; Pomorski, Thomas Guenther] Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol,Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Mueller, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Daleke, David L.] Indiana Univ, Dept Biochem & Mol Biol, Bloomington, IN 47405 USA; [Dittmar, Gunnar] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Danmarks Grundforskningsfond; University of Copenhagen; Humboldt University of Berlin; Indiana University System; Indiana University Bloomington; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Pomorski, TG (corresponding author), Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol,Fac Life Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	tgp@life.ku.dk	Dittmar, Gunnar/B-6383-2016; Daleke, David/T-3123-2019; Pomorski, Thomas Günther/G-4804-2014; Dittmar, Gunnar/C-6333-2019	Dittmar, Gunnar/0000-0003-3647-8623; Pomorski, Thomas Günther/0000-0002-4889-0829; Dittmar, Gunnar/0000-0003-3647-8623; Marek, Magdalena/0000-0001-6901-920X	Marie Curie Flippase Network; Carlsberg Foundation; Deutsche Forschungsgemeinschaft [MU 1017/5]	Marie Curie Flippase Network; Carlsberg Foundation(Carlsberg Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Marie Curie Flippase Network (to M. M. and A. H.), the Carlsberg Foundation (to T. G. P.), and Deutsche Forschungsgemeinschaft Grant MU 1017/5 (to P. M. and T. G. P.).	Al-Shawi MK, 2005, J BIOENERG BIOMEMBR, V37, P489, DOI 10.1007/s10863-005-9497-5; Alimardani P, 2004, BIOCHEM J, V381, P195, DOI 10.1042/BJ20040297; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Gulshan K, 2010, MOL BIOL CELL, V21, P443, DOI 10.1091/mbc.E09-06-0519; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIKIJI T, 1988, J BIOCHEM-TOKYO, V104, P894, DOI 10.1093/oxfordjournals.jbchem.a122579; Ketchum CJ, 2001, J BIOL CHEM, V276, P29007, DOI 10.1074/jbc.M100810200; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kohut P, 2011, BIOCHEM BIOPH RES CO, V404, P233, DOI 10.1016/j.bbrc.2010.11.099; Kovalchuk A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-177; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Langheim S, 2005, J LIPID RES, V46, P1732, DOI 10.1194/jlr.M500115-JLR200; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Nagao K, 2010, FEBS LETT, V584, P2717, DOI 10.1016/j.febslet.2010.04.036; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Rahimi Y, 2008, BIOCHEM BIOPH RES CO, V370, P57, DOI 10.1016/j.bbrc.2008.03.034; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Reiner S, 2006, MOL BIOL CELL, V17, P90, DOI 10.1091/mbc.e05-06-0515; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; van Meer G, 2006, FEBS LETT, V580, P1171, DOI 10.1016/j.febslet.2005.12.019; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zarubica A, 2009, FASEB J, V23, P1775, DOI 10.1096/fj.08-122192; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	48	29	30	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21835	21843		10.1074/jbc.M111.244525	http://dx.doi.org/10.1074/jbc.M111.244525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521689	Green Published, hybrid			2022-12-25	WOS:000291464700078
J	Reisetter, AC; Stebounova, LV; Baltrusaitis, J; Powers, L; Gupta, A; Grassian, VH; Monick, MM				Reisetter, Anna C.; Stebounova, Larissa V.; Baltrusaitis, Jonas; Powers, Linda; Gupta, Amit; Grassian, Vicki H.; Monick, Martha M.			Induction of Inflammasome-dependent Pyroptosis by Carbon Black Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIESEL EXHAUST PARTICLES; HOST-CELL DEATH; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; ALVEOLAR MACROPHAGES; ULTRAFINE PARTICLES; IN-VIVO; PULMONARY INFLAMMATION; LIPID MEDIATORS	Inhalation of nanoparticles has been implicated in respiratory morbidity and mortality. In particular, carbon black nanoparticles are found in many different environmental exposures. Macrophages take up inhaled nanoparticles and respond via release of inflammatory mediators and in some cases cell death. Based on new data, we propose that exposure of macrophages (both a macrophage cell line and primary human alveolar macrophages) to carbon black nanoparticles induces pyroptosis, an inflammasome-dependent form of cell death. Exposure of macrophages to carbon black nanoparticles resulted in inflammasome activation as defined by cleavage of caspase 1 to its active form and downstream IL-1 beta release. The cell death that occurred with carbon black nanoparticle exposure was identified as pyroptosis by the protective effect of a caspase 1 inhibitor and a pyroptosis inhibitor. These data demonstrate that carbon black nanoparticle exposure activates caspase 1, increases IL-1 beta release after LPS priming, and induces the proinflammatory cell death, pyroptosis. The identification of pyroptosis as a cellular response to carbon nanoparticle exposure is novel and relates to environmental and health impacts of carbon-based particulates.	[Monick, Martha M.] Univ Iowa, EMRB, Div Pulm Crit Care & Occupat Med, Dept Med, Iowa City, IA 52242 USA; [Stebounova, Larissa V.; Baltrusaitis, Jonas; Grassian, Vicki H.] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Monick, MM (corresponding author), Univ Iowa, EMRB, Div Pulm Crit Care & Occupat Med, Dept Med, Rm 100, Iowa City, IA 52242 USA.	martha-monick@uiowa.edu	Baltrusaitis, Jonas/AAW-6072-2021; Baltrusaitis, Jonas/AAT-3166-2020; Baltrusaitis, Jonas/F-9367-2013	Baltrusaitis, Jonas/0000-0001-5634-955X; 	National Institutes of Health [R01 HL079901, R01HL96625]; National Center for Research Resources, National Institutes of Health [UL1RR024979]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096625, R01HL079901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL079901 and R01HL96625 (to M. M. M.) and R01HL96625 (to V. H. G.). This publication was made possible by National Center for Research Resources, National Institutes of Health Grant UL1RR024979.	Aam BB, 2007, ARCH TOXICOL, V81, P441, DOI 10.1007/s00204-006-0164-3; Baltrusaitis J, 2007, PHYS CHEM CHEM PHYS, V9, P3011, DOI 10.1039/b617697f; Barlow PG, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-11; Beck-Speier I, 2005, FREE RADICAL BIO MED, V38, P1080, DOI 10.1016/j.freeradbiomed.2005.01.004; Beck-Speier I, 2001, ENVIRON HEALTH PERSP, V109, P613, DOI 10.2307/3454679; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Brown DM, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215104; Cassee FR., 1999, DEV MODEL HUMAN RAT; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cassel SL, 2010, EUR J IMMUNOL, V40, P607, DOI 10.1002/eji.200940207; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Davis MJ, 2010, J LEUKOCYTE BIOL, V88, P813, DOI 10.1189/jlb.0310159; Dick CAJ, 2003, INHAL TOXICOL, V15, P39, DOI 10.1080/08958370304454; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; FERIN J, 1992, AM J RESP CELL MOL, V6, P535, DOI 10.1165/ajrcmb/6.5.535; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; HARADA RN, 1985, CHEST, V87, P247, DOI 10.1378/chest.87.2.247; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hu Y, 2010, J IMMUNOL, V185, P7699, DOI 10.4049/jimmunol.1001099; Hussain S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-10; Hussain S, 2009, TOXICOLOGY, V260, P142, DOI 10.1016/j.tox.2009.04.001; Ito T, 2000, ENVIRON TOXICOL PHAR, V9, P1, DOI 10.1016/S1382-6689(00)00053-3; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Kinney PL, 2000, ENVIRON HEALTH PERSP, V108, P213, DOI 10.2307/3454436; Koike E, 2006, CHEMOSPHERE, V65, P946, DOI 10.1016/j.chemosphere.2006.03.078; LIPPMANN M, 1980, BRIT J IND MED, V37, P337; LOEFFLER J, 2010, NANOROAD SME EUROPEA; Lundborg M, 2001, ENVIRON RES, V86, P244, DOI 10.1006/enrs.2001.4269; Ma JYC, 2002, J ENVIRON SCI HEAL C, V20, P117, DOI 10.1081/GNC-120016202; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; Mauderly J L, 1994, Res Rep Health Eff Inst, P1; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Moller W, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-7; Monack DM, 2001, MICROBES INFECT, V3, P1201, DOI 10.1016/S1286-4579(01)01480-0; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Moss OR, 2006, INHAL TOXICOL, V18, P711, DOI 10.1080/08958370600747770; Ngai S, 2010, FEBS J, V277, P119, DOI 10.1111/j.1742-4658.2009.07458.x; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; OBERDORSTER G, 1994, ANN OCCUP HYG, V38, P601, DOI 10.1093/annhyg/38.4.601; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Renwick LC, 2004, OCCUP ENVIRON MED, V61, P442, DOI 10.1136/oem.2003.008227; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; Stoeger T, 2006, ENVIRON HEALTH PERSP, V114, P328, DOI 10.1289/ehp.8266; Stoeger T, 2009, ENVIRON HEALTH PERSP, V117, P54, DOI 10.1289/ehp.11370; Stone V, 1998, TOXICOL IN VITRO, V12, P649, DOI 10.1016/S0887-2333(98)00050-2; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Twigg HL, 2004, SEMIN RESP CRIT CARE, V25, P21, DOI 10.1055/s-2004-822302; Val Stephanie, 2009, Inhal Toxicol, V21 Suppl 1, P115, DOI 10.1080/08958370902942533; Vesterdal LK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-33; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Whitfield NN, 2010, INFECT IMMUN, V78, P423, DOI 10.1128/IAI.00070-09; Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	78	128	133	6	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21844	21852		10.1074/jbc.M111.238519	http://dx.doi.org/10.1074/jbc.M111.238519			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525001	Green Published, hybrid			2022-12-25	WOS:000291464700079
J	Soss, SE; Yue, YY; Dhe-Paganon, S; Chazin, WJ				Soss, Sarah E.; Yue, Yuanyuan; Dhe-Paganon, Sirano; Chazin, Walter J.			E2 Conjugating Enzyme Selectivity and Requirements for Function of the E3 Ubiquitin Ligase CHIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U-BOX; PROTEIN LIGASES; C-TERMINUS; COMPLEX; DEGRADATION; CHAINS; IDENTIFICATION; UBIQUITYLATION; INSIGHTS; POLYUBIQUITINATION	The transfer of ubiquitin (Ub) to a substrate protein requires a cascade of E1 activating, E2 conjugating, and E3 ligating enzymes. E3 Ub ligases containing U-box and RING domains bind both E2 similar to Ub conjugates and substrates to facilitate transfer of the Ub molecule. Although the overall mode of action of E3 ligases is well established, many of the mechanistic details that determine the outcome of ubiquitination are poorly understood. CHIP (carboxyl terminus of Hsc70-interacting protein) is a U-box E3 ligase that serves as a co-chaperone to heat shock proteins and is critical for the regulation of unfolded proteins in the cytosol. We have performed a systematic analysis of the interactions of CHIP with E2 conjugating enzymes and found that only a subset bind and function. Moreover, some E2 enzymes function in pairs to create products that neither create individually. Characterization of the products of these reactions showed that different E2 enzymes produce different ubiquitination products, i.e. that E2 determines the outcome of Ub transfer. Site-directed mutagenesis on the E2 enzymes Ube2D1 and Ube2L3 (UbcH5a and UbcH7) established that an SPA motif in loop 7 of E2 is required for binding to CHIP but is not sufficient for activation of the E2 similar to Ub conjugate and consequent ubiquitination activity. These data support the proposal that the E2 SPA motif provides specificity for binding to CHIP, whereas activation of the E2 similar to Ub conjugate is derived from other molecular determinants.	[Soss, Sarah E.; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Soss, Sarah E.; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Yue, Yuanyuan] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	Vanderbilt University; Vanderbilt University; Vanderbilt University; Lanzhou University; University of Toronto; Structural Genomics Consortium; University of Toronto	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu			National Institutes of Health [R01GM075156, T32CA009582, F32GM087050]; China Scholarship Council; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087050, R01GM075156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM075156 (to W.J.C.) and Grants T32CA009582 and F32GM087050 (to S.E.S.). This work was also supported by the China Scholarship Council (to Y.Y.).	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Chiang AN, 2009, BIOORGAN MED CHEM, V17, P1527, DOI 10.1016/j.bmc.2009.01.024; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Dimitrova YN, 2010, J BIOL CHEM, V285, P13507, DOI 10.1074/jbc.M109.049411; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Goddard T. D., 2006, SPARKY 3; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Shloush J, 2011, J BIOL CHEM, V286, P4796, DOI 10.1074/jbc.M110.157669; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Wang DX, 2005, J PROTEOME RES, V4, P1554, DOI 10.1021/pr050104e; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	41	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21277	21286		10.1074/jbc.M111.224006	http://dx.doi.org/10.1074/jbc.M111.224006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518764	Green Published, hybrid			2022-12-25	WOS:000291464700026
J	Ahmady, E; Deeke, SA; Rabaa, S; Kouri, L; Kenney, L; Stewart, AFR; Burgon, PG				Ahmady, Elmira; Deeke, Shelley A.; Rabaa, Seham; Kouri, Lara; Kenney, Laura; Stewart, Alexandre F. R.; Burgon, Patrick G.			Identification of a Novel Muscle A-type Lamin-interacting Protein (MLIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; HUTCHINSON-GILFORD PROGERIA; TRANSCRIPTION FACTOR MOK2; INNER NUCLEAR-MEMBRANE; IN-VITRO INTERACTION; DILATED CARDIOMYOPATHY; RETINOBLASTOMA PROTEIN; LMNA MUTATIONS; A/C EXPRESSION; GENE	Mutations in the A-type lamin (LMNA) gene are associated with age-associated degenerative disorders of mesenchymal tissues, such as dilated cardiomyopathy, Emery-Dreifuss muscular dystrophy, and limb-girdle muscular dystrophy. The molecular mechanisms that connect mutations in LMNA with different human diseases are poorly understood. Here, we report the identification of a Muscle-enriched A-type Lamin-interacting Protein, MLIP (C6orf142 and 2310046A06rik), a unique single copy gene that is an innovation of amniotes (reptiles, birds, and mammals). MLIP encodes alternatively spliced variants (23-57 kDa) and possesses several novel structural motifs not found in other proteins. MLIP is expressed ubiquitously and most abundantly in heart, skeletal, and smooth muscle. MLIP interacts directly and co-localizes with lamin A and C in the nuclear envelope. MLIP also co-localizes with promyelocytic leukemia (PML) bodies within the nucleus. PML, like MLIP, is only found in amniotes, suggesting that a functional link between the nuclear envelope and PML bodies may exist through MLIP. Down-regulation of lamin A/C expression by shRNA results in the up-regulation and mislocalization of MLIP. Given that MLIP is expressed most highly in striated and smooth muscle, it is likely to contribute to the mesenchymal phenotypes of laminopathies.	[Ahmady, Elmira; Deeke, Shelley A.; Rabaa, Seham; Kouri, Lara; Kenney, Laura; Stewart, Alexandre F. R.; Burgon, Patrick G.] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada	University of Ottawa; University of Ottawa Heart Institute	Burgon, PG (corresponding author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	pburgon@ottawaheart.ca	Burgon, Patrick/ABB-1027-2021; Stewart, Alexandre F.R./A-5677-2011	Stewart, Alexandre/0000-0003-2673-9164; Burgon, Patrick/0000-0003-4771-023X	Canadian Institute of Health Research [MOP77682, MOP82748]; Ontario Graduate Student Science and Technology stipend; Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Student Science and Technology stipend; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Operating Grants MOP77682 (to A. F. R. S.) and MOP82748 (to P. G. B.), an Ontario Graduate Student Science and Technology stipend (to E. A.), and a Canadian Institute of Health Research stipend (to L. K.).	Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Broers JLV, 1999, J CELL SCI, V112, P3463; Charniot JC, 2003, HUM MUTAT, V21, P473, DOI 10.1002/humu.10170; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2000, J CELL SCI, V113, P3473; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fairley EAL, 1999, J CELL SCI, V112, P2571; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; Harper M, 2009, FEBS J, V276, P3137, DOI 10.1111/j.1742-4658.2009.07032.x; Hegele RA, 2005, CLIN GENET, V68, P31, DOI 10.1111/j.1399-0004.2005.00447.x; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Holmer L, 2001, CELL MOL LIFE SCI, V58, P1741, DOI 10.1007/PL00000813; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Lattanzi G, 2003, BIOCHEM BIOPH RES CO, V303, P764, DOI 10.1016/S0006-291X(03)00415-7; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Martelli AM, 2000, CANCER RES, V60, P815; Martelli AM, 2002, J CELL BIOCHEM, V86, P320, DOI 10.1002/jcb.10227; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Munoz-Alarcon A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000532; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Raharjo WH, 2001, J CELL SCI, V114, P4447; ROBER RA, 1989, DEVELOPMENT, V105, P365; Sakaki M, 2001, J BIOCHEM-TOKYO, V129, P321, DOI 10.1093/oxfordjournals.jbchem.a002860; Sasseville AMJ, 1998, FEBS LETT, V425, P485, DOI 10.1016/S0014-5793(98)00294-4; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tang KQ, 2000, BIOCHEMISTRY-US, V39, P3185, DOI 10.1021/bi992664v; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; Vaughan OA, 2001, J CELL SCI, V114, P2577; Wakamatsu A, 2009, DNA RES, V16, P371, DOI 10.1093/dnares/dsp022; Wilkinson FL, 2003, EUR J BIOCHEM, V270, P2459, DOI 10.1046/j.1432-1033.2003.03617.x	50	23	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19702	19713		10.1074/jbc.M110.165548	http://dx.doi.org/10.1074/jbc.M110.165548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498514	hybrid, Green Published			2022-12-25	WOS:000291027700053
J	Dai, F; Qiu, L; Ye, LZ; Wu, DZ; Zhou, MX; Zhang, GP				Dai, Fei; Qiu, Long; Ye, Lingzhen; Wu, Dezhi; Zhou, Meixue; Zhang, Guoping			Identification of a Phytase Gene in Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							PHYTIC ACID CONTENT; MYOINOSITOL HEXAKISPHOSPHATE PHOSPHOHYDROLASES; INOSITOL PHOSPHATE-ESTERS; BIOCHEMICAL-CHARACTERIZATION; GERMINATION CONDITIONS; DEGRADING ENZYME; IRON-ABSORPTION; TOTAL-P; PURIFICATION; LOCALIZATION	Background: Endogenous phytase plays a crucial role in phytate degradation and is thus closely related to nutrient efficiency in barley products. The understanding of genetic information of phytase in barley can provide a useful tool for breeding new barley varieties with high phytase activity. Methodology/Principal Findings: Quantitative trait loci (QTL) analysis for phytase activity was conducted using a doubled haploid population. Phytase protein was purified and identified by the LC-ESI MS/MS Shotgun method. Purple acid phosphatase (PAP) gene was sequenced and the position was compared with the QTL controlling phytase activity. A major QTL for phytase activity was mapped to chromosome 5 H in barley. The gene controlling phytase activity in the region was named as mqPhy. The gene HvPAP a was mapped to the same position as mqPhy, supporting the colinearity between HvPAP a and mqPhy. Conclusions/Significance: It is the first report on QTLs for phytase activity and the results showed that HvPAP a, which shares a same position with the QTL, is a major phytase gene in barley grains.	[Dai, Fei; Qiu, Long; Ye, Lingzhen; Wu, Dezhi; Zhang, Guoping] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Meixue] Univ Tasmania, Tasmanian Inst Agr Res, Launceston, Tas 7250, Australia	Zhejiang University; University of Tasmania	Dai, F (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China.	mzhou@utas.edu.au; zhanggp@zju.edu.cn	Wu, Dezhi/AAO-9316-2020; Dai, Fei/F-6512-2010; wu, dezhi/C-2735-2011; , Meixue/C-2387-2014	Wu, Dezhi/0000-0002-7900-0542; , Meixue/0000-0003-3009-7854	China Natural Science Foundation [30971719]; Grains Research and Development Corporation of Australia	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Grains Research and Development Corporation of Australia(Grains R&D Corp)	The project was supported by China Natural Science Foundation (30971719) and "Australia China Collaboration on Barley Germplasm" funded by Grains Research and Development Corporation of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; Bergman EL, 2000, J AGR FOOD CHEM, V48, P4647, DOI 10.1021/jf000525a; Bilgicli N, 2006, FOOD CHEM, V98, P329, DOI 10.1016/j.foodchem.2005.05.078; BRUNE M, 1992, J NUTR, V122, P442, DOI 10.1093/jn/122.3.442; Cashikar AG, 1997, PLANT PHYSIOL, V114, P907, DOI 10.1104/pp.114.3.907; Centeno C, 2003, J AGR SCI, V141, P313, DOI 10.1017/S0021859603003666; Centeno C, 2001, J AGR FOOD CHEM, V49, P3208, DOI 10.1021/jf010023c; COSGROVE DJ, 1970, AUST J BIOL SCI, V23, P1207, DOI 10.1071/BI9701207; Dai F, 2010, J AGR FOOD CHEM, V58, P11821, DOI 10.1021/jf1029948; Dai F, 2007, FOOD CHEM, V105, P606, DOI 10.1016/j.foodchem.2007.04.019; Dionisio G, 2007, PLANT BIOTECHNOL J, V5, P325, DOI 10.1111/j.1467-7652.2007.00244.x; Greiner R, 1999, J SCI FOOD AGR, V79, P1453, DOI [10.1002/(SICI)1097-0010(199908)79:11<1453::AID-JSFA386>3.0.CO;2-R, 10.1002/(SICI)1097-0010(199908)79:11&lt;1453::AID-JSFA386&gt;3.0.CO;2-R]; Greiner R, 2000, J CEREAL SCI, V31, P127, DOI 10.1006/jcrs.1999.0254; Greiner R, 2001, J AGR FOOD CHEM, V49, P2234, DOI 10.1021/jf0100806; Greiner R, 2006, FOOD TECHNOL BIOTECH, V44, P125; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Hegeman CE, 2001, PLANT PHYSIOL, V126, P1598, DOI 10.1104/pp.126.4.1598; Hubel F, 1996, PLANT PHYSIOL, V112, P1429, DOI 10.1104/pp.112.4.1429; Klabunde T, 1996, J MOL BIOL, V259, P737, DOI 10.1006/jmbi.1996.0354; KONIETZNY U, 1995, J FOOD BIOCHEM, V18, P165, DOI 10.1111/j.1745-4514.1994.tb00495.x; Konietzny U, 2002, INT J FOOD SCI TECH, V37, P791, DOI 10.1046/j.1365-2621.2002.00617.x; Kouas S, 2009, AFR J BIOTECHNOL, V8, P5301; Kuang RB, 2009, PLANT PHYSIOL, V151, P199, DOI 10.1104/pp.109.143180; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; LABOURE AM, 1993, BIOCHEM J, V295, P413, DOI 10.1042/bj2950413; Larsson M, 1996, BRIT J NUTR, V76, P677, DOI 10.1079/BJN19960075; Lei X.G., 2007, IND ENZYMES STRUCTUR, P505, DOI DOI 10.1007/1-4020-5377-0_; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; Lung SC, 2008, PHYTOCHEMISTRY, V69, P365, DOI 10.1016/j.phytochem.2007.06.036; Ockenden I, 2004, PLANT SCI, V167, P1131, DOI 10.1016/j.plantsci.2004.06.008; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Rao DECS, 2009, CRIT REV BIOTECHNOL, V29, P182, DOI 10.1080/07388550902919571; Rickard SE, 1997, ACS SYM SER, V662, P294, DOI 10.1021/bk-1997-0662.ch017; SANDBERG AS, 1988, J NUTR, V118, P469, DOI 10.1093/jn/118.4.469; Tye AJ, 2002, APPL MICROBIOL BIOT, V59, P190, DOI 10.1007/s00253-002-1033-5; Van Ooijen JW, 2004, MAPQTLH 5 SOFTWARE M; Vats P, 2005, J IND MICROBIOL BIOT, V32, P141, DOI 10.1007/s10295-005-0214-5; Vohra A, 2003, CRIT REV BIOTECHNOL, V23, P29, DOI 10.1080/713609297; Wang JM, 2007, CEREAL RES COMMUN, V35, P129, DOI 10.1556/CRC.35.2007.1.15; Wang JM, 2010, GENETICA, V138, P1191, DOI 10.1007/s10709-010-9511-7; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Wyss M, 1999, APPL ENVIRON MICROB, V65, P367; Zhou MX, 2009, ADV TOP SCI TECH CHI, P1, DOI 10.1007/978-3-642-01279-2_1	45	14	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18829	10.1371/journal.pone.0018829	http://dx.doi.org/10.1371/journal.pone.0018829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533044	gold, Green Published, Green Submitted			2022-12-25	WOS:000290014500013
J	Gomez-Carballa, A; Cerezo, M; Balboa, E; Heredia, C; Castro-Feijoo, L; Rica, I; Barreiro, J; Eiris, J; Cabanas, P; Martinez-Soto, I; Fernandez-Toral, J; Castro-Gago, M; Pombo, M; Carracedo, A; Barros, F; Salas, A				Gomez-Carballa, Alberto; Cerezo, Maria; Balboa, Emilia; Heredia, Claudia; Castro-Feijoo, Lidia; Rica, Itxaso; Barreiro, Jesus; Eiris, Jesus; Cabanas, Paloma; Martinez-Soto, Isabel; Fernandez-Toral, Joaquin; Castro-Gago, Manuel; Pombo, Manuel; Carracedo, Angel; Barros, Francisco; Salas, Antonio			Evolutionary Analyses of Entire Genomes Do Not Support the Association of mtDNA Mutations with Ras/MAPK Pathway Syndromes	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; OF-FUNCTION MUTATIONS; NOONAN-SYNDROME; POPULATION-GENETICS; REGION SEQUENCES; HAPLOGROUP-H; PTPN11; SOS1; DISORDERS; PHYLOGENY	Background: There are several known autosomal genes responsible for Ras/MAPK pathway syndromes, including Noonan syndrome (NS) and related disorders (such as LEOPARD, neurofibromatosis type 1), although mutations of these genes do not explain all cases. Due to the important role played by the mitochondrion in the energetic metabolism of cardiac muscle, it was recently proposed that variation in the mitochondrial DNA (mtDNA) genome could be a risk factor in the Noonan phenotype and in hypertrophic cardiomyopathy (HCM), which is a common clinical feature in Ras/MAPK pathway syndromes. In order to test these hypotheses, we sequenced entire mtDNA genomes in the largest series of patients suffering from Ras/MAPK pathway syndromes analyzed to date (n = 45), most of them classified as NS patients (n = 42). Methods/Principal Findings: The results indicate that the observed mtDNA lineages were mostly of European ancestry, reproducing in a nutshell the expected haplogroup (hg) patterns of a typical Iberian dataset (including hgs H, T, J, and U). Three new branches of the mtDNA phylogeny (H1j1, U5b1e, and L2a5) are described for the first time, but none of these are likely to be related to NS or Ras/MAPK pathway syndromes when observed under an evolutionary perspective. Patterns of variation in tRNA and protein genes, as well as redundant, private and heteroplasmic variants, in the mtDNA genomes of patients were as expected when compared with the patterns inferred from a worldwide mtDNA phylogeny based on more than 8700 entire genomes. Moreover, most of the mtDNA variants found in patients had already been reported in healthy individuals and constitute common polymorphisms in human population groups. Conclusions/Significance: As a whole, the observed mtDNA genome variation in the NS patients was difficult to reconcile with previous findings that indicated a pathogenic role of mtDNA variants in NS.	[Gomez-Carballa, Alberto; Cerezo, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Galicia, Spain; [Gomez-Carballa, Alberto; Cerezo, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, Inst Med Legal, Fac Med, Santiago De Compostela, Galicia, Spain; [Balboa, Emilia; Carracedo, Angel; Barros, Francisco] CIBERER, Unidad Med Mol, Fdn Publ Galega Med Xenom, Santiago De Compostela, Galicia, Spain; [Heredia, Claudia; Castro-Feijoo, Lidia; Barreiro, Jesus; Cabanas, Paloma; Pombo, Manuel] Hosp Clin Univ, Unidad Endocrinol Pediat Crecimiento & Adolescenc, Dept Pediat, Santiago De Compostela, Galicia, Spain; [Rica, Itxaso] Hosp Cruces, Serv Endocrinol Infantil, Baracaldo, Basque Country, Spain; [Eiris, Jesus; Castro-Gago, Manuel] Hosp Clin Univ, Unidad Neurol Pediat, Dept Pediat, Santiago De Compostela, Galicia, Spain; [Martinez-Soto, Isabel] Hosp Clin Univ Santiago de Compostela, Unidad Cardiol Infantil, Dept Pediat, Santiago De Compostela, Galicia, Spain; [Fernandez-Toral, Joaquin] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Asturias, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitario Cruces; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Central University Hospital Asturias; University of Oviedo	Gomez-Carballa, A (corresponding author), Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patol & Ciencias Forenses, Santiago De Compostela, Galicia, Spain.	antonio.salas@usc.es	Rica, Itxaso/E-7645-2012; Carracedo, Angel/D-4257-2012; Salas, Antonio/E-3977-2012; Gómez-Carballa, Alberto/I-4610-2014; Salas, Antonio/U-2029-2019	Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Salas, Antonio/0000-0002-2336-702X; Eiris, Jesus/0000-0003-4835-6674; Barros, Francisco/0000-0001-6895-4140; Cerezo Fernandez, Maria/0000-0003-3073-1130; Balboa Beltran, Emilia/0000-0003-3395-8672	Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion [SAF2008-02971]	Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This research received support from two grants from the Fundacion de Investigacion Medica Mutua Madrilena, and a grant from the Ministerio de Ciencia e Innovacion (SAF2008-02971), given to AS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Araki T, 2009, P NATL ACAD SCI USA, V106, P4736, DOI 10.1073/pnas.0810053106; Attimonelli M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S4; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2008, INT J CARDIOL, V126, P439, DOI 10.1016/j.ijcard.2007.02.049; Bandelt HJ, 2007, EUR J HUM GENET, V15, P400, DOI 10.1038/sj.ejhg.5201781; Bandelt HJ, 2006, J HUM GENET, V51, P1073, DOI 10.1007/s10038-006-0066-5; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bertola D R, 2000, Arq Bras Cardiol, V75, P409, DOI 10.1590/S0066-782X2000001100005; BURCH M, 1993, J AM COLL CARDIOL, V22, P1189, DOI 10.1016/0735-1097(93)90436-5; Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; Dhandapany PS, 2007, INT J CARDIOL, V120, P284, DOI 10.1016/j.ijcard.2006.07.229; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Gasparre G, 2008, HUM MOL GENET, V17, P986, DOI 10.1093/hmg/ddm371; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Heredia CE, 2009, HORM RES, V72, P317; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; NOONAN JA, 1963, J PEDIATR-US, V63, P468; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pereira L, 2007, MOL BIOL EVOL, V24, P868, DOI 10.1093/molbev/msm004; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566; Prasad GN, 2006, INT J CARDIOL, V109, P432, DOI 10.1016/j.ijcard.2005.07.065; Rani DS, 2010, MITOCHONDRION, V10, P166, DOI 10.1016/j.mito.2009.12.146; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Salas A, 2007, REV CLIN ESP, V207, P563, DOI 10.1157/13111575; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Shchelochkov OA, 2008, AM J MED GENET A, V146A, P1042, DOI 10.1002/ajmg.a.32215; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Takahashi K, 2005, EUR J PEDIATR, V164, P497, DOI 10.1007/s00431-005-1679-y; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2010, MOL SYNDROMOL, V1, P2, DOI 10.1159/000276766; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023; Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012	66	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18348	10.1371/journal.pone.0018348	http://dx.doi.org/10.1371/journal.pone.0018348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526175	Green Submitted, Green Published, gold			2022-12-25	WOS:000289671100002
J	Sorrells, TR; Kuritzky, LY; Kauhanen, PG; Fitzgerald, K; Sturgis, SJ; Chen, J; Dijamco, CA; Basurto, KN; Gordon, DM				Sorrells, Trevor R.; Kuritzky, Leah Y.; Kauhanen, Peter G.; Fitzgerald, Katherine; Sturgis, Shelby J.; Chen, Jimmy; Dijamco, Cheri A.; Basurto, Kimberly N.; Gordon, Deborah M.			Chemical Defense by the Native Winter Ant (Prenolepis imparis) against the Invasive Argentine Ant (Linepithema humile)	PLOS ONE			English	Article							IRIDOMYRMEX-HUMILIS; ABIOTIC FACTORS; HYMENOPTERA; SUCCESS; INTERFERENCE; EXPLOITATION; COMMUNITIES; AGGRESSION; ARTHROPODS; MECHANISMS	The invasive Argentine ant (Linepithema humile) is established worldwide and displaces native ant species. In northern California, however, the native winter ant (Prenolepis imparis) persists in invaded areas. We found that in aggressive interactions between the two species, P. imparis employs a potent defensive secretion. Field observations were conducted at P. imparis nest sites both in the presence and absence of L. humile. These observations suggested and laboratory assays confirmed that P. imparis workers are more likely to secrete when outnumbered by L. humile. Workers of P. imparis were also more likely to secrete near their nest entrances than when foraging on trees. One-on-one laboratory trials showed that the P. imparis secretion is highly lethal to L. humile, causing 79% mortality. The nonpolar fraction of the secretion was chemically analyzed with gas chromatography/mass spectrometry, and found to be composed of long-chain and cyclic hydrocarbons. Chemical analysis of dissected P. imparis workers showed that the nonpolar fraction is derived from the Dufour's gland. Based on these conclusions, we hypothesize that this chemical defense may help P. imparis to resist displacement by L. humile.	[Sorrells, Trevor R.; Kuritzky, Leah Y.; Kauhanen, Peter G.; Fitzgerald, Katherine; Sturgis, Shelby J.; Chen, Jimmy; Dijamco, Cheri A.; Basurto, Kimberly N.; Gordon, Deborah M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Sorrells, TR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	trevor.sorrells@ucsf.edu			Stanford University Office of the Vice Provost for Undergraduate Education	Stanford University Office of the Vice Provost for Undergraduate Education	This research was funded by the Stanford University Office of the Vice Provost for Undergraduate Education. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abril S, 2009, SOCIOBIOLOGY, V53, P559; ANDERSEN AN, 1991, OECOLOGIA, V88, P157, DOI 10.1007/BF00320805; BERGSTROM G, 1973, J INSECT PHYSIOL, V19, P877, DOI 10.1016/0022-1910(73)90159-5; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; Burnam K. P., 2002, MODEL SELECTION MULT, V2nd; Carpintero S, 2008, BIOL INVASIONS, V10, P25, DOI 10.1007/s10530-007-9103-3; DiGirolamo LA, 2006, BIOL INVASIONS, V8, P125, DOI 10.1007/s10530-004-1572-z; EISNER T, 1961, J INSECT PHYSIOL, V6, P272, DOI 10.1016/0022-1910(61)90054-3; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; FRANKS NR, 1993, ANIM BEHAV, V45, P197, DOI 10.1006/anbe.1993.1021; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 1998, OECOLOGIA, V116, P252, DOI 10.1007/s004420050586; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Human KG, 1997, CONSERV BIOL, V11, P1242, DOI 10.1046/j.1523-1739.1997.96264.x; Human KG, 1999, INSECT SOC, V46, P159, DOI 10.1007/s000400050127; Kabashima JN, 2007, J ECON ENTOMOL, V100, P148, DOI 10.1603/0022-0493(2007)100[148:AIBSIA]2.0.CO;2; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; LaPolla JS, 2002, INSECT SOC, V49, P251, DOI 10.1007/s00040-002-8310-2; Laurent P, 2005, TOP CURR CHEM, V240, P167; LYNCH JF, 1980, ECOL ENTOMOL, V5, P353, DOI 10.1111/j.1365-2311.1980.tb01160.x; Martin SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2717, DOI 10.1098/rspb.2007.0795; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Nygard JP, 2008, ECOL ENTOMOL, V33, P789, DOI 10.1111/j.1365-2311.2008.01035.x; O'Donnell S, 1997, J KANSAS ENTOMOL SOC, V70, P175; Palmer TM, 2004, ANIM BEHAV, V68, P993, DOI 10.1016/j.anbehav.2004.02.005; ROTH LM, 1962, ANNU REV ENTOMOL, V7, P107, DOI 10.1146/annurev.en.07.010162.000543; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Sagata K, 2009, J APPL ECOL, V46, P19, DOI 10.1111/j.1365-2664.2008.01523.x; Sakata H, 2001, ECOL RES, V16, P395, DOI 10.1046/j.1440-1703.2001.00404.x; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Talbot M, 1943, ECOLOGY, V24, P31, DOI 10.2307/1929858; Tanner CJ, 2009, INSECT SOC, V56, P64, DOI 10.1007/s00040-008-1039-9; Tanner CJ, 2006, P ROY SOC B-BIOL SCI, V273, P2737, DOI 10.1098/rspb.2006.3626; Tanner CJ, 2009, ANIM BEHAV, V77, P297, DOI 10.1016/j.anbehav.2008.10.016; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; WARD PS, 1987, HILGARDIA, V55, P1; WHEELER WILLIAM MORTON, 1930, ANN ENT SOC AMER, V23, P1; Zee J, 2006, INSECT SOC, V53, P161, DOI 10.1007/s00040-005-0853-6	43	26	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18717	10.1371/journal.pone.0018717	http://dx.doi.org/10.1371/journal.pone.0018717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526231	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100015
J	Abbas, UL; Hood, G; Wetzel, AW; Mellors, JW				Abbas, Ume L.; Hood, Gregory; Wetzel, Arthur W.; Mellors, John W.			Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP)	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 POPULATIONS; UNITED-STATES; VIRAL LOAD; IN-VIVO; TRANSMISSION; MUTATIONS; INTERRUPTION; K65R; CHEMOPROPHYLAXIS	Background: The potential for emergence and spread of HIV drug resistance from rollout of antiretroviral (ARV) pre-exposure prophylaxis (PrEP) is an important public health concern. We investigated determinants of HIV drug resistance prevalence after PrEP implementation through mathematical modeling. Methodology: A model incorporating heterogeneity in age, gender, sexual activity, HIV infection status, stage of disease, PrEP coverage/discontinuation, and HIV drug susceptibility, was designed to simulate the impact of PrEP on HIV prevention and drug resistance in a sub-Saharan epidemic. Principal Findings: Analyses suggest that the prevalence of HIV drug resistance is influenced most by the extent and duration of inadvertent PrEP use in individuals already infected with HIV. Other key factors affecting drug resistance prevalence include the persistence time of transmitted resistance and the duration of inadvertent PrEP use in individuals who become infected on PrEP. From uncertainty analysis, the median overall prevalence of drug resistance at 10 years was predicted to be 9.2% (interquartile range 6.9%-12.2%). An optimistic scenario of 75% PrEP efficacy, 60% coverage of the susceptible population, and 5% inadvertent PrEP use predicts a rise in HIV drug resistance prevalence to only 2.5% after 10 years. By contrast, in a pessimistic scenario of 25% PrEP efficacy, 15% population coverage, and 25% inadvertent PrEP use, resistance prevalence increased to over 40%. Conclusions: Inadvertent PrEP use in previously-infected individuals is the major determinant of HIV drug resistance prevalence arising from PrEP. Both the rate and duration of inadvertent PrEP use are key factors. PrEP rollout programs should include routine monitoring of HIV infection status to limit the spread of drug resistance.	[Abbas, Ume L.] Cleveland Clin Fdn, Dept Infect Dis, Cleveland, OH 44195 USA; [Hood, Gregory; Wetzel, Arthur W.] Pittsburgh Supercomp Ctr, Pittsburgh, PA USA; [Mellors, John W.] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Abbas, UL (corresponding author), Cleveland Clin Fdn, Dept Infect Dis, 9500 Euclid Ave, Cleveland, OH 44195 USA.	abbasu@ccf.org	Abbas, Ume/AAW-4590-2021		National Institute of Allergy and Infectious Diseases [R21AI078789]; Bill and Melinda Gates Foundation [OPP1005974]; AIDS Clinical Trials Group (NIAID) [U01AI38858]; Microbicide Trials Network (NIAID) [U01AI068633]; National Cancer Institute (SAIC) [20XS190A]; Merck; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068633, R21AI078789, U01AI038858] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); AIDS Clinical Trials Group (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Microbicide Trials Network (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (SAIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institute of Allergy and Infectious Diseases (R21AI078789) and the Bill and Melinda Gates Foundation. Ume L. Abbas acknowledges grant support from the National Institute of Allergy and Infectious Diseases (R21AI078789) and the Bill and Melinda Gates Foundation (OPP1005974). John W. Mellors acknowledges support from the AIDS Clinical Trials Group (NIAID U01AI38858), the Microbicide Trials Network (NIAID U01AI068633) and the National Cancer Institute (SAIC contract 20XS190A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; John W. Mellors reports that he is a consultant to Gilead Sciences, Merck, and RFS Pharmaceuticals, has received grant support from Merck, and owns share options in RFS Pharmaceuticals. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; ANDERSON R M, 1991; Atchison RE, 2005, ANTIVIR THER, V10, pS45; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; BrunVezinet F, 1997, LANCET, V350, P983, DOI 10.1016/S0140-6736(97)03380-1; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Delaugerre C, 2001, AIDS, V15, P2189, DOI 10.1097/00002030-200111090-00016; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Gandhi RT, 2003, CLIN INFECT DIS, V37, P1693, DOI 10.1086/379773; Garcia-Lerma JG, 2006, ANTIVIR THER, V11, pS52; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2010, TRENDS PHARMACOL SCI, V31, P74, DOI 10.1016/j.tips.2009.10.009; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; GRANT R, 2006, 16 INT AIDS C TOR CA; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grassly N. C., 2003, International Journal of Drug Policy, V14, P25, DOI 10.1016/S0955-3959(02)00224-4; Hance AJ, 2001, J VIROL, V75, P6410, DOI 10.1128/JVI.75.14.6410-6417.2001; Hofer E, 1999, COMPUT PHYS COMMUN, V117, P21, DOI 10.1016/S0010-4655(98)00153-2; Iman RL, 2002, RELIAB ENG SYST SAFE, V78, P131, DOI 10.1016/S0951-8320(02)00133-3; Iman RL, 2002, RELIAB ENG SYST SAFE, V78, P147, DOI 10.1016/S0951-8320(02)00134-5; IMAN RL, 1979, TECHNOMETRICS, V21, P499, DOI 10.2307/1268289; Izopet J, 2002, J INFECT DIS, V185, P1506, DOI 10.1086/340215; JOHNSON J, 2006, 13 C RETR OPP INF DE; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; May R., 2001, VIRUS DYNAMICS MATH; MILLER DK, 1994, MED DECIS MAKING, V14, P52, DOI 10.1177/0272989X9401400107; Miller MD, 2007, AIDS, V21, P265, DOI 10.1097/QAD.0b013e32801199ee; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Rey D, 1998, J ACQ IMMUN DEF SYND, V17, P203, DOI 10.1097/00042560-199803010-00003; SALTELLI A, 2000, SENSITIVITY ANAL, P475; SMITH D, 2006, ANTIRETROVIRAL RESIS; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Tedder RS, 1998, J CLIN MICROBIOL, V36, P1056, DOI 10.1128/JCM.36.4.1056-1063.1998; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; van de Vijver DAMC, 2009, J INFECT DIS, V199, P1310, DOI 10.1086/597804; Van Rompay KKA, 2006, J VIROL, V80, P6399, DOI 10.1128/JVI.02308-05; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Weber J, 2005, J CLIN MICROBIOL, V43, P1395, DOI 10.1128/JCM.43.3.1395-1400.2005; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; Yerly S, 2004, ANTIVIR THER, V9, P375; AIDS VACCINE ADVOCAC	46	49	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18165	10.1371/journal.pone.0018165	http://dx.doi.org/10.1371/journal.pone.0018165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525976	Green Published, gold, Green Accepted			2022-12-25	WOS:000289578600007
J	Lambert, JC; Dallongeville, J; Ellis, KA; Schraen-Maschke, S; Lui, J; Laws, S; Dumont, J; Richard, F; Cottel, D; Berr, C; Ames, D; Masters, CL; Rowe, CC; Szoeke, C; Tzourio, C; Dartigues, JF; Buee, L; Martins, R; Amouyel, P				Lambert, Jean-Charles; Dallongeville, Jean; Ellis, Kathryn A.; Schraen-Maschke, Susanna; Lui, James; Laws, Simon; Dumont, Julie; Richard, Florence; Cottel, Dominique; Berr, Claudine; Ames, David; Masters, Colin L.; Rowe, Christopher C.; Szoeke, Cassandra; Tzourio, Christophe; Dartigues, Jean-Francois; Buee, Luc; Martins, Ralph; Amouyel, Philippe			Association of Plasma A beta Peptides with Blood Pressure in the Elderly	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BASE-LINE CHARACTERISTICS; ALZHEIMERS-DISEASE; RISK-FACTORS; DEMENTIA; BRAIN; VASOACTIVITY; LIPOPROTEINS; POPULATION; TRANSPORT	Background: A beta peptides are often considered as catabolic by-products of the amyloid beta protein precursor (APP), with unknown physiological functions. However, several biological properties have been tentatively attributed to these peptides, including a role in vasomotion. We assess whether plasma A beta peptide levels might be associated with systolic and diastolic blood pressure values (SBP and DBP, respectively). Methodology/Principal Findings: Plasma A beta(1-40) and A beta(1-42) levels were measured using an xMAP-based assay in 1,972 individuals (none of whom were taking antihypertensive drugs) from 3 independent studies: the French population-based 3C and MONA-LISA (Lille) studies (n = 627 and n = 769, respectively) and the Australian, longitudinal AIBL study (n = 576). In the combined sample, the A beta(1-42)/ A beta(1-40) ratio was significantly and inversely associated with SBP (p = 0.03) and a similar trend was observed for DBP (p = 0.06). Using the median age (69) as a cut-off, the A beta(1-42)/A beta(1-40) ratio was strongly associated with both SBP and DBP in elderly individuals (p = 0.002 and p = 0.03, respectively). Consistently, a high A beta(1-42)/ A beta(1-40) ratio was associated with a lower risk of hypertension in both the combined whole sample (odds ratio [OR], 0.71; 95% confidence interval [CI], 0.56-0.90) and (to an even greater extent) in the elderly subjects (OR, 0.53; 95% CI, 0.37-0.75). Lastly, all these associations appeared to be primarily driven by the level of plasma A beta(1-40). Conclusion: The plasma A beta(1-42)/A beta(1-40) ratio is inversely associated with SBP, DBP and the risk of hypertension in elderly subjects, suggesting that A beta peptides affect blood pressure in vivo. These results may be particularly relevant in Alzheimer's disease, in which a high A beta(1-42)/A beta(1-40) plasma ratio is reportedly associated with a decreased risk of incident disease.	[Lambert, Jean-Charles; Dallongeville, Jean; Dumont, Julie; Richard, Florence; Cottel, Dominique; Amouyel, Philippe] INSERM, U744, F-59045 Lille, France; [Lambert, Jean-Charles; Dallongeville, Jean; Dumont, Julie; Richard, Florence; Cottel, Dominique; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Lambert, Jean-Charles; Dallongeville, Jean; Schraen-Maschke, Susanna; Dumont, Julie; Richard, Florence; Cottel, Dominique; Buee, Luc; Amouyel, Philippe] Univ Lille Nord France, UDSL, Lille, France; [Ellis, Kathryn A.; Ames, David] Univ Melbourne, St Georges Hosp, Dept Psychiat, Melbourne, Vic 3010, Australia; [Ellis, Kathryn A.; Masters, Colin L.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Ellis, Kathryn A.; Ames, David; Szoeke, Cassandra] Natl Ageing Res Inst, Parkville, Vic, Australia; [Schraen-Maschke, Susanna; Buee, Luc] INSERM, U837, F-59045 Lille, France; [Lui, James; Laws, Simon; Martins, Ralph] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA, Australia; [Lui, James; Laws, Simon; Martins, Ralph] Sir James McCusker Alzheimers Res Unit, Perth, WA, Australia; [Schraen-Maschke, Susanna; Richard, Florence; Buee, Luc; Amouyel, Philippe] Ctr Hosp Reg Univ, Lille, France; [Berr, Claudine] Univ Montpellier 1, INSERM, U888, Montpellier, France; [Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Rowe, Christopher C.] Austin Hlth, Heidelberg, Vic, Australia; [Szoeke, Cassandra] Australian Commonwealth Sci & Res Org CSIRO, Parkville, Vic, Australia; [Tzourio, Christophe] INSERM, U708, Paris, France; [Dartigues, Jean-Francois] Victor Segalen Univ, INSERM, U593, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; St George Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; National Ageing Research Institute; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Edith Cowan University; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Lambert, JC (corresponding author), INSERM, U744, F-59045 Lille, France.	jean-charles.lambert@pasteur-lille.fr	Szoeke, CAssandra/AAE-8715-2019; Tzourio, christophe/L-6344-2019; Lambert, jean-charles/A-9553-2014; Szoeke, Cassandra/AAI-8631-2021; berr, Claudine/D-5238-2014; Dumont, Julie/F-4687-2018; IBL, A/C-8408-2013; Tzourio, christophe/B-4015-2009; DARTIGUES, Jean François/T-4513-2019; Laws, Simon/C-2858-2014; Rowe, Christopher/AAX-8748-2021; lambert, jean-charles/F-8787-2013; BUEE, Luc/B-3126-2010; Dumont, Julie/AAD-9763-2022	Tzourio, christophe/0000-0002-6517-2984; Lambert, jean-charles/0000-0003-0829-7817; Szoeke, Cassandra/0000-0002-3698-2590; berr, Claudine/0000-0001-5254-7655; Dumont, Julie/0000-0002-6009-0111; Tzourio, christophe/0000-0002-6517-2984; Laws, Simon/0000-0002-4355-7082; lambert, jean-charles/0000-0003-0829-7817; BUEE, Luc/0000-0002-6261-4230; SCHRAEN, Susanna/0000-0002-7247-4809; Amouyel, Philippe/0000-0001-9088-234X; Martins, Ralph/0000-0002-4828-9363; Ellis, Kathryn/0000-0001-9097-9037	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Aquitaine Regional Council; Fondation de France; French Ministry of Research/INSERM; Sanofi-Synthelabo; Eisai; CNRS; Nord Pas-de-Calais Regional Council; European Regional Development Fund; INSERM-DHOS-INCA [A08037ECS]; European Community [LSHM-CT-2007-037950]; Bourgogne Regional Councils	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Agence Francaise de Securite Sanitaire des Produits de Sante; Aquitaine Regional Council(Region Nouvelle-Aquitaine); Fondation de France(Fondation de France); French Ministry of Research/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Ministry of Research, France); Sanofi-Synthelabo; Eisai(Eisai Co Ltd); CNRS(Centre National de la Recherche Scientifique (CNRS)); Nord Pas-de-Calais Regional Council(Region Hauts-de-France); European Regional Development Fund(European Commission); INSERM-DHOS-INCA; European Community(European Commission); Bourgogne Regional Councils	The 3C Study was performed as part of a collaboration between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen-Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise de Securite Sanitaire des Produits de Sante, the Aquitaine and Bourgogne Regional Councils, Fondation de France and the joint French Ministry of Research/INSERM "Cohortes et collections de donnees biologiques" programme. Sanofi-Synthelabo provided funding for this study. Lille Genopole received an unconditional grant from Eisai. This work was additionally funded by the CNRS, the Nord Pas-de-Calais Regional Council, the European Regional Development Fund and grants from INSERM-DHOS-INCA (Project A08037ECS) and the European Community's cNEUPRO programme (contract LSHM-CT-2007-037950). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdullah L, 2009, MOL MED, V15, P95, DOI 10.2119/molmed.2008.00118; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Casiglia Edoardo, 2009, Expert Rev Cardiovasc Ther, V7, P659, DOI 10.1586/erc.09.17; Crawford F, 1998, EXP NEUROL, V150, P159, DOI 10.1006/exnr.1997.6743; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Feldstein CA, 2010, NEUROEPIDEMIOLOGY, V35, P202, DOI 10.1159/000316872; Ferrieres J, 2009, ARCH CARDIOVASC DIS, V102, P293, DOI 10.1016/j.acvd.2009.02.002; Frackowiak J, 2004, BRAIN RES, V1002, P67, DOI 10.1016/j.brainres.2003.12.015; Gurol ME, 2006, NEUROLOGY, V66, P23, DOI 10.1212/01.wnl.0000191403.95453.6a; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Kontush A, 2001, CELL MOL NEUROBIOL, V21, P299, DOI 10.1023/A:1012629603390; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Le YY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0003.2001; Li QX, 1998, LAB INVEST, V78, P461; Lui JK, 2010, J ALZHEIMERS DIS, V20, P1233, DOI 10.3233/JAD-2010-090249; Luo F, 2008, NEUROSCIENCE, V155, P263, DOI 10.1016/j.neuroscience.2008.04.021; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Nagai M, 2010, AM J HYPERTENS, V23, P116, DOI 10.1038/ajh.2009.212; Paris D, 1998, EXP NEUROL, V152, P116, DOI 10.1006/exnr.1998.6828; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Qiu CX, 2003, ARCH NEUROL-CHICAGO, V60, P223, DOI 10.1001/archneur.60.2.223; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; Wynne BM, 2009, J AM SOC HYPERTENS, V3, P84, DOI 10.1016/j.jash.2008.09.002; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397	30	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18536	10.1371/journal.pone.0018536	http://dx.doi.org/10.1371/journal.pone.0018536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525986	gold, Green Published			2022-12-25	WOS:000289578600013
J	Xu, MB; He, XL				Xu, Meibo; He, Xionglei			Genetic Incompatibility Dampens Hybrid Fertility More Than Hybrid Viability: Yeast as a Case Study	PLOS ONE			English	Article							STERILITY; SPECIATION; DROSOPHILA; EVOLUTION; PROTEIN; SACCHAROMYCES; RESOLUTION; EPISTASIS; THALIANA; NUCLEAR	Genetic incompatibility is believed to be the major cause of postzygotic reproductive isolation. Despite huge efforts seeking for speciation-related incompatibilities in the past several decades, a general understanding of how genetic incompatibility evolves in affecting hybrid fitness is not available, primarily due to the fact that the number of known incompatibilities is small. Instead of further mapping specific incompatible genes, in this paper we aimed to know the overall effects of incompatibility on fertility and viability, the two aspects of fitness, by examining 89 gametes produced by yeast S. cerevisiae - S. paradoxus F1 hybrids. Homozygous F2 hybrids formed by autodiploidization of F1 gametes were subject to tests for growth rate and sporulation efficiency. We observed much stronger defects in sporulation than in clonal growth for every single F2 hybrid strain, indicating that genetic incompatibility affects hybrid fertility more than hybrid viability in yeast. We related this finding in part to the fast-evolving nature of meiosis-related genes, and proposed that the generally low expression levels of these genes might be a cause of the observation.	[Xu, Meibo; He, Xionglei] Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, MB (corresponding author), Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	hexiongl@mail.sysu.edu.cn			National Natural Science Foundation of China [30871371, 40930212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (#30871371 and #40930212 to XH). The agency did not influence the design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.	Alcazar R, 2010, NAT GENET, V42, P1135, DOI 10.1038/ng.704; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Chou JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000432; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dobzhansky T, 1936, GENETICS, V21, P113; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Fishman L, 2001, EVOLUTION, V55, P1932, DOI 10.1111/j.0014-3820.2001.tb01311.x; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Greig D, 2009, HEREDITY, V102, P39, DOI 10.1038/hdy.2008.73; Greig D, 2007, PLOS GENET, V3, P281, DOI 10.1371/journal.pgen.0030021; Greig D, 2009, CURR BIOL, V19, pR886, DOI 10.1016/j.cub.2009.07.037; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kao KC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001038; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Muller HJ, 1942, BIOL S, V6, P71; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Tang SW, 2009, SCIENCE, V323, P779, DOI 10.1126/science.1169123; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Zhang JZ, 2005, MOL BIOL EVOL, V22, P1147, DOI 10.1093/molbev/msi101	36	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18341	10.1371/journal.pone.0018341	http://dx.doi.org/10.1371/journal.pone.0018341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494679	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400021
J	Ikezawa, N; Gopfert, JC; Nguyen, DT; Kim, SU; O'Maille, PE; Spring, O; Ro, DK				Ikezawa, Nobuhiro; Goepfert, Jens Christian; Nguyen, Don Trinh; Kim, Soo-Un; O'Maille, Paul E.; Spring, Otmar; Ro, Dae-Kyun			Lettuce Costunolide Synthase (CYP71BL2) and Its Homolog (CYP71BL1) from Sunflower Catalyze Distinct Regio- and Stereoselective Hydroxylations in Sesquiterpene Lactone Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPITATE GLANDULAR TRICHOMES; ANTIMALARIAL-DRUG PRECURSOR; BIOLOGICAL-ACTIVITIES; ARTEMISINIC ACID; SAUSSUREA-LAPPA; ASTERACEAE; GENES; CHARACTERS; EXPRESSION; ANALOGS	Sesquiterpene lactones (STLs) are terpenoid natural products possessing the gamma-lactone, well known for their diverse biological and medicinal activities. The occurrence of STLs is sporadic in nature, but most STLs have been isolated from plants in the Asteraceae family. Despite the implication of the gamma-lactone group in many reported bioactivities of STLs, the biosynthetic origins of the gamma-lactone ring remains elusive. Germacrene A acid (GAA) has been suggested as a central precursor of diverse STLs. The regioselective (C6 or C8) and stereoselective (alpha or beta) hydroxylation on a carbon of GAA adjacent to its carboxylic acid at C12 is responsible for the gamma-lactone formation. Here, we report two cytochrome P450 monooxygenases (P450s) capable of catalyzing 6 alpha- and 8 beta-hydroxylation of GAA from lettuce and sunflower, respectively. To identify these P450s, sunflower trichomes were isolated to generate a trichome-specific transcript library, from which 10 P450 clones were retrieved. Expression of these clones in a yeast strain metabolically engineered to synthesize substrate GAA identified a P450 catalyzing 8 beta-hydroxylation of GAA, but the STL was not formed by spontaneous lactonization. Subsequently, we identified the closest homolog of the GAA 8 beta-hydroxylase from lettuce and discovered 6 alpha-hydroxylation of GAA by the recombinant enzyme. The resulting 6 alpha-hydroxy-GAA spontaneously undergoes a lactonization to yield the simplest form of STL, costunolide. Furthermore, we demonstrate the milligram per liter scale de novo synthesis of costunolide using the lettuce P450 in an engineered yeast strain, an important advance that will enable exploitation of STLs. Evolution and homology models of these two P450s are discussed.	[Ikezawa, Nobuhiro; Nguyen, Don Trinh; Ro, Dae-Kyun] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Goepfert, Jens Christian; Spring, Otmar] Univ Hohenheim, Inst Bot, D-70599 Stuttgart, Germany; [Kim, Soo-Un] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151951, South Korea; [O'Maille, Paul E.] Inst Food Res, John Innes Ctr, Norwich NR4 7UH, Norfolk, England	University of Calgary; University Hohenheim; Seoul National University (SNU); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Quadram Institute; University of East Anglia	Ro, DK (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	daekyun.ro@ucalgary.ca	Ro, Dae-Kyun/G-9289-2012	Ro, Dae-Kyun/0000-0003-1288-5347; Nguyen, Trinh-Don/0000-0002-2759-5791	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair; Canada Foundation for Innovation; Japan Society for the Promotion of Science; Deutsche Forschungsgemeinschaft [SP292/20-2]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0644] Funding Source: researchfish; BBSRC [BBS/E/J/000C0644] Funding Source: UKRI	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grant, Canada Research Chair program Alberta Innovates Bio Solutions, and Canada Foundation for Innovation (to D.-K. R.) and by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (to N. I.). This work was also supported by German Research Foundation Grant (Deutsche Forschungsgemeinschaft) SP292/20-2 (to O. S. and J. C. G.).	Barreda VD, 2010, SCIENCE, V329, P1621, DOI 10.1126/science.1193108; Bennett MH, 2002, PHYTOCHEMISTRY, V60, P255, DOI 10.1016/S0031-9422(02)00103-6; Bouwmeester HJ, 2002, PLANT PHYSIOL, V129, P134, DOI 10.1104/pp.001024; BRECKNELL DJ, 1979, AUST J CHEM, V32, P2455, DOI 10.1071/CH9792455; CHEN HC, 1995, ANTIVIR RES, V27, P99, DOI 10.1016/0166-3542(94)00083-K; Christensen SB, 1999, BIOORGAN MED CHEM, V7, P1273; Dall'Acqua S, 2006, CHEM PHARM BULL, V54, P1187, DOI 10.1248/cpb.54.1187; de Kraker JW, 2002, PLANT PHYSIOL, V129, P257, DOI 10.1104/pp.010957; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Eliza J, 2009, CHEM-BIOL INTERACT, V179, P329, DOI 10.1016/j.cbi.2008.10.017; FISCHER NH, 1990, RECENT ADV PHYTOCHEM, V24, P161; Gopfert JC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-86; Gopfert JC, 2005, PLANT BIOLOGY, V7, P148, DOI 10.1055/s-2005-837575; GOTOH O, 1992, J BIOL CHEM, V267, P83; HOLUB M, 1987, BIOCHEM SYST ECOL, V15, P321, DOI 10.1016/0305-1978(87)90006-8; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Kassuya CAL, 2009, J ETHNOPHARMACOL, V124, P369, DOI 10.1016/j.jep.2009.06.003; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; Park SH, 2001, PLANTA MED, V67, P358, DOI 10.1055/s-2001-14315; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PICMAN AK, 1986, BIOCHEM SYST ECOL, V14, P255, DOI 10.1016/0305-1978(86)90101-8; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; RAO AS, 1960, TETRAHEDRON, V9, P275, DOI 10.1016/0040-4020(60)80017-8; Ro DK, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-83; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Robinson A, 2008, BIOORG MED CHEM LETT, V18, P4015, DOI 10.1016/j.bmcl.2008.06.008; RODRIGUEZ E, 1976, PHYTOCHEMISTRY, V15, P1573, DOI 10.1016/S0031-9422(00)97430-2; Satou T, 2002, VET PARASITOL, V104, P131, DOI 10.1016/S0304-4017(01)00619-7; SEAMAN FC, 1982, BOT REV, V48, P121, DOI 10.1007/BF02919190; Sessa RA, 2000, J BIOL CHEM, V275, P26877; TAKASUGI M, 1985, J CHEM SOC CHEM COMM, P621, DOI 10.1039/c39850000621; Wedge DE, 2000, PHYTOCHEMISTRY, V53, P747, DOI 10.1016/S0031-9422(00)00008-X	36	86	95	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21601	21611		10.1074/jbc.M110.216804	http://dx.doi.org/10.1074/jbc.M110.216804			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515683	hybrid, Green Published			2022-12-25	WOS:000291464700057
J	Leung, JW; Leitch, A; Wood, JL; Shaw-Smith, C; Metcalfe, K; Bicknell, LS; Jackson, AP; Chen, JJ				Leung, Justin W.; Leitch, Andrea; Wood, Jamie L.; Shaw-Smith, Charles; Metcalfe, Kay; Bicknell, Louise S.; Jackson, Andrew P.; Chen, Junjie			SET Nuclear Oncogene Associates with Microcephalin/MCPH1 and Regulates Chromosome Condensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; ACTIVATING FACTOR-I; CHROMATIN DECONDENSATION; PROTEIN; TRANSCRIPTION; BRIT1/MCPH1; ACETYLATION; ONCOPROTEIN; HISTONE; PATHWAY	Primary microcephaly is an autosomal recessive disorder characterized by marked reduction in human brain size. Microcephalin (MCPH1), one of the genes mutated in primary microcephaly, plays an important role in DNA damage checkpoint control and mitotic entry. Additionally, MCPH1 ensures the proper temporal activation of chromosome condensation during mitosis, by acting as a negative regulator of the condensin II complex. We previously found that deletion of the of the MCPH1 N terminus leads to the premature chromosome condensation (PCC) phenotype. In the present study, we unexpectedly observed that a truncated form of MCPH1 appears to be expressed in MCPH1(S25X/S25X) patient cells. This likely results from utilization of an alternative translational start codon, which would produce a mutant MCPH1 protein with a small deletion of its N-terminal BRCT domain. Furthermore, missense mutations in the MCPH1 cluster at its N terminus, suggesting that intact function of this BRCT protein-interaction domain is required both for coordinating chromosome condensation and human brain development. Subsequently, we identified the SET nuclear oncogene as a direct binding partner of the MCPH1 N-terminal BRCT domain. Cells with SET knockdown exhibited abnormal condensed chromosomes similar to those observed in MCPH1-deficient mouse embryonic fibroblasts. Condensin II knockdown rescued the abnormal chromosome condensation phenotype in SET-depleted cells. In addition, MCPH1 V50G/I51V missense mutations, impair binding to SET and fail to fully rescue the abnormal chromosome condensation phenotype in Mcph1(-/-) mouse embryonic fibroblasts. Collectively, our findings suggest that SET is an important regulator of chromosome condensation/decondensation and that disruption of the MCPH1-SET interaction might be important for the pathogenesis of primary microcephaly.	[Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, Houston, TX 77030 USA; [Leitch, Andrea; Bicknell, Louise S.; Jackson, Andrew P.] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Wood, Jamie L.] Univ Minnesota, Sch Med, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA; [Shaw-Smith, Charles] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Metcalfe, Kay] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England	University of Texas System; UTMD Anderson Cancer Center; University of Edinburgh; University of Minnesota System; University of Minnesota Twin Cities; Wellcome Trust Sanger Institute; University of Manchester	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 66, 1515 Holcombe Blvd,Room Y3-6006, Houston, TX 77030 USA.	jchen8@mdanderson.org	Bicknell, Louise/GLR-4215-2022; Bicknell, Louise/AAL-8003-2020; Jackson, Andrew/D-3442-2009	Bicknell, Louise/0000-0001-6899-9322; Jackson, Andrew/0000-0002-8739-2646; Leung, Justin Wai Chung/0000-0003-4601-390X	National Institutes of Health [CA089239, CA092312]; Medical Research Council; Lister Institute of Preventative Medicine; Department of Defense [W81XWH-05-1-0470]; MRC [MC_U127580972] Funding Source: UKRI; Medical Research Council [MC_U127580972] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute of Preventative Medicine; Department of Defense(United States Department of Defense); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants (CA089239 and CA092312) from the National Institutes of Health (to J.C.).; A Medical Research Council Senior Clinical Fellow and supported by the Medical Research Council and Lister Institute of Preventative Medicine.; Recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470) and a member of M.D. Anderson Cancer Center (CA016672). To whom correspondence should be addressed: Dept. of Experimental Radiation Oncology, Unit 66, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Room Y3.6006, Houston, TX 77030. Tel.: 713-792-4863; Fax: 713-794-5369; E-mail: jchen8@mdanderson.org.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; BRAUTIGAN DL, 1990, NATURE, V344, P74, DOI 10.1038/344074a0; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Darvish H, 2010, J MED GENET, V47, P823, DOI 10.1136/jmg.2009.076398; Gavvovidis I, 2010, CELL CYCLE, V9, P4893, DOI 10.4161/cc.9.24.14157; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Karetsou Z, 2004, FEBS LETT, V577, P496, DOI 10.1016/j.febslet.2004.09.091; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Matsumoto K, 1999, FEBS LETT, V463, P285, DOI 10.1016/S0014-5793(99)01632-4; Matsumoto K, 1999, MOL CELL BIOL, V19, P6940; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Trimborn Marc, 2005, Hum Mutat, V26, P496, DOI 10.1002/humu.9382; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200	26	26	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21393	21400		10.1074/jbc.M110.208793	http://dx.doi.org/10.1074/jbc.M110.208793			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515671	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000291464700038
J	Certain, G; Skarpaas, O; Bjerke, JW; Framstad, E; Lindholm, M; Nilsen, JE; Norderhaug, A; Oug, E; Pedersen, HC; Schartau, AK; van der Meeren, GI; Aslaksen, I; Engen, S; Garnasjordet, PA; Kvaloy, P; Lillegard, M; Yoccoz, NG; Nybo, S				Certain, Gregoire; Skarpaas, Olav; Bjerke, Jarle-Werner; Framstad, Erik; Lindholm, Markus; Nilsen, Jan-Erik; Norderhaug, Ann; Oug, Eivind; Pedersen, Hans-Christian; Schartau, Ann-Kristin; van der Meeren, Gro I.; Aslaksen, Iulie; Engen, Steinar; Garnasjordet, Per-Arild; Kvaloy, Pal; Lillegard, Magnar; Yoccoz, Nigel G.; Nybo, Signe			The Nature Index: A General Framework for Synthesizing Knowledge on the State of Biodiversity	PLOS ONE			English	Article							INDICATORS; CONSERVATION; DIVERSITY; ACIDIFICATION; MANAGEMENT; VEGETATION; RICHNESS; SPACE; LONG	The magnitude and urgency of the biodiversity crisis is widely recognized within scientific and political organizations. However, a lack of integrated measures for biodiversity has greatly constrained the national and international response to the biodiversity crisis. Thus, integrated biodiversity indexes will greatly facilitate information transfer from science toward other areas of human society. The Nature Index framework samples scientific information on biodiversity from a variety of sources, synthesizes this information, and then transmits it in a simplified form to environmental managers, policymakers, and the public. The Nature Index optimizes information use by incorporating expert judgment, monitoring-based estimates, and model-based estimates. The index relies on a network of scientific experts, each of whom is responsible for one or more biodiversity indicators. The resulting set of indicators is supposed to represent the best available knowledge on the state of biodiversity and ecosystems in any given area. The value of each indicator is scaled relative to a reference state, i.e., a predicted value assessed by each expert for a hypothetical undisturbed or sustainably managed ecosystem. Scaled indicator values can be aggregated or disaggregated over different axes representing spatiotemporal dimensions or thematic groups. A range of scaling models can be applied to allow for different ways of interpreting the reference states, e.g., optimal situations or minimum sustainable levels. Statistical testing for differences in space or time can be implemented using Monte-Carlo simulations. This study presents the Nature Index framework and details its implementation in Norway. The results suggest that the framework is a functional, efficient, and pragmatic approach for gathering and synthesizing scientific knowledge on the state of biodiversity in any marine or terrestrial ecosystem and has general applicability worldwide.	[Certain, Gregoire; Pedersen, Hans-Christian; Engen, Steinar; Kvaloy, Pal; Nybo, Signe] Norwegian Inst Nat Res NINA, Trondheim, Norway; [Skarpaas, Olav; Framstad, Erik; Schartau, Ann-Kristin] Norwegian Inst Nat Res NINA, Oslo, Norway; [Bjerke, Jarle-Werner; Yoccoz, Nigel G.] Norwegian Inst Nat Res NINA, Tromso, Norway; [Lindholm, Markus; Oug, Eivind] Norwegian Inst Water Res NIVA, Oslo, Norway; [Nilsen, Jan-Erik] Norwegian Forest & Landscape Inst, As, Norway; [Norderhaug, Ann] Norwegian Inst Agr & Environm Res BIOFORSK, Stjordal, Norway; [van der Meeren, Gro I.] IMR, Bergen, Norway; [Aslaksen, Iulie; Garnasjordet, Per-Arild; Lillegard, Magnar] Stat Norway SSB, Oslo, Norway; [Engen, Steinar] Ctr Conservat Biol, Dept Math Sci, Trondheim, Norway; [Yoccoz, Nigel G.] Univ Tromso UiT, Tromso, Norway; [Nybo, Signe] Directorate Nat Management, Trondheim, Norway	Norwegian Institute Nature Research; Norwegian Institute Nature Research; Norwegian Institute Nature Research; Norwegian Institute for Water Research (NIVA); The Norwegian Forest & Landscape Institute; Bioforsk; Institute of Marine Research - Norway; Statistics Norway; UiT The Arctic University of Tromso	Certain, G (corresponding author), Inst Marine Res, Tromso, Norway.	Gregoire.Certain@imr.no	Yoccoz, Nigel/C-8561-2014	Yoccoz, Nigel/0000-0003-2192-1039; Bjerke, Jarle W./0000-0003-2721-1492; Skarpaas, Olav/0000-0001-9727-1672	Norwegian Ministry of Environment; Research Council of Norway [190054]	Norwegian Ministry of Environment; Research Council of Norway(Research Council of Norway)	This study was financed by the Norwegian Ministry of Environment and organized and overseen by the Directorate for Nature Management. The interdisciplinary research was financed by the Research Council of Norway, grant 190054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkemade R, 2009, ECOSYSTEMS, V12, P374, DOI 10.1007/s10021-009-9229-5; Arts GHP, 2002, AQUAT BOT, V73, P373, DOI 10.1016/S0304-3770(02)00031-1; BLUMENRATH S, 2010, DATAGRUNNLAG NATURIN, P8; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CERTAIN G, 2010, 542 NINA, P1; CHAPMAN AD, 2009, CSIRO, V2, P1; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; Duelli P, 2003, AGR ECOSYST ENVIRON, V98, P87, DOI 10.1016/S0167-8809(03)00072-0; Faiths DP, 2008, GLOBAL CHANGE BIOL, V14, P207, DOI 10.1111/j.1365-2486.2007.01500.x; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Fonderflick J, 2010, BIOL CONSERV, V143, P737, DOI 10.1016/j.biocon.2009.12.014; Frank DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010688; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Garthwaite PH, 2005, J AM STAT ASSOC, V100, P680, DOI 10.1198/016214505000000105; Grantham HS, 2009, ECOL LETT, V12, P293, DOI 10.1111/j.1461-0248.2009.01287.x; Henry PY, 2008, BIODIVERS CONSERV, V17, P3357, DOI 10.1007/s10531-008-9417-1; HESTHAGEN T, 1995, BIOL CONSERV, V74, P115, DOI 10.1016/0006-3207(95)00020-5; HINDAR K, 2010, ATLANTIC SALMON ECOL, P299; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Johnson CJ, 2004, J APPL ECOL, V41, P1032, DOI 10.1111/j.0021-8901.2004.00975.x; Kaennel M, 1998, FOR SCI, V51, P71; Kell LT, 1999, ICES J MAR SCI, V56, P834, DOI 10.1006/jmsc.1999.0544; Larsen FW, 2009, DIVERS DISTRIB, V15, P70, DOI 10.1111/j.1472-4642.2008.00507.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Loreau M, 2006, NATURE, V442, P245, DOI 10.1038/442245a; Manley PN, 2004, ECOL APPL, V14, P296, DOI 10.1890/02-5249; Nielsen SE, 2007, BIOL CONSERV, V137, P403, DOI 10.1016/j.biocon.2007.02.024; Nilsen EB, 2009, WILDLIFE BIOL, V15, P10, DOI 10.2981/06-084; Norderhaug KM, 2009, MAR BIOL RES, V5, P515, DOI 10.1080/17451000902932985; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; NYBO S, 2008, 425 NINA, P1; NYBO S, 2010, NATURINDEKS NORGE 20, P1; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roth T, 2008, J APPL ECOL, V45, P987, DOI 10.1111/j.1365-2664.2007.01435.x; Rouget M, 2006, GLOBAL CHANGE BIOL, V12, P2032, DOI 10.1111/j.1365-2486.2006.01238.x; Rounsevell MDA, 2006, AGR ECOSYST ENVIRON, V114, P57, DOI 10.1016/j.agee.2005.11.027; Sachs JD, 2009, SCIENCE, V325, P1502, DOI 10.1126/science.1175035; Samhouri JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008907; Samper C., 2009, NAT CLIM CHANGE, V1, P118; Schindler DW, 2010, BIOL CONSERV, V143, P1571, DOI 10.1016/j.biocon.2010.04.003; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; Scholes RJ, 2005, NATURE, V434, P45, DOI 10.1038/nature03289; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SOLIMINI AG, 2006, INDICATORS METHODS E, P1; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stuart SN, 2010, SCIENCE, V328, P177, DOI 10.1126/science.1188606; Suominen O, 2008, ECOGRAPHY, V31, P636, DOI 10.1111/j.0906-7590.2008.05480.x; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Teder T, 2007, CONSERV BIOL, V21, P313, DOI 10.1111/j.1523-1739.2006.00575.x; Ten Brink B.J.E., 2002, 402001014 RIVM; UNEP and IOC-UNESCO, 2009, ASS ASS FIND GROUP E; van Strien AJ, 2009, ECOL INDIC, V9, P1041, DOI 10.1016/j.ecolind.2008.12.001; Veiberg V, 2007, OIKOS, V116, P1805, DOI 10.1111/j.2007.0030-1299.16159.x; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	63	33	33	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18930	10.1371/journal.pone.0018930	http://dx.doi.org/10.1371/journal.pone.0018930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526118	Green Published, gold, Green Submitted			2022-12-25	WOS:000290015800023
J	Iwanczyk, J; Leong, V; Ortega, J				Iwanczyk, Jack; Leong, Vivian; Ortega, Joaquin			Factors Defining the Functional Oligomeric State of Escherichia coli DegP Protease	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ELEVATED-TEMPERATURES; PROTEOLYTIC ACTIVITY; ELECTRON-MICROSCOPY; HTRA GENE; CHAPERONE; ACTIVATION; MECHANISM; GROWTH	Escherichia coli DegP protein is a periplasmic protein that functions both as a protease and as a chaperone. In the absence of substrate, DegP oligomerizes as a hexameric cage but in its presence DegP reorganizes into 12 and 24-mer cages with large chambers that house the substrate for degradation or refolding. Here, we studied the factors that determine the oligomeric state adopted by DegP in the presence of substrate. Using size exclusion chromatography and electron microscopy, we found that the size of the substrate molecule is the main factor conditioning the oligomeric state adopted by the enzyme. Other factors such as temperature, a major regulatory factor of the activity of this enzyme, did not influence the oligomeric state adopted by DegP. In addition, we observed that substrate concentration exerted an effect only when large substrates (full-length proteins) were used. However, small substrate molecules (peptides) always triggered the same oligomeric state regardless of their concentration. These results clarify important aspects of the regulation of the oligomeric state of DegP.	[Iwanczyk, Jack; Leong, Vivian; Ortega, Joaquin] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Iwanczyk, Jack; Leong, Vivian; Ortega, Joaquin] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University; McMaster University	Iwanczyk, J (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	ortegaj@mcmaster.ca	Ortega, Joaquin/AAS-1322-2020		Canadian Institutes of Health Research (CIHR) [MOP-82930]; Ministry of Research and Innovation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This study was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) to J.O. (MOP-82930). J.O. is a recipient of a CIHR salary award and an Early Researcher Award from the Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Jomaa A, 2009, J BACTERIOL, V191, P1924, DOI 10.1128/JB.01187-08; Kim KI, 1999, J MOL BIOL, V294, P1363, DOI 10.1006/jmbi.1999.3320; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Misra R, 2000, J BACTERIOL, V182, P4882, DOI 10.1128/JB.182.17.4882-4888.2000; Ruprecht J, 2001, PROG BIOPHYS MOL BIO, V75, P121, DOI 10.1016/S0079-6107(01)00004-9; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; SKORKOGLONEK J, 1995, GENE, V163, P47, DOI 10.1016/0378-1119(95)00406-V; Sobiecka-Szkatula A, 2009, BBA-PROTEINS PROTEOM, V1794, P1573, DOI 10.1016/j.bbapap.2009.07.002; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989	22	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18944	10.1371/journal.pone.0018944	http://dx.doi.org/10.1371/journal.pone.0018944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526129	Green Submitted, gold, Green Published			2022-12-25	WOS:000290015800025
J	Woolf, PJ; Fu, LL; Basu, A				Woolf, Peter J.; Fu, Leeann L.; Basu, Avik			vProtein: Identifying Optimal Amino Acid Complements from Plant-Based Foods	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; CHILDREN; MAINTENANCE; QUALITY; LEUCINE; INFANTS; GROWTH; HEALTH; IMPACT; MUSCLE	BACKGROUND: Indispensible amino acids (IAAs) are used by the body in different proportions. Most animal-based foods provide these IAAs in roughly the needed proportions, but many plant-based foods provide different proportions of IAAs. To explore how these plant-based foods can be better used in human nutrition, we have created the computational tool vProtein to identify optimal food complements to satisfy human protein needs. METHODS: vProtein uses 1251 plant-based foods listed in the United States Department of Agriculture standard release 22 database to determine the quantity of each food or pair of foods required to satisfy human IAA needs as determined by the 2005 daily recommended intake. The quantity of food in a pair is found using a linear programming approach that minimizes total calories, total excess IAAs, or the total weight of the combination. RESULTS: For single foods, vProtein identifies foods with particularly balanced IAA patterns such as wheat germ, quinoa, and cauliflower. vProtein also i entifies foods with particularly unbalanced IAA patterns such as macadamia nuts, degermed corn products, and wakame seaweed. Although less useful alone, some unbalanced foods provide unusually good complements, such as Brazil nuts to legumes. Interestingly, vProtein finds no statistically significant bias toward grain/legume pairings for protein complementation. These analyses suggest that pairings of plant-based foods should be based on the individual foods themselves instead of based on broader food group-food group pairings. Overall, the most efficient pairings include sweet corn/tomatoes, apple/coconut, and sweet corn/cherry. The top pairings also highlight the utility of less common protein sources such as the seaweeds laver and spirulina, pumpkin leaves, and lambsquarters. From a public health perspective, many of the food pairings represent novel, low cost food sources to combat malnutrition. Full analysis results are available online at http://www.foodwiki.com/vprotein.	[Woolf, Peter J.; Fu, Leeann L.; Basu, Avik] Foodwiki, Ann Arbor, MI USA		Woolf, PJ (corresponding author), Foodwiki, Ann Arbor, MI USA.	pwoolf@foodwiki.com			Foodwiki	Foodwiki	Funding for this article was provided by Foodwiki, and Foodwiki was also responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alizadeh F, 2003, MATH PROGRAM, V95, P3, DOI 10.1007/s10107-002-0339-5; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Cohen A, 2009, CELL, V136, P399, DOI 10.1016/j.cell.2009.01.021; Dahl J., CVXOPT PYTHON SOFTWA; DIPIERRO M, 2009, WEB2PY ENTERPRISE WE; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; Lutter CK, 2008, J NUTR, V138, P379, DOI 10.3945/jn.108.095406; Lutter CK, 2003, J NUTR, V133, p2940S, DOI 10.1093/jn/133.9.2940S; Millward DJ, 2008, AM J CLIN NUTR, V87, p1576S, DOI 10.1093/ajcn/87.5.1576S; MILLWARD DJ, 1990, P NUTR SOC, V49, P473, DOI 10.1079/PNS19900056; Mintz SW, 2001, ETHNOLOGY, V40, P113, DOI 10.2307/3773926; Nordlee JA, 1996, NEW ENGL J MED, V334, P688, DOI 10.1056/NEJM199603143341103; Norton LE, 2006, J NUTR, V136, p533S, DOI 10.1093/jn/136.2.533S; Okubo H, 2008, INT J OBESITY, V32, P541, DOI 10.1038/sj.ijo.0803737; Paul KH, 2008, J NUTR, V138, P1963; Rennie MJ, 2007, BIOCHEM SOC T, V35, P1302, DOI 10.1042/BST0351302; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Sarwar G, 1997, J NUTR, V127, P758, DOI 10.1093/jn/127.5.758; Schaafsma G, 2000, J NUTR, V130, p1865S, DOI 10.1093/jn/130.7.1865S; Simpore J, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-3; Stipanuk MH, 2007, NUTR REV, V65, P122, DOI 10.1111/j.1753-4887.2007.tb00289.x; Taylor PM, 2009, BIOCHEM SOC T, V37, P237, DOI 10.1042/BST0370237; Teufel Nicolette I., 1996, Journal of Nutritional and Environmental Medicine (Abingdon), V6, P273, DOI 10.3109/13590849609007254; USDA Agricultural Research Service, 2009, USDA NAT NUTR DAT ST; Viteri FE, 2010, FOOD NUTR BULL, V31, P42, DOI 10.1177/156482651003100106; WESTRICH BJ, 1994, INT NETWORK FOOD DAT, V7, P223; *WHO, 1985, JOINT FAO WHO UNO ED; YOUNG V R, 1990, Food and Nutrition Bulletin, V12, P289; YOUNG VR, 1994, AM J CLIN NUTR, V59, p1203S, DOI 10.1093/ajcn/59.5.1203S; 2005, PROTEIN AMINO ACIDS	30	27	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18836	10.1371/journal.pone.0018836	http://dx.doi.org/10.1371/journal.pone.0018836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526128	Green Published, gold, Green Submitted			2022-12-25	WOS:000290015800015
J	Clavero, M; Villero, D; Brotons, L				Clavero, Miguel; Villero, Daniel; Brotons, Lluis			Climate Change or Land Use Dynamics: Do We Know What Climate Change Indicators Indicate?	PLOS ONE			English	Article							BIODIVERSITY; LANDSCAPE; RESPONSES; BIRDS	Different components of global change can have interacting effects on biodiversity and this may influence our ability to detect the specific consequences of climate change through biodiversity indicators. Here, we analyze whether climate change indicators can be affected by land use dynamics that are not directly determined by climate change. To this aim, we analyzed three community-level indicators of climate change impacts that are based on the optimal thermal environment and average latitude of the distribution of bird species present at local communities. We used multiple regression models to relate the variation in climate change indicators to: i) environmental temperature; and ii) three landscape gradients reflecting important current land use change processes (land abandonment, fire impacts and urbanization), all of them having forest areas at their positive extremes. We found that, with few exceptions, landscape gradients determined the figures of climate change indicators as strongly as temperature. Bird communities in forest habitats had colder-dwelling bird species with more northern distributions than farmland, burnt or urban areas. Our results show that land use changes can reverse, hide or exacerbate our perception of climate change impacts when measured through community-level climate change indicators. We stress the need of an explicit incorporation of the interactions between climate change and land use dynamics to understand what are current climate change indicators indicating and be able to isolate real climate change impacts.	[Clavero, Miguel; Villero, Daniel; Brotons, Lluis] Ctr Tecnol Forestal Catalunya, Area Biodiversitat, Grp Ecol Paisatge, Solsona, Catalonia, Spain; [Clavero, Miguel] Univ Girona, Dept Ciencies Ambientals, Girona, Catalonia, Spain; [Brotons, Lluis] European Bird Census Council, Barcelona, Spain; [Brotons, Lluis] Museu Ciencies Nat, Inst Catala Ornitol, Barcelona, Spain	Centre Tecnologic Forestal de Catalunya (CTFC); Universitat de Girona; Museu de Ciencies Naturals de Barcelona	Clavero, M (corresponding author), Ctr Tecnol Forestal Catalunya, Area Biodiversitat, Grp Ecol Paisatge, Solsona, Catalonia, Spain.	miguelito.clavero@gmail.com	Brotons, Lluís/D-1570-2009; Clavero, Miguel/A-9040-2015; Villero, Dani/E-1761-2014	Brotons, Lluís/0000-0002-4826-4457; Clavero, Miguel/0000-0002-5186-0153; Villero, Dani/0000-0002-5562-3809	Spanish Ministry of Education and Science (MEC) [CGL2005- 2000031/BOS, CGL2008-05506-C02-01/BOS, CSD2008-00040]; Catalan Government [SGR2009-531]; MEC	Spanish Ministry of Education and Science (MEC)(Spanish Government); Catalan Government; MEC(European Commission)	This work has received financial support from the projects CGL2005- 2000031/BOS, CGL2008-05506-C02-01/BOS and Consolider Montes CSD2008-00040 granted by the Spanish Ministry of Education and Science (MEC). Partial funding was also provided by the Catalan Government grant SGR2009-531. LB benefited from a Ramon y Cajal contract and MC from a Juan de la Cierva contract, both funded by MEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Clavero M, 2010, GLOBAL ECOL BIOGEOGR, V19, P684, DOI 10.1111/j.1466-8238.2010.00544.x; Covas R, 1998, IBIS, V140, P395, DOI 10.1111/j.1474-919X.1998.tb04600.x; Debussche M, 1999, GLOBAL ECOL BIOGEOGR, V8, P3, DOI 10.1046/j.1365-2699.1999.00316.x; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Estrada J., 2004, ATLES DELS OCELLS NI; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Fidell L.S., 2001, COMPUTER ASSISTED RE; Gil-Tena A, 2010, FOREST ECOL MANAG, V259, P1338, DOI 10.1016/j.foreco.2009.10.026; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Mazzoleni S., 2004, RECENT DYNAMICS MEDI; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pausas JC, 2008, INT J WILDLAND FIRE, V17, P713, DOI 10.1071/WF07151; Pimm SL, 2009, CURR BIOL, V19, pR595, DOI 10.1016/j.cub.2009.05.055; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Prodon R., 1993, ALAUDA, V62, P83; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Suarez-Seoane S, 2002, BIOL CONSERV, V105, P333, DOI 10.1016/S0006-3207(01)00213-0; Vallecillo S, 2009, ECOL APPL, V19, P538, DOI 10.1890/08-0348.1; [No title captured]; [No title captured]; [No title captured]	30	107	107	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18581	10.1371/journal.pone.0018581	http://dx.doi.org/10.1371/journal.pone.0018581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533025	Green Published, gold, Green Submitted			2022-12-25	WOS:000290014500007
J	Reboul, CF; Andrews, DA; Nahar, MF; Buckle, AM; Roujeinikova, A				Reboul, Cyril F.; Andrews, Daniel A.; Nahar, Musammat F.; Buckle, Ashley M.; Roujeinikova, Anna			Crystallographic and Molecular Dynamics Analysis of Loop Motions Unmasking the Peptidoglycan-Binding Site in Stator Protein MotB of Flagellar Motor	PLOS ONE			English	Article							DOMAIN; PAL	Background: The C-terminal domain of MotB (MotB-C) shows high sequence similarity to outer membrane protein A and related peptidoglycan (PG)-binding proteins. It is believed to anchor the power-generating MotA/MotB stator unit of the bacterial flagellar motor to the peptidoglycan layer of the cell wall. We previously reported the first crystal structure of this domain and made a puzzling observation that all conserved residues that are thought to be essential for PG recognition are buried and inaccessible in the crystal structure. In this study, we tested a hypothesis that peptidoglycan binding is preceded by, or accompanied by, some structural reorganization that exposes the key conserved residues. Methodology/Principal Findings: We determined the structure of a new crystalline form (Form B) of Helicobacter pylori MotB-C. Comparisons with the existing Form A revealed conformational variations in the petal-like loops around the carbohydrate binding site near one end of the beta-sheet. These variations are thought to reflect natural flexibility at this site required for insertion into the peptidoglycan mesh. In order to understand the nature of this flexibility we have performed molecular dynamics simulations of the MotB-C dimer. The results are consistent with the crystallographic data and provide evidence that the three loops move in a concerted fashion, exposing conserved MotB residues that have previously been implicated in binding of the peptide moiety of peptidoglycan. Conclusion/Significance: Our structural analysis provides a new insight into the mechanism by which MotB inserts into the peptidoglycan mesh, thus anchoring the power-generating complex to the cell wall.	[Reboul, Cyril F.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3168, Australia	Monash University; Monash University	Reboul, CF (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	Anna.Roujeinikova@monash.edu	Buckle, Ashley/P-8366-2016	Buckle, Ashley/0000-0003-2943-9044; Roujeinikova, Anna/0000-0001-8478-4751; Reboul, Cyril/0000-0002-6258-2697	Australian Research Council; NHMRC	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council Discovery grant and a Research Fellowship to AR and a NHMRC Senior Research Fellowship to AMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W. L., 2003, PYMOL MOL GENETICS G; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hizukuri Y, 2009, J BIOCHEM, V146, P219, DOI 10.1093/jb/mvp061; Hosking ER, 2006, J MOL BIOL, V364, P921, DOI 10.1016/j.jmb.2006.09.035; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KEMPNER ES, 1993, FEBS LETT, V326, P4, DOI 10.1016/0014-5793(93)81749-P; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; Liebscher M, 2009, J BACTERIOL, V191, P1456, DOI 10.1128/JB.01131-08; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nguyen CC, 1996, RES MICROBIOL, V147, P317, DOI 10.1016/0923-2508(96)84707-3; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roujeinikova A, 1999, J BIOL CHEM, V274, P30811, DOI 10.1074/jbc.274.43.30811; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Roujeinikova A, 2008, ACTA CRYSTALLOGR F, V64, P277, DOI 10.1107/S1744309108005277; TEETER MM, 1990, J PHYS CHEM-US, V94, P8091, DOI 10.1021/j100384a021; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332	29	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18981	10.1371/journal.pone.0018981	http://dx.doi.org/10.1371/journal.pone.0018981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533052	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400044
J	Wu, C; Cai, PF; Chang, QC; Hao, LL; Peng, SA; Sun, XJ; Lu, HJ; Yin, JG; Jiang, N; Chen, QJ				Wu, Chuang; Cai, Pengfei; Chang, Qiaocheng; Hao, Lili; Peng, Shuai; Sun, Xiaojing; Lu, Huijun; Yin, Jigang; Jiang, Ning; Chen, Qijun			Mapping the Binding between the Tetraspanin Molecule (Sjc23) of Schistosoma japonicum and Human Non-Immune IgG	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; MONOCLONAL-ANTIBODY; MANSONI; ANTIGEN; SURFACE; IMMUNIZATION; PARAMYOSIN; SM23; SJ23; SUPERFAMILY	Background: Schistosomal parasites can establish parasitization in a human host for decades; evasion of host immunorecognition including surface masking by acquisition of host serum components is one of the strategies explored by the parasites. Parasite molecules anchored on the membrane are the main elements in the interaction. Sjc23, a member of the tetraspanin (TSP) family of Schistosoma japonicum, was previously found to be highly immunogenic and regarded as a vaccine candidate against schistosomiasis. However, studies indicated that immunization with Sjc23 generated rapid antibody responses which were less protective than that with other antigens. The biological function of this membrane-anchored molecule has not been defined after decades of vaccination studies. Methodology and Principal Findings: In this study, we explored affinity pull-down and peptide competition assays to investigate the potential binding between Sjc23 molecule and human non-immune IgG. We determined that Sjc23 could bind human non-immune IgG and the binding was through the interaction of the large extra-cellular domain (LED) of Sjc23 (named Sjc23-LED) with the Fc domain of human IgG. Sjc23 had no affinity to other immunoglobulin types. Affinity precipitation (pull-down assay) in the presence of overlapping peptides further pinpointed to a 9-amino acid motif within Sjc23-LED that mediated the binding to human IgG. Conclusion and Significance: S. japonicum parasites cloak themselves through interaction with human non-immune IgG, and a member of the tetraspanin family, Sjc23, mediated the acquisition of human IgG via the interaction of a motif of 9 amino acids with the Fc domain of the IgG molecule. The consequence of this interaction will likely benefit parasitism of S. japonicum by evasion of host immune recognition or immunoresponses. This is the first report that an epitope of schistosomal ligand and its immunoglobulin receptor are defined, which provides further evidence of immune evasion strategy adopted by S. japonicum.	[Wu, Chuang; Chang, Qiaocheng; Peng, Shuai; Sun, Xiaojing; Lu, Huijun; Yin, Jigang; Jiang, Ning; Chen, Qijun] Jilin Univ, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Cai, Pengfei; Chen, Qijun] Chinese Acad Med Sci, Parasitol Lab, Inst Basic Med, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Cai, Pengfei; Chen, Qijun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hao, Lili] SW Univ Nationalities, Coll Life Sci & Technol, Chengdu, Peoples R China	Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Southwest Minzu University	Wu, C (corresponding author), Jilin Univ, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China.	jiangning@jlu.edu.cn; cqj@jlu.edu.cn	Chang, Qiao-Cheng/GPF-6176-2022; yin, jigang/GWV-1397-2022; Cai, Pengfe/AAF-2759-2020	Cai, Pengfei/0000-0003-4975-4615	National Natural Science Foundation of China [30901254]; Institute of Pathogen Biology, CAMS [2008IPB204]; national science and technology specific projects [2008ZX10401]; NSFC [30625029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology, CAMS; national science and technology specific projects; NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (#30901254), the intramural grant from Institute of Pathogen Biology, CAMS (2008IPB204), and the national science and technology specific projects (2008ZX10401), and the Grant for Young Distinguished Scientist to QC (NSFC, 30625029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN D, 1987, MOL BIOCHEM PARASIT, V23, P123, DOI 10.1016/0166-6851(87)90147-2; Bergquist R, 2002, ACTA TROP, V82, P183, DOI 10.1016/S0001-706X(02)00048-7; Cai PF, 2008, BIOCHEM BIOPH RES CO, V372, P197, DOI 10.1016/j.bbrc.2008.05.042; Da'dara AA, 2002, PARASITE IMMUNOL, V24, P179, DOI 10.1046/j.1365-3024.2002.00453.x; Da'dara AA, 2001, VACCINE, V20, P359, DOI 10.1016/S0264-410X(01)00374-7; DAVERN KM, 1991, MOL BIOCHEM PARASIT, V48, P67, DOI 10.1016/0166-6851(91)90165-3; Deng JS, 2007, INT J PARASITOL, V37, P67, DOI 10.1016/j.ijpara.2006.09.011; Fenwick A, 2006, CURR OPIN INFECT DIS, V19, P577, DOI 10.1097/01.qco.0000247591.13671.6a; Gobert GN, 1997, PARASITOLOGY, V114, P45, DOI 10.1017/S0031182096008001; HARN DA, 1985, J IMMUNOL, V135, P2115; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hu Y, 2007, EXP PARASITOL, V115, P379, DOI 10.1016/j.exppara.2006.09.022; Jiang N, 2010, ACTA TROP, V116, P9, DOI 10.1016/j.actatropica.2010.04.015; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Loukas A, 2001, INFECT IMMUN, V69, P3646, DOI 10.1128/IAI.69.6.3646-3651.2001; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Mcintosh RS, 2006, PARASITE IMMUNOL, V28, P407, DOI 10.1111/j.1365-3024.2006.00829.x; Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002; PEARCE EJ, 1988, P NATL ACAD SCI USA, V85, P5678, DOI 10.1073/pnas.85.15.5678; Ren L, 2003, ANAL BIOCHEM, V322, P164, DOI 10.1016/j.ab.2003.07.023; REYNOLDS SR, 1992, J IMMUNOL, V149, P3995; ROGERS MV, 1988, MOL BIOCHEM PARASIT, V29, P77, DOI 10.1016/0166-6851(88)90122-3; Shi FH, 2001, VACCINE, V20, P462, DOI 10.1016/S0264-410X(01)00340-1; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Waine GJ, 1999, PARASITE IMMUNOL, V21, P377, DOI 10.1046/j.1365-3024.1999.00221.x; WRIGHT MD, 1991, J IMMUNOL, V147, P4338; Zhou D, 1994, World Health Forum, V15, P387	30	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19112	10.1371/journal.pone.0019112	http://dx.doi.org/10.1371/journal.pone.0019112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533061	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400060
J	Buehler, DM; Versteegh, MA; Matson, KD; Tieleman, I				Buehler, Deborah M.; Versteegh, Maaike A.; Matson, Kevin D.; Tieleman, Irene			One Problem, Many Solutions: Simple Statistical Approaches Help Unravel the Complexity of the Immune System in an Ecological Context	PLOS ONE			English	Article							PHENOTYPIC COVARIANCE STRUCTURE; MATRIX CORRELATION; LIFE-HISTORY; ANNUAL-CYCLE; TRADE-OFFS; GREENFINCHES; ENVIRONMENTS; IMMUNOLOGY; CHALLENGE; PATTERNS	The immune system is a complex collection of interrelated and overlapping solutions to the problem of disease. To deal with this complexity, researchers have devised multiple ways to measure immune function and to analyze the resulting data. In this way both organisms and researchers employ many tactics to solve a complex problem. One challenge facing ecological immunologists is the question of how these many dimensions of immune function can be synthesized to facilitate meaningful interpretations and conclusions. We tackle this challenge by employing and comparing several statistical methods, which we used to test assumptions about how multiple aspects of immune function are related at different organizational levels. We analyzed three distinct datasets that characterized 1) species, 2) subspecies, and 3) among-and within-individual level differences in the relationships among multiple immune indices. Specifically, we used common principal components analysis (CPCA) and two simpler approaches, pair-wise correlations and correlation circles. We also provide a simple example of how these techniques could be used to analyze data from multiple studies. Our findings lead to several general conclusions. First, relationships among indices of immune function may be consistent among some organizational groups (e. g. months over the annual cycle) but not others (e. g. species); therefore any assumption of consistency requires testing before further analyses. Second, simple statistical techniques used in conjunction with more complex multivariate methods give a clearer and more robust picture of immune function than using complex statistics alone. Moreover, these simpler approaches have potential for analyzing comparable data from multiple studies, especially as the field of ecological immunology moves towards greater methodological standardization.	[Buehler, Deborah M.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Buehler, Deborah M.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Versteegh, Maaike A.; Matson, Kevin D.; Tieleman, Irene] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of Toronto; Royal Ontario Museum; University of Groningen	Buehler, DM (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	m.a.versteegh@rug.nl	Matson, Kevin/G-3855-2010; Tieleman, Irene/H-4296-2011; Matson, Kevin D./R-1986-2019; Buehler, Deborah/ABB-2088-2021	Matson, Kevin/0000-0002-4373-5926; Buehler, Deborah/0000-0003-3669-6364	Natural Science and Engineering Council of Canada (NSERC) [PDF-373488-2009]; Netherlands Organization for Scientific Research (NWO) [Rubicon 825.09.019, 863.08.026]; VENI fellowship [863.04.023]; Rosalind Franklin fellowship	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); VENI fellowship; Rosalind Franklin fellowship	Financial support came from grants to DMB from the Natural Science and Engineering Council of Canada (NSERC; PDF-373488-2009) and the Netherlands Organization for Scientific Research (NWO; Rubicon 825.09.019); to KDM from a VENI fellowship (863.08.026) from NWO; to BIT from a VENI fellowship (863.04.023) and a Rosalind Franklin fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDI H, 2010, WILEY INTER IN PRESS, V2; Ackermann RR, 2000, AM J PHYS ANTHROPOL, V111, P489, DOI 10.1002/(SICI)1096-8644(200004)111:4<489::AID-AJPA5>3.0.CO;2-U; Adamo SA, 2004, ANIM BEHAV, V68, P1443, DOI 10.1016/j.anbehav.2004.05.005; Buehler DM, 2008, J AVIAN BIOL, V39, P560, DOI 10.1111/j.0908-8857.2008.04408.x; Buehler DM, 2010, INTEGR COMP BIOL, V50, P346, DOI 10.1093/icb/icq055; Buehler DM, 2009, PHYSIOL BIOCHEM ZOOL, V82, P561, DOI 10.1086/603635; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Clark W.R., 2008, DEFENSE SELF IMMUNE; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duckworth RA, 2010, AUK, V127, P752, DOI 10.1525/auk.2010.127.4.752; Flury B, 1988, COMMON PRINCIPAL COM; Gonzalez G, 1999, BEHAV ECOL SOCIOBIOL, V46, P117, DOI 10.1007/s002650050600; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Horak P, 2006, J EXP BIOL, V209, P4329, DOI 10.1242/jeb.02502; Houle D, 2002, EVOLUTION, V56, P433; Houle D, 2010, P NATL ACAD SCI USA, V107, P1793, DOI 10.1073/pnas.0906195106; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Martin LB, 2007, ECOLOGY, V88, P2516, DOI 10.1890/07-0060.1; Martin LB, 2006, INTEGR COMP BIOL, V46, P1030, DOI 10.1093/icb/icl039; Matson KD, 2006, P ROY SOC B-BIOL SCI, V273, P815, DOI 10.1098/rspb.2005.3376; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Mendes L, 2006, J EXP BIOL, V209, P284, DOI 10.1242/jeb.02015; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; PHILLIPS P, 2000, CPC COMMON PRINCIPAL; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2022, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sokal R. R., 2012, BIOMETRY; Sparkman AM, 2009, J ANIM ECOL, V78, P1242, DOI 10.1111/j.1365-2656.2009.01587.x; Steppan SJ, 1997, EVOLUTION, V51, P571, DOI 10.1111/j.1558-5646.1997.tb02444.x; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239	35	38	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18592	10.1371/journal.pone.0018592	http://dx.doi.org/10.1371/journal.pone.0018592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526186	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100009
J	Kwon, Y; Cukierman, E; Godwin, AK				Kwon, Youngjoo; Cukierman, Edna; Godwin, Andrew K.			Differential Expressions of Adhesive Molecules and Proteases Define Mechanisms of Ovarian Tumor Cell Matrix Penetration/Invasion	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; COHORT MIGRATION; CARCINOMA-CELLS; METALLOPROTEINASE INHIBITOR; PHENOTYPIC PLASTICITY; SURFACE EPITHELIUM; CANCER; INVASION; COLLAGEN	Epithelial ovarian cancer is an aggressive and deadly disease and understanding its invasion mechanisms is critical for its treatment. We sought to study the penetration/invasion of ovarian tumor cells into extracellular matrices (ECMs) using a fibroblast-derived three-dimensional (3D) culture model and time-lapse and confocal imaging. Twelve ovarian tumor cells were evaluated and classified into distinct groups based on their ECM remodeling phenotypes; those that degraded the ECM (represented by OVCAR5 cells) and those that did not (represented by OVCAR10 cells). Cells exhibiting a distinct ECM modifying behavior were also segregated by epithelial- or mesenchymal-like phenotypes and uPA or MMP-2/MMP-9 expression. The cells, which presented epithelial- like phenotypes, penetrated the ECM using proteases and maintained intact cell-cell interactions, while cells exhibiting mesenchymal phenotypes modified the matrices via Rho-associated serine/threonine kinase (ROCK) in the absence of apparent cell-cell interactions. Overall, this study demonstrates that different mechanisms of modifying matrices by ovarian tumor cells may reflect heterogeneity among tumors and emphasize the need to systematically assess these mechanisms to better design effective therapies.	[Kwon, Youngjoo; Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Cukierman, Edna] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center	Kwon, Y (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	Edna.Cukierman@FCCC.edu; AGodwin@kumc.edu	cukierman, edna/AAU-8932-2020; Cukierman, Edna/A-3951-2013	cukierman, edna/0000-0002-1452-9576; Kwon, Youngjoo/0000-0003-3582-4192	Ovarian Cancer Research Fund; National Cancer Institute (NCI); National Institutes of Health (NIH) [CA113451, CA140323]; NATIONAL CANCER INSTITUTE [R01CA113451, R01CA140323] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a program project grant from Ovarian Cancer Research Fund (http://www.ocrf.org to A.K.G.) and grants from the National Cancer Institute (NCI) and National Institutes of Health (NIH) (CA113451 to E.C. and CA140323 to A.K.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; AUERSPERG N, 1994, LAB INVEST, V71, P510; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Belgiovine C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014154; Burleson KM, 2004, CLIN EXP METASTAS, V21, P685, DOI 10.1007/s10585-004-5768-5; Cai KQ, 2007, MOL CARCINOGEN, V46, P130, DOI 10.1002/mc.20273; Capo-Chichi CD, 2003, CANCER RES, V63, P4967; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1104, DOI 10.1167/iovs.02-0412; EHRLICH HP, 1991, J CELL PHYSIOL, V146, P1, DOI 10.1002/jcp.1041460102; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GEISLER JP, 1995, GYNECOL ONCOL, V57, P246, DOI 10.1006/gyno.1995.1134; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Jankun J, 1999, Cancer Biochem Biophys, V17, P109; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Lakshman N, 2007, CELL MOTIL CYTOSKEL, V64, P434, DOI 10.1002/cm.20194; LANGDON SP, 1988, CANCER RES, V48, P6166; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Mirastschijski U, 2004, EXP CELL RES, V299, P465, DOI 10.1016/j.yexcr.2004.06.007; Nabeshima K, 2000, CANCER RES, V60, P3364; Nabeshima K, 1999, HISTOL HISTOPATHOL, V14, P1183, DOI 10.14670/HH-14.1183; Nabeshima K, 1997, LAB INVEST, V76, P139; Nabeshima K, 1998, INT J CANCER, V78, P750, DOI 10.1002/(SICI)1097-0215(19981209)78:6<750::AID-IJC13>3.0.CO;2-#; OZOLS RF, 1991, SEMIN ONCOL, V18, P222; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; SCHULTZ DC, 1995, CANCER RES, V55, P2150; Scott KA, 1998, FEBS LETT, V441, P137, DOI 10.1016/S0014-5793(98)01542-7; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Sood AK, 1999, CLIN CANCER RES, V5, P2485; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sundfeldt K, 1997, INT J CANCER, V74, P275, DOI 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.3.CO;2-V; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; WOLF CR, 1987, INT J CANCER, V39, P695, DOI 10.1002/ijc.2910390607; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; YAMATO M, 1995, J BIOCHEM-TOKYO, V117, P940, DOI 10.1093/oxfordjournals.jbchem.a124824; Zuo JH, 2010, MOL CANCER RES, V8, P170, DOI 10.1158/1541-7786.MCR-09-0354	64	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18872	10.1371/journal.pone.0018872	http://dx.doi.org/10.1371/journal.pone.0018872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526198	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100032
J	Porto-Pazos, AB; Veiguela, N; Mesejo, P; Navarrete, M; Alvarellos, A; Ibanez, O; Pazos, A; Araque, A				Porto-Pazos, Ana B.; Veiguela, Noha; Mesejo, Pablo; Navarrete, Marta; Alvarellos, Alberto; Ibanez, Oscar; Pazos, Alejandro; Araque, Alfonso			Artificial Astrocytes Improve Neural Network Performance	PLOS ONE			English	Article								Compelling evidence indicates the existence of bidirectional communication between astrocytes and neurons. Astrocytes, a type of glial cells classically considered to be passive supportive cells, have been recently demonstrated to be actively involved in the processing and regulation of synaptic information, suggesting that brain function arises from the activity of neuron-glia networks. However, the actual impact of astrocytes in neural network function is largely unknown and its application in artificial intelligence remains untested. We have investigated the consequences of including artificial astrocytes, which present the biologically defined properties involved in astrocyte-neuron communication, on artificial neural network performance. Using connectionist systems and evolutionary algorithms, we have compared the performance of artificial neural networks (NN) and artificial neuron-glia networks (NGN) to solve classification problems. We show that the degree of success of NGN is superior to NN. Analysis of performances of NN with different number of neurons or different architectures indicate that the effects of NGN cannot be accounted for an increased number of network elements, but rather they are specifically due to astrocytes. Furthermore, the relative efficacy of NGN vs. NN increases as the complexity of the network increases. These results indicate that artificial astrocytes improve neural network performance, and established the concept of Artificial Neuron-Glia Networks, which represents a novel concept in Artificial Intelligence with implications in computational science as well as in the understanding of brain function.	[Porto-Pazos, Ana B.; Veiguela, Noha; Mesejo, Pablo; Alvarellos, Alberto; Ibanez, Oscar; Pazos, Alejandro] Univ A Coruna, Fac Informat, Dept Tecnol Informac & Comunicac, La Coruna, Spain; [Navarrete, Marta; Araque, Alfonso] CSIC, Inst Cajal, E-28002 Madrid, Spain	Universidade da Coruna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Porto-Pazos, AB (corresponding author), Univ A Coruna, Fac Informat, Dept Tecnol Informac & Comunicac, Campus Elvina, La Coruna, Spain.	ana.portop@udc.es	Navarrete, Marta/E-9266-2013; Alvarellos, Alberto/L-9841-2019; Mesejo, Pablo/K-4589-2014; Pazos, Alejandro/AAI-5887-2020; Ibáñez, Oscar/B-2680-2015; Porto-Pazos, Ana/A-9971-2012; Sierra, Alejandro Pazos/K-8927-2017	Navarrete, Marta/0000-0003-2097-4788; Alvarellos, Alberto/0000-0002-3404-3354; Mesejo, Pablo/0000-0001-9955-2101; Ibáñez, Oscar/0000-0002-5301-8277; Porto-Pazos, Ana/0000-0003-1428-2523; Sierra, Alejandro Pazos/0000-0003-2324-238X; Araque, Alfonso/0000-0003-3840-1144	Ministry of Science and Innovation of Spain [TIN2009-07707, BFU2010-15832, CSD2010-00045]; Xunta de Galicia, Spain [REGICC 2009/58, 08SIN010105PR]; CYTED (Ibero-NBIC Network) [209RT0366]; Cajal Blue Brain, Spain; European Union [HEALTH-F2-2007-202167]	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia); CYTED (Ibero-NBIC Network); Cajal Blue Brain, Spain; European Union(European Commission)	The work was supported by grants from Ministry of Science and Innovation of Spain (TIN2009-07707, BFU2010-15832, CSD2010-00045), Xunta de Galicia, Spain (REGICC 2009/58, 08SIN010105PR), CYTED (Ibero-NBIC Network 209RT0366), Cajal Blue Brain, Spain, and European Union (HEALTH-F2-2007-202167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; *CESGA, 2010, COMP EQ WAS PROV CTR; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Holland JH., 1975, Q REV BIOL; HOLLAND JH, 1987, P 2 INT C GEN ALG, P82; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; MERTZ CJ, 2002, U CALIFORNIA IRVINE; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2010, BRAIN RES REV, V63, P93, DOI 10.1016/j.brainresrev.2009.10.005; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Rabunal JR, 2004, NEURAL COMPUT, V16, P1483, DOI 10.1162/089976604323057461; Volterra A., 2002, TRIPARTITE SYNAPSE G, P164; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yao X, 1999, P IEEE, V87, P1423, DOI 10.1109/5.784219	21	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19109	10.1371/journal.pone.0019109	http://dx.doi.org/10.1371/journal.pone.0019109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526157	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100052
J	Roseboom, W; Nishida, S; Fujisaki, W; Arnold, DH				Roseboom, Warrick; Nishida, Shin'ya; Fujisaki, Waka; Arnold, Derek H.			Audio-Visual Speech Timing Sensitivity Is Enhanced in Cluttered Conditions	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; PERCEPTION; SYNCHRONY; RECALIBRATION; CAPTURE; ORDER; EXPOSURE; VISION; POP	Events encoded in separate sensory modalities, such as audition and vision, can seem to be synchronous across a relatively broad range of physical timing differences. This may suggest that the precision of audio-visual timing judgments is inherently poor. Here we show that this is not necessarily true. We contrast timing sensitivity for isolated streams of audio and visual speech, and for streams of audio and visual speech accompanied by additional, temporally offset, visual speech streams. We find that the precision with which synchronous streams of audio and visual speech are identified is enhanced by the presence of additional streams of asynchronous visual speech. Our data suggest that timing perception is shaped by selective grouping processes, which can result in enhanced precision in temporally cluttered environments. The imprecision suggested by previous studies might therefore be a consequence of examining isolated pairs of audio and visual events. We argue that when an isolated pair of cross-modal events is presented, they tend to group perceptually and to seem synchronous as a consequence. We have revealed greater precision by providing multiple visual signals, possibly allowing a single auditory speech stream to group selectively with the most synchronous visual candidate. The grouping processes we have identified might be important in daily life, such as when we attempt to follow a conversation in a crowded room.	[Roseboom, Warrick; Arnold, Derek H.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Nishida, Shin'ya] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa 24301, Japan; [Fujisaki, Waka] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Higashi Ku, Tsukuba, Ibaraki, Japan	University of Queensland; Nippon Telegraph & Telephone Corporation; National Institute of Advanced Industrial Science & Technology (AIST)	Roseboom, W (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	w.roseboom@psy.uq.edu.au	Fujisaki, Waka/N-6151-2016	Fujisaki, Waka/0000-0003-3844-5235; Arnold, Derek/0000-0003-1027-6222	Australian Research Council	Australian Research Council(Australian Research Council)	This project was funded by an Australian Research Council Discovery Grant and Fellowship awarded to DHA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Arnold DH, 2007, P ROY SOC B-BIOL SCI, V274, P2331, DOI 10.1098/rspb.2007.0576; Arnold DH, 2009, J VISION, V9, DOI 10.1167/9.5.4; Arnold DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010217; Arnold DH, 2005, VISION RES, V45, P1275, DOI 10.1016/j.visres.2004.11.014; Arnold DH, 2005, VISION RES, V45, P3015, DOI 10.1016/j.visres.2005.06.031; Cook LA, 2009, PERCEPTION, V38, P1220, DOI 10.1068/p6344; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Fujisaki W, 2006, P ROY SOC B-BIOL SCI, V273, P865, DOI 10.1098/rspb.2005.3327; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Green DM, 1966, SIGNAL DETECTION THE; Guski R, 2003, PERCEPT PSYCHOPHYS, V65, P789, DOI 10.3758/BF03194815; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Jackson C. V., 1953, Q J EXPT PSYCHOL, V5, P52, DOI [10.1080/17470215308416626, DOI 10.1080/17470215308416626]; Keetels M, 2007, EXP BRAIN RES, V180, P449, DOI 10.1007/s00221-007-0881-8; King AJ, 2005, CURR BIOL, V15, pR339, DOI 10.1016/j.cub.2005.04.022; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Lewald J, 2001, BEHAV BRAIN RES, V121, P69, DOI 10.1016/S0166-4328(00)00386-7; Macmillan N. A., 1991, DETECTION THEORY USE; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Miner N, 1998, PRESENCE-TELEOP VIRT, V7, P396, DOI 10.1162/105474698565802; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Navarra J, 2010, BRAIN RES, V1323, P84, DOI 10.1016/j.brainres.2010.01.059; Nishida S, 2002, CURR BIOL, V12, P359, DOI 10.1016/S0960-9822(02)00698-X; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; RADEAU M, 1987, PSYCHOL RES-PSYCH FO, V49, P17, DOI 10.1007/BF00309198; Roseboom W, 2009, J VISION, V9, DOI 10.1167/9.12.4; Sanabria D, 2005, NEUROSCI LETT, V377, P59, DOI 10.1016/j.neulet.2004.11.069; Spence C, 2003, CURR BIOL, V13, pR519, DOI 10.1016/S0960-9822(03)00445-7; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010664; Van der Burg E, 2009, NEUROSCI LETT, V450, P60, DOI 10.1016/j.neulet.2008.11.002; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Vatakis A, 2007, EXP BRAIN RES, V181, P173, DOI 10.1007/s00221-007-0918-z; Vatakis A, 2006, BRAIN RES, V1111, P134, DOI 10.1016/j.brainres.2006.05.078; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2006, J EXP PSYCHOL HUMAN, V32, P1063, DOI 10.1037/0096-1523.32.4.1063; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Zampini M, 2005, ACTA PSYCHOL, V118, P277, DOI 10.1016/j.actpsy.2004.10.017	50	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18309	10.1371/journal.pone.0018309	http://dx.doi.org/10.1371/journal.pone.0018309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494684	Green Published, Green Submitted, gold			2022-12-25	WOS:000289192400018
J	Wu, J; Ru, NY; Zhang, Y; Li, Y; Wei, D; Ren, Z; Huang, XF; Chen, ZN; Bian, H				Wu, J.; Ru, N-Y; Zhang, Y.; Li, Y.; Wei, D.; Ren, Z.; Huang, X-F; Chen, Z-N; Bian, H.			HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-beta signaling and is transcriptionally regulated by Slug	ONCOGENE			English	Article						hepatocarcinogenesis; epithelial-mesenchymal transition; PI3K/Akt; hepatocellular carcinoma; CD147; TGF-beta	GROWTH-FACTOR-BETA; FETAL-RAT HEPATOCYTES; HEPATOCELLULAR-CARCINOMA; TUMOR PROGRESSION; DOWN-REGULATION; EXPRESSION; METASTASIS; INVASION; RECEPTOR; PATHWAYS	Epithelial-mesenchymal transition (EMT) induced by transforming growth factor-beta (TGF-beta) is implicated in hepatocarcinogenesis and hepatocellular carcinoma (HCC) metastasis. HAb18G/CD147, which belongs to the CD147 family, is an HCC-associated antigen that has a crucial role in tumor invasion and metastasis. The goal of this study was to investigate the role of HAb18G/CD147 during EMT in hepatocarcinogenesis. Human normal hepatic cell lines QZG and L02, primary mouse hepatocytes and nude mouse models were used to determine the role of HAb18G/CD147 in EMT, and the involvement of the TGF-beta-driven pathway. A dual-luciferase reporter assay and ChIP were used to investigate the transcriptional regulation of the CD147 gene. Samples from patients with liver disease were assessed to determine the relationship between HAb18G/CD147 and typical markers for EMT. Our results show that upregulation of HAb18G/CD147 is induced by TGF-beta coupled with downregulation of E-cadherin and upregulation of N-cadherin and vimentin. The expression of HAb18G/CD147 is controlled by the cell survival PI3K/Akt/GSK3 beta signaling pathway, and is directly regulated by the transcription factor Slug. Transfection of CD147 also induces an elevated expression of TGF-beta. CD147-transfected hepatocytes have mesenchymal phenotypes that accelerate tumor formation and tumor metastasis in vivo. Immunohistochemistry analysis shows a negative correlation between HAb18G/CD147 and E-cadherin expression (r(s) = -0.3622, P = 0.0105), and a positive correlation between HAb18G/CD147 and Slug expression (r(s) = 0.3064, P = 0.0323) in human HCC tissues. Our study uncovers a novel role of HAb18G/CD147 in mediating EMT in the process of HCC progression and showed that CD147 is a Slug target gene in the signaling cascade TGF-beta -> PI3K/Akt -> GSK3 beta -> Snail -> Slug -> CD147. Our results suggest that CD147 may be a potential target for the treatment and prevention of HCC. Oncogene (2011) 30, 4410-4427; doi:10.1038/onc.2011.149; published online 2 May 2011	[Wu, J.; Ru, N-Y; Zhang, Y.; Li, Y.; Wei, D.; Chen, Z-N; Bian, H.] Fourth Mil Med Univ, Cell Engn Res Ctr, Xian 710032, Shaanxi, Peoples R China; [Wu, J.; Ru, N-Y; Zhang, Y.; Li, Y.; Wei, D.; Chen, Z-N; Bian, H.] Fourth Mil Med Univ, Dept Cell Biol, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Ren, Z.] Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China; [Huang, X-F] Fourth Mil Med Univ, Cent Lab, Sch Basic Med, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Army Medical University; Air Force Military Medical University	Chen, ZN (corresponding author), Fourth Mil Med Univ, Cell Engn Res Ctr, 17 Changle W Rd, Xian 710032, Shaanxi, Peoples R China.	znchen@fmmu.edu.cn; hjbian@fmmu.edu.cn			National Natural Science Foundation of China [30870944, 30671196]; Hi-tech Research and Development Programme of China [2009CB521706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-tech Research and Development Programme of China(National High Technology Research and Development Program of China)	We thank Professor Xiao-Long Ji (Department of Pathology, General Hospital of the Chinese People's Armed Police Forces, Beijing, China), Professor Wei Zhang (Department of Pathology, Tangdu Hospital of Fourth Military Medical University, Xi'an, China) and Professor Qiao-Nan Guo (Department of Pathology, Southwest Hospital of Third Military Medical University, Chongqing, China) for their pathology analyses. We thank Professor Mien-Chie Hung (Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA) for providing pEGFP-Snail1, and Dr Ling-Min Kong and Xia Ke in our lab for providing pGL3-CD147 (-1761/+37), pGL3-CD147 (-644/+37) and pGL3-CD147 (-338/+37). Financial support: This work was supported by grants from the National Natural Science Foundation of China (Nos. 30870944 and 30671196), and the Hi-tech Research and Development Programme of China (No. 2009CB521706). Writing assistance was provided by American Journal Experts, USA.	Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Battaglia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004355; BEDOSSA P, 1995, HEPATOLOGY, V21, P760, DOI 10.1016/0270-9139(95)90530-8; Belton RJ, 2008, J BIOL CHEM, V283, P17805, DOI 10.1074/jbc.M801876200; Chen ZN, 2006, INT J RADIAT ONCOL, V65, P435, DOI 10.1016/j.ijrobp.2005.12.034; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Gou XC, 2009, CANCER SCI, V100, P837, DOI 10.1111/j.1349-7006.2009.01113.x; Huet E, 2008, FASEB J, V22, P1144, DOI 10.1096/fj.07-8748com; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Jiang JL, 2001, J BIOL CHEM, V276, P46870, DOI 10.1074/jbc.M108291200; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Li Y, 2009, HISTOPATHOLOGY, V54, P677, DOI 10.1111/j.1365-2559.2009.03280.x; Liu FF, 2010, BREAST CANCER RES TR, V124, P677, DOI 10.1007/s10549-010-0790-6; Matsuzaki K, 2009, FRONT BIOSCI-LANDMRK, V14, P2923, DOI 10.2741/3423; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Nitta T, 2008, HEPATOLOGY, V48, P909, DOI 10.1002/hep.22397; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sidhu SS, 2010, ONCOGENE, V29, P4145, DOI 10.1038/onc.2010.166; Song BC, 2002, CANCER-AM CANCER SOC, V94, P175, DOI 10.1002/cncr.10170; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Tsai JF, 1997, BRIT J CANCER, V76, P244, DOI 10.1038/bjc.1997.369; Valdes F, 2002, MOL CANCER RES, V1, P68; Valdes F, 2004, EXP CELL RES, V292, P209, DOI 10.1016/j.yexcr.2003.08.015; Vigneswaran N, 2006, EXP MOL PATHOL, V80, P147, DOI 10.1016/j.yexmp.2005.09.011; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Xu J, 2007, HEPATOLOGY, V45, P269, DOI 10.1002/hep.21465; Yan L, 2007, AM J HEMATOL, V82, P949, DOI 10.1002/ajh.21030; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang YA, 2006, CANCER CELL, V9, P445, DOI 10.1016/j.ccr.2006.04.025; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146	40	130	143	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	43					4410	4427		10.1038/onc.2011.149	http://dx.doi.org/10.1038/onc.2011.149			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HQ	21532623				2022-12-25	WOS:000296356500004
J	Zhai, Y; Iura, A; Yeasmin, S; Wiese, AB; Wu, R; Feng, Y; Fearon, ER; Cho, KR				Zhai, Y.; Iura, A.; Yeasmin, S.; Wiese, A. B.; Wu, R.; Feng, Y.; Fearon, E. R.; Cho, K. R.			MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma	ONCOGENE			English	Article						MSX2; ovarian cancer; endometrioid; WNT signaling; beta-catenin	BETA-CATENIN GENE; CELL FACTOR; NEOPLASTIC TRANSFORMATION; EXPRESSION ANALYSIS; WNT/BETA-CATENIN; HOMEOBOX GENE; UP-REGULATION; CLEAR-CELL; HOX GENES; CARCINOMAS	Ovarian endometrioid adenocarcinomas (OEAs) frequently exhibit constitutive activation of canonical WNT signaling, usually as a result of oncogenic mutations that stabilize and dysregulate the beta-catenin protein. In previous work, we used microarray-based methods to compare gene expression in OEAs with and without dysregulated beta-catenin as a strategy for identifying novel beta-catenin/TCF target genes with important roles in ovarian cancer pathogenesis. Among the genes highlighted by the microarray studies was MSX2, which encodes a homeobox transcription factor. We found MSX2 expression was markedly increased in primary human and murine OEAs with dysregulated beta-catenin compared with OEAs with intact beta-catenin regulation. WNT pathway activation by WNT3a ligand or GSK3b inhibitor treatment potently induced MSX2 and ectopic expression of a dominant negative form of TCF4 inhibited MSX2 expression in ovarian cancer cells. Chromatin immunoprecipitation studies demonstrated that beta-catenin/TCF directly regulates MSX2 expression via binding to TCF binding elements in multiple regions of the MSX2 gene. Notably, ectopic MSX2 expression was found to promote neoplastic transformation of the rodent RK3E model epithelial cell line and to enhance the invasiveness of immortalized human ovarian epithelial cells in vitro and ovarian carcinoma cells in vivo. Inhibition of endogenous MSX2 expression in ovarian endometrioid cancer cells carrying a beta-catenin mutation using shRNA approaches inhibited neoplastic properties of the cells in vitro and in vivo. Expression of MSX2 in selected ovarian carcinoma cells induced changes suggestive of epithelial-mesenchymal transition (EMT), but based on analysis of ovarian cell lines and primary tumor tissues, effects of MSX2 on EMT appear to be complex and context-dependent. Our findings indicate MSX2 is a direct downstream transcriptional target of beta-catenin/TCF and has a key contributing role in the cancer phenotype of OEAs carrying WNT/beta-catenin pathway defects. Oncogene (2011) 30, 4152-4162; doi:10.1038/onc.2011.123; published online 18 April 2011	[Zhai, Y.; Iura, A.; Yeasmin, S.; Wiese, A. B.; Wu, R.; Fearon, E. R.; Cho, K. R.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Feng, Y.; Fearon, E. R.; Cho, K. R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Fearon, E. R.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Fearon, E. R.; Cho, K. R.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cho, KR (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1506 BSRB,109 Zina Pitcher, Ann Arbor, MI 48109 USA.	kathcho@umich.edu		Cho, Kathleen/0000-0003-0500-9998; Saito, Ayaka/0000-0002-9916-0463	National Cancer Institute [RO1 CA94172, RO1 CA85463]; NATIONAL CANCER INSTITUTE [R01CA094172, R01CA085463] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank Rork Kuick for assistance in analyzing the microarray data from human and mouse tissue samples. This work was supported by grants from the National Cancer Institute (RO1 CA94172 and RO1 CA85463).	Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Bommer GT, 2010, J BIOL CHEM, V285, P1928, DOI 10.1074/jbc.M109.060319; Catasus L, 2004, HUM PATHOL, V35, P1360, DOI 10.1016/j.humpath.2004.07.019; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Di Bari MG, 2009, J CELL PHYSIOL, V219, P659, DOI 10.1002/jcp.21712; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Dodig M, 1999, DEV BIOL, V209, P298, DOI 10.1006/dbio.1999.9258; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang TX, 1999, J INVEST DERMATOL, V113, P230, DOI 10.1046/j.1523-1747.1999.00680.x; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Parker DS, 2008, MOL CELL BIOL, V28, P1815, DOI 10.1128/MCB.01230-07; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Sagae S, 1999, JPN J CANCER RES, V90, P510, DOI 10.1111/j.1349-7006.1999.tb00777.x; Satoh K, 2004, J MAMMARY GLAND BIOL, V9, P195, DOI 10.1023/B:JOMG.0000037162.84758.b5; Satoh K, 2008, AM J PATHOL, V172, P926, DOI 10.2353/ajpath.2008.070346; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schwartz DR, 2003, CANCER RES, V63, P2913; Schwartz DR, 2002, CANCER RES, V62, P4722; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Song LY, 2009, DEVELOPMENT, V136, P3161, DOI 10.1242/dev.037440; SUZUKI M, 1993, BIOCHEM BIOPH RES CO, V194, P187, DOI 10.1006/bbrc.1993.1802; Takahashi C, 1996, ONCOGENE, V12, P2137; Whyte DB, 2006, BIOCHEM BIOPH RES CO, V340, P469, DOI 10.1016/j.bbrc.2005.12.025; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wright K, 1999, INT J CANCER, V82, P625, DOI 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2; Wu R, 2001, CANCER RES, V61, P8247; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056	38	21	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	40					4152	4162		10.1038/onc.2011.123	http://dx.doi.org/10.1038/onc.2011.123			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	833ZK	21499300	Green Accepted, Bronze			2022-12-25	WOS:000295924600002
J	Giordano, C; Catalano, S; Panza, S; Vizza, D; Barone, I; Bonofiglio, D; Gelsomino, L; Rizza, P; Fuqua, SAW; Ando, S				Giordano, C.; Catalano, S.; Panza, S.; Vizza, D.; Barone, I.; Bonofiglio, D.; Gelsomino, L.; Rizza, P.; Fuqua, S. A. W.; Ando, S.			Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression	ONCOGENE			English	Article						FXR; breast cancer; tamoxifen resistance; HER2; NF-kappa B	ESTROGEN-RECEPTOR; NUCLEAR RECEPTOR; CROSS-TALK; IDENTIFICATION; AMPLIFICATION; HER-2/NEU; PROMOTER; THERAPY; TARGET; FXR	Tamoxifen (Tam) treatment is a first-line endocrine therapy for estrogen receptor-alpha-positive breast cancer patients. Unfortunately, resistance frequently occurs and is often related with overexpression of the membrane tyrosine kinase receptor HER2. This is the rationale behind combined treatments with endocrine therapy and novel inhibitors that reduce HER2 expression and signaling and thus inhibit Tam-resistant breast cancer cell growth. In this study, we show that activation of farnesoid X receptor (FXR), by the primary bile acid chenodeoxycholic acid (CDCA) or the synthetic agonist GW4064, inhibited growth of Tam-resistant breast cancer cells (termed MCF-7 TR1), which was used as an in vitro model of acquired Tam resistance. Our results demonstrate that CDCA treatment significantly reduced both anchorage-dependent and anchorage-independent epidermal growth factor (EGF)-induced growth in MCF-7 TR1 cells. Furthermore, results from western blot analysis and real-time reverse transcription-PCR revealed that CDCA treatment reduced HER2 expression and inhibited EGF-mediated HER2 and p42/44 mitogen-activated protein kinase (MAPK) phosphorylation in these Tam-resistant breast cancer cells. Transient transfection experiments, using a vector containing the human HER2 promoter region, showed that CDCA treatment downregulated basal HER2 promoter activity. This occurred through an inhibition of nuclear factor-kappa B transcription factor binding to its specific responsive element located in the HER2 promoter region as revealed by mutagenesis studies, electrophoretic mobility shift assay and chromatin immunoprecipitation analysis. Collectively, these data suggest that FXR ligand-dependent activity, blocking HER2/MAPK signaling, may overcome anti-estrogen resistance in human breast cancer cells and could represent a new therapeutic tool to treat breast cancer patients that develop resistance. Oncogene (2011) 30, 4129-4140; doi:10.1038/onc.2011.124; published online 18 April 2011	[Barone, I.; Rizza, P.; Ando, S.] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; [Giordano, C.; Catalano, S.; Barone, I.; Bonofiglio, D.; Ando, S.] Univ Calabria, Ctr Sanit, I-87036 Arcavacata Di Rende, Italy; [Catalano, S.; Panza, S.; Vizza, D.; Bonofiglio, D.; Gelsomino, L.] Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, Italy; [Fuqua, S. A. W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Fuqua, S. A. W.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	University of Calabria; University of Calabria; University of Calabria; Baylor College of Medicine; Baylor College of Medicine	Ando, S (corresponding author), Univ Calabria, Dept Cell Biol, Via P Bucci, I-87036 Arcavacata Di Rende, Italy.	sebastiano.ando@unical.it	Bonofiglio, Daniela/AAV-8371-2020	BONOFIGLIO, Daniela/0000-0002-4142-0496; GIORDANO, Cinzia/0000-0003-4969-0607; BARONE, Ines/0000-0002-9769-1615; Gelsomino, Luca/0000-0003-3076-3482; CATALANO, Stefania/0000-0002-6352-9628; RIZZA, Pietro/0000-0002-1267-3910	AIRC; MIUR; Lilli Funaro Foundation; NIH/NCI [R01 CA72038]; Cancer Prevention and Research Institute of Texas (SAWF) [RP101251]; NATIONAL CANCER INSTITUTE [R01CA072038] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR)); Lilli Funaro Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas (SAWF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by AIRC grants, MIUR Ex 60% 2009, PRIN 2009 and Lilli Funaro Foundation. NIH/NCI R01 CA72038 and RP101251 from the Cancer Prevention and Research Institute of Texas (SAWF). We thank Dr Mien-Chie Hung for providing the pNeuLite plasmid and Dr T. A. Kocarek for providing the FXR-responsive reporter gene and FXR-DN expression plasmids. We also thank Dr Rachel Schiff for providing the MCF-7/HER2-18 cells.	ALLRED DC, 1992, HUM PATHOL, V23, P974, DOI 10.1016/0046-8177(92)90257-4; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Arpino G, 2004, CLIN CANCER RES, V10, P5670, DOI 10.1158/1078-0432.CCR-04-0110; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; BARONE I, 2011, J NATL CANC IN PRESS; Barone I, 2009, CANCER RES, V69, P4724, DOI 10.1158/0008-5472.CAN-08-4194; Bishop-Bailey D, 2004, DRUG NEWS PERSPECT, V17, P499, DOI 10.1358/dnp.2004.17.8.863693; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Catalano S, 2010, J BIOL CHEM, V285, P5581, DOI 10.1074/jbc.M109.052670; Chung YL, 2002, INT J CANCER, V97, P306, DOI 10.1002/ijc.1614; Claudel T, 2002, J CLIN INVEST, V109, P961; De Laurentiis M, 2005, CLIN CANCER RES, V11, P4741, DOI 10.1158/1078-0432.CCR-04-2569; ENCARNACION CA, 1993, BREAST CANCER RES TR, V26, P237, DOI 10.1007/BF00665801; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Giordano C, 2010, BREAST CANCER RES TR, V119, P71, DOI 10.1007/s10549-009-0334-0; Glockner S, 2001, LAB INVEST, V81, P565, DOI 10.1038/labinvest.3780265; Gradishar WJ, 2004, ONCOLOGIST, V9, P378, DOI 10.1634/theoncologist.9-4-378; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; He FT, 2006, CIRC RES, V98, P192, DOI 10.1161/01.RES.0000200400.55539.85; Herynk MH, 2006, MOL CANCER THER, V5, P3023, DOI 10.1158/1535-7163.MCT-06-0394; Hurst HC, 2001, BREAST CANCER RES, V3, P395, DOI 10.1186/bcr329; ISHII S, 1987, P NATL ACAD SCI USA, V84, P4374, DOI 10.1073/pnas.84.13.4374; Johnston SRD, 2009, CLIN BREAST CANCER, V9, pS28, DOI 10.3816/CBC.2009.s.003; Journe F, 2008, BREAST CANCER RES TR, V107, P49, DOI 10.1007/s10549-007-9535-6; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kirkegaard T, 2007, CLIN CANCER RES, V13, P1405, DOI 10.1158/1078-0432.CCR-06-1933; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kocarek TA, 2002, J PHARMACOL TOXICOL, V47, P177, DOI 10.1016/S1056-8719(03)00002-9; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Morelli C, 2004, ONCOGENE, V23, P7517, DOI 10.1038/sj.onc.1208014; Nicholson RI, 2004, ENDOCR-RELAT CANCER, V11, P623, DOI 10.1677/erc.1.00778; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Sabnis GJ, 2005, CANCER RES, V65, P3903, DOI 10.1158/0008-5472.CAN-04-4092; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Seidman AD, 2001, J CLIN ONCOL, V19, P2587, DOI 10.1200/JCO.2001.19.10.2587; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Sirianni R, 2007, CANCER RES, V67, P8368, DOI 10.1158/0008-5472.CAN-06-4064; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Staka CM, 2005, ENDOCR-RELAT CANCER, V12, pS85, DOI 10.1677/erc.1.01006; Swales KE, 2006, CANCER RES, V66, P10120, DOI 10.1158/0008-5472.CAN-06-2399; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294; Yarden Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055396	49	52	54	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	39					4129	4140		10.1038/onc.2011.124	http://dx.doi.org/10.1038/onc.2011.124			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	826ME	21499302	Green Accepted			2022-12-25	WOS:000295357500008
J	Golubkov, VS; Aleshin, AE; Strongin, AY				Golubkov, Vladislav S.; Aleshin, Alexander E.; Strongin, Alex Y.			Potential Relation of Aberrant Proteolysis of Human Protein Tyrosine Kinase 7 (PTK7) chuzhoi by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) to Congenital Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; NEURAL CREST MIGRATION; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; CANCER-CELLS; OFF-TRACK; RECEPTOR; INVASION; FAMILY; GASTRULATION	Membrane PTK7 pseudo-kinase plays an essential role in planar cell polarity and the non-canonical Wnt pathway in vertebrates. Recently, a new N-ethyl-N-nitrosourea-induced mutant named chuzhoi (chz) was isolated in mice. chz embryos have severe birth defects, including a defective neural tube, defective heart and lung development, and a shortened anterior-posterior body axis. The chz mutation was mapped to the Ala-Asn-Pro tripeptide insertion into the junction region between the fifth and the sixth Ig-like domains of PTK7. Unexpectedly, chz reduced membrane localization of the PTK7 protein. We hypothesized and then proved that the chz mutation caused an insertion of an additional membrane type 1 matrix metalloproteinase cleavage site in PTK7 and that the resulting aberrant proteolysis of chz affected the migratory parameters of the cells. It is likely that aberrations in the membrane type 1 matrix metalloproteinase/PTK7 axis are detrimental to cell movements that shape the body plan and that chz represents a novel model system for increasing our understanding of the role of proteolysis in developmental pathologies, including congenital defects.	[Golubkov, Vladislav S.; Aleshin, Alexander E.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Golubkov, Vladislav/L-6828-2017; Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [CA83017, CA77470]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 (to A. Y. S.).	Cantrell VA, 2010, CANCER LETT, V287, P54, DOI 10.1016/j.canlet.2009.05.041; Coyle RC, 2008, EXP CELL RES, V314, P2150, DOI 10.1016/j.yexcr.2008.03.010; Dale TC, 1998, BIOCHEM J, V329, P209; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Golldack D, 2002, J BIOL CHEM, V277, P5541, DOI 10.1074/jbc.M106197200; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Goodrich LV, 2008, NEURON, V60, P9, DOI 10.1016/j.neuron.2008.09.003; Grassot J, 2006, MOL BIOL EVOL, V23, P1232, DOI 10.1093/molbev/msk007; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Jung JW, 2004, GENE, V328, P75, DOI 10.1016/j.gene.2003.12.006; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Katoh M, 2005, ONCOL REP, V14, P1583; LEE HK, 2011, BLOOD IN PRESS; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MOSSIE K, 1995, ONCOGENE, V11, P2179; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; Park SK, 1996, J BIOCHEM, V119, P235; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Polakis P, 2000, GENE DEV, V14, P1837; Prebet T, 2010, BLOOD, V116, P2315, DOI 10.1182/blood-2010-01-262352; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wagner G, 2010, BIOCHEM BIOPH RES CO, V402, P402, DOI 10.1016/j.bbrc.2010.10.044; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8	52	20	20	4	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20970	20976		10.1074/jbc.M111.237669	http://dx.doi.org/10.1074/jbc.M111.237669			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518755	Green Published, hybrid			2022-12-25	WOS:000291267600081
J	Testoni, B; Vollenkle, C; Guerrieri, F; Gerbal-Chaloin, S; Blandino, G; Levrero, M				Testoni, Barbara; Voellenkle, Christine; Guerrieri, Francesca; Gerbal-Chaloin, Sabine; Blandino, Giovanni; Levrero, Massimo			Chromatin Dynamics of Gene Activation and Repression in Response to Interferon alpha (IFN alpha) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C; TARGET GENES; EXPRESSION; CELLS; COMPLEX; PROTEIN; IMMUNOPRECIPITATION; IDENTIFICATION; MECHANISMS; PATHWAY	Signal transducer and activator of transcription 2 (STAT2), the critical component of type I interferons signaling, is a prototype latent cytoplasmic signal-dependent transcription factor. Activated tyrosine-phosphorylated STAT2 associates with STAT1 and IRF9 to bind the ISRE elements in the promoters of a subset of IFN-inducible genes (ISGs). In addition to activate hundreds of ISGs, IFN alpha also represses numerous target genes but the mechanistic basis for this dual effect and transcriptional repression is largely unknown. We investigated by ChIP-chip the binding dynamics of STAT2 and "active" phospho(P)-STAT2 on 113 putative IFN alpha direct target promoters before and after IFN alpha induction in Huh7 cells and primary human hepatocytes (PHH). STAT2 is already bound to 62% of our target promoters, including most "classical" ISGs, before IFN alpha treatment. 31% of STAT2 basally bound promoters also show P-STAT2 positivity. By correlating in vivo promoter occupancy with gene expression and changes in histone methylation marks we found that: 1) STAT2 plays a role in regulating ISGs expression, independently from its phosphorylation; 2) P-STAT2 is involved in ISGs repression; 3) "activated" ISGs are marked by H3K4me1 and H3K4me3 before IFN alpha; 4) "repressed" genes are marked by H3K27me3 and histone methylation plays a dominant role in driving IFN alpha-mediated ISGs repression.	[Testoni, Barbara; Levrero, Massimo] Univ Roma La Sapienza, DMISM, I-00161 Rome, Italy; [Testoni, Barbara; Voellenkle, Christine; Guerrieri, Francesca; Levrero, Massimo] Fdn A Cesalpino, Gene Express Lab, I-00161 Rome, Italy; [Testoni, Barbara; Voellenkle, Christine; Blandino, Giovanni; Levrero, Massimo] Regina Elena Inst Canc Res, Rome Oncogen Ctr, I-00144 Rome, Italy; [Guerrieri, Francesca; Levrero, Massimo] INSERM, LEA U785, I-00161 Rome, Italy; [Gerbal-Chaloin, Sabine] INSERM, U632, Inst Rech Biotherapie, F-34090 Montpellier, France; [Blandino, Giovanni] Regina Elena Inst Canc Res, Translat Oncogen Unit, I-00144 Rome, Italy	Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Testoni, B (corresponding author), Univ Roma La Sapienza, DMISM, Viale Policlin 155, I-00161 Rome, Italy.	barbara.testoni@uniroma1.it; massimo.levrero@uniroma1.it	Guerrieri, Francesca/K-5504-2016; guerrieri, francesca/G-3908-2013; Voellenkle, Christine/J-8144-2016; Voellenkle, Christine/AAD-3092-2021; GERBAL-CHALOIN, sabine/M-8783-2017; Levrero, Massimo/G-5680-2016; TESTONI, Barbara/F-3767-2017	Guerrieri, Francesca/0000-0003-2751-6050; Voellenkle, Christine/0000-0003-0824-060X; GERBAL-CHALOIN, sabine/0000-0002-2549-7899; Levrero, Massimo/0000-0002-4978-0875; TESTONI, Barbara/0000-0001-5588-5465; Guerrieri, Francesca/0000-0002-2021-4394	AIRC; European Community [LSHC-CT-2004-503576]; MIUR-Cofin; Progetti di Ateneo; Sapienza University of Rome; Schering-Plough; AICF (American Italian Cancer Foundation); Fondazione Adriano Buzzati-Traverso; Fondazione A. Cesalpino; Rome Oncogenomic Center at the Regina Elena Cancer Institute	AIRC(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); MIUR-Cofin(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Progetti di Ateneo; Sapienza University of Rome; Schering-Plough(Merck & CompanySchering Plough Corporation); AICF (American Italian Cancer Foundation); Fondazione Adriano Buzzati-Traverso; Fondazione A. Cesalpino; Rome Oncogenomic Center at the Regina Elena Cancer Institute	This work was supported in part by grants from AIRC, European Community (LSHC-CT-2004-503576), MIUR-Cofin, and Progetti di Ateneo, Sapienza University of Rome and Schering-Plough (to M.L.). This work was also supported in part by fellowships from the AICF (American Italian Cancer Foundation) and from the Fondazione Adriano Buzzati-Traverso (to B.T.) and fellowships from the Fondazione A. Cesalpino and Rome Oncogenomic Center at the Regina Elena Cancer Institute (to F.G.).	Banninger G, 2004, J BIOL CHEM, V279, P39199, DOI 10.1074/jbc.M400815200; Barry Michele, 2006, Sci STKE, V2006, ppe21; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Bluyssen HAR, 1997, J BIOL CHEM, V272, P4600, DOI 10.1074/jbc.272.7.4600; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; D'Acunto CW, 2010, ANTICANCER RES, V30, P887; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Geiss GK, 2003, J VIROL, V77, P6367, DOI 10.1128/JVI.77.11.6367-6375.2003; Gerber SA, 2008, J IMMUNOL, V181, P1052, DOI 10.4049/jimmunol.181.2.1052; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gupta S, 1999, J IMMUNOL, V163, P3834; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hong SW, 2009, MOL CELLS, V27, P243, DOI 10.1007/s10059-009-0030-2; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Inagaki Y, 2003, HEPATOLOGY, V38, P890, DOI 10.1053/jhep.2003.50408; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; KISSELEV L, 1993, TRENDS BIOCHEM SCI, V18, P263, DOI 10.1016/0968-0004(93)90178-P; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Kraus TA, 2003, J BIOL CHEM, V278, P13033, DOI 10.1074/jbc.M212972200; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Noskov VN, 1998, MOL CELL BIOL, V18, P4914, DOI 10.1128/MCB.18.8.4914; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Park BL, 2007, BIOCHEM BIOPH RES CO, V363, P776, DOI 10.1016/j.bbrc.2007.09.026; Pichard-Garcia L, 2002, METHOD ENZYMOL, V357, P311; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Shaked H, 2008, CANCER RES, V68, P9671, DOI 10.1158/0008-5472.CAN-08-0865; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shi Zheng-Zheng, 2007, Journal of Zhejiang University-Science B, V8, P170, DOI 10.1631/jzus.2007.B0170; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Testoni B, 2006, NUCLEIC ACIDS RES, V34, P928, DOI 10.1093/nar/gkj477; TESTONI B, 2011, ONCOGENE IN PRESS; Uddin S, 2004, J BIOCHEM MOL BIOL, V37, P635; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Ward SV, 2003, VIROLOGY, V313, P553, DOI 10.1016/S0042-6822(03)00347-7; Wesoly J, 2007, ACTA BIOCHIM POL, V54, P27, DOI 10.18388/abp.2007_3266; Wohrle S, 2007, MOL CELL BIOL, V27, P8164, DOI 10.1128/MCB.00555-07; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Wormald S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-254; Wu WZ, 2005, WORLD J GASTROENTERO, V11, P6613, DOI 10.3748/wjg.v11.i42.6613; Xu DW, 2000, BLOOD, V96, P4313, DOI 10.1182/blood.V96.13.4313.h8004313_4313_4318; Zhao XX, 2009, BIOCHEM BIOPH RES CO, V378, P21, DOI 10.1016/j.bbrc.2008.10.123; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184	69	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20217	20227		10.1074/jbc.M111.231068	http://dx.doi.org/10.1074/jbc.M111.231068			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498520	hybrid, Green Published			2022-12-25	WOS:000291267600009
J	Luijten, M; Littel, M; Franken, IHA				Luijten, Maartje; Littel, Marianne; Franken, Ingmar H. A.			Deficits in Inhibitory Control in Smokers During a Go/NoGo Task: An Investigation Using Event-Related Brain Potentials	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; OBSESSIVE-COMPULSIVE DISORDER; STOP-SIGNAL TASK; RESPONSE-INHIBITION; EXECUTIVE CONTROL; NICOTINE DEPENDENCE; ADDICTIVE BEHAVIORS; FAGERSTROM TEST; DRUG-ADDICTION; ERP COMPONENTS	Introduction: The role of inhibitory control in addictive behaviors is highlighted in several models of addictive behaviors. Although reduced inhibitory control has been observed in addictive behaviors, it is inconclusive whether this is evident in smokers. Furthermore, it has been proposed that drug abuse individuals with poor response inhibition may experience greater difficulties not consuming substances in the presence of drug cues. The major aim of the current study was to provide electrophysiological evidence for reduced inhibitory control in smokers and to investigate whether this is more pronounced during smoking cue exposure. Methods: Participants (19 smokers and 20 non-smoking controls) performed a smoking Go/NoGo task. Behavioral accuracy and amplitudes of the N2 and P3 event-related potential (ERP), both reflecting aspects of response inhibition, were the main variables of interest. Results: Reduced NoGo N2 amplitudes in smokers relative to controls were accompanied by decreased task performance, whereas no differences between groups were found in P3 amplitudes. This was found to represent a general lack of inhibition in smokers, and not dependent on the presence of smoking cues. Conclusions: The current results suggest that smokers have difficulties with response inhibition, which is an important finding that eventually can be implemented in smoking cessation programs. More research is needed to clarify the exact role of cue exposure on response inhibition.	[Luijten, Maartje; Littel, Marianne; Franken, Ingmar H. A.] Erasmus Univ, Inst Psychol, Rotterdam, Netherlands	Erasmus University Rotterdam	Luijten, M (corresponding author), Erasmus Univ, Inst Psychol, Rotterdam, Netherlands.	luijten@fsw.eur.nl	Franken, Ingmar/AAB-7562-2019; Franken, Ingmar/C-2382-2008	Franken, Ingmar/0000-0002-7853-2694; Franken, Ingmar/0000-0002-7853-2694; Littel, Marianne/0000-0002-3741-6005	Netherlands Organization for Scientific Research (NWO) [016.08.322]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant of the Netherlands Organization for Scientific Research (NWO; VIDI grant number 016.08.322). The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagot KS, 2007, AM J ADDICTION, V16, P62, DOI 10.1080/10550490601080100; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Burle B, 2004, NEUROSCI LETT, V360, P77, DOI 10.1016/j.neulet.2004.02.034; Chen CY, 2005, NEUROREPORT, V16, P1213, DOI 10.1097/00001756-200508010-00016; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Dawe S, 2004, ADDICT BEHAV, V29, P1389, DOI 10.1016/j.addbeh.2004.06.004; Dimoska A, 2006, BRAIN COGNITION, V62, P98, DOI 10.1016/j.bandc.2006.03.011; Dinn WM, 2004, ADDICT BEHAV, V29, P107, DOI 10.1016/j.addbeh.2003.07.001; Evans DE, 2009, GENES BRAIN BEHAV, V8, P86, DOI 10.1111/j.1601-183X.2008.00445.x; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Falkenstein M, 2006, CLIN NEUROPHYSIOL, V117, P1638, DOI 10.1016/j.clinph.2006.05.002; Feil J, 2010, NEUROSCI BIOBEHAV R, V35, P248, DOI 10.1016/j.neubiorev.2010.03.001; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Field M, 2007, ADDICTION, V102, P579, DOI 10.1111/j.1360-0443.2007.01743.x; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Gamma A, 2005, J PSYCHOPHARMACOL, V19, P504, DOI 10.1177/0269881105056535; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Groman SM, 2009, NEUROSCI BIOBEHAV R, V33, P690, DOI 10.1016/j.neubiorev.2008.08.008; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heil M, 2000, J PSYCHOPHYSIOL, V14, P218, DOI 10.1027//0269-8803.14.4.218; Houlihan ME, 1996, PSYCHOPHARMACOLOGY, V123, P231, DOI 10.1007/BF02246577; Houlihan ME, 2001, PSYCHOPHARMACOLOGY, V156, P388, DOI 10.1007/s002130100751; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Johnstone SJ, 2009, INT J PSYCHOPHYSIOL, V72, P145, DOI 10.1016/j.ijpsycho.2008.11.007; Kaiser S, 2003, PSYCHIAT RES-NEUROIM, V122, P169, DOI 10.1016/S0925-4927(03)00004-0; Kaiser S, 2006, INT J PSYCHOPHYSIOL, V61, P279, DOI 10.1016/j.ijpsycho.2005.09.006; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; Kiehl KA, 2000, BIOL PSYCHIAT, V48, P210, DOI 10.1016/S0006-3223(00)00834-9; Kim MS, 2007, DEPRESS ANXIETY, V24, P22, DOI 10.1002/da.20195; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Monterosso JR, 2005, DRUG ALCOHOL DEPEN, V79, P273, DOI 10.1016/j.drugalcdep.2005.02.002; Nakata H, 2004, CLIN NEUROPHYSIOL, V115, P361, DOI 10.1016/j.clinph.2003.09.013; Nakata H, 2006, CLIN NEUROPHYSIOL, V117, P1669, DOI 10.1016/j.clinph.2006.03.032; Olmstead MC, 2006, Q J EXP PSYCHOL, V59, P625, DOI 10.1080/17470210500356308; PFEFFERBAUM A, 1987, ALCOHOL, V4, P275, DOI 10.1016/0741-8329(87)90023-1; Reynolds B, 2007, EXP CLIN PSYCHOPHARM, V15, P264, DOI 10.1037/1064-1297.15.3.264; Rubio G, 2008, ALCOHOL CLIN EXP RES, V32, P1681, DOI 10.1111/j.1530-0277.2008.00746.x; Ruchsow M, 2008, J NEURAL TRANSM, V115, P127, DOI 10.1007/s00702-007-0819-0; Ruchsow M, 2007, J NEURAL TRANSM, V114, P1595, DOI 10.1007/s00702-007-0779-4; Ruchsow M, 2008, INT J PSYCHOPHYSIOL, V68, P209, DOI 10.1016/j.ijpsycho.2008.01.010; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Smith JL, 2004, CLIN NEUROPHYSIOL, V115, P1320, DOI 10.1016/j.clinph.2004.01.008; Spinella M, 2002, ADDICT BIOL, V7, P381, DOI 10.1080/1355621021000005964; Tiffany ST, 1999, ALCOHOL RES HEALTH, V23, P215; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Vink JM, 2005, ADDICT BEHAV, V30, P575, DOI 10.1016/j.addbeh.2004.05.023; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Yang B, 2009, SCI CHINA SER C, V52, P780, DOI 10.1007/s11427-009-0106-4	54	107	115	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18898	10.1371/journal.pone.0018898	http://dx.doi.org/10.1371/journal.pone.0018898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756MO	21526125	Green Published, gold			2022-12-25	WOS:000290015800020
J	Ackermann, J; Ashton, G; Lyons, S; James, D; Hornung, JP; Jones, N; Breitwieser, W				Ackermann, Julien; Ashton, Garry; Lyons, Steve; James, Dominic; Hornung, Jean-Pierre; Jones, Nic; Breitwieser, Wolfgang			Loss of ATF2 Function Leads to Cranial Motoneuron Degeneration during Embryonic Mouse Development	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATING TRANSCRIPTION FACTOR-2; SIGNAL-TRANSDUCTION PATHWAY; ELEMENT-BINDING PROTEIN; MOTOR-NEURON IDENTITY; N-TERMINAL KINASES; C-JUN; NERVOUS-SYSTEM; SEROTONERGIC NEURONS; SOMATIC MOTONEURONS	The AP-1 family transcription factor ATF2 is essential for development and tissue maintenance in mammals. In particular, ATF2 is highly expressed and activated in the brain and previous studies using mouse knockouts have confirmed its requirement in the cerebellum as well as in vestibular sense organs. Here we present the analysis of the requirement for ATF2 in CNS development in mouse embryos, specifically in the brainstem. We discovered that neuron-specific inactivation of ATF2 leads to significant loss of motoneurons of the hypoglossal, abducens and facial nuclei. While the generation of ATF2 mutant motoneurons appears normal during early development, they undergo caspase-dependent and independent cell death during later embryonic and foetal stages. The loss of these motoneurons correlates with increased levels of stress activated MAP kinases, JNK and p38, as well as aberrant accumulation of phosphorylated neurofilament proteins, NF-H and NF-M, known substrates for these kinases. This, together with other neuropathological phenotypes, including aberrant vacuolisation and lipid accumulation, indicates that deficiency in ATF2 leads to neurodegeneration of subsets of somatic and visceral motoneurons of the brainstem. It also confirms that ATF2 has a critical role in limiting the activities of stress kinases JNK and p38 which are potent inducers of cell death in the CNS.	[Ackermann, Julien; Ashton, Garry; Lyons, Steve; James, Dominic; Jones, Nic; Breitwieser, Wolfgang] Univ Manchester, Paterson Inst Canc Res, Cell Regulat Dept, Manchester, Lancs, England; [Ackermann, Julien; Hornung, Jean-Pierre] Inst Biol Cellulaire & Morphol, Lausanne, Switzerland	Paterson Institute for Cancer Research; University of Manchester	Ackermann, J (corresponding author), Univ Manchester, Paterson Inst Canc Res, Cell Regulat Dept, Manchester, Lancs, England.	wbreitwieser@picr.man.ac.uk	James, Dominic/G-6435-2016; Hornung, Jean-Pierre/O-7505-2015	James, Dominic/0000-0002-0452-2178; Hornung, Jean-Pierre/0000-0002-9229-7520; Jones, Nic/0000-0002-7619-8151	Cancer Research UK; European Science Foundation; Cancer Research UK [12485] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Science Foundation(European Science Foundation (ESF)European Commission); Cancer Research UK(Cancer Research UK)	The project was funded by Cancer Research UK. J.A. was funded by the European Science Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2004, MOL CELL NEUROSCI, V26, P354, DOI 10.1016/j.mcn.2004.02.009; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bayliss High OB, 1990, THEORY PRACTICE HIST, P215; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; Blanchi B, 2005, TRENDS MOL MED, V11, P23, DOI 10.1016/j.molmed.2004.11.005; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Brownlees J, 2000, J CELL SCI, V113, P401; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cutler RG, 2002, ANN NEUROL, V52, P448, DOI 10.1002/ana.10312; Dauger S, 2003, DEVELOPMENT, V130, P6635, DOI 10.1242/dev.00866; De Girolamo LA, 2006, J NEUROSCI RES, V83, P680, DOI 10.1002/jnr.20765; Dewil M, 2007, NEUROBIOL DIS, V26, P332, DOI 10.1016/j.nbd.2006.12.023; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; DYKSTRA MJ, 1992, BIOL ELECT MICROSCOP; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Gaufo GO, 2003, DEVELOPMENT, V130, P5191, DOI 10.1242/dev.00730; Gelderblom M, 2004, INT J DEV NEUROSCI, V22, P559, DOI 10.1016/j.ijdevneu.2004.07.014; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Herdegen T, 1997, NEUROSCIENCE, V81, P199, DOI 10.1016/S0306-4522(97)00170-X; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Holasek SS, 2005, BRAIN RES, V1045, P185, DOI 10.1016/j.brainres.2005.03.037; Hu BR, 1999, NEUROSCIENCE, V89, P437, DOI 10.1016/S0306-4522(98)00352-2; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kojima M, 2008, J NEUROSCI RES, V86, P544, DOI 10.1002/jnr.21510; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Manley NR, 1997, DEV BIOL, V192, P274, DOI 10.1006/dbio.1997.8765; Martin-Villalba A, 1998, MOL BRAIN RES, V62, P158, DOI 10.1016/S0169-328X(98)00239-3; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; Mechta-Grigoriou F, 2003, DEV BIOL, V258, P419, DOI 10.1016/S0012-1606(03)00135-0; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Ottaviani G, 2006, J CLIN PATHOL, V59, P497, DOI 10.1136/jcp.2005.032037; Ottaviani G, 2009, VIRCHOWS ARCH, V454, P451, DOI 10.1007/s00428-009-0754-6; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Reimold AM, 2001, INT IMMUNOL, V13, P241, DOI 10.1093/intimm/13.2.241; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Shibata N, 2001, BRAIN RES, V917, P97, DOI 10.1016/S0006-8993(01)02926-2; Talley EM, 2000, DEV BRAIN RES, V122, P1, DOI 10.1016/S0165-3806(00)00036-5; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Veglianese P, 2006, MOL CELL NEUROSCI, V31, P218, DOI 10.1016/j.mcn.2005.09.009; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	68	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19090	10.1371/journal.pone.0019090	http://dx.doi.org/10.1371/journal.pone.0019090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533046	Green Submitted, Green Published, gold			2022-12-25	WOS:000290014500023
J	Lin, JT; Bethell, D; Tyner, SD; Lon, C; Shah, NK; Saunders, DL; Sriwichai, S; Khemawoot, P; Kuntawunggin, W; Smith, BL; Noedl, H; Schaecher, K; Socheat, D; Se, Y; Meshnick, SR; Fukuda, MM				Lin, Jessica T.; Bethell, Delia; Tyner, Stuart D.; Lon, Chanthap; Shah, Naman K.; Saunders, David L.; Sriwichai, Sabaithip; Khemawoot, Phisit; Kuntawunggin, Worachet; Smith, Bryan L.; Noedl, Harald; Schaecher, Kurt; Socheat, Duong; Se, Youry; Meshnick, Steven R.; Fukuda, Mark M.			Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment	PLOS ONE			English	Article							MALARIA; ANTIMALARIAL; INFECTIONS	Mixed P. falciparum/P. vivax infections are common in southeast Asia. When patients with P. falciparum malaria are treated and followed for several weeks, a significant proportion will develop P. vivax malaria. In a combined analysis of 243 patients recruited to two malaria treatment trials in western Cambodia, 20/43 (47%) of those with P. falciparum gametocytes on admission developed P. vivax malaria by Day 28 of follow-up. The presence of Pf gametocytes on an initial blood smear was associated with a 3.5-fold greater rate of vivax parasitemia post-treatment (IRR = 3.5, 95% CI 2.0-6.0, p < 0.001). The increased rate of post-treatment P. vivax infection persisted when correlates of exposure and immunity such as a history of malaria, male gender, and age were controlled for (IRR = 3.0, 95% CI 1.9-4.7, p < 0.001). Polymerase chain reaction (PCR) confirmed that only a low proportion of subjects (5/55 or 9.1%) who developed vivax during follow-up had detectable Pv parasites in the peripheral blood at baseline. Molecular detection of falciparum gametocytes by reverse transcriptase PCR in a subset of patients strengthened the observed association, while PCR detection of Pv parasitemia at follow-up was similar to microscopy results. These findings suggest that the majority of vivax infections arising after treatment of falciparum malaria originate from relapsing liver-stage parasites. In settings such as western Cambodia, the presence of both sexual and asexual forms of P. falciparum on blood smear at presentation with acute falciparum malaria serves as a marker for possible occult P. vivax coinfection and subsequent relapse. These patients may benefit from empiric treatment with an 8-aminoquinolone such as primaquine.	[Lin, Jessica T.; Bethell, Delia; Tyner, Stuart D.; Lon, Chanthap; Saunders, David L.; Sriwichai, Sabaithip; Khemawoot, Phisit; Kuntawunggin, Worachet; Smith, Bryan L.; Schaecher, Kurt; Se, Youry; Fukuda, Mark M.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Socheat, Duong] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Noedl, Harald] Med Univ Vienna, Dept Specif Prophylaxis & Trop Med, Vienna, Austria; [Shah, Naman K.; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Lin, Jessica T.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Fukuda, Mark M.] Armed Forces Hlth Surveillance Ctr, Div Global Emerging Infect Dis Operat, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); National Center Parasitology, Entomology & Malaria Control; Medical University of Vienna; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lin, JT (corresponding author), Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand.	jesstlin@gmail.com	Lin, Jessica/I-2705-2019; Khemawoot, Phisit/ABE-2110-2020		U.S. Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS); American Society of Tropical Medicine and Hygiene; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070114] Funding Source: NIH RePORTER	U.S. Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS)(United States Department of Defense); American Society of Tropical Medicine and Hygiene; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the U.S. Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS) Program (for funding of the clinical trial) and a Pfizer Centennial Travel Award sponsored by the American Society of Tropical Medicine and Hygiene granted to Dr. Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JK, 2011, CLIN INFECT DIS, V52, P621, DOI 10.1093/cid/ciq258; Bousema JT, 2008, AM J TROP MED HYG, V78, P442, DOI 10.4269/ajtmh.2008.78.442; BOYD MARK F., 1938, AMER JOUR TROP MED, V18, P505; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; BUNNAG D, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P534; Dixon MWA, 2008, TRENDS PARASITOL, V24, P168, DOI 10.1016/j.pt.2008.01.004; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Hasugian AR, 2007, CLIN INFECT DIS, V44, P1067, DOI 10.1086/512677; LOOAREESUWAN S, 1987, LANCET, V2, P1052, DOI 10.1016/S0140-6736(87)91479-6; Mayxay M, 2004, TRENDS PARASITOL, V20, P233, DOI 10.1016/j.pt.2004.03.006; McKenzie FE, 2002, AM J TROP MED HYG, V67, P411, DOI 10.4269/ajtmh.2002.67.411; Mlambo G, 2008, AM J TROP MED HYG, V78, P114, DOI 10.4269/ajtmh.2008.78.114; Noedl H, 2004, ANTIMICROB AGENTS CH, V48, P4485, DOI 10.1128/AAC.48.11.4485-4487.2004; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Price RN, 2010, LANCET INFECT DIS, V10, P654, DOI 10.1016/S1473-3099(10)70192-4; Pukrittayakamee S, 2004, ACTA TROP, V89, P351, DOI 10.1016/j.actatropica.2003.10.012; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; SE Y, 2009, ANN M AM SOC TROP ME; Smithuis F, 2010, LANCET INFECT DIS, V10, P673, DOI 10.1016/S1473-3099(10)70187-0; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; Zimmerman PA, 2004, TRENDS PARASITOL, V20, P440, DOI 10.1016/j.pt.2004.07.004; Zwang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006358	22	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18716	10.1371/journal.pone.0018716	http://dx.doi.org/10.1371/journal.pone.0018716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533092	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400021
J	Poplawski, MM; Mastaitis, JW; Isoda, F; Grosjean, F; Zheng, F; Mobbs, CV				Poplawski, Michal M.; Mastaitis, Jason W.; Isoda, Fumiko; Grosjean, Fabrizio; Zheng, Feng; Mobbs, Charles V.			Reversal of Diabetic Nephropathy by a Ketogenic Diet	PLOS ONE			English	Article							OXIDATIVE STRESS; ALZHEIMERS-DISEASE; MOUSE MODEL; APOPTOSIS; NEURONS; GLUCOSE; RESTRICTION; EXPRESSION; COMPLICATIONS; HYSTERESIS	Intensive insulin therapy and protein restriction delay the development of nephropathy in a variety of conditions, but few interventions are known to reverse nephropathy. Having recently observed that the ketone 3-beta-hydroxybutyric acid (3-OHB) reduces molecular responses to glucose, we hypothesized that a ketogenic diet, which produces prolonged elevation of 3-OHB, may reverse pathological processes caused by diabetes. To address this hypothesis, we assessed if prolonged maintenance on a ketogenic diet would reverse nephropathy produced by diabetes. In mouse models for both Type 1 (Akita) and Type 2 (db/db) diabetes, diabetic nephropathy (as indicated by albuminuria) was allowed to develop, then half the mice were switched to a ketogenic diet. After 8 weeks on the diet, mice were sacrificed to assess gene expression and histology. Diabetic nephropathy, as indicated by albumin/creatinine ratios as well as expression of stress-induced genes, was completely reversed by 2 months maintenance on a ketogenic diet. However, histological evidence of nephropathy was only partly reversed. These studies demonstrate that diabetic nephropathy can be reversed by a relatively simple dietary intervention. Whether reduced glucose metabolism mediates the protective effects of the ketogenic diet remains to be determined.	[Poplawski, Michal M.; Isoda, Fumiko; Mobbs, Charles V.] Mt Sinai Sch Med, Fishberg Ctr Neurobiol, New York, NY USA; [Mastaitis, Jason W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Grosjean, Fabrizio; Zheng, Feng] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Yale University; Icahn School of Medicine at Mount Sinai	Poplawski, MM (corresponding author), Mt Sinai Sch Med, Fishberg Ctr Neurobiol, New York, NY USA.	charles.mobbs@mssm.edu		Mobbs, Charles/0000-0002-5815-8711	Juvenile Diabetes Foundation International; NIH/NIDDK [1R01HD060914-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD060914] Funding Source: NIH RePORTER	Juvenile Diabetes Foundation International; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	These studies were supported by the Juvenile Diabetes Foundation International. Grant support: NIH/NIDDK (1R01HD060914-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, AM J PHYSL ENDOCRINO; Bailey EE, 2005, EPILEPSY BEHAV, V6, P4, DOI 10.1016/j.yebeh.2004.10.006; Barutta F, 2010, DIABETES, V59, P1046, DOI 10.2337/db09-1336; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Cheng H, 2008, ENDOCRINOLOGY, V149, P703, DOI 10.1210/en.2007-0772; CROFFORD OB, 1995, ANNU REV MED, V46, P267; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Ghosh S, 2009, AM J PHYSIOL-RENAL, V296, pF700, DOI 10.1152/ajprenal.90548.2008; Grant MM, 2005, PROTEOMICS, V5, P534, DOI 10.1002/pmic.200300924; Gum ET, 2004, STROKE, V35, P590, DOI 10.1161/01.STR.0000110790.05859.DA; Hamada Yasuhiro, 2007, Kobe J Med Sci, V53, P53; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kojima S, 2009, PEPTIDES, V30, P962, DOI 10.1016/j.peptides.2009.01.007; Kowluru RA, 2004, J DIABETES COMPLICAT, V18, P282, DOI 10.1016/j.jdiacomp.2004.03.002; Laurent M, 2005, CELL MOL BIOL, V51, P583, DOI 10.1170/T667; Lee Y, 2004, NEUROCHEM INT, V44, P107, DOI 10.1016/S0197-0186(03)00112-8; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Menini S, 2007, DIABETOLOGIA, V50, P2591, DOI 10.1007/s00125-007-0821-y; Mercer LD, 2005, BIOCHEM PHARMACOL, V69, P339, DOI 10.1016/j.bcp.2004.09.018; Mobbs Charles V., 2007, V35, P39; Osakada F, 2004, J PHARMACOL EXP THER, V311, P51, DOI 10.1124/jpet.104.070334; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pelsman A, 2003, INT J DEV NEUROSCI, V21, P117, DOI 10.1016/S0736-5748(03)00031-5; Smith SL, 2005, CNS DRUG REV, V11, P113; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Zhang MH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000245	33	55	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18604	10.1371/journal.pone.0018604	http://dx.doi.org/10.1371/journal.pone.0018604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533091	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400016
J	Catanzaro, JM; Guerriero, JL; Liu, JX; Ullman, E; Sheshadri, N; Chen, JJ; Zong, WX				Catanzaro, Joseph M.; Guerriero, Jennifer L.; Liu, Jingxuan; Ullman, Erica; Sheshadri, Namratha; Chen, John J.; Zong, Wei-Xing			Elevated Expression of Squamous Cell Carcinoma Antigen (SCCA) Is Associated with Human Breast Carcinoma	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; TREATMENT RESPONSE; CERVICAL-CANCER; LUNG-CANCER; SENSITIVITY; ORIGIN; LINES	Squamous cell carcinoma antigen (SCCA) belongs to the serine protease inhibitor (Serpin) family of proteins. Elevated expression of SCCA has been used as a biomarker for aggressive squamous cell carcinoma (SCC) in cancers of the cervix, lung, head and neck, and liver. However, SCCA expression in breast cancer has not been investigated. Immunohistochemical analysis of SCCA expression was performed on tissue microarrays containing breast tumor tissues (n = 1,360) and normal breast epithelium (n = 124). SCCA expression was scored on a tiered scale (0-3) independently by two evaluators blind to the patient's clinical status. SCCA expression was observed in Grade I (0.3%), Grade II (2.5%), and Grade III (9.4%) breast cancers (p < 0.0001). Comparing tissues categorized into the three non-metastatic TNM stages, I-III, SCCA positivity was seen in 2.4% of Stage I cancers, 3.1% of Stage II cancers, and 8.6% of Stage III breast cancers (p = 0.0005). No positive staining was observed in normal/non-neoplastic breast tissue (0 out of 124). SCCA expression also correlated to estrogen receptor/progesterone receptor (ER/PR) double-negative tumors (p = 0.0009). Compared to SCCA-negative patients, SCCA-positive patients had both a worse overall survival and recurrence-free survival (p < 0.0001 and p < 0.0001, respectively). This study shows that SCCA is associated with both advanced stage and high grade human breast carcinoma, and suggests the necessity to further explore the role of SCCA in breast cancer development and treatment.	[Catanzaro, Joseph M.; Guerriero, Jennifer L.; Ullman, Erica; Sheshadri, Namratha; Zong, Wei-Xing] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Liu, Jingxuan] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Chen, John J.] SUNY Stony Brook, Dept Preventat Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Catanzaro, JM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	wzong@notes.cc.sunysb.edu	Sheshadri, Namratha/AAM-7384-2021; chen, JJ/HGB-6029-2022	Sheshadri, Namratha/0000-0003-4912-7275; 	National Institutes of Health (NIH) [T32GM00796247, NIH T32CA009176, NIH CA098092, NIH CA129536, Susan Komen KG081538]; Carol Baldwin Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [K01CA098092, T32CA009176, R01CA129536] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol Baldwin Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) T32GM00796247, NIH T32CA009176, NIH CA098092, NIH CA129536, Susan Komen KG081538, and the Carol Baldwin Breast Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIOSCHI PA, 1991, INT J CANCER, V47, P376, DOI 10.1002/ijc.2910470311; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Cataltepe S, 2000, CLIN CHIM ACTA, V295, P107, DOI 10.1016/S0009-8981(00)00197-2; Cataltepe S, 2000, J HISTOCHEM CYTOCHEM, V48, P113, DOI 10.1177/002215540004800112; CORNOG JL, 1971, AM J CLIN PATHOL, V55, P410; DEJAGER D, 1995, J SURG ONCOL, V59, P199, DOI 10.1002/jso.2930590313; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DUK JM, 1990, GYNECOL ONCOL, V39, P186, DOI 10.1016/0090-8258(90)90430-S; Edge SB, 2010, AJCC CANC STAGING MA; Einarsson R, 2005, ADV CLIN EXP MED, V14, P643; Guido M, 2008, J CLIN PATHOL, V61, P445, DOI 10.1136/jcp.2007.051383; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hennessy BT, 2005, J CLIN ONCOL, V23, P7827, DOI 10.1200/JCO.2004.00.9589; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Masumoto K, 2003, J BIOL CHEM, V278, P45296, DOI 10.1074/jbc.M307741200; Molina R, 2003, TUMOR BIOL, V24, P209, DOI 10.1159/000074432; NGAN HYS, 1990, GYNECOL ONCOL, V37, P260, DOI 10.1016/0090-8258(90)90344-K; Nustad K, 2004, TUMOR BIOL, V25, P69, DOI 10.1159/000077726; SCHNEIDER SS, 1995, P NATL ACAD SCI USA, V92, P3147, DOI 10.1073/pnas.92.8.3147; Shimada H, 2003, SURGERY, V133, P486, DOI 10.1067/msy.2003.139; Takeshima N, 1998, GYNECOL ONCOL, V68, P263, DOI 10.1006/gyno.1998.4939; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vassilakopoulos T, 2001, LUNG CANCER, V32, P137, DOI 10.1016/S0169-5002(00)00225-7; YAZIGI R, 1991, GYNECOL ONCOL, V41, P135, DOI 10.1016/0090-8258(91)90272-7	26	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19096	10.1371/journal.pone.0019096	http://dx.doi.org/10.1371/journal.pone.0019096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526154	gold, Green Submitted, Green Published			2022-12-25	WOS:000289671100050
J	He, SP; Tan, GH; Liu, Q; Huang, KW; Ren, J; Zhang, X; Yu, XC; Huang, P; An, CC				He, Shanping; Tan, Guihong; Liu, Qian; Huang, Kuowei; Ren, Jiao; Zhang, Xu; Yu, Xiangchun; Huang, Ping; An, Chengcai			The LSD1-Interacting Protein GILP Is a LITAF Domain Protein That Negatively Regulates Hypersensitive Cell Death in Arabidopsis	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; GENE-EXPRESSION; RESISTANCE; THALIANA; PLANTS; IDENTIFICATION; MUTATION; DEFENSE; LSD1; LESION-SIMULATING-DISEASE1	Background: Hypersensitive cell death, a form of avirulent pathogen-induced programmed cell death (PCD), is one of the most efficient plant innate immunity. However, its regulatory mechanism is poorly understood. AtLSD1 is an important negative regulator of PCD and only two proteins, AtbZIP10 and AtMC1, have been reported to interact with AtLSD1. Methodology/Principal Findings: To identify a novel regulator of hypersensitive cell death, we investigate the possible role of plant LITAF domain protein GILP in hypersensitive cell death. Subcellular localization analysis showed that AtGILP is localized in the plasma membrane and its plasma membrane localization is dependent on its LITAF domain. Yeast two-hybrid and pull-down assays demonstrated that AtGILP interacts with AtLSD1. Pull-down assays showed that both the N-terminal and the C-terminal domains of AtGILP are sufficient for interactions with AtLSD1 and that the N-terminal domain of AtLSD1 is involved in the interaction with AtGILP. Real-time PCR analysis showed that AtGILP expression is up-regulated by the avirulent pathogen Pseudomonas syringae pv. tomato DC3000 avrRpt2 (Pst avrRpt2) and fumonisin B1 (FB1) that trigger PCD. Compared with wild-type plants, transgenic plants overexpressing AtGILP exhibited significantly less cell death when inoculated with Pst avrRpt2, indicating that AtGILP negatively regulates hypersensitive cell death. Conclusions/Significance: These results suggest that the LITAF domain protein AtGILP localizes in the plasma membrane, interacts with AtLSD1, and is involved in negatively regulating PCD. We propose that AtGILP functions as a membrane anchor, bringing other regulators of PCD, such as AtLSD1, to the plasma membrane. Human LITAF domain protein may be involved in the regulation of PCD, suggesting the evolutionarily conserved function of LITAF domain proteins in the regulation of PCD.	[He, Shanping; Tan, Guihong; Liu, Qian; Huang, Kuowei; Ren, Jiao; Zhang, Xu; Yu, Xiangchun; Huang, Ping; An, Chengcai] Peking Univ, State Key Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China	Peking University	He, SP (corresponding author), Peking Univ, State Key Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China.	chcaian@pku.edu.cn			National Key Basic Science '973' Program [2006CB101905]; National Natural Science Foundation [90817001, 30671402]; National Special Projects for R&D of Transgenic Plants [2008ZX08009-004]; Chinese Government [2006AA06Z341]	National Key Basic Science '973' Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Special Projects for R&D of Transgenic Plants; Chinese Government	This work was supported by grants from the National Key Basic Science '973' Program (2006CB101905), the National Natural Science Foundation (90817001 and 30671402), the National Special Projects for R&D of Transgenic Plants (2008ZX08009-004), and the State '863' High Technology R&D Program (2006AA06Z341) of the Chinese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; Bennett CL, 2004, ANN NEUROL, V55, P713, DOI 10.1002/ana.20094; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Dellagi A, 1998, MOL PLANT MICROBE IN, V11, P734, DOI 10.1094/MPMI.1998.11.8.734; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Epple P, 2003, P NATL ACAD SCI USA, V100, P6831, DOI 10.1073/pnas.1130421100; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gilchrist DG, 1997, CELL DEATH DIFFER, V4, P689, DOI 10.1038/sj.cdd.4400312; Greenberg JT, 1996, P NATL ACAD SCI USA, V93, P12094, DOI 10.1073/pnas.93.22.12094; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Katagiri F., 2002, ARABIDOPSIS BOOK; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; KING EO, 1954, J LAB CLIN MED, V44, P301; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Malinovsky FG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012586; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; Matsumura Y, 2004, INT J CANCER, V111, P218, DOI 10.1002/ijc.20251; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Moriwaki Y, 2001, J BIOL CHEM, V276, P23065, DOI 10.1074/jbc.M011660200; Muhlenbock P, 2008, PLANT CELL, V20, P2339, DOI 10.1105/tpc.108.059618; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Saifi GM, 2005, HUM MUTAT, V25, P372, DOI 10.1002/humu.20153; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	48	17	26	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18750	10.1371/journal.pone.0018750	http://dx.doi.org/10.1371/journal.pone.0018750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526181	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100017
J	Kwon, HJ; Palnitkar, M; Deisenhofer, J				Kwon, Hyock Joo; Palnitkar, Maya; Deisenhofer, Johann			The Structure of the NPC1L1 N-Terminal Domain in a Closed Conformation	PLOS ONE			English	Article							CHOLESTEROL ABSORPTION; BINDING; EZETIMIBE; PROTEIN; REVEALS; TARGET	Background: NPC1L1 is the molecular target of the cholesterol lowering drug Ezetimibe and mediates the intestinal absorption of cholesterol. Inhibition or deletion of NPC1L1 reduces intestinal cholesterol absorption, resulting in reduction of plasma cholesterol levels. Principal Findings: Here we present the 2.8 angstrom crystal structure of the N-terminal domain (NTD) of NPC1L1 in the absence of cholesterol. The structure, combined with biochemical data, reveals the mechanism of cholesterol selectivity of NPC1L1. Comparison to the cholesterol free and bound structures of NPC1(NTD) reveals that NPC1L1(NTD) is in a closed conformation and the sterol binding pocket is occluded from solvent. Conclusion: The structure of NPC1L1(NTD) reveals a degree of flexibility surrounding the entrance to the sterol binding pocket, suggesting a gating mechanism that relies on multiple movements around the entrance to the sterol binding pocket.	[Kwon, Hyock Joo; Deisenhofer, Johann] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Palnitkar, Maya; Deisenhofer, Johann] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kwon, HJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	hyockjoo.kwon@gmail.com; johann.deisenhofer@utsouthwestern.edu			Welch Foundation [I-1185]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	Welch Foundation(The Welch Foundation); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported in part by Welch Foundation Grant I-1185 (to J.D). J.D. is an Investigator in the Howard Hughes Medical Institute. Results shown in this article are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dixit SS, 2007, BIOCHEM J, V408, P1, DOI 10.1042/BJ20071167; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Haikal Z, 2008, LIPIDS, V43, P401, DOI 10.1007/s11745-008-3172-7; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; LUTJOHANN D, 1995, J LIPID RES, V36, P1763; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Wasilko D., 2006, BIOPROCESS J, V5, P29, DOI [10.12665/J53.WasilkoLee, DOI 10.12665/J53.WASILKOLEE]; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Yamanashi Y, 2007, J PHARMACOL EXP THER, V320, P559, DOI 10.1124/jpet.106.114181; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200	23	41	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18722	10.1371/journal.pone.0018722	http://dx.doi.org/10.1371/journal.pone.0018722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525977	Green Published, gold, Green Submitted			2022-12-25	WOS:000289578600024
J	Ban, HJ; Kim, SC; Seo, J; Kang, HB; Choi, JK				Ban, Hyo-Jeong; Kim, Sang Cheol; Seo, Jungmin; Kang, Ho-Bum; Choi, Jung Kyoon			Genetic and Metabolic Characterization of Insomnia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RESTLESS-LEGS-SYNDROME; BIPOLAR-DISORDER; SCHIZOAFFECTIVE DISORDER; CALCIUM; SCHIZOPHRENIA; EXPRESSION; SLEEP; TRANSCRIPTION; DISRUPTION	Insomnia is reported to chronically affect 10 similar to 15% of the adult population. However, very little is known about the genetics and metabolism of insomnia. Here we surveyed 10,038 Korean subjects whose genotypes have been previously profiled on a genome-wide scale. About 16.5% reported insomnia and displayed distinct metabolic changes reflecting an increase in insulin secretion, a higher risk of diabetes, and disrupted calcium signaling. Insomnia-associated genotypic differences were highly concentrated within genes involved in neural function. The most significant SNPs resided in ROR1 and PLCB1, genes known to be involved in bipolar disorder and schizophrenia, respectively. Putative enhancers, as indicated by the histone mark H3K4me1, were discovered within both genes near the significant SNPs. In neuronal cells, the enhancers were bound by PAX6, a neural transcription factor that is essential for central nervous system development. Open chromatin signatures were found on the enhancers in human pancreas, a tissue where PAX6 is known to play a role in insulin secretion. In PLCB1, CTCF was found to bind downstream of the enhancer and interact with PAX6, suggesting that it can probably inhibit gene activation by PAX6. PLCB4, a circadian gene that is closely located downstream of PLCB1, was identified as a candidate target gene. Hence, dysregulation of ROR1, PLCB1, or PLCB4 by PAX6 and CTCF may be one mechanism that links neural and pancreatic dysfunction not only in insomnia but also in the relevant psychiatric disorders that are accompanied with circadian rhythm disruption and metabolic syndrome.	[Ban, Hyo-Jeong] Korea Ctr Dis Control & Prevent, Div Biomed Informat, Ctr Genome Sci, Natl Inst Hlth, Choongchung Buk Do, South Korea; [Kim, Sang Cheol] Yonsei Univ, Dept Appl Stat, Seoul 120749, South Korea; [Seo, Jungmin] Korea Res Inst Biosci & Biotechnol, BVC, Res Inst Bioinformat, Omicsis Inc, Taejon, South Korea; [Kang, Ho-Bum] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Choi, Jung Kyoon] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Choi, Jung Kyoon] Genome Inst Singapore, Singapore, Singapore	Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ban, HJ (corresponding author), Korea Ctr Dis Control & Prevent, Div Biomed Informat, Ctr Genome Sci, Natl Inst Hlth, Choongchung Buk Do, South Korea.	jungkyoon@kaist.ac.kr	Choi, Jung Kyoon/C-2070-2011					Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Basu R, 2004, BIPOLAR DISORD, V6, P314, DOI 10.1111/j.1399-5618.2004.00126.x; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Fagiolini A, 2005, BIPOLAR DISORD, V7, P424, DOI 10.1111/j.1399-5618.2005.00234.x; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Hanahisa Y, 1996, MOL CELL BIOCHEM, V158, P1; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hong HX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S17; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; JOBORN C, 1991, PSYCHONEUROENDOCRINO, V16, P311, DOI 10.1016/0306-4530(91)90017-N; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Katayama T, 2009, PHARMACOGENOMICS, V10, P1967, DOI [10.2217/pgs.09.147, 10.2217/PGS.09.147]; Klein DC, 2010, MOL CELL ENDOCRINOL, V314, P170, DOI 10.1016/j.mce.2009.07.010; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MacDonald PE, 2006, PLOS BIOL, V4, P167, DOI 10.1371/journal.pbio.0040049; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; MARCHEVA B, 2010, NATURE; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; MCINTYRE RS, 2010, J AFFECT DISORD; McOmish CE, 2008, HIPPOCAMPUS, V18, P824, DOI 10.1002/hipo.20443; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Paganoni S, 2010, NEUROSCIENCE, V165, P1261, DOI 10.1016/j.neuroscience.2009.11.056; Park D, 2003, NAT NEUROSCI, V6, P337, DOI 10.1038/nn1033; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reijo T, 2008, J AM GERIATR SOC, V56, P1573, DOI 10.1111/j.1532-5415.2008.01774.x; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Shin J, 2005, P NATL ACAD SCI USA, V102, P18165, DOI 10.1073/pnas.0505498102; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Tournier-Lasserve E, 1999, NEUROLOGY, V53, P3, DOI 10.1212/WNL.53.1.3; Watson NF, 2006, SLEEP, V29, P645, DOI 10.1093/sleep/29.5.645; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Yamamoto N, 2010, J AM GERIATR SOC, V58, P801, DOI 10.1111/j.1532-5415.2010.02794.x; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888	38	37	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18455	10.1371/journal.pone.0018455	http://dx.doi.org/10.1371/journal.pone.0018455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494683	Green Submitted, Green Published, gold			2022-12-25	WOS:000289192400029
J	Hossain, M; Khan, AY; Kumar, GS				Hossain, Maidul; Khan, Asma Yasmeen; Kumar, Gopinatha Suresh			Interaction of the Anticancer Plant Alkaloid Sanguinarine with Bovine Serum Albumin	PLOS ONE			English	Article							DRUG BINDING-SITES; BENZOPHENANTHRIDINE ALKALOIDS; SPECTROSCOPIC APPROACH; ALKANOLAMINE FORM; MOLECULAR ASPECTS; INDUCED APOPTOSIS; DOWN-REGULATION; BCL-2 FAMILY; FLUORESCENCE; CELLS	Background: Interaction of the iminium and alkanolamine forms of sanguinarine with bovine serum albumin (BSA) was characterized by spectroscopic and calorimetric techniques. Methodology/Principal Findings: Formation of strong complexes of BSA with both iminium and alkanolamine forms was revealed from fluorescence quenching of sanguinarine. Binding parameters calculated from Stern-Volmer quenching method revealed that the neutral alkanolamine had higher affinity to BSA compared to the charged iminium form. Specific binding distances of 3.37 and 2.38 nm between Trp 212 (donor) and iminium and alkanolamine forms (acceptor), respectively, were obtained from Forster resonance energy transfer studies. Competitive binding using the site markers warfarin and ibuprofen, having definite binding sites, demonstrated that both forms of sanguinarine bind to site I (subdomain IIA) on BSA. Sanguinarine binding alters protein conformation by reducing the alpha-helical organization and increasing the coiled structure, indicating a small but definitive partial unfolding of the protein. Thermodynamic parameters evaluated from isothermal titration calorimetry suggested that the binding was enthalpy driven for the iminium form but favoured by negative enthalpy and strong favourable entropy contributions for the alkanolamine form, revealing the involvement of different molecular forces in the complexation. Conclusions/Significance: The results suggest that the neutral alkanolamine form binds to the protein more favourably compared to the charged iminium, in stark contrast to the reported DNA binding preference of sanguinarine.	[Hossain, Maidul; Khan, Asma Yasmeen; Kumar, Gopinatha Suresh] CSIR, Indian Inst Chem Biol, Biophys Chem Lab, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Hossain, M (corresponding author), CSIR, Indian Inst Chem Biol, Biophys Chem Lab, Kolkata, W Bengal, India.	gskumar@iicb.res.in	Kumar, Gopinatha Suresh/W-1461-2019; Kumar, Dr Suresh/HHZ-2615-2022; Hossain, Maidul/AAW-7669-2021	Kumar, Dr Suresh/0000-0002-2539-6553; Hossain, Maidul/0000-0003-1408-2273	Council of Scientific and Industrial Research, Government of India [NWP0036]; University Grants Commission, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by grants from the project NWP0036 of the Council of Scientific and Industrial Research, Government of India, University Grants Commission, Government of India fellowship (to AYK). This work was performed during the tenure of MH as a Project Associate under NWP0036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2004, MOL CANCER THER, V3, P933; Ahsan H, 2007, CANCER LETT, V249, P198, DOI 10.1016/j.canlet.2006.08.018; BHADRA K, 2011, MED RES REV IN PRESS; Bhadra K, 2011, BBA-GEN SUBJECTS, V1810, P485, DOI 10.1016/j.bbagen.2011.01.011; Bojko B, 2010, J PHARMACEUT BIOMED, V52, P384, DOI 10.1016/j.jpba.2009.09.004; Bose D, 2010, PHOTOCHEM PHOTOBIOL, V86, P538, DOI 10.1111/j.1751-1097.2009.00688.x; Bourassa P, 2010, J PHYS CHEM B, V114, P3348, DOI 10.1021/jp9115996; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; Chowdhury SR, 2010, MOL BIOSYST, V6, P1265, DOI 10.1039/b927001a; Cyril L., 1961, BIOCH HDB; DALVI RR, 1985, EXPERIENTIA, V41, P77, DOI 10.1007/BF02005884; Debiton E, 2003, CANCER CHEMOTH PHARM, V51, P474, DOI 10.1007/s00280-003-0609-9; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Foster J.F, 1977, ALBUMIN STRUCTURE FU, VFunction and Uses; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Giri P, 2010, MOL BIOSYST, V6, P81, DOI 10.1039/b910706a; GODOWSKI K C, 1989, Journal of Clinical Dentistry, V1, P96; Graf TN, 2007, J AGR FOOD CHEM, V55, P1205, DOI 10.1021/jf062498f; Han MH, 2007, ANTI-CANCER DRUG, V18, P913; Han XL, 2009, SPECTROCHIM ACTA A, V74, P781, DOI 10.1016/j.saa.2009.08.018; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hedoux A, 2009, J PHYS CHEM B, V113, P6119, DOI 10.1021/jp900330r; Hu YJ, 2010, J LUMIN, V130, P1394, DOI 10.1016/j.jlumin.2010.02.053; Hu YJ, 2010, PROTEIN J, V29, P234, DOI 10.1007/s10930-010-9244-6; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Katrahalli U, 2010, J LUMIN, V130, P211, DOI 10.1016/j.jlumin.2009.07.033; Kim S, 2008, J CELL BIOCHEM, V104, P895, DOI 10.1002/jcb.21672; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LENFELD J, 1981, PLANTA MED, V43, P161, DOI 10.1055/s-2007-971493; Liu BS, 2010, J LUMIN, V130, P859, DOI 10.1016/j.jlumin.2009.12.014; Maiti M, 2002, J BIOMOL STRUCT DYN, V20, P455, DOI 10.1080/07391102.2002.10506864; MAITI M, 1983, PHOTOCHEM PHOTOBIOL, V38, P245, DOI 10.1111/j.1751-1097.1983.tb03869.x; Maiti M, 2007, TOP HETEROCYCL CHEM, V10, P155, DOI 10.1007/7081_2007_071; Maiti M, 2007, MED RES REV, V27, P649, DOI 10.1002/med.20087; Maiti Motilal, 2009, Biophys Rev, V1, P119, DOI 10.1007/s12551-009-0014-7; Mandeville JS, 2010, BIOMACROMOLECULES, V11, P465, DOI 10.1021/bm9011979; MAURICE RE, 1981, ANAL BIOCHEM, V114, P199, DOI DOI 10.1016/0003-2697(81)90474-7; Monti S, 2009, PHYS CHEM CHEM PHYS, V11, P9104, DOI 10.1039/b906021a; Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X; O'Brien R, 1998, J MOL BIOL, V279, P117, DOI 10.1006/jmbi.1998.1743; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T, 1996, ALL ALBUMINS BIOCH G; Sahoo BK, 2008, BIOPHYS CHEM, V132, P81, DOI 10.1016/j.bpc.2007.10.007; SEN A, 1994, BIOCHEM PHARMACOL, V48, P2097, DOI 10.1016/0006-2952(94)90510-X; Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096; SJOHOLM I, 1979, MOL PHARMACOL, V16, P767; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sun Meng, 2010, Genes Cancer, V1, P283, DOI 10.1177/1947601910368849; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Thoppil AA, 2008, BIOPOLYMERS, V89, P831, DOI 10.1002/bip.21021; Uversky VN, 1997, BIOCHEMISTRY-US, V36, P13638, DOI 10.1021/bi970332p; Valeur B., 2001, NEW TRENDS FLUORESCE, VThird; Vogel M, 2010, J BIOL CHEM, V285, P18397, DOI 10.1074/jbc.M109.088989; WANWIMOLRUK S, 1983, MOL PHARMACOL, V24, P458; Zhang GW, 2010, SPECTROCHIM ACTA A, V76, P410, DOI 10.1016/j.saa.2010.04.009; Zhang QL, 2010, J PHARMACEUT BIOMED, V52, P280, DOI 10.1016/j.jpba.2010.01.006	62	72	72	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18333	10.1371/journal.pone.0018333	http://dx.doi.org/10.1371/journal.pone.0018333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494677	gold, Green Submitted, Green Published			2022-12-25	WOS:000289192400020
J	Kahyo, T; Iwaizumi, M; Shinmura, K; Matsuura, S; Nakamura, T; Watanabe, Y; Yamada, H; Sugimura, H				Kahyo, T.; Iwaizumi, M.; Shinmura, K.; Matsuura, S.; Nakamura, T.; Watanabe, Y.; Yamada, H.; Sugimura, H.			A novel tumor-derived SGOL1 variant causes abnormal mitosis and unstable chromatid cohesion	ONCOGENE			English	Article						chromosomal instability; colon cancer; mitosis; shugoshin; splicing variant	PROTEIN PHOSPHATASE 2A; CHROMOSOMAL INSTABILITY; CENTROMERIC PROTECTION; DROSOPHILA MEI-S332; SPINDLE CHECKPOINT; SISTER CHROMATIDS; DOWN-REGULATION; CANCER-CELLS; MEIOSIS-I; SHUGOSHIN	Mitosis is the most conspicuous cell cycle phase, because it is the phase in which the dynamic physical distributions of cellular components into the two daughter cells occur. The separation of sister chromatids is especially important during mitosis, because of the extreme accuracy required for distribution to the next generation of cells. Shugoshin-like 1 (SGOL1) is a key protein in protecting sister chromatids from precocious separation. We have reported finding that chromosome instability is more likely in SGOL1-downregulated colorectal cancers, but it is still unknown whether there is an association between cancer and SGOL1 transcript variation. Here, we identified a novel SGOL1 variant, SGOL1-P1, in human colon cancer. The SGOL1-P1 transcript contains an exon-skip of exon 3 that results in a stop codon occurring within exon 4. Overexpression of SGOL1-P1 in HCT116 cells resulted in an increased number of cells with aberrant chromosome alignment, precociously separated chromatids and delayed mitotic progression, occasionally followed by inaccurate distribution of the chromosomes. These phenotypes, observed when SGOL1-P1 was present, were also observed very frequently in SGOL1-knockdown cells. Furthermore, the overexpression of SGOL1-P1 inhibited the localization of endogenous SGOL1 and cohesin subunit RAD21/SCC1 to the centromere. These results suggest that SGOL1-P1 may function as a negative factor to native SGOL1, and that abundant expression of SGOL1-P1 may be responsible for chromosomal instability. Oncogene (2011) 30, 4453-4463; doi: 10.1038/onc.2011.152; published online 2 May 2011	[Sugimura, H.] Hamamatsu Univ Sch Med, Dept Pathol 1, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Iwaizumi, M.] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Matsuura, S.] Hamamatsu Univ Sch Med, Dept Med 2, Hamamatsu, Shizuoka 4313192, Japan; [Nakamura, T.] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka 4313192, Japan; [Watanabe, Y.] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; University of Tokyo	Sugimura, H (corresponding author), Hamamatsu Univ Sch Med, Dept Pathol 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	hsugimur@hama-med.ac.jp	YAMADA, Hidetaka/AAK-5085-2021; Matsuura, Shun/AAW-5353-2021; Shinmura, Kazuya/K-8940-2012; Iwaizumi, Moriya/AAG-3173-2019	Matsuura, Shun/0000-0001-8844-6100; Shinmura, Kazuya/0000-0003-4963-746X; Iwaizumi, Moriya/0000-0002-2629-0830; Watanabe, Yoshinori/0000-0002-5488-4812	Japanese Ministry of Education, Culture, Sports, Science and Technology [22590356, 20014007, 221S0001]; Japanese Ministry of Health [21-1]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [22590356] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health; Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Suzuki of The Jikei University School of Medicine for providing the anti-hSgo1 antibody. This work was supported by a Grant-in-Aid for Scientific Research (C) (22590356) and for priority areas (20014007 and 221S0001) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Grants-in-Aid for the 3rd Term Comprehensive 10-Year-Strategy for Cancer Control and Grants-in-Aid for Cancer Research from the Japanese Ministry of Health (21-1) and from the Smoking Research Foundation.	Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Clift D, 2009, GENE DEV, V23, P766, DOI 10.1101/gad.507509; Dai J, 2009, J CELL SCI, V122, P4168, DOI 10.1242/jcs.054122; Eot-Houllier G, 2008, GENE DEV, V22, P2639, DOI 10.1101/gad.484108; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; GOLDSTEIN LSB, 1980, CHROMOSOMA, V78, P79, DOI 10.1007/BF00291909; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Iwaizumi M, 2009, GUT, V58, P249, DOI 10.1136/gut.2008.149468; Kahyo T, 2008, FEBS LETT, V582, P2479, DOI 10.1016/j.febslet.2008.06.031; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Karamysheva Z, 2009, J BIOL CHEM, V284, P1772, DOI 10.1074/jbc.M807083200; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kienitz A, 2005, ONCOGENE, V24, P4301, DOI 10.1038/sj.onc.1208589; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kothe M, 2007, BIOCHEMISTRY-US, V46, P5960, DOI 10.1021/bi602474j; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Moore DP, 1998, J CELL BIOL, V140, P1003, DOI 10.1083/jcb.140.5.1003; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pihan GA, 1999, SEMIN CANCER BIOL, V9, P289, DOI 10.1006/scbi.1999.0131; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Shinmura K, 2008, J PATHOL, V216, P365, DOI 10.1002/path.2422; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Suzuki H, 2006, CELL CYCLE, V5, P1094, DOI 10.4161/cc.5.10.2747; Tang TTL, 1998, GENE DEV, V12, P3843, DOI 10.1101/gad.12.24.3843; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	48	26	26	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	44					4453	4463		10.1038/onc.2011.152	http://dx.doi.org/10.1038/onc.2011.152			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	844FN	21532624				2022-12-25	WOS:000296733200001
J	Toulorge, D; Guerreiro, S; Hild, A; Maskos, U; Hirsch, EC; Michel, PP				Toulorge, Damien; Guerreiro, Serge; Hild, Audrey; Maskos, Uwe; Hirsch, Etienne C.; Michel, Patrick P.			Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+	FASEB JOURNAL			English	Article						calcium; dopaminergic; excitability; nicotinic acetylcholine receptors	PARKINSONS-DISEASE; NIGROSTRIATAL DAMAGE; CALCIUM-CHANNELS; RAT MIDBRAIN; RECEPTORS; ACETYLCHOLINE; STIMULATION; ACTIVATION; PROTECTS; DEGENERATION	Epidemiological and experimental evidence indicates that nicotine is protective for Parkinson disease vulnerable dopamine neurons, but the underlying mechanism of this effect remains only partly characterized. To address this question, we established rat midbrain cultures maintained in experimental conditions that favor the selective and spontaneous loss of dopamine neurons. We report here that nicotine afforded neuroprotection to dopamine neurons (EC50 = 0.32 mu M) but only in a situation where cytosolic Ca2+ (Ca2+ (cyt)) was slightly and chronically elevated above control levels by concurrent depolarizing treatments. By a pharmacological approach, we demonstrated that the rise in Ca2+ (cyt) was necessary to sensitize dopamine neurons to the action of nicotine through a mechanism involving alpha-bungarotoxin-sensitive (presumably alpha 7) nicotinic acetylcholine receptors (nAChRs) and secondarily T-type voltage-gated calcium channels. Confirming the role played by alpha 7 nAChRs in this effect, nicotine had no protective action in midbrain cultures prepared from genetically engineered mice lacking this receptor subtype. Signaling studies revealed that Ca2+ (cyt) elevations evoked by nicotine and concomitant depolarizing treatments served to activate a survival pathway involving the calcium effector protein calmodulin and phosphatidylinositol 3-kinase. Collectively, our data support the idea that the protective action of nicotine for dopamine neurons is activity-dependent and gated by Ca2+ (cyt).-Toulorge, D., Guerreiro, S., Hild, A., Maskos, U., Hirsch, E. C., Michel, P. P. Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+. FASEB J. 25, 2563-2573 (2011). www.fasebj.org	[Toulorge, Damien; Guerreiro, Serge; Hild, Audrey; Hirsch, Etienne C.; Michel, Patrick P.] Univ Paris 06, Inst Cerveau & Moelle Epiniere, Ctr Rech, Unite Mixte Rech S975, Paris, France; [Toulorge, Damien; Guerreiro, Serge; Hild, Audrey; Hirsch, Etienne C.; Michel, Patrick P.] Inst Natl Sante & Rech Med, U975, Paris, France; [Toulorge, Damien; Guerreiro, Serge; Hild, Audrey; Hirsch, Etienne C.; Michel, Patrick P.] Ctr Natl Rech Sci, Unite Mixte Rech 7225, Paris, France; [Maskos, Uwe] Inst Pasteur, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Michel, PP (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, 47 Bd Hop, F-75013 Paris, France.	patrick-pierre.michel@upmc.fr	Michel, Patrick Pierre/J-5248-2019; Hirsch, Etienne/AAC-7655-2019	Michel, Patrick Pierre/0000-0001-5607-3119; Hirsch, Etienne/0000-0003-4823-276X; Guerreiro, Serge/0000-0003-1744-6351; Toulorge, Damien/0000-0002-9651-8132	Rotary International through the fundraising campaign Espoir en Tete; Fondation pour la Recherche sur le Cerveau (FRC); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre et Marie Curie-Paris; Fondation pour la Recherche Medicale (FRM)	Rotary International through the fundraising campaign Espoir en Tete; Fondation pour la Recherche sur le Cerveau (FRC); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie-Paris; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	The authors thank Christian Lobsiger for helpful discussions throughout the course of this work. The authors gratefully acknowledge the technical assistance of Aurelien Dauphin for confocal imaging. This work received financial support from Rotary International through the fundraising campaign Espoir en Tete, Fondation pour la Recherche sur le Cerveau (FRC), Institut National de la Sante et de la Recherche Medicale (INSERM), and Universite Pierre et Marie Curie-Paris 6. D.T. was supported by Fondation pour la Recherche Medicale (FRM).	Abin-Carriquiry JA, 2008, EUR J PHARMACOL, V589, P80, DOI 10.1016/j.ejphar.2008.05.013; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Darcy DP, 2009, J NEUROSCI, V29, P2510, DOI 10.1523/JNEUROSCI.5333-08.2009; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Douhou A, 2001, J NEUROCHEM, V78, P163, DOI 10.1046/j.1471-4159.2001.00401.x; Forster GL, 2003, EUR J NEUROSCI, V17, P751, DOI 10.1046/j.1460-9568.2003.02511.x; Guerreiro S, 2008, MOL PHARMACOL, V74, P980, DOI 10.1124/mol.108.048207; HALVORSEN SW, 1986, J NEUROSCI, V6, P3405; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Karachi C, 2010, J CLIN INVEST, V120, P2745, DOI 10.1172/JCI42642; Katsuki H, 2001, NEUROSCI LETT, V300, P166, DOI 10.1016/S0304-3940(01)01570-1; Kawai H, 2002, J NEUROSCI, V22, P7903; Khwaja M, 2007, J NEUROCHEM, V100, P180, DOI 10.1111/j.1471-4159.2006.04177.x; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; Liu QS, 1999, J NEUROPHYSIOL, V82, P1124, DOI 10.1152/jn.1999.82.3.1124; Livingstone PD, 2009, BIOCHEM PHARMACOL, V78, P744, DOI 10.1016/j.bcp.2009.06.004; Marinelli M, 2000, J NEUROSCI, V20, P8876; Maskos U, 2010, J NEUROCHEM, V114, P641, DOI 10.1111/j.1471-4159.2010.06798.x; Michel PP, 2007, J NEUROCHEM, V101, P289, DOI 10.1111/j.1471-4159.2006.04424.x; Michel PP, 1997, J NEUROCHEM, V69, P1499; NagamotoCombs K, 1997, J BIOL CHEM, V272, P6051, DOI 10.1074/jbc.272.9.6051; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Quik M, 2007, TRENDS PHARMACOL SCI, V28, P229, DOI 10.1016/j.tips.2007.03.001; Radcliffe PM, 2009, J NEUROCHEM, V109, P1272, DOI 10.1111/j.1471-4159.2009.06056.x; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Sato A, 2006, J CELL PHYSIOL, V209, P172, DOI 10.1002/jcp.20719; Thacker EL, 2007, NEUROLOGY, V68, P764, DOI 10.1212/01.wnl.0000256374.50227.4b; Toulorge D, 2010, J NEUROCHEM, V114, P553, DOI 10.1111/j.1471-4159.2010.06785.x; Traver S, 2006, MOL PHARMACOL, V70, P30, DOI 10.1124/mol.106.022715; Tsuneki H, 2000, EUR J NEUROSCI, V12, P2475, DOI 10.1046/j.1460-9568.2000.00138.x; Turner TJ, 2004, J NEUROSCI, V24, P11328, DOI 10.1523/JNEUROSCI.1559-04.2004; Visanji NP, 2006, NEUROPHARMACOLOGY, V51, P506, DOI 10.1016/j.neuropharm.2006.04.015; Yang F, 2001, NAT NEUROSCI, V4, P1071, DOI 10.1038/nn734	39	61	67	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2563	2573		10.1096/fj.11-182824	http://dx.doi.org/10.1096/fj.11-182824			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21507900	Bronze			2022-12-25	WOS:000293337800007
J	Egger, S; Chaikuad, A; Kavanagh, KL; Oppermann, U; Nidetzky, B				Egger, Sigrid; Chaikuad, Apirat; Kavanagh, Kathryn L.; Oppermann, Udo; Nidetzky, Bernd			Structure and Mechanism of Human UDP-glucose 6-Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE REVEALS; CATALYTIC MECHANISM; HYALURONAN; CANCER; INHIBITION; BREAST; DINUCLEOTIDE; RESIDUES; BINDING; DESIGN	Elevated production of the matrix glycosaminoglycan hyaluronan is strongly implicated in epithelial tumor progression. Inhibition of synthesis of the hyaluronan precursor UDP-glucuronic acid (UDP-GlcUA) therefore presents an emerging target for cancer therapy. Human UDP-glucose 6-dehydrogenase (hUGDH) catalyzes, in two NAD(+)-dependent steps without release of intermediate aldehyde, the biosynthetic oxidation of UDP-glucose (UDP-Glc) to UDP-GlcUA. Here, we present a structural characterization of the hUGDH reaction coordinate using crystal structures of the apoenzyme and ternary complexes of the enzyme bound with UDP-Glc/NADH and UDP-GlcUA/NAD(+). The quaternary structure of hUGDH is a disc-shaped trimer of homodimers whose subunits consist of two discrete alpha/beta domains with the active site located in the interdomain cleft. Ternary complex formation is accompanied by rigid-body and restrained movement of the N-terminal NAD(+) binding domain, sequestering substrate and coenzyme in their reactive positions through interdomain closure. By alternating between conformations in and out of the active site during domain motion, Tyr(14), Glu(161), and Glu(165) participate in control of coenzyme binding and release during 2-fold oxidation. The proposed mechanism of hUGDH involves formation and breakdown of thiohemiacetal and thioester intermediates whereby Cys(276) functions as the catalytic nucleophile. Stopped-flow kinetic data capture the essential deprotonation of Cys(276) in the course of the first oxidation step, allowing the thiolate side chain to act as a trap of the incipient aldehyde. Because thiohemiacetal intermediate accumulates at steady state under physiological reaction conditions, hUGDH inhibition might best explore ligand binding to the NAD(+) binding domain.	[Egger, Sigrid; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Chaikuad, Apirat; Kavanagh, Kathryn L.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Oppermann, Udo] Univ Oxford, NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England	Graz University of Technology; University of Oxford; University of Oxford	Nidetzky, B (corresponding author), Graz Univ Technol, Inst Biotechnol & Biochem Engn, Petersgasse 12-1, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Chaikuad, Apirat/0000-0003-1120-2209; Nidetzky, Bernd/0000-0002-5030-2643	Austrian Science Fund DK Molecular Enzymology [W901-B05]; Wellcome Trust [1097737]; GlaxoSmithKline [1097737]; Genome Canada [1097737]; Canadian Institutes of Health Research [1097737]; Ontario Innovation Trust [1097737]; Ontario Research and Development Challenge Fund [1097737]; Canadian Foundation for Innovation [1097737]; Vinnova [1097737]; Swedish Strategic Research Foundation [1097737]; Knut and Alice Wallenberg Foundation [1097737]; Karolinska Institutet [1097737]; NIHR Oxford Biomedical Research Unit; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund DK Molecular Enzymology(Austrian Science Fund (FWF)); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Innovation Trust; Ontario Research and Development Challenge Fund(General Electric); Canadian Foundation for Innovation(Canada Foundation for Innovation); Vinnova(Vinnova); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet); NIHR Oxford Biomedical Research Unit; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund DK Molecular Enzymology W901-B05 and the Structural Genomics Consortium registered charity (number 1097737) funded by the Wellcome Trust, GlaxoSmithKline, Genome Canada, the Canadian Institutes of Health Research, the Ontario Innovation Trust, the Ontario Research and Development Challenge Fund, the Canadian Foundation for Innovation, Vinnova, the Swedish Strategic Research Foundation, the Knut and Alice Wallenberg Foundation, and the Karolinska Institutet. This work was additionally supported by the NIHR Oxford Biomedical Research Unit.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Campbell RE, 1999, J ORG CHEM, V64, P9487, DOI 10.1021/jo991092h; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; CAMPBELL RE, 1997, ANGEW CHEM INT EDIT, V36, P3; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEINGOLD DS, 1981, TRENDS BIOCHEM SCI, V6, P103, DOI 10.1016/0968-0004(81)90038-4; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Ge X, 1998, J AM CHEM SOC, V120, P6613, DOI 10.1021/ja9805977; Ge X, 2008, J MED CHEM, V51, P4571, DOI 10.1021/jm8002284; Graham CE, 2006, BIOCHEM J, V394, P67, DOI 10.1042/BJ20050918; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Huang DL, 2010, INT J CANCER, V126, P315, DOI 10.1002/ijc.24820; Huh JW, 2007, J BIOCHEM MOL BIOL, V40, P690; Huh JW, 2005, BIOTECHNOL LETT, V27, P1229, DOI 10.1007/s10529-005-0022-z; Klimacek M, 2010, BIOCHEM J, V425, P455, DOI 10.1042/BJ20091441; Lee HS, 2009, ARCH BIOCHEM BIOPHYS, V486, P35, DOI 10.1016/j.abb.2009.03.017; Lei Z, 1999, BIOCHEMISTRY-US, V38, P11231, DOI 10.1021/bi990433i; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Lin SL, 2007, CARCINOGENESIS, V28, P310, DOI 10.1093/carcin/bgl134; Marchal S, 2000, BIOCHEMISTRY-US, V39, P3327, DOI 10.1021/bi9914208; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; ORDMAN AB, 1977, BIOCHIM BIOPHYS ACTA, V481, P25, DOI 10.1016/0005-2744(77)90133-4; ORDMAN AB, 1977, J BIOL CHEM, V252, P1320; Pival SL, 2009, BIOCHEM J, V421, P43, DOI 10.1042/BJ20090128; SCHILLER JG, 1972, CARBOHYD RES, V21, P249, DOI 10.1016/S0008-6215(00)82151-5; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Singh R, 2009, METHODS MOL BIOL, V575, P93, DOI 10.1007/978-1-60761-274-2_4; Slomiany MG, 2009, HYALURONAN IN CANCER BIOLOGY, 1ST EDITION, P19, DOI 10.1016/B978-012374178-3.10002-X; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vander Jagt DL, 2000, CURR MED CHEM, V7, P479, DOI 10.2174/0929867003375119; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang TP, 2010, EXP CELL RES, V316, P2893, DOI 10.1016/j.yexcr.2010.07.017; Wei Q, 2009, CANCER RES, V69, P2332, DOI 10.1158/0008-5472.CAN-08-3083; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035	49	48	50	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23877	23887		10.1074/jbc.M111.234682	http://dx.doi.org/10.1074/jbc.M111.234682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21502315	Green Published, hybrid			2022-12-25	WOS:000292294900030
J	Zotti, T; Uva, A; Ferravante, A; Vessichelli, M; Scudiero, I; Ceccarelli, M; Vito, P; Stilo, R				Zotti, Tiziana; Uva, Antonio; Ferravante, Angela; Vessichelli, Mariangela; Scudiero, Ivan; Ceccarelli, Michele; Vito, Pasquale; Stilo, Romania			TRAF7 Protein Promotes Lys-29-linked Polyubiquitination of I kappa B Kinase (IKK gamma)/NF-kappa B Essential Modulator (NEMO) and p65/RelA Protein and Represses NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATOR; DEGRADATION; TERMINATION; APOPTOSIS; PATHWAY; TARGET; CHAINS; CELLS; A20; UBIQUITINATION	Tumor necrosis factor receptor-associated factor (TRAF) proteins are cytoplasmic regulatory molecules that function as signal transducers for receptors involved in both innate and adaptive humoral immune responses. In this study, we show that TRAF7, the unique noncanonical member of the TRAF family, physically associates with I kappa B kinase/NF-kappa B essential modulator (NEMO) and with the RelA/p65 (p65) member of the NF-kappa B transcription factor family. TRAF7 promotes Lys-29-linked polyubiquitination of NEMO and p65 that results in lysosomal degradation of both proteins and altered activation. TRAF7 also influences p65 nuclear distribution. Microarray expression data are consistent with an inhibitory role for TRAF7 on NF-kappa B and a positive control of AP-1 transcription factor. Finally, functional data indicate that TRAF7 promotes cell death. Thus, this study identifies TRAF7 as a NEMO- and p65-interacting molecule and brings important information on the ubiquitination events that control NF-kappa B transcriptional activity.	[Vito, Pasquale] Univ Sannio, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy; BioGeM Consortium, I-83031 Ariano Irpino, Italy	University of Sannio	Vito, P (corresponding author), Univ Sannio, Dipartimento Sci Biol & Ambientali, Via PortArsa 11, I-82100 Benevento, Italy.	vito@unisannio.it	Zotti, Tiziana/AAV-6768-2021; vito, pasquale/ABF-5505-2020; Ceccarelli, Michele/AGP-1739-2022	Zotti, Tiziana/0000-0003-4753-116X; ferravante, angela/0000-0002-4932-3877; Ceccarelli, Michele/0000-0002-4702-6617; vito, pasquale/0000-0002-5721-7716; scudiero, ivan/0000-0001-5559-5548				Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Cazals V, 1999, BBA-MOL CELL RES, V1448, P349, DOI 10.1016/S0167-4889(98)00095-0; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hampson L, 2001, Hematol J, V2, P150, DOI 10.1038/sj.thj.6200102; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lang CH, 1999, AM J PHYSIOL-GASTR L, V276, pG719, DOI 10.1152/ajpgi.1999.276.3.G719; Liu LP, 2010, CANCER INVEST, V28, P443, DOI 10.3109/07357900903405959; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; Ruan WJ, 2010, ACTA DIABETOL, V47, P5, DOI 10.1007/s00592-009-0142-3; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Stilo R, 2002, FEBS LETT, V521, P165, DOI 10.1016/S0014-5793(02)02869-7; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tsikitis M, 2010, EMBO REP, V11, P969, DOI 10.1038/embor.2010.154; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	35	58	62	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22924	22933		10.1074/jbc.M110.215426	http://dx.doi.org/10.1074/jbc.M110.215426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21518757	hybrid, Green Published			2022-12-25	WOS:000292025000027
J	Iwaki, S; Lu, YB; Xie, ZH; Druey, KM				Iwaki, Shoko; Lu, Yunbiao; Xie, Zhihui; Druey, Kirk M.			p53 Negatively Regulates RGS13 Protein Expression in Immune Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELLS; GENE-EXPRESSION; TRANSCRIPTION; RESPONSIVENESS; RESPONSES; LYMPHOMA	RGS13, a member of the regulator of G protein signaling (RGS) family, inhibits G protein-coupled receptor signaling in B cells and mast cells (MCs) and suppresses IgE-antigen-induced MC degranulation and anaphylaxis. Although RGS13 expression is induced by immune receptor and chemokine receptor stimulation, the molecular regulation of RGS13 transcription is unknown. Here, we investigated the role of two p53 response elements (REs) in the regulation of RGS13 promoter activity and expression. We found that a 1000-bp DNA fragment upstream of the ATG translation start site (TSS) had promoter activity in reporter gene assays, and deletion or mutation of a p53-binding motif nearest the TSS abolished promoter activity. Notably, p53 bound to both REs in the RGS13 promoter in vivo as assessed by chromatin immunoprecipitation, suggesting that the p53 RE most distal to the TSS is physiologically inactive. We detected reduced RGS13 expression in MCs exogenously expressing p53 or treated with doxorubicin, which induces genotoxic stress and leads to p53 accumulation. RNA silencing of p53 up-regulated RGS13 expression in B lymphocytes, and bone marrow-derived MCs from p53(-/-) mice had increased RGS13 expression. Finally, p53-depleted B cells with increased RGS13 expression had reduced Ca2+ mobilization in response to sphingosine 1-phosphate. These studies indicate that p53 may modulate immune responses through suppression of RGS13 transcription in MCs and B cells.	[Iwaki, Shoko; Lu, Yunbiao; Xie, Zhihui; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Druey, KM (corresponding author), NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, Room 11N242,10 Ctr Dr, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov			National Institutes of Health, NIAID [AI000939-06 LAD]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000939, ZIAAI000746] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant AI000939-06 LAD from NIAID.	Ashley N, 2009, ONCOGENE, V28, P3880, DOI 10.1038/onc.2009.242; Bansal G, 2008, NAT IMMUNOL, V9, P73, DOI 10.1038/ni1533; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Buckbinder L, 1997, P NATL ACAD SCI USA, V94, P7868, DOI 10.1073/pnas.94.15.7868; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Islam TC, 2003, LEUKEMIA, V17, P1880, DOI 10.1038/sj.leu.2403057; Johnson EN, 2002, J BIOL CHEM, V277, P16768, DOI 10.1074/jbc.M200751200; KEMLER I, 1990, FASEB J, V4, P1444, DOI 10.1096/fasebj.4.5.2407588; Kitamura Y, 2006, IMMUNOL ALLERGY CLIN, V26, P387, DOI 10.1016/j.iac.2006.05.004; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Marcel V, 2010, ONCOGENE, V29, P2691, DOI 10.1038/onc.2010.26; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Shi GX, 2002, J IMMUNOL, V169, P2507, DOI 10.4049/jimmunol.169.5.2507; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Takemoto CM, 2010, J IMMUNOL, V184, P4349, DOI 10.4049/jimmunol.0900927; Wang JM, 2010, CARCINOGENESIS, V31, P1755, DOI 10.1093/carcin/bgq138; Wang JH, 2010, J IMMUNOL, V184, P442, DOI 10.4049/jimmunol.0900870; Xie ZH, 2010, J MOL CELL BIOL, V2, P357, DOI 10.1093/jmcb/mjq031; Yagi R, 2007, MOL CELL BIOL, V27, P8087, DOI 10.1128/MCB.00631-07	28	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22219	22226		10.1074/jbc.M111.228924	http://dx.doi.org/10.1074/jbc.M111.228924			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531726	Green Published, hybrid			2022-12-25	WOS:000291719900029
J	McCluskey, JT; Hamid, M; Guo-Parke, H; McClenaghan, NH; Gomis, R; Flatt, PR				McCluskey, Jane T.; Hamid, Muhajir; Guo-Parke, Hong; McClenaghan, Neville H.; Gomis, Ramon; Flatt, Peter R.			Development and Functional Characterization of Insulin-releasing Human Pancreatic Beta Cell Lines Produced by Electrofusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO GROWTH; GLUCOSE; ESTABLISHMENT; ISLETS; DIFFERENTIATION; GLUCOKINASE; RESPONSES; BRIN-BD11; PATHWAY; GENE	Three novel human insulin-releasing cell lines designated 1.1B4, 1.4E7, and 1.1E7 were generated by electrofusion of freshly isolated of human pancreatic beta cells and the immortal human PANC-1 epithelial cell line. Functional studies demonstrated glucose sensitivity and responsiveness to known modulators of insulin secretion. Western blot, RT-PCR, and immunohistochemistry showed expression of the major genes involved in proinsulin processing and the pancreatic beta cell stimulus-secretion pathway including PC1/3, PC2, GLUT-1, glucokinase, and K-ATP channel complex (Sur1 and Kir6.2) and the voltage-dependent L-type Ca2+ channel. The cells stained positively for insulin, and 1.1B4 cells were used to demonstrate specific staining for insulin, C-peptide, and proinsulin together with insulin secretory granules by electron microscopy. Analysis of metabolic function indicated intact mechanisms for glucose uptake, oxidation/utilization, and phosphorylation by glucokinase. Glucose, alanine, and depolarizing concentrations of K+ were all able to increase [Ca2+](i) in at least two of the cell lines tested. Insulin secretion was also modulated by other nutrients, hormones, and drugs acting as stimulators or inhibitors in normal beta cells. Subscapular implantation of the 1.1B4 cell line improved hyperglycemia and resulted in glucose lowering in streptozotocin-diabetic SCID mice. These novel human electrofusion- derived beta cell lines therefore exhibit stable characteristics reminiscent of normal pancreatic beta cells, thereby providing an unlimited source of human insulin-producing cells for basic biochemical studies and pharmacological drug testing plus proof of concept for cellular insulin replacement therapy.	[McCluskey, Jane T.; Hamid, Muhajir; Guo-Parke, Hong; McClenaghan, Neville H.; Flatt, Peter R.] Univ Ulster, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland; [Gomis, Ramon] Univ Barcelona, CIBERDEM, IDIBAPS, Hosp Clin Univ,Endocrinol & Diabet Unit, E-08007 Barcelona, Spain	Ulster University; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Guo-Parke, H (corresponding author), Univ Ulster, SAAD Ctr Pharm & Diabet, Cromore Rd, Coleraine BT52 1SA, Londonderry, North Ireland.	jt.mccluskey@ulster.ac.uk		Guo-Parke, Hong/0000-0001-8210-5321; Flatt, Peter/0000-0001-8548-7943; Hamid, Muhajir/0000-0002-2475-7628	University of Ulster; Diabetes UK; Innovation Ulster	University of Ulster; Diabetes UK(Diabetes UK); Innovation Ulster	This work was supported by grants from University of Ulster Research Strategy Funding, Diabetes UK, Innovation Ulster, and University of Ulster Vice Chancellor Studentships (to M. H. and H. G.-P.).	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT SJH, 1986, DIABETOLOGIA, V29, P727, DOI 10.1007/BF00870283; BURNHAM DB, 1982, J BIOL CHEM, V257, P523; CHICK WL, 1977, P NATL ACAD SCI USA, V74, P628, DOI 10.1073/pnas.74.2.628; de la Tour DD, 2001, MOL ENDOCRINOL, V15, P476; Efrat Shimon, 1996, P438; Ehses JA, 2001, J BIOL CHEM, V276, P23667, DOI 10.1074/jbc.M103023200; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Gartner W, 2006, NEUROENDOCRINOLOGY, V83, P123, DOI 10.1159/000094875; GUELI N, 1987, J EXP CLIN CANC RES, V6, P281; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hellman B., 1992, NUTR REGULATION INSU, P213; HENQUIN JC, 1992, NUTR REGULATION INSU, P172; JARRETT RJ, 1966, LANCET, V1, P633; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kramer W, 1996, HORM METAB RES, V28, P464, DOI 10.1055/s-2007-979838; LENZEN S, 1986, BIOCHEM PHARMACOL, V35, P2841, DOI 10.1016/0006-2952(86)90202-9; LENZEN S, 1994, BIOCHEM SOC T, V22, P1; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; MacFarlane WM, 1999, J BIOL CHEM, V274, P34059, DOI 10.1074/jbc.274.48.34059; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; Miguel JC, 2004, CELL CALCIUM, V36, P43, DOI 10.1016/j.ceca.2003.11.007; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; OHNEDA M, 1994, AM J PHYSIOL, V267, pE9668; RADVANYI F, 1993, MOL CELL BIOL, V13, P4223, DOI 10.1128/MCB.13.7.4223; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; SOLDEVILA G, 1991, J AUTOIMMUN, V4, P381, DOI 10.1016/0896-8411(91)90154-5; THIVOLET C, 1986, CR ACAD SCI III-VIE, V303, P381; THIVOLET CH, 1988, DIABETES, V37, P1279, DOI 10.2337/diabetes.37.9.1279; Tsang WG, 2007, TRANSPLANTATION, V83, P685, DOI 10.1097/01.tp.0000256178.57359.4f; Wang S, 1997, CELL TRANSPLANT, V6, P59, DOI 10.1016/S0963-6897(96)00120-0; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568	35	104	108	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21982	21992		10.1074/jbc.M111.226795	http://dx.doi.org/10.1074/jbc.M111.226795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515691	Green Published, hybrid			2022-12-25	WOS:000291719900005
J	Wang, SH; Wang, Y; Ma, J; Ding, YC; Zhang, SC				Wang, Shaohui; Wang, Yuan; Ma, Jie; Ding, Yunchao; Zhang, Shicui			Phosvitin Plays a Critical Role in the Immunity of Zebrafish Embryos via Acting as a Pattern Recognition Receptor and an Antimicrobial Effector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPHIOXUS BRANCHIOSTOMA-BELCHERI; MATERNAL COMPLEMENT COMPONENTS; IGM-BEARING CELLS; IMMUNOGLOBULIN PROTEIN; DICENTRARCHUS-LABRAX; KATSUWONUS-PELAMIS; GENE TRANSCRIPTS; ATLANTIC SALMON; INNATE IMMUNITY; SKIPJACK TUNA	How fish embryos that develop externally survive microbial attacks is poorly understood. Here, we clearly demonstrated that the embryo extract of zebrafish and its early embryo both displayed antimicrobial activity against microbes, including pathogenic Aeromonas hydrophila, and phosvitin (Pv), a nutritional protein abundant in eggs, was related to this antimicrobial activity. We also showed that recombinant Pv (rPv) acted as a pattern recognition receptor capable of recognizing the microbial signature molecules LPS, lipoteichoic acid, and peptidoglycan, as well as binding the Gram-negative and -positive microbes Escherichia coli, A. hydrophila, and Staphylococcus aureus and functioned as an antimicrobial agent capable of killing the microbes. Furthermore, we revealed that its C-terminal 55 residues (Pt5) with the functional sites Arg(242) and Ala(201)/Ile(203) were indispensable for Pv antimicrobial activity. Importantly, microinjection of rPv or Pt5 into early embryos significantly enhanced their resistance to A. hydrophila challenge, and this enhanced bacterial resistance was markedly reduced by co-injection of anti-Pv antibody plus rPv (or Pt5) but not by injection of anti-actin antibody plus rPv. Moreover, the generated mutants with in vitro antimicrobial activity, when injected into the embryos, could also promote their resistance to A. hydrophila, but those without in vitro antimicrobial activity could not. It is thus proposed that Pv participates in the protection of early embryos against pathogenic attacks via binding and disrupting potential pathogens. This work also opens a new way for the study of the immunological roles of yolk proteins in oviparous animals that rely on yolk proteins for embryonic development.	[Wang, Shaohui; Wang, Yuan; Ma, Jie; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao 266003, Peoples R China; [Ding, Yunchao; Zhang, Shicui] Ocean Univ China, Lab Evolut & Dev, Dept Marine Biol, Qingdao 266003, Peoples R China	Ocean University of China; Ocean University of China	Zhang, SC (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Rm 205,Ke Xue Guan,5 Yushan Rd, Qingdao 266003, Peoples R China.	sczhang@ouc.edu.cn	Wang, Shaohui/G-7247-2012		Natural Science Foundation of China [30972274, 30730072]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 30972274 and 30730072 from the Natural Science Foundation of China (to S. Z.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An Y, 2009, MOL IMMUNOL, V46, P2666, DOI 10.1016/j.molimm.2009.04.001; BILDFELL R J, 1992, Journal of Aquatic Animal Health, V4, P97, DOI 10.1577/1548-8667(1992)004&lt;0097:PAPCOA&gt;2.3.CO;2; BLY JE, 1986, COMP BIOCHEM PHYS A, V84, P309, DOI 10.1016/0300-9629(86)90620-1; Breuil G, 1997, FISH SHELLFISH IMMUN, V7, P29, DOI 10.1006/fsim.1996.0061; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; CASTILLO A, 1993, DEV COMP IMMUNOL, V17, P419, DOI 10.1016/0145-305X(93)90033-M; Choi JH, 2002, FISHERIES SCI, V68, P1367, DOI 10.1046/j.1444-2906.2002.00576.x; Ellingsen T, 2005, FISH SHELLFISH IMMUN, V18, P351, DOI 10.1016/j.fsi.2004.09.002; Ellis A. E., 1988, Fish vaccination., P20; Fan CX, 2008, MOL IMMUNOL, V45, P3338, DOI 10.1016/j.molimm.2008.04.019; Finn RN, 2010, AQUAC RES, V41, P684, DOI 10.1111/j.1365-2109.2009.02220.x; Garcia J, 2010, FISH SHELLFISH IMMUN, V29, P293, DOI 10.1016/j.fsi.2010.04.010; Gotoh M, 2005, IMMUNOL LETT, V98, P297, DOI 10.1016/j.imlet.2004.12.004; GROGAN J, 1987, J INORG BIOCHEM, V29, P33, DOI 10.1016/0162-0134(87)80010-7; Hanif A, 2004, FISH SHELLFISH IMMUN, V17, P411, DOI 10.1016/j.fsi.2004.04.013; Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V20, P586, DOI 10.1016/j.fsi.2005.07.008; ITOH T, 1983, J FOOD SCI, V48, P1755, DOI 10.1111/j.1365-2621.1983.tb05077.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung WK, 2003, INT J BIOCHEM CELL B, V35, P255, DOI 10.1016/S1357-2725(02)00176-0; Khan MAS, 2000, J AGR FOOD CHEM, V48, P1503, DOI 10.1021/jf990700r; Li ZJ, 2009, MOL IMMUNOL, V46, P3232, DOI 10.1016/j.molimm.2009.08.006; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; Liu J, 2009, MOL IMMUNOL, V46, P3117, DOI 10.1016/j.molimm.2009.06.001; LOSSO JN, 1994, EGG USES PROCESSING, P150; Lovoll M, 2007, FISH SHELLFISH IMMUN, V23, P542, DOI 10.1016/j.fsi.2007.01.002; Lvoll M, 2006, IMMUNOGENETICS, V58, P168, DOI 10.1007/s00251-006-0096-3; MOR A, 1990, J FISH BIOL, V37, P249, DOI 10.1111/j.1095-8649.1990.tb05856.x; Olsen YA, 1997, FISH SHELLFISH IMMUN, V7, P81, DOI 10.1006/fsim.1996.0064; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Picchietti S, 2006, FISH SHELLFISH IMMUN, V20, P398, DOI 10.1016/j.fsi.2005.06.001; Picchietti S, 2004, CELL TISSUE RES, V315, P259, DOI 10.1007/s00441-003-0819-9; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Roque ACA, 2004, J MOL RECOGNIT, V17, P262, DOI 10.1002/jmr.661; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sinha N, 2002, CURR PROTEIN PEPT SC, V3, P601, DOI 10.2174/1389203023380431; Swain P, 2006, FISH SHELLFISH IMMUN, V20, P519, DOI 10.1016/j.fsi.2005.06.011; TABORSKY G, 1983, ADV INORG BIOCHEM, V5, P235; Tateno H, 2002, DEV COMP IMMUNOL, V26, P543, DOI 10.1016/S0145-305X(02)00007-1; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; VANLOON JJA, 1981, COMP DEV IMMUNOL, V1, P469; Wang ZP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001463; Wang ZP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004498; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Yamashita M, 1996, J BIOL CHEM, V271, P1282, DOI 10.1074/jbc.271.3.1282; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; YOUSIF AN, 1994, DIS AQUAT ORGAN, V19, P15, DOI 10.3354/dao019015; YOUSIF AN, 1991, DIS AQUAT ORGAN, V10, P45, DOI 10.3354/dao010045; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003; Zhang SC, 2009, REPROD BIOL PHYLOGEN, V8B, P485, DOI 10.1201/b10257-13	52	69	75	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22653	22664		10.1074/jbc.M111.247635	http://dx.doi.org/10.1074/jbc.M111.247635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531722	Green Published, hybrid			2022-12-25	WOS:000291719900072
J	Suaud, L; Miller, K; Alvey, L; Yan, WS; Robay, A; Kebler, C; Kreindler, JL; Guttentag, S; Hubbard, MJ; Rubenstein, RC				Suaud, Laurence; Miller, Katelyn; Alvey, Lora; Yan, Wusheng; Robay, Amal; Kebler, Catherine; Kreindler, James L.; Guttentag, Susan; Hubbard, Michael J.; Rubenstein, Ronald C.			ERp29 Regulates Delta F508 and Wild-type Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Trafficking to the Plasma Membrane in Cystic Fibrosis (CF) and Non-CF Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM PROTEIN; MOLECULAR CHAPERONE HSC70; HEAT-SHOCK PROTEINS; SODIUM 4-PHENYLBUTYRATE; XENOPUS OOCYTES; INTRACELLULAR TRAFFICKING; NUCLEOTIDE-BINDING; LUMENAL PROTEIN; RAT-LIVER; DEGRADATION	Sodium 4-phenylbutyrate (4PBA) improves the intracellular trafficking of Delta F508-CFTR in cystic fibrosis (CF) epithelial cells. The underlying mechanism is uncertain, but 4PBA modulates the expression of some cytosolic molecular chaperones. To identify other 4PBA-regulated proteins that might regulate Delta F508-CFTR trafficking, we performed a differential display RT-PCR screen on IB3-1 CF bronchiolar epithelial cells exposed to 4PBA. One transcript up-regulated by 4PBA encoded ERp29, a luminal resident of the endoplasmic reticulum (ER) thought to be a novel molecular chaperone. We tested the hypothesis that ERp29 is a 4PBA-regulated ER chaperone that influences Delta F508-CFTR trafficking. ERp29 mRNA and protein expression was significantly increased (similar to 1.5-fold) in 4PBA-treated IB3-1 cells. In Xenopus oocytes, ERp29 overexpression increased the functional expression of both wild-type and Delta F508-CFTR over 3-fold and increased wild-type cystic fibrosis transmembrane conductance regulator (CFTR) plasma membrane expression. In CFBE41o- WT-CFTR cells, expression of and short circuit currents mediated by CFTR decreased upon depletion of ERp29 as did maturation of newly synthesized CFTR. In IB3-1 cells, Delta F508-CFTR co-immunoprecipitated with endogenous ERp29, and overexpression of ERp29 led to increased Delta F508-CFTR expression at the plasma membrane. These data suggest that ERp29 is a 4PBA-regulated ER chaperone that regulates WT-CFTR biogenesis and can promote Delta F508-CFTR trafficking in CF epithelial cells.	[Suaud, Laurence; Miller, Katelyn; Alvey, Lora; Yan, Wusheng; Robay, Amal; Kebler, Catherine; Kreindler, James L.; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Suaud, Laurence; Miller, Katelyn; Alvey, Lora; Yan, Wusheng; Robay, Amal; Kebler, Catherine; Kreindler, James L.; Rubenstein, Ronald C.] Childrens Hosp Philadelphia, Cyst Fibrosis Ctr, Philadelphia, PA 19104 USA; [Guttentag, Susan] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Kreindler, James L.; Guttentag, Susan; Rubenstein, Ronald C.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Hubbard, Michael J.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Hubbard, Michael J.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Melbourne; University of Melbourne	Rubenstein, RC (corresponding author), Childrens Hosp Philadelphia, Div Pulm Med, Abramson 410C,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rrubenst@mail.med.upenn.edu	Hubbard, Mike (Michael) J/AAE-6573-2022; Guttentag, Susan/ABE-7405-2020; Guttentag, Susan H/D-8705-2013	Hubbard, Mike (Michael) J/0000-0002-5432-9421; Guttentag, Susan/0000-0003-4420-5879; Guttentag, Susan H/0000-0003-4420-5879; Rubenstein, Ronald/0000-0002-3138-4006	National Institutes of Health, NIDDK [R01 DK058046, R01 DK073185]; NHLBI [R01 HL059959, K08 HL081080]; American Pediatric Society-Society for Pediatric Research [T35 HD0744]; American Heart Association; Cystic Fibrosis Foundation; Lottery Health Research New Zealand; Melbourne Research Unit for Facial Disorders; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD000744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059959, K08HL081080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073185, R01DK058046] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Pediatric Society-Society for Pediatric Research; American Heart Association(American Heart Association); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Lottery Health Research New Zealand; Melbourne Research Unit for Facial Disorders; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK058046 and R01 DK073185 from the NIDDK (to R. C. R.), R01 HL059959 (to S. G.) and K08 HL081080 from the NHLBI (to J. L. K.), and T35 HD0744 (a student research fellowship to L. A. through the American Pediatric Society-Society for Pediatric Research). This work was also supported by grants from the Pennsylvania-Delaware Chapter of the American Heart Association (to L. S.) and the Cystic Fibrosis Foundation (to R. C. R.).; Supported by Lottery Health Research New Zealand and a professorial fellowship from the Melbourne Research Unit for Facial Disorders.	Ahner A, 2007, MOL BIOL CELL, V18; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Barak NN, 2009, J MOL BIOL, V385, P1630, DOI 10.1016/j.jmb.2008.11.052; Baryshev M, 2006, BIOCHEM BIOPH RES CO, V340, P617, DOI 10.1016/j.bbrc.2005.12.052; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; Demmer J, 1997, FEBS LETT, V402, P145, DOI 10.1016/S0014-5793(96)01513-X; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Ferrari DM, 1998, EUR J BIOCHEM, V255, P570, DOI 10.1046/j.1432-1327.1998.2550570.x; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; Hermann VM, 2005, J BIOL CHEM, V280, P13529, DOI 10.1074/jbc.M410889200; Hubbard MJ, 2004, BIOCHEM J, V383, P589, DOI 10.1042/BJ20040983; Hubbard MJ, 2000, EUR J BIOCHEM, V267, P1945, DOI 10.1046/j.1432-1327.2000.01193.x; Hubbard MJ, 2002, PROTEOMICS, V2, P1069, DOI 10.1002/1615-9861(200209)2:9<1069::AID-PROT1069>3.0.CO;2-R; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jiang QS, 2000, J BIOL CHEM, V275, P13266, DOI 10.1074/jbc.275.18.13266; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kelly JW, 2006, NAT CHEM BIOL, V2, P224, DOI 10.1038/nchembio0506-224; Konsolaki M, 1998, GENE DEV, V12, P120, DOI 10.1101/gad.12.1.120; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; MacLeod JC, 2004, J COMP NEUROL, V477, P29, DOI 10.1002/cne.20222; Magnuson B, 2005, MOL CELL, V20, P289, DOI 10.1016/j.molcel.2005.08.034; MCGRATH SA, 1993, AM J RESP CELL MOL, V8, P201, DOI 10.1165/ajrcmb/8.2.201; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Mkrtchian S, 1998, EUR J BIOCHEM, V251, P304, DOI 10.1046/j.1432-1327.1998.2510304.x; Mkrtchian S, 2006, ANTIOXID REDOX SIGN, V8, P325, DOI 10.1089/ars.2006.8.325; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Okiyoneda T, 2002, FEBS LETT, V526, P87, DOI 10.1016/S0014-5793(02)03134-4; Park S, 2005, MOL BIOL REP, V32, P7, DOI 10.1007/s11033-004-3069-3; PIND S, 1994, J BIOL CHEM, V269, P12784; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Rubenstein RC, 2005, CURR OPIN PEDIATR, V17, P385, DOI 10.1097/01.mop.0000158846.95469.6f; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 2001, AM J PHYSIOL-LUNG C, V281, pL43, DOI 10.1152/ajplung.2001.281.1.L43; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Samaha FF, 2004, J BIOL CHEM, V279, P23900, DOI 10.1074/jbc.M401941200; Sargsyan E, 2002, J BIOL CHEM, V277, P17009, DOI 10.1074/jbc.M200539200; Sen J, 2000, DEVELOPMENT, V127, P5541; Shnyder SD, 2002, J HISTOCHEM CYTOCHEM, V50, P557, DOI 10.1177/002215540205000413; Singh OV, 2006, J PROTEOME RES, V5, P562, DOI 10.1021/pr050319o; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Suaud L, 2002, J BIOL CHEM, V277, P8928, DOI 10.1074/jbc.M111482200; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wright JM, 2004, PHYSIOL GENOMICS, V16, P204, DOI 10.1152/physiolgenomics.00160.2003; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639; Zhang H, 2006, J BIOL CHEM, V281, P11312, DOI 10.1074/jbc.M512013200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	68	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21239	21253		10.1074/jbc.M111.240267	http://dx.doi.org/10.1074/jbc.M111.240267			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525008	Green Published, hybrid			2022-12-25	WOS:000291464700023
J	Venugopalan, SR; Li, X; Amen, MA; Florez, S; Gutierrez, D; Cao, HJ; Wang, JB; Amendt, BA				Venugopalan, Shankar R.; Li, Xiao; Amen, Melanie A.; Florez, Sergio; Gutierrez, Diana; Cao, Huojun; Wang, Jianbo; Amendt, Brad A.			Hierarchical Interactions of Homeodomain and Forkhead Transcription Factors in Regulating Odontogenic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOOTH DEVELOPMENT; EPITHELIAL-CELLS; DLX2 EXPRESSION; RIEGER-SYNDROME; BETA-CATENIN; PITX2; PROTEIN; FOXJ1; DIFFERENTIATION	FoxJ1 is a forkhead transcription factor expressed in multiple tissues during development and a major regulator of cilia development. FoxJ1(-/-) mice present with defects in odontogenesis, and we correlate these defects to hierarchical interactions between homeodomain factors Pitx2 and Dlx2 with FoxJ1 in regulating their expression through direct physical interactions. Chromatin immunoprecipitation assays reveal endogenous Pitx2 and Dlx2 binding to the Dlx2 promoter and Dlx2 binding to the FoxJ1 promoter as well as Dlx2 and FoxJ1 binding to the amelogenin promoter. PITX2 activation of the Dlx2 promoter is attenuated by a direct Dlx2 physical interaction with PITX2. Dlx2 autoregulates its promoter, and Dlx2 transcriptionally activates the downstream gene FoxJ1. Dlx2 and FoxJ1 physically interact and synergistically regulate both Dlx2 and FoxJ1 promoters. Dlx2 and FoxJ1 also activate the amelogenin promoter, and amelogenin is required for enamel formation and late stage tooth development. FoxJ1(-/-) mice maxillary and mandibular incisors are reduced in length and width and have reduced amelogenin expression. FoxJ1(-/-) mice show a reduced and defective ameloblast layer, revealing a biological effect of these transcription factor hierarchies during tooth morphogenesis. These transcriptional mechanisms may contribute to other developmental processes such as neuronal, pituitary, and heart development.	[Venugopalan, Shankar R.; Li, Xiao; Amen, Melanie A.; Florez, Sergio; Gutierrez, Diana; Cao, Huojun; Wang, Jianbo; Amendt, Brad A.] TAMU Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA		Amendt, BA (corresponding author), TAMU Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	bamendt@ibt.tamhsc.edu	Rengasamy Venugopalan, Shankar/GPX-7671-2022; Li, Xiao/X-3429-2019; cao, huojun/M-5431-2017	Li, Xiao/0000-0001-8527-4438; Cao, Huojun/0000-0003-4428-8686; Amendt, Brad A./0000-0001-6524-1006; Gutierrez Lopez, Diana E./0000-0003-0158-8558	National Institutes of Health [DE 18885]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant DE 18885 (NIDCR; to B.A.A.).	Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Bei M, 2004, DEV DYNAM, V231, P758, DOI 10.1002/dvdy.20182; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; Diamond E, 2006, NUCLEIC ACIDS RES, V34, P5951, DOI 10.1093/nar/gkl689; Espinoza HM, 2005, BIOCHEMISTRY-US, V44, P3942, DOI 10.1021/bi048362x; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Lezot F, 2000, J BONE MINER RES, V15, P430, DOI 10.1359/jbmr.2000.15.3.430; Lezot F, 2008, J CELL PHYSIOL, V216, P688, DOI 10.1002/jcp.21448; Lim L, 1997, P NATL ACAD SCI USA, V94, P3094, DOI 10.1073/pnas.94.7.3094; Lin L, 2005, J IMMUNOL, V175, P951, DOI 10.4049/jimmunol.175.2.951; Lin L, 2004, SCIENCE, V303, P1017, DOI 10.1126/science.1093889; Liu JK, 1997, DEV DYNAM, V210, P498, DOI 10.1002/(SICI)1097-0177(199712)210:4<498::AID-AJA12>3.0.CO;2-3; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Tamakoshi T, 2006, BIOCHEM BIOPH RES CO, V339, P932, DOI 10.1016/j.bbrc.2005.11.097; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9; Thomas BL, 2000, DEVELOPMENT, V127, P217; Thomas BL, 1995, CONNECT TISSUE RES, V32, P27, DOI 10.3109/03008209509013702; Thomas BL, 1997, DEVELOPMENT, V124, P4811; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zhou QP, 2004, NUCLEIC ACIDS RES, V32, P884, DOI 10.1093/nar/gkh233	36	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21372	21383		10.1074/jbc.M111.252031	http://dx.doi.org/10.1074/jbc.M111.252031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21504905	Green Published, hybrid			2022-12-25	WOS:000291464700036
J	Yuan, KF; Huang, CH; Fox, J; Gaid, M; Weaver, A; Li, GP; Singh, BB; Gao, HW; Wu, M				Yuan, Kefei; Huang, Canhua; Fox, John; Gaid, Madeleine; Weaver, Andrew; Li, Guoping; Singh, Brij B.; Gao, Hongwei; Wu, Min			Elevated Inflammatory Response in Caveolin-1-deficient Mice with Pseudomonas aeruginosa Infection Is Mediated by STAT3 Protein and Nuclear Factor kappa B (NF-kappa B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; VENTILATOR-ASSOCIATED PNEUMONIA; CAVEOLIN GENE FAMILY; RICH MEMBRANE RAFTS; LIPID RAFTS; ALVEOLAR MACROPHAGES; OXIDATIVE STRESS; PLASMA-MEMBRANE; T-CELLS; ACTIVATION	Caveolin-1 (Cav-1), an important composition protein within the flask-shaped membrane invaginations termed caveolae, may play a role in host defense against infections. However, the phenotype in Pseudomonas aeruginosa-infected cav1 knock-out (KO) mice is still unresolved, and the mechanism involved is almost entirely unknown. Using a respiratory infection model, we confirmed a crucial role played by Cav-1 in host defense against this pathogen because Cav-1 KO mice showed increased mortality, severe lung injury, and systemic dissemination as compared with wild-type (WT) littermates. In addition, cav1 KO mice exhibited elevated inflammatory cytokines (IL-6, TNF-alpha, and IL-12a), decreased phagocytic ability of macrophages, and increased superoxide release in the lung, liver, and kidney. We further studied relevant cellular signaling processes and found that STAT3 and NF-kappa B are markedly activated. Our data revealed that the Cav-1/STAT3/NF-kappa B axis is responsible for a dysregulated cytokine response, which contributes to increased mortality and disease progression. Moreover, down-regulating Cav-1 in cell culture with a dominant negative strategy demonstrated that STAT3 activation was essential for the translocation of NF-kappa B into the nucleus, confirming the observations from cav1 KO mice. Collectively, our studies indicate that Cav-1 is critical for inflammatory responses regulating the STAT3/NF-kappa B pathway and thereby impacting P. aeruginosa infection.	[Yuan, Kefei; Huang, Canhua] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Gao, Hongwei] Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Med Sch, Boston, MA 02115 USA; [Fox, John; Gaid, Madeleine; Weaver, Andrew; Li, Guoping; Singh, Brij B.; Wu, Min] Univ N Dakota, Dept Biochem & Mol Biol, Grand Forks, ND 58203 USA	Sichuan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of North Dakota Grand Forks	Huang, CH (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.	hcanhua@hotmail.com; min.wu@med.und.edu	Yuan, Kefei/AGX-5504-2022	Wu, Min/0000-0003-1205-982X; Singh, Brij/0000-0003-0535-5997	National Institutes of Health [ES014690, 5R01HL092905-04, 3R01HL092905-02S1]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES014690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES014690 (to M. W.) and 5R01HL092905-04 and 3R01HL092905-02S1 (to H. G.). This work was also supported by an American Heart Association scientist development grant (to M. W.).	Amano H, 2004, J IMMUNOL, V172, P398, DOI 10.4049/jimmunol.172.1.398; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Arita Y, 2008, WORLD J GASTROENTERO, V14, P4473, DOI 10.3748/wjg.14.4473; Barar J, 2007, BIOCHEM BIOPH RES CO, V359, P360, DOI 10.1016/j.bbrc.2007.05.106; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; CROUCH BS, 1996, CHEST, V109, P1019, DOI DOI 10.1378/CHEST.109.4.1019; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; DUNN M, 1995, CLIN CHEST MED, V16, P95; Fagon JY, 1996, CLIN INFECT DIS, V23, P538, DOI 10.1093/clinids/23.3.538; Gadjeva M, 2010, J IMMUNOL, V184, P296, DOI 10.4049/jimmunol.0900604; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; Ivashkiv LB, 2010, CELL HOST MICROBE, V8, P132, DOI 10.1016/j.chom.2010.07.011; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jones MR, 2006, J INFECT DIS, V193, P360, DOI 10.1086/499312; Kannan S, 2006, CELL DEATH DIFFER, V13, P311, DOI 10.1038/sj.cdd.4401736; Kannan S, 2008, J IMMUNOL, V180, P2396, DOI 10.4049/jimmunol.180.4.2396; Kannan S, 2006, EUR J IMMUNOL, V36, P1739, DOI 10.1002/eji.200635973; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; KENNETH RF, 2005, CLIN CANCER RES, V11, pA277; Korade Z, 2008, NEUROPHARMACOLOGY, V55, P1265, DOI 10.1016/j.neuropharm.2008.02.019; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Maruvada R, 2008, CELL MICROBIOL, V10, P2326, DOI 10.1111/j.1462-5822.2008.01214.x; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Mora R, 1999, J BIOL CHEM, V274, P25708, DOI 10.1074/jbc.274.36.25708; Nakayama M, 2009, J BIOL CHEM, V284, P1612, DOI 10.1074/jbc.M806981200; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; OZAKI T, 1989, AM REV RESPIR DIS, V140, P1595, DOI 10.1164/ajrccm/140.6.1595; Park DS, 2002, MOL BIOL CELL, V13, P3416, DOI 10.1091/mbc.02-05-0071; Priebe GP, 2002, INFECT IMMUN, V70, P1507, DOI 10.1128/IAI.70.3.1507-1517.2002; RENIER M, 1995, HUM GENE THER, V6, P1275, DOI 10.1089/hum.1995.6.10-1275; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Shaykhiev R, 2010, FASEB J, V24, P4756, DOI 10.1096/fj.09-151332; Shen-Tu G, 2010, LAB INVEST, V90, P266, DOI 10.1038/labinvest.2009.131; Sugahara K, 2010, AM J RESP CRIT CARE, V181; Suntres ZE, 2002, MICROB PATHOGENESIS, V32, P27, DOI 10.1006/mpat.2001.0475; Takeda K, 1998, J IMMUNOL, V161, P4652; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Thomas S, 2004, ARCH IMMUNOL THER EX, V52, P215; Thomas S, 2004, MOL IMMUNOL, V41, P399, DOI 10.1016/j.molimm.2004.03.022; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang L, 2007, ONCOGENE, V26, P2851, DOI 10.1038/sj.onc.1210092; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wisniowski PE, 2000, AM J RESP CRIT CARE, V162, P733, DOI 10.1164/ajrccm.162.2.9808015; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Wu M, 2002, ELECTROPHORESIS, V23, P2373, DOI 10.1002/1522-2683(200208)23:15<2373::AID-ELPS2373>3.0.CO;2-W; WU M, 1995, BIOCONJUGATE CHEM, V6, P587, DOI 10.1021/bc00035a013; Wu M, 2001, P NATL ACAD SCI USA, V98, P14589, DOI 10.1073/pnas.251451498; Wu M, 2011, INFECT IMMUN, V79, P75, DOI 10.1128/IAI.00815-10; Wu M, 2009, J NEUROCHEM, V111, P1011, DOI 10.1111/j.1471-4159.2009.06390.x; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084; Zaas DW, 2009, J BIOL CHEM, V284, P9955, DOI 10.1074/jbc.M808629200; Zaas DW, 2005, J BIOL CHEM, V280, P4864, DOI 10.1074/jbc.M411702200	64	68	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21814	21825		10.1074/jbc.M111.237628	http://dx.doi.org/10.1074/jbc.M111.237628			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515682	Green Published, hybrid			2022-12-25	WOS:000291464700076
J	Dickens, LC; Goatley, CHR; Tanner, JK; Bellwood, DR				Dickens, Luke C.; Goatley, Christopher H. R.; Tanner, Jennifer K.; Bellwood, David R.			Quantifying Relative Diver Effects in Underwater Visual Censuses	PLOS ONE			English	Article							REEF FISH ASSEMBLAGES; MARINE RESERVE; SIZE-STRUCTURE; SCUBA-DIVERS; HABITAT USE; BEHAVIOR; DENSITY; ABUNDANCE; COUNTS; POPULATION	Diver-based Underwater Visual Censuses (UVCs), particularly transect-based surveys, are key tools in the study of coral reef fish ecology. These techniques, however, have inherent problems that make it difficult to collect accurate numerical data. One of these problems is the diver effect (defined as the reaction of fish to a diver). Although widely recognised, its effects have yet to be quantified and the extent of taxonomic variation remains to be determined. We therefore examined relative diver effects on a reef fish assemblage on the Great Barrier Reef. Using common UVC methods, the recorded abundance of seven reef fish groups were significantly affected by the ongoing presence of SCUBA divers. Overall, the diver effect resulted in a 52% decrease in the mean number of individuals recorded, with declines of up to 70% in individual families. Although the diver effect appears to be a significant problem, UVCs remain a useful approach for quantifying spatial and temporal variation in relative fish abundances, especially if using methods that minimise the exposure of fishes to divers. Fixed distance transects using tapes or lines deployed by a second diver (or GPS-calibrated timed swims) would appear to maximise fish counts and minimise diver effects.	[Dickens, Luke C.; Goatley, Christopher H. R.; Tanner, Jennifer K.; Bellwood, David R.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia; [Dickens, Luke C.; Goatley, Christopher H. R.; Tanner, Jennifer K.; Bellwood, David R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia	James Cook University; James Cook University	Dickens, LC (corresponding author), James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia.	david.bellwood@jcu.edu.au	Goatley, Christopher/C-1492-2016	Goatley, Christopher/0000-0002-2930-5591	ARC Centre of Excellence for Coral Reef Studies	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	This research received financial support from the ARC Centre of Excellence for Coral Reef Studies (DRB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Azzurro E, 2007, MAR BIOL, V151, P2245, DOI 10.1007/s00227-007-0661-9; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2006, GLOBAL CHANGE BIOL, V12, P1587, DOI 10.1111/j.1365-2486.2006.01204.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; BOHNSACK JA, 1986, NOOA TECHNICAL REPOR, V41; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Chapman C.J., 1986, Progress in Underwater Science, V11, P1; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Chateau O, 2009, ICES J MAR SCI, V66, P50, DOI 10.1093/icesjms/fsn165; Cole RG, 2007, MAR BIOL, V150, P1379, DOI 10.1007/s00227-006-0420-3; COLE RG, 1994, BIOL CONSERV, V70, P93, DOI 10.1016/0006-3207(94)90276-3; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Cowman PF, 2009, MOL PHYLOGENET EVOL, V52, P621, DOI 10.1016/j.ympev.2009.05.015; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; FOWLER AJ, 1987, CORAL REEFS, V6, P49, DOI 10.1007/BF00302212; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2008, MAR BIOL, V154, P325, DOI 10.1007/s00227-008-0927-x; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Fulton CJ, 2001, MAR BIOL, V139, P25; Goatley CHR, 2009, CORAL REEFS, V28, P449, DOI 10.1007/s00338-009-0477-9; Guidetti P, 2008, J MAR BIOL ASSOC UK, V88, P625, DOI 10.1017/S0025315408000933; HARMELINVIVIEN ML, 1985, REV ECOL-TERRE VIE, V40, P466; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Jayewardene D, 2009, CORAL REEFS, V28, P499, DOI 10.1007/s00338-009-0475-y; JENNINGS S, 1995, J FISH BIOL, V47, P733, DOI 10.1111/j.1095-8649.1995.tb01938.x; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Kulbicki M, 2010, J EXP MAR BIOL ECOL, V387, P15, DOI 10.1016/j.jembe.2010.03.003; Lobel PS, 2001, MAR TECHNOL SOC J, V35, P19, DOI 10.4031/002533201788001884; MacNeil MA, 2008, J FISH BIOL, V73, P1748, DOI 10.1111/j.1095-8649.2008.02067.x; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; Myrberg AA., 2006, CORAL REEF FISHES, P123; Patterson HM, 2007, ENVIRON BIOL FISH, V78, P291, DOI 10.1007/s10641-006-9096-2; Radford CA, 2005, MAR FRESHW BEHAV PHY, V38, P259, DOI 10.1080/10236240500333908; Randall JE, 1997, FISHES GREAT BARRIER; Sale P.F., 1983, Coral Reefs, V2, P37, DOI 10.1007/BF00304730; Sale Peter F., 1997, P1435; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sano M, 2000, MAR ECOL PROG SER, V198, P121, DOI 10.3354/meps198121; Schmidt MB, 2006, FISH RES, V82, P131, DOI 10.1016/j.fishres.2006.08.014; SMITH MPL, 1988, MAR ECOL PROG SER, V43, P223, DOI 10.3354/meps043223; STANLEY DR, 1995, T AM FISH SOC, V124, P946, DOI 10.1577/1548-8659(1995)124<0946:EOSDOF>2.3.CO;2; Stockwell B, 2009, MAR ECOL PROG SER, V389, P1, DOI 10.3354/meps08150; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Thompson AA, 2002, MAR ECOL PROG SER, V232, P247, DOI 10.3354/meps232247; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; WATSON RA, 1995, ECOL MODEL, V77, P205, DOI 10.1016/0304-3800(93)E0085-H; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790	56	133	134	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18965	10.1371/journal.pone.0018965	http://dx.doi.org/10.1371/journal.pone.0018965			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533039	Green Published, gold, Green Accepted			2022-12-25	WOS:000290014500017
J	Diaz, T; Navarro, A; Ferrer, G; Gel, B; Gaya, A; Artells, R; Bellosillo, B; Garcia-Garcia, M; Serrano, S; Martinez, A; Monzo, M				Diaz, Tania; Navarro, Alfons; Ferrer, Gerardo; Gel, Bernat; Gaya, Anna; Artells, Rosa; Bellosillo, Beatriz; Garcia-Garcia, Mar; Serrano, Sergi; Martinez, Antonio; Monzo, Mariano			Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis	PLOS ONE			English	Article							JAK2 INHIBITOR; FLOW-CYTOMETRY; THERAPY; CELLS; ABERRATIONS; EXPRESSION; FREQUENT; DISEASE; NODES	Standard cytotoxic chemotherapy for Hodgkin Lymphoma (HL) has changed little in 30 years; the treatment for patients with relapsed or refractory disease remains challenging and novel agents are under development. JAK/STAT constitutive activation plays an important role in the pathogenesis of HL. Lestaurtinib is an orally bioavailable multikinase inhibitor that has recently been shown to inhibit JAK2 in myeloproliferative disorders. The potential role of Lestaurtinib in HL therapy is unknown. We have analyzed the effect of Lestaurtinib treatment in five HL cell lines from refractory patients, L-428, L-1236, L-540, HDML-2 and HD-MY-Z. At 48 h, a dose-dependent cell growth inhibition (23%-66% at 300 nM) and apoptotic increment (10%-64% at 300 nM) were observed. Moreover, Lestaurtinib inhibited JAK2, STAT5 and STAT3 phosphorylation and reduced the mRNA expression of its downstream antiapoptotic target Bcl-xL. In addition, we have analyzed the effect of Lestaurtinib treatment in lymph nodes from four classic HL patients. We observed a decrease in cell viability at 24 hours of treatment in three patients (mean decrease of 27% at 300 nM). Our findings provide, for the first time, a molecular rationale for testing JAK2 inhibitors, specifically Lestaurtinib, in HL patients.	[Diaz, Tania; Navarro, Alfons; Artells, Rosa; Monzo, Mariano] Univ Barcelona, Sch Med, Human Anat Unit, Mol Oncol & Embryol Lab,IDIBAPS, Barcelona, Spain; [Ferrer, Gerardo; Gaya, Anna] Hosp Clin Barcelona, Inst Hematol & Oncol, IDIBAPS, Barcelona, Spain; [Gel, Bernat] Univ Politecn Cataluna, Software Dept, Barcelona, Spain; [Bellosillo, Beatriz; Garcia-Garcia, Mar; Serrano, Sergi] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Martinez, Antonio] Hosp Clin Barcelona, Pathol Lab, Hematopathol Sect, IDIBAPS, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Politecnica de Catalunya; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Diaz, T (corresponding author), Univ Barcelona, Sch Med, Human Anat Unit, Mol Oncol & Embryol Lab,IDIBAPS, Barcelona, Spain.	anavarroponz@ub.edu	Ferrer, Gerardo/AAU-1173-2020; Martinez, Antonio/D-8188-2012; Gel Moreno, Bernat/B-8806-2016; Garcia, Mar/GOG-9086-2022; Navarro, Alfons/C-2453-2015; MARTINEZ, ANTONIO/AAB-2633-2020	Ferrer, Gerardo/0000-0002-4084-6815; Martinez, Antonio/0000-0003-0790-9017; Gel Moreno, Bernat/0000-0001-8878-349X; Garcia, Mar/0000-0003-2078-8205; Navarro, Alfons/0000-0001-6071-0926; MARTINEZ, ANTONIO/0000-0003-0790-9017; Artells Prats, Rosa/0000-0003-1745-9478; MONZO, MARIANO/0000-0003-2322-4851	Spanish Ministry of Public Health [FIS-PI0900547, FIS-PI080095]; SDCSD of the School of Medicine of the University of Barcelona; Instituto de Salud Carlos III [RD09/0076/00036]; Pla Director d'Oncologia de Catalunya (XBTC); AGAUR; Generalitat de Catalunya; Fondo Social Europeo	Spanish Ministry of Public Health; SDCSD of the School of Medicine of the University of Barcelona; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Pla Director d'Oncologia de Catalunya (XBTC); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Generalitat de Catalunya(Generalitat de Catalunya); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported in part by FIS-PI0900547 and by FIS-PI080095 from the Spanish Ministry of Public Health, by the SDCSD of the School of Medicine of the University of Barcelona, by Instituto de Salud Carlos III FEDER (RD09/0076/00036) and by the Xarxa de Bancs de Tumors sponsored by Pla Director d'Oncologia de Catalunya (XBTC). Tania Diaz and Bernat Gel are FI fellows supported by AGAUR, Generalitat de Catalunya and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Bai M, 2007, HUM PATHOL, V38, P103, DOI 10.1016/j.humpath.2006.06.017; Buglio D, 2007, EXPERT REV ANTICANC, V7, P735, DOI 10.1586/14737140.7.5.735; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Chu WS, 1999, HUM PATHOL, V30, P1065, DOI 10.1016/S0046-8177(99)90224-1; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Evens AM, 2008, NAT CLIN PRACT ONCOL, V5, P543, DOI 10.1038/ncponc1186; Fromm JR, 2006, AM J CLIN PATHOL, V126, P764, DOI 10.1309/7370XK6F6P7474XX; Fromm JR, 2009, AM J CLIN PATHOL, V131, P322, DOI 10.1309/AJCPW3UN9DYLDSPB; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Horning S, 2008, ANN ONCOL, V19, P120; HORNING SJ, 2007, HEMATOLOGY, V1, P197; Jemal Ahmedin, 2009, V471, P3, DOI 10.1007/978-1-59745-416-2_1; Joos S, 2000, CANCER RES, V60, P549; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; Kube D, 2001, BLOOD, V98, P762, DOI 10.1182/blood.V98.3.762; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Meier C, 2009, MODERN PATHOL, V22, P476, DOI 10.1038/modpathol.2008.207; Melzner I, 2006, LEUKEMIA, V20, P157, DOI 10.1038/sj.leu.2404036; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Shabbir M, 2010, EXPERT OPIN INV DRUG, V19, P427, DOI 10.1517/13543781003598862; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; YOUNES MFA, 2009, BLOOD, V114, P588	26	54	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18856	10.1371/journal.pone.0018856	http://dx.doi.org/10.1371/journal.pone.0018856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533094	gold, Green Submitted, Green Published			2022-12-25	WOS:000289719400031
J	Schrader, PS; Milligan, AJ; Behrenfeld, MJ				Schrader, Paul S.; Milligan, Allen J.; Behrenfeld, Michael J.			Surplus Photosynthetic Antennae Complexes Underlie Diagnostics of Iron Limitation in a Cyanobacterium	PLOS ONE			English	Article							CHLOROPHYLL-BINDING PROTEIN; SYNECHOCYSTIS SP PCC-6803; EQUATORIAL PACIFIC-OCEAN; PHYTOPLANKTON PHOTOSYNTHESIS; PHOTOSYSTEM-I; ENERGY-DISSIPATION; ELECTRON-TRANSPORT; OXYGENIC PHOTOSYNTHESIS; ACTIVE FLUORESCENCE; ISIA	Chlorophyll fluorescence from phytoplankton provides a tool to assess iron limitation in the oceans, but the physiological mechanism underlying the fluorescence response is not understood. We examined fluorescence properties of the model cyanobacterium Synechocystis PCC6803 and a Delta isiA knock-out mutant of the same species grown under three culture conditions which simulate nutrient conditions found in the open ocean: (1) nitrate and iron replete, (2) limiting-iron and high-nitrate, representative of natural high-nitrate, low-chlorophyll regions, and (3) iron and nitrogen co-limiting. We show that low variable fluorescence, a key diagnostic of iron limitation, results from synthesis of antennae complexes far in excess of what can be accommodated by the iron-restricted pool of photosynthetic reaction centers. Under iron and nitrogen co-limiting conditions, there are no excess antennae complexes and variable fluorescence is high. These results help to explain the well-established fluorescence characteristics of phytoplankton in high-nutrient, low-chlorophyll ocean regions, while also accounting for the lack of these properties in low-iron, low-nitrogen regions. Importantly, our results complete the link between unique molecular consequences of iron stress in phytoplankton and global detection of iron stress in natural populations from space.	[Schrader, Paul S.; Milligan, Allen J.; Behrenfeld, Michael J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University	Schrader, PS (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	mjb@science.oregonstate.edu			National Science Foundation; Biological Oceanography [NSF-OCE 0726116]; National Aeronautics and Space Administration [NNX08AF72G]	National Science Foundation(National Science Foundation (NSF)); Biological Oceanography(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This research was funded through a grant from the National Science Foundation, Biological Oceanography (NSF-OCE 0726116) and the National Aeronautics and Space Administration (NNX08AF72G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Behrenfeld MJ, 2009, BIOGEOSCIENCES, V6, P779, DOI 10.5194/bg-6-779-2009; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Behrenfeld MJ, 2006, NATURE, V442, P1025, DOI 10.1038/nature05083; Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Berera R, 2009, BIOPHYS J, V96, P2261, DOI 10.1016/j.bpj.2008.12.3905; Bibby TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004601; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Bibby TS, 2001, J BIOL CHEM, V276, P43246, DOI 10.1074/jbc.M106541200; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; Boyd PW, 2001, DEEP-SEA RES PT II, V48, P2529, DOI 10.1016/S0967-0645(01)00007-8; Buick R, 2008, PHILOS T R SOC B, V363, P2731, DOI 10.1098/rstb.2008.0041; Cadoret JC, 2004, BBA-BIOENERGETICS, V1659, P100, DOI 10.1016/j.bbabio.2004.08.001; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; DITULLIO GR, 1993, LIMNOL OCEANOGR, V38, P495, DOI 10.4319/lo.1993.38.3.0495; GREENE RM, 1994, LIMNOL OCEANOGR, V39, P1061, DOI 10.4319/lo.1994.39.5.1061; Gustafsson JP, 2009, VISUAL MINTEQ VER 2; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Hopkinson BM, 2007, LIMNOL OCEANOGR, V52, P2540, DOI 10.4319/lo.2007.52.6.2540; Ihalainen JA, 2005, BIOCHEMISTRY-US, V44, P10846, DOI 10.1021/bi0510680; Ivanov AG, 2000, FEBS LETT, V485, P173, DOI 10.1016/S0014-5793(00)02211-0; Jeanjean R, 2003, FEBS LETT, V549, P52, DOI 10.1016/S0014-5793(03)00769-5; Kojima K, 2006, PHYSIOL PLANTARUM, V128, P507, DOI 10.1111/j.1399-3054.2006.00781.x; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; KOLBER ZS, 1994, NATURE, V371, P145, DOI 10.1038/371145a0; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larbi A, 2004, PHOTOSYNTH RES, V79, P59, DOI 10.1023/B:PRES.0000011919.35309.5e; LaRoche J, 1996, NATURE, V382, P802; Le Bouteiller A, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000914; Lopez-Gomollon S, 2007, J MOL BIOL, V374, P267, DOI 10.1016/j.jmb.2007.09.010; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; Olson RJ, 2000, DEEP-SEA RES PT II, V47, P3181, DOI 10.1016/S0967-0645(00)00064-3; OQUIST G, 1974, PHYSIOL PLANTARUM, V31, P55, DOI 10.1111/j.1399-3054.1974.tb03677.x; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; SANDMANN G, 1985, PHOTOSYNTH RES, V6, P261, DOI 10.1007/BF00049282; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Singh AK, 2006, FEMS MICROBIOL LETT, V256, P159, DOI 10.1111/j.1574-6968.2006.00114.x; Singh AK, 2005, PHOTOSYNTH RES, V84, P65, DOI 10.1007/s11120-004-6429-x; Skolnick S, 2007, BBA-BIOENERGETICS, V1767, P814, DOI 10.1016/j.bbabio.2006.11.015; Varsano T, 2006, J BIOL CHEM, V281, P10305, DOI 10.1074/jbc.M511057200; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963; Vavilin DV, 1999, BIOCHEMISTRY-US, V38, P14690, DOI 10.1021/bi9915622; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l; YU JJ, 1993, J BIOL CHEM, V268, P7407	53	55	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18753	10.1371/journal.pone.0018753	http://dx.doi.org/10.1371/journal.pone.0018753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533084	Green Published, Green Submitted, gold			2022-12-25	WOS:000289719400023
J	Rodrigues, AJ; Neves-Carvalho, A; Teixeira-Castro, A; Rokka, A; Corthals, G; Logarinho, E; Maciel, P				Rodrigues, Ana Joao; Neves-Carvalho, Andreia; Teixeira-Castro, Andreia; Rokka, Anne; Corthals, Garry; Logarinho, Elsa; Maciel, Patricia			Absence of Ataxin-3 Leads to Enhanced Stress Response in C. elegans	PLOS ONE			English	Article							HEAT-SHOCK-FACTOR; MACHADO-JOSEPH-DISEASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASE; PROTEIN ATAXIN-3; LONGEVITY; GENES; DAF-16	Ataxin-3, the protein involved in Machado-Joseph disease, is able to bind ubiquitylated substrates and act as a deubiquitylating enzyme in vitro, and it has been involved in the modulation of protein degradation by the ubiquitin-proteasome pathway. C. elegans and mouse ataxin-3 knockout models are viable and without any obvious phenotype in a basal condition however their phenotype in stress situations has never been described. Considering the role of ataxin-3 in the protein degradation pathway, we analyzed the effects of heat shock, a known protein homeostasis stressor, in C. elegans ataxin-3 (ATX-3) knockout animals. We found that ATX-3 mutants have an exacerbated stress response and survive significantly better than wild type animals when subjected to a noxious heat shock stimulus. This increased thermotolerance of mutants was further enhanced by pre-exposure to a mild heat shock. At a molecular level, ATX-3 mutants have a distinct transcriptomic and proteomic profile with several molecular chaperones abnormally up-regulated during heat shock and recovery, consistent with the observed resistance phenotype. The improved thermotolerancein ATX-3 mutants is independent of heat shock factor 1, the maestro of the heat shock response, but fully dependent on DAF-16, a critical stress responsive transcription factor involved in longevity and stress resistance. We also show that the increased thermotolerance of ATX-3 mutants is mainly due to HSP-16.2, C12C8.1 and F44E5.5 given that the knockdown of these heat shock proteins using RNA interference causes the phenotype to revert. This report suggests that the absence of ATX-3 activates the DAF-16 pathway leading to an overexpression of molecular chaperones, which yields knockout animals with an improved capacity for dealing with deleterious stimuli.	[Rodrigues, Ana Joao; Neves-Carvalho, Andreia; Teixeira-Castro, Andreia; Logarinho, Elsa; Maciel, Patricia] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Rokka, Anne; Corthals, Garry] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Rokka, Anne; Corthals, Garry] Abo Akad Univ, Turku, Finland; [Logarinho, Elsa] Inst Biol Mol & Celular IBMC, Oporto, Portugal	Universidade do Minho; University of Turku; Abo Akademi University; Universidade do Porto	Rodrigues, AJ (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.	pmaciel@ecsaude.uminho.pt	Rodrigues, Ana João/D-3782-2012; Rodrigues, Ana/GYQ-6273-2022; Teixeira-Castro, Andreia/T-5167-2018; Carvalho, Andreia/T-5406-2018; Logarinho, Elsa/I-5616-2013; Corthals, Garry/G-9417-2016; Maciel, Patrícia/B-5989-2009; Maciel, Patricia/AAH-2102-2020	Rodrigues, Ana João/0000-0003-1968-7968; Teixeira-Castro, Andreia/0000-0003-4999-5996; Carvalho, Andreia/0000-0002-5710-0040; Logarinho, Elsa/0000-0002-8741-0744; Corthals, Garry/0000-0001-9423-5596; Maciel, Patrícia/0000-0002-0920-6350; Maciel, Patricia/0000-0002-0920-6350; Rokka, Anne/0000-0003-1482-9154	Fundacao Ciencia e Tecnologia (FCT) [POCI/SAU-MMO/60412/2004, PTDC/SAU-GMG/101572/2008]; Fundação para a Ciência e a Tecnologia [POCI/SAU-MMO/60412/2004, PTDC/SAU-GMG/101572/2008] Funding Source: FCT	Fundacao Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao Ciencia e Tecnologia (FCT) with project "POCI/SAU-MMO/60412/2004" and "PTDC/SAU-GMG/101572/2008". AJR and ATC received post-doctoral and PhD scholarships from FCT, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Cypser J, 2001, HUM EXP TOXICOL, V20, P295, DOI 10.1191/096032701701548070; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Fonte V, 2008, J BIOL CHEM, V283, P784, DOI 10.1074/jbc.M703339200; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; HESCHL MFP, 1989, DNA-J MOLEC CELL BIO, V8, P233, DOI 10.1089/dna.1.1989.8.233; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; KUHLBRODT K, 2011, NAT CELL BIOL; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee W, 2006, PROTEOMICS, V6, P1329, DOI 10.1002/pmic.200500320; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; REINA CP, 2009, HUM MOL GENET; Rodrigues AJ, 2007, FASEB J, V21, P1126, DOI 10.1096/fj.06-7002com; Rodrigues AJ, 2009, BIOCHEM BIOPH RES CO, V386, P575, DOI 10.1016/j.bbrc.2009.06.092; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scheibel T, 2006, HANDB EXP PHARM, V172, P199; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SNUTCH TP, 1988, GENE, V64, P241, DOI 10.1016/0378-1119(88)90339-3; Stirling PC, 2003, EMBO REP, V4, P565, DOI 10.1038/sj.embor.embor869; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Walker GA, 2001, J GERONTOL A-BIOL, V56, pB281, DOI 10.1093/gerona/56.7.B281; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	48	19	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18512	10.1371/journal.pone.0018512	http://dx.doi.org/10.1371/journal.pone.0018512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526185	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100006
J	Koole, O; Thai, S; Khun, KE; Pe, R; van Griensven, J; Apers, L; Van den Ende, J; Mao, TE; Lynen, L				Koole, Olivier; Thai, Sopheak; Khun, Kim Eam; Pe, Reaksmey; van Griensven, Johan; Apers, Ludwig; Van den Ende, Jef; Mao, Tan Eang; Lynen, Lutgarde			Evaluation of the 2007 WHO Guideline to Improve the Diagnosis of Tuberculosis in Ambulatory HIV-Positive Adults	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; RESOURCE-LIMITED SETTINGS; INFECTED PERSONS; AFRICA; PEOPLE; DEATH; CAMBODIA; RATES	Background: In 2007 WHO issued a guideline to improve the diagnosis of smear-negative and extrapulmonary tuberculosis (EPTB) in HIV-positive patients. This guideline relies heavily on the acceptance of HIV-testing and availability of chest X-rays. Methods and Findings: Cohort study of TB suspects in four tuberculosis (TB) clinics in Phnom Penh, Cambodia. We assessed the operational performance of the guideline, the incremental yield of investigations, and the diagnostic accuracy for smear-negative tuberculosis in HIV-positive patients using culture positivity as reference standard. 1,147 (68.9%) of 1,665 TB suspects presented with unknown HIV status, 1,124 (98.0%) agreed to be tested, 79 (7.0%) were HIV-positive. Compliance with the guideline for chest X-rays and sputum culture requests was 97.1% and 98.3% respectively. Only 35 of 79 HIV-positive patients (44.3%) with a chest X-ray suggestive of TB started TB treatment within 10 days. 105 of 442 HIV-positive TB suspects started TB treatment (56.2% smear-negative pulmonary TB (PTB), 28.6% smear-positive PTB, 15.2% EPTB). The median time to TB treatment initiation was 5 days (IQR: 2-13 days), ranging from 2 days (IQR: 1-11.5 days) for EPTB, over 2.5 days (IQR: 1-4 days) for smear-positive PTB to 9 days (IQR: 3-17 days) for smear-negative PTB. Among the 34 smear-negative TB patients with a confirmed diagnosis, the incremental yield of chest X-ray, clinical suspicion or abdominal ultrasound, and culture was 41.2%, 17.6% and 41.2% respectively. The sensitivity and specificity of the algorithm to diagnose smear-negative TB in HIV-positive TB suspects was 58.8% (95% CI: 42.2%-73.6%) and 79.4% (95% CI: 74.8%-82.4%) respectively. Conclusions: Pending point-of-care rapid diagnostic tests for TB disease, diagnostic algorithms are needed. The diagnostic accuracy of the 2007 WHO guideline to diagnose smear-negative TB is acceptable. There is, however, reluctance to comply with the guideline in terms of immediate treatment initiation.	[Koole, Olivier; van Griensven, Johan; Apers, Ludwig; Van den Ende, Jef; Lynen, Lutgarde] Inst Trop Med, B-2000 Antwerp, Belgium; [Thai, Sopheak; Pe, Reaksmey] Sihanouk Hosp Ctr HOPE SHCH, Phnom Penh, Cambodia; [Khun, Kim Eam; Mao, Tan Eang] Natl Ctr TB & Leprosy Control CENAT, Phnom Penh, Cambodia	Institute of Tropical Medicine (ITM)	Koole, O (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	okoole@itg.be	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; Koole, Olivier/0000-0002-1122-5382	WHO [T9-181-298]; Belgian Development cooperation (DGDC); Institute of Tropical Medicine in Antwerp [920800]; Belgian National Association against Tuberculosis (BNBTTB)	WHO(World Health Organization); Belgian Development cooperation (DGDC); Institute of Tropical Medicine in Antwerp; Belgian National Association against Tuberculosis (BNBTTB)	The study was funded by WHO (WHO registry file number T9-181-298), with additional funding from the Belgian Development cooperation (DGDC) through a framework agreement with the Institute of Tropical Medicine in Antwerp (institutional strengthening project 920800) and the Belgian National Association against Tuberculosis (BNBTTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Banda H, 2000, INT J TUBERC LUNG D, V4, P968; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cain KR, 2007, INT J TUBERC LUNG D, V11, P1008; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Deribew A, 2010, INT J TUBERC LUNG D, V14, P1442; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; GREENBERG AE, 1995, AIDS, V9, P1251, DOI 10.1097/00002030-199511000-00006; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Johnson JL, 1998, INT J TUBERC LUNG D, V2, P397; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LUCAS SB, 1994, BRIT MED J, V308, P1531, DOI 10.1136/bmj.308.6943.1531; *MIN HLTH CAMB, 2008, TUB REP; MONKONGDEE P, 2009, AM J RESP CRIT CARE; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; National AIDS Authority, 2008, UNGASS COUNTR PROGR; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Post FA, 1995, TUBERCLE LUNG DIS, V76, P518, DOI 10.1016/0962-8479(95)90527-8; Ralph AP, 2009, CLIN INFECT DIS, V49, P574, DOI 10.1086/600889; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Sculier D, 2010, JAIDS-J ACQ IMM DEF, V55, P500, DOI 10.1097/QAI.0b013e3181e6a703; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; TRINH TT, 2007, PLOS ONE, V2, pE507; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, 2009, STRAT TECHN ADV GROU; WHO, 2007, IMPR DIAGN TREATM SM; WHO, 2009, GLOB TUB CONTR 2009; Wilson D, 2006, INT J TUBERC LUNG D, V10, P31; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2	39	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18502	10.1371/journal.pone.0018502	http://dx.doi.org/10.1371/journal.pone.0018502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494694	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000289192400032
J	Shulman, M; Cohen, M; Soto-Gutierrez, A; Yagi, H; Wang, HY; Goldwasser, J; Lee-Parsons, CW; Benny-Ratsaby, O; Yarmush, ML; Nahmias, Y				Shulman, Maria; Cohen, Merav; Soto-Gutierrez, Alejandro; Yagi, Hiroshi; Wang, Hongyun; Goldwasser, Jonathan; Lee-Parsons, Carolyn W.; Benny-Ratsaby, Ofra; Yarmush, Martin L.; Nahmias, Yaakov			Enhancement of Naringenin Bioavailability by Complexation with Hydroxypropoyl-beta-Cyclodextrin	PLOS ONE			English	Article							CITRUS FLAVONOID NARINGENIN; ORAL BIOAVAILABILITY; GRAPEFRUIT JUICE; INSULIN-RECEPTOR; B SECRETION; APO-B; HESPERETIN; INHIBITION; EXPRESSION; PHARMACOKINETICS	The abundant flavonoid aglycone, naringenin, which is responsible for the bitter taste in grapefruits, has been shown to possess hypolipidemic and anti-inflammatory effects both in vitro and in vivo. Recently, our group demonstrated that naringenin inhibits hepatitis C virus (HCV) production, while others demonstrated its potential in the treatment of hyperlipidemia and diabetes. However, naringenin suffers from low oral bioavailability critically limiting its clinical potential. In this study, we demonstrate that the solubility of naringenin is enhanced by complexation with beta-cyclodextrin, an FDA approved excipient. Hydroxypropoyl-beta-cyclodextrin (HP beta CD), specifically, increased the solubility of naringenin by over 400-fold, and its transport across a Caco-2 model of the gut epithelium by 11-fold. Complexation of naringenin with HP beta CD increased its plasma concentrations when fed to rats, with AUC values increasing by 7.4-fold and C-max increasing 14.6-fold. Moreover, when the complex was administered just prior to a meal it decreased VLDL levels by 42% and increased the rate of glucose clearance by 64% compared to naringenin alone. These effects correlated with increased expression of the PPAR co-activator, PGC1 alpha in both liver and skeletal muscle. Histology and blood chemistry analysis indicated this route of administration was not associated with damage to the intestine, kidney, or liver. These results suggest that the complexation of naringenin with HP beta CD is a viable option for the oral delivery of naringenin as a therapeutic entity with applications in the treatment of dyslipidemia, diabetes, and HCV infection.	[Shulman, Maria; Cohen, Merav; Nahmias, Yaakov] Hebrew Univ Jerusalem, Inst Life Sci, Sch Comp Sci & Engn, Ctr Bioengn, IL-91904 Jerusalem, Israel; [Soto-Gutierrez, Alejandro; Yagi, Hiroshi; Wang, Hongyun; Goldwasser, Jonathan; Yarmush, Martin L.; Nahmias, Yaakov] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med, Boston, MA USA; [Goldwasser, Jonathan] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Benny-Ratsaby, Ofra] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Lee-Parsons, Carolyn W.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Hebrew University of Jerusalem; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard Medical School; Northeastern University; Rutgers State University New Brunswick	Shulman, M (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Sch Comp Sci & Engn, Ctr Bioengn, IL-91904 Jerusalem, Israel.	ynahmias@cs.huji.ac.il	Nahmias, Yaakov/H-4725-2013; Nahmias, Yaakov/AAM-3872-2020	Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Yarmush, Martin/0000-0003-4986-8444	National Institute of Diabetes and Digestive and Kidney Diseases [K01DK080241]; Harvard Clinical Nutrition Research Center [P30-DK040561]; European Research Council [TMIHCV 242699]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080241, P30DK040561] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Clinical Nutrition Research Center; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K01DK080241) and the Harvard Clinical Nutrition Research Center (P30-DK040561). Resources were provided by European Research Council Starting Grant (TMIHCV 242699), the BioMEMS Resource Center (P41 EB-002503), and the Alexander Silberman Institute of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allister EM, 2005, DIABETES, V54, P1676, DOI 10.2337/diabetes.54.6.1676; Allister EM, 2008, J LIPID RES, V49, P2218, DOI 10.1194/jlr.M800297-JLR200; Borradaile NM, 2003, DIABETES, V52, P2554, DOI 10.2337/diabetes.52.10.2554; Carrier RL, 2007, J CONTROL RELEASE, V123, P78, DOI 10.1016/j.jconrel.2007.07.018; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; Choudhury R, 1999, BIOCHEM BIOPH RES CO, V265, P410, DOI 10.1006/bbrc.1999.1695; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Erlund I, 2001, J NUTR, V131, P235, DOI 10.1093/jn/131.2.235; FUHR U, 1995, CLIN PHARMACOL THER, V58, P365, DOI 10.1016/0009-9236(95)90048-9; GAO J, 2000, CURRENT PROTOCOLS PH; Goldwasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012399; Huong DTT, 2006, NUTRITION, V22, P546, DOI 10.1016/j.nut.2005.11.006; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Jeon SM, 2007, TRANSL RES, V149, P15, DOI 10.1016/j.trsl.2006.08.001; Jung UJ, 2003, CLIN NUTR, V22, P561, DOI 10.1016/S0261-5614(03)00059-1; Kanaze FI, 2007, EUR J CLIN NUTR, V61, P472, DOI 10.1038/sj.ejcn.1602543; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kurowska EM, 2000, NUTR RES, V20, P121, DOI 10.1016/S0271-5317(99)00144-X; Liu L, 2008, PHYTOTHER RES, V22, P1400, DOI 10.1002/ptr.2504; Miyake K, 2000, PHARM DEV TECHNOL, V5, P399, DOI 10.1081/PDT-100100556; Mulvihill EE, 2009, DIABETES, V58, P2198, DOI 10.2337/db09-0634; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; Renugadevi J, 2009, TOXICOLOGY, V256, P128, DOI 10.1016/j.tox.2008.11.012; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; Stella VJ, 1997, PHARMACEUT RES, V14, P556, DOI 10.1023/A:1012136608249; Tommasini S, 2004, J PHARMACEUT BIOMED, V35, P379, DOI 10.1016/S0731-7085(03)00647-2; Wilcox LJ, 2001, J LIPID RES, V42, P725; Wilcox LJ, 1999, CARDIOVASC DRUG REV, V17, P160, DOI 10.1111/j.1527-3466.1999.tb00011.x; Yanez JA, 2008, BIOPHARM DRUG DISPOS, V29, P63, DOI 10.1002/bdd.588	31	114	123	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18033	10.1371/journal.pone.0018033	http://dx.doi.org/10.1371/journal.pone.0018033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494673	Green Submitted, gold, Green Published			2022-12-25	WOS:000289192400007
J	Watts, SM; Dodson, CD; Reichman, OJ				Watts, Sean M.; Dodson, Craig D.; Reichman, O. J.			The Roots of Defense: Plant Resistance and Tolerance to Belowground Herbivory	PLOS ONE			English	Article							POCKET GOPHER; EVOLUTION; RESPONSES; COSTS; STRATEGIES; PSEUDOREPLICATION; AVAILABILITY; DISTURBANCE; SELECTION; REGROWTH	Background: There is conclusive evidence that there are fitness costs of plant defense and that herbivores can drive selection for defense. However, most work has focused on above-ground interactions, even though belowground herbivory may have greater impacts on individual plants than above-ground herbivory. Given the role of belowground plant structures in resource acquisition and storage, research on belowground herbivores has much to contribute to theories on the evolution of plant defense. Pocket gophers (Geomyidae) provide an excellent opportunity to study root herbivory. These subterranean rodents spend their entire lives belowground and specialize on consuming belowground plant parts. Methodology and Principal Findings: We compared the root defenses of native forbs from mainland populations (with a history of gopher herbivory) to island populations (free from gophers for up to 500,000 years). Defense includes both resistance against herbivores and tolerance of herbivore damage. We used three approaches to compare these traits in island and mainland populations of two native California forbs: 1) Eschscholzia californica populations were assayed to compare alkaloid deterrents, 2) captive gophers were used to test the palatability of E. californica roots and 3) simulated root herbivory assessed tolerance to root damage in Deinandra fasciculata and E. californica. Mainland forms of E. californica contained 2.5 times greater concentration of alkaloids and were less palatable to gophers than island forms. Mainland forms of D. fasciculata and, to a lesser extent, E. californica were also more tolerant of root damage than island conspecifics. Interestingly, undamaged island individuals of D. fasciculata produced significantly more fruit than either damaged or undamaged mainland individuals. Conclusions and Significance: These results suggest that mainland plants are effective at deterring and tolerating pocket gopher herbivory. Results also suggest that both forms of defense are costly to fitness and thus reduced in the absence of the putative target herbivore.	[Watts, Sean M.] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Dodson, Craig D.] Mesa State Coll, Dept Phys & Environm Sci, Grand Junction, CO USA; [Reichman, O. J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	Santa Clara University; University of California System; University of California Santa Barbara	Watts, SM (corresponding author), Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA.	SWatts@scu.edu			University of California Natural Reserve System; Mellon Foundation; NSF [DEB 98-06377, DEB 02-35624]	University of California Natural Reserve System; Mellon Foundation; NSF(National Science Foundation (NSF))	This research was supported by a Mildred E. Mathias Graduate Student Research Grant from the University of California Natural Reserve System, Sigma Xi Grants-in-Aid-of-Research Award, The Mellon Foundation, and NSF (DEB 98-06377 & DEB 02-35624 to Reichman and Seabloom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Alm U, 2002, ANIM BEHAV, V64, P439, DOI 10.1006/anbe.2002.3057; ANDERSEN DC, 1981, ECOL MONOGR, V51, P179, DOI 10.2307/2937262; ANDERSEN DC, 1987, Q REV BIOL, V62, P261, DOI 10.1086/415512; BANDOLI JH, 1981, J MAMMAL, V62, P293, DOI 10.2307/1380706; BEHREND A F, 1988, Prairie Naturalist, V20, P99; BERLANDSON JM, 1984, AM ANTIQUITIES, V49, P785; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Bowen L, 1997, CONSERV BIOL, V11, P1249, DOI 10.1046/j.1523-1739.1997.96368.x; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Carlquist S, 1965, ISLAND LIFE NATURAL; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Darwin C., 1872, ORIGIN SPECIES MEANS, V144, P971; DOAK DF, 1992, ECOLOGY, V73, P2086, DOI 10.2307/1941457; Dudley JP, 1999, CONSERV BIOL, V13, P209, DOI 10.1046/j.1523-1739.1999.98008.x; Dyer LA, 2004, ECOLOGY, V85, P2795, DOI 10.1890/03-0233; Fabre T, 2000, J CHROMATOGR A, V904, P35, DOI 10.1016/S0021-9673(00)00919-5; Feeny P., 1976, BIOCH INTERACTION PL, P1, DOI [DOI 10.1007/978-1-4684-2646-5_1, 10.1007/978-1-4684-2646-5_1]; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gabet EJ, 2003, ANNU REV EARTH PL SC, V31, P249, DOI 10.1146/annurev.earth.31.100901.141314; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; HARGROVE WW, 1992, LANDSCAPE ECOL, V6, P251, DOI 10.1007/BF00129703; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HOBBS RJ, 1991, ECOLOGY, V72, P59, DOI 10.2307/1938902; Hochwender CG, 2000, OECOLOGIA, V122, P361, DOI 10.1007/s004420050042; HOOVEN EF, 1971, J WILDLIFE MANAGE, V35, P346, DOI 10.2307/3799611; HUNTLY N, 1994, J MAMMAL, V75, P852, DOI 10.2307/1382467; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; JANZEN D H, 1973, Biotropica, V5, P15, DOI 10.2307/2989677; JENKINS SH, 1989, J MAMMAL, V70, P406, DOI 10.2307/1381529; JONES CG, 1991, PHILOS T R SOC B, V333, P273, DOI 10.1098/rstb.1991.0077; JUNAK S, 1995, FLORA S CRUZ ISLAND; KARBAN R, 1993, ECOLOGY, V74, P39, DOI 10.2307/1939499; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Lidicker W. Z. Jr., 1989, Grassland structure and function: California annual grassland., P135; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; Major J., 1977, TERRESTRIAL VEGETATI; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, ECOLOGY, V78, P1301, DOI 10.1890/0012-9658(1997)078[1301:VITDSO]2.0.CO;2; MOONEY HA, 1960, AM J BOT, V47, P594, DOI 10.2307/2439439; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Pilson D, 2000, EVOL ECOL, V14, P457, DOI 10.1023/A:1010953714344; REICHMAN OJ, 1988, AM MIDL NAT, V120, P58, DOI 10.2307/2425887; REICHMAN OJ, 1985, J MAMMAL, V66, P720, DOI 10.2307/1380798; REICHMAN OJ, 1991, ECOLOGY, V72, P116, DOI 10.2307/1938907; Reichman OJ, 2002, TRENDS ECOL EVOL, V17, P44, DOI 10.1016/S0169-5347(01)02329-1; REICHMAN OJ, 1982, ECOLOGY, V63, P687, DOI 10.2307/1936789; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; RICKSON FR, 1977, AM J BOT, V64, P585, DOI 10.2307/2442007; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; SIMMS EL, 1989, EVOLUTION, V43, P573, DOI 10.1111/j.1558-5646.1989.tb04253.x; SIMMS EL, 1994, EVOLUTION, V48, P1973, DOI 10.1111/j.1558-5646.1994.tb02227.x; STOCK C, 1946, RANCHO BREA RECORD P; Stowe KA, 1998, EVOLUTION, V52, P703, DOI [10.2307/2411265, 10.1111/j.1558-5646.1998.tb03695.x]; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Stromberg MR, 1996, ECOL APPL, V6, P1189, DOI 10.2307/2269601; Tiffin P, 2000, AM NAT, V155, P128, DOI 10.1086/303301; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; Van Der Meijden E, 2000, EVOL ECOL, V14, P439, DOI 10.1023/A:1010985028360; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; VLECK D, 1981, OECOLOGIA, V49, P391, DOI 10.1007/BF00347605; Vourc'h G, 2001, OECOLOGIA, V126, P84, DOI 10.1007/s004420000491; Wallace A. R., 1880; WILLIAMS LR, 1986, J MAMMAL, V67, P489, DOI 10.2307/1381280	68	14	15	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18463	10.1371/journal.pone.0018463	http://dx.doi.org/10.1371/journal.pone.0018463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494690	Green Published, Green Submitted, gold			2022-12-25	WOS:000289192400030
J	Gill, RK; Yang, SH; Meerzaman, D; Mechanic, LE; Bowman, ED; Jeon, HS; Chowdhuri, SR; Shakoori, A; Dracheva, T; Hong, KM; Fukuoka, J; Zhang, JH; Harris, CC; Jen, J				Gill, R. K.; Yang, S-H; Meerzaman, D.; Mechanic, L. E.; Bowman, E. D.; Jeon, H-S; Chowdhuri, S. Roy; Shakoori, A.; Dracheva, T.; Hong, K-M; Fukuoka, J.; Zhang, J-H; Harris, C. C.; Jen, J.			Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer	ONCOGENE			English	Article						LKB1 gene; LOH; homozygous deletion; mutation; CISH; primary lung cancer	PEUTZ-JEGHERS-SYNDROME; TUMOR-SUPPRESSOR GENE; SOMATIC MUTATIONS; GLUCOSE-HOMEOSTASIS; LKB1; KINASE; PATHWAYS; KNOCKOUT; PTEN; ADENOCARCINOMA	LKB1/STK11 is a tumor suppressor and a negative regulator of mammalian target of rapamycin signaling. It is inactivated in 30% of lung cancer cell lines but only 5-15% of primary lung adenocarcinomas. There is evidence that homozygous deletion (HD) of chromosome 19p at the LKB locus contributes to the inactivation of the gene in primary human lung cancers. Here, we used several complementary genetic approaches to assess the LKB1 locus in primary non-small cell lung cancers (NSCLCs). We first analyzed 124 NSCLC cases for allelic imbalance using eight microsatellite markers on chromosome 19p, which revealed an overall rate of 65% (80 of 124) loss of heterozygosity (LOH). We next used chromogenic in situ hybridization (CISH) to directly examine the chromosomal status of the LKB1 locus. In all, 65 of 124 LOH tested samples were available for CISH and 58 of those (89%) showed either loss of one copy of chromosome 19p (LOH, 40 of 65 cases, 62%) or both copies (HD 18 of 65 cases, 28%). The occurrence of HD was significantly more frequent in Caucasian (35%) than in African-American patients (6%) (P = 0.04). A total of 62 of 124 samples with LOH at one or both markers immediately flanking the LKB1 gene were further analyzed by directly sequencing the complete coding region, which identified 7 of 62 (11%) tumors with somatic mutations in the gene. Jointly, our data identified total inactivation of the LKB1 gene by either HD or LOH with somatic mutation in 39% of tested samples, whereas loss of chromosome 19p region by HD or LOH at the LKB1 region occured in 90% of NSCLC. Oncogene (2011) 30, 3784-3791; doi:10.1038/onc.2011.98; published online 2 May 2011	[Jen, J.] Mayo Clin Fdn, Div Pulm & Crit Care Med & Microarray Shared Reso, Rochester, MN USA; [Gill, R. K.; Yang, S-H; Mechanic, L. E.; Bowman, E. D.; Jeon, H-S; Shakoori, A.; Dracheva, T.; Fukuoka, J.; Harris, C. C.] NCI, Human Carcinogenesis Lab, Bethesda, MD 20892 USA; [Meerzaman, D.; Chowdhuri, S. Roy; Hong, K-M; Zhang, J-H] NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Hong, K-M] Natl Canc Ctr, Res Inst, Goyang, South Korea	Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Cancer Center - Korea (NCC)	Jen, J (corresponding author), Mayo Clin, Div Pulm & Crit Care Med & Microarray Shared Reso, Adv Genom Technol Ctr, Stabile 13-74,200 1st St SW, Rochester, MN 55905 USA.	Jen.Jin@mayo.edu	SHAKOORI, ABDUL RAUF/Q-9373-2019; Fukuoka, Junya/AAT-2924-2021	Fukuoka, Junya/0000-0002-2496-3050; shakoori, abbas/0000-0002-4363-1967; Roy-Chowdhuri, Sinchita/0000-0002-9447-7701	Center for Cancer Research at CCR; Mayo Cancer Center; Center for Individualized Medicine, Rochester, MN; NATIONAL CANCER INSTITUTE [P30CA015083, Z01CP010164, ZIABC010874] Funding Source: NIH RePORTER	Center for Cancer Research at CCR; Mayo Cancer Center; Center for Individualized Medicine, Rochester, MN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank John Cottrell, Ray Jones, Audrey Salabes and Mike Lipsky at University of Maryland Medical Center for tissue collection and clinical information. We thank the members of Dr. Thomas Reid's lab for technical support during the course of this study. We thank Ms Stacy Johnson for editorial and graphical/technical assistance. The current addresses are RKG, Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, Bethesda, MD 20892-4258; SHY, Wonkwang University Hospital, Department of Pulmonary and Critical Care Medicine, Iksan, South Korea; HSJ, Laboratory of Biochemistry and Cell Biology, Kyungpook National University, School of Medicine, Deagu, South Korea; SRC, Laboratory of Pathology, National Cancer Institute, Bethesda, MD; AS, Department of Medical Genetics, Tehran University of Medical Sciences, Cancer Institute Hospital, Tehran, Iran; TVD, J. Craig Venter Institute, Rockville, MD; KMH, National Cancer Center, Cancer Cell and Molecular Biology Branch, Goyang, Korea; JF, Toyama University Hospital, Department of Surgical Pathology, Toyama, Japan; and JHZ, St. Jude Children's Research Hospital, Biotechnology, Memphis, TN. This work was supported by intramural research funds from the Center for Cancer Research at CCR and funds for JJ from the Mayo Cancer Center and Center for Individualized Medicine, Rochester, MN.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Avizienyte E, 1998, CANCER RES, V58, P2087; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Bignell GR, 1998, CANCER RES, V58, P1384; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Conde E, 2007, HUM PATHOL, V38, P1351, DOI 10.1016/j.humpath.2007.01.022; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Gill RK, 2008, CLIN CANCER RES, V14, P7481, DOI 10.1158/1078-0432.CCR-07-5242; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Guldberg P, 1999, ONCOGENE, V18, P1777, DOI 10.1038/sj.onc.1202486; Gurumurthy S, 2008, CANCER RES, V68, P55, DOI 10.1158/0008-5472.CAN-07-3225; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Launonen V, 2005, HUM MUTAT, V26, P291, DOI 10.1002/humu.20222; LEVIN NA, 1995, GENE CHROMOSOME CANC, V13, P175, DOI 10.1002/gcc.2870130307; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lim W, 2003, BRIT J CANCER, V89, P308, DOI 10.1038/sj.bjc.6601030; LUKEIS R, 1990, GENE CHROMOSOME CANC, V2, P116, DOI 10.1002/gcc.2870020207; Luukko K, 1999, MECH DEVELOP, V83, P187, DOI 10.1016/S0925-4773(99)00050-7; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Mechanic LE, 2005, CARCINOGENESIS, V26, P597, DOI 10.1093/carcin/bgh344; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Rowan A, 1999, J INVEST DERMATOL, V112, P509, DOI 10.1046/j.1523-1747.1999.00551.x; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sanchez-Cespedes M, 2001, CANCER RES, V61, P1309; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Virmani AK, 1998, GENE CHROMOSOME CANC, V21, P308, DOI 10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2; Wang ZJ, 1998, AM J PATHOL, V153, P363, DOI 10.1016/S0002-9440(10)65579-4; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhong DS, 2006, LUNG CANCER, V53, P285, DOI 10.1016/j.lungcan.2006.05.018	44	80	85	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	35					3784	3791		10.1038/onc.2011.98	http://dx.doi.org/10.1038/onc.2011.98			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	814TZ	21532627	Green Accepted			2022-12-25	WOS:000294481400005
J	Brown, MJ; Thoren, KL; Krantz, BA				Brown, Michael J.; Thoren, Katie L.; Krantz, Bryan A.			Charge Requirements for Proton Gradient-driven Translocation of Anthrax Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTIVE ANTIGEN; PROTEIN TRANSLOCATION; LETHAL FACTOR; PRECURSOR PROTEINS; CRYSTAL-STRUCTURE; PORE FORMATION; EDEMA FACTORS; ATP SYNTHASE; MITOCHONDRIAL; MECHANISM	Anthrax lethal toxin is used as a model system to study protein translocation. The toxin is composed of a translocase channel, called protective antigen (PA), and an enzyme, called lethal factor (LF). A proton gradient (Delta pH) can drive LF unfolding and translocation through PA channels; however, the mechanism of Delta pH-mediated force generation, substrate unfolding, and establishment of directionality are poorly understood. One recent hypothesis suggests that the Delta pH may act through changes in the protonation state of residues in the substrate. Here we report the charge requirements of LF's amino-terminal binding domain (LFN) using planar lipid bilayer electrophysiology. We found that acidic residues are required in LFN to utilize a proton gradient for translocation. Constructs lacking negative charges in the unstructured presequence of LFN translocate independently of the Delta pH driving force. Acidic residues markedly increase the rate of Delta pH-driven translocation, and the presequence is optimized in its natural acidic residue content for efficient Delta pH-driven unfolding and translocation. We discuss a Delta pH-driven charge state Brownian ratchet mechanism for translocation, where glutamic and aspartic acid residues in the substrate are the "molecular teeth" of the ratchet. Our Brownian ratchet model includes a mechanism for unfolding and a novel role for positive charges, which we propose chaperone negative charges through the PA channel during Delta pH translocation.	[Brown, Michael J.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Thoren, Katie L.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Krantz, Bryan A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krantz, BA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 476 Stanley Hall,3220, Berkeley, CA 94720 USA.	bakrantz@berkeley.edu		Krantz, Bryan/0000-0002-4911-5824	National Institutes of Health [R01-AI077703]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI077703.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ASTUMIAN RD, 1994, PHYS REV LETT, V72, P1766, DOI 10.1103/PhysRevLett.72.1766; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Feynman R., 1963, FEYNMAN LECT PHYS, V1; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; GLICK BS, 1993, PROTEIN SCI, V2, P1901, DOI 10.1002/pro.5560021112; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; Gregorini M, 2007, J STRUCT BIOL, V158, P445, DOI 10.1016/j.jsb.2007.01.002; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; Huang SH, 2002, NAT STRUCT BIOL, V9, P301, DOI 10.1038/nsb772; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oster G, 1999, STRUCTURE, V7, pR67, DOI 10.1016/S0969-2126(99)80046-X; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Pentelute BL, 2010, ACS CHEM BIOL, V5, P359, DOI 10.1021/cb100003r; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Shariff K, 2004, BIOPHYS J, V86, P3647, DOI 10.1529/biophysj.104.040865; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; STUART RA, 1994, TRENDS BIOCHEM SCI, V19, P87, DOI 10.1016/0968-0004(94)90041-8; Thoren KL, 2011, MOL MICROBIOL, V80, P588, DOI 10.1111/j.1365-2958.2011.07614.x; Thoren KL, 2009, P NATL ACAD SCI USA, V106, P21555, DOI 10.1073/pnas.0905880106; Voos W, 1999, BBA-REV BIOMEMBRANES, V1422, P235, DOI 10.1016/S0304-4157(99)00007-6; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Yamano K, 2008, J BIOL CHEM, V283, P27325, DOI 10.1074/jbc.M805249200; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864	53	29	29	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23189	23199		10.1074/jbc.M111.231167	http://dx.doi.org/10.1074/jbc.M111.231167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21507946	hybrid, Green Published			2022-12-25	WOS:000292025000053
J	Roche, CJ; Malashkevich, V; Balazs, TC; Dantsker, D; Chen, Q; Moreira, J; Almo, SC; Friedman, JM; Hirsch, RE				Roche, Camille J.; Malashkevich, Vladimir; Balazs, Tatiana C.; Dantsker, David; Chen, Qiuying; Moreira, Juan; Almo, Steven C.; Friedman, Joel M.; Hirsch, Rhoda Elison			Structural and Functional Studies Indicating Altered Redox Properties of Hemoglobin E IMPLICATIONS FOR PRODUCTION OF BIOACTIVE NITRIC OXIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-BETA-THALASSEMIA; PULMONARY-HYPERTENSION; REDUCTASE-ACTIVITY; BLOOD-CELLS; HEME REDOX; OXYGEN-AFFINITY; REACTIVITY; DEOXYHEMOGLOBIN; HEMOLYSIS; IRON	Hemoglobin (Hb) E (beta-Glu26Lys) remains an enigma in terms of its contributions to red blood cell (RBC) pathophysiological mechanisms; for example, EE individuals exhibit a mild chronic anemia, and HbE/beta-thalassemia individuals show a range of clinical manifestations, including high morbidity and death, often resulting from cardiac dysfunction. The purpose of this study was to determine and evaluate structural and functional consequences of the HbE mutation that might account for the pathophysiology. Functional studies indicate minimal allosteric consequence to both oxygen and carbon monoxide binding properties of the ferrous derivatives of HbE. In contrast, redox-sensitive reactions are clearly impacted as seen in the following: 1) the similar to 2.5 times decrease in the rate at which HbE catalyzes nitrite reduction to nitric oxide (NO) relative to HbA, and 2) the accelerated rate of reduction of aquometHbE by L-cysteine (L-Cys). Sol-gel encapsulation studies imply a shift toward a higher redox potential for both the T and R HbE structures that can explain the origin of the reduced nitrite reductase activity of deoxyHbE and the accelerated rate of reduction of aquometHbE by cysteine. Deoxy- and CO HbE crystal structures (derived from crystals grown at or near physiological pH) show loss of hydrogen bonds in the microenvironment of beta Lys-26 and no significant tertiary conformational perturbations at the allosteric transition sites in the R and T states. Together, these data suggest a model in which the HbE mutation, as a consequence of a relative change in redox properties, decreases the overall rate of Hb-mediated production of bioactive NO.	[Friedman, Joel M.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Malashkevich, Vladimir; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Balazs, Tatiana C.; Chen, Qiuying; Hirsch, Rhoda Elison] Albert Einstein Coll Med, Dept Med, Div Hematol, Bronx, NY 10461 USA; [Hirsch, Rhoda Elison] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Friedman, JM (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	joel.friedman@einstein.yu.edu; rhoda.hirsch@einstein.yu.edu			National Institutes of Health [R21 DK064123, R21 HL106421]; American Heart Association [0755906T]; FJC, a foundation of philanthropic funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK064123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); FJC, a foundation of philanthropic funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DK064123 (to R. E. H.) and R21 HL106421 (to R. E. H. and J. M. F.). This work was also supported by American Heart Association Heritage Affiliate Grant-in-aid 0755906T (to R. E. H.) and FJC, a foundation of philanthropic funds (to J. M. F.).	Adachi K, 2003, BIOCHEMISTRY-US, V42, P10252, DOI 10.1021/bi030095s; Allen BW, 2009, TRENDS MOL MED, V15, P452, DOI 10.1016/j.molmed.2009.08.002; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN JM, 1980, J MOL BIOL, V136, P103, DOI 10.1016/0022-2836(80)90308-3; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Bonaventura C, 2002, J BIOL CHEM, V277, P14557, DOI 10.1074/jbc.M107658200; Bonaventura C, 2007, IUBMB LIFE, V59, P498, DOI 10.1080/15216540601188546; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; BUNN HF, 1972, J CLIN INVEST, V51, P2299, DOI [10.1172/JCI107040, 10.1172/JCI107125]; CABRALES P., 2007, TRANSFUS ALTERN TRAN, V9, P281; Cao ZL, 2009, AM J PHYSIOL-HEART C, V297, pH1494, DOI 10.1152/ajpheart.01233.2008; Chakraborty I, 2010, ANN ACAD MED SINGAP, V39, P13; CHAVEZ MD, 1990, BIOCHEMISTRY-US, V29, P4844, DOI 10.1021/bi00472a014; Chen QY, 2006, FEBS LETT, V580, P4485, DOI 10.1016/j.febslet.2006.07.021; Chen QY, 2004, BLOOD CELL MOL DIS, V33, P303, DOI 10.1016/j.bcmd.2004.07.006; Chiu DTY, 1996, FREE RADICAL BIO MED, V21, P89, DOI 10.1016/0891-5849(96)00035-4; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Conran N, 2009, CLIN BIOCHEM, V42, P1824, DOI 10.1016/j.clinbiochem.2009.06.024; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dantsker D, 2002, J MOL BIOL, V315, P239, DOI 10.1006/jmbi.2001.5218; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fucharoen S, 2000, J PEDIAT HEMATOL ONC, V22, P552, DOI 10.1097/00043426-200011000-00022; Fucharoeon S., 2001, DISORDERS HEMOGLOBIN; GACON G, 1974, FEBS LETT, V41, P147, DOI 10.1016/0014-5793(74)80975-0; Geraci G, 1981, Methods Enzymol, V76, P262; Giardine B, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9479; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Gow AJ, 2005, AM J RESP CELL MOL, V32, P479, DOI 10.1165/rcmb.F299; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; HIRSCH RE, 1988, J BIOL CHEM, V263, P5936; Hirsch RE, 1996, J BIOL CHEM, V271, P372, DOI 10.1074/jbc.271.1.372; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Huang J, 1999, BIOCHEMISTRY-US, V38, P4514, DOI 10.1021/bi982724h; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Jia YL, 1996, J APPL PHYSIOL, V80, P404, DOI 10.1152/jappl.1996.80.2.404; Kato GJ, 2010, BRIT J HAEMATOL, V148, P690, DOI 10.1111/j.1365-2141.2009.08004.x; Kato GJ, 2009, BRIT J HAEMATOL, V145, P506, DOI 10.1111/j.1365-2141.2009.07658.x; Kaul DK, 2008, AM J PHYSIOL-HEART C, V295, pH39, DOI 10.1152/ajpheart.00162.2008; Khan I, 2001, BIOCHEMISTRY-US, V40, P7581, DOI 10.1021/bi010051o; Khan I, 2000, BIOCHEMISTRY-US, V39, P16099, DOI 10.1021/bi000536x; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kluger R, 2010, CURR OPIN CHEM BIOL, V14, P538, DOI 10.1016/j.cbpa.2010.03.021; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kukongviriyapan V, 2008, PEDIATR CARDIOL, V29, P130, DOI 10.1007/s00246-007-9107-x; LALEZARI I, 1990, BIOCHEMISTRY-US, V29, P1515, DOI 10.1021/bi00458a024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lohr NL, 2009, J MOL CELL CARDIOL, V47, P256, DOI 10.1016/j.yjmcc.2009.03.009; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; Luchsinger BP, 2005, J INORG BIOCHEM, V99, P912, DOI 10.1016/j.jinorgbio.2004.12.010; Lui FE, 2008, BIOCHEMISTRY-US, V47, P10773, DOI 10.1021/bi801116k; MACDONALD VW, 1983, J LAB CLIN MED, V102, P762; Manconi B, 2010, BBA-GEN SUBJECTS, V1800, P327, DOI 10.1016/j.bbagen.2009.10.010; McMahon TJ, 1999, METHOD ENZYMOL, V301, P99; Morris CR, 2008, CURR MOL MED, V8, P620, DOI 10.2174/156652408786241447; Morris Claudia R, 2008, Hematology Am Soc Hematol Educ Program, P177, DOI 10.1182/asheducation-2008.1.177; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nagababu E, 2007, BIOCHEMISTRY-US, V46, P11650, DOI 10.1021/bi700364e; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Nuntakarn L, 2009, BLOOD CELL MOL DIS, V42, P32, DOI 10.1016/j.bcmd.2008.09.002; Olivieri NF, 2000, J PEDIAT HEMATOL ONC, V22, P593, DOI 10.1097/00043426-200011000-00029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perutz M. F., 1970, BIOCHEM J, V119, P31; Peterson ES, 2004, BIOCHEMISTRY-US, V43, P4832, DOI 10.1021/bi035481o; Premawardhena A, 2005, ANN NY ACAD SCI, V1054, P33, DOI 10.1196/annals.1345.005; Puddu Paolo, 2010, Can J Cardiol, V26, P140; Rees DC, 2000, J PEDIAT HEMATOL ONC, V22, P567, DOI 10.1097/00043426-200011000-00025; Rees DC, 1998, BLOOD, V92, P2141, DOI 10.1182/blood.V92.6.2141.418k05_2141_2146; Rifkind JM, 2009, ADV EXP MED BIOL, V645, P27, DOI 10.1007/978-0-387-85998-9_5; Roche CJ, 2006, J BIOL CHEM, V281, P36874, DOI 10.1074/jbc.M603914200; Roche CJ, 2010, NITRIC OXIDE-BIOL CH, V22, P180, DOI 10.1016/j.niox.2009.11.003; ROMERO FJ, 1992, J BIOL CHEM, V267, P1680; Safo MK, 2003, METH MOLEC MED, V82, P1; Salgado MT, 2009, J BIOL CHEM, V284, P12710, DOI 10.1074/jbc.M808647200; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Samuni U, 2006, BIOCHEMISTRY-US, V45, P2820, DOI 10.1021/bi050010i; Samuni U, 2004, BIOCHEMISTRY-US, V43, P13674, DOI 10.1021/bi048531d; Samuni U, 2003, BIOCHEMISTRY-US, V42, P8272, DOI 10.1021/bi020648j; Samuni U, 2002, J BIOL CHEM, V277, P25783, DOI 10.1074/jbc.M200301200; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; Samuni Uri, 2008, V9, P133; SASSAROLI M, 1987, BIOCHEMISTRY-US, V26, P3092, DOI 10.1021/bi00385a022; Sen U, 2004, BIOCHEMISTRY-US, V43, P12477, DOI 10.1021/bi048903i; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; SHAKLAI N, 1981, P NATL ACAD SCI-BIOL, V78, P65, DOI 10.1073/pnas.78.1.65; SHAKLAI N, 1977, BIOCHEMISTRY-US, V16, P5585, DOI 10.1021/bi00644a031; SHINAR E, 1990, SEMIN HEMATOL, V27, P70; SHINAR E, 1990, ANN NY ACAD SCI, V612, P118; Singer ST, 2005, BRIT J HAEMATOL, V131, P378, DOI 10.1111/j.1365-2141.2005.05768.x; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P1, DOI 10.1017/CBO9780511596582; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Takeoka S, 1997, BIOCONJUGATE CHEM, V8, P539, DOI 10.1021/bc970091y; TRAEGER J, 1980, NATURE, V288, P497, DOI 10.1038/288497a0; Vekilov PG, 2003, METH MOLEC MED, V82, P155; Vichinsky E., 2007, AM SOC HEMATOLOGY ED, P79; Watanapokasin Y, 2000, HEMOGLOBIN, V24, P105, DOI 10.3109/03630260009003429; Weatherall DJ, 2000, J PEDIAT HEMATOL ONC, V22, P551, DOI 10.1097/00043426-200011000-00021; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; WINICHAGOON P, 1985, AM J HEMATOL, V20, P217, DOI 10.1002/ajh.2830200303; Winichagoon P, 1995, Southeast Asian J Trop Med Public Health, V26 Suppl 1, P241	109	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23452	23466		10.1074/jbc.M110.183186	http://dx.doi.org/10.1074/jbc.M110.183186			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531715	Green Published, hybrid			2022-12-25	WOS:000292025000076
J	Zhu, YB; Sheng, ZH				Zhu, Yi-Bing; Sheng, Zu-Hang			Increased Axonal Mitochondrial Mobility Does Not Slow Amyotrophic Lateral Sclerosis (ALS)-like Disease in Mutant SOD1 Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; ALS-LINKED SOD1; RESPIRATORY-CHAIN FUNCTION; WILD-TYPE; TRANSPORT DEFECTS; SKELETAL-MUSCLE; TRANSGENIC MICE; INHERITED ALS; MOUSE MODEL; DYNEIN	Reduced axonal mitochondrial transport has been observed in major neurodegenerative diseases, including fALS patients and SOD1(G93A) mice. However, it is unclear whether this defect plays a critical role in axonal degeneration or simply reflects sequelae of general transport alteration. Using genetic mouse models combined with time-lapse imaging of live neurons, we previously discovered that axon-targeted syntaphilin (SNPH) acts as a docking receptor specific for axonal mitochondria. Deletion of the snph gene in mice results in a substantially higher proportion of axonal mitochondria in the mobile state without any effect on the transport of other axonal organelles. Here we address whether increased (rescued) axonal mitochondrial mobility changes the disease course by crossing fALS-linked transgenic SOD1(G93A) and snph(-/-) knock-out mice. We found that a 2-fold increase in axonal mitochondrial mobility in SOD1(G93A)/snph(-/-) mice did not affect the onset of ALS-like symptoms. Both SOD1(G93A) and SOD1(G93A)/snph(-/-) mice exhibit similar weight loss, deterioration in motor function and motor neuron loss, significant gliosis, and a lifespan of 152-154 days. Thus, for the first time, our study provides genetic and pathological evidence that the impairment of mitochondrial transport seen in SOD1(G93A) mice plays a minimal role in the rapid-onset of fALS-linked pathology.	[Zhu, Yi-Bing; Sheng, Zu-Hang] NINDS, Synapt Funct Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Sheng, ZH (corresponding author), NINDS, Synapt Funct Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	shengz@ninds.nih.gov			NINDS, National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002946, ZIANS003029] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the Intramural Research Program of the NINDS, National Institutes of Health (to Z.-H. S.).	Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cai Q, 2009, NEURON, V61, P493, DOI 10.1016/j.neuron.2009.02.003; Chang DTW, 2006, NEUROSCIENCE, V141, P727, DOI 10.1016/j.neuroscience.2006.01.034; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Echaniz-Laguna A, 2002, ANN NEUROL, V52, P623, DOI 10.1002/ana.10357; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; Guipponi M, 2010, J MOL NEUROSCI, V41, P172, DOI 10.1007/s12031-009-9317-1; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Higgins CMJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-16; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Kong JM, 1998, J NEUROSCI, V18, P3241; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Magrane J, 2009, HUM MOL GENET, V18, P4552, DOI 10.1093/hmg/ddp421; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nguyen KT, 2009, P NATL ACAD SCI USA, V106, P2007, DOI 10.1073/pnas.0810934106; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sasaki S, 1996, NEUROLOGY, V47, P535, DOI 10.1212/WNL.47.2.535; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b; Tateno M, 2009, HUM MOL GENET, V18, P942, DOI 10.1093/hmg/ddn422; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Warita H, 1999, BRAIN RES, V819, P120, DOI 10.1016/S0006-8993(98)01351-1; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200	52	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23432	23440		10.1074/jbc.M111.237818	http://dx.doi.org/10.1074/jbc.M111.237818			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21518771	Green Published, hybrid			2022-12-25	WOS:000292025000074
J	Chen, K; Xu, XM; Kobayashi, S; Timm, D; Jepperson, T; Liang, QR				Chen, Kai; Xu, Xianmin; Kobayashi, Satoru; Timm, Derek; Jepperson, Tyler; Liang, Qiangrong			Caloric Restriction Mimetic 2-Deoxyglucose Antagonizes Doxorubicin-induced Cardiomyocyte Death by Multiple Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HEART-FAILURE; SIGNALING PATHWAY; OXIDATIVE STRESS; IN-VITRO; DIETARY SUPPLEMENTATION; REGULATES AUTOPHAGY; ENERGY RESTRICTION; TRANSGENIC MICE; CANCER-THERAPY	Caloric restriction (CR) is a dietary intervention known to enhance cardiovascular health. The glucose analog 2-deoxy-D-glucose (2-DG) mimics CR effects in several animal models. However, whether 2-DG is beneficial to the heart remains obscure. Here, we tested the ability of 2-DG to reduce cardiomyocyte death triggered by doxorubicin (DOX, 1 mu M), an antitumor drug that can cause heart failure. Treatment of neonatal rat cardiomyocytes with 0.5 mM 2-DG dramatically suppressed DOX cytotoxicity as indicated by a decreased number of cells that stained positive for propidium iodide and reduced apoptotic markers. 2-DG decreased intracellular ATP levels by 17.9%, but it prevented DOX-induced severe depletion of ATP, which may contribute to 2-DG-mediated cytoprotection. Also, 2-DG increased the activity of AMP-activated protein kinase (AMPK). Blocking AMPK signaling with compound C or small interfering RNA-mediated knockdown of the catalytic subunit markedly attenuated the protective effects of 2-DG. Conversely, AMPK activation by pharmacological or genetic approach reduced DOX cardiotoxicity but did not produce additive effects when used together with 2-DG. In addition, 2-DG induced autophagy, a cellular degradation pathway whose activation could be either protective or detrimental depending on the context. Paradoxically, despite its ability to activate autophagy, 2-DG prevented DOX-induced detrimental autophagy. Together, these results suggest that the CR mimetic 2-DG can antagonize DOX-induced cardiomyocyte death, which is mediated through multiple mechanisms, including the preservation of ATP content, the activation of AMPK, and the inhibition of autophagy.	[Chen, Kai; Xu, Xianmin; Kobayashi, Satoru; Timm, Derek; Jepperson, Tyler; Liang, Qiangrong] Univ S Dakota, Sanford Res, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA	Sanford Health; University of South Dakota	Liang, QR (corresponding author), Univ S Dakota, Sanford Res, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA.	Qiangrong.Liang@sanfordhealth.org			National Institutes of Health [2P20RR017662-06A1]; American Diabetes Association [1-09-CD-09, 1-2007-741]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 2P20RR017662-06A1 (Project 3) from the NCRR (to Q. L.).; Supported by Juvenile Diabetes Research Foundation Research Grant 1-2007-741 and Career Development Grant 1-09-CD-09 from the American Diabetes Association.	Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Bhamra GS, 2008, BASIC RES CARDIOL, V103, P274, DOI [10.1007/s00395-007-0691-y, 10.1007/s00395-008-0736-x]; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dwarakanath BS, 2009, FUTURE ONCOL, V5, P581, DOI 10.2217/FON.09.44; Dwarakanath BS, 2009, J CANCER RES THER, V5, P21, DOI 10.4103/0973-1482.55136; Dwarukanath BS, 2004, CANCER BIOL THER, V3, P864, DOI 10.4161/cbt.3.9.1040; Dwivedi M, 2009, BMB REP, V42, P65, DOI 10.5483/BMBRep.2009.42.2.065; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Farooque A, 2009, J CANCER RES THER, V5, P32, DOI 10.4103/0973-1482.55138; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Ingram DK, 2011, EXP GERONTOL, V46, P148, DOI 10.1016/j.exger.2010.12.001; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang CH, 2008, AUTOPHAGY, V4, P82, DOI 10.4161/auto.5154; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Kobayashi S, 2007, J BIOL CHEM, V282, P21945, DOI 10.1074/jbc.M703048200; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Kritchevsky D, 2003, J NUTR, V133, p3827S, DOI 10.1093/jn/133.11.3827S; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Lane Mark A, 2007, Methods Mol Biol, V371, P143; Lee HT, 2002, J AM SOC NEPHROL, V13, P2753, DOI 10.1097/01.ASN.0000032421.79225.6E; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Lipshultz SE, 2010, LANCET ONCOL, V11, P950, DOI 10.1016/S1470-2045(10)70204-7; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Martin Bronwen, 2007, IBS J Sci, V2, P35; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Masoro EJ, 2009, BBA-GEN SUBJECTS, V1790, P1040, DOI 10.1016/j.bbagen.2009.02.011; Matsuda F, 2009, AUTOPHAGY, V5, P484, DOI 10.4161/auto.5.4.7760; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043; Minor RK, 2010, TOXICOL APPL PHARM, V243, P332, DOI 10.1016/j.taap.2009.11.025; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mitra MS, 2007, TOXICOL APPL PHARM, V225, P90, DOI 10.1016/j.taap.2007.07.018; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muthukumar A, 2003, J CLIN IMMUNOL, V23, P23, DOI 10.1023/A:1021996130672; Nagata D, 2010, HYPERTENS RES, V33, P22, DOI 10.1038/hr.2009.187; Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294; Paiva M, 2009, J CARDIOVASC PHARM, V53, P373, DOI 10.1097/FJC.0b013e31819fd4e7; Perumal V, 2009, J CANCER RES THER, V5, P48, DOI 10.4103/0973-1482.55142; Pointon AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012733; Raeini-Sarjaz M, 2001, AM J CLIN NUTR, V73, P262; Rattan SIS, 2004, MECH AGEING DEV, V125, P285, DOI 10.1016/j.mad.2004.01.006; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Simons AL, 2007, CANCER RES, V67, P3364, DOI 10.1158/0008-5472.CAN-06-3717; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Sun XH, 2001, CANCER RES, V61, P3382; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tebbi CK, 2007, J CLIN ONCOL, V25, P493, DOI 10.1200/JCO.2005.02.3879; THAKKAR NS, 1993, CANCER RES, V53, P2057; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wan RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1186, DOI 10.1152/ajpheart.00932.2003; Wan RQ, 2003, FASEB J, V17, P1133, DOI 10.1096/fj.02-0996fje; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Young LH, 2005, TRENDS CARDIOVAS MED, V15, P110, DOI 10.1016/j.tcm.2005.04.005; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zhang FJ, 2009, J CANCER RES THER, V5, P41, DOI 10.4103/0973-1482.55140; Zhang XD, 2006, ANTICANCER RES, V26, P3561; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8	88	50	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21993	22006		10.1074/jbc.M111.225805	http://dx.doi.org/10.1074/jbc.M111.225805			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21521688	Green Published, hybrid			2022-12-25	WOS:000291719900006
J	Murata, T; Noda, C; Saito, S; Kawashima, D; Sugimoto, A; Isomura, H; Kanda, T; Yokoyama, KK; Tsurumi, T				Murata, Takayuki; Noda, Chieko; Saito, Shinichi; Kawashima, Daisuke; Sugimoto, Atsuko; Isomura, Hiroki; Kanda, Teru; Yokoyama, Kazunari K.; Tsurumi, Tatsuya			Involvement of Jun Dimerization Protein 2 (JDP2) in the Maintenance of Epstein-Barr Virus Latency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BZLF1 GENE PROMOTER; AP-1 REPRESSOR PROTEIN; LYTIC-SWITCH; TRANSCRIPTION FACTOR; INSERTIONAL MUTAGENESIS; DEPENDENT TRANSCRIPTION; HISTONE ACETYLATION; BINDING; IDENTIFICATION; DIFFERENTIATION	Reactivation of the Epstein-Barr virus from latency is dependent on expression of the BZLF1 viral immediate-early protein. The BZLF1 promoter (Zp) normally exhibits only low basal activity but is activated in response to chemical inducers such as 12-O-tetradecanoylphorbol-13-acetate and calcium ionophore. We found that Jun dimerization protein 2 (JDP2) plays a significant role in suppressing Zp activity. Reporter, EMSA, and ChIP assays of a Zp mutant virus revealed JDP2 association with Zp at the ZII cis-element, a binding site for CREB/ATF/AP-1. Suppression of Zp activity by JDP2 correlated with HDAC3 association and reduced levels of histone acetylation. Although introduction of point mutations into the ZII element of the viral genome did not increase the level of BZLF1 production, silencing of endogenous JDP2 gene expression by RNA interference increased the levels of viral early gene products and viral DNA replication. These results indicate that JDP2 plays a role as a repressor of Zp and that its replacement by CREB/ATF/AP-1 at ZII is crucial to triggering reactivation from latency to lytic replication.	[Murata, Takayuki; Noda, Chieko; Saito, Shinichi; Kawashima, Daisuke; Sugimoto, Atsuko; Isomura, Hiroki; Kanda, Teru; Tsurumi, Tatsuya] Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Ctr Canc, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan	Aichi Cancer Center; Kaohsiung Medical University	Tsurumi, T (corresponding author), Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ttsurumi@aichi-cc.jp	Murata, Takayuki/I-2621-2013; Kanda, Teru/J-7313-2019	Murata, Takayuki/0000-0001-7228-0839; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Science, Sports, Culture and Technology of Japan [20390137, 21022055, 20790362, 22790448]; Uehara Memorial Research Fund; Japan Leukaemia Research Fund	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Research Fund(Uehara Memorial Foundation); Japan Leukaemia Research Fund	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan 20390137 and 21022055 (to T. T.) and 20790362 and 22790448 (to T. M.), and grants from the Uehara Memorial Research Fund (to T. T.) and the Japan Leukaemia Research Fund (to T. M.).	Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bhende PM, 2007, J VIROL, V81, P7363, DOI 10.1128/JVI.00154-07; Bitton-Worms K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-54; Blazek E, 2003, ONCOGENE, V22, P2151, DOI 10.1038/sj.onc.1206312; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Ego T, 2005, ONCOGENE, V24, P1914, DOI 10.1038/sj.onc.1208394; Ellis AL, 2010, J VIROL, V84, P6139, DOI 10.1128/JVI.02706-09; Feng WH, 2007, J VIROL, V81, P10113, DOI 10.1128/JVI.00692-07; FLEMINGTON E, 1990, J VIROL, V64, P1217, DOI 10.1128/JVI.64.3.1217-1226.1990; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Heinrich R, 2004, J BIOL CHEM, V279, P5708, DOI 10.1074/jbc.M307608200; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Kraus RJ, 2003, J VIROL, V77, P199, DOI 10.1128/JVI.77.1.199-207.2003; Lerdrup M, 2005, BBA-MOL CELL RES, V1745, P29, DOI 10.1016/j.bbamcr.2005.06.008; Liu PF, 1998, J VIROL, V72, P8230, DOI 10.1128/JVI.72.10.8230-8239.1998; Liu SF, 1997, VIROLOGY, V228, P11, DOI 10.1006/viro.1996.8371; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; MONTALVO EA, 1995, J VIROL, V69, P4158, DOI 10.1128/JVI.69.7.4158-4165.1995; Murata T, 2010, J BIOL CHEM, V285, P23925, DOI 10.1074/jbc.M109.095356; Murata T, 2009, J BIOL CHEM, V284, P8033, DOI 10.1074/jbc.M808466200; Murata T, 2009, VIROLOGY, V389, P75, DOI 10.1016/j.virol.2009.04.007; Nakade K, 2007, CELL DEATH DIFFER, V14, P1398, DOI 10.1038/sj.cdd.4402129; Nakade K, 2009, J BIOL CHEM, V284, P10808, DOI 10.1074/jbc.M808333200; Nakayama S, 2010, J VIROL, V84, P12589, DOI 10.1128/JVI.01394-10; Ostrovsky O, 2002, J BIOL CHEM, V277, P40043, DOI 10.1074/jbc.M205494200; Piu F, 2001, MOL CELL BIOL, V21, P3012, DOI 10.1128/MCB.21.9.3012-3024.2001; Rasmussen MH, 2005, VIROLOGY, V337, P353, DOI 10.1016/j.virol.2005.04.027; RUF IK, 1995, J VIROL, V69, P7648, DOI 10.1128/JVI.69.12.7648-7657.1995; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Thomas C, 2003, J GEN VIROL, V84, P959, DOI 10.1099/vir.0.18740-0; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu XM, 2007, PLOS PATHOG, V3, P1993, DOI 10.1371/journal.ppat.0030194; Zhang Q, 1999, VIROLOGY, V255, P160, DOI 10.1006/viro.1998.9588	42	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22007	22016		10.1074/jbc.M110.199836	http://dx.doi.org/10.1074/jbc.M110.199836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525011	Green Published, hybrid			2022-12-25	WOS:000291719900007
J	Samai, P; Shuman, S				Samai, Poulami; Shuman, Stewart			Structure-Function Analysis of the OB and Latch Domains of Chlorella Virus DNA Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; NICK RECOGNITION; MECHANISM; YEAST	Chlorella virus DNA ligase (ChVLig) is a minimized eukaryal ATP-dependent DNA sealing enzyme with an intrinsic nick-sensing function. ChVLig consists of three structural domains, nucleotidyltransferase (NTase), OB-fold, and latch, that envelop the nicked DNA as a C-shaped protein clamp. The OB domain engages the DNA minor groove on the face of the duplex behind the nick, and it makes contacts to amino acids in the NTase domain surrounding the ligase active site. The latch module occupies the DNA major groove flanking the nick. Residues at the tip of the latch contact the NTase domain to close the ligase clamp. Here we performed a structure-guided mutational analysis of the OB and latch domains. Alanine scanning defined seven individual amino acids as essential in vivo (Lys-274, Arg-285, Phe-286, and Val-288 in the OB domain; Asn-214, Phe-215, and Tyr-217 in the latch), after which structure-activity relations were clarified by conservative substitutions. Biochemical tests of the composite nick sealing reaction and of each of the three chemical steps of the ligation pathway highlighted the importance of Arg-285 and Phe-286 in the catalysis of the DNA adenylylation and phosphodiester synthesis reactions. Phe-286 interacts with the nick 5'-phosphate nucleotide and the 3'-OH base pair and distorts the DNA helical conformation at the nick. Arg-285 is a key component of the OB-NTase interface, where it forms a salt bridge to the essential Asp-29 side chain, which is imputed to coordinate divalent metal catalysts during the nick sealing steps.	[Samai, Poulami; Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM63611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63611 (to S. S.).	Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Crut A, 2008, P NATL ACAD SCI USA, V105, P6894, DOI 10.1073/pnas.0800113105; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Odell M, 2003, NUCLEIC ACIDS RES, V31, P5090, DOI 10.1093/nar/gkg665; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Sannai P, 2011, J BIOL CHEM, V286, P13314, DOI 10.1074/jbc.M111.226191; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Sriskanda V, 2002, J BIOL CHEM, V277, P9661, DOI 10.1074/jbc.M110613200; Sriskanda V, 2002, NUCLEIC ACIDS RES, V30, P903, DOI 10.1093/nar/30.4.903	22	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22642	22652		10.1074/jbc.M111.245399	http://dx.doi.org/10.1074/jbc.M111.245399			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21527793	Green Published, hybrid			2022-12-25	WOS:000291719900071
J	Boltz, A; Piater, B; Toleikis, L; Guenther, R; Kolmar, H; Hock, B				Boltz, Achim; Piater, Birgit; Toleikis, Lars; Guenther, Ralf; Kolmar, Harald; Hock, Bjoern			Bi-specific Aptamers Mediating Tumor Cell Lysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; FC-GAMMA-RIII; CHAIN ANTIBODY CONSTRUCT; DNA APTAMERS; IN-VIVO; EFFECTIVE ELIMINATION; BIVALENT APTAMER; TYROSINE KINASE; LEUKEMIC-CELLS; MET ANTIBODY	Antibody-dependent cellular cytotoxicity plays a pivotal role in antibody-based tumor therapies and is based on the recruitment of natural killer cells to antibody-bound tumor cells via binding of the Fc gamma receptor III (CD16). Here we describe the generation of chimeric DNA aptamers that simultaneously bind to CD16 alpha and c-Met, a receptor that is overexpressed in many tumors. By application of the systematic evolution of ligands by exponential enrichment (SELEX) method, CD16 alpha specific DNA aptamers were isolated that bound with high specificity and affinity (91 pM-195 nM) to their respective recombinant and cellularly expressed target proteins. Two optimized CD16 alpha specific aptamers were coupled to each of two c-Met specific aptamers using different linkers. Bi-specific aptamers retained suitable binding properties and displayed simultaneous binding to both antigens. Moreover, they mediated cellular cytotoxicity dependent on aptamer and effector cell concentration. Displacement of a bi-specific aptamer from CD16 alpha by competing antibody 3G8 reduced cytotoxicity and confirmed the proposed mode of action. These results represent the first gain of a tumor-effective function of two distinct oligonucleotides by linkage into a bi-specific aptamer mediating cellular cytotoxicity.	[Boltz, Achim; Piater, Birgit; Toleikis, Lars; Guenther, Ralf; Hock, Bjoern] Merck KGaA, Merck Serono, Prot Engn & Antibody Technol Dept, D-64293 Darmstadt, Germany; Tech Univ Darmstadt, Clemens Schoepf Inst Organ Chem & Biochem, D-64289 Darmstadt, Germany	Merck KGaA; EMD Serono Inc.; Technical University of Darmstadt	Hock, B (corresponding author), Merck KGaA, Merck Serono, Prot Engn & Antibody Technol Dept, Frankfurter Str 250, D-64293 Darmstadt, Germany.	Bjoern.Hock@merck.de	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993; Doerner, Achim/0000-0002-4741-8039				Aarden L, 2008, CURR OPIN IMMUNOL, V20, P431, DOI 10.1016/j.coi.2008.06.011; Arndt MAE, 1999, BLOOD, V94, P2562, DOI 10.1182/blood.V94.8.2562.420k20_2562_2568; Baeuerle PA, 2003, CURR OPIN MOL THER, V5, P413; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Bates Paula J., 2009, V542, P379, DOI 10.1007/978-1-59745-561-9_21; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bluemel C, 2010, CANCER IMMUNOL IMMUN, V59, P1197, DOI 10.1007/s00262-010-0844-y; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Bruenke J, 2004, BRIT J HAEMATOL, V125, P167, DOI 10.1111/j.1365-2141.2004.04893.x; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Choi EW, 2010, NUCLEIC ACIDS RES, V38, P1623, DOI 10.1093/nar/gkp1088; Chu TC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl388; Constantinou A, 2010, BIOTECHNOL LETT, V32, P609, DOI 10.1007/s10529-010-0214-z; Cui Z, 2003, P NATL ACAD SCI USA, V100, P6682, DOI 10.1073/pnas.1031601100; Dang C, 1996, J MOL BIOL, V264, P268, DOI 10.1006/jmbi.1996.0640; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Desjarlais JR, 2007, DRUG DISCOV TODAY, V12, P898, DOI 10.1016/j.drudis.2007.08.009; Di Giusto DA, 2006, CHEMBIOCHEM, V7, P535, DOI 10.1002/cbic.200500316; Di Giusto DA, 2004, J BIOL CHEM, V279, P46483, DOI 10.1074/jbc.M408037200; Dollins CM, 2008, CHEM BIOL, V15, P675, DOI 10.1016/j.chembiol.2008.05.016; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Farag SS, 2003, INT J HEMATOL, V78, P7, DOI 10.1007/BF02983234; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; HARRISON D, 1991, J IMMUNOL, V147, P3459; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; HUIZINGA TWJ, 1994, BRIT J HAEMATOL, V87, P459, DOI 10.1111/j.1365-2141.1994.tb08298.x; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Kaur G, 2008, EXPERT OPIN INV DRUG, V17, P43, DOI 10.1517/13543784.17.1.43; Keefe AD, 2008, CURR OPIN CHEM BIOL, V12, P448, DOI 10.1016/j.cbpa.2008.06.028; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kellner C, 2008, J IMMUNOTHER, V31, P871, DOI 10.1097/CJI.0b013e318186c8b4; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Kim Y, 2008, P NATL ACAD SCI USA, V105, P5664, DOI 10.1073/pnas.0711803105; Kipriyanov SM, 2002, J IMMUNOL, V169, P137, DOI 10.4049/jimmunol.169.1.137; Kontermann RE, 2009, BIODRUGS, V23, P93, DOI 10.2165/00063030-200923020-00003; Kugler M, 2010, BRIT J HAEMATOL, V150, P574, DOI 10.1111/j.1365-2141.2010.08300.x; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li M, 1996, J EXP MED, V183, P1259, DOI 10.1084/jem.183.3.1259; Li P, 2007, J BIOL CHEM, V282, P6210, DOI 10.1074/jbc.M609064200; Lopez-Albaitero A, 2009, CANCER IMMUNOL IMMUN, V58, P1855, DOI 10.1007/s00262-009-0697-4; MACK M, 1995, P NATL ACAD SCI USA, V92, P7021, DOI 10.1073/pnas.92.15.7021; McCall AM, 1999, MOL IMMUNOL, V36, P433, DOI 10.1016/S0161-5890(99)00057-7; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Michalowski D, 2008, NUCLEIC ACIDS RES, V36, P7124, DOI 10.1093/nar/gkn891; Muller J, 2008, J THROMB HAEMOST, V6, P2105, DOI 10.1111/j.1538-7836.2008.03162.x; Muller J, 2007, CHEMBIOCHEM, V8, P2223, DOI 10.1002/cbic.200700535; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Orava EW, 2010, BBA-BIOMEMBRANES, V1798, P2190, DOI 10.1016/j.bbamem.2010.02.004; Pacchiana G, 2010, J BIOL CHEM, V285, P36149, DOI 10.1074/jbc.M110.134031; Pendergrast P Shannon, 2005, J Biomol Tech, V16, P224; Peng CG, 2007, NUCLEIC ACIDS RES, V35, P4977, DOI 10.1093/nar/gkm520; Que-Gewirth NS, 2007, GENE THER, V14, P283, DOI 10.1038/sj.gt.3302900; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Roda JM, 2006, CANCER RES, V66, P517, DOI 10.1158/0008-5472.CAN-05-2429; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Santulli-Marotto S, 2003, CANCER RES, V63, P7483; Sazani PL, 2004, J AM CHEM SOC, V126, P8370, DOI 10.1021/ja049171k; Schmidt KS, 2004, NUCLEIC ACIDS RES, V32, P5757, DOI 10.1093/nar/gkh862; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Shaw JP, 1995, PHARMACEUT RES, V12, P1937, DOI 10.1023/A:1016243923195; Singer H, 2010, J IMMUNOTHER, V33, P599, DOI 10.1097/CJI.0b013e3181dda225; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Stellrecht CM, 2009, CANCER LETT, V280, P1, DOI 10.1016/j.canlet.2008.10.045; Tahiri-Alaoui A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e45; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Taylor RJ, 2009, CANCER IMMUNOL IMMUN, V58, P997, DOI 10.1007/s00262-008-0613-3; Tsang J, 1996, J MOL BIOL, V262, P31, DOI 10.1006/jmbi.1996.0496; TSARFATY I, 1994, SCIENCE, V263, P98, DOI 10.1126/science.7505952; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Wallace ME, 2005, SPRINGER SEMIN IMMUN, V27, P49, DOI 10.1007/s00281-004-0195-x; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325; Zhou JH, 2009, NUCLEIC ACIDS RES, V37, P3094, DOI 10.1093/nar/gkp185; Zompi S, 2005, IMMUNOL LETT, V97, P31, DOI 10.1016/j.imlet.2004.10.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	80	92	99	6	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21896	21905		10.1074/jbc.M111.238261	http://dx.doi.org/10.1074/jbc.M111.238261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531729	Green Published, hybrid			2022-12-25	WOS:000291464700084
J	Goto, Y; Ogawa, K; Hattori, A; Tsujimoto, M				Goto, Yoshikuni; Ogawa, Kenji; Hattori, Akira; Tsujimoto, Masafumi			Secretion of Endoplasmic Reticulum Aminopeptidase 1 Is Involved in the Activation of Macrophages Induced by Lipopolysaccharide and Interferon-gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCYL-SPECIFIC AMINOPEPTIDASE; PLACENTAL LEUCINE AMINOPEPTIDASE/OXYTOCINASE; ANTIGEN-PROCESSING MACHINERY; EXTRACELLULAR TNFR1 RELEASE; HAMSTER OVARY CELLS; ANKYLOSING-SPONDYLITIS; OXYTOCINASE SUBFAMILY; ENZYMATIC-PROPERTIES; CERVICAL-CARCINOMA; ENDOTHELIAL-CELLS	Endoplasmic reticulum aminopeptidase 1 (ERAP1) is a multifunctional enzyme with an important role in processing antigenic peptides presented to class I major histocompatibility complex in the endoplasmic reticulum. In this study, we found that endoplasmic reticulum-retained ERAP1 was secreted from macrophages in response to activation by treatment with lipopolysaccharide (LPS) and interferon (IFN)-gamma and enhanced their phagocytic activity. Enhancement of the phagocytic activity of murine macrophage RAW264.7 cells induced by LPS/IFN-gamma was inhibited by a potent aminopeptidase inhibitor, amastatin. The addition of recombinant wild-type but not inactive mutant ERAP1 to culture medium enhanced phagocytosis. These results suggest that enhancement of phagocytic activity is at least in part mediated by secreted ERAP1 through the generation of active peptides processed by the enzyme. Our data reveal ERAP1-mediated activation of macrophages for the first time and will provide new insights into the role of this enzyme in innate immunity.	[Goto, Yoshikuni; Tsujimoto, Masafumi] Teikyo Heisei Univ, Fac Pharmaceut Sci, Chiba 2900193, Japan; [Goto, Yoshikuni; Ogawa, Kenji; Tsujimoto, Masafumi] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Hattori, Akira] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Chemotherapy & Mol Sci, Kyoto 6068501, Japan	RIKEN; Kyoto University	Tsujimoto, M (corresponding author), Teikyo Heisei Univ, Fac Pharmaceut Sci, 4-1 Uruido Minami, Chiba 2900193, Japan.	tsujimot@thu.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Suzuken Memorial Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Suzuken Memorial Foundation	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan and a grant from Suzuken Memorial Foundation.	Adamik B, 2008, BIOCHEM BIOPH RES CO, V371, P505, DOI 10.1016/j.bbrc.2008.04.103; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; DELAFUENTE M, 1993, IMMUNOLOGY, V80, P259; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Goto Y, 2008, BIOCHEM J, V416, P109, DOI 10.1042/BJ20080965; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Haroon N, 2010, NAT REV RHEUMATOL, V6, P461, DOI 10.1038/nrrheum.2010.85; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Hattori A, 2000, J BIOCHEM-TOKYO, V128, P755, DOI 10.1093/oxfordjournals.jbchem.a022812; Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200; IWAKI S, 1986, J BIOCHEM-TOKYO, V99, P1317, DOI 10.1093/oxfordjournals.jbchem.a135599; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Johnson MP, 2009, HUM GENET, V126, P655, DOI 10.1007/s00439-009-0714-x; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; Masuda S, 2003, EUR J BIOCHEM, V270, P1988, DOI 10.1046/j.1432-1033.2003.03570.x; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; Mehta AM, 2008, CANCER IMMUNOL IMMUN, V57, P197, DOI 10.1007/s00262-007-0362-8; Mehta AM, 2009, GENE CHROMOSOME CANC, V48, P410, DOI 10.1002/gcc.20648; Miyashita H, 2002, BLOOD, V99, P3241, DOI 10.1182/blood.V99.9.3241; NAJJAR VA, 1970, NATURE, V228, P672, DOI 10.1038/228672a0; Nakamura H, 2000, ENDOCRINOLOGY, V141, P4481, DOI 10.1210/en.141.12.4481; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; NIHIRA S, 1983, J BIOCHEM-TOKYO, V94, P565, DOI 10.1093/oxfordjournals.jbchem.a134388; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Sato Y, 2004, BIOL PHARM BULL, V27, P772, DOI 10.1248/bpb.27.772; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; Taranta A, 2009, NEPHROL DIAL TRANSPL, V24, P1851, DOI 10.1093/ndt/gfn720; Thomas GP, 2010, IMMUNOL REV, V233, P162, DOI 10.1111/j.0105-2896.2009.00852.x; Tsui FWL, 2010, ANN RHEUM DIS, V69, P733, DOI 10.1136/ard.2008.103804; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Tsujimoto M, 2008, HEART FAIL REV, V13, P285, DOI 10.1007/s10741-007-9064-8; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Yamada Y, 2007, INT J MOL MED, V19, P791; Yamamoto N, 2002, HUM MUTAT, V19, P251, DOI 10.1002/humu.10047; Yamazaki T, 2004, BLOOD, V104, P2345, DOI 10.1182/blood-2003-12-4260	44	61	61	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21906	21914		10.1074/jbc.M111.239111	http://dx.doi.org/10.1074/jbc.M111.239111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531727	Green Published, hybrid			2022-12-25	WOS:000291464700085
J	Ikner, A; Ashkenazi, A				Ikner, Aminah; Ashkenazi, Avi			TWEAK Induces Apoptosis through a Death-signaling Complex Comprising Receptor-interacting Protein 1 (RIP1), Fas-associated Death Domain (FADD), and Caspase-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCED CELL-DEATH; TNF-ALPHA; ACTIVATION; NECROSIS; FN14; C-IAP2; UBIQUITINATION; INHIBITOR; CYTOKINE	The tumor necrosis factor (TNF) superfamily member TNF-like weak inducer of apoptosis (TNFSF12, CD255) (TWEAK) can stimulate apoptosis in certain cancer cells. Previous studies suggest that TWEAK activates cell death indirectly, by inducing TNF alpha-mediated autocrine signals. However, the underlying death-signaling mechanism has not been directly defined. Consistent with earlier work, TWEAK assembled a proximal signaling complex containing its cognate receptor FN14, the adaptor TRAF2, and cellular inhibitor of apoptosis protein 1 (cIAP1). Neither the death domain adaptor Fas-associated death domain nor the apoptosis-initiating protease caspase-8 associated with this primary complex. Rather, TWEAK induced TNF alpha secretion and TNF receptor 1-dependent assembly of a death-signaling complex containing receptor-interacting protein 1 (RIP1), FADD, and caspase-8. Knockdown of RIP1 by siRNA prevented TWEAK-induced association of FADD with caspase-8 but not formation of the FN14-TRAF2-cIAP1 complex and inhibited apoptosis activation. Depletion of the RIP1 E3 ubiquitin ligase cIAP1 enhanced assembly of the RIP1-FADD-caspase-8 complex and augmented cell death. Conversely, knockdown of the RIP1 deubiquitinase CYLD inhibited these functions. Depletion of FADD, caspase-8, BID, or BAX and BAK but not RIP3 attenuated TWEAK-induced cell death. Pharmacologic inhibition of the NF-kappa B pathway or siRNA knockdown of RelA attenuated TWEAK induction of TNF alpha and association of RIP1 with FADD and caspase-8. These results suggest that TWEAK triggers apoptosis by promoting assembly of a RIP1-FADD-caspse-8 complex via autocrine TNF alpha-TNFR1 signaling. The proapoptotic activity of TWEAK is modulated by cIAP1 and CYLD and engages both the extrinsic and intrinsic signaling pathways.	[Ikner, Aminah; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashwell JD, 2008, J CELL BIOL, V182, P15, DOI 10.1083/jcb.200806036; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Gao HX, 2009, CYTOKINE, V46, P24, DOI 10.1016/j.cyto.2008.12.001; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kaplan MJ, 2002, J IMMUNOL, V169, P6020, DOI 10.4049/jimmunol.169.10.6020; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Ortiz A, 2009, CYTOKINE GROWTH F R, V20, P251, DOI 10.1016/j.cytogfr.2009.05.002; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2006, CELL DEATH DIFFER, V13, P1842, DOI 10.1038/sj.cdd.4402027; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang DF, 2010, CANCER LETT, V294, P91, DOI 10.1016/j.canlet.2010.01.027; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Zhao Z, 2007, J IMMUNOL, V179, P7949, DOI 10.4049/jimmunol.179.11.7949; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	60	75	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21546	21554		10.1074/jbc.M110.203745	http://dx.doi.org/10.1074/jbc.M110.203745			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525013	Green Published, hybrid			2022-12-25	WOS:000291464700052
J	Kwon, S; Christian, JL				Kwon, Sunjong; Christian, Jan L.			Sortilin Associates with Transforming Growth Factor-beta Family Proteins to Enhance Lysosome-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIN RECEPTOR; TRAFFICKING; DOMAIN; PRODOMAIN; BRAIN; ENDOCYTOSIS; SORLA/LR11; VESICLES; CLEAVAGE; FURIN	Transforming growth factor (TGF)-beta family proteins are synthesized as precursors that are cleaved to generate an active ligand. Previous studies suggest that TGF-beta activity can be controlled by lysosomal degradation of both precursor proteins and ligands, but how these soluble proteins are trafficked to the lysosome is incompletely understood. The current studies show that sortilin selectively co-immunoprecipitates with the cleaved prodomain and/or precursor form of TGF-beta family members. Furthermore, sortilin co-localizes with, and enhances accumulation of a nodal family member in the Golgi. Co-expression of sortilin with TGF-beta family members leads to decreased accumulation of precursor proteins and cleavage products and this is attenuated by lysosomal, but not proteosomal inhibitors. In Xenopus embryos, overexpression of sortilin leads to a decrease in phospho-Smad2 levels and phenocopies loss of nodal signaling. Conversely, down-regulation of sortilin expression in HeLa cells leads to an up-regulation of endogenous bone morphogenic protein pathway activation, as indicated by an increase in phospho-Smad1/5/8 levels. Our results suggest that sortilin negatively regulates TGF-beta signaling by diverting trafficking of precursor proteins to the lysosome during transit through the biosynthetic pathway.	[Kwon, Sunjong; Christian, Jan L.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Christian, JL (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	christia@ohsu.edu			National Institutes of Health [R03HD058841, RO1 HD37976]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037976] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R03HD058841 and RO1 HD37976 (to J. L. C.).	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Blanchet MH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1165027; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Boutilier J, 2008, J BIOL CHEM, V283, P12709, DOI 10.1074/jbc.M710018200; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Chang CB, 2006, J BIOL CHEM, V281, P30794, DOI 10.1074/jbc.M607054200; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Cui YZ, 2001, GENE DEV, V15, P2797; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Kjolby M, 2010, CELL METAB, V12, P213, DOI 10.1016/j.cmet.2010.08.006; Konrad S, 2007, J BIOL CHEM, V282, P37906, DOI 10.1074/jbc.M707937200; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Moon R. T., 1989, TECHNIQUE, V1, P76; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakayama T, 1998, DEVELOPMENT, V125, P857; Ni XY, 2006, TRAFFIC, V7, P889, DOI 10.1111/j.1600-0854.2006.00429.x; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2007, J BIOL CHEM, V282, P9008, DOI 10.1074/jbc.M608971200; SOPORY S, 2006, METHODS SIGNAL TRANS, P37; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Tian J, 2008, DEVELOPMENT, V135, P2649, DOI 10.1242/dev.019794; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735; Zeng JB, 2009, EXP CELL RES, V315, P3112, DOI 10.1016/j.yexcr.2009.08.016; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	51	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21876	21885		10.1074/jbc.M111.228262	http://dx.doi.org/10.1074/jbc.M111.228262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521695	Green Published, hybrid			2022-12-25	WOS:000291464700082
J	Satoh, K; Matsu-ura, T; Enomoto, M; Nakamura, H; Michikawa, T; Mikoshiba, K				Satoh, Kanayo; Matsu-ura, Toru; Enomoto, Masahiro; Nakamura, Hideki; Michikawa, Takayuki; Mikoshiba, Katsuhiko			Highly Cooperative Dependence of Sarco/Endoplasmic Reticulum Calcium ATPase (SERCA) 2a Pump Activity on Cytosolic Calcium in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; SARCOPLASMIC-RETICULUM; FUNCTIONAL COMPARISONS; IMPROVED FLUORESCENCE; CA2+ OSCILLATIONS; STRUCTURAL BASIS; RECEPTOR; PROTEIN; CA2+-ATPASE; TRANSPORT	Sarco/endoplasmic reticulum (SR/ER) Ca2+-ATPase (SERCA) is an intracellular Ca2+ pump localized on the SR/ER membrane. The role of SERCA in refilling intracellular Ca2+ stores is pivotal for maintaining intracellular Ca2+ homeostasis, and disturbed SERCA activity causes many disease phenotypes, including heart failure, diabetes, cancer, and Alzheimer disease. Although SERCA activity has been described using a simple enzyme activity equation, the dynamics of SERCA activity in living cells is still unknown. To monitor SERCA activity in living cells, we constructed an enhanced CFP (ECFP)- and FlAsH-tagged SERCA2a, designated F-L577, which retains the ATP-dependent Ca2+ pump activity. The FRET efficiency between ECFP and FlAsH of F-L577 is dependent on the conformational state of the molecule. ER luminal Ca2+ imaging confirmed that the FRET signal changes directly reflect the Ca2+ pump activity. Dual imaging of cytosolic Ca2+ and the FRET signals of F-L577 in intact COS7 cells revealed that SERCA2a activity is coincident with the oscillatory cytosolic Ca2+ concentration changes evoked by ATP stimulation. The Ca2+ pump activity of SERCA2a in intact cells can be expressed by the Hill equation with an apparent affinity for Ca2+ of 0.41 +/- 0.0095 +/- mu M and a Hill coefficient of 5.7 +/- 0.73. These results indicate that in the cellular environment the Ca2+ dependence of ATPase activation is highly cooperative and that SERCA2a acts as a rapid switch to refill Ca2+ stores in living cells for shaping the intracellular Ca2+ dynamics. F-L577 will be useful for future studies on Ca2+ signaling involving SERCA2a activity.	[Satoh, Kanayo; Matsu-ura, Toru; Enomoto, Masahiro; Nakamura, Hideki; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Satoh, Kanayo] Univ Tokyo, Grad Sch Med, Dept Cognit Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Int Cooperat Res Project, Kawaguchi, Saitama 3320012, Japan; [Michikawa, Takayuki; Mikoshiba, Katsuhiko] Solut Oriented Res Sci & Technol, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST)	Michikawa, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Neurogenesis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-michikawa@brain.riken.jp; mikosiba@brain.riken.jp	Mikoshiba, Katsuhiko/N-7943-2015; Matsu-ura, Toru/P-3461-2017; Enomoto, Masahiro/L-2209-2019	Matsu-ura, Toru/0000-0002-9876-3086; Enomoto, Masahiro/0000-0002-9411-2999; Satoh, Kanayo/0000-0001-9684-239X; Nakamura, Hideki/0000-0003-2749-8323	Ministry of Education, Culture, Sports, Science and Technology of Japan [20370054, 2022007]; Grants-in-Aid for Scientific Research [23650197] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan Grants 20370054 (to T. M.) and 2022007 (to K. M.).	Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Engelender S, 1996, MOL PHARMACOL, V50, P1243; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Herman Brian, 2004, Methods Mol Biol, V261, P351; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirose K, 1998, J PHYSIOL-LONDON, V506, P407, DOI 10.1111/j.1469-7793.1998.407bw.x; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1988, METHOD ENZYMOL, V157, P154; KEIZER J, 1992, BIOPHYS J, V61, P649, DOI 10.1016/S0006-3495(92)81870-2; Kubala M, 2006, PROTEINS, V64, P1, DOI 10.1002/prot.20969; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sano KI, 2002, FEBS LETT, V532, P143, DOI 10.1016/S0014-5793(02)03659-1; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; TEPIKIN AV, 1992, BIOCHIM BIOPHYS ACTA, V1137, P197, DOI 10.1016/0167-4889(92)90202-M; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; Tsao ML, 2005, CHEMBIOCHEM, V6, P2147, DOI 10.1002/cbic.200500314; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Yano K, 2004, BIOCHEM J, V383, P353, DOI 10.1042/BJ20040629	45	29	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20591	20599		10.1074/jbc.M110.204685	http://dx.doi.org/10.1074/jbc.M110.204685			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515674	hybrid, Green Published			2022-12-25	WOS:000291267600045
J	Wickham, SE; Hotze, EM; Farrand, AJ; Polekhina, G; Nero, TL; Tomlinson, S; Parker, MW; Tweten, RK				Wickham, Stephanie E.; Hotze, Eileen M.; Farrand, Allison J.; Polekhina, Galina; Nero, Tracy L.; Tomlinson, Stephen; Parker, Michael W.; Tweten, Rodney K.			Mapping the Intermedilysin-Human CD59 Receptor Interface Reveals a Deep Correspondence with the Binding Site on CD59 for Complement Binding Proteins C8 alpha and C9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; PORE-FORMING TOXINS; CLOSTRIDIUM-PERFRINGENS; THETA-TOXIN; REGULATORY PROTEIN; PERFRINGOLYSIN-O; MEMBRANE-BINDING; ACTIVE-SITE; C5B-9; MECHANISM	CD59 is a glycosylphosphatidylinositol-anchored protein that inhibits the assembly of the terminal complement membrane attack complex (MAC) pore, whereas Streptococcus intermedius intermedilysin (ILY), a pore forming cholesterol-dependent cytolysin (CDC), specifically binds to human CD59 (hCD59) to initiate the formation of its pore. The identification of the residues of ILY and hCD59 that form their binding interface revealed a remarkably deep correspondence between the hCD59 binding site for ILY and that for the MAC proteins C8 alpha and C9. ILY disengages from hCD59 during the prepore to pore transition, suggesting that loss of this interaction is necessary to accommodate specific structural changes associated with this transition. Consistent with this scenario, mutants of hCD59 or ILY that increased the affinity of this interaction decreased the cytolytic activity by slowing the transition of the prepore to pore but not the assembly of the prepore oligomer. A signature motif was also identified in the hCD59 binding CDCs that revealed a new hCD59-binding member of the CDC family. Although the binding site on hCD59 for ILY, C8 alpha, and C9 exhibits significant homology, no similarity exists in their binding sites for hCD59. Hence, ILY and the MAC proteins interact with common amino acids of hCD59 but lack detectable conservation in their binding sites for hCD59.	[Wickham, Stephanie E.; Hotze, Eileen M.; Farrand, Allison J.; Tweten, Rodney K.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Polekhina, Galina; Nero, Tracy L.; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Tomlinson, Stephen] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Oklahoma System; University of Oklahoma Health Sciences Center; St. Vincent's Institute of Medical Research; Medical University of South Carolina; University of Melbourne	Tweten, RK (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB-1053, Oklahoma City, OK 73104 USA.	Rod-Tweten@ouhsc.edu	Parker, Michael W/F-9069-2013	Parker, Michael W/0000-0002-3101-1138; Nero, Tracy/0000-0002-3393-1843	National Institutes of Health [AI063444 (NIAID), AI47386]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047386, R01AI063444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063444 (NIAID) (to R. K. T.) and AI47386 (to S. T.).	Bodian DL, 1997, J EXP MED, V185, P507, DOI 10.1084/jem.185.3.507; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Farkas I, 2002, J PHYSIOL-LONDON, V539, P537, DOI 10.1113/jphysiol.2001.013381; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Farrand S, 2008, BIOCHEMISTRY-US, V47, P7097, DOI 10.1021/bi8005835; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; HAMILTON KK, 1990, BLOOD, V76, P2572; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; Huang YX, 2005, J BIOL CHEM, V280, P34073, DOI 10.1074/jbc.M504922200; Hughes TR, 2009, MOL IMMUNOL, V46, P1561, DOI 10.1016/j.molimm.2009.01.003; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; LaChapelle S, 2009, J BIOL CHEM, V284, P12719, DOI 10.1074/jbc.M900772200; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Leath KJ, 2007, ACTA CRYSTALLOGR F, V63, P648, DOI 10.1107/S1744309107033477; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Nagamune H, 2004, MICROBIOL IMMUNOL, V48, P677, DOI 10.1111/j.1348-0421.2004.tb03479.x; OHNOIWASHITA Y, 1988, EUR J BIOCHEM, V176, P95, DOI 10.1111/j.1432-1033.1988.tb14255.x; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROLLINS SA, 1991, J IMMUNOL, V146, P2345; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; TWETEN RK, 1991, J BIOL CHEM, V266, P12449; TWETEN RK, 1988, INFECT IMMUN, V56, P3228, DOI 10.1128/IAI.56.12.3228-3234.1988; Yu JH, 1997, J EXP MED, V185, P745, DOI 10.1084/jem.185.4.745; Zhao XJ, 1998, J BIOL CHEM, V273, P10665, DOI 10.1074/jbc.273.17.10665	40	45	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20952	20962		10.1074/jbc.M111.237446	http://dx.doi.org/10.1074/jbc.M111.237446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507937	Green Published, hybrid			2022-12-25	WOS:000291267600079
J	Motta-Mena, LB; Smith, SA; Mallory, MJ; Jackson, J; Wang, JR; Lynch, KW				Motta-Mena, Laura B.; Smith, Sarah A.; Mallory, Michael J.; Jackson, Jason; Wang, Jiarong; Lynch, Kristen W.			A Disease-associated Polymorphism Alters Splicing of the Human CD45 Phosphatase Gene by Disrupting Combinatorial Repression by Heterogeneous Nuclear Ribonucleoproteins (hnRNPs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POINT MUTATION; EXON; ACTIVATION; KINASE; RNA	Alternative splicing is typically controlled by complexes of regulatory proteins that bind to sequences within or flanking variable exons. The identification of regulatory sequence motifs and the characterization of sequence motifs bound by splicing regulatory proteins have been essential to predicting splicing regulation. The activation-responsive sequence (ARS) motif has previously been identified in several exons that undergo changes in splicing upon T cell activation. hnRNP L binds to this ARS motif and regulates ARS-containing exons; however, hnRNP L does not function alone. Interestingly, the proteins that bind together with hnRNP L differ for different exons that contain the ARS core motif. Here we undertake a systematic mutational analysis of the best characterized context of the ARS motif, namely the ESS1 sequence from CD45 exon 4, to understand the determinants of binding specificity among the components of the ESS1 regulatory complex and the relationship between protein binding and function. We demonstrate that different mutations within the ARS motif affect specific aspects of regulatory function and disrupt the binding of distinct proteins. Most notably, we demonstrate that the C77G polymorphism, which correlates with autoimmune disease susceptibility in humans, disrupts exon silencing by preventing the redundant activity of hnRNPs K and E2 to compensate for the weakened function of hnRNP L. Therefore, these studies provide an important example of the functional relevance of combinatorial function in splicing regulation and suggest that additional polymorphisms may similarly disrupt function of the ESS1 silencer.	[Motta-Mena, Laura B.; Jackson, Jason; Wang, Jiarong; Lynch, Kristen W.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Smith, Sarah A.; Mallory, Michael J.; Lynch, Kristen W.] Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Lynch, KW (corresponding author), 422 Curie Blvd, Philadelphia, PA 19104 USA.	klync@mail.med.upenn.edu			National Institutes of Health [R01 GM067719, GM084034]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067719, R01GM084034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM067719 and GM084034 (to K. W. L.).	Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CHAN RC, 1995, MOL CELL BIOL, V15, P6377; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dornan S, 2002, J BIOL CHEM, V277, P1912, DOI 10.1074/jbc.M108386200; Evsyukova I, 2010, RNA BIOL, V7, P462, DOI 10.4161/rna.7.4.12301; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Jacobsen M, 2000, NAT GENET, V26, P495, DOI 10.1038/82659; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Tchilian EZ, 2001, AIDS, V15, P1892, DOI 10.1097/00002030-200109280-00024; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Zilch CF, 1998, EUR J IMMUNOL, V28, P22, DOI 10.1002/(SICI)1521-4141(199801)28:01<22::AID-IMMU22>3.0.CO;2-7	26	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20043	20053		10.1074/jbc.M111.218727	http://dx.doi.org/10.1074/jbc.M111.218727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21507955	Green Published, hybrid			2022-12-25	WOS:000291027700081
J	Dobson-Belaire, WN; Cochrane, A; Ostrowski, MA; Gray-Owen, SD				Dobson-Belaire, Wendy N.; Cochrane, Alan; Ostrowski, Mario A.; Gray-Owen, Scott D.			Differential Response of Primary and Immortalized CD4(+) T Cells to Neisseria gonorrhoeae-Induced Cytokines Determines the Effect on HIV-1 Replication	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS FACTOR-ALPHA; DENDRITIC CELLS; CANCER-CELLS; IFN-ALPHA; INFECTION; TRANSMISSION; EXPRESSION; INDUCTION	To compare the effect of gonococcal co-infection on immortalized versus primary CD4(+) T cells the Jurkat cell line or freshly isolated human CD4(+) T cells were infected with the HIV-1 X4 strain NL4-3. These cells were exposed to whole gonococci, supernatants from gonococcal-infected PBMCs, or N. gonorrhoeae-induced cytokines at varying levels. Supernatants from gonococcal-infected PBMCs stimulated HIV-1 replication in Jurkat cells while effectively inhibiting HIV-1 replication in primary CD4(+) T cells. ELISA-based analyses revealed that the gonococcal-induced supernatants contained high levels of proinflammatory cytokines that promote HIV-1 replication, as well as the HIV-inhibitory IFN alpha. While all the T cells responded to the HIV-stimulatory cytokines, albeit to differing degrees, the Jurkat cells were refractory to IFN alpha. Combined, these results indicate that N. gonorrhoeae elicits immune-modulating cytokines that both activate and inhibit HIV-production; the outcome of co-infection depending upon the balance between these opposing signals.	[Dobson-Belaire, Wendy N.; Cochrane, Alan; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Ostrowski, Mario A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Dobson-Belaire, WN (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	scott.gray.owen@utoronto.ca	Gray-Owen, Scott/AFL-7380-2022; Gray-Owen, Scott/AAG-7337-2022	Gray-Owen, Scott D./0000-0002-1477-3616	Ontario HIV Treatment Network [ROGB-208]; Canadian Institutes for Health Research [HET-85518]	Ontario HIV Treatment Network; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Ontario HIV Treatment Network grant ROGB-208 (www.ohtn.on.ca) and the Canadian Institutes for Health Research grant HET-85518 (www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccellino M, 2004, J CELL PHYSIOL, V201, P71, DOI 10.1002/jcp.20058; Camargo JF, 2009, J IMMUNOL, V182, P171, DOI 10.4049/jimmunol.182.1.171; Caraglia M, 2009, CURR CANCER DRUG TAR, V9, P690, DOI 10.2174/156800909789056980; Chen A, 2003, AIDS, V17, P625, DOI 10.1097/00002030-200303070-00019; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Connolly NC, 2005, AIDS REV, V7, P168; Ding J, 2010, J IMMUNOL, V184, P2814, DOI 10.4049/jimmunol.0902125; Dobson-Belaire WN, 2010, CELL MICROBIOL, V12, P1703, DOI 10.1111/j.1462-5822.2010.01502.x; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; Liu XY, 2006, J INFECT DIS, V194, P751, DOI 10.1086/506360; Naviglio S, 2007, J INTERF CYTOK RES, V27, P129, DOI 10.1089/jir.2006.0101; OKAMOTO T, 1989, AIDS RES HUM RETROV, V5, P131, DOI 10.1089/aid.1989.5.131; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; POLI G, 1992, AIDS RES HUM RETROV, V8, P191, DOI 10.1089/aid.1992.8.191; SALYERS AA, 2002, BACTERIAL PATHOGENES, P437; Zhang JZ, 2005, J IMMUNOL, V174, P7995, DOI 10.4049/jimmunol.174.12.7995	21	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18133	10.1371/journal.pone.0018133	http://dx.doi.org/10.1371/journal.pone.0018133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526113	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800005
J	Meriaux, C; Arafah, K; Tasiemski, A; Wisztorski, M; Bruand, J; Boidin-Wichlacz, C; Desmons, A; Debois, D; Laprevote, O; Brunelle, A; Gaasterland, T; Macagno, E; Fournier, I; Salzet, M				Meriaux, Celine; Arafah, Karim; Tasiemski, Aurelie; Wisztorski, Maxence; Bruand, Jocelyne; Boidin-Wichlacz, Celine; Desmons, Annie; Debois, Delphine; Laprevote, Olivier; Brunelle, Alain; Gaasterland, Terry; Macagno, Eduardo; Fournier, Isabelle; Salzet, Michel			Multiple Changes in Peptide and Lipid Expression Associated with Regeneration in the Nervous System of the Medicinal Leech	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; HIRUDO-MEDICINALIS; DIFFERENTIAL GLYCOSYLATION; MASS-SPECTROMETRY; SINGLE-CELL; FATTY-ACIDS; PROTEIN; NEURONS; GENES; BRAIN	BACKGROUND: The adult medicinal leech central nervous system (CNS) is capable of regenerating specific synaptic circuitry after a mechanical lesion, displaying evidence of anatomical repair within a few days and functional recovery within a few weeks. In the present work, spatiotemporal changes in molecular distributions during this phenomenon are explored. Moreover, the hypothesis that neural regeneration involves some molecular factors initially employed during embryonic neural development is tested. RESULTS: Imaging mass spectrometry coupled to peptidomic and lipidomic methodologies allowed the selection of molecules whose spatiotemporal pattern of expression was of potential interest. The identification of peptides was aided by comparing MS/MS spectra obtained for the peptidome extracted from embryonic and adult tissues to leech transcriptome and genome databases. Through the parallel use of a classical lipidomic approach and secondary ion mass spectrometry, specific lipids, including cannabinoids, gangliosides and several other types, were detected in adult ganglia following mechanical damage to connected nerves. These observations motivated a search for possible effects of cannabinoids on neurite outgrowth. Exposing nervous tissues to Transient Receptor Potential Vanilloid (TRPV) receptor agonists resulted in enhanced neurite outgrowth from a cut nerve, while exposure to antagonists blocked such outgrowth. CONCLUSION: The experiments on the regenerating adult leech CNS reported here provide direct evidence of increased titers of proteins that are thought to play important roles in early stages of neural development. Our data further suggest that endocannabinoids also play key roles in CNS regeneration, mediated through the activation of leech TRPVs, as a thorough search of leech genome databases failed to reveal any leech orthologs of the mammalian cannabinoid receptors but revealed putative TRPVs. In sum, our observations identify a number of lipids and proteins that may contribute to different aspects of the complex phenomenon of leech nerve regeneration, establishing an important base for future functional assays.	[Meriaux, Celine; Arafah, Karim; Tasiemski, Aurelie; Wisztorski, Maxence; Boidin-Wichlacz, Celine; Desmons, Annie; Fournier, Isabelle; Salzet, Michel] Univ Lille 1, Univ Lille Nord France, Lab Spectrometrie Masse Biol Fondamentale & Appl, EA 4550, F-59655 Villeneuve Dascq, France; [Bruand, Jocelyne; Macagno, Eduardo] Univ Calif San Diego, Div Biol Sci, La Jolla, CA USA; [Debois, Delphine; Laprevote, Olivier; Brunelle, Alain] Ctr Rech Gif, Inst Chim Subst Nat, Gif Sur Yvette, France; [Laprevote, Olivier] Univ Paris 05, Fac Sci Pharmaceut & Biol, Paris, France; [Gaasterland, Terry] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, Div Biol Sci,Inst Genom Med, La Jolla, CA 92093 USA	Universite de Lille - ISITE; Universite de Lille; University of California System; University of California San Diego; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Diego; Scripps Institution of Oceanography	Meriaux, C (corresponding author), Univ Lille 1, Univ Lille Nord France, Lab Spectrometrie Masse Biol Fondamentale & Appl, EA 4550, F-59655 Villeneuve Dascq, France.	isabelle.fournier@univ-lille1.fr; michel.salzet@univ-lille1.fr	Brunelle, Alain/L-3889-2013; Wisztorski, Maxence/F-4380-2010; FOURNIER, Isabelle/H-9195-2015; Arafah, Karim/ABE-1699-2021; Salzet, Michel/A-7675-2011; Tasiemski, Aurelie/S-2537-2016	Brunelle, Alain/0000-0001-6526-6481; Wisztorski, Maxence/0000-0003-1320-075X; FOURNIER, Isabelle/0000-0003-1096-5044; Salzet, Michel/0000-0003-4318-0817; Meriaux, Celine/0000-0002-2413-2599; Boidin, Capucine/0000-0002-4488-9361; Tasiemski, Aurelie/0000-0003-3559-5115; Wichlacz, Celine/0000-0002-0242-868X	Centre National de la Recherche Scientifique (CNRS); Ministere de l'Enseignement, de la Recherche et des Technologies (MERT); Genoscope; Agence Nationale de la Recherche (ANR); NSF [DBI-0852081]; National Institutes of Health [1RC2EY020678]; NATIONAL EYE INSTITUTE [RC2EY020678] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement, de la Recherche et des Technologies (MERT); Genoscope; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the Centre National de la Recherche Scientifique (CNRS), by the Ministere de l'Enseignement, de la Recherche et des Technologies (MERT), by the Genoscope, by the Agence Nationale de la Recherche (ANR), by NSF Grant DBI-0852081 and by National Institutes of Health Grant 1RC2EY020678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisemberg G.O., 1995, Experientia Supplementum (Basel), V72, P77; Aisemberg GO, 2001, DEV GENES EVOL, V211, P589, DOI 10.1007/s00427-001-0183-2; AISEMBERG GO, 1993, J NEUROBIOL, V24, P1423, DOI 10.1002/neu.480241012; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Baker MW, 2010, DEV BIOL, V344, P346, DOI 10.1016/j.ydbio.2010.06.005; Baker MW, 2000, CURR BIOL, V10, P1071, DOI 10.1016/S0960-9822(00)00674-6; Batchelor PE, 2003, J CLIN NEUROSCI, V10, P523, DOI 10.1016/S0967-5868(03)00004-3; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Biswas SC, 2002, MOL CELL NEUROSCI, V21, P657, DOI 10.1006/mcne.2002.1209; Blackshaw SE, 2004, J ANAT, V204, P13, DOI 10.1111/j.1469-7580.2004.00260.x; Blackshaw SE, 2003, J NEUROBIOL, V55, P355, DOI 10.1002/neu.10214; Bruand J., 2011, J PROTEOME IN PRESS; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Calon F, 2007, PROSTAG LEUKOTR ESS, V77, P287, DOI 10.1016/j.plefa.2007.10.019; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Croq F, 2010, GLIA, V58, P1649, DOI 10.1002/glia.21036; DERIEMER SA, 1983, BRAIN RES, V272, P157, DOI 10.1016/0006-8993(83)90373-6; DROUET J, 1972, CR SOC BIOL, V166, P1585; Dykes IM, 2004, J NEUROSCI, V24, P886, DOI 10.1523/JNEUROSCI.3676-03.2004; Emes RD, 2003, FEBS LETT, V533, P124, DOI 10.1016/S0014-5793(02)03741-9; Farber K, 2009, J NEUROSCI RES, V87, P644, DOI 10.1002/jnr.21875; Farooqui AA, 2007, BRAIN RES REV, V56, P443, DOI 10.1016/j.brainresrev.2007.09.004; FERNANDEZ J, 1982, J EMBRYOL EXP MORPH, V72, P71; Finger FP, 2003, DEV BIOL, V261, P220, DOI 10.1016/S0012-1606(03)00296-3; Galve-Roperh I, 2007, NEUROSCIENTIST, V13, P109, DOI 10.1177/1073858406296407; Gan WB, 1999, J NEUROBIOL, V40, P103, DOI 10.1002/(SICI)1097-4695(199907)40:1<103::AID-NEU9>3.3.CO;2-X; GORIO A, 1986, CRC CR REV CL NEUROB, V2, P241; Guo LH, 2004, J NEUROIMMUNOL, V146, P39, DOI 10.1016/j.jneuroim.2003.09.017; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Huang YQ, 1998, J COMP NEUROL, V397, P394; Huang YQ, 1997, J CELL BIOL, V138, P143, DOI 10.1083/jcb.138.1.143; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; *JGI, HELL ROB GEN VERS 1; Ji Y, 2005, J NEUROBIOL, V64, P157, DOI 10.1002/neu.20131; Ji Y, 2001, BBA-GENE STRUCT EXPR, V1519, P246, DOI 10.1016/S0167-4781(01)00234-2; Jie CF, 2000, BBA-PROTEIN STRUCT M, V1479, P1, DOI 10.1016/S0167-4838(00)00030-3; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Korneev Sergei, 1997, Invertebrate Neuroscience, V3, P185, DOI 10.1007/BF02480373; Lemaire R, 2006, ANAL CHEM, V78, P7145, DOI 10.1021/ac060565z; Liebrich M, 2007, ARCH IMMUNOL THER EX, V55, P41, DOI 10.1007/s00005-007-0003-0; Lin YH, 2007, J LIPID RES, V48, P2709, DOI 10.1194/jlr.M700369-JLR200; Lopez-Vales R, 2008, BRAIN, V131, P2620, DOI 10.1093/brain/awn188; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Magnusson YK, 2008, OBESITY, V16, P2745, DOI 10.1038/oby.2008.424; Matias I, 2001, MOL BRAIN RES, V87, P145, DOI 10.1016/S0169-328X(00)00290-4; Mazza M, 2007, PROG NEURO-PSYCHOPH, V31, P12, DOI 10.1016/j.pnpbp.2006.07.010; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Mueller CA, 2006, J NEUROSURG-SPINE, V4, P233, DOI 10.3171/spi.2006.4.3.233; MULLER KJ, 1979, SCIENCE, V206, P87, DOI 10.1126/science.482931; NICHOLLS JG, 1989, Q J EXP PHYSIOL CMS, V74, P965, DOI 10.1113/expphysiol.1989.sp003372; NICHOLLS JG, 1968, J NEUROPHYSIOL, V31, P740, DOI 10.1152/jn.1968.31.5.740; Pereira LA, 2008, CELL BIOCHEM FUNCT, V26, P197, DOI 10.1002/cbf.1432; Popovich PG, 2000, PROG BRAIN RES, V128, P43; Salzet M, 2000, EUR J BIOCHEM, V267, P4917, DOI 10.1046/j.1432-1327.2000.01550.x; Salzet M, 2002, PROSTAG LEUKOTR ESS, V66, P353, DOI 10.1054/plef.2001.0347; Salzet M, 2000, BRAIN RES REV, V34, P69, DOI 10.1016/S0165-0173(00)00041-2; Salzet M, 2009, ANNELIDS IN MODERN BIOLOGY, P154; Samuels SE, 2010, J GEN PHYSIOL, V136, P425, DOI 10.1085/jgp.201010476; Schikorski D, 2008, J IMMUNOL, V181, P1083, DOI 10.4049/jimmunol.181.2.1083; Schikorski D, 2009, J IMMUNOL, V183, P7119, DOI 10.4049/jimmunol.0900538; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Seeley EH, 2008, J AM SOC MASS SPECTR, V19, P1069, DOI 10.1016/j.jasms.2008.03.016; Sethi J, 2010, MOL CELL NEUROSCI, V45, P430, DOI 10.1016/j.mcn.2010.08.002; SHEFI O, 2008, J VIS EXP; Silverman-Gavrila LB, 2009, NEUROSCIENCE, V161, P621, DOI 10.1016/j.neuroscience.2009.03.043; Stefano GB, 1998, BRAIN RES, V793, P341, DOI 10.1016/S0006-8993(98)00273-X; Stefano GB, 1997, BRAIN RES, V763, P63, DOI 10.1016/S0006-8993(97)00403-4; Stefano GB, 1996, ADV NEUROIMMUNOL, V6, P265, DOI 10.1016/S0960-5428(96)00022-8; Stefano George B, 2002, Med Sci Monit, V8, pBR199; Stubiger G, 2008, ANAL CHEM, V80, P1664, DOI 10.1021/ac7018766; Tahtouh M, 2009, MOL IMMUNOL, V46, P523, DOI 10.1016/j.molimm.2008.07.026; Tahtouh M, 2009, EUR CYTOKINE NETW, V20, P95, DOI 10.1684/ecn.2009.0157; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Tasiemski A, 2004, J BIOL CHEM, V279, P30973, DOI 10.1074/jbc.M312156200; Tasiemski A, 2000, J NEUROIMMUNOL, V109, P228, DOI 10.1016/S0165-5728(00)00314-3; TASIEMSKI A, 2010, LANDES BIOSCIENCE DE, P708; Touboul D, 2005, J AM SOC MASS SPECTR, V16, P1608, DOI 10.1016/j.jasms.2005.06.005; *U MISS BIOINF CON, VELV OPT VERS 2 1 4; Venkitaramani DV, 2004, J NEUROBIOL, V60, P369, DOI 10.1002/neu.20035; Vergote D, 2004, J BIOL CHEM, V279, P43828, DOI 10.1074/jbc.M403073200; Vergote D, 2006, PROTEOMICS, V6, P4817, DOI 10.1002/pmic.200500902; Wang WZ, 2005, CELL MOL NEUROBIOL, V25, P427, DOI 10.1007/s10571-005-3151-y; Xu YZ, 2003, J BIOL CHEM, V278, P4322, DOI 10.1074/jbc.M210775200; Xu YZ, 1999, J NEUROBIOL, V40, P244, DOI 10.1002/(SICI)1097-4695(199908)40:2<244::AID-NEU10>3.0.CO;2-A; Young AL, 2010, GENOME RES, V20, P249, DOI 10.1101/gr.097956.109; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang X, 2010, BRIT J PHARMACOL, V160, P1583, DOI 10.1111/j.1476-5381.2010.00841.x	89	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18359	10.1371/journal.pone.0018359	http://dx.doi.org/10.1371/journal.pone.0018359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526169	Green Published, gold			2022-12-25	WOS:000290015800007
J	Olsson, M; Pauliny, A; Wapstra, E; Uller, T; Schwartz, T; Blomqvist, D				Olsson, Mats; Pauliny, Angela; Wapstra, Erik; Uller, Tobias; Schwartz, Tonia; Blomqvist, Donald			Sex Differences in Sand Lizard Telomere Inheritance: Paternal Epigenetic Effects Increases Telomere Heritability and Offspring Survival	PLOS ONE			English	Article							LACERTA-AGILIS; OXIDATIVE STRESS; LIFE EXPECTANCY; X-CHROMOSOME; VIPERA-BERUS; LENGTH; AGE; POPULATION; LONGEVITY; SENESCENCE	BACKGROUND: To date, the only estimate of the heritability of telomere length in wild populations comes from humans. Thus, there is a need for analysis of natural populations with respect to how telomeres evolve. METHODOLOGY/PRINCIPAL FINDINGS: Here, we show that telomere length is heritable in free-ranging sand lizards, Lacerta agilis. More importantly, heritability estimates analysed within, and contrasted between, the sexes are markedly different; son-sire heritability is much higher relative to daughter-dam heritability. We assess the effect of paternal age on Telomere Length (TL) and show that in this species, paternal age at conception is the best predictor of TL in sons. Neither paternal age per se at blood sampling for telomere screening, nor corresponding age in sons impact TL in sons. Processes maintaining telomere length are also associated with negative fitness effects, most notably by increasing the risk of cancer and show variation across different categories of individuals (e.g. males vs. females). We therefore tested whether TL influences offspring survival in their first year of life. Indeed such effects were present and independent of sex-biased offspring mortality and offspring malformations. CONCLUSIONS/SIGNIFICANCE: TL show differences in sex-specific heritability with implications for differences between the sexes with respect to ongoing telomere selection. Paternal age influences the length of telomeres in sons and longer telomeres enhance offspring survival.	[Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Olsson, Mats; Pauliny, Angela; Blomqvist, Donald] Univ Gothenburg, Dept Zool, Gothenburg, Sweden; [Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Schwartz, Tonia] Iowa State Univ, Ecol Evolut & Organismal Biol Dept, Interdept Genet Program, Ames, IA USA	University of Sydney; University of Gothenburg; University of Tasmania; University of Oxford; Iowa State University	Olsson, M (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	molsson@uow.edu.au	Olsson, Mats/AAK-5565-2021; Wapstra, Erik/J-7482-2014	Olsson, Mats/0000-0002-4130-1323; Wapstra, Erik/0000-0002-2050-8026; Schwartz, Tonia/0000-0002-7712-2810	Australian Research Council [LX 0774959]; Swedish Science Council	Australian Research Council(Australian Research Council); Swedish Science Council	This project was funded by the Australian Research Council, grant number:LX 0774959. www.arc.gov.au. The authors thank the Swedish Science Council for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001739; ARMANIOS M, 2004, GENETICS, V102, P15960; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Banerjee Partha P., 2009, V523, P383, DOI 10.1007/978-1-59745-190-1_25; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; BECK S, 1990, ANAL CHEM, V62, P2258, DOI 10.1021/ac00220a003; Betts DH, 2001, THERIOGENOLOGY, V55, P171, DOI 10.1016/S0093-691X(00)00453-2; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Chiang YJ, 2010, P NATL ACAD SCI USA, V107, P10148, DOI 10.1073/pnas.0913125107; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Eskes T, 2007, EUR J OBSTET GYN R B, V133, P126, DOI 10.1016/j.ejogrb.2007.01.006; Falconer D. S., 1981, INTRO QUANTITATIVE G; Francis N, 2006, FEBS LETT, V580, P4713, DOI 10.1016/j.febslet.2006.07.049; Graakjaer J, 2004, AGING CELL, V3, P97, DOI 10.1111/j.1474-9728.2004.00093.x; Grant JD, 2001, BIOTECHNIQUES, V31, P1314, DOI 10.2144/01316bc02; Harlow Peter S., 1996, Herpetological Review, V27, P71; Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244; Haussmann MF, 2002, OECOLOGIA, V130, P325, DOI 10.1007/s00442-001-0827-y; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Kappei D, 2008, MECH AGEING DEV, V129, P17, DOI 10.1016/j.mad.2007.10.009; Keefe DL, 2005, AM J OBSTET GYNECOL, V192, P1256, DOI 10.1016/j.ajog.2005.01.036; Londono-Vallejo JA, 2010, EPIGENETICS OF AGING, P205, DOI 10.1007/978-1-4419-0639-7_12; Madsen T, 2000, BIOL CONSERV, V94, P257, DOI 10.1016/S0006-3207(99)00127-5; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; ODIERNA G, 1993, AMPHIBIA-REPTILIA, V4, P1; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; Olsson M, 2004, ECOL LETT, V7, P924, DOI 10.1111/j.1461-0248.2004.00652.x; Olsson M, 2001, J HERED, V92, P190, DOI 10.1093/jhered/92.2.190; Olsson M, 2005, EVOLUTION, V59, P221; Olsson M, 2010, BIOL LETTERS, V6, P651, DOI 10.1098/rsbl.2010.0126; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Perez-Rivero G, 2008, FREE RADICAL BIO MED, V45, P1243, DOI 10.1016/j.freeradbiomed.2008.07.017; Price DC, 1996, SCI JUSTICE, V36, P275, DOI 10.1016/S1355-0306(96)72614-X; Roff Derek A., 2006, P267; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sambrook J., 2002, MOL CLONING LAB MANU; Schwartz TS, 2008, CONSERV GENET, V9, P715, DOI 10.1007/s10592-006-9238-2; Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062; Stindl R, 2004, MED HYPOTHESES, V62, P151, DOI 10.1016/S0306-9877(03)00316-5; Surralles J, 1999, AM J HUM GENET, V65, P1617, DOI 10.1086/302665; Ujvari B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007493; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; Vogel G, 2009, SCIENCE, V326, P212, DOI 10.1126/science.326_212; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Woo J, 2008, MECH AGEING DEV, V129, P642, DOI 10.1016/j.mad.2008.08.003	51	67	67	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e17473	10.1371/journal.pone.0017473	http://dx.doi.org/10.1371/journal.pone.0017473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526170	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800001
J	Li, Y; Yi, HY; Yao, YX; Liao, XD; Xie, YQ; Yang, J; Yan, Z; Wang, L; Lu, SY; Kuang, Y; Gu, MM; Fei, J; Wang, ZG; Huang, L				Li, Yuan; Yi, Haiying; Yao, Yixin; Liao, Xiaodong; Xie, Yiqun; Yang, Jie; Yan, Zheng; Wang, Long; Lu, Shunyuan; Kuang, Ying; Gu, Mingmin; Fei, Jian; Wang, Zhugang; Huang, Lei			The Cytoplasmic Domain of MUC1 Induces Hyperplasia in the Mammary Gland and Correlates with Nuclear Accumulation of beta-Catenin	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; TRANSGENIC MOUSE MODELS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; CYCLIN D1; C-MYC; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; EPITHELIAL-CELLS; MICE	MUC1 is an oncoprotein that is overexpressed in up to 90% of breast carcinomas. A previous in vitro study by our group demonstrated that the cytoplasmic domain of MUC1 (MUC1-CD), the minimal functional unit of MUC1, contributes to the malignant phenotype in cells by binding directly to beta-catenin and protecting beta-catenin from GSK3 beta-induced degradation. To understand the in vivo role of MUC1-CD in breast development, we generated a MUC1-CD transgenic mouse model under the control of the MMTV promoter in a C57BL/6J background, which is more resistant to breast tumor. We show that the expression of MUC1-CD in luminal epithelial cells of the mammary gland induced a hyperplasia phenotype characterized by the development of hyper-branching and extensive lobuloalveoli in transgenic mice. In addition to this hyperplasia, there was a marked increase in cellular proliferation in the mouse mammary gland. We further show that MUC1-CD induces nuclear localization of beta-catenin, which is associated with a significant increase of beta-catenin activity, as shown by the elevated expression of cyclin D1 and c-Myc in MMTV-MUC1-CD mice. Consistent with this finding, we observed that overexpression of MUC1-C is associated with beta-catenin nuclear localization in tumor tissues and increased expression of Cyclin D1 and c-Myc in breast carcinoma specimens. Collectively, our data indicate a critical role for MUC1-CD in the development of mammary gland preneoplasia and tumorigenesis, suggesting MUC1-CD as a potential target for the diagnosis and chemoprevention of human breast cancer.	[Li, Yuan; Yao, Yixin; Liao, Xiaodong; Yang, Jie; Yan, Zheng; Gu, Mingmin; Wang, Zhugang; Huang, Lei] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, E Inst Shanghai Univ, Shanghai 200030, Peoples R China; [Yi, Haiying; Xie, Yiqun] Shanghai Huangpu Ctr Hosp, Dept Breast Surg, Shanghai, Peoples R China; [Wang, Long; Lu, Shunyuan; Kuang, Ying; Fei, Jian; Wang, Zhugang] Shanghai Res Ctr Model Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University	Li, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, E Inst Shanghai Univ, Shanghai 200030, Peoples R China.	zhugangw@shsmu.edu.cn; leihuang@shsmu.edu.cn		Yao, Yixin/0000-0003-1891-7186; Huang, Lei/0000-0002-4851-4807	National Natural Science Foundation of China [30671169, 30871363]; New Century Excellent Talents in University; SRF for ROCS of State Education Ministry [NCET-08-0349]; Ministry of Science & Technology of China [2006BAI23B02]; Shanghai Pujiang Program [07pj14065]; Natural Science Foundation of Shanghai by Science and Technology Commission of Shanghai Municipality [06ZR14067]; Shanghai Municipal Education Commission [E03003]; National comprehensive technology platforms for innovative drug R D [2009ZX09301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); SRF for ROCS of State Education Ministry; Ministry of Science & Technology of China(Ministry of Science and Technology, China); Shanghai Pujiang Program(Shanghai Pujiang Program); Natural Science Foundation of Shanghai by Science and Technology Commission of Shanghai Municipality; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); National comprehensive technology platforms for innovative drug R D	This work was supported by the National Natural Science Foundation of China (grant numbers 30671169, 30871363), the New Century Excellent Talents in University and SRF for ROCS of State Education Ministry grant number NCET-08-0349, the Ministry of Science & Technology of China (grant number 2006BAI23B02), the Shanghai Pujiang Program (grant number 07pj14065), the Natural Science Foundation of Shanghai by Science and Technology Commission of Shanghai Municipality (grant number 06ZR14067), the Shanghai Municipal Education Commission (grant number E03003) and the National comprehensive technology platforms for innovative drug R & D, 2009ZX09301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 1996, BREAST CANCER RES TR, V39, P119, DOI 10.1007/BF01806083; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blake JA, 1999, NUCLEIC ACIDS RES, V27, P95, DOI 10.1093/nar/27.1.95; Boras-Granic Kata, 2008, Organogenesis, V4, P116; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Brayman Melissa, 2004, Reprod Biol Endocrinol, V2, P4, DOI 10.1186/1477-7827-2-4; Brisken C, 2000, GENE DEV, V14, P650; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Djonov V, 2001, MICROSC RES TECHNIQ, V52, P182, DOI 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.3.CO;2-D; GILLETT C, 1994, CANCER RES, V54, P1812; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huang L, 2003, CANCER BIOL THER, V2, P702; Huang Lei, 2010, Genes Cancer, V1, P239; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2008, CANCER BIOL THER, V7, P81, DOI 10.4161/cbt.7.1.5631; Kumar R, 2000, ENDOCR-RELAT CANCER, V7, P257, DOI 10.1677/erc.0.0070257; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; MCINTOSH GG, 1995, ONCOGENE, V11, P885; Medina D, 1996, J MAMMARY GLAND BIOL, V1, P5, DOI 10.1007/BF02096299; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Moser AR, 2001, CANCER RES, V61, P3480; Nass SJ, 1997, BREAST CANCER RES TR, V44, P1, DOI 10.1023/A:1005858611585; PIERCE DF, 1993, GENE DEV, V7, P2308, DOI 10.1101/gad.7.12a.2308; Poh TW, 2009, CANCER RES, V69, P3554, DOI 10.1158/0008-5472.CAN-08-3806; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SPICER AP, 1995, MAMM GENOME, V6, P885, DOI 10.1007/BF00292441; Sutherland RL, 2002, BREAST CANCER RES, V4, P14, DOI 10.1186/bcr411; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Tepera SB, 2003, J CELL SCI, V116, P1137, DOI 10.1242/jcs.00334; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Wen YF, 2003, J BIOL CHEM, V278, P38029, DOI 10.1074/jbc.M304333200; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yin L, 2004, J BIOL CHEM, V279, P45721, DOI 10.1074/jbc.M408027200; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhao XD, 2006, INT J CANCER, V118, P643, DOI 10.1002/ijc.21400; ZOTTER S, 1988, Cancer Reviews, V11-12, P55	58	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19102	10.1371/journal.pone.0019102	http://dx.doi.org/10.1371/journal.pone.0019102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533058	Green Submitted, Green Published, gold			2022-12-25	WOS:000289719400059
J	Stapleton, CM; Mashek, DG; Wang, SL; Nagle, CA; Cline, GW; Thuillier, P; Leesnitzer, LM; Li, LO; Stimmel, JB; Shulman, GI; Coleman, RA				Stapleton, Cliona M.; Mashek, Douglas G.; Wang, Shuli; Nagle, Cynthia A.; Cline, Gary W.; Thuillier, Philippe; Leesnitzer, Lisa M.; Li, Lei O.; Stimmel, Julie B.; Shulman, Gerald I.; Coleman, Rosalind A.			Lysophosphatidic Acid Activates Peroxisome Proliferator Activated Receptor-gamma in CHO Cells That Over-Express Glycerol 3-Phosphate Acyltransferase-1	PLOS ONE			English	Article							PPAR-GAMMA; FATTY-ACIDS; ALPHA; DIACYLGLYCEROL; MECHANISMS; TRIACYLGLYCEROL; TISSUE; DOMAIN; GENES; LIVER	Lysophosphatidic acid (LPA) is an agonist for peroxisome proliferator activated receptor-gamma (PPAR gamma). Although glycerol-3-phosphate acyltransferase-1 (GPAT1) esterifies glycerol-3-phosphate to form LPA, an intermediate in the de novo synthesis of glycerolipids, it has been assumed that LPA synthesized by this route does not have a signaling role. The availability of Chinese Hamster Ovary (CHO) cells that stably overexpress GPAT1, allowed us to analyze PPAR gamma activation in the presence of LPA produced as an intracellular intermediate. LPA levels in CHO-GPAT1 cells were 6-fold higher than in wild-type CHO cells, and the mRNA abundance of CD36, a PPAR gamma target, was 2-fold higher. Transactivation assays showed that PPAR gamma activity was higher in the cells that overexpressed GPAT1. PPAR gamma activity was enhanced further in CHO-GPAT1 cells treated with the PPAR gamma ligand troglitazone. Extracellular LPA, phosphatidic acid (PA) or a membrane-permeable diacylglycerol had no effect, showing that PPAR gamma had been activated by LPA generated intracellularly. Transient transfection of a vector expressing 1-acylglycerol-3-phosphate acyltransferase-2, which converts endogenous LPA to PA, markedly reduced PPAR gamma activity, as did over-expressing diacylglycerol kinase, which converts DAG to PA, indicating that PA could be a potent inhibitor of PPAR gamma. These data suggest that LPA synthesized via the glycerol-3-phosphate pathway can activate PPAR gamma and that intermediates of de novo glycerolipid synthesis regulate gene expression.	[Stapleton, Cliona M.; Mashek, Douglas G.; Wang, Shuli; Nagle, Cynthia A.; Li, Lei O.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA; [Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Cline, Gary W.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Thuillier, Philippe] Oregon Hlth & Sci Univ, Oregon Canc Inst, Portland, OR USA; [Leesnitzer, Lisa M.; Stimmel, Julie B.] GlaxoSmithKline Inc, Dept Screening & Compound Profiling, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Yale University; Yale University; Oregon Health & Science University; GlaxoSmithKline	Stapleton, CM (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA.	rcoleman@unc.edu	Shulman, Gerald I./P-7176-2019; Mashek, Douglas/ABD-6844-2021	Shulman, Gerald I./0000-0003-1529-5668; Mashek, Douglas/0000-0001-7033-3386	NIH [DK56598, DK59935, DK68993, DK40936, U24 DK59635, P30 DK34987]; AICR/WRF; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, F32DK068993, P30DK034987, R01DK059935, R01DK056598, U24DK059635, R56DK056598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AICR/WRF; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH grants DK56598, DK59935, DK68993, DK40936, U24 DK59635, P30 DK34987; Marilyn Gentry Fellowship from AICR/WRF; Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anliker B, 2004, J BIOL CHEM, V279, P20555, DOI 10.1074/jbc.R400013200; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; DAVIS RJ, 1985, J BIOL CHEM, V260, P1562; DEUTSCH J, 1994, ANAL BIOCHEM, V220, P321, DOI 10.1006/abio.1994.1344; Gervois P, 2004, INT J CLIN PRACT, V58, P22, DOI 10.1111/j.1368-504X.2004.00376.x; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Guo W, 2006, AM J PHYSIOL-GASTR L, V290, pG528, DOI 10.1152/ajpgi.00386.2005; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Haque W, 2005, BIOCHEM BIOPH RES CO, V327, P446, DOI 10.1016/j.bbrc.2004.12.024; Holdsworth G, 2005, GENE, V350, P59, DOI 10.1016/j.gene.2005.01.016; Igal RA, 2001, J BIOL CHEM, V276, P42205, DOI 10.1074/jbc.M103386200; Jiang Y, 2000, J BIOL CHEM, V275, P34092, DOI 10.1074/jbc.M004914200; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Nichols JS, 1998, ANAL BIOCHEM, V257, P112, DOI 10.1006/abio.1997.2557; PAGANO RE, 1985, J BIOL CHEM, V260, P1909; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; Simon MF, 2002, J BIOL CHEM, V277, P23131, DOI 10.1074/jbc.M201530200; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Tigyi G, 2003, PROG LIPID RES, V42, P498, DOI 10.1016/S0163-7827(03)00035-3; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; Yan ZH, 1998, J BIOL CHEM, V273, P10948, DOI 10.1074/jbc.273.18.10948; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	34	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18932	10.1371/journal.pone.0018932	http://dx.doi.org/10.1371/journal.pone.0018932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533082	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400035
J	Mazandu, GK; Mulder, NJ				Mazandu, Gaston K.; Mulder, Nicola J.			Scoring Protein Relationships in Functional Interaction Networks Predicted from Sequence Data	PLOS ONE			English	Article							INTEGRATION; INTERPRO; INFORMATION; ANNOTATION; FRAMEWORK	The abundance of diverse biological data from various sources constitutes a rich source of knowledge, which has the power to advance our understanding of organisms. This requires computational methods in order to integrate and exploit these data effectively and elucidate local and genome wide functional connections between protein pairs, thus enabling functional inferences for uncharacterized proteins. These biological data are primarily in the form of sequences, which determine functions, although functional properties of a protein can often be predicted from just the domains it contains. Thus, protein sequences and domains can be used to predict protein pair-wise functional relationships, and thus contribute to the function prediction process of uncharacterized proteins in order to ensure that knowledge is gained from sequencing efforts. In this work, we introduce information-theoretic based approaches to score protein-protein functional interaction pairs predicted from protein sequence similarity and conserved protein signature matches. The proposed schemes are effective for data-driven scoring of connections between protein pairs. We applied these schemes to the Mycobacterium tuberculosis proteome to produce a homology-based functional network of the organism with a high confidence and coverage. We use the network for predicting functions of uncharacterised proteins.	[Mazandu, Gaston K.; Mulder, Nicola J.] Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Cape Town	Mazandu, GK (corresponding author), Univ Cape Town, Computat Biol Grp, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Nicola.Mulder@uct.ac.za	Mazandu, Gaston/AAH-6401-2019	Mazandu, Gaston/0000-0002-6441-8006; Mulder, Nicola J/0000-0003-4905-0941	National Bioinformatics Network in South Africa [NBN RFA2008]	National Bioinformatics Network in South Africa	This work was funded by the National Bioinformatics Network in South Africa, grant number NBN RFA2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARON PG, 2008, BMC BIOINFORMATICS, V9, P198; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALDI P, 2001, BIOINFORMATICS MACHI; Bastien O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-49; Bastien O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-332; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P6414, DOI 10.1093/nar/gkh978; Cho YR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-382; Chua HN, 2007, BIOINFORMATICS, V23, P3364, DOI 10.1093/bioinformatics/btm520; Chua HN, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S8; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Deng MH, 2004, J COMPUT BIOL, V11, P463, DOI 10.1089/1066527041410346; Deng Minghua, 2003, Pac Symp Biocomput, P140; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Hartley RVL, 1928, BELL SYST TECH J, V7, P535, DOI 10.1002/j.1538-7305.1928.tb01236.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; KRAWCZYK J, 2009, NUCLEIC ACIDS RES, P1; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; MACKAY JCD, 2004, INFORM THEORY INFERE; Mahdavi Mahmood A., 2007, Genomics Proteomics & Bioinformatics, V5, P177, DOI 10.1016/S1672-0229(08)60005-4; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Murali TM, 2006, NAT BIOTECHNOL, V24, P1474, DOI 10.1038/nbt1206-1474; Myers CL, 2007, BIOINFORMATICS, V23, P2322, DOI 10.1093/bioinformatics/btm332; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; PEARSON WR, TUT ISBM2000; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Subramanian G, 2000, INFECT IMMUN, V68, P1633, DOI 10.1128/IAI.68.3.1633-1648.2000; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Tsuda K, 2005, BIOINFORMATICS, V21, P59, DOI 10.1093/bioinformatics/bti1110; *UNIPROT CONS, 2007, NUCLEIC ACIDS RES, V35, pD224; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Xiong JH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-268; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607	43	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18607	10.1371/journal.pone.0018607	http://dx.doi.org/10.1371/journal.pone.0018607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526183	Green Published, gold			2022-12-25	WOS:000289671100012
J	Choi, CH; DeGuzman, JV; Lamont, RJ; Yilmaz, O				Choi, Chul Hee; DeGuzman, Jefferson V.; Lamont, Richard J.; Yilmaz, Ozlem			Genetic Transformation of an Obligate Anaerobe, P. gingivalis for FMN-Green Fluorescent Protein Expression in Studying Host-Microbe Interaction	PLOS ONE			English	Article							PATHOGEN PORPHYROMONAS-GINGIVALIS; CLPP SERINE-PROTEASE; EPITHELIAL-CELLS; LISTERIA-MONOCYTOGENES; PERIODONTAL-DISEASE; REPORTER PROTEINS; ORAL BACTERIA; SURVIVAL; INVASION; ACTIVATION	The recent introduction of "oxygen-independent" flavin mononucleotide (FMN)-based fluorescent proteins (FbFPs) is of major interest to both eukaryotic and prokaryotic microbial biologists. Accordingly, we demonstrate for the first time that an obligate anaerobe, the successful opportunistic pathogen of the oral cavity, Porphyromonas gingivalis, can be genetically engineered for expression of the non-toxic green FbFP. The resulting transformants are functional for studying dynamic bacterial processes in living host cells. The visualization of the transformed P. gingivalis (PgFbFP) revealed strong fluorescence that reached a maximum emission at 495 nm as determined by fluorescence microscopy and spectrofluorometry. Human primary gingival epithelial cells (GECs) were infected with PgFbFP and the bacterial invasion of host cells was analyzed by a quantitative fluorescence microscopy and antibiotic protection assays. The results showed similar levels of intracellular bacteria for both wild type and PgFbFP strains. In conjunction with organelle specific fluorescent dyes, utilization of the transformed strain provided direct and accurate determination of the live/metabolically active P. gingivalis' trafficking in the GECs over time. Furthermore, the GECs were co-infected with PgFbFP and the ATP-dependent Clp serine protease-deficient mutant (ClpP-) to study the differential fates of the two strains within the same host cells. Quantitative co-localization analyses displayed the intracellular PgFbFP significantly associated with the endoplasmic reticulum network, whereas the majority of ClpP- organisms trafficked into the lysosomes. Hence, we have developed a novel and reliable method to characterize live host cell-microbe interactions and demonstrated the adaptability of FMN-green fluorescent protein for studying persistent host infections induced by obligate anaerobic organisms.	[Choi, Chul Hee; DeGuzman, Jefferson V.; Yilmaz, Ozlem] Univ Florida, Dept Periodontol, Gainesville, FL 32611 USA; [Lamont, Richard J.] Univ Louisville, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA; [Yilmaz, Ozlem] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; University of Louisville; State University System of Florida; University of Florida	Choi, CH (corresponding author), Univ Florida, Dept Periodontol, Gainesville, FL 32611 USA.	oyilmaz@epi.ufl.edu	Yilmaz, Ozlem/ABG-5367-2021	Yilmaz, Ozlem/0000-0003-3487-7217; Choi, Chul Hee/0000-0003-2373-048X	United States National Institute of Dental and Craniofacial Research, National Institutes of Health [R01DE16593, R01DE11111]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011111, R01DE016593] Funding Source: NIH RePORTER	United States National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided by the United States National Institute of Dental and Craniofacial Research, National Institutes of Health, R01DE16593 (OY) and R01DE11111(RJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Bajno L, 1999, J IMMUNOL METHODS, V232, P67, DOI 10.1016/S0022-1759(99)00155-6; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chalmers NI, 2007, APPL ENVIRON MICROB, V73, P630, DOI 10.1128/AEM.02164-06; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Colombo AV, 2007, J PERIODONTAL RES, V42, P236, DOI 10.1111/j.1600-0765.2006.00938.x; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Gaillot O, 2000, MOL MICROBIOL, V35, P1286, DOI 10.1046/j.1365-2958.2000.01773.x; Gaillot O, 2001, INFECT IMMUN, V69, P4938, DOI 10.1128/IAI.69.8.4938-4943.2001; Genco CA, 1998, TRENDS MICROBIOL, V6, P444, DOI 10.1016/S0966-842X(98)01363-8; Graves DT, 2008, J CLIN PERIODONTOL, V35, P89, DOI 10.1111/j.1600-051X.2007.01172.x; Hajishengallis G, 2007, FRONT BIOSCI-LANDMRK, V12, P4547, DOI 10.2741/2409; Hasegawa Y, 2008, INFECT IMMUN, V76, P2420, DOI 10.1128/IAI.00156-08; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Kuboniwa M, 2008, MICROBES INFECT, V10, P122, DOI 10.1016/j.micinf.2007.10.011; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Piekarski T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-265; Rudney JD, 2005, J DENT RES, V84, P59, DOI 10.1177/154405910508400110; Scannapieco F A, 2001, Ann Periodontol, V6, P78, DOI 10.1902/annals.2001.6.1.78; Sheets SM, 2008, FRONT BIOSCI-LANDMRK, V13, P3215; Shoemaker NB, 2000, J BACTERIOL, V182, P928, DOI 10.1128/JB.182.4.928-936.2000; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Tielker D, 2009, EUKARYOT CELL, V8, P913, DOI 10.1128/EC.00394-08; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Valdivia RH, 1998, CURR OPIN MICROBIOL, V1, P359, DOI 10.1016/S1369-5274(98)80042-8; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; WYSS C, 1992, J CLIN MICROBIOL, V30, P2225, DOI 10.1128/JCM.30.9.2225-2229.1992; Xia QW, 2007, PROTEOMICS, V7, P4323, DOI 10.1002/pmic.200700543; Xie H, 1999, INFECT IMMUN, V67, P3227, DOI 10.1128/IAI.67.7.3227-3235.1999; Yao L, 2010, MOL ORAL MICROBIOL, V25, P89, DOI 10.1111/j.2041-1014.2010.00569.x; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Yilmaz O, 2004, INFECT IMMUN, V72, P3743, DOI 10.1128/IAI.72.7.3743-3751.2004; Yilmaz O, 2003, MICROBIOL-SGM, V149, P2417, DOI 10.1099/mic.0.26483-0; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Yilmaz O, 2010, CELL MICROBIOL, V12, P188, DOI 10.1111/j.1462-5822.2009.01390.x; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0; Zhang Y, 2005, PROTEOMICS, V5, P198, DOI 10.1002/pmic.200400922	42	39	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18499	10.1371/journal.pone.0018499	http://dx.doi.org/10.1371/journal.pone.0018499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525983	Green Published, gold, Green Submitted			2022-12-25	WOS:000289578600011
J	Jeong, HJ; Choi, Y; Kim, MH; Kang, IC; Lee, JH; Park, C; Park, R; Kim, HM				Jeong, Hyun-Ja; Choi, Youngjin; Kim, Min-Ho; Kang, In-Cheol; Lee, Jeong-Han; Park, Channy; Park, Raekil; Kim, Hyung-Min			Rosmarinic Acid, Active Component of Dansam-Eum Attenuates Ototoxicity of Cochlear Hair Cells through Blockage of Caspase-1 Activity	PLOS ONE			English	Article							CISPLATIN-INDUCED APOPTOSIS; DEATH; HYPOXIA; LINE; SAGE	Cisplatin causes auditory impairment due to the apoptosis of auditory hair cells. There is no strategy to regulate ototoxicity by cisplatin thus far. Dansam-Eum (DSE) has been used for treating the central nerve system injury including hearing loss in Korea. However, disease-related scientific investigation by DSE has not been elucidated. Here, we demonstrated that DSE and its component rosmarinic acid (RA) were shown to inhibit apoptosis of the primary organ of Corti explants as well as the auditory cells. Administration of DSE and RA reduced the thresholds of the auditory brainstem response in cisplatin-injected mice. A molecular docking simulation and a kinetic assay show that RA controls the activity of caspase-1 by interaction with the active site of caspase-1. Pretreatment of RA inhibited caspase-1 downstream signal pathway, such as the activation of caspase-3 and 9, release of cytochrome c, translocation of apoptosis-inducing factor, up-regulation of Bax, down-regulation of Bcl-2, generation of reactive oxygen species, and activation of nuclear factor-kappa B. Anticancer activity by cisplatin was not affected by treatment with RA in SNU668, A549, HCT116, and HeLa cells but not B16F10 cells. These findings show that blocking a critical step by RA in apoptosis may be useful strategy to prevent harmful side effects of ototoxicity in patients with having to undergo chemotherapy.	[Jeong, Hyun-Ja; Choi, Youngjin; Kang, In-Cheol] Hoseo Univ, Biochip Res Ctr, Asan, Chungnam, South Korea; [Kim, Min-Ho] Chonbuk Natl Univ, High Enthalpy Plasma Res Ctr, Jeonju, South Korea; [Lee, Jeong-Han; Park, Raekil] Wonkwang Univ, Sch Med, Vestibulocochlear Res Ctr, Jeonbuk, South Korea; [Lee, Jeong-Han; Park, Raekil] Wonkwang Univ, Sch Med, Dept Microbiol, Jeonbuk, South Korea; [Park, Channy] Nambu Univ, Dept Audiol, Kwangju, Jeonnam, South Korea; [Kim, Hyung-Min] Kyung Hee Univ, Coll Oriental Med, Dept Pharmacol, Seoul, South Korea	Hoseo University; Jeonbuk National University; Wonkwang University; Wonkwang University; Nambu University; Kyung Hee University	Jeong, HJ (corresponding author), Hoseo Univ, Biochip Res Ctr, Asan, Chungnam, South Korea.	hmkim@khu.ac.kr			Ministry of Education, Science and Technology [2009-0067477]; Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF) through the Vestibulocochlear Research Center (VCRC) at Wonkwang University [R13-2002-055-00000-0]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF) through the Vestibulocochlear Research Center (VCRC) at Wonkwang University(Korea Science and Engineering Foundation)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0067477) and the Ministry of Science and Technology (MoST)/Korea Science and Engineering Foundation (KOSEF) through the Vestibulocochlear Research Center (VCRC) at Wonkwang University (R13-2002-055-00000-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SA, 2000, HEARING RES, V141, P28, DOI 10.1016/S0378-5955(99)00211-7; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Cao H, 2005, J MOL STRUC-THEOCHEM, V719, P177, DOI 10.1016/j.theochem.2005.01.029; Cardinaal RM, 2000, HEARING RES, V144, P147, DOI 10.1016/S0378-5955(00)00060-5; Cheng AG, 1999, BRAIN RES, V850, P234, DOI 10.1016/S0006-8993(99)01983-6; Devarajan P, 2002, HEARING RES, V174, P45, DOI 10.1016/S0378-5955(02)00634-2; Exarchou V, 2002, J AGR FOOD CHEM, V50, P5294, DOI 10.1021/jf020408a; Feng Q, 2005, CANCER RES, V65, P8591, DOI 10.1158/0008-5472.CAN-05-0239; Fernandez-Luna JL, 2007, CLIN TRANSL ONCOL, V9, P555, DOI 10.1007/s12094-007-0103-7; Gao LP, 2005, PHARMAZIE, V60, P62; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; HUANG Y S, 1992, Yaoxue Xuebao, V27, P96; Humes HD, 1999, ANN NY ACAD SCI, V884, P15, DOI 10.1111/j.1749-6632.1999.tb00278.x; Iuvone T, 2006, J PHARMACOL EXP THER, V317, P1143, DOI 10.1124/jpet.105.099317; Jeong HJ, 2007, J NEUROSCI RES, V85, P896, DOI 10.1002/jnr.21168; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; KIM BC, 2000, J KOREAN ORIENTAL ME, V21, P126; KONDO S, 1995, CANCER RES, V55, P6166; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lee HJ, 2008, TOXICOLOGY, V250, P109, DOI 10.1016/j.tox.2008.06.010; Lee S, 2006, NEPHROL DIAL TRANSPL, V21, P2085, DOI 10.1093/ndt/gfl209; Li XC, 2007, DRUG METAB DISPOS, V35, P234, DOI 10.1124/dmd.106.013045; Liu W, 1998, NEUROREPORT, V9, P2609, DOI 10.1097/00001756-199808030-00034; Osakabe N, 2004, CARCINOGENESIS, V25, P549, DOI 10.1093/carcin/bgh034; Pirvola U, 2000, J NEUROSCI, V20, P43, DOI 10.1523/JNEUROSCI.20-01-00043.2000; Renzulli C, 2004, J APPL TOXICOL, V24, P289, DOI 10.1002/jat.982; So HS, 2005, HEARING RES, V204, P127, DOI 10.1016/j.heares.2005.01.011; Takeda H, 2002, EUR J PHARMACOL, V449, P261, DOI 10.1016/S0014-2999(02)02037-X; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Trimmer EE, 1999, ESSAYS BIOCHEM, V34, P191, DOI 10.1042/bse0340191; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Youn J, 2003, J RHEUMATOL, V30, P1203; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100	34	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18815	10.1371/journal.pone.0018815	http://dx.doi.org/10.1371/journal.pone.0018815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526214	Green Submitted, Green Published, gold			2022-12-25	WOS:000289578600035
J	Lian, P; Wei, DQ; Wang, JF; Chou, KC				Lian, Peng; Wei, Dong-Qing; Wang, Jing-Fang; Chou, Kuo-Chen			An Allosteric Mechanism Inferred from Molecular Dynamics Simulations on Phospholamban Pentamer in Lipid Membranes	PLOS ONE			English	Article							SOLID-STATE NMR; CARDIAC SARCOPLASMIC-RETICULUM; PERSONALIZED DRUG DESIGN; M2 PROTON CHANNEL; MONOMERIC PHOSPHOLAMBAN; CALCIUM-PUMP; DODECYLPHOSPHOCHOLINE MICELLES; DILATED CARDIOMYOPATHY; CONFORMATIONAL SWITCH; BINDING INTERACTIONS	Phospholamban functions as a regulator of Ca(2+) concentration of cardiac muscle cells by triggering the bioactivity of sarcoplasmic reticulum Ca(2+)-ATPase. In order to understand its dynamic mechanism in the environment of bilayer surroundings, we performed long time-scale molecular dynamic simulations based on the high-resolution NMR structure of phospholamban pentamer. It was observed from the molecular dynamics trajectory analyses that the conformational transitions between the "bellflower" and "pinwheel" modes were detected for phospholamban. Particularly, the two modes became quite similar to each other after phospholamban was phosphorylated at Ser16. Based on these findings, an allosteric mechanism was proposed to elucidate the dynamic process of phospholamban interacting with Ca(2+)-ATPase.	[Lian, Peng; Wei, Dong-Qing] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Lian, Peng; Wei, Dong-Qing] Shanghai Jiao Tong Univ, Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Lian, Peng; Wang, Jing-Fang] Shanghai Jiao Tong Univ, Key Lab Syst Biomed, Minist Educ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Wang, Jing-Fang] Shanghai Ctr Bioinformat & Technol, Shanghai, Peoples R China; [Wei, Dong-Qing; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences	Lian, P (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	dqwei@sjtu.edu.cn; jfwang8113@sjtu.edu.cn	Chou, Kuo-Chen/A-8340-2009; Wang, Jingfang/Q-2597-2018; Lian, Peng/L-3862-2013	Wang, Jingfang/0000-0002-1355-5481; 	Chinese National Basic Research Program (973 Program) [2011CB707500]; Chinese National Comprehensive Technology Platforms for Innovative Drug RD [2009ZX9301-007]; Chinses National Science Foundation [30870476]; Shanghai Natural Science Foundation [10ZR1421500]	Chinese National Basic Research Program (973 Program)(National Basic Research Program of China); Chinese National Comprehensive Technology Platforms for Innovative Drug RD; Chinses National Science Foundation; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work was supported by the grants from Chinese National Basic Research Program (973 Program, No. 2011CB707500), Chinese National Comprehensive Technology Platforms for Innovative Drug R&D (No. 2009ZX9301-007), Chinses National Science Foundation (No. 30870476), and Shanghai Natural Science Foundation (No. 10ZR1421500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Chen AA, 2007, J PHYS CHEM B, V111, P6469, DOI 10.1021/jp0708547; CHOU KC, 1989, TRENDS BIOCHEM SCI, V14, P212, DOI 10.1016/0968-0004(89)90026-1; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; COLYER J, 1993, CARDIOVASC RES, V27, P1766, DOI 10.1093/cvr/27.10.1766; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Decrouy A, 1996, J MOL CELL CARDIOL, V28, P767, DOI 10.1006/jmcc.1996.0071; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Gong K, 2009, MED CHEM, V5, P242, DOI 10.2174/157340609788185936; Gu RX, 2009, MED CHEM, V5, P250, DOI 10.2174/157340609788185909; Guo XL, 2010, CURR COMPUT-AID DRUG, V6, P139, DOI 10.2174/157340910791202487; Haghighi K, 2004, BIOCHEM BIOPH RES CO, V322, P1214, DOI 10.1016/j.bbrc.2004.07.164; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Houndonougbo Y, 2005, BIOCHEMISTRY-US, V44, P1780, DOI 10.1021/bi0488404; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Kim T, 2009, PROTEINS, V76, P86, DOI 10.1002/prot.22322; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; Lee SJ, 2008, BIOPHYS J, V94, P3565, DOI 10.1529/biophysj.107.116335; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Maffeo C, 2009, BIOPHYS J, V96, P4853, DOI 10.1016/j.bpj.2009.03.053; Mascioni A, 2002, J AM CHEM SOC, V124, P9392, DOI 10.1021/ja026507m; Metcalfe EE, 2005, BIOCHEMISTRY-US, V44, P4386, DOI 10.1021/bi047571e; Metcalfe EE, 2004, BIOPHYS J, V87, P1205, DOI 10.1529/biophysj.103.038844; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Oxenoid K, 2007, PROTEIN SCI, V16, P1977, DOI 10.1110/ps.072975107; Pantano S, 2007, PROTEINS, V66, P930, DOI 10.1002/prot.21239; Paterlini MG, 2005, BIOPHYS J, V88, P3243, DOI 10.1529/biophysj.104.054460; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POST RL, 1972, J BIOL CHEM, V247, P6530; Potluri S, 2006, PROTEINS, V65, P203, DOI 10.1002/prot.21091; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; SAYADI M, BIOPHYS J, V98, P805; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Sugita Y, 2006, BIOCHEMISTRY-US, V45, P11752, DOI 10.1021/bi061071z; Thomas DD, 1998, ANN NY ACAD SCI, V853, P186, DOI 10.1111/j.1749-6632.1998.tb08266.x; Traaseth NJ, 2006, BIOCHEMISTRY-US, V45, P13827, DOI 10.1021/bi0607610; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; Wang JF, 2009, PHARMACOGENOMICS, V10, P1213, DOI 10.2217/PGS.09.81; Wang JF, 2008, PROTEIN PEPTIDE LETT, V15, P27; Wang JF, 2007, BIOCHEM BIOPH RES CO, V359, P323, DOI 10.1016/j.bbrc.2007.05.101; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Wang JF, 2009, INTERDISCIP SCI, V1, P214, DOI 10.1007/s12539-009-0047-4; Wang JF, 2010, PROTEIN ENG DES SEL, V23, P663, DOI 10.1093/protein/gzq040; Wang JF, 2009, BIOCHEM BIOPH RES CO, V388, P413, DOI 10.1016/j.bbrc.2009.08.026; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang JF, 2009, MED CHEM, V5, P263, DOI 10.2174/157340609788185954; Wang JF, 2008, CURR TOP MED CHEM, V8, P1656, DOI 10.2174/156802608786786633; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Zamoon J, 2005, P NATL ACAD SCI USA, V102, P4747, DOI 10.1073/pnas.0406039102; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5	60	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18587	10.1371/journal.pone.0018587	http://dx.doi.org/10.1371/journal.pone.0018587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525996	Green Published, Green Submitted, gold			2022-12-25	WOS:000289578600016
J	Walther, BD; Dempster, T; Letnic, M; McCulloch, MT				Walther, Benjamin D.; Dempster, Tim; Letnic, Mike; McCulloch, Malcolm T.			Movements of Diadromous Fish in Large Unregulated Tropical Rivers Inferred from Geochemical Tracers	PLOS ONE			English	Article							BARRAMUNDI LATES-CALCARIFER; STRONTIUM ISOTOPE COMPOSITION; SHAD ALOSA-SAPIDISSIMA; FRESH-WATER; OTOLITH CHEMISTRY; LIFE-HISTORY; JUVENILE BARRAMUNDI; MARINE FISH; SR ISOTOPES; ENVIRONMENTAL HISTORIES	Patterns of migration and habitat use in diadromous fishes can be highly variable among individuals. Most investigations into diadromous movement patterns have been restricted to populations in regulated rivers, and little information exists for those in unregulated catchments. We quantified movements of migratory barramundi Lates calcarifer (Bloch) in two large unregulated rivers in northern Australia using both elemental (Sr/Ba) and isotope ((87)Sr/(86)Sr) ratios in aragonitic ear stones, or otoliths. Chemical life history profiles indicated significant individual variation in habitat use, particularly among chemically distinct freshwater habitats within a catchment. A global zoning algorithm was used to quantify distinct changes in chemical signatures across profiles. This algorithm identified between 2 and 6 distinct chemical habitats in individual profiles, indicating variable movement among habitats. Profiles of (87)Sr/(86)Sr ratios were notably distinct among individuals, with highly radiogenic values recorded in some otoliths. This variation suggested that fish made full use of habitats across the entire catchment basin. Our results show that unrestricted movement among freshwater habitats is an important component of diadromous life histories for populations in unregulated systems.	[Walther, Benjamin D.; McCulloch, Malcolm T.] Australian Natl Univ, Res Sch Earth Sci, Australian Res Council Ctr Excellence Coral Reef, Canberra, ACT, Australia; [Walther, Benjamin D.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Dempster, Tim] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Letnic, Mike] Univ Western Sydney, Sch Nat Sci, Penrith, NSW, Australia; [McCulloch, Malcolm T.] Univ Western Australia, Sch Earth & Environm, Australian Res Council Ctr Excellence Coral Reef, Crawley, WA, Australia	Australian National University; University of Texas System; University of Texas Austin; University of Melbourne; Western Sydney University; University of Western Australia	Walther, BD (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Australian Res Council Ctr Excellence Coral Reef, Canberra, ACT, Australia.	bwalther@mail.utexas.edu	McCulloch, Malcolm T/C-3651-2009; Walther, Benjamin/W-2681-2019; Walther, Benjamin D/A-7284-2009; Dempster, Tim/E-9630-2011	McCulloch, Malcolm T/0000-0003-1538-1558; Walther, Benjamin D/0000-0002-2902-4001; Dempster, Tim/0000-0001-8041-426X; Letnic, Michael/0000-0003-4191-8427	ARC Centre of Excellence for Coral Reef Studies; Hermon Slade Foundation [HSF 07/10]	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Hermon Slade Foundation	BDW and MTM gratefully acknowledge support by the ARC Centre of Excellence for Coral Reef Studies (http://www.coralcoe.org.au/). ML and TD were supported by an award from the Hermon Slade Foundation, grant number HSF 07/10 (http://www.hermonslade.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG G, 1989, J HYDROL, V109, P65, DOI 10.1016/0022-1694(89)90007-3; Aubert D, 2002, APPL GEOCHEM, V17, P285, DOI 10.1016/S0883-2927(01)00080-4; BACON MP, 1972, EARTH PLANET SC LETT, V16, P66, DOI 10.1016/0012-821X(72)90237-3; Bailey SW, 1996, WATER RESOUR RES, V32, P707, DOI 10.1029/95WR03642; Bain DC, 1998, CATENA, V32, P143, DOI 10.1016/S0341-8162(97)00055-6; Banner JL, 2004, EARTH-SCI REV, V65, P141, DOI 10.1016/S0012-8252(03)00086-2; Barnett-Johnson R, 2008, LIMNOL OCEANOGR, V53, P1633, DOI 10.4319/lo.2008.53.4.1633; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; Brown RJ, 2009, CAN J FISH AQUAT SCI, V66, P1790, DOI 10.1139/F09-112; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Cappo M, 2005, MAR FRESHWATER RES, V56, P713, DOI 10.1071/MF04218; CHAN LH, 1976, EARTH PLANET SC LETT, V32, P258, DOI 10.1016/0012-821X(76)90066-2; Coffey M, 1997, ESTUAR COAST SHELF S, V45, P113, DOI 10.1006/ecss.1996.0157; Cook PG, 2003, J HYDROL, V277, P74, DOI 10.1016/S0022-1694(03)00087-8; Daverat F, 2006, MAR ECOL PROG SER, V308, P231, DOI 10.3354/meps308231; DAVIS TLO, 1988, ENVIRON BIOL FISH, V21, P161, DOI 10.1007/BF00004860; DAVIS TLO, 1985, AUST J MAR FRESH RES, V36, P177; Doupe RG, 2002, RIVER RES APPL, V18, P307, DOI 10.1002/rra.676; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Elsdon TS, 2002, CAN J FISH AQUAT SCI, V59, P1796, DOI 10.1139/F02-154; Faure G., 1972, STRONTIUM ISOTOPE GE; Griffin R.K., 1987, AM FISH SOC S, V1, P358; Griffin RK, 1994, THIRD ASIAN FISHERIES FORUM, P472; GRIFFIN RK, 2007, 84 NO TERR DEP PRIM; Hedger RD, 2008, ECOL INFORM, V3, P207, DOI 10.1016/j.ecoinf.2008.04.001; Jonsson B, 1999, ICES J MAR SCI, V56, P405, DOI 10.1006/jmsc.1999.0483; KEENAN CP, 1994, AUST J MAR FRESH RES, V45, P1123, DOI 10.1071/MF9941123; Kennedy BP, 2002, CAN J FISH AQUAT SCI, V59, P925, DOI [10.1139/f02-070, 10.1139/F02-070]; Kennedy BP, 2000, CAN J FISH AQUAT SCI, V57, P2280, DOI 10.1139/cjfas-57-11-2280; KOWARSKY J, 1981, AUST J MAR FRESH RES, V32, P93; Krabbenhoft A, 2010, GEOCHIM COSMOCHIM AC, V74, P4097, DOI 10.1016/j.gca.2010.04.009; Kraus RT, 2004, J EXP MAR BIOL ECOL, V302, P85, DOI 10.1016/j.jembe.2003.10.004; Letnic M, 2006, WILDLIFE RES, V33, P529, DOI 10.1071/WR05090; Limburg KE, 2009, BIOSCIENCE, V59, P955, DOI 10.1525/bio.2009.59.11.7; LIMBURG KE, 1995, MAR ECOL PROG SER, V119, P25, DOI 10.3354/meps119025; Martin GB, 2004, CAN J FISH AQUAT SCI, V61, P34, DOI 10.1139/F03-143; McCulloch M, 2005, MAR FRESHWATER RES, V56, P637, DOI 10.1071/MF04184; McDowall RM, 1999, ICES J MAR SCI, V56, P410, DOI 10.1006/jmsc.1999.0450; McDowall RM, 2009, AM FISH S S, V69, P1; Miller JA, 2010, MAR ECOL PROG SER, V408, P227, DOI 10.3354/meps08613; Milton DA, 2005, MAR ECOL PROG SER, V301, P279, DOI 10.3354/meps301279; Milton DA, 2003, CAN J FISH AQUAT SCI, V60, P1376, DOI 10.1139/F03-133; Milton DA, 2001, J EXP MAR BIOL ECOL, V264, P47, DOI 10.1016/S0022-0981(01)00301-X; Milton D, 2008, ESTUAR COAST SHELF S, V78, P301, DOI 10.1016/j.ecss.2007.12.009; MOORE R, 1982, AUST J MAR FRESH RES, V33, P671, DOI 10.1071/MF9820671; Moore WS, 2008, MAR CHEM, V108, P236, DOI 10.1016/j.marchem.2007.03.004; PALMER MR, 1992, GEOCHIM COSMOCHIM AC, V56, P2099, DOI 10.1016/0016-7037(92)90332-D; Pender PJ, 1996, T AM FISH SOC, V125, P679, DOI 10.1577/1548-8659(1996)125<0679:HHOBCI>2.3.CO;2; Quinn TP, 2009, AM FISH S S, V69, P23; Robins J, 2006, J FISH BIOL, V69, P379, DOI 10.1111/j.1095-8649.2006.01100.x; Rose S, 2005, APPL GEOCHEM, V20, P1571, DOI 10.1016/j.apgeochem.2005.04.015; RUSSELL DJ, 1988, AUST J MAR FRESH RES, V39, P117; RUSSELL DJ, 1983, AUST J MAR FRESH RES, V34, P805; RUSSELL DJ, 1985, AUST J MAR FRESH RES, V36, P191, DOI 10.1071/MF9850191; SALINI J, 1988, AUST J MAR FRESH RES, V39, P317, DOI 10.1071/MF9880317; Secor DH, 2007, J SEA RES, V57, P91, DOI 10.1016/j.seares.2006.09.004; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; Shand P, 2009, APPL GEOCHEM, V24, P574, DOI 10.1016/j.apgeochem.2008.12.011; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; Staunton-Smith J, 2004, MAR FRESHWATER RES, V55, P787, DOI 10.1071/MF03198; Tipper ET, 2006, GEOCHIM COSMOCHIM AC, V70, P2737, DOI 10.1016/j.gca.2006.03.005; WALKER KF, 1985, HYDROBIOLOGIA, V125, P111, DOI 10.1007/BF00045929; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Walther BD, 2010, ENVIRON BIOL FISH, V89, P441, DOI 10.1007/s10641-010-9661-6; Walther BD, 2008, CAN J FISH AQUAT SCI, V65, P2623, DOI 10.1139/F08-164; Wells BK, 2003, T AM FISH SOC, V132, P409, DOI 10.1577/1548-8659(2003)132<0409:RBWOAS>2.0.CO;2; Zar JH., 1999, BIOSTAT ANAL	72	39	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18351	10.1371/journal.pone.0018351	http://dx.doi.org/10.1371/journal.pone.0018351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494693	Green Submitted, Green Published, gold			2022-12-25	WOS:000289192400024
J	Flach, RJR; Qin, H; Zhang, L; Bennett, AM				Flach, Rachel J. Roth; Qin, Hui; Zhang, Lei; Bennett, Anton M.			Loss of Mitogen-activated Protein Kinase Phosphatase-1 Protects from Hepatic Steatosis by Repression of Cell Death-inducing DNA Fragmentation Factor A (DFFA)-like Effector C (CIDEC)/Fat-specific Protein 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAT-SPECIFIC PROTEIN-27; LEPTIN-DEFICIENT MICE; PPAR-GAMMA; MAP KINASE; RECEPTOR-GAMMA; ADIPOSE-TISSUE; POTENTIAL ROLE; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL REGULATION; MOUSE MODELS	The integration of metabolic signals required for the regulation of hepatic lipid homeostasis is complex. Previously, we showed that mice lacking expression of the mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) have increased fatty acid oxidation and are protected from the development of hepatic steatosis. Here, we show that leptin receptor-deficient (db/db) mice lacking MKP-1 are also resistant to the development of hepatic steatosis. Microarray analyses of livers from db/db mice lacking MKP-1 showed suppression of peroxisome proliferator-activated receptor gamma (PPAR gamma) target genes. We identified the fat-specific protein 27 (Fsp27), which promotes PPAR gamma-mediated hepatic steatosis, as repressed in livers of both db/db and high fat diet-fed mice lacking MKP-1. Hepatocytes from MKP-1-deficient mice exhibited reduced PPAR gamma-induced lipid droplet formation. Mechanistically, loss of MKP-1 inhibited PPAR gamma function by increasing MAPK-dependent phosphorylation on PPAR gamma at its inhibitory residue of serine 112. These results demonstrate that in addition to inhibiting hepatic fatty acid oxidation, MKP-1 promotes hepatic lipogenic gene expression through PPAR gamma. Hence, MKP-1 plays an important role in MAPK-mediated control of hepatic lipid homeostasis.	[Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA	Yale University; Yale University	Bennett, AM (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, SHM B226D,333 Cedar St, New Haven, CT 06520 USA.	anton.bennett@yale.edu		Bennett, Anton/0000-0001-5187-7599	National Institutes of Health [R01 DK75776, DK57751, T32 DK07356]; Yale Liver Center [P30 DK34989]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, T32DK007356, R01DK075776, P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Liver Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK75776 and DK57751 (to A.M.B.). This work was also supported by Yale Liver Center Grant P30 DK34989.; Supported by National Institutes of Health Grant T32 DK07356. Present address: Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Aguilo F, 2010, BIOCHEM J, V427, P255, DOI 10.1042/BJ20090851; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; BOYER JL, 1990, METHOD ENZYMOL, V192, P501; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Camp HS, 1997, J BIOL CHEM, V272, P10811; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Festuccia WT, 2006, DIABETOLOGIA, V49, P2427, DOI 10.1007/s00125-006-0336-y; Flach RJR, 2010, AGING-US, V2, P170, DOI 10.18632/aging.100135; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Reddy ST, 2004, ARTERIOSCL THROM VAS, V24, P1676, DOI 10.1161/01.ATV.0000138342.94314.64; Roth RJ, 2009, J CLIN INVEST, V119, P3817, DOI 10.1172/JCI39054; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yin R, 2006, ACTA PHARMACOL SIN, V27, P1146, DOI 10.1111/j.1745-7254.2006.00359.x; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	46	42	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22195	22202		10.1074/jbc.M110.210237	http://dx.doi.org/10.1074/jbc.M110.210237			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21521693	Green Published, hybrid			2022-12-25	WOS:000291719900026
J	Levy-Ontman, O; Arad, S; Harvey, DJ; Parsons, TB; Fairbanks, A; Tekoah, Y				Levy-Ontman, Oshrat; Arad, Shoshana (Malis); Harvey, David J.; Parsons, Thomas B.; Fairbanks, Antony; Tekoah, Yoram			Unique N-Glycan Moieties of the 66-kDa Cell Wall Glycoprotein from the Red Microalga Porphyridium sp.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-D-MANNOSIDASE; SCALE-ASSOCIATED GLYCOPROTEINS; LASER-DESORPTION IONIZATION; EXTRACELLULAR POLYSACCHARIDE; LINKED OLIGOSACCHARIDES; NEGATIVE-IONS; INSECT CELLS; RAT-LIVER; IDENTIFICATION; FRAGMENTATION	We report here the structural determination of the N-linked glycans in the 66-kDa glycoprotein, part of the unique sulfated complex cell wall polysaccharide of the red microalga Porphyridium sp. Structures were elucidated by a combination of normal phase/reverse phase HPLC, positive ion MALDI-TOF MS, negative ion electrospray ionization, and MS/MS. The sugar moieties of the glycoprotein consisted of at least four fractions of N-linked glycans, each composed of the same four monosaccharides, GlcNAc, Man, 6-O-MeMan, and Xyl, with compositions Man(8-9)Xyl(1-2)Me(3)GlcNAc(2). The present study is the first report of N-glycans with the terminal Xyl attached to the 6-mannose branch of the 6-antenna and to the 3-oxygen of the penultimate (core) GlcNAc. Another novel finding was that all four glycans contain three O-methylmannose residues in positions that have never been reported before. Although it is known that some lower organisms are able to methylate terminal monosaccharides in glycans, the present study on Porphyridium sp. is the first describing an organism that is able to methylate non-terminal mannose residues. This study will thus contribute to understanding of N-glycosylation in algae and might shed light on the evolutionary development from prokaryotes to multicellular organisms. It also may contribute to our understanding of the red algae polysaccharide formation. The additional importance of this research lies in its potential for biotechnological applications, especially in evaluating the use of microalgae as cell factories for the production of therapeutic proteins.	[Levy-Ontman, Oshrat; Arad, Shoshana (Malis); Tekoah, Yoram] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Harvey, David J.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Parsons, Thomas B.] Chem Res Lab, Oxford OX1 3TA, England; [Fairbanks, Antony] Univ Canterbury, Dept Chem, Christchurch 8140, New Zealand	Ben Gurion University; University of Oxford; University of Oxford; University of Canterbury	Levy-Ontman, O (corresponding author), Sami Shamoon Coll Engn, Dept Chem Engn, IL-84100 Beer Sheva, Israel.	oshrale@sce.ac.il	Harvey, David/A-5579-2013; Parsons, Thomas/AAC-8142-2021; Fairbanks, Antony John/I-9313-2019	Fairbanks, Antony John/0000-0002-9975-3269; levy-ontman, oshrat/0000-0002-3977-7066; Harvey, David/0000-0003-0544-771X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altmann F, 1998, EUR J BIOCHEM, V252, P118, DOI 10.1046/j.1432-1327.1998.2520118.x; ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Arad (Malis) S, 1999, CHEM MICROALGAE, P282; Arad S., 2004, Handbook of microalgal culture: biotechnology and applied phycology, P289; Arad S., 2003, BIOMEDIC, V1, P32; Arad S. M., 1988, ALGAL BIOTECHNOLOGY, P65; Arad S, 2010, CURR OPIN BIOTECH, V21, P358, DOI 10.1016/j.copbio.2010.02.008; BALSHUSEMANN D, 1990, EUR J BIOCHEM, V192, P231, DOI 10.1111/j.1432-1033.1990.tb19220.x; Becker B, 1996, PLANTA, V199, P503; Becker B, 1995, EUR J PHYCOL, V30, P307, DOI 10.1080/09670269500651091; BECKER D, 1992, EUR J CELL BIOL, V57, P109; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; BORNSEN KO, 1995, RAPID COMMUN MASS SP, V9, P1031, DOI 10.1002/rcm.1290091112; Dolashka-Angelova P, 2003, BIOCHEM J, V374, P185, DOI 10.1042/BJ20030291; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; GarciaCasado G, 1996, GLYCOBIOLOGY, V6, P471, DOI 10.1093/glycob/6.4.471; GERESH S, 1992, PHYTOCHEMISTRY, V31, P4181, DOI 10.1016/0031-9422(92)80439-L; GERESH S, 1991, BIORESOURCE TECHNOL, V38, P195, DOI 10.1016/0960-8524(91)90154-C; GERESH S, 1990, CARBOHYD RES, V208, P301, DOI 10.1016/0008-6215(90)80116-K; Geresh S, 2009, CARBOHYD RES, V344, P343, DOI 10.1016/j.carres.2008.11.012; Gloaguen V, 2004, CARBOHYD RES, V339, P97, DOI 10.1016/j.carres.2003.09.020; Godel S, 2000, PROTIST, V151, P147, DOI 10.1078/1434-4610-00015; GRUNOW A, 1993, EUR J CELL BIOL, V61, P10; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; GUILE GR, 1994, ANAL BIOCHEM, V222, P231, DOI 10.1006/abio.1994.1478; Gutternigg M, 2004, EUR J BIOCHEM, V271, P1348, DOI 10.1111/j.1432-1033.2004.04045.x; HALL RL, 1977, BIOCHEM J, V165, P173, DOI 10.1042/bj1650173; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P622, DOI 10.1016/j.jasms.2005.01.004; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P647, DOI 10.1016/j.jasms.2005.01.006; Harvey DJ, 2005, J AM SOC MASS SPECTR, V16, P631, DOI 10.1016/j.jasms.2005.01.005; HEANEYKIERAS J, 1976, CARBOHYD RES, V52, P169, DOI 10.1016/S0008-6215(00)85957-1; Kamerling JP, 1997, N COMP BIOC B, P123; KHOO K-H, 1991, Glycobiology, V1, P163, DOI 10.1093/glycob/1.2.163; Khoo KH, 1997, GLYCOBIOLOGY, V7, P663, DOI 10.1093/glycob/7.5.663; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Lapidot M, 2010, CELL ORIG LIFE EXTRE, V13, P205, DOI 10.1007/978-90-481-3795-4_11; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Lommerse JPM, 1997, EUR J BIOCHEM, V249, P195, DOI 10.1111/j.1432-1033.1997.00195.x; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; LUBAS WA, 1988, J BIOL CHEM, V263, P3990; LUPESCU N, 1991, CARBOHYD RES, V210, P349, DOI 10.1016/0008-6215(91)80136-B; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; MURAKATA C, 1992, CARBOHYD RES, V235, P95, DOI 10.1016/0008-6215(92)80081-B; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; Navazio L, 2002, BIOCHEMISTRY-US, V41, P14141, DOI 10.1021/bi0204701; PUANGLARP N, 1995, EUR J BIOCHEM, V232, P873; Shrestha RP, 2004, J PHYCOL, V40, P568, DOI 10.1111/j.1529-8817.2004.02177.x; SHRESTHA RP, 1999, THESIS BENGURION U N; Simon-Bercovitch B, 1999, J PHYCOL, V35, P78, DOI 10.1046/j.1529-8817.1999.3510078.x; Simon-Bercovitch B, 1997, THESIS BENGURION U N; STOEVA S, 1995, COMP BIOCHEM PHYS B, V110, P761, DOI 10.1016/0305-0491(94)00201-5; Stoeva S, 1999, BBA-PROTEIN STRUCT M, V1435, P94, DOI 10.1016/S0167-4838(99)00198-3; TARENTINO AL, 1974, J BIOL CHEM, V249, P818; Taylor ME, 2003, INTRO GLYCOBIOLOGY; Tennant-Eyles RJ, 2000, TETRAHEDRON-ASYMMETR, V11, P231, DOI 10.1016/S0957-4166(99)00494-2; TRIMBLE RB, 1978, J BIOL CHEM, V253, P4508; Ucko M, 1999, J PHYCOL, V35, P1276, DOI 10.1046/j.1529-8817.1999.3561276.x; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vliegenthart J. F. G., 1995, GLYCOPROTEINS, P13; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1	67	42	44	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21340	21352		10.1074/jbc.M110.175042	http://dx.doi.org/10.1074/jbc.M110.175042			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515680	Green Published, hybrid			2022-12-25	WOS:000291464700033
J	Xie, SZ; Ni, J; Lee, YF; Liu, S; Li, GH; Shyr, CR; Chang, CS				Xie, Shaozhen; Ni, Jing; Lee, Yi-Fen; Liu, Su; Li, Gonghui; Shyr, Chih-Rong; Chang, Chawnshang			Increased Acetylation in the DNA-binding Domain of TR4 Nuclear Receptor by the Coregulator ARA55 Leads to Suppression of TR4 Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; TESTICULAR ORPHAN RECEPTOR-4; PROSTATE-CANCER CELLS; REVERSIBLE ACETYLATION; CEREBELLAR DEVELOPMENT; LYSINE ACETYLATION; EXPRESSION; COACTIVATOR; GENE; PHOSPHORYLATION	The nuclear receptor TR4 is a key regulator for many physiological processes, including growth, development, and metabolism. However, how the transcriptional activity of TR4 is regulated in the absence of ligand(s) remains largely unknown. Here we found that an androgen receptor (AR) coactivator, ARA55, might function as a corepressor to suppress TR4 transactivation. Molecular mechanistic dissection with mutation analysis found that ARA55 could enhance TR4 acetylation at the conserved acetylation sites of lysine 175 and lysine 176 in the DNA-binding domain via recruiting proteins with histone acetyl transferase activity, which might then reduce significantly the TR4 DNA binding activity that resulted in the suppression of TR4 transactivation. These results are in contrast to the classic ARA55 coactivator function to enhance AR transactivation partially via increased AR acetylation in the hinge/ligand-binding domain. Together, these results not only provide a novel functional mechanism showing that acetylation of different nuclear receptors at different domains by coregulator may lead to differential receptor transactivation activity but also provide a new way for small molecules to control TR4 transactivation via altering TR4 acetylation levels, and such small molecules may have potential therapeutic applications in the future.	[Xie, Shaozhen; Ni, Jing; Lee, Yi-Fen; Liu, Su; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; [Xie, Shaozhen; Ni, Jing; Lee, Yi-Fen; Liu, Su; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Xie, Shaozhen; Ni, Jing; Lee, Yi-Fen; Liu, Su; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, Rochester, NY 14642 USA; [Shyr, Chih-Rong; Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	University of Rochester; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, CS (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA.	chang@urmc.rochester.edu		Chang, Chawnshang/0000-0001-8510-3516	National Institutes of Health [DK06312]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; George Whipple Professorship Endowment	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan Department of Health Clinical Trial and Research Center of Excellence; George Whipple Professorship Endowment	This work was supported, in whole or in part, by National Institutes of Health Grant DK06312. This work was also supported by a George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH99-TD-B-111-004 (to China Medical University, Taiwan).	Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Chan HM, 2001, J CELL SCI, V114, P2363; CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040; Chen YT, 2008, CEREBELLUM, V7, P9, DOI 10.1007/s12311-008-0006-3; Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Close P, 2010, CELL MOL LIFE SCI, V67, P1255, DOI 10.1007/s00018-009-0252-7; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guerrero-Santoro J, 2004, J CELL BIOCHEM, V92, P810, DOI 10.1002/jcb.20109; Heitzer MD, 2007, STEROIDS, V72, P218, DOI 10.1016/j.steroids.2006.11.010; Heitzer Marjet D, 2006, Nucl Recept Signal, V4, pe019; Heitzer MD, 2006, MOL ENDOCRINOL, V20, P56, DOI 10.1210/me.2005-0065; Huq MDM, 2006, MOL CELL PROTEOMICS, V5, P2072, DOI 10.1074/mcp.M600180-MCP200; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim E, 2005, BIOCHEM BIOPH RES CO, V328, P85, DOI 10.1016/j.bbrc.2004.12.146; Kim E, 2003, J BIOL CHEM, V278, P46919, DOI 10.1074/jbc.M304088200; Kim YS, 2010, CEREBELLUM, V9, P310, DOI 10.1007/s12311-010-0163-z; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Lee YF, 2002, J STEROID BIOCHEM, V81, P291, DOI 10.1016/S0960-0760(02)00118-8; Li G, 2008, ENDOCRINOLOGY, V149, P3490, DOI 10.1210/en.2008-0121; Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359; Liu NC, 2009, ENDOCRINE, V36, P211, DOI 10.1007/s12020-009-9220-0; Luhrs H, 2002, INT J CANCER, V97, P567, DOI 10.1002/ijc.10098; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Rahman MM, 2003, P NATL ACAD SCI USA, V100, P5124, DOI 10.1073/pnas.0530097100; Shyr CR, 2009, ENDOCRINOLOGY, V150, P2454, DOI 10.1210/en.2008-1165; Smith KT, 2009, NAT BIOTECHNOL, V27, P917, DOI 10.1038/nbt1009-917; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Tsai NP, 2009, BBA-GENE REGUL MECH, V1789, P734, DOI 10.1016/j.bbagrm.2009.09.010; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xie S, 2009, P NATL ACAD SCI USA, V106, P13353, DOI 10.1073/pnas.0905724106; Xie SZ, 2004, PROSTATE, V60, P61, DOI 10.1002/pros.20048; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang YQ, 2007, MOL ENDOCRINOL, V21, P908, DOI 10.1210/me.2006-0219; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	55	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21129	21136		10.1074/jbc.M110.208181	http://dx.doi.org/10.1074/jbc.M110.208181			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515881	Green Published, hybrid			2022-12-25	WOS:000291464700012
J	Bader, JR; Kasuboski, JM; Winding, M; Vaughan, PS; Hinchcliffe, EH; Vaughan, KT				Bader, Jason R.; Kasuboski, James M.; Winding, Michael; Vaughan, Patricia S.; Hinchcliffe, Edward H.; Vaughan, Kevin T.			Polo-like Kinase1 Is Required for Recruitment of Dynein to Kinetochores during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; LIGHT INTERMEDIATE CHAIN; CYTOPLASMIC DYNEIN; HUMAN-CELLS; PHOSPHORYLATION; DYNACTIN; ZW10; REVEALS; CYTOKINESIS; ASSOCIATION	Kinetochore dynein has been implicated in microtubule capture, correcting inappropriate microtubule attachments, chromosome movement, and checkpoint silencing. It remains unclear how dynein coordinates this diverse set of functions. Phosphorylation is responsible for some dynein heterogeneity (Whyte, J., Bader, J. R., Tauhata, S. B., Raycroft, M., Hornick, J., Pfister, K. K., Lane, W. S., Chan, G. K., Hinchcliffe, E. H., Vaughan, P. S., and Vaughan, K. T. (2008) J. Cell Biol. 183, 819-834), and phosphorylated and dephosphorylated forms of dynein coexist at prometaphase kinetochores. In this study, we measured the impact of inhibiting polo-like kinase 1 (Plk1) on both dynein populations. Phosphorylated dynein was ablated at kinetochores after inhibiting Plk1 with a small molecule inhibitor (5-Cyano-7-nitro-2-(benzothiazolo-N-oxide)-carboxamide) or chemical genetic approaches. The total complement of kinetochore dynein was also reduced but not eliminated, reflecting the presence of some dephosphorylated dynein after Plk1 inhibition. Although Plk1 inhibition had a profound effect on dynein, kinetochore populations of dynactin, spindly, and zw10 were not reduced. Plk1-independent dynein was reduced after p150(Glued) depletion, consistent with the binding of dephosphorylated dynein to dynactin. Plk1 phosphorylated dynein intermediate chains at Thr-89 in vitro and generated the phospho-Thr-89 phospho-epitope on recombinant dynein intermediate chains. Finally, inhibition of Plk1 induced defects in microtubule capture and persistent microtubule attachment, suggesting a role for phosphorylated dynein in these functions during prometaphase. These findings suggest that Plk1 is a dynein kinase required for recruitment of phosphorylated dynein to kinetochores.	[Bader, Jason R.; Kasuboski, James M.; Winding, Michael; Vaughan, Patricia S.; Vaughan, Kevin T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Hinchcliffe, Edward H.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Notre Dame; University of Minnesota System	Vaughan, KT (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	Vaughan.4@nd.edu		Winding, Michael James/0000-0003-1965-3266	National Institutes of Health [GM60560, GM072754]; American Cancer Society [RSG 05-117-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060560, R01GM072754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60560 (to K. T. V.) and GM072754 (E. H. H.). This work was also supported by American Cancer Society Grant RSG 05-117-01 (to K. T. V.).	Addinall SG, 2001, J BIOL CHEM, V276, P15939, DOI 10.1074/jbc.M011628200; Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bader JR, 2010, SEMIN CELL DEV BIOL, V21, P269, DOI 10.1016/j.semcdb.2009.12.015; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Dell KR, 2000, TRAFFIC, V1, P38, DOI 10.1034/j.1600-0854.2000.010107.x; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; GORBSKY GJ, 1993, J CELL BIOL, V122, P1311, DOI 10.1083/jcb.122.6.1311; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Hornick JE, 2011, CURR BIOL, V21, P598, DOI 10.1016/j.cub.2011.02.049; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Savoian MS, 2000, NAT CELL BIOL, V2, P948, DOI 10.1038/35046605; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Starr DA, 2000, J CELL SCI, V113, P1939; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Varma D, 2006, J CELL BIOL, V172, P655, DOI 10.1083/jcb.200510120; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; Vaughan KT, 1999, J CELL SCI, V112, P1437; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Wojcik E, 2001, NAT CELL BIOL, V3, P1001, DOI 10.1038/ncb1101-1001; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103	35	25	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20769	20777		10.1074/jbc.M111.226605	http://dx.doi.org/10.1074/jbc.M111.226605			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507953	Green Published, hybrid			2022-12-25	WOS:000291267600062
J	Gray, DW; Breneman, SR; Topper, LA; Sharkey, TD				Gray, Dennis W.; Breneman, Steven R.; Topper, Lauren A.; Sharkey, Thomas D.			Biochemical Characterization and Homology Modeling of Methylbutenol Synthase and Implications for Understanding Hemiterpene Synthase Evolution in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTIONS; ISOPRENE SYNTHASE; TERPENE SYNTHASES; SWISS-MODEL; DIMETHYLALLYL DIPHOSPHATE; MONOTERPENE CYCLASE; ENZYMATIC-SYNTHESIS; EXPRESSION; 2-METHYL-3-BUTEN-2-OL; EMISSION	2-Methyl-3-buten-2-ol (MBO) is a five-carbon alcohol produced and emitted in large quantities by many species of pine native to western North America. MBO is structurally and bio-synthetically related to isoprene and can have an important impact on regional atmospheric chemistry. The gene for MBO synthase was identified from Pinus sabiniana, and the protein encoded was functionally characterized. MBO synthase is a bifunctional enzyme that produces both MBO and isoprene in a ratio of similar to 90:1. Divalent cations are required for activity, whereas monovalent cations are not. MBO production is enhanced by K+, whereas isoprene production is inhibited by K+ such that, at physiologically relevant [K+], little or no isoprene emission should be detected from MBO-emitting trees. The K-m of MBO synthase for dimethylallyl diphosphate (20mM) is comparable with that observed for angiosperm isoprene synthases and 3 orders of magnitude higher than that observed for monoterpene and sesquiterpene synthases. Phylogenetic analysis showed that MBO synthase falls into the TPS-d1 group (gymnosperm monoterpene synthases) and is most closely related to linalool synthase from Picea abies. Structural modeling showed that up to three phenylalanine residues restrict the size of the active site and may be responsible for making this a hemiterpene synthase rather than a monoterpene synthase. One of these residues is homologous to a Phe residue found in the active site of isoprene synthases. The remaining two Phe residues do not have homologs in isoprene synthases but occupy the same space as a second Phe residue that closes off the isoprene synthase active site.	[Gray, Dennis W.; Breneman, Steven R.; Sharkey, Thomas D.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Topper, Lauren A.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	Michigan State University; University of New Mexico	Sharkey, TD (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	tsharkey@msu.edu	Sharkey, Thomas D/B-4032-2009; Sharkey, Thomas/ABF-1317-2020	Sharkey, Thomas D/0000-0002-4423-3223; Sharkey, Thomas/0000-0002-4423-3223	National Science Foundation [IOS-0950574]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-0950574 and a gift from ZuvaChem, Inc. A patent has been filed covering the MBO gene sequence.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Copolovici LO, 2005, CHEMOSPHERE, V61, P1390, DOI 10.1016/j.chemosphere.2005.05.003; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fisher AJ, 2000, ARCH BIOCHEM BIOPHYS, V383, P128, DOI 10.1006/abbi.2000.2051; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Green S, 2009, J BIOL CHEM, V284, P8652, DOI 10.1074/jbc.M807140200; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hanson DT, 1999, AM J BOT, V86, P634, DOI 10.2307/2656571; Harley P, 1998, J GEOPHYS RES-ATMOS, V103, P25479, DOI 10.1029/98JD00820; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iraci LT, 1999, J ATMOS CHEM, V33, P321, DOI 10.1023/A:1006169029230; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Kawaide H, 2011, FEBS J, V278, P123, DOI 10.1111/j.1742-4658.2010.07938.x; Keeling CI, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-43; Koksal M, 2010, J MOL BIOL, V402, P363, DOI 10.1016/j.jmb.2010.07.009; Lerdau M, 2003, NEW PHYTOL, V157, P199, DOI 10.1046/j.1469-8137.2003.00673.x; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; LiCata VJ, 1997, BIOPHYS CHEM, V64, P225, DOI 10.1016/S0301-4622(96)02204-1; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Miller B, 2001, PLANTA, V213, P483, DOI 10.1007/s004250100557; NEET KE, 1995, METHOD ENZYMOL, V249, P519; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pechous SW, 2004, PLANTA, V219, P84, DOI 10.1007/s00425-003-1191-4; RAJAONARIVONY JIM, 1992, ARCH BIOCHEM BIOPHYS, V296, P49, DOI 10.1016/0003-9861(92)90543-6; Sasaki K, 2005, FEBS LETT, V579, P2514, DOI 10.1016/j.febslet.2005.03.066; Schade GW, 2000, ATMOS ENVIRON, V34, P3535, DOI 10.1016/S1352-2310(00)00120-5; Schnitzler JP, 2005, PLANTA, V222, P777, DOI 10.1007/s00425-005-0022-1; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; SILVER GM, 1991, PLANT PHYSIOL, V97, P1588, DOI 10.1104/pp.97.4.1588; SILVER GM, 1995, J BIOL CHEM, V270, P13010, DOI 10.1074/jbc.270.22.13010; Trapp SC, 2001, GENETICS, V158, P811; Vickers CE, 2010, PLANT MOL BIOL, V73, P547, DOI 10.1007/s11103-010-9642-3; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k	48	39	43	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20582	20590		10.1074/jbc.M111.237438	http://dx.doi.org/10.1074/jbc.M111.237438			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21504898	Green Published, hybrid			2022-12-25	WOS:000291267600044
J	Lingner, U; Munch, S; Deising, HB; Sauer, N				Lingner, Ulrike; Muench, Steffen; Deising, Holger B.; Sauer, Norbert			Hexose Transporters of a Hemibiotrophic Plant Pathogen FUNCTIONAL VARIATIONS AND REGULATORY DIFFERENCES AT DIFFERENT STAGES OF INFECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLETOTRICHUM-GRAMINICOLA; SACCHAROMYCES-CEREVISIAE; SUCROSE TRANSPORTERS; GLUCOSE-TRANSPORT; YEAST; GENES; SIGNAL; IDENTIFICATION; TRANSFORMATION; VIRULENCE	Plant pathogenic fungi use a wide range of different strategies to gain access to the carbon sources of their host plants. The hemibiotrophic maize pathogen Colletotrichum graminicola (teleomorph Glomerella graminicola) colonizes its host plants, and, after a short biotrophic phase, switches to destructive, necrotrophic development. Here we present the identification of five hexose transporter genes from C. graminicola, CgHXT1 to CgHXT5, the functional characterization of the encoded proteins, and detailed expression studies for these genes during vegetative and pathogenic development. Whereas CgHXT4 is expressed under all conditions analyzed, transcript abundances of CgHXT1 and CgHXT3 are transiently up-regulated during the biotrophic phase, and CgHXT2 and CgHXT5 are expressed exclusively during necrotrophic development. Analyses of the encoded proteins characterized CgHXT5 as a low-affinity/high-capacity hexose transporter with a narrow substrate specificity for glucose and mannose. In contrast, CgHXT1 to CgHXT3 are high affinity/low capacity transporters that also accept other substrates, including fructose, galactose, or xylose. CgHXT4, the largest of the identified proteins, has only little transport activity and may function as a sugar sensor. Phylogenetic studies revealed hexose transporters closely related to the five CgHXT proteins also in other pathogenic fungi suggesting conserved functions of these proteins during fungal pathogenesis.	[Sauer, Norbert] Univ Erlangen Nurnberg, Erlangen Ctr Plant Sci CROPS, D-91058 Erlangen, Germany; [Deising, Holger B.] Univ Halle Wittenberg, Interdisciplinary Ctr Crop Plant Res, D-06120 Halle, Saale, Germany	University of Erlangen Nuremberg; Martin Luther University Halle Wittenberg	Sauer, N (corresponding author), Univ Erlangen Nurnberg, Erlangen Ctr Plant Sci CROPS, Staudtstr 5, D-91058 Erlangen, Germany.	nsauer@biologie.uni-erlangen.de		Deising, Holger Bruno/0000-0001-5789-4269	Deutsche Forschungsgemeinschaft [FOR666-DE 403-16, FOR666-SA 382-21]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR666-DE 403-16 (to H. B. D.) and FOR666-SA 382-21 (to N. S.).	Behr M, 2010, MOL PLANT MICROBE IN, V23, P879, DOI 10.1094/MPMI-23-7-0879; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; DELROT S, 1981, PLANT PHYSIOL, V67, P560, DOI 10.1104/pp.67.3.560; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; Fang WG, 2010, PLANT PHYSIOL, V154, P1549, DOI 10.1104/pp.110.163014; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Horbach R, 2011, J PLANT PHYSIOL, V168, P51, DOI 10.1016/j.jplph.2010.06.014; Horbach R, 2009, PLANT CELL, V21, P3379, DOI 10.1105/tpc.108.064188; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Kliebenstein DJ, 2008, PLANT SCI, V174, P551, DOI 10.1016/j.plantsci.2008.03.005; Korripally P, 2010, FUNGAL GENET BIOL, V47, P237, DOI 10.1016/j.fgb.2009.12.006; Krijger JJ, 2008, MOL PLANT MICROBE IN, V21, P1325, DOI 10.1094/MPMI-21-10-1325; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SH, 2009, EUKARYOT CELL, V8, P1155, DOI 10.1128/EC.00335-08; Leonardi MG, 1998, AM J PHYSIOL-REG I, V274, pR1372, DOI 10.1152/ajpregu.1998.274.5.R1372; Li HM, 2010, EUR J DERMATOL, V20, P378, DOI 10.1684/ejd.2010.0904; Madi L, 1997, GENETICS, V146, P499; Maier A, 2002, FEMS YEAST RES, V2, P539, DOI 10.1016/S1567-1356(02)00140-X; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; Meyer S, 2000, PLANT J, V24, P869, DOI 10.1046/j.1365-313x.2000.00934.x; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Munch S, 2011, MOL PLANT PATHOL, V12, P43, DOI 10.1111/j.1364-3703.2010.00651.x; Muencha S, 2008, J PLANT PHYSIOL, V165, P41, DOI 10.1016/j.jplph.2007.06.008; OKAZAWA H, 2007, PROTEIN REV, V6, P451, DOI DOI 10.1007/978-0-387-36534-3_; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Qin JC, 2009, STEROIDS, V74, P786, DOI 10.1016/j.steroids.2009.04.011; RUSSEL JB, 1990, NATURE, V56, P3304; SAUER N, 1994, PLANT J, V6, P67, DOI 10.1046/j.1365-313X.1994.6010067.x; Sauer N, 2004, PLANT J, V40, P120, DOI 10.1111/j.1365-313X.2004.02196.x; Schussler A, 2006, NATURE, V444, P933, DOI 10.1038/nature05364; TOURNAS V, 1994, CRIT REV MICROBIOL, V20, P243, DOI 10.3109/10408419409113558; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Zheng Y, 2011, MOL PLANT MICROBE IN, V24, P13, DOI 10.1094/MPMI-10-09-0240	41	41	41	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20913	20922		10.1074/jbc.M110.213678	http://dx.doi.org/10.1074/jbc.M110.213678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502323	Green Published, hybrid			2022-12-25	WOS:000291267600075
J	Roder, G; Geironson, L; Rasmussen, M; Harndahl, M; Buus, S; Paulsson, K				Roder, Gustav; Geironson, Linda; Rasmussen, Michael; Harndahl, Mikkel; Buus, Soren; Paulsson, Kajsa			Tapasin Discriminates Peptide-Human Leukocyte Antigen-A*02:01 Complexes Formed with Natural Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ALPHA-2 DOMAIN; MOLECULES; REGION; TAP; IMMUNODOMINANCE; POLYMORPHISM; STABILITY; MECHANISM; PROVIDES	A plethora of peptides are generated intracellularly, and most peptide-human leukocyte antigen (HLA)-I interactions are of a transient, unproductive nature. Without a quality control mechanism, the HLA-I system would be stressed by futile attempts to present peptides not sufficient for the stable peptide-HLA-I complex formation required for long term presentation. Tapasin is thought to be central to this essential quality control, but the underlying mechanisms remain unknown. Here, we report that the N-terminal region of tapasin, Tpn(1-87), assisted folding of peptide-HLA-A*02: 01 complexes according to the identity of the peptide. The facilitation was also specific for the identity of the HLA-I heavy chain, where it correlated to established tapasin dependence hierarchies. Two large sets of HLA-A*02: 01 binding peptides, one extracted from natural HLA-I ligands from the SYFPEITHI database and one consisting of medium to high affinity non-SYFPEITHI ligands, were studied in the context of HLA-A*02: 01 binding and stability. We show that the SYFPEITHI peptides induced more stable HLAA*02:01 molecules than the other ligands, although affinities were similar. Remarkably, Tpn(1-87) could functionally discriminate the selected SYFPEITHI peptides from the other peptide binders with high sensitivity and specificity. We suggest that this HLA-I- and peptide-specific function, together with the functions exerted by the more C-terminal parts of tapasin, are major features of tapasin-mediated HLA-I quality control. These findings are important for understanding the biogenesis of HLA-I molecules, the selection of presented T-cell epitopes, and the identification of immunogenic targets in both basic research and vaccine design.	[Paulsson, Kajsa] Lund Univ, Immunol Sect, Dept Expt Med Sci, BMC D14, SE-22184 Lund, Sweden; [Roder, Gustav; Rasmussen, Michael; Harndahl, Mikkel; Buus, Soren; Paulsson, Kajsa] Univ Copenhagen, Expt Immunol Lab, Inst Int Hlth Immunol & Microbiol, DK-2200 Copenhagen, Denmark	Lund University; University of Copenhagen	Paulsson, K (corresponding author), Lund Univ, Immunol Sect, Dept Expt Med Sci, BMC D14, SE-22184 Lund, Sweden.	kajsa_m.paulsson@med.lu.se	Buus, Soren/F-5446-2010	Buus, Soren/0000-0001-8363-1999	National Institutes of Health [HHSN266200400025C]; Novo Nordisk Foundation; Lundbeck Foundation; Wedell-Wedellsborgs Foundation; Benzon Foundation; Swedish Medical Research Council [2006-6500]; Crafoord Foundation; Royal Physiographic Society in Lund; Thelma Zoegas Foundation; Magnus Bergvalls Foundation; Groshinskys Foundation; Greta and Johan Kocks Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Wedell-Wedellsborgs Foundation; Benzon Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoord Foundation; Royal Physiographic Society in Lund; Thelma Zoegas Foundation; Magnus Bergvalls Foundation; Groshinskys Foundation; Greta and Johan Kocks Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN266200400025C. This work was also supported by the Novo Nordisk Foundation, the Lundbeck Foundation, the Wedell-Wedellsborgs Foundation, the Benzon Foundation, the Copenhagen Cluster of Immunology, Swedish Medical Research Council Grant 2006-6500, the Crafoord Foundation, the Royal Physiographic Society in Lund, and the Thelma Zoegas, Magnus Bergvalls, Groshinskys, and Greta and Johan Kocks Foundations.	Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Chen MN, 2002, BIOCHEMISTRY-US, V41, P14539, DOI 10.1021/bi020521u; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ferre H, 2003, PROTEIN SCI, V12, P551, DOI 10.1110/ps.0233003; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; HARNDAHL M, 2010, J IMMUNOL M IN PRESS; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Papadopoulos M, 2007, J BIOL CHEM, V282, P9401, DOI 10.1074/jbc.M610429200; PARHAM P, 1979, J IMMUNOL, V123, P342; Park B, 2003, J IMMUNOL, V170, P961, DOI 10.4049/jimmunol.170.2.961; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Paulsson KM, 2006, J IMMUNOL, V176, P7482, DOI 10.4049/jimmunol.176.12.7482; Paulsson KM, 2004, FASEB J, V18, P31, DOI 10.1096/fj.03-0846rev; Paulsson KM, 2002, J BIOL CHEM, V277, P18266, DOI 10.1074/jbc.M201388200; Paulsson KM, 2001, INT IMMUNOL, V13, P23, DOI 10.1093/intimm/13.1.23; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Petersen JL, 2005, J IMMUNOL, V174, P962, DOI 10.4049/jimmunol.174.2.962; Praveen PVK, 2010, EUR J IMMUNOL, V40, P214, DOI 10.1002/eji.200939342; Purcell AW, 2008, CURR OPIN IMMUNOL, V20, P75, DOI 10.1016/j.coi.2007.12.005; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rizvi SM, 2006, P NATL ACAD SCI USA, V103, P18220, DOI 10.1073/pnas.0605131103; Roder G, 2009, EUR J IMMUNOL, V39, P2682, DOI 10.1002/eji.200939364; Stryhn A, 1996, EUR J IMMUNOL, V26, P1911, DOI 10.1002/eji.1830260836; Thirdborough SM, 2008, EUR J IMMUNOL, V38, P364, DOI 10.1002/eji.200737832; Turnquist HR, 2000, EUR J IMMUNOL, V30, P3021, DOI 10.1002/1521-4141(200010)30:10<3021::AID-IMMU3021>3.0.CO;2-U; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287	40	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20547	20557		10.1074/jbc.M111.230151	http://dx.doi.org/10.1074/jbc.M111.230151			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518758	Green Published, hybrid			2022-12-25	WOS:000291267600041
J	Alvarez, ML; DiStefano, JK				Alvarez, M. Lucrecia; DiStefano, Johanna K.			Functional Characterization of the Plasmacytoma Variant Translocation 1 Gene (PVT1) in Diabetic Nephropathy	PLOS ONE			English	Article							STAGE RENAL-DISEASE; HUMAN MESANGIAL CELLS; HIGH-GLUCOSE; MESSENGER-RNA; TGF-BETA; MAMMALIAN-CELLS; ANGIOTENSIN-II; PIMA-INDIANS; MICRORNAS; KIDNEY	We previously observed association between variants in the plasmacytoma variant translocation 1 gene (PVT1) and end-stage renal disease (ESRD) attributed to both type 1 and type 2 diabetes, and demonstrated PVT1 expression in a variety of renal cell types. While these findings suggest a role for PVT1 in the development of ESRD, potential mechanisms for involvement remain unknown. The goal of this study was to identify possible molecular mechanisms by which PVT1 may contribute to the development and progression of diabetic kidney disease. We knocked-down PVT1 expression in mesangial cells using RNA interference, and analyzed RNA and protein levels of fibronectin 1 (FN1), collagen, type IV, alpha 1 (COL4A1), transforming growth factor beta 1 (TGFB1) and plasminogen activator inhibitor-1 (SERPINE1 or PAI-1) by qPCR and ELISA, respectively. PVT1 expression was significantly upregulated by glucose treatment in human mesangial cells, as were levels of FN1, COL4A1, TGFB1, and PAI-1. Importantly, PVT1 knockdown significantly reduced mRNA and protein levels of the major ECM proteins, FN1 and COL4A1, and two key regulators of ECM proteins, TGFB1 and PAI-1. However, we observed a higher and more rapid reduction in levels of secreted FN1, COL4A1, and PAI-1 compared with TGFB1, suggesting that at least some of the PVT1 effects on ECM proteins may be independent of this cytokine. These results indicate that PVT1 may mediate the development and progression of diabetic nephropathy through mechanisms involving ECM accumulation.	[Alvarez, M. Lucrecia; DiStefano, Johanna K.] Translat Genom Res Inst, Diabet Cardiovasc & Metab Dis Ctr, Phoenix, AZ 85004 USA	Translational Genomics Research Institute	Alvarez, ML (corresponding author), Translat Genom Res Inst, Diabet Cardiovasc & Metab Dis Ctr, Phoenix, AZ 85004 USA.	jdistefano@tgen.org	DiStefano, Johanna K/V-7801-2019	DiStefano, Johanna K/0000-0002-3286-0270	American Diabetes Association	American Diabetes Association(American Diabetes Association)	This work was supported by the American Diabetes Association. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSIELLO DA, 1980, J CLIN INVEST, V65, P754, DOI 10.1172/JCI109723; AYO SH, 1991, AM J PHYSIOL, V260, pF185, DOI 10.1152/ajprenal.1991.260.2.F185; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BLANTZ RC, 1976, J CLIN INVEST, V57, P419, DOI 10.1172/JCI108293; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Craig DW, 2009, DIABETIC MED, V26, P1090, DOI 10.1111/j.1464-5491.2009.02846.x; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; HANEDA M, 1991, DIABETOLOGIA, V34, P198, DOI 10.1007/BF00418276; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Hoffman BB, 1998, KIDNEY INT, V54, P1107, DOI 10.1046/j.1523-1755.1998.00119.x; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Isono M, 2000, J AM SOC NEPHROL, V11, P2222, DOI 10.1681/ASN.V11122222; Jones CA, 2005, KIDNEY INT, V67, P1684, DOI 10.1111/j.1523-1755.2005.00265.x; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Lee EA, 2005, KIDNEY INT, V67, P1762, DOI 10.1111/j.1523-1755.2005.00274.x; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; McLennan SV, 2000, KIDNEY INT, V58, pS81, DOI 10.1046/j.1523-1755.2000.07713.x; MENGLEGAW L, 1987, EMBO J, V6, P1959, DOI 10.1002/j.1460-2075.1987.tb02458.x; Millis MP, 2007, DIABETES, V56, P3027, DOI 10.2337/db07-0675; NELSON RG, 1995, DIABETES CARE, V18, P182, DOI 10.2337/diacare.18.2.182; Oh JH, 1998, KIDNEY INT, V54, P1872, DOI 10.1046/j.1523-1755.1998.00193.x; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; PETTITT DJ, 1990, DIABETOLOGIA, V33, P438, DOI 10.1007/BF00404096; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Quinn M, 1996, DIABETOLOGIA, V39, P940; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Rossi JJ, 2005, NAT CELL BIOL, V7, P643, DOI 10.1038/ncb0705-643; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Shimazaki A, 2005, DIABETES, V54, P1171, DOI 10.2337/diabetes.54.4.1171; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; TADA H, 1994, DIABETES RES CLIN PR, V24, P33, DOI 10.1016/0168-8227(94)90083-3; *USRDS, 2002, US REN DAT SYST ANN, P296; Wahab NA, 1996, BIOCHEM J, V316, P985, DOI 10.1042/bj3160985; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; WOLF G, 1992, KIDNEY INT, V42, P647, DOI 10.1038/ki.1992.330	49	123	141	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18671	10.1371/journal.pone.0018671	http://dx.doi.org/10.1371/journal.pone.0018671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526116	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800012
J	Fiz, J; Duran, M; Capella, D; Carbonell, J; Farre, M				Fiz, Jimena; Duran, Marta; Capella, Dolors; Carbonell, Jordi; Farre, Magi			Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life	PLOS ONE			English	Article							SPANISH VERSION; PAIN; CLASSIFICATION; NABILONE	Background: The aim of this study was to describe the patterns of cannabis use and the associated benefits reported by patients with fibromyalgia (FM) who were consumers of this drug. In addition, the quality of life of FM patients who consumed cannabis was compared with FM subjects who were not cannabis users. Methods: Information on medicinal cannabis use was recorded on a specific questionnaire as well as perceived benefits of cannabis on a range of symptoms using standard 100-mm visual analogue scales (VAS). Cannabis users and non-users completed the Fibromyalgia Impact Questionnaire (FIQ), the Pittsburgh Sleep Quality Index (PSQI) and the Short Form 36 Health Survey (SF-36). Results: Twenty-eight FM patients who were cannabis users and 28 non-users were included in the study. Demographics and clinical variables were similar in both groups. Cannabis users referred different duration of drug consumption; the route of administration was smoking (54%), oral (46%) and combined (43%). The amount and frequency of cannabis use were also different among patients. After 2 hours of cannabis use, VAS scores showed a statistically significant (p < 0.001) reduction of pain and stiffness, enhancement of relaxation, and an increase in somnolence and feeling of well being. The mental health component summary score of the SF-36 was significantly higher (p < 0.05) in cannabis users than in non-users. No significant differences were found in the other SF-36 domains, in the FIQ and the PSQI. Conclusions: The use of cannabis was associated with beneficial effects on some FM symptoms. Further studies on the usefulness of cannabinoids in FM patients as well as cannabinoid system involvement in the pathophysiology of this condition are warranted.	[Fiz, Jimena; Farre, Magi] Inst Recerca Hosp Mar IMIM, Human Pharmacol & Neurosci Unit, Barcelona, Spain; [Fiz, Jimena; Capella, Dolors; Farre, Magi] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Duran, Marta; Capella, Dolors] Fundacio Inst Catala Farmacol, Barcelona, Spain; [Carbonell, Jordi] Rheumatol Unit, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona	Fiz, J (corresponding author), Inst Recerca Hosp Mar IMIM, Human Pharmacol & Neurosci Unit, Parc Salut Mar, Barcelona, Spain.	mfarre@imim.es			Ministerio de Sanidad - Plan Nacional sobre Drogas [SOC/3386/2004]; Instituto de Salud Carlos III (FIS-Red de Transtornos Adictivos) [RTA RD06/0001/1009]; Generalitat de Catalunya [AGAUR 2009 SGR 718]	Ministerio de Sanidad - Plan Nacional sobre Drogas; Instituto de Salud Carlos III (FIS-Red de Transtornos Adictivos)(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya)	The work was partially supported by grants from Ministerio de Sanidad - Plan Nacional sobre Drogas (SOC/3386/2004), Instituto de Salud Carlos III (FIS-Red de Transtornos Adictivos -RTA RD06/0001/1009) and Generalitat de Catalunya (AGAUR 2009 SGR 718). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles AM, 2007, ANN INTERN MED, V146, P726, DOI 10.7326/0003-4819-146-10-200705150-00006; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Blackburn-Munro Gordon, 2004, Curr Pain Headache Rep, V8, P116, DOI 10.1007/s11916-004-0025-9; Buskila D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2720; Carrier EJ, 2005, CNS NEUROL DISORD-DR, V4, P657, DOI 10.2174/156800705774933023; Dadabhoy D, 2006, NAT CLIN PRACT RHEUM, V2, P364, DOI 10.1038/ncprheum0221; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Iskedjian M, 2007, CURR MED RES OPIN, V23, P17, DOI 10.1185/030079906X158066; Lynch ME, 2006, J PAIN SYMPTOM MANAG, V32, P497, DOI 10.1016/j.jpainsymman.2006.05.016; Martinez-Lavin M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2146; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; RICO AR, 1997, VIGILIA SUENO, V9, P81; Rivera J, 2004, CLIN EXP RHEUMATOL, V22, P554; Russo EB, 2008, NEUROENDOCRINOL LETT, V29, P192; Schley M, 2006, CURR MED RES OPIN, V22, P1269, DOI 10.1185/030079906X112651; Skrabek RQ, 2008, J PAIN, V9, P164, DOI 10.1016/j.jpain.2007.09.002; Ware MA, 2010, ANESTH ANALG, V110, P604, DOI 10.1213/ANE.0b013e3181c76f70; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	18	80	87	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18440	10.1371/journal.pone.0018440	http://dx.doi.org/10.1371/journal.pone.0018440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533029	gold, Green Published, Green Submitted			2022-12-25	WOS:000290014500003
J	Cowley, M; de Burca, A; McCole, RB; Chahal, M; Saadat, G; Oakey, RJ; Schulz, R				Cowley, Michael; de Burca, Anna; McCole, Ruth B.; Chahal, Mandeep; Saadat, Ghazal; Oakey, Rebecca J.; Schulz, Reiner			Short Interspersed Element (SINE) Depletion and Long Interspersed Element (LINE) Abundance Are Not Features Universally Required for Imprinting	PLOS ONE			English	Article							L1 ELEMENTS; MOUSE; SEQUENCE; METHYLATION; GENES; RETROTRANSPOSITION; PROMOTER	Genomic imprinting is a form of gene dosage regulation in which a gene is expressed from only one of the alleles, in a manner dependent on the parent of origin. The mechanisms governing imprinted gene expression have been investigated in detail and have greatly contributed to our understanding of genome regulation in general. Both DNA sequence features, such as CpG islands, and epigenetic features, such as DNA methylation and non-coding RNAs, play important roles in achieving imprinted expression. However, the relative importance of these factors varies depending on the locus in question. Defining the minimal features that are absolutely required for imprinting would help us to understand how imprinting has evolved mechanistically. Imprinted retrogenes are a subset of imprinted loci that are relatively simple in their genomic organisation, being distinct from large imprinting clusters, and have the potential to be used as tools to address this question. Here, we compare the repeat element content of imprinted retrogene loci with non-imprinted controls that have a similar locus organisation. We observe no significant differences that are conserved between mouse and human, suggesting that the paucity of SINEs and relative abundance of LINEs at imprinted loci reported by others is not a sequence feature universally required for imprinting.	[Cowley, Michael; de Burca, Anna; McCole, Ruth B.; Chahal, Mandeep; Saadat, Ghazal; Oakey, Rebecca J.; Schulz, Reiner] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Cowley, M (corresponding author), Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England.	reiner.schulz@kcl.ac.uk	de Burca, Anna/GYV-1552-2022; Schulz, Reiner/A-5940-2011; Schulz, Reiner/H-4451-2011; Cowley, Mike/B-9425-2013; Oakey, Rebecca/A-5958-2011	Schulz, Reiner/0000-0001-5047-7921; Cowley, Michael/0000-0001-8564-4224; Oakey, Rebecca/0000-0003-2706-8139	Wellcome Trust [085448\Z\08\Z]; Philip Harris studentship; Research Councils UK; Engineering and Physical Sciences Research Council [836374] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Philip Harris studentship; Research Councils UK(UK Research & Innovation (UKRI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the Wellcome Trust (http://www.wellcome.ac.uk/) for supporting this work (grant ref. no.: 085448\Z\08\Z). RBM is the recipient of a Philip Harris studentship. RS is the recipient of a Research Councils UK fellowship (http://www.rcuk.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY NB, 1994, P NATL ACAD SCI USA, V91, P1569, DOI 10.1073/pnas.91.4.1569; Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Chai JH, 2001, MAMM GENOME, V12, P813, DOI 10.1007/s00335-001-2083-1; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Cowley M, 2010, BRIEF FUNCT GENOMICS, V9, P340, DOI 10.1093/bfgp/elq015; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Ding WY, 2006, IUBMB LIFE, V58, P677, DOI 10.1080/15216540601034856; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Greally JM, 2002, P NATL ACAD SCI USA, V99, P327, DOI 10.1073/pnas.012539199; HASSE A, 1994, J BIOL CHEM, V269, P1821; John RM, 2010, BRIEF FUNCT GENOMICS, V9, P294, DOI 10.1093/bfgp/elq010; JUBIERMAURIN V, 1992, MOL BIOL EVOL, V9, P41; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Ke XY, 2002, HUM GENET, V111, P511, DOI 10.1007/s00439-002-0822-3; Ke XY, 2002, MAMM GENOME, V13, P639, DOI 10.1007/s00335-002-3038-x; KITAGAWA K, 1995, GENOMICS, V30, P257, DOI 10.1006/geno.1995.9879; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; MCCOLE RB, 2011, EVOLUTION; Nabetani A, 1997, MOL CELL BIOL, V17, P789, DOI 10.1128/MCB.17.2.789; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Schulz R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001214; Schulz R, 2009, HUM MOL GENET, V18, P118, DOI 10.1093/hmg/ddn322; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Walter J, 2006, CYTOGENET GENOME RES, V113, P109, DOI 10.1159/000090821; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020; Yates PA, 1999, J BIOL CHEM, V274, P36357, DOI 10.1074/jbc.274.51.36357	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18953	10.1371/journal.pone.0018953	http://dx.doi.org/10.1371/journal.pone.0018953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533089	gold, Green Published, Green Submitted			2022-12-25	WOS:000289719400037
J	Salva, OR; Farroni, T; Regolin, L; Vallortigara, G; Johnson, MH				Salva, Orsola Rosa; Farroni, Teresa; Regolin, Lucia; Vallortigara, Giorgio; Johnson, Mark Henry			The Evolution of Social Orienting: Evidence from Chicks (Gallus gallus) and Human Newborns	PLOS ONE			English	Article							BIOLOGICAL MOTION; FILIAL PREFERENCES; FACE PERCEPTION; EXPERIENCE; RECOGNITION; PATHWAYS; STIMULI; UPRIGHT; GAZE; HENS	Background: Converging evidence from different species indicates that some newborn vertebrates, including humans, have visual predispositions to attend to the head region of animate creatures. It has been claimed that newborn preferences for faces are domain-relevant and similar in different species. One of the most common criticisms of the work supporting domain-relevant face biases in human newborns is that in most studies they already have several hours of visual experience when tested. This issue can be addressed by testing newly hatched face-naive chicks (Gallus gallus) whose preferences can be assessed prior to any other visual experience with faces. Methods: In the present study, for the first time, we test the prediction that both newly hatched chicks and human newborns will demonstrate similar preferences for face stimuli over spatial frequency matched structured noise. Chicks and babies were tested using identical stimuli for the two species. Chicks underwent a spontaneous preference task, in which they have to approach one of two stimuli simultaneously presented at the ends of a runway. Human newborns participated in a preferential looking task. Results and Significance: We observed a significant preference for orienting toward the face stimulus in both species. Further, human newborns spent more time looking at the face stimulus, and chicks preferentially approached and stood near the face-stimulus. These results confirm the view that widely diverging vertebrates possess similar domain-relevant biases toward faces shortly after hatching or birth and provide a behavioural basis for a comparison with neuroimaging studies using similar stimuli.	[Salva, Orsola Rosa; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Farroni, Teresa] Univ Padua, Dept Dev Psychol, Padua, Italy; [Farroni, Teresa; Johnson, Mark Henry] Univ London, Ctr Brain & Cognit Dev, London, England; [Regolin, Lucia] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Trento; University of Padua; University of London; Birkbeck University London; University of Padua	Salva, OR (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	orsola.rosasalva@unipd.it	Regolin, Lucia/N-9564-2019; Rosa Salva, Orsola/B-7831-2010; Farroni, Teresa/AAE-2219-2020	Regolin, Lucia/0000-0001-8960-0309; Rosa Salva, Orsola/0000-0003-1662-6094; Johnson, Mark/0000-0003-4229-2585	Medical Research Council [G0701484] Funding Source: Medline; MRC [G0701484] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acerra F, 2002, DEVELOPMENTAL SCI, V5, P98, DOI 10.1111/1467-7687.00215; BANKS MS, 1981, J EXP CHILD PSYCHOL, V31, P1, DOI 10.1016/0022-0965(81)90002-3; Blasi A, 2007, PHYS MED BIOL, V52, P6849, DOI 10.1088/0031-9155/52/23/005; Blasi CH, 2003, HUM DEV, V46, P259, DOI 10.1159/000071935; BOLHUIS JJ, 1985, DEV PSYCHOBIOL, V18, P299, DOI 10.1002/dev.420180403; Bolhuis JJ, 2009, NATURE, V458, P832, DOI 10.1038/458832a; Butler AB, 2006, BIOL BULL-US, V211, P106, DOI 10.2307/4134586; CANDLAND DK, 1969, J COMP PHYSIOL PSYCH, V69, P281, DOI 10.1037/h0028246; Clara E, 2007, J EXP PSYCHOL-ANIM B, V33, P12, DOI 10.1037/0097-7403.33.1.12; Csibra G, 2004, J PEDIAT NEUROL, V2, P85, DOI DOI 10.1055/S-0035-15; Dawkins MS, 1996, BEHAVIOUR, V133, P663, DOI 10.1163/156853996X00413; DAWKINS MS, 1995, BEHAVIOUR, V132, P591, DOI 10.1163/156853995X00225; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P661, DOI 10.1016/0028-3932(95)00002-K; Farah MJ, 2000, COGNITIVE NEUROPSYCH, V17, P117, DOI 10.1080/026432900380526; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2004, INFANCY, V5, P39, DOI 10.1207/s15327078in0501_2; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Forsman A, 2004, BEHAV ECOL, V15, P141, DOI 10.1093/beheco/arg092; GUHL A. M., 1953, CONDOR, V55, P287, DOI 10.2307/1365008; Horn G, 2004, NAT REV NEUROSCI, V5, P108, DOI 10.1038/nrn1324; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Johnson M. H., 1992, CURRENT DIRECTIONS P, V1, P52; Johnson MH, 2006, CURR BIOL, V16, pR376, DOI 10.1016/j.cub.2006.04.008; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; JOHNSON MH, 1988, ANIM BEHAV, V36, P675, DOI 10.1016/S0003-3472(88)80150-7; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KLEINER KA, 1987, INFANT BEHAV DEV, V10, P49, DOI 10.1016/0163-6383(87)90006-3; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Otsuka Y, 2007, NEUROIMAGE, V34, P399, DOI 10.1016/j.neuroimage.2006.08.013; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; PHELPS MT, 1994, J COMP PSYCHOL, V108, P114, DOI 10.1037/0735-7036.108.2.114; Reiner A, 2005, ANAT REC PART A, V287A, P1080, DOI 10.1002/ar.a.20253; Reiner A, 2005, BRAIN RES BULL, V66, P317, DOI 10.1016/j.brainresbull.2005.05.007; Rosa-Salva O, 2010, DEVELOPMENTAL SCI, V13, P565, DOI 10.1111/j.1467-7687.2009.00914.x; Salva OR, 2007, BEHAV BRAIN RES, V177, P15, DOI 10.1016/j.bbr.2006.11.020; Sewards TV, 2002, COMP BIOCHEM PHYS A, V132, P861, DOI 10.1016/S1095-6433(02)00119-8; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Southgate V, 2008, J COGNITIVE NEUROSCI, V20, P741, DOI 10.1162/jocn.2008.20052; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; Tovee MJ, 1998, NEURON, V21, P1239, DOI 10.1016/S0896-6273(00)80644-3; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Turati C, 2002, DEV PSYCHOL, V38, P875, DOI 10.1037//0012-1649.38.6.875; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; Vallortigara G, 2006, CURR BIOL, V16, pR279, DOI 10.1016/j.cub.2006.03.052; VALLORTIGARA G, 1991, ANIM BEHAV, V41, P187, DOI 10.1016/S0003-3472(05)80470-1	53	74	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18802	10.1371/journal.pone.0018802	http://dx.doi.org/10.1371/journal.pone.0018802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533093	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000289719400026
J	Yoshida, I; Sugiura, W; Shibata, J; Ren, FR; Yang, ZH; Tanaka, H				Yoshida, Izumi; Sugiura, Wataru; Shibata, Junko; Ren, Fengrong; Yang, Ziheng; Tanaka, Hiroshi			Change of Positive Selection Pressure on HIV-1 Envelope Gene Inferred by Early and Recent Samples	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE NUCLEOTIDE POLYMORPHISMS; 41 CANDIDATE GENES; CD4 CELL COUNTS; REPLICATIVE FITNESS; LIKELIHOOD METHOD; TEMPORAL TRENDS; SEROCONVERSION; IDENTIFICATION; ASSOCIATION	HIV-1 infection has been on the rise in Japan recently, and the main transmission route has changed from blood transmission in the 1980s to homo- and/or hetero-sexual transmission in the 2000s. The lack of early viral samples with clinical information made it difficult to investigate the possible virological changes over time. In this study, we sequenced 142 full-length env genes collected from 16 Japanese subjects infected with HIV-1 in the 1980s and in the 2000s. We examined the diversity change in sequences and potential adaptive evolution of the virus to the host population. We used a codon-based likelihood method under the branch-site and clade models to detect positive selection operating on the virus. The clade model was extended to account for different positive selection pressures in different viral populations. The result showed that the selection pressure was weaker in the 2000s than in the 1980s, indicating that it might have become easier for the HIV to infect a new host and to develop into AIDS now than 20 years ago and that the HIV may be becoming more virulent in the Japanese population. The study provides useful information on the surveillance of HIV infection and highlights the utility of the extended clade models in analysis of virus populations which may be under different selection pressures.	[Yoshida, Izumi; Shibata, Junko; Ren, Fengrong; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Sugiura, Wataru] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Sugiura, Wataru; Shibata, Junko] Natl Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Yang, Ziheng] UCL, Dept Biol, London, England	Tokyo Medical & Dental University (TMDU); National Institute of Infectious Diseases (NIID); Nagoya Medical Center; University of London; University College London	Yoshida, I (corresponding author), Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan.	ren@bioinfo.tmd.ac.jp		TAKEUCHI, Junko S/0000-0002-4844-9013	Ministry of Education, Culture, Sports, and Technology of Japan [19510208]	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology of Japan to F. R. and H.T (19510208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bielawski JP, 2003, J STRUCT FUNCT GENOM, V3, P201, DOI DOI 10.1007/978-94-010-0263-9_20; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Crum-Cianflone N, 2009, CLIN INFECT DIS, V48, P1285, DOI 10.1086/597777; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dorrucci M, 2005, AIDS, V19, P331; Dorrucci M, 2007, J INFECT DIS, V195, P525, DOI 10.1086/510911; Draenert R, 2006, J EXP MED, V203, P529, DOI 10.1084/jem.20052116; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Gali Y, 2007, VIROLOGY, V364, P140, DOI 10.1016/j.virol.2007.02.021; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GOUDSMIT, 1998, VIRAL SEX NATURE AID; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525; HOLMES EC, 1992, P NATL ACAD SCI USA, V89, P4835, DOI 10.1073/pnas.89.11.4835; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keet IPM, 1996, AIDS, V10, P1601, DOI 10.1097/00002030-199611000-00025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KNIPE D, FIELDS VIROLOGY LIPP, V1, P331; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kupfer B, 2007, J MED VIROL, V79, P1629, DOI 10.1002/jmv.20976; Leitner T, 1997, J VIROL, V71, P4761, DOI 10.1128/JVI.71.6.4761-4770.1997; Muller V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000454; Muller V, 2006, AIDS, V20, P889, DOI 10.1097/01.aids.0000218553.51908.6b; Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503; Ohnishi Y, 2000, HUM GENET, V106, P288, DOI 10.1007/s004390051039; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Ross HA, 2002, J VIROL, V76, P11715, DOI 10.1128/JVI.76.22.11715-11720.2002; Shioda T, 1997, J VIROL, V71, P4871, DOI 10.1128/JVI.71.7.4871-4881.1997; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tokunaga K, 1997, IMMUNOGENETICS, V46, P199, DOI 10.1007/s002510050262; Vanhems P, 1999, J INFECT DIS, V180, P1803, DOI 10.1086/315110; Yamada R, 2000, HUM GENET, V106, P293; Yamaguchi Y, 1997, P NATL ACAD SCI USA, V94, P1264, DOI 10.1073/pnas.94.4.1264; Yamaguchi-Kabata Y, 2000, J VIROL, V74, P4335, DOI 10.1128/JVI.74.9.4335-4350.2000; Yang Z, 2005, SYST BIOL, V54, P455, DOI 10.1080/10635150590945313; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yap VB, 2010, MOL BIOL EVOL, V27, P726, DOI 10.1093/molbev/msp232	45	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18630	10.1371/journal.pone.0018630	http://dx.doi.org/10.1371/journal.pone.0018630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526184	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100014
J	Arner, P; Arner, E; Hammarstedt, A; Smith, U				Arner, Peter; Arner, Erik; Hammarstedt, Ann; Smith, Ulf			Genetic Predisposition for Type 2 Diabetes, but Not for Overweight/Obesity, Is Associated with a Restricted Adipogenesis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; ABDOMINAL OBESITY; DIFFERENTIATION; GLUCOSE; ACCUMULATION; MECHANISMS; WNT	Background: Development of Type 2 diabetes, like obesity, is promoted by a genetic predisposition. Although several genetic variants have been identified they only account for a small proportion of risk. We have asked if genetic risk is associated with abnormalities in storing excess lipids in the abdominal subcutaneous adipose tissue. Methodology/Principal Findings: We recruited 164 lean and 500 overweight/obese individuals with or without a genetic predisposition for Type 2 diabetes or obesity. Adipose cell size was measured in biopsies from the abdominal adipose tissue as well as insulin sensitivity (HOMA index), HDL-cholesterol and Apo AI and Apo B. 166 additional non-obese individuals with a genetic predisposition for Type 2 diabetes underwent a euglycemic hyperinsulinemic clamp to measure insulin sensitivity. Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, was associated with inappropriate expansion of the adipose cells, reduced insulin sensitivity and a more proatherogenic lipid profile in non-obese individuals. However, obesity per se induced a similar expansion of adipose cells and dysmetabolic state irrespective of genetic predisposition. Conclusions/Significance: Genetic predisposition for Type 2 diabetes, but not obesity, is associated with an impaired ability to recruit new adipose cells to store excess lipids in the subcutaneous adipose tissue, thereby promoting ectopic lipid deposition. This becomes particularly evident in non-obese individuals since obesity per se promotes a dysmetabolic state irrespective of genetic predisposition. These results identify a novel susceptibility factor making individuals with a genetic predisposition for Type 2 diabetes particularly sensitive to the environment and caloric excess.	[Arner, Peter; Arner, Erik] Karolinska Inst, Karolinska Hosp, Dept Med, S-10401 Stockholm, Sweden; [Hammarstedt, Ann; Smith, Ulf] Univ Gothenburg, Sahlgrenska Acad, Lundberg Lab Diabet Res,Dept Mol & Clin Med, Ctr Excellence Metab & Cardiovasc Res, Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; University of Gothenburg	Arner, P (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Med, S-10401 Stockholm, Sweden.	ulf.smith@medic.gu.se	Arner, Erik/A-1895-2010; Northe, Hilda/I-1916-2012	Arner, Erik/0000-0003-1225-4908; Northe, Hilda/0000-0002-8873-5014; Arner, Peter/0000-0002-6208-6220	Novo Nordisk Foundation; Swedish Diabetes Association; Swedish Heart and Lung Foundation; Swedish Research Council [K2008-54X-01034-42-4, K2010-54X-03506-39-3]; Karolinska Institutet; Torsten and Ragnar Soderberg Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Association; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Torsten and Ragnar Soderberg Foundation	The study was funded by the Novo Nordisk Foundation, Swedish Diabetes Association, Swedish Heart and Lung Foundation, Swedish Research Council (K2008-54X-01034-42-4 and K2010-54X-03506-39-3), the Diabetes Research Program at Karolinska Institutet and the Torsten and Ragnar Soderberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hellstrom L, 1996, DIABETOLOGIA, V39, P921; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wilding J, 2006, LANCET, V367, P1053, DOI 10.1016/S0140-6736(06)68463-8; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	21	93	96	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18284	10.1371/journal.pone.0018284	http://dx.doi.org/10.1371/journal.pone.0018284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532749	Green Submitted, gold, Green Published			2022-12-25	WOS:000289404700008
J	Reilly, KT; Sirigu, A				Reilly, Karen T.; Sirigu, Angela			Motor Cortex Representation of the Upper-Limb in Individuals Born without a Hand	PLOS ONE			English	Article							PHANTOM-LIMB; CORTICAL REORGANIZATION; MAGNETIC STIMULATION; CORTICOMOTOR THRESHOLD; MUSCLE REPRESENTATION; OUTPUT MAPS; AMPUTEES; BODY; AMPUTATION; PAIN	The body schema is an action-related representation of the body that arises from activity in a network of multiple brain areas. While it was initially thought that the body schema developed with experience, the existence of phantom limbs in individuals born without a limb (amelics) led to the suggestion that it was innate. The problem with this idea, however, is that the vast majority of amelics do not report the presence of a phantom limb. Transcranial magnetic stimulation (TMS) applied over the primary motor cortex (M1) of traumatic amputees can evoke movement sensations in the phantom, suggesting that traumatic amputation does not delete movement representations of the missing hand. Given this, we asked whether the absence of a phantom limb in the majority of amelics means that the motor cortex does not contain a cortical representation of the missing limb, or whether it is present but has been deactivated by the lack of sensorimotor experience. In four upper-limb amelic subjects we directly stimulated the arm/hand region of M1 to see 1) whether we could evoke phantom sensations, and 2) whether muscle representations in the two cortices were organised asymmetrically. TMS applied over the motor cortex contralateral to the missing limb evoked contractions in stump muscles but did not evoke phantom movement sensations. The location and extent of muscle maps varied between hemispheres but did not reveal any systematic asymmetries. In contrast, forearm muscle thresholds were always higher for the missing limb side. We suggest that phantom movement sensations reported by some upper limb amelics are mostly driven by vision and not by the persistence of motor commands to the missing limb within the sensorimotor cortex. We propose that prewired movement representations of a limb need the experience of movement to be expressed within the primary motor cortex.	[Reilly, Karen T.; Sirigu, Angela] CNRS, Cognit Neurosci Ctr, UMR 5229, Bron, France; [Reilly, Karen T.; Sirigu, Angela] Univ Lyon 1, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Reilly, KT (corresponding author), CNRS, Cognit Neurosci Ctr, UMR 5229, Bron, France.	sirigu@isc.cnrs.fr	Reilly, Karen T/D-4423-2016; Sirigu, Angela/L-4683-2017	Reilly, Karen T/0000-0002-2840-1610; 	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR); Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants to AS from the Centre National de la Recherche Scientifique (CNRS), Agence Nationale de la Recherche (ANR), and the Fondation pour la Recherche Medicale.	Bernard JA, 2011, J NEUROPHYSIOL, V105, P88, DOI 10.1152/jn.00512.2010; Brugger P, 2000, P NATL ACAD SCI USA, V97, P6167, DOI 10.1073/pnas.100510697; Chen R, 1998, J NEUROSCI, V18, P3443; Cicinelli P, 1997, MUSCLE NERVE, V20, P535, DOI 10.1002/(SICI)1097-4598(199705)20:5<535::AID-MUS1>3.0.CO;2-A; Civardi C, 2000, CLIN NEUROPHYSIOL, V111, P624, DOI 10.1016/S1388-2457(99)00301-6; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; Dettmers C, 1999, NEUROSCI LETT, V263, P41, DOI 10.1016/S0304-3940(99)00105-6; DEVIGNEMONT F, 2009, NEUROPSYCHOLOGIA; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Elbert T, 1997, EXP BRAIN RES, V117, P161, DOI 10.1007/s002210050210; Flor H, 1998, EXP BRAIN RES, V119, P205, DOI 10.1007/s002210050334; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Funk M, 2008, NEUROIMAGE, V43, P121, DOI 10.1016/j.neuroimage.2008.06.011; Gagne M, 2009, NEUROSCIENCE, V162, P78, DOI 10.1016/j.neuroscience.2009.04.061; GAGNE M, 2010, HUMAN BRAIN MAPPING; Gallagher S, 1998, BRAIN COGNITION, V38, P53, DOI 10.1006/brcg.1998.1020; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; Irlbacher K, 2002, NEUROSCI LETT, V321, P129, DOI 10.1016/S0304-3940(02)00039-3; JENSEN TS, 1983, PAIN, V17, P243, DOI 10.1016/0304-3959(83)90097-0; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; KEW JJM, 1994, J NEUROPHYSIOL, V72, P2517, DOI 10.1152/jn.1994.72.5.2517; Kimiskidis VK, 2004, NEUROPHYSIOL CLIN, V34, P259, DOI 10.1016/j.neucli.2004.10.002; Lotze M, 2001, BRAIN, V124, P2268, DOI 10.1093/brain/124.11.2268; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Matsunaga K, 1998, ELECTROMYOGR MOTOR C, V109, P502, DOI 10.1016/S1388-2457(98)00020-0; Melzack R, 1997, BRAIN, V120, P1603, DOI 10.1093/brain/120.9.1603; MELZACK R, 1990, TRENDS NEUROSCI, V13, P88, DOI 10.1016/0166-2236(90)90179-E; Mercier C, 2006, BRAIN, V129, P2202, DOI 10.1093/brain/awl180; Merleau-Ponty Maurice, 2013, PHENOMENOLOGY PERCEP; Mills KR, 1997, MUSCLE NERVE, V20, P570, DOI 10.1002/(SICI)1097-4598(199705)20:5<570::AID-MUS5>3.3.CO;2-F; Montoya P, 1998, EUR J NEUROSCI, V10, P1095, DOI 10.1046/j.1460-9568.1998.00122.x; MORASSO P, 1995, J MOTOR BEHAV, V27, P52, DOI 10.1080/00222895.1995.9941699; Nico D, 2004, BRAIN, V127, P120, DOI 10.1093/brain/awh006; Noirhomme Q, 2004, IEEE T BIO-MED ENG, V51, P1994, DOI 10.1109/TBME.2004.834266; Park MC, 2001, J NEUROSCI, V21, P2784, DOI 10.1523/JNEUROSCI.21-08-02784.2001; PascualLeone A, 1996, NEUROREPORT, V7, P2068, DOI 10.1097/00001756-199609020-00002; Price EH, 2006, CONSCIOUS COGN, V15, P310, DOI 10.1016/j.concog.2005.07.003; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Reilly KT, 2008, NEUROSCIENTIST, V14, P195, DOI 10.1177/1073858407309466; Reilly KT, 2006, BRAIN, V129, P2211, DOI 10.1093/brain/awl154; Roricht S, 1999, NEUROLOGY, V53, P106, DOI 10.1212/WNL.53.1.106; ROSSINI PM, 1992, BRAIN RES, V593, P14, DOI 10.1016/0006-8993(92)91256-E; SAADAH ESM, 1994, CORTEX, V30, P479, DOI 10.1016/S0010-9452(13)80343-7; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Schilder, 1999, IMAGE APPEARANCE HUM; Schwenkreis P, 2001, CLIN NEUROPHYSIOL, V112, P627, DOI 10.1016/S1388-2457(01)00486-2; SIMMEL ML, 1962, SOC RES, V29, P337; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; TRIGGS WJ, 1994, BRAIN RES, V636, P270, DOI 10.1016/0006-8993(94)91026-X; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; vanderKamp W, 1996, J CLIN NEUROPHYSIOL, V13, P164, DOI 10.1097/00004691-199603000-00007; VETTER RJ, 1967, NEUROPSYCHOLOGIA, V5, P335, DOI 10.1016/0028-3932(67)90005-X; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Wilkins KL, 1998, PAIN, V78, P7, DOI 10.1016/S0304-3959(98)00109-2; WILSON SA, 1993, J NEUROL SCI, V118, P134, DOI 10.1016/0022-510X(93)90102-5	61	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18100	10.1371/journal.pone.0018100	http://dx.doi.org/10.1371/journal.pone.0018100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494663	gold, Green Published			2022-12-25	WOS:000289292800003
J	Nariai, Y; Hayashi, S; Morita, S; Umemura, Y; Tainaka, K; Sota, T; Cooley, JR; Yoshimura, J				Nariai, Yukiko; Hayashi, Saki; Morita, Satoru; Umemura, Yoshitaka; Tainaka, Kei-ichi; Sota, Teiji; Cooley, John R.; Yoshimura, Jin			Life Cycle Replacement by Gene Introduction under an Allee Effect in Periodical Cicadas	PLOS ONE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; MAGICICADA SPP.; 13-YEAR; 17-YEAR; SPECIATION; HEMIPTERA; HOMOPTERA; SELECTION; CICADIDAE; EVOLUTION	Periodical cicadas (Magicicada spp.) in the USA are divided into three species groups (-decim, -cassini, -decula) of similar but distinct morphology and behavior. Each group contains at least one species with a 17-year life cycle and one with a 13-year cycle; each species is most closely related to one with the other cycle. One explanation for the apparent polyphyly of 13- and 17-year life cycles is that populations switch between the two cycles. Using a numerical model, we test the general feasibility of life cycle switching by the introduction of alleles for one cycle into populations of the other cycle. Our results suggest that fitness reductions at low population densities of mating individuals (the Allee effect) could play a role in life cycle switching. In our model, if the 13-year cycle is genetically dominant, a 17-year cycle population will switch to a 13-year cycle given the introduction of a few 13-year cycle alleles under a moderate Allee effect. We also show that under a weak Allee effect, different year-classes ("broods") with 17-year life cycles can be generated. Remarkably, the outcomes of our models depend only on the dominance relationships of the cycle alleles, irrespective of any fitness advantages.	[Nariai, Yukiko; Hayashi, Saki; Morita, Satoru; Umemura, Yoshitaka; Tainaka, Kei-ichi; Cooley, John R.; Yoshimura, Jin] Shizuoka Univ, Dept Syst Engn, Hamamatsu, Shizuoka, Japan; [Hayashi, Saki] Shizuoka Univ, Fac Informat Sci, Hamamatsu, Shizuoka, Japan; [Sota, Teiji] Kyoto Univ, Dept Zool, Kyoto, Japan; [Cooley, John R.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Chiba, Japan; [Yoshimura, Jin] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	Shizuoka University; Shizuoka University; Kyoto University; University of Connecticut; Chiba University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Nariai, Y (corresponding author), Shizuoka Univ, Dept Syst Engn, Hamamatsu, Shizuoka, Japan.	jin@sys.eng.shizuoka.ac.jp	Morita, Satoru/W-7768-2018; Morita, Satoru/A-3736-2013	Morita, Satoru/0000-0001-5219-6218; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [22255004, 22370010, 20500204]; Ryozo Yamada Funds; National Science Foundation [DEB04-22386, DEB05-29679, DEB07-20664, DEB07-22101]; Grants-in-Aid for Scientific Research [20405007, 21570100, 22370010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ryozo Yamada Funds; National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan to J. Y. (nos. 22255004 and 22370010) and K. T. (20500204), a research grant from Ryozo Yamada Funds to J. Y. and J. R. C. acknowledge support from National Science Foundation DEB04-22386, DEB05-29679, DEB07-20664, and DEB07-22101 to Chris Simon. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. D., 1962, Miscellaneous Publications Museum of Zoology University of Michigan, Vno. 121, P1; Allee W.C, 1931, ANIMAL AGGREGATION S; ANDERSON E, 1949, INTROGRESSIVE HYBRID, P118; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Beamer R. H., 1931, Journal of the Kansas Entomological Society, V4, P53; Benko TP, 2006, J BIOL SYST, V14, P555, DOI 10.1142/S0218339006002008; Cooley JR, 2006, J EVOLUTION BIOL, V19, P855, DOI 10.1111/j.1420-9101.2005.01056.x; Cooley JR, 2001, MOL ECOL, V10, P661, DOI 10.1046/j.1365-294x.2001.01210.x; Cooley JR, 2001, BEHAVIOUR, V138, P827, DOI 10.1163/156853901753172674; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; COX RT, 1991, AM MIDL NAT, V125, P63, DOI 10.2307/2426370; Cox RT, 2003, EVOLUTION, V57, P428; COX RT, 1992, EVOLUTION, V46, P845, DOI 10.1111/j.1558-5646.1992.tb02092.x; DYBAS HS, 1962, ECOLOGY, V43, P432, DOI 10.2307/1933372; DYBAS HS, 1969, FIELD MUS NAT HIST B, V40, P10; Gogala Matija, 1995, Malayan Nature Journal, V48, P297; HELIOVAARA K, 1994, TRENDS ECOL EVOL, V9, P475, DOI 10.1016/0169-5347(94)90312-3; KARBAN R, 1982, ECOLOGY, V63, P321, DOI 10.2307/1938949; Kato M., 1956, BIOL CICADAS, V1981; Kato M., 1932, MONOGRAPH CICADIDAE; Kritsky G., 1988, Proceedings of the Indiana Academy of Science, V97, P295; Kritsky G, 2004, PERIODICAL CICADAS P; KUNO E, 1992, RES POPUL ECOL, V34, P275, DOI 10.1007/BF02514797; LLOYD M, 1966, EVOLUTION, V20, P466, DOI 10.1111/j.1558-5646.1966.tb03381.x; LLOYD M, 1983, EVOLUTION, V37, P1162, DOI 10.1111/j.1558-5646.1983.tb00231.x; LLOYD M, 1966, EVOLUTION, V20, P133, DOI 10.1111/j.1558-5646.1966.tb03350.x; Marlatt CL, 1923, BUREAU ENTOMOLOGY B, V71, P1; Marshall DC, 2000, EVOLUTION, V54, P1313, DOI 10.1111/j.0014-3820.2000.tb00564.x; MARTIN AP, 1988, NATURE, V336, P237, DOI 10.1038/336237a0; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Simon C, 2000, EVOLUTION, V54, P1326; Simon C., 1988, Bulletin of the Entomological Society of America, V34, P163; SIMON C, 1981, ECOLOGY, V62, P1525, DOI 10.2307/1941509; SIMON C, 1982, J NEW YORK ENTOMOL S, V90, P275; Smits A, 2010, ENTOMOL AM-NY, V116, P73, DOI 10.1664/09-RA-004R.1; Tanaka Y, 2009, P NATL ACAD SCI USA, V106, P8975, DOI 10.1073/pnas.0900215106; WASSERMAN M, 1977, EVOLUTION, V31, P812, DOI 10.1111/j.1558-5646.1977.tb01073.x; WHITE JA, 1975, AM MIDL NAT, V94, P127, DOI 10.2307/2424544; WILLIAMS KS, 1995, ANNU REV ENTOMOL, V40, P269, DOI 10.1146/annurev.en.40.010195.001413; Yoshimura J, 1997, AM NAT, V149, P112, DOI 10.1086/285981; YOSHIMURA J, 1994, THEOR POPUL BIOL, V45, P121, DOI 10.1006/tpbi.1994.1007; Yoshimura J, 1997, RES POPUL ECOL, V39, P191, DOI 10.1007/BF02765265; Yoshimura J, 2009, EVOLUTION, V63, P288, DOI 10.1111/j.1558-5646.2008.00545.x	44	8	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18347	10.1371/journal.pone.0018347	http://dx.doi.org/10.1371/journal.pone.0018347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494682	Green Submitted, gold, Green Published			2022-12-25	WOS:000289192400023
J	Thiam, S; Thior, M; Faye, B; Ndiop, M; Diouf, ML; Diouf, MB; Diallo, I; Fall, FB; Ndiaye, JL; Albertini, A; Lee, E; Jorgensen, P; Gaye, O; Bell, D				Thiam, Sylla; Thior, Moussa; Faye, Babacar; Ndiop, Medoune; Diouf, Mamadou Lamine; Diouf, Mame Birame; Diallo, Ibrahima; Fall, Fatou Ba; Ndiaye, Jean Louis; Albertini, Audrey; Lee, Evan; Jorgensen, Pernille; Gaye, Oumar; Bell, David			Major Reduction in Anti-Malarial Drug Consumption in Senegal after Nation-Wide Introduction of Malaria Rapid Diagnostic Tests	PLOS ONE			English	Article							COMBINATION THERAPY; COST-EFFECTIVENESS; RANDOMIZED-TRIAL; FEBRILE ILLNESS; TANZANIA; CHILDREN; ERA	Background: While WHO recently recommended universal parasitological confirmation of suspected malaria prior to treatment, debate has continued as to whether wide-scale use of rapid diagnostic tests (RDTs) can achieve this goal. Adherence of health service personnel to RDT results has been poor in some settings, with little impact on anti-malarial drug consumption. The Senegal national malaria control programme introduced universal parasite-based diagnosis using malaria RDTs from late 2007 in all public health facilities. This paper assesses the impact of this programme on anti-malarial drug consumption and disease reporting. Methods and Findings: Nationally-collated programme data from 2007 to 2009 including malaria diagnostic outcomes, prescription of artemisinin-based combination therapy (ACT) and consumption of RDTs in public health facilities, were reviewed and compared. Against a marked seasonal variation in all-cause out-patient visits, non-malarial fever and confirmed malaria, parasite-based diagnosis increased nationally from 3.9% of reported malaria-like febrile illness to 86.0% over a 3 year period. The prescription of ACT dropped throughout this period from 72.9% of malaria-like febrile illness to 31.5%, reaching close equivalence to confirmed malaria (29.9% of 584873 suspect fever cases). An estimated 516576 courses of inappropriate ACT prescription were averted. Conclusions: The data indicate high adherence of anti-malarial prescribing practice to RDT results after an initial run-in period. The large reduction in ACT consumption enabled by the move from symptom-based to parasite-based diagnosis demonstrates that effective roll-out and use of malaria RDTs is achievable on a national scale through well planned and structured implementation. While more detailed information on management of parasite-negative cases is required at point of care level to assess overall cost-benefits to the health sector, considerable cost-savings were achieved in ACT procurement. Programmes need to be allowed flexibility in management of these funds to address increases in other programmatic costs that may accrue from improved diagnosis of febrile disease.	[Thiam, Sylla; Thior, Moussa; Ndiop, Medoune; Diouf, Mamadou Lamine; Diouf, Mame Birame; Diallo, Ibrahima; Fall, Fatou Ba] Minist Sante, Programme Natl Lutte Paludisme, Dakar, Senegal; [Faye, Babacar; Ndiaye, Jean Louis; Gaye, Oumar] Univ Cheikh Anta Diop Dakar, Fac Med, Fann Dakar, Senegal; [Albertini, Audrey; Lee, Evan; Jorgensen, Pernille] FIND, Geneva, Switzerland; [Bell, David] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland	University Cheikh Anta Diop Dakar; Foundation For Innovative New Diagnostics; World Health Organization	Thiam, S (corresponding author), Minist Sante, Programme Natl Lutte Paludisme, Dakar, Senegal.	david.bell@finddiagnostics.org		Ndiaye, Jean/0000-0003-0450-5551	Global Fund to fight AIDS, Tuberculosis and Malaria; United States Presidents' Malaria Initiative; Foundation for Innovative New Diagnostics (FIND) through Bill and Melinda Gates Foundation	Global Fund to fight AIDS, Tuberculosis and Malaria; United States Presidents' Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); Foundation for Innovative New Diagnostics (FIND) through Bill and Melinda Gates Foundation	This study was funded through pre-existing grants to the Senegal Programme National de lutte contre le Paludisme from the Global Fund to fight AIDS, Tuberculosis and Malaria and the United States Presidents' Malaria Initiative, and by the Foundation for Innovative New Diagnostics (FIND) through a grant from the Bill and Melinda Gates Foundation. The funding agencies had no role in the decision to undertake the study, study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2009, MAL MICR QUAL ASS MA; ANSAH EK, 2010, RAPID TESTING MALARI; Armstrong Schellenberg J. R. M., 1994, Parasitology Today, V10, P439; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; Black RE, 2010, LANCET; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Faucher JF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-104; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; Ly AB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-153; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; SABOT SYO, 2009, CONS FOR AMFM AFF ME; SENEGAL NMC, 2006, DIRECTIVES NATL TRAI; SENEGAL NMC, 2008, MANUEL PROCEDURES CO; SHIFF CJ, 1993, T ROY SOC TROP MED H, V87, P646, DOI 10.1016/0035-9203(93)90273-S; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; WHO, 2008, METH MAN LAB QUAL CO; *WHO FIND CDC TDR, 2010, MAL RAP DIAGN TEST P; *WHO WPRO, 2010, MAL RDT JOB AIDS TRA; WHO-TDR-FIND, 2010, METH MAN LAB QUAL CO; Williams HA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-239; World Health Organization, 2009, MAL CAS MAN OP MAN; Yukich J, 2010, AM J TROP MED HYG, V83, P61, DOI 10.4269/ajtmh.2010.09-0632	32	118	119	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18419	10.1371/journal.pone.0018419	http://dx.doi.org/10.1371/journal.pone.0018419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494674	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400026
J	Walpita, P; Barr, J; Sherman, M; Basler, CF; Wang, LF				Walpita, Pramila; Barr, Jennifer; Sherman, Michael; Basler, Christopher F.; Wang, Linfa			Vaccine Potential of Nipah Virus-Like Particles	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; HENDRA-VIRUS; NEUTRALIZING ANTIBODIES; MEMBRANE-FUSION; ENCEPHALITIS; CELLS; INFECTION; PROTEINS; RECEPTOR; REQUIREMENTS	Nipah virus (NiV) was first recognized in 1998 in a zoonotic disease outbreak associated with highly lethal febrile encephalitis in humans and a predominantly respiratory disease in pigs. Periodic deadly outbreaks, documentation of person-to-person transmission, and the potential of this virus as an agent of agroterror reinforce the need for effective means of therapy and prevention. In this report, we describe the vaccine potential of NiV virus-like particles (NiV VLPs) composed of three NiV proteins G, F and M. Co-expression of these proteins under optimized conditions resulted in quantifiable amounts of VLPs with many virus-like/vaccine desirable properties including some not previously described for VLPs of any paramyxovirus: The particles were fusogenic, inducing syncytia formation; PCR array analysis showed NiV VLP-induced activation of innate immune defense pathways; the surface structure of NiV VLPs imaged by cryoelectron microscopy was dense, ordered, and repetitive, and consistent with similarly derived structure of paramyxovirus measles virus. The VLPs were composed of all the three viral proteins as designed, and their intracellular processing also appeared similar to NiV virions. The size, morphology and surface composition of the VLPs were consistent with the parental virus, and importantly, they retained their antigenic potential. Finally, these particles, formulated without adjuvant, were able to induce neutralizing antibody response in Balb/c mice. These findings indicate vaccine potential of these particles and will be the basis for undertaking future protective efficacy studies in animal models of NiV disease.	[Walpita, Pramila] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Microbiol, Galveston, TX USA; [Walpita, Pramila] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Immunol, Galveston, TX USA; [Barr, Jennifer; Wang, Linfa] Australian Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Sherman, Michael] Univ Texas Med Branch, Dept Biochem & Struct Biol, Galveston, TX USA; [Basler, Christopher F.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Texas System; University of Texas Medical Branch Galveston; Icahn School of Medicine at Mount Sinai	Walpita, P (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Microbiol, Galveston, TX USA.	prwalpit@utmb.edu	wang, lin/GSE-3040-2022; Basler, Christopher/AAG-8346-2019; Barr, Jennifer A/H-9254-2013	Basler, Christopher/0000-0003-4195-425X; Barr, Jennifer/0000-0001-5266-9142	NIH/WRCE [U54 AI057156-07]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	NIH/WRCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Developmental grant to PW from NIH/WRCE U54 AI057156-07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; [Anonymous], 2005, HSB (Health Science Bulletin), V3, P1; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P168; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bossart KN, 2005, J VIROL, V79, P6690, DOI 10.1128/JVI.79.11.6690-6702.2005; Bossart KN, 2002, J VIROL, V76, P11186, DOI 10.1128/JVI.76.22.11186-11198.2002; BRATT MA, 1969, P NATL ACAD SCI USA, V64, P536, DOI 10.1073/pnas.64.2.536; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chan KP, 2002, EPIDEMIOL INFECT, V128, P93, DOI 10.1017/S0950268801006422; CHATTOPADHYAY A, 2010, J VIROL; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Ciancanelli MJ, 2006, J VIROL, V80, P12070, DOI 10.1128/JVI.01743-06; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Coronel EC, 1999, J VIROL, V73, P7035, DOI 10.1128/JVI.73.8.7035-7038.1999; Defang GN, 2010, VACCINE, V29, P212, DOI 10.1016/j.vaccine.2010.10.053; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Gilbert JM, 1997, J VIROL, V71, P4555, DOI 10.1128/JVI.71.6.4555-4563.1997; Goldsmith CS, 2003, VIRUS RES, V92, P89, DOI 10.1016/S0168-1702(02)00323-4; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; Guillaume V, 2006, J VIROL, V80, P1972, DOI 10.1128/JVI.80.4.1972-1978.2006; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Gurley ES, 2007, INFECT CONT HOSP EP, V28, P740, DOI 10.1086/516665; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Harcourt BH, 2005, EMERG INFECT DIS, V11, P1594, DOI 10.3201/eid1110.050513; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Hyatt AD, 2001, MICROBES INFECT, V3, P297, DOI 10.1016/S1286-4579(01)01383-1; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Jennings GT, 2007, CURR MOL MED, V7, P143, DOI 10.2174/156652407780059140; Jennings GT, 2009, ANNU REV PHARMACOL, V49, P303, DOI 10.1146/annurev-pharmtox-061008-103129; Johnson JE, 2007, VIROLOGY, V360, P36, DOI 10.1016/j.virol.2006.10.026; KNUTTON S, 1977, J CELL SCI, V28, P179; Lam SK, 2003, ANTIVIR RES, V57, P113, DOI 10.1016/S0166-3542(02)00204-8; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Lo MK, 2010, VIROLOGY, V404, P78, DOI 10.1016/j.virol.2010.05.005; Lokugamage KG, 2008, VACCINE, V26, P797, DOI 10.1016/j.vaccine.2007.11.092; Mao CP, 2010, J VIROL, V84, P2331, DOI 10.1128/JVI.01954-09; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; McGinnes LW, 2010, J VIROL, V84, P4513, DOI 10.1128/JVI.01931-09; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Pager CT, 2006, VIROLOGY, V346, P251, DOI 10.1016/j.virol.2006.01.007; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Pantua HD, 2006, J VIROL, V80, P11062, DOI 10.1128/JVI.00726-06; Patch JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-1; PATTNAIK AK, 1991, P NATL ACAD SCI USA, V88, P1379, DOI 10.1073/pnas.88.4.1379; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Reading SA, 2007, ARCH VIROL, V152, P1047, DOI 10.1007/s00705-006-0923-8; Schmitt AP, 2004, CURR TOP MICROBIOL, V283, P145; Schmitt AP, 2002, J VIROL, V76, P3952, DOI 10.1128/JVI.76.8.3952-3964.2002; Sherman MB, 2010, J VIROL, V84, P9775, DOI 10.1128/JVI.00876-10; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Teng MN, 1998, J VIROL, V72, P5707, DOI 10.1128/JVI.72.7.5707-5716.1998; Walpita P, 2005, FEMS MICROBIOL LETT, V244, P9, DOI 10.1016/j.femsle.2005.01.046; Walpita P, 2007, J GEN VIROL, V88, P2542, DOI 10.1099/vir.0.83035-0; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; Whelan SPJ, 1999, J VIROL, V73, P307, DOI 10.1128/JVI.73.1.307-315.1999; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; 2004, HLTH SCI B, V2, P5; 2004, HLTH SCI B ICDDR B, V2, P7	77	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18437	10.1371/journal.pone.0018437	http://dx.doi.org/10.1371/journal.pone.0018437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494680	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400028
J	Al-Bahlani, S; Fraser, M; Wong, AYC; Sayan, BS; Bergeron, R; Melino, G; Tsang, BK				Al-Bahlani, S.; Fraser, M.; Wong, A. Y. C.; Sayan, B. S.; Bergeron, R.; Melino, G.; Tsang, B. K.			P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism	ONCOGENE			English	Article						CDDP; p73 alpha; calpain; calcium; ovarian cancer	X-LINKED INHIBITOR; P53 FAMILY; NEUROBLASTOMA-CELLS; CARCINOMA CELLS; FEEDBACK LOOP; IN-VIVO; CALPAIN; PROTEIN; BAX; CHEMOSENSITIVITY	P73 is important in drug-induced apoptosis in some cancer cells, yet its role in the regulation of chemosensitivity in ovarian cancer (OVCA) is poorly understood. Furthermore, if and how the deregulation of p73-mediated apoptosis confers resistance to cisplatin (CDDP) treatment is unclear. Here we demonstrate that TAp73 alpha over-expression enhanced CDDP-induced PARP cleavage and apoptosis in both chemosensitive (OV2008 and A2780s) and their resistant counterparts (C13* and A2780cp) and another chemoresistant OVCA cells (Hey); in contrast, the effect of Delta Np73 alpha over-expression was variable. P73 alpha downregulation attenuated CDDP-induced PUMA and NOXA upregulation and apoptosis in OV2008 cells. CDDP decreased p73 alpha steady-state protein levels in OV2008, but not in C13*, although the mRNA expression was identical. CDDP-induced p73 alpha downregulation was mediated by a calpain-dependent pathway. CDDP induced calpain activation and enhanced its cytoplasmic interaction and co-localization with p73 alpha in OV2008, but not C13* cells. CDDP increased the intracellular calcium concentration ([Ca(2+)](i)) in OV2008 but not C13* whereas cyclopiazonic acid (CPA), a Ca(2+)-ATPase inhibitor, caused this response and calpain activation, p73 alpha processing and apoptosis in both cell types. CDDP-induced [Ca(2+)](i) increase in OV2008 cells was not effected by the elimination of extracellular Ca(2+), but this was attenuated by the depletion of internal Ca(2+) store, indicating that mobilization of intracellular Ca(2+1) stores was potentially involved. These findings demonstrate that p73 alpha and its regulation by the Ca(2+)-mediated calpain pathway are involved in CDDP-induced apoptosis in OVCA cells and that dysregulation of Ca(2+)/calpain/p73 signaling may in part be the pathophysiology of CDDP resistance. Understanding the cellular and molecular mechanisms of chemoresistance will direct the development of effective strategies for the treatment of chemoresistant OVCA. Oncogene (2011) 30, 4219-4230; doi: 10.1038/onc.2011.134; published online 25 April 2011	[Al-Bahlani, S.; Fraser, M.; Tsang, B. K.] Univ Ottawa, Ottawa Hosp, Res Inst, Dept Obstet & Gynaecol, Ottawa, ON K1Y 4E9, Canada; [Al-Bahlani, S.; Fraser, M.; Wong, A. Y. C.; Bergeron, R.; Tsang, B. K.] Univ Ottawa, Ottawa Hosp, Res Inst, Dept Cellular & Mol Med, Ottawa, ON K1Y 4E9, Canada; [Al-Bahlani, S.; Fraser, M.] Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada; [Al-Bahlani, S.] Sultan Qaboos Univ, Dept Pathol, Muscat, Oman; [Wong, A. Y. C.; Bergeron, R.] Ottawa Hosp, Res Inst, Neurosci Program, Ottawa, ON, Canada; [Sayan, B. S.; Melino, G.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England; [Bergeron, R.; Tsang, B. K.] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; [Melino, G.] Univ Rome, Dept Expt Med, IDI IRCCS Biochem Lab, Rome, Italy; [Fraser, M.] Princess Margaret Hosp, Ontario Canc Inst, Radiat Med Program, Toronto, ON M4X 1K9, Canada; [Fraser, M.] Princess Margaret Hosp, Ontario Canc Inst, STTARR Innovat Facil, Toronto, ON M4X 1K9, Canada; [Tsang, B. K.] Seoul Natl Univ, World Class Univ WCU Biomodulat Major, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul, South Korea	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Sultan Qaboos University; University of Ottawa; Ottawa Hospital Research Institute; University of Leicester; University of Ottawa; Sapienza University Rome; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Seoul National University (SNU)	Tsang, BK (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Dept Obstet & Gynaecol, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.	btsang@ohri.ca	Bahlani, Shadia/AAZ-3711-2020	Tsang, Benjamin K./0000-0003-1213-3946; Bergeron, Richard/0000-0002-5632-750X; Wong, Adrian/0000-0001-5652-3482	Canadian Institute of Health Research [MOP-15691]; WCU (World Class University) through National Research Foundation of Korea [R31-10056]; Ministry of Education, Science and Technology; UK Medical Research Council; Sultan Qaboos University, Sultanate of Oman; MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: researchfish	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); WCU (World Class University) through National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sultan Qaboos University, Sultanate of Oman; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Canadian Institute of Health Research (MOP-15691), the WCU (World Class University) program (R31-10056) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology and the UK Medical Research Council. SA is a scholarship recipient of Sultan Qaboos University, Sultanate of Oman.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bernassola F, 2004, J EXP MED, V199, P1545, DOI 10.1084/jem.20031943; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Chen CL, 2000, CLIN CANCER RES, V6, P3910; Di Sano F, 2006, J BIOL CHEM, V281, P2693, DOI 10.1074/jbc.M509110200; Eltabbakh G H, 2001, Expert Opin Pharmacother, V2, P109, DOI 10.1517/14656566.2.1.109; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Fraser Michael, 2003, Reprod Biol Endocrinol, V1, P66, DOI 10.1186/1477-7827-1-66; Gao G, 2000, J CELL BIOCHEM, V80, P53; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Gunes DA, 2009, NEUROTOXICOLOGY, V30, P194, DOI 10.1016/j.neuro.2008.12.001; Holcakova J, 2008, CELL MOL BIOL LETT, V13, P404, DOI 10.2478/s11658-008-0011-z; Irwin MS, 2004, CELL CYCLE, V3, P319; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Marabese M, 2005, CELL DEATH DIFFER, V12, P805, DOI 10.1038/sj.cdd.4401622; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004; Million K, 2006, INT J ONCOL, V29, P147; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Muller M, 2005, CELL DEATH DIFFER, V12, P1564, DOI 10.1038/sj.cdd.4401774; Munarriz E, 2005, BIOCHEM BIOPH RES CO, V333, P954, DOI 10.1016/j.bbrc.2005.05.188; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Nyman U, 2005, J BIOL CHEM, V280, P34159, DOI 10.1074/jbc.M500394200; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Ramadan S, 2005, BIOCHEM BIOPH RES CO, V331, P713, DOI 10.1016/j.bbrc.2005.03.156; Righetti SC, 2008, CANCER LETT, V263, P140, DOI 10.1016/j.canlet.2007.12.024; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Sabatino MA, 2007, INT J CANCER, V120, P506, DOI 10.1002/ijc.22362; Sang MX, 2009, GENES CELLS, V14, P775, DOI 10.1111/j.1365-2443.2009.01309.x; Sayan AE, 2005, BIOCHEM BIOPH RES CO, V330, P186, DOI 10.1016/j.bbrc.2005.02.145; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Splettstoesser F, 2007, BRIT J PHARMACOL, V151, P1176, DOI 10.1038/sj.bjp.0707335; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Vayssade M, 2005, INT J CANCER, V116, P860, DOI 10.1002/ijc.21033; Vikhanskaya F, 2001, CANCER RES, V61, P935; Yoshida K, 2008, ONCOGENE, V27, P1183, DOI 10.1038/sj.onc.1210722	50	63	63	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	41					4219	4230		10.1038/onc.2011.134	http://dx.doi.org/10.1038/onc.2011.134			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HO	21516125	Green Published, hybrid			2022-12-25	WOS:000296356300001
J	Lossaint, G; Besnard, E; Fisher, D; Piette, J; Dulic, V				Lossaint, G.; Besnard, E.; Fisher, D.; Piette, J.; Dulic, V.			Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional	ONCOGENE			English	Article						G2-M checkpoint; cyclin B1; cell cycle; Chk2; ATM	CELL-CYCLE EXIT; G(2) CHECKPOINT; ATAXIA-TELANGIECTASIA; P53-DEFICIENT CELLS; GENOMIC INSTABILITY; MITOTIC CATASTROPHE; CARCINOMA CELLS; PROTEIN-KINASE; P53; CANCER	In the presence of sustained DNA damage occurring in S-phase or G2, normal cells arrest before mitosis and eventually become senescent. The checkpoint kinases Chk1/Chk2 and the CDK inhibitor p21 are known to have important complementary roles in this process, in G2 arrest and cell cycle exit, respectively. However, additional checkpoint roles have been reported for these regulators and it is not clear to what extent their functions are redundant. Here we compared the respective roles of Chk1, Chk2 and p21 in DNA damage-induced G2 arrest in normal human fibroblasts, normal epithelial cells and frequently used p53 proficient cancer cells. We show that in normal cells, Chk1, but not Chk2, is involved in G2 arrest whereas neither are essential. In contrast, p21 is required. However, Chk1, but not Chk2, becomes necessary for arrest in U2OS osteosarcoma cells. We find that their ATM/p53/p21 response in G2 phase is defective, like in other cancer cells with wild-type p53, and conclude that cross-talk between the Chk1 and p21 pathways allows them to switch dependency for G2 arrest onto Chk1. Using the specific ATM inhibitor KU-55933 we confirm the essential role of ATM in the induction of p21 for G2 arrest of normal cells. Efficient p21 induction is required for nuclear sequestration of inactive cyclin B1-Cdk1 complexes preceding irreversible cell cycle exit in G2. Our results demonstrate that p21 is able to fulfill the Chk1 functions in G2 arrest under continuous genotoxic stress, which has important implications for cancer chemotherapy. Oncogene (2011) 30, 4261-4274; doi: 10.1038/onc.2011.135; published online 2 May 2011	[Lossaint, G.; Fisher, D.; Piette, J.; Dulic, V.] Univ Montpellier I, Inst Genet Mol Montpellier, CNRS, UMR 5535, F-34293 Montpellier, Herault, France; [Lossaint, G.; Fisher, D.; Piette, J.; Dulic, V.] Univ Montpellier 2, F-34293 Montpellier, Herault, France; [Besnard, E.] CNRS, INSERM, Inst Genet Fonct, UMR 5203,U661, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Piette, J (corresponding author), Univ Montpellier I, Inst Genet Mol Montpellier, CNRS, UMR 5535, 1919 Route Mende, F-34293 Montpellier, Herault, France.	jacques.piette@igmm.cnrs.fr; vjekoslav.dulic@igmm.cnrs.fr	Fisher, Daniel/D-6915-2018; Besnard, Emilie/K-6161-2015	Fisher, Daniel/0000-0002-0822-3482; Dulic, Vjekoslav/0000-0003-1201-3901	ARC [3631, 3793]; Canceropole du Grand Sud Ouest; Ministere de l'Education Nationale et de la Recherche (MENR); LNCC	ARC(Australian Research Council); Canceropole du Grand Sud Ouest; Ministere de l'Education Nationale et de la Recherche (MENR); LNCC	This work was supported by grants of ARC (grant N<SUP>o</SUP> 3631 to JP and N<SUP>o</SUP>3793 to VD) the Canceropole du Grand Sud Ouest and the Ministere de l'Education Nationale et de la Recherche (MENR, EB). The team (GL, VD and DF) is 'Equipe labellise' by the Ligue Nationale Contre le Cancer (LNCC, N<SUP>o</SUP> EL2010.LNCC/DF). GL was recipient of a PhD fellowship from LNCC. We are grateful to KUDOS Pharmaceuticals for gift KU-55933, Dr AM Creighton for gift ICRF-193, Dr D Galloway (Seattle, USA) for the E6 retroviral vector and Dr A Constantinou for DNA-PKcs-specific antibodies. We thank Dr D Fraillery for helping us in analysis of HeLa and U2OS cells, Drs V Gire and J Loncarek for the retroviral transduction of the HMEC-derived cell lines, Drs E Julien, C Sardet, A Camasses, P Coopman and N Taylor for critical reading of the manuscript and Dr A Constantinou for encouragement. We acknowledge the Montpellier RIO imaging facility (Head Dr P Travo) for their help. Finally, we thank the reviewers for insightful suggestions.	Ahn JW, 2003, J BIOL CHEM, V278, P20480, DOI 10.1074/jbc.M213185200; Andreassen PR, 2001, CANCER RES, V61, P7660; Arlander SJH, 2008, CANCER RES, V68, P89, DOI 10.1158/0008-5472.CAN-07-0675; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chan TA, 2000, GENE DEV, V14, P1584; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Flatt PM, 2000, MOL CELL BIOL, V20, P4210, DOI 10.1128/MCB.20.12.4210-4223.2000; Foijer F, 2005, CANCER CELL, V8, P455, DOI 10.1016/j.ccr.2005.10.021; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gillis LD, 2009, CELL CYCLE, V8, P253, DOI 10.4161/cc.8.2.7550; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jin J, 2008, J BIOL CHEM, V283, P19322, DOI 10.1074/jbc.M802474200; Jurvansuu J, 2007, J MOL BIOL, V372, P397, DOI 10.1016/j.jmb.2007.06.077; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee J, 2009, MOL BIOL CELL, V20, P1891, DOI 10.1091/mbc.E08-08-0818; LEVEDAKOU EN, 1995, CANCER RES, V55, P2500; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Meng S, 2009, CELL CYCLE, V8, P2238, DOI 10.4161/cc.8.14.8998; Merry C, 2010, CELL CYCLE, V9, P279, DOI 10.4161/cc.9.2.10445; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Palmero EI, 2010, CURR OPIN ONCOL, V22, P64, DOI 10.1097/CCO.0b013e328333bf00; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; van Vugt MATM, 2010, CELL CYCLE, V9, P2097, DOI 10.4161/cc.9.11.11840; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Zhang WH, 2008, CELL CYCLE, V7, P1668, DOI 10.4161/cc.7.11.5982; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	65	58	59	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	41					4261	4274		10.1038/onc.2011.135	http://dx.doi.org/10.1038/onc.2011.135			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HO	21532626				2022-12-25	WOS:000296356300004
J	Furu, M; Kajita, Y; Nagayama, S; Ishibe, T; Shima, Y; Nishijo, K; Uejima, D; Takahashi, R; Aoyama, T; Nakayama, T; Nakamura, T; Nakashima, Y; Ikegawa, M; Imoto, S; Katagiri, T; Nakamura, Y; Toguchida, J				Furu, M.; Kajita, Y.; Nagayama, S.; Ishibe, T.; Shima, Y.; Nishijo, K.; Uejima, D.; Takahashi, R.; Aoyama, T.; Nakayama, T.; Nakamura, T.; Nakashima, Y.; Ikegawa, M.; Imoto, S.; Katagiri, T.; Nakamura, Y.; Toguchida, J.			Identification of AFAP1L1 as a prognostic marker for spindle cell sarcomas	ONCOGENE			English	Article						AFAP1L1; spindle cell sarcoma; metastasis; prognostic marker	ACTIN-FILAMENT INTEGRITY; SOFT-TISSUE SARCOMAS; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION; SYNOVIAL SARCOMAS; MATRIX METALLOPROTEINASES; MUTATION SPECTRUM; ADAPTER PROTEIN; AFAP-110; CANCER	Spindle cell sarcomas consist of tumors with different biological features, of which distant metastasis is the most ominous sign for a poor prognosis. However, metastasis is difficult to predict on the basis of current histopathological analyses. We have identified actin filament-associated protein 1-like 1 (AFAP1L1) as a candidate for a metastasis-predicting marker from the gene expression profiles of 65 spindle cell sarcomas. A multivariate analysis determined that AFAP1L1 was an independent factor for predicting the occurrence of distant metastasis (P = 0.0001), which was further confirmed in another set of 41 tumors by a quantitative mRNA expression analysis. Immunohistochemical staining using paraffin-embedded tumor tissues revealed that the metastasis-free rate was significantly better in tumors negative for AFAP1L1 (P = 0.0093 by log-rank test). Knocking down the AFAP1L1 gene in sarcoma cells resulted in inhibition of the cell invasion, and forced expression of AFAP1L1 in immortalized human mesenchymal stem cells induced anchorage-independent growth and increased cell invasiveness with high activity levels of matrix metallo-peptidase. Furthermore, tumor growth in vivo was accelerated in AFAP1L1-transduced sarcoma cell lines. These results suggest that AFAP1L1 has a role in the progression of spindle cell sarcomas and is a prognostic biomarker. Oncogene (2011) 30, 4015-4025; doi:10.1038/onc.2011.108; published online 25 April 2011	[Toguchida, J.] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Sakyo Ku, Kyoto 6068507, Japan; [Furu, M.; Ishibe, T.; Shima, Y.; Nishijo, K.; Nakayama, T.; Nakamura, T.; Toguchida, J.] Kyoto Univ, Dept Orthopaed Surg, Grad Sch Med, Kyoto 6068507, Japan; [Kajita, Y.] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto 6068507, Japan; [Nagayama, S.; Takahashi, R.] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068507, Japan; [Uejima, D.; Aoyama, T.] Kansai Med Univ, Dept Orthopaed Surg, Osaka, Japan; [Nakashima, Y.] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Ikegawa, M.] Kyoto Prefectural Univ Med, Dept Genom Med Sci, Grad Sch Med Sci, Kyoto, Japan; [Imoto, S.] Univ Tokyo, Lab DNA Informat Anal, Ctr Human Genome, Inst Med Sci, Kyoto, Japan; [Katagiri, T.; Nakamura, Y.] Univ Tokyo, Mol Med Lab, Ctr Human Genome, Inst Med Sci, Kyoto, Japan; [Toguchida, J.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kansai Medical University; Kyoto University; Kyoto Prefectural University of Medicine; University of Tokyo; University of Tokyo; Kyoto University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	togjun@frontier.kyoto-u.ac.jp	Katagiri, Toyomasa/I-7344-2012; Ikegawa, Masaya/AAG-5327-2020		Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [21390420] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Drs H Sonobe, A Kawai, S Tanaka, O Larsson, A Ogose, and H Kanda for providing cell lines, and T Tsunoda and S Miyano for data analyses. This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology.	Aoyama T, 2004, J BIOL CHEM, V279, P28789, DOI 10.1074/jbc.M401273200; Baisden JM, 2001, ONCOGENE, V20, P6607, DOI 10.1038/sj.onc.1204802; Baisden JM, 2001, ONCOGENE, V20, P6435, DOI 10.1038/sj.onc.1204784; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Dorfleutner A, 2007, J CELL PHYSIOL, V213, P740, DOI 10.1002/jcp.21143; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fletcher CDM, 2001, J CLIN ONCOL, V19, P3045, DOI 10.1200/JCO.2001.19.12.3045; Fletcher CDM., 2002, WHO CLASSIFICATION T; FLYNN DC, 1993, MOL CELL BIOL, V13, P7892, DOI 10.1128/MCB.13.12.7892; Francis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-73; Gatesman A, 2004, MOL CELL BIOL, V24, P7578, DOI 10.1128/MCB.24.17.7578-7597.2004; Guappone AC, 1997, MOL CELL BIOCHEM, V175, P243, DOI 10.1023/A:1006840104666; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Ishibe T, 2005, CLIN CANCER RES, V11, P2702, DOI 10.1158/1078-0432.CCR-04-2057; Ishibe T, 2008, CLIN ORTHOP RELAT R, V466, P2147, DOI 10.1007/s11999-008-0343-z; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Kohno Y, 2006, J BIOL CHEM, V281, P38941, DOI 10.1074/jbc.M608389200; Lee YF, 2004, CANCER RES, V64, P7201, DOI 10.1158/0008-5472.CAN-04-1673; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Nagayama S, 2005, ONCOGENE, V24, P6201, DOI 10.1038/sj.onc.1208780; Nagayama S, 2002, CANCER RES, V62, P5859; Nakayama R, 2007, MODERN PATHOL, V20, P749, DOI 10.1038/modpathol.3800794; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Ottaiano A, 2005, ANTICANCER RES, V25, P4519; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Qian Y, 2004, J CELL BIOCHEM, V91, P602, DOI 10.1002/jcb.10725; Qian Y, 1998, ONCOGENE, V16, P2185, DOI 10.1038/sj.onc.1201753; Qian Y, 2000, EXP CELL RES, V255, P102, DOI 10.1006/excr.1999.4795; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Shima Y, 2007, BIOCHEM BIOPH RES CO, V353, P60, DOI 10.1016/j.bbrc.2006.11.137; St-Pierre Y, 2004, EXPERT OPIN THER TAR, V8, P473, DOI 10.1517/14728222.8.5.473; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; TOGUCHIDA J, 1992, CANCER RES, V52, P6194; Toguchida J, 2009, CANCER SCI, V100, P1573, DOI 10.1111/j.1349-7006.2009.01232.x; WADAYAMA B, 1994, CANCER RES, V54, P3042; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710	40	11	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	38					4015	4025		10.1038/onc.2011.108	http://dx.doi.org/10.1038/onc.2011.108			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	823KR	21516130	Green Submitted			2022-12-25	WOS:000295121600003
J	Shi, Y; Chen, J; Li, Z; Zhang, Z; Yu, H; Sun, K; Wang, X; Song, X; Wang, Y; Zhen, Y; Yang, T; Lou, K; Zhang, Y; Zhang, G; Hu, Y; Ji, J; Hui, R				Shi, Y.; Chen, J.; Li, Z.; Zhang, Z.; Yu, H.; Sun, K.; Wang, X.; Song, X.; Wang, Y.; Zhen, Y.; Yang, T.; Lou, K.; Zhang, Y.; Zhang, G.; Hu, Y.; Ji, J.; Hui, R.			C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer	ONCOGENE			English	Article						C10ORF97; tumor suppressor; non-small-cell lung cancer; genetic variant	DEPENDENT-KINASE INHIBITOR; DOMAIN-BINDING PROTEIN-1; REDUCED EXPRESSION; INVERSE EXPRESSION; COP9 SIGNALOSOME; JAB1 EXPRESSION; POOR-PROGNOSIS; P27(KIP1); P27; DEREGULATION	In an earlier study we showed that C10ORF97 (chromosome-10, open reading frame-97) was expressed in almost all of the tissues and cell lines tested, and that it inhibited the growth of seven tumor cell lines, including two lung carcinoma cell lines (A549 and PG). Here, we show that C10ORF97 is downregulated in non-small-cell lung cancer (NSCLC) tissue compared with normal lung tissue. Overexpression of C10ORF97 significantly suppressed human lung carcinoma A549 cell growth (proliferation and anchorage-independent growth in soft agar) and motility (migration and adhesion). This tumor-suppressive function of C10ORF97 was also verified in vivo. We further found that C10ORF97 caused G(1) arrest of A549 cells and modulated the expression level of several cell-cycle regulators (such as CDK2, cyclin-E and p27). These effects of C10ORF97 were mediated by physical association between C10ORF97 and Jun-activating domain-binding protein-1 (JAB1), and blocking of JAB1-mediated translocation of p27 from the nucleus to the cytoplasm. Together, these results indicated that C10ORF97 functions as a novel tumor suppressor by modulating several key G(1)/S-regulatory proteins by interacting with JAB1. These findings led us to hypothesize that a single-nucleotide polymorphism (SNP) in the C10ORF97 gene that affects its expression might be associated with susceptibility to NSCLC. SNP216 C > T (rs2297882) in the C10ORF97 Kozak sequence was identified, and allele T of SNP216 suppressed C10ORF97 expression in vitro and in vivo. Furthermore, the TT genotype of SNP216 was associated with an increased risk of NSCLC (adjusted odds ratio = 1.73 (95% confidence interval: 1.33-2.25), P = 4.6 x 10(-5)). These data indicated that C10ORF97 is a tumor suppressor of NSCLC progression and C10ORF97-SNP216 may serve as a predictor of NSCLC. Oncogene (2011) 30, 4107-4117; doi:10.1038/onc.2011.116; published online 18 April 2011	[Li, Z.; Zhang, G.; Hu, Y.; Ji, J.] Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Surg,Key Lab Carcinogenesis & Translat Res, Beijing 100042, Peoples R China; [Shi, Y.; Zhang, Z.; Yu, H.; Sun, K.; Wang, X.; Song, X.; Wang, Y.; Zhen, Y.; Yang, T.; Lou, K.; Zhang, Y.; Hui, R.] Chinese Acad Med Sci, Peking Union Med Coll, Key Lab Clin Cardiovasc Genet, Sino German Lab Mol Med,Fuwai Hosp,Minist Educ, Beijing 100037, Peoples R China; [Shi, Y.] Sichuan Acad Med Sci, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Shi, Y.] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Ji, J (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Dept Surg,Key Lab Carcinogenesis & Translat Res, 52 Fucheng Rd, Beijing 100042, Peoples R China.	jiafuj@hotmail.com; huirutai@sglab.org	Zhang, Zhen/F-8561-2011; Wang, Weili/D-1546-2011		National High Technology Research and Development Program of China (863 Program) [2006AA02Z477]; National Natural Science Foundation of China [30500199, 30900809]; Foundation of Beijing Municipal Committee of Science and Technology [D0905001040631]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Beijing Municipal Committee of Science and Technology	We thank Professor Gu Xiaocheng and Zheng Xiaofeng (Department of Biochemistry and Molecular Biology, College of Life Sciences, Peking University, Beijing, China) for preparation and purification of the C10ORF97 protein. Sources of support: This study was supported by the National High Technology Research and Development Program of China (863 Program, No. 2006AA02Z477 to RH), the National Natural Science Foundation of China (No. 30500199 to JC and No. 30900809 to YS) and the Foundation of Beijing Municipal Committee of Science and Technology (No. D0905001040631 to JJ).	Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Catzavelos C, 1999, CANCER RES, V59, P684; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Esposito V, 1997, CANCER RES, V57, P3381; Frolova N, 2009, TUMOR BIOL, V30, P148, DOI 10.1159/000228908; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Korbonits M, 2002, J CLIN ENDOCR METAB, V87, P2635, DOI 10.1210/jc.87.6.2635; Kouvaraki MA, 2003, CANCER RES, V63, P2977; Liu BH, 2002, BIOCHEM BIOPH RES CO, V293, P1396, DOI 10.1016/S0006-291X(02)00379-0; Lloyd RV, 1999, AM J PATHOL, V154, P313, DOI 10.1016/S0002-9440(10)65277-7; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Masciullo V, 2003, CLIN CANCER RES, V9, P5332; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Meyerson M, 2004, SEMIN ONCOL, V31, P4, DOI 10.1053/j.seminoncol.2003.12.009; Osoegawa A, 2006, CANCER, V107, P154, DOI 10.1002/cncr.21961; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rassidakis GZ, 2003, CLIN CANCER RES, V9, P1121; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shintani S, 2003, ONCOLOGY-BASEL, V65, P355, DOI 10.1159/000074649; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Sui L, 2001, CLIN CANCER RES, V7, P4130; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tsukamoto S, 2001, LUNG CANCER-J IASLC, V34, P83, DOI 10.1016/S0169-5002(01)00216-1; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304	36	5	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	39					4107	4117		10.1038/onc.2011.116	http://dx.doi.org/10.1038/onc.2011.116			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	826ME	21499297				2022-12-25	WOS:000295357500006
J	Tanizaki, J; Okamoto, I; Fumita, S; Okamoto, W; Nishio, K; Nakagawa, K				Tanizaki, J.; Okamoto, I.; Fumita, S.; Okamoto, W.; Nishio, K.; Nakagawa, K.			Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification	ONCOGENE			English	Article						BIM; survivin; HER2 amplification; PIK3CA mutation; apoptosis; breast cancer	MAMMARY EPITHELIAL-CELLS; DUAL PI3K/MTOR INHIBITOR; PIK3CA MUTATIONS; NVP-BEZ235; RESISTANCE; GENE; EXPRESSION; ONCOGENE; EFFICACY; THERAPY	Lapatinib, a dual tyrosine kinase inhibitor of the epidermal growth factor receptor and human epidermal growth factor receptor 2 (HER2), is clinically active in patients with breast cancer positive for HER2 amplification. The mechanism of this anti-tumor action has remained unclear, however. We have now investigated the effects of lapatinib in HER2 amplification-positive breast cancer cells with or without an activating PIK3CA mutation. Lapatinib induced apoptosis in association with upregulation of the pro-apoptotic protein Bcl-2 interacting mediator of cell death (BIM) through inhibition of the MEK-ERK signaling pathway in breast cancer cells with HER2 amplification. RNA interference (RNAi)-mediated depletion of BIM inhibited lapatinib-induced apoptosis, implicating BIM induction in this process. The proapoptotic effect of lapatinib was less pronounced in cells with a PIK3CA mutation than in those without one. Lapatinib failed to inhibit AKT phosphorylation in PIK3CA mutant cells, likely because of hyperactivation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway by the mutation. Depletion of PIK3CA (a catalytic subunit of PI3K) revealed that survivin expression is regulated by the PI3K pathway in these cells, suggesting that insufficient inhibition of PI3K-survivin signaling is responsible for the limited pro-apoptotic effect of lapatinib in HER2 amplification-positive cells with a PIK3CA mutation. Consistent with this notion, depletion of survivin by RNAi or treatment with a PI3K inhibitor markedly increased the level of apoptosis in PIK3CA mutant cells treated with lapatinib. Our results thus suggest that inhibition of both PI3K-survivin and MEK-ERK-BIM pathways is required for effective induction of apoptosis in breast cancer cells with HER2 amplification. Oncogene (2011) 30, 4097-4106; doi:10.1038/onc.2011.111; published online 18 April 2011	[Tanizaki, J.; Okamoto, I.; Fumita, S.; Okamoto, W.; Nakagawa, K.] Kinki Univ, Dept Med Oncol, Fac Med, Osaka, Japan; [Nishio, K.] Kinki Univ, Dept Genome Biol, Fac Med, Osaka, Japan	Kindai University (Kinki University); Kindai University (Kinki University)	Okamoto, I (corresponding author), Kinki Univ, Dept Med Oncol, Fac Med, 377-2 Ohno Higashi, Osaka, Japan.	chi-okamoto@dotd.med.kindai.ac.jp	Okamoto, Wataru/AIE-0808-2022	Fumita, Soichi/0000-0003-0253-0681				Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Burris HA, 2009, CLIN CANCER RES, V15, P6702, DOI 10.1158/1078-0432.CCR-09-0369; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Di Leo A, 2008, J CLIN ONCOL, V26, P5544, DOI 10.1200/JCO.2008.16.2578; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kanwar JR, 2001, J NATL CANCER I, V93, P1541, DOI 10.1093/jnci/93.20.1541; Kataoka Y, 2010, ANN ONCOL, V21, P255, DOI 10.1093/annonc/mdp304; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; LoRusso PM, 2008, J CLIN ONCOL, V26, P3051, DOI 10.1200/JCO.2007.14.9633; McKenzie JA, 2010, CANCER RES, V70, P7927, DOI 10.1158/0008-5472.CAN-10-0194; Olie RA, 2000, CANCER RES, V60, P2805; PEIRCE SK, 2010, CANCER CHEMOTH PHARM, DOI DOI 10.1007/S00280-1010-1486-7; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Slamon D J, 1990, Cancer Invest, V8, P253, DOI 10.3109/07357909009017573; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Toi M, 2009, BRIT J CANCER, V101, P1676, DOI 10.1038/sj.bjc.6605343; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Zhang HJ, 2008, BREAST CANCER RES TR, V112, P217, DOI 10.1007/s10549-007-9847-6; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	37	45	49	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	39					4097	4106		10.1038/onc.2011.111	http://dx.doi.org/10.1038/onc.2011.111			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	826ME	21499301				2022-12-25	WOS:000295357500005
J	Zhang, HM; Hao, Q				Zhang, HongMin; Hao, Quan			Crystal structure of NDM-1 reveals a common beta-lactam hydrolysis mechanism	FASEB JOURNAL			English	Article						New Delhi metallo-beta-lactamase; antibiotic resistance; ampicillin; inhibitor design	PSEUDOMONAS-AERUGINOSA; BACILLUS-CEREUS; CLINICAL ISOLATE; ACTIVE-SITE; INHIBITION; GENE; CATALYSIS; ARP/WARP; COMPLEX; CLONING	Metallo-beta-lactamases (MBLs) hydrolyze most beta-lactam antibiotics, and bacteria containing this kind of enzyme pose a serious threat to the public health. The newly identified New Delhi MBL (NDM-1) is a new member of this family that shows tight binding to penicillin and cephalosporins. The rapid dissemination of NDM-1 in clinically relevant bacteria has become a global concern. However, no clinically useful inhibitors against MBLs exist, partly due to the lack of knowledge about the catalysis mechanism of this kind of enzyme. Here we report the crystal structure of this novel enzyme in complex with a hydrolyzed ampicillin at its active site at 1.3-angstrom resolution. Structural comparison with other MBLs revealed a new hydrolysis mechanism applicable to all three subclasses of MBLs, which might help the design of mechanism based inhibitors.-Zhang, H.-M., Hao, Q. Crystal structure of NDM-1 reveals a common beta-lactam hydrolysis mechanism. FASEB J. 25, 2574-2582 (2011). www.fasebj.org	[Zhang, HongMin; Hao, Quan] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Zhang, HM (corresponding author), L4-55,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	hzhang20@hku.hk; qhao@hku.hk	Zhang, Hongmin/C-4503-2009; Hao, Quan/C-4304-2009; Zhang, Hongmin/S-9953-2017	Zhang, Hongmin/0000-0001-6357-4106; Zhang, Hongmin/0000-0003-4356-3615; Hao, Quan/0000-0002-9642-0514	Research Grant Council of Hong Kong [HKU765909M, HKU785110M]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Research Grant Council of Hong Kong grants HKU765909M and HKU785110M to Q.H. and H.-M.Z. The crystallographic data were collected at the Shanghai Synchrotron Radiation Facility (Shanghai, China).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P47, DOI 10.1107/S090744499700927X; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556; DAVIES RB, 1974, BIOCHEM J, V143, P129, DOI 10.1042/bj1430129; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; FELICI A, 1993, BIOCHEM J, V291, P151, DOI 10.1042/bj2910151; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Gonzalez JM, 2007, J MOL BIOL, V373, P1141, DOI 10.1016/j.jmb.2007.08.031; Gonzalez JM, 2010, BIOCHEMISTRY-US, V49, P7930, DOI 10.1021/bi100894r; Hu ZX, 2008, J AM CHEM SOC, V130, P14207, DOI 10.1021/ja8035916; HUSSAIN M, 1985, J BACTERIOL, V164, P223, DOI 10.1128/JB.164.1.223-229.1985; Lienard BMR, 2008, ORG BIOMOL CHEM, V6, P2282, DOI 10.1039/b802311e; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; MASSIDDA O, 1991, J BACTERIOL, V173, P4611, DOI 10.1128/jb.173.15.4611-4617.1991; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71, DOI 10.1128/AAC.38.1.71; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MI, 1999, CURR PHARM DESIGN, V5, P895; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P891, DOI 10.1128/AAC.44.4.891-897.2000; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; RASMUSSEN BA, 1990, ANTIMICROB AGENTS CH, V34, P1590, DOI 10.1128/AAC.34.8.1590; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502; Spencer J, 2006, ANGEW CHEM INT EDIT, V45, P1022, DOI 10.1002/anie.200502984; Spencer J, 2005, J AM CHEM SOC, V127, P14439, DOI 10.1021/ja0536062; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Walsh TR, 1996, J ANTIMICROB CHEMOTH, V37, P423, DOI 10.1093/jac/37.3.423; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Yamaguchi Y, 2005, J BIOL CHEM, V280, P20824, DOI 10.1074/jbc.M414314200; Yamaguchi Y, 2007, J MED CHEM, V50, P6647, DOI 10.1021/jm701031n; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	47	194	211	0	68	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2574	2582		10.1096/fj.11-184036	http://dx.doi.org/10.1096/fj.11-184036			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21507902				2022-12-25	WOS:000293337800008
J	Wu, LC; Pfeiffer, DR; Calhoon, EA; Madiai, F; Marcucci, G; Liu, SJ; Jurkowitz, MS				Wu, Lai-Chu; Pfeiffer, Douglas R.; Calhoon, Elisabeth A.; Madiai, Francesca; Marcucci, Guido; Liu, Shujun; Jurkowitz, Marianne S.			Purification, Identification, and Cloning of Lysoplasmalogenase, the Enzyme That Catalyzes Hydrolysis of the Vinyl Ether Bond of Lysoplasmalogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MICROSOMES; ZINC-FINGER PROTEIN; PHOSPHOLIPID-COMPOSITION; LYSOPHOSPHATIDIC ACID; CELL-LINE; PLASMALOGEN; BRAIN; BIOSYNTHESIS; METABOLISM; DISEASE	Lysoplasmalogenase (EC 3.3.2.2 and EC 3.3.2.5) is an enzyme that catalyzes hydrolytic cleavage of the vinyl ether bond of lysoplasmalogen, forming fatty aldehyde and glycerophosphoethanolamine or glycerophosphocholine and is specific for the sn-2-deacylated form of plasmalogen. Here we report the purification, characterization, identification, and cloning of lysoplasmalogenase. Rat liver microsomal lysoplasmalogenase was solubilized with octyl glucoside and purified 500-fold to near homogeneity using four chromatography steps. The purified enzyme has apparent K-m values of similar to 50 mu M for both lysoplasmenylcholine and lysoplasmenylethanolamine and apparent 0 values of 24.5 and 17.5 mu mol/min/mg protein for the two substrates, respectively. The pH optimum was 7.0. Lysoplasmalogenase was competitively inhibited by lysophosphatidic acid (K-i similar to 20 mu M). The predominant band on a gel at similar to 19 kDa was subjected to trypsinolysis, and the peptides were identified by mass spectrometry as Tmem86b, a protein of unknown function. Transient transfection of human embryonic kidney (HEK) 293T cells showed that TMEM86b cDNA yielded lysoplasmalogenase activity, and Western blot analyses confirmed the synthesis of TMEM86b protein. The protein was localized in the membrane fractions. The TMEM86b gene was also transformed into Escherichia coli, and its expression was verified by Western blot and activity analyses. Tmem86b is a hydrophobic transmembrane protein of the YhhN family. Northern blot analyses demonstrated that liver expressed the highest level of Tmem86b, which agreed with tissue distribution of activity. Overexpression of TMEM86b in HEK 293T cells resulted in decreased levels of plasmalogens, suggesting that the enzyme may be important in regulating plasmalogen levels in animal cells.	[Wu, Lai-Chu; Pfeiffer, Douglas R.; Jurkowitz, Marianne S.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wu, Lai-Chu; Marcucci, Guido; Liu, Shujun] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Calhoon, Elisabeth A.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Madiai, Francesca; Marcucci, Guido; Liu, Shujun] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Jurkowitz, MS (corresponding author), 1645 Neil Ave,Rm 310,Hamilton Hall, Columbus, OH 43210 USA.	jurkowitz.1@osu.edu	Wu, Lai-Chu/E-4328-2011	Wu, Lai-Chu/0000-0002-1348-269X	Ohio State University [306500]; Columbus Medical Research Foundation; National Institutes of Health (NCI) [CA149623]; NATIONAL CANCER INSTITUTE [R01CA149623] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); Columbus Medical Research Foundation; National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Ohio State University Development fund Grant 306500 (from Daniel S. and Amy E. F. Jurkowitz) (to M. S. J.) and a grant from the Columbus Medical Research Foundation (to L.-C. W.). The work was also supported by National Institutes of Health (NCI) ROI Grant CA149623 (to S. L.).	Allen CE, 2002, GENE CHROMOSOME CANC, V35, P287, DOI 10.1002/gcc.10128; ARTHUR G, 1986, BIOCHEM J, V236, P475, DOI 10.1042/bj2360475; BLANK ML, 1995, BBA-LIPID LIPID MET, V1254, P295, DOI 10.1016/0005-2760(94)00189-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Broderson S. H., 1967, THESIS STATE U NEW Y; CORR PB, 1984, CIRC RES, V55, P135, DOI 10.1161/01.RES.55.2.135; CORR PB, 1981, CIRC RES, V49, P354, DOI 10.1161/01.RES.49.2.354; ELLINGSON JS, 1968, LIPIDS, V3, P111, DOI 10.1007/BF02531727; FREEMAN NM, 1984, NEUROCHEM INT, V6, P273, DOI 10.1016/0197-0186(84)90103-7; Gaposchkin DP, 1999, J LIPID RES, V40, P495; GINSBERG L, 1995, BRAIN RES, V698, P223, DOI 10.1016/0006-8993(95)00931-F; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; GOTTFRIED EL, 1962, J BIOL CHEM, V237, P329; Graham J M, 1993, Methods Mol Biol, V19, P19; GUNAWAN J, 1985, J NEUROCHEM, V44, P370, DOI 10.1111/j.1471-4159.1985.tb05426.x; GUNAWAN J, 1979, H-S Z PHYSIOL CHEM, V360, P971, DOI 10.1515/bchm2.1979.360.2.971; GUNAWAN J, 1982, J NEUROCHEM, V39, P693, DOI 10.1111/j.1471-4159.1982.tb07948.x; GUNAWAN J, 1981, H-S Z PHYSIOL CHEM, V362, P445, DOI 10.1515/bchm2.1981.362.1.445; HAN XL, 1991, BIOCHIM BIOPHYS ACTA, V1069, P37, DOI 10.1016/0005-2736(91)90101-D; Horrocks L.A., 1982, NEW COMPR BIOCH, V4, P51, DOI [10.1016/s0167-7306(08)60006-x, DOI 10.1016/S0167-7306(08)60006-X]; HOWARD BV, 1972, CANCER RES, V32, P1533; HUNTER MJ, 1961, BIOCHIM BIOPHYS ACTA, V47, P580, DOI 10.1016/0006-3002(61)90553-4; HUQUE T, 1987, COMP BIOCHEM PHYS B, V86, P135, DOI 10.1016/0305-0491(87)90188-X; JAFFE ER, 1968, J CLIN INVEST, V47, P1375, DOI 10.1172/JCI105829; Jurkowitz MS, 1999, BBA-MOL CELL BIOL L, V1437, P142, DOI 10.1016/S1388-1981(99)00013-X; JURKOWITZALEXANDER M, 1989, BIOCHIM BIOPHYS ACTA, V1002, P203, DOI 10.1016/0005-2760(89)90288-9; JURKOWITZALEXANDER MS, 1991, METHOD ENZYMOL, V197, P79; JURKOWITZALEXANDER MS, 1991, METHOD ENZYMOL, V197, P483; KRAMER RM, 1983, J BIOL CHEM, V258, P3806; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Murphy EJ, 2000, BRAIN RES, V867, P9, DOI 10.1016/S0006-8993(00)02205-8; Mutch DM, 2004, PHYSIOL GENOMICS, V17, P11, DOI 10.1152/physiolgenomics.00150.2003; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; NIETO ML, 1991, J BIOL CHEM, V266, P18699; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; RUSNAK F, 1990, BIOCHEMISTRY-US, V29, P1425, DOI 10.1021/bi00458a013; Schonefeld M, 1996, KIDNEY INT, V49, P1289, DOI 10.1038/ki.1996.184; SNYDER F, 1972, ETHER LIPIDS CHEM BI, P273; Snyder F., 1972, ETHER LIPIDS CHEM BI, DOI DOI 10.1016/B978-0-12-654150-2.50014-2; SOODSMA JF, 1970, CANCER RES, V30, P309; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; VANCE JE, 1990, BIOCHIM BIOPHYS ACTA, V1045, P128, DOI 10.1016/0005-2760(90)90141-J; Von Jagow G., 1994, PRACTICAL GUIDE MEMB, P68; WARNER HR, 1961, J BIOL CHEM, V236, P2404; White MC, 2007, AM J PHYSIOL-CELL PH, V293, pC1467, DOI 10.1152/ajpcell.00290.2007; Williams SD, 1997, FEBS LETT, V420, P33, DOI 10.1016/S0014-5793(97)01482-8; WU LC, 1993, NUCLEIC ACIDS RES, V21, P5067, DOI 10.1093/nar/21.22.5067; WYKLE RL, 1974, J BIOL CHEM, V249, P1742; ZHANG Y, 1988, J BIOL CHEM, V263, P9965	56	35	38	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24916	24930		10.1074/jbc.M111.247163	http://dx.doi.org/10.1074/jbc.M111.247163			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21515882	Green Published, hybrid			2022-12-25	WOS:000292547900041
J	Quintanar-Audelo, M; Yusoff, P; Sinniah, S; Chandramouli, S; Guy, GR				Quintanar-Audelo, Martina; Yusoff, Permeen; Sinniah, Saravanan; Chandramouli, Sumana; Guy, Graeme R.			Sprouty-related Ena/Vasodilator-stimulated Phosphoprotein Homology 1-Domain-containing Protein (SPRED1), a Tyrosine-Protein Phosphatase Non-receptor Type 11 (SHP2) Substrate in the Ras/Extracellular Signal-regulated Kinase (ERK) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; FACTOR RECEPTOR STIMULATION; SOMATIC PTPN11 MUTATIONS; OF-FUNCTION MUTATIONS; CAUSE NOONAN-SYNDROME; DROSOPHILA-SPROUTY; RAS; ACTIVATION; GERMLINE; PHOSPHORYLATION	SHP2 is a tyrosine phosphatase involved in the activation of the Ras/ERK signaling pathway downstream of a number of receptor tyrosine kinases. One of the proposed mechanisms involving SHP2 in this context is to dephosphorylate and inactivate inhibitors of the Ras/ERK pathway. Two protein families bearing a unique, common domain, Sprouty and SPRED proteins, are possible candidates because they have been reported to inhibit the Ras/ERK pathway upon FGF activation. We tested whether any of these proteins are likely substrates of SHP2. Our findings indicate that Sprouty2 binds to the C-terminal tail of SHP2, which is an unlikely substrate binding site, whereas SPRED proteins bind to the tyrosine phosphatase domain that is known to be the binding site for its substrates. Overexpressed SHP2 was able to dephosphorylate SPREDs but not Sprouty2. Finally, we found two tyrosine residues on SPRED1 that are required, when phosphorylated, to inhibit Ras/ERK activation and identified Tyr-420 as a specific dephosphorylation target of SHP2. The evidence obtained indicates that SPRED1 is a likely substrate of SHP2, whose tyrosine dephosphorylation is required to attenuate the inhibitory action of SPRED1 in the Ras/ERK pathway.	[Quintanar-Audelo, Martina; Yusoff, Permeen; Sinniah, Saravanan; Guy, Graeme R.] Inst Mol & Cell Biol, Signal Transduct Lab, Proteos 138673, Singapore; [Chandramouli, Sumana] Novartis Vaccines & Diagnost, Cambridge, MA 02139 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Novartis	Guy, GR (corresponding author), Inst Mol & Cell Biol, Signal Transduct Lab, 61 Biopolis Dr, Proteos 138673, Singapore.	mcbgg@imcb.a-star.edu.sg		Chandramouli, Sumana/0000-0001-6994-506X	Agency of Science, Technology, and Research (A-STAR), Singapore	Agency of Science, Technology, and Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency of Science, Technology, and Research (A-STAR), Singapore.	Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Jarvis LA, 2006, DEVELOPMENT, V133, P1133, DOI 10.1242/dev.02255; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; Loh ML, 2004, LEUKEMIA, V18, P1831, DOI 10.1038/sj.leu.2403492; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, BRIT J HAEMATOL, V129, P333, DOI 10.1111/j.1365-2141.2005.05457.x; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493	35	24	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23102	23112		10.1074/jbc.M110.212662	http://dx.doi.org/10.1074/jbc.M110.212662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531714	Green Published, hybrid			2022-12-25	WOS:000292025000044
J	Wood, P; Mulay, V; Darabi, M; Chan, KC; Heeren, J; Pol, A; Lambert, G; Rye, KA; Enrich, C; Grewal, T				Wood, Peta; Mulay, Vishwaroop; Darabi, Masoud; Chan, Karen Cecilia; Heeren, Joerg; Pol, Albert; Lambert, Gilles; Rye, Kerry-Anne; Enrich, Carlos; Grewal, Thomas			Ras/Mitogen-activated Protein Kinase (MAPK) Signaling Modulates Protein Stability and Cell Surface Expression of Scavenger Receptor SR-BI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; PDZ-INTERACTING DOMAIN; CHOLESTEROL EFFLUX; PPAR-GAMMA; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PEROXISOME PROLIFERATORS; ABCA1 TRANSPORTER; ALPHA; PHOSPHORYLATION	The mitogen-activated protein kinase (MAPK) Erk1/2 has been implicated to modulate the activity of nuclear receptors, including peroxisome proliferator activator receptors (PPARs) and liver X receptor, to alter the ability of cells to export cholesterol. Here, we investigated if the Ras-Raf-Mek-Erk1/2 signaling cascade could affect reverse cholesterol transport via modulation of scavenger receptor class BI (SR-BI) levels. We demonstrate that in Chinese hamster ovary (CHO) and human embryonic kidney (HEK293) cells, Mek1/2 inhibition reduces PPAR alpha-inducible SR-BI protein expression and activity, as judged by reduced efflux onto high density lipoprotein (HDL). Ectopic expression of constitutively active H-Ras and Mek1 increases SR-BI protein levels, which correlates with elevated PPAR alpha Ser-21 phosphorylation and increased cholesterol efflux. In contrast, SR-BI levels are insensitive to Mek1/2 inhibitors in PPAR alpha-depleted cells. Most strikingly, Mek1/2 inhibition promotes SR-BI degradation in SR-BI-overexpressing CHO cells and human HuH7 hepatocytes, which is associated with reduced uptake of radiolabeled and 1,1'-dioctadecyl-3,3,3',3'-tetra-methylindocarbocyane-labeled HDL. Loss of Mek1/2 kinase activity reduces SR-BI expression in the presence of bafilomycin, an inhibitor of lysosomal degradation, indicating down-regulation of SR-BI via proteasomal pathways. In conclusion, Mek1/2 inhibition enhances the PPAR alpha-dependent degradation of SR-BI in hepatocytes.	[Pol, Albert; Enrich, Carlos] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Pol, Albert] Univ Barcelona, Fac Med, Inst Catalana Recerca & Estudis Avancats, Barcelona 7, Spain; [Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol 2, D-20246 Hamburg, Germany; [Wood, Peta; Mulay, Vishwaroop; Darabi, Masoud; Chan, Karen Cecilia; Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Lambert, Gilles; Rye, Kerry-Anne] Heart Res Inst, Lipid Res Grp, Sydney, NSW 2042, Australia	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Barcelona; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Sydney; University of Sydney; Heart Research Institute	Enrich, C (corresponding author), Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Inst Invest Biomed August Pi & Sunyer, Casanova 143, Barcelona, Spain.	enrich@ub.edu; thomas.grewal@sydney.edu.au	Darabi, Masoud/B-3525-2008; Pol, Albert/M-1865-2014	Darabi, Masoud/0000-0001-6380-272X; Pol, Albert/0000-0002-1750-1085; Grewal, Thomas/0000-0002-7937-8887; Enrich, Carlos/0000-0003-0382-2993	National Health and Medical Research Council of Australia [510293, 510294]; National Heart Foundation of Australia [G06S2559]; Ministerio de Ciencia y Tecnologia [BFU2009- 10335]; Ministerio de Sanidad y Consumo [RTICC-2006 ISCIII]; Fundacio Marato TV3, Barcelona, Spain [PI040236]; CONSOLIDER-INGENIO2010 [CSD2009-00016]; National Heart Foundation/National Health and Medical Research Council of Australia; Tabriz University of Medical Sciences (Iran); ICREA Funding Source: Custom	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Fundacio Marato TV3, Barcelona, Spain; CONSOLIDER-INGENIO2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Heart Foundation/National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of AustraliaNational Heart Foundation of Australia); Tabriz University of Medical Sciences (Iran); ICREA(ICREA)	This work was supported by Grants 510293 and 510294 from the National Health and Medical Research Council of Australia and Grant G06S2559 from the National Heart Foundation of Australia (to T. G.) and Grants BFU2009- 10335 from Ministerio de Ciencia y Tecnologia, RTICC-2006 ISCIII from Ministerio de Sanidad y Consumo, and PI040236 from Fundacio Marato TV3, Barcelona, Spain and CONSOLIDER-INGENIO2010 (CSD2009-00016) (to C. E.).; Recipient of a National Heart Foundation/National Health and Medical Research Council of Australia postgraduate scholarship.; Recipient of a travel and research scholarship from the Tabriz University of Medical Sciences (Iran).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Agassandian M, 2007, BIOCHEM J, V403, P409, DOI 10.1042/BJ20061364; Al-Jarallah A, 2010, BBA-MOL CELL BIOL L, V1801, P1239, DOI 10.1016/j.bbalip.2010.08.006; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Barger PM, 2000, J CLIN INVEST, V105, P1723, DOI 10.1172/JCI9056; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chen MY, 2006, FEBS LETT, V580, P4835, DOI 10.1016/j.febslet.2006.07.074; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Chinetti G, 2006, BIOCHEM SOC T, V34, P1128, DOI 10.1042/BST0341128; Chinetti-Gbaguidi G, 2009, BBA-MOL CELL BIOL L, V1791, P486, DOI 10.1016/j.bbalip.2009.01.009; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Deeg MA, 1997, ARTERIOSCL THROM VAS, V17, P1667, DOI 10.1161/01.ATV.17.9.1667; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frank PG, 2001, AM J PHYSIOL-CELL PH, V280, pC1204, DOI 10.1152/ajpcell.2001.280.5.C1204; Fridman M, 2000, J BIOL CHEM, V275, P30363, DOI 10.1074/jbc.M003193200; Fu Y, 2004, J BIOL CHEM, V279, P14140, DOI 10.1074/jbc.M311061200; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; George J, 2004, ARTERIOSCL THROM VAS, V24, P363, DOI 10.1161/01.ATV.0000112021.98971.f0; George J, 2002, CIRCULATION, V105, P2416, DOI 10.1161/01.CIR.0000016065.90068.96; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2003, J BIOL CHEM, V278, P16478, DOI 10.1074/jbc.C300085200; Gusterson R, 2002, J BIOL CHEM, V277, P2517, DOI 10.1074/jbc.M104626200; Haidar B, 2004, J BIOL CHEM, V279, P9963, DOI 10.1074/jbc.M313487200; Han JH, 2002, J BIOL CHEM, V277, P23582, DOI 10.1074/jbc.M200685200; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Heuvel JPV, 1999, J NUTR, V129, p575S, DOI 10.1093/jn/129.2.575S; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Juge-Aubry CE, 1999, J BIOL CHEM, V274, P10505, DOI 10.1074/jbc.274.15.10505; Kee P, 2006, ARTERIOSCL THROM VAS, V26, P884, DOI 10.1161/01.ATV.0000201064.89581.35; Kiss RS, 2005, J LIPID RES, V46, P1877, DOI 10.1194/jlr.M400482-JLR200; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Lan DB, 2005, J BIOL CHEM, V280, P23390, DOI 10.1074/jbc.M502777200; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macoritto M, 2008, J BIOL CHEM, V283, P4943, DOI 10.1074/jbc.M707517200; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; Mineo C, 2007, TRENDS CARDIOVAS MED, V17, P156, DOI 10.1016/j.tcm.2007.03.005; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Miura S, 2004, ATHEROSCLEROSIS, V175, P235, DOI 10.1016/j.atherosclerosis.2004.04.017; Mogilenko DA, 2010, BIOCHEM BIOPH RES CO, V402, P477, DOI 10.1016/j.bbrc.2010.10.053; Niemeier A, 2009, ATHEROSCLEROSIS, V202, P169, DOI 10.1016/j.atherosclerosis.2008.04.018; Nofer JR, 2006, J LIPID RES, V47, P794, DOI 10.1194/jlr.M500502-JLR200; Nofer JR, 2001, THROMB HAEMOSTASIS, V85, P730; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Qiu LX, 2008, J BIOL CHEM, V283, P17175, DOI 10.1074/jbc.M801791200; Rentero C, 2006, CELL SIGNAL, V18, P1006, DOI 10.1016/j.cellsig.2005.08.008; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Rokos CL, 1997, J BIOL CHEM, V272, P13452, DOI 10.1074/jbc.272.20.13452; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; See RH, 2001, J BIOL CHEM, V276, P16310, DOI 10.1074/jbc.M008113200; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Taketa K, 2008, J BIOL CHEM, V283, P9852, DOI 10.1074/jbc.M703318200; Tamasi V, 2008, MOL PHARMACOL, V73, P968, DOI 10.1124/mol.107.036780; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; de Muga SV, 2009, ONCOGENE, V28, P363, DOI 10.1038/onc.2008.386; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601; Zitzer H, 2006, ENDOCRINOLOGY, V147, P3898, DOI 10.1210/en.2005-1483	74	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23077	23092		10.1074/jbc.M111.236398	http://dx.doi.org/10.1074/jbc.M111.236398			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21525007	Green Published, hybrid			2022-12-25	WOS:000292025000042
J	Fukuda, K; Knight, JDR; Piszczek, G; Kothary, R; Qin, J				Fukuda, Koichi; Knight, James D. R.; Piszczek, Grzegorz; Kothary, Rashmi; Qin, Jun			Biochemical, Proteomic, Structural, and Thermodynamic Characterizations of Integrin-linked Kinase (ILK) CROSS-VALIDATION OF THE PSEUDOKINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; CRYSTAL-STRUCTURE; ALPHA-PARVIN; PROTEIN; BINDING; PINCH; COMPLEX; CRYSTALLOGRAPHY; LOCALIZATION; EXPRESSION	Integrin-linked kinase (ILK) is one of the few evolutionarily conserved focal adhesion proteins involved in diverse cell adhesion-dependent physiological and pathological responses. Despite more than a decade of studies and extensive literature, the kinase function of ILK is controversial. ILK contains a highly degraded kinase active site but it has been argued that ILK may be an unusual manganese (Mn)-dependent serine-threonine kinase that targets specific substrates such as glycogen synthase kinase-3 beta (GSK-3 beta). In this study, we have tackled this issue by a systematic bottom-up biochemical, proteomic, structural, and thermodynamic analysis of ILK. We show that recombinant ILK from either bacteria or mammalian cells exhibits no kinase activity on GSK-3 beta in the presence of either Mn2+ or the conventional kinase co-factor Mg2+. A comprehensive and unbiased whole cell-based kinase assay using entire mammalian CG-4 and C2C12 cell lysate did not identify any specific ILK substrates. High resolution crystallographic structure analysis further confirmed that the Mn-bound ILK adopts the same pseudo active site conformation as that of the Mg-bound ILK. More importantly, thermodynamic analysis revealed that the K220M mutation, previously thought to inactivate ILK by disrupting ATP binding, significantly impairs the structural integrity and stability of ILK, which provides a new basis for understanding how this mutation caused renal agenesis, a failure of fetal kidney development. Collectively, our data provide strong evidence that ILK lacks intrinsic kinase function. It is a bona fide pseudokinase that likely evolved from an ancestral catalytic counterpart to act as a distinct scaffold to mediate protein-protein interactions during focal adhesion assembly and many other cellular events.	[Qin, Jun] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Knight, James D. R.; Kothary, Rashmi] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Knight, James D. R.; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Piszczek, Grzegorz] NHLBI, Biophys Core Facil, NIH, Bethesda, MD 20892 USA	Cleveland Clinic Foundation; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Qin, J (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Mail Code NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Piszczek, Grzegorz/GYU-2029-2022	Kothary, Rashmi/0000-0002-9239-7310; Qin, Jun/0000-0002-2647-9270	National Institute of Health; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Kirschstein-NRSA (the National Institutes of Health); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Kirschstein-NRSA (the National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institute of Health (to J. Q.) and from Canadian Institutes of Health Research and the Multiple Sclerosis Society of Canada (to R. K.).; Supported by the Kirschstein-NRSA institutional research training grants (the National Institutes of Health).	Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Ding L, 2009, CIRCULATION, V120, P764, DOI 10.1161/CIRCULATIONAHA.109.870725; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li FG, 1999, J CELL SCI, V112, P4589; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perez VAD, 2011, J CELL BIOL, V192, P171, DOI 10.1083/jcb.201008060; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pontier SM, 2010, ONCOGENE, V29, P3374, DOI 10.1038/onc.2010.86; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; ROUSSEL A, 1991, TURBO FRODO SILICON; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Smeeton J, 2010, DEVELOPMENT, V137, P3233, DOI 10.1242/dev.052845; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang YW, 2009, J BIOL CHEM, V284, P5836, DOI 10.1074/jbc.M805319200; Youn SW, 2011, BLOOD, V117, P4376, DOI 10.1182/blood-2010-07-295964; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	51	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21886	21895		10.1074/jbc.M111.240093	http://dx.doi.org/10.1074/jbc.M111.240093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21524996	Green Published, hybrid			2022-12-25	WOS:000291464700083
J	Tipton, AR; Wang, KX; Link, L; Bellizzi, JJ; Huang, HM; Yen, T; Liu, ST				Tipton, Aaron R.; Wang, Kexi; Link, Laura; Bellizzi, John J.; Huang, Haomin; Yen, Tim; Liu, Song-Tao			BUBR1 and Closed MAD2 (C-MAD2) Interact Directly to Assemble a Functional Mitotic Checkpoint Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; SPINDLE CHECKPOINT; CONFORMATIONAL DIMERIZATION; PROTEIN BUBR1; CDC20; ACTIVATION; P31(COMET); APC/C; INHIBITION; REQUIRES	The mitotic checkpoint maintains genomic stability by ensuring that chromosomes are accurately segregated during mitosis. When the checkpoint is activated, the mitotic checkpoint complex (MCC), assembled from BUBR1, BUB3, CDC20, and MAD2, directly binds and inhibits the anaphase-promoting complex/cyclosome (APC/C) until all chromosomes are properly attached and aligned. The mechanisms underlying MCC assembly and MCC-APC/C interaction are not well characterized. Here, we show that a novel interaction between BUBR1 and closed MAD2 (C-MAD2) is essential for MCC-mediated inhibition of APC/C. Intriguingly, Arg(133) and Gln(134) in C-MAD2 are required for BUBR1 interaction. The same residues are also critical for MAD2 dimerization and MAD2 binding to p31(comet), a mitotic checkpoint silencing protein. Along with previously characterized BUBR1-CDC20 and C-MAD2-CDC20 interactions, our results underscore the integrity of the MCC for its activity and suggest the fundamental importance of the MAD2 alpha C helix in modulating mitotic checkpoint activation and silencing.	[Tipton, Aaron R.; Wang, Kexi; Link, Laura; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Bellizzi, John J.] Univ Toledo, Dept Chem, Toledo, OH 43606 USA; [Huang, Haomin; Yen, Tim] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Fox Chase Cancer Center	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Liu, Song-Tao/Y-4732-2019	Liu, Song-Tao/0000-0002-9623-8579; Bellizzi, John/0000-0003-4833-2795; Yen, Tim/0000-0003-2159-0997	National Institutes of Health [GM86877, GM44762, CA06927]; Commonwealth of Pennsylvania; Greenberg Fund; Ohio Cancer Research Associates; University of Toledo; National Science Foundation [MCB-1052413]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086877, R01GM044762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Greenberg Fund; Ohio Cancer Research Associates; University of Toledo; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grants GM86877 and GM44762, Core Grant CA06927, an appropriation from the Commonwealth of Pennsylvania, and the Greenberg Fund.; Supported by the deArce Memorial Fund, Ohio Cancer Research Associates, the University of Toledo Interdisciplinary Research Initiation Award, and National Science Foundation Grant MCB-1052413.	Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Ciliberto A, 2009, EMBO J, V28, P2162, DOI 10.1038/emboj.2009.186; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Serebriiskii I, 1999, J BIOL CHEM, V274, P17080, DOI 10.1074/jbc.274.24.17080; Simonetta M, 2009, PLOS BIOL, V7, P175, DOI 10.1371/journal.pbio.1000010; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048	33	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21173	21179		10.1074/jbc.M111.238543	http://dx.doi.org/10.1074/jbc.M111.238543			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525009	hybrid, Green Published			2022-12-25	WOS:000291464700017
J	Cheng, NH; Liu, JZ; Liu, X; Wu, QY; Thompson, SM; Lin, J; Chang, J; Whitham, SA; Park, S; Cohen, JD; Hirschi, KD				Cheng, Ning-Hui; Liu, Jian-Zhong; Liu, Xing; Wu, Qingyu; Thompson, Sean M.; Lin, Julie; Chang, Joyce; Whitham, Steven A.; Park, Sunghun; Cohen, Jerry D.; Hirschi, Kendal D.			Arabidopsis Monothiol Glutaredoxin, AtGRXS17, Is Critical for Temperature-dependent Postembryonic Growth and Development via Modulating Auxin Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MERISTEM DEVELOPMENT; GENE-EXPRESSION; STRESS-RESPONSE; TGA FACTORS; PLANT; TRANSPORT; THIOREDOXIN; ACID; BIOSYNTHESIS	Global environmental temperature changes threaten innumerable plant species. Although various signaling networks regulate plant responses to temperature fluctuations, the mechanisms unifying these diverse processes are largely unknown. Here, we demonstrate that an Arabidopsis monothiol glutaredoxin, AtGRXS17 (At4g04950), plays a critical role in redox homeostasis and hormone perception to mediate temperature-dependent postembryonic growth. AtGRXS17 expression was induced by elevated temperatures. Lines altered in AtGRXS17 expression were hypersensitive to elevated temperatures and phenocopied mutants altered in the perception of the phytohormone auxin. We show that auxin sensitivity and polar auxin transport were perturbed in these mutants, whereas auxin biosynthesis was not altered. In addition, atgrxs17 plants displayed phenotypes consistent with defects in proliferation and/or cell cycle control while accumulating higher levels of reactive oxygen species and cellular membrane damage under high temperature. Together, our findings provide a nexus between reactive oxygen species homeostasis, auxin signaling, and temperature responses.	[Cheng, Ning-Hui; Lin, Julie; Chang, Joyce; Hirschi, Kendal D.] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Houston, TX 77030 USA; [Liu, Jian-Zhong; Whitham, Steven A.] Iowa State Univ, Dept Plant Pathol, Ames, IA 50011 USA; [Liu, Xing; Cohen, Jerry D.] Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA; [Liu, Xing; Cohen, Jerry D.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Wu, Qingyu; Park, Sunghun] Kansas State Univ, Dept Hort Forestry & Recreat Resources, Manhattan, KS 66506 USA; [Thompson, Sean M.; Hirschi, Kendal D.] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX 77845 USA	Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA); Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Kansas State University; Texas A&M University System; Texas A&M University College Station	Cheng, NH (corresponding author), Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Houston, TX 77030 USA.	ncheng@bcm.tmc.edu	Liu, Jianzhong/B-9205-2012; Wu, Qingyu/AAF-3675-2020; Wu, Qingyu/E-4636-2017; hirschi, kendal/GNP-0351-2022; Cohen, Jerry/AAF-3737-2020	Wu, Qingyu/0000-0003-3064-2445; Wu, Qingyu/0000-0003-3064-2445; Cohen, Jerry/0000-0003-2816-8676; Liu, Jianzhong/0000-0001-7826-7045; Liu, Xing/0000-0001-9677-4470; Thompson, Sean/0000-0002-6847-0397	United States National Science Foundation [MCB-0725149, OIS-PGRP-0606666, OIS-PGRP-0923960, PGRP-0820642]; United States Department of Agriculture, National Research Initiative [2005-35318-16197]; United States Department of Agriculture/Agricultural Research Service [6250-51000-055]; National Science Foundation [NSF 90344350]; Designing Foods for Health Grant [CSREES 2005-34404-16401]; Direct For Biological Sciences [0820642] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture, National Research Initiative(United States Department of Agriculture (USDA)); United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); Designing Foods for Health Grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by United States National Science Foundation Grants MCB-0725149, OIS-PGRP-0606666, OIS-PGRP-0923960, and PGRP-0820642 and the United States Department of Agriculture, National Research Initiative 2005-35318-16197 (to J. D. C. and S. A. W.) and United States Department of Agriculture/Agricultural Research Service under Cooperation Agreement 6250-51000-055 (to N.-H. C.). This work was also supported by National Science Foundation Grant NSF 90344350) and Designing Foods for Health Grant CSREES 2005-34404-16401) (to K. D. H.).	Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Barkawi LS, 2010, NAT PROTOC, V5, P1609, DOI 10.1038/nprot.2010.118; Bashandy T, 2010, PLANT CELL, V22, P376, DOI 10.1105/tpc.109.071225; Benitez-Alfonso Y, 2009, P NATL ACAD SCI USA, V106, P3615, DOI 10.1073/pnas.0808717106; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Beveridge CA, 2007, CURR OPIN PLANT BIOL, V10, P44, DOI 10.1016/j.pbi.2006.11.011; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Cheng NH, 2008, FEBS LETT, V582, P848, DOI 10.1016/j.febslet.2008.02.006; Cheng NH, 2006, J BIOL CHEM, V281, P26280, DOI 10.1074/jbc.M601354200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Franklin KA, 2009, CURR OPIN PLANT BIOL, V12, P63, DOI 10.1016/j.pbi.2008.09.007; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GARDNER G, 1989, PLANT PHYSIOL, V90, P291, DOI 10.1104/pp.90.1.291; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ilic N, 1996, PLANT PHYSIOL, V111, P781, DOI 10.1104/pp.111.3.781; Jiang K, 2003, DEVELOPMENT, V130, P1429, DOI 10.1242/dev.00359; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Lemaire SD, 2004, PHOTOSYNTH RES, V79, P305, DOI 10.1023/B:PRES.0000017174.60951.74; Lewis DR, 2009, NAT PROTOC, V4, P437, DOI 10.1038/nprot.2009.1; Li S, 2009, PLANT CELL, V21, P429, DOI 10.1105/tpc.108.064477; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Liu CJ, 2002, P NATL ACAD SCI USA, V99, P14578, DOI 10.1073/pnas.212522099; Ludwig-Muller J, 2000, PLANT PHYSIOL, V123, P949, DOI 10.1104/pp.123.3.949; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Mei H, 2009, NEW PHYTOL, V183, P95, DOI 10.1111/j.1469-8137.2009.02831.x; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Muday GK, 2001, TRENDS PLANT SCI, V6, P535, DOI 10.1016/S1360-1385(01)02101-X; Ndamukong I, 2007, PLANT J, V50, P128, DOI 10.1111/j.1365-313X.2007.03039.x; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Pitzschke A, 2006, ANTIOXID REDOX SIGN, V8, P1757, DOI 10.1089/ars.2006.8.1757; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Reichheld JP, 1999, PLANT J, V17, P647, DOI 10.1046/j.1365-313X.1999.00413.x; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Sundaram S, 2010, PLANTA, V231, P361, DOI 10.1007/s00425-009-1055-7; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Toh S, 2008, PLANT PHYSIOL, V146, P1368, DOI 10.1104/pp.107.113738; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vernoux T, 2000, PLANT CELL, V12, P97, DOI 10.1105/tpc.12.1.97; Vigh L, 2007, ANN NY ACAD SCI, V1113, P40, DOI 10.1196/annals.1391.027; Vranova E, 2002, P NATL ACAD SCI USA, V99, P10870, DOI 10.1073/pnas.152337999; Xing S, 2008, PLANT J, V53, P790, DOI 10.1111/j.1365-313X.2007.03375.x; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	68	98	100	0	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20398	20406		10.1074/jbc.M110.201707	http://dx.doi.org/10.1074/jbc.M110.201707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515673	Green Published, hybrid			2022-12-25	WOS:000291267600027
J	Lee, YJ; Burlet, E; Galiano, F; Circu, ML; Aw, TY; Williams, BJ; Witt, SN				Lee, Yong Joo; Burlet, Elodie; Galiano, Floyd; Circu, Magdalena L.; Aw, Tak Yee; Williams, B. Jill; Witt, Stephan N.			Phosphate and Succinate Use Different Mechanisms to Inhibit Sugar-induced Cell Death in Yeast INSIGHT INTO THE CRABTREE EFFECT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CARBOHYDRATE-METABOLISM; LIFE-SPAN; GLUCOSE; GROWTH; FRUCTOSE-1,6-BISPHOSPHATE; PHOSPHORYLATION; MITOCHONDRIA; ACTIVATION; TRANSPORT	Stationary-phase Saccharomyces cerevisiae cells transferred from spent rich media into water live for weeks, whereas the same cells die within hours if transferred into water with 2% glucose in a process called sugar-induced cell death (SICD). Our hypothesis is that SICD is due to a dysregulated Crabtree effect, which is the phenomenon whereby glucose transiently inhibits respiration and ATP synthesis. We found that stationary-phase cells in glucose/water consume 21 times more O-2 per cell than exponential-phase cells in rich media, and such excessive O-2 consumption causes reactive oxygen species to accumulate. We also found that inorganic phosphate and succinate protect against SICD but by different mechanisms. Phosphate protects by triggering the synthesis of Fru-1,6-P-2, which inhibits respiration in isolated mitochondria. Succinate protects in wild-type cells but fails to protect in dic1 Delta cells. DIC1 codes for a mitochondrial inner membrane protein that exchanges cytosolic succinate for matrix phosphate. We propose that succinate depletes matrix phosphate, which in turn inhibits respiration and ATP synthesis. In sum, restoring the Crabtree effect, whether with phosphate or succinate, protects cells from SICD.	[Witt, Stephan N.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; [Circu, Magdalena L.; Aw, Tak Yee] Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71130 USA; [Williams, B. Jill] Louisiana State Univ, Hlth Sci Ctr, Dept Urol, Shreveport, LA 71130 USA; [Galiano, Floyd; Williams, B. Jill] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Witt, SN (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	switt1@lsuhsc.edu	Witt, Stephan N/M-7922-2013	Witt, Stephan N/0000-0002-6462-2840	National Institutes of Health, NINDS [NS057656]; NIDDK [DK44510]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057656] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057656 from NINDS (to S.N.W.) and Grant DK44510 from NIDDK (to T.Y.A. for support of M.L.C.).	BANUELOS M, 1977, J BIOL CHEM, V252, P6394; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; BLOCHFRANKENTHAL L, 1959, CANCER RES, V19, P835; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Ehringer WD, 2002, LIPIDS, V37, P885, DOI 10.1007/s11745-002-0975-2; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; GRANOT D, 1993, YEAST, V9, P465, DOI 10.1002/yea.320090503; GRANOT D, 1991, P NATL ACAD SCI USA, V88, P5724, DOI 10.1073/pnas.88.13.5724; Granot D, 1997, CELL DEATH DIFFER, V4, P555, DOI 10.1038/sj.cdd.4400280; Hardin CD, 2001, AM J PHYSIOL-HEART C, V281, pH2654, DOI 10.1152/ajpheart.2001.281.6.H2654; KATCHMAN BERNARD J., 1955, JOUR BACT, V69, P607; KOOBS DH, 1972, SCIENCE, V178, P127, DOI 10.1126/science.178.4057.127; Lemasters J J, 1979, Methods Enzymol, V56, P530; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCammon MT, 1996, GENETICS, V144, P57; Palmieri L, 1999, MOL MICROBIOL, V31, P569, DOI 10.1046/j.1365-2958.1999.01197.x; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; RIQUELME PT, 1983, P NATL ACAD SCI-BIOL, V80, P4301, DOI 10.1073/pnas.80.14.4301; SALHANY JM, 1975, P NATL ACAD SCI USA, V72, P4966, DOI 10.1073/pnas.72.12.4966; SENER A, 1988, J BIOL CHEM, V263, P1904; Shirahama K, 1996, PLANT CELL PHYSIOL, V37, P1090, DOI 10.1093/oxfordjournals.pcp.a029058; SLONIMSKI PP, 1968, BIOCHEM BIOPH RES CO, V30, P232, DOI 10.1016/0006-291X(68)90440-3; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; SUSSMAN I, 1980, BIOCHIM BIOPHYS ACTA, V591, P209, DOI 10.1016/0005-2728(80)90153-X; TSUIKI S, 1968, ARCH BIOCHEM BIOPHYS, V126, P436, DOI 10.1016/0003-9861(68)90428-1; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Werner TP, 2005, ARCH MICROBIOL, V184, P129, DOI 10.1007/s00203-005-0031-2; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206; ZIZI M, 1994, J BIOL CHEM, V269, P1614	37	14	16	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20267	20274		10.1074/jbc.M110.209379	http://dx.doi.org/10.1074/jbc.M110.209379			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515692	Green Published, hybrid			2022-12-25	WOS:000291267600014
J	Wegmann, S; Scholer, J; Bippes, CA; Mandelkow, E; Muller, DJ				Wegmann, Susanne; Schoeler, Jonas; Bippes, Christian A.; Mandelkow, Eckhard; Muller, Daniel J.			Competing Interactions Stabilize Pro- and Anti-aggregant Conformations of Human Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; TITIN IMMUNOGLOBULIN DOMAINS; FULL-LENGTH TAU; PROTEIN-TAU; IN-VITRO; MICROTUBULE-BINDING; ALZHEIMERS-DISEASE; BETA-STRUCTURE; AGGREGATION; FORCE	Aggregation of Tau into amyloid-like fibrils is a key process in neurodegenerative diseases such as Alzheimer. To understand how natively disordered Tau stabilizes conformations that favor pathological aggregation, we applied single-molecule force spectroscopy. Intramolecular interactions that fold polypeptide stretches of similar to 19 and similar to 42 amino acids in the functionally important repeat domain of full-length human Tau (hTau40) support aggregation. In contrast, the unstructured N terminus randomly folds long polypeptide stretches > 100 amino acids that prevent aggregation. The pro-aggregant mutant hTau40 Delta K280 observed in frontotemporal dementia favored the folding of short polypeptide stretches and suppressed the folding of long ones. This trend was reversed in the anti-aggregant mutant hTau40 Delta K280/PP. The aggregation inducer heparin introduced strong interactions in hTau40 and hTau40 Delta K280 that stabilized aggregation-prone conformations. We show that the conformation and aggregation of Tau are regulated through a complex balance of different intra-and intermolecular interactions.	[Mandelkow, Eckhard] DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; [Wegmann, Susanne; Bippes, Christian A.; Muller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Schoeler, Jonas] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Mandelkow, Eckhard] CAESAR, German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Friedrich Miescher Institute for Biomedical Research; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Mandelkow, E (corresponding author), DESY, Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	mand@mpasmb.desy.de; daniel.mueller@bsse.ethz.ch	Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665	Deutsche Forschungsgemeinschaft; ETH Zurich; Max-Planck Society; VW Foundation [1/82544]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ETH Zurich(ETH Zurich); Max-Planck Society(Max Planck SocietyFoundation CELLEX); VW Foundation(Volkswagen)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and ETH Zurich (to D. J. M.), the Max-Planck Society (to D. J. M. and E. M.), and VW Foundation Grant 1/82544 (to E. M.).	Abraha A, 2000, J CELL SCI, V113, P3737; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn Stefan, 2004, V299, P35; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bippes CA, 2009, J BIOL CHEM, V284, P18651, DOI 10.1074/jbc.M109.004267; BRANDT R, 1994, J BIOL CHEM, V269, P11776; BUTT HJ, 1995, BIOELECTROCH BIOENER, V38, P191, DOI 10.1016/0302-4598(95)01800-T; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; CROWTHER RA, 1990, BIOCHIM BIOPHYS ACTA, V1096, P1, DOI 10.1016/0925-4439(90)90004-9; Eckermann K, 2007, J BIOL CHEM, V282, P31755, DOI 10.1074/jbc.M705282200; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Goedert M, 1996, COLD SPRING HARB SYM, V61, P565; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Horowitz PM, 2006, BIOCHEMISTRY-US, V45, P12859, DOI 10.1021/bi061325g; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Lippens G, 2007, PRION, V1, P21, DOI 10.4161/pri.1.1.4055; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MAWALDEWAN M, 1992, J BIOL CHEM, V267, P19705; Moreno-Herrero F, 2004, BIOPHYS J, V86, P517, DOI 10.1016/S0006-3495(04)74130-2; Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Oberhauser AF, 2008, J BIOL CHEM, V283, P6617, DOI 10.1074/jbc.R700050200; Perez M, 1996, J NEUROCHEM, V67, P1183; Puchner EM, 2008, BIOPHYS J, V95, P426, DOI 10.1529/biophysj.108.129999; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Sapra KT, 2008, LANGMUIR, V24, P1330, DOI 10.1021/la702299z; Schaap IAT, 2007, J STRUCT BIOL, V158, P282, DOI 10.1016/j.jsb.2006.11.010; Schlierf M, 2006, BIOPHYS J, V90, pL33, DOI 10.1529/biophysj.105.077982; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Skrabana R, 2006, CELL MOL NEUROBIOL, V26, P1085, DOI 10.1007/s10571-006-9083-3; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yao TM, 2003, J BIOCHEM, V134, P91, DOI 10.1093/jb/mvg116; Yin HS, 2006, FEBS LETT, V580, P211, DOI 10.1016/j.febslet.2005.11.077	74	34	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20512	20524		10.1074/jbc.M111.237875	http://dx.doi.org/10.1074/jbc.M111.237875			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498513	Green Published, hybrid			2022-12-25	WOS:000291267600038
J	Xu, CL; Bai, T; Iuliano, AD; Wang, M; Yang, L; Wen, LY; Zeng, YH; Li, XD; Chen, T; Wang, W; Hu, Y; Yang, LM; Li, Z; Zou, SM; Li, DX; Wang, SW; Feng, ZJ; Zhang, YP; Yu, HJ; Yang, WZ; Wang, Y; Widdowson, MA; Shu, YL				Xu, Cuiling; Bai, Tian; Iuliano, A. Danielle; Wang, Min; Yang, Lei; Wen, Leying; Zeng, Yuhong; Li, Xiaodan; Chen, Tao; Wang, Wei; Hu, Ying; Yang, Limei; Li, Zi; Zou, Shumei; Li, Dexin; Wang, Shiwen; Feng, Zijian; Zhang, Yanping; Yu, Hongjie; Yang, Weizhong; Wang, Yu; Widdowson, Marc-Alain; Shu, Yuelong			The Seroprevalence of Pandemic Influenza H1N1 (2009) Virus in China	PLOS ONE			English	Article							A H1N1; ANTIBODIES; INFECTION; HUMANS	Background: Mainland China experienced pandemic influenza H1N1 (2009) virus (pH1N1) with peak activity during November-December 2009. To understand the geographic extent, risk factors, and attack rate of pH1N1 infection in China we conducted a nationwide serological survey to determine the prevalence of antibodies to pH1N1. Methodology/Principal Findings: Stored serum samples (n = 2,379) collected during 2006-2008 were used to estimate baseline serum reactogenicity to pH1N1. In January 2010, we used a multistage-stratified random sampling method to select 50,111 subjects who met eligibility criteria and collected serum samples and administered a standardized questionnaire. Antibody response to pH1N1 was measured using haemagglutination inhibition (HI) assay and the weighted seroprevalence was calculated using the Taylor series linearization method. Multivariable logistic regression analyses were used to examine risk factors for pH1N1 seropositivity. Baseline seroprevalence of pH1N1 antibody (HI titer >= 40) was 1.2%. The weighted seroprevalence of pH1N1 among the Chinese population was 21.5%(vaccinated: 62.0%; unvaccinated: 17.1%). Among unvaccinated participants, those aged 6-15 years (32.9%) and 16-24 years (30.3%) had higher seroprevalence compared with participants aged 25-59 years (10.7%) and >= 60 years (9.9%, P < 0.0001). Children in kindergarten and students had higher odds of seropositivity than children in family care (OR: 1.36 and 2.05, respectively). We estimated that 207.7 million individuals (15.9%) experienced pH1N1 infection in China. Conclusions/Significance: The Chinese population had low pre-existing immunity to pH1N1 and experienced a relatively high attack rate in 2009 of this virus. We recommend routine control measures such as vaccination to reduce transmission and spread of seasonal and pandemic influenza viruses.	[Xu, Cuiling; Bai, Tian; Wang, Min; Yang, Lei; Wen, Leying; Zeng, Yuhong; Li, Xiaodan; Chen, Tao; Wang, Wei; Hu, Ying; Yang, Limei; Li, Zi; Zou, Shumei; Li, Dexin; Wang, Shiwen; Zhang, Yanping; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Iuliano, A. Danielle; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA	Xu, CL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China.	yshu@cnic.org.cn	Yu, Hongjie/GZK-5351-2022; Yang, Wei/HIA-0360-2022; Yang, Lei/GSD-3834-2022	Widdowson, Marc-Alain/0000-0002-0682-6933	central government; NIH/NIAID [5-U54-AI-057157-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER	central government; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was mainly supported by the financial allocation of the central government and partly supported by NIH/NIAID Grant 5-U54-AI-057157-08 (Epidemiology and Molecular Mechanism of Highly Pathogenic Avian Influenza H5N1 and Pandemic Influenza H1N1). None of the sponsors participated in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Cao B, 2009, EMERG INFECT DIS, V15, P1418, DOI 10.3201/eid1509.090794; Centers for Disease Control and Prevention, 2010, CDC EST 2009 H1N1 IN; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; *CHIN NAT INFL CTR, 2009, CHIN INFL WEEKL REP; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng Y, 2011, EPIDEMIOL INFECT, V139, P52, DOI 10.1017/S0950268810002189; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Health Protection Agency, 2009, PAND H1N1 2009 INFL; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; LIU J, 2008, CHINESE, V24, P377; Lohr Sharon L., 2002, SAMPLING DESIGN ANAL, P12; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; *MIN HLTH PEOPL RE, BRIEF REP PAND H1N1; *NAT BUR STAT, 2010, PEOPL REP CHIN CHIN; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Reed C, 2010, LANCET, V375, P1062, DOI 10.1016/S0140-6736(09)62194-2; ROSS T, 2010, PLOS CURR INFLUENZA; *SAS I INC, 2004, SAS STAT 9 1 US GUID; Tang JW, 2010, EMERG INFECT DIS, V16, P874, DOI 10.3201/eid1605.091678; Turbelin C, 2009, EURO SURVEILL, V14; *WHO, WHOCDSCSRNCS20025; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; WORLD NOW START 2009	32	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e17919	10.1371/journal.pone.0017919	http://dx.doi.org/10.1371/journal.pone.0017919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533034	Green Published, gold, Green Submitted			2022-12-25	WOS:000290014500001
J	He, B; Zhang, H; Shi, TL				He, Bing; Zhang, Hao; Shi, Tieliu			A Comprehensive Analysis of the Dynamic Biological Networks in HCV Induced Hepatocarcinogenesis	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; CHRONIC HEPATITIS-C; PORTAL-VEIN THROMBOSIS; HEPATOCELLULAR-CARCINOMA; LIVER-CIRRHOSIS; FOLLOW-UP; EXPRESSION; LUMICAN; PROTEIN; GENE	Hepatocellular carcinoma (HCC) is a primary malignancy of the liver, which is closely related to hepatitis C and cirrhosis. The molecular mechanisms underlying the hepatocarcinogenesis induced by HCV infection remain clarified from a standpoint of systems biology. By integrating data from protein-protein interactions, transcriptional regulation, and disease related microarray analysis, we carried out a dynamic biological network analysis on the progression of HCV induced hepatocarcinogenesis, and systematically explored the potentially disease-related mechanisms through a network view. The dysfunctional interactions among proteins and deregulatory relationships between transcription factors and their target genes could be causes for the occurrence and progression of this disease. The six pathologically defined disease stages in the development and progression of HCC after HCV infection were included in this study. We constructed disease-related biological networks for each disease stage, and identified progression-related sub-networks that potentially play roles in the developmental stage of the corresponding disease and participate in the later stage of cancer progression. In addition, we identified novel risk factors related to HCC based on the analysis of the progression-related sub-networks. The dynamic characteristics of the network reflect important features of the disease development and progression, which provide important information for us to further explore underlying mechanisms of the disease.	[He, Bing; Shi, Tieliu] E China Normal Univ, Ctr Bioinformat & Computat Biol, Inst Biomed Sci, Sch Life Sci, Shanghai 200062, Peoples R China; [Zhang, Hao] Fudan Univ, Dept Gen Surg, Huashan Hosp, Shanghai 200433, Peoples R China; [Shi, Tieliu] Chinese Acad Sci, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China	East China Normal University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	He, B (corresponding author), E China Normal Univ, Ctr Bioinformat & Computat Biol, Inst Biomed Sci, Sch Life Sci, Shanghai 200062, Peoples R China.	tlshi@sibs.ac.cn		He, Bing/0000-0003-1719-9290	National 973 Key Basic Research Program [2010CB945400, 2008CB713807, 2007CB108800]; National Natural Science Foundation of China [30870575, 31071162, 31000590]	National 973 Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National 973 Key Basic Research Program (Grant Nos. 2010CB945400, 2008CB713807 and 2007CB108800), and the National Natural Science Foundation of China (Grant No. 30870575, 31071162, 31000590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albornoz L, 1999, J HEPATOL, V30, P451, DOI 10.1016/S0168-8278(99)80104-4; Amitrano L, 2004, J HEPATOL, V40, P736, DOI 10.1016/j.jhep.2004.01.001; ARBUTHNOT P, 1991, ANTICANCER RES, V11, P921; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bray D, 2003, SCIENCE, V301, P1864, DOI 10.1126/science.1089118; CASELMANN WH, 1995, J HEPATOL, V22, P34; Chakravarti S, 2002, GLYCOCONJUGATE J, V19, P287, DOI 10.1023/A:1025348417078; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chiba T, 2005, EUR J CANCER, V41, P1185, DOI 10.1016/j.ejca.2005.02.014; COE JE, 1990, HEPATOLOGY, V11, P570, DOI 10.1002/hep.1840110408; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; El-Chennawi FA, 2008, IMMUNOL INVEST, V37, P661, DOI 10.1080/08820130802111605; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Ferro D, 1996, HEPATOLOGY, V23, P1377, DOI 10.1053/jhep.1996.v23.pm0008675154; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; Han ZG, 2009, SCI CHINA SER C, V52, P24, DOI 10.1007/s11427-009-0010-y; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He B, 2010, CELL RES, V20, P732, DOI 10.1038/cr.2010.67; Hohler T, 1997, J HEPATOL, V27, P259, DOI 10.1016/S0168-8278(97)80169-9; Huang J, 2009, SCI CHINA SER C, V52, P31, DOI 10.1007/s11427-009-0014-7; Inagaki Y, 1998, BIOCHEM BIOPH RES CO, V250, P606, DOI 10.1006/bbrc.1998.9345; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; KNITTEL T, 1995, HEPATOLOGY, V21, P470, DOI 10.1002/hep.1840210231; KRULL NB, 1992, FEBS LETT, V312, P47, DOI 10.1016/0014-5793(92)81407-D; LANGLEY PG, 1985, THROMB HAEMOSTASIS, V54, P693; Liu C, 2007, INT J IMMUNOGENET, V34, P373, DOI 10.1111/j.1744-313X.2007.00702.x; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Monnier J, 2008, WORLD J GASTROENTERO, V14, P1182, DOI 10.3748/wjg.14.1182; Nelson R, 2002, LANCET, V360, P2053, DOI 10.1016/S0140-6736(02)12045-9; NEUBERGER J, 1986, BRIT MED J, V292, P1355, DOI 10.1136/bmj.292.6532.1355; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; OKA K, 1979, THROMB HAEMOSTASIS, V42, P564; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; RAKE MO, 1970, LANCET, V1, P533; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun CA, 2003, AM J EPIDEMIOL, V157, P674, DOI 10.1093/aje/kwg041; URASHIMA S, 1993, ALCOHOL ALCOHOLISM, V28, P77, DOI 10.1093/alcalc/28.Supplement_1B.77; WANLESS IR, 1995, HEPATOLOGY, V21, P1238, DOI 10.1002/hep.1840210505; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Yu RB, 2008, J GASTROEN HEPATOL, V23, P1394, DOI 10.1111/j.1440-1746.2007.05215.x; Zhai Y, 2006, GASTROENTEROLOGY, V130, P2001, DOI 10.1053/j.gastro.2006.02.030; Zhao YP, 2009, DIGEST DIS SCI, V54, P369, DOI 10.1007/s10620-008-0340-9; Zhou HJ, 2007, J CANCER RES CLIN, V133, P663, DOI 10.1007/s00432-007-0218-9	49	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18516	10.1371/journal.pone.0018516	http://dx.doi.org/10.1371/journal.pone.0018516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526182	gold, Green Published, Green Submitted			2022-12-25	WOS:000289671100007
J	Makarova, N; Zhao, CX; Zhang, YY; Bhosle, S; Suppiah, S; Rhea, JM; Kozyr, N; Arnold, RS; Ly, H; Molinaro, RJ; Parslow, TG; Hunter, E; Liotta, D; Petros, J; Blackwell, JL				Makarova, Natalia; Zhao, Chunxia; Zhang, Yuanyuan; Bhosle, Sushma; Suppiah, Suganthi; Rhea, Jeanne M.; Kozyr, Natalia; Arnold, Rebecca S.; Ly, Hinh; Molinaro, Ross J.; Parslow, Tristram G.; Hunter, Eric; Liotta, Dennis; Petros, John; Blackwell, Jerry L.			Antibody Responses against Xenotropic Murine Leukemia Virus-Related Virus Envelope in a Murine Model	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; HIV-1-INFECTED PATIENTS; INFECTIOUS RETROVIRUS; XMRV INFECTION; IN-VIVO; CELLS; ADENOVIRUS; TYPE-1; HIV-1	Background: Xenotropic murine leukemia virus-related virus (XMRV) was recently discovered to be the first human gammaretrovirus that is associated with chronic fatigue syndrome and prostate cancer (PC). Although a mechanism for XMRV carcinogenesis is yet to be established, this virus belongs to the family of gammaretroviruses well known for their ability to induce cancer in the infected hosts. Since its original identification XMRV has been detected in several independent investigations; however, at this time significant controversy remains regarding reports of XMRV detection/prevalence in other cohorts and cell type/tissue distribution. The potential risk of human infection, coupled with the lack of knowledge about the basic biology of XMRV, warrants further research, including investigation of adaptive immune responses. To study immunogenicity in vivo, we vaccinated mice with a combination of recombinant vectors expressing codon-optimized sequences of XMRV gag and env genes and virus-like particles (VLP) that had the size and morphology of live infectious XMRV. Results: Immunization elicited Env-specific binding and neutralizing antibodies (NAb) against XMRV in mice. The peak titers for ELISA-binding antibodies and NAb were 1: 1024 and 1: 464, respectively; however, high ELISA-binding and NAb titers were not sustained and persisted for less than three weeks after immunizations. Conclusions: Vaccine-induced XMRV Env antibody titers were transiently high, but their duration was short. The relatively rapid diminution in antibody levels may in part explain the differing prevalences reported for XMRV in various prostate cancer and chronic fatigue syndrome cohorts. The low level of immunogenicity observed in the present study may be characteristic of a natural XMRV infection in humans.	[Makarova, Natalia; Zhao, Chunxia; Zhang, Yuanyuan; Kozyr, Natalia; Hunter, Eric; Blackwell, Jerry L.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Makarova, Natalia; Zhao, Chunxia; Zhang, Yuanyuan; Kozyr, Natalia; Hunter, Eric; Blackwell, Jerry L.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Blackwell, Jerry L.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; [Bhosle, Sushma; Suppiah, Suganthi; Rhea, Jeanne M.; Ly, Hinh; Molinaro, Ross J.; Parslow, Tristram G.; Hunter, Eric; Petros, John] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Arnold, Rebecca S.; Petros, John] Emory Univ, Dept Urol, Atlanta, GA 30322 USA; [Petros, John] Emory Univ, Dept Hematol Oncol, Atlanta, GA 30322 USA; [Liotta, Dennis] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Molinaro, Ross J.] Emory Univ, Core Labs Emory Univ Hosp Midtown, Atlanta, GA 30322 USA; [Petros, John] Atlanta Vet Affairs Med Ctr, Decatur, GA USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Makarova, N (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	jerry.blackwell@emory.edu	zhang, yuanyuan/GYA-4428-2022	Rhea, Jeanne M/0000-0001-8107-6872	Emory Department of Chemistry, Immunology and Developmental Cores of the Emory CFAR [P30-AI050409]; Yerkes National Primate Research Center [RR-00165]; National Institutes of Health National Institute of Allergy and Infectious Diseases [R01-AI069987, R0-1AI076096-01, R21-AI076080]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069987, R21AI076080, R33AI076096, P30AI050409, R21AI076096] Funding Source: NIH RePORTER	Emory Department of Chemistry, Immunology and Developmental Cores of the Emory CFAR; Yerkes National Primate Research Center; National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Emory Department of Chemistry, Immunology and Developmental Cores of the Emory CFAR (P30-AI050409), Yerkes National Primate Research Center base grant (RR-00165) and National Institutes of Health National Institute of Allergy and Infectious Diseases grants (R01-AI069987, R0-1AI076096-01 and R21-AI076080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Blackwell JL, 1999, ARCH OTOLARYNGOL, V125, P856, DOI 10.1001/archotol.125.8.856; Blaise S, 2001, J GEN VIROL, V82, P1597, DOI 10.1099/0022-1317-82-7-1597; Bronte V, 2003, J IMMUNOL, V171, P6396, DOI 10.4049/jimmunol.171.12.6396; Burkhart MD, 2003, J VIROL, V77, P3993, DOI 10.1128/JVI.77.7.3993-4003.2003; CHESEBRO B, 1983, VIROLOGY, V127, P134, DOI 10.1016/0042-6822(83)90378-1; Crevar CJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-131; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; GRAHAM FL, 1991, GENE TRANSFER EXPRES, P109, DOI DOI 10.1385/0-89603-178-0:109; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hammonds J, 2005, J VIROL, V79, P14804, DOI 10.1128/JVI.79.23.14804-14814.2005; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Luo LX, 2003, VIRUS RES, V92, P75, DOI 10.1016/S0168-1702(02)00316-7; MAIZEL JV, 1968, VIROLOGY, V36, P126, DOI 10.1016/0042-6822(68)90122-0; Mangeney M, 1998, P NATL ACAD SCI USA, V95, P14920, DOI 10.1073/pnas.95.25.14920; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Quan FS, 2007, VACCINE, V25, P3841, DOI 10.1016/j.vaccine.2007.01.107; Sakuma T, 2011, J VIROL, V85, P1205, DOI 10.1128/JVI.00886-10; Santra S, 2005, J VIROL, V79, P6516, DOI 10.1128/JVI.79.10.6516-6522.2005; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schlecht-Louf G, 2010, P NATL ACAD SCI USA, V107, P3782, DOI 10.1073/pnas.0913122107; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Spearman P, 2006, CURR OPIN HIV AIDS, V1, P200, DOI 10.1097/01.COH.0000221592.49412.1f; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Stieler KSC, 2010, VIROLOGY; Sundstrom JB, 2007, BLOOD, V109, P5293, DOI 10.1182/blood-2006-11-058438; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; VOGEL T, 1994, J IMMUNOL, V153, P1895; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xin KQ, 2005, GENE THER, V12, P1769, DOI 10.1038/sj.gt.3302590; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003; Ye L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/497219	54	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18272	10.1371/journal.pone.0018272	http://dx.doi.org/10.1371/journal.pone.0018272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494670	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400012
J	Sabbagh, A; Darlu, P; Crouau-Roy, B; Poloni, ES				Sabbagh, Audrey; Darlu, Pierre; Crouau-Roy, Brigitte; Poloni, Estella S.			Arylamine N-Acetyltransferase 2 (NAT2) Genetic Diversity and Traditional Subsistence: A Worldwide Population Survey	PLOS ONE			English	Article							LACTASE-PERSISTENCE; HUMAN ADAPTATION; CANCER-RISK; HISTORY; CULTURE; POLYMORPHISMS; EVOLUTION; AFRICA; DIET	Arylamine N-acetyltransferase 2 (NAT2) is involved in human physiological responses to a variety of xenobiotic compounds, including common therapeutic drugs and exogenous chemicals present in the diet and the environment. Many questions remain about the evolutionary mechanisms that have led to the high prevalence of slow acetylators in the human species. Evidence from recent surveys of NAT2 gene variation suggests that NAT2 slow-causing variants might have become targets of positive selection as a consequence of the shift in modes of subsistence and lifestyle in human populations in the last 10,000 years. We aimed to test more extensively the hypothesis that slow acetylation prevalence in humans is related to the subsistence strategy adopted by the past populations. To this end, published frequency data on the most relevant genetic variants of NAT2 were collected from 128 population samples (14,679 individuals) representing different subsistence modes and dietary habits, allowing a thorough analysis at both a worldwide and continent scale. A significantly higher prevalence of the slow acetylation phenotype was observed in populations practicing farming (45.4%) and herding (48.2%) as compared to populations mostly relying on hunting and gathering (22.4%) (P = 0.0007). This was closely mirrored by the frequency of the slow 590A variant that was found to occur at a three-fold higher frequency in food producers (25%) as compared to hunter-gatherers (8%). These findings are consistent with the hypothesis that the Neolithic transition to subsistence economies based on agricultural and pastoral resources modified the selective regime affecting the NAT2 acetylation pathway. Furthermore, the vast amount of data collected enabled us to provide a comprehensive and up-to-date description of NAT2 worldwide genetic diversity, thus building up a useful resource of frequency data for further studies interested in epidemiological or anthropological research questions involving NAT2.	[Sabbagh, Audrey] IRD, UMR 216, Paris, France; [Sabbagh, Audrey] Univ Paris 05, UMR 216, Paris, France; [Darlu, Pierre] Univ Paris 07, CNRS, MNHN, UMR Ecoanthropol & Ethnobiol 7206, Paris, France; [Crouau-Roy, Brigitte] CNRS, UMR 5174, EDB, Toulouse, France; [Crouau-Roy, Brigitte] Univ Toulouse 3, F-31062 Toulouse, France; [Poloni, Estella S.] Univ Geneva, Dept Genet & Evolut, Anthropol Unit, Lab Anthropol Genet & Peopling Hist, Geneva, Switzerland	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Geneva	Sabbagh, A (corresponding author), IRD, UMR 216, Paris, France.	audrey.sabbagh@parisdescartes.fr		Poloni, Estella S./0000-0002-8465-003X; SABBAGH, Audrey/0000-0003-0283-8803				Agundez JAG, 2008, CURR DRUG METAB, V9, P520, DOI 10.2174/138920008784892083; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; BLUM M, 1990, DNA CELL BIOL, V9, P193, DOI 10.1089/dna.1990.9.193; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fuselli S, 2007, PHARMACOGENOMICS J, V7, P144, DOI 10.1038/sj.tpj.6500407; Fuselli S, 2010, PHARMACOGENET GENOM, V20, P485, DOI 10.1097/FPC.0b013e32833bba25; Garcia-Martin E, 2008, CURR DRUG METAB, V9, P487, DOI 10.2174/138920008784892155; GARCIACLOSAS M, 2010, PHARMACOGEN IN PRESS; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hein DW, 2009, EXPERT OPIN DRUG MET, V5, P353, DOI [10.1517/17425250902877698, 10.1517/17425250902877698 ]; Hein DW, 2006, ONCOGENE, V25, P1649, DOI 10.1038/sj.onc.1209374; Ladero JM, 2008, CURR DRUG METAB, V9, P532, DOI 10.2174/138920008784892038; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Levinson D., 1991, ENCY WORLD CULTURES; Luca F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003136; Magalon H, 2008, EUR J HUM GENET, V16, P243, DOI 10.1038/sj.ejhg.5201963; Matimba Alice, 2009, Human Genomics, V3, P169; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Patin E, 2006, AM J HUM GENET, V78, P423, DOI 10.1086/500614; Patin E, 2006, HUM MUTAT, V27, P720, DOI 10.1002/humu.9438; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Peng Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-15; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Richerson PJ, 2010, P NATL ACAD SCI USA, V107, P8985, DOI 10.1073/pnas.0914631107; Sabbagh A, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-21; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Stanislawska-Sachadyn A, 2006, AM J MED GENET A, V140A, P2374, DOI 10.1002/ajmg.a.31475; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Wakefield L, 2007, BIOCHEM BIOPH RES CO, V364, P556, DOI 10.1016/j.bbrc.2007.10.026; Wakefield L, 2010, GENE, V452, P16, DOI 10.1016/j.gene.2009.12.002; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	36	96	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18507	10.1371/journal.pone.0018507	http://dx.doi.org/10.1371/journal.pone.0018507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494681	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400034
J	Morinaka, A; Funato, Y; Uesugi, K; Miki, H				Morinaka, A.; Funato, Y.; Uesugi, K.; Miki, H.			Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis	ONCOGENE			English	Article						MST1; PRX-I; reactive oxygen species (ROS); p53; cisplatin	OXIDATIVE-STRESS; HYDROGEN-PEROXIDE; HIPPO PATHWAY; P53-DEPENDENT APOPTOSIS; TUMOR SUPPRESSION; PROTEIN-KINASE; CANCER-CELLS; DNA-DAMAGE; C-MYC; PHOSPHORYLATION	Mammalian Ste20-like kinase-1 (MST1) kinase mediates H(2)O(2)-induced cell death by anticancer drugs such as cisplatin in a p53-dependent manner. However, the mechanism underlying MST1 activation by H(2)O(2) remains unknown. Here we show that peroxiredoxin-I (PRX-I) is an essential intermediate in H(2)O(2)-induced MST1 activation and cisplatin-induced cell death through p53. Cell stimulation with H(2)O(2) resulted in PRX-I oxidation to form homo-oligomers and interaction with MST1, leading to MST1 autophosphorylation and augmentation of kinase activity. In addition, RNA interference knockdown experiments indicated that endogenous PRX-I is required for H(2)O(2)-induced MST1 activation. Live-cell imaging showed H(2)O(2) generation by cisplatin treatment, which likewise caused PRX-I oligomer formation, MST1 activation and cell death. Cisplatin-induced PRX-I oligomer formation was not observed in embryonic fibroblasts obtained from p53-knockout mice, confirming the importance of p53. Indeed, ectopic expression of p53 induced PRX-I oligomer formation and cell death, both of which were cancelled by the antioxidant NAC. Moreover, we succeeded in reconstituting H(2)O(2)-induced MST1 activation in vitro, using purified PRX-I and MST1 proteins. Collectively, our results show a novel PRX-I function to cause cell death in response to high levels of oxidative stress by activating MST1, which underlies the p53-dependent cytotoxicity caused by anticancer agents. Oncogene (2011) 30, 4208-4218; doi:10.1038/onc.2011.139; published online 25 April 2011	[Morinaka, A.; Funato, Y.; Uesugi, K.; Miki, H.] Osaka Univ, Inst Prot Res, Lab Intracellular Signaling, Osaka 5650871, Japan	Osaka University	Miki, H (corresponding author), Osaka Univ, Inst Prot Res, Lab Intracellular Signaling, 3-2 Yamadaoka, Osaka 5650871, Japan.	hmiki@protein.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Japan; Grants-in-Aid for Scientific Research [22770195] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Yoshiaki Kise (Flanders Institute for Biotechnology, Belgium) for technical assistance in preparing the expression constructs. This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Japan.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Colombani J, 2006, CURR BIOL, V16, P1453, DOI 10.1016/j.cub.2006.05.059; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; de Souza PM, 2004, BIOCHEM SOC T, V32, P485, DOI 10.1042/BST0320485; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Konig J, 2002, P NATL ACAD SCI USA, V99, P5738, DOI 10.1073/pnas.072644999; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; O'Neill EE, 2005, CANCER RES, V65, P5485, DOI 10.1158/0008-5472.CAN-05-1453; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Ren AX, 2008, CANCER RES, V68, P2266, DOI 10.1158/0008-5472.CAN-07-6248; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; TSUKADA T, 1993, ONCOGENE, V8, P3313; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011	37	64	67	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	40					4208	4218		10.1038/onc.2011.139	http://dx.doi.org/10.1038/onc.2011.139			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	833ZK	21516123				2022-12-25	WOS:000295924600007
J	Abdeen, SK; Salah, Z; Maly, B; Smith, Y; Tufail, R; Abu-Odeh, M; Zanesi, N; Croce, CM; Nawaz, Z; Aqeilan, RI				Abdeen, S. K.; Salah, Z.; Maly, B.; Smith, Y.; Tufail, R.; Abu-Odeh, M.; Zanesi, N.; Croce, C. M.; Nawaz, Z.; Aqeilan, R. I.			Wwox inactivation enhances mammary tumorigenesis	ONCOGENE			English	Article						WWOX; WW domains; breast cancer; triple negative; tumor suppressor	BREAST-CANCER; E6-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; EXPRESSION; GENE; IDENTIFICATION; ESTROGEN; GROWTH	Breast cancer is the leading cause of cancer-related death in women worldwide. Expression of the WWOX tumor suppressor is absent or reduced in a large proportion of breast tumors suggesting that loss of WWOX may contribute to breast tumorigenesis. Wwox-deficient mice die by 3-4 weeks of age precluding adult tumor analysis. To evaluate the effect of WWOX-altered expression on mammary tumor formation, the Wwox-heterozygous allele was back crossed onto the C3H mammary tumor-susceptible genetic background (Wwox(C3H) +/-) and incidence of mammary tumor formation was evaluated. Although 50% of the female Wwox(C3H) +/- mice developed mammary carcinomas, only 7% of Wwox(C3H) +/- mice did. Intriguingly, mammary tumors in Wwox(C3H) +/- mice frequently lost WWOX protein expression suggesting a genetic predisposition toward mammary tumorigenesis. Immunohistochemical staining of hormone receptors revealed loss of estrogen receptor-a (ER) and progesterone receptor in the majority of these tumors. In vitro, depletion of WWOX in MCF7 ER-positive cells led to reduced ER expression and reduced sensitivity to tamoxifen and estrogen treatment and was associated with enhanced survival and anchorage-independent growth. Finally, cDNA array analyses of murine normal mammary epithelial cells and mammary tumors identified 163 significantly downreguated and 129 upregulated genes in the tumors. The majority of differentially expressed genes were part of pathways involved in cellular movement, cell-to-cell signaling and interaction, cellular development, cellular growth and proliferation and cell death. These changes in gene expression of mouse mammary tumors in Wwox(C3H) +/- mice resemble, at least in part, human breast cancer development. Our findings demonstrate the critical role that the WWOX tumor suppressor gene has in preventing tumorigenesis in breast cancer. Oncogene (2011) 30, 3900-3906; doi:10.1038/onc.2011.115; published online 18 April 2011	[Abdeen, S. K.; Salah, Z.; Abu-Odeh, M.; Aqeilan, R. I.] Hebrew Univ Jerusalem, Dept Immunol & Canc Res IMRIC, Lautenberg Ctr Gen & Tumor Immunol, Hadassah Med Sch, IL-91120 Jerusalem, Israel; [Maly, B.] Hebrew Univ Jerusalem, Dept Expt Pathol, Hadassah Med Sch, IL-91120 Jerusalem, Israel; [Smith, Y.] Hebrew Univ Jerusalem, Genom Data Anal Unit, Hadassah Med Sch, IL-91120 Jerusalem, Israel; [Tufail, R.; Nawaz, Z.] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL USA; [Zanesi, N.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Miami; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Aqeilan, RI (corresponding author), Hebrew Univ Jerusalem, Dept Immunol & Canc Res IMRIC, Lautenberg Ctr, POB 12272, IL-91120 Jerusalem, Israel.	aqeilan@cc.huji.ac.il	Aqeilan, Rami/R-4443-2016; Young, Richard A/F-6495-2012; Aqeilan, Rami/AAT-7785-2020	Aqeilan, Rami/0000-0002-6034-023X; Young, Richard A/0000-0001-8855-8647; 	NIH [R01DK060907]; Israeli Science Foundation [1331/08]; Israel Cancer Research Funds (ICRF); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060907, R01DK079217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Science Foundation(Israel Science Foundation); Israel Cancer Research Funds (ICRF); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to all the Aqeilan's lab members for helpful suggestions and technical assistance. This research was supported by grants from NIH (R01DK060907) to ZN and RIA, Israeli Science Foundation (#1331/08) to RIA and Israel Cancer Research Funds (ICRF) to ZS.	Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147; Bednarek AK, 2000, CANCER RES, V60, P2140; Del Mare S, 2009, J CELL BIOCHEM, V108, P737, DOI 10.1002/jcb.22298; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Gao XH, 2005, ENDOCRINOLOGY, V146, P1707, DOI 10.1210/en.2004-1198; Guler G, 2005, PATHOL INT, V55, P471, DOI 10.1111/j.1440-1827.2005.01855.x; Guler G, 2009, CANCER-AM CANCER SOC, V115, P899, DOI 10.1002/cncr.24103; Hu YH, 2004, CANCER RES, V64, P7748, DOI 10.1158/0008-5472.CAN-04-1827; Iliopoulos D, 2007, CLIN CANCER RES, V13, P268, DOI 10.1158/1078-0432.CCR-06-2038; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Klein A, 2007, INT J CANCER, V121, P683, DOI 10.1002/ijc.22630; Kurek KC, 2010, CANCER RES, V70, P5577, DOI 10.1158/0008-5472.CAN-09-4602; Nunez M, 2005, BREAST CANCER RES TR, V89, P99, DOI 10.1007/s10549-004-1474-x; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Radmacher MD, 2000, J NATL CANCER I, V92, P48, DOI 10.1093/jnci/92.1.48; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Salah Z, 2010, FUTURE ONCOL, V6, P249, DOI [10.2217/fon.09.152, 10.2217/FON.09.152]; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Turner BC, 2002, CANCER RES, V62, P4054	23	51	53	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	36					3900	3906		10.1038/onc.2011.115	http://dx.doi.org/10.1038/onc.2011.115			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	817PV	21499303				2022-12-25	WOS:000294687200007
J	Babu, E; Ramachandran, S; CoothanKandaswamy, V; Elangovan, S; Prasad, PD; Ganapathy, V; Thangaraju, M				Babu, E.; Ramachandran, S.; CoothanKandaswamy, V.; Elangovan, S.; Prasad, P. D.; Ganapathy, V.; Thangaraju, M.			Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate	ONCOGENE			English	Article						SLC5A8; dichloroacetate; anticancer drug; Warburg effect; pyruvate dehydrogenase kinase; mitochondrial oxidation in cancer	NA+-COUPLED TRANSPORTER; CANCER-CELLS; COLON-CANCER; GENE SLC5A8; ELECTROGENIC TRANSPORT; PYRUVATE-DEHYDROGENASE; PERIPHERAL NEUROPATHY; IN-VITRO; APOPTOSIS; WARBURG	There has been growing interest among the public and scientists in dichloroacetate (DCA) as a potential anticancer drug. Credible evidence exists for the antitumor activity of this compound, but high concentrations are needed for significant therapeutic effect. Unfortunately, these high concentrations produce detrimental side effects involving the nervous system, thereby precluding its use for cancer treatment. The mechanistic basis of the compound's antitumor activity is its ability to activate the pyruvate dehydrogenase complex through inhibition of pyruvate dehydrogenase kinase. As the compound inhibits the kinase at micromolar concentrations, it is not known why therapeutically prohibitive high doses are needed for suppression of tumor growth. We hypothesized that lack of effective mechanisms for the entry of DCA into tumor cells may underlie this phenomenon. Here we show that SLC5A8 transports DCA very effectively with high affinity. This transporter is expressed in normal cells, but expression is silenced in tumor cells by epigenetic mechanisms. The lack of the transporter makes tumor cells resistant to the antitumor activity of DCA. However, if the transporter is expressed in tumor cells ectopically, the cells become sensitive to the drug at low concentrations. This is evident in breast cancer cells, colon cancer cells and prostate cancer cells. Normal cells, which constitutively express the transporter, are however not affected by the compound, indicating tumor cell-selective therapeutic activity. The mechanism of the compound's antitumor activity still remains its ability to inhibit pyruvate dehydrogenase kinase and force mitochondrial oxidation of pyruvate. As silencing of SLC5A8 in tumors involves DNA methylation and its expression can be induced by treatment with DNA methylation inhibitors, our findings suggest that combining DCA with a DNA methylation inhibitor would offer a means to reduce the doses of DCA to avoid detrimental effects associated with high doses but without compromising antitumor activity. Oncogene (2011) 30, 4026-4037; doi:10.1038/onc. 2011.113; published online 18 April 2011	[Babu, E.; Ramachandran, S.; CoothanKandaswamy, V.; Elangovan, S.; Prasad, P. D.; Ganapathy, V.; Thangaraju, M.] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Thangaraju, M (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, 1459 Laney Walker Blvd,CB 2515, Augusta, GA 30912 USA.	mthangaraju@georgiahealth.edu	Elangovan, Selvakumar/ABB-9558-2021	Elangovan, Selvakumar/0000-0001-9906-5477	National Institutes of Health [CA131402]; NATIONAL CANCER INSTITUTE [R01CA131402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work described here is supported in part by the National Institutes of Health Grant CA131402.	Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Brandsma D, 2010, J NEUROL, V257, P2099, DOI 10.1007/s00415-010-5654-9; Calcutt NA, 2009, J NEUROPATH EXP NEUR, V68, P985, DOI 10.1097/NEN.0b013e3181b40217; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Coady MJ, 2004, J PHYSIOL-LONDON, V557, P719, DOI 10.1113/jphysiol.2004.063859; COOPER RH, 1974, BIOCHEM J, V143, P625, DOI 10.1042/bj1430625; Ganapathy V, 2005, BIOCHEM SOC T, V33, P237, DOI 10.1042/BST0330237; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gopal E, 2005, BIOCHEM J, V388, P309, DOI 10.1042/BJ20041916; Gopal E, 2004, J BIOL CHEM, V279, P44522, DOI 10.1074/jbc.M405365200; Gupta N, 2006, LIFE SCI, V78, P2419, DOI 10.1016/j.lfs.2005.10.028; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heshe D, 2011, CANCER CHEMOTH PHARM, V67, P647, DOI 10.1007/s00280-010-1361-6; Hong CB, 2005, CANCER RES, V65, P3617, DOI 10.1158/0008-5472.CAN-05-0048; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Martin PM, 2006, J NEUROCHEM, V98, P279, DOI 10.1111/j.1471-4159.2006.03878.x; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Miyauchi S, 2010, BBA-BIOMEMBRANES, V1798, P1164, DOI 10.1016/j.bbamem.2010.03.002; Park JY, 2008, PANCREAS, V36, pE32, DOI 10.1097/MPA.0b013e3181630ffe; Park JY, 2007, CANCER DETECT PREV, V31, P359, DOI 10.1016/j.cdp.2007.09.002; Pearson H, 2007, NATURE, V446, P474, DOI 10.1038/446474a; Porra V, 2005, J CLIN ENDOCR METAB, V90, P3028, DOI 10.1210/jc.2004-1394; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Stacpoole PW, 1998, DRUG METAB REV, V30, P499, DOI 10.3109/03602539808996323; Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637; Stapoole PW, 2008, ADV DRUG DELIVER REV, V60, P1478, DOI 10.1016/j.addr.2008.02.014; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Thangaraju M, 2008, J GASTROINTEST SURG, V12, P1773, DOI 10.1007/s11605-008-0573-0; Thangaraju M, 2006, CANCER RES, V66, P11560, DOI 10.1158/0008-5472.CAN-06-1950; Thangaraju M, 2009, CANCER, V115, P4655, DOI 10.1002/cncr.24532; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Ueno M, 2004, TUMOR BIOL, V25, P134, DOI 10.1159/000079145; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weimer LH, 2009, CURR NEUROL NEUROSCI, V9, P69, DOI 10.1007/s11910-009-0011-z; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Xiao LL, 2010, MOL CELL BIOCHEM, V340, P31, DOI 10.1007/s11010-010-0397-6	49	63	67	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	38					4026	4037		10.1038/onc.2011.113	http://dx.doi.org/10.1038/onc.2011.113			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	823KR	21499304	Green Accepted			2022-12-25	WOS:000295121600004
J	France, KA; Anderson, JL; Park, A; Denny, CT				France, Kelly A.; Anderson, Jennifer L.; Park, Ann; Denny, Christopher T.			Oncogenic Fusion Protein EWS/FLI1 Down-regulates Gene Expression by Both Transcriptional and Posttranscriptional Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; EWINGS-SARCOMA; TARGET GENE; FAMILY TUMORS; NIH3T3 CELLS; EWS; ONCOPROTEINS; EWS-FLI1; DOMAIN; TRANSLOCATION	Ewing family tumors are characterized by a translocation between the RNA binding protein EWS and one of five ETS transcription factors, most commonly FLI1. The fusion protein produced by the translocation has been thought to act as an aberrant transcription factor, leading to changes in gene expression and cellular transformation. In this study, we investigated the specific processes EWS/FLI1 utilizes to alter gene expression. Using both heterologous NIH 3T3 and human Ewing Family Tumor cell lines, we have demonstrated by quantitative pre-mRNA analysis that EWS/FLI1 repressed the expression of previously validated direct target genes at the level of transcript synthesis. ChIP experiments showed that EWS/FLI1 decreases the amount of Pol II at the promoter of down-regulated genes in both murine and human model systems. However, in down-regulated target genes, there was a significant disparity between the modulation of cognate mRNA and pre-mRNAs, suggesting that these genes could also be regulated at a posttranscriptional level. Confirming this, we found that EWS/FLI1 decreased the transcript half-life of insulin-like growth factor binding protein 3, a down-regulated direct target gene in human tumor-derived Ewing's sarcoma cell lines. Additionally, we have shown through reexpression experiments that full EWS/FLI1-mediated transcriptional repression requires intact EWS and ETS domains. Together these data demonstrate that EWS/FLI1 can dictate steady-state target gene expression by modulating both transcript synthesis and degradation.	[Denny, Christopher T.] Univ Calif Los Angeles, Med Ctr, Inst Mol Biol, Los Angeles, CA 90095 USA; [Denny, Christopher T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Park, Ann; Denny, Christopher T.] Univ Calif Los Angeles, Dept Pediat, Gwynne Hazen Cherry Mem Labs, Div Hematol Oncol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Denny, CT (corresponding author), Univ Calif Los Angeles, Med Ctr, Inst Mol Biol, A2-312 MDCC, Los Angeles, CA 90095 USA.	cdenny@ucla.edu			National Institutes of Health [CA087771]; Ruth L. Kirschstein National Research Service Award [GM007185]; NATIONAL CANCER INSTITUTE [R01CA087771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA087771. This work was also supported by Ruth L. Kirschstein National Research Service Award GM007185 (to K. A. F. and J. L. A.).	Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bernstein M, 2006, ONCOLOGIST, V11, P503, DOI 10.1634/theoncologist.11-5-503; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Bradley MN, 2003, MOL CELL BIOL, V23, P4841, DOI 10.1128/MCB.23.14.4841-4858.2003; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deneen B, 2003, CANCER RES, V63, P4268; Dohjima T, 2003, MOL THER, V7, P811, DOI 10.1016/S1525-0016(03)00101-1; Gill G, 2001, ESSAYS BIOCHEM, V37, P33, DOI 10.1042/bse0370033; GUYETTE WA, 1979, CELL, V17, P1013, DOI 10.1016/0092-8674(79)90340-4; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Im YH, 2000, CANCER RES, V60, P1536; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Matsunobu T, 2006, CANCER RES, V66, P803, DOI 10.1158/0008-5472.CAN-05-1972; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Melet F, 1996, MOL CELL BIOL, V16, P2708; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Ng KP, 2007, P NATL ACAD SCI USA, V104, P479, DOI 10.1073/pnas.0607007104; Papas Takis S., 1997, Leukemia (Basingstoke), V11, P557; Petermann R, 1998, ONCOGENE, V17, P603, DOI 10.1038/sj.onc.1201964; Potikyan G, 2007, CANCER RES, V67, P6675, DOI 10.1158/0008-5472.CAN-06-4140; Potikyan G, 2008, LAB INVEST, V88, P1291, DOI 10.1038/labinvest.2008.99; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Sanchez G, 2008, P NATL ACAD SCI USA, V105, P6004, DOI 10.1073/pnas.0710748105; SETH A, 1992, CELL GROWTH DIFFER, V3, P327; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; SPENCER CA, 1990, ONCOGENE, V5, P777; Teitell MA, 1999, LAB INVEST, V79, P1535; Thompson AD, 1999, ONCOGENE, V18, P5506, DOI 10.1038/sj.onc.1202928; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; TURCCAREL C, 1983, CR ACAD SCI III-VIE, V296, P1101; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761	40	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22750	22757		10.1074/jbc.M111.225433	http://dx.doi.org/10.1074/jbc.M111.225433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531709	Green Published, hybrid			2022-12-25	WOS:000292025000009
J	Kroh, HK; Panizzi, P; Tchaikovski, S; Baird, TR; Wei, N; Krishnaswamy, S; Tans, G; Rosing, J; Furie, B; Furie, BC; Bock, PE				Kroh, Heather K.; Panizzi, Peter; Tchaikovski, Svetlana; Baird, T. Regan; Wei, Nancy; Krishnaswamy, Sriram; Tans, Guido; Rosing, Jan; Furie, Bruce; Furie, Barbara C.; Bock, Paul E.			Active Site-labeled Prothrombin Inhibits Prothrombinase in Vitro and Thrombosis in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR SUBSTRATE RECOGNITION; BLOOD-COAGULATION PROTEINASES; PEPTIDE CHLOROMETHYL KETONES; VEIN ENDOTHELIAL-CELLS; REGULATORY EXOSITE-I; PLATELET P-SELECTIN; FACTOR-XA; FACTOR-VA; TISSUE FACTOR; CATALYZED ACTIVATION	Mouse and human prothrombin (ProT) active site specifically labeled with D-Phe-Pro-Arg-CH2Cl (FPR-ProT) inhibited tissue factor-initiated thrombin generation in platelet-rich and platelet-poor mouse and human plasmas. FPR-prethrombin 1 (Pre 1), fragment 1 (F1), fragment 1.2 (F1.2), and FPR-thrombin produced no significant inhibition, demonstrating the requirement for all three ProT domains. Kinetics of inhibition of ProT activation by the inactive ProT(S195A) mutant were compatible with competitive inhibition as an alternate nonproductive substrate, although FPR-ProT deviated from this mechanism, implicating a more complex process. FPR-ProT exhibited similar to 10-fold more potent anticoagulant activity compared with ProT(S195A) as a result of conformational changes in the ProT catalytic domain that induce a more proteinase-like conformation upon FPR labeling. Unlike ProT and ProT(S195A), the pathway of FPR-ProT cleavage by prothrombinase was redirected from meizothrombin toward formation of the FPR-prethrombin 2 (Pre 2).F1.2 inhibitory intermediate. Localization of ProT labeled with Alexa Fluor (R) 660 tethered through FPR-CH2Cl ([AF660]FPR-ProT) during laser-induced thrombus formation in vivo in murine arterioles was examined in real time wide-field and confocal fluorescence microscopy. [AF660]FPR-ProT bound rapidly to the vessel wall at the site of injury, preceding platelet accumulation, and subsequently to the thrombus proximal, but not distal, to the vessel wall. [AF660]FPR-ProT inhibited thrombus growth, whereas [AF660]FPR-Pre 1, lacking the F1 membrane-binding domain did not bind or inhibit. Labeled F1.2 localized similarly to [AF660]FPR-ProT, indicating binding to phosphatidylserine-rich membranes, but did not inhibit thrombosis. The studies provide new insight into the mechanism of ProT activation in vivo and in vitro, and the properties of a unique exosite-directed prothrombinase inhibitor.	[Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37232 USA; [Panizzi, Peter] Auburn Univ, Harrison Sch Pharm, Dept Pharmacal Sci, Auburn, AL 36849 USA; [Tchaikovski, Svetlana; Tans, Guido; Rosing, Jan] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Baird, T. Regan; Furie, Bruce; Furie, Barbara C.] Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; [Baird, T. Regan; Wei, Nancy; Furie, Bruce] Harvard Univ, Dept Med, Sch Med, Boston, MA 02115 USA; [Krishnaswamy, Sriram] Univ Penn, Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	Vanderbilt University; Auburn University System; Auburn University; Maastricht University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Bock, PE (corresponding author), C3321A Med Ctr N, Nashville, TN USA.	paul.bock@vanderbilt.edu	Panizzi, Peter/A-6072-2019; Krishnaswamy, Sriram/Z-4380-2019	Panizzi, Peter/0000-0003-0141-8807; 	National Institutes of Health [RO1 HL038779, R37 HL071544, K99 HL094533, PO1 HL87203, RO1 HL095084, RO1 HL92125, PO1 HL74124, T32 HL0007751]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095084, K99HL094533, R01HL092125, T32HL007751, P01HL074124, P01HL087203, R01HL038779, R37HL071544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL038779 and R37 HL071544 (to P. E. B.), K99 HL094533 (to P. P.), PO1 HL87203 and RO1 HL095084 (to B. F.), RO1 HL92125 (to B. C. F.), and PO1 HL74124 (to S. K.).; Supported in part by National Institutes of Health Grant T32 HL0007751.	Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Anderson PJ, 2003, J BIOL CHEM, V278, P44482, DOI 10.1074/jbc.M306917200; Anderson PJ, 2003, J BIOL CHEM, V278, P44489, DOI 10.1074/jbc.M306916200; Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Arocas V, 1998, THROMB HAEMOSTASIS, V79, P1157, DOI 10.1055/s-0037-1615033; Atkinson BT, 2010, BLOOD, V116, P4675, DOI 10.1182/blood-2010-05-283986; Beck DO, 2004, J BIOL CHEM, V279, P3084, DOI 10.1074/jbc.M306850200; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; Bono F, 1997, J CELL PHYSIOL, V172, P36, DOI 10.1002/(SICI)1097-4652(199707)172:1<36::AID-JCP4>3.0.CO;2-E; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Celi A, 2003, J THROMB HAEMOST, V1, P60, DOI 10.1046/j.1538-7836.2003.t01-1-00033.x; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; Curvers J, 2002, THROMB HAEMOSTASIS, V87, P483, DOI 10.1055/s-0037-1613029; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; DAHLBACK B, 1980, EUR J BIOCHEM, V104, P549, DOI 10.1111/j.1432-1033.1980.tb04458.x; Dubois C, 2007, PLATELETS, 2ND EDITION, P611, DOI 10.1016/B978-012369367-9/50796-5; Dubois C, 2007, J CLIN INVEST, V117, P953, DOI 10.1172/JCI30537; Dubois C, 2006, BLOOD, V107, P3902, DOI 10.1182/blood-2005-09-3687; Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Furie B, 2004, TRENDS MOL MED, V10, P171, DOI 10.1016/j.molmed.2004.02.008; GAJDUSEK C, 1986, J CELL BIOL, V103, P419, DOI 10.1083/jcb.103.2.419; Gross PL, 2005, J LEUKOCYTE BIOL, V78, P1318, DOI 10.1189/jlb.0405193; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kamath P, 2008, J BIOL CHEM, V283, P30164, DOI 10.1074/jbc.M806158200; Koenen RR, 2003, BLOOD, V102, P1686, DOI 10.1182/blood-2003-02-0620; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1990, BLOOD, V76, P1; MARUYAMA I, 1984, J CLIN INVEST, V74, P224, DOI 10.1172/JCI111405; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; RODGERS GM, 1983, P NATL ACAD SCI-BIOL, V80, P7001, DOI 10.1073/pnas.80.22.7001; RODGERS GM, 1988, FASEB J, V2, P116, DOI 10.1096/fasebj.2.2.3277885; RODGERS GM, 1988, J CLIN INVEST, V81, P1911, DOI 10.1172/JCI113538; ROSING J, 1985, BLOOD, V65, P319; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; SHAPIRO SS, 1969, J CLIN INVEST, V48, P1292, DOI 10.1172/JCI106095; STERN DM, 1984, J CLIN INVEST, V74, P1910, DOI 10.1172/JCI111611; TANS G, 1991, J BIOL CHEM, V266, P21864; Tchaikovski SN, 2007, J THROMB HAEMOST, V5, P2079, DOI 10.1111/j.1538-7836.2007.02719.x; TIJBURG PNM, 1991, J BIOL CHEM, V266, P4017; TRACY PB, 1981, J BIOL CHEM, V256, P743; TRACY PB, 1985, J BIOL CHEM, V260, P2119; TRACY PB, 1983, J BIOL CHEM, V258, P7264; Van Zutphen L.F., 2001, PRINCIPLES LAB ANIMA, Vfirst; Vandendries ER, 2007, P NATL ACAD SCI USA, V104, P288, DOI 10.1073/pnas.0610188104; Wilkens M, 2002, J BIOL CHEM, V277, P9366, DOI 10.1074/jbc.M110848200; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	69	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23345	23356		10.1074/jbc.M111.230292	http://dx.doi.org/10.1074/jbc.M111.230292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21531712	Green Published, hybrid			2022-12-25	WOS:000292025000066
J	Lee, CJJ; Goncalves, LL; Wells, PG				Lee, Crystal J. J.; Goncalves, Luisa L.; Wells, Peter G.			Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism	FASEB JOURNAL			English	Article						2-phthalimidoglutaramic acid; 2-phthalimidoglutaric acid; otic vesicle development; 8-oxoguanine	OXIDATIVE DNA-DAMAGE; CATALYZED BIOACTIVATION; TERATOGENIC ACTIVITY; CHIRAL INVERSION; SCORING SYSTEM; SERUM-ALBUMIN; IN-VIVO; PHENYTOIN; LIMB; GLUTATHIONE	Thalidomide (TD) causes birth defects in humans and rabbits via several potential mechanisms, including bioactivation by embryonic prostaglandin H synthase (PHS) enzymes to a reactive intermediate that enhances reactive oxygen species (ROS) formation. We show herein that TD in rabbit embryo culture produces relevant embryopathies, including decreases in head/brain development by 28% and limb bud growth by 71% (P<0.05). Two TD hydrolysis products, 2-phthalimidoglutaramic acid (PGMA) and 2-phthalimidoglutaric acid (PGA), were similarly embryopathic, attenuating otic vesicle (ear) and limb bud formation by up to 36 and 77%, respectively (P<0.05). TD, PGMA, and PGA all increased embryonic DNA oxidation measured as 8-oxoguanine (8-oxoG) by up to 2-fold (P<0.05). Co- or pretreatment with the PHS inhibitors eicosatetraynoic acid (ETYA) or acetylsalicylic acid (ASA), or the free-radical spin trap phenyl-butylnitrone (PBN), completely blocked embryonic 8-oxoG formation and/or embryopathies initiated by TD, PGMA, and PGA. This is the first demonstration of limb bud embryopathies initiated by TD, as well as its hydrolysis products, in a mammalian embryo culture model of a species susceptible to TD in vivo, indicating that all likely contribute to TD teratogenicity in vivo, in part through PHS-dependent, ROS-mediated mechanisms.-Lee, C. J. J., Goncalves, L. L., Wells, P. G. Embryopathic effects of thalidomide and its hydrolysis products in rabbit embryo culture: evidence for a prostaglandin H synthase (PHS)-dependent, reactive oxygen species (ROS)-mediated mechanism. FASEB J. 25, 2468-2483 (2011). www.fasebj.org	[Lee, Crystal J. J.; Goncalves, Luisa L.; Wells, Peter G.] Univ Toronto, Fac Pharm, Toronto, ON M5S 3M2, Canada; [Wells, Peter G.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 3M2, Canada	University of Toronto; University of Toronto	Wells, PG (corresponding author), Univ Toronto, Fac Pharm, 144 Coll St, Toronto, ON M5S 3M2, Canada.	pg.wells@utoronto.ca	Gonçalves, Luisa/A-4120-2016	Gonçalves, Luisa/0000-0002-3654-8612; Goncalves, Luisa/0000-0002-2385-7395	Canadian Institutes of Health Research (CIHR); Canadian Rx&D Health Research Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Rx&D Health Research Foundation	The authors thank Dr. Edward Carney, technician Valerie Marshall, and their colleagues at Dow Chemical Co. for their training and guidance in the techniques for rabbit embryo culture; University of Toronto veterinarian Dr. Kate Banks for her expertise and advice, and animal technicians Sara Johnson and Erin Dunning for the high quality of their care for the rabbits. Funding for this research was provided by the Canadian Institutes of Health Research (CIHR). C.J.J.L. was supported by a doctoral award jointly funded by CIHR and the Canadian Rx&D Health Research Foundation. A preliminary report of this research was presented at the 2009 annual meeting of the Teratology Society (USA; ref. 77).	Arlen RR, 1996, J PHARMACOL EXP THER, V277, P1649; Ballmaier D, 2006, TOXICOLOGY, V221, P166, DOI 10.1016/j.tox.2006.01.009; Beaudoin S, 2003, FETAL DIAGN THER, V18, P422, DOI 10.1159/000073136; BRAUN AG, 1986, TOXICOL APPL PHARM, V82, P175, DOI 10.1016/0041-008X(86)90449-7; Carney EW, 2007, BIRTH DEFECTS RES B, V80, P213, DOI 10.1002/bdrb.20118; Castilla EE, 1996, TERATOLOGY, V54, P273, DOI 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; DELAHUNT CS, 1964, SCIENCE, V146, P1300, DOI 10.1126/science.146.3649.1300; Eriksson T, 1998, CHIRALITY, V10, P223, DOI 10.1002/(SICI)1520-636X(1998)10:3<223::AID-CHIR4>3.0.CO;2-A; FABRO S, 1967, BIOCHEM J, V104, P565, DOI 10.1042/bj1040565; FABRO S, 1967, BIOCHEM J, V104, P570, DOI 10.1042/bj1040570; FABRO S, 1964, NATURE, V201, P1125, DOI 10.1038/2011125a0; FABRO S, 1965, BRIT J PHARM CHEMOTH, V25, P352, DOI 10.1111/j.1476-5381.1965.tb02055.x; FABRO S, 1966, J PATHOL BACTERIOL, V91, P511, DOI 10.1002/path.1700910227; Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3; FRITZ H, 1966, J REPROD FERTIL, V11, P157; GORDON GB, 1981, P NATL ACAD SCI-BIOL, V78, P2545, DOI 10.1073/pnas.78.4.2545; Halliwell B., 2007, FREE RADICALS BIOL M; HANLEY TR, 1984, TOXICOL APPL PHARM, V75, P409, DOI 10.1016/0041-008X(84)90178-9; Hansen JM, 2002, J PHARMACOL EXP THER, V300, P768, DOI 10.1124/jpet.300.3.768; Hansen JM, 2002, DEV DYNAM, V225, P186, DOI 10.1002/dvdy.10150; Hansen JM, 1999, REPROD TOXICOL, V13, P547, DOI 10.1016/S0890-6238(99)00053-2; HENDRICKX AG, 1973, TERATOLOGY, V7, P151, DOI 10.1002/tera.1420070206; Huang PHT, 1997, TERATOGEN CARCIN MUT, V17, P1, DOI 10.1002/(SICI)1520-6866(1997)17:1<1::AID-TCM2>3.0.CO;2-L; HUANG PHT, 1990, TERATOGEN CARCIN MUT, V10, P281, DOI 10.1002/tcm.1770100402; Huang PHT, 1999, PHARMACOL TOXICOL, V85, P103, DOI 10.1111/j.1600-0773.1999.tb00074.x; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jansen MS, 2004, P NATL ACAD SCI USA, V101, P7199, DOI 10.1073/pnas.0402014101; Kastritis E, 2007, BEST PRACT RES CL HA, V20, P681, DOI 10.1016/j.beha.2007.09.001; Kennedy JC, 2004, MOL PHARMACOL, V66, P404; KING FE, 1949, J CHEM SOC, P3315, DOI 10.1039/jr9490003315; Knobloch J, 2008, MOL CELL BIOL, V28, P529, DOI 10.1128/MCB.00533-07; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; Knobloch J, 2008, MOL PHARMACEUT, V5, P1138, DOI 10.1021/mp8001232; KOCHERBECKER U, 1982, NATURWISSENSCHAFTEN, V69, P191, DOI 10.1007/BF00364900; LECK IM, 1962, BMJ-BRIT MED J, V2, P14, DOI 10.1136/bmj.2.5296.16; Lee CJJ, 2009, BIRTH DEFECTS RES A, V85, P400; Lee CJJ, 2011, TOXICOL SCI, V122, P146, DOI 10.1093/toxsci/kfr084; Lee CJJ, 2011, TOXICOL SCI, V122, P157, DOI 10.1093/toxsci/kfr086; LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303; Matthews SJ, 2003, CLIN THER, V25, P342, DOI 10.1016/S0149-2918(03)80085-1; MCBRIDE WG, 1961, LANCET, V2, P1358; MCBRIDE WG, 1977, TERATOLOGY, V16, P79, DOI 10.1002/tera.1420160113; MEISE W, 1973, EXPERIENTIA, V29, P423, DOI 10.1007/BF01926758; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; MIRANDA AF, 1994, TOXICOL APPL PHARM, V124, P230, DOI 10.1006/taap.1994.1027; Neubert R, 1995, LIFE SCI, V58, P295, DOI 10.1016/0024-3205(95)02290-2; Nicolai S, 1997, BIOCHEM PHARMACOL, V53, P1553, DOI 10.1016/S0006-2952(97)00096-8; OCKENFELS H, 1970, EXPERIENTIA, V26, P1236, DOI 10.1007/BF01897987; Parman T, 1998, J BIOL CHEM, V273, P25079, DOI 10.1074/jbc.273.39.25079; Parman T, 1999, NAT MED, V5, P582, DOI 10.1038/8466; Pitt JA, 1999, TERATOLOGY, V59, P88, DOI 10.1002/(SICI)1096-9926(199902)59:2<88::AID-TERA3>3.0.CO;2-7; Pitt JA, 1999, TERATOLOGY, V59, P102, DOI 10.1002/(SICI)1096-9926(199902)59:2<102::AID-TERA4>3.0.CO;2-6; Ramkissoon A, 2011, FREE RADICAL BIO MED, V50, P295, DOI 10.1016/j.freeradbiomed.2010.11.010; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Reist M, 1998, CHEM RES TOXICOL, V11, P1521, DOI 10.1021/tx9801817; Sauer H, 2000, AM J PATHOL, V156, P151, DOI 10.1016/S0002-9440(10)64714-1; Schuler-Faccini L, 2007, BIRTH DEFECTS RES A, V79, P671, DOI 10.1002/bdra.20384; SCHUMACHER H, 1968, J PHARMACOL EXP THER, V160, P189; SCHUMACHER H, 1965, BRIT J PHARM CHEMOTH, V25, P324, DOI 10.1111/j.1476-5381.1965.tb02053.x; SCHUMACHER H, 1965, BRIT J PHARM CHEMOTH, V25, P338, DOI 10.1111/j.1476-5381.1965.tb02054.x; SCHUMACHER HJ, 1970, J PHARMACOL EXP THER, V173, P265; SCOTT WJ, 1977, TERATOLOGY, V16, P333, DOI 10.1002/tera.1420160313; Silverstein R., 1977, SPECTROMETRIC IDENTI; SOMERS GF, 1962, LANCET, V1, P912; Stephens TD, 2000, BIOCHEM PHARMACOL, V59, P1489, DOI 10.1016/S0006-2952(99)00388-3; STROMLAND K, 1993, ACTA OPHTHALMOL, V71, P238; TAKEMORI S, 1976, ARCH OTOLARYNGOL, V102, P425; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Walker SL, 2007, LEPROSY REV, V78, P197; Webster WS, 1997, INT J DEV BIOL, V41, P329; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; WILLIAMS RT, 1968, ARCH ENVIRON HEALTH, V16, P493, DOI 10.1080/00039896.1968.10665097; Winn LM, 2002, TOXICOL APPL PHARM, V184, P144, DOI 10.1006/taap.2002.9504; Wong AW, 2008, J NEUROSCI, V28, P9047, DOI 10.1523/JNEUROSCI.2557-08.2008; WUEST HM, 1964, LIFE SCI, V3, P721, DOI 10.1016/0024-3205(64)90025-6; YU WK, 1995, TOXICOL APPL PHARM, V131, P1, DOI 10.1006/taap.1995.1040	77	28	36	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2011	25	7					2468	2483		10.1096/fj.10-178814	http://dx.doi.org/10.1096/fj.10-178814			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	785PY	21502285				2022-12-25	WOS:000292242200037
J	Czarna, A; Breitkreuz, H; Mahrenholz, CC; Arens, J; Strauss, HM; Wolf, E				Czarna, Anna; Breitkreuz, Helena; Mahrenholz, Carsten C.; Arens, Julia; Strauss, Holger M.; Wolf, Eva			Quantitative Analyses of Cryptochrome-mBMAL1 Interactions MECHANISTIC INSIGHTS INTO THE TRANSCRIPTIONAL REGULATION OF THE MAMMALIAN CIRCADIAN CLOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; BLUE-LIGHT PHOTORECEPTOR; CIRCULAR-DICHROISM SPECTRA; CRYSTAL-STRUCTURE; FEEDBACK LOOP; C-TERMINUS; CLOCK; CRY2; BMAL1; ACETYLATION	The mammalian cryptochromes mCRY1 and mCRY2 act as transcriptional repressors within the 24-h transcription-translational feedback loop of the circadian clock. The C-terminal tail and a preceding predicted coiled coil (CC) of the mCRYs as well as the C-terminal region of the transcription factor mBMAL1 are involved in transcriptional feedback repression. Here we show by fluorescence polarization and isothermal titration calorimetry that purified mCRY1/2CCtail proteins form stable heterodimeric complexes with two C-terminal mBMAL1 fragments. The longer mBMAL1 fragment (BMAL490) includes Lys-537, which is rhythmically acetylated by mCLOCK in vivo. mCRY1 (but not mCRY2) has a lower affinity to BMAL490 than to the shorter mBMAL1 fragment (BMAL577) and a K537Q mutant version of BMAL490. Using peptide scan analysis we identify two mBMAL1 binding epitopes within the coiled coil and tail regions of mCRY1/2 and document the importance of positively charged mCRY1 residues for mBMAL1 binding. A synthetic mCRY coiled coil peptide binds equally well to the short and to the long (wild-type and K537Q mutant) mBMAL1 fragments. In contrast, a peptide including the mCRY1 tail epitope shows a lower affinity to BMAL490 compared with BMAL577 and BMAL490(K537Q). We propose that Lys-537(mBMAL1) acetylation enhances mCRY1 binding by affecting electrostatic interactions predominantly with the mCRY1 tail. Our data reveal different molecular interactions of the mCRY1/2 tails with mBMAL1, which may contribute to the non-redundant clock functions of mCRY1 and mCRY2. Moreover, our study suggests the design of peptidic inhibitors targeting the interaction of the mCRY1 tail with mBMAL1.	[Wolf, Eva] Max Planck Inst Biochem, Dept Struct Cell Biol, Grp Struct Chronobiol, D-82152 Martinsried, Germany; [Breitkreuz, Helena; Arens, Julia] Max Planck Inst Mol Physiol, Dept Biol Struct, D-44227 Dortmund, Germany; [Mahrenholz, Carsten C.] Charite, Inst Med Immunol, Mol Lib, D-10115 Berlin, Germany; [Mahrenholz, Carsten C.] Charite, Inst Med Immunol, Recognit Grp, D-10115 Berlin, Germany; [Strauss, Holger M.] Gesell Kolloidanalyt mbH, Nanolyt, D-14476 Potsdam, Germany	Max Planck Society; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wolf, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Grp Struct Chronobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	ewolf@biochem.mpg.de	Strauss, Holger Martin/I-8403-2012	Czarna, Anna/0000-0003-1068-0671	Deutsche Forschungsgemeinschaft [WO-695/3, WO-695/4, WO-695/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants WO-695/3, WO-695/4, and WO-695/5 (to E. W.).	Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kondratov RV, 2007, TRENDS CELL BIOL, V17, P311, DOI 10.1016/j.tcb.2007.07.001; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; McCarthy EV, 2009, MOL CELL BIOL, V29, P5465, DOI 10.1128/MCB.00641-09; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Sakakida Y, 2005, J BIOL CHEM, V280, P13272, DOI 10.1074/jbc.M413236200; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Takahata S, 2000, GENES CELLS, V5, P739, DOI 10.1046/j.1365-2443.2000.00363.x; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	34	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22414	22425		10.1074/jbc.M111.244749	http://dx.doi.org/10.1074/jbc.M111.244749			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21521686	Green Published, hybrid			2022-12-25	WOS:000291719900051
J	Kwezi, L; Ruzvidzo, O; Wheeler, JI; Govender, K; Iacuone, S; Thompson, PE; Gehring, C; Irving, HR				Kwezi, Lusisizwe; Ruzvidzo, Oziniel; Wheeler, Janet I.; Govender, Kershini; Iacuone, Sylvana; Thompson, Philip E.; Gehring, Chris; Irving, Helen R.			The Phytosulfokine (PSK) Receptor Is Capable of Guanylate Cyclase Activity and Enabling Cyclic GMP-dependent Signaling in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE GROWTH-FACTOR; ARABIDOPSIS-THALIANA; PROTEIN-KINASE; IN-VITRO; BINDING PROTEINS; GENE-EXPRESSION; MESOPHYLL-CELLS; MEMBRANE FORM; CGMP LEVELS; IDENTIFICATION	Phytosulfokines (PSKs) are sulfated pentapeptides that stimulate plant growth and differentiation mediated by the PSK receptor (PSKR1), which is a leucine-rich repeat receptor-like kinase. We identified a putative guanylate cyclase (GC) catalytic center in PSKR1 that is embedded within the kinase domain and hypothesized that the GC works in conjunction with the kinase in downstream PSK signaling. We expressed the recombinant complete kinase (cytoplasmic) domain of AtPSKR1 and show that it has serine/threonine kinase activity using the Ser/Thr peptide 1 as a substrate with an approximate K-m of 7.5 mu M and V-max of 1800 nmol min(-1) mg(-1) of protein. This same recombinant protein also has GC activity in vitro that is dependent on the presence of either Mg2+ or Mn2+. Overexpression of the full-length AtPSKR1 receptor in Arabidopsis leaf protoplasts raised the endogenous basal cGMP levels over 20-fold, indicating that the receptor has GC activity in vivo. In addition, PSK-alpha itself, but not the non-sulfated backbone, induces rapid increases in cGMP levels in protoplasts. Together these results indicate that the PSKR1 contains dual GC and kinase catalytic activities that operate in vivo and that this receptor constitutes a novel class of enzymes with overlapping catalytic domains.	[Kwezi, Lusisizwe; Wheeler, Janet I.; Iacuone, Sylvana; Thompson, Philip E.; Irving, Helen R.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Kwezi, Lusisizwe; Ruzvidzo, Oziniel; Govender, Kershini; Gehring, Chris] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa; [Gehring, Chris] King Abdullah Univ Sci & Technol, Div Chem Life Sci & Engn, Thuwal 239556900, Saudi Arabia	Monash University; University of the Western Cape; King Abdullah University of Science & Technology	Irving, HR (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville Campus,381 Royal Parade, Parkville, Vic 3052, Australia.	helen.irving@monash.edu	Irving, Helen/B-4425-2019	Irving, Helen/0000-0002-1514-0909; Thompson, Philip/0000-0002-5910-7625; Gehring, Christoph/0000-0003-4355-4591	Australian Research Council [DP0878194]; National Research Fund South Africa	Australian Research Council(Australian Research Council); National Research Fund South Africa	This work was supported by the Australian Research Council Discovery funding scheme (Project Number DP0878194) and by the National Research Fund South Africa.	Aparicio JG, 1996, J BIOL CHEM, V271, P27083, DOI 10.1074/jbc.271.43.27083; ASSMANN SM, 1995, PLANT PHYSIOL, V108, P885, DOI 10.1104/pp.108.3.885; Biswas KH, 2009, J MOL EVOL, V68, P587, DOI 10.1007/s00239-009-9242-5; BOWLER C, 1994, CELL, V77, P73, DOI 10.1016/0092-8674(94)90236-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Cousson A, 1998, PLANTA, V206, P308, DOI 10.1007/s004250050405; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Donaldson L, 2004, FEBS LETT, V569, P317, DOI 10.1016/j.febslet.2004.06.016; Hanai H, 2000, FEBS LETT, V470, P97, DOI 10.1016/S0014-5793(00)01299-0; Kaplan B, 2007, FEBS LETT, V581, P2237, DOI 10.1016/j.febslet.2007.02.017; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kitagawa K, 2001, J ORG CHEM, V66, P1, DOI 10.1021/jo000895y; Kutschmar A, 2009, NEW PHYTOL, V181, P820, DOI 10.1111/j.1469-8137.2008.02710.x; Kwezi L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000449; Leng Q, 1999, PLANT PHYSIOL, V121, P753, DOI 10.1104/pp.121.3.753; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Linder JU, 2002, MOL CELL BIOCHEM, V230, P149, DOI 10.1023/A:1014200325422; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Lorbiecke R, 2002, PLANT SCI, V163, P321, DOI 10.1016/S0168-9452(02)00101-2; Ludidi N, 2003, J BIOL CHEM, V278, P6490, DOI 10.1074/jbc.M210983200; Maathuis FJM, 2006, PLANT J, V45, P700, DOI 10.1111/j.1365-313X.2005.02616.x; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsubayashi Y, 1996, BIOCHEM BIOPH RES CO, V225, P209, DOI 10.1006/bbrc.1996.1155; Matsubayashi Y, 2006, PLANT PHYSIOL, V142, P45, DOI 10.1104/pp.106.081109; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; Meier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008904; Motose H, 2009, PLANT PHYSIOL, V150, P437, DOI 10.1104/pp.109.135954; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Newton RP, 2004, PHYTOCHEMISTRY, V65, P2423, DOI 10.1016/j.phytochem.2004.07.026; NEWTON RP, 1984, PHYTOCHEMISTRY, V23, P1367, DOI 10.1016/S0031-9422(00)80467-7; Newton RP, 1999, NEW PHYTOL, V143, P427, DOI 10.1046/j.1469-8137.1999.00478.x; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751; Penson SP, 1996, PLANT CELL, V8, P2325, DOI 10.1105/tpc.8.12.2325; Pharmawati M, 1998, PLANT SCI, V137, P107, DOI 10.1016/S0168-9452(98)00135-6; Pharmawati M, 2001, PLANT PHYSIOL BIOCH, V39, P385, DOI 10.1016/S0981-9428(01)01252-9; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; Shults MD, 2003, J AM CHEM SOC, V125, P14248, DOI 10.1021/ja0380502; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Szmidt-Jaworska A, 2008, J PLANT PHYSIOL, V165, P858, DOI 10.1016/j.jplph.2007.02.010; Szmidt-Jaworska A, 2009, J PLANT GROWTH REGUL, V28, P367, DOI 10.1007/s00344-009-9105-8; THORPE DS, 1990, J BIOL CHEM, V265, P14717; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Volotovski ID, 1998, PLANT PHYSIOL, V117, P1023, DOI 10.1104/pp.117.3.1023; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang YH, 2007, FUNCT PLANT BIOL, V34, P645, DOI 10.1071/FP06316; Wheeler JI, 2010, FUNCT PLANT BIOL, V37, P382, DOI 10.1071/FP09242; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Yang HP, 1999, P NATL ACAD SCI USA, V96, P13560, DOI 10.1073/pnas.96.23.13560; Yang HP, 2001, PLANT PHYSIOL, V127, P842, DOI 10.1104/pp.010452; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	58	78	85	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22580	22588		10.1074/jbc.M110.168823	http://dx.doi.org/10.1074/jbc.M110.168823			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21504901	hybrid, Green Published			2022-12-25	WOS:000291719900065
J	Miranda-Laferte, E; Gonzalez-Gutierrez, G; Schmidt, S; Zeug, A; Ponimaskin, EG; Neely, A; Hidalgo, P				Miranda-Laferte, Erick; Gonzalez-Gutierrez, Giovanni; Schmidt, Silke; Zeug, Andre; Ponimaskin, Evgeni G.; Neely, Alan; Hidalgo, Patricia			Homodimerization of the Src Homology 3 Domain of the Calcium Channel beta-Subunit Drives Dynamin-dependent Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CA2+ CHANNELS; GUANYLATE KINASE DOMAIN; TUMOR-SUPPRESSOR; SYNAPTIC PROTEIN; CONSERVED MOTIF; SH3 DOMAINS; MEMBRANE; COMPLEX; PALMITOYLATION; LOCALIZATION	Voltage-dependent calcium channels constitute the main entry pathway for calcium into excitable cells. They are heteromultimers formed by an alpha(1) pore-forming subunit (Ca-V alpha(1)) and accessory subunits. To achieve a precise coordination of calcium signals, the expression and activity of these channels is tightly controlled. The accessory beta-subunit (Ca-V beta), a membrane associated guanylate kinase containing one guanylate kinase (beta-GK) and one Src homology 3 (beta-SH3) domain, has antagonistic effects on calcium currents by regulating different aspects of channel function. Although beta-GK binds to a conserved site within the alpha(1)-pore-forming subunit and facilitates channel opening, beta-SH3 binds to dynamin and promotes endocytosis. Here, we investigated the molecular switch underlying the functional duality of this modular protein. We show that beta-SH3 homodimerizes through a single disulfide bond. Substitution of the only cysteine residue abolishes dimerization and impairs internalization of L-type Ca(V)1.2 channels expressed in Xenopus oocytes while preserving dynamin binding. Covalent linkage of the beta-SH3 dimerization-deficient mutant yields a concatamer that binds to dynamin and restores endocytosis. Moreover, using FRET analysis, we show in living cells that Ca-V beta form oligomers and that this interaction is reduced by Ca-V alpha(1). Association of Ca-V beta with a polypeptide encoding the binding motif in Ca-V alpha(1) inhibited endocytosis. Together, these findings reveal that beta-SH3 dimerization is crucial for endocytosis and suggest that channel activation and internalization are two mutually exclusive functions of Ca-V beta . We propose that a change in the oligomeric state of Ca-V beta is the functional switch between channel activator and channel internalizer.	[Miranda-Laferte, Erick; Gonzalez-Gutierrez, Giovanni; Schmidt, Silke; Zeug, Andre; Ponimaskin, Evgeni G.; Hidalgo, Patricia] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Neely, Alan] Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2349400, Chile	Hannover Medical School; Universidad de Valparaiso	Hidalgo, P (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	hidalgo.patricia@mh-hannover.de	Zeug, Andre/X-3208-2019; Hidalgo, Patricia/I-7506-2013	Zeug, Andre/0000-0001-9858-5841; Hidalgo, Patricia/0000-0002-4162-6590; Gonzalez-Gutierrez, Giovanni/0000-0002-1044-943X; Ponimaskin, evgeni/0000-0002-4570-5130; Neely, Alan/0000-0002-6007-2159	Deutsche Forschungsgemeinschaft [DFG Hi 800/3-1, 4-1]; Red de Anillo de Ciencia y Tecnologia [RED-24]; Deutsche Forschungsgemeinschaft-Comision Nacional de Investigacion Cientifica y Tecnologica	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Red de Anillo de Ciencia y Tecnologia(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Deutsche Forschungsgemeinschaft-Comision Nacional de Investigacion Cientifica y Tecnologica	This work was supported by grants from the Deutsche Forschungsgemeinschaft Grants DFG Hi 800/3-1 and 4-1 (to P. H.), Red de Anillo de Ciencia y Tecnologia Grant RED-24 (to A. N.), and the German-Chilean Scientific Cooperation Program Deutsche Forschungsgemeinschaft-Comision Nacional de Investigacion Cientifica y Tecnologica 2010 (to P. H. and A. N.).	Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; Bezanilla F, 1998, METHOD ENZYMOL, V293, P331; Brenman JE, 1998, J NEUROSCI, V18, P8805; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1998, J BIOL CHEM, V273, P23590, DOI 10.1074/jbc.273.36.23590; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Cingolani E, 2007, CIRC RES, V101, P166, DOI 10.1161/CIRCRESAHA.107.155721; Dalton S, 2005, J PHYSIOL-LONDON, V567, P757, DOI 10.1113/jphysiol.2005.093195; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dzhura I, 2003, BIOPHYS J, V85, P274, DOI 10.1016/S0006-3495(03)74473-7; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Horiuchi M, 2001, P NATL ACAD SCI USA, V98, P1448, DOI 10.1073/pnas.041329498; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kobe F, 2008, BBA-MOL CELL RES, V1783, P1503, DOI 10.1016/j.bbamcr.2008.02.021; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; Lao QZ, 2010, FASEB J, V24, P5013, DOI 10.1096/fj.10-165381; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Mayer BJ, 2001, J CELL SCI, V114, P1253; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; Neely A, 2004, J BIOL CHEM, V279, P21689, DOI 10.1074/jbc.M312675200; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Noceti F, 1996, J GEN PHYSIOL, V108, P143, DOI 10.1085/jgp.108.3.143; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Paarmann I, 2002, J BIOL CHEM, V277, P40832, DOI 10.1074/jbc.M205618200; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Reese ML, 2007, NAT STRUCT MOL BIOL, V14, P155, DOI 10.1038/nsmb1195; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Takahashi SX, 2005, J GEN PHYSIOL, V126, P365, DOI 10.1085/jgp.200509354; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Woehler A, 2009, GLYCOCONJUGATE J, V26, P749, DOI 10.1007/s10719-008-9187-8; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203	65	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22203	22210		10.1074/jbc.M110.201871	http://dx.doi.org/10.1074/jbc.M110.201871			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21502319	hybrid, Green Published			2022-12-25	WOS:000291719900027
J	Nonaka, M; Ma, BY; Imaeda, H; Kawabe, K; Kawasaki, N; Hodohara, K; Kawasaki, N; Andoh, A; Fujiyama, Y; Kawasaki, T				Nonaka, Motohiro; Ma, Bruce Yong; Imaeda, Hirotsugu; Kawabe, Keiko; Kawasaki, Nobuko; Hodohara, Keiko; Kawasaki, Nana; Andoh, Akira; Fujiyama, Yoshihide; Kawasaki, Toshisuke			Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Recognizes a Novel Ligand, Mac-2-binding Protein, Characteristically Expressed on Human Colorectal Carcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOEMBRYONIC ANTIGEN; COLON-CANCER; LINKED OLIGOSACCHARIDES; IMMUNE-RESPONSES; APOPTOSIS; CEACAM1; INNATE; CEA; DIFFERENTIATION; GLYCOSYLATION	Dendritic cell (DC)-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) is a type II transmembrane C-type lectin expressed on DCs such as myeloid DCs and monocyte-derived DCs (MoDCs). Recently, we have reported that DC-SIGN interacts with carcinoembryonic antigen (CEA) expressed on colorectal carcinoma cells. CEA is one of the most widely used tumor markers for gastrointestinal cancers such as colorectal cancer. On the other hand, other groups have reported that the level of Mac-2-binding protein (Mac-2BP) increases in patients with pancreatic, breast, and lung cancers, virus infections such as human immunodeficiency virus and hepatitis C virus, and autoimmune diseases. Here, we first identified Mac-2BP expressed on several colorectal carcinoma cell lines as a novel DC-SIGN ligand through affinity chromatography and mass spectrometry. Interestingly, we found that DC-SIGN selectively recognizes Mac-2BP derived from some colorectal carcinomas but not from the other ones. Furthermore, we found that the alpha 1-3,4-fucose moieties of Le glycans expressed on DC-SIGN-binding Mac-2BP were important for recognition. DC-SIGN-dependent cellular interactions between immature MoDCs and colorectal carcinoma cells significantly inhibited MoDC functional maturation, suggesting that Mac-2BP may provide a tolerogenic microenvironment for colorectal carcinoma cells through DC-SIGN-dependent recognition. Importantly, Mac-2BP was detected as a predominant DC-SIGN	[Nonaka, Motohiro; Ma, Bruce Yong; Kawabe, Keiko; Kawasaki, Nobuko; Kawasaki, Toshisuke] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Shiga 5250058, Japan; [Imaeda, Hirotsugu; Hodohara, Keiko; Fujiyama, Yoshihide] Shiga Univ Med Sci, Grad Sch Med, Dept Med, Shiga 5202192, Japan; [Andoh, Akira] Shiga Univ Med Sci, Grad Sch Med, Div Mucosal Immunol, Shiga 5202192, Japan; [Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan; [Ma, Bruce Yong] Muroran Inst Technol, Dept Comp Sci & Syst Engn, Muroran, Hokkaido 0508585, Japan; [Ma, Bruce Yong] Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Jiangsu 213164, Peoples R China	Ritsumeikan University; Shiga University of Medical Science; Shiga University of Medical Science; National Institute of Health Sciences - Japan; Muroran Institute of Technology; Changzhou University	Ma, BY (corresponding author), Ritsumeikan Univ, Res Ctr Glycobiotechnol, Shiga 5250058, Japan.	bruceyongma@gmail.com; tkawasak@fc.ritsumei.ac.jp	Andoh, Akira/AAB-9303-2022; Imaeda, Hirotsugu/B-9907-2016	Imaeda, Hirotsugu/0000-0002-5516-8527	JSPS [20370052, 20890255, 21590543, 22-9530, 17005]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Foundation for Applied Enzymology (Osaka, Japan)	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology (Osaka, Japan)	This work was supported by Grants-in-aid for Scientific Research B 20370052 (to T. K.) and C 21590543 (to B. Y. M.), for Young Scientists Start-up 20890255 (to M. N.), and for Japan Society for the Promotion of Science (JSPS) Fellows 22-9530 (to M. N.) from JSPS, the Ministry of Education, Culture, Sports, Science, and Technology of Japan, JSPS Core-to-Core Program Strategic Research Networks (17005) from JSPS, and Research Proposal Grants from Japan Foundation for Applied Enzymology (Osaka, Japan; to B. Y. M.).	AHNEN DJ, 1982, CANCER, V49, P2077, DOI 10.1002/1097-0142(19820515)49:10<2077::AID-CNCR2820491020>3.0.CO;2-X; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Duffy MJ, 2001, CLIN CHEM, V47, P624; FERNANDES B, 1991, CANCER RES, V51, P718; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; HAMADA Y, 1985, CANCER, V55, P136, DOI 10.1002/1097-0142(19850101)55:1<136::AID-CNCR2820550121>3.0.CO;2-P; Kiertscher SM, 2000, J IMMUNOL, V164, P1269, DOI 10.4049/jimmunol.164.3.1269; LAFERTE S, 1992, BIOCHEM J, V283, P193, DOI 10.1042/bj2830193; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; MIDIRI G, 1985, CANCER, V55, P2624, DOI 10.1002/1097-0142(19850601)55:11<2624::AID-CNCR2820551115>3.0.CO;2-#; Nittka S, 2008, ONCOGENE, V27, P3721, DOI 10.1038/sj.onc.1211033; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Nonaka M, 2008, J IMMUNOL, V180, P3347, DOI 10.4049/jimmunol.180.5.3347; Seelentag WKF, 1998, CANCER RES, V58, P5559; SHI ZR, 1983, CANCER RES, V43, P4045; Shively JE, 2004, ONCOGENE, V23, P9303, DOI 10.1038/sj.onc.1208266; Ulmer TA, 2006, J CELL BIOCHEM, V98, P1351, DOI 10.1002/jcb.20784; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006	33	32	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22403	22413		10.1074/jbc.M110.215301	http://dx.doi.org/10.1074/jbc.M110.215301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515679	Green Published, hybrid			2022-12-25	WOS:000291719900050
J	Shaughnessy, J; Ram, S; Bhattacharjee, A; Pedrosa, J; Tran, C; Horvath, G; Monks, B; Visintin, A; Jokiranta, TS; Rice, PA				Shaughnessy, Jutamas; Ram, Sanjay; Bhattacharjee, Arnab; Pedrosa, Joana; Tran, Connie; Horvath, Gabor; Monks, Brian; Visintin, Alberto; Jokiranta, T. Sakari; Rice, Peter A.			Molecular Characterization of the Interaction between Sialylated Neisseria gonorrhoeae and Factor H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; HEMOLYTIC-UREMIC SYNDROME; NORMAL HUMAN-SERA; BINDING-SITE; SIALIC-ACID; AMPLIFICATION CONVERTASE; 3-DIMENSIONAL STRUCTURE; BACTERICIDAL ACTIVITY; ENDOTHELIAL-CELLS; PROTEIN BETA-1H	Human factor H (HufH), a key inhibitor of the alternative pathway of complement, binds to Neisseria gonorrhoeae and constitutes an important mechanism of human-specific complement evasion. The C-terminal domain 20 of HufH contains the binding site for sialylated gonococci. We exploited differences in amino acid sequences between human and non-binding chimpanzee fH domain 20 to create cross-species mutations to define amino acids important for binding to sialylated gonococci. We used fH/Fc fusion constructs that contained contiguous fH domains 18-20 fused to Fc fragments of murine IgG2a. The Fc region was used both as a tag for detection of each fusion molecule on the bacterial surface and as an indicator for complement-dependent killing. Arg-1203 was critical for binding to both porin (Por) B.1A and PorB.1B strains. Modeling of the R1203N human-to-chimpanzee mutation using the crystal structure of HufH19-20 as a template showed a loss of positive charge that protrudes at the C terminus of domain 20. We tested the functional importance of Arg-1203 by incubating sialylated gonococci with normal human serum, in the presence of wildtype HufH18-20/Fc or its R1203A mutant. Gonococci bound and were killed by wild-type HufH18-20/Fc but not by the R1203A mutant. A recombinant fH/Fc molecule that contained chimpanzee domain 20, humanized only at amino acid 1203 (N1203R) also bound to sialylated gonococci and restored killing. These findings provide further insights into the species specificity of gonococcal infections and proof-of-concept of a novel therapeutic approach against gonorrhea, a disease rapidly becoming resistant to conventional antibiotics.	[Shaughnessy, Jutamas; Ram, Sanjay; Pedrosa, Joana; Tran, Connie; Horvath, Gabor; Monks, Brian; Rice, Peter A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Bhattacharjee, Arnab; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Visintin, Alberto] Pfizer Inc, Ctr Therapeut Innovat, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Helsinki; Pfizer	Shaughnessy, J (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Lazare Res Bldg,Rm 370T,364 Plantat St, Worcester, MA 01605 USA.	jutamas.shaughnessy@umassmed.edu	Jokiranta, T. Sakari/F-1906-2011; Monks, Brian/B-8362-2015; Horvath, Gabor L/J-3917-2014	Monks, Brian/0000-0003-4008-3093; Horvath, Gabor L/0000-0003-0309-595X; Bhattacharjee, Arnab/0000-0002-9613-7911; Shaughnessy, Jutamas/0000-0003-0832-9954	National Institutes of Health [AI32725, AI054544, AI084048, AI069084]; Academy of Finland [201506, 202529]; Sigrid Juselius Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032725, R37AI032725, R01AI054544, U19AI084048, R56AI032725, R21AI069084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI32725, AI054544, AI084048, and AI069084. This work was also supported by the Academy of Finland (Projects 201506 and 202529) and The Sigrid Juselius Foundation.	Agarwal S, 2010, J IMMUNOL, V185, P4344, DOI 10.4049/jimmunol.0904191; APICELLA MA, 1990, J INFECT DIS, V162, P506, DOI 10.1093/infdis/162.2.506; Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Bhattacharjee A, 2008, MOL IMMUNOL, V45, P4125, DOI 10.1016/j.molimm.2008.08.090; BLAKE MS, 1986, BACTERIAL OUTER MEMB, P377; BRUNHAM RC, 1985, J INFECT DIS, V152, P339, DOI 10.1093/infdis/152.2.339; CANNON JG, 1983, INFECT IMMUN, V40, P816, DOI 10.1128/IAI.40.2.816-819.1983; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; FEARON DT, 1977, P NATL ACAD SCI USA, V74, P1683, DOI 10.1073/pnas.74.4.1683; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; GRIFFISS JM, 1991, J IMMUNOL, V147, P298; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jokiranta TS, 1996, FEBS LETT, V393, P297; KRISTENSEN T, 1986, P NATL ACAD SCI USA, V83, P3963, DOI 10.1073/pnas.83.11.3963; Madico G, 2007, J IMMUNOL, V178, P4489, DOI 10.4049/jimmunol.178.7.4489; MANDRELL RE, 1988, J EXP MED, V168, P107, DOI 10.1084/jem.168.1.107; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; MCQUILLEN DP, 1994, METHOD ENZYMOL, V236, P137; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; NAIRN CA, 1988, J GEN MICROBIOL, V134, P3295; Ngampasutadol J, 2008, J IMMUNOL, V180, P3426, DOI 10.4049/jimmunol.180.5.3426; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; OBRIEN JP, 1983, MEDICINE, V62, P395, DOI 10.1097/00005792-198311000-00005; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PARSONS NJ, 1988, MICROB PATHOGENESIS, V5, P303, DOI 10.1016/0882-4010(88)90103-9; PRICE RJ, 1979, FERTIL STERIL, V32, P61; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; Ray TD, 2011, J IMMUNOL, V186, P4881, DOI 10.4049/jimmunol.1003623; RICE PA, 1980, J IMMUNOL, V124, P2105; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; SCHNEIDER H, 1982, J GEN MICROBIOL, V128, P13; SCHOOLNIK GK, 1979, J IMMUNOL, V122, P1771; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Swanson J, 1997, J BACTERIOL, V179, P3541, DOI 10.1128/jb.179.11.3541-3548.1997; Tapsall John W, 2009, Expert Rev Anti Infect Ther, V7, P821, DOI 10.1586/eri.09.63; Vogel U, 1997, INFECT IMMUN, V65, P4022, DOI 10.1128/IAI.65.10.4022-4029.1997; WARD ME, 1970, NATURE, V227, P382, DOI 10.1038/227382a0; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Yamasaki R, 2005, J BIOCHEM, V137, P487, DOI 10.1093/jb/mvi061	53	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22235	22242		10.1074/jbc.M111.225516	http://dx.doi.org/10.1074/jbc.M111.225516			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531728	Green Published, hybrid			2022-12-25	WOS:000291719900031
J	Yamamoto, R; Akazawa, H; Fujihara, H; Ozasa, Y; Yasuda, N; Ito, K; Kudo, Y; Qin, YJ; Ueta, Y; Komuro, I				Yamamoto, Rie; Akazawa, Hiroshi; Fujihara, Hiroaki; Ozasa, Yukako; Yasuda, Noritaka; Ito, Kaoru; Kudo, Yoko; Qin, Yingjie; Ueta, Yoichi; Komuro, Issei			Angiotensin II Type 1 Receptor Signaling Regulates Feeding Behavior through Anorexigenic Corticotropin-releasing Hormone in Hypothalamus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASED ENERGY-EXPENDITURE; INDUCED WEIGHT-GAIN; MICE LACKING; RAT HYPOTHALAMUS; DEFICIENT MICE; 1A RECEPTOR; FOOD-INTAKE; EXPRESSION; LEPTIN; OBESITY	The activation of renin-angiotensin system contributes to the development of metabolic syndrome and diabetes as well as hypertension. However, it remains undetermined how renin-angiotensin system is implicated in feeding behavior. Here, we show that angiotensin II type 1 (AT(1)) receptor signaling regulates the hypothalamic neurocircuit that is involved in the control of food intake. Compared with wild-type Agtr1a(+/+) mice, AT(1) receptor knock-out (Agtr1a(-/-)) mice were hyperphagic and obese with increased adiposity on an ad libitum diet, whereas Agtr1a(-/-) mice were lean with decreased adiposity on a pair-fed diet. In the hypothalamus, mRNA levels of anorexigenic neuropeptide corticotropin-releasing hormone (Crh) were lower in Agtr1a(-/-) mice than in Agtr1a(+/+) mice both on an ad libitum and pair-fed diet. Furthermore, intracerebroventricular administration of CRH suppressed food intake both in Agtr1a(+/+) and Agtr1a(-/-) mice. In addition, the Crh gene promoter was significantly transactivated via the cAMP-responsive element by angiotensin II stimulation. These results thus demonstrate that central AT(1) receptor signaling plays a homeostatic role in the regulation of food intake by maintaining gene expression of Crh in hypothalamus and suggest a therapeutic potential of central AT(1) receptor blockade in feeding disorders.	[Akazawa, Hiroshi; Komuro, Issei] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yamamoto, Rie; Ozasa, Yukako; Yasuda, Noritaka; Ito, Kaoru; Kudo, Yoko; Qin, Yingjie] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba 2608670, Japan; [Fujihara, Hiroaki; Ueta, Yoichi] Univ Occupat & Environm Hlth, Sch Med, Dept Physiol, Fukuoka 8078555, Japan	Osaka University; Chiba University; University of Occupational & Environmental Health - Japan	Komuro, I (corresponding author), Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	komuro-tky@umin.ac.jp	Ito, Kaoru/AAZ-3440-2021	Akazawa, Hiroshi/0000-0002-3574-9607	Japan Society for the Promotion of Science [KAKENHI 20390218, 21229010]; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Ichiro Kanehara Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Japan Association for the Advancement of Medical Equipment; Grants-in-Aid for Scientific Research [23790280, 23390213] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Ichiro Kanehara Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Japan Association for the Advancement of Medical Equipment; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from Japan Society for the Promotion of Science (KAKENHI 20390218 and 21229010); Health and Labor Sciences Research Grants (to I.K. and H.A.) and grants from Takeda Science Foundation, Astellas Foundation for Research on Metabolic Disorders, The Uehara Memorial Foundation, The Ichiro Kanehara Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Suzuken Memorial Foundation (to H.A.); and a Research Fellowship from the Japan Association for the Advancement of Medical Equipment (to R.Y.).	Bailer UF, 2003, CNS NEUROL DISORD-DR, V2, P53, DOI 10.2174/1568007033338689; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; de Gasparo M, 2000, PHARMACOL REV, V52, P415; GASC JM, 1994, HYPERTENSION, V24, P531, DOI 10.1161/01.HYP.24.5.531; Hashimoto H, 2007, CLIN CANCER RES, V13, P292, DOI 10.1158/1078-0432.CCR-06-1487; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heinrichs SC, 1999, NEUROPEPTIDES, V33, P350, DOI 10.1054/npep.1999.0047; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jacobson L, 1999, ENDOCRINOLOGY, V140, P310, DOI 10.1210/en.140.1.310; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; Lenkei Z, 1997, FRONT NEUROENDOCRIN, V18, P383, DOI 10.1006/frne.1997.0155; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Masaki T, 2003, ENDOCRINOLOGY, V144, P3547, DOI 10.1210/en.2003-0301; Massiera F, 2001, ENDOCRINOLOGY, V142, P5220, DOI 10.1210/en.142.12.5220; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Oliverio MI, 1998, P NATL ACAD SCI USA, V95, P15496, DOI 10.1073/pnas.95.26.15496; Prasad A, 2004, CIRCULATION, V110, P1507, DOI 10.1161/01.CIR.0000141736.76561.78; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Sharma AM, 2008, NAT CLIN PRACT CARD, V5, pS3, DOI 10.1038/ncpcardio0854; Sommer WH, 2008, J MOL MED, V86, P723, DOI 10.1007/s00109-008-0333-3; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Takahashi N, 2007, CELL METAB, V6, P506, DOI 10.1016/j.cmet.2007.10.011; Tsuchida S, 1998, J CLIN INVEST, V101, P755, DOI 10.1172/JCI1899; Uehara Y, 1998, DIABETES, V47, P890, DOI 10.2337/diabetes.47.6.890; Yamamori E, 2004, J MOL ENDOCRINOL, V33, P639, DOI 10.1677/jme.1.01415; Yamamori E, 2007, MOL CELL ENDOCRINOL, V264, P142, DOI 10.1016/j.mce.2006.11.001; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	32	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21458	21465		10.1074/jbc.M110.192260	http://dx.doi.org/10.1074/jbc.M110.192260			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525005	Green Published, hybrid			2022-12-25	WOS:000291464700044
J	Lin, JS; Wilson, MA				Lin, Jiusheng; Wilson, Mark A.			Escherichia coli Thioredoxin-like Protein YbbN Contains an Atypical Tetratricopeptide Repeat Motif and Is a Negative Regulator of GroEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CHAPERONE; RESOLUTION; COMPLEXES; RESIDUES; TOOL	Many proteins contain a thioredoxin (Trx)-like domain fused with one or more partner domains that diversify protein function by the modular construction of new molecules. The Escherichia coli protein YbbN is a Trx-like protein that contains a C-terminal domain with low homology to tetratricopeptide repeat motifs. YbbN has been proposed to act as a chaperone or co-chaperone that aids in heat stress response and DNA synthesis. We report the crystal structure of YbbN, which is an elongated molecule with a mobile Trx domain and four atypical tetratricopeptide repeat motifs. The Trx domain lacks a canonical CXXC active site architecture and is not a functional oxidoreductase. A variety of proteins in E. coli interact with YbbN, including multiple ribosomal protein subunits and a strong interaction with GroEL. YbbN acts as a mild inhibitor of GroESL chaperonin function and ATPase activity, suggesting that it is a negative regulator of the GroESL system. Combined with previous observations that YbbN enhances the DnaK-DnaJ-GrpE chaperone system, we propose that YbbN coordinately regulates the activities of these two prokaryotic chaperones, thereby helping to direct client protein traffic initially to DnaK. Therefore, YbbN may play a role in integrating the activities of different chaperone pathways in E. coli and related bacteria.	[Wilson, Mark A.] Univ Nebraska, Beadle Ctr N118, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Wilson, MA (corresponding author), Univ Nebraska, Beadle Ctr N118, Dept Biochem, Lincoln, NE 68588 USA.	mwilson13@unl.edu			National Institutes of Health [R01GM092999-01]; National Institutes of Health (NCI) [Y1-CO-1020]; NIGMS [Y1-GM-1104]; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM092999-01 (to M. A. W.).; We thank Dr. Ronald Cerny and the Nebraska Mass Spectrometry Core Facility for mass spectrometry protein identification, Dr. Nandakumar Madayiputhiya and the Redox Biology Center Mass Spectrometry Core facility for assistance with lysine modification studies, Dr. James Bardwell (University of Michigan) for discussion of YbbN chaperone assays, and Drs. Todd Holyoak and Mark Fisher (University of Kansas Medical Center) for discussion of GroESL chaperone activity. GM/CA-CAT has been funded in whole or in part with federal funds from the National Institutes of Health (NCI, Y1-CO-1020; NIGMS, Y1-GM-1104). Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract DE-AC02-06CH11357.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Caldas T, 2006, BIOCHEM BIOPH RES CO, V343, P780, DOI 10.1016/j.bbrc.2006.03.028; Cortajarena AL, 2010, FEBS J, V277, P1058, DOI 10.1111/j.1742-4658.2009.07549.x; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dekker C, 2011, PROTEINS, V79, P1172, DOI 10.1002/prot.22952; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Fomenko DE, 2008, MOL CELLS, V26, P228; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Katayama Hiroo, 2009, Journal of Structural and Functional Genomics, V10, P57, DOI 10.1007/s10969-008-9053-8; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kim SG, 2010, BBA-PROTEINS PROTEOM, V1804, P2213, DOI 10.1016/j.bbapap.2010.09.005; Krachler AM, 2010, PROTEINS, V78, P2131, DOI 10.1002/prot.22726; Kthiri F, 2008, BIOCHEM BIOPH RES CO, V374, P668, DOI 10.1016/j.bbrc.2008.07.080; Lakshminarasimhan M, 2008, BIOCHEMISTRY-US, V47, P1381, DOI 10.1021/bi701189c; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Le HT, 2011, BIOCHEM BIOPH RES CO, V405, P52, DOI 10.1016/j.bbrc.2010.12.122; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Novotny M, 2004, PROTEINS, V54, P260, DOI 10.1002/prot.10553; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Prasad BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012761; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	49	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19459	19469		10.1074/jbc.M111.238741	http://dx.doi.org/10.1074/jbc.M111.238741			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498507	Green Published, hybrid			2022-12-25	WOS:000291027700029
J	Mounier, A; Condemi, S; Manzi, G				Mounier, Aurelien; Condemi, Silvana; Manzi, Giorgio			The Stem Species of Our Species: A Place for the Archaic Human Cranium from Ceprano, Italy	PLOS ONE			English	Article							MIDDLE PLEISTOCENE; PHYLOGENETIC POSITION; HOMO-ERECTUS; RECONSTRUCTION; NEANDERTHALS; CALVARIUM; EVOLUTION; HOMININ	One of the present challenges in the study of human evolution is to recognize the hominin taxon that was ancestral to Homo sapiens. Some researchers regard H. heidelbergensis as the stem species involved in the evolutionary divergence leading to the emergence of H. sapiens in Africa, and to the evolution of the Neandertals in Europe. Nevertheless, the diagnosis and hypodigm of H. heidelbergensis still remain to be clarified. Here we evaluate the morphology of the incomplete cranium (calvarium) known as Ceprano whose age has been recently revised to the mid of the Middle Pleistocene, so as to test whether this specimen may be included in H. heidelbergensis. The analyses were performed according to a phenetic routine including geometric morphometrics and the evaluation of diagnostic discrete traits. The results strongly support the uniqueness of H. heidelbergensis on a wide geographical horizon, including both Eurasia and Africa. In this framework, the Ceprano calvarium - with its peculiar combination of archaic and derived traits - may represent, better than other penecontemporaneous specimens, an appropriate ancestral stock of this species, preceding the appearance of regional autapomorphic features.	[Mounier, Aurelien; Condemi, Silvana] Univ Aix Marseille 2, CNRS, Unite Anthropol Bioculturelle, Etab Francais Sang,UMR 6578, Marseille, France; [Manzi, Giorgio] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Manzi, Giorgio] Ist Italiano Paleontol Umana, Rome, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Sapienza University Rome	Mounier, A (corresponding author), Univ Aix Marseille 2, CNRS, Unite Anthropol Bioculturelle, Etab Francais Sang,UMR 6578, Marseille, France.	giorgio.manzi@uniroma1.it	Condemi, Silvana/ABE-2701-2021	Condemi, Silvana/0000-0002-6516-0879; Manzi, Giorgio/0000-0002-8611-1371; Mounier, Aurelien/0000-0001-9713-7246	Sapienza - University of Rome; Italian Ministry of University and Research (MIUR)	Sapienza - University of Rome; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was partly supported by resources of the Sapienza - University of Rome and co-financed by the Italian Ministry of University and Research (MIUR), including grants for Progetti di Rilevante Interesse Nazionale (PRIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P., 1984, Courier Forschungsinstitut Senckenberg, V69, P167; Ascenzi A, 2000, J HUM EVOL, V39, P443, DOI 10.1006/jhev.2000.0425; ASCENZI A, 1996, J HUM EVOL, V31, P429; AUTON SC, 2003, YEARB PHYS ANTHROPOL, V46, P126; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Braun M., 1998, AM J PHYS ANTHROPOL, VS26, P113; Bruner E, 2005, ANAT REC PART A, V285A, P643, DOI 10.1002/ar.a.20205; Bruner E, 2007, AM J PHYS ANTHROPOL, V132, P355, DOI 10.1002/ajpa.20545; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Clarke RJ, 2000, J HUM EVOL, V39, P433, DOI 10.1006/jhev.2000.0426; Colley W, 1971, MULTIVARIATE DATA AN; Condemi S., 2001, NEANDERTHALIENS CHAI; Condemi S, 1992, HOMMES FOSSILES SACC; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; deCastro JMB, 1997, SCIENCE, V276, P1392; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Mallegni F, 2003, C R PALEVOL, V2, P153, DOI 10.1016/S1631-0683(03)00015-0; Manzi G, 2004, EVOL ANTHROPOL, V13, P11, DOI 10.1002/evan.10127; Manzi G, 2001, P NATL ACAD SCI USA, V98, P10011, DOI 10.1073/pnas.151259998; MANZI G, 2011, INT J EVOL IN PRESS; Manzi G, 2010, J HUM EVOL, V59, P580, DOI 10.1016/j.jhevol.2010.06.010; Marchal Francois, 2003, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V15, P7; MOUNIER A, 2009, THESIS U MEDITERRANN; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Muttoni G, 2009, EARTH PLANET SC LETT, V286, P255, DOI 10.1016/j.epsl.2009.06.032; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Rightmire GP, 1996, J HUM EVOL, V31, P21; ROEBROEKS W, 1994, ANTIQUITY, V68, P489, DOI 10.1017/S0003598X00047001; Rosas A, 1998, GEOBIOS-LYON, V31, P687, DOI 10.1016/S0016-6995(98)80055-7; Schoetensack O., 1908, LINKS, V5; Segre AG, 2009, ANTHROPOLOGIE, V113, P59, DOI 10.1016/j.anthro.2009.01.011; Stringer C.B., 1984, Courier Forschungsinstitut Senckenberg, V69, P131; Vandermeersch B., 1981, HOMMES QAFZEH ISRAEL; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; Weidenreich F., 1943, Palaeontologia Sinica, VD 10, P1; Wilks SS, 1962, MATH STAT; Wolpoff MH, 2001, SCIENCE, V291, P293, DOI 10.1126/science.291.5502.293; Wood Bernard, 1994, Courier Forschungsinstitut Senckenberg, V171, P159; WU R, 1988, ACTA ANTHROPOL SINIC, V7, P101	44	35	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18821	10.1371/journal.pone.0018821	http://dx.doi.org/10.1371/journal.pone.0018821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533096	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400028
J	Altomare, DA; Menges, CW; Xu, JF; Pei, JM; Zhang, LL; Tadevosyan, A; Neumann-Domer, E; Liu, ZM; Carbone, M; Chudoba, I; Klein-Szanto, AJ; Testa, JR				Altomare, Deborah A.; Menges, Craig W.; Xu, Jinfei; Pei, Jianming; Zhang, Lili; Tadevosyan, Ara; Neumann-Domer, Erin; Liu, Zemin; Carbone, Michele; Chudoba, Ilse; Klein-Szanto, Andres J.; Testa, Joseph R.			Losses of Both Products of the Cdkn2a/Arf Locus Contribute to Asbestos-Induced Mesothelioma Development and Cooperate to Accelerate Tumorigenesis	PLOS ONE			English	Article							TUMOR SUPPRESSION; INK4A LOCUS; P16(INK4A)	The CDKN2A/ARF locus encompasses overlapping tumor suppressor genes p16(INK4A) and p14(ARF), which are frequently co-deleted in human malignant mesothelioma (MM). The importance of p16(INK4A) loss in human cancer is well established, but the relative significance of p14(ARF) loss has been debated. The tumor predisposition of mice singly deficient for either Ink4a or Arf, due to targeting of exons 1 alpha or 1 beta, respectively, supports the idea that both play significant and nonredundant roles in suppressing spontaneous tumors. To further test this notion, we exposed Ink4a(+/-) and Arf(+/-) mice to asbestos, the major cause of MM. Asbestos-treated Ink4a(+/-) and Arf(+/-) mice showed increased incidence and shorter latency of MM relative to wild-type littermates. MMs from Ink4a(+/-) mice exhibited biallelic inactivation of Ink4a, loss of Arf or p53 expression and frequent loss of p15(Ink4b). In contrast, MMs from Arf(+/-) mice exhibited loss of Arf expression, but did not require loss of Ink4a or Ink4b. Mice doubly deficient for Ink4a and Arf, due to deletion of Cdkn2a/Arf exon 2, showed accelerated asbestos-induced MM formation relative to mice deficient for Ink4a or Arf alone, and MMs exhibited biallelic loss of both tumor suppressor genes. The tumor suppressor function of Arf in MM was p53-independent, since MMs with loss of Arf retained functional p53. Collectively, these in vivo data indicate that both CDKN2A/ARF gene products suppress asbestos carcinogenicity. Furthermore, while inactivation of Arf appears to be crucial for MM pathogenesis, the inactivation of both p16(Ink4a) and p19(Arf) cooperate to accelerate asbestos-induced tumorigenesis.	[Altomare, Deborah A.; Menges, Craig W.; Xu, Jinfei; Pei, Jianming; Zhang, Lili; Tadevosyan, Ara; Neumann-Domer, Erin; Liu, Zemin; Klein-Szanto, Andres J.; Testa, Joseph R.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Carbone, Michele] Univ Hawaii, Canc Res Ctr Hawaii, Thorac Oncol Program, Honolulu, HI 96813 USA; [Chudoba, Ilse] MetaSystems, Altlussheim, Germany	Fox Chase Cancer Center; Cancer Research Center of Hawaii; University of Hawaii System	Altomare, DA (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	joseph.testa@fccc.edu			National Cancer Institute [P01CA114047, CA06927]; Commonwealth of Pennsylvania (Fox Chase Cancer Center) [CA009035]; International Association of Heat and Frost Insulators Allied Workers; NATIONAL CANCER INSTITUTE [P01CA114047, P30CA006927, T32CA009035] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth of Pennsylvania (Fox Chase Cancer Center); International Association of Heat and Frost Insulators Allied Workers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the National Cancer Institute (P01CA114047 to J.R.T., M.C., CA06927 to J.R.T., A.J.K.-S.), and CA009035 (C.W.M.), by the Commonwealth of Pennsylvania (Fox Chase Cancer Center), and by the Local No. 14 Mesothelioma Fund of the International Association of Heat and Frost Insulators & Allied Workers (J.R.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; Altomare DA, 2009, P NATL ACAD SCI USA, V106, P3420, DOI 10.1073/pnas.0808816106; Fleury-Feith J, 2003, ONCOGENE, V22, P3799, DOI 10.1038/sj.onc.1206593; Heintz NH, 2010, AM J RESP CELL MOL, V42, P133, DOI 10.1165/rcmb.2009-0206TR; Hopkins-Donaldson S, 2006, NEOPLASIA, V8, P551, DOI 10.1593/neo.06148; Jongsma J, 2008, CANCER CELL, V13, P261, DOI 10.1016/j.ccr.2008.01.030; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; TESTA JR, 1994, CANCER RES, V54, P2778	13	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18828	10.1371/journal.pone.0018828	http://dx.doi.org/10.1371/journal.pone.0018828			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526190	Green Published, gold			2022-12-25	WOS:000289671100026
J	Mallett, CL; Foster, PJ				Mallett, Christiane L.; Foster, Paula J.			Optimization of the Balanced Steady State Free Precession (bSSFP) Pulse Sequence for Magnetic Resonance Imaging of the Mouse Prostate at 3T	PLOS ONE			English	Article							GREEN TEA POLYPHENOLS; IN-VIVO; TRAMP MICE; TRANSGENIC ADENOCARCINOMA; CANCER CELLS; 1.5 T; MODEL; CARCINOGENESIS; TUMORS; SSFP	Introduction: MRI can be used to non-invasively monitor tumour growth and response to treatment in mouse models of prostate cancer, particularly for longitudinal studies of orthotopically-implanted models. We have optimized the balanced steady-state free precession (bSSFP) pulse sequence for mouse prostate imaging. Methods: Phase cycling, excitations, flip angle and receiver bandwidth parameters were optimized for signal to noise ratio and contrast to noise ratio of the prostate. The optimized bSSFP sequence was compared to T1- and T2-weighted spin echo sequences. Results: SNR and CNR increased with flip angle. As bandwidth increased, SNR, CNR and artifacts such as chemical shift decreased. The final optimized sequence was 4 PC, 2 NEX, FA 50 degrees, BW +/- 662.5 kHz and took 14-26 minutes with 200 mm isotropic resolution. The SNR efficiency of the bSSFP images was higher than for T1WSE and T2WSE. CNR was highest for T1WSE, followed closely by bSSFP, with the T2WSE having the lowest CNR. With the bSSFP images the whole body and organs of interest including renal, iliac, inguinal and popliteal lymph nodes were visible. Conclusion: We were able to obtain fast, high-resolution, high CNR images of the healthy mouse prostate with an optimized bSSFP sequence.	[Mallett, Christiane L.; Foster, Paula J.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Mallett, Christiane L.; Foster, Paula J.] Robarts Res Inst, Imaging Res Labs, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Mallett, CL (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.	cmall@imaging.robarts.ca	Foster, Paula/M-2201-2013	Foster, Paula/0000-0002-4868-3395	Ontario Institute for Cancer Research; Canadian Institutes of Health Research	Ontario Institute for Cancer Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Ontario Institute for Cancer Research 1 mm Challenge (http://www.oicr.on.ca/Research/programs/millimetre/overview.htm). CLM is supported by a Doctoral Research Scholarship from the Canadian Institutes of Health Research. (www.cihr.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2009, CLIN CANCER RES, V15, P1947, DOI 10.1158/1078-0432.CCR-08-2332; Bangerter NK, 2004, MAGN RESON MED, V51, P1038, DOI 10.1002/mrm.20052; Bastide C, 2002, PROSTATE CANCER P D, V5, P311, DOI 10.1038/sj.pcan.4500606; Bernas LM, 2010, MAGN RESON MED, V64, P23, DOI 10.1002/mrm.22210; Canadian Cancer Society's Steering Committee, 2010, CAN CANC STAT 2010; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Deeb D, 2009, PROSTATE, V69, P851, DOI 10.1002/pros.20937; Degrassi A, 2007, PROSTATE, V67, P396, DOI 10.1002/pros.20511; Eng MH, 1999, UROLOGY, V54, P1112, DOI 10.1016/S0090-4295(99)00297-6; Foster-Gareau P, 2003, MAGN RESON MED, V49, P968, DOI 10.1002/mrm.10417; Fricke ST, 2006, PROSTATE, V66, P708, DOI 10.1002/pros.20392; Gonzalez-Lara LE, 2009, J NEUROTRAUM, V26, P753, DOI 10.1089/neu.2008.0704; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gupta S, 2001, P NATL ACAD SCI USA, V98, P10350, DOI 10.1073/pnas.171326098; Gupta S, 2004, CANCER RES, V64, P3334, DOI 10.1158/0008-5472.CAN-03-2422; Heyn C, 2006, MAGNET RESON MED, V55, P23, DOI 10.1002/mrm.20747; Heyn C, 2005, MAGN RESON MED, V53, P312, DOI 10.1002/mrm.20356; Hsu CX, 1998, J UROLOGY, V160, P1500, DOI 10.1016/S0022-5347(01)62603-X; Jennbacken K, 2009, PROSTATE, V69, P1164, DOI 10.1002/pros.20965; Jirak D, 2009, MAGN RESON MATER PHY, V22, P257, DOI 10.1007/s10334-009-0172-4; Kiss P, 2009, PROSTATE, V69, P449, DOI 10.1002/pros.20880; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Kumar AP, 2007, CLIN CANCER RES, V13, P2784, DOI 10.1158/1078-0432.CCR-06-2974; Miraux S, 2008, J MAGN RESON IMAGING, V28, P497, DOI 10.1002/jmri.21449; Nastiuk Kent L, 2007, BMC Urol, V7, P12, DOI 10.1186/1471-2490-7-12; Rad A M, 2008, Open Magn Reson Rev, V1, P60, DOI 10.2174/1874769800801010060; Ramadan SS, 2008, MAGN RESON MATER PHY, V21, P251, DOI 10.1007/s10334-008-0118-2; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Song SK, 2002, CANCER RES, V62, P1555; Stadler A, 2007, EUR RADIOL, V17, P1242, DOI 10.1007/s00330-006-0470-4; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Stoyanova R, 2007, INT J RADIAT ONCOL, V68, P1151, DOI 10.1016/j.ijrobp.2007.03.047; Thalmann GN, 2000, PROSTATE, V44, P91; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wolf P, 2008, PROSTATE, V68, P129, DOI 10.1002/pros.20684	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2011	6	4							e18361	10.1371/journal.pone.0018361	http://dx.doi.org/10.1371/journal.pone.0018361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747AP	21494660	Green Published, gold, Green Submitted			2022-12-25	WOS:000289292800010
J	Sun, MM; Abdula, SE; Lee, HJ; Cho, YC; Han, LZ; Koh, HJ; Cho, YG				Sun, Ming-Mao; Abdula, Sailila E.; Lee, Hye-Jung; Cho, Young-Chan; Han, Long-Zhi; Koh, Hee-Jong; Cho, Yong-Gu			Molecular Aspect of Good Eating Quality Formation in Japonica Rice	PLOS ONE			English	Article							ORYZA-SATIVA L.; STARCH BRANCHING ENZYME; SINGLE NUCLEOTIDE POLYMORPHISMS; PHYSICOCHEMICAL PROPERTIES; VISCOSITY CHARACTERISTICS; CARBOHYDRATE-METABOLISM; SYNTHESIZING GENES; SYNTHASE-IIA; ENDOSPERM; EXPRESSION	The composition of amylopectin is the determinant of rice eating quality under certain threshold of protein content and the ratio of amylose and amylopectin. In molecular biology level, the fine structure of amylopectin is determined by relative activities of starch branching enzyme (SBE), granule-bound starch synthase (GBSS), and soluble starch synthase (SSS) in rice grain under the same ADP-Glucose level. But the underlying mechanism of eating quality in molecular biology level remains unclear. This paper reports the differences on major parameters such as SNP and insertion-deletion sites, RNA expressions, and enzyme activities associated with eating quality of japonica varieties. Eight japonica rice varieties with significant differences in various eating quality parameters such as palatability and protein content were used in this experiment. Association analysis between nucleotide polymorphism and eating quality showed that S12 and S13 loci in SBE1, S55 in SSS1, S58 in SSS2A were significantly associated with apparent amylose content, alkali digestion value, setback viscosity, consistency viscosity, pasting temperature, which explained most of the variation in apparent amylose content, setback viscosity, and consistency viscosity; and explained almost all variations in alkali digestion value and pasting temperature. Thirty-five SNPs and insertion-deletions from SBE1, SBE3, GBSS1, SSS1, and SSS2A differentiated high or intermediate palatability rice varieties from low palatability rice varieties. Correlation analysis between enzyme activities and eating quality properties revealed that SBE25 and SSS15/W15 were positively correlated with palatability, whereas GBSS10 and GBSS15 were negatively correlated. Gene expressions showed that SBE1 and SBE3 expressions in high palatability varieties tended to be higher than middle and low palatability varieties. Collectively, SBE1, SBE3, SSS1, and SSS2A, especially SBE1 and SBE3 could improve eating quality, but GBSS1 decreased eating quality. The results indicated the possibility of developing high palatability cultivars through modification of key genes related to japonica rice eating quality formation in starch biosynthesis.	[Sun, Ming-Mao; Abdula, Sailila E.; Lee, Hye-Jung; Cho, Yong-Gu] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea; [Cho, Young-Chan] Rural Dev Adm, Natl Inst Crop Sci, Suwon, South Korea; [Han, Long-Zhi] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Koh, Hee-Jong] Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea	Chungbuk National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Seoul National University (SNU)	Sun, MM (corresponding author), Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea.	ygcho@chungbuk.ac.kr	Cho, Yong-Gu/AAV-1904-2021		BioGreen 21 Program; Rural Development Administration; MIFAFF, Korea [306005-04-2-HD110]	BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); MIFAFF, Korea	This work was supported by a grant from the BioGreen 21 Program, Rural Development Administration and by a grant (code # 306005-04-2-HD110) from MIFAFF, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1995, PROT CRUD AN FEED CO; Ayres NM, 1997, THEOR APPL GENET, V94, P773, DOI 10.1007/s001220050477; Bao JS, 2006, THEOR APPL GENET, V113, P1185, DOI 10.1007/s00122-006-0394-z; Bao JS, 2006, THEOR APPL GENET, V113, P1171, DOI 10.1007/s00122-006-0355-6; Bao JS, 2008, J AGR FOOD CHEM, V56, P1589, DOI 10.1021/jf073128+; Bao JS, 1999, THEOR APPL GENET, V98, P1120, DOI 10.1007/s001220051175; CAGAMPANG GB, 1973, J SCI FOOD AGR, V24, P1589, DOI 10.1002/jsfa.2740241214; Chen Neng, 2006, Acta Agronomica Sinica, V32, P1193; Cho YG, 2007, CROP SCI, V47, P2403, DOI 10.2135/cropsci2006.08.0509; Comparot-Moss S, 2009, J EXP BOT, V60, P2481, DOI 10.1093/jxb/erp141; Dian WM, 2005, J EXP BOT, V56, P623, DOI 10.1093/jxb/eri065; Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9; Fujita N, 2009, J EXP BOT, V60, P1009, DOI 10.1093/jxb/ern349; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Han YP, 2004, PLANT SCI, V166, P357, DOI 10.1016/j.plantsci.2003.09.023; Hanashiro I, 2008, PLANT CELL PHYSIOL, V49, P925, DOI 10.1093/pcp/pcn066; Hansen J., 2002, RICE SITUATION OUTLO, P32; Harushima Y, 2002, GENETICS, V160, P313; HAWKER JS, 1974, ARCH BIOCHEM BIOPHYS, V160, P530, DOI 10.1016/0003-9861(74)90430-5; Hong HC, 2006, THESIS DONGGUK U KOR, P1; Hosoya LA, 2010, ARCHAEOL ANTHROP SCI, V2, P57, DOI 10.1007/s12520-010-0034-z; Huang YS, 1998, CHINESE J RICE SCI, V12, P172; Jiang HW, 2003, PHYTOCHEMISTRY, V63, P53, DOI 10.1016/S0031-9422(03)00005-0; Juliano B.O., 1985, RICE CHEM TECHNOLOGY, V2nd ed., P443; Lestari P, 2009, J AGR FOOD CHEM, V57, P2754, DOI 10.1021/jf803804k; LITTLE RR, 1958, CEREAL CHEM, V35, P111; LIU B, 2008, SCI SINICA VITAC, V38, P766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; NAKAMURA Y, 1992, PLANT SCI, V82, P15, DOI 10.1016/0168-9452(92)90003-5; Nakamura Y, 2005, PLANT MOL BIOL, V58, P213, DOI 10.1007/s11103-005-6507-2; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; NAKAMURA Y, 1989, PLANT CELL PHYSIOL, V30, P833, DOI 10.1093/oxfordjournals.pcp.a077813; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; Oh-e I., 2007, Scientific Reports of the Faculty of Agriculture, Okayama University, V96, P13; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PEREZ CM, 1978, STARKE, V30, P424, DOI 10.1002/star.19780301206; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Ramesh M, 2000, CRIT REV FOOD SCI, V40, P449, DOI 10.1080/10408690091189220; SAKAMOTO S, 1996, REDEFINING NATURE EC, P215; SATOH H, 2000, POSSIBLE PATHWAY STA; Shen Bo, 1997, Chinese Journal of Rice Science, V11, P183; Shen Peng, 2006, Rice Science, V13, P43; SHUN QY, 1998, SCI AGR SINICA, V31, P25; TAKEDA Y, 1987, CARBOHYD RES, V168, P79, DOI 10.1016/0008-6215(87)80008-3; Tanaka N, 2004, PLANT BIOTECHNOL J, V2, P507, DOI 10.1111/j.1467-7652.2004.00097.x; Tanaka R., 1992, Report of the Tohoku Branch, the Crop Science Society of Japan, P45; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Umemoto T, 2002, FUNCT PLANT BIOL, V29, P1121, DOI 10.1071/PP01145; YAMANOUCHI H, 1992, PLANT CELL PHYSIOL, V33, P985; Yu TengQiong, 2008, Journal of Crop Science and Biotechnology, V11, P135; ZHANG Z, 2009, THESIS HUAZHONG AGR, P1; Zhao BuHong, 2005, Agricultural Sciences in China, V4, P26	53	53	60	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18385	10.1371/journal.pone.0018385	http://dx.doi.org/10.1371/journal.pone.0018385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494675	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400025
J	Saji, M; Narahara, K; McCarty, SK; Vasko, VV; La Perle, KM; Porter, K; Jarjoura, D; Lu, C; Cheng, SY; Ringel, MD				Saji, M.; Narahara, K.; McCarty, S. K.; Vasko, V. V.; La Perle, K. M.; Porter, K.; Jarjoura, D.; Lu, C.; Cheng, S-Y; Ringel, M. D.			Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer	ONCOGENE			English	Article						PI3 kinase; thyroid hormone receptor beta; thyrotropin; p27; gelsolin	EPITHELIAL-MESENCHYMAL TRANSITION; MOUSE MODEL; CELL-MIGRATION; BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE; DISTINCT ROLES; BETA-RECEPTOR; P27(KIP1); GROWTH; MICE	Akt activation is common in progressive thyroid cancer. In breast cancer, Akt1 induces primary cancer growth, but is reported to inhibit metastasis in vivo in several model systems. In contrast, clinical and in vitro studies suggest a metastasis-promoting role for Akt1 in thyroid cancer. The goal of this study was to determine the functional role of Akt1 in thyroid cancer growth and metastatic progression in vivo using thyroid hormone receptor (TR) beta(PV/PV) knock-in (PV) mice, which develop metastatic thyroid cancer. We crossed Akt1(-/-) and PV mice and compared tumor development, local progression, metastasis and histology in TR beta(PV/PV)/Akt1(+/+) (PVPV-Akt1WT) and TR beta(PV/PV)/Akt1(-/-) (PVPV-Akt1KO) mice. Mice were killed at 3, 6, 9, 12 and 15 months; necropsy was performed and serum thyroid stimulating hormone (TSH) was measured. Thyroid hyperplasia occurred in both groups beginning at 3 months; the thyroid size was greater in the PVPV-Akt1WT mice (P<0.001). In comparison with PVPV-Akt1WT mice, thyroid cancer development was delayed in the PVPV-Akt1KO mice (P = 0.003) and the degree of tumor invasiveness was reduced. The PVPV-Akt1WT mice displayed pulmonary metastases at 12 and 15 months of age, by contrast PVPV-Akt1KO mice did not develop distant metastases at 15 months of age. Despite continued expression of Akt2 or Akt3, pAkt levels were decreased and there was evidence of reduced Akt effect on p27 in the PVPV-Akt1KO thyroids. TSH levels were similarly elevated in PV mice regardless of Akt1 expression. In conclusion, thyroid cancer development and progression in TR beta(PV/PV) mice are Akt1-dependent, consistent with a tumor progression-promoting role in this murine thyroid cancer model. Oncogene (2011) 30, 4307-4315; doi: 10.1038/onc.2011.136; published online 2 May 2011	[Saji, M.; Narahara, K.; McCarty, S. K.; Ringel, M. D.] Ohio State Univ, Coll Med, Div Endocrinol, Columbus, OH 43210 USA; [Saji, M.; Narahara, K.; McCarty, S. K.; Ringel, M. D.] Ohio State Univ, Coll Med, Div Diabet, Columbus, OH 43210 USA; [Saji, M.; Narahara, K.; McCarty, S. K.; Ringel, M. D.] Ohio State Univ, Coll Med, Div Metab, Columbus, OH 43210 USA; [Saji, M.; Narahara, K.; McCarty, S. K.; Porter, K.; Jarjoura, D.; Ringel, M. D.] Arthur G James Comprehens Canc Ctr, Columbus, OH USA; [Ringel, M. D.] Ohio State Univ, Coll Med, Div Oncol, Columbus, OH 43210 USA; [Porter, K.; Jarjoura, D.] Ohio State Univ, Coll Med, Ctr Biostat, Columbus, OH 43210 USA; [Vasko, V. V.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [La Perle, K. M.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Lu, C.; Cheng, S-Y] NCI, NIH, Bethesda, MD 20892 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Uniformed Services University of the Health Sciences - USA; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ringel, MD (corresponding author), Ohio State Univ, Coll Med, Div Endocrinol, 445D McCampbell Hall,1581 Dodd Dr, Columbus, OH 43210 USA.	matthew.ringel@osumc.edu	Saji, Motoyasu/E-4007-2011; La Perle, Krista Marie DuBray/B-3099-2015	Ringel, Matthew/0000-0001-8672-3266	NIH [P01CA124570, R01CA102572]; NATIONAL CANCER INSTITUTE [R01CA102572, P01CA124570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the work is from NIH grants (P01CA124570 and R01CA102572) to MDR. We appreciate the technical assistance of Michael Ostrowski, John Thompson and Jun Liu.	Chellaiah MA, 2001, J BIOL CHEM, V276, P47434, DOI 10.1074/jbc.M107494200; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Coulonval K, 2000, BIOCHEM J, V348, P351, DOI 10.1042/0264-6021:3480351; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2007, CARCINOGENESIS, V28, P2451, DOI 10.1093/carcin/bgm174; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Guigon CJ, 2010, CARCINOGENESIS, V31, P1284, DOI 10.1093/carcin/bgq059; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Kim CS, 2007, ENDOCRINOLOGY, V148, P1306, DOI 10.1210/en.2006-0923; Kim CS, 2009, THYROID, V19, P1317, DOI 10.1089/thy.2009.1609; Kim CS, 2005, ENDOCRINOLOGY, V146, P4456, DOI 10.1210/en.2005-0172; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Lu CX, 2010, ENDOCRINOLOGY, V151, P1929, DOI 10.1210/en.2009-1017; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Mielnicki LM, 1999, EXP CELL RES, V249, P161, DOI 10.1006/excr.1999.4461; Ni XG, 2008, MOL MED, V14, P582, DOI 10.2119/2008-00020.Ni; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Pohlenz J, 1999, THYROID, V9, P1265, DOI 10.1089/thy.1999.9.1265; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Ringel MD, 2001, CANCER RES, V61, P6105; Saito J, 2001, THYROID, V11, P339, DOI 10.1089/10507250152039073; Saji M, 2005, BIOCHEM BIOPH RES CO, V332, P167, DOI 10.1016/j.bbrc.2005.04.109; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Suzuki H, 2002, THYROID, V12, P963, DOI 10.1089/105072502320908295; Tanaka H, 2006, INT J CANCER, V118, P1680, DOI 10.1002/ijc.21559; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Vasko V, 2004, J MED GENET, V41, P161, DOI 10.1136/jmg.2003.015339; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304; Ying H, 2003, CARCINOGENESIS, V24, P1467, DOI 10.1093/carcin/bgg111; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	50	37	37	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	42					4307	4315		10.1038/onc.2011.136	http://dx.doi.org/10.1038/onc.2011.136			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HP	21532616	Green Accepted			2022-12-25	WOS:000296356400002
J	Bolscher, JGM; Oudhoff, MJ; Nazmi, K; Antos, JM; Guimaraes, CP; Spooner, E; Haney, EF; Vallejo, JJG; Vogel, HJ; van't Hof, W; Ploegh, HL; Veerman, ECI				Bolscher, Jan G. M.; Oudhoff, Menno J.; Nazmi, Kamran; Antos, John M.; Guimaraes, Carla P.; Spooner, Eric; Haney, Evan F.; Vallejo, Juan J. Garcia; Vogel, Hans J.; van't Hof, Wim; Ploegh, Hidde L.; Veerman, Enno C. I.			Sortase A as a tool for high-yield histatin cyclization	FASEB JOURNAL			English	Article						intramolecular transpeptidation; wound closure stimulating peptide	GRAM-POSITIVE BACTERIA; MEDIATED LIGATION; SURFACE-PROTEINS; MOTIF	Cyclic peptides are highly valued tools in biomedical research. In many cases, they show higher receptor affinity, enhanced biological activity, and improved serum stability. Technical difficulties in producing cyclic peptides, especially larger ones, in appreciable yields have precluded a prolific use in biomedical research. Here, we describe a novel and efficient cyclization method that uses the peptidyl-transferase activity of the Staphylococcus aureus enzyme sortase A to cyclize linear synthetic precursor peptides. As a model, we used histatin 1, a 38-mer salivary peptide with motogenic activity. Chemical cyclization of histatin 1 resulted in <= 3% yields, whereas sortase-mediated cyclization provided a yield of > 90%. The sortase-cyclized peptide displayed a maximum wound closure activity at 10 nM, whereas the linear peptide displayed maximal activity at 10 mu M. Circular dichroism and NMR spectroscopic analysis of the linear and cyclic peptide in solution showed no evidence for conformational changes, suggesting that structural differences due to cyclization only became manifest when these peptides were located in the binding domain of the receptor. The sortase-based cyclization technology provides a general method for easy and efficient manufacturing of large cyclic peptides.-Bolscher, J. G. M., Oudhoff, M. J., Nazmi, K., Antos, J. M., Guimaraes, C. P., Spooner, E., Haney, E. F., Garcia-Vallejo, J. J., Vogel, H. J., van't Hof, W., Ploegh, H. L., Veerman. E. C. I. Sortase A as a tool for high-yield histatin cyclization. FASEB J. 25, 2650 -2658 (2011). www.fasebj.org	[Bolscher, Jan G. M.; Oudhoff, Menno J.; Nazmi, Kamran; van't Hof, Wim; Veerman, Enno C. I.] Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam, NL-1081 LA Amsterdam, Netherlands; [Bolscher, Jan G. M.; Oudhoff, Menno J.; Nazmi, Kamran; van't Hof, Wim; Veerman, Enno C. I.] Vrije Univ VU Amsterdam, NL-1081 LA Amsterdam, Netherlands; [Vallejo, Juan J. Garcia] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Antos, John M.; Guimaraes, Carla P.; Spooner, Eric; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; [Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA USA; [Haney, Evan F.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Calgary	Bolscher, JGM (corresponding author), Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam, Gustav Mahlerlaan 3004, NL-1081 LA Amsterdam, Netherlands.	j.bolscher@acta.nl	Haney, Evan/S-5501-2019; Garcia-Vallejo, Juan/H-4162-2012; Bolscher, Jan/ABF-6102-2021; Vallejo, Juan Garcia/AAA-3765-2020	Haney, Evan/0000-0003-3645-770X; Garcia-Vallejo, Juan/0000-0001-6238-7069; Bolscher, Jan/0000-0001-5669-6164; Oudhoff, Menno/0000-0002-1180-8975	Skeletal Tissue Engineering Group Amsterdam; European Molecular Biology Organization; Journal of Cell Science	Skeletal Tissue Engineering Group Amsterdam; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Journal of Cell Science	This work was supported by the Skeletal Tissue Engineering Group Amsterdam and travel funds of the European Molecular Biology Organization and Journal of Cell Science.	Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Antos JM, 2009, J BIOL CHEM, V284, P16028, DOI 10.1074/jbc.M901752200; Brewer D, 2002, BIOCHEMISTRY-US, V41, P5526, DOI 10.1021/bi015926d; Cascales L, 2010, ORG BIOMOL CHEM, V8, P5035, DOI 10.1039/c0ob00139b; Melino S, 1999, BIOCHEMISTRY-US, V38, P9626, DOI 10.1021/bi990212c; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nguyen LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012684; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Popp MW, 2011, P NATL ACAD SCI USA, V108, P3169, DOI 10.1073/pnas.1016863108; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Rydengard V, 2006, FEBS J, V273, P2399, DOI 10.1111/j.1742-4658.2006.05246.x; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Zhou HX, 2010, BIOPHYS J, V98, pL15, DOI 10.1016/j.bpj.2009.11.029	18	71	79	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2650	2658		10.1096/fj.11-182212	http://dx.doi.org/10.1096/fj.11-182212			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21525488				2022-12-25	WOS:000293337800015
J	Sheets, JJ; Hey, TD; Fencil, KJ; Burton, SL; Ni, WT; Lang, AE; Benz, R; Aktories, K				Sheets, Joel J.; Hey, Tim D.; Fencil, Kristin J.; Burton, Stephanie L.; Ni, Weiting; Lang, Alexander E.; Benz, Roland; Aktories, Klaus			Insecticidal Toxin Complex Proteins from Xenorhabdus nematophilus STRUCTURE AND PORE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORHABDUS-LUMINESCENS; BACTERIA; GENES; PATHOGENICITY; SPP.	Toxin complexes from Xenorhabdus and Photorhabdus spp. bacteria represent novel insecticidal proteins. We purified a native toxin complex (toxin complex 1) from Xenorhabdus nematophilus. The toxin complex is composed of three different proteins, XptA2, XptB1, and XptC1, representing products from class A, B, and C toxin complex genes, respectively. We showed that recombinant XptA2 and co-produced recombinant XptB1 and XptC1 bind together with a 4: 1: 1 stoichiometry. XptA2 forms a tetramer of similar to 1,120 kDa that bound to solubilized insect brush border membranes and induced pore formation in black lipid membranes. Co-expressed XptB1 and XptC1 form a tight 1: 1 binary complex where XptC1 is C-terminally truncated, resulting in a 77-kDa protein. The similar to 30-kDa C-terminally cleaved portion of XptC1 apparently only loosely associates with this binary complex. XptA2 had only modest oral toxicity against lepidopteran insects but as a complex with co-produced XptB1 and XptC1 had high levels of insecticidal activity. Addition of co-expressed class B (TcdB2) and class C (TccC3) proteins from Photorhabdus luminescens to the Xenorhabdus XptA2 protein resulted in formation of a hybrid toxin complex protein with the same 4: 1: 1 stoichiometry as the native Xenorhabdus toxin complex 1. This hybrid toxin complex, like the native toxin complex, was highly active against insects.	[Sheets, Joel J.; Hey, Tim D.; Fencil, Kristin J.; Ni, Weiting] Dow AgroSci, Dept Biochem & Mol Biol, Indianapolis, IN 46268 USA; [Burton, Stephanie L.] Dow AgroSci, Dept Biol, Indianapolis, IN 46268 USA; [Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Inst Expt, D-79104 Freiburg, Germany; [Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Benz, Roland] Univ Wurzburg, Deutsch Forsch Gemeinschaft Forschungszentrum Exp, Rudolf Virchow Zentrum, D-97078 Wurzburg, Germany; [Benz, Roland] Univ Bremen, Sch Sci & Engn, D-28725 Bremen, Germany	Dow Chemical Company; Dow Chemical Company; University of Freiburg; University of Freiburg; University of Wurzburg; University of Bremen	Sheets, JJ (corresponding author), Dow AgroSci, Dept Biochem & Mol Biol, 9330 Zionsville Rd, Indianapolis, IN 46268 USA.	jjsheets@dow.com	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Benz, Roland/0000-0002-9510-9265	German Science Foundation Deutsche Forschungsgemeinschaft (DFG) [AK6/22-1, SFB487 TP5]; excellence cluster Centre for Biological Signalling Studies (BIOSS)	German Science Foundation Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); excellence cluster Centre for Biological Signalling Studies (BIOSS)	This work was supported by German Science Foundation Deutsche Forschungsgemeinschaft (DFG) Grant AK6/22-1 (to K. A.), the excellence cluster Centre for Biological Signalling Studies (BIOSS) (to K. A.), and DFG Grant SFB487 TP5 (to R. B.).	BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Dodd SJ, 2006, APPL ENVIRON MICROB, V72, P6584, DOI 10.1128/AEM.00954-06; Ffrench-Constant R, 2006, ADV APPL MICROBIOL, V58, P169, DOI 10.1016/S0065-2164(06)58005-5; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Guo LN, 1999, J BIOL CHEM, V274, P9836, DOI 10.1074/jbc.274.14.9836; Hares MC, 2008, MICROBIOL-SGM, V154, P3503, DOI 10.1099/mic.0.2008/018440-0; Heermann R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-40; Hurst MRH, 2000, J BACTERIOL, V182, P5127, DOI 10.1128/JB.182.18.5127-5138.2000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang AE, 2008, BIOCHEMISTRY-US, V47, P8406, DOI 10.1021/bi800615g; Lang AE, 2011, N-S ARCH PHARMACOL, V383, P227, DOI 10.1007/s00210-010-0579-5; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; Lee SC, 2007, J MOL BIOL, V366, P1558, DOI 10.1016/j.jmb.2006.12.057; Liu D, 2003, NAT BIOTECHNOL, V21, P1222, DOI 10.1038/nbt866; Sergeant M, 2003, APPL ENVIRON MICROB, V69, P3344, DOI 10.1128/AEM.69.6.3344-3349.2003; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; Waterfield NR, 2004, NAT REV MICROBIOL, V2, P833, DOI 10.1038/nrmicro1008; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304	23	56	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22742	22749		10.1074/jbc.M111.227009	http://dx.doi.org/10.1074/jbc.M111.227009			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21527640	Green Published, hybrid			2022-12-25	WOS:000292025000008
J	Szabo, A; Heja, D; Szakacs, D; Zboray, K; Kekesi, KA; Radisky, ES; Sahin-Toth, M; Pal, G				Szabo, Andras; Heja, David; Szakacs, David; Zboray, Katalin; Kekesi, Katalin A.; Radisky, Evette S.; Sahin-Toth, Miklos; Pal, Gabor			High Affinity Small Protein Inhibitors of Human Chymotrypsin C (CTRC) Selected by Phage Display Reveal Unusual Preference for P4 ' Acidic Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CATIONIC TRYPSINOGEN GENE; OVOMUCOID 3RD DOMAINS; SCHISTOCERCA-GREGARIA; DESERT LOCUST; SCANNING MUTAGENESIS; CHRONIC-PANCREATITIS; ACTIVE-SITE; PROCARBOXYPEPTIDASE-A; ENZYMATIC SPECIFICITY	Human chymotrypsin C (CTRC) is a pancreatic protease that participates in the regulation of intestinal digestive enzyme activity. Other chymotrypsins and elastases are inactive on the regulatory sites cleaved by CTRC, suggesting that CTRC recognizes unique sequence patterns. To characterize the molecular determinants underlying CTRC specificity, we selected high affinity substrate-like small protein inhibitors against CTRC from a phage library displaying variants of SGPI-2, a natural chymotrypsin inhibitor from Schistocerca gregaria. On the basis of the sequence pattern selected, we designed eight inhibitor variants in which amino acid residues in the reactive loop at P1 (Met or Leu), P2' (Leu or Asp), and P4' (Glu, Asp, or Ala) were varied. Binding experiments with CTRC revealed that (i) inhibitors with Leu at P1 bind 10-fold stronger than those with P1 Met; (ii) Asp at P2' (versus Leu) decreases affinity but increases selectivity, and (iii) Glu or Asp at P4' (versus Ala) increase affinity 10-fold. The highest affinity SGPI-2 variant (K-D 20 pM) bound to CTRC 575-fold tighter than the parent molecule. The most selective inhibitor variant exhibited a K-D of 110 pM and a selectivity ranging from 225- to 112,664-fold against other human chymotrypsins and elastases. Homology modeling and mutagenesis identified a cluster of basic amino acid residues (Lys(51), Arg(56), and Arg(80)) on the surface of human CTRC that interact with the P4' acidic residue of the inhibitor. The acidic preference of CTRC at P4' is unique among pancreatic proteases and might contribute to the high specificity of CTRC-mediated digestive enzyme regulation.	[Szabo, Andras; Sahin-Toth, Miklos] Boston Univ Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Heja, David; Szakacs, David; Zboray, Katalin; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Kekesi, Katalin A.] Eotvos Lorand Univ, Lab Prote, Inst Biol, H-1117 Budapest, Hungary; [Kekesi, Katalin A.] Eotvos Lorand Univ, Dept Physiol & Neurobiol, H-1117 Budapest, Hungary; [Radisky, Evette S.] Mayo Clin Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Mayo Clinic	Sahin-Toth, M (corresponding author), 72 E Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu; palgabor@elte.hu	Radisky, Evette S/C-8526-2012; Szakacs, David/K-1985-2018; Kékesi, Katalin Adrienna A/H-3484-2017; Pal, Gabor/A-6244-2009	Radisky, Evette S/0000-0003-3121-109X; Szakacs, David/0000-0002-8758-6387; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Pal, Gabor/0000-0001-7868-7971; Szabo, Andras/0000-0001-8687-470X; Sahin-Toth, Miklos/0000-0003-4513-9922	National Institutes of Health [R01 DK082412-S2, R01 DK082412, R01 DK058088]; Hungarian Scientific Research Fund [NK81950, K68408]; European Union [4.2.1./B-09/KMR-2010-0003]; Janos Bolyai Research Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082412, R01DK058088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	s This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082412-S2 (ARRA), R01 DK082412, and R01 DK058088 (to M. S.-T.), Hungarian Scientific Research Fund (OTKA) Grants NK81950 and K68408, the European Union and European Social Fund (TAMOP) Grant 4.2.1./B-09/KMR-2010-0003, and a Janos Bolyai Research Fellowship (to G. P.).	APOSTOL I, 1993, J PROTEIN CHEM, V12, P419, DOI 10.1007/BF01025042; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boigegrain RA, 2000, INSECT BIOCHEM MOLEC, V30, P145, DOI 10.1016/S0965-1748(99)00109-5; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; Fodor K, 2006, BIOCHEMISTRY-US, V45, P2114, DOI 10.1021/bi0517133; Fodor K, 2005, J MOL BIOL, V350, P156, DOI 10.1016/j.jmb.2005.04.039; FOLK JE, 1965, J BIOL CHEM, V240, P193; FOLK JE, 1965, J BIOL CHEM, V240, P181; Gaspari Z, 2006, FEBS J, V273, P1831, DOI 10.1111/j.1742-4658.2006.05204.x; Gaspari Z, 2002, EUR J BIOCHEM, V269, P527, DOI 10.1046/j.0014-2956.2001.02685.x; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; Grahn S, 1999, BBA-PROTEIN STRUCT M, V1431, P329, DOI 10.1016/S0167-4838(99)00059-X; Hamdaoui A, 1998, FEBS LETT, V422, P74, DOI 10.1016/S0014-5793(97)01585-8; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; KEILDLOUHA V, 1972, BIOCHIM BIOPHYS ACTA, V276, P531, DOI 10.1016/0005-2744(72)91013-3; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kurth T, 1997, BIOCHEMISTRY-US, V36, P10098, DOI 10.1021/bi970937l; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Leone P, 2008, ACTA CRYSTALLOGR D, V64, P1165, DOI 10.1107/S0907444908030400; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Malik Z, 1999, BBA-PROTEIN STRUCT M, V1434, P143, DOI 10.1016/S0167-4838(99)00167-3; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; Mer G, 1996, NAT STRUCT BIOL, V3, P45, DOI 10.1038/nsb0196-45; Mer G, 1996, J MOL BIOL, V258, P158, DOI 10.1006/jmbi.1996.0240; MER G, 1994, BIOCHEMISTRY-US, V33, P15397, DOI 10.1021/bi00255a021; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Pal G, 1996, FEBS LETT, V385, P165, DOI 10.1016/0014-5793(96)00376-6; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; Pal G, 2005, PROTEIN SCI, V14, P2405, DOI 10.1110/ps.051519805; Pal G, 2003, J MOL BIOL, V332, P195, DOI 10.1016/S0022-2836(03)00898-2; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Patthy A, 2002, ARCH BIOCHEM BIOPHYS, V398, P179, DOI 10.1006/abbi.2001.2686; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Roussel A, 2001, J BIOL CHEM, V276, P38893, DOI 10.1074/jbc.M105707200; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4349, DOI 10.1021/bi00067a026; SCHELLENBERGER V, 1994, BIOCHEMISTRY-US, V33, P4251, DOI 10.1021/bi00180a020; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sidhu SS, 2003, CHEMBIOCHEM, V4, P14, DOI 10.1002/cbic.200390008; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; Simonet G, 2003, PROTEIN EXPRES PURIF, V31, P188, DOI 10.1016/S1046-5928(03)00170-0; Sun J, 2001, J BIOL CHEM, V276, P15177, DOI 10.1074/jbc.M006645200; Szenthe B, 2004, BIOCHEMISTRY-US, V43, P3376, DOI 10.1021/bi035689+; Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2011, J BIOL CHEM, V286, P1819, DOI 10.1074/jbc.M110.187369; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Zani ML, 2010, BIOCHIMIE, V92, P1689, DOI 10.1016/j.biochi.2010.05.003	56	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22535	22545		10.1074/jbc.M111.235754	http://dx.doi.org/10.1074/jbc.M111.235754			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515688	hybrid, Green Published			2022-12-25	WOS:000291719900061
J	Kale, A; Phansopa, C; Suwannachart, C; Craven, CJ; Rafferty, JB; Kelly, DJ				Kale, Avinash; Phansopa, Chatchawal; Suwannachart, Chatrudee; Craven, C. Jeremy; Rafferty, John B.; Kelly, David J.			The Virulence Factor PEB4 (Cj0596) and the Periplasmic Protein Cj1289 Are Two Structurally Related SurA-like Chaperones in the Human Pathogen Campylobacter jejuni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; OUTER-MEMBRANE PROTEINS; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; BORDETELLA-PERTUSSIS; TRIGGER FACTOR; BINDING; BAMB; ISOMERIZATION; COMPONENT	The PEB4 protein is an antigenic virulence factor implicated in host cell adhesion, invasion, and colonization in the food-borne pathogen Campylobacter jejuni. peb4 mutants have defects in outer membrane protein assembly and PEB4 is thought to act as a periplasmic chaperone. The crystallographic structure of PEB4 at 2.2-angstrom resolution reveals a dimer with distinct SurA-like chaperone and peptidyl-prolyl cis/trans isomerase (PPIase) domains encasing a large central cavity. Unlike SurA, the chaperone domain is formed by interlocking helices from each monomer, creating a domain-swapped architecture. PEB4 stimulated the rate of proline isomerization limited refolding of denatured RNase T-1 in a juglone-sensitive manner, consistent with parvulin-like PPIase domains. Refolding and aggregation of denatured rhodanese was significantly retarded in the presence of PEB4 or of an engineered variant specifically lacking the PPIase domain, suggesting the chaperone domain possesses a holdase activity. Using bioinformatics approaches, we identified two other SurA-like proteins (Cj1289 and Cj0694) in C. jejuni. The 2.3-angstrom structure of Cj1289 does not have the domain-swapped architecture of PEB4 and thus more resembles SurA. Purified Cj1289 also enhanced RNase T1 refolding, although poorly compared with PEB4, but did not retard the refolding of denatured rhodanese. Structurally, Cj1289 is the most similar protein to SurA in C. jejuni, whereas PEB4 has most structural similarity to the Par27 protein of Bordetella pertussis. Our analysis predicts that Cj0694 is equivalent to the membrane-anchored chaperone PpiD. These results provide the first structural insights into the periplasmic assembly of outer membrane proteins in C. jejuni.	[Kale, Avinash; Phansopa, Chatchawal; Suwannachart, Chatrudee; Craven, C. Jeremy; Rafferty, John B.; Kelly, David J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Rafferty, JB (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, 5th Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	j.rafferty@sheffield.ac.uk; d.kelly@sheffield.ac.uk		Rafferty, John/0000-0003-1183-7474; Phansopa, Chatchawal/0000-0003-4943-9228	United Kingdom Biotechnology and Biological Sciences Research Council; Royal Thai government; BBSRC [BB/D524975/1, BB/E017576/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017576/1, BB/D524975/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Thai government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by a grant from the United Kingdom Biotechnology and Biological Sciences Research Council.; Supported by the Royal Thai government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Asakura H, 2007, FEMS MICROBIOL LETT, V275, P278, DOI 10.1111/j.1574-6968.2007.00893.x; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bitto E, 2004, FEBS LETT, V568, P94, DOI 10.1016/j.febslet.2004.05.014; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Britton KL, 1998, J BIOL CHEM, V273, P9023, DOI 10.1074/jbc.273.15.9023; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clantin B, 2010, J STRUCT BIOL, V169, P253, DOI 10.1016/j.jsb.2009.11.007; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; DOUBLIE S, 1997, METHODS ENZYMOLOGY M; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Hodak H, 2008, J MOL BIOL, V376, P414, DOI 10.1016/j.jmb.2007.10.088; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOROWITZ P, 1970, J BIOL CHEM, V245, P986; Hu L, 2008, INFECT IMMUN, V76, P5294, DOI 10.1128/IAI.01408-07; Ideno A, 2000, EUR J BIOCHEM, V267, P3139, DOI 10.1046/j.1432-1327.2000.01332.x; Jacobs BC, 2008, J NEUROIMMUNOL, V194, P181, DOI 10.1016/j.jneuroim.2007.11.017; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KERN D, 1995, BIOCHEMISTRY-US, V34, P13594, DOI 10.1021/bi00041a039; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Misra R, 2007, ACS CHEM BIOL, V2, P649, DOI 10.1021/cb700212p; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; MUCKE M, 1994, BIOCHEMISTRY-US, V33, P14608; MUCKE M, 1992, BIOCHEMISTRY-US, V31, P7848; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rathbun KM, 2009, FEMS MICROBIOL LETT, V300, P188, DOI 10.1111/j.1574-6968.2009.01795.x; Rathbun KM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-160; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Stirling PC, 2006, NAT STRUCT MOL BIOL, V13, P865, DOI 10.1038/nsmb1153; Stymest KH, 2008, FEBS J, V275, P3470, DOI 10.1111/j.1742-4658.2008.06493.x; Suzuki H, 2009, J VET MED SCI, V71, P255, DOI 10.1292/jvms.71.255; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; Weininger U, 2010, PROTEIN SCI, V19, P6, DOI 10.1002/pro.277; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069	70	26	26	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21254	21265		10.1074/jbc.M111.220442	http://dx.doi.org/10.1074/jbc.M111.220442			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21524997	hybrid, Green Published			2022-12-25	WOS:000291464700024
J	Mailloux, RJ; Seifert, EL; Bouillaud, F; Aguer, C; Collins, S; Harper, ME				Mailloux, Ryan J.; Seifert, Erin L.; Bouillaud, Frederic; Aguer, Celine; Collins, Sheila; Harper, Mary-Ellen			Glutathionylation Acts as a Control Switch for Uncoupling Proteins UCP2 and UCP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PROTON LEAK; OXIDATIVE STRESS; SKELETAL-MUSCLE; S-GLUTATHIONYLATION; HYDROGEN-PEROXIDE; ENERGY-METABOLISM; CELLS; ACID; OVEREXPRESSION; EXPRESSION	The mitochondrial uncoupling proteins 2 and 3 (UCP2 and -3) are known to curtail oxidative stress and participate in a wide array of cellular functions, including insulin secretion and the regulation of satiety. However, the molecular control mechanism( s) governing these proteins remains elusive. Here we reveal that UCP2 and UCP3 contain reactive cysteine residues that can be conjugated to glutathione. We further demonstrate that this modification controls UCP2 and UCP3 function. Both reactive oxygen species and glutathionylation were found to activate and deactivate UCP3-dependent increases in non-phosphorylating respiration. We identified both Cys(25) and Cys(259) as the major glutathionylation sites on UCP3. Additional experiments in thymocytes from wild-type and UCP2 null mice demonstrated that glutathionylation similarly diminishes non-phosphorylating respiration. Our results illustrate that UCP2- and UCP3-mediated state 4 respiration is controlled by reversible glutathionylation. Altogether, these findings advance our understanding of the roles UCP2 and UCP3 play in modulating metabolic efficiency, cell signaling, and oxidative stress processes.	[Mailloux, Ryan J.; Seifert, Erin L.; Aguer, Celine; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Bouillaud, Frederic] Univ Paris 05, CNRS, INSERM, Inst Cochin,UMR 8104,U1016, F-75270 Paris, France; [Collins, Sheila] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA	University of Ottawa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Sanford Burnham Prebys Medical Discovery Institute	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca	Bouillaud, Frédéric R/L-3238-2017; Harper, Mary-Ellen/C-3103-2009; Aguer, Celine/K-4444-2012; Aguer, Celine/U-7848-2019	Bouillaud, Frédéric R/0000-0002-7518-9237; Aguer, Celine/0000-0001-8828-8472; Mailloux, Ryan/0000-0003-3986-9830; Harper, Mary-Ellen/0000-0003-3864-5886	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes; CIHR	Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism, and Diabetes (to M. E. H.).; Supported by a CIHR postdoctoral fellowship.	Aguirre E, 2010, BBA-BIOENERGETICS, V1797, P1716, DOI 10.1016/j.bbabio.2010.06.009; Alves-Guerra MC, 2003, J BIOL CHEM, V278, P42307, DOI 10.1074/jbc.M306951200; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; Carroll AM, 2008, BBA-BIOENERGETICS, V1777, P1060, DOI 10.1016/j.bbabio.2008.04.030; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; Costford SR, 2009, DIABETOLOGIA, V52, P2405, DOI 10.1007/s00125-009-1480-y; Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1018, DOI 10.1152/ajpendo.00779.2007; DEQUIROGA GB, 1991, BIOCHEM J, V277, P289, DOI 10.1042/bj2770289; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gustafsson H, 2004, J NEUROSCI RES, V77, P285, DOI 10.1002/jnr.20142; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hill BG, 2010, BBA-BIOENERGETICS, V1797, P285, DOI 10.1016/j.bbabio.2009.11.005; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Krauss S, 1999, BBA-BIOENERGETICS, V1412, P129, DOI 10.1016/S0005-2728(99)00058-4; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Marino SM, 2010, BIOCHEMISTRY-US, V49, P7709, DOI 10.1021/bi100677a; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Silva JP, 2005, EMBO J, V24, P4061, DOI 10.1038/sj.emboj.7600866; Vesce S, 2005, J BIOL CHEM, V280, P38720, DOI 10.1074/jbc.M506575200; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200	51	136	136	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21865	21875		10.1074/jbc.M111.240242	http://dx.doi.org/10.1074/jbc.M111.240242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515686	hybrid, Green Published			2022-12-25	WOS:000291464700081
J	Hajicek, N; Kukimoto-Niino, M; Mishima-Tsumagari, C; Chow, CR; Shirouzu, M; Terada, T; Patel, M; Yokoyama, S; Kozasa, T				Hajicek, Nicole; Kukimoto-Niino, Mutsuko; Mishima-Tsumagari, Chiemi; Chow, Christina R.; Shirouzu, Mikako; Terada, Takaho; Patel, Maulik; Yokoyama, Shigeyuki; Kozasa, Tohru			Identification of Critical Residues in G alpha(13) for Stimulation of p115RhoGEF Activity and the Structure of the G alpha(13)-p115RhoGEF Regulator of G Protein Signaling Homology (RH) Domain Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; SERUM RESPONSE FACTOR; RGRGS DOMAIN; P115 RHOGEF; TRANSITION-STATE; ALPHA-SUBUNIT; MEMBRANE; BINDING; MECHANISMS	RH-RhoGEFs are a family of guanine nucleotide exchange factors that contain a regulator of G protein signaling homology (RH) domain. The heterotrimeric G protein G alpha(13) stimulates the guanine nucleotide exchange factor (GEF) activity of RH-RhoGEFs, leading to activation of RhoA. The mechanism by which G alpha(13) stimulates the GEF activity of RH-RhoGEFs, such as p115RhoGEF, has not yet been fully elucidated. Here, specific residues in G alpha(13) that mediate activation of p115RhoGEF are identified. Mutation of these residues significantly impairs binding of G alpha(13) to p115RhoGEF as well as stimulation of GEF activity. These data suggest that the exchange activity of p115RhoGEF is stimulated allosterically by G alpha(13) and not through its interaction with a secondary binding site. A crystal structure of G alpha(13) bound to the RH domain of p115RhoGEF is also presented, which differs from a previously crystallized complex with a G alpha(13)-G alpha(11) chimera. Taken together, these data provide new insight into the mechanism by which p115RhoGEF is activated by G alpha(13).	[Hajicek, Nicole; Kozasa, Tohru] Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Hajicek, Nicole; Chow, Christina R.; Patel, Maulik; Kozasa, Tohru] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Kukimoto-Niino, Mutsuko; Mishima-Tsumagari, Chiemi; Shirouzu, Mikako; Terada, Takaho; Yokoyama, Shigeyuki; Kozasa, Tohru] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; RIKEN; University of Tokyo	Kozasa, T (corresponding author), Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	kozasa@lsbm.org	Kukimoto-Niino, Mutsuko/C-6704-2017; Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015	Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Yokoyama, Shigeyuki/0000-0003-3133-7338; Chow, Christina/0000-0003-3944-4234	National Institutes of Health [GM61454, GM074001]; American Heart Association; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074001, R01GM061454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61454 and GM074001 (to T. K.). This work was also supported by a grant-in-aid from the Greater Midwest Affiliate of the American Heart Association (to T. K.), the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Funding Program for World-Leading Innovative R&D on Science and Technology from the Japan Society for the Promotion of Science; a predoctoral fellowship from the Greater Midwest Affiliate of the American Heart Association (to N. H.); and the Japan Society for the Promotion of Science (to N. H.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bhattacharyya R, 2003, BIOCHEM J, V371, P709, DOI 10.1042/BJ20021897; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chen Z, 2003, J BIOL CHEM, V278, P9912, DOI 10.1074/jbc.M212695200; Chen Z, 2001, NAT STRUCT BIOL, V8, P805, DOI 10.1038/nsb0901-805; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kreutz B, 2007, CELL SIGNAL, V19, P1681, DOI 10.1016/j.cellsig.2007.03.004; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Mao JH, 1998, P NATL ACAD SCI USA, V95, P12973, DOI 10.1073/pnas.95.22.12973; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SINGER WD, 1994, J BIOL CHEM, V269, P19796; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Vazquez-Prado J, 2004, J BIOL CHEM, V279, P54283, DOI 10.1074/jbc.M410594200; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Zheng MY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-36	45	12	12	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20625	20636		10.1074/jbc.M110.201392	http://dx.doi.org/10.1074/jbc.M110.201392			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507947	hybrid, Green Published			2022-12-25	WOS:000291267600049
J	Liu, J; Jha, P; Lyzogubov, VV; Tytarenko, RG; Bora, NS; Bora, PS				Liu, Juan; Jha, Purushottam; Lyzogubov, Valeriy V.; Tytarenko, Ruslana G.; Bora, Nalini S.; Bora, Puran S.			Relationship between Complement Membrane Attack Complex, Chemokine (C-C Motif) Ligand 2 (CCL2) and Vascular Endothelial Growth Factor in Mouse Model of Laser-induced Choroidal Neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; PIGMENT EPITHELIAL-CELLS; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; CHEMOTACTIC PROTEIN-1; ANIMAL-MODEL; FACTOR-B; ANGIOGENESIS; SUPPRESSION; VEGF	The present study investigated the interactions among the complement membrane attack complex (MAC), CCL2, and VEGF that occur in vivo during the development of choroidal neovascularization (CNV). We first investigated the sequential expression of MAC, CCL2, and VEGF during laser-induced CNV in C57BL/6 mice. Increased MAC deposition was detected at 1 h, CCL2 increased at 3 h, and VEGF was up-regulated at day 3 post-laser treatment. These results suggested that during laser-induced CNV, MAC, CCL2 and VEGF are formed and/or expressed in the following order: MAC -> CCL2 -> VEGF. To determine the cross-talk between MAC, CCL2, and VEGF during laser-induced CNV, neutralizing antibodies were injected both systemically and locally to block the bioactivity of each molecule. Blocking MAC formation inhibited CCL2 and VEGF expression and also limited CNV formation, whereas neutralization of CCL2 bioactivity did not affect MAC deposition; however, it reduced VEGF expression and CNV formation. When bioactivity of VEGF was blocked, CNV formation was significantly inhibited, but MAC deposition was not affected. Together, our results demonstrate that MAC is an upstream mediator and effect of MAC on the development of laser-induced CNV can be attributed to its direct effect on VEGF as well as its effect on VEGF that is mediated by CCL2. Understanding the interplay between immune mediators is critical to gain insight into the pathogenesis of CNV.	[Liu, Juan; Jha, Purushottam; Lyzogubov, Valeriy V.; Tytarenko, Ruslana G.; Bora, Nalini S.; Bora, Puran S.] Univ Arkansas Med Sci Hosp, Dept Ophthalmol, Jones Eye Inst, Little Rock, AR 72205 USA; [Liu, Juan; Bora, Nalini S.] Univ Arkansas Med Sci Hosp, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Bora, NS (corresponding author), Univ Arkansas Med Sci Hosp, Dept Ophthalmol, Jones Eye Inst, 4301 W Markham,523, Little Rock, AR 72205 USA.	NBora@UAMS.edu; PBora@UAMS.edu		Bora, Puran/0000-0003-4781-1217	National Institutes of Health [EY014623, EY018812]; Pat and Willard Walker Eye Research Center; Jones Eye Institute; University of Arkansas for Medical Sciences (Little Rock, AR); NATIONAL EYE INSTITUTE [R01EY018812, R01EY014623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pat and Willard Walker Eye Research Center; Jones Eye Institute; University of Arkansas for Medical Sciences (Little Rock, AR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY014623 and EY018812. This work was also supported by grants from the Pat and Willard Walker Eye Research Center, Jones Eye Institute, and the University of Arkansas for Medical Sciences (Little Rock, AR).	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Andreoli CM, 2007, CURR OPIN OPHTHALMOL, V18, P502, DOI 10.1097/ICU.0b013e3282f0ca54; Ashikari M, 2010, INVEST OPHTH VIS SCI, V51, P3820, DOI 10.1167/iovs.09-5121; Augustin AJ, 2009, CLIN OPHTHALMOL, V3, P175; Barakat MR, 2009, EXPERT OPIN INV DRUG, V18, P637, DOI [10.1517/13543780902855316, 10.1517/13543780902855316 ]; Bora NS, 2008, SEMIN IMMUNOPATHOL, V30, P85, DOI 10.1007/s00281-008-0110-y; Bora NS, 2007, J IMMUNOL, V178, P1783, DOI 10.4049/jimmunol.178.3.1783; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872; Bora NS, 2010, J BIOL CHEM, V285, P33826, DOI 10.1074/jbc.M110.153130; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Bora PS, 2003, P NATL ACAD SCI USA, V100, P2679, DOI 10.1073/pnas.0438014100; Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Chung EJ, 2009, BRIT J OPHTHALMOL, V93, P958, DOI 10.1136/bjo.2008.149187; Cohen SY, 2009, RETINA-J RET VIT DIS, V29, P1062, DOI 10.1097/IAE.0b013e3181b1bb1a; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Edelman JL, 2000, EXP EYE RES, V71, P523, DOI 10.1006/exer.2000.0907; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; ESSER AF, 1994, TOXICOLOGY, V87, P229, DOI 10.1016/0300-483X(94)90253-4; Goverdhan SV, 2008, BRIT J OPHTHALMOL, V92, P537, DOI 10.1136/bjo.2007.123190; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hogg RE, 2008, OPHTHALMOLOGY, V115, P1046, DOI 10.1016/j.ophtha.2007.07.031; Hong KH, 2005, BLOOD, V105, P1405, DOI 10.1182/blood-2004-08-3178; Hwang J, 2005, CYTOKINE, V30, P254, DOI 10.1016/j.cyto.2005.01.018; Inomata Y, 2009, INVEST OPHTH VIS SCI, V50, P3970, DOI 10.1167/iovs.07-1177; Itaya M, 2007, INVEST OPHTH VIS SCI, V48, P5677, DOI 10.1167/iovs.07-0156; Jha P, 2007, MOL IMMUNOL, V44, P3901, DOI 10.1016/j.molimm.2007.06.145; Joussen AM, 2009, DTSCH ARZTEBL INT, V106, P312, DOI 10.3238/arztebl.2009.0312; Kaliappan S, 2008, FEBS LETT, V582, P3451, DOI 10.1016/j.febslet.2008.09.009; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kilgore KS, 1996, AM J PATHOL, V149, P953; Kim SJ, 2010, EXP EYE RES, V91, P537, DOI 10.1016/j.exer.2010.07.011; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Liutkeviciene R, 2010, MEDICINA-LITHUANIA, V46, P89, DOI 10.3390/medicina46020013; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Lyzogubov VV, 2010, AM J PATHOL, V177, P1870, DOI 10.2353/ajpath.2010.091168; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Michels Stephan, 2006, Expert Opin Investig Drugs, V15, P779, DOI 10.1517/13543784.15.7.779; Miller DG, 2006, OPTOMETRY VISION SCI, V83, P316, DOI 10.1097/01.opx.0000216019.88256.eb; MILLER H, 1990, INVEST OPHTH VIS SCI, V31, P899; Nussenblatt RB, 2009, CURR OPIN INVEST DR, V10, P434; OShea JG, 1996, MED J AUSTRALIA, V165, P561, DOI 10.5694/j.1326-5377.1996.tb138643.x; Ozkiris A, 2010, EXPERT OPIN THER PAT, V20, P103, DOI 10.1517/13543770902762885; PODACK ER, 1984, MOL IMMUNOL, V21, P589, DOI 10.1016/0161-5890(84)90044-0; Prasad PS, 2010, MATURITAS, V66, P46, DOI 10.1016/j.maturitas.2010.02.006; Rambach Guenter, 2008, V15, P78, DOI 10.1159/000136316; Risnes I, 2003, ANN THORAC SURG, V75, P981, DOI 10.1016/S0003-4975(02)04556-3; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Selvan RS, 1998, J IMMUNOL, V161, P4388; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Suner IJ, 2004, INVEST OPHTH VIS SCI, V45, P311, DOI 10.1167/iovs.03-0733; Takahashi H, 2008, INVEST OPHTH VIS SCI, V49, P2143, DOI 10.1167/iovs.07-0523; Tettamanti G, 2006, CURR MED CHEM, V13, P2737, DOI 10.2174/092986706778521986; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Torzewski J, 1996, ARTERIOSCL THROM VAS, V16, P673, DOI 10.1161/01.ATV.16.5.673; Tsai YY, 2008, INVEST OPHTH VIS SCI, V49, P693, DOI 10.1167/iovs.07-0125; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Wang Y, 2010, EXP EYE RES, V91, P135, DOI 10.1016/j.exer.2010.02.008; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085; Yamada M, 2003, ARTERIOSCL THROM VAS, V23, P1996, DOI 10.1161/01.ATV.0000096208.80992.63	70	35	41	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20991	21001		10.1074/jbc.M111.226266	http://dx.doi.org/10.1074/jbc.M111.226266			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515678	hybrid, Green Published			2022-12-25	WOS:000291267600083
J	Guessous, I; Bonny, O; Paccaud, F; Mooser, V; Waeber, G; Vollenweider, P; Bochud, M				Guessous, Idris; Bonny, Olivier; Paccaud, Fred; Mooser, Vincent; Waeber, Gerard; Vollenweider, Peter; Bochud, Murielle			Serum Calcium Levels Are Associated with Novel Cardiometabolic Risk Factors in the Population-Based CoLaus Study	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; CARDIOVASCULAR-DISEASE MORTALITY; BONE-MINERAL DENSITY; MIDDLE-AGED MEN; METABOLIC SYNDROME; URIC-ACID; INSULIN-RESISTANCE; PRIMARY HYPERPARATHYROIDISM; OXIDATIVE STRESS; HEART-DISEASE	Background: Associations of serum calcium levels with the metabolic syndrome and other novel cardio-metabolic risk factors not classically included in the metabolic syndrome, such as those involved in oxidative stress, are largely unexplored. We analyzed the association of albumin-corrected serum calcium levels with conventional and non-conventional cardio-metabolic risk factors in a general adult population. Methodology/Principal Findings: The CoLaus study is a population-based study including Caucasians from Lausanne, Switzerland. The metabolic syndrome was defined using the Adult Treatment Panel III criteria. Non-conventional cardio-metabolic risk factors considered included: fat mass, leptin, LDL particle size, apolipoprotein B, fasting insulin, adiponectin, ultrasensitive CRP, serum uric acid, homocysteine, and gamma-glutamyltransferase. We used adjusted standardized multivariable regression to compare the association of each cardio-metabolic risk factor with albumin-corrected serum calcium. We assessed associations of albumin-corrected serum calcium with the cumulative number of non-conventional cardio-metabolic risk factors. We analyzed 4,231 subjects aged 35 to 75 years. Corrected serum calcium increased with both the number of the metabolic syndrome components and the number of non-conventional cardio-metabolic risk factors, independently of the metabolic syndrome and BMI. Among conventional and non-conventional cardio-metabolic risk factors, the strongest positive associations were found for factors related to oxidative stress (uric acid, homocysteine and gamma-glutamyltransferase). Adiponectin had the strongest negative association with corrected serum calcium. Conclusions/Significance: Serum calcium was associated with the metabolic syndrome and with non-conventional cardio-metabolic risk factors independently of the metabolic syndrome. Associations with uric acid, homocysteine and gammaglutamyltransferase were the strongest. These novel findings suggest that serum calcium levels may be associated with cardiovascular risk via oxidative stress.	[Guessous, Idris; Paccaud, Fred; Bochud, Murielle] Univ Lausanne, Inst Social & Prevent Med, Community Prevent Unit, Ctr Hosp Univ Vaudois, CH-1000 Lausanne, Switzerland; [Guessous, Idris] Univ Hosp Geneva, Dept Community Med Primary Care & Emergency Med, Div Primary Care Med, Unit Populat Epidemiol, Geneva, Switzerland; [Bonny, Olivier] Univ Lausanne Hosp, Serv Nephrol & Hypertens, Lausanne, Switzerland; [Bonny, Olivier] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; GlaxoSmithKline Res & Dev Ltd, Div Genet, King Of Prussia, PA USA; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Guessous, I (corresponding author), Univ Lausanne, Inst Social & Prevent Med, Community Prevent Unit, Ctr Hosp Univ Vaudois, CH-1000 Lausanne, Switzerland.	Idris.Guessous@chuv.ch	Colaus, PsyColaus/K-6607-2013; paccaud, fred/M-7516-2019; Bochud, Murielle/A-3981-2010	Bochud, Murielle/0000-0002-5727-0218; Waeber, Gerard/0000-0003-4193-788X; bonny, olivier/0000-0003-4123-4279	GlaxoSmithKline (GSK); Swiss National Science Foundation [33CSCO-122661, SNF 33CM30-124087/1]	GlaxoSmithKline (GSK)(GlaxoSmithKline); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The CoLaus study was sponsored in part by GlaxoSmithKline (GSK), and currently by the Swiss National Science Foundation (33CSCO-122661). IG is supported by a Swiss National Science Foundation grant (SNF 33CM30-124087/1). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VM is a full-time employee of GSK and played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Ahlstrom T, 2009, CLIN ENDOCRINOL, V71, P673, DOI 10.1111/j.1365-2265.2009.03558.x; Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0; Andre P, 2006, DIABETOLOGIA, V49, P2599, DOI 10.1007/s00125-006-0418-x; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Bjorck J, 2006, METABOLISM, V55, P1007, DOI 10.1016/j.metabol.2006.03.010; Dawson J, 2007, CURR MED CHEM, V14, P1879; DEBACQUER D, 1994, ATHEROSCLEROSIS, V108, P193, DOI 10.1016/0021-9150(94)90114-7; DUH QY, 1986, WORLD J SURG, V10, P729, DOI 10.1007/BF01655570; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Giral P, 2008, ARTERIOSCL THROM VAS, V28, P587, DOI 10.1161/ATVBAHA.107.157891; Giral P, 2010, ATHEROSCLEROSIS, V210, P607, DOI 10.1016/j.atherosclerosis.2009.12.026; Godsland IF, 2001, J CLIN ENDOCR METAB, V86, P719, DOI 10.1210/jc.86.2.719; GOLDBERG DM, 1980, CRC CR REV CL LAB SC, V12, P1, DOI 10.3109/10408368009108725; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guven A, 2005, HEART VESSELS, V20, P290, DOI 10.1007/s00380-004-0822-4; Hagstrom E, 2007, DIABETOLOGIA, V50, P317, DOI 10.1007/s00125-006-0532-9; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huschenbett J, 1998, BBA-BIOMEMBRANES, V1374, P34, DOI 10.1016/S0005-2736(98)00121-7; Jebb SA, 2007, INT J OBESITY, V31, P756, DOI 10.1038/sj.ijo.0803475; Jorde R, 1999, HYPERTENSION, V34, P484, DOI 10.1161/01.HYP.34.3.484; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kajikawa Y, 2011, INT HEART J, V52, P17, DOI 10.1536/ihj.52.17; Kawamoto R, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-87; KIM ES, 2010, J DIABETES COMPLICAT; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lee CT, 2009, J RENAL NUTR, V19, P220, DOI 10.1053/j.jrn.2008.11.004; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Leyva F, 1998, ARTERIOSCL THROM VAS, V18, P928, DOI 10.1161/01.ATV.18.6.928; Lind L, 1997, J CLIN EPIDEMIOL, V50, P967, DOI 10.1016/S0895-4356(97)00104-2; LIND L, 1988, BMJ-BRIT MED J, V297, P960, DOI 10.1136/bmj.297.6654.960; Lippi G, 2008, CLIN CHIM ACTA, V392, P1, DOI 10.1016/j.cca.2008.02.024; LJUNGHALL S, 1982, UROL INT, V37, P73, DOI 10.1159/000280800; Newaz MA, 1996, CLIN EXP HYPERTENS, V18, P1035, DOI 10.3109/10641969609081033; Okamoto Y, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/313179; Onat A, 2007, INT J OBESITY, V31, P1119, DOI 10.1038/sj.ijo.0803552; Onat A, 2006, PREV MED, V43, P136, DOI 10.1016/j.ypmed.2006.04.005; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; VONBANK A, 2011, CLIN CHIM ACTA; WANNAMETHEE G, 1995, AM J EPIDEMIOL, V142, P699, DOI 10.1093/oxfordjournals.aje.a117699; Wareham NJ, 1997, METABOLISM, V46, P1171, DOI 10.1016/S0026-0495(97)90212-2; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yilmaz N, 2009, AGING CLIN EXP RES, V21, P353; Zaidi A, 1999, FREE RADICAL BIO MED, V27, P810, DOI 10.1016/S0891-5849(99)00128-8; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889	47	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18865	10.1371/journal.pone.0018865	http://dx.doi.org/10.1371/journal.pone.0018865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533040	Green Published, gold			2022-12-25	WOS:000290014500015
J	Ayala, VI; Teijaro, JR; Farber, DL; Dorsey, SG; Carbonetti, NH				Ayala, Victor I.; Teijaro, John R.; Farber, Donna L.; Dorsey, Susan G.; Carbonetti, Nicholas H.			Bordetella pertussis Infection Exacerbates Influenza Virus Infection through Pertussis Toxin-Mediated Suppression of Innate Immunity	PLOS ONE			English	Article							RESPIRATORY-TRACT COLONIZATION; ADENYLATE-CYCLASE TOXIN; 1918 SPANISH INFLUENZA; A-VIRUS; ALVEOLAR MACROPHAGES; LETHAL SYNERGISM; STREPTOCOCCUS-PNEUMONIAE; NEUTROPHIL RECRUITMENT; BIOLOGICAL-ACTIVITIES; PULMONARY INFECTION	Pertussis (whooping cough) is frequently complicated by concomitant infections with respiratory viruses. Here we report the effect of Bordetella pertussis infection on subsequent influenza virus (PR8) infection in mouse models and the role of pertussis toxin (PT) in this effect. BALB/c mice infected with a wild-type strain of B. pertussis (WT) and subsequently (up to 14 days later) infected with PR8 had significantly increased pulmonary viral titers, lung pathology and mortality compared to mice similarly infected with a PT-deficient mutant strain (Delta PT) and PR8. Substitution of WT infection by intranasal treatment with purified active PT was sufficient to replicate the exacerbating effects on PR8 infection in BALB/c and C57/BL6 mice, but the effects of PT were lost when toxin was administered 24 h after virus inoculation. PT had no effect on virus titers in primary cultures of murine tracheal epithelial cells (mTECs) in vitro, suggesting the toxin targets an early immune response to increase viral titers in the mouse model. However, type I interferon responses were not affected by PT. Whole genome microarray analysis of gene expression in lung tissue from PT-treated and control PR8-infected mice at 12 and 36 h post-virus inoculation revealed that PT treatment suppressed numerous genes associated with communication between innate and adaptive immune responses. In mice depleted of alveolar macrophages, increase of pulmonary viral titers by PT treatment was lost. PT also suppressed levels of IL-1 beta, IL-12, IFN-gamma, IL-6, KC, MCP-1 and TNF-alpha in the airways after PR8 infection. Furthermore PT treatment inhibited early recruitment of neutrophils and NK cells to the airways. Together these findings demonstrate that infection with B. pertussis through PT activity predisposes the host to exacerbated influenza infection by countering protective innate immune responses that control virus titers.	[Ayala, Victor I.; Carbonetti, Nicholas H.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Teijaro, John R.; Farber, Donna L.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Dorsey, Susan G.] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ayala, VI (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	ncarbone@umaryland.edu		Farber, Donna/0000-0001-8236-9183	NIH [R01 AI063080, U19 AI083022, 1 P30 NR011396, F31 AI077320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083022, F31AI077320, R01AI063080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM081803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [P30NR011396] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by Public Health Service grants R01 AI063080 to NHC, U19 AI083022 to DLF, 1 P30 NR011396 to SGD, and F31 AI077320 to VIA from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1989, J VIROL, V63, P2252, DOI 10.1128/JVI.63.5.2252-2259.1989; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Andreasen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007079; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Byrne P, 2004, EUR J IMMUNOL, V34, P2579, DOI 10.1002/eji.200425092; CANDEIAS J, 1971, J HYGIENE, P399; Carbonetti NH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-7; Carbonetti NH, 2004, INFECT IMMUN, V72, P3350, DOI 10.1128/IAI.72.6.3350-3358.2004; Carbonetti NH, 2003, INFECT IMMUN, V71, P6358, DOI 10.1128/IAI.71.11.6358-6366.2003; Carbonetti NH, 2007, CURR OPIN PHARMACOL, V7, P272, DOI 10.1016/j.coph.2006.12.004; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Cosnes-Lambe C, 2008, PRESSE MED, V37, P1371, DOI 10.1016/j.lpm.2008.05.008; Cosnes-Lambe C, 2008, EUR J PEDIATR, V167, P1017, DOI 10.1007/s00431-007-0633-6; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Crowcroft NS, 2003, ARCH DIS CHILD, V88, P802, DOI 10.1136/adc.88.9.802; Culley FJ, 2006, J VIROL, V80, P8151, DOI 10.1128/JVI.00496-06; Dang O, 2004, J IMMUNOL, V172, P747, DOI 10.4049/jimmunol.172.2.747; FELS AOS, 1986, J APPL PHYSIOL, V60, P353, DOI 10.1152/jappl.1986.60.2.353; Ferson MJ, 2004, INFECT CONT HOSP EP, V25, P962, DOI 10.1086/502327; Fischer JE, 2000, J INFECT DIS, V182, P1029, DOI 10.1086/315806; Fujimoto I, 2000, J VIROL, V74, P3399, DOI 10.1128/JVI.74.7.3399-3403.2000; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Grantham ML, 2009, J VIROL, V83, P8655, DOI 10.1128/JVI.01129-09; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Harju TH, 2006, THORAX, V61, P579, DOI 10.1136/thx.2005.056291; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Jackson LA, 2000, CLIN INFECT DIS, V31, P3, DOI 10.1086/313911; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; KASUGA T, 1954, Kitasato Arch Exp Med, V27, P57; KATADA T, 1983, ARCH BIOCHEM BIOPHYS, V224, P290, DOI 10.1016/0003-9861(83)90212-6; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; KIMURA A, 1990, INFECT IMMUN, V58, P3337, DOI 10.1128/IAI.58.10.3337-3347.1990; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; KLENK HD, 1977, J GEN VIROL, V36, P151, DOI 10.1099/0022-1317-36-1-151; Korppi M, 2007, PEDIATR INFECT DIS J, V26, P316, DOI 10.1097/01.inf.0000258690.06349.91; Kretzschmar M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000291; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Lee LN, 2010, AM J PATHOL, V176, P800, DOI 10.2353/ajpath.2010.090596; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Li R, 2010, J VIROL, V84, P7105, DOI 10.1128/JVI.02542-09; Lieberman D, 1998, EUR J CLIN MICROBIOL, V17, P685, DOI 10.1007/s100960050161; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; LUNDEEN A, 2010, WHOOPING COUGH EPIDE; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Martino A, 2006, J CLIN IMMUNOL, V26, P153, DOI 10.1007/s10875-006-9009-3; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; MOSS J, 1983, J BIOL CHEM, V258, P1879; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; NENCIONI L, 1990, INFECT IMMUN, V58, P1308, DOI 10.1128/IAI.58.5.1308-1315.1990; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Newby CM, 2007, J VIROL, V81, P9469, DOI 10.1128/JVI.00989-07; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; PARFENTJEV IA, 1955, P SOC EXP BIOL MED, V90, P373, DOI 10.3181/00379727-90-22037; Prabhakar S, 2003, INFECT IMMUN, V71, P2487, DOI 10.1128/IAI.71.5.2487-2497.2003; Reid AH, 2001, MICROBES INFECT, V3, P81, DOI 10.1016/S1286-4579(00)01351-4; Ronni T, 1997, J IMMUNOL, V158, P2363; Sawal M, 2009, PEDIATR PULM, V44, P970, DOI 10.1002/ppul.21082; SCHEIBLAUER H, 1992, J INFECT DIS, V166, P783, DOI 10.1093/infdis/166.4.783; SCHULMAN JL, 1963, J EXP MED, V118, P267, DOI 10.1084/jem.118.2.267; Seki M, 2004, CLIN EXP IMMUNOL, V137, P35, DOI 10.1111/j.1365-2249.2004.02481.x; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shumilla JA, 2004, INFECT IMMUN, V72, P1450, DOI 10.1128/IAI.72.3.1450-1462.2004; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Taubenberger JK, 2000, VIROLOGY, V274, P241, DOI 10.1006/viro.2000.0495; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Teijaro JR, 2009, J IMMUNOL, V182, P6834, DOI 10.4049/jimmunol.0803860; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Veckman V, 2006, VIROLOGY, V345, P96, DOI 10.1016/j.virol.2005.09.043; Versteegh F G A, 2006, Minerva Pediatr, V58, P131; Wareing MD, 2007, J LEUKOCYTE BIOL, V81, P793, DOI 10.1189/jlb.0506299; Webster R, 2002, WHO MANUAL ANIMAL IN; WESLEY AG, 1983, S AFR MED J, V64, P577; Wijburg OLC, 1997, J VIROL, V71, P9450, DOI 10.1128/JVI.71.12.9450-9457.1997; Winters A L, 1985, Dev Biol Stand, V61, P233; WINTERS AL, 1985, INFECT IMMUN, V47, P587, DOI 10.1128/IAI.47.3.587-591.1985; Wong WSF, 1996, CAN J PHYSIOL PHARM, V74, P559, DOI 10.1139/cjpp-74-5-559; WYDE PR, 1982, INFECT IMMUN, V38, P1249, DOI 10.1128/IAI.38.3.1249-1255.1982; Xu YF, 2010, P NATL ACAD SCI USA, V107, P2950, DOI 10.1073/pnas.0912717107; Zavitz CCJ, 2010, J IMMUNOL, V184, P2001, DOI 10.4049/jimmunol.0903304; Zhang WJ, 1996, J IMMUNOL, V157, P5049; 2010, PERTUSSIS OUTBREAKS	94	22	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19016	10.1371/journal.pone.0019016	http://dx.doi.org/10.1371/journal.pone.0019016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533103	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400049
J	Ding, LN; Xu, HB; Yi, HY; Yang, LM; Kong, ZX; Zhang, LX; Xue, SL; Jia, HY; Ma, ZQ				Ding, Lina; Xu, Haibin; Yi, Hongying; Yang, Liming; Kong, Zhongxin; Zhang, Lixia; Xue, Shulin; Jia, Haiyan; Ma, Zhengqiang			Resistance to Hemi-Biotrophic F-graminearum Infection Is Associated with Coordinated and Ordered Expression of Diverse Defense Signaling Pathways	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; PHOSPHATIDIC-ACID ACCUMULATION; PATTERN-RECOGNITION RECEPTORS; SYSTEMIC ACQUIRED-RESISTANCE; JASMONATE-DEPENDENT DEFENSE; HYPERSENSITIVE CELL-DEATH; X WANGSHUIBAI POPULATION; SALICYLIC-ACID; WHEAT SPIKES; OXIDATIVE BURST	Fusarium species cause serious diseases in cereal staple food crops such as wheat and maize. Currently, the mechanisms underlying resistance to Fusarium-caused diseases are still largely unknown. In the present study, we employed a combined proteomic and transcriptomic approach to investigate wheat genes responding to F. graminearum infection that causes Fusarium head blight (FHB). We found a total of 163 genes and 37 proteins that were induced by infection. These genes and proteins were associated with signaling pathways mediated by salicylic acid (SA), jasmonic acid (JA), ethylene (ET), calcium ions, phosphatidic acid (PA), as well as with reactive oxygen species (ROS) production and scavenging, antimicrobial compound synthesis, detoxification, and cell wall fortification. We compared the time-course expression profiles between FHB-resistant Wangshuibai plants and susceptible Meh0106 mutant plants of a selected set of genes that are critical to the plants' resistance and defense reactions. A biphasic phenomenon was observed during the first 24 h after inoculation (hai) in the resistant plants. The SA and Ca2+ signaling pathways were activated within 6 hai followed by the JA mediated defense signaling activated around 12 hai. ET signaling was activated between these two phases. Genes for PA and ROS synthesis were induced during the SA and JA phases, respectively. The delayed activation of the SA defense pathway in the mutant was associated with its susceptibility. After F. graminearum infection, the endogenous contents of SA and JA in Wangshuibai and the mutant changed in a manner similar to the investigated genes corresponding to the individual pathways. A few genes for resistance-related cell modification and phytoalexin production were also identified. This study provided important clues for designing strategies to curb diseases caused by Fusarium.	[Ding, Lina; Xu, Haibin; Yi, Hongying; Yang, Liming; Kong, Zhongxin; Zhang, Lixia; Xue, Shulin; Jia, Haiyan; Ma, Zhengqiang] Nanjing Agr Univ, Appl Plant Genom Lab, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Ding, Lina; Xu, Haibin; Yi, Hongying; Yang, Liming; Kong, Zhongxin; Zhang, Lixia; Xue, Shulin; Jia, Haiyan; Ma, Zhengqiang] Nanjing Agr Univ, Crop Genom & Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China; [Yang, Liming] Huaiyin Normal Univ, Huaian, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Huaiyin Normal University	Ma, ZQ (corresponding author), Nanjing Agr Univ, Appl Plant Genom Lab, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.; Ma, ZQ (corresponding author), Nanjing Agr Univ, Crop Genom & Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China.	zqm2@njau.edu.cn	Ma, Zhengqiang/AAQ-9160-2021; Ma, Zhengqiang/AAI-9876-2020	Ma, Zhengqiang/0000-0003-4950-5387; 	'863' program [2006AA10A104]; '973' program [2004CB117205]; NSFC [31030054, 30430440, 30025030, 30721140555]; MOE	'863' program(National High Technology Research and Development Program of China); '973' program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); MOE(Ministry of Higher Education & Scientific Research (MHESR))	This study was partially supported by '863' program (2006AA10A104), '973' program (2004CB117205), NSFC programs (31030054, 30430440, 30025030, 30721140555), and '111' project of MOE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABELES FB, 1971, PLANT PHYSIOL, V47, P129, DOI 10.1104/pp.47.1.129; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Bernardo A, 2007, FUNCT INTEGR GENOMIC, V7, P69, DOI 10.1007/s10142-006-0028-1; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Bogacki P, 2008, MOL PLANT PATHOL, V9, P645, DOI 10.1111/J.1364-3703.2008.00485.X; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chen J, 2007, PROTOPLASMA, V230, P13, DOI 10.1007/s00709-006-0195-x; Chen X, 2009, NEW PHYTOL, V182, P975, DOI 10.1111/j.1469-8137.2009.02821.x; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cuzick A, 2008, MOL PLANT PATHOL, V9, P697, DOI [10.1111/j.1364-3703.2008.00488.x, 10.1111/J.1364-3703.2008.00488.X]; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; de Ilarduya OM, 2003, MOL PLANT MICROBE IN, V16, P699, DOI 10.1094/MPMI.2003.16.8.699; de Jong CF, 2004, PLANT J, V39, P1, DOI 10.1111/j.1365-313X.2004.02110.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Fung F, 2004, J TOXICOL-CLIN TOXIC, V42, P217, DOI 10.1081/CLT-120030947; Geddes J, 2008, PROTEOMICS, V8, P545, DOI 10.1002/pmic.200700115; Geraats BPJ, 2002, MOL PLANT MICROBE IN, V15, P1078, DOI 10.1094/MPMI.2002.15.10.1078; Golkari S, 2007, PLANT BIOTECHNOL J, V5, P38, DOI 10.1111/j.1467-7652.2006.00213.x; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; He CY, 2001, EUR J PLANT PATHOL, V107, P473, DOI 10.1023/A:1011218304331; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jarosch B, 2003, MOL PLANT MICROBE IN, V16, P107, DOI 10.1094/MPMI.2003.16.2.107; Jia HY, 2009, MOL PLANT MICROBE IN, V22, P1366, DOI 10.1094/MPMI-22-11-1366; Johansson A, 2006, MOL PLANT MICROBE IN, V19, P958, DOI 10.1094/MPMI-19-0958; Kang Z, 2000, PHYSIOL MOL PLANT P, V57, P255, DOI 10.1006/pmpp.2000.0305; Kang Z, 2003, J PHYTOPATHOL, V151, P120, DOI 10.1046/j.1439-0434.2003.00693.x; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Kong L, 2007, GENOME, V50, P1038, DOI 10.1139/G07-085; Krinke O, 2009, PLANT PHYSIOL, V150, P424, DOI 10.1104/pp.108.133595; Kruger WM, 2002, MOL PLANT MICROBE IN, V15, P445, DOI 10.1094/MPMI.2002.15.5.445; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Laxalt AM, 2007, J BIOL CHEM, V282, P21160, DOI 10.1074/jbc.M701212200; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; LEE HI, 1995, P NATL ACAD SCI USA, V92, P4076, DOI 10.1073/pnas.92.10.4076; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; LEON J, 1995, PLANT PHYSIOL, V108, P1673, DOI 10.1104/pp.108.4.1673; Leon-Reyes A, 2010, MOL PLANT MICROBE IN, V23, P187, DOI 10.1094/MPMI-23-2-0187; LEVIN DA, 1976, ANNU REV ECOL SYST, V7, P121, DOI 10.1146/annurev.es.07.110176.001005; Lherminier J, 2009, MOL PLANT MICROBE IN, V22, P868, DOI 10.1094/MPMI-22-7-0868; Li GL, 2008, CROP SCI, V48, P1888, DOI 10.2135/cropsci2008.02.0097; Li WL, 2001, THEOR APPL GENET, V102, P353, DOI 10.1007/s001220051653; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; LI Y, 2011, PHYTOCHEM A IN PRESS; Lin F, 2006, THEOR APPL GENET, V112, P528, DOI 10.1007/s00122-005-0156-3; Lin F, 2004, THEOR APPL GENET, V109, P1504, DOI 10.1007/s00122-004-1772-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lu ZX, 2005, PHYSIOL MOL PLANT P, V67, P138, DOI 10.1016/j.pmpp.2005.12.001; Makandar R, 2006, MOL PLANT MICROBE IN, V19, P123, DOI 10.1094/MPMI-19-0123; Makandar R, 2010, MOL PLANT MICROBE IN, V23, P861, DOI 10.1094/MPMI-23-7-0861; MARTIN JT, 1964, ANNU REV PHYTOPATHOL, V2, P81100; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Nganje W. E., 2002, 2002 NAT FUS HEAD BL, P275; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; OLSON PD, 1993, PLANT J, V4, P887, DOI 10.1046/j.1365-313X.1993.04050887.x; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHI JR, 1999, PLANT PROTECTION, V2, P17; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Steiner B, 2009, THEOR APPL GENET, V118, P753, DOI 10.1007/s00122-008-0935-8; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Thomma BPHJ, 1999, PLANT J, V19, P163, DOI 10.1046/j.1365-313X.1999.00513.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; van Damme M, 2008, PLANT J, V54, P785, DOI 10.1111/j.1365-313X.2008.03427.x; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; WOLPERT TJ, 1994, PLANT CELL, V6, P1145, DOI 10.1105/tpc.6.8.1145; Xu HB, 2007, PROTEOMICS, V7, P177, DOI 10.1002/pmic.200600508; Yamaguchi T, 2005, PLANT CELL PHYSIOL, V46, P579, DOI 10.1093/pcp/pci065; Yoda H, 2006, PLANT PHYSIOL, V142, P193, DOI 10.1104/pp.106.080515; Yu ZL, 2008, J INTEGR PLANT BIOL, V50, P157, DOI 10.1111/j.1744-7909.2007.00609.x; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zhou WC, 2005, GENOME, V48, P770, DOI 10.1139/g05-041; Zuppini A, 2004, J CELL SCI, V117, P2591, DOI 10.1242/jcs.01126	107	155	170	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19008	10.1371/journal.pone.0019008	http://dx.doi.org/10.1371/journal.pone.0019008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533105	Green Submitted, Green Published, gold			2022-12-25	WOS:000289719400048
J	McGehee, AM; Strijbis, K; Guillen, E; Eng, T; Kirak, O; Ploegh, HL				McGehee, Annette M.; Strijbis, Karin; Guillen, Eduardo; Eng, Thomas; Kirak, Oktay; Ploegh, Hidde L.			Ubiquitin-Dependent Control of Class II MHC Localization Is Dispensable for Antigen Presentation and Antibody Production	PLOS ONE			English	Article							DENDRITIC CELLS; TRANSGENIC MICE; MEMBRANE; EXPRESSION; MATURATION; TRANSPORT; SELECTION; SURFACE; GENES	Controlled localization of class II MHC molecules is essential for proper class II MHC-restricted antigen presentation and the subsequent initiation of an adaptive immune response. Ubiquitination of class II MHC molecules on cytosolic lysine (K225) of the beta-chain has been shown to affect localization of the complex. We generated mice in which the endogenous beta-chain locus is replaced with a GFP tagged mutant version that lacks the cytosolic lysine residue (I-A-beta-K225R-EGFP). These mice have elevated levels of class II MHC as compared to I-A-beta-EGFP mice, and immature bone marrow-derived dendritic cells show redistribution of class II MHC to the cell surface. Nonetheless, in these same cells efficiency of antigen presentation is unaffected in I-A-beta-K225R-EGFP mice, as assayed for presentation of ovalbumin to appropriately specific T cells. The I-A-beta-K225R-EGFP animals have normal CD4 T cell populations and are capable of generating antigen-specific antibody in response to model antigens and viral infection. We therefore conclude that in our experimental system modulation of trafficking by ubiquitination of residue K225 of the b-chain is not essential for the function of class II MHC products in antigen presentation or antibody production.	[McGehee, Annette M.; Strijbis, Karin; Guillen, Eduardo; Eng, Thomas; Kirak, Oktay; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	McGehee, AM (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA.	ploegh@wi.mit.edu	Kirak, Oktay/H-6347-2013; Eng, Thomas/AAV-5157-2020	Kirak, Oktay/0000-0002-6524-4685; Eng, Thomas/0000-0002-4974-3863; McGehee, Annette/0000-0002-8175-3404; Strijbis, Karin/0000-0001-9167-7137	National Science Foundation (NSF); Netherlands Science Organization NOW	National Science Foundation (NSF)(National Science Foundation (NSF)); Netherlands Science Organization NOW	M. M. was supported by a National Science Foundation (NSF) Graduate Research Fellowship. K. S. was supported by a Rubicon Fellowship from the Netherlands Science Organization NOW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Rehm A, 2001, EMBO J, V20, P1573, DOI 10.1093/emboj/20.7.1573; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Siemasko K, 2001, CURR OPIN IMMUNOL, V13, P32, DOI 10.1016/S0952-7915(00)00178-3; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665	20	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18817	10.1371/journal.pone.0018817	http://dx.doi.org/10.1371/journal.pone.0018817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533087	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400027
J	Calderon-Cortes, N; Quesada, M; Escalera-Vazquez, LH				Calderon-Cortes, Nancy; Quesada, Mauricio; Escalera-Vazquez, Luis H.			Insects as Stem Engineers: Interactions Mediated by the Twig-Girdler Oncideres albomarginata chamela Enhance Arthropod Diversity	PLOS ONE			English	Article							TROPICAL DECIDUOUS FOREST; WOOD-BORING INSECTS; ECOSYSTEM ENGINEERS; HOST-PLANT; BORER; CERAMBYCIDAE; BIODIVERSITY; COLEOPTERA; HERBIVORY; MUTUALISM	Background: Ecosystem engineering may influence community structure and biodiversity by controlling the availability of resources and/or habitats used by other organisms. Insect herbivores may act as ecosystem engineers but there is still poor understanding of the role of these insects structuring arthropod communities. Methodology/Principal Findings: We evaluated the effect of ecosystem engineering by the stem-borer Oncideres albomarginata chamela on the arthropod community of a tropical dry forest for three consecutive years. The results showed that ecosystem engineering by O. albomarginata chamela had strong positive effects on the colonization, abundance, species richness and composition of the associated arthropod community, and it occurred mainly through the creation of a habitat with high availability of oviposition sites for secondary colonizers. These effects cascade upward to higher trophic levels. Overall, ecosystem engineering by O. albomarginata chamela was responsible for nearly 95% of the abundance of secondary colonizers and 82% of the species richness. Conclusions/Significance: Our results suggest that ecosystem engineering by O. albomarginata chamela is a keystone process structuring an arthropod community composed by xylovores, predators and parasitoids. This study is the first to empirically demonstrate the effect of the ecosystem engineering by stem-boring insects on important attributes of arthropod communities. The results of this study have important implications for conservation.	[Calderon-Cortes, Nancy; Quesada, Mauricio] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Escalera-Vazquez, Luis H.] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Calderon-Cortes, N (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	ncalderon@oikos.unam.mx		Quesada, Mauricio/0000-0002-7776-9286	Inter-American Institute for Global Change Research (IAI) by the US National Science Foundation [021, GEO-0452325]; National Council of Science and Technology (CONACyT), Mexico [CONACyT 31826-N, U50863Q, SEMARNAT-CONACyT 2002-C01-0597, 2002-C01-0544]; Direccion General de Asuntos del Personal Academico at the Universidad Nacional Autonoma de Mexico (UNAM) [IN221305, IN224108]; CONACyT [164921]; UNAM; Direccion General de Estudios en Posgrado (DGEP-UNAM)	Inter-American Institute for Global Change Research (IAI) by the US National Science Foundation; National Council of Science and Technology (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico at the Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM(Universidad Nacional Autonoma de Mexico); Direccion General de Estudios en Posgrado (DGEP-UNAM)(Universidad Nacional Autonoma de Mexico)	This study was supported by Inter-American Institute for Global Change Research (IAI) CRN II # 021 by the US National Science Foundation (grant GEO-0452325), and by grants from the National Council of Science and Technology (CONACyT), Mexico (CONACyT 31826-N, U50863Q; SEMARNAT-CONACyT 2002-C01-0597 and 2002-C01-0544, and CONACyT sabbatical fellowship to MQ) and the Direccion General de Asuntos del Personal Academico at the Universidad Nacional Autonoma de Mexico (UNAM) (grants # IN221305 and IN224108). CONACyT (scholarship # 164921), the Graduate Program in Biological Sciences, UNAM, and the Direccion General de Estudios en Posgrado (DGEP-UNAM) provided financial support for graduate studies to NCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Amman GD., 1977, ROLE ARTHROPODS FORE, P3; [Anonymous], 2006, SAS MIXED MODELS; Arnett Jr RH, 1963, BEETLES US MANUAL ID; AUKEMA BH, 2002, POPUL ECOL, P483; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Binda F., 1991, Boletin de Entomologia Venezolana, V6, P83; BULLOCK SH, 1992, BIOTROPICA, V24, P140, DOI 10.2307/2388667; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; BULLOCK SH, 1988, FOLIA ENTOMOLOGICA M, V77, P5; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Calderon-Cortes N, 2010, INSECT MOL BIOL, V19, P323, DOI 10.1111/j.1365-2583.2010.00991.x; Chemsak John A., 1993, Folia Entomologica Mexicana, V0, P55; Daleo P, 2007, ECOL LETT, V10, P902, DOI 10.1111/j.1461-0248.2007.01082.x; Damman Hans, 1993, P132; DiIorio OR, 1996, REV BIOL TROP, V44, P551; Duffy E.A.J., 1960, MONOGRAPH IMMATURE S; Duval BD, 2008, ECOL ENTOMOL, V33, P161, DOI 10.1111/j.1365-2311.2007.00928.x; Equihua M. A., 1986, FL ENTOMOL, V69, P619; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Feller IC, 1997, BIOTROPICA, V29, P440, DOI 10.1111/j.1744-7429.1997.tb00038.x; Feller IC, 1999, BIOTROPICA, V31, P607, DOI 10.1111/j.1744-7429.1999.tb00408.x; Feller IC, 2002, OIKOS, V97, P167, DOI 10.1034/j.1600-0706.2002.970202.x; FORCELLA F, 1982, NATURWISSENSCHAFTEN, V69, P398, DOI 10.1007/BF00396699; GERBERG EUGENE J., 1957, U S DEPT AGRIC TECH BULL, V1157, P1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gotelli NJ, 2004, ECOSIM NULL MODELS S; Hairston N. G., 1989, ECOLOGICAL EXPT PURP; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; Hastings A, 2007, ECOL LETT, V10, P153, DOI 10.1111/j.1461-0248.2006.00997.x; Helbig J, 1996, J STORED PROD RES, V32, P91, DOI 10.1016/0022-474X(95)00030-B; HOVORE FT, 1982, SOUTHWEST NAT, V27, P23, DOI 10.2307/3671403; Johnson SN, 2002, FUNCT ECOL, V16, P575, DOI 10.1046/j.1365-2435.2002.00654.x; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kagata H, 2004, ANN ENTOMOL SOC AM, V97, P923, DOI 10.1603/0013-8746(2004)097[0923:LMAAPE]2.0.CO;2; Kenis M, 2004, BARK AND WOOD BORING INSECTS IN LIVING TREES IN EUROPE, A SYNTHESIS, P475; Lieutier F., 2004, BARK WOOD BORING INS, P1; Lill JT, 2003, ECOLOGY, V84, P682, DOI 10.1890/0012-9658(2003)084[0682:EEBCII]2.0.CO;2; Maass JM, 2002, J TROP ECOL, V18, P821, DOI 10.1017/S0266467402002535; Marquis Robert J., 2007, P246, DOI 10.1017/CBO9780511542701.012; Martinez AJ, 2009, POPUL ECOL, V51, P533, DOI 10.1007/s10144-009-0149-1; Martinsen GD, 1998, ECOLOGY, V79, P192, DOI 10.1890/0012-9658(1998)079[0192:IIMBCP]2.0.CO;2; Martinsen GD, 2000, OECOLOGIA, V123, P82, DOI 10.1007/s004420050992; Morin P., 1999, COMMUNITY ECOL; Noguera Felipe A., 1994, Folia Entomologica Mexicana, V88, P9; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; POLK KL, 1973, ANN ENTOMOL SOC AM, V66, P411, DOI 10.1093/aesa/66.2.411; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; RAMIREZMARTINEZ M, 1994, J APPL ENTOMOL, V118, P354, DOI 10.1111/j.1439-0418.1994.tb00811.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; *SAS I, 2010, SAS SOFTW VERS 9 2; SCHOWALTER TD, 1981, OIKOS, V37, P126, DOI 10.2307/3544083; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Tilman D., 1982, Monographs in Population Biology, pi; Uribe-Mu CA, 2006, OIKOS, V112, P691, DOI 10.1111/j.0030-1299.2006.13957.x; Utsumi S, 2009, OIKOS, V118, P1805, DOI 10.1111/j.1600-0706.2009.17580.x; Waltz AM, 1997, ECOLOGY, V78, P2133, DOI 10.1890/0012-9658(1997)078[2133:PDAACO]2.0.CO;2; Wright JP, 2004, ECOLOGY, V85, P2071, DOI 10.1890/02-8018	61	44	46	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19083	10.1371/journal.pone.0019083	http://dx.doi.org/10.1371/journal.pone.0019083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526161	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100048
J	Deribew, A; Negussu, N; Melaku, Z; Deribe, K				Deribew, Amare; Negussu, Nebiyu; Melaku, Zenebe; Deribe, Kebede			Investigation Outcomes of Tuberculosis Suspects in the Health Centers of Addis Ababa, Ethiopia	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; RISK-FACTORS; PREVENTIVE THERAPY; SOUTH-AFRICA; TB SUSPECTS; HIV; PREVALENCE; INFECTION	Background: Little is known about the prevalence of tuberculosis (TB) and HIV among TB suspects in primary health care units in Ethiopia. Methods: In the period of February to March, 2009, a cross sectional survey was done in 27 health centers of Addis Ababa to assess the prevalence of TB and HIV among TB suspects who have >= 2 weeks symptoms of TB such as cough, fever and weight loss. Diagnosis of TB and HIV was based on the national guidelines. Information concerning socio-demographic variables and knowledge of the respondents about TB was collected using pretested questionnaire. Results: Of the 545 TB suspects, 506 (92.7%) of them participated in the study. The prevalence of both pulmonary and extra pulmonary TB was 46.0% (233/506). The smear positivity rate among pulmonary TB suspect was 21.3%. Of the TB suspects, 298 (58.9%) of them were tested for HIV and 27.2% (81/298) were HIV seropositive. Fifty percent of the HIV positive TB suspects had TB. TB suspects who had a contact history with a TB patient in the family were 9 times more likely to have TB than those who did not have a contact history, [OR = 9.1, (95%CI:4.0, 20.5)]. Individuals who had poor [OR = 5.2, (95% CI: 2.3, 11.2)] and fair knowledge [OR = 3.7, (95% CI: 1.3, 10.4)] about TB were more likely to have TB than individuals who had good knowledge. Conclusion: In conclusion, the prevalence of TB among TB suspects with duration of 2 or more weeks is high. Fifty percent of the HIV positive TB suspects had TB. Case finding among TB suspects with duration of 2 or more weeks should be intensified particularly among those who have a contact history with a TB patient.	[Deribew, Amare] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Negussu, Nebiyu] Somali Reg Hlth Bur, Jijiga, Ethiopia; [Melaku, Zenebe] Int Ctr AIDS Care & Treatment Program ICAP, Addis Ababa, Ethiopia; [Deribe, Kebede] Jimma Univ, Dept Gen Publ Hlth, Jimma, Ethiopia	Jimma University; Jimma University	Deribew, A (corresponding author), Jimma Univ, Dept Epidemiol, Jimma, Ethiopia.	amare_deribew@yahoo.com	Deribe, Kebede/K-7055-2019; Deribe, Kebede/I-5422-2019	Deribe, Kebede/0000-0002-8526-6996; Deribew, Amare/0000-0003-2031-6080	Jimma University	Jimma University	The study was funded by Jimma University. The funder had no role in the study design, data collection, and analysis, decision to publish or preparation of the manuscript.	[Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; Ariyothai Niorn, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P219; *AUTH ETH, 2000, SPUT EX TUB DIR MICR; Ayenew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009702; Banda HT, 1998, T ROY SOC TROP MED H, V92, P161, DOI 10.1016/S0035-9203(98)90727-1; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Bruchfeld J, 2002, SCAND J INFECT DIS, V34, P331, DOI 10.1080/00365540110080025; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; *CENTR STAT AUTH E, 2008, SUMM STAT REP 2007 P; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; Demissie M, 2002, INT J TUBERC LUNG D, V6, P580; Deribew A, 2010, INT J TUBERC LUNG D, V14, P1442; *FED MIN HLTH ETH, 2005, BEH SURV SURV 2005; Federal Ministry of Health Ethiopia, 2007, TB LEPR TB HIV PREV; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Kassu Afework, 2007, Journal of Microbiology Immunology and Infection, V40, P116; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Lin HH, 2009, AM J RESP CRIT CARE, V180, P475, DOI 10.1164/rccm.200904-0549OC; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Romero-Sandoval NC, 2007, INT J TUBERC LUNG D, V11, P550; Sanchez-Perez HJ, 2001, INT J EPIDEMIOL, V30, P386, DOI 10.1093/ije/30.2.386; SHABBIR I, 1995, J TROP MED HYG, V98, P338; Shah NS, 2008, INT J TUBERC LUNG D, V12, P404; Shargie EB, 2006, B WORLD HEALTH ORGAN, V84, P112, DOI 10.2471/BLT.05.024489; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; Tatek Wondimu, 2007, Ethiopian Journal of Health Development, V21, P148; Wesen Amenu, 2009, Ethiop Med J, V47, P109; *WHO, 2004, INT POL COLL TB HIV; WHO, 2009, WHOHTMTB2009411; *WHO, 2004, WHOHTMTB200433; Yassin MA, 2004, SCAND J INFECT DIS, V36, P670, DOI 10.1080/00365540410020848; Yimer S, 2009, INT J TUBERC LUNG D, V13, P1399	37	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18614	10.1371/journal.pone.0018614	http://dx.doi.org/10.1371/journal.pone.0018614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526179	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100013
J	Eller, MA; Blom, KG; Gonzalez, VD; Eller, LA; Naluyima, P; Laeyendecker, O; Quinn, TC; Kiwanuka, N; Serwadda, D; Sewankambo, NK; Tasseneetrithep, B; Wawer, MJ; Gray, RH; Marovich, MA; Michael, NL; de Souza, MS; Wabwire-Mangen, F; Robb, ML; Currier, JR; Sandberg, JK				Eller, Michael A.; Blom, Kim G.; Gonzalez, Veronica D.; Eller, Leigh Anne; Naluyima, Prossy; Laeyendecker, Oliver; Quinn, Thomas C.; Kiwanuka, Noah; Serwadda, David; Sewankambo, Nelson K.; Tasseneetrithep, Boonrat; Wawer, Maria J.; Gray, Ronald H.; Marovich, Mary A.; Michael, Nelson L.; de Souza, Mark S.; Wabwire-Mangen, Fred; Robb, Merlin L.; Currier, Jeffrey R.; Sandberg, Johan K.			Innate and Adaptive Immune Responses Both Contribute to Pathological CD4 T Cell Activation in HIV-1 Infected Ugandans	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; AFRICAN-GREEN MONKEYS; MICROBIAL TRANSLOCATION; VIRAL LOAD; DISEASE PROGRESSION; PERIPHERAL-BLOOD; LYMPHOCYTE-ACTIVATION; VIRUS-INFECTIONS; PD-1 EXPRESSION; RAKAI DISTRICT	HIV-1 disease progression is associated with persistent immune activation. However, the nature of this association is incompletely understood. Here, we investigated immune activation in the CD4 T cell compartment of chronically HIV-1 infected individuals from Rakai, Uganda. Levels of CD4 T cell activation, assessed as co-expression of PD-1, CD38 and HLA-DR, correlated directly to viral load and inversely to CD4 count. Deeper characterization of these cells indicated an effector memory phenotype with relatively frequent expression of Ki67 despite their PD-1 expression, and levels of these cells were inversely associated with FoxP3+ regulatory T cells. We therefore use the term deregulated effector memory (DEM) cells to describe them. CD4 T cells with a DEM phenotype could be generated by antigen stimulation of recall responses in vitro. Responses against HIV-1 and CMV antigens were enriched among the DEM CD4 T cells in patients, and the diverse V beta repertoire of DEM CD4 T cells suggested they include diverse antigen-specificities. Furthermore, the levels of DEM CD4 T cells correlated directly to soluble CD14 (sCD14) and IL-6, markers of innate immune activation, in plasma. The size of the activated DEM CD4 T cell subset was predictive of the rate of disease progression, whereas IL-6 was only weakly predictive and sCD14 was not predictive. Taken together, these results are consistent with a model where systemic innate immune activation and chronic antigen stimulation of adaptive T cell responses both play important roles in driving pathological CD4 T cell immune activation in HIV-1 disease.	[Eller, Michael A.; Eller, Leigh Anne; Naluyima, Prossy; Wabwire-Mangen, Fred] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Eller, Michael A.; Eller, Leigh Anne; Tasseneetrithep, Boonrat; Marovich, Mary A.; Michael, Nelson L.; de Souza, Mark S.; Robb, Merlin L.; Currier, Jeffrey R.] US Mil HIV Res Program, Rockville, MD USA; [Eller, Michael A.; Blom, Kim G.; Gonzalez, Veronica D.; Sandberg, Johan K.] Karolinska Inst, Ctr Infect Med, Dept Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, NIH, Bethesda, MD 20892 USA; [Laeyendecker, Oliver; Quinn, Thomas C.] Johns Hopkins Sch Med, Baltimore, MD USA; [Kiwanuka, Noah; Serwadda, David; Wabwire-Mangen, Fred] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Kiwanuka, Noah; Serwadda, David; Sewankambo, Nelson K.; Wawer, Maria J.; Gray, Ronald H.] Uganda Virus Res Inst, Rakai Hlth Sci Program, Entebbe, Uganda; [Sewankambo, Nelson K.] Makerere Univ, Fac Med, Coll Hlth Sci, Kampala, Uganda; [Tasseneetrithep, Boonrat] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Wawer, Maria J.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Gray, Ronald H.] Johns Hopkins Ctr Global Hlth, Baltimore, MD USA; [de Souza, Mark S.] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand	Makerere University; Walter Reed Army Institute of Research (WRAIR); Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Medicine; Makerere University; Rakai Health Sciences Program; Uganda Virus Research Institute; Makerere University; Mahidol University; Columbia University; Johns Hopkins University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Eller, MA (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	johan.sandberg@ki.se	Laeyendecker, Oliver B/B-9331-2009; Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877; Sewankambo, Nelson/0000-0001-9362-053X; Laeyendecker, Oliver/0000-0002-6429-4760; Sandberg, Johan/0000-0002-6275-0750; Blom, Kim/0000-0002-5286-3735; Naluyima, Prossy/0000-0001-6911-2199	National Institute of Allergy and Infectious Diseases (NIAID) [R01 A134826, R01 A134265]; National Institute of Child and Health Development [5P30HD06826]; Fogarty Foundation [5D43TW00010]; NIH [R01 A134826]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, ZIAAI001040] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child and Health Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Primary support was provided by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U. S. Department of Defense. Data collection was supported, in part, by grants R01 A134826 and R01 A134265 from the National Institute of Allergy and Infectious Diseases (NIAID); grant 5P30HD06826 from the National Institute of Child and Health Development; grant 5D43TW00010 from the Fogarty Foundation and NIH grant R01 A134826. Additional support was provided by the Swedish Research Council, the Swedish Cancer Foundation, the Stockholm County Council, Karolinska Institutet, and the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Barry SM, 2003, JAIDS-J ACQ IMM DEF, V34, P351, DOI 10.1097/00126334-200312010-00001; BIRX DL, 1990, BLOOD, V76, P2303; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; BREEN EC, 1990, J IMMUNOL, V144, P480; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; D'Souza M, 2007, J IMMUNOL, V179, P1979, DOI 10.4049/jimmunol.179.3.1979; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; GIORGI JV, 1989, CLIN IMMUNOL IMMUNOP, V52, P10, DOI 10.1016/0090-1229(89)90188-8; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hoshino S, 2010, J LEUKOCYTE BIOL, V87, P1133, DOI 10.1189/jlb.0809547; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Leinert C, 2010, J MED PRIMATOL, V39, P243, DOI 10.1111/j.1600-0684.2010.00429.x; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Milush JM, 2007, J IMMUNOL, V179, P3047, DOI 10.4049/jimmunol.179.5.3047; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Olemukan RE, 2010, CLIN VACCINE IMMUNOL, V17, P910, DOI 10.1128/CVI.00492-09; Onlamoon N, 2008, IMMUNOLOGY, V124, P277, DOI 10.1111/j.1365-2567.2007.02766.x; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Thomas C, 2009, NAT MED, V15, P855, DOI 10.1038/nm0809-855; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662	49	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18779	10.1371/journal.pone.0018779	http://dx.doi.org/10.1371/journal.pone.0018779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526194	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100021
J	Mai, XQ; Tardif, T; Doan, SN; Liu, C; Gehring, WJ; Luo, YJ				Mai, Xiaoqin; Tardif, Twila; Doan, Stacey N.; Liu, Chao; Gehring, William J.; Luo, Yue-Jia			Brain Activity Elicited by Positive and Negative Feedback in Preschool-Aged Children	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; REWARD MAGNITUDE; ERROR; PICTURES; STIMULI; BAD; IMMATURITY; MATURATION; MOTIVATION; RESPONSES	To investigate the processing of positive vs. negative feedback in children aged 4-5 years, we devised a prize-guessing game that is analogous to gambling tasks used to measure feedback-related brain responses in adult studies. Unlike adult studies, the feedback-related negativity (FRN) elicited by positive feedback was as large as that elicited by negative feedback, suggesting that the neural system underlying the FRN may not process feedback valence in early childhood. In addition, positive feedback, compared with negative feedback, evoked a larger P1 over the occipital scalp area and a larger positive slow wave (PSW) over the right central-parietal scalp area. We believe that the PSW is related to emotional arousal and the intensive focus on positive feedback that is present in the preschool and early school years has adaptive significance for both cognitive and emotional development during this period.	[Mai, Xiaoqin; Tardif, Twila] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Tardif, Twila; Gehring, William J.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Doan, Stacey N.] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Liu, Chao; Luo, Yue-Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Boston University; Beijing Normal University	Mai, XQ (corresponding author), Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA.	twila@umich.edu; luoyj@bnu.edu.cn	Liu, Chao/E-9068-2017	Liu, Chao/0000-0003-1149-2314; Doan, Stacey/0000-0003-3661-2175; Tardif, Twila Z/0000-0001-8739-9090	NSF on Emotion Regulation as a Complex System [SES-0527475]; Center for Human Growth and Development; NSFC [30930031]; Ministry of Sci Tech [2011CB711001]; National Key Technologies RD Program [2009BAI77B01]; NIH, USA [1R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	NSF on Emotion Regulation as a Complex System; Center for Human Growth and Development; NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Sci Tech; National Key Technologies RD Program(National Key Technology R&D Program); NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by NSF grant SES-0527475 on Emotion Regulation as a Complex System, internal funding from the Center for Human Growth and Development to TT, and by NSFC (30930031), Ministry of Sci & Tech (973 Program, 2011CB711001), National Key Technologies R&D Program (2009BAI77B01) and Global Research Initiative Program, NIH, USA (1R01TW007897) to Y-JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WH, 2010, TOP COGN SCI, V2, P658, DOI 10.1111/j.1756-8765.2010.01085.x; Alorda C, 2007, NEUROPSYCHOLOGIA, V45, P3223, DOI 10.1016/j.neuropsychologia.2007.06.017; BARRETT SE, 1990, BRAIN COGNITION, V14, P201, DOI 10.1016/0278-2626(90)90029-N; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Bjorklund DF, 1997, PSYCHOL BULL, V122, P153, DOI 10.1037/0033-2909.122.2.153; BJORKLUND DF, 1992, AM PSYCHOL, V47, P46, DOI 10.1037/0003-066X.47.1.46; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COLE PM, 1986, CHILD DEV, V57, P1309, DOI 10.2307/1130411; Crone EA, 2004, DEVELOPMENTAL SCI, V7, P443, DOI 10.1111/j.1467-7687.2004.00365.x; Crone EA, 2008, COGN AFFECT BEHAV NE, V8, P165, DOI 10.3758/CABN.8.2.165; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Davies PL, 2004, ANN NY ACAD SCI, V1021, P324, DOI 10.1196/annals.1308.039; DeBoer T., 2005, EVENT RELATED POTENT, P263; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Eppinger B, 2009, PSYCHOPHYSIOLOGY, V46, P1043, DOI 10.1111/j.1469-8986.2009.00838.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; Groen Y, 2007, BIOL PSYCHOL, V76, P174, DOI 10.1016/j.biopsycho.2007.07.006; Groen Y, 2008, CLIN NEUROPHYSIOL, V119, P2476, DOI 10.1016/j.clinph.2008.08.004; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2009, BIOL PSYCHOL, V80, P333, DOI 10.1016/j.biopsycho.2008.11.006; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; HARACKIEWICZ JM, 1986, J PERS SOC PSYCHOL, V51, P547; Heller W., 1993, NEUROPSYCHOLOGY, V7, P476, DOI [10.1037/0894-4105.7.4.476, DOI 10.1037/0894-4105.7.4.476]; Hewig J, 2007, CEREB CORTEX, V17, P865, DOI 10.1093/cercor/bhk040; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hogan AM, 2005, DEVELOPMENTAL SCI, V8, P525, DOI 10.1111/j.1467-7687.2005.00444.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Lambe EK, 2000, J NEUROSCI, V20, P8780; Liu C, 2010, HUM BRAIN MAPP, V31, P1786, DOI 10.1002/hbm.20974; Liu YN, 2009, NEUROREPORT, V20, P632, DOI 10.1097/WNR.0b013e32832a3250; Luo Y.J., 2011, CULTURE NEURAL FRAME, P249, DOI [10.1007/978-3-642-15423-2_16, DOI 10.1007/978-3-642-15423-2_16]; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; ROSENBERG DR, 1995, J COMP NEUROL, V358, P383, DOI 10.1002/cne.903580306; SAARNI C, 1984, CHILD DEV, V55, P1504, DOI 10.2307/1130020; Sato A, 2005, NEUROREPORT, V16, P407, DOI 10.1097/00001756-200503150-00020; SCHWARTZ GE, 1975, SCIENCE, V190, P286, DOI 10.1126/science.1179210; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; van Meel CS, 2005, NEUROPSYCHOLOGIA, V43, P1946, DOI 10.1016/j.neuropsychologia.2005.03.018; Van Strien JW, 2009, BRAIN RES, V1251, P223, DOI 10.1016/j.brainres.2008.11.027; Wiersema JR, 2007, NEUROPSYCHOLOGIA, V45, P1649, DOI 10.1016/j.neuropsychologia.2007.01.004; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	48	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18774	10.1371/journal.pone.0018774	http://dx.doi.org/10.1371/journal.pone.0018774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752EC	21526189	gold, Green Submitted, Green Published			2022-12-25	WOS:000289671100020
J	Whitlock, JA				Whitlock, John A.			Inferences of Diplodocoid (Sauropoda: Dinosauria) Feeding Behavior from Snout Shape and Microwear Analyses	PLOS ONE			English	Article							JURASSIC MORRISON FORMATION; DENTAL MICROWEAR; INCISOR MICROWEAR; QUANTITATIVE-ANALYSIS; NECK POSTURE; EXTINCT RUMINANTS; LARGE CARNIVORES; GROWTH-RATES; LATE MIOCENE; DIET	Background: As gigantic herbivores, sauropod dinosaurs were among the most important members of Mesozoic communities. Understanding their ecology is fundamental to developing a complete picture of Jurassic and Cretaceous food webs. One group of sauropods in particular, Diplodocoidea, has long been a source of debate with regard to what and how they ate. Because of their long lineage duration (Late Jurassic-Late Cretaceous) and cosmopolitan distribution, diplodocoids formed important parts of multiple ecosystems. Additionally, fortuitous preservation of a large proportion of cranial elements makes them an ideal clade in which to examine feeding behavior. Methodology/Principal Findings: Hypotheses of various browsing behaviors (selective and nonselective browsing at ground-height, mid-height, or in the upper canopy) were examined using snout shape (square vs. round) and dental microwear. The square snouts, large proportion of pits, and fine subparallel scratches in Apatosaurus, Diplodocus, Nigersaurus, and Rebbachisaurus suggest ground-height nonselective browsing; the narrow snouts of Dicraeosaurus, Suuwassea, and Tornieria and the coarse scratches and gouges on the teeth of Dicraeosaurus suggest mid-height selective browsing in those taxa. Comparison with outgroups (Camarasaurus and Brachiosaurus) reinforces the inferences of ground- and mid-height browsing and the existence of both non-selective and selective browsing behaviors in diplodocoids. Conclusions/Significance: These results reaffirm previous work suggesting the presence of diverse feeding strategies in sauropods and provide solid evidence for two different feeding behaviors in Diplodocoidea. These feeding behaviors can subsequently be tied to paleoecology, such that non-selective, ground-height behaviors are restricted to open, savanna-type environments. Selective browsing behaviors are known from multiple sauropod clades and were practiced in multiple environments.	Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Whitlock, JA (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	jawhitl@umich.edu	Whitlock, John/A-3079-2009; Whitlock, John/G-5814-2018	Whitlock, John/0000-0002-1118-2925; Whitlock, John/0000-0002-1118-2925	University of Michigan; Jurassic Foundation; Geological Society of America [8689-07]	University of Michigan(University of Michigan System); Jurassic Foundation; Geological Society of America	Funding was provided by the Scott Turner Fund (University of Michigan), the Jurassic Foundation (http://jurassicfoundation.org/), and the Geological Society of America (8689-07; http://geosociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERHAN M, 2002, GEOWISSENSCHAFTLICHE, V5, P19; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; Anyonge W, 1996, J MAMMAL, V77, P1059, DOI 10.2307/1382786; ASH SR, 1998, MOD GEOL, V22, P321; Bakker RT., 1986, DINOSAUR HERESIES; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Barrett Paul M., 1994, Gaia, V10, P195; Barrett PM, 2001, LIFE O PAST, P25; Barrett PM, 2001, BIOL REV, V76, P411, DOI 10.1017/S1464793101005735; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; BODMER RE, 1990, OIKOS, V57, P319, DOI 10.2307/3565960; Boue C., 1970, Mammalia, V34, P696, DOI 10.1515/mamm.1970.34.4.696; Brown B, 1916, B AM MUS NAT HIST, V35, P701; Brown B, 1912, B AM MUS NAT HIST, V31, P131; Bunnell F.L., 1985, P53; Calvo Jorge O., 1994, Gaia, V10, P183; Campione N, 2010, J VERTEBRATE PALE S3, V30, p69A; CARPENTER K, 1982, CAN J EARTH SCI, V19, P689, DOI 10.1139/e82-058; Carrano MT, 1999, ACTA PALAEONTOL POL, V44, P237; Chapman R.E., 1990, P163, DOI 10.1017/CBO9780511608377.015; Chin Karen, 1998, Modern Geology, V23, P249; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; CHRISTIAN A, BIOL LETT IN PRESS; Christian Andreas, 2007, Fossil Record, V10, P38; Christiansen Per, 1999, Historical Biology, V13, P269; Christiansen Per, 2000, Historical Biology, V14, P137; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; DEMIGUEL D, 2008, BMC EVOLUTIONARY BIO, V13, P1; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dodson P., 1990, P402; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Domning DP, 2007, ANAT REC, V290, P523, DOI 10.1002/ar.20540; Dompierre H, 1996, J VERTEBR PALEONTOL, V16, P141, DOI 10.1080/02724634.1996.10011292; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Fastovsky DE, 2004, DINOSAURIA, 2ND EDITION, P614; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; FIORILLO AR, 1991, 5 S MES TERR EC BIOT, P23; Foster J.R., 2003, NEW MEXICO MUSEUM NA, V23, P1; FOSTER JR, 2001, MESA SW MUSEUM B, V8, P47; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; Garcia RA, 2010, AMEGHINIANA, V47, P45, DOI 10.5710/AMGH.v47i1.6; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Gordon IJ, 1988, FUNCT ECOL, V2, P15, DOI 10.2307/2389455; GORDON IJ, 1994, OECOLOGIA, V98, P167, DOI 10.1007/BF00341469; Goswami A, 2005, J VERTEBR PALEONTOL, V25, P320, DOI 10.1671/0272-4634(2005)025[0320:DMITAI]2.0.CO;2; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Gunga HC, 2008, FOSS REC, V11, P33, DOI 10.1002/mmng.200700011; Gunga Hanns-Christian, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P91; Harris JD, 2004, ACTA PALAEONTOL POL, V49, P197; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Hay OP, 1908, AM NAT, V42, P672, DOI 10.1086/278992; Hiiemae K.M., 1985, P262; HIIEMAE KM, 1968, J ZOOL, V154, P139; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; Hoffman J, 2008, J VERTEBR PALEONTOL, V28, p92A; Holland W. J., 1924, Memoirs of the Carnegie Museum, V9, P379; HOLLAND WJ, 1906, MEM CARNEGIE MUS, V2, P225; Horner J.R., 1983, J VERTEBR PALEONTOL, V3, P29, DOI [DOI 10.1080/02724634.1983.10011954, 10.1080/02724634.1983.10011954]; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner John R., 1994, P312; Hotton C.L., 2010, PLANTS MESOZOIC TIME, P295; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Janensch W., PALAEONTOGRAPHIC, V2, P147; JANIS CM, 1988, ZOOL J LINN SOC-LOND, V92, P267, DOI 10.1111/j.1096-3642.1988.tb01513.x; JARMAN PJ, 1979, ZOOLOGICAL J LINNEAN, V92, P267; KELLEY J, 1990, FOLIA PRIMATOL, V55, P73, DOI 10.1159/000156502; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lockley M.G., 1991, TRACKING DINOSAURS; Lovelace David M., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P527; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mainland IL, 2003, J ARCHAEOL SCI, V30, P1513, DOI 10.1016/S0305-4403(03)00055-4; Mazumdar J, 2011, S AFR J BOT, V77, P10, DOI 10.1016/j.sajb.2010.07.020; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2007, GEODIVERSITAS, V29, P421; MIHLBACHLER M, 2010, J VERTEBRATE PALE S3, V30, pA134; Myers J.H., 1992, PHYTOCHEMICAL INDUCT, P325; Nelson S, 2005, PALAEONTOL ELECTRON, V8; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P393; Norman DB., 1991, BIOMECHANICS EVOLUTI, P161; Noto CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012553; OSBORN HF, 1899, MEMOIRS AM MUSEUM NA, V1, P189; Owen-Smith R.N., 1992, MEGAHERBIVORES INFLU; OWENSMITH N, 1979, S AFR J WILDL RES, V9, P102; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; Parrish JT, 2004, SEDIMENT GEOL, V167, P137, DOI 10.1016/j.sedgeo.2004.01.004; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Puech P.-F., 1986, HUM EVOL, V1, P507, DOI DOI 10.1007/BF02437467; Purnell MA, 2006, J ANIM ECOL, V75, P967, DOI 10.1111/j.1365-2656.2006.01116.x; Purnell MA, 2007, SCIENCE, V317, P1887, DOI 10.1126/science.1147337; Reilly SM, 2001, COMP BIOCHEM PHYS A, V128, P397, DOI 10.1016/S1095-6433(00)00326-3; Remes K, 2006, J VERTEBR PALEONTOL, V26, P651, DOI 10.1671/0272-4634(2006)26[651:ROTTSD]2.0.CO;2; Rivals F, 2010, MAMMALIA, V74, P401, DOI 10.1515/MAMM.2010.044; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2082, DOI 10.1139/e93-180; RUSSELL DA, 1980, MEMOIRS SOC GEOLOGIQ, P169; RYAN A S, 1981, Primates, V22, P533, DOI 10.1007/BF02381245; Rybczynski N, 2001, LIFE O PAST, P299; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Searle Kate R., 2008, V195, P117, DOI 10.1007/978-3-540-72422-3_5; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P157; Sereno PC, 2010, P ROY SOC B-BIOL SCI, V277, P199, DOI 10.1098/rspb.2009.0691; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1993, J MAMMAL, V74, P1059, DOI 10.2307/1382445; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; Stephens D.W., 1986, pi; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1149; Thorington RW, 1996, J MORPHOL, V230, P145, DOI 10.1002/(SICI)1097-4687(199611)230:2<145::AID-JMOR3>3.0.CO;2-G; TIDWELL W. D., 1990, HUNTERIA, V2, P1, DOI DOI 10.1016/J.PALWOR.2008.10.004; TORNIER G, 1911, BERICHT SENCKENBERGI, V42, P112; Townsend KEB, 2008, J MAMMAL, V89, P730, DOI 10.1644/06-MAMM-A-336R1.1; Turner CE, 2004, SEDIMENT GEOL, V167, P309, DOI 10.1016/j.sedgeo.2004.01.009; Ungar P, 1998, EVOL ANTHROPOL, V6, P205, DOI 10.1002/(SICI)1520-6505(1998)6:6<205::AID-EVAN3>3.3.CO;2-G; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V94, P339, DOI 10.1002/ajpa.1330940305; UNGAR PS, 1990, AM J PRIMATOL, V20, P43, DOI 10.1002/ajp.1350200107; Ungar PS, 1999, AM J PHYS ANTHROPOL, V109, P387, DOI 10.1002/(SICI)1096-8644(199907)109:3&lt;387::AID-AJPA7&gt;3.0.CO;2-F; UNGAR PS, 2002, MICROWARE 4 02; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; VANVALKENBURGH B, 1990, J ZOOL, V222, P319; Walker A., 1984, P119; WALKER PL, 1976, AM J PHYS ANTHROPOL, V45, P299, DOI 10.1002/ajpa.1330450215; WEAVER JC, 1983, PALEOBIOLOGY, V9, P173, DOI 10.1017/S0094837300007557; Weishampel D.B., 1984, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V167, P224; Weishampel David B., 1994, P229; Whitlock J.A., 2010, J VERTEBRATE PALE S3, V30, p186A; WHITLOCK JA, ZOOLOGICAL IN PRESS; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P1637, DOI 10.1080/02724634.2010.501452; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P442, DOI 10.1080/02724631003617647; Williams VS, 2009, P NATL ACAD SCI USA, V106, P11194, DOI 10.1073/pnas.0812631106; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; You Hailu, 2004, P478; YOUNG W G, 1990, Memoirs of the Queensland Museum, V28, P337; YOUNG WG, 1986, CAN J ZOOL, V64, P2467, DOI 10.1139/z86-367; Zardoya R, 1998, P NATL ACAD SCI USA, V95, P14226, DOI 10.1073/pnas.95.24.14226	153	80	80	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18304	10.1371/journal.pone.0018304	http://dx.doi.org/10.1371/journal.pone.0018304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745UM	21494685	Green Published, Green Submitted, gold			2022-12-25	WOS:000289192400017
J	Guillaumond, F; Boyer, B; Becquet, D; Guillen, S; Kuhn, L; Garin, J; Belghazi, M; Bosler, O; Franc, JL; Francois-Bellan, AM				Guillaumond, Fabienne; Boyer, Benedicte; Becquet, Denis; Guillen, Severine; Kuhn, Lauriane; Garin, Jerome; Belghazi, Maya; Bosler, Olivier; Franc, Jean-Louis; Francois-Bellan, Anne-Marie			Chromatin remodeling as a mechanism for circadian prolactin transcription: rhythmic NONO and SFPQ recruitment to HLTF	FASEB JOURNAL			English	Article						helicase-like-transcription factor; PIT-1; paraspeckle proteins; pituitary gland	GENE-EXPRESSION; HISTONE ACETYLATION; E-BOX; BINDING; CLOCK; HORMONE; BASAL; ACTIVATOR; PROMOTER; COREPRESSOR	Most clock-controlled genes (CCGs) lack the specific E-box response element necessary for direct circadian regulation. This is the case for the prolactin (Prl) gene, the expression of which oscillates in individual lactotrope pituitary cells. To characterize the processes underlying this oscillation, we used a lactotrope cell line (GH4C1 cells). In these cells, Prl gene expression fluctuated significantly during 24 h (P = 0.0418). Circadian Prl transcription depended on an interaction between the pituitary-specific transcription factor, PIT-1, and the helicase-like transcription factor (HLTF), a SWI/SNF chromatin remodeler, shown here to bind the Prl promoter on an E-box that differs from the specific E-box preferentially bound by clock proteins. Circadian Prl transcription was further accompanied by marked daily chromatin transitions. While neither HLTF nor PIT-1 was rhythmically expressed, NONO and SFPQ, identified as HLTF-associated proteins by mass spectrometry, displayed a circadian pattern and bound rhythmically to the Prl promoter. Furthermore, NONO and SFPQ were functionally involved in circadian Prl transcription since overexpression of both proteins greatly reduced Prl promoter activity (P < 0.001) and disrupted its circadian pattern. A mechanism involving a rhythm in paraspeckle protein recruitment is proposed to explain how the core oscillator can generate a circadian pattern of CCGs lacking the specific E-box response element.-Guillaumond, F., Boyer, B., Becquet, D., Guillen, S., Kuhn, L., Garin, J., Belghazi, M., Bosler, O., Franc, J. L., Franc, ois-Bellan, A. M. Chromatin remodeling as a mechanism for circadian prolactin transcription: rhythmic NONO and SFPQ recruitment to HLTF. FASEB J. 25, 2740-2756 (2011). www.fasebj.org	[Boyer, Benedicte; Becquet, Denis; Guillen, Severine; Bosler, Olivier; Franc, Jean-Louis; Francois-Bellan, Anne-Marie] Univ Aix Marseille 2, Ctr Rech Neurobiol & Neurophysiol Marseille CRN2M, Ctr Natl Rech Sci CNRS, Unite Mixte Rech UMR 6231, F-13344 Marseille 15, France; [Guillaumond, Fabienne] Univ Aix Marseille 3, Inst Sci Mol Marseille ISM2, UMR6263, Marseille, France; [Garin, Jerome] Plateforme Etud Dynam Proteomes EDyP Serv, Grenoble, France; [Belghazi, Maya] Inst Federatif Rech IFR, Ctr Anal Prote Marseille, Marseille, France; [Kuhn, Lauriane] Plateforme Prote Esplanade Inst Biol Mol & Cellul, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Francois-Bellan, AM (corresponding author), Univ Aix Marseille 2, CNRS, CRN2M, Fac Med Nord,UMR 6231, Bd Pierre Dramard CS 80011, F-13344 Marseille 15, France.	anne-marie.francois@univmed.fr	Becquet, Denis/E-3675-2010; François-Bellan, anne-marie/D-3116-2017; francois, anne-marie/H-1193-2011; Guillaumond, Fabienne/E-8265-2017; Franc, Jean-Louis/C-8861-2009	Becquet, Denis/0000-0001-8232-7418; François-Bellan, anne-marie/0000-0002-3278-4642; Guillaumond, Fabienne/0000-0001-7456-7315; Franc, Jean-Louis/0000-0002-2900-5468; Kuhn, Lauriane/0000-0002-2637-1024	National Research Agency [ANR-08-GENO-026-01]	National Research Agency(French National Research Agency (ANR))	The authors are indebted to Dr. Alexandra Belayew (University of Leuven, Leuven, Belgium) for generous gifts of monoclonal antiserum to HLTF and plasmid pCIneo-His6-HLTF and to Dr. Hiroshi Hosoda (Tokyo University of Agriculture, Tokyo, Japan) for supplying plasmid construct of R91A, a dominant negative mutant of BMAL1. The authors also thank Dr. Raymond Miquelis for useful advice in proteomic analysis and Gary Burkhart for editing. This work was supported by grants from the National Research Agency (ANR-08-GENO-026-01).	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; BAUREN G, 1994, CELL, V76, P183, DOI 10.1016/0092-8674(94)90182-1; Becquet D, 2001, MOL CELL ENDOCRINOL, V175, P93, DOI 10.1016/S0303-7207(01)00393-8; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; BERWAER M, 1993, MOL CELL ENDOCRINOL, V92, P1, DOI 10.1016/0303-7207(93)90068-U; Bose S, 2010, ENDOCRINOLOGY, V151, P2287, DOI 10.1210/en.2009-1252; Brooks YS, 2009, J BIOL CHEM, V284, P18033, DOI 10.1074/jbc.M109.006999; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Caccavelli L, 1998, MOL ENDOCRINOL, V12, P1215, DOI 10.1210/me.12.8.1215; Delaunay F, 2002, TRENDS GENET, V18, P595, DOI 10.1016/S0168-9525(02)02794-4; Dennis Jr G, 2003, GENOME BIOL, V4, P3, DOI [10.1186/gb-2003-4-5-p3, DOI 10.1186/GB-2003-4-5-P3]; Ding H, 1996, DNA CELL BIOL, V15, P429, DOI 10.1089/dna.1996.15.429; Ding H, 1999, J BIOL CHEM, V274, P19573, DOI 10.1074/jbc.274.28.19573; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; Hosoda H, 2004, GENE, V338, P235, DOI 10.1016/j.gene.2004.05.022; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUGHES M, 2007, COLD SPRING HARB SYM, V72, P381; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ito T, 2008, BIOCHEM J, V411, P201, DOI 10.1042/BJ20071075; Izumo M, 2003, P NATL ACAD SCI USA, V100, P16089, DOI 10.1073/pnas.2536313100; Leclerc GM, 2005, ENDOCRINOLOGY, V146, P2782, DOI 10.1210/en.2005-0100; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mahajan MC, 2002, BLOOD, V99, P348, DOI 10.1182/blood.V99.1.348; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Onishi Y, 2008, MOL CELL BIOL, V28, P3477, DOI 10.1128/MCB.02227-07; PEERS B, 1992, EUR J BIOCHEM, V210, P53, DOI 10.1111/j.1432-1033.1992.tb17389.x; Pellegrini I, 2006, MOL ENDOCRINOL, V20, P3212, DOI 10.1210/me.2006-0122; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qi Y, 2008, P NATL ACAD SCI USA, V105, P2481, DOI 10.1073/pnas.0712196105; Quentien MH, 2002, J BIOL CHEM, V277, P44408, DOI 10.1074/jbc.M207824200; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shimizu F, 2007, J NEUROCHEM, V103, P1834, DOI 10.1111/j.1471-4159.2007.04900.x; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Yamajuku D, 2010, NUCLEIC ACIDS RES, V38, P7964, DOI 10.1093/nar/gkq678; ZHANG GH, 1994, NATURE, V372, P809; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	41	29	30	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2740	2756		10.1096/fj.10-178616	http://dx.doi.org/10.1096/fj.10-178616			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21507896				2022-12-25	WOS:000293337800023
J	Abdou, HS; Atlas, E; Hache, RJG				Abdou, Houssein-Salem; Atlas, Ella; Hache, Robert J. G.			Liver-enriched Inhibitory Protein (LIP) Actively Inhibits Preadipocyte Differentiation through Histone Deacetylase 1 (HDAC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C/EBP-BETA; ADIPOCYTE DIFFERENTIATION; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; GENE-TRANSCRIPTION; PHOSPHORYLATION; ACETYLATION; EXPRESSION; DELTA; TRANSACTIVATION	The CCAAT/enhancer-binding protein beta (C/EBP beta) is expressed as three isoforms (LAP*, liver-enriched activating protein (LAP), and liver-enriched inhibitory protein (LIP)) that differentially regulate gene expression. The interplay between LAP*, LAP, and LIP in regulating cellular processes is largely unknown, and LIP has been largely regarded to repress transcription through a passive heterodimerization-dependent mechanism. Recently, we have shown that p300/GCN5 and mSin3A/HDAC1 differentially regulate the ability of C/EBP beta to stimulate preadipocyte differentiation through activation of C/ebp alpha transcription. Here, we have mapped requirements for binding of mSin3A/HDAC1 to LAP/LAP* and LIP to a 4-amino acid motif in the central region of LAP/LAP* (residues 153-156) and the N terminus of LIP. Reducing mSin3A/HDAC1 binding to LAP/LAP* and LIP through deletion of this motif reduced the recruitment of HDAC1 to the C/ebp alpha promoter and increased preadipocyte differentiation stimulated by insulin and 1-methyl-3-isobutylxanthine. Additional studies showed that the interaction of HDAC1 with LIP provides for active repression of C/ebp alpha transcription and is largely responsible for the ability of LIP and HDAC1 to repress preadipocyte differentiation. Thus, although mSin3A/HDAC1 interacted readily with LAP/LAP* in addition to LIP and that expression of LAP/LAP* was sufficient to recruitHDAC1 to the C/ebp alpha promoter, mutations in C/ebp beta that abrogated HDAC1 association to LAP/LAP* in the absence of LIP provided no additional stimulation of differentiation or transcription beyond the deletion of LIP alone. The implication of these results for the interaction between p300/GCN5 and mSin3A/HDAC1 in regulating C/EBP alpha transcription and preadipocyte differentiation are discussed.	[Hache, Robert J. G.] Univ Calgary, So Alberta Canc Res Inst, Dept Anat & Cell Biol, Calgary, AB T2N 1N4, Canada; [Abdou, Houssein-Salem] Univ Ottawa, Grad Program Biochem, Ottawa, ON K1N 6N5, Canada; [Atlas, Ella] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON KIA OK9, Canada	University of Calgary; University of Ottawa; Health Canada	Hache, RJG (corresponding author), Univ Calgary, So Alberta Canc Res Inst, Dept Anat & Cell Biol, Calgary, AB T2N 1N4, Canada.	rjhache@ucalgary.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant (to R. J. G. H.) and by a studentship (to H.-S. A.) from the Canadian Institutes of Health Research.	CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cesena TI, 2008, MOL CELL ENDOCRINOL, V289, P94, DOI 10.1016/j.mce.2008.03.009; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; Elberg G, 2000, J BIOL CHEM, V275, P27815; Gantt KR, 2004, BIOCHEM BIOPH RES CO, V313, P619, DOI 10.1016/j.bbrc.2003.11.162; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Haas SC, 2010, BRIT J HAEMATOL, V148, P777, DOI 10.1111/j.1365-2141.2009.08012.x; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Lee S, 2010, J BIOL CHEM, V285, P21399, DOI 10.1074/jbc.M110.128413; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; TRAUTWEIN C, 1995, J BIOL CHEM, V270, P15130, DOI 10.1074/jbc.270.25.15130; Turgeon N, 2008, J CELL BIOCHEM, V103, P1573, DOI 10.1002/jcb.21544; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhu M, 2007, EXP GERONTOL, V42, P733, DOI 10.1016/j.exger.2007.05.011	30	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21488	21499		10.1074/jbc.M110.211540	http://dx.doi.org/10.1074/jbc.M110.211540			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521687	Green Published, hybrid			2022-12-25	WOS:000291464700047
J	Micheva-Viteva, S; Kobayashi, Y; Edelstein, LC; Pacchia, AL; Lee, HLR; Graci, JD; Breslin, J; Phelan, BD; Miller, LK; Colacino, JM; Gu, ZX; Ron, Y; Peltz, SW; Dougherty, JP				Micheva-Viteva, Sofiya; Kobayashi, Yoshifumi; Edelstein, Leonard C.; Pacchia, Annmarie L.; Lee, Hui-Ling Rose; Graci, Jason D.; Breslin, Jamie; Phelan, Bradley D.; Miller, Leia K.; Colacino, Joseph M.; Gu, Zhengxian; Ron, Yacov; Peltz, Stuart W.; Dougherty, Joseph P.			High-throughput Screening Uncovers a Compound That Activates Latent HIV-1 and Acts Cooperatively with a Histone Deacetylase (HDAC) Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; NF-KAPPA-B; VALPROIC ACID; IN-VIVO; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; GENE-EXPRESSION; RESERVOIR; INTERLEUKIN-2	Current antiretroviral therapy (ART) provides potent suppression of HIV-1 replication. However, ART does not target latent viral reservoirs, so persistent infection remains a challenge. Small molecules with pharmacological properties that allow them to reach and activate viral reservoirs could potentially be utilized to eliminate the latent arm of the infection when used in combination with ART. Here we describe a cell-based system modeling HIV-1 latency that was utilized in a high-throughput screen to identify small molecule antagonists of HIV-1 latency. A more detailed analysis is provided for one of the hit compounds, antiviral 6 (AV6), which required nuclear factor of activated T cells for early mRNA expression while exhibiting RNA-stabilizing activity. It was found that AV6 reproducibly activated latent provirus from different lymphocyte-based clonal cell lines as well as from latently infected primary resting CD4(+) T cells without causing general T cell proliferation or activation. Moreover, AV6 complemented the latency antagonist activity of a previously described histone deacetylase (HDAC) inhibitor. This is a proof of concept showing that a high-throughput screen employing a cell-based model of HIV-1 latency can be utilized to identify new classes of compounds that can be used in concert with other persistent antagonists with the aim of viral clearance.	[Micheva-Viteva, Sofiya; Kobayashi, Yoshifumi; Edelstein, Leonard C.; Pacchia, Annmarie L.; Lee, Hui-Ling Rose; Phelan, Bradley D.; Miller, Leia K.; Ron, Yacov; Dougherty, Joseph P.] Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Graci, Jason D.; Breslin, Jamie; Colacino, Joseph M.; Gu, Zhengxian; Peltz, Stuart W.] PTC Therapeut Inc, S Plainfield, NJ 07080 USA; [Micheva-Viteva, Sofiya; Lee, Hui-Ling Rose; Phelan, Bradley D.; Miller, Leia K.; Ron, Yacov; Dougherty, Joseph P.] Rutgers State Univ, Grad Program Mol Biosci, Newark, NJ 07102 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick	Dougherty, JP (corresponding author), Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	doughejp@umdnj.edu		Edelstein, Leonard/0000-0002-8976-6410	National Institutes of Health [AI070039, AI081307]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070039, R01AI081307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070039 and AI081307 (to J. P. D.). J. D. G., J. B., Z. G., and S. W. P. declare competing financial interests.	Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Agosto LM, 2009, J VIROL, V83, P8153, DOI 10.1128/JVI.00220-09; Ahlberg C, 1999, DRUG DISCOV TODAY, V4, P370, DOI 10.1016/S1359-6446(99)01373-2; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brooks DG, 2003, P NATL ACAD SCI USA, V100, P12955, DOI 10.1073/pnas.2233345100; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Dybul M, 2002, J INFECT DIS, V185, P61, DOI 10.1086/338123; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fondere JM, 2004, J VIROL, V78, P10536, DOI 10.1128/JVI.78.19.10536-10542.2004; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Krishnan V, 2004, J VIROL, V78, P9458, DOI 10.1128/JVI.78.17.9458-9473.2004; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Micheva-Viteva S, 2005, ANTIMICROB AGENTS CH, V49, P5185, DOI 10.1128/AAC.49.12.5185-5188.2005; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Rullas J, 2004, ANTIVIR THER, V9, P545; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	44	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21083	21091		10.1074/jbc.M110.195537	http://dx.doi.org/10.1074/jbc.M110.195537			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498519	hybrid, Green Published			2022-12-25	WOS:000291464700007
J	Kozlov, G; Denisov, AY; Girard, M; Dicaire, MJ; Hamlin, J; McPherson, PS; Brais, B; Gehring, K				Kozlov, Guennadi; Denisov, Alexey Y.; Girard, Martine; Dicaire, Marie-Josee; Hamlin, Jason; McPherson, Peter S.; Brais, Bernard; Gehring, Kalle			Structural Basis of Defects in the Sacsin HEPN Domain Responsible for Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE; REFINEMENT; MUTATIONS; AGGREGATION; RESOLUTION; MITOPHAGY; PROTEINS; SYSTEMS; COMMON	Sacsin is a 520-kDa protein mutated in the early-onset neuro-developmental and neurodegenerative disease autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). The C terminus of the protein contains an HEPN (higher eukaryotes and prokaryotes nucleotide-binding) domain of unknown function. Here, we determined the high-resolution 1.9-angstrom crystal structure of the HEPN domain from human sacsin. The structure is composed of five parallel alpha-helices with a large loop of several short helical segments. Two HEPN protomers assemble as a dimer to form a large positively charged cavity at the dimer interface that binds GTP and other nucleotides. The crystal structure reveals that the ARSACS N4549D mutation disrupts dimerization and protein folding. This study provides novel insights into the oligomerization state of sacsin and functions that are lost in mutations that cause ARSACS.	[Kozlov, Guennadi; Denisov, Alexey Y.; Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Dicaire, Marie-Josee; Brais, Bernard] Ctr Hosp Univ Montreal, Ctr Rech, Lab Neurogenet Motricite, Montreal, PQ H2L 4M1, Canada; [Girard, Martine; Hamlin, Jason; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University; Universite de Montreal; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Brais, Bernard/Y-3910-2019; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Fondation de l'Ataxie Charlevoix-Saguenay; Canadian Institutes of Health Research; Muscular Dystrophy Canada; ALS Society of Canada; National Science Foundation [DMR 0225180]; National Institutes of Health [RR01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Fondation de l'Ataxie Charlevoix-Saguenay; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Canada(Muscular Dystrophy Association); ALS Society of Canada; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Fondation de l'Ataxie Charlevoix-Saguenay, the Neuromuscular Research Partnership Program of the Canadian Institutes of Health Research, Muscular Dystrophy Canada, and the ALS Society of Canada.; We thank Francois Blondeau for help in the initial stages of the project. Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source was supported by National Science Foundation Award DMR 0225180 and National Institutes of Health Grant RR01646.	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Anderson JF, 2010, J MOL BIOL, V400, P665, DOI 10.1016/j.jmb.2010.05.023; Baets J, 2010, NEUROLOGY, V75, P1181, DOI 10.1212/WNL.0b013e3181f4d86c; Bouchard JP, 1998, NEUROMUSCULAR DISORD, V8, P474, DOI 10.1016/S0960-8966(98)00055-8; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Erlandsen H, 2004, PROTEINS, V54, P806, DOI 10.1002/prot.10631; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Grynberg M, 2003, TRENDS BIOCHEM SCI, V28, P224, DOI 10.1016/S0968-0004(03)00060-4; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Richter AM, 2004, NEUROGENETICS, V5, P165, DOI 10.1007/s10048-004-0179-y; Rose JM, 2011, HUM MOL GENET, V20, P16, DOI 10.1093/hmg/ddq428; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; TAKIYAMA Y, 2007, CEREBELLUM, P1; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	26	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20407	20412		10.1074/jbc.M111.232884	http://dx.doi.org/10.1074/jbc.M111.232884			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507954	hybrid, Green Published			2022-12-25	WOS:000291267600028
J	Lu, H; Wang, XH; Li, TS; Urvalek, AM; Yu, L; Li, JL; Zhu, JH; Lin, QS; Peng, X; Zhao, JH				Lu, Heng; Wang, Xianhui; Li, Tianshu; Urvalek, Alison M.; Yu, Lin; Li, Jieli; Zhu, Jinghua; Lin, Qishan; Peng, Xu; Zhao, Jihe			Identification of Poly (ADP-ribose) Polymerase-1 (PARP-1) as a Novel Kruppel-like Factor 8-interacting and -regulating Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CELL-CYCLE PROGRESSION; NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1; KLF8 TRANSCRIPTION; NUCLEAR EXPORT; IN-VIVO; CANCER; TARGET; CARCINOGENESIS	Kruppel-like factor 8 (KLF8) regulates critical gene transcription and cellular events associated with cancer. However, KLF8-interacting proteins remain largely unidentified. Using co-immunoprecipitation (co-IP), mass spectrometry, and GST pulldown assays, we identified poly(ADP-ribose) polymerase-1(PARP-1) as a novel KLF8-interacting protein. Co-IP and Western blotting indicated that KLF8 is also a PARP-1 substrate. Mutation of the cysteines in the zinc finger domain of KLF8 abolished PARP-1 interaction. Surprisingly, immunofluorescent staining revealed a cytoplasmic mislocalization of KLF8 in PARP-1(-/-) cells or when the interaction was disrupted. This mislocalization was prevented by either PARP-1 re-expression or inhibition of CRM1-dependent nuclearexport. Interestingly, co-IP indicated competition between PARP-1 and CRM1 for KLF8 binding. Cycloheximide chase assay showed a decrease in the half-life of KLF8 protein when PARP-1 expression was suppressed or KLF8-PARP-1 interaction was disrupted. Ubiquitination assays implicated KLF8 as a target of ubiquitination that was significantly higher in PARP-1(-/-) cells. Promoter reporter assays and chromatin immunoprecipitation assays showed that KLF8 activation on the cyclin D1 promoter was markedly reduced when PARP-1 was deleted or inhibited or when KLF8-PARP-1 interaction was disrupted. Overall, this work has identified PARP-1 as a novel KLF8-binding and-regulating protein and provided new insights into the mechanisms underlying the regulation of KLF8 nuclear localization, stability, and functions.	[Lu, Heng; Wang, Xianhui; Li, Tianshu; Urvalek, Alison M.; Yu, Lin; Zhao, Jihe] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Zhu, Jinghua; Lin, Qishan] SUNY Albany, Ctr Funct Genom, Rensselaer, NY 12144 USA; [Li, Jieli; Peng, Xu] Texas A&M Hlth Sci Ctr, Coll Med, Dept Syst Biol & Translat Med, Temple, TX 76504 USA	State University System of Florida; University of Central Florida; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Zhao, JH (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Room BBS-313, Orlando, FL 32827 USA.	jizhao@mail.ucf.edu	Li, Tianshu/L-6426-2014	Li, Tianshu/0000-0002-9972-4644; Lin, Qishan/0000-0002-1756-1432	National Institutes of Health, NCI [CA132977]; American Cancer Society [RSG CCG-111381]; Susan G. Komen for Cure [KG090444, KG080616]; NATIONAL CANCER INSTITUTE [R01CA132977] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Susan G. Komen for Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA132977 from the NCI (to J.Z.). This work was also supported by the American Cancer Society (Grant RSG CCG-111381) and Susan G. Komen for Cure (Grants KG090444 and KG080616) (to J.Z.).	Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Chang HS, 2010, INT J BIOCHEM CELL B, V42, P1831, DOI 10.1016/j.biocel.2010.07.019; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Drew Y, 2009, DRUG RESIST UPDATE, V12, P153, DOI 10.1016/j.drup.2009.10.001; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Hassa PO, 2009, FRONT BIOSCI-LANDMRK, V14, P72, DOI 10.2741/3232; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kinsella TJ, 2009, CLIN CANCER RES, V15, P1853, DOI 10.1158/1078-0432.CCR-08-1307; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Liang YL, 2009, WORLD J SURG, V33, P661, DOI 10.1007/s00268-008-9840-1; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Peralta-Leal A, 2008, CLIN TRANSL ONCOL, V10, P318, DOI 10.1007/s12094-008-0207-8; Suzuki T, 2007, J BIOL CHEM, V282, P9895, DOI 10.1074/jbc.M608098200; Urvalek AM, 2011, AM J TRANSL RES, V3, P121; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Wei DY, 2010, GASTROENTEROLOGY, V139, P2135, DOI 10.1053/j.gastro.2010.08.022; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	35	32	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20335	20344		10.1074/jbc.M110.215632	http://dx.doi.org/10.1074/jbc.M110.215632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518760	hybrid, Green Published			2022-12-25	WOS:000291267600021
J	Patel, G; Johnson, DS; Sun, B; Pandey, M; Yu, X; Egelman, EH; Wang, MD; Patel, SS				Patel, Gayatri; Johnson, Daniel S.; Sun, Bo; Pandey, Manjula; Yu, Xiong; Egelman, Edward H.; Wang, Michelle D.; Patel, Smita S.			A257T Linker Region Mutant of T7 Helicase-Primase Protein Is Defective in DNA Loading and Rescued by T7 DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; BACTERIOPHAGE T7; CRYSTAL-STRUCTURE; GENE-4 PROTEIN; NUCLEOTIDE HYDROLYSIS; HEXAMERIC HELICASES; CENTRAL CHANNEL; RING HELICASE; REPLICATION; MECHANISM	The helicase and primase activities of the hexameric ring-shaped T7 gp4 protein reside in two separate domains connected by a linker region. This linker region is part of the subunit interface between monomers, and point mutations in this region have deleterious effects on the helicase functions. One such linker region mutant, A257T, is analogous to the A359T mutant of the homologous human mitochondrial DNA helicase Twinkle, which is linked to diseases such as progressive external opthalmoplegia. Electron microscopy studies show that A257T gp4 is normal in forming rings with dTTP, but the rings do not assemble efficiently on the DNA. Therefore, A257T, unlike the WT gp4, does not preassemble on the unwinding DNA substrate with dTTP without Mg(II), and its DNA unwinding activity in ensemble assays is slow and limited by the DNA loading rate. Single molecule assays measured a 45 times slower rate of A257T loading on DNA compared with WT gp4. Interestingly, once loaded, A257T has almost WT-like translocation and DNA unwinding activities. Strikingly, A257T preassembles stably on the DNA in the presence of T7 DNA polymerase, which restores the ensemble unwinding activity of A257T to similar to 75% of WT, and the rescue does not require DNA synthesis. The DNA loading rate of A257T, however, remains slow even in the presence of the polymerase, which explains why A257T does not support T7 phage growth. Similar types of defects in the related human mitochondrial DNA helicase may be responsible for inefficient DNA replication leading to the disease states.	[Patel, Gayatri; Pandey, Manjula; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Johnson, Daniel S.; Sun, Bo; Wang, Michelle D.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA; [Yu, Xiong; Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Cornell University; Cornell University; Howard Hughes Medical Institute; University of Virginia	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu		Sun, Bo/0000-0002-4590-7795; Egelman, Edward/0000-0003-4844-5212; Johnson, Daniel/0000-0001-8906-0509	National Institutes of Health [GM55310, GM035269, GM059849]; National Science Foundation [MCB-0820293]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310, R01GM059849, R01GM035269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55310 (to S. S. P.), GM035269 (to E. H. E.), and GM059849 (to M. D. W.). This work was also supported by National Science Foundation Grant MCB-0820293 (to M. D. W.).	Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; BERNSTEIN JA, 1989, J BIOL CHEM, V264, P13066; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Ghosh S, 2008, J BIOL CHEM, V283, P32077, DOI 10.1074/jbc.M805062200; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Koch SJ, 2002, BIOPHYS J, V83, P1098, DOI 10.1016/S0006-3495(02)75233-8; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee SJ, 2004, J BIOL CHEM, V279, P23384, DOI 10.1074/jbc.M400857200; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Mao Chih-Chieh, 2009, Chang Gung Med J, V32, P354; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Matsushima Y, 2009, BBA-BIOENERGETICS, V1787, P290, DOI 10.1016/j.bbabio.2008.11.005; MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208; Pandey M, 2010, METHODS MOL BIOL, V587, P57, DOI 10.1007/978-1-60327-355-8_5; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rosenberg AH, 1996, J BIOL CHEM, V271, P26819, DOI 10.1074/jbc.271.43.26819; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; STUDIER FW, 1972, SCIENCE, V176, P367, DOI 10.1126/science.176.4033.367; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740	41	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20490	20499		10.1074/jbc.M110.201657	http://dx.doi.org/10.1074/jbc.M110.201657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21515672	Green Published, hybrid			2022-12-25	WOS:000291267600036
J	Prutting, S; Grissmer, S				Pruetting, Sylvia; Grissmer, Stephan			A Novel Current Pathway Parallel to the Central Pore in a Mutant Voltage-gated Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; K+ CHANNEL; BINDING-SITE; ION CONDUCTION; GATING PORE; PERMEATION; STATE; TETRAETHYLAMMONIUM; CHARYBDOTOXIN	Voltage-gated potassium channels are proteins composed of four subunits consisting of six membrane-spanning segments S1-S6, with S4 as the voltage sensor. The region between S5 and S6 forms the potassium-selective ion-conducting central alpha-pore. Recent studies showed that mutations in the voltage sensor of the Shaker channel could disclose another ion permeation pathway through the voltage-sensing domain (S1-S4) of the channel, the alpha-pore. In our studies we used the voltage-gated hKv1.3 channel, and the insertion of a cysteine at position V388C (Shaker position 438) generated a current through the alpha-pore in high potassium outside and an inward current at hyperpolarizing potentials carried by different cations like Na+, Li+, Cs+, and NH4+. The observed inward current looked similar to the omega-current described for the R1C/S Shaker mutant channel and was not affected by some pore blockers like charybdotoxin and tetraethylammonium but was inhibited by a phenylalkylamine blocker (verapamil) that acts from the intracellular side. Therefore, we hypothesize that the hKv1.3_V388C mutation in the P-region generated a channel with two ion-conducting pathways. One, the alpha-pore allowing K+ flux in the presence of K+, and the second pathway, the sigma-pore, functionally similar but physically distinct from the omega-pathway. The entry of this new pathway (alpha-pore) is presumably located at the backside of Y395 (Shaker position 445), proceeds parallel to the alpha-pore in the S6-S6 interface gap, ending between S5 and S6 at the intracellular side of one alpha-subunit, and is blocked by verapamil.	[Pruetting, Sylvia; Grissmer, Stephan] Univ Ulm, Inst Appl Physiol, D-89081 Ulm, Germany	Ulm University	Grissmer, S (corresponding author), Univ Ulm, Inst Appl Physiol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	stephan.grissmer@uni-ulm.de			4SC AG (Martinsried); Land Baden-Wurttemberg [1423/74]; Deutsche Forschungsgemeinschaft [Gr848/14-1]	4SC AG (Martinsried); Land Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the 4SC AG (Martinsried), Land Baden-Wurttemberg Grant 1423/74, and Deutsche Forschungsgemeinschaft Grant Gr848/14-1.	AIYAR J, 1994, BIOPHYS J, V67, P2261, DOI 10.1016/S0006-3495(94)80710-6; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; CATTERALL WA, 2002, IUPHAR COMPENDIUM VO, P74; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DECOURSEY TE, 1995, J GEN PHYSIOL, V106, P745, DOI 10.1085/jgp.106.4.745; Dreker T, 2005, MOL PHARMACOL, V68, P966, DOI 10.1124/mol.105.012401; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Furini S, 2009, PROTEINS, V74, P437, DOI 10.1002/prot.22163; Gao YD, 2003, PROTEINS, V52, P146, DOI 10.1002/prot.10341; GRISSMER S, 1989, J GEN PHYSIOL, V93, P609, DOI 10.1085/jgp.93.4.609; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hille B., 2001, ION CHANNELS EXCITAB, P131; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; KAVANAUGH MP, 1991, J BIOL CHEM, V266, P7583; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MCCLOSKEY MA, 1990, J GEN PHYSIOL, V95, P205, DOI 10.1085/jgp.95.2.205; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ogielska EM, 1998, J GEN PHYSIOL, V112, P243, DOI 10.1085/jgp.112.2.243; Oliva C, 2005, BIOPHYS J, V89, P1009, DOI 10.1529/biophysj.105.060152; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Rauer H, 1999, BRIT J PHARMACOL, V127, P1065, DOI 10.1038/sj.bjp.0702599; Rauer H, 1996, MOL PHARMACOL, V50, P1625; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Starkus JG, 1998, J GEN PHYSIOL, V112, P85, DOI 10.1085/jgp.112.1.85; Thompson J, 2000, BIOPHYS J, V78, P2382, DOI 10.1016/S0006-3495(00)76782-8; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; VanDongen AMJ, 2004, P NATL ACAD SCI USA, V101, P3248, DOI 10.1073/pnas.0308743101	48	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20031	20042		10.1074/jbc.M110.185405	http://dx.doi.org/10.1074/jbc.M110.185405			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498510	Green Published, hybrid			2022-12-25	WOS:000291027700080
J	Ballanco, J; Mansfield, ML				Ballanco, Joshua; Mansfield, Marc L.			A Model for the Evolution of Nucleotide Polymerase Directionality	PLOS ONE			English	Article								Background: In all known living organisms, every enzyme that synthesizes nucleic acid polymers does so by adding nucleotide 5'-triphosphates to the 3'-hydroxyl group of the growing chain. This results in the well known 5'-> 3' directionality of all DNA and RNA Polymerases. The lack of any alternative mechanism, e. g. addition in a 3'-> 5' direction, may indicate a very early founder effect in the evolution of life, or it may be the result of a selective pressure against such an alternative. Methodology/Principal Findings: In an attempt to determine whether the lack of an alternative polymerase directionality is the result of a founder effect or evolutionary selection, we have constructed a basic model of early polymerase evolution. This model is informed by the essential chemical properties of the nucleotide polymerization reaction. With this model, we are able to simulate the growth of organisms with polymerases that synthesize either 5'-> 3' or 3'-> 5' in isolation or in competition with each other. Conclusions/Significance: We have found that a competition between organisms with 5'-> 3' polymerases and 3'-> 5' polymerases only results in a evolutionarily stable strategy under certain conditions. Furthermore, we have found that mutations lead to a much clearer delineation between conditions that lead to a stable coexistence of these populations and conditions which ultimately lead to success for the 5'-> 3' form. In addition to presenting a plausible explanation for the uniqueness of enzymatic polymerization reactions, we hope these results also provide an example of how whole organism evolution can be understood based on molecular details.	[Ballanco, Joshua] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA; [Mansfield, Marc L.] Bingham Res Ctr, Energy Dynam Lab, Vernal, UT USA	Stevens Institute of Technology	Ballanco, J (corresponding author), Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA.	jballanc@stevens.edu		Ballanco, Joshua/0000-0002-4684-7130				BAGSHAW CR, 1973, BIOCHEM J, V133, P323, DOI 10.1042/bj1330323; Cady F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036011; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Ferenci T, 1999, RES MICROBIOL, V150, P431, DOI 10.1016/S0923-2508(99)00114-X; Griep M, 2006, AICHE J, V52, P384, DOI 10.1002/aic.10604; Ihaka R., 1996, J COMPUTATIONAL GRAP; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Levene PA, 1934, J BIOL CHEM, V104, P299; NOWAK MA, 2006, EVOLUTIONARY DYNAMIC, pP363; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; SIGEL H, 1983, EUR J BIOCHEM, V132, P569, DOI 10.1111/j.1432-1033.1983.tb07401.x; TEMPLETON AR, 1980, GENETICS, V94, P1011; Zannis-Hadjopoulos M, 1999, J CELL BIOCHEM, P1	13	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18881	10.1371/journal.pone.0018881	http://dx.doi.org/10.1371/journal.pone.0018881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526126	Green Submitted, Green Published, gold			2022-12-25	WOS:000290015800019
J	Koblik, EA; Red'kin, YA; Meer, MS; Derelle, R; Golenkina, SA; Kondrashov, FA; Arkhipov, VY				Koblik, Evgeny A.; Red'kin, Yaroslav A.; Meer, Margarita S.; Derelle, Romain; Golenkina, Sofia A.; Kondrashov, Fyodor A.; Arkhipov, Vladimir Yu.			Acrocephalus orinus: A Case of Mistaken Identity	PLOS ONE			English	Article							IDENTIFICATION; DISCOVERY; FAMILY	Recent discovery of the Large-billed Reed Warbler (Acrocephalus orinus) in museums and in the wild significantly expanded our knowledge of its morphological traits and genetic variability, and revealed new data on geographical distribution of the breeding grounds, migration routes and wintering locations of this species. It is now certain that A. orinus is breeding in Central Asia; however, the precise area of distribution remains unclear. The difficulty in the further study of this species lies in the small number of known specimens, with only 13 currently available in museums, and in the relative uncertainty of the breeding area and habitat of this species. Following morphological and genetic analyses from Svensson, et al, we describe 14 new A. orinus specimens from collections of Zoological Museums of the former USSR from the territory of Central Asian states. All of these specimens were erroneously labeled as Blyth's Reed Warbler (A. dumetorum), which is thought to be a breeding species in these areas. The 14 new A. orinus specimens were collected during breeding season while most of the 85 A. dumetorum specimens from the same area were collected during the migration period. Our data indicate that the Central Asian territory previously attributed as breeding grounds of A. dumetorum is likely to constitute the breeding territory of A. orinus. This rare case of a re-description of the breeding territory of a lost species emphasizes the importance of maintenance of museum collections around the world. If the present data on the breeding grounds of A. orinus are confirmed with field observations and collections, the literature on the biology of A. dumetorum from the southern part of its range may have to be reconsidered.	[Koblik, Evgeny A.; Red'kin, Yaroslav A.] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia; [Meer, Margarita S.; Derelle, Romain; Kondrashov, Fyodor A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona, Spain; [Golenkina, Sofia A.] Russian Acad Sci, Vavilov Inst Gen Genet, Lab Evolutionary Genom, Moscow, Russia; [Arkhipov, Vladimir Yu.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Moscow Region, Russia	Lomonosov Moscow State University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics	Koblik, EA (corresponding author), Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia.	v.arkhipov@rambler.ru	Kondrashov, Fyodor Alexeevich/H-6331-2015; Red'kin, Yaroslav/AAE-4218-2021; Arkhipov, Vladimir/B-4085-2010	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Arkhipov, Vladimir/0000-0001-9877-575X	Spanish Ministry of Science and Innovation [BFU2009-09271]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The work was supported by the Plan Nacional grant number BFU2009-09271 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDUSALYAMOV IA, 1973, FAUNA TADZHIK SSR 2, V19; Anderson A, 1875, STRAY FEATHERS, V3, P350; Aye R, 2010, J AVIAN BIOL, V41, P452, DOI 10.1111/j.1600-048X.2010.05031.x; DAVRANOV E, 1991, FAUNA ECOLOGY VERTER, P128; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fregin S, 2009, MOL PHYLOGENET EVOL, V52, P866, DOI 10.1016/j.ympev.2009.04.006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; IVANOV AI, 1969, BIRDS PAMIR ALAI; Koblik E. A., 2006, CHECKLIST BIRDS RUSS; KOVSHAR AF, 1972, BIRDS KAZAKHSTAN, V5, P75; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; MEKLENBURTSEV RN, 1958, BIRDS UZBEKISTAN, P202; NIMNUAN S, 2008, BIRDING ASIA, V9, P10; Pearson D. J., 2008, Bulletin of the British Ornithologists' Club, V128, P136; PEKLO AM, 2008, CATALOGUE COLLECTION, V4; Portenko L. A., 1976, ATLAS VERBREITUNG PA, V5; Rogaev EI, 2009, P NATL ACAD SCI USA, V106, P5258, DOI 10.1073/pnas.0811190106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Round PD, 2007, J AVIAN BIOL, V38, P133, DOI 10.1111/j.2007.0908-8857.04064.x; SHNITNIKOV VN, 1949, BIRDS SEMYRECHYE; Stepanyan L.S., 1990, CONSPECTUS ORNITHOLO; Stepanyan L. S., 2003, CONSPECTUS ORNITHOLO; Svensson L., 1992, IDENTIFICATION GUIDE; Svensson L, 2010, IBIS, V152, P323; Svensson L, 2008, J AVIAN BIOL, V39, P605, DOI 10.1111/j.1600-048X.2008.04634.x; Timmins Robert J., 2009, BirdingASIA, V12, P42; YANUSHEVICH AI, 1960, BIRDS KIRGHIZIA, V2	27	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e17716	10.1371/journal.pone.0017716	http://dx.doi.org/10.1371/journal.pone.0017716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526114	Green Published, gold, Green Submitted			2022-12-25	WOS:000290015800003
J	Fang, L; Hou, XL; Yen, L; Lee, C; Liu, L; Yan, XJ; Yu, H				Fang, Lei; Hou, Xingliang; Yen, Li; Lee, Candy; Liu, Lu; Yan, Xiaojing; Yu, Hao			AtPV42a and AtPV42b Redundantly Regulate Reproductive Development in Arabidopsis thaliana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE SNF1; PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; GAMETOPHYTE DEVELOPMENT; POLLEN DEVELOPMENT; CARBON METABOLISM; GLOBAL REGULATORS; ENERGY CONTROL; SYNERGID CELL; CBS DOMAINS	Background: The conserved SNF1/AMPK/SnRK1 complexes are global regulators of metabolic responses in eukaryotes and play a key role in the control of energy balance. Although alpha-type subunits of the SnRK1 complex have been characterized in several plant species, the biological function of beta-type and gamma-type subunits remains largely unknown. Here, we characterized AtPV42a and AtPV42b, the two homologous genes in Arabidopsis, which encode cystathionine-beta-synthase (CBS) domain-containing proteins that belong to the PV42 class of gamma-type subunits of the plant SnRK1 complexes. Methodology/Principal Findings: Real-time polymerase chain reaction was performed to examine the expression of AtPV42a and AtPV42b in various tissues. Transgenic plants that expressed artificial microRNAs targeting these two genes were created. Reproductive organ development and fertilization in these plants were examined by various approaches, including histological analysis, scanning electron microscopy, transmission electron microscopy, and phenotypic analyses of reciprocal crosses between wild-type and transgenic plants. We found that AtPV42a and AtPV42b were expressed in various tissues during different developmental stages. Transgenic plants where AtPV42a and AtPV42b were simultaneously silenced developed shorter siliques and reduced seed sets. Such low fertility phenotype resulted from deregulation of late stamen development and impairment of pollen tube attraction conferred by the female gametophyte. Conclusions: Our results demonstrate that AtPV42a and AtPV42b play redundant roles in regulating male gametogenesis and pollen tube guidance, indicating that the Arabidopsis SnRK1 complexes might be involved in the control of reproductive development.	[Fang, Lei] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Fang, L (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsyuhao@nus.edu.sg	Yu, Hao/A-3867-2010; Liu, Lu/AAF-6465-2021	Yu, Hao/0000-0002-9778-8855; Liu, Lu/0000-0003-4353-1795; Lee, Candy/0000-0002-3297-4091	Ministry of Education, Singapore [T208B3113]; Temasek Life Sciences Laboratory	Ministry of Education, Singapore(Ministry of Education, Singapore); Temasek Life Sciences Laboratory(National University of Singapore)	This work was supported in the HY group by an Academic Research Fund T208B3113 from the Ministry of Education, Singapore, and the intramural research funds from Temasek Life Sciences Laboratory. The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON A, 1991, P NATL ACAD SCI USA, V88, P8602, DOI 10.1073/pnas.88.19.8602; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Bhalerao RP, 1999, P NATL ACAD SCI USA, V96, P5322, DOI 10.1073/pnas.96.9.5322; Bouly JP, 1999, PLANT J, V18, P541, DOI 10.1046/j.1365-313X.1999.00476.x; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Capron A, 2008, PLANT CELL, V20, P3038, DOI 10.1105/tpc.108.061713; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CELENZA JL, 1989, MOL CELL BIOL, V9, P5034, DOI 10.1128/MCB.9.11.5034; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; CELENZA JL, 1984, MOL CELL BIOL, V4, P54, DOI 10.1128/MCB.4.1.54; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Gissot L, 2006, PLANT PHYSIOL, V142, P931, DOI 10.1104/pp.106.087718; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Halford NG, 2003, PLANT BIOTECHNOL J, V1, P381, DOI 10.1046/j.1467-7652.2003.00046.x; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hedbacker K, 2004, MOL CELL BIOL, V24, P1836, DOI 10.1128/MCB.24.5.1836-1843.2004; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Jakobsen MK, 2005, GENE DEV, V19, P2757, DOI 10.1101/gad.357305; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kleinow T, 2000, PLANT J, V23, P115, DOI 10.1046/j.1365-313x.2000.00809.x; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Lovas A, 2003, GENE, V321, P123, DOI 10.1016/j.gene.2003.08.001; Lu CA, 2007, PLANT CELL, V19, P2484, DOI 10.1105/tpc.105.037887; Lumbreras V, 2001, EMBO REP, V2, P55, DOI 10.1093/embo-reports/kve001; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; MURANAKA T, 1994, MOL CELL BIOL, V14, P2958, DOI 10.1128/MCB.14.5.2958; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Punwani JA, 2008, SEX PLANT REPROD, V21, P7, DOI 10.1007/s00497-007-0059-3; Punwani JA, 2007, PLANT CELL, V19, P2557, DOI 10.1105/tpc.107.052076; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Sanders PM, 1999, SEX PLANT REPROD, V11, P297, DOI 10.1007/s004970050158; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Slocombe SP, 2002, PLANT MOL BIOL, V49, P31, DOI 10.1023/A:1014464314113; Takano M, 1998, MOL GEN GENET, V260, P388, DOI 10.1007/s004380050908; Thelander M, 2004, EMBO J, V23, P1900, DOI 10.1038/sj.emboj.7600182; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Weterings K, 2004, PLANT CELL, V16, pS107, DOI 10.1105/tpc.016873; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286; Yu H, 2000, PLANT CELL, V12, P2143, DOI 10.1105/tpc.12.11.2143; Zhang YH, 2001, PLANT J, V28, P431, DOI 10.1046/j.1365-313X.2001.01167.x	52	12	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19033	10.1371/journal.pone.0019033	http://dx.doi.org/10.1371/journal.pone.0019033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533063	gold, Green Published, Green Submitted			2022-12-25	WOS:000289719400053
J	Schultheis, C; Liewald, JF; Bamberg, E; Nagel, G; Gottschalk, A				Schultheis, Christian; Liewald, Jana Fiona; Bamberg, Ernst; Nagel, Georg; Gottschalk, Alexander			Optogenetic Long-Term Manipulation of Behavior and Animal Development	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; C-ELEGANS; MILLISECOND-TIMESCALE; CHEMOSENSORY NEURONS; GLUTAMATE-RECEPTOR; LARVAL DEVELOPMENT; OPTICAL CONTROL; DAUER FORMATION; CHANNELRHODOPSIN-2; PHEROMONE	Channelrhodopsin-2 (ChR2) is widely used for rapid photodepolarization of neurons, yet, as it requires high-intensity blue light for activation, it is not suited for long-term in vivo applications, e. g. for manipulations of behavior, or photoactivation of neurons during development. We used "slow" ChR2 variants with mutations in the C128 residue, that exhibit delayed off-kinetics and increased light sensitivity in Caenorhabditis elegans. Following a 1 s light pulse, we could photodepolarize neurons and muscles for minutes (and with repeated brief stimulation, up to days) with low-intensity light. Photoactivation of ChR2(C128S) in command interneurons elicited long-lasting alterations in locomotion. Finally, we could optically induce profound changes in animal development: Long-term photoactivation of ASJ neurons, which regulate larval growth, bypassed the constitutive entry into the "dauer" larval state in daf-11 mutants. These lack a guanylyl cyclase, which possibly renders ASJ neurons hyperpolarized. Furthermore, photostimulated ASJ neurons could acutely trigger dauer-exit. Thus, slow ChR2s can be employed to long-term photoactivate behavior and to trigger alternative animal development.	[Schultheis, Christian; Liewald, Jana Fiona; Gottschalk, Alexander] Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany; [Schultheis, Christian; Liewald, Jana Fiona; Gottschalk, Alexander] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, Frankfurt, Germany; [Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, D-6000 Frankfurt, Germany; [Nagel, Georg] Univ Wurzburg, Wurzburg, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; University of Wurzburg	Schultheis, C (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Frankfurt, Germany.	a.gottschalk@em.uni-frankfurt.de	Gottschalk, Alexander/D-3155-2011	Gottschalk, Alexander/0000-0002-1197-6119; Nagel, Georg/0000-0001-8174-8712	Deutsche Forschungsgemeinschaft [GO1011/2-1, GO1011/4-1 (FOR1279)]; SFB807 "Membrane Transport"; Cluster of Excellence Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SFB807 "Membrane Transport"; Cluster of Excellence Frankfurt	This work was funded by the Deutsche Forschungsgemeinschaft, grants GO1011/2-1, GO1011/4-1 (FOR1279), the SFB807 "Membrane Transport", and through the Cluster of Excellence Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Birnby DA, 2000, GENETICS, V155, P85; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRENNER S, 1974, GENETICS, V77, P71; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; VOWELS JJ, 1994, GENETICS, V138, P303; VOWELS JJ, 1992, GENETICS, V130, P105; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1; Zwaal RR, 1997, GENETICS, V145, P715	33	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18766	10.1371/journal.pone.0018766	http://dx.doi.org/10.1371/journal.pone.0018766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533086	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400024
J	Baker, AM; Fu, Q; Hayward, W; Victoria, S; Pedroso, IM; Lindsay, SM; Fletcher, TM				Baker, Asmaa M.; Fu, Qiang; Hayward, William; Victoria, Samuel; Pedroso, Ilene M.; Lindsay, Stuart M.; Fletcher, Terace M.			The Telomere Binding Protein TRF2 Induces Chromatin Compaction	PLOS ONE			English	Article							AGAROSE-GEL ELECTROPHORESIS; WERNER-SYNDROME HELICASE; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; SELF-ASSOCIATION; IN-VITRO; NUCLEOSOMAL ARRAYS; HOLLIDAY JUNCTIONS; IONIC-STRENGTH; FISSION YEAST	Mammalian telomeres are specialized chromatin structures that require the telomere binding protein, TRF2, for maintaining chromosome stability. In addition to its ability to modulate DNA repair activities, TRF2 also has direct effects on DNA structure and topology. Given that mammalian telomeric chromatin includes nucleosomes, we investigated the effect of this protein on chromatin structure. TRF2 bound to reconstituted telomeric nucleosomal fibers through both its basic N-terminus and its C-terminal DNA binding domain. Analytical agarose gel electrophoresis (AAGE) studies showed that TRF2 promoted the folding of nucleosomal arrays into more compact structures by neutralizing negative surface charge. A construct containing the N-terminal and TRFH domains together altered the charge and radius of nucleosomal arrays similarly to full-length TRF2 suggesting that TRF2-driven changes in global chromatin structure were largely due to these regions. However, the most compact chromatin structures were induced by the isolated basic N-terminal region, as judged by both AAGE and atomic force microscopy. Although the N-terminal region condensed nucleosomal array fibers, the TRFH domain, known to alter DNA topology, was required for stimulation of a strand invasion-like reaction with nucleosomal arrays. Optimal strand invasion also required the C-terminal DNA binding domain. Furthermore, the reaction was not stimulated on linear histone-free DNA. Our data suggest that nucleosomal chromatin has the ability to facilitate this activity of TRF2 which is thought to be involved in stabilizing looped telomere structures.	[Baker, Asmaa M.; Hayward, William; Victoria, Samuel; Pedroso, Ilene M.; Fletcher, Terace M.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Fu, Qiang; Lindsay, Stuart M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	University of Miami; Arizona State University; Arizona State University-Tempe	Baker, AM (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.	tfletcher@med.miami.edu	Fu, Qiang/ABE-5606-2021	Fu, Qiang/0000-0003-4554-0644; Hayward, William/0000-0002-9344-4203	James and Esther King [04NAR-06]; American Heart Association [07552813]; National Institutes of Health [F31-GM75427-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM075427] Funding Source: NIH RePORTER	James and Esther King; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the James and Esther King, Florida Biomedical Research Program (04NAR-06; http://www.floridabiomed.com/about.html); the American Heart Association (Grant-in-aid, 07552813; http://www.americanheart.org/presenter.jhtml?identifier=3059871) to T. Fletcher; and a National Institutes of Health Fellowship (F31-GM75427-01) to A. Baker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Baker AM, 2009, NUCLEIC ACIDS RES, V37, P5019, DOI 10.1093/nar/gkp515; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Benetti R, 2008, CELL CYCLE, V7, P3461, DOI 10.4161/cc.7.21.7013; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Buscemi G, 2009, CURR BIOL, V19, P874, DOI 10.1016/j.cub.2009.03.064; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Falk M, 2010, MUTAT RES-REV MUTAT, V704, P88, DOI 10.1016/j.mrrev.2010.01.013; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; FLETCHER TM, 1994, BIOCHEMISTRY-US, V33, P10859, DOI 10.1021/bi00202a002; FLETCHER TM, 1994, BIOCHEMISTRY-US, V33, P2226, DOI 10.1021/bi00174a032; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Galati A, 2006, J MOL BIOL, V360, P377, DOI 10.1016/j.jmb.2006.04.071; GRIESS GA, 1989, BIOPOLYMERS, V28, P1475, DOI 10.1002/bip.360280811; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Groff-Vindman C, 2005, MOL CELL BIOL, V25, P4406, DOI 10.1128/MCB.25.11.4406-4412.2005; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1994, P NATL ACAD SCI USA, V91, P2339, DOI 10.1073/pnas.91.6.2339; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Kan PY, 2007, MOL CELL BIOL, V27, P2084, DOI 10.1128/MCB.02181-06; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Khan SJ, 2007, BIOCHEM BIOPH RES CO, V363, P44, DOI 10.1016/j.bbrc.2007.08.122; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Lu X, 2006, BIOCHEM CELL BIOL, V84, P411, DOI 10.1139/O06-068; Lu X, 2009, BIOCHEMISTRY-US, V48, P164, DOI 10.1021/bi801636y; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Misri S, 2008, CYTOGENET GENOME RES, V122, P297, DOI 10.1159/000167816; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nishikawa T, 2001, STRUCTURE, V9, P1237, DOI 10.1016/S0969-2126(01)00688-8; Nora GJ, 2010, NUCLEIC ACIDS RES, V38, P3984, DOI 10.1093/nar/gkq144; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Pedroso IM, 2009, NUCLEIC ACIDS RES, V37, P1541, DOI 10.1093/nar/gkn1081; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Pisano S, 2010, NUCLEIC ACIDS RES, V38, P2247, DOI 10.1093/nar/gkp1228; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stansel RM, 2001, EMBO J, V20, P5532; Steger DJ, 1997, METHODS, V12, P276, DOI 10.1006/meth.1997.0479; STEIN A, 1979, P NATL ACAD SCI USA, V76, P5000, DOI 10.1073/pnas.76.10.5000; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wu P, 2008, MOL CELL BIOL, V28, P5724, DOI 10.1128/MCB.01764-07; Yanez GH, 2005, BIOCHEM BIOPH RES CO, V328, P49, DOI 10.1016/j.bbrc.2004.12.134; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032; Yoshimura SH, 2004, GENES CELLS, V9, P205, DOI 10.1111/j.1356-9597.2004.00719.x	76	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19124	10.1371/journal.pone.0019124	http://dx.doi.org/10.1371/journal.pone.0019124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526145	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100054
J	Hsieh, MT; Chen, RH				Hsieh, Meng-Ti; Chen, Rey-Huei			Cdc48 and Cofactors Npl4-Ufd1 Are Important for G1 Progression during Heat Stress by Maintaining Cell Wall Integrity in Saccharomyces cerevisiae	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; AAA-ATPASE CDC48/P97; MAP KINASE PATHWAY; PROTEIN-KINASE; UPSTREAM ACTIVATOR; POSITIVE FEEDBACK; MEMBRANE-PROTEIN; GENE-EXPRESSION; YEAST; CYCLE	The ubiquitin-selective chaperone Cdc48, a member of the AAA (ATPase Associated with various cellular Activities) ATPase superfamily, is involved in many processes, including endoplasmic reticulum-associated degradation (ERAD), ubiquitin-and proteasome-mediated protein degradation, and mitosis. Although Cdc48 was originally isolated as a cell cycle mutant in the budding yeast Saccharomyces cerevisiae, its cell cycle functions have not been well appreciated. We found that temperature-sensitive cdc48-3 mutant is largely arrested at mitosis at 37 degrees C, whereas the mutant is also delayed in G1 progression at 38.5 degrees C. Reporter assays show that the promoter activity of G1 cyclin CLN1, but not CLN2, is reduced in cdc48-3 at 38.5 degrees C. The cofactor npl4-1 and ufd1-2 mutants also exhibit G1 delay and reduced CLN1 promoter activity at 38.5 degrees C, suggesting that Npl4-Ufd1 complex mediates the function of Cdc48 at G1. The G1 delay of cdc48-3 at 38.5 degrees C is a consequence of cell wall defect that over-activates Mpk1, a MAPK family member important for cell wall integrity in response to stress conditions including heat shock. cdc48-3 is hypersensitive to cell wall perturbing agents and is synthetic-sick with mutations in the cell wall integrity signaling pathway. Our results suggest that the cell wall defect in cdc48-3 is exacerbated by heat shock, which sustains Mpk1 activity to block G1 progression. Thus, Cdc48-Npl4-Ufd1 is important for the maintenance of cell wall integrity in order for normal cell growth and division.	[Hsieh, Meng-Ti; Chen, Rey-Huei] Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan; [Hsieh, Meng-Ti; Chen, Rey-Huei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Hsieh, MT (corresponding author), Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan.	rhchen@imb.sinica.edu.tw	Chen, Rey-Huei/AAA-5087-2021	Chen, Rey-Huei/0000-0002-6006-2137	Academia Sinica; National Science Council, Taiwan	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from Academia Sinica and National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Breeden L, 1996, CURR TOP MICROBIOL, V208, P95; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; CROSS FR, 1995, CURR OPIN CELL BIOL, V7, P790, DOI 10.1016/0955-0674(95)80062-X; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Heubes S, 2007, J CELL SCI, V120, P1325, DOI 10.1242/jcs.006924; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ikai N, 2006, J STRUCT BIOL, V156, P50, DOI 10.1016/j.jsb.2006.04.003; JOHNSTON GC, 1980, MOL GEN GENET, V178, P357, DOI 10.1007/BF00270484; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Mai B, 1997, MOL CELL BIOL, V17, P6491, DOI 10.1128/MCB.17.11.6491; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MOIR D, 1982, GENETICS, V100, P547; Molina M, 2000, MICROSC RES TECHNIQ, V51, P601, DOI 10.1002/1097-0029(20001215)51:6<601::AID-JEMT9>3.3.CO;2-9; NASMYTH K, 1991, CELL, V66, P995, DOI 10.1016/0092-8674(91)90444-4; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; ROWLEY A, 1993, MOL CELL BIOL, V13, P1034, DOI 10.1128/MCB.13.2.1034; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; RUIS H, 1995, BIOESSAYS, V17, P959, DOI 10.1002/bies.950171109; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; ZHANG SR, 1995, MOL CELL BIOL, V15, P2037	55	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18988	10.1371/journal.pone.0018988	http://dx.doi.org/10.1371/journal.pone.0018988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526151	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100045
J	Nakata, I; Yamashiro, K; Yamada, R; Gotoh, N; Nakanishi, H; Hayashi, H; Tsujikawa, A; Otani, A; Saito, M; Iida, T; Oishi, A; Matsuo, K; Tajima, K; Matsuda, F; Yoshimura, N				Nakata, Isao; Yamashiro, Kenji; Yamada, Ryo; Gotoh, Norimoto; Nakanishi, Hideo; Hayashi, Hisako; Tsujikawa, Akitaka; Otani, Atsushi; Saito, Masaaki; Iida, Tomohiro; Oishi, Akio; Matsuo, Keitaro; Tajima, Kazuo; Matsuda, Fumihiko; Yoshimura, Nagahisa			Association between the SERPING1 Gene and Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; POLYMORPHISM; RISK; VARIANTS; CFH; MACULOPATHY; INCREASES	Purpose: Recently, a complement component 1 inhibitor (SERPING1) gene polymorphism was identified as a novel risk factor for age-related macular degeneration (AMD) in Caucasians. We aimed to investigate whether variations in SERPING1 are associated with typical AMD or with polypoidal choroidal vasculopathy (PCV) in a Japanese population. Methods: We performed a case-control study in a group of Japanese patients with typical AMD (n = 401) or PCV (n = 510) and in 2 independent control groups-336 cataract patients without age-related maculopathy and 1,194 healthy Japanese individuals. Differences in the observed genotypic distribution between the case and control groups were tested using chi-square test for trend. Age and gender were adjusted using logistic regression analysis. Results: We targeted rs2511989 as the haplotype-tagging single nucleotide polymorphism (SNP) for the SERPING1 gene, which was reported to be associated with the risk of AMD in Caucasians. Although we compared the genotypic distributions of rs2511989 in typical AMD and PCV patients against 2 independent control groups (cataract patients and healthy Japanese individuals), SERPING1 rs2511989 was not significantly associated with typical AMD (P = 0.932 and 0.513, respectively) or PCV (P = 0.505 and 0.141, respectively). After correction for age and gender differences based on a logistic regression model, the difference in genotypic distributions remained insignificant (P>0.05). Our sample size had a statistical power of more than 90% to detect an association of a risk allele with an odds ratio reported in the original studies for rs2511989 for developing AMD. Conclusions: In the present study, we could not replicate the reported association between SERPING1 and either neovascular AMD or PCV in a Japanese population; thus, the results suggest that SERPING1 does not play a significant role in the risk of developing AMD or PCV in Japanese.	[Nakata, Isao; Yamashiro, Kenji; Gotoh, Norimoto; Nakanishi, Hideo; Hayashi, Hisako; Tsujikawa, Akitaka; Otani, Atsushi; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Nakata, Isao; Yamada, Ryo; Gotoh, Norimoto; Nakanishi, Hideo; Hayashi, Hisako; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, INSERM,U852, Kyoto, Japan; [Saito, Masaaki; Iida, Tomohiro] Fukushima Med Univ, Dept Ophthalmol, Fukushima, Japan; [Oishi, Akio] Kobe City Med Ctr Gen Hosp, Dept Ophthalmol, Kobe, Hyogo, Japan; [Matsuo, Keitaro; Tajima, Kazuo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan	Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University; Fukushima Medical University; Kobe City Medical Center General Hospital; Aichi Cancer Center	Nakata, I (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	yamashro@kuhp.kyoto-u.ac.jp	Matsuda, Fumihiko/B-9893-2009; Matsuo, Keitaro/H-6758-2019; Saito, Masaaki/ABI-2783-2020; Oishi, Akio/AAE-9996-2020	Matsuo, Keitaro/0000-0003-1761-6314; Saito, Masaaki/0000-0003-1494-6350; Oishi, Akio/0000-0002-0977-9458; Yamada, Ryo/0000-0002-1587-630X; Yamashiro, Kenji/0000-0001-9354-8558; Tsujikawa, Akitaka/0000-0003-0779-7799	Japan Society for the Promotion of Science, Tokyo, Japan [19390442, 22791706, 27091294]; Japanese National Society for the Prevention of Blindness	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese National Society for the Prevention of Blindness	The study was supported in part by grants-in-aid for scientific research (Nos. 19390442, 22791706, and 27091294) from the Japan Society for the Promotion of Science, Tokyo, Japan, and by the Japanese National Society for the Prevention of Blindness. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 2009, LANCET, V374, P875, DOI 10.1016/S0140-6736(09)61618-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bird AC, 2003, EYE, V17, P457, DOI 10.1038/sj.eye.6700562; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chang TS, 1999, CAN J OPHTHALMOL, V34, P266; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ennis S, 2008, LANCET, V372, P1828, DOI 10.1016/S0140-6736(08)61348-3; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gotoh N, 2008, CLIN EXP OPHTHALMOL, V36, P437, DOI 10.1111/j.1442-9071.2008.01791.x; Gotoh N, 2009, AM J OPHTHALMOL, V147, P1037, DOI 10.1016/j.ajo.2008.12.036; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Kawasaki R, 2008, OPHTHALMOLOGY, V115, P1376, DOI 10.1016/j.ophtha.2007.11.015; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondo N, 2009, OPHTHALMOLOGY, V116, P304, DOI 10.1016/j.ophtha.2008.11.011; Lee AY, 2010, BRIT J OPHTHALMOL, V94, P915, DOI 10.1136/bjo.2009.172007; Lee KY, 2008, INVEST OPHTH VIS SCI, V49, P2613, DOI 10.1167/iovs.07-0860; Li M, 2010, MOL VIS, V16, P231; Lu F, 2010, MOL VIS, V16, P1; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Mori K, 2010, OPHTHALMOLOGY, V117, P928, DOI 10.1016/j.ophtha.2009.10.001; Park KH, 2009, MOL VIS, V15, P200; Seitsonen S, 2006, MOL VIS, V12, P796; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Terasaki H, 2002, BRIT J OPHTHALMOL, V86, P321, DOI 10.1136/bjo.86.3.321; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	34	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19108	10.1371/journal.pone.0019108	http://dx.doi.org/10.1371/journal.pone.0019108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526158	gold, Green Submitted, Green Published			2022-12-25	WOS:000289671100051
J	Malachowa, N; Whitney, AR; Kobayashi, SD; Sturdevant, DE; Kennedy, AD; Braughton, KR; Shabb, DW; Diep, BA; Chambers, HF; Otto, M; DeLeo, FR				Malachowa, Natalia; Whitney, Adeline R.; Kobayashi, Scott D.; Sturdevant, Daniel E.; Kennedy, Adam D.; Braughton, Kevin R.; Shabb, Duncan W.; Diep, Binh An; Chambers, Henry F.; Otto, Michael; DeLeo, Frank R.			Global Changes in Staphylococcus aureus Gene Expression in Human Blood	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; GAMMA-HEMOLYSIN; VIRULENCE DETERMINANT; IRON; IDENTIFICATION; USA300; INFECTION; PHAGOCYTOSIS; SIDEROPHORE; DESTRUCTION	Staphylococcus aureus is a leading cause of bloodstream infections worldwide. In the United States, many of these infections are caused by a strain known as USA300. Although progress has been made, our understanding of the S. aureus molecules that promote survival in human blood and ultimately facilitate metastases is incomplete. To that end, we analyzed the USA300 transcriptome during culture in human blood, human serum, and trypticase soy broth (TSB), a standard laboratory culture media. Notably, genes encoding several cytolytic toxins were up-regulated in human blood over time, and hlgA, hlgB, and hlgC (encoding gamma-hemolysin subunits HlgA, HlgB, and HlgC) were among the most highly up-regulated genes at all time points. Compared to culture supernatants from a wild-type USA300 strain (LAC), those derived from an isogenic hlgABC-deletion strain (LAC Delta hlgABC) had significantly reduced capacity to form pores in human neutrophils and ultimately cause neutrophil lysis. Moreover, LAC Delta hlgABC had modestly reduced ability to cause mortality in a mouse bacteremia model. On the other hand, wild-type and LAC Delta hlgABC strains caused virtually identical abscesses in a mouse skin infection model, and bacterial survival and neutrophil lysis after phagocytosis in vitro was similar between these strains. Comparison of the cytolytic capacity of culture supernatants from wild-type and isogenic deletion strains lacking hlgABC, lukS/F-PV (encoding PVL), and/or lukDE revealed functional redundancy among two-component leukotoxins in vitro. These findings, along with a requirement of specific growth conditions for leukotoxin expression, may explain the apparent limited contribution of any single two-component leukotoxin to USA300 immune evasion and virulence.	[Malachowa, Natalia; Whitney, Adeline R.; Kobayashi, Scott D.; Kennedy, Adam D.; Braughton, Kevin R.; DeLeo, Frank R.] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT USA; [Sturdevant, Daniel E.; Shabb, Duncan W.] NIAID, Genom Unit, Res Technol Sect, Rocky Mt Labs,NIH, Hamilton, MT USA; [Diep, Binh An; Chambers, Henry F.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA; [Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Malachowa, N (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT USA.	fdeleo@niaid.nih.gov		DeLeo, Frank/0000-0003-3150-2516; Kobayashi, Scott/0000-0002-5705-1381; Otto, Michael/0000-0002-2222-4115	National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH); U.S. Public Health Service from National Institute of Allergy and Infectious Diseases, NIH [R01 AI070289, R01 AI087674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070289, ZIAAI000904, ZIAAI001079, R01AI087674] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Public Health Service from National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) and U.S. Public Health Service grants, R01 AI070289 (HFC) and R01 AI087674 (BAD), from the National Institute of Allergy and Infectious Diseases, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Beasley FC, 2010, J INORG BIOCHEM, V104, P282, DOI 10.1016/j.jinorgbio.2009.09.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chauvaux S, 2007, MICROBIOL-SGM, V153, P3112, DOI 10.1099/mic.0.2007/006213-0; COONEY J, 1993, INFECT IMMUN, V61, P768, DOI 10.1128/IAI.61.2.768-771.1993; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Dale SE, 2004, J BACTERIOL, V186, P8356, DOI 10.1128/JB.186.24.8356-8362.2004; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graves SF, 2010, MICROBES INFECT, V12, P446, DOI 10.1016/j.micinf.2010.02.005; Heinrichs JH, 1999, J BACTERIOL, V181, P1436, DOI 10.1128/JB.181.5.1436-1443.1999; Jenkins TC, 2009, INFECT CONT HOSP EP, V30, P233, DOI 10.1086/595963; Kempker RR, 2010, J INFECTION, V61, P372, DOI 10.1016/j.jinf.2010.09.021; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; PREVOST G, 1995, INFECT IMMUN, V63, P4121; RAHMAN A, 1993, BIOSCI BIOTECH BIOCH, V57, P1234, DOI 10.1271/bbb.57.1234; Rosso ML, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-211; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sebulsky MT, 2001, J BACTERIOL, V183, P4994, DOI 10.1128/JB.183.17.4994-5000.2001; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Siqueira JA, 1997, J MED MICROBIOL, V46, P486, DOI 10.1099/00222615-46-6-486; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Supersac G, 1998, MICROB PATHOGENESIS, V24, P241, DOI 10.1006/mpat.1997.0192; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Yamazaki K, 2006, FEMS MICROBIOL LETT, V259, P174, DOI 10.1111/j.1574-6968.2006.00236.x	46	159	166	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18617	10.1371/journal.pone.0018617	http://dx.doi.org/10.1371/journal.pone.0018617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525981	Green Submitted, Green Published, gold			2022-12-25	WOS:000289578600018
J	Martel, C; Cointe, S; Maurice, P; Matar, S; Ghitescu, M; Theroux, P; Bonnefoy, A				Martel, Catherine; Cointe, Sylvie; Maurice, Pascal; Matar, Said; Ghitescu, Marta; Theroux, Pierre; Bonnefoy, Arnaud			Requirements for Membrane Attack Complex Formation and Anaphylatoxins Binding to Collagen-Activated Platelets	PLOS ONE			English	Article							PROTEINS C5B-9; PROCOAGULANT ACTIVITY; BLOOD-PLATELETS; C5A RECEPTOR; EXPRESSION; SECRETION; PROTHROMBINASE; MICROPARTICLES; COMPONENT; PATHWAY	Background: The activation of complement during platelet activation is incompletely understood. Objectives: We sought to explore the formation of C5b-9 and anaphylatoxins binding to collagen-activated platelets. Methods: C5b-9, anaphylatoxins C3a, C4a and C5a, and anaphylatoxin receptors C3aR1 and C5aR were measured by flow cytometry and/or confocal microscopy. Platelet microparticles were quantified by flow cytometry, and their C5b-9 content was determined by western blot analyses. In all experiments, sodium citrate was used for blood anticoagulation. Results: C5b-9 rapidly formed on the platelet surface following activation with collagen, TRAP, ADP or A23187, but was surprisingly restricted to a subset of platelets (1 to 15%) independently of P-selectin or phosphatidylserine exposure. Following collagen activation, C5b-9-positive platelets in thrombi were found associated with collagen fibres. C5b-9 formation was obliterated by Mg(2+)-EGTA and significantly reduced by the thrombin inhibitor hirudin (237%, p<0.05), but was unaffected by chondroitinase, compstatin, SCH79797 (PAR-1 inhibitor), or in the PRP of a MBL-deficient donor. Compstatin and Mg(2+)-EGTA, but not hirudin, SCH79797 or chondroitinase, inhibited the formation of collagen-induced microparticles (-71% and -44%, respectively, p<0.04). These microparticles contained greater amounts of C5b-9 compared with the other agonists. Platelet activation by collagen or convulxin resulted in the strong binding of anaphylatoxins and the exposure of receptors C3aR1 and C5aR (CD88) on their surface. Conclusions: C5b-9 formation on collagen-activated platelets is i) partially controlled by thrombin, ii) restricted to a subset of platelets, and iii) can occur without P-selectin expression or phosphatidylserine exposure. Activated platelets bind anaphylatoxins on their surface and express C3a and C5a receptors, which may contribute to the localization of inflammatory processes during thrombosis.	[Martel, Catherine; Cointe, Sylvie; Maurice, Pascal; Matar, Said; Ghitescu, Marta; Theroux, Pierre; Bonnefoy, Arnaud] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Bonnefoy, Arnaud] Univ Montreal, INSERM, U743, Montreal, PQ, Canada	Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal	Martel, C (corresponding author), Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada.	arnaudbonnefoy@yahoo.fr	Maurice, Pascal/AAM-9126-2021	cointe, sylvie/0000-0001-6539-7879; MAURICE, Pascal/0000-0003-2167-4808	Agence Nationale de la Recherche [ANR-05-PCOD-031-02, ANR-07-PHYSIO-025-02]; Canadian Institutes of Health Research (CIHR)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Agence Nationale de la Recherche (grants ANR-05-PCOD-031-02 and ANR-07-PHYSIO-025-02). CM was the recipient of a Doctoral Research Award from the Canadian Institutes of Health Research (CIHR). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bexborn F, 2009, J BIOMED MATER RES A, V89A, P951, DOI 10.1002/jbm.a.32034; CAUGHMAN GB, 1982, MOL IMMUNOL, V19, P287, DOI 10.1016/0161-5890(82)90342-X; CHANG CP, 1993, J BIOL CHEM, V268, P7171; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; del Conde I, 2005, J EXP MED, V201, P871, DOI 10.1084/jem.20041497; FROJMOVIC MM, 1990, THROMB HAEMOSTASIS, V64, P582; FUKUOKA Y, 1988, J IMMUNOL, V140, P3496; Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x; Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810; HOULE JJ, 1989, CLIN IMMUNOL IMMUNOP, V50, P385, DOI 10.1016/0090-1229(89)90145-1; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; HUGO F, 1987, J IMMUNOL METHODS, V99, P243, DOI 10.1016/0022-1759(87)90134-7; KAZATCHKINE MD, 1981, J CLIN INVEST, V67, P223, DOI 10.1172/JCI110017; Kulkarni S, 2004, J BIOL CHEM, V279, P30697, DOI 10.1074/jbc.M403559200; Legler DF, 1996, EUR J IMMUNOL, V26, P753, DOI 10.1002/eji.1830260405; Peerschke EIB, 2006, J THROMB HAEMOST, V4, P2035, DOI 10.1111/j.1538-7836.2006.02065.x; PEERSCHKE EIB, 1993, J EXP MED, V178, P579, DOI 10.1084/jem.178.2.579; Peerschke EI, 2010, MOL IMMUNOL, V47, P2170, DOI 10.1016/j.molimm.2010.05.009; POLLEY MJ, 1979, J EXP MED, V150, P633, DOI 10.1084/jem.150.3.633; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Siljander P, 1996, BLOOD, V87, P4651, DOI 10.1182/blood.V87.11.4651.bloodjournal87114651; SIMS PJ, 1988, J BIOL CHEM, V263, P18205; TEDESCO F, 1986, CLIN EXP IMMUNOL, V66, P472; WATANABE H, 1995, J IMMUNOL METHODS, V185, P19, DOI 10.1016/0022-1759(95)00101-F; WIEDMER T, 1987, J BIOL CHEM, V262, P13674; WIEDMER T, 1985, J BIOL CHEM, V260, P8014; WIEDMER T, 1986, BLOOD, V68, P875; YANCEY KB, 1989, J INVEST DERMATOL, V92, P184, DOI 10.1111/1523-1747.ep12276710; Yin W, 2008, PLATELETS, V19, P225, DOI 10.1080/09537100701777311	30	52	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18812	10.1371/journal.pone.0018812	http://dx.doi.org/10.1371/journal.pone.0018812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526204	gold, Green Published			2022-12-25	WOS:000289578600034
J	Necela, BM; Carr, JM; Asmann, YW; Thompson, EA				Necela, Brian M.; Carr, Jennifer M.; Asmann, Yan W.; Thompson, E. Aubrey			Differential Expression of MicroRNAs in Tumors from Chronically Inflamed or Genetic (APC(Min/+)) Models of Colon Cancer	PLOS ONE			English	Article							CHRONIC ULCERATIVE-COLITIS; GROWTH-INHIBITION; TARGETS; RNAS; PROLIFERATION; INFLAMMATION; TRANSCRIPTS; MECHANISM; MIGRATION; PROFILES	Background: Chronic inflammation associated with ulcerative colitis predisposes individuals to increased colon cancer risk. The aim of these studies was to identify microRNAs that are aberrantly regulated during inflammation and may participate in transformation of colonic epithelial cells in the inflammatory setting. Methodology/Principal Findings: We have use quantitative PCR arrays to compare microRNA (miRNA) expression in tumors and control colonic epithelial cells isolated from distal colons of chronically inflamed mice and APC(Min/+) mice. Rank order statistics was utilized to identify differentially regulated miRNAs in tumors that arose due to chronic inflammation and/or to germline APC mutation. Eight high priority miRNAs were identified: miR-215, miR-137, miR-708, miR-31, and miR-135b were differentially expressed in APC tumors and miR-215, miR-133a, miR-467d, miR-218, miR-708, miR-31, and miR-135b in colitis-associated tumors. Four of these (miR-215, miR-708, miR-31, and miR-135b) were common to both tumors types, and dysregulation of these miRNAs was confirmed in an independent sample set. Target prediction and pathway analysis suggests that these microRNAs, in the aggregate, regulate signaling pathways related to MAPK, PI3K, WNT, and TGF-beta, all of which are known to be involved in transformation. Conclusions/Significance: We conclude that these four miRNAs are dysregulated at some very early stage in transformation of colonic epithelial cells. This response is not dependent on the mechanism of initiation of transformation (inflammation versus germline mutation), suggesting that the miRNAs that we have identified are likely to regulate critical signaling pathways that are central to early events in transformation of colonic epithelial cells.	[Necela, Brian M.; Carr, Jennifer M.; Thompson, E. Aubrey] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Asmann, Yan W.] Mayo Clin, Coll Med, Dept Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Necela, BM (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA.	thompson.aubrey@mayo.edu			CCFA	CCFA	This work was funded in part by a CCFA Career Development Award to BMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P281; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BONI V, 2010, MOL CANC THER; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Davidson LA, 2009, CARCINOGENESIS, V30, P2077, DOI 10.1093/carcin/bgp245; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Earle JSL, 2010, J MOL DIAGN, V12, P433, DOI 10.2353/jmoldx.2010.090154; Fantini MC, 2008, CURR DRUG TARGETS, V9, P375, DOI 10.2174/138945008784221206; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; GUSEV Y, MICRORNA PROFILING C, P257; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; La Rocca G, 2009, CELL CYCLE, V8, P2255, DOI 10.4161/cc.8.14.9026; Lanza G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-54; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Maatouk D, 2006, THESCIENTIFICWORLDJO, V6, P1828, DOI 10.1100/tsw.2006.313; Michael MZ, 2003, MOL CANCER RES, V1, P882; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nakajima Go, 2006, Cancer Genomics & Proteomics, V3, P317; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Seril DN, 2002, CARCINOGENESIS, V23, P993, DOI 10.1093/carcin/23.6.993; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Slattery ML, 2011, GENE CHROMOSOME CANC, V50, P196, DOI 10.1002/gcc.20844; Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Su WD, 2007, PHYSIOL GENOMICS, V30, P342, DOI 10.1152/physiolgenomics.00042.2007; Sun ZH, 2010, INT J CORROS, V2010, DOI 10.1155/2010/528573; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-616; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Yang LD, 2009, WORLD J SURG, V33, P638, DOI 10.1007/s00268-008-9865-5; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhang JJ, 2011, CANCER-AM CANCER SOC, V117, P86, DOI 10.1002/cncr.25522	64	57	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18501	10.1371/journal.pone.0018501	http://dx.doi.org/10.1371/journal.pone.0018501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532750	gold, Green Published, Green Submitted			2022-12-25	WOS:000289404700015
J	Lemaire, K; Moura, RF; Granvik, M; Igoillo-Esteve, M; Hohmeier, HE; Hendrickx, N; Newgard, CB; Waelkens, E; Cnop, M; Schuit, F				Lemaire, Katleen; Moura, Rodrigo F.; Granvik, Mikaela; Igoillo-Esteve, Mariana; Hohmeier, Hans E.; Hendrickx, Nico; Newgard, Christopher B.; Waelkens, Etienne; Cnop, Miriam; Schuit, Frans			Ubiquitin Fold Modifier 1 (UFM1) and Its Target UFBP1 Protect Pancreatic Beta Cells from ER Stress-Induced Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; STIMULATED INSULIN-SECRETION; FREE FATTY-ACIDS; BINDING PROTEIN; TRANSLATIONAL CONTROL; DIABETES-MELLITUS; OXIDATIVE STRESS; MESSENGER-RNA; ISLET CELLS; KAPPA-B	UFM1 is a member of the ubiquitin like protein family. While the enzymatic cascade of UFM1 conjugation has been elucidated in recent years, the biological function remains largely unknown. In this report we demonstrate that the recently identified C20orf116 [1], which we name UFM1-binding protein 1 containing a PCI domain (UFBP1), and CDK5RAP3 interact with UFM1. Components of the UFM1 conjugation pathway (UFM1, UFBP1, UFL1 and CDK5RAP3) are highly expressed in pancreatic islets of Langerhans and some other secretory tissues. Co-localization of UFM1 with UFBP1 in the endoplasmic reticulum (ER) depends on UFBP1. We demonstrate that ER stress, which is common in secretory cells, induces expression of Ufm1, Ufbp1 and Ufl1 in the beta-cell line INS-1E. siRNA-mediated Ufm1 or Ufbp1knockdown enhances apoptosis upon ER stress. Silencing the E3 enzyme UFL1, results in similar outcomes, suggesting that UFM1-UFBP1 conjugation is required to prevent ER stress-induced apoptosis. Together, our data suggest that UFM1-UFBP1participate in preventing ER stress-induced apoptosis in protein secretory cells.	[Lemaire, Katleen; Granvik, Mikaela; Hendrickx, Nico; Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium; [Moura, Rodrigo F.; Igoillo-Esteve, Mariana; Cnop, Miriam] Univ Libre Brussels, Expt Med Lab, Brussels, Belgium; [Hohmeier, Hans E.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Hohmeier, Hans E.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; [Hohmeier, Hans E.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Durham, NC USA; [Igoillo-Esteve, Mariana; Cnop, Miriam] Erasmus Hosp, Div Endocrinol, Brussels, Belgium	KU Leuven; Universite Libre de Bruxelles; Duke University; Duke University; Duke University; Universite Libre de Bruxelles	Lemaire, K (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium.	katleen.lemaire@med.kuleuven.be; frans.schuit@med.kuleuven.be		de Moura, Rodrigo Ferreira/0000-0002-6617-6434; Cnop, Miriam/0000-0002-5112-1692; Igoillo-Esteve, Mariana/0000-0002-3264-7912	F.W.O.-Vlaanderen [G.0733.09]; Interuniversity Attraction Poles [IAP6/14]; K.U.Leuven [GOA2009/10]; Juvenile Diabetes Research Foundation; European Foundation for the Study of Diabetes (EFSD) - Lilly European Diabetes Research Programme; CAPES (Brazilian Coordination for the Improvement of Higher Education Personnel)	F.W.O.-Vlaanderen(FWO); Interuniversity Attraction Poles(Belgian Federal Science Policy Office); K.U.Leuven(KU Leuven); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Foundation for the Study of Diabetes (EFSD) - Lilly European Diabetes Research Programme; CAPES (Brazilian Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from F.W.O.-Vlaanderen (fellowship to KL and G.0733.09 to FS), Interuniversity Attraction Poles (IAP6/14 to FS and MC), the K.U.Leuven (GOA2009/10 to FS), the Juvenile Diabetes Research Foundation (to FS, HH and CBN) and the European Foundation for the Study of Diabetes (EFSD) - Lilly European Diabetes Research Programme (to MC). RFM. is the recipient of a fellowship from CAPES (Brazilian Coordination for the Improvement of Higher Education Personnel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Ha BH, 2008, J BIOL CHEM, V283, P14893, DOI 10.1074/jbc.M708756200; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang XH, 2005, FEBS J, V272, P3909, DOI 10.1111/j.1742-4658.2005.04807.x; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; POWERS AC, 1990, DIABETES, V39, P406, DOI 10.2337/diabetes.39.4.406; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shiwaku H, 2010, EMBO J, V29, P2446, DOI 10.1038/emboj.2010.116; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	54	123	129	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18517	10.1371/journal.pone.0018517	http://dx.doi.org/10.1371/journal.pone.0018517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494687	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400035
J	Chen, J; Xie, J; Jiang, Z; Wang, B; Wang, Y; Hu, X				Chen, J.; Xie, J.; Jiang, Z.; Wang, B.; Wang, Y.; Hu, X.			Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2	ONCOGENE			English	Article						shikonin; alkannin; pyruvate kinase-M2; glycolysis; inhibitor	ALLOSTERIC REGULATION; DRUG-RESISTANCE; DEATH; M2; IDENTIFICATION; INDUCTION; ISOZYMES; METABOLISM; APOPTOSIS; GROWTH	We recently reported that shikonin and its analogs were a class of necroptotic inducers that could bypass cancer drug resistance. However, the molecular targets of shikonin are not known. Here, we showed that shikonin and its analogs are inhibitors of tumor-specific pyruvate kinase-M2 (PKM2), among which shikonin and its enantiomeric isomer alkannin were the most potent and showed promising selectivity, that is, shikonin and alkannin at concentrations that resulted in over 50% inhibition of PKM2 activity did not inhibit PKM1 and pyruvate kinase-L (PKL). Shikonin and alkannin significantly inhibited the glycolytic rate, as manifested by cellular lactate production and glucose consumption in drug-sensitive and resistant cancer cell lines (MCF-7, MCF-7/Adr, MCF-7/Bcl-2, MCF-7/Bcl-x(L) and A549) that primarily express PKM2. HeLa cells transfected with PKM1 showed reduced sensitivity to shikonin-or alkannin-induced cell death. To the best of our knowledge, shikonin and alkannin are the most potent and specific inhibitors to PKM2 reported so far. As PKM2 universally expresses in cancer cells and dictates the last rate-limiting step of glycolysis vital for cancer cell proliferation and survival, enantiomeric shikonin and alkannin may have potential in future clinical application. Oncogene (2011) 30, 4297-4306; doi: 10.1038/onc.2011.137; published online 25 April 2011	[Chen, J.; Xie, J.; Wang, B.; Hu, X.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310009, Zhejiang, Peoples R China; [Jiang, Z.; Wang, Y.] Zhejiang Univ, Dept Chem, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Hu, X (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	huxun@zju.edu.cn			China National 863 project [2007AA02Z143]; China Natural Sciences Foundation [30772544, 81071802]; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	China National 863 project(National High Technology Research and Development Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, National Ministry of Education, China	We thank BPS Bioscience Inc (San Diego, CA, USA) for technical support of their product-recombinant human PKM2. This work was supported in part by the China National 863 project (2007AA02Z143) to XH; China Natural Sciences Foundation projects (30772544, 81071802) to XH and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China, to XH.	AHN BZ, 1995, J MED CHEM, V38, P1044, DOI 10.1021/jm00006a025; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; ANDERSON SR, 1964, J BIOL CHEM, V239, P2991; Bailly C, 2000, CURR MED CHEM, V7, P39, DOI 10.2174/0929867003375489; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Guo X P, 1991, Zhong Xi Yi Jie He Za Zhi, V11, P598; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Han WD, 2009, APOPTOSIS, V14, P674, DOI 10.1007/s10495-009-0334-x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu X, 2008, CANCER LETT, V259, P127, DOI 10.1016/j.canlet.2007.11.007; IBSEN KH, 1977, CANCER RES, V37, P341; Ikeda Y, 1998, J BIOL CHEM, V273, P12227, DOI 10.1074/jbc.273.20.12227; IMAMURA K, 1973, J BIOCHEM, V74, P1165, DOI 10.1093/oxfordjournals.jbchem.a130344; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kim SH, 2001, CANCER LETT, V172, P171, DOI 10.1016/S0304-3835(01)00665-6; Li L, 2007, CANCER RES, V67, P4894, DOI 10.1158/0008-5472.CAN-06-3818; Liu K, 2008, J MED CHEM, V51, P7843, DOI 10.1021/jm800869t; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Masuda Y, 2003, ONCOGENE, V22, P1012, DOI 10.1038/sj.onc.1206200; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2003, ANTICANCER RES, V23, P1149; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Nakaya K, 2003, ANTI-CANCER DRUG, V14, P683, DOI 10.1097/01.cad.0000092781.37568.df; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; PAPAGEORGIOU VPA, 1999, ANGEW CHEM INT EDIT, V38, P32; PARKISON C, 1991, BIOCHEM BIOPH RES CO, V179, P668, DOI 10.1016/0006-291X(91)91424-B; Shimada N, 2008, GENES CELLS, V13, P245, DOI 10.1111/j.1365-2443.2008.01165.x; Spoden GA, 2008, INT J CANCER, V123, P312, DOI 10.1002/ijc.23512; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xuan YY, 2009, CANCER LETT, V274, P233, DOI 10.1016/j.canlet.2008.09.029; Yang HJ, 2009, INT J CANCER, V124, P2450, DOI 10.1002/ijc.24195	43	311	324	14	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	42					4297	4306		10.1038/onc.2011.137	http://dx.doi.org/10.1038/onc.2011.137			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HP	21516121				2022-12-25	WOS:000296356400001
J	Nakayama, F; Yasuda, T; Umeda, S; Asada, M; Imamura, T; Meineke, V; Akashi, M				Nakayama, Fumiaki; Yasuda, Takeshi; Umeda, Sachiko; Asada, Masahiro; Imamura, Toru; Meineke, Viktor; Akashi, Makoto			Fibroblast Growth Factor-12 (FGF12) Translocation into Intestinal Epithelial Cells Is Dependent on a Novel Cell-penetrating Peptide Domain INVOLVEMENT OF INTERNALIZATION IN THE IN VIVO ROLE OF EXOGENOUS FGF12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; FACTOR HOMOLOGOUS FACTORS; FACTOR-I; NUCLEAR-LOCALIZATION; INTRACELLULAR PROTEIN; TAT PROTEIN; MAST-CELLS; ANTENNAPEDIA HOMEODOMAIN; 3RD HELIX; FGF-1	The extracellular effect of fibroblast growth factor-12 (FGF12) remains unknown because FGF12 cannot activate any fibroblast growth factor receptors (FGFRs), and FGF12 is not currently thought to be released from cells. We reported previously that FGF12 plays an intracellular role in the inhibition of radiation-induced apoptosis. In this study, we demonstrated that recombinant FGF12 was able to be internalized into the cytoplasm of a rat intestinal epithelial cell line, IEC6, and this process was dependent on two novel cell-penetrating peptide (CPP) domains (CPP-M and CPP-C). In particular, CPP-C, composed of similar to 10 amino acids, was identified as a specific domain of FGF12 and its subfamily in the C-terminal region (residues 140149), although CPP-M was a common domain in the internal region of the FGF family. The absence of CPP-C from FGF12 or a mutation (E142L) in the CPP-C domain drastically reduced the internalization of FGF12 into cells. Therefore, CPP-C played an essential role in the internalization of FGF12. In addition, CPP-C was able to deliver other polypeptides into cells as a CPP because an FGF1/CPP-C chimeric protein was internalized into IEC6 cells more efficiently than wild-type FGF1. Finally, intraperitoneally added FGF12 inhibited radiation-induced apoptosis in the intestinal epithelial cells of BALB/c mice, and deletion of the CPP-C domain decreased the inhibition of the apoptosis. These findings suggest that exogenous FGF12 can play a role in tissues by translocating into cells through the plasma membrane, and the availability of this novel CPP provides a new tool for the intracellular delivery of bioactive molecules.	[Nakayama, Fumiaki] Natl Inst Radiol Sci, Adv Radiat Biol Res Program, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan; [Nakayama, Fumiaki; Yasuda, Takeshi; Umeda, Sachiko; Akashi, Makoto] Natl Inst Radiol Sci, Dept Radiat Emergency Med, Inage Ku, Chiba 2638555, Japan; [Asada, Masahiro; Imamura, Toru] Natl Inst Adv Ind Sci & Technol, Signaling Mol Res Grp, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Meineke, Viktor] Univ Ulm, Bundeswehr Inst Radiobiol, D-80937 Munich, Germany	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Institute of Advanced Industrial Science & Technology (AIST); Ulm University	Nakayama, F (corresponding author), Natl Inst Radiol Sci, Adv Radiat Biol Res Program, Res Ctr Charged Particle Therapy, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	f_naka@nirs.go.jp	Yasuda, Takeshi/AAJ-4044-2021; ASADA, MASAHIRO/M-4086-2018	ASADA, MASAHIRO/0000-0001-6092-2080	Research Project for High-Dose Radiation Injuries at NIRS;  [22510065]; Grants-in-Aid for Scientific Research [22510065] Funding Source: KAKEN	Research Project for High-Dose Radiation Injuries at NIRS; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported as a part of the Research Project for High-Dose Radiation Injuries at NIRS and by KAKENHI (22510065).	Artuc M, 2002, J INVEST DERMATOL, V118, P391, DOI 10.1046/j.0022-202x.2001.01705.x; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fu XB, 2004, WORLD J GASTROENTERO, V10, P3590, DOI 10.3748/wjg.v10.i24.3590; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Hagiwara A, 2009, RADIAT RES, V172, P58, DOI 10.1667/RR1570.1; IMAMURA T, 1994, EXP CELL RES, V215, P363, DOI 10.1006/excr.1994.1353; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; IMAMURA T, 1995, BBA-MOL CELL RES, V1266, P124, DOI 10.1016/0167-4889(95)00009-H; Itoch N., 2011, J BIOCH, V149, P121; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; Klingenberg O, 2000, J BIOL CHEM, V275, P11972, DOI 10.1074/jbc.275.16.11972; Kolpakova E, 1998, BIOCHEM J, V336, P213, DOI 10.1042/bj3360213; Komi A, 1998, EXP CELL RES, V243, P408, DOI 10.1006/excr.1998.4176; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; MIGNATTI P, 1991, P NATL ACAD SCI USA, V88, P11007, DOI 10.1073/pnas.88.24.11007; Miyakawa K, 1999, GROWTH FACTORS, V16, P191, DOI 10.3109/08977199909002129; Mizukoshi E, 1999, BIOCHEM J, V343, P461, DOI 10.1042/0264-6021:3430461; Nakayama F, 2008, J RADIAT RES, V49, P491, DOI 10.1269/jrr.08021; Nakayama F, 2010, INT J RADIAT ONCOL, V78, P860, DOI 10.1016/j.ijrobp.2010.04.045; Nakayama F, 2009, EXP DERMATOL, V18, P889, DOI 10.1111/j.1600-0625.2009.00849.x; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002; PEREZ F, 1992, J CELL SCI, V102, P717; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; REED JA, 1995, LAB INVEST, V72, P215; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Schoorlemmer J, 2002, J BIOL CHEM, V277, P49111, DOI 10.1074/jbc.M205520200; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Skjerpen CS, 2002, J BIOL CHEM, V277, P23864, DOI 10.1074/jbc.M112193200; Skjerpen CS, 2002, EMBO J, V21, P4058, DOI 10.1093/emboj/cdf402; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Soomets U, 2000, BBA-BIOMEMBRANES, V1467, P165, DOI 10.1016/S0005-2736(00)00216-9; Sorensen V, 2006, J CELL SCI, V119, P4332, DOI 10.1242/jcs.03209; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wesche J, 2005, BIOCHEMISTRY-US, V44, P6071, DOI 10.1021/bi047403m; Wesche J, 2006, J BIOL CHEM, V281, P11405, DOI 10.1074/jbc.M600477200; Zakrzewska M, 2005, J MOL BIOL, V352, P860, DOI 10.1016/j.jmb.2005.07.066	49	43	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25823	25834		10.1074/jbc.M110.198267	http://dx.doi.org/10.1074/jbc.M110.198267			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21518765	Green Published, hybrid			2022-12-25	WOS:000293073000044
J	Satie, AP; Mazaud-Guittot, S; Seif, I; Mahe, D; He, ZG; Jouve, G; Jegou, B; Dejucq-Rainsford, N				Satie, Anne-Pascale; Mazaud-Guittot, Severine; Seif, Isabelle; Mahe, Dominique; He, Zhiguo; Jouve, Guilhem; Jegou, Bernard; Dejucq-Rainsford, Nathalie			Excess Type I Interferon Signaling in the Mouse Seminiferous Tubules Leads to Germ Cell Loss and Sterility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2'-5' OLIGOADENYLATE SYNTHETASE; TRANSGENIC MICE; SERTOLI-CELLS; MESSENGER-RNA; TESTOSTERONE PRODUCTION; SPERMATOGENIC CELLS; STIMULATED GENES; LEYDIG-CELLS; EXPRESSION; GAMMA	Type I (alpha and beta) interferons (IFNs) elicit antiproliferative and antiviral activities via the surface receptor IFNAR. Serendipitous observations in transgenic mice in 1988 strongly suggested that IFN alpha/beta overexpression in the testis disrupts spermatogenesis. Here, we compare a new mouse strain transgenic for IFN beta (Tg10) and a sister strain lacking the IFNAR1 subunit of IFNAR (Tg10-Ifnar1(-/-)), both strains expressing the transgene in the testis. The main source of IFN beta RNA was the spermatid population. Importantly, the Tg10 mice, but not the double mutant Tg10-Ifnar1(-/-), showed altered spermatogenesis. The first IFNAR-dependent histological alteration was a higher apoptosis index in all germ cell categories apart from non-dividing spermatogonia. This occurred 3 weeks after the onset of IFN beta production at postnatal day 20 and in the absence of somatic cell defects in terms of cell number, expression of specific cell markers, and hormonal activities. Several known interferon-stimulated genes were up-regulated in Tg10 Sertoli cells and prepachytene germ cells but not in pachytene spermatocytes and spermatids. In concordance with this, pachytene spermatocytes and spermatids isolated from wild-type testes did not display measurable amounts of IFNAR1 and phosphorylated STAT1 upon IFN beta challenge in vitro, suggesting hyporesponsiveness of these cell types to IFN. At day 60, Tg10 males were sterile, and Sertoli cells showed increased amounts of anti-Mullerian hormone and decreased production of inhibin B, both probably attributable to the massive germ cell loss. Type I interferon signaling may lead to idiopathic infertilities by affecting the interplay between germ cells and Sertoli cells.	[Satie, Anne-Pascale; Mazaud-Guittot, Severine; Mahe, Dominique; He, Zhiguo; Jouve, Guilhem; Jegou, Bernard; Dejucq-Rainsford, Nathalie] Univ Rennes 1, INSERM, U625, Inst Federatif Rech, F-35042 Rennes, France; [Seif, Isabelle] Univ Paris 11, Ctr Natl Rech Sci, EA 3544, Fac Pharm, F-92296 Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Dejucq-Rainsford, N (corresponding author), Univ Rennes 1, INSERM, U625, Inst Federatif Rech, Campus Beaulieu, F-35042 Rennes, France.	nathalie.dejucq-rainsford@inserm.fr	DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; Mazaud-Guittot, Severine/I-4694-2015; Jégou, Bernard/I-4742-2015; MAHE, Dominique MD/I-7316-2015	Mazaud-Guittot, Severine/0000-0003-0566-4124; Dejucq-Rainsford, Nathalie/0000-0002-1788-2690; JEGOU, Bernard/0000-0003-0623-3609				ALSHAWI R, 1988, MOL CELL BIOL, V8, P4821, DOI 10.1128/MCB.8.11.4821; Aubry F, 2000, EUR CYTOKINE NETW, V11, P690; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; BRAUN RE, 1990, BIOL REPROD, V43, P684, DOI 10.1095/biolreprod43.4.684; Cai LY, 2009, REPROD TOXICOL, V27, P14, DOI 10.1016/j.reprotox.2008.11.052; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; CHAPMAN DL, 1994, INT J DEV BIOL, V38, P491; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Cheng CY, 2010, MOL CELL ENDOCRINOL, V315, P49, DOI 10.1016/j.mce.2009.08.004; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Dal Secco V, 2008, BIOL REPROD, V78, P234, DOI 10.1095/biolreprod.107.063578; de Kretser DM, 2004, MOL CELL ENDOCRINOL, V225, P57, DOI 10.1016/j.mce.2004.07.008; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; DEJUCQ N, 1995, ENDOCRINOLOGY, V136, P4925, DOI 10.1210/en.136.11.4925; Dejucq N, 1998, ENDOCRINOLOGY, V139, P3081, DOI 10.1210/en.139.7.3081; Dejucq N, 1997, J CELL BIOL, V139, P865, DOI 10.1083/jcb.139.4.865; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Fujisawa M, 1998, ARCH ANDROLOGY, V40, P211, DOI 10.3109/01485019808987944; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; Ghosh A, 2001, J BIOL CHEM, V276, P25447, DOI 10.1074/jbc.M100496200; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Guillaume E, 2001, MOL REPROD DEV, V60, P439, DOI 10.1002/mrd.1108; Guitton N, 2000, INT J ANDROL, V23, P332, DOI 10.1046/j.1365-2605.2000.00248.x; HEKMAN ACP, 1988, J BIOL CHEM, V263, P12151; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; ISRAEL A, 1986, NATURE, V322, P743, DOI 10.1038/322743a0; IWAKURA Y, 1988, EMBO J, V7, P3757, DOI 10.1002/j.1460-2075.1988.tb03259.x; JEGOU B, 1983, J ANDROL, V4, P88; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanzaki M, 1998, ENDOCRINOLOGY, V139, P2636, DOI 10.1210/en.139.5.2636; Kodym R, 2009, BIOCHEM BIOPH RES CO, V388, P317, DOI 10.1016/j.bbrc.2009.07.167; KRAMER JM, 1981, DEV BIOL, V87, P37, DOI 10.1016/0012-1606(81)90058-0; Kristiansen H, 2010, J VIROL, V84, P11898, DOI 10.1128/JVI.01003-10; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Lin T, 1998, ENDOCRINOLOGY, V139, P2217, DOI 10.1210/en.139.5.2217; Mazaud S, 2002, ENDOCRINOLOGY, V143, P4775, DOI 10.1210/en.2002-220464; MEIKLE AW, 1992, J ANDROL, V13, P437; Melaine N, 2003, J REPROD IMMUNOL, V59, P53, DOI 10.1016/S0165-0378(02)00061-X; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; ORAVA M, 1985, BIOCHEM BIOPH RES CO, V127, P809, DOI 10.1016/S0006-291X(85)80015-2; ORAVA M, 1989, J INTERFERON RES, V9, P135, DOI 10.1089/jir.1989.9.135; ORAVA M, 1989, MOL ENDOCRINOL, V3, P887, DOI 10.1210/mend-3-6-887; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; PINEAU C, 1990, MOL CELL ENDOCRINOL, V72, P13, DOI 10.1016/0303-7207(90)90235-Z; Riccioli A, 2000, J IMMUNOL, V165, P743, DOI 10.4049/jimmunol.165.2.743; Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Schweyer S, 2003, BRIT J CANCER, V89, P915, DOI 10.1038/sj.bjc.6601209; SEIF I, 1991, J VIROL, V65, P664, DOI 10.1128/JVI.65.2.664-671.1991; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SKINNER MK, 1991, ANN NY ACAD SCI, V637, P354, DOI 10.1111/j.1749-6632.1991.tb27322.x; Starace D, 2008, BIOL REPROD, V79, P766, DOI 10.1095/biolreprod.108.068619; TOEBOSCH AMW, 1989, J ENDOCRINOL, V122, P757, DOI 10.1677/joe.0.1220757; Ulusoy E, 2004, ARCH ANDROLOGY, V50, P379, DOI 10.1080/01485010490474823; WANG ZX, 1989, INT J ANDROL, V12, P58, DOI 10.1111/j.1365-2605.1989.tb01285.x; Willey S, 2003, AIDS, V17, P183, DOI 10.1097/00002030-200301240-00007; WYROBEK AJ, 1975, P NATL ACAD SCI USA, V72, P4425, DOI 10.1073/pnas.72.11.4425	62	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23280	23295		10.1074/jbc.M111.229120	http://dx.doi.org/10.1074/jbc.M111.229120			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21515676	hybrid, Green Published			2022-12-25	WOS:000292025000061
J	Dabrowska, P; Shabab, M; Brand, W; Vogel, H; Boland, W				Dabrowska, Paulina; Shabab, Mohammed; Brand, Wolfgang; Vogel, Heiko; Boland, Wilhelm			Isomerization of the Phytohormone Precursor 12-Oxophytodienoic Acid (OPDA) in the Insect Gut A MECHANISTIC AND COMPUTATIONAL STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE TRANSFERASE A3-3; STEROID ISOMERASE ACTIVITY; PARTIAL-PURIFICATION; CRYSTAL-STRUCTURE; S-TRANSFERASE; RABBIT SERUM; FORCE-FIELD; CAT PLASMA; PROSTAGLANDIN; ENZYME	12-Oxophytodienoic acid (OPDA) is isomerized in the gut of herbivorous insects to tetrahydrodicranenone B (iso-OPDA). The transformation is achieved by a glutathione S-transferase present in the gut epithelium. Experiments with 9-[H-2]-iso-OPDA demonstrated the complete retention of the deuterium atom in the product 11-[H-2]-OPDA consistent with an intramolecular 1,3-hydrogen shift. Homology modeling based on the x-ray structure of a glutathione S-transferase from Anopheles gambiae revealed that the co-factor glutathione does not covalently bind to the substrate but appears to be involved in the initial deprotonation and enolization of the OPDA. The transformation resembles that of a mammalian GST-catalyzed isomerization of Delta(5)-3-ketosteroids to Delta(4)-3-ketosteroids or the conversion of prostaglandin A(1) to the biologically inactive prostaglandin B-1.	Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany; [Brand, Wolfgang] Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany; [Vogel, Heiko] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, D-06120 Halle, Saale, Germany	Max Planck Society; Max Planck Society; Leibniz Institut fur Pflanzenbiochemie		boland@ice.mpg.de	Dabrowska-Schlepp, Paulina/A-3882-2016; Boland, Wilhelm/K-7762-2012	Dabrowska-Schlepp, Paulina/0000-0002-9906-667X; Boland, Wilhelm/0000-0001-6784-2534				BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158; BERGOMAZ R, 1986, Journal of the Lepidopterists' Society, V40, P131; Cho HS, 1998, BIOCHEMISTRY-US, V37, P8325, DOI 10.1021/bi9801614; CHRISTHAZELHOF E, 1979, BIOCHIM BIOPHYS ACTA, V572, P43, DOI 10.1016/0005-2760(79)90198-X; CROMBIE L, 1992, J CHEM SOC P1, V1, P1929; Dabrowska P, 2009, P NATL ACAD SCI USA, V106, P16304, DOI 10.1073/pnas.0906942106; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HEHRE WJ, 2010, SPARTAN 02; HO PPK, 1974, PREP BIOCHEM, V4, P257, DOI 10.1080/00327487408068202; Johansson AS, 2002, J BIOL CHEM, V277, P16648, DOI 10.1074/jbc.M201062200; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; JONES RL, 1972, BIOCHIM BIOPHYS ACTA, V280, P588, DOI 10.1016/0005-2760(72)90139-7; JONES RL, 1970, BIOCHEM J, V119, pP64; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Khojasteh-Bakht SC, 1999, ARCH BIOCHEM BIOPHYS, V370, P59, DOI 10.1006/abbi.1999.1361; Korb Oliver, 2007, Swarm Intelligence, V1, P115, DOI 10.1007/s11721-007-0006-9; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; KUBAL G, 1995, CHEM RES TOXICOL, V8, P780, DOI 10.1021/tx00047a019; MALHOTRA SK, 1965, J AM CHEM SOC, V87, P3228, DOI 10.1021/ja01092a039; Mazumder D, 2003, J AM CHEM SOC, V125, P7553, DOI 10.1021/ja030138s; Pettersson PL, 2001, J BIOL CHEM, V276, P11698, DOI 10.1074/jbc.M009146200; Pohnert G, 2004, CHEM PHYS LIPIDS, V131, P159, DOI 10.1016/j.chemphyslip.2004.04.011; Pohnert G, 1999, CHEM COMMUN, P1087, DOI 10.1039/a902020i; POLET H, 1975, ARCH BIOCHEM BIOPHYS, V168, P96, DOI 10.1016/0003-9861(75)90232-5; SAUNDERS M, 1972, J AM CHEM SOC, V94, P4049, DOI 10.1021/ja00766a085; Schulze B, 2007, CHEMBIOCHEM, V8, P208, DOI 10.1002/cbic.200600379; Stewart JJP, 2004, J MOL MODEL, V10, P6, DOI 10.1007/s00894-003-0157-6; Stewart JJP, 2004, J MOL MODEL, V10, P155, DOI 10.1007/s00894-004-0183-z; TALALAY P, 1955, BIOCHIM BIOPHYS ACTA, V18, P300, DOI 10.1016/0006-3002(55)90079-2; Tars K, 2010, J MOL BIOL, V397, P332, DOI 10.1016/j.jmb.2010.01.023; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; ZIMMERMAN DC, 1978, LIPIDS, V13, P313, DOI 10.1007/BF02533720	36	5	5	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22348	22354		10.1074/jbc.M111.244509	http://dx.doi.org/10.1074/jbc.M111.244509			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21527631	Green Published, hybrid			2022-12-25	WOS:000291719900044
J	Molina-Sanchez, MD; Barrientos-Duran, A; Toro, N				Dolores Molina-Sanchez, Maria; Barrientos-Duran, Antonio; Toro, Nicolas			Relevance of the Branch Point Adenosine, Coordination Loop, and 3 ' Exon Binding Site for in Vivo Excision of the Sinorhizobium meliloti Group II Intron RmInt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARIAT FORMATION; ACTIVE-SITE; SELECTION; MITOCHONDRIA; RECOGNITION; MECHANISM; CIRCLES; ADENINE; INVITRO; RNAS	Excision of the bacterial group II intron RmInt1 has been demonstrated in vivo, resulting in the formation of both intron lariat and putative intron RNA circles. We show here that the bulged adenosine in domain VI of RmInt1 is required for splicing via the branching pathway, but branch site mutants produce small numbers of RNA molecules in which the first G residue of the intron is linked to the last C residue. Mutations in the coordination loop in domain I reduced splicing efficiency, but branched templates clearly predominated among splicing products. We also found that a single substitution at the EBS3 position (G329C), preventing EBS3-IBS3 pairing, resulted in the production of 50 to 100 times more RNA molecules in which the 5' and 3' extremities were joined. We provide evidence that these intron molecules may correspond to both, intron circles linked by a 2'-5' phosphodiester bond, and tandem, head-to-tail intron copies.	[Dolores Molina-Sanchez, Maria; Barrientos-Duran, Antonio; Toro, Nicolas] CSIC, Estn Expt Zaidin, Grp Ecol Genet, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Toro, N (corresponding author), CSIC, Estn Expt Zaidin, Grp Ecol Genet, Calle Prof Albareda 1, E-18008 Granada, Spain.	ntoro@eez.csic.es	Molina-Sánchez, Maria Dolores/J-1925-2016; Toro, Nicolas/K-4909-2014	Molina-Sánchez, Maria Dolores/0000-0002-3627-9360; Toro, Nicolas/0000-0002-3614-807X; BARRIENTOS-DURAN, ANTONIO MANUEL/0000-0003-2236-0958	Spanish Ministerio de Ciencia e Innovacion [BIO2008-00740, CSD 2009-0006]; Junta de Andalucia [CVI-01522]; Fondo Europeo de Desarrollo Regional (Spanish Ministerio de Ciencia e Innovacion); Junta de Andalucia	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia); Fondo Europeo de Desarrollo Regional (Spanish Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (BIO2008-00740 and CSD 2009-0006 of Programme Consolider-Ingenio 2010), Junta de Andalucia (CVI-01522), and Fondo Europeo de Desarrollo Regional (funding for open access charge from Programme Consolider-Ingenio 2010 from the Spanish Ministerio de Ciencia e Innovacion).; Recipient of grants from Junta de Andalucia.	AUGUSTIN S, 1990, NATURE, V343, P383, DOI 10.1038/343383a0; Chillon I, 2011, NUCLEIC ACIDS RES, V39, P1095, DOI 10.1093/nar/gkq847; CHIN K, 1995, RNA, V1, P391; Chu VT, 2001, EMBO J, V20, P6866, DOI 10.1093/emboj/20.23.6866; Costa M, 2000, EMBO J, V19, P5007, DOI 10.1093/emboj/19.18.5007; Costa M, 2006, BIOCHIMIE, V88, P711, DOI 10.1016/j.biochi.2005.12.007; Daniels DL, 1996, J MOL BIOL, V256, P31, DOI 10.1006/jmbi.1996.0066; de Lencastre A, 2005, NAT STRUCT MOL BIOL, V12, P626, DOI 10.1038/nsmb957; Hamill S, 2006, MOL CELL, V23, P831, DOI 10.1016/j.molcel.2006.07.017; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; JACQUIER A, 1991, J MOL BIOL, V219, P415, DOI 10.1016/0022-2836(91)90183-7; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; Li-Pook-Than J, 2006, NUCLEIC ACIDS RES, V34, P2782, DOI 10.1093/nar/gkl328; Liu QL, 1997, J MOL BIOL, V267, P163, DOI 10.1006/jmbi.1996.0845; LORSCH JR, 1995, NUCLEIC ACIDS RES, V23, P2811, DOI 10.1093/nar/23.15.2811; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; Molina-Sanchez MD, 2006, J BIOL CHEM, V281, P28737, DOI 10.1074/jbc.M602695200; Munoz-Adelantado E, 2003, J MOL BIOL, V327, P931, DOI 10.1016/S0022-2836(03)00208-0; Murray HL, 2001, MOL CELL, V8, P201, DOI 10.1016/S1097-2765(01)00300-8; Nisa-Martinez R, 2007, NUCLEIC ACIDS RES, V35, P214, DOI 10.1093/nar/gkl1072; NYBERG TM, 2006, THESIS U TEXAS SW ME; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Podar M, 1998, NATURE, V391, P915, DOI 10.1038/36142; PYLE AM, 1996, NUCLEIC ACIDS MOL BI, P75; Pyle Anna Marie, 2008, P201; Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x; Roitzsch M, 2009, RNA, V15, P473, DOI 10.1261/rna.1392009; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; VANDERVEEN R, 1987, EMBO J, V6, P3827, DOI 10.1002/j.1460-2075.1987.tb02719.x; Vogel J, 1997, NUCLEIC ACIDS RES, V25, P2030, DOI 10.1093/nar/25.10.2030; Vogel J, 2002, EMBO J, V21, P3794, DOI 10.1093/emboj/cdf359; Zimmerly S, 2001, NUCLEIC ACIDS RES, V29, P1238, DOI 10.1093/nar/29.5.1238	35	13	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21154	21163		10.1074/jbc.M110.210013	http://dx.doi.org/10.1074/jbc.M110.210013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21521690	Green Published, hybrid			2022-12-25	WOS:000291464700015
J	Lee, WH; Lee, HH; Vo, MT; Kim, HJ; Ko, MS; Im, YC; Min, YJ; Lee, BJ; Cho, WJ; Park, JW				Lee, Won Hyeok; Lee, Hyun Hee; Vo, Mai-Tram; Kim, Hyo Jeong; Ko, Myoung Seok; Im, Yeong-Cheol; Min, Young Joo; Lee, Byung Ju; Cho, Wha Ja; Park, Jeong Woo			Casein Kinase 2 Regulates the mRNA-destabilizing Activity of Tristetraprolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; TETRADECANOYL PHORBOL ACETATE; TGF-BETA; MAP KINASE; TUMOR-SUPPRESSOR; RECOMBINANT TRISTETRAPROLIN; NUCLEAR-LOCALIZATION; SIGNALING PATHWAY	Tristetraprolin (TTP) is an AU-rich element-binding protein that regulates mRNA stability. We previously showed that TTP acts as a negative regulator of VEGF gene expression in colon cancer cells. The p38 MAPK pathway is known to suppress the TTP activity. However, until now the signaling pathway to enhance TTP function is not well known. Here, we show that casein kinase 2 (CK2) enhances the TTP function in the regulation of the VEGF expression in colon cancer cells. CK2 increased TTP protein levels and enhanced VEGF mRNA decaying activity of TTP. TTP was not a direct target of CK2. Instead, CK2 increased the phosphorylation of MKP-1, which led to a decrease in the phosphorylation of p38 MAPK. Inhibition of MKP-1 by siRNA attenuated the increase in TTP function and the decrease of p38 phosphorylation induced by CK2 alpha overexpression. TGF-beta 1 increased the expressions of CK2 and TTP and the TTP function. The siRNA against CK2 alpha or TTP reversed TGF-beta 1-induced increases in the expression of CK2 and TTP and the TTP function. Our data suggest that CK2 enhances the protein level and activity of TTP via the modulation of the MKP-1-p38 MAPK signaling pathway and that TGF-beta 1 enhances the activity of CK2.	[Cho, Wha Ja] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Biomed Res Ctr, Ulsan 682060, South Korea; [Lee, Won Hyeok; Lee, Hyun Hee; Vo, Mai-Tram; Kim, Hyo Jeong; Ko, Myoung Seok; Lee, Byung Ju; Park, Jeong Woo] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Im, Yeong-Cheol] Univ Ulsan, Ulsan Univ Hosp, Dept Surg, Coll Med, Ulsan 682060, South Korea; [Min, Young Joo] Univ Ulsan, Ulsan Univ Hosp, Dept Internal Med, Coll Med, Ulsan 682060, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Cho, WJ (corresponding author), Univ Ulsan, Ulsan Univ Hosp, Coll Med, Biomed Res Ctr, Ulsan 682060, South Korea.	wjcho26@ulsan.ac.kr; jwpark@ulsan.ac.kr			Korean government (MOEHRD) [KRF-2005-070-C00088, BRL2009-0087350, 2009-0094050, 2009-0070260]; Ministry of Health and Welfare [A101086]	Korean government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Korea Research Foundation Grants KRF-2005-070-C00088, BRL2009-0087350, 2009-0094050, and 2009-0070260 funded by the Korean government (MOEHRD) and by Korea Health 21 R&D Project Grant A101086 from the Ministry of Health and Welfare.	ACKERMAN P, 1990, P NATL ACAD SCI USA, V87, P821, DOI 10.1073/pnas.87.2.821; Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Ahmed K, 1999, CRIT REV EUKAR GENE, V9, P329, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.170; Ahmed K, 2000, J CELL BIOCHEM, P130; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Bian ZM, 2007, EXP EYE RES, V84, P812, DOI 10.1016/j.exer.2006.12.016; BROGI E, 1994, CIRCULATION, V90, P649, DOI 10.1161/01.CIR.90.2.649; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Cao HP, 2008, OBESITY, V16, P1208, DOI 10.1038/oby.2008.65; Cao HP, 2008, PROTEIN J, V27, P163, DOI 10.1007/s10930-007-9119-7; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Graham KC, 2000, J BIOL CHEM, V275, P5003, DOI 10.1074/jbc.275.7.5003; Guerra B, 1999, PHARMACOL THERAPEUT, V82, P303, DOI 10.1016/S0163-7258(98)00064-3; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kramerov AA, 2008, MOL CELL BIOCHEM, V316, P177, DOI 10.1007/s11010-008-9831-4; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Litchfield DW, 1996, BIOCHEM CELL BIOL, V74, P541, DOI 10.1139/o96-458; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Mallet C, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0494; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Negulescu O, 2002, KIDNEY INT, V62, P1989, DOI 10.1046/j.1523-1755.2002.00679.x; Ogawa K, 2003, J BIOL CHEM, V278, P30373, DOI 10.1074/jbc.M304856200; Orlandini M, 1998, J BIOL CHEM, V273, P21291, DOI 10.1074/jbc.273.33.21291; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Saunier EF, 2006, CURR CANCER DRUG TAR, V6, P565, DOI 10.2174/156800906778742460; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Singh NN, 2006, ARTERIOSCL THROM VAS, V26, P1323, DOI 10.1161/01.ATV.0000220383.19192.55; Smoak K, 2006, MOL CELL BIOL, V26, P9126, DOI 10.1128/MCB.00679-06; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; STAVRI GT, 1995, CIRCULATION, V92, P11, DOI 10.1161/01.CIR.92.1.11; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; van Royen N, 2002, FASEB J, V16, P432, DOI 10.1096/fj.01-0563fje; VARNUM BC, 1989, ONCOGENE, V4, P119; VARNUM BC, 1989, MOL CELL BIOL, V9, P3580, DOI 10.1128/MCB.9.8.3580; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Yamamoto T, 2001, J CELL BIOCHEM, V82, P591, DOI 10.1002/jcb.1179; Zdunek M, 2001, KIDNEY INT, V60, P2097, DOI 10.1046/j.1523-1755.2001.00041.x; Zheng W, 2001, AM J PHYSIOL-HEART C, V280, pH909, DOI 10.1152/ajpheart.2001.280.2.H909; Zhou J, 2003, J BIOL CHEM, V278, P6936, DOI 10.1074/jbc.M210628200; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	81	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21577	21587		10.1074/jbc.M110.201137	http://dx.doi.org/10.1074/jbc.M110.201137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507959	Green Published, hybrid			2022-12-25	WOS:000291464700055
J	Mannangatti, P; Arapulisamy, O; Shippenberg, TS; Ramamoorthy, S; Jayanthi, LD				Mannangatti, Padmanabhan; Arapulisamy, Obulakshmi; Shippenberg, Toni S.; Ramamoorthy, Sammanda; Jayanthi, Lankupalle D.			Cocaine Up-regulation of the Norepinephrine Transporter Requires Threonine 30 Phosphorylation by p38 Mitogen-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE TRANSPORTER; EXTRACELLULAR DOPAMINE; SURFACE EXPRESSION; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; SEROTONIN TRANSPORTERS; STRIA TERMINALIS; PHOSPHATASE 2A; BED NUCLEUS; TRAFFICKING	The norepinephrine (NE) transporter (NET) regulates NE signaling by rapidly clearing synaptic NE. Cocaine binds NET and modulates NE transport. These actions contribute to rewarding effects and abuse liability of cocaine. Activation of mitogen-activated protein kinase (MAPK) cascades is implicated in cocaine-induced neuroadaptations. However, the role of MAPK and the mechanisms involved in cocaine modulation of NET are not clear. Acute intra-peritoneal injections of cocaine (20 mg/kg body weight) to rats resulted in increased NE uptake by prefrontal cortex (PFC) synaptosomes with a parallel increase in the surface expression of endogenous NET. Cocaine also enhanced the immunoreactivity of phospho-p38 MAPK in the PFC synaptosomes without affecting the total p38 MAPK. In vitro cocaine (30-50 mu M) treatment of rat PFC synaptosomes increased native NET function, surface expression, and phosphorylation in a manner sensitive to p38 MAPK inhibition by PD169316. We next examined cocaine-elicited effects on wild-type human NET (hNET) expressed heterologously in human placental trophoblast cells to gain more insights into the mechanisms involved. Cocaine treatment of hNET expressing human placental trophoblast cells up-regulated the function, surface expression, and phosphorylation of hNET in a PD169316-sensitive manner. In addition, cocaine inhibited constitutive endocytosis of hNET. Mutational analysis of serine and threonine residues revealed that substitution of threonine 30, located at the amino terminus of hNET with alanine (T30A-hNET), abolished cocaine-induced up-regulation of NET function, surface expression, and phosphorylation. Furthermore, cocaine did not alter T30A-hNET endocytosis. These studies identify a novel molecular mechanism that cocaine-activated p38 MAPK-mediated phosphorylation of NET-T30 dictates surface NET availability, and hence, NE transport.	[Mannangatti, Padmanabhan; Arapulisamy, Obulakshmi; Ramamoorthy, Sammanda; Jayanthi, Lankupalle D.] Med Univ S Carolina, Dept Neurosci, Div Neurosci Res, Charleston, SC 29425 USA; [Shippenberg, Toni S.] NIDA, Integrat Neurosci Sect, Intramural Res Program, US Dept HHS, Baltimore, MD 21224 USA	Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Jayanthi, LD (corresponding author), Med Univ S Carolina, Dept Neurosci, Div Neurosci Res, Charleston, SC 29425 USA.	jayanthi@musc.edu			National Institutes of Health [RO1-GM081054]; NIGMS, National Institute of Mental Health [RO1-MH62612]; National Institute on Drug Abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute of General Medical Sciences (NIGMS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-GM081054 (to L.D.J.) from the NIGMS, National Institute of Mental Health Grant RO1-MH62612 (to S.R.), and the National Institute on Drug Abuse Intramural Research Program (to T.S.S.).	Ahmed BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004730; Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Apparsundaram S, 2001, J PHARMACOL EXP THER, V299, P666; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Brooks AC, 2007, INFLAMM RES, V56, P154, DOI 10.1007/s00011-006-6151-6; Carboni E, 2006, J NEUROCHEM, V96, P473, DOI 10.1111/j.1471-4159.2005.03556.x; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; Choe ES, 2002, NEUROREPORT, V13, P1013, DOI 10.1097/00001756-200206120-00006; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Dipace C, 2007, MOL PHARMACOL, V71, P230, DOI 10.1124/mol.106.026690; Fan L, 2009, J PHARMACOL EXP THER, V328, P99, DOI 10.1124/jpet.108.145201; Ganapathy Vadivel, 2005, Toxicol Appl Pharmacol, V207, P381, DOI 10.1016/j.taap.2005.02.023; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; JAYANTHI LD, 1993, BIOCHEMISTRY-US, V32, P12178, DOI 10.1021/bi00096a030; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; KOOB GF, 1992, ANN NY ACAD SCI, V654, P171, DOI 10.1111/j.1749-6632.1992.tb25966.x; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; Li GH, 2005, J PHARMACOL EXP THER, V312, P112, DOI 10.1124/jpet.104.073494; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Macey DJ, 2003, J NEUROSCI, V23, P12; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; Mash DC, 2005, J NEUROSCI METH, V143, P79, DOI 10.1016/j.jneumeth.2004.09.013; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; Miner LH, 2006, J NEUROSCI, V26, P1571, DOI 10.1523/JNEUROSCI.4450-05.2006; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Moron JA, 2003, J NEUROSCI, V23, P8480; Nestler EJ, 1996, MOL PSYCHIATR, V1, P190; Platt DM, 2007, J PHARMACOL EXP THER, V322, P894, DOI 10.1124/jpet.107.121806; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Samuvel DJ, 2008, J PHARMACOL EXP THER, V325, P293, DOI 10.1124/jpet.107.130534; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; SCHOMIG E, 1989, N-S ARCH PHARMACOL, V340, P502; Shearman LP, 1999, EUR J PHARMACOL, V386, P1, DOI 10.1016/S0014-2999(99)00624-X; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Sung U, 2005, BIOCHEM BIOPH RES CO, V333, P671, DOI 10.1016/j.bbrc.2005.05.165; Sung U, 2007, MOL CELL NEUROSCI, V34, P251, DOI 10.1016/j.mcn.2006.11.007; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; TRENDELENBURG U, 1991, TRENDS PHARMACOL SCI, V12, P334; Tzschentke TM, 2000, CRIT REV NEUROBIOL, V14, P131; Valentini V, 2004, J NEUROCHEM, V88, P917, DOI 10.1046/j.1471-4159.2003.02238.x; Valjent E, 2005, M S-MED SCI, V21, P453, DOI 10.1051/medsci/2005215453; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhu CB, 2004, MOL PHARMACOL, V65, P1462, DOI 10.1124/mol.65.6.1462; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200	57	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20239	20250		10.1074/jbc.M111.226811	http://dx.doi.org/10.1074/jbc.M111.226811			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21498515	Green Published, hybrid			2022-12-25	WOS:000291267600011
J	Osawa, S; Jo, R; Xiong, YB; Reidel, B; Tserentsoodol, N; Arshavsky, VY; Iuvone, PM; Weiss, ER				Osawa, Shoji; Jo, Rebecca; Xiong, Yubin; Reidel, Boris; Tserentsoodol, Nomingerel; Arshavsky, Vadim Y.; Iuvone, P. Michael; Weiss, Ellen R.			Phosphorylation of G Protein-coupled Receptor Kinase 1 (GRK1) Is Regulated by Light but Independent of Phototransduction in Rod Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; N-TERMINAL REGION; RHODOPSIN KINASE; ADENYLYL-CYCLASE; CYCLIC-AMP; PHOTOEXCITED RHODOPSIN; DRIVEN TRANSLOCATION; OGUCHI-DISEASE; RETINAL RODS; CELLS	Phosphorylation of rhodopsin by G protein-coupled receptor kinase 1 (GRK1, or rhodopsin kinase) is critical for the deactivation of the phototransduction cascade in vertebrate photoreceptors. Based on our previous studies in vitro, we predicted that Ser(21) in GRK1 would be phosphorylated by cAMP-dependent protein kinase (PKA) in vivo. Here, we report that dark-adapted, wild-type mice demonstrate significantly elevated levels of phosphorylated GRK1 compared with light-adapted animals. Based on comparatively slow half-times for phosphorylation and dephosphorylation, phosphorylation of GRK1 by PKA is likely to be involved in light and dark adaptation. In mice missing the gene for adenylyl cyclase type 1, levels of phosphorylated GRK1 were low in retinas from both dark-and light-adapted animals. These data are consistent with reports that cAMP levels are high in the dark and low in the light and also indicate that cAMP generated by adenylyl cyclase type 1 is required for phosphorylation of GRK1 on Ser(21). Surprisingly, dephosphorylation was induced by light in mice missing the rod transducin alpha-subunit. This result indicates that phototransduction does not play a direct role in the light-dependent dephosphorylation of GRK1.	[Osawa, Shoji; Jo, Rebecca; Xiong, Yubin; Weiss, Ellen R.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Weiss, Ellen R.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Reidel, Boris; Tserentsoodol, Nomingerel; Arshavsky, Vadim Y.] Duke Univ, Albert Eye Res Inst, Durham, NC 27710 USA; [Iuvone, P. Michael] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Iuvone, P. Michael] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Emory University; Emory University	Weiss, ER (corresponding author), CB 7090,108 Taylor Hall, Chapel Hill, NC 27599 USA.	erweiss@med.unc.edu	Reidel, Boris/AAG-2714-2020; Weiss, Ellen/AAK-9868-2020		National Institutes of Health Grants [EY072224, EY10336, R01EY004864, EY5722, EY006360]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY005722, R01EY004864, P30EY006360, R01EY010336] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY072224 (to E. R. W.), EY10336 (to V. Y. A.), and R01EY004864 (to P. M. I.) and National Institutes of Health Core Grants for Vision Research EY5722 (to V. Y. A. and E. R. W.) and EY006360 (to P. M. I.) This work was also supported by Research to Prevent Blindness (to P. M. I.).	BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Burns ME, 2010, PHYSIOLOGY, V25, P72, DOI 10.1152/physiol.00001.2010; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Cideciyan AV, 2003, INVEST OPHTH VIS SCI, V44, P1268, DOI 10.1167/iovs.02-0494; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; COHEN AI, 1990, VISUAL NEUROSCI, V4, P43, DOI 10.1017/S0952523800002753; DICKERSON CD, 1995, EXP CELL RES, V216, P46, DOI 10.1006/excr.1995.1006; Dryja TP, 2000, AM J OPHTHALMOL, V130, P547, DOI 10.1016/S0002-9394(00)00737-6; FARBER DB, 1981, INVEST OPHTH VIS SCI, V20, P24; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; FOWLES C, 1988, FEBS LETT, V238, P56, DOI 10.1016/0014-5793(88)80224-2; FUTUYAMA DJ, 1998, EVOLUTIONARY BIOL, P130; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Horner TJ, 2005, J BIOL CHEM, V280, P28241, DOI 10.1074/jbc.M505117200; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Jackson CR, 2009, J NEUROCHEM, V109, P148, DOI 10.1111/j.1471-4159.2009.05920.x; Krispel CM, 2003, J GEN PHYSIOL, V122, P703, DOI 10.1085/jgp.200308938; Lee BY, 2004, J BIOL CHEM, V279, P54008, DOI 10.1074/jbc.M405669200; LEE RH, 1990, J BIOL CHEM, V265, P15860; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li HY, 2009, J NEUROSCI, V29, P15178, DOI 10.1523/JNEUROSCI.3517-09.2009; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Osawa S, 2008, J NEUROCHEM, V107, P1314, DOI 10.1111/j.1471-4159.2008.05691.x; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Pozdeyev N, 2006, J NEUROSCI, V26, P9153, DOI 10.1523/JNEUROSCI.1384-06.2006; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Rajala A, 2007, J BIOL CHEM, V282, P9865, DOI 10.1074/jbc.M608845200; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Strissel KJ, 2005, J BIOL CHEM, V280, P29250, DOI 10.1074/jbc.M501789200; Traverso V, 2002, INVEST OPHTH VIS SCI, V43, P1655; WEISS ER, 1990, J MOL ENDOCRINOL, V4, P71, DOI 10.1677/jme.0.0040071; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x	53	11	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20923	20929		10.1074/jbc.M111.230904	http://dx.doi.org/10.1074/jbc.M111.230904			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21504899	hybrid, Green Published			2022-12-25	WOS:000291267600076
J	Kansara, SG; Sukhodolets, MV				Kansara, Seema G.; Sukhodolets, Maxim V.			Oligomerization of the E-coli Core RNA Polymerase: Formation of (alpha(2)beta beta 'omega)(2)-DNA Complexes and Regulation of the Oligomerization by Auxiliary Subunits	PLOS ONE			English	Article							BACTERIAL HOMOLOG; PROTEIN; RAPA; ASSOCIATION; ELONGATION; COMPONENTS; MOLECULES; DYNAMICS; BINDING	In this work, using multiple, dissimilar physico-chemical techniques, we demonstrate that the Escherichia coli RNA polymerase core enzyme obtained through a classic purification procedure forms stable (alpha(2)beta beta'omega)(2) complexes in the presence or absence of short DNA probes. Multiple control experiments indicate that this self-association is unlikely to be mediated by RNA polymerase-associated non-protein molecules. We show that the formation of (alpha(2)beta beta'omega)(2) complexes is subject to regulation by known RNA polymerase interactors, such as the auxiliary SWI/SNF subunit of RNA polymerase RapA, as well as NusA and sigma(70). We also demonstrate that the separation of the core RNA polymerase and RNA polymerase holoenzyme species during Mono Q chromatography is likely due to oligomerization of the core enzyme. We have analyzed the oligomeric state of the polymerase in the presence or absence of DNA, an aspect that was missing from previous studies. Importantly, our work demonstrates that RNA polymerase oligomerization is compatible with DNA binding. Through in vitro transcription and in vivo experiments (utilizing a RapA(R599/Q602) mutant lacking transcription-stimulatory function), we demonstrate that the formation of tandem (alpha(2)beta beta'omega)(2)-DNA complexes is likely functionally significant and beneficial for the transcriptional activity of the polymerase. Taken together, our findings suggest a novel structural aspect of the E. coli elongation complex. We hypothesize that transcription by tandem RNA polymerase complexes initiated at hypothetical bidirectional "origins of transcription'' may explain recurring switches of the direction of transcription in bacterial genomes.	[Kansara, Seema G.; Sukhodolets, Maxim V.] Lamar Univ, Dept Chem & Biochem, Beaumont, TX 77710 USA	Texas State University System; Lamar University	Kansara, SG (corresponding author), Lamar Univ, Dept Chem & Biochem, Beaumont, TX 77710 USA.	msoukhodol@lamar.edu			National Institute of General Medical Sciences [R15GM081803]; Welch Foundation [V-0004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM081803] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grant number R15GM081803 from the National Institute of General Medical Sciences (to M. V. S.) (the content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health), a Welch Foundation grant (V-0004), and departmental funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BERG D, 1970, BIOCHEMISTRY-US, V9, P5055; BURGESS R, 1987, RNA POLYMERASE REGUL; BURGESS RR, 1969, J BIOL CHEM, V244, P6168; Das A, 1996, METHOD ENZYMOL, V274, P374; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; HARRIS SJ, 1995, BIOCHEMISTRY-US, V34, P8752, DOI 10.1021/bi00027a026; HORWITZ RJ, 1987, CELL, V51, P631, DOI 10.1016/0092-8674(87)90132-2; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; McKinley BA, 2007, NUCLEIC ACIDS RES, V35, P7044, DOI 10.1093/nar/gkm747; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; RICHARDS.JP, 1966, P NATL ACAD SCI USA, V55, P1616, DOI 10.1073/pnas.55.6.1616; SHANER SL, 1982, BIOCHEMISTRY-US, V21, P5539, DOI 10.1021/bi00265a025; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; SQUIRES CL, 1993, P NATL ACAD SCI USA, V90, P970, DOI 10.1073/pnas.90.3.970; STEVENS A, 1966, BIOCHEM BIOPH RES CO, V24, P929, DOI 10.1016/0006-291X(66)90339-1; SUKHODOLETS MV, 1988, FEBS LETT, V238, P161, DOI 10.1016/0014-5793(88)80248-5; Sukhodolets MV, 1998, J BIOL CHEM, V273, P7018, DOI 10.1074/jbc.273.12.7018; Sukhodolets MV, 2003, METHOD ENZYMOL, V370, P283; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Sukhodolets MV, 2000, J BIOL CHEM, V275, P22090, DOI 10.1074/jbc.M000056200; TRAVERS AA, 1982, NUCLEIC ACIDS RES, V10, P5043, DOI 10.1093/nar/10.16.5043; Yawn B, 2009, BIOCHEMISTRY-US, V48, P7794, DOI 10.1021/bi9004123	25	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18990	10.1371/journal.pone.0018990	http://dx.doi.org/10.1371/journal.pone.0018990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533049	Green Published, Green Submitted, gold			2022-12-25	WOS:000289719400046
J	Zheng, ZJ; Ma, CQ; Gao, C; Li, FS; Qin, JY; Zhang, HW; Wang, K; Xu, P				Zheng, Zhaojuan; Ma, Cuiqing; Gao, Chao; Li, Fengsong; Qin, Jiayang; Zhang, Haiwei; Wang, Kai; Xu, Ping			Efficient Conversion of Phenylpyruvic Acid to Phenyllactic Acid by Using Whole Cells of Bacillus coagulans SDM	PLOS ONE			English	Article							D-LACTATE DEHYDROGENASE; ANTIFUNGAL ACTIVITY; LACTOBACILLUS; PURIFICATION; CATABOLISM; CATALYSIS	Background: Phenyllactic acid (PLA), a novel antimicrobial compound with broad and effective antimicrobial activity against both bacteria and fungi, can be produced by many microorganisms, especially lactic acid bacteria. However, the concentration and productivity of PLA have been low in previous studies. The enzymes responsible for conversion of phenylpyruvic acid (PPA) into PLA are equivocal. Methodology/Principal Findings: A novel thermophilic strain, Bacillus coagulans SDM, was isolated for production of PLA. When the solubility and dissolution rate of PPA were enhanced at a high temperature, whole cells of B. coagulans SDM could effectively convert PPA into PLA at a high concentration (37.3 g l(-1)) and high productivity (2.3 g l(-1) h(-1)) under optimal conditions. Enzyme activity staining and kinetic studies identified NAD-dependent lactate dehydrogenases as the key enzymes that reduced PPA to PLA. Conclusions/Significance: Taking advantage of the thermophilic character of B. coagulans SDM, a high yield and productivity of PLA were obtained. The enzymes involved in PLA production were identified and characterized, which makes possible the rational design and construction of microorganisms suitable for PLA production with metabolic engineering.	[Zheng, Zhaojuan; Ma, Cuiqing; Li, Fengsong; Qin, Jiayang; Zhang, Haiwei; Wang, Kai; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Gao, Chao; Xu, Ping] Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Gao, Chao; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zheng, ZJ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn; pingxu@sjtu.edu.cn		Ma, Cuiqing/0000-0002-7468-1027; Gao, Chao/0000-0002-5205-0670	National Basic Research Program of China [2007CB707803]; Chinese National Program for High Technology Research and Development [2006AA020102]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Program for High Technology Research and Development(National High Technology Research and Development Program of China)	This work was supported by National Basic Research Program of China (2007CB707803) and Chinese National Program for High Technology Research and Development (2006AA020102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2002, PROTEIN ENG, V15, P35, DOI 10.1093/protein/15.1.35; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUDT KH, 1991, Patent No. 4030350; Dieuleveux V, 1998, APPL ENVIRON MICROB, V64, P800; Dieuleveux V, 1998, INT J FOOD MICROBIOL, V40, P177, DOI 10.1016/S0168-1605(98)00031-2; DUNN CR, 1991, PHILOS T ROY SOC B, V332, P177, DOI 10.1098/rstb.1991.0047; Gummalla S, 2001, J DAIRY SCI, V84, P1011, DOI 10.3168/jds.S0022-0302(01)74560-2; HUMMEL W, 1983, EUR J APPL MICROBIOL, V18, P75, DOI 10.1007/BF00500828; KANO S, 1988, J ORG CHEM, V53, P3865, DOI 10.1021/jo00251a042; Lavermicocca P, 2003, APPL ENVIRON MICROB, V69, P634, DOI 10.1128/AEM.69.1.634-640.2003; Lavermicocca P, 2000, APPL ENVIRON MICROB, V66, P4084, DOI 10.1128/AEM.66.9.4084-4090.2000; Li XF, 2008, J AGR FOOD CHEM, V56, P2392, DOI 10.1021/jf0731503; Li XF, 2007, BIOTECHNOL LETT, V29, P593, DOI 10.1007/s10529-006-9275-4; Lind H, 2005, INT J FOOD MICROBIOL, V98, P157, DOI 10.1016/j.ijfoodmicro.2004.05.020; Ma CQ, 2007, APPL MICROBIOL BIOT, V77, P91, DOI 10.1007/s00253-007-1132-4; Magnusson J, 2003, FEMS MICROBIOL LETT, V219, P129, DOI 10.1016/S0378-1097(02)01207-7; Marilley L, 2004, INT J FOOD MICROBIOL, V90, P139, DOI 10.1016/S0168-1605(03)00304-0; MORITA H, 1996, Patent No. 5684186; Mu WM, 2009, BIORESOURCE TECHNOL, V100, P5226, DOI 10.1016/j.biortech.2009.05.024; Razeto A, 2002, J MOL BIOL, V318, P109, DOI 10.1016/S0022-2836(02)00086-4; Stoll VS, 1996, STRUCTURE, V4, P437, DOI 10.1016/S0969-2126(96)00049-4; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; TAGUCHI H, 1993, J BIOL CHEM, V268, P18030; Thierry A, 2002, LAIT, V82, P17, DOI 10.1051/lait:2001002; Tokuda C, 2003, J BACTERIOL, V185, P5023, DOI 10.1128/JB.185.16.5023-5026.2003; URBAN FJ, 1992, J HETEROCYCLIC CHEM, V29, P431, DOI 10.1002/jhet.5570290223; Valerio F, 2004, FEMS MICROBIOL LETT, V233, P289, DOI [10.1111/j.1574-6968.2004.tb09494.x, 10.1016/j.femsle.2004.02.020]; Vermeulen N, 2006, J AGR FOOD CHEM, V54, P3832, DOI 10.1021/jf052733e; Wong H. N. C., 1992, SYNTHESIS-STUTTGART, V8, P793, DOI DOI 10.1055/S-1992-26228; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Yang RX, 2010, ACTA PHARMACOL SIN, V31, P1395, DOI 10.1038/aps.2010.167; Yvon M, 2001, INT DAIRY J, V11, P185, DOI 10.1016/S0958-6946(01)00049-8; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	33	61	83	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19030	10.1371/journal.pone.0019030	http://dx.doi.org/10.1371/journal.pone.0019030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533054	Green Submitted, gold, Green Published			2022-12-25	WOS:000289719400052
J	Ball, S; Li, CL; Li, PK; Lin, JY				Ball, Sarah; Li, Chenglong; Li, Pui-Kai; Lin, Jiayuh			The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; MALIGNANT GLIOMA; GROWTH; TUMORS; SIGNAL-TRANSDUCER-AND-ACTIVATOR-OF-TRANSCRIPTION-3; EXPRESSION; INTERLEUKIN-6; TRANSLOCATION; STRATEGIES; SURVIVIN	Tumors of the central nervous system represent a major source of cancer-related deaths, with medulloblastoma and glioblastoma being the most common malignant brain tumors in children and adults respectively. While significant advances in treatment have been made, with the 5-year survival rate for medulloblastoma at 70-80%, treating patients under 3 years of age still poses a problem due to the deleterious effects of radiation on the developing brain, and the median survival for patients with glioblastoma is only 15 months. The transcription factor, STAT3, has been found constitutively activated in a wide variety of cancers and in recent years it has become an attractive therapeutic target. We designed a non-peptide small molecule STAT3 inhibitor, LLL12, using structure-based design. LLL12 was able to inhibit STAT3 phosphorylation, decrease cell viability and induce apoptosis in medulloblastoma and glioblastoma cell lines with elevated levels of p-STAT3 (Y705). IC50 values for LLL12 were found to be between 1.07 mu M and 5.98 mu M in the five cell lines expressing phosphorylated STAT3. STAT3 target genes were found to be downregulated and a decrease in STAT3 DNA binding was observed following LLL12 treatment, indicating that LLL12 is an effective STAT3 inhibitor. LLL12 was also able to inhibit colony formation, wound healing and decreased IL-6 and LIF secretion. Our results suggest that LLL12 is a potent STAT3 inhibitor and that it may be a potential therapeutic treatment for medulloblastoma and glioblastoma.	[Ball, Sarah; Lin, Jiayuh] Nationwide Childrens Hosp, Ctr Childhood Canc, Res Inst, Columbus, OH USA; [Ball, Sarah; Lin, Jiayuh] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Li, Chenglong; Li, Pui-Kai] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ball, S (corresponding author), Nationwide Childrens Hosp, Ctr Childhood Canc, Res Inst, Columbus, OH USA.	lin.674@osu.edu	Lin, Jiayuh/E-3515-2011; Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719; Li, Pui Kai/0000-0002-4831-7213	department of pediatrics at The Ohio State University	department of pediatrics at The Ohio State University	This research was funded by a start-up grant from the department of pediatrics at The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Bhasin D, 2008, BIOORG MED CHEM LETT, V18, P391, DOI 10.1016/j.bmcl.2007.10.031; Bidros DS, 2009, NEUROTHERAPEUTICS, V6, P539, DOI 10.1016/j.nurt.2009.04.004; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Calvin D. P., 2003, International Journal of Radiation Oncology Biology Physics, V57, pS297, DOI 10.1016/S0360-3016(03)01158-1; *CBTRUS, 2007, PRIM BRAIN TUM US ST; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Collins VP, 1998, CANCER SURV, V32, P37; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; DOHRMANN GJ, 1976, J NEUROSURG, V44, P442, DOI 10.3171/jns.1976.44.4.0442; Duan ZF, 2006, CLIN CANCER RES, V12, P6844, DOI 10.1158/1078-0432.CCR-06-1330; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu J, 1999, J CANCER RES CLIN, V125, P475, DOI 10.1007/s004320050304; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Miyamoto N, 2001, LEUKEMIA, V15, P1758, DOI 10.1038/sj.leu.2402260; Mueller S, 2009, NEUROTHERAPEUTICS, V6, P570, DOI 10.1016/j.nurt.2009.04.006; Nicholas M Kelly, 2007, Expert Rev Anticancer Ther, V7, pS23, DOI 10.1586/14737140.7.12s.S23; Pizem J, 2005, NEUROPATH APPL NEURO, V31, P422, DOI 10.1111/j.1365-2990.2005.00664.x; Rosen DG, 2006, CANCER-AM CANCER SOC, V107, P2730, DOI 10.1002/cncr.22293; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Stearns D, 2006, CANCER RES, V66, P673, DOI 10.1158/0008-5472.CAN-05-1580; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3	44	58	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18820	10.1371/journal.pone.0018820	http://dx.doi.org/10.1371/journal.pone.0018820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526200	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100024
J	Isono, T				Isono, Takahiro			O-GlcNAc-Specific Antibody CTD110.6 Cross-Reacts with N-GlcNAc(2)-Modified Proteins Induced under Glucose Deprivation	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE; PROTEOMIC ANALYSIS; BLADDER-CANCER; GLYCOSYLATION; CALRETICULIN; DIVERSITY; PERIOSTIN; STRESS; KINASE; CELLS	Modification of serine and threonine residues in proteins by O-linked beta-N-acetylgulcosamine (O-GlcNAc) glycosylation is a feature of many cellular responses to the nutritional state and to stress. O-GlcNAc modification is reversibly regulated by O-linked beta-N-acetylgulcosamine transferase (OGT) and beta-D-N-acetylgulcosaminase (O-GlcNAcase). O-GlcNAc modification of proteins is dependent on the concentration of uridine 5`-diphospho-N-acetylgulcosamine (UDP-GlcNAc), which is a substrate of OGT and is synthesized via the hexosamine biosynthetic pathway. Immunoblot analysis using the O-GlcNAc-specific antibody CTD110.6 has indicated that glucose deprivation increases protein O-GlcNAcylation in some cancer cells. The mechanism of this paradoxical phenomenon has remained unclear. Here we show that the increased glycosylation induced by glucose deprivation and detected by CTD110.6 antibodies is actually modification by N-GlcNAc(2), rather than by O-GlcNAc. We found that this induced glycosylation was not regulated by OGT and O-GlcNAcase, unlike typical O-GlcNAcylation, and it was inhibited by treatment with tunicamycin, an N-glycosylation inhibitor. Proteomics analysis showed that proteins modified by this induced glycosylation were N-GlcNAc(2)-modified glycoproteins. Furthermore, CTD110.6 antibodies reacted with N-GlcNAc(2)-modified glycoproteins produced by a yeast strain with a ts-mutant of ALG1 that could not add a mannose residue to dolichol-PP-GlcNAc(2). Our results demonstrated that N-GlcNAc(2)-modified glycoproteins were induced under glucose deprivation and that they cross-reacted with the O-GlcNAc-specific antibody CTD110.6. We therefore propose that the glycosylation status of proteins previously classified as O-GlcNAc-modified proteins according to their reactivity with CTD110.6 antibodies must be re-examined. We also suggest that the repression of mature N-linked glycoproteins due to increased levels of N-GlcNAc(2)-modifed proteins is a newly recognized pathway for effective use of sugar under stress and deprivation conditions. Further research is needed to clarify the physiological and pathological roles of N-GlcNAc(2)-modifed proteins.	Shiga Univ Med Sci, Cent Res Lab, Shiga, Japan	Shiga University of Medical Science	Isono, T (corresponding author), Shiga Univ Med Sci, Cent Res Lab, Shiga, Japan.	isono@belle.shiga-med.ac.jp						Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; BUTKINAREE C, 2010, BIOCHIM BIOPHYS ACTA, P96; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Cueva R, 1998, YEAST, V14, P773, DOI 10.1002/(SICI)1097-0061(19980615)14:8<773::AID-YEA284>3.3.CO;2-J; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Grubenmann CE, 2004, HUM MOL GENET, V13, P535, DOI 10.1093/hmg/ddh050; HAEUPTLE M, 2009, HUM MUTAT, V130, P1; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Isono T, 2002, CLIN CHEM, V48, P2187; Isono T, 2009, INT J ONCOL, V35, P425, DOI 10.3892/ijo_00000355; Iwaki H, 2004, CANCER SCI, V95, P955, DOI 10.1111/j.1349-7006.2004.tb03183.x; Kageyama S, 2004, CLIN CHEM, V50, P857, DOI 10.1373/clinchem.2003.027425; Kageyama S, 2007, PROTEOM CLIN APPL, V1, P192, DOI 10.1002/prca.200600468; Kang JG, 2009, J BIOL CHEM, V284, P34777, DOI 10.1074/jbc.M109.026351; Kim CJ, 2008, INT J ONCOL, V32, P161; KUKURUZINSKA MA, 1994, GLYCOBIOLOGY, V4, P437, DOI 10.1093/glycob/4.4.437; Menniti M, 2005, AM J PHYSIOL-CELL PH, V288, pC148, DOI 10.1152/ajpcell.00284.2004; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	24	70	70	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18959	10.1371/journal.pone.0018959	http://dx.doi.org/10.1371/journal.pone.0018959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526146	Green Submitted, Green Published, gold			2022-12-25	WOS:000289671100041
J	Tractenberg, RE; Pietrzak, RH				Tractenberg, Rochelle E.; Pietrzak, Robert H.			Intra-Individual Variability in Alzheimer's Disease and Cognitive Aging: Definitions, Context, and Effect Sizes	PLOS ONE			English	Article							MINI-MENTAL-STATE; CROSS-DOMAIN VARIABILITY; OLDER-ADULTS; PERFORMANCE VARIABILITY; REACTION-TIME; IMPAIRMENT; DEMENTIA; DECLINE; UTILITY; SCALE	Background/Aims: To explore different definitions of intra-individual variability (IIV) to summarize performance on commonly utilized cognitive tests (Mini Mental State Exam; Clock Drawing Test); compare them and their potential to differentiate clinically-defined populations; and to examine their utility in predicting clinical change in individuals from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Methods: Sample statistics were computed from ADNI cohorts with no cognitive diagnosis, a diagnosis of mild cognitive impairment (MCI), and a diagnosis of possible or probable Alzheimer's disease (AD). Nine different definitions of IIV were computed for each sample, and standardized effect sizes (Cohen's d) were computed for each of these definitions in 500 simulated replicates using scores on the Mini Mental State Exam and Clock Drawing Test. IIV was computed based on test items separately ('within test' IIV) and the two tests together ('across test' IIV). The best performing definition was then used to compute IIV for a third test, the Alzheimer's Disease Assessment Scale-Cognitive, and the simulations and effect sizes were again computed. All effect size estimates based on simulated data were compared to those computed based on the total scores in the observed data. Association between total score and IIV summaries of the tests and the Clinician's Dementia Rating were estimated to test the utility of IIV in predicting clinically meaningful changes in the cohorts over 12- and 24-month intervals. Results: ES estimates differed substantially depending on the definition of IIV and the test(s) on which IIV was based. IIV (coefficient of variation) summaries of MMSE and Clock-Drawing performed similarly to their total scores, the ADAS total performed better than its IIV summary. Conclusion: IIV can be computed within (items) or across (totals) items on commonly-utilized cognitive tests, and may provide a useful additional summary measure of neuropsychological test performance.	[Tractenberg, Rochelle E.] Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20057 USA; [Tractenberg, Rochelle E.] Georgetown Univ, Sch Med, Dept Biostat, Washington, DC USA; [Tractenberg, Rochelle E.] Georgetown Univ, Sch Med, Dept Bioinformat & Biomath, Washington, DC USA; [Tractenberg, Rochelle E.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Natl Ctr Posttraumat Stress Disorder, Clin Neurosci Div,VA Connecticut Healthcare Syst, New Haven, CT USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Tractenberg, Rochelle E.; Pietrzak, Robert H.] Collaborat Res Outcomes & Metr, Washington, DC USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University	Tractenberg, RE (corresponding author), Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20057 USA.	ret7@georgetown.edu	Scharre, Douglas W/E-4030-2011		National Institute on Aging [K01 AG027172]; Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE ON AGING [U19AG010483, K01AG027172, K01AG030514, P30AG010129, U01AG024904] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grant K01 AG027172 from the National Institute on Aging (RET) and in part by the Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder and a private donation (RHP). Data collection and sharing for this project were funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904); ADNI was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. ADNI and its funders and investigators had no role in study design, data selection and analysis, decision to publish, or preparation of the manuscript. ADNI and its funders and investigators were wholly responsible for all data collection under the ADNI protocols. The co-authors have sole responsibility for this study's design, data analysis, decision to publish, and preparation of this manuscript.; RET is an academic editor at PLoS ONE. RHP declares no competing interests. ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., and Wyeth, as well as nonprofit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U. S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro-Imaging at the University of California, Los Angeles. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Allaire JC, 2005, PSYCHOL AGING, V20, P390, DOI 10.1037/0882-7974.20.3.390; BRITTON TC, 1991, ELECTROEN CLIN NEURO, V81, P186, DOI 10.1016/0168-5597(91)90071-5; Christensen H, 2005, NEUROPSYCHOLOGY, V19, P309, DOI 10.1037/0894-4105.19.3.309; COHEN J, 1988, STAT POWER ANAL BE E, V2; Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381; Duchek JM, 2009, NEUROPSYCHOLOGY, V23, P746, DOI 10.1037/a0016583; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GIORDANI B, 1990, NEUROLOGY, V40, P1894, DOI 10.1212/WNL.40.12.1894; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Grissom R.J., 2005, EFFECT SIZES RES BRO, pxv, 253; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; Hogan MJ, 2006, BRAIN RES, V1119, P215, DOI 10.1016/j.brainres.2006.08.075; Holtzer R, 2008, JAMA-J AM MED ASSOC, V300, P823, DOI 10.1001/jama.300.7.823; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hultsch D.F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Hultsch DF., 2008, HDB AGING COGNITION, P491, DOI DOI 10.4324/9780203837665.CH10; Kliegel M, 2004, GERONTOLOGY, V50, P39, DOI 10.1159/000074388; LEZAK MD, 2004, NEUROPSYCHOLOGICAL E, V4; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; MOHS RC, 1988, PSYCHOPHARMACOL BULL, V24, P627; Nesselroade JR, 2004, J GERONTOL B-PSYCHOL, V59, pP49, DOI 10.1093/geronb/59.2.P49; Rabbitt P, 2001, Q J EXP PSYCHOL-A, V54, P981, DOI 10.1080/02724980042000534; Rapp MA, 2005, GERONTOLOGY, V51, P206, DOI 10.1159/000083995; Salthouse TA, 2006, J GERONTOL B-PSYCHOL, V61, pP144, DOI 10.1093/geronb/61.3.P144; Schmiedek F, 2009, PSYCHOL AGING, V24, P841, DOI 10.1037/a0017799; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Thomann PA, 2008, BRAIN COGNITION, V67, P88, DOI 10.1016/j.bandc.2007.11.008; Tierney MC, 1997, ARCH NEUROL-CHICAGO, V54, P713, DOI 10.1001/archneur.1997.00550180035009; TRACTENBERG RE, LATENT CLASS APPROAC	34	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e16973	10.1371/journal.pone.0016973	http://dx.doi.org/10.1371/journal.pone.0016973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752EC	21526188	Green Published, Green Submitted, gold			2022-12-25	WOS:000289671100001
J	Cirio, MC; Hui, Z; Haldin, CE; Cosentino, CC; Stuckenholz, C; Chen, XF; Hong, SK; Dawid, IB; Hukriede, NA				Cirio, M. Cecilia; Hui, Zhao; Haldin, Caroline E.; Cosentino, Chiara Cianciolo; Stuckenholz, Carsten; Chen, Xiongfong; Hong, Sung-Kook; Dawid, Igor B.; Hukriede, Neil A.			Lhx1 Is Required for Specification of the Renal Progenitor Cell Field	PLOS ONE			English	Article							CIS-ACTING ELEMENTS; IN-VITRO INDUCTION; HOMEOBOX GENE LIM1; RETINOIC ACID; INTERMEDIATE MESODERM; PRONEPHROS DEVELOPMENT; TRANSCRIPTION FACTOR; EXPRESSION PATTERNS; GROWTH-FACTOR; XENOPUS	In the vertebrate embryo, the kidney is derived from the intermediate mesoderm. The LIM-class homeobox transcription factor lhx1 is expressed early in the intermediate mesoderm and is one of the first genes to be expressed in the nephric mesenchyme. In this study, we investigated the role of Lhx1 in specification of the kidney field by either overexpressing or depleting lhx1 in Xenopus embryos or depleting lhx1 in an explant culture system. By overexpressing a constitutively-active form of Lhx1, we established its capacity to expand the kidney field during the specification stage of kidney organogenesis. In addition, the ability of Lhx1 to expand the kidney field diminishes as kidney organogenesis transitions to the morphogenesis stage. In a complimentary set of experiments, we determined that embryos depleted of lhx1, show an almost complete loss of the kidney field. Using an explant culture system to induce kidney tissue, we confirmed that expression of genes from both proximal and distal kidney structures is affected by the absence of lhx1. Taken together our results demonstrate an essential role for Lhx1 in driving specification of the entire kidney field from the intermediate mesoderm.	[Cirio, M. Cecilia; Haldin, Caroline E.; Cosentino, Chiara Cianciolo; Hukriede, Neil A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Hui, Zhao] Chinese Univ Hong Kong, Sch Biomed Sci, Ma Liu Shui, Hong Kong, Peoples R China; [Stuckenholz, Carsten] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Chen, Xiongfong] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Unit Biol Computat, Bethesda, MD USA; [Hong, Sung-Kook; Dawid, Igor B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Mol Genet Lab, Bethesda, MD USA; [Hukriede, Neil A.] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cirio, MC (corresponding author), Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA.	hukriede@pitt.edu	Zhao, Hui/B-8429-2016	Zhao, Hui/0000-0001-8160-6415; Cirio, Cecilia/0000-0001-7693-9792	National Institutes of Health [R01DK069403]; National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053287, ZIAHD001002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01DK069403 (NAH) and by the intramural research program of the National Institute of Child Health and Human Development (IBD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Ariizumi T, 2001, INT J DEV BIOL, V45, P273; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Barnett MW, 1998, DEV GROWTH DIFFER, V40, P47; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Brandli AW, 1999, INT J DEV BIOL, V43, P381; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; Brennan HC, 1998, MECH DEVELOP, V75, P127, DOI 10.1016/S0925-4773(98)00094-X; Brennan HC, 1999, DEVELOPMENT, V126, P5847; Carroll TJ, 1996, DEV DYNAM, V206, P131, DOI 10.1002/(SICI)1097-0177(199606)206:2<131::AID-AJA2>3.3.CO;2-I; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Carroll TJ, 1999, DEV GENET, V24, P199, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<199::AID-DVG3>3.0.CO;2-D; Cartry J, 2006, DEV BIOL, V299, P35, DOI 10.1016/j.ydbio.2006.06.047; Chan TC, 2000, DEV BIOL, V228, P256, DOI 10.1006/dbio.2000.9951; Chan TC, 1999, NATURWISSENSCHAFTEN, V86, P224, DOI 10.1007/s001140050602; Chen YA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-101; Cho GS, 2011, DEVELOPMENT, V138, P465, DOI 10.1242/dev.061234; Dagle JM, 2001, DIFFERENTIATION, V69, P75, DOI 10.1046/j.1432-0436.2001.690201.x; DALE L, 1987, DEVELOPMENT, V99, P527; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Drews C, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-5; Eid SR, 2001, DIFFERENTIATION, V68, P115, DOI 10.1046/j.1432-0436.2001.680205.x; Faber J., 1994, NORMAL TABLE XENOPUS, P2; FUJII T, 1994, DEV DYNAM, V199, P73, DOI 10.1002/aja.1001990108; Gawantka V, 1998, MECH DEVELOP, V77, P95, DOI 10.1016/S0925-4773(98)00115-4; GODSAVE S, 1994, DEV BIOL, V166, P465, DOI 10.1006/dbio.1994.1330; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Guillaume R, 2009, DEV BIOL, V329, P169, DOI 10.1016/j.ydbio.2009.02.034; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; HERZLINGER D, 1995, SEMIN NEPHROL, V15, P255; Huang S, 1998, DEV GROWTH DIFFER, V40, P189; Hukriede NA, 2003, DEV CELL, V4, P83, DOI 10.1016/S1534-5807(02)00398-2; James RG, 2005, DEV BIOL, V288, P113, DOI 10.1016/j.ydbio.2005.09.025; James RG, 2003, DEV BIOL, V253, P109, DOI 10.1006/dbio.2002.0863; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kodjabachian L, 2001, INT J DEV BIOL, V45, P209; KOLM PJ, 1995, DEV BIOL, V171, P267, DOI 10.1006/dbio.1995.1279; Lemaire P, 1996, TRENDS GENET, V12, P525, DOI 10.1016/S0168-9525(97)81401-1; Mauch TJ, 2000, DEV BIOL, V220, P62, DOI 10.1006/dbio.2000.9623; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; MOHUN TJ, 1989, EMBO J, V8, P1153, DOI 10.1002/j.1460-2075.1989.tb03486.x; Moriya N, 2000, DEV GROWTH DIFFER, V42, P593; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Osafune K, 2002, DEV GROWTH DIFFER, V44, P161; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; Plaisier E, 2005, BBA-GENE STRUCT EXPR, V1727, P106, DOI 10.1016/j.bbaexp.2004.12.005; Potter SS, 2007, GENESIS, V45, P432, DOI 10.1002/dvg.20309; Raciti D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r84; Serluca FC, 2001, DEVELOPMENT, V128, P2233; Seufert DW, 1999, DEV BIOL, V215, P233, DOI 10.1006/dbio.1999.9476; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; SLACK JMW, 1993, MECH DEVELOP, V41, P91, DOI 10.1016/0925-4773(93)90040-5; SMITH JC, 1985, DIFFERENTIATION, V29, P109, DOI 10.1111/j.1432-0436.1985.tb00302.x; Swanhart LM, 2010, INT J DEV BIOL, V54, P731, DOI 10.1387/ijdb.092969ls; TAIRA M, 1994, DEVELOPMENT, V120, P1525; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Toyama R, 1997, DEV DYNAM, V209, P406, DOI 10.1002/(SICI)1097-0177(199708)209:4<406::AID-AJA8>3.3.CO;2-T; Tsang TE, 2000, DEV BIOL, V223, P77, DOI 10.1006/dbio.2000.9733; Vize PD, 1997, DEV BIOL, V188, P189, DOI 10.1006/dbio.1997.8629; VIZE PD, 1995, DEV BIOL, V171, P531, DOI 10.1006/dbio.1995.1302; VOGELS R, 1993, DEVELOPMENT, V118, P71; Wilm B, 2004, DEV BIOL, V271, P176, DOI 10.1016/j.ydbio.2004.03.034; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Wu GZ, 2004, EUR J BIOCHEM, V271, P3715, DOI 10.1111/j.1432-1033.2004.04312.x	70	30	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18858	10.1371/journal.pone.0018858	http://dx.doi.org/10.1371/journal.pone.0018858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526205	Green Published, gold, Green Accepted			2022-12-25	WOS:000289578600036
J	Le Breton, C; Hennion, M; Arimondo, PB; Hyrien, O				Le Breton, Cyrille; Hennion, Magali; Arimondo, Paola B.; Hyrien, Olivier			Replication-Fork Stalling and Processing at a Single Psoralen Interstrand Crosslink in Xenopus Egg Extracts	PLOS ONE			English	Article							DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; FORMING OLIGONUCLEOTIDES; EXCISION-REPAIR; NUCLEASE; CELLS; CHECKPOINT; INITIATION; AGENTS; HELIX	Interstrand crosslink (ICL)-inducing agents block the separation of the two DNA strands. They prevent transcription and replication and are used in clinics for the treatment of cancer and skin diseases. Here, we have introduced a single psoralen ICL at a specific site in plasmid DNA using a triplex-forming-oligonucleotide (TFO)-psoralen conjugate and studied its repair in Xenopus egg extracts that support nuclear assembly and replication of plasmid DNA. Replication forks arriving from either side stalled at the psoralen ICL. In contrast to previous observations with other ICL-inducing agents, the leading strands advanced up to the lesion without any prior pausing. Subsequently, incisions were introduced on one parental strand on both sides of the ICL. These incisions could be detected whether one or both forks reached the ICL. Using small molecule inhibitors, we found that the ATR-Chk1 pathway, but not the ATM-Chk2 pathway, stimulated both the incision step and the subsequent processing of the broken replication intermediates. Our results highlight both similarities and differences in fork stalling and repair induced by psoralen and by other ICL-forming agents.	[Le Breton, Cyrille; Hennion, Magali; Hyrien, Olivier] Ecole Normale Super, CNRS, INSERM, Inst Biol,UMR 8197,U1024, Paris, France; [Hennion, Magali; Arimondo, Paola B.] Museum Natl Hist Nat, CNRS, INSERM, UMR 7196,U565, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN)	Le Breton, C (corresponding author), Ecole Normale Super, CNRS, INSERM, Inst Biol,UMR 8197,U1024, Paris, France.	hyrien@biologie.ens.fr	Hyrien, Olivier/R-5108-2017; Arimondo, Paola B/R-9095-2017	Hyrien, Olivier/0000-0001-8879-675X; Arimondo, Paola B/0000-0001-5175-4396; Hennion, Magali/0000-0002-0352-2790	Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale (FRM); Association pour la Recherche sur le Cancer; Ligue Contre le Cancer (Comite de Paris)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Contre le Cancer (Comite de Paris)(Ligue nationale contre le cancer)	This work was supported by fellowships of the Centre National de la Recherche Scientifique (CNRS-www.cnrs.fr) and of the Fondation pour la Recherche Medicale (FRM-www.frm.org) to CLB and grants from the Association pour la Recherche sur le Cancer (www.arc-cancer.net), the Ligue Contre le Cancer (www.ligue-cancer.net) (Comite de Paris) and the Fondation pour la Recherche Medicale (equipe labellisee) to OH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Arimondo PB, 1999, CR ACAD SCI III-VIE, V322, P785, DOI 10.1016/S0764-4469(00)80037-2; Arimondo PB, 2002, J BIOL CHEM, V277, P3132, DOI 10.1074/jbc.M110181200; Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; Blow J J, 1987, Philos Trans R Soc Lond B Biol Sci, V317, P483, DOI 10.1098/rstb.1987.0075; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Christensen LA, 2008, NUCLEIC ACIDS RES, V36, P7136, DOI 10.1093/nar/gkn880; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; COUVEPRIVAT S, 2009, J BIOL CHEM; DARDALHON M, 1995, MUTAT RES-DNA REPAIR, V336, P49, DOI 10.1016/0921-8777(94)00037-7; ESTERBAUER H, 1993, AM J CLIN NUTR, V57, P779, DOI 10.1093/ajcn/57.5.779S; Fierro-Fernandez M, 2007, J BIOL CHEM, V282, P18190, DOI 10.1074/jbc.M701559200; Grillari J, 2007, NUCLEIC ACIDS RES, V35, P7566, DOI 10.1093/nar/gkm1065; Guieysse AL, 2000, J MOL BIOL, V296, P373, DOI 10.1006/jmbi.1999.3466; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; HARAN TE, 1988, BIOCHEMISTRY-US, V27, P6967, DOI 10.1021/bi00418a044; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; KUMARESAN KR, 1992, BIOCHEMISTRY-US, V31, P6774, DOI 10.1021/bi00144a018; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Lacroix L, 1999, BIOCHEMISTRY-US, V38, P1893, DOI 10.1021/bi982290q; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lu XY, 2005, BIOCHEM BIOPH RES CO, V336, P69, DOI 10.1016/j.bbrc.2005.08.042; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Malinge JM, 1999, J INORG BIOCHEM, V77, P23, DOI 10.1016/S0162-0134(99)00148-8; MALINGE JM, 1994, NUCLEIC ACIDS RES, V22, P3834, DOI 10.1093/nar/22.19.3834; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke Kathrin, 2009, V521, P575, DOI [10.1007/978-1-60327-817-5_33, 10.1007/978-1-60327-815-7_33]; MARTINPARRAS L, 1992, J BIOL CHEM, V267, P22496; McHugh PJ, 1999, NUCLEIC ACIDS RES, V27, P3259, DOI 10.1093/nar/27.16.3259; MILLER RD, 1982, MOL CELL BIOL, V2, P939, DOI 10.1128/MCB.2.8.939; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Oussedik K, 2010, FASEB J, V24, P2235, DOI 10.1096/fj.09-132324; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rajski SR, 1998, CHEM REV, V98, P2723, DOI 10.1021/cr9800199; Rouse J, 2009, BIOCHEM SOC T, V37, P495, DOI 10.1042/BST0370495; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shen X, 2006, J BIOL CHEM, V281, P13869, DOI 10.1074/jbc.C600071200; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023	45	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18554	10.1371/journal.pone.0018554	http://dx.doi.org/10.1371/journal.pone.0018554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525992	Green Published, Green Submitted, gold			2022-12-25	WOS:000289578600014
J	Picard, M; Taivassalo, T; Ritchie, D; Wright, KJ; Thomas, MM; Romestaing, C; Hepple, RT				Picard, Martin; Taivassalo, Tanja; Ritchie, Darmyn; Wright, Kathryn J.; Thomas, Melissa M.; Romestaing, Caroline; Hepple, Russell T.			Mitochondrial Structure and Function Are Disrupted by Standard Isolation Methods	PLOS ONE			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; PERMEABILITY TRANSITION PORE; IN-VIVO; RETICULUM; CAPACITY; FIBERS; MOUSE; AGE; APOPTOSIS; DISEASES	Mitochondria regulate critical components of cellular function via ATP production, reactive oxygen species production, Ca(2+) handling and apoptotic signaling. Two classical methods exist to study mitochondrial function of skeletal muscles: isolated mitochondria and permeabilized myofibers. Whereas mitochondrial isolation removes a portion of the mitochondria from their cellular environment, myofiber permeabilization preserves mitochondrial morphology and functional interactions with other intracellular components. Despite this, isolated mitochondria remain the most commonly used method to infer in vivo mitochondrial function. In this study, we directly compared measures of several key aspects of mitochondrial function in both isolated mitochondria and permeabilized myofibers of rat gastrocnemius muscle. Here we show that mitochondrial isolation i) induced fragmented organelle morphology; ii) dramatically sensitized the permeability transition pore sensitivity to a Ca(2+) challenge; iii) differentially altered mitochondrial respiration depending upon the respiratory conditions; and iv) dramatically increased H(2)O(2) production. These alterations are qualitatively similar to the changes in mitochondrial structure and function observed in vivo after cellular stress-induced mitochondrial fragmentation, but are generally of much greater magnitude. Furthermore, mitochondrial isolation markedly altered electron transport chain protein stoichiometry. Collectively, our results demonstrate that isolated mitochondria possess functional characteristics that differ fundamentally from those of intact mitochondria in permeabilized myofibers. Our work and that of others underscores the importance of studying mitochondrial function in tissue preparations where mitochondrial structure is preserved and all mitochondria are represented.	[Picard, Martin; Taivassalo, Tanja] McGill Univ, Dept Kinesiol, Montreal, PQ, Canada; [Ritchie, Darmyn; Wright, Kathryn J.; Thomas, Melissa M.; Hepple, Russell T.] Univ Calgary, Muscle & Aging Lab, Fac Kinesiol, Calgary, AB, Canada; [Ritchie, Darmyn; Wright, Kathryn J.; Thomas, Melissa M.; Hepple, Russell T.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Romestaing, Caroline] Univ Lyon, Lab Physiol Integrat Cellulaire & Mol, Villeurbanne, France	McGill University; University of Calgary; University of Calgary	Picard, M (corresponding author), McGill Univ, Dept Kinesiol, Montreal, PQ, Canada.	hepple@ucalgary.ca	romestaing, caroline/O-8794-2017	romestaing, caroline/0000-0002-6877-9626; Picard, Martin/0000-0003-2835-0478; Jacob, Kathryn/0000-0001-8373-5915; Hepple, Russell/0000-0003-3640-486X	Canadian Institutes for Health Research [MOP 57808, IAO 84673]; Alberta Heritage Foundation for Medical Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by operating grants from the Canadian Institutes for Health Research (MOP 57808 and IAO 84673 to RTH). RTH holds a Senior Scholar Award from the Alberta Heritage Foundation for Medical Research, MP holds a PhD fellowship from the Natural Sciences and Engineering Research Council of Canada and is a CIHR Fellow in Systems Biology. TT is a Chercheur Boursier Junior I Research Scholar from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; BAKEEVA LE, 1978, BIOCHIM BIOPHYS ACTA, V501, P349, DOI 10.1016/0005-2728(78)90104-4; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Braschi E, 2010, BIOESSAYS, V32, P958, DOI 10.1002/bies.201000073; Burelle Y, 2002, J APPL PHYSIOL, V92, P2429, DOI 10.1152/japplphysiol.01024.2001; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Figueiredo PA, 2008, J GERONTOL A-BIOL, V63, P350, DOI 10.1093/gerona/63.4.350; Figueiredo PA, 2008, BIOGERONTOLOGY, V9, P67, DOI 10.1007/s10522-007-9121-7; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; Hom J, 2009, J MOL CELL CARDIOL, V46, P811, DOI 10.1016/j.yjmcc.2009.02.023; ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Johannsen DL, 2009, CURR OPIN PHARMACOL, V9, P780, DOI 10.1016/j.coph.2009.09.002; Joseph AM, 2010, AM J PHYSIOL-CELL PH, V298, pC1308, DOI 10.1152/ajpcell.00644.2008; KAYAR SR, 1988, ANAT REC, V222, P333, DOI 10.1002/ar.1092220405; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Lemieux H, 2010, J GERONTOL A-BIOL, DOI [DOI 10.1093/GERONA/GLQ1141, 10.1093/gerona/glq1141]; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; McBride H, 2010, CURR BIOL, V20, pR274, DOI 10.1016/j.cub.2010.02.011; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Ogata T, 1997, ANAT REC, V248, P214; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Patel SP, 2009, INVEST OPHTH VIS SCI, V50, P180, DOI 10.1167/iovs.08-1911; Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Rasmussen HN, 1997, MOL CELL BIOCHEM, V174, P55, DOI 10.1023/A:1006851705996; Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Seelert H, 2009, BBA-BIOENERGETICS, V1787, P657, DOI 10.1016/j.bbabio.2009.02.028; Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WILLIAMS GR, 1965, CAN J BIOCHEM CELL B, V43, P603, DOI 10.1139/o65-070; WILSON EJ, 1987, NEUROCHEM RES, V12, P831; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	51	211	215	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2011	6	3							e18317	10.1371/journal.pone.0018317	http://dx.doi.org/10.1371/journal.pone.0018317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743XV	21512578	Green Published, gold, Green Submitted			2022-12-25	WOS:000289053800041
J	Nishikata, I; Nakahata, S; Saito, Y; Kaneda, K; Ichihara, E; Yamakawa, N; Morishita, K				Nishikata, I.; Nakahata, S.; Saito, Y.; Kaneda, K.; Ichihara, E.; Yamakawa, N.; Morishita, K.			Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation	ONCOGENE			English	Article						MEL1; sumoylation; CtBP; G-CSF	TERMINAL BINDING-PROTEINS; CELL-LINE 32D; TRANSCRIPTIONAL REPRESSION; SUMO MODIFICATION; GENE FAMILY; LEUKEMOGENESIS; COMPLEX; BROWN; T(1-3)(P36-Q21); DISORDERS	MEL1 (MDS1/EVI1-like gene 1/PRDM16), which was identified as a gene near the chromosomal breakpoint in t(1;3)(p36;q21)-positive human acute myeloid leukemia cells, belongs to the (P) under bar RDI-BF1-(R) under bar IZ1 homologous (PR) domain (PRDM) family of transcription repressors. The short form of MEL1 (MEL1S), which lacks the PR-domain at the N-terminus, is the main form expressed in t(1; 3)(p36; q21)-positive acute myeloid leukemia cells. The overexpression of MEL1S blocks granulocyte colony-stimulating factor (G-CSF)-induced myeloid differentiation in interleukin-3-dependent murine myeloid L-G3 cells. In this study, we show that treatment with the histone deacetylase inhibitor trichostatin A abolished the blockade of myeloid differentiation in L-G3 cells over-expressing MEL1S. The expression of MEL1S containing mutated CtBP-interacting motif (CIM) in L-G3 cells still blocked the myeloid differentiation induced by G-CSF. We found that the small ubiquitin-related modifier (SUMO) motif (SM) at lysine 568 (V (K) under bar AE) adjacent to the CIM was necessary to obtain the maximum transcriptional repressor activity of MEL1S. L-G3 cells expressing MEL1S, and bearing mutated CIM and SM differentiated into granulocytes in response to G-CSF; this indicated that both the SUMO modification at lysine 568 and CtBP binding were required for MEL1S-mediated transcriptional repression and blockade of differentiation, which might be relevant for the process of leukemogenesis. Oncogene (2011) 30, 4194-4207; doi:10.1038/onc.2011.132; published online 25 April 2011	[Nishikata, I.; Nakahata, S.; Saito, Y.; Kaneda, K.; Ichihara, E.; Yamakawa, N.; Morishita, K.] Miyazaki Univ, Fac Med, Dept Med Sci, Div Tumor & Cellular Biochem, Miyazaki 8891692, Japan	University of Miyazaki	Morishita, K (corresponding author), Miyazaki Univ, Fac Med, Dept Med Sci, Div Tumor & Cellular Biochem, 5200 Kihara, Miyazaki 8891692, Japan.	kmorishi@med.miyazaki-u.ac.jp	Kaneda-Nakashima, Kazuko/GZM-6591-2022	Kaneda-Nakashima, Kazuko/0000-0001-6657-5059	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research of Priority Area from the Ministry of Education, Culture, Sports, Science and Technology in Japan.	BLOOMFIELD CD, 1985, BLOOD, V66, P1409; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FRIEDMAN AD, 1991, BLOOD, V78, P2426; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; KINASHI T, 1991, J EXP MED, V173, P1267, DOI 10.1084/jem.173.5.1267; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Maki K, 2008, CANCER SCI, V99, P1878, DOI 10.1111/j.1349-7006.2008.00956.x; MIGLIACCIO G, 1989, J CELL BIOL, V109, P833, DOI 10.1083/jcb.109.2.833; Mitani K, 2004, ONCOGENE, V23, P4263, DOI 10.1038/sj.onc.1207777; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; MOIR DJ, 1984, BLOOD, V64, P553; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shimahara A, 2010, J BIOL CHEM, V285, P16967, DOI 10.1074/jbc.M110.102046; Shimizu S, 2000, GENE CHROMOSOME CANC, V27, P229, DOI 10.1002/(SICI)1098-2264(200003)27:3<229::AID-GCC2>3.0.CO;2-0; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; WELBORN JL, 1987, CANCER GENET CYTOGEN, V28, P277, DOI 10.1016/0165-4608(87)90214-7	33	17	20	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	40					4194	4207		10.1038/onc.2011.132	http://dx.doi.org/10.1038/onc.2011.132			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	833ZK	21516122				2022-12-25	WOS:000295924600006
J	Shao, H; Cai, L; Grichnik, JM; Livingstone, AS; Velazquez, OC; Liu, ZJ				Shao, H.; Cai, L.; Grichnik, J. M.; Livingstone, A. S.; Velazquez, O. C.; Liu, Z-J			Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1	ONCOGENE			English	Article						tumor microenvironment; melanoma; fibroblasts; Notch; WISP-1	EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-GROWTH; CANCER-THERAPY; BREAST-CANCER; LUNG-CANCER; ANGIOGENESIS; CELLS; PROGRESSION; DLL4; DIFFERENTIATION	The tumor microenvironment is emerging as an important target for cancer therapy. Fibroblasts (Fbs) within the tumor stroma are critically involved in promoting tumor growth and angiogenesis through secretion of soluble factors, synthesis of extracellular matrix and direct cell-cell interaction. In this work, we aim to alter the biological activity of stromal Fbs by modulating the Notch1 signaling pathway. We show that Fbs engineered to constitutively activate the Notch1 pathway significantly inhibit melanoma growth and tumor angiogenesis. We determine that the inhibitory effect of 'Notch-engineered' Fbs is mediated by increased secretion of Wnt-induced secreted protein-1 (WISP-1) as the effects of Notch1 activation in Fbs are reversed by shRNA-mediated blockade of WISP-1. When 'Notch-engineered' Fbs are co-grafted with melanoma cells in SCID mice, shRNA-mediated blockade of WISP-1 reverses the tumor-suppressive phenotype of the 'Notch-engineered' Fbs, significantly increases melanoma growth and tumor angiogenesis. Consistent with these findings, supplement of recombinant WISP-1 protein inhibits melanoma cell growth in vitro. In addition, WISP-1 is modestly expressed in melanoma-activated Fbs but highly expressed in inactivated Fbs. Evaluation of human melanoma skin biopsies indicates that expression of WISP-1 is significantly lower in melanoma nests and surrounding areas filled with infiltrated immune cells than in the adjacent dermis unaffected by the melanoma. Overall, our study shows that constitutive activation of the Notch1 pathway confers Fbs with a suppressive phenotype to melanoma growth, partially through WISP-1. Thus, targeting tumor stromal Fbs by activating Notch signaling and/or increasing WISP-1 may represent a novel therapeutic approach to combat melanoma. Oncogene (2011) 30, 4316-4326; doi: 10.1038/onc.2011.142; published online 25 April 2011	[Liu, Z-J] Univ Miami, Sylvester Comprehens Canc Ctr, Sch Med, Dept Surg, Miami, FL 33136 USA; [Shao, H.; Cai, L.; Livingstone, A. S.; Velazquez, O. C.; Liu, Z-J] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Cai, L.] Hangzhou Red Cross Hosp, Hangzhou, Zhejiang, Peoples R China; [Grichnik, J. M.] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Liu, ZJ (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Sch Med, Dept Surg, RMSB 1046,1600 NW 10th Ave, Miami, FL 33136 USA.	zliu@med.miami.edu	Livingstone, Alan/AAA-4026-2019; Grichnik, James/R-3887-2019	Grichnik, James/0000-0002-9185-0056; Shao, Hongwei/0000-0001-9770-4132	James & Esther King Biomedical Research Program [08KN-10]; Bankhead-Coley Cancer Research [09BN-11]	James & Esther King Biomedical Research Program; Bankhead-Coley Cancer Research	We thank Dr M Herlyn for providing the melanoma cells (1205Lu, WM35, WM3248, Sbcl2, WM278 and WM3899) and Dr G McNamara for laser-scanning confocal microscopy. The work of Dr Liu was supported by grants from the James & Esther King Biomedical Research Program (08KN-10) and the Bankhead-Coley Cancer Research Program (09BN-11).	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anton K, 2009, CURR PHARM BIOTECHNO, V10, P185, DOI 10.2174/138920109787315088; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Davies SR, 2007, ANN SURG ONCOL, V14, P1909, DOI 10.1245/s10434-007-9376-x; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Hayward SW, 2001, CANCER RES, V61, P8135; Ishikawa Y, 2008, ONCOGENE, V27, P6164, DOI 10.1038/onc.2008.216; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Liu ZJ, 2010, ANN SURG, V252, P625, DOI 10.1097/SLA.0b013e3181f5a079; Liu ZJ, 2009, J CELL BIOCHEM, V106, P984, DOI 10.1002/jcb.22091; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; LIU ZJ, 2005, MOL BIOL CUTANEOUS M; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Soon LL, 2003, J BIOL CHEM, V278, P11465, DOI 10.1074/jbc.M210945200; Tanaka S, 2001, ONCOGENE, V20, P5525, DOI 10.1038/sj.onc.1204723; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Urs S, 2008, AM J PATHOL, V173, P865, DOI 10.2353/ajpath.2008.080006; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Zeisberg M, 2008, FRONT BIOSCI, V13, P6991	40	48	50	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	42					4316	4326		10.1038/onc.2011.142	http://dx.doi.org/10.1038/onc.2011.142			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HP	21516124				2022-12-25	WOS:000296356400003
J	Reimer, D; Hubalek, M; Kiefel, H; Riedle, S; Skvortsov, S; Erdel, M; Hofstetter, G; Concin, N; Fiegl, H; Muller-Holzner, E; Marth, C; Altevogt, P; Zeimet, AG				Reimer, D.; Hubalek, M.; Kiefel, H.; Riedle, S.; Skvortsov, S.; Erdel, M.; Hofstetter, G.; Concin, N.; Fiegl, H.; Mueller-Holzner, E.; Marth, C.; Altevogt, P.; Zeimet, A. G.			Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer	ONCOGENE			English	Article						E2F3a; EGFR; miR-34a; 6p22 amplification; ovarian cancer; prognosis	COMPARATIVE GENOMIC HYBRIDIZATION; BLADDER; AMPLIFICATION; APOPTOSIS; GROWTH; OVEREXPRESSION; PROLIFERATION; CARCINOMA; MIR-34A	Recently we showed an integral epidermal growth factor receptor (EGFR)-E2F3a signaling path, in which E2F3a was found to be essential in EGFR-mediated proliferation in ovarian cancer cells. The present work evaluates the clinical relevance of this novel axis and of E2F3a itself in a large set of 130 ovarian cancer specimens. For this purpose E2F3a and its counterpart, E2F3b, were measured by RT-PCR and activated EGFR was assessed by immunohistochemistry. When compared with healthy control tissue, both E2F3 isoforms were overexpressed in the cancers, but only E2F3a expression correlated with tumor stage (rho = 0.349, P = 0.0001) and residual disease (rho = 0.254, P = 0.004). Univariate survival analyses showed E2F3a and activated EGFR to be associated with poor PFS and OS. Furthermore, a strong, positive correlation between activated EGFR and E2F3a expression was shown (P 0.0001). We further identified two EGFR-independent mechanisms that regulate E2F3a expression, namely one, acting by promoter methylation of miR-34a, which by its physical interaction with E2F3a transcripts causes their degradation, and the second based on 6p22 gene locus amplification. MiRIDIAN-based knockdown and induction of miR-34a evidenced a direct regulatory link between miR-34a and E2F3a, and the tumor-suppressive character of miR-34a was documented by its association with improved survival. Although, 6p22 gene locus amplification was detected in a significant number of ovarian cancer specimens, 6p22 ploidy was not relevant in predicting survival. In Cox regression analysis, E2F3a, but not activated EGFR or miR-34a expression, retained independent prognostic significance (PFS: hazards ratio 3.785 (1.326-9.840), P = 0.013; OS: hazards ratio 4.651 (1.189-15.572), P 0.013). These clinical findings highlight the relevance of E2F3a in the biology of ovarian cancer. Moreover, identification of EGFR-independent mechanisms in E2F3a control can be helpful in explaining the non-responsiveness of therapeutic EGFR targeting in ovarian cancer. Oncogene (2011) 30, 4038-4049; doi:10.1038/onc.2011.119; published online 25 April 2011	[Reimer, D.; Hubalek, M.; Hofstetter, G.; Concin, N.; Fiegl, H.; Mueller-Holzner, E.; Marth, C.; Zeimet, A. G.] Innsbruck Med Univ, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria; [Kiefel, H.; Riedle, S.; Altevogt, P.] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Skvortsov, S.] Innsbruck Med Univ, Dept Radiotherapy, A-6020 Innsbruck, Austria; [Erdel, M.] Krankenhaus Barmherzigen Schwestern Linz, Lab Mol Biol & Cytogenet, Linz, Austria	Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Innsbruck; Konventhospital Der Barmherzigen Bruder	Zeimet, AG (corresponding author), Innsbruck Med Univ, Dept Obstet & Gynecol, Anichstr 35, A-6020 Innsbruck, Austria.	alain.zeimet@i-med.ac.at	Hubalek, Michael/ABD-8041-2021; Fiegl, Heidi/K-4445-2017	Concin, Nicole/0000-0002-9795-2643; Hofstetter, Gerda/0000-0001-8912-3725; Fiegl, Heidi/0000-0002-1236-6806	Verein fur Krebsforschung in der Frauenheilkunde; Department of Obstetrics and Gynecology; Innsbruck Medical University	Verein fur Krebsforschung in der Frauenheilkunde; Department of Obstetrics and Gynecology; Innsbruck Medical University	This work was supported by the 'Verein fur Krebsforschung in der Frauenheilkunde', Department of Obstetrics and Gynecology, Innsbruck Medical University. We thank Annemarie Wiedemair, Martina Champson, Julia Rossler and Martina Fleischer for technical assistance. We also thank Dr Wolfgang A Schulz (Department of Urology, University Hospital Dusseldorf, Germany) for his generous gift of the bladder cancer cell lines.	Bruch J, 2000, CANCER RES, V60, P4526; Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Concin N, 2005, CLIN CANCER RES, V11, P8372, DOI 10.1158/1078-0432.CCR-05-0899; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Gordon AN, 2005, INT J GYNECOL CANCER, V15, P785, DOI 10.1111/j.1525-1438.2005.00137.x; Koo SH, 1999, CANCER GENET CYTOGEN, V110, P87, DOI 10.1016/S0165-4608(98)00193-9; Krugmann J, 2004, J CLIN PATHOL, V57, P360, DOI 10.1136/jcp.2003.012369; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Markman M, 2008, DRUGS, V68, P771, DOI 10.2165/00003495-200868060-00004; Oeggerli M, 2004, ONCOGENE, V23, P5616, DOI 10.1038/sj.onc.1207749; Paulson QX, 2006, CELL CYCLE, V5, P184, DOI 10.4161/cc.5.2.2307; Reimer D, 2007, CLIN CANCER RES, V13, P144, DOI 10.1158/1078-0432.CCR-06-0780; Reimer D, 2010, CANCER RES, V70, P4613, DOI 10.1158/0008-5472.CAN-09-3551; Schilder RJ, 2009, GYNECOL ONCOL, V113, P21, DOI 10.1016/j.ygyno.2008.12.003; Simon R, 2000, INT J ONCOL, V17, P1025; Stadlmann S, 2006, MODERN PATHOL, V19, P607, DOI 10.1038/modpathol.3800575; Takai Daiya, 2003, In Silico Biology, V3, P235; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Van Cutsem E, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2; Veltman JA, 2003, CANCER RES, V63, P2872; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Zeimet AG, 2009, INT J CANCER, V124, P2353, DOI 10.1002/ijc.24214	24	36	37	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	38					4038	4049		10.1038/onc.2011.119	http://dx.doi.org/10.1038/onc.2011.119			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	823KR	21516127				2022-12-25	WOS:000295121600005
J	Gong, ZH; Chen, JJ				Gong, Zihua; Chen, Junjie			E3 Ligase RFWD3 Participates in Replication Checkpoint Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; PROTEIN-A RPA; PHYSICAL INTERACTION; BINDING-PROTEIN; DAMAGE; ATR; RECOMBINATION; RECRUITMENT; REGULATOR; COMPLEXES	RFWD3 has E3 ligase activity in vitro, but its in vivo function remains unknown. In this study we identified RFWD3 as a novel replication protein A (RPA)-associated protein. Using purified proteins, we observed a direct interaction between RPA2 and RFWD3. Further analysis showed that RFWD3 is recruited to stalled replication forks and co-localizes with RPA2 in response to replication stress. Moreover, RFWD3 is important for ATR-dependent Chk1 activation in response to replication stress. Upon replication stress, deletion of RPA2 binding region on RFWD3 impairs its localization to stalled replication forks and decreases Chk1 activation. Taken together, our results suggest that RFWD3 and RPA2 functionally interact and participate in replication checkpoint control.	[Gong, Zihua; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org			National Institutes of Health [CA089239, CA092312, CA100109]; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [R01CA089239, R01CA100109, R01CA092312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470). To whom correspondence should be addressed: Dept. of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. E-mail: jchen8@mdanderson.org.	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Driscoll R, 2009, GENE DEV, V23, P2359, DOI 10.1101/gad.1860609; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fu XY, 2010, P NATL ACAD SCI USA, V107, P4579, DOI 10.1073/pnas.0912094107; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Perrault R, 2001, INT J RADIAT BIOL, V77, P593, DOI 10.1080/09553000110036773; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	25	37	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22308	22313		10.1074/jbc.M111.222869	http://dx.doi.org/10.1074/jbc.M111.222869			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21504906	Green Published, hybrid			2022-12-25	WOS:000291719900039
J	Jaafar, R; Zeiller, C; Pirola, L; Di Grazia, A; Naro, F; Vidal, H; Lefai, E; Nemoz, G				Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Di Grazia, Antonio; Naro, Fabio; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges			Phospholipase D Regulates Myogenic Differentiation through the Activation of Both mTORC1 and mTORC2 Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; SKELETAL-MUSCLE REGENERATION; MAMMALIAN TARGET; PHOSPHATIDIC-ACID; MYOBLAST DIFFERENTIATION; SUBCELLULAR-LOCALIZATION; PROTEIN-SYNTHESIS; RAPAMYCIN; VASOPRESSIN; HYPERTROPHY	How phospholipase D (PLD) is involved in myogenesis remains unclear. At the onset of myogenic differentiation of L6 cells induced by the PLD agonist vasopressin in the absence of serum, mTORC1 complex was rapidly activated, as reflected by phosphorylation of S6 kinase1 (S6K1). Both the long (p85) and short (p70) S6K1 isoforms were phosphorylated in a PLD1-dependent way. Short rapamycin treatment specifically inhibiting mTORC1 suppressed p70 but not p85 phosphorylation, suggesting that p85 might be directly activated by phosphatidic acid. Vasopressin stimulation also induced phosphorylation of Akt on Ser-473 through PLD1-dependent activation of mTORC2 complex. In this model of myogenesis, mTORC2 had a positive role mostly unrelated to Akt activation, whereas mTORC1 had a negative role, associated with S6K1-induced Rictor phosphorylation. The PLD requirement for differentiation can thus be attributed to its ability to trigger via mTORC2 activation the phosphorylation of an effector that could be PKC alpha. Moreover, PLD is involved in a counter-regulation loop expected to limit the response. This study thus brings new insights in the intricate way PLD and mTOR cooperate to control myogenesis.	[Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges] Lyon Univ, UMR1235, F-69600 Oullins, France; [Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges] INSERM, U1060, UMR1235, F-69600 Oullins, France; [Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges] CarMeN Lab, UMR1235, F-69600 Oullins, France; [Jaafar, Rami; Zeiller, Caroline; Pirola, Luciano; Vidal, Hubert; Lefai, Etienne; Nemoz, Georges] Univ Lyon 1, UMR1235, F-69600 Oullins, France; [Vidal, Hubert; Lefai, Etienne] INRA, UMR1235, F-69600 Oullins, France; [Di Grazia, Antonio; Naro, Fabio] Univ Roma La Sapienza, Dipartimento Istol & Embriol Med, I-00161 Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Sapienza University Rome	Nemoz, G (corresponding author), INSERM, U1060, F-69921 Oullins, France.	georges.nemoz@insa-lyon.fr	Pirola, Luciano/I-5250-2018; Vidal, Hubert/M-6674-2017; Lefai, Etienne/L-7961-2019; Lefai, Etienne/E-9615-2019; Jaafar, Rami/K-1027-2019	Vidal, Hubert/0000-0002-9467-0317; Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; Jaafar, Rami/0000-0002-1649-4792; Pirola, Luciano/0000-0001-6539-5435	Association Francaise contre les Myopathies [MNM2 2007]; Association pour la Recherche sur le Cancer	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work has been supported by a grant from the Association Francaise contre les Myopathies (MNM2 2007) and a fellowship from the Association pour la Recherche sur le Cancer (to R. J.).	Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Breton C, 2002, J CLIN ENDOCR METAB, V87, P1415, DOI 10.1210/jc.87.3.1415; COFFER PJ, 1994, BIOCHEM BIOPH RES CO, V198, P780, DOI 10.1006/bbrc.1994.1112; CONVERTINO VA, 1983, J APPL PHYSIOL, V54, P508, DOI 10.1152/jappl.1983.54.2.508; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Hu TH, 2003, J BIOL CHEM, V278, P2348, DOI 10.1074/jbc.M210093200; Huang JX, 2009, CANCER RES, V69, P6107, DOI 10.1158/0008-5472.CAN-09-0975; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kenessey A, 2006, J BIOL CHEM, V281, P20666, DOI 10.1074/jbc.M512671200; Kim SJ, 1997, BIOCHEM BIOPH RES CO, V234, P681, DOI 10.1006/bbrc.1997.6699; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Komati H, 2004, FEBS LETT, V577, P409, DOI 10.1016/j.febslet.2004.10.036; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Kubica N, 2005, J BIOL CHEM, V280, P7570, DOI 10.1074/jbc.M413732200; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Laser M, 1998, J BIOL CHEM, V273, P24610, DOI 10.1074/jbc.273.38.24610; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Mebarek S, 2007, J CELL SCI, V120, P407, DOI 10.1242/jcs.03331; Minotti S, 1998, CELL GROWTH DIFFER, V9, P155; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Moresi V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005570; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Park IH, 2005, EXP CELL RES, V309, P211, DOI 10.1016/j.yexcr.2005.05.017; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Raghu P, 2009, BBA-MOL CELL BIOL L, V1791, P889, DOI 10.1016/j.bbalip.2009.03.013; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; SMITH A, 1992, EARLY HUM DEV, V28, P215, DOI 10.1016/0378-3782(92)90168-G; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Thibonnier M, 1996, GENOMICS, V31, P327, DOI 10.1006/geno.1996.0055; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Uhlenbrock K, 2009, FEBS LETT, V583, P965, DOI 10.1016/j.febslet.2009.02.015; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Zeiller C, 2009, BBA-MOL CELL RES, V1793, P1236, DOI 10.1016/j.bbamcr.2009.04.001	62	22	23	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22609	22621		10.1074/jbc.M110.203885	http://dx.doi.org/10.1074/jbc.M110.203885			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21525000	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000291719900068
J	Singh, AK; Swarnalatha, M; Kumar, V				Singh, Anup Kumar; Swarnalatha, Manickavinayaham; Kumar, Vijay			c-ETS1 Facilitates G(1)/S-phase Transition by Up-regulating Cyclin E and CDK2 Genes and Cooperates with Hepatitis B Virus X Protein for Their Deregulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; HISTONE DEACETYLASE; EXPRESSION; PROMOTER; ACTIVATION; BINDING; ETS-1; CHROMATIN	Recent studies on the molecular mechanisms responsible for cell cycle deregulation in cancer have puzzled out the role of oncogenes in mediating unscheduled cellular proliferation. This is reminiscence of their activity as proto-oncogenes that drives scheduled cell cycle progression under physiological conditions. Working on the cell cycle regulatory activity of protooncogene, we observed that c-ETS1 transcriptionally up-regulated both cyclin E and CDK2 genes, the master regulators of G(1)/S-phase transition. The process was mediated by kinetic coherence of c-ETS1 expression and its recruitment to both promoters during G(1)/S-phase transition. Furthermore, enforced expression of c-ETS1 helped G(0)-arrested cells to progress into G(1)/S-phases apparently due to the activation of cyclin E/CDK2 genes. Physiological induction of c-ETS1 by EGF showed the remodeling of mononucleosomes bound to the c-ETS1 binding site on both promoters during their activation. The exchange of HDAC1 with histone acetyltransferase-p300 was contemporaneous to the chromatin remodeling with consequent increase in histone H3K9 acetylation. Furthermore, the ATP-dependent chromatin remodeler hBRM1 recruitment was also associated with nucleosome remodeling and promoter occupancy of phos-pho-Ser5 RNA polymerase II. Intriguingly, the activity of the HBx viral oncoprotein was dependent on c-ETS1 in a hepatotropic manner, which led to the activation of cyclin E/CDK2 genes. Thus, cyclin E and CDK2 genes are key physiological effectors of the c-ETS1 proto-oncogene. Furthermore, c-ETS1 is indispensable for the hepatotropic action of HBx in cell cycle deregulation.	[Singh, Anup Kumar; Swarnalatha, Manickavinayaham; Kumar, Vijay] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Kumar, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	vijay@icgeb.res.in			International Centre for Genetic Engineering and Biotechnology, New Delhi; Council of Scientific and Industrial Research (New Delhi); Indian Council of Medical Research (New Delhi)	International Centre for Genetic Engineering and Biotechnology, New Delhi; Council of Scientific and Industrial Research (New Delhi)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (New Delhi)(Indian Council of Medical Research (ICMR))	This work was supported by a core grant of the International Centre for Genetic Engineering and Biotechnology, New Delhi.; Recipient of a Senior Research Fellowship from the Council of Scientific and Industrial Research (New Delhi).; Recipient of a Senior Research Fellowship from the Indian Council of Medical Research (New Delhi).	AVANTAGGIATI ML, 1993, ONCOGENE, V8, P1567; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Botz J, 1996, MOL CELL BIOL, V16, P3401; Bouchard M, 2001, J VIROL, V75, P4247, DOI 10.1128/JVI.75.9.4247-4257.2001; BRADFORD AP, 1995, MOL CELL BIOL, V15, P2849; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Davie JR, 1999, J CELL BIOCHEM, P141; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Geng Y, 1996, ONCOGENE, V12, P1173; Gilles F, 1996, EXP CELL RES, V222, P370, DOI 10.1006/excr.1996.0046; Glass CK, 2000, GENE DEV, V14, P121; Goodman RH, 2000, GENE DEV, V14, P1553; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Janbandhu VC, 2010, J BIOL CHEM, V285, P17453, DOI 10.1074/jbc.M109.058974; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krude T, 2000, J BIOL CHEM, V275, P13699, DOI 10.1074/jbc.275.18.13699; Kumar V, 1998, HYBRIDOMA, V17, P157, DOI 10.1089/hyb.1998.17.157; KUMAR V, 2008, PLEIOTROPIC FUNCTION, P221; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; Le Cam L, 1999, EMBO J, V18, P1878, DOI 10.1093/emboj/18.7.1878; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; MAJERUS MA, 1992, NUCLEIC ACIDS RES, V20, P2699, DOI 10.1093/nar/20.11.2699; McGowan Clare H, 2003, Prog Cell Cycle Res, V5, P1; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mukherji A, 2007, BIOCHEM J, V401, P247, DOI 10.1042/BJ20061091; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; PerezRoger I, 1997, ONCOGENE, V14, P2373, DOI 10.1038/sj.onc.1201197; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Schang Luis M, 2003, Prog Cell Cycle Res, V5, P103; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shiffman D, 1996, J BIOL CHEM, V271, P12199, DOI 10.1074/jbc.271.21.12199; Sugimoto H, 2003, J BIOL CHEM, V278, P19716, DOI 10.1074/jbc.M301590200; Takai N, 2002, INT J MOL MED, V9, P287; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; TOPOL LZ, 1992, CANCER LETT, V67, P71, DOI 10.1016/0304-3835(92)90010-S; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yoo YD, 1996, J CLIN INVEST, V97, P388, DOI 10.1172/JCI118427	56	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					21961	21970		10.1074/jbc.M111.238238	http://dx.doi.org/10.1074/jbc.M111.238238			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21515670	hybrid, Green Published			2022-12-25	WOS:000291719900003
J	Nikiforov, A; Dolle, C; Niere, M; Ziegler, M				Nikiforov, Andrey; Dolle, Christian; Niere, Marc; Ziegler, Mathias			Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells FROM ENTRY OF EXTRACELLULAR PRECURSORS TO MITOCHONDRIAL NAD GENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE RIBOSIDE; MAMMALIAN-CELLS; WALLERIAN DEGENERATION; METABOLISM; PHOSPHORIBOSYLTRANSFERASE; POLY(ADP-RIBOSE); NUCLEOTIDE; SIRTUINS; ENZYME; LIFE	NAD is a vital redox carrier, and its degradation is a key element of important regulatory pathways. NAD-mediated functions are compartmentalized and have to be fueled by specific biosynthetic routes. However, little is known about the different pathways, their subcellular distribution, and regulation in human cells. In particular, the route(s) to generate mitochondrial NAD, the largest subcellular pool, is still unknown. To visualize organellar NAD changes in cells, we targeted poly( ADP-ribose) polymerase activity into the mitochondrial matrix. This activity synthesized immunodetectable poly(ADPribose) depending on mitochondrial NAD availability. Based on this novel detector system, detailed subcellular enzyme localizations, and pharmacological inhibitors, we identified extracellular NAD precursors, their cytosolic conversions, and the pathway of mitochondrial NAD generation. Our results demonstrate that, besides nicotinamide and nicotinic acid, only the corresponding nucleosides readily enter the cells. Nucleotides (e. g. NAD and NMN) undergo extracellular degradation resulting in the formation of permeable precursors. These precursors can all be converted to cytosolic and mitochondrial NAD. For mitochondrial NAD synthesis, precursors are converted to NMN in the cytosol. When taken up into the organelles, NMN (together with ATP) serves as substrate of NMNAT3 to form NAD. NMNAT3 was conclusively localized to the mitochondrial matrix and is the only known enzyme of NAD synthesis residing within these organelles. We thus present a comprehensive dissection of mammalian NAD biosynthesis, the groundwork to understand regulation of NAD-mediated processes, and the organismal homeostasis of this fundamental molecule.	[Nikiforov, Andrey; Dolle, Christian; Niere, Marc; Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway	University of Bergen	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, PB 7803, N-5020 Bergen, Norway.	Mathias.Ziegler@mbi.uib.no	Nikiforov, Andrey A/B-6643-2012	Nikiforov, Andrey A/0000-0002-5009-6130; Ziegler, Mathias/0000-0001-6961-2396	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council.	Abdelraheim SR, 2003, BIOCHEM J, V374, P329, DOI 10.1042/BJ20030441; Aleo MF, 2001, J CELL BIOCHEM, V80, P360, DOI 10.1002/1097-4644(20010301)80:3<360::AID-JCB90>3.0.CO;2-X; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Billington RA, 2008, J BIOL CHEM, V283, P6367, DOI 10.1074/jbc.M706204200; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Bruzzone S, 2001, FASEB J, V15, P10; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; Dolle C, 2009, ANAL BIOCHEM, V385, P377, DOI 10.1016/j.ab.2008.10.033; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Formentini L, 2009, BIOCHEM PHARMACOL, V77, P1612, DOI 10.1016/j.bcp.2009.02.017; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Grobben B, 1999, J NEUROCHEM, V72, P826, DOI 10.1046/j.1471-4159.1999.0720826.x; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; HENDERSON LM, 1947, J BIOL CHEM, V170, P261; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; PREISS J, 1958, J BIOL CHEM, V233, P493; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; TYLER D, 1992, MITOCHONDRION HLTH D; Vollmayer P, 2003, EUR J BIOCHEM, V270, P2971, DOI 10.1046/j.1432-1033.2003.03674.x; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Zhang QH, 2002, SCIENCE, V295, P1895; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	52	223	230	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21767	21778		10.1074/jbc.M110.213298	http://dx.doi.org/10.1074/jbc.M110.213298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21504897	hybrid, Green Published			2022-12-25	WOS:000291464700072
J	Edwards, AM; Potter, U; Meenan, NAG; Potts, JR; Massey, RC				Edwards, Andrew M.; Potter, Ursula; Meenan, Nicola A. G.; Potts, Jennifer R.; Massey, Ruth C.			Staphylococcus aureus Keratinocyte Invasion Is Dependent upon Multiple High-Affinity Fibronectin-Binding Repeats within FnBPA	PLOS ONE			English	Article							PROTEIN-A; BACTERIAL-INFECTIONS; LACTOCOCCUS-LACTIS; EXPRESSION; ADHESION; MECHANISMS; COMPLEX; CELLS; EPIDEMIOLOGY; CONSEQUENCES	Staphylococcus aureus is a commensal organism and a frequent cause of skin and soft tissue infections, which can progress to serious invasive disease. This bacterium uses its fibronectin binding proteins (FnBPs) to invade host cells and it has been hypothesised that this provides a protected niche from host antimicrobial defences, allows access to deeper tissues and provides a reservoir for persistent or recurring infections. FnBPs contain multiple tandem fibronectin-binding repeats (FnBRs) which bind fibronectin with varying affinity but it is unclear what selects for this configuration. Since both colonisation and skin infection are dependent upon the interaction of S. aureus with keratinocytes we hypothesised that this might select for FnBP function and thus composition of the FnBR region. Initial experiments revealed that S. aureus attachment to keratinocytes is rapid but does not require FnBRs. By contrast, invasion of keratinocytes was dependent upon the FnBR region and occurred via similar cellular processes to those described for endothelial cells. Despite this, keratinocyte invasion was relatively inefficient and appeared to include a lag phase, most likely due to very weak expression of alpha(5)beta(1) integrins. Molecular dissection of the role of the FnBR region revealed that efficient invasion of keratinocytes was dependent on the presence of at least three high-affinity (but not low-affinity) FnBRs. Over-expression of a single high-affinity or three low-affinity repeats promoted invasion but not to the same levels as S. aureus expressing an FnBPA variant containing three high-affinity repeats. In summary, invasion of keratinocytes by S. aureus requires multiple high-affinity FnBRs within FnBPA, and given the importance of the interaction between these cell types and S. aureus for both colonisation and infection, may have provided the selective pressure for the multiple binding repeats within FnBPA.	[Edwards, Andrew M.; Massey, Ruth C.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Meenan, Nicola A. G.; Potts, Jennifer R.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Potts, Jennifer R.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England	University of Bath; University of York - UK; University of York - UK	Edwards, AM (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	ae248@bath.ac.uk	Massey, Ruth/AAT-6415-2021; Meenan, Nicola/A-4884-2010	Massey, Ruth/0000-0002-8154-4039; Edwards, Andrew/0000-0002-7173-7355; Meenan, Nicola/0000-0002-0294-4983	British Heart Foundation; Wellcome Trust [WT 079588]; Medical Research Council [G0700836] Funding Source: researchfish; MRC [G0700836] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JRP acknowledges the British Heart Foundation (http://www.bhf.org.uk/) for a Senior Basic Science Research Fellowship. This work was funded by the Wellcome Trust (http://www.wellcome.ac.uk/), grant number WT 079588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufiero B, 2007, INT J DERMATOL, V46, P687, DOI 10.1111/j.1365-4632.2007.03161.x; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Boukamp P, 1997, GENE CHROMOSOME CANC, V19, P201, DOI 10.1002/(SICI)1098-2264(199708)19:4<201::AID-GCC1>3.0.CO;2-0; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brook I, 2002, J MED MICROBIOL, V51, P808, DOI 10.1099/0022-1317-51-10-808; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Dombek PE, 1999, MOL MICROBIOL, V31, P859, DOI 10.1046/j.1365-2958.1999.01223.x; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104; FROMAN G, 1987, J BIOL CHEM, V262, P6564; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Hirt H, 2000, J BACTERIOL, V182, P2299, DOI 10.1128/JB.182.8.2299-2306.2000; Ingham KC, 2004, J BIOL CHEM, V279, P42945, DOI 10.1074/jbc.M406984200; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Kisich KO, 2007, J INVEST DERMATOL, V127, P2368, DOI 10.1038/sj.jid.5700861; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Massey RC, 2001, CELL MICROBIOL, V3, P839, DOI 10.1046/j.1462-5822.2001.00157.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mempel M, 1998, J INVEST DERMATOL, V111, P452, DOI 10.1046/j.1523-1747.1998.00293.x; Mempel M, 2002, BRIT J DERMATOL, V146, P943, DOI 10.1046/j.1365-2133.2002.04752.x; Nitsche-Schmitz DP, 2007, THROMB HAEMOSTASIS, V98, P488, DOI 10.1160/TH07-03-0179; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657; PELLEGRINI G, 1992, J CLIN INVEST, V89, P1783, DOI 10.1172/JCI115782; Plouin-Gaudon I, 2006, RHINOLOGY, V44, P249; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schroder A, 2006, MOL BIOL CELL, V17, P5198, DOI 10.1091/mbc.E06-05-0463; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Sinha B, 2005, THROMB HAEMOSTASIS, V94, P266, DOI 10.1160/TH05-04-0235; von Eiff C, 2001, CLIN INFECT DIS, V32, P1643, DOI 10.1086/320519; von Eiff C, 2006, INJURY, V37, P26, DOI 10.1016/j.injury.2006.04.006; Wang BN, 2007, CELL MICROBIOL, V9, P1519, DOI 10.1111/j.1462-5822.2007.00889.x; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Zautner AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009452	53	47	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18899	10.1371/journal.pone.0018899	http://dx.doi.org/10.1371/journal.pone.0018899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526122	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800021
J	Li, HL; Zhai, JF; Sun, XP				Li, Hailong; Zhai, Junfeng; Sun, Xuping			Electrostatic-Assembly-Driven Formation of Supramolecular Rhombus Microparticles and Their Application for Fluorescent Nucleic Acid Detection	PLOS ONE			English	Article							SENSING PLATFORM; CARBON NANOTUBES; DNA ANALYSIS; NANOPARTICLES; GRAPHENE; PROBES; OLIGONUCLEOTIDES; BIOMOLECULES	In this paper, we report on the large-scale formation of supramolecular rhombus microparticles (SRMs) driven by electrostatic assembly, carried out by direct mixing of an aqueous HAuCl4 solution and an ethanol solution of 4,4`-bipyridine at room temperature. We further demonstrate their use as an effective fluorescent sensing platform for nucleic acid detection with a high selectivity down to single-base mismatch. The general concept used in this approach is based on adsorption of the fluorescently labeled single-stranded DNA (ssDNA) probe by SRM, which is accompanied by substantial fluorescence quenching. In the following assay, specific hybridization with its target to form double-stranded DNA (dsDNA) results in desorption of ssDNA from SRM surface and subsequent fluorescence recovery.	[Li, Hailong; Zhai, Junfeng; Sun, Xuping] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Li, Hailong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, HL (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	sunxp@ciac.jl.cn	Li, Hailong/H-2527-2018; Zhai, Junfeng/D-9321-2016	Li, Hailong/0000-0002-1209-2315; Zhai, Junfeng/0000-0001-5421-6999	National Basic Research Program of China [2011CB935800]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (No. 2011CB935800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard Valeur, 2001, MOL FLUORESCENCE PRI; Boal AK, 2000, NATURE, V404, P746, DOI 10.1038/35008037; Brayner R, 2008, NANO TODAY, V3, P48, DOI 10.1016/S1748-0132(08)70015-X; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Fendler JH, 2001, CHEM MATER, V13, P3196, DOI 10.1021/cm010165m; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Li D, 2010, ACCOUNTS CHEM RES, V43, P631, DOI 10.1021/ar900245u; Li H., 2011, SMALL IN PRESS; Li H-Y, 2011, UNPUB; Li HL, 2011, ANAL METHODS-UK, V3, P1051, DOI 10.1039/c0ay00746c; Li HL, 2011, J MATER CHEM, V21, P824, DOI 10.1039/c0jm02695f; Li HL, 2011, J MATER CHEM, V21, P4663, DOI 10.1039/c0jm04107f; Li HL, 2011, CHEM COMMUN, V47, P2625, DOI 10.1039/c0cc05394e; Li HL, 2011, CHEM COMMUN, V47, P961, DOI 10.1039/c0cc04326e; Li HX, 2004, ANAL CHEM, V76, P5414, DOI 10.1021/ac049173n; Liu S, 2011, NANOSCALE, V3, P967, DOI 10.1039/c0nr00873g; Liu S, 2011, J MATER CHEM, V21, P339, DOI 10.1039/c0jm03337e; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p; Ray PC, 2007, PLASMONICS, V2, P173, DOI 10.1007/s11468-007-9036-9; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Song SP, 2009, ANGEW CHEM INT EDIT, V48, P8670, DOI 10.1002/anie.200901887; Sun XP, 2007, ANAL CHEM, V79, P2588, DOI 10.1021/ac062130h; Sun XP, 2010, LANGMUIR, V26, P6133, DOI 10.1021/la100646e; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; Tian JQ, 2011, LANGMUIR, V27, P874, DOI 10.1021/la103799e; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; Wang L, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1294; Yang RH, 2008, ANAL CHEM, V80, P7408, DOI 10.1021/ac801118p; Yang RH, 2008, J AM CHEM SOC, V130, P8351, DOI 10.1021/ja800604z; Zhang YW, 2011, LANGMUIR, V27, P2170, DOI 10.1021/la105092f	36	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18958	10.1371/journal.pone.0018958	http://dx.doi.org/10.1371/journal.pone.0018958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526152	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100040
J	Schibille, N				Schibille, Nadine			Late Byzantine Mineral Soda High Alumina Glasses from Asia Minor: A New Primary Glass Production Group	PLOS ONE			English	Article							ROMAN GLASS; ISLAMIC GLASS; OBSIDIAN CHARACTERIZATION; RAW GLASS; ICP-MS; ISOTOPES; PROVENANCE; PLANTS; EAST; TECHNOLOGY	The chemical characterisation of archaeological glass allows the discrimination between different glass groups and the identification of raw materials and technological traditions of their production. Several lines of evidence point towards the large-scale production of first millennium CE glass in a limited number of glass making factories from a mixture of Egyptian mineral soda and a locally available silica source. Fundamental changes in the manufacturing processes occurred from the eight/ninth century CE onwards, when Egyptian mineral soda was gradually replaced by soda-rich plant ash in Egypt as well as the Islamic Middle East. In order to elucidate the supply and consumption of glass during this transitional period, 31 glass samples from the assemblage found at Pergamon (Turkey) that date to the fourth to fourteenth centuries CE were analysed by electron microprobe analysis (EPMA) and by laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS). The statistical evaluation of the data revealed that the Byzantine glasses from Pergamon represent at least three different glass production technologies, one of which had not previously been recognised in the glass making traditions of the Mediterranean. While the chemical characteristics of the late antique and early medieval fragments confirm the current model of glass production and distribution at the time, the elemental make-up of the majority of the eighth-to fourteenth-century glasses from Pergamon indicate the existence of a late Byzantine glass type that is characterised by high alumina levels. Judging from the trace element patterns and elevated boron and lithium concentrations, these glasses were produced with a mineral soda different to the Egyptian natron from the Wadi Natrun, suggesting a possible regional Byzantine primary glass production in Asia Minor.	Univ Oxford, Archaeol & Hist Art Res Lab, Oxford OX1 3QJ, England	University of Oxford	Schibille, N (corresponding author), Univ Oxford, Archaeol & Hist Art Res Lab, Oxford OX1 3QJ, England.	nadine.schibille@rlaha.ox.ac.uk		Schibille, Nadine/0000-0001-9242-0392	Marie Curie Intra-European Fellowship for Career Development [FP7-PEOPLE-IEF-2008, 236809]	Marie Curie Intra-European Fellowship for Career Development	This work was supported by a Marie Curie Intra-European Fellowship for Career Development (FP7-PEOPLE-IEF-2008; Grant Agreement No. 236809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESCUTREADG.I, 2006, ARTE MEDIEVALE, V5, P87; [Anonymous], 2008, COMPOSITION PRODUCTI; Arletti R, 2010, ARCHAEOMETRY, V52, P796, DOI 10.1111/j.1475-4754.2009.00504.x; Arletti R., 2005, ANN 16 C ASS INT HIS, P80; Boulogne S, 2009, J GLASS STUD, V51, P53; Brill R. H., 1968, P 8 INT C GLASS SHEF, P47; Brill RH, 1999, CHEM ANALYSES EARLY; Camacho-Cristobal JJ, 2008, J INTEGR PLANT BIOL, V50, P1247, DOI 10.1111/j.1744-7909.2008.00742.x; Carter T, 2006, J ARCHAEOL SCI, V33, P893, DOI 10.1016/j.jas.2005.10.023; Degryse P, 2008, J ARCHAEOL SCI, V35, P1993, DOI 10.1016/j.jas.2008.01.002; Degryse P., 2010, GLASS BYZANTIUM PROD, P83; Dussubieux L, 2008, ARCHAEOMETRY, V50, P797, DOI 10.1111/j.1475-4754.2007.00350.x; Dussubieux L, 2010, J ARCHAEOL SCI, V37, P1646, DOI 10.1016/j.jas.2010.01.025; Dussubieux L, 2009, INT J MASS SPECTROM, V284, P152, DOI 10.1016/j.ijms.2008.11.003; FOSS C, 1977, AM J ARCHAEOL, V81, P469, DOI 10.2307/503279; Foy D., 2000, ANN 14 C ASS INT HIS, P51; Foy D., 2003, CHANGES COMMERCE VER, P41; Foy D, 2003, ANN 15E CONGRES LASS, P138; Freestone I.C., 2000, TRAVAUX MAISON ORIEN, P65; Freestone I. C., 2006, WEARMOUTH JARROW MON, P147; Freestone I.C., 2001, P HYAL VITR GLASS P, P167; Freestone IC, 2008, J GLASS STUD, V50, P67; Freestone IC, 2006, GEOL SOC SPEC PUBL, V257, P201, DOI 10.1144/GSL.SP.2006.257.01.16; Freestone IC, 2005, MATER RES SOC SYMP P, V852, P195; Freestone IC, 2003, ARCHAEOMETRY, V45, P19, DOI 10.1111/1475-4754.00094; Freestone IC, 2002, ARCHAEOMETRY, V44, P257, DOI 10.1111/1475-4754.t01-1-00058; Freestone IC, 1999, J GLASS STUD, V41, P105; Gorin-Rosen Y., 2000, ROUTE VERRE ATELIERS, P49; GORINROSEN Y, 1995, EXCAVATIONS SURVEYS, V13, P42; GRATUZE B, 1990, ARCHAEOMETRY, V32, P155, DOI 10.1111/j.1475-4754.1990.tb00462.x; Gratuze B, 1999, J ARCHAEOL SCI, V26, P869, DOI 10.1006/jasc.1999.0459; Helvaci C, 2004, INT GEOL REV, V46, P177, DOI 10.2747/0020-6814.46.2.177; Henderson J, 2004, ARCHAEOMETRY, V46, P439, DOI 10.1111/j.1475-4754.2004.00167.x; Henderson J, 2009, ANTIQUITY, V83, P414, DOI 10.1017/S0003598X00098525; HEVACI C, 2000, TURKISH J EARTH SCI, V9, P1; Jackson CM, 2003, ARCHAEOMETRY, V45, P435, DOI 10.1111/1475-4754.00120; JAPP S, 2010, ISTANBULER MITTEILUN, V60, P455; Kamber BS, 2005, GEOCHIM COSMOCHIM AC, V69, P1041, DOI 10.1016/j.gca.2004.08.020; Krom MD, 2002, GEOLOGY, V30, P71, DOI 10.1130/0091-7613(2002)030<0071:NRSFOT>2.0.CO;2; Lankton JW, 2006, J GLASS STUD, V48, P121; Leslie KA, 2006, ARCHAEOMETRY, V48, P253, DOI 10.1111/j.1475-4754.2006.00255.x; MIRTI P, 1993, ARCHAEOMETRY, V35, P225, DOI 10.1111/j.1475-4754.1993.tb01037.x; Miwa K, 2007, SCIENCE, V318, P1417, DOI 10.1126/science.1146634; Nenna M.D., 1997, REV ARCHAEOMETRIE, V21, P81, DOI [DOI 10.3406/arsci.1997.949, 10.3406/arsci.1997.949, DOI 10.3406/ARSCI.1997.949]; Nenna MD, 2000, ROUTE VERRE ATELIERS, P97; Paynter S, 2008, J GLASS STUD, V50, P271; Radt W., 1999, PERGAMON GESCHICHTE; Rehren T., 2008, ARCHAEOLOGY HIST SCI, P77; Rehren T, 2008, J ARCHAEOL SCI, V35, P1345, DOI 10.1016/j.jas.2007.09.005; RHEIDT K, 1991, ALTERTUMER PERGAMON; SAYRE EV, 1961, SCIENCE, V133, P1824, DOI 10.1126/science.133.3467.1824; Schwarzer H., 2009, LATE ANTIQUE EARLY B, P85; Shennan S., 1997, QUANTIFYING ARCHAEOL; Shortland A, 2006, J ARCHAEOL SCI, V33, P521, DOI 10.1016/j.jas.2005.09.011; Silvestri A, 2008, J ARCHAEOL SCI, V35, P1489, DOI 10.1016/j.jas.2007.10.014; Silvestri A, 2008, J ARCHAEOL SCI, V35, P331, DOI 10.1016/j.jas.2007.03.010; Silvestri A, 2005, ARCHAEOMETRY, V47, P797, DOI 10.1111/j.1475-4754.2005.00233.x; Tanimoto S, 2008, J ARCHAEOL SCI, V35, P2566, DOI 10.1016/j.jas.2008.04.016; Wedepohl KH, 2010, CHEM ERDE-GEOCHEM, V70, P89, DOI 10.1016/j.chemer.2009.12.006; Wedepohl KH, 2000, NATURWISSENSCHAFTEN, V87, P129, DOI 10.1007/s001140050690; Whitehouse D, 2002, J GLASS STUD, V44, P193	61	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18970	10.1371/journal.pone.0018970	http://dx.doi.org/10.1371/journal.pone.0018970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	752EC	21526144	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000289671100042
J	Geisel, N; Vilar, JMG; Rubi, JM				Geisel, Nico; Vilar, Jose M. G.; Miguel Rubi, J.			Optimal Resting-Growth Strategies of Microbial Populations in Fluctuating Environments	PLOS ONE			English	Article							VIBRIO SP S14; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; CHANGING ENVIRONMENTS; GENE-EXPRESSION; STRESS-RESPONSE; CELL-CYCLE; STARVATION; SURVIVAL; PROTEIN	Bacteria spend most of their lifetime in non-growing states which allow them to survive extended periods of stress and starvation. When environments improve, they must quickly resume growth to maximize their share of limited nutrients. Cells with higher stress resistance often survive longer stress durations at the cost of needing more time to resume growth, a strong disadvantage in competitive environments. Here we analyze the basis of optimal strategies that microorganisms can use to cope with this tradeoff. We explicitly show that the prototypical inverse relation between stress resistance and growth rate can explain much of the different types of behavior observed in stressed microbial populations. Using analytical mathematical methods, we determine the environmental parameters that decide whether cells should remain vegetative upon stress exposure, downregulate their metabolism to an intermediate optimum level, or become dormant. We find that cell-cell variability, or intercellular noise, is consistently beneficial in the presence of extreme environmental fluctuations, and that it provides an efficient population-level mechanism for adaption in a deteriorating environment. Our results reveal key novel aspects of responsive phenotype switching and its role as an adaptive strategy in changing environments.	[Geisel, Nico; Miguel Rubi, J.] Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; [Geisel, Nico] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Vilar, Jose M. G.] Univ Basque Country, Biophys Unit, CSIC, UPV,EHU,Dept Biochem & Mol Biol, Bilbao, Spain; [Vilar, Jose M. G.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	University of Barcelona; Princeton University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; Basque Foundation for Science	Geisel, N (corresponding author), Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain.	Nico.Geisel@ffn.ub.es	Vilar, Jose MG/A-9069-2013	Vilar, Jose MG/0000-0003-4037-0746	Spanish Ministry of Education [FPU AP-2007-00975]; Spanish Ministry of Science [FIS 2008-04386]	Spanish Ministry of Education(Spanish Government); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by the Spanish Ministry of Education grant no. FPU AP-2007-00975 and the Spanish Ministry of Science grant no. FIS 2008-04386. Nico Geisel would like to thank Matthias Kaschube for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; ALBERTSON NH, 1990, J GEN MICROBIOL, V136, P2201, DOI 10.1099/00221287-136-11-2201; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Cole JJ, 1999, ECOSYSTEMS, V2, P215, DOI 10.1007/s100219900069; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dupont C, 2009, APPL ENVIRON MICROB, V75, P3069, DOI 10.1128/AEM.02864-08; ELLIOTT B, 1993, YEAST, V9, P33, DOI 10.1002/yea.320090105; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; KJELLEBERG S, 1993, ANTON LEEUW INT J G, V63, P333, DOI 10.1007/BF00871228; Koch AL, 1997, MICROBIOL MOL BIOL R, V61, P305, DOI 10.1128/.61.3.305-318.1997; Kolter R, 1999, J BACTERIOL, V181, P697, DOI 10.1128/JB.181.3.697-699.1999; Konopka A, 2002, J IND MICROBIOL BIOT, V29, P286, DOI 10.1038/sj.jim.7000322; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LACHMANN M, 1995, J THEOR BIOL, V181, P1; LEGEWIE S, 2010, BIOPHYS J, V95, P3232; LENGELER JW, 1998, BIOL PROKARYOTES, P655; Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485; Li YQ, 2006, INT J FOOD MICROBIOL, V110, P278, DOI 10.1016/j.ijfoodmicro.2006.04.029; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; MCCANN MP, 1991, J BACTERIOL, V173, P4188, DOI 10.1128/jb.173.13.4188-4194.1991; MCCLURE PJ, 1993, INT J FOOD MICROBIOL, V19, P161, DOI 10.1016/0168-1605(93)90074-Q; NYSTROM T, 1990, FEMS MICROBIOL ECOL, V74, P129, DOI 10.1111/j.1574-6968.1990.tb04059.x; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; REEVE CA, 1984, J BACTERIOL, V160, P1041, DOI 10.1128/JB.160.3.1041-1046.1984; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; SCHULTZ D, 2009, P NATL ACAD SCI USA, V106; SHLEEVA M, 2002, MICROBIOLOGY, P148; SIEGELE DA, 1992, J BACTERIOL, V174, P345, DOI 10.1128/jb.174.2.345-348.1992; Su SSY, 1996, J CELL SCI, V109, P1347; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; VASI F, 1994, AM NATURALIST, V144; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105	43	12	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18622	10.1371/journal.pone.0018622	http://dx.doi.org/10.1371/journal.pone.0018622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525975	Green Published, Green Submitted, gold			2022-12-25	WOS:000289578600020
J	Sneve, MH; Alnaes, D; Endestad, T; Greenlee, MW; Magnussen, S				Sneve, Markus H.; Alnaes, Dag; Endestad, Tor; Greenlee, Mark W.; Magnussen, Svein			Modulation of Activity in Human Visual Area V1 during Memory Masking	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; MOTION INFORMATION; SPATIAL-FREQUENCY; CORTEX; REPRESENTATION; ADAPTATION; ACTIVATION; PSYCHOPHYSICS; SUPPRESSION	Neurons in the primary visual cortex, V1, are specialized for the processing of elemental features of the visual stimulus, such as orientation and spatial frequency. Recent fMRI evidence suggest that V1 neurons are also recruited in visual perceptual memory; a number of studies using multi-voxel pattern analysis have successfully decoded stimulus-specific information from V1 activity patterns during the delay phase in memory tasks. However, consistent fMRI signal modulations reflecting the memory process have not yet been demonstrated. Here, we report evidence, from three subjects, that the low V1 BOLD activity during retention of low-level visual features is caused by competing interactions between neural populations coding for different values along the spectrum of the dimension remembered. We applied a memory masking paradigm in which the memory representation of a masker stimulus interferes with a delayed spatial frequency discrimination task when its frequency differs from the discriminanda with +/- 1 octave and found that impaired behavioral performance due to masking is reflected in weaker V1 BOLD signals. This cross-channel inhibition in V1 only occurs with retinotopic overlap between the masker and the sample stimulus of the discrimination task. The results suggest that memory for spatial frequency is a local process in the retinotopically organized visual cortex.	[Sneve, Markus H.; Alnaes, Dag; Endestad, Tor; Magnussen, Svein] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway; [Greenlee, Mark W.] Univ Regensburg, Dept Expt Psychol, Regensburg, Germany	University of Oslo; University of Regensburg	Sneve, MH (corresponding author), Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway.	m.h.sneve@psykologi.uio.no	Greenlee, Mark/M-6414-2018	Greenlee, Mark/0000-0003-2305-9286; Endestad, Tor/0000-0002-4403-6887; Alnaes, Dag/0000-0001-7361-5418	University of Oslo	University of Oslo	This work was supported by a grant from the University of Oslo (www.uio.no) to the Center for the Study of Human Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett PJ, 1996, VISION RES, V36, P233, DOI 10.1016/0042-6989(95)00085-E; Boynton GM, 2003, J NEUROSCI, V23, P8781; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Campana G, 2007, NEUROPSYCHOLOGIA, V45, P2340, DOI 10.1016/j.neuropsychologia.2007.02.009; Cattaneo Z, 2009, EUR J NEUROSCI, V30, P1393, DOI 10.1111/j.1460-9568.2009.06911.x; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Danilova MV, 2003, PERCEPTION, V32, P395, DOI 10.1068/p3393; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Ester EF, 2009, J NEUROSCI, V29, P15258, DOI 10.1523/JNEUROSCI.4388-09.2009; Fang F, 2005, J NEUROPHYSIOL, V94, P4188, DOI 10.1152/jn.00378.2005; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Hubel DH., 2005, BRAIN VISUAL PERCEPT; Issa NP, 2008, J NEUROPHYSIOL, V99, P2745, DOI 10.1152/jn.90211.2008; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Lakha L, 2004, VISION RES, V44, P1707, DOI 10.1016/j.visres.2004.02.006; Lalonde J, 2002, VISION RES, V42, P1759, DOI 10.1016/S0042-6989(02)00111-6; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MacEvoy SP, 2009, NAT NEUROSCI, V12, P637, DOI 10.1038/nn.2310; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; MAGNUSSEN S, 1991, VISION RES, V31, P1213, DOI 10.1016/0042-6989(91)90046-8; MAGNUSSEN S, 1992, J EXP PSYCHOL LEARN, V18, P151, DOI 10.1037/0278-7393.18.1.151; Magnussen S, 2000, TRENDS NEUROSCI, V23, P247, DOI 10.1016/S0166-2236(00)01569-1; Magnussen S, 2010, MEMORY, AGING AND THE BRAIN: A FESTSCHRIFT IN HONOUR OF LARS-GORAN NILSSON, P53; McKeefry DJ, 2007, VISION RES, V47, P2418, DOI 10.1016/j.visres.2007.05.011; Meese TS, 2007, P ROY SOC B-BIOL SCI, V274, P127, DOI 10.1098/rspb.2006.3697; Motes MA, 2010, NEUROIMAGE, V49, P1933, DOI 10.1016/j.neuroimage.2009.08.054; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Offen S, 2009, VISION RES, V49, P1352, DOI 10.1016/j.visres.2007.12.022; Ogmen H, 2003, VISION RES, V43, P1337, DOI 10.1016/S0042-6989(03)00138-X; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Ong WS, 2009, J NEUROPHYSIOL, V102, P2435, DOI 10.1152/jn.00684.2009; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; PASTERNAK T, 2003, HDB PSYCHOL BIOL PSY, P139; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Qiu AQ, 2006, NEUROIMAGE, V31, P125, DOI 10.1016/j.neuroimage.2005.11.049; Ruge H, 2009, NEUROIMAGE, V47, P501, DOI 10.1016/j.neuroimage.2009.04.075; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SCHILLER PH, 1995, NATURE, V376, P342, DOI 10.1038/376342a0; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; Sligte IG, 2009, J NEUROSCI, V29, P7432, DOI 10.1523/JNEUROSCI.0784-09.2009; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P2874, DOI 10.1016/j.neuropsychologia.2006.06.021; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Smith AT, 2006, NEUROIMAGE, V29, P328, DOI 10.1016/j.neuroimage.2005.07.003; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Veltman DJ, 2002, NEUROIMAGE, V17, P1203, DOI 10.1006/nimg.2002.1242; Vidyasagar TR, 2007, EUR J NEUROSCI, V25, P2547, DOI 10.1111/j.1460-9568.2007.05483.x; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Zaksas D, 2001, J NEUROPHYSIOL, V86, P912, DOI 10.1152/jn.2001.86.2.912	57	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18651	10.1371/journal.pone.0018651	http://dx.doi.org/10.1371/journal.pone.0018651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750WK	21525988	gold, Green Submitted, Green Published			2022-12-25	WOS:000289578600022
J	Li, Y; Cai, L; Wang, H; Wu, P; Gu, W; Chen, Y; Hao, H; Tang, K; Yi, P; Liu, M; Miao, S; Ye, D				Li, Y.; Cai, L.; Wang, H.; Wu, P.; Gu, W.; Chen, Y.; Hao, H.; Tang, K.; Yi, P.; Liu, M.; Miao, S.; Ye, D.			Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2	ONCOGENE			English	Article						formyl peptide receptor-2; macrophage colony-stimulating factor; monocyte chemoattractant protein-1; macrophages; tumorigenesis	TUMOR-ASSOCIATED MACROPHAGES; NF-KAPPA-B; IN-VIVO; SIGNAL TRANSDUCER; LIPID MEDIATORS; A(4) RECEPTOR; CANCER-CELLS; INFLAMMATION; ACTIVATION; RESOLUTION	Cancer cells recruit monocytes, macrophages and other inflammatory cells by producing abundant chemo-attractants and growth factors, such as macrophage colony-stimulating factor (M-CSF/CSF-1) and monocyte chemoattractant protein-1 (MCP-1/CCL2), to promote tumor growth and dissemination. An understanding of the mechanisms that target cancer cells and regulate tumor microenvironment is essential in designing anticancer therapies. Here, we showed that serum amyloid-A (SAA) and cathelicidin (LL-37) stimulated M-CSF and MCP-1 expression with or without lipopolysaccharide (LPS) administration; conversely, lipoxin-A(4) (LXA(4)) and annexin-A1 (ANXA1) inhibited LPS-induced M-CSF and MCP-1 production by human (HepG2) and mouse (H22) hepatocellular carcinoma cells (HCCs). The effects of LXA(4), ANXA1, SAA and LL-37 were dependent on the activation of their mutual cell-surface receptor formyl peptide receptor-2 (FPR2) and subsequent ROS-MAPK-NF-kB signalings. Furthermore, our results indicated that LPS switched macrophages into an IL-10(low)IL-12(high) M1 profile, whereas M-CSF + MCP-1 and FPR2 agonists skewed them into M2 (IL-10(high)IL-12(low)). In that respect, through modulating the phosphorylation of signal transducer and activator of transcription-3 (STAT3), LXA(4) and ANXA1 induced monocyte differentiation into M2a + M2c-like cells and showed antitumorigenetic activities, whereas SAA, LL-37 and M-CSF + MCP-1 led to M2b- or M2d-like polarization, which exacerbated HCC invasion in vitro and in vivo, respectively. Our results suggest that FPR2 has an appreciable pleiotropic regulator role in tumor immunoediting. Oncogene (2011) 30, 3887-3899; doi:10.1038/onc.2011.112; published online 18 April 2011	[Li, Y.; Cai, L.; Wu, P.; Gu, W.; Hao, H.; Tang, K.; Yi, P.; Liu, M.; Miao, S.; Ye, D.] Huazhong Univ Sci & Technol, Dept Pathophysiol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Li, Y.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol, Boston, MA 02115 USA; [Wang, H.] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Chen, Y.] Univ Aizu, Grad Sch Comp Sci & Engn, Biomed Informat Technol Lab, Aizu Wakamatsu, Japan	Huazhong University of Science & Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Aizu	Li, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Pathophysiol, Tongji Med Coll, Wuhan 430030, Peoples R China.	yli@zeus.bwh.harvard.edu; yedy@mails.tjmu.edu.cn		Li, Yongsheng/0000-0003-2175-9449	China Scholarship Council [2009616073]; National Natural Science Foundation of China [30570726, 30772154]	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Professor Charles N Serhan for helpful comments about FPR2. We also appreciate all anonymous reviewers for helpful suggestions on quality improvement of the paper. This work was supported by China Scholarship Council Fellowship No. 2009616073 and National Natural Science Foundation of China Grants 30570726 and 30772154.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Cocco E, 2010, CANCER-AM CANCER SOC, V116, P843, DOI 10.1002/cncr.24838; Coimbra M, 2009, CURR PHARM DESIGN, V15, P1825, DOI 10.2174/138161209788453220; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Craig M, 2008, J CELL BIOCHEM, V103, P1, DOI 10.1002/jcb.21379; Duff MD, 2007, J SURG RES, V142, P119, DOI 10.1016/j.jss.2006.12.542; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; EMOTO M, 1992, J EXP MED, V176, P363, DOI 10.1084/jem.176.2.363; Fan SJ, 2005, ONCOGENE, V24, P1749, DOI 10.1038/sj.onc.1208327; FIORE S, 1992, J BIOL CHEM, V267, P16168; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; GAO JL, 1993, J BIOL CHEM, V268, P25395; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Janssen-Heininger YMW, 1999, AM J RESP CELL MOL, V20, P942, DOI 10.1165/ajrcmb.20.5.3452; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kuninaka S, 2000, CYTOKINE, V12, P8, DOI 10.1006/cyto.1998.0504; Lawrence T, 2007, TRENDS PHARMACOL SCI, V28, P162, DOI 10.1016/j.tips.2007.02.003; Li Y, 2010, CURR CANCER DRUG TAR, V10, P782, DOI 10.2174/156800910793605857; Li YS, 2008, ARCH BIOCHEM BIOPHYS, V478, P110, DOI 10.1016/j.abb.2008.07.002; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McMahon B, 2000, J BIOL CHEM, V275, P27566; Miao T, 2006, J NEUROSCI, V26, P9512, DOI 10.1523/JNEUROSCI.2160-06.2006; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Panzer U, 2009, AM J PHYSIOL-RENAL, V297, pF429, DOI 10.1152/ajprenal.90435.2008; Peng J, 2010, CELL RES, V20, P62, DOI 10.1038/cr.2009.128; PEPINSKY RB, 1986, J BIOL CHEM, V261, P4239; Perretti M, 2002, J IMMUNOL, V169, P2085, DOI 10.4049/jimmunol.169.4.2085; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Varney ML, 2002, IN VIVO, V16, P471; Wang QS, 2010, CELL RES, V20, P701, DOI 10.1038/cr.2010.52; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang L, 2007, CHINESE MED J-PEKING, V120, P981, DOI 10.1097/00029330-200706010-00008; Zhang T, 2010, CANCER IMMUNOL IMMUN, V59, P1097, DOI 10.1007/s00262-010-0836-y; Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204	49	114	123	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2011	30	36					3887	3899		10.1038/onc.2011.112	http://dx.doi.org/10.1038/onc.2011.112			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	817PV	21499310				2022-12-25	WOS:000294687200006
J	Moran-Salvador, E; Lopez-Parra, M; Garcia-Alonso, V; Titos, E; Martinez-Clemente, M; Gonzalez-Periz, A; Lopez-Vicario, C; Barak, Y; Arroyo, V; Claria, J				Moran-Salvador, Eva; Lopez-Parra, Marta; Garcia-Alonso, Veronica; Titos, Esther; Martinez-Clemente, Marcos; Gonzalez-Periz, Ana; Lopez-Vicario, Cristina; Barak, Yaacov; Arroyo, Vicente; Claria, Joan			Role for PPAR gamma in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts	FASEB JOURNAL			English	Article						nuclear receptors; liver cells; nonalcoholic fatty liver disease	ACTIVATED RECEPTOR-GAMMA; FATTY LIVER IMPROVEMENT; INSULIN-RESISTANCE; GENE-EXPRESSION; NONALCOHOLIC STEATOHEPATITIS; MOUSE MODEL; MICE; ROSIGLITAZONE; MUSCLE; ALPHA	Peroxisome proliferator-activated receptor (PPAR) gamma is a nuclear receptor central to glucose and lipid homeostasis. PPAR gamma role in nonalcoholic fatty liver disease is controversial because PPAR gamma overexpression is a general property of steatotic livers, but its activation by thiazolidinediones reduces hepatic steatosis. Here, we investigated hepatic PPAR gamma function by using Cre-loxP technology to generate hepatocyte (PPAR gamma(Delta hep))- and macrophage (PPAR gamma(Delta mac))-specific PPAR gamma-knockout mice. Targeted deletion of PPAR gamma in hepatocytes, and to a lesser extent in macrophages, protected mice against high-fat diet-induced hepatic steatosis. Down-regulated expression of genes involved in lipogenesis (SCD1, SREBP-1c, and ACC), lipid transport (CD36/FAT, L-FABP, and MTP), and beta-oxidation (PPAR alpha and ACO) was observed in PPAR gamma(Delta hep) mice. Moreover, PPAR gamma(Delta hep) mice showed improved glucose tolerance and reduced PEPCK expression without changes in Pcx, Fbp1, and G6Pc expression and CREB and JNK phosphorylation. In precision-cut liver slices (PCLSs) and hepatocytes, rosiglitazone either alone or in combination with oleic acid increased triglyceride accumulation, an effect that was blocked by the PPAR gamma antagonist biphenol A diglycidyl ether (BADGE). PCLSs and hepatocytes from PPAR gamma(Delta hep) mice showed blunted responses to rosiglitazone and oleic acid, whereas the response to these compounds remained intact in PCLSs from PPAR gamma(Delta mac) mice. Collectively, these findings establish PPAR gamma expression in hepatocytes as a prosteatotic factor in fatty liver disease.-Moran-Salvador, E., Lopez-Parra, M., Garcia-Alonso, V., Titos, E., Martinez-Clemente, M., Gonzalez-Periz, A., Lopez-Vicario, C., Barak, Y., Arroyo, V., Claria, J. Role for PPAR gamma in obesity-induced hepatic steatosis as determined by hepatocyte-and macrophage-specific conditional knockouts. FASEB J. 25, 2538-2550 (2011). www.fasebj.org	[Moran-Salvador, Eva; Lopez-Parra, Marta; Garcia-Alonso, Veronica; Titos, Esther; Martinez-Clemente, Marcos; Gonzalez-Periz, Ana; Lopez-Vicario, Cristina; Claria, Joan] Univ Barcelona, Hosp Clin, Dept Biochem & Mol Genet, Esther Koplowitz Ctr,IDIBAPS, E-08036 Barcelona, Spain; [Arroyo, Vicente] Univ Barcelona, Hosp Clin, Liver Unit, Esther Koplowitz Ctr,IDIBAPS, E-08036 Barcelona, Spain; [Titos, Esther; Gonzalez-Periz, Ana; Arroyo, Vicente; Claria, Joan] Univ Barcelona, Hosp Clin, Ctr Invest Biomed Red Area Temat Enfermedades Hep, Esther Koplowitz Ctr,IDIBAPS, E-08036 Barcelona, Spain; [Barak, Yaacov] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Claria, J (corresponding author), Univ Barcelona, Hosp Clin, Dept Biochem & Mol Genet, Esther Koplowitz Ctr,IDIBAPS, Villarroel 170, E-08036 Barcelona, Spain.	jclaria@clinic.ub.es	Titos, Esther/AAA-5394-2019; Claria, Joan/M-7772-2019; Arroyo, Vicente/F-9189-2015	Titos, Esther/0000-0002-2543-2243; Arroyo, Vicente/0000-0002-2728-1848; Lopez-Vicario, Cristina/0000-0002-6609-8501; Claria, Joan/0000-0003-4333-7749	Ministerio de Ciencia e Innovacion (MICINN) [SAF 09/08767, AP2007-02004]; Instituto de Salud Carlos III; IDIBAPS	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); IDIBAPS	Supported by a grant from the Ministerio de Ciencia e Innovacion (MICINN; SAF 09/08767). CIBERehd is funded by the Instituto de Salud Carlos III. The authors' laboratory is a consolidated research group recognized by the Generalitat de Catalunya (2009SGR1484). This work was carried out, in part, at the Esther Koplowitz Center (Barcelona, Spain). E.M.-S. (contract AP2007-02004) was supported by MICINN. E.T. and A.G.-P. had contracts with CIBERehd. C.L.-V. and V.G.-A. were supported by IDIBAPS and MICINN, respectively.	Barak Y, 2007, PPAR RES, V2007, DOI 10.1155/2007/12781; Bedoucha M, 2001, J HEPATOL, V35, P17, DOI 10.1016/S0168-8278(01)00066-6; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Ceni E, 2006, GASTROENTEROLOGY, V131, P1235, DOI 10.1053/j.gastro.2006.08.009; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheung O, 2008, SEMIN LIVER DIS, V28, P351, DOI 10.1055/s-0028-1091979; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Edvardsson U, 2006, BIOCHEM BIOPH RES CO, V340, P111, DOI 10.1016/j.bbrc.2005.12.008; Edvardsson U, 1999, J LIPID RES, V40, P1177; Enomoto N, 2003, J PHARMACOL EXP THER, V306, P846, DOI 10.1124/jpet.102.047217; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Klassen LW, 2008, BIOCHEM PHARMACOL, V76, P426, DOI 10.1016/j.bcp.2008.05.012; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Marra F, 2000, GASTROENTEROLOGY, V119, P466, DOI 10.1053/gast.2000.9365; Martinez-Clemente M, 2010, HEPATOLOGY, V51, P817, DOI 10.1002/hep.23463; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Planaguma A, 2005, FASEB J, V19, P1120, DOI 10.1096/fj.04-2753fje; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; Ratziu V, 2008, GASTROENTEROLOGY, V135, P100, DOI 10.1053/j.gastro.2008.03.078; Ratziu V, 2010, HEPATOLOGY, V51, P445, DOI 10.1002/hep.23270; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tsukamoto H, 2008, J GASTROEN HEPATOL, V23, pS104, DOI 10.1111/j.1440-1746.2007.05294.x; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Yu J, 2010, INT J BIOCHEM CELL B, V42, P948, DOI 10.1016/j.biocel.2010.02.006; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200	41	286	294	2	51	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2538	2550		10.1096/fj.10-173716	http://dx.doi.org/10.1096/fj.10-173716			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21507897				2022-12-25	WOS:000293337800005
J	Aran, M; Ferrero, D; Wolosiuk, A; Mora-Garcia, S; Wolosiuk, RA				Aran, Martin; Ferrero, Diego; Wolosiuk, Alejandro; Mora-Garcia, Santiago; Wolosiuk, Ricardo A.			ATP and Mg2+ Promote the Reversible Oligomerization and Aggregation of Chloroplast 2-Cys Peroxiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPAREDOXIN PEROXIDASE; ANTIOXIDANT PROTEIN; CRYSTAL-STRUCTURE; MOLTEN GLOBULE; MODULATION; PHOSPHORYLATION; MECHANISM; 2,2,2-TRIFLUOROETHANOL; REDUCTASE; TOXICITY	2-Cys peroxiredoxins (2-Cys Prxs) are ubiquitous peroxidases with important roles in cellular antioxidant defense and hydrogen peroxide-mediated signaling. Post-translational modifications of conserved cysteines cause the transition from low to high molecular weight oligomers, triggering the functional change from peroxidase to molecular chaperone. However, it remains unclear how non-covalent interactions of 2-Cys Prx with metabolites modulate the quaternary structure. Here, we disclose that ATP and Mg2+ (ATP/Mg) promote the self-polymerization of chloroplast 2-Cys Prx (polypeptide 23.5 kDa) into soluble higher order assemblies (> 2 MDa) that proceed to insoluble aggregates beyond 5mM ATP. Remarkably, the withdrawal of ATP or Mg2+ brings soluble oligomers and insoluble aggregates back to the native conformation without compromising the associated functions. As confirmed by transmission electron microscopy, ATP/Mg drive the toroid-like decamers (diameter 13 nm) to the formation of large sphere-like particles (diameter similar to 30 nm). Circular dichroism studies on ATP-labeled 2-Cys Prx reveal that ATP/Mg enhance the proportion of beta-sheets with the concurrent decrease in the content of alpha-helices. In line with this observation, the formation of insoluble aggregates is strongly prevented by 2,2,2-trifluoroethanol, a cosolvent employed to induce alpha-helical conformations. We further find that the response of self-polymerization to ATP/Mg departs abruptly from that of the associated peroxidase and chaperone activities when two highly conserved residues, Arg(129) and Arg(152), are mutated. Collectively, our data uncover that non-covalent interactions of ATP/Mg with 2-Cys Prx modulate dynamically the quaternary structure, thereby coupling the non-redox chemistry of cell energy with redox transformations at cysteine residues.	[Aran, Martin; Ferrero, Diego; Mora-Garcia, Santiago; Wolosiuk, Ricardo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Invest Bioquim Buenos Aires, Consejo Nacl Invest Cient & Tecn,Inst Leloir,Dept, RA-1053 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Wolosiuk, RA (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Invest Bioquim Buenos Aires, Consejo Nacl Invest Cient & Tecn,Inst Leloir,Dept, Patricias Argentinas 435,C1405BWE Buenos Aires, RA-1053 Buenos Aires, DF, Argentina.	rwolosiuk@leloir.org.ar	Ferrero, Diego Sebastian/ABI-6041-2020; Aran, Martin/N-2095-2019	Ferrero, Diego Sebastian/0000-0001-6848-9939; Wolosiuk, Alejandro/0000-0003-0854-9949	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Universidad de Buenos Aires	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This study was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) and Universidad de Buenos Aires.	Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Aran M, 2008, FEBS J, V275, P1450, DOI 10.1111/j.1742-4658.2008.06299.x; Aran M, 2009, FEBS J, V276, P2478, DOI 10.1111/j.1742-4658.2009.06984.x; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Bemporad F, 2006, ACCOUNTS CHEM RES, V39, P620, DOI 10.1021/ar050067x; Caporaletti D, 2007, BIOCHEM BIOPH RES CO, V355, P722, DOI 10.1016/j.bbrc.2007.02.013; Carulla N, 2010, ACCOUNTS CHEM RES, V43, P1072, DOI 10.1021/ar9002784; Cha MK, 2000, BIOCHEMISTRY-US, V39, P6944, DOI 10.1021/bi000034j; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chauhan R, 2001, BIOCHEM J, V354, P209, DOI 10.1042/0264-6021:3540209; Chellgren BW, 2006, J MOL BIOL, V361, P362, DOI 10.1016/j.jmb.2006.06.044; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Copley SD, 2004, BIOCHEMISTRY-US, V43, P13981, DOI 10.1021/bi048947r; Dietz KJ, 2010, NEW PHYTOL, V188, P919, DOI 10.1111/j.1469-8137.2010.03502.x; Duek PD, 2001, BBA-PROTEIN STRUCT M, V1546, P299, DOI 10.1016/S0167-4838(01)00150-9; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Flohe L, 2002, ARCH BIOCHEM BIOPHYS, V397, P324, DOI 10.1006/abbi.2001.2688; Gestwicki JE, 2001, ANAL CHEM, V73, P5732, DOI 10.1021/ac0105888; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Harris JR, 2001, BBA-PROTEIN STRUCT M, V1547, P221, DOI 10.1016/S0167-4838(01)00184-4; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jayaraman G, 1996, BIOCHEM BIOPH RES CO, V222, P33, DOI 10.1006/bbrc.1996.0693; KAUR P, 1993, J BACTERIOL, V175, P351, DOI 10.1128/JB.175.2.351-357.1993; KIERDASZUK B, 1988, BIOCHEMISTRY-US, V27, P4952, DOI 10.1021/bi00413a054; Kitano K, 1999, J BIOCHEM, V126, P313, DOI 10.1093/oxfordjournals.jbchem.a022451; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Konig J, 2002, P NATL ACAD SCI USA, V99, P5738, DOI 10.1073/pnas.072644999; Kristensen P, 1999, BIOCHEM BIOPH RES CO, V262, P127, DOI 10.1006/bbrc.1999.1107; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Kumsta C, 2009, BIOCHEMISTRY-US, V48, P4666, DOI 10.1021/bi9003556; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Meissner U, 2007, MICRON, V38, P29, DOI 10.1016/j.micron.2006.04.010; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Montemartini M, 1999, EUR J BIOCHEM, V264, P516, DOI 10.1046/j.1432-1327.1999.00656.x; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Mora-Garcia S., 2005, CONTROL PRIMARY META, V22, P150; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Muthuramalingam M, 2009, MOL PLANT, V2, P1273, DOI 10.1093/mp/ssp089; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Noguera-Mazon V, 2006, PHOTOSYNTH RES, V89, P277, DOI 10.1007/s11120-006-9106-4; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Poole Leslie B., 2007, V44, P61; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Scheibel T., 2005, PROTEIN FOLDING HD 2, P197; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Schuck P., 1999, CURR PROTOC PROTEIN, V3, P2021; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065; Soito L, 2011, NUCLEIC ACIDS RES, V39, pD332, DOI 10.1093/nar/gkq1060; Sota H, 1998, ANAL CHEM, V70, P2019, DOI 10.1021/ac9713666; Starzyk A, 2005, BIOCHEMISTRY-US, V44, P369, DOI 10.1021/bi0481444; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Winzor DJ, 2003, ANAL BIOCHEM, V318, P1, DOI 10.1016/S0003-2697(03)00133-7; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905	67	5	5	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23441	23451		10.1074/jbc.M111.239434	http://dx.doi.org/10.1074/jbc.M111.239434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21525006	Green Published, hybrid			2022-12-25	WOS:000292025000075
J	Li, GF; Xu, YD; Guan, DY; Liu, ZS; Liu, DX				Li, Guangfu; Xu, Yidi; Guan, Dongyin; Liu, Zhengshan; Liu, David X.			HSP70 Protein Promotes Survival of C6 and U87 Glioma Cells by Inhibition of ATF5 Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR; HEAT-SHOCK-PROTEIN-70 HSP70; CHAPERONE ACTIVITY; INDUCED APOPTOSIS; MESSENGER-RNA; STRESS; EXPRESSION; BINDING; GLIOBLASTOMA	Although both the heat shock protein 70 (HSP70) and the activating transcription factor 5 (ATF5) have been shown to promote cell survival of transformed cells but not survival of non-transformed cells, the relationship of the two molecules is unknown. Here we show that HSP70 and ATF5 are concomitantly up-regulated upon transient but down-regulated over prolonged cellular stress and apoptotic stimulation in the rat C6 glioma and human U87 glioma cells. HSP70 interacts strongly with the N-terminal activation domain of ATF5, which is expected to be rigid and uniquely structured under physiological conditions because of extraordinary high concentration (over 25%) of proline residues. Binding of HSP70 to ATF5 is an ATP-driven process and requires functional ATPase on the nucleotide binding domain of the HSP70 molecule. Overexpression of HSP70 dramatically stabilizes the ATF5 protein, which is otherwise subject to rapid degradation, facilitated by both proteasome-dependent and caspase-dependent processes, whereas HSP70 depletion leads to acceleration of ATF5 degradation and transcription repression of Bcl-2 and Egr-1, which are down-stream targets of ATF5 in C6 and U87 glioma cells. Our data reveal an essential role for HSP70 in maintaining high levels of ATF5 expression in glioma cells and support the conclusion that ATF5 is an important substrate protein of HSP70 that mediates HSP70-promoted cell survival in glioma cells.	[Li, Guangfu; Xu, Yidi; Guan, Dongyin; Liu, Zhengshan; Liu, David X.] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA; [Liu, David X.] Penn State Univ, Penn State Canc Inst, Coll Med, Hershey, PA 17033 USA; [Liu, David X.] Penn State Univ, Penn State Hershey Neurosci Inst, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Liu, DX (corresponding author), C3710,500 Univ Dr, Hershey, PA 17033 USA.	dliu@psu.edu		Li, Guangfu/0000-0002-9817-568X	American Cancer Society; United States Department of Defense	American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense)	This work was supported by grants from the American Cancer Society and the United States Department of Defense (to D.X.L.).	Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; Buzzard KA, 1998, J BIOL CHEM, V273, P17147, DOI 10.1074/jbc.273.27.17147; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chuang HC, 2008, AM J PATHOL, V173, P1397, DOI 10.2353/ajpath.2008.080440; Ciaccio NA, 2009, MOL PHARMACEUT, V6, P1205, DOI 10.1021/mp900058t; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Dluzen D, 2011, J BIOL CHEM, V286, P7705, DOI 10.1074/jbc.M110.207639; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Garcia-Morales P, 2007, ONCOGENE, V26, P7185, DOI 10.1038/sj.onc.1210534; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jiang BM, 2010, FEBS J, V277, P642, DOI 10.1111/j.1742-4658.2009.07510.x; Jung JH, 2010, J CELL PHYSIOL, V223, P408, DOI 10.1002/jcp.22049; Li GF, 2009, MOL CANCER RES, V7, P933, DOI 10.1158/1541-7786.MCR-08-0365; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mao HP, 2003, J BIOL CHEM, V278, P18214, DOI 10.1074/jbc.M300126200; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Nylandsted J, 2002, CANCER RES, V62, P7139; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Pati D, 1999, MOL CELL BIOL, V19, P5001; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Robins H Ian, 2007, Curr Oncol Rep, V9, P66, DOI 10.1007/BF02951428; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Seo JS, 1996, BIOCHEM BIOPH RES CO, V218, P582, DOI 10.1006/bbrc.1996.0103; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Uekusa H, 2009, BIOCHEM BIOPH RES CO, V380, P673, DOI 10.1016/j.bbrc.2009.01.158; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Watatani Y, 2007, LIFE SCI, V80, P879, DOI 10.1016/j.lfs.2006.11.013; WEI YQ, 1995, CANCER IMMUNOL IMMUN, V40, P73, DOI 10.1007/s002620050146; Wei YY, 2008, J BIOL CHEM, V283, P18773, DOI 10.1074/jbc.M707879200; Wei YY, 2010, J BIOCHEM, V148, P171, DOI 10.1093/jb/mvq047; Xanthoudakis S, 2000, NAT CELL BIOL, V2, pE163, DOI 10.1038/35023643; Yang JW, 2009, FEBS LETT, V583, P1409, DOI 10.1016/j.febslet.2009.04.011; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	49	44	47	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20251	20259		10.1074/jbc.M110.211771	http://dx.doi.org/10.1074/jbc.M110.211771			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21521685	Green Published, hybrid			2022-12-25	WOS:000291267600012
J	Balasubramanian, S; Fan, MY; Messmer-Blust, AF; Yang, CH; Trendel, JA; Jeyaratnam, JA; Pfeffer, LM; Vestal, DJ				Balasubramanian, Sujata; Fan, Meiyun; Messmer-Blust, Angela F.; Yang, Chuan H.; Trendel, Jill A.; Jeyaratnam, Jonathan A.; Pfeffer, Lawrence M.; Vestal, Deborah J.			The Interferon-gamma-induced GTPase, mGBP-2, Inhibits Tumor Necrosis Factor alpha(TNF-alpha) Induction of Matrix Metalloproteinase-9 (MMP-9) by Inhibiting NF-kappa B and Rac Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY FACTOR-I; FACTOR-ALPHA; MATRIX METALLOPROTEINASES; IFN-GAMMA; TNF-ALPHA; GELATINASE-B; ENDOTHELIAL-CELLS; EXPRESSION; ACTIVATION; BINDING	Matrix metalloproteinase-9 (MMP-9) is important in numerous normal and pathological processes, including the angiogenic switch during tumor development and tumor metastasis. Whereas TNF-alpha and other cytokines up-regulate MMP-9 expression, interferons (IFNs) inhibit MMP-9 expression. We found that IFN-gamma treatment or forced expression of the IFN-induced GTPase, mGBP-2, inhibit TNF-alpha-induced MMP-9 expression in NIH 3T3 fibroblasts, by inhibiting MMP-9 transcription. The NF-kappa B transcription factor is required for full induction of MMP-9 by TNF-alpha. Both IFN-gamma and mGBP-2 inhibit the transcription of a NF-kappa B-dependent reporter construct, suggesting that mGBP-2 inhibits MMP-9 induction via inhibition of NF-kappa B-mediated transcription. Interestingly, mGBP-2 does not inhibit TNF-alpha-induced degradation of I kappa B alpha or p65/RelA translocation into the nucleus. However, mGBP-2 inhibits p65 binding to a kappa B oligonucleotide probe in gel shift assays and to the MMP-9 promoter in chromatin immunoprecipitation assays. In addition, TNF-alpha activation of NF-kappa B in NIH 3T3 cells is dependent on Rac activation, as evidenced by the inhibition of TNF-alpha induction of NF-kappa B-mediated transcription by a dominant inhibitory form of Rac1. A role for Rac in the inhibitory action of mGBP-2 on NF-kappa B is further shown by the findings that mGBP-2 inhibits TNF-alpha activation of endogenous Rac and constitutively activate Rac can restore NF-kappa B transcription in the presence of mGBP-2. This is a novel mechanism by which IFNs can inhibit the cytokine induction of MMP-9 expression.	[Balasubramanian, Sujata; Messmer-Blust, Angela F.; Trendel, Jill A.; Jeyaratnam, Jonathan A.; Vestal, Deborah J.] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Fan, Meiyun; Yang, Chuan H.; Pfeffer, Lawrence M.] Univ Tennessee, Hlth Sci Ctr, Dept Pathol, Memphis, TN 38163 USA	University System of Ohio; University of Toledo; University of Tennessee System; University of Tennessee Health Science Center	Vestal, DJ (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	Deborah.Vestal@utoledo.edu		Pfeffer, Lawrence/0000-0003-2809-1234; Messmer-Blust, Angela/0000-0001-9582-5301	American Cancer Society [RPM-CIM-88031]; National Institutes of Health [CA73753]; Muirhead Chair Endowment; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA140346, R01CA073753] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muirhead Chair Endowment; University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the American Cancer Society (RPM-CIM-88031) (to D. J. V.), National Institutes of Health Grant CA73753, and funds from the Muirhead Chair Endowment and the University of Tennessee Health Science Center (to L. M. P.).	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; AUSUBEL FM, 1989, PREPARATION ANAL DNA; Bachmeier BE, 2001, ANTICANCER RES, V21, P3821; Balasubramanian S, 2006, CELL MOL BIOL, V52, P43, DOI 10.1170/T696; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Bauvois B, 2002, LEUKEMIA, V16, P791, DOI 10.1038/sj.leu.2402472; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; Boyer L, 2004, MOL BIOL CELL, V15, P1124, DOI 10.1091/mbc.E03-05-0301; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; Chen BC, 2009, MOL IMMUNOL, V46, P1179, DOI 10.1016/j.molimm.2008.11.006; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Friedland JC, 2007, J CELL SCI, V120, P3700, DOI 10.1242/jcs.03484; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Gorbacheva VY, 2002, J BIOL CHEM, V277, P6080, DOI 10.1074/jbc.M110542200; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Han YP, 2001, J BIOL CHEM, V276, P22341, DOI 10.1074/jbc.M010839200; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Karabudak R, 2004, J NEUROL, V251, P279, DOI 10.1007/s00415-004-0285-7; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kim BC, 1999, J BIOL CHEM, V274, P24372, DOI 10.1074/jbc.274.34.24372; Kroger A, 2003, ONCOGENE, V22, P1045, DOI 10.1038/sj.onc.1206260; Kupferman ME, 2000, AM J PATHOL, V157, P1777, DOI 10.1016/S0002-9440(10)64815-8; Leber TM, 1998, BRIT J CANCER, V78, P724, DOI 10.1038/bjc.1998.568; Liao JH, 2003, J BIOL CHEM, V278, P31871, DOI 10.1074/jbc.M301931200; MA Z, 2005, J LEUKOCYTE BIOL, V78, P512; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Migita K, 2006, LIFE SCI, V78, P2510, DOI 10.1016/j.lfs.2005.10.003; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Nelissen I, 2002, J LEUKOCYTE BIOL, V71, P89; Nguyen J, 2005, FEBS LETT, V579, P5487, DOI 10.1016/j.febslet.2005.09.012; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Tensen CP, 1999, BBA-GENE STRUCT EXPR, V1446, P167, DOI 10.1016/S0167-4781(99)00084-6; Tsuruda T, 2004, HEART FAIL REV, V9, P53, DOI 10.1023/B:HREV.0000011394.34355.bb; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Vestal DJ, 1998, J INTERF CYTOK RES, V18, P977, DOI 10.1089/jir.1998.18.977; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Vestal DJ, 2005, J INTERF CYTOK RES, V25, P435, DOI 10.1089/jir.2005.25.435; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang TN, 2002, SURGERY, V132, P220, DOI 10.1067/msy.2002.125353; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; Woo CH, 2004, J IMMUNOL, V173, P6973, DOI 10.4049/jimmunol.173.11.6973; Wu AJ, 1997, J CELL PHYSIOL, V171, P117, DOI 10.1002/(SICI)1097-4652(199705)171:2<117::AID-JCP1>3.0.CO;2-R; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057; Yang CH, 2007, J IMMUNOL, V178, P986, DOI 10.4049/jimmunol.178.2.986; Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353; Yim JH, 2003, J INTERF CYTOK RES, V23, P501, DOI 10.1089/10799900360708623; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Yushchenko M, 2003, J NEUROL, V250, P1224, DOI 10.1007/s00415-003-0191-4; Zhou M, 2003, J BIOL CHEM, V278, P45406, DOI 10.1074/jbc.M309075200	70	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					20054	20064		10.1074/jbc.M111.249326	http://dx.doi.org/10.1074/jbc.M111.249326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21502320	hybrid, Green Published			2022-12-25	WOS:000291027700082
J	Haque, U; Sunahara, T; Hashizume, M; Shields, T; Yamamoto, T; Haque, R; Glass, GE				Haque, Ubydul; Sunahara, Toshihiko; Hashizume, Masahiro; Shields, Timothy; Yamamoto, Taro; Haque, Rashidul; Glass, Gregory E.			Malaria Prevalence, Risk Factors and Spatial Distribution in a Hilly Forest Area of Bangladesh	PLOS ONE			English	Article								Background: Malaria is a major public health concern in Bangladesh and it is highly endemic in the Chittagong Hill Tracts where prevalence was 11.7% in 2007. One sub-district, Rajasthali, had a prevalence of 36%. Several interventions were introduced in early 2007 to control malaria. This study was undertaken to evaluate the impacts of these intensive early stage interventions on malaria in Bangladesh. This prevalence study assesses whether or not high malaria prevalence remains, and if so, which areas and individuals remain at high risk of infection. Methods and Principal Findings: A 2-stage cluster sampling technique was used to sample 1,400 of 5,322 (26.3%) households in Rajasthali, and screened using a rapid diagnostic test (Falci-vax). Overall malaria prevalence was 11.5%. The proportions of Plasmodium falciparum, Plasmodium vivax and infection with both species were 93.2%, 1.9% and 5.0%, respectively. Univariate, multivariate logistic regression, and spatial cluster analyses were performed separately. Sex, age, number of bed nets, forest cover, altitude and household density were potential risk factors. A statistically significant malaria cluster was identified. Significant differences among risk factors were observed between cluster and non-cluster areas. Conclusion and Significance: Malaria has significantly decreased within 2 years after onset of intervention program. Both aspects of the physical and social environment, as well as demographic characteristics are associated with spatial heterogeneity of risk. The ability to identify and locate these areas provides a strategy for targeting interventions during initial stages of intervention programs. However, in high risk clusters of transmission, even extensive coverage by current programs leaves transmission ongoing at reduced levels. This indicates the need for continued development of new strategies for identification and treatment as well as improved understanding of the patterns and determinants of parasitaemia.	[Haque, Ubydul; Haque, Rashidul] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Haque, Ubydul; Sunahara, Toshihiko; Hashizume, Masahiro; Yamamoto, Taro] Nagasaki Univ, Dept Int Hlth, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Haque, Ubydul; Sunahara, Toshihiko; Hashizume, Masahiro; Yamamoto, Taro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Shields, Timothy; Glass, Gregory E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); Nagasaki University; Nagasaki University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Haque, U (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	uhicddrb@yahoo.com		Hashizume, Masahiro/0000-0003-4720-1750	ICDDR,B; Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	ICDDR,B; Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by ICDDR,B and its donors which provide unrestricted support to ICDDR,B for its operations and research. Current donors providing unrestricted support include: Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The authors gratefully acknowledge these donors for their support and commitment to ICDDR,B's research efforts. TS and GG were supported by the Johns Hopkins Malaria Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Alam MS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-15; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Dysoley L, 2008, ACTA TROP, V106, P207, DOI 10.1016/j.actatropica.2007.01.007; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Garros C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-11; Haque U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-156; Haque U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-120; Haque U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006737; JASMIN A, 2010, MALAR J S2, V9, pP2; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; *M PDC, 2009, MAL COUNTR REP BANGL; *M PDC, 2010, MAL COUNTR REP BAN 2; Maude Richard J, 2008, Bangladesh Med Res Counc Bull, V34, P87; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Rahman A, 2006, AM J TROP MED HYG, V74, P17, DOI 10.4269/ajtmh.2006.74.17; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P183, DOI 10.4269/ajtmh.1982.31.183; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; Sintasath DM, 2005, AM J TROP MED HYG, V72, P682, DOI 10.4269/ajtmh.2005.72.682; UBYDUL H, 2010, PLOS ONE, V5; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization, 2004, US MAL RAP DIAGN TES; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5	25	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18908	10.1371/journal.pone.0018908	http://dx.doi.org/10.1371/journal.pone.0018908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533048	gold, Green Submitted, Green Published			2022-12-25	WOS:000290014500016
J	Guinane, CM; Kent, RM; Norberg, S; Hill, C; Fitzgerald, GF; Stanton, C; Ross, RP				Guinane, Caitriona M.; Kent, Robert M.; Norberg, Sarah; Hill, Colin; Fitzgerald, Gerald F.; Stanton, Catherine; Ross, R. Paul			Host Specific Diversity in Lactobacillus johnsonii as Evidenced by a Major Chromosomal Inversion and Phage Resistance Mechanisms	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GENOME SEQUENCE; IDENTIFICATION; EVOLUTION; REVEALS; STRAINS; NCC533; LA1; COMBINATION; ANNOTATION	Genetic diversity and genomic rearrangements are a driving force in bacterial evolution and niche adaptation. We sequenced and annotated the genome of Lactobacillus johnsonii DPC6026, a strain isolated from the porcine intestinal tract. Although the genome of DPC6026 is similar in size (1.97mbp) and GC content (34.8%) to the sequenced human isolate L. johnsonii NCC 533, a large symmetrical inversion of approximately 750 kb differentiated the two strains. Comparative analysis among 12 other strains of L. johnsonii including 8 porcine, 3 human and 1 poultry isolate indicated that the genome architecture found in DPC6026 is more common within the species than that of NCC 533. Furthermore a number of unique features were annotated in DPC6026, some of which are likely to have been acquired by horizontal gene transfer (HGT) and contribute to protection against phage infection. A putative type III restriction-modification system was identified, as were novel Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) elements. Interestingly, these particular elements are not widely distributed among L. johnsonii strains. Taken together these data suggest intra-species genomic rearrangements and significant genetic diversity within the L. johnsonii species and indicate towards a host-specific divergence of L. johnsonii strains with respect to genome inversion and phage exposure.	[Guinane, Caitriona M.; Kent, Robert M.; Stanton, Catherine; Ross, R. Paul] TEAGASC, Food Res Ctr, Food Biosci Dept, Cork, Ireland; [Kent, Robert M.; Norberg, Sarah; Hill, Colin; Fitzgerald, Gerald F.; Ross, R. Paul] Univ Coll, Dept Microbiol, Cork, Ireland; [Hill, Colin; Fitzgerald, Gerald F.; Stanton, Catherine; Ross, R. Paul] Univ Coll, Alimentary Pharmabiot Ctr, Cork, Ireland	Teagasc; University College Cork; University College Cork	Guinane, CM (corresponding author), TEAGASC, Food Res Ctr, Food Biosci Dept, Cork, Ireland.	paul.ross@teagasc.ie	Hill, Colin/A-5611-2012; Stanton, Catherine/A-9549-2015; Ross, Paul/A-7584-2015	Hill, Colin/0000-0002-8527-1445; Stanton, Catherine/0000-0002-6724-7011; Ross, Paul/0000-0003-4876-8839; Guinane, Caitriona/0000-0001-8215-1387	Enterprise Ireland commercialisation fund [CFTD/07/116]; Teagasc Walsh Fellowship	Enterprise Ireland commercialisation fund; Teagasc Walsh Fellowship	This work was funded by an Enterprise Ireland commercialisation fund CFTD/07/116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge E. Barrett for technical assistance. R. Kent is in receipt of a Teagasc Walsh Fellowship. We also gratefully acknowledge the use of the Nestle NCC 533 strain.	Achaz G, 2003, GENETICS, V164, P1279; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Altermann Eric, 2003, OMICS A Journal of Integrative Biology, V7, P161, DOI 10.1089/153623103322246557; Azcarate-Peril MA, 2008, APPL ENVIRON MICROB, V74, P4610, DOI 10.1128/AEM.00054-08; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Berger B, 2007, J BACTERIOL, V189, P1311, DOI 10.1128/JB.01393-06; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; BernetCamard MF, 1997, APPL ENVIRON MICROB, V63, P2747, DOI 10.1128/AEM.63.7.2747-2753.1997; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; Callanan M, 2008, J BACTERIOL, V190, P727, DOI 10.1128/JB.01295-07; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Canchaya C, 2006, MICROBIOL-SGM, V152, P3185, DOI 10.1099/mic.0.29140-0; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casey PG, 2007, APPL ENVIRON MICROB, V73, P1858, DOI 10.1128/AEM.01840-06; Claesson MJ, 2006, P NATL ACAD SCI USA, V103, P6718, DOI 10.1073/pnas.0511060103; Darling Aaron E., 2007, V396, P135; Daveran-Mingot ML, 1998, J BACTERIOL, V180, P4834, DOI 10.1128/JB.180.18.4834-4842.1998; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Denou E, 2008, J BACTERIOL, V190, P5806, DOI 10.1128/JB.01802-07; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Haller D, 2000, GUT, V47, P79, DOI 10.1136/gut.47.1.79; Hayes A, 2006, APPL ENVIRON MICROB, V72, P2260, DOI 10.1128/AEM.72.3.2260-2264.2006; HILL CW, 1988, GENETICS, V119, P771; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Ibnou-Zekri N, 2003, INFECT IMMUN, V71, P428, DOI 10.1128/IAI.71.1.428-436.2003; Inoue R, 2007, FEMS IMMUNOL MED MIC, V50, P67, DOI 10.1111/j.1574-695X.2007.00233.x; Kaburagi T, 2007, NUTRITION, V23, P342, DOI 10.1016/j.nut.2007.02.001; Klaenhammer T, 2002, ANTON LEEUW INT J G, V82, P29, DOI 10.1023/A:1020638309912; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; La Ragione RM, 2004, LETT APPL MICROBIOL, V38, P197, DOI 10.1111/j.1472-765X.2004.01474.x; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Morita H, 2008, DNA RES, V15, P151, DOI 10.1093/dnares/dsn009; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Neeser JR, 2000, GLYCOBIOLOGY, V10, P1193, DOI 10.1093/glycob/10.11.1193; O'Shea EF, 2009, FEMS MICROBIOL LETT, V291, P24, DOI 10.1111/j.1574-6968.2008.01427.x; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Rozen S, 2000, Methods Mol Biol, V132, P365; Schatz MC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r34; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Ventura M, 2004, VIROLOGY, V320, P229, DOI 10.1016/j.virol.2003.11.034; Ventura M, 2003, J BACTERIOL, V185, P4603, DOI 10.1128/JB.185.15.4603-4608.2003; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wegmann U, 2009, J BACTERIOL, V191, P7142, DOI 10.1128/JB.01182-09; Zhang ZG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-1	61	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18740	10.1371/journal.pone.0018740	http://dx.doi.org/10.1371/journal.pone.0018740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533100	Green Published, Green Submitted, gold			2022-12-25	WOS:000289719400022
J	Akca, S; Foroughi, A; Frochtzwajg, D; Postma, HWC				Akca, Saliha; Foroughi, Ashkan; Frochtzwajg, Daniel; Postma, Henk W. Ch.			Competing Interactions in DNA Assembly on Graphene	PLOS ONE			English	Article							ORIENTED PYROLYTIC-GRAPHITE; ATOMIC-FORCE MICROSCOPY; WALLED CARBON NANOTUBES; SINGLE-STRANDED-DNA; ELECTRODE SURFACE; HOPG ELECTRODE; ADSORPTION; BINDING	We study the patterns that short strands of single-stranded DNA form on the top graphene surface of graphite. We find that the DNA assembles into two distinct patterns, small spherical particles and elongated networks. Known interaction models based on DNA-graphene binding, hydrophobic interactions, or models based on the purine/pyrimidine nature of the bases do not explain our observed crossover in pattern formation. We argue that the observed assembly behavior is caused by a crossover in the competition between base-base pi stacking and base-graphene pi stacking and we infer a critical crossover energy of 0.3-0.5 eV. The experiments therefore provide a projective measurement of the base-base interaction strength.	[Akca, Saliha; Foroughi, Ashkan; Frochtzwajg, Daniel; Postma, Henk W. Ch.] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA	California State University System; California State University Northridge	Akca, S (corresponding author), Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA.	postma@csun.edu	Postma, Henk W.Ch./A-8770-2014	Postma, Henk/0000-0003-4349-9406	National Science Foundation [DMR-1034937]; Division Of Materials Research [1034937] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors acknowledge financial support from the National Science Foundation under award DMR-1034937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcik J, 2006, FEBS LETT, V580, P5671, DOI 10.1016/j.febslet.2006.09.017; Antony J, 2008, PHYS CHEM CHEM PHYS, V10, P2722, DOI 10.1039/b718788b; Brett AMO, 2005, BIOELECTROCHEMISTRY, V66, P117, DOI 10.1016/j.bioelechem.2004.05.009; Brett AMO, 2003, LANGMUIR, V19, P3830, DOI 10.1021/la027047d; Brett AMO, 2003, ELECTROCHEM COMMUN, V5, P178, DOI 10.1016/S1388-2481(03)00014-6; Paquim AMC, 2006, BIOPHYS CHEM, V121, P131, DOI 10.1016/j.bpc.2005.12.017; Gorodetsky AA, 2006, LANGMUIR, V22, P7917, DOI 10.1021/la0611054; Gowtham S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.033401; Jeng ES, 2006, NANO LETT, V6, P371, DOI 10.1021/nl051829k; Manohar S, 2008, NANO LETT, V8, P4365, DOI 10.1021/nl8022143; Mascini M, 2001, FRESEN J ANAL CHEM, V369, P15, DOI 10.1007/s002160000629; Matta CF, 2006, J PHYS CHEM B, V110, P563, DOI 10.1021/jp054986g; Mohanty N, 2008, NANO LETT, V8, P4469, DOI 10.1021/nl802412n; Murakami H, 2003, CHEM PHYS LETT, V378, P481, DOI 10.1016/S0009-2614(03)01329-0; Paquim AMC, 2006, ELECTROCHIM ACTA, V51, P5037, DOI 10.1016/j.electacta.2006.03.041; Penazova H, 1997, BIOPHYS J, V73, P2054, DOI 10.1016/S0006-3495(97)78235-3; Postma HWC, 2010, NANO LETT, V10, P420, DOI 10.1021/nl9029237; Postma HWC, 2000, ADV MATER, V12, P1299, DOI 10.1002/1521-4095(200009)12:17<1299::AID-ADMA1299>3.0.CO;2-O; Saenger W., 1984, PRINCIPLES NUCL ACID; Star A, 2006, P NATL ACAD SCI USA, V103, P921, DOI 10.1073/pnas.0504146103; Tang LAL, 2010, J AM CHEM SOC, V132, P10976, DOI 10.1021/ja104017y; Tang ZW, 2010, SMALL, V6, P1205, DOI 10.1002/smll.201000024; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911	25	78	79	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18442	10.1371/journal.pone.0018442	http://dx.doi.org/10.1371/journal.pone.0018442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532757	Green Published, gold			2022-12-25	WOS:000289404700013
J	Lutz, S; Tubert-Brohman, I; Yang, YG; Meuwly, M				Lutz, Stephan; Tubert-Brohman, Ivan; Yang, Yonggang; Meuwly, Markus			Water-assisted Proton Transfer in Ferredoxin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MOLECULAR-DYNAMICS SIMULATION; AB-INITIO; INTERNAL WATER; THEORETICAL INVESTIGATIONS; CARBONIC-ANHYDRASE; ELECTRON-TRANSFER; 3FE-4S CLUSTER; FORCE-FIELDS; PROTEIN	The role of water molecules in assisting proton transfer (PT) is investigated for the proton-pumping protein ferredoxin I (FdI) from Azotobacter vinelandii. It was shown previously that individual water molecules can stabilize between Asp(15) and the buried [3Fe-4S](0) cluster and thus can potentially act as a proton relay in transferring H+ from the protein to the mu(2) sulfur atom. Here, we generalize molecular mechanics with proton transfer to studying proton transfer reactions in the condensed phase. Both umbrella sampling simulations and electronic structure calculations suggest that the PT Asp(15)-COOH + H2O + [3Fe-4S](0) -> Asp(15)-COO- + H2O + [3Fe-4S](0) H+ is concerted, and no stable intermediate hydronium ion (H3O+) is expected. The free energy difference of 11.7 kcal/mol for the forward reaction is in good agreement with the experimental value (13.3 kcal/mol). For the reverse reaction (Asp(15)-COO- + H2O + [3Fe-4S]H-0(+) -> Asp(15)-COOH + H2O + [3Fe-4S](0)), a larger barrier than for the forward reaction is correctly predicted, but it is quantitatively overestimated (23.1 kcal/mol from simulations versus 14.1 from experiment). Possible reasons for this discrepancy are discussed. Compared with the water-assisted process (Delta E approximate to 10 kcal/mol), water-unassisted proton transfer yields a considerably higher barrier of Delta E approximate to 35 kcal/mol.	[Lutz, Stephan; Tubert-Brohman, Ivan; Yang, Yonggang; Meuwly, Markus] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	University of Basel	Meuwly, M (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.	m.meuwly@unibas.ch	Yang, Yonggang/A-9863-2012	Yang, Yonggang/0000-0003-3711-2842	Schweizerischer National Fonds [200021-117810]; National Center of Competence in Research - Molecular Ultrafast Science and Technology; European Commission [MIF1-CT2006-039088]	Schweizerischer National Fonds(Swiss National Science Foundation (SNSF)); National Center of Competence in Research - Molecular Ultrafast Science and Technology; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Schweizerischer National Fonds through Projects 200021-117810 and the National Center of Competence in Research - Molecular Ultrafast Science and Technology (to M.M.).; Supported by a Marie Curie Fellowship (MIF1-CT2006-039088) from the European Commission.	BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Bala P, 1996, J PHYS CHEM-US, V100, P2535, DOI 10.1021/jp952642s; Banushkina P, 2005, J PHYS CHEM B, V109, P16911, DOI 10.1021/jp051938n; BASH PA, 1987, J AM CHEM SOC, V109, P8092, DOI 10.1021/ja00260a028; Belevich I, 2006, NATURE, V440, P829, DOI 10.1038/nature04619; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; BERG JM, 2002, BIOCHEMISTRY-US, P96; Bolhuis PG, 2005, BIOPHYS J, V88, P50, DOI 10.1529/biophysj.104.048744; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUSCHI M, 1988, FEMS MICROBIOL LETT, V54, P155, DOI 10.1111/j.1574-6968.1988.tb02741.x; Camba R, 2003, BIOCHEMISTRY-US, V42, P10589, DOI 10.1021/bi035021v; CHAN SI, 1990, BIOCHEMISTRY-US, V29, P1, DOI 10.1021/bi00453a001; CHANDRASEKHAR I, 1992, J MOL BIOL, V226, P239, DOI 10.1016/0022-2836(92)90136-8; Chen KS, 2000, NATURE, V405, P814, DOI 10.1038/35015610; Cheng HP, 1996, J CHEM PHYS, V105, P6844, DOI 10.1063/1.471979; Cherepanov DA, 2001, BBA-BIOENERGETICS, V1505, P179, DOI 10.1016/S0005-2728(01)00162-1; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P5671, DOI 10.1021/bi00476a004; Cui Q, 2003, J PHYS CHEM B, V107, P1071, DOI 10.1021/jp021931v; Dai J, 2003, J CHEM PHYS, V119, P6571, DOI 10.1063/1.1603220; Day TJF, 2000, J AM CHEM SOC, V122, P12027, DOI 10.1021/ja002506n; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DU M, 1993, BIOPHYS CHEM, V48, P101, DOI 10.1016/0301-4622(93)85002-Y; ERNST JA, 1995, SCIENCE, V267, P1813, DOI 10.1126/science.7892604; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; Fischer S, 1999, P NATL ACAD SCI USA, V96, P9613, DOI 10.1073/pnas.96.17.9613; Friedman R, 2007, J PHYS CHEM B, V111, P6059, DOI 10.1021/jp070781r; Frisch M., 2016, GAUSSIAN 16 REVISION; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Geissler PL, 2000, CHEM PHYS LETT, V321, P225, DOI 10.1016/S0009-2614(00)00381-X; Gennis RB, 1998, P NATL ACAD SCI USA, V95, P12747, DOI 10.1073/pnas.95.22.12747; Gottschalk M, 2001, J MOL BIOL, V311, P605, DOI 10.1006/jmbi.2001.4895; Hirst J, 1998, J AM CHEM SOC, V120, P7085, DOI 10.1021/ja980380c; Im S, 1998, EUR J BIOCHEM, V258, P465, DOI 10.1046/j.1432-1327.1998.2580465.x; Iwata T, 2009, BIOCHEMISTRY-US, V48, P1220, DOI 10.1021/bi801990s; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kadirvelraj R, 2008, J AM CHEM SOC, V130, P16933, DOI 10.1021/ja8039663; Kaledin M, 2006, J PHYS CHEM A, V110, P2933, DOI 10.1021/jp054374w; Kim YC, 2009, P NATL ACAD SCI USA, V106, P13707, DOI 10.1073/pnas.0903938106; KOTTALAM J, 1988, J AM CHEM SOC, V110, P7690, DOI 10.1021/ja00231a018; KUMAR S, 1995, J COMPUT CHEM, V16, P1339, DOI 10.1002/jcc.540161104; LAIDLER KJ, 1969, THEORIES CHEM REACTI, P41; Lammers S, 2004, AUST J CHEM, V57, P1223, DOI 10.1071/CH04164; Lammers S, 2008, J COMPUT CHEM, V29, P1048, DOI 10.1002/jcc.20864; Lammers S, 2007, J PHYS CHEM A, V111, P1638, DOI 10.1021/jp065323h; LANYI JK, 1995, NATURE, V375, P461, DOI 10.1038/375461a0; Lanyi JK, 1998, J STRUCT BIOL, V124, P164, DOI 10.1006/jsbi.1998.4044; Liu Y, 2001, J PHYS CHEM B, V105, P6598, DOI 10.1021/jp010008a; Loerting T, 2001, J PHYS CHEM A, V105, P5137, DOI 10.1021/jp0038862; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MATHIES RA, 1991, ANNU REV BIOPHYS BIO, V20, P491, DOI 10.1146/annurev.bb.20.060191.002423; Mei HS, 1998, J PHYS CHEM B, V102, P10446, DOI 10.1021/jp982623t; Meuwly M, 2004, BIOPHYS J, V86, P1987, DOI 10.1016/S0006-3495(04)74261-7; Meuwly M, 2002, J CHEM PHYS, V116, P2572, DOI 10.1063/1.1431285; Meuwly M, 2003, FARADAY DISCUSS, V124, P297, DOI 10.1039/b211407k; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Papoian GA, 2003, J AM CHEM SOC, V125, P9170, DOI 10.1021/ja034729u; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pomes R, 1996, J PHYS CHEM-US, V100, P2519, DOI 10.1021/jp9525752; Sagnella DE, 1998, J CHEM PHYS, V108, P2073, DOI 10.1063/1.475586; Schipke CG, 1999, BIOCHEMISTRY-US, V38, P8228, DOI 10.1021/bi983008i; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; SHEN BH, 1993, J BIOL CHEM, V268, P25928; Siwick BJ, 2007, J AM CHEM SOC, V129, P13412, DOI 10.1021/ja069265p; Smedarchina Z, 2003, J AM CHEM SOC, V125, P243, DOI 10.1021/ja0210594; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; Walter NG, 2007, MOL CELL, V28, P923, DOI 10.1016/j.molcel.2007.12.001; WARSHEL A, 1980, J AM CHEM SOC, V102, P6218, DOI 10.1021/ja00540a008; WARSHEL A, 1976, NATURE, V260, P679, DOI 10.1038/260679a0; Wei DQ, 1997, J CHEM PHYS, V106, P6086, DOI 10.1063/1.473607; WILLIAMS RJP, 1988, ANNU REV BIOPHYS BIO, V17, P71; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P18461, DOI 10.1073/pnas.0707647104; Zheng C, 1996, J AM CHEM SOC, V118, P2818, DOI 10.1021/ja9523092	74	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23679	23687		10.1074/jbc.M111.230003	http://dx.doi.org/10.1074/jbc.M111.230003			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21531725	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000292294900009
J	Estrada, DF; De Guzman, RN				Estrada, D. Fernando; De Guzman, Roberto N.			Structural Characterization of the Crimean-Congo Hemorrhagic Fever Virus Gn Tail Provides Insight into Virus Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKBONE DYNAMICS; CYTOPLASMIC TAIL; NMR; PROTEIN; GLYCOPROTEINS; SYSTEM; DOMAIN; SPECTROSCOPY; ASSIGNMENT	The RNA virus that causes the Crimean Congo Hemorrhagic Fever (CCHF) is a tick-borne pathogen of the Nairovirus genus, family Bunyaviridae. Unlike many zoonotic viruses that are only passed between animals and humans, the CCHF virus can also be transmitted from human to human with an overall mortality rate approaching 30%. Currently, there are no atomic structures for any CCHF virus proteins or for any Nairovirus proteins. A critical component of the virus is the envelope Gn glycoprotein, which contains a C-terminal cytoplasmic tail. In other Bunyaviridae viruses, the Gn tail has been implicated in host-pathogen interaction and viral assembly. Here we report the NMR structure of the CCHF virus Gn cytoplasmic tail, residues 729-805. The structure contains a pair of tightly arranged dual beta beta alpha zinc fingers similar to those found in the Hantavirus genus, with which it shares about 12% sequence identity. Unlike Hantavirus zinc fingers, however, the CCHF virus zinc fingers bind viral RNA and contain contiguous clusters of conserved surface electrostatics. Our results provide insight into a likely role of the CCHF virus Gn zinc fingers in Nairovirus assembly.	[Estrada, D. Fernando; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu			AHA [0755724Z]; K-INBRE; NIH [P20 RR016475]; Madison and Lila Self Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR017708] Funding Source: NIH RePORTER	AHA(American Heart Association); K-INBRE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Madison and Lila Self Graduate Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by AHA 0755724Z, K-INBRE, and NIH P20 RR016475 (to R. N. D.) and the Madison and Lila Self Graduate Fellowship (to D. F. E.).	Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Briknarova K, 2011, J BIOL CHEM, V286, P1528, DOI 10.1074/jbc.M110.166025; CASE DA, 2002, AMBER7; Chatterjee S, 2011, PROTEIN SCI, V20, P75, DOI 10.1002/pro.537; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ELLIOTT RM, 2000, VIRUS TAXONOMY CLASS; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Estrada DF, 2009, J BIOL CHEM, V284, P8645, DOI 10.1074/jbc.M808081200; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Flick R, 2003, J VIROL, V77, P5997, DOI 10.1128/JVI.77.10.5997-6006.2003; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hepojoki J, 2010, J GEN VIROL, V91, P2341, DOI 10.1099/vir.0.021006-0; HOFFMAN RC, 1993, J MAGN RESON SER B, V102, P61, DOI 10.1006/jmrb.1993.1062; JANERT PK, 2009, GNUPLOT ACTION UNDER; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Overby AK, 2007, J VIROL, V81, P3198, DOI 10.1128/JVI.02655-06; PELTON JG, 1993, PROTEIN SCI, V2, P543; Sanchez AJ, 2006, J VIROL, V80, P514, DOI 10.1128/JVI.80.1.514-525.2006; Sanchez AJ, 2002, J VIROL, V76, P7263, DOI 10.1128/JVI.76.14.7263-7275.2002; SCHMALJOHN CAH, 2001, BUNYAVIRIDAE VIRUSES; Shi XH, 2007, J VIROL, V81, P10151, DOI 10.1128/JVI.00573-07; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	36	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21678	21686		10.1074/jbc.M110.216515	http://dx.doi.org/10.1074/jbc.M110.216515			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21507948	Green Published, hybrid			2022-12-25	WOS:000291464700064
J	Hisaoka, K; Tsuchioka, M; Yano, R; Maeda, N; Kajitani, N; Morioka, N; Nakata, Y; Takebayashi, M				Hisaoka, Kazue; Tsuchioka, Mami; Yano, Ryoya; Maeda, Natsuko; Kajitani, Naoto; Morioka, Norimitsu; Nakata, Yoshihiro; Takebayashi, Minoru			Tricyclic Antidepressant Amitriptyline Activates Fibroblast Growth Factor Receptor Signaling in Glial Cells INVOLVEMENT IN GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C6 GLIOBLASTOMA CELLS; MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; GLIOMA-CELLS; FACTOR GDNF; MAJOR DEPRESSION; GENE-EXPRESSION; BIPOLAR DISORDER; ASTROCYTES; TRANSACTIVATION	Recently, both clinical and animal studies demonstrated neuronal and glial plasticity to be important for the therapeutic action of antidepressants. Antidepressants increase glial cell line-derived neurotrophic factor (GDNF) production through monoamine-independent protein-tyrosine kinase, extracellular signal-regulated kinase (ERK), and cAMP responsive element-binding protein (CREB) activation in glial cells (Hisaoka, K., Takebayashi, M., Tsuchioka, M., Maeda, N., Nakata, Y., and Yamawaki, S. (2007) J. Pharmacol. Exp. Ther. 321, 148-157; Hisaoka, K., Maeda, N., Tsuchioka, M., and Takebayashi, M. (2008) Brain Res. 1196, 53-58). This study clarifies the type of tyrosine kinase and mechanism of antidepressant-induced GDNF production in C6 glioma cells and normal human astrocytes. The amitriptyline (a tricyclic antidepressant)-induced ERK activation was specifically and completely inhibited by fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors and siRNA for FGFR1 and -2. Treatment with amitriptyline or several different classes of antidepressants, but not non-antidepressants, acutely increased the phosphorylation of FGFRs and FGFR substrate 2 alpha (FRS2 alpha). Amitriptyline-induced CREB phosphorylation and GDNF production were blocked by FGFR-tyrosine kinase inhibitors. Therefore, antidepressants activate the FGFR/FRS2 alpha/ERK/CREB signaling cascade, thus resulting in GDNF production. Furthermore, we attempted to elucidate how antidepressants activate FGFR signaling. The effect of amitriptyline was inhibited by heparin, non-permeant FGF-2 neutralizing antibodies, and matrix metalloproteinase (MMP) inhibitors. Serotonin (5-HT) also increased GDNF production through FGFR2 (Tsuchioka, M., Takebayashi, M., Hisaoka, K., Maeda, N., and Nakata, Y. (2008) J. Neurochem. 106, 244-257); however, the effect of 5-HT was not inhibited by heparin and MMP inhibitors. These results suggest that amitriptyline-induced FGFR activation might occur through an extracellular pathway, in contrast to that of 5-HT. The current data show that amitriptyline-induced FGFR activation might occur by the MMP-dependent shedding of FGFR ligands, such as FGF-2, thus resulting in GDNF production.	[Takebayashi, Minoru] NHO Kure Med Ctr, Dept Psychiat, Kure 7370023, Japan; [Takebayashi, Minoru] NHO Kure Med Ctr, Inst Clin Res, Div Psychiat & Neurosci, Kure 7370023, Japan; Chugoku Canc Ctr, Kure 7370023, Japan; [Hisaoka, Kazue; Yano, Ryoya; Kajitani, Naoto; Morioka, Norimitsu; Nakata, Yoshihiro] Hiroshima Univ, Grad Sch Biomed Sci, Dept Pharmacol, Minami Ku, Hiroshima 7348553, Japan	Hiroshima University	Takebayashi, M (corresponding author), NHO Kure Med Ctr, Dept Psychiat, 3-1 Aoyama, Kure 7370023, Japan.	mtakebayashi@kure-nh.go.jp	Morioka, Norimitsu/J-3165-2019	Morioka, Norimitsu/0000-0001-9148-4167; Kajitani, Naoto/0000-0001-7245-9206	Ministry of Health, Labor, and Welfare of Japan; Pharmacological Research Foundation, Tokyo	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo)	This work was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan and by the Pharmacological Research Foundation, Tokyo.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Belien ATJ, 1999, J CELL BIOL, V144, P373, DOI 10.1083/jcb.144.2.373; Cha JYY, 2009, J BIOL CHEM, V284, P6227, DOI 10.1074/jbc.M803998200; Coumoul Xavier, 2003, Birth Defects Research, V69, P286, DOI 10.1002/bdrc.10025; Dhalluin C, 2000, MOL CELL, V6, P921, DOI 10.1016/S1097-2765(00)00089-7; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Gaughran F, 2006, BRAIN RES BULL, V70, P221, DOI 10.1016/j.brainresbull.2006.04.008; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Hisaoka K, 2001, J NEUROCHEM, V79, P25, DOI 10.1046/j.1471-4159.2001.00531.x; Hisaoka K, 2008, BRAIN RES, V1196, P53, DOI 10.1016/j.brainres.2007.12.019; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Ko HG, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-16; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lazar J, 2004, LIFE SCI, V75, P153, DOI 10.1016/j.lfs.2003.11.023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsunaga H, 2006, NEUROCHEM INT, V49, P294, DOI 10.1016/j.neuint.2006.01.017; Mercier G, 2004, J MOL NEUROSCI, V24, P207, DOI 10.1385/JMN:24:2:207; Michel TM, 2008, EUR PSYCHIAT, V23, P413, DOI 10.1016/j.eurpsy.2008.06.001; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamua S, 1999, GLIA, V28, P53, DOI 10.1002/(SICI)1098-1136(199910)28:1<53::AID-GLIA7>3.0.CO;2-V; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; OKUMURA N, 1989, J BIOCHEM-TOKYO, V106, P904, DOI 10.1093/oxfordjournals.jbchem.a122950; Otsuki K, 2008, J PSYCHIATR RES, V42, P1145, DOI 10.1016/j.jpsychires.2008.01.010; Pertusa A, 2008, NEUROBIOL AGING, V29, P1366, DOI 10.1016/j.neurobiolaging.2007.02.026; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rauch BH, 2004, CIRC RES, V94, P340, DOI 10.1161/01.RES.0000111805.09592.D8; Rosa AR, 2006, NEUROSCI LETT, V407, P146, DOI 10.1016/j.neulet.2006.08.026; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Shibata SB, 2007, BRAIN RES, V1144, P74, DOI 10.1016/j.brainres.2007.01.090; Shin SY, 2009, J BIOL CHEM, V284, P30583, DOI 10.1074/jbc.M109.010678; SuterCrazzolara C, 1996, MOL BRAIN RES, V41, P175, DOI 10.1016/0169-328X(96)00089-7; Takebayashi M, 2009, RECENT DEV DEPRESSIO, P125; Takebayashi M, 2006, INT J NEUROPSYCHOPH, V9, P607, DOI 10.1017/S1461145705006085; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Verity AN, 1998, J NEUROCHEM, V70, P531; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Wu YJ, 2003, BIOL CHEM, V384, P1215, DOI 10.1515/BC.2003.134; Yamada T, 2008, BIOMATERIALS, V29, P3503, DOI 10.1016/j.biomaterials.2008.03.044; Yan Y, 2007, FASEB J, V21, P1994, DOI 10.1096/fj.06-7772com; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773; Zhang LQ, 2010, J PHARMACOL EXP THER, V332, P977, DOI 10.1124/jpet.109.162644; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004; Zhang XB, 2009, PSYCHIAT RES, V170, P273, DOI 10.1016/j.psychres.2009.01.011; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910	55	42	44	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21118	21128		10.1074/jbc.M111.224683	http://dx.doi.org/10.1074/jbc.M111.224683			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515689	Green Published, hybrid			2022-12-25	WOS:000291464700011
J	Li, Z; Xu, XL; Bai, L; Chen, WS; Lin, Y				Li, Zi; Xu, Xiuling; Bai, Lang; Chen, Wenshu; Lin, Yong			Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED CYTOTOXICITY; CHOLANGIOCARCINOMA CELLS; DRUG-RESISTANCE; OVARIAN-CANCER; ACTIVATION; PATHWAY; MECHANISMS; INVASION; SENSITIZATION; THERAPEUTICS	Acquired chemoresistance not only blunts anticancer therapy but may also promote cancer cell migration and metastasis. Our previous studies have revealed that acquired tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) resistance in lung cancer cells is associated with Akt-mediated stabilization of cellular caspase 8 and Fas-associated death domain (FADD)-like apoptosis regulator-like inhibitory protein (c-FLIP) and myeloid cell leukemia 1 (Mcl-1). In this report, we show that cells with acquired TRAIL resistance have significantly increased capacities in migration and invasion. By gene expression screening, tissue transglutaminase (TGM2) was identified as one of the genes with the highest expression increase in TRAIL-resistant cells. Suppressing TGM2 dramatically alleviated TRAIL resistance and cell migration, suggesting that TGM2 contributes to these two phenotypes in TRAIL-resistant cells. TGM2-mediated TRAIL resistance is likely through c-FLIP because TGM2 suppression significantly reduced c-FLIP but not Mcl-1 expression. The expression of matrix metalloproteinase 9 (MMP-9) was suppressed when TGM2 was inhibited, suggesting that TGM2 potentiates cell migration through up-regulating MMP-9 expression. We found that EGF receptor (EGFR) was highly active in the TRAIL-resistant cells, and suppression of EGFR dramatically reduced TGM2 expression. We further determined JNK and ERK, but not Akt and NF-kappa B, are responsible for EGFR-mediated TGM2 expression. These results identify a novel pathway that involves EGFR, MAPK (JNK and ERK), and TGM2 for acquired TRAIL resistance and cell migration in lung cancer cells. Because TGM2 couples TRAIL resistance and cell migration, it could be a molecular target for circumventing acquired chemoresistance and metastasis in lung cancer.	[Li, Zi; Xu, Xiuling; Bai, Lang; Chen, Wenshu; Lin, Yong] Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, Albuquerque, NM 87108 USA; [Li, Zi] Guangzhou Med Univ, Dept Pathogen Biol & Immunol, Guangzhou 510182, Guangdong, Peoples R China	Lovelace Respiratory Research Institute; Guangzhou Medical University	Lin, Y (corresponding author), Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	ylin@lrri.org			National Institutes of Health NIEHS [R01ES017328]; Department of Energy [DE-SC0001173]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017328] Funding Source: NIH RePORTER	National Institutes of Health NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health NIEHS Grant R01ES017328 and Department of Energy Low Dose Radiation Research Program DE-SC0001173.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Chen WJ, 2010, MOL PHARMACOL, V77, P416, DOI 10.1124/mol.109.061226; Chen WS, 2007, CARCINOGENESIS, V28, P2114, DOI 10.1093/carcin/bgm133; Fingas CD, 2010, HEPATOLOGY, V52, P550, DOI 10.1002/hep.23729; Frese-Schaper M, 2010, FEBS LETT, V584, P2867, DOI 10.1016/j.febslet.2010.04.072; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Ho C, 2009, EXPERT OPIN INV DRUG, V18, P1133, DOI 10.1517/13543780903066772; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Jang JH, 2010, CANCER LETT, V287, P224, DOI 10.1016/j.canlet.2009.06.013; Ju W, 2007, MOL PHARMACOL, V71, P1381, DOI 10.1124/mol.106.032185; Lane D, 2006, MOL CANCER THER, V5, P509, DOI 10.1158/1535-7163.MCT-05-0362; Leong S, 2009, J CLIN ONCOL, V27, P4413, DOI 10.1200/JCO.2008.21.7422; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lonning PE, 2010, MOL ONCOL, V4, P284, DOI 10.1016/j.molonc.2010.04.005; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Malhi H, 2006, ONCOGENE, V25, P7333, DOI 10.1038/sj.onc.1209765; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Park KS, 2010, J CANCER RES CLIN, V136, P493, DOI 10.1007/s00432-009-0681-6; Roche H, 2011, ANN ONCOL, V22, P1000, DOI 10.1093/annonc/mdq429; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Stegehuis JH, 2010, DRUG RESIST UPDATE, V13, P2, DOI 10.1016/j.drup.2009.11.001; Tucholski J, 2003, J BIOL CHEM, V278, P26838, DOI 10.1074/jbc.M303683200; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Wajant H, 2005, CYTOKINE GROWTH F R, V16, P55, DOI 10.1016/j.cytogfr.2004.12.001; Wajant H, 2004, VITAM HORM, V67, P101; Wang XD, 2001, GENE DEV, V15, P2922; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Wenger T, 2006, CELL DEATH DIFFER, V13, P1740, DOI 10.1038/sj.cdd.4401867; Wilson TR, 2009, CURR CANCER DRUG TAR, V9, P307, DOI 10.2174/156800909788166547; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	40	66	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21164	21172		10.1074/jbc.M110.207571	http://dx.doi.org/10.1074/jbc.M110.207571			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21525012	hybrid, Green Published			2022-12-25	WOS:000291464700016
J	French, JB; Yates, PA; Soysa, DR; Boitz, JM; Carter, NS; Chang, BL; Ullman, B; Ealick, SE				French, Jarrod B.; Yates, Phillip A.; Soysa, D. Radika; Boitz, Jan M.; Carter, Nicola S.; Chang, Bailey; Ullman, Buddy; Ealick, Steven E.			The Leishmania donovani UMP Synthase Is Essential for Promastigote Viability and Has an Unusual Tetrameric Structure That Exhibits Substrate-controlled Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; NOVO PYRIMIDINE BIOSYNTHESIS; PROTEIN SECONDARY STRUCTURE; MOLECULAR-WEIGHT FORMS; DE-NOVO; OROTATE PHOSPHORIBOSYLTRANSFERASE; PROFICIENT ENZYME; PURINE METABOLISM; CRYSTAL-STRUCTURE; MECHANISM	The final two steps of de novo uridine 5'-monophosphate (UMP) biosynthesis are catalyzed by orotate phosphoribosyltransferase (OPRT) and orotidine 5'-monophosphate decarboxylase (OMPDC). In most prokaryotes and simple eukaryotes these two enzymes are encoded by separate genes, whereas in mammals they are expressed as a bifunctional gene product called UMP synthase (UMPS), with OPRT at the N terminus and OMPDC at the C terminus. Leishmania and some closely related organisms also express a bifunctional enzyme for these two steps, but the domain order is reversed relative to mammalian UMPS. In this work we demonstrate that L. donovani UMPS (LdUMPS) is an essential enzyme in promastigotes and that it is sequestered in the parasite glycosome. We also present the crystal structure of the LdUMPS in complex with its product, UMP. This structure reveals an unusual tetramer with two head to head and two tail to tail interactions, resulting in two dimeric OMPDC and two dimeric OPRT functional domains. In addition, we provide structural and biochemical evidence that oligomerization of LdUMPS is controlled by product binding at the OPRT active site. We propose a model for the assembly of the catalytically relevant LdUMPS tetramer and discuss the implications for the structure of mammalian UMPS.	[French, Jarrod B.; Chang, Bailey; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Yates, Phillip A.; Soysa, D. Radika; Boitz, Jan M.; Carter, Nicola S.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Cornell University; Oregon Health & Science University	Ealick, SE (corresponding author), Cornell Univ, Baker Lab 120, Ithaca, NY 14853 USA.	see3@cornell.edu	French, Jarrod/K-6669-2014	French, Jarrod/0000-0002-6762-1309	National Institutes of Health [GM073220, AI023682]; Tri-institutional Training Program in Chemical Biology; National Center for Research Resources at the National Institutes of Health [RR-15301]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tri-institutional Training Program in Chemical Biology; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM073220 (to S. E. E.) and AI023682 (to B. U.).; Supported by the Tri-institutional Training Program in Chemical Biology.; We thank the staff at the Northeastern Collaborative Access Team (NE-CAT) beamlines for advice with data collection and processing. Data collected at the NE-CAT beamlines of the Advanced Photon Source are supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, contract number DE-AC02-06CH11357. We acknowledge Cynthia Kinsland of the Protein Production Facility in the Department of Chemistry and Chemical Biology for help with molecular biology and Leslie Kinsland for help with manuscript preparation.	Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; ARDALAN B, 1981, CANCER TREAT REV, V8, P157, DOI 10.1016/S0305-7372(81)80014-X; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bello AM, 2009, J MED CHEM, V52, P1648, DOI 10.1021/jm801224t; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; BOFILL M, 1995, J BIOL CHEM, V270, P29690, DOI 10.1074/jbc.270.50.29682; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN GK, 1975, J BIOL CHEM, V250, P7352; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; Carter NS, 2010, MOL MICROBIOL, V78, P92, DOI 10.1111/j.1365-2958.2010.07327.x; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Datta AK, 2008, ADV EXP MED BIOL, V625, P116, DOI 10.1007/978-0-387-77570-8_10; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dobie F, 2007, MOL BIOCHEM PARASIT, V152, P11, DOI 10.1016/j.molbiopara.2006.11.007; el Kouni MH, 2003, PHARMACOL THERAPEUT, V99, P283, DOI 10.1016/S0163-7258(03)00071-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Gao GH, 1999, J MOL BIOL, V285, P149, DOI 10.1006/jmbi.1998.2293; Gonzalez-Segura L, 2007, BIOCHEMISTRY-US, V46, P14075, DOI 10.1021/bi701023z; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; HAMMOND DJ, 1981, FEBS LETT, V128, P27, DOI 10.1016/0014-5793(81)81070-8; Harris P, 2000, BIOCHEMISTRY-US, V39, P4217, DOI 10.1021/bi992952r; HASSAN HF, 1986, COMP BIOCHEM PHYS B, V84, P217, DOI 10.1016/0305-0491(86)90209-9; Henriksen A, 1996, BIOCHEMISTRY-US, V35, P3803, DOI 10.1021/bi952226y; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones M E, 1978, Methods Enzymol, V51, P155; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krungkrai SR, 2005, BIOCHEMISTRY-US, V44, P1643, DOI 10.1021/bi048439h; KUNJARA S, 1991, BIOCHEM MED METAB B, V46, P215, DOI 10.1016/0885-4505(91)90069-W; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; McClard RW, 2006, BIOCHEMISTRY-US, V45, P5330, DOI 10.1021/bi051650o; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sanders S, 2002, AM J MED SCI, V323, P190, DOI 10.1097/00000441-200204000-00004; SCAPIN G, 1994, BIOCHEMISTRY-US, V33, P1287, DOI 10.1021/bi00172a001; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Smith JL, 1999, NAT STRUCT BIOL, V6, P502, DOI 10.1038/9266; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; TRAUT TW, 1977, J BIOL CHEM, V252, P8374; TRAUT TW, 1979, J BIOL CHEM, V254, P1143; UMEZU K, 1971, J BIOCHEM, V70, P249, DOI 10.1093/oxfordjournals.jbchem.a129637; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wang GP, 1999, BIOCHEMISTRY-US, V38, P275, DOI 10.1021/bi9820560; Wang GP, 1999, BIOCHEMISTRY-US, V38, P284, DOI 10.1021/bi982057s; Weber G, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1164, DOI 10.1023/A:1012493232344; Wittmann JG, 2008, STRUCTURE, V16, P82, DOI 10.1016/j.str.2007.10.020; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797; Yablonski MJ, 1996, J BIOL CHEM, V271, P10704, DOI 10.1074/jbc.271.18.10704	60	29	29	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20930	20941		10.1074/jbc.M111.228213	http://dx.doi.org/10.1074/jbc.M111.228213			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507942	Green Published, hybrid			2022-12-25	WOS:000291267600077
J	Huang, XY; Kocabas, E; Hernick, M				Huang, Xinyi; Kocabas, Evren; Hernick, Marcy			The Activity and Cofactor Preferences of N-Acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside Deacetylase (MshB) Change Depending on Environmental Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONONUCLEAR IRON PROTEIN; CARBONIC-ANHYDRASE-II; S-CONJUGATE AMIDASE; SITE METAL-ION; MYCOBACTERIUM-TUBERCULOSIS; PEPTIDE DEFORMYLASE; ESCHERICHIA-COLI; D-PENICILLAMINE; MYCOTHIOL; ENZYME	Actinomycetes, such as Mycobacterium species, are Gram-positive bacteria that utilize the small molecule mycothiol (MSH) as their primary reducing agent. Consequently, the enzymes involved in MSH biosynthesis are targets for drug development. The metal-dependent enzyme N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) catalyzes the hydrolysis of N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside to form 1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside and acetate, the fourth overall step in MSH biosynthesis. Inhibitors of metalloenzymes typically contain a group that binds to the active site metal ion; thus, a comprehensive understanding of the native cofactor(s) of metalloenzymes is critical for the development of biologically effective inhibitors. Herein, we examined the effect of metal ions on the overall activity of MshB and probed the identity of the native cofactor. We found that the activity of MshB follows the trend Fe2+ > Co2+ > Zn2+ > Mn2+ and Ni2+. Additionally, our results show that the identity of the cofactor bound to purified MshB is highly dependent on the purification conditions used (aerobic versus anaerobic), as well as the metal ion content of the medium during protein expression. MshB prefers Fe2+ under anaerobic conditions regardless of the metal ion content of the medium and switches between Fe2+ and Zn2+ under aerobic conditions as the metal content of the medium is altered. These results indicate that the cofactor bound to MshB under biological conditions is dependent on environmental conditions, suggesting that MshB may be a cambialistic metallohydrolase that contains a dynamic cofactor. Consequently, biologically effective inhibitors will likely need to dually target Fe2+-MshB and Zn2+-MshB.	[Huang, Xinyi; Kocabas, Evren; Hernick, Marcy] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hernick, M (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	hernickm@vt.edu		Hernick, Marcy/0000-0002-2839-5767	Jeffress Memorial Trust [J960]	Jeffress Memorial Trust	This work was supported by Jeffress Memorial Trust Grant J960 (to M.H.)	ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Chong CR, 2000, BIOCHEMISTRY-US, V39, P7580, DOI 10.1021/bi000101+; Chong CR, 2007, J MED CHEM, V50, P5524, DOI 10.1021/jm070803y; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Fan F, 2009, CURR OPIN CHEM BIOL, V13, P451, DOI 10.1016/j.cbpa.2009.07.018; Gammon DW, 2010, BIOORGAN MED CHEM, V18, P2501, DOI 10.1016/j.bmc.2010.02.049; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Gattis SG, 2010, J BIOL CHEM, V285, P33788, DOI 10.1074/jbc.M110.147173; Groche D, 1998, BIOCHEM BIOPH RES CO, V246, P342, DOI 10.1006/bbrc.1998.8616; Gutierrez-Lugo MT, 2008, J MED CHEM, V51, P2606, DOI 10.1021/jm070719i; Gutierrez-Lugo MT, 2009, J BIOMOL SCREEN, V14, P643, DOI 10.1177/1087057109335743; Hernick M, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P547; Hernick M, 2010, BIOCHEMISTRY-US, V49, P2246, DOI 10.1021/bi902066t; Huang CC, 1996, BIOCHEMISTRY-US, V35, P3439, DOI 10.1021/bi9526692; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; KIEFER LL, 1994, BIOCHEMISTRY-US, V33, P15233, DOI 10.1021/bi00255a003; Li NG, 2009, CURR MED CHEM, V16, P3805, DOI 10.2174/092986709789178037; Maynes JT, 2003, J BIOL CHEM, V278, P47166, DOI 10.1074/jbc.M308914200; Metaferia BB, 2007, J MED CHEM, V50, P6326, DOI 10.1021/jm070669h; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2006, PROTEIN EXPRES PURIF, V47, P542, DOI 10.1016/j.pep.2006.03.003; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P2641, DOI 10.1016/S0968-0896(03)00154-8; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P601, DOI 10.1016/S0968-0896(02)00345-0; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Ragusa S, 1998, J MOL BIOL, V280, P515, DOI 10.1006/jmbi.1998.1883; Rajagopalan PTR, 1997, J AM CHEM SOC, V119, P12418, DOI 10.1021/ja9734096; Rajagopalan PTR, 1998, J BIOL CHEM, V273, P22305, DOI 10.1074/jbc.273.35.22305; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; Sobrado P, 2008, PROTEIN EXPRES PURIF, V58, P229, DOI 10.1016/j.pep.2007.11.018; Steffek M, 2003, BIOCHEMISTRY-US, V42, P12067, DOI 10.1021/bi030080u; Supuran CT, 2010, BIOORG MED CHEM LETT, V20, P3467, DOI 10.1016/j.bmcl.2010.05.009; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; White RJ, 2003, CURR OPIN PHARMACOL, V3, P502, DOI 10.1016/S1471-4892(03)00115-2; Zhu JG, 2003, BIOCHEMISTRY-US, V42, P4717, DOI 10.1021/bi034289j	38	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20275	20282		10.1074/jbc.M111.234229	http://dx.doi.org/10.1074/jbc.M111.234229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507949	hybrid, Green Published			2022-12-25	WOS:000291267600015
J	Spears, JL; Rubio, MAT; Gaston, KW; Wywial, E; Strikoudis, A; Bujnicki, JM; Papavasiliou, FN; Alfonzo, JD				Spears, Jessica L.; Rubio, Mary Anne T.; Gaston, Kirk W.; Wywial, Ewa; Strikoudis, Alexandros; Bujnicki, Janusz M.; Papavasiliou, F. Nina; Alfonzo, Juan D.			A Single Zinc Ion Is Sufficient for an Active Trypanosoma brucei tRNA Editing Deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; ADENOSINE-DEAMINASE; CRYSTAL-STRUCTURE; CYTIDINE DEAMINASE; ESCHERICHIA-COLI; WOBBLE POSITION; INOSINE; ENZYME; TADA; IDENTIFICATION	Editing of adenosine (A) to inosine (I) at the first anticodon position in tRNA is catalyzed by adenosine deaminases acting on tRNA (ADATs). This essential reaction in bacteria and eukarya permits a single tRNA to decode multiple codons. Bacterial ADATa is a homodimer with two bound essential Zn2+. The ADATa crystal structure revealed residues important for substrate binding and catalysis; however, such high resolution structural information is not available for eukaryotic tRNA deaminases. Despite significant sequence similarity among deaminases, we continue to uncover unexpected functional differences between Trypanosoma brucei ADAT2/3 (TbADAT2/3) and its bacterial counterpart. Previously, we demonstrated that TbADAT2/3 is unique in catalyzing two different deamination reactions. Here we show by kinetic analyses and inductively coupled plasma emission spectrometry that wild type TbADAT2/3 coordinates two Zn2+ per heterodimer, but unlike any other tRNA deaminase, mutation of one of the key Zn2+-coordinating cysteines in TbADAT2 yields a functional enzyme with a single-bound zinc. These data suggest that, at least, TbADAT3 may play a role in catalysis via direct coordination of the catalytic Zn2+. These observations raise the possibility of an unusual Zn2+ coordination interface with important implications for the function and evolution of editing deaminases.	[Spears, Jessica L.; Rubio, Mary Anne T.; Gaston, Kirk W.; Alfonzo, Juan D.] Ohio State Univ, Ohio State Ctr RNA Biol, Dept Microbiol, Columbus, OH 43210 USA; [Alfonzo, Juan D.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Wywial, Ewa; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol Warsaw, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Strikoudis, Alexandros; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA; [Bujnicki, Janusz M.] Adam Mickiewicz Univ Poznan, Fac Biol, Inst Mol Biol & Biotechnol, PL-02109 Poznan, Poland	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Rockefeller University; Adam Mickiewicz University	Alfonzo, JD (corresponding author), 484 W 12th Ave,376 Biosci Bldg, Columbus, OH 43210 USA.	alfonzo.1@osu.edu			National Institutes of Health [GM084065]; Polish Ministry of Science and Higher Education [POIG.02.03.00-00-003/09]; European Research Council [RNA+p = 123D]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084065 (to J.D.A.).; Supported by Polish Ministry of Science and Higher Education Grant POIG.02.03.00-00-003/09.; Supported by European Research Council StG Grant RNA+p = 123D.	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Auxilien S, 1996, J MOL BIOL, V262, P437, DOI 10.1006/jmbi.1996.0527; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Delannoy E, 2009, PLANT CELL, V21, P2058, DOI 10.1105/tpc.109.066654; Elias Y, 2005, BIOCHEMISTRY-US, V44, P12057, DOI 10.1021/bi050499f; FASSEL VA, 1978, SCIENCE, V202, P183, DOI 10.1126/science.202.4364.183; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; GRAY MW, 1976, NUCLEIC ACIDS RES, V3, P977, DOI 10.1093/nar/3.4.977; Grosjean H, 1996, BIOCHIMIE, V78, P488, DOI 10.1016/0300-9084(96)84755-9; Habig JW, 2007, MOL CELL, V25, P792, DOI 10.1016/j.molcel.2007.03.010; Hurst SR, 1995, RNA, V1, P1051; Karcher D, 2009, RNA, V15, P1251, DOI 10.1261/rna.1600609; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim J, 2006, BIOCHEMISTRY-US, V45, P6407, DOI 10.1021/bi0522394; Kosinski J, 2003, PROTEINS, V53, P369, DOI 10.1002/prot.10545; Kuratani M, 2005, J BIOL CHEM, V280, P16002, DOI 10.1074/jbc.M414541200; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; MACELREVEY C, 2008, RNA DNA EDITING MOL, P369; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P11251, DOI 10.1038/nsmb866; ROGONE FL, 2011, RNA IN PRESS; Rubio MAT, 2007, P NATL ACAD SCI USA, V104, P7821, DOI 10.1073/pnas.0702394104; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Schaub M, 2002, BIOCHIMIE, V84, P791, DOI 10.1016/S0300-9084(02)01446-3; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SMITH AA, 1994, BIOCHEMISTRY-US, V33, P6468, DOI 10.1021/bi00187a012; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101	35	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20366	20374		10.1074/jbc.M111.243568	http://dx.doi.org/10.1074/jbc.M111.243568			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21507956	hybrid, Green Published			2022-12-25	WOS:000291267600024
J	Tanneberger, K; Pfister, AS; Kriz, V; Bryja, V; Schambony, A; Behrens, J				Tanneberger, Kristina; Pfister, Astrid S.; Kriz, Vitezslav; Bryja, Vitezslav; Schambony, Alexandra; Behrens, Juergen			Structural and Functional Characterization of the Wnt Inhibitor APC Membrane Recruitment 1 (Amer1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; SIGNALING PATHWAY; AXIN; PHOSPHORYLATION; LRP6; WTX; ACTIVATION; MECHANISM; CADHERIN; COMPLEX	Amer1/WTX binds to the tumor suppressor adenomatous polyposis coli and acts as an inhibitor of Wnt signaling by inducing beta-catenin degradation. We show here that Amer1 directly interacts with the armadillo repeats of beta-catenin via a domain consisting of repeated arginine-glutamic acid-alanine (REA) motifs, and that Amer1 assembles the beta-catenin destruction complex at the plasma membrane by recruiting beta-catenin, adenomatous polyposis coli, and Axin/Conductin. Deletion or specific mutations of the membrane binding domain of Amer1 abolish its membrane localization and abrogate negative control of Wnt signaling, which can be restored by artificial targeting of Amer1 to the plasma membrane. In line, a natural splice variant of Amer1 lacking the plasma membrane localization domain is deficient for Wnt inhibition. Knockdown of Amer1 leads to the activation of Wnt target genes, preferentially in dense compared with sparse cell cultures, suggesting that Amer1 function is regulated by cell contacts. Amer1 stabilizes Axin and counteracts Wnt-induced degradation of Axin, which requires membrane localization of Amer1. The data suggest that Amer1 exerts its negative regulatory role in Wnt signaling by acting as a scaffold protein for the beta-catenin destruction complex and promoting stabilization of Axin at the plasma membrane.	[Tanneberger, Kristina; Pfister, Astrid S.; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany; [Schambony, Alexandra] Univ Erlangen Nurnberg, Dev Biol Unit, Dept Biol, D-91054 Erlangen, Germany; [Kriz, Vitezslav; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Kriz, Vitezslav; Bryja, Vitezslav] Acad Sci Czech Republ, Inst Biophys, Dept Cytokinet, Brno 61137, Czech Republic	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Gluckstr 6, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de	Bryja, Vítězslav/P-4217-2019; Bryja, Vít?zslav/H-1925-2014; Kriz, Vitezslav/G-6353-2014	Bryja, Vítězslav/0000-0002-9136-5085; Bryja, Vít?zslav/0000-0002-9136-5085; Schambony, Alexandra/0000-0001-8771-5487	DFG [BE 1550/6-1, SCHA965/6-1]; Czech Science Foundation [204/09/J030]	DFG(German Research Foundation (DFG)); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by DFG Research Grants BE 1550/6-1 (to J. B.) and SCHA965/6-1 (to A. S.). This work was also supported by Czech Science Foundation Grant 204/09/J030 (to V. B.).	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kofron M, 2007, DEVELOPMENT, V134, P503, DOI 10.1242/dev.02739; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Nieukoop P. D., 1994, NORMAL TABLE XENOPUS; Perotti D, 2008, ONCOGENE, V27, P4625, DOI 10.1038/onc.2008.93; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	39	35	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19204	19214		10.1074/jbc.M111.224881	http://dx.doi.org/10.1074/jbc.M111.224881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498506	hybrid, Green Published			2022-12-25	WOS:000291027700003
J	Dean, RT; Bailes, F; Schubert, E				Dean, Roger T.; Bailes, Freya; Schubert, Emery			Acoustic Intensity Causes Perceived Changes in Arousal Levels in Music: An Experimental Investigation	PLOS ONE			English	Article							EMOTIONAL RESPONSES; PERCEPTION; SOUNDS; LOUDNESS; MODEL; CUES	Listener perceptions of changes in the arousal expressed by classical music have been found to correlate with changes in sound intensity/loudness over time. This study manipulated the intensity profiles of different pieces of music in order to test the causal nature of this relationship. Listeners (N = 38) continuously rated their perceptions of the arousal expressed by each piece. An extract from Dvorak's Slavonic Dance Opus 46 No 1 was used to create a variant in which the direction of change in intensity was inverted, while other features were retained. Even though it was only intensity that was inverted, perceived arousal was also inverted. The original intensity profile was also superimposed on three new pieces of music. The time variation in the perceived arousal of all pieces was similar to their intensity profile. Time series analyses revealed that intensity variation was a major influence on the arousal perception in all pieces, in spite of their stylistic diversity.	[Dean, Roger T.; Bailes, Freya] Univ Western Sydney, MARCS Auditory Labs, Milperra, NSW, Australia; [Schubert, Emery] Univ New S Wales, Empir Musicol Grp, Sydney, NSW, Australia	Western Sydney University; University of New South Wales Sydney	Dean, RT (corresponding author), Univ Western Sydney, MARCS Auditory Labs, Milperra, NSW, Australia.	f.bailes@uws.edu.au	Bailes, Freya/C-6932-2008	Dean, Roger Thornton/0000-0002-8859-8902; Schubert, Emery/0000-0002-6541-8083; Bailes, Freya/0000-0003-2723-3579				Bailes F, 2009, PERCEPTION, V38, P1386, DOI 10.1068/p6063; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Bigand E, 2005, COGNITION EMOTION, V19, P1113, DOI 10.1080/02699930500204250; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; BREWSTER A, 2003, AFFECTIONS FRIENDSHI; CABRERA D, 2010, 129 CONV AUD ENG SOC; Dean RT, 2010, ORGAN SOUND, V15, P147, DOI 10.1017/S1355771810000142; DEAN RT, EMPIRICAL M IN PRESS; Dubnov S, 2006, J AM SOC INF SCI TEC, V57, P1526, DOI 10.1002/asi.20429; Evans P, 2008, MUSIC SCI, V12, P75, DOI 10.1177/102986490801200105; Gabrielsson Alf, 2010, HDB MUSIC EMOTION TH, P367, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0014; Geringer J. M., 1993, PSYCHOMUSICOLOGY, V12, P22, DOI 10.1037/h0094120; Glasberg BR, 2002, J AUDIO ENG SOC, V50, P331; Gower J.C., 2004, PROCRUSTES PROBLEMS; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Khalfa S, 2002, NEUROSCI LETT, V328, P145, DOI 10.1016/S0304-3940(02)00462-7; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Leman M, 2005, J NEW MUSIC RES, V34, P39, DOI 10.1080/09298210500123978; Mertens Wim., 1983, AM MINIMAL MUSIC; Namba S, 2008, JPN PSYCHOL RES, V50, P154, DOI 10.1111/j.1468-5884.2008.00372.x; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Ollen J. E., 2006, CRITERION RELATED VA; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561; SCHUBERT E, 2001, MUSIC EMOTION THEORY, P393; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Todd NPM, 2000, J ACOUST SOC AM, V107, P496, DOI 10.1121/1.428317; VIEMEISTER NF, 1991, J ACOUST SOC AM, V90, P858, DOI 10.1121/1.401953; Witvliet CVO, 2007, COGNITION EMOTION, V21, P3, DOI 10.1080/02699930601000672; Zwicker E., 1999, PSYCHOACOUSTICS, DOI [10.1007/978-3-662-09562-1, DOI 10.1007/978-3-662-09562-1]	32	42	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18591	10.1371/journal.pone.0018591	http://dx.doi.org/10.1371/journal.pone.0018591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533095	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400014
J	Davies, AJ; Guinotte, JM				Davies, Andrew J.; Guinotte, John M.			Global Habitat Suitability for Framework-Forming Cold-Water Corals	PLOS ONE			English	Article							LOPHELIA-PERTUSA SCLERACTINIA; PREDICTING SUITABLE HABITAT; SPECIES DISTRIBUTIONS; NORTHEAST ATLANTIC; OCEAN ACIDIFICATION; REEFS; CONSERVATION; PERFORMANCE; BATHYMETRY; IMPACTS	Predictive habitat models are increasingly being used by conservationists, researchers and governmental bodies to identify vulnerable ecosystems and species' distributions in areas that have not been sampled. However, in the deep sea, several limitations have restricted the widespread utilisation of this approach. These range from issues with the accuracy of species presences, the lack of reliable absence data and the limited spatial resolution of environmental factors known or thought to control deep-sea species' distributions. To address these problems, global habitat suitability models have been generated for five species of framework-forming scleractinian corals by taking the best available data and using a novel approach to generate high resolution maps of seafloor conditions. High-resolution global bathymetry was used to resample gridded data from sources such as World Ocean Atlas to produce continuous 30-arc second (similar to 1 km(2)) global grids for environmental, chemical and physical data of the world's oceans. The increased area and resolution of the environmental variables resulted in a greater number of coral presence records being incorporated into habitat models and higher accuracy of model predictions. The most important factors in determining cold-water coral habitat suitability were depth, temperature, aragonite saturation state and salinity. Model outputs indicated the majority of suitable coral habitat is likely to occur on the continental shelves and slopes of the Atlantic, South Pacific and Indian Oceans. The North Pacific has very little suitable scleractinian coral habitat. Numerous small scale features (i.e., seamounts), which have not been sampled or identified as having a high probability of supporting cold-water coral habitat were identified in all ocean basins. Field validation of newly identified areas is needed to determine the accuracy of model results, assess the utility of modelling efforts to identify vulnerable marine ecosystems for inclusion in future marine protected areas and reduce coral bycatch by commercial fisheries.	[Davies, Andrew J.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Guinotte, John M.] Marine Conservat Biol Inst, Bellevue, WA USA	Bangor University	Davies, AJ (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.	andrew.j.davies@bangor.ac.uk	Davies, Andrew/A-4222-2008	Davies, Andrew/0000-0002-2087-0885	Winston Churchill Memorial Fellowship; Arcadia Foundation; Sally Brown Foundation; Curtis and Edith Munson Foundation; Henry Foundation; Herbert W. Hoover Foundation; International Union for the Conservation of Nature; J.M. Kaplan Fund; Naomi and Nehemiah Cohen Foundation; Oak Foundation; Pew Charitable Trusts; Richard and Rhoda Goldman Fund; Tiffany Co. Foundation	Winston Churchill Memorial Fellowship; Arcadia Foundation; Sally Brown Foundation; Curtis and Edith Munson Foundation; Henry Foundation; Herbert W. Hoover Foundation; International Union for the Conservation of Nature; J.M. Kaplan Fund; Naomi and Nehemiah Cohen Foundation; Oak Foundation; Pew Charitable Trusts; Richard and Rhoda Goldman Fund; Tiffany Co. Foundation	The up-scaling approach was devised during a Winston Churchill Memorial Fellowship awarded to AJD. The ESRI Conservation Program provided ArcGIS software to MCBI. MCBI would like to thank the following foundations, organizations, and individuals for their support: Arcadia, Sally Brown, Curtis and Edith Munson and Henry Foundations, Jonathan Edwards, Ben and Ruth Hammett, Herbert W. Hoover Foundation, International Union for the Conservation of Nature, J.M. Kaplan Fund, Naomi and Nehemiah Cohen Foundation, Oak Foundation, Pew Charitable Trusts, Richard and Rhoda Goldman Fund, and the Tiffany & Co. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Becker JJ, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003879; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Boyer T, 2005, INT J CLIMATOL, V25, P931, DOI 10.1002/joc.1173; Brooke SD, 2009, MAR ECOL PROG SER, V390, P137, DOI 10.3354/meps08191; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Cairns SD., 1995, NZ OCEANOGRAPHIC I M, V103, P210, DOI DOI 10.1017/CBO9781107415324.004; Carton JA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002817; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; Dunn DC, 2009, MAR ECOL PROG SER, V377, P1, DOI 10.3354/meps07839; Edinger EN, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P101; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Freiwald A., 2004, COLD WATER CORAL REE; Garcia H. E., 2006, NOAA ATLAS NESDIS, V63; Garcia H. E., 2006, NOAA ATLAS NESDIS, V64; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guinan J, 2009, MAR ECOL PROG SER, V375, P125, DOI 10.3354/meps07739; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; KAMPSTRA P, 2008, J STAT SOFTW, V28, pCS1; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kiriakoulakis K, 2005, ERLANGEN EARTH C SER, P715, DOI 10.1007/3-540-27673-4_37; Leverette TL, 2005, ERLANGEN EARTH C SER, P467, DOI 10.1007/3-540-27673-4_23; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; Mortensen PB, 2001, J MAR BIOL ASSOC UK, V81, P581, DOI 10.1017/S002531540100426X; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Raes N, 2009, ECOGRAPHY, V32, P180, DOI 10.1111/j.1600-0587.2009.05800.x; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; Riordan EC, 2009, J BIOGEOGR, V36, P2176, DOI 10.1111/j.1365-2699.2009.02151.x; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2005, CORAL REEFS, V24, P654, DOI 10.1007/s00338-005-0049-6; Roberts JM, 2003, MAR POLLUT BULL, V46, P7, DOI 10.1016/S0025-326X(02)00259-X; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; ROGERS AD, 2007, SCI GUIDELINES SCI G; Ross S. W., 2007, STATE DEEP CORAL ECO, P233; SABINE CL, 2005, ORNLCDIAC145 US DEP; Schroder-Ritzrau A, 2005, ERLANGEN EARTH C SER, P157, DOI 10.1007/3-540-27673-4_8; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Thiem O, 2006, CONT SHELF RES, V26, P1481, DOI 10.1016/j.csr.2006.02.016; WILSON JB, 1979, J MAR BIOL ASSOC UK, V59, P165, DOI 10.1017/S0025315400046257; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Woodby D, 2009, MAR ECOL PROG SER, V397, P227, DOI 10.3354/meps08358; Wright D.J., 2005, ARCGIS BENTHIC TERRA	57	243	247	2	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18483	10.1371/journal.pone.0018483	http://dx.doi.org/10.1371/journal.pone.0018483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525990	Green Published, gold			2022-12-25	WOS:000289578600010
J	Lin, ZF; Zhou, ZH; Liu, YL; Gong, Q; Yan, XX; Xiao, J; Wang, XJ; Lin, SQ; Feng, WK; Li, XK				Lin, Zhuofeng; Zhou, Zhihong; Liu, Yanlong; Gong, Qi; Yan, Xinxin; Xiao, Jian; Wang, Xiaojie; Lin, Shaoqiang; Feng, Wenke; Li, Xiaokun			Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; LEFT-VENTRICULAR HYPERTROPHY; SERUM CYSTATIN-C; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; INSULIN SENSITIVITY; FIBROBLAST-GROWTH-FACTOR-23; BETA-2-MICROGLOBULIN; OBESITY; HEALTH	Background: Fibroblast growth factor 21 (FGF21) is a hepatic hormone involved in the regulation of lipid and carbohydrate metabolism. This study aims to test the hypothesis that elevated FGF21 concentrations are associated with the change of renal function and the presence of left ventricular hypertrophy (LVH) in the different stages of chronic kidney disease (CKD) progression. Methodology/Principal Findings: 240 subjects including 200 CKD patients (146 outpatients and 54 long-term hemodialytic patients) and 40 healthy control subjects were recruited. All CKD subjects underwent echocardiograms to assess left ventricular mass index. Plasma FGF21 levels and other clinical and biochemical parameters in all subjects were obtained based on standard clinical examination methods. Plasma FGF21 levels were significantly increased with the development of CKD from early-and end-stage (P < 0.001 for trend), and significantly higher in CKD subjects than those in healthy subjects (P < 0.001). Plasma FGF21 levels in CKD patients with LVH were higher than those in patients without LVH (P=0.001). Furthermore, plasma FGF21 level correlated positively with creatinine, blood urea nitrogen (BUN), beta 2 microglobulin, systolic pressure, adiponectin, phosphate, proteinuria, CRP and triglyceride, but negatively with creatinine clearance rate (CCR), estimated glomerular filtrate rate (eGFR), HDL-c, LDL-c, albumin and LVH after adjusting for BMI, gender, age and the presence of diabetes mellitus. Multiple stepwise regression analyses indicated that FGF21 was independently associated with BUN, Phosphate, LVMI and beta 2 microglobulin (all P < 0.05). Conclusion: Plasma FGF21 levels are significantly increased with the development of early-to end-stage CKD and are independently associated with renal function and adverse lipid profiles in Chinese population. Understanding whether increased FGF21 is associated with myocardial hypertrophy in CKD requires further study.	[Lin, Zhuofeng; Liu, Yanlong; Gong, Qi; Yan, Xinxin; Xiao, Jian; Wang, Xiaojie; Lin, Shaoqiang; Feng, Wenke; Li, Xiaokun] Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China; [Lin, Zhuofeng] Jinan Univ, Sch Pharm, Guanghzou, Peoples R China; [Zhou, Zhihong] Wenzhou Med Coll, Div Kidney, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Li, Xiaokun] Jilin Univ, Key Lab Pathobiol, Natl Minist Educ, Changchun 130023, Peoples R China; [Feng, Wenke] Univ Louisville, Sch Med, Louisville, KY 40292 USA	Wenzhou Medical University; Jinan University; Wenzhou Medical University; Jilin University; University of Louisville	Lin, ZF (corresponding author), Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China.	xiaokunli@163.com	Lin, Zhuofeng/K-2431-2013		Changjiang Scholars and Innovative Research Team; Zhejiang Provincial Natural Science Foundation of China [R2090550, Y2100048]; Natural Science Grant of Zhejiang Province, China [2009J1-C451]	Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Grant of Zhejiang Province, China	This work was supported by grants from Changjiang Scholars and Innovative Research Team (to XL), Zhejiang Provincial Natural Science Foundation of China (R2090550, Y2100048), and Natural Science Grant of Zhejiang Province, China (2009J1-C451). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplin IR, 2001, BLOOD, V97, P3450, DOI 10.1182/blood.V97.11.3450; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Corda S, 1997, CIRC RES, V81, P679; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; DEVEREUX RB, 1986, AM J CARDIOL, V57, P1388, DOI 10.1016/0002-9149(86)90224-9; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; FU XB, 1995, CHINESE MED J-PEKING, V108, P209; Fu Xiaobing, 1996, Wound Repair and Regeneration, V4, P297, DOI 10.1046/j.1524-475X.1996.40219.x; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; HAN SH, 2010, METABOLISM; Hei ZQ, 2008, CHINESE MED J-PEKING, V121, P1251, DOI 10.1097/00029330-200807020-00001; HOLZMANN MJ, 2010, ANN MED; Hostetter TH, 2004, NEW ENGL J MED, V351, P1344, DOI 10.1056/NEJMe048211; Imel EA, 2005, J AM SOC NEPHROL, V16, P2565, DOI 10.1681/ASN.2005050573; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Jovanovic D, 2003, RENAL FAILURE, V25, P123, DOI 10.1081/JDI-120017475; Khan IA, 2006, AM J CARDIOL, V97, P1530, DOI 10.1016/j.amjcard.2005.11.090; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2009, CURR OPIN INVEST DR, V10, P359; Kida Y, 2003, NEW ENGL J MED, V349, P505; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Lin ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015534; Liu YB, 2006, J FORMOS MED ASSOC, V105, P17, DOI 10.1016/S0929-6646(09)60104-2; Michelis R, 2007, BLOOD PURIFICAT, V25, P505, DOI 10.1159/000113010; Middleton RJ, 2001, J AM SOC NEPHROL, V12, P1079, DOI 10.1681/ASN.V1251079; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; *NAT KIDN FDN, 2010, DIAB KIDN DIS; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Scheinowitz M, 2002, ISRAEL MED ASSOC J, V4, P109; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Stein S, 2010, METABOLISM, V59, P33, DOI 10.1016/j.metabol.2009.07.003; Suzuki G, 2005, CIRC RES, V96, P767, DOI 10.1161/01.RES.0000162099.01268.d1; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Vaziri ND, 2010, J RENAL NUTR, V20, pS35, DOI 10.1053/j.jrn.2010.05.010; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018; Whaley-Connell A, 2009, AM J KIDNEY DIS, V53, pS11, DOI 10.1053/j.ajkd.2009.01.004; WIBELL L, 1978, PATHOL BIOL, V26, P295; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; YU Y, 2000, HYPERTENSION, P1428; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	48	75	83	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18398	10.1371/journal.pone.0018398	http://dx.doi.org/10.1371/journal.pone.0018398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525989	Green Published, Green Submitted, gold			2022-12-25	WOS:000289578600008
J	Guan, RL; Purohit, S; Wang, HJ; Bode, B; Reed, JC; Steed, RD; Anderson, SW; Steed, L; Hopkins, D; Xia, C; She, JX				Guan, Ruili; Purohit, Sharad; Wang, Hongjie; Bode, Bruce; Reed, John Chip; Steed, R. Dennis; Anderson, Stephen W.; Steed, Leigh; Hopkins, Diane; Xia, Chun; She, Jin-Xiong			Chemokine (C-C Motif) Ligand 2 (CCL2) in Sera of Patients with Type 1 Diabetes and Diabetic Complications	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SYSTEMIC-SCLEROSIS; HIGH VALUES; TH1 CXCL10; MCP-1; POLYMORPHISM; EXPRESSION; ABSENCE; RISK; CRYOGLOBULINEMIA	Background: Chemokine (C-C motif) ligand 2 (CCL2), commonly known as monocyte chemoattractant protein-1 (MCP-1), has been implicated in the pathogenesis of many diseases characterized by monocytic infiltration. However, limited data have been reported on MCP-1 in type 1 diabetes (T1D) and the findings are inconclusive and inconsistent. Methods: In this study, MCP-1 was measured in the sera from 2,472 T1D patients and 2,654 healthy controls using a Luminex assay. The rs1024611 SNP in the promoter region of MCP-1 was genotyped for a subset of subjects (1764 T1D patients and 1323 controls) using the TaqMan-assay. Results: Subject age, sex or genotypes of MCP-1 rs1024611SNP did not have a major impact on serum MCP-1 levels in either healthy controls or patients. While hemoglobin A1c levels did not have a major influence on serum MCP-1 levels, the mean serum MCP-1 levels are significantly higher in patients with multiple complications (mean = 242 ng/ml) compared to patients without any complications (mean = 201 ng/ml) (p = 3.5x10(-6)). Furthermore, mean serum MCP-1 is higher in controls (mean = 261 ng/ml) than T1D patients (mean = 208 ng/ml) (p, 10 223). More importantly, the frequency of subjects with extremely high levels (> 99(th) percentile of patients or 955 ng/ml) of serum MCP-1 is significantly lower in the T1D group compared to the control group (odds ratio = 0.11, p < 10(-33)). Conclusion: MCP-1may have a dual role in T1D and its complications. While very high levels of serum MCP-1may be protective against the development of T1D, complications are associated with higher serum MCP-1 levels within the T1D group.	[Guan, Ruili] Nanjing Univ Technol, Inst Translat Med, Nanjing 210009, Jiangsu, Peoples R China; [Guan, Ruili] Nanjing Univ Technol, Sch Pharmaceut Sci, Nanjing 210009, Jiangsu, Peoples R China; [Guan, Ruili; Xia, Chun] China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing 100094, Peoples R China; [Guan, Ruili; Purohit, Sharad; Wang, Hongjie; Steed, Leigh; Hopkins, Diane; Xia, Chun; She, Jin-Xiong] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Purohit, Sharad; She, Jin-Xiong] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; [Bode, Bruce] Atlanta Diabet Associates, Atlanta, GA USA; [Reed, John Chip; Steed, R. Dennis] SE Endocrine & Diabet, Atlanta, GA USA; [Anderson, Stephen W.] Pediat Endocrine Associates, Atlanta, GA USA	Nanjing Tech University; Nanjing Tech University; China Agricultural University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Guan, RL (corresponding author), Nanjing Univ Technol, Inst Translat Med, Nanjing 210009, Jiangsu, Peoples R China.	jshe@georgiahealth.edu	Purohit, Sharad/ABA-8054-2021	Purohit, Sharad/0000-0003-0385-3829	National Institutes of Health [4R33HD050196, 4R33-DK069878, 2RO1HD37800]; JDRF [1-2004-661, JDRF 10-2006-792]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037800, R33HD050196, R21HD050196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK069878, R21DK069878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (4R33HD050196, 4R33-DK069878 and 2RO1HD37800) and JDRF (1-2004-661) to JXS. Sharad Purohit was supported by a JDRF senior postdoctoral fellowship (JDRF 10-2006-792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Antonelli A, 2008, DIABETIC MED, V25, P1349, DOI 10.1111/j.1464-5491.2008.02577.x; Antonelli A, 2008, RHEUMATOLOGY, V47, P45, DOI 10.1093/rheumatology/kem313; Antonelli A, 2009, CLIN EXP RHEUMATOL, V27, P22; Antonelli A, 2009, DIGEST LIVER DIS, V41, P42, DOI 10.1016/j.dld.2008.04.009; Antonelli A, 2008, AUTOIMMUNITY, V41, P537, DOI 10.1080/08916930802170401; Antonelli A, 2008, METABOLISM, V57, P1270, DOI 10.1016/j.metabol.2008.04.023; Antonelli A, 2008, J RHEUMATOL, V35, P1809; Antonelli A, 2009, J INTERF CYTOK RES, V29, P345, DOI 10.1089/jir.2008.0090; Berman MA, 1996, J IMMUNOL, V157, P4690; Del Guerra S, 2010, TRANSPL P, V42, P2247, DOI 10.1016/j.transproceed.2010.05.039; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gu L, 1997, J LEUKOCYTE BIOL, V62, P577, DOI 10.1002/jlb.62.5.577; Hanifi-Moghaddam P, 2006, DIABETIC MED, V23, P156, DOI 10.1111/j.1464-5491.2005.01743.x; Harsimran K, 2009, DIABETES VASC DIS RE, V6, P288, DOI 10.1177/1479164109346364; Kanamori H, 2007, BIOCHEM BIOPH RES CO, V360, P772, DOI 10.1016/j.bbrc.2007.06.148; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kiyici S, 2006, ARCH MED RES, V37, P998, DOI 10.1016/j.arcmed.2006.06.002; Kokkotou E, 2002, METABOLISM, V51, P1489, DOI 10.1053/meta.2002.34717; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Martinovic I, 2005, CIRC J, V69, P1484, DOI 10.1253/circj.69.1484; Mazur G, 2007, NEOPLASMA, V54, P285; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; Palmieri O, 2010, AM J GASTROENTEROL, V105, P1586, DOI 10.1038/ajg.2010.4; Park HJ, 2007, SCAND J RHEUMATOL, V36, P299, DOI 10.1080/03009740701288165; Piemonti L, 2009, DIABETES CARE, V32, P2105, DOI 10.2337/dc09-0763; Radstake TRDJ, 2009, HUM IMMUNOL, V70, P130, DOI 10.1016/j.humimm.2008.10.012; ROLLINS BJ, 1991, AM J PATHOL, V138, P1315; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Scarpini E, 2002, J NEUROL SCI, V195, P41, DOI 10.1016/S0022-510X(01)00680-3; Sia Charles, 2005, Rev Diabet Stud, V2, P182, DOI 10.1900/RDS.2005.2.182; Stankovic A, 2009, BRATISL MED J, V110, P641; Tarabra E, 2009, DIABETES, V58, P2109, DOI 10.2337/db08-0895; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Zineh I, 2009, DIABETES CARE, V32, P465, DOI 10.2337/dc08-1849; [No title captured]; [No title captured]	37	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e17822	10.1371/journal.pone.0017822	http://dx.doi.org/10.1371/journal.pone.0017822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21532752	Green Published, gold, Green Submitted			2022-12-25	WOS:000289404700006
J	Boutte, AM; Friedman, DB; Bogyo, M; Min, YF; Yang, L; Lin, PC				Boutte, Angela M.; Friedman, David B.; Bogyo, Matthew; Min, Yongfen; Yang, Li; Lin, P. Charles			Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis	FASEB JOURNAL			English	Article						cathepsin; angiogenesis; lymphanogenesis; NGP	CATHEPSIN-B; BREAST-CANCER; STEFIN-A; TUMOR; ANGIOGENESIS; ASSOCIATION; DEGRADATION; PROGRESSION; MEMBRANE; MICE	Myeloid-derived suppressor cells (MDSCs) are significantly increased in cancer patients and tumor bearing-animals. MDSCs infiltrate into tumors and promote tumor invasion and metastasis. To identify the mediator responsible for the prometastatic property of MDSCs, we used proteomics. We found neutrophilic granule protein (NGP) was decreased > 2-fold in MDSCs from metastatic 4T1 tumor-bearing mice compared to nonmetastatic 67NR controls. NGP mRNA levels were decreased in bone marrow and in tumor-infiltrating MDSCs by 45 and 66%, respectively, in 4T1 tumor-bearing mice compared to 67NR controls. Interestingly, 4T1-conditioned medium reduced myeloid cell NGP expression by similar to 40%, suggesting that a secreted factor mediates gene reduction. Sequence analysis shows a putative cystatin domain in NGP, and biochemical analysis confirms NGP a novel cathepsin inhibitor. It inhibited cathepsin B activity by nearly 40% in vitro. NGP expression in 4T1 tumor cells suppressed cell invasion, delayed primary tumor growth, and greatly reduced lung metastasis in vivo. A 2.8-fold reduction of cathepsin activity was found in tumors expressing NGP compared to controls. NGP significantly reduced tumor angiogenesis to 12.6 from 19.6 and lymphangiogenesis to 4.6 from 9.1 vessels/field. Necrosis was detectable only in NGP-expressing tumors, and the number of apoptotic cells increased to 22.4 from 8.3 in controls. Taken together, this study identifies a negative regulator of tumor metastasis in MDSCs, NGP, which is down-regulated in metastatic conditions. The finding suggests that malignant tumors promote invasion/metastasis not only through up-regulation of proteases but also down-regulation of protease inhibitors.-Boutte, A. M., Friedman, D. B., Bogyo, M., Min, Y., Yang, L., Lin, P. C. Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis. FASEB J. 25, 2626-2637 (2011). www.fasebj.org	[Min, Yongfen; Yang, Li; Lin, P. Charles] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Friedman, David B.] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA; [Boutte, Angela M.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Bogyo, Matthew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University; Stanford University	Lin, PC (corresponding author), NCI, 1050 Boyles St,Bldg 560,Rm 12-32, Frederick, MD 21702 USA.	p.lin@nih.edu		Bogyo, Matthew/0000-0003-3753-4412	U.S. National Institutes of Health [1F32CA136118, UL1 RR 024975, CA108856, NS45888, AR053718]; NATIONAL CANCER INSTITUTE [F32CA136118, ZIABC011390, R01CA108856] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Drs. Lynn Matrisian and Barbara Fingleton at Vanderbilt University Medical Center for critical comments on the manuscript. The authors thank Dr. Kelli Boyd for analysis of tumor histology and Dr. Swati Biswas for her expertise in mouse models of cancer at Vanderbilt University Medical Center. This work is supported in part by U.S. National Institutes of Health grants to A.M.B. (1F32CA136118 and UL1 RR 024975) and P.C.L. (CA108856, NS45888, and AR053718).	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; BARRETT AJ, 1986, BIOMED BIOCHIM ACTA, V45, P1363; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Cavallo-Medved D, 2009, EXP CELL RES, V315, P1234, DOI 10.1016/j.yexcr.2009.01.021; Chang SH, 2009, CANCER RES, V69, P4537, DOI 10.1158/0008-5472.CAN-08-4539; Chen XB, 2010, BIOCHEM BIOPH RES CO, V391, P1070, DOI 10.1016/j.bbrc.2009.12.022; Colbert JD, 2009, TRAFFIC, V10, P425, DOI 10.1111/j.1600-0854.2009.00881.x; Cox JL, 2009, FRONT BIOSCI-LANDMRK, V14, P463, DOI 10.2741/3255; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Ekstrom U, 2008, FEBS J, V275, P4571, DOI 10.1111/j.1742-4658.2008.06600.x; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Friedman David B., 2008, V428, P93; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Kioulafa M, 2009, INT J CANCER, V125, P2887, DOI 10.1002/ijc.24686; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Moscinski LC, 1995, J CELL BIOCHEM, V59, P431, DOI 10.1002/jcb.240590404; Niedergethmann M, 2004, PANCREAS, V29, P204, DOI 10.1097/00006676-200410000-00005; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Sinha AA, 2002, CANCER-AM CANCER SOC, V94, P3141, DOI 10.1002/cncr.10604; SLOANE BF, 1986, P NATL ACAD SCI USA, V83, P2483, DOI 10.1073/pnas.83.8.2483; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Wegiel B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007953; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	30	20	23	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2626	2637		10.1096/fj.10-180604	http://dx.doi.org/10.1096/fj.10-180604			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21518852	Green Published			2022-12-25	WOS:000293337800013
J	Clark, EA; Walker, N; Ford, DC; Cooper, IA; Oyston, PCF; Acharya, KR				Clark, Elizabeth A.; Walker, Nicola; Ford, Donna C.; Cooper, Ian A.; Oyston, Petra C. F.; Acharya, K. Ravi			Molecular Recognition of Chymotrypsin by the Serine Protease Inhibitor Ecotin from Yersinia pestis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; POTENT INHIBITOR; BACTERIA; GENES; ENTEROCOLITICA; RESISTANCE; SYSTEM	Resistance to antibiotics is a problem not only in terms of healthcare but also biodefense. Engineering of resistance into a human pathogen could create an untreatable biothreat pathogen. One such pathogen is Yersinia pestis, the causative agent of plague. Previously, we have used a bioinformatic approach to identify proteins that may be suitable targets for antimicrobial therapy and in particular for the treatment of plague. The serine protease inhibitor ecotin was identified as one such target. We have carried out mutational analyses in the closely related Yersinia pseudotuberculosis, validating that the ecotin gene is a virulence-associated gene in this bacterium. Y. pestis ecotin inhibits chymotrypsin. Here, we present the structure of ecotin in complex with chymotrypsin to 2.74 angstrom resolution. The structure features a biologically relevant tetramer whereby an ecotin dimer binds to two chymotrypsin molecules, similar to what was observed in related serine protease inhibitor structures. However, the vast majority of the interactions in the present structure are distinctive, indicating that the broad specificity of the inhibitor for these proteases is based largely on its capacity to recognize features unique to each of them. These findings will have implications for the development of small ecotin inhibitors for therapeutic use.	[Clark, Elizabeth A.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Walker, Nicola; Ford, Donna C.; Cooper, Ian A.; Oyston, Petra C. F.] Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England	University of Bath; Defence Science & Technology Laboratory	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	k.r.acharya@bath.ac.uk	Cooper, Ian/F-8015-2016	Acharya, K. Ravi/0000-0002-3009-4058	Ministry of Defence; Wellcome Trust [088464]; Royal Society (U.K.)	Ministry of Defence; Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society (U.K.)(Royal Society of London)	This work was supported by the Ministry of Defence, Wellcome Trust (U. K.) Equipment Grant 088464 and by a Royal Society (U.K.) industry fellowship (to K. R. A.).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRETER R, 1981, INFECT IMMUN, V34, P241, DOI 10.1128/IAI.34.1.241-249.1981; Gillmor SA, 2000, J MOL BIOL, V299, P993, DOI 10.1006/jmbi.2000.3812; Guiyoule A, 2001, EMERG INFECT DIS, V7, P43, DOI 10.3201/eid0701.010106; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Laws TR, 2010, MICROBES INFECT, V12, P331, DOI 10.1016/j.micinf.2010.01.007; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCGRATH ME, 1994, EMBO J, V13, P1502, DOI 10.1002/j.1460-2075.1994.tb06411.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perona JJ, 1997, BIOCHEMISTRY-US, V36, P5381, DOI 10.1021/bi9617522; RILEY G, 1989, J CLIN MICROBIOL, V27, P213, DOI 10.1128/JCM.27.1.213-214.1989; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SEYMOUR JL, 1994, BIOCHEMISTRY-US, V33, P3949, DOI 10.1021/bi00179a022; Stoop AA, 2003, NAT BIOTECHNOL, V21, P1063, DOI 10.1038/nbt860; Stubben CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-501; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; ULMER JS, 1995, FEBS LETT, V365, P159, DOI 10.1016/0014-5793(95)00466-M; Wang SX, 2001, BIOCHEMISTRY-US, V40, P10038, DOI 10.1021/bi010712h; WIRNT R, 1974, METHODS ENZYMATIC AN	34	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					24015	24022		10.1074/jbc.M111.225730	http://dx.doi.org/10.1074/jbc.M111.225730			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21531711	Green Published, hybrid			2022-12-25	WOS:000292294900044
J	Chim, SM; Qin, A; Tickner, J; Pavlos, N; Davey, T; Wang, H; Guo, YJ; Zheng, MH; Xu, JK				Chim, Shek Man; Qin, An; Tickner, Jennifer; Pavlos, Nathan; Davey, Tamara; Wang, Hao; Guo, Yajun; Zheng, Ming Hao; Xu, Jiake			EGFL6 Promotes Endothelial Cell Migration and Angiogenesis through the Activation of Extracellular Signal-regulated Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; PROTEIN NEPHRONECTIN; RECEPTOR ACTIVATOR; BONE REPAIR; DIFFERENTIATION; EXPRESSION; DOMAIN; GENE; IDENTIFICATION	Angiogenesis is required for bone development, growth, and repair. It is influenced by the local bone environment that involves cross-talks between endothelial cells and adjacent bone cells. However, data regarding factors that directly contribute to angiogenesis by bone cells remain poorly understood. Here, we report that EGFL6, a member of the epidermal growth factor (EGF) repeat superfamily proteins, induces angiogenesis by a paracrine mechanism in which EGFL6 is expressed in osteoblastic- like cells but promotes migration and angiogenesis of endothelial cells. Co-immunoprecipitation assays revealed that EGFL6 is secreted in culture medium as a homodimer protein. Using scratch wound healing and transwell assays, we found that conditioned medium containing EGFL6 potentiates SVEC (a simian virus 40-transformed mouse microvascular endothelial cell line) endothelial cell migration. In addition, EGFL6 promotes the endothelial cell tube-like structure formation in Matrigel assays and angiogenesis in a chick embryo chorioallantoic membrane. Furthermore, we show that EGFL6 recombinant protein induces phosphorylation of ERK in SVEC endothelial cells. Inhibition of ERK impaired EGFL6-induced ERK activation and endothelial cell migration. Together, these results demonstrate, for the first time, that osteoblastic-like cells express EGFL6 that is capable of promoting endothelial cell migration and angiogenesis via ERK activation. Thus, the EGLF6 mediates a paracrine mechanism of cross-talk between vascular endothelial cells and osteoblasts and might offer an important new target for the potential treatment of bone diseases, including osteonecrosis, osteoporosis, and fracture healing.	[Chim, Shek Man; Tickner, Jennifer; Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Qin, An; Pavlos, Nathan; Davey, Tamara; Zheng, Ming Hao] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Nedlands, WA 6009, Australia; [Qin, An] Shanghai Jiao Tong Univ, Sch Med, Ninth Peoples Hosp, Dept Orthopaed, Shanghai 200011, Peoples R China; [Wang, Hao; Guo, Yajun] Second Mil Med Univ, Gen Hosp Canc Ctr 301, Shanghai 200433, Peoples R China; [Wang, Hao; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Wang, Hao; Guo, Yajun] Shanghai Key Lab Cell Engn & Antibody, Shanghai 201203, Peoples R China; [Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, Shanghai 201203, Peoples R China; [Wang, Hao; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Med, Shanghai 200025, Peoples R China; [Wang, Hao; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200025, Peoples R China	University of Western Australia; University of Western Australia; Shanghai Jiao Tong University; Naval Medical University; Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, JK (corresponding author), Univ Western Australia M508, Sch Pathol & Lab Med, 35 Stirling Hwy, Crawley, WA 6009, Australia.	jiake.xu@uwa.edu.au	Chim, Shek Man/AAK-6809-2020; Tickner, Jennifer/H-5965-2014	Chim, Shek Man/0000-0002-5116-8394; Tickner, Jennifer/0000-0002-5020-0671; Zheng, Minghao/0000-0003-1185-4768; Xu, Jiake/0000-0003-2021-8309; Pavlos, Nathan/0000-0001-7003-188X	National Health and Medical Research Council of Australia; Sir Charles Gairdner Hospital	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Sir Charles Gairdner Hospital	This work was supported in part by the National Health and Medical Research Council of Australia and the Sir Charles Gairdner Hospital Research Fund.	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Buchner G, 2000, MECH DEVELOP, V98, P179, DOI 10.1016/S0925-4773(00)00462-7; Buchner G, 2000, GENOMICS, V65, P16, DOI 10.1006/geno.2000.6146; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Campagnolo L, 2005, AM J PATHOL, V167, P275, DOI 10.1016/S0002-9440(10)62972-0; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Carlevaro MF, 2000, J CELL SCI, V113, P59; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Fang TD, 2005, J BONE MINER RES, V20, P1114, DOI 10.1359/JBMR.050301; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8; Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lee S, 2003, FASEB J, V17, pA326, DOI 10.1096/fj.02-0570fje; Leker RR, 2009, NEUROSCIENCE, V163, P233, DOI 10.1016/j.neuroscience.2009.05.050; Liekens S, 2001, BIOCHEM PHARMACOL, V61, P253, DOI 10.1016/S0006-2952(00)00529-3; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Nakamura A, 2007, BONE, V40, P305, DOI 10.1016/j.bone.2006.09.001; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; Parfitt AM, 2001, J BONE MINER RES, V16, P1583, DOI 10.1359/jbmr.2001.16.9.1583; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Qin L, 2005, J BIOL CHEM, V280, P3974, DOI 10.1074/jbc.M409807200; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; SCHNEIDER MR, 2009, J BONE MINER RES; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; Wang K, 2004, J BIOL CHEM, V279, P53848, DOI 10.1074/jbc.M403114200; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200; Yeung G, 1999, GENOMICS, V62, P304, DOI 10.1006/geno.1999.6011; Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200	46	79	93	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22035	22046		10.1074/jbc.M110.187633	http://dx.doi.org/10.1074/jbc.M110.187633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21531721	Green Published, hybrid			2022-12-25	WOS:000291719900010
J	Hamatake, M; Miyazaki, N; Sudo, K; Matsuda, M; Sadakata, T; Furuya, A; Ichisaka, S; Hata, Y; Nakagawa, C; Nagata, K; Furuichi, T; Katoh-Semba, R				Hamatake, Michiko; Miyazaki, Noriko; Sudo, Kaori; Matsuda, Motoko; Sadakata, Tetsushi; Furuya, Asako; Ichisaka, Satoshi; Hata, Yoshio; Nakagawa, Chiaki; Nagata, Koh-ichi; Furuichi, Teiichi; Katoh-Semba, Ritsuko			Phase Advance of the Light-Dark Cycle Perturbs Diurnal Rhythms of Brain-derived Neurotrophic Factor and Neurotrophin-3 Protein Levels, Which Reduces Synaptophysin-positive Presynaptic Terminals in the Cortex of Juvenile Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL DENDRITIC GROWTH; BDNF MESSENGER-RNA; CIRCADIAN-RHYTHM; IN-VIVO; HIPPOCAMPUS; EXPRESSION; SLEEP; NEURONS; ACTIVATION; RECEPTOR	In adult rat brains, brain-derived neurotrophic factor (BDNF) rhythmically oscillates according to the light-dark cycle and exhibits unique functions in particular brain regions. However, little is known of this subject in juvenile rats. Here, we examined diurnal variation in BDNF and neurotrophin-3 (NT-3) levels in 14-day-old rats. BDNF levels were high in the dark phase and low in the light phase in a majority of brain regions. In contrast, NT-3 levels demonstrated an inverse phase relationship that was limited to the cerebral neocortex, including the visual cortex, and was most prominent on postnatal day 14. An 8-h phase advance of the light-dark cycle and sleep deprivation induced an increase in BDNF levels and a decrease in NT-3 levels in the neocortex, and the former treatment reduced synaptophysin expression and the numbers of synaptophysin-positive presynaptic terminals in cortical layer IV and caused abnormal BDNF and NT-3 rhythms 1 week after treatment. A similar reduction of synaptophysin expression was observed in the cortices of Bdnf gene-deficient mice and Ca2+-dependent activator protein for secretion 2 gene-deficient mice with abnormal free-running rhythm and autistic-like phenotypes. In the latter mice, no diurnal variation in BDNF levels was observed. These results indicate that regular rhythms of BDNF and NT-3 are essential for correct cortical network formation in juvenile rodents.	[Sadakata, Tetsushi; Furuya, Asako; Furuichi, Teiichi; Katoh-Semba, Ritsuko] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan; [Hamatake, Michiko; Miyazaki, Noriko; Sudo, Kaori; Matsuda, Motoko; Nakagawa, Chiaki; Nagata, Koh-ichi; Katoh-Semba, Ritsuko] Aichi Human Serv Ctr, Inst Dev Res, Aichi 4800392, Japan; [Ichisaka, Satoshi] Tottori Univ, Fac Med, Sch Life Sci, Div Neurobiol, Tottori 6838503, Japan; [Hata, Yoshio] Tottori Univ, Grad Sch Med Sci, Div Integrat Biosci, Tottori 6838503, Japan; [Sadakata, Tetsushi; Furuichi, Teiichi; Katoh-Semba, Ritsuko] Japan Sci & Technol, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	RIKEN; Tottori University; Tottori University; Japan Science & Technology Agency (JST)	Katoh-Semba, R (corresponding author), RIKEN Brain Sci Inst, Lab Mol Neurogenesis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	katohsemba@brain.riken.jp	Sadakata, Tetsushi/W-9324-2018; Furuichi, Teiichi/B-5086-2014	Sadakata, Tetsushi/0000-0003-0276-4162; Furuichi, Teiichi/0000-0002-9676-1888				Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bender KJ, 2006, J NEUROSCI, V26, P4155, DOI 10.1523/JNEUROSCI.0175-06.2006; Bova R, 1998, MOL BRAIN RES, V57, P321, DOI 10.1016/S0169-328X(98)00092-8; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Conner JM, 1997, J NEUROSCI, V17, P2295; Croll SD, 1998, BRAIN RES, V812, P200, DOI 10.1016/S0006-8993(98)00993-7; Dolci C, 2003, BRAIN RES, V994, P67, DOI 10.1016/j.brainres.2003.09.018; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Fawcett JP, 1998, J NEUROSCI, V18, P2808; Glantz LA, 2007, NEUROSCIENCE, V149, P582, DOI 10.1016/j.neuroscience.2007.06.036; Gonzalez MMC, 2008, P NATL ACAD SCI USA, V105, P4898, DOI 10.1073/pnas.0703615105; Gorski JA, 2003, J NEUROSCI, V23, P6856; Hairston IS, 2004, J NEUROPHYSIOL, V91, P1586, DOI 10.1152/jn.00894.2003; He J, 2005, CELL PHYSIOL BIOCHEM, V16, P69, DOI 10.1159/000087733; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; IBUKA N, 1975, BRAIN RES, V96, P76, DOI 10.1016/0006-8993(75)90574-0; Itami C, 2007, J NEUROSCI, V27, P2241, DOI 10.1523/JNEUROSCI.3345-06.2007; KAISHO Y, 1994, BRAIN RES, V666, P143, DOI 10.1016/0006-8993(94)90297-6; Katoh-Semba R, 2009, NEUROSCIENCE, V163, P352, DOI 10.1016/j.neuroscience.2009.06.011; Katoh-Semba R, 1999, NEUROSCI RES, V35, P19, DOI 10.1016/S0168-0102(99)00059-0; Katoh-Semba R, 2001, J NEUROCHEM, V77, P71, DOI 10.1046/j.1471-4159.2001.00138.x; Katoh-Semba R, 2008, J NEUROCHEM, V106, P2131, DOI 10.1111/j.1471-4159.2008.05565.x; Katoh-Semba R, 2007, INT J DEV NEUROSCI, V25, P367, DOI 10.1016/j.ijdevneu.2007.07.002; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kushikata T, 1999, AM J PHYSIOL-REG I, V276, pR1334, DOI 10.1152/ajpregu.1999.276.5.R1334; Liang FQ, 2000, J NEUROSCI, V20, P2978; LINDSAY RM, 1993, NEUROTROPHIC FACTORS, P257; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Minshew NJ, 2007, ARCH NEUROL-CHICAGO, V64, P945, DOI 10.1001/archneur.64.7.945; Moore RY, 2007, SLEEP MED, V8, pS27, DOI 10.1016/j.sleep.2007.10.003; Ohta H, 2002, EUR J NEUROSCI, V15, P1953, DOI 10.1046/j.1460-9568.2002.02016.x; Perez-Cruz C, 2009, BEHAV BRAIN RES, V205, P406, DOI 10.1016/j.bbr.2009.07.021; Pollock GS, 2001, J NEUROSCI, V21, P3923, DOI 10.1523/JNEUROSCI.21-11-03923.2001; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Schaaf MJM, 2000, MOL BRAIN RES, V75, P342, DOI 10.1016/S0169-328X(99)00314-9; Sei H, 2003, LIFE SCI, V73, P53, DOI 10.1016/S0024-3205(03)00251-0; Shinoda Y, 2005, BRAIN RES, V1042, P99, DOI 10.1016/j.brainres.2005.02.028; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Xiong H, 2002, NEUROPHARMACOLOGY, V42, P903, DOI 10.1016/S0028-3908(02)00043-6; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21478	21487		10.1074/jbc.M110.195859	http://dx.doi.org/10.1074/jbc.M110.195859			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527636	Green Published, hybrid			2022-12-25	WOS:000291464700046
J	Rengstl, B; Oster, U; Stengel, A; Nickelsen, J				Rengstl, Birgit; Oster, Ulrike; Stengel, Anna; Nickelsen, Joerg			An Intermediate Membrane Subfraction in Cyanobacteria Is Involved in an Assembly Network for Photosystem II Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL PROCESSING PROTEASE; CHLOROPHYLL BIOSYNTHESIS; MANGANESE CLUSTER; MUTANT STRAIN; REPAIR; HOMOLOG; PLASMA; PSB27	Early steps in the biogenesis of Photosystem II (PSII) in the cyanobacterium Synechocystis sp. PCC 6803 are thought to occur in a specialized membrane fraction that is characterized by the specific accumulation of the PSII assembly factor PratA and its interaction partner pD1, the precursor of the D1 protein of PSII. Here, we report the molecular characterization of this membrane fraction, called the PratA-defined membrane (PDM), with regard to its lipid and pigment composition and its association with PSII assembly factors, including YCF48, Slr1471, Sll0933, and Pitt. We demonstrate that YCF48 and Slr1471 are present and that the chlorophyll precursor chlorophyllide a accumulates in the PDM. Analysis of PDMs from various mutant lines suggests a central role for PratA in the spatial organization of PSII biogenesis. Moreover, quantitative immunoblot analyses revealed a network of interdependences between several PSII assembly factors and chlorophyll synthesis. In addition, formation of complexes containing both YCF48 and Sll0933 was substantiated by co-immunoprecipitation experiments. The findings are integrated into a refined model for PSII biogenesis in Synechocystis 6803.	[Rengstl, Birgit; Oster, Ulrike; Stengel, Anna; Nickelsen, Joerg] Univ Munich, Biozentrum, D-82152 Planegg Martinsried, Germany	University of Munich	Nickelsen, J (corresponding author), Univ Munich, Biozentrum, Grosshaderner Str 2-4, D-82152 Planegg Martinsried, Germany.	joerg.nickelsen@lrz.uni-muenchen.de	Nickelsen, Jörg/J-8896-2014	Nickelsen, Joerg/0000-0003-4184-4560	Deutsche Forschungsgemeinschaft [SFB TR1 TPC10]; Ludwig-Maximilians-Universitat Munchen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ludwig-Maximilians-Universitat Munchen	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB TR1 TPC10 (to J. N.) and a Bayerische Gleichstellungsforderung (BGF) scholarship from the Ludwig-Maximilians-Universitat Munchen (to A. S.).	ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; Armbruster U, 2010, PLANT CELL, V22, P3439, DOI 10.1105/tpc.110.077453; Armstrong GA, 1998, J PHOTOCH PHOTOBIO B, V43, P87, DOI 10.1016/S1011-1344(98)00063-3; Bergantino E, 2003, J BIOL CHEM, V278, P41820, DOI 10.1074/jbc.M303096200; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; Eaton-Rye JJ, 2004, METH MOL B, V274, P309; EATONRYE JJ, 1991, PLANT MOL BIOL, V17, P1165, DOI 10.1007/BF00028733; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; He QF, 1998, P NATL ACAD SCI USA, V95, P5830, DOI 10.1073/pnas.95.10.5830; HINTERSTOISSER B, 1993, J PLANT PHYSIOL, V142, P407, DOI 10.1016/S0176-1617(11)81245-9; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Nickelsen J, 2011, FEMS MICROBIOL LETT, V315, P1, DOI 10.1111/j.1574-6968.2010.02096.x; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Ossenbuhl F, 2006, PLANT CELL, V18, P2236, DOI 10.1105/tpc.106.043646; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; Schottkowski M, 2009, J BIOL CHEM, V284, P1813, DOI 10.1074/jbc.M806116200; SHESTAKOV SV, 1994, J BIOL CHEM, V269, P19354; Uniacke J, 2007, PLANT CELL, V19, P3640, DOI 10.1105/tpc.107.054882; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; Vermaas W. F. J., 2001, ENCY LIFE SCI, DOI [10.1038/npg.els.0001670, DOI 10.1038/NPG.ELS.0001670]; Yaronskaya E, 2003, PLANT J, V35, P512, DOI 10.1046/j.1365-313X.2003.01825.x; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898	30	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21944	21951		10.1074/jbc.M111.237867	http://dx.doi.org/10.1074/jbc.M111.237867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531723	Green Published, hybrid			2022-12-25	WOS:000291464700089
J	Veeraraghavan, J; Natarajan, M; Aravindan, S; Herman, TS; Aravindan, N				Veeraraghavan, Jamunarani; Natarajan, Mohan; Aravindan, Sheeja; Herman, Terence S.; Aravindan, Natarajan			Radiation-triggered Tumor Necrosis Factor (TNF) alpha-NF kappa B Cross-signaling Favors Survival Advantage in Human Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOSE IONIZING-RADIATION; INDUCED APOPTOSIS; THERAPEUTIC TARGET; LUNG-CANCER; ACTIVATION; SENSITIZATION; CARCINOMA; TRANSCRIPTION; INVOLVEMENT; IRRADIATION	Induced radioresistance in the surviving cancer cells after radiotherapy could be associated with clonal selection leading to tumor regrowth at the treatment site. Previously we reported that post-translational modification of I kappa B alpha activates NF kappa B in response to ionizing radiation (IR) and plays a key role in regulating apoptotic signaling. Herein, we investigated the orchestration of NF kappa B after IR in human neuroblastoma. Both in vitro (SH-SY5Y, SK-N-MC, and IMR-32) and in vivo (xenograft) studies showed that IR persistently induced NF kappa B DNA binding activity and NF kappa B-dependent TNF alpha transactivation and secretion. Approaches including silencing NF kappa B transcription, blocking post-translational NF kappa B nuclear import, muting TNF receptor, overexpression, and physiological induction of either NF kappa B or TNF alpha precisely demonstrated the initiation and occurrence of NF kappa B -> TNF alpha -> NF kappa B positive feedback cycle after IR that leads to and sustains NF kappa B activation. Selective TNF-dependent NF kappa B regulation was confirmed with futile inhibition of AP-1 and SP-1 in TNF receptor muted cells. Moreover, IR increased both transactivation and translation of Birc1, Birc2, and Birc5 and induced metabolic activity and clonal expansion. This pathway was further defined to show that IR-induced functional p65 transcription (not NF kappa B1, NF kappa B2, or c-Rel) is necessary for activation of these survival molecules and associated survival advantage. Together, these results demonstrate for the first time the functional orchestration of NF kappa B in response to IR and further imply that p65-dependent survival advantage and initiation of clonal expansion may correlate with an unfavorable prognosis of human neuroblastoma.	[Veeraraghavan, Jamunarani; Herman, Terence S.; Aravindan, Natarajan] Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, Oklahoma City, OK 73104 USA; [Veeraraghavan, Jamunarani; Natarajan, Mohan; Aravindan, Natarajan] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Aravindan, Sheeja] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA; [Veeraraghavan, Jamunarani; Natarajan, Mohan; Aravindan, Natarajan] Univ Texas Hlth Sci Ctr San Antonio, Dept Otolaryngol Head & Neck Surg, San Antonio, TX 78229 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; University of Texas Health San Antonio	Aravindan, N (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Radiat Oncol, OUPB 1430,825 NE 10th St, Oklahoma City, OK 73104 USA.	naravind@ouhsc.edu	Aravindan, Natarajan/M-3203-2013	Aravindan, Natarajan/0000-0001-9150-3911; Aravindan, Sheeja/0000-0002-4810-789X; Veeraraghavan, Jamunarani/0000-0002-9524-9487	National Institutes of Health [R01 CA112175]; University of Oklahoma; American Cancer Society [IRG-05-066-01]; Presbyterian Health Foundation [C5046201]; Office of Science (Biological and Environmental Research); United States Department of Energy [DE-FG03-02ER63449]; NATIONAL CANCER INSTITUTE [R01CA112175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Oklahoma; American Cancer Society(American Cancer Society); Presbyterian Health Foundation; Office of Science (Biological and Environmental Research)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA112175 (to M. N.). This work was also supported by University of Oklahoma Health Sciences Center Department of Radiation Oncology research development funds, American Cancer Society Grant IRG-05-066-01, Presbyterian Health Foundation Grant C5046201 (to N. A.), funds from the Office of Science (Biological and Environmental Research), and United States Department of Energy Grant NO.DE-FG03-02ER63449.	Abal M, 2006, HISTOL HISTOPATHOL, V21, P197, DOI 10.14670/HH-21.197; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Aravindan N, 2008, CANCER BIOL THER, V7, P569, DOI 10.4161/cbt.7.4.5534; Aravindan N, 2008, MOL CELL BIOCHEM, V310, P167, DOI 10.1007/s11010-007-9678-0; Aravindan N, 2009, J CELL BIOCHEM, V106, P999, DOI 10.1002/jcb.22079; Armstrong MB, 2006, NEOPLASIA, V8, P967, DOI 10.1593/neo.06574; Baeuerle P. A., 1991, MOL ASPECTS CELLULAR, P409; BERNSTEIN ML, 1992, J CLIN ONCOL, V10, P323, DOI 10.1200/JCO.1992.10.2.323; Bian X, 2002, J BIOL CHEM, V277, P42144, DOI 10.1074/jbc.M203891200; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Blonska M, 2004, MOL CELL BIOL, V24, P10757, DOI 10.1128/MCB.24.24.10757-10765.2004; Bradbury CM, 2001, CANCER RES, V61, P7689; Cao C, 2004, ONCOGENE, V23, P7047, DOI 10.1038/sj.onc.1207929; Carlson DL, 2003, AM J PHYSIOL-HEART C, V284, pH804, DOI 10.1152/ajpheart.00394.2001; CASTLEBERRY RP, 1991, J CLIN ONCOL, V9, P789, DOI 10.1200/JCO.1991.9.5.789; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Giagkousiklidis S, 2005, CANCER RES, V65, P10502, DOI 10.1158/0008-5472.CAN-05-0866; Haase MG, 2003, INT J RADIAT BIOL, V79, P863, DOI 10.1080/09553000310001632903; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Javelaud D, 2000, ONCOGENE, V19, P61, DOI 10.1038/sj.onc.1203246; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Kasof GM, 2001, ONCOGENE, V20, P7965, DOI 10.1038/sj.onc.1204985; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Lu B, 2004, CANCER RES, V64, P2840, DOI 10.1158/0008-5472.CAN-03-3547; Madhusoodhanan R, 2009, J RADIAT RES, V50, P311, DOI 10.1269/jrr.08110; MCGINN CJ, 1992, SEMIN ONCOL, V19, P21; MOHAN N, 1994, RADIAT RES, V140, P97, DOI 10.2307/3578574; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Natarajan M, 2002, RADIAT ENVIRON BIOPH, V41, P139, DOI 10.1007/s00411-002-0143-x; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Parisi MT, 1999, RADIOGRAPHICS, V19, P283, DOI 10.1148/radiographics.19.2.g99mr05283; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; PRASAD AV, 1994, RADIAT RES, V138, P367, DOI 10.2307/3578685; Ravi R, 2004, DRUG RESIST UPDATE, V7, P53, DOI 10.1016/j.drup.2004.01.003; Rodel C, 2003, INT J RADIAT ONCOL, V55, P1341, DOI 10.1016/S0360-3016(02)04618-7; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; SATRIANO J, 1994, J CLIN INVEST, V94, P1629, DOI 10.1172/JCI117505; SCHULTZ RM, 1990, J INTERFERON RES, V10, P229, DOI 10.1089/jir.1990.10.229; STAAB HJ, 1982, BRIT J CANCER, V46, P841, DOI 10.1038/bjc.1982.293; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Vazquez E, 2003, RADIOGRAPHICS, V23, P1155, DOI 10.1148/rg.235035040; Wang T, 2005, J BIOL CHEM, V280, P12593, DOI 10.1074/jbc.M410982200; Weng HR, 2005, NEUROSCI LETT, V386, P18, DOI 10.1016/j.neulet.2005.05.049	48	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21588	21600		10.1074/jbc.M110.193755	http://dx.doi.org/10.1074/jbc.M110.193755			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527635	Green Published, hybrid			2022-12-25	WOS:000291464700056
J	Whitaker, RD; Pember, S; Wallace, BC; Brodley, CE; Walt, DR				Whitaker, Ragnhild D.; Pember, Steven; Wallace, Byron C.; Brodley, Carla E.; Walt, David R.			Single Cell Time-resolved Quorum Responses Reveal Dependence on Cell Density and Configuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACYLHOMOSERINE LACTONES; GENE-EXPRESSION; SENSING INHIBITORS; BACTERIA; DIFFUSION; SIGNALS; SYSTEMS	Bacterial communication via quorum sensing has been extensively investigated in recent years. Bacteria communicate in a complex manner through the production, release, and reception of diffusible low molecular weight chemical signaling molecules. Much work has focused on understanding the basic mechanisms of quorum sensing. As more and more bacteria grow resistant to conventional antibiotics, the development of drugs that do not kill bacteria but instead interrupt their communication is of increasing interest. This study presents a method for analyzing bacterial communication by investigating single cell responses. Most conventional analysis methods for bacterial communication are based on the averaged response from many bacteria, masking how individual cells respond to their immediate environment. We applied a fiber-optic microarray to record cellular communication from single cells. Single cell quorum sensing systems have previously been employed, but the highly ordered array reported here is an improvement because it allows us to simultaneously investigate cellular communication in many different environments with known cellular densities and configurations. We employed this method to detect how genes under quorum regulation are induced or repressed over time on the single cell level and to determine whether cellular density and configuration are indicative of the single cell temporal patterns of gene expression.	[Whitaker, Ragnhild D.; Walt, David R.] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Pember, Steven; Wallace, Byron C.; Brodley, Carla E.] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA	Tufts University; Tufts University	Walt, DR (corresponding author), 62 Talbot Ave, Medford, MA 02155 USA.	david.walt@tufts.edu						Andersen JB, 2001, APPL ENVIRON MICROB, V67, P575, DOI 10.1128/AEM.67.2.575-585.2001; Barnard Anne M. L., 2004, ComPlexUs, V2, P87, DOI 10.1159/000089986; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Biran I, 2002, ANAL CHEM, V74, P3046, DOI 10.1021/ac020009e; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Burmolle M, 2005, MICROB ECOL, V50, P221, DOI 10.1007/s00248-004-0113-8; CRAWSHAW J, 1999, CONCISE COURSE ADV L; Fekete A, 2007, ANAL BIOANAL CHEM, V387, P455, DOI 10.1007/s00216-006-0970-8; Frommberger M, 2005, ELECTROPHORESIS, V26, P1523, DOI 10.1002/elps.200410365; Gotz C, 2007, ANAL BIOANAL CHEM, V389, P1447, DOI 10.1007/s00216-007-1579-2; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Hentzer M, 2003, J CLIN INVEST, V112, P1300, DOI [10.1172/JCI20074, 10.1172/JCI200320074]; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Khmel IA, 2006, MICROBIOLOGY+, V75, P390, DOI 10.1134/S0026261706040047; Kuang Y, 2004, ANAL CHEM, V76, P2902, DOI 10.1021/ac0354589; Kuang Y, 2004, ANAL CHEM, V76, P6282, DOI 10.1021/ac049053f; Kumari A, 2006, ANAL CHEM, V78, P7603, DOI 10.1021/ac061421n; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Obst U, 2007, ANAL BIOANAL CHEM, V387, P369, DOI 10.1007/s00216-006-0965-5; Rasmussen TB, 2006, MICROBIOL-SGM, V152, P895, DOI 10.1099/mic.0.28601-0; Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Shah IM, 2009, CURR BIOL, V19, pR689, DOI 10.1016/j.cub.2009.07.010; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Whitaker RD, 2007, ANAL BIOCHEM, V360, P63, DOI 10.1016/j.ab.2006.10.013; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Winans SC, 2006, ACS CHEM BIOL, V1, P429, DOI 10.1021/cb6003417	32	9	9	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21623	21632		10.1074/jbc.M111.239897	http://dx.doi.org/10.1074/jbc.M111.239897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21527637	Green Published, hybrid			2022-12-25	WOS:000291464700059
J	Torres, MP; Clement, ST; Cappell, SD; Dohlman, HG				Torres, Matthew P.; Clement, Sarah T.; Cappell, Steven D.; Dohlman, Henrik G.			Cell Cycle-dependent Phosphorylation and Ubiquitination of a G Protein alpha Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; DNA-REPLICATION; ANALYSIS REVEALS; KINASE; YEAST; DEGRADATION; ELM1; FAR1; SCF; ACTIVATION	A diverse array of external stimuli, including most hormones and neurotransmitters, bind to cell surface receptors that activate G proteins. Mating pheromones in yeast Saccharomyces cerevisiae activate G protein-coupled receptors and initiate events leading to cell cycle arrest in G(1) phase. Here, we show that the G alpha subunit (Gpa1) is phosphorylated and ubiquitinated in response to changes in the cell cycle. We systematically screened 109 gene deletion strains representing the non-essential yeast kinome and identified a single kinase gene, ELM1, as necessary and sufficient for Gpa1 phosphorylation. Elm1 is expressed in a cell cycle-dependent manner, primarily at S and G(2)/M. Accordingly, phosphorylation of Gpa1 in G(2)/M phase leads to poly-ubiquitination in G(1) phase. These findings demonstrate that Gpa1 is dynamically regulated. More broadly, they reveal how G proteins can simultaneously regulate, and become regulated by, progression through the cell cycle.	[Torres, Matthew P.; Clement, Sarah T.; Cappell, Steven D.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Genet Med Bldg,120 Mason Farm Rd,Suite 3010, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu	Cappell, Steven/O-4072-2018	Cappell, Steven/0000-0002-2885-7327; Torres, Matthew/0000-0001-7296-4536; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [R01 GM059167, R01 GM080739, R01 GM080739-S1, K99 GM094533-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059167, R01GM080739, K99GM094533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM059167 and R01 GM080739 (to H.G.D.) and R01 GM080739-S1 and K99 GM094533-01 (to M.P.T.).	Asano S, 2006, J BIOL CHEM, V281, P27090, DOI 10.1074/jbc.M601483200; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Bouquin N, 2000, J CELL SCI, V113, P1435; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Caydasi AK, 2010, J CELL BIOL, V190, P975, DOI 10.1083/jcb.201006151; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; Crutchley J, 2009, MOL BIOL CELL, V20, P1926, DOI 10.1091/mbc.E08-08-0848; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Deshaies RJ, 1997, CURR OPIN GENET DEV, V7, P7, DOI 10.1016/S0959-437X(97)80103-7; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Hepler JR, 2003, MOL PHARMACOL, V64, P547, DOI 10.1124/mol.64.3.547; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Koehler CM, 1997, FEBS LETT, V408, P109, DOI 10.1016/S0014-5793(97)00401-8; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; Manderson EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001500; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MCKINNEY JD, 1993, GENE DEV, V7, P833, DOI 10.1101/gad.7.5.833; NEIMAN AM, 1990, CELL REGUL, V1, P391, DOI 10.1091/mbc.1.5.391; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Palecek SP, 2000, GENETICS, V156, P1005; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SPAIN BH, 1995, J BIOL CHEM, V270, P25435, DOI 10.1074/jbc.270.43.25435; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suchkov DV, 2010, MOL BIOL CELL, V21, P1737, DOI 10.1091/mbc.E09-08-0706; Szkotnicki L, 2008, MOL BIOL CELL, V19, P4675, DOI 10.1091/mbc.E08-06-0663; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; TYERS M, 1993, MOL CELL BIOL, V13, P5659, DOI 10.1128/MCB.13.9.5659; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Willems AR, 1999, PHILOS T ROY SOC B, V354, P1533, DOI 10.1098/rstb.1999.0497; Wittenberg C, 2003, BIOESSAYS, V25, P856, DOI 10.1002/bies.10327	57	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20208	20216		10.1074/jbc.M111.239343	http://dx.doi.org/10.1074/jbc.M111.239343			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21521692	Green Published, hybrid			2022-12-25	WOS:000291267600008
J	Anderson, ER; Xue, X; Shah, YM				Anderson, Erik R.; Xue, Xiang; Shah, Yatrik M.			Intestinal Hypoxia-inducible Factor-2 alpha(HIF-2 alpha) Is Critical for Efficient Erythropoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-ABSORPTION; EPITHELIAL-CELLS; HEPCIDIN; ANEMIA; MICE; TRANSPORTER; METABOLISM; EXPRESSION; FERROPORTIN; HOMEOSTASIS	Erythropoiesis is a coordinated process by which RBCs are produced. Erythropoietin, a kidney-derived hormone, and iron are critical for the production of oxygen-carrying mature RBCs. To meet the high demands of iron during erythropoiesis, small intestinal iron absorption is increased through an undefined mechanism. In this study, erythropoietic induction of iron absorption was further investigated. Hypoxia-inducible factor-2 alpha (HIF-2 alpha) signaling was activated in the small intestine during erythropoiesis. Genetic disruption of HIF-2 alpha in the intestine abolished the increase in iron absorption genes as assessed by quantitative real-time reverse transcription-PCR and Western blot analyses. Moreover, the increase in serum iron following induction of erythropoiesis was entirely dependent on intestinal HIF-2 alpha expression. Complete blood count analysis demonstrated that disruption of intestinal HIF-2 alpha inhibited efficient erythropoiesis; mice disrupted for HIF-2 alpha demonstrated lower hematocrit, RBCs, and Hb compared with wildtype mice. These data further cement the essential role of HIF-2 alpha in regulating iron absorption and also demonstrate that hypoxia sensing in the intestine, as well as in the kidney, is essential for regulation of erythropoiesis by HIF-2 alpha.	[Anderson, Erik R.; Xue, Xiang; Shah, Yatrik M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48108 USA; [Shah, Yatrik M.] Univ Michigan, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48108 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shah, YM (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, 1301 E Catherine St, Ann Arbor, MI 48108 USA.	shahy@umich.edu	Xue, Xiang/P-9071-2014	Xue, Xiang/0000-0003-4704-1814	National Institutes of Health [CA148828]; University of Michigan Gastrointestinal Peptide Center; NATIONAL CANCER INSTITUTE [R01CA148828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Gastrointestinal Peptide Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA148828 (to Y. M. S.). This work was also supported by a grant from the University of Michigan Gastrointestinal Peptide Center (to Y. M. S.).	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; ANDERSON GJ, 1990, GASTROENTEROLOGY, V98, P576, DOI 10.1016/0016-5085(90)90276-7; Bittorf T, 1997, CELL SIGNAL, V9, P85, DOI 10.1016/S0898-6568(96)00121-0; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Chaston T, 2008, GUT, V57, DOI 10.1136/gut.2007.131722; CONRAD ME, 1965, BLOOD-J HEMATOL, V25, P990, DOI 10.1182/blood.V25.6.990.990; Corwin HL, 2006, TRANSFUS MED REV, V20, P27, DOI 10.1016/j.tmrv.2005.08.002; Dev A, 2010, BLOOD, V116, P5334, DOI 10.1182/blood-2009-12-258947; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fatrai S, 2011, BLOOD, V117, P3320, DOI 10.1182/blood-2010-08-303669; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Gardenghi S, 2007, BLOOD, V109, P5027, DOI 10.1182/blood-2006-09-048868; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hodgkiss RJ, 1998, ANTI-CANCER DRUG DES, V13, P687; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Koch CJ, 2002, METHOD ENZYMOL, V352, P3; Kong WN, 2008, J GASTROENTEROL, V43, P136, DOI 10.1007/s00535-007-2138-5; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Laftah AH, 2004, BLOOD, V103, P3940, DOI 10.1182/blood-2003-03-0953; Latunde-Dada GO, 2008, J NUTR, V138, P991, DOI 10.1093/jn/138.6.991; Latunde-Dada GO, 2004, BBA-MOL BASIS DIS, V1690, P169, DOI 10.1016/j.bbadis.2004.06.011; Mackenzie B, 2005, AM J PHYSIOL-GASTR L, V289, pG981, DOI 10.1152/ajpgi.00363.2005; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Mena NP, 2008, AM J PHYSIOL-GASTR L, V294, pG192, DOI 10.1152/ajpgi.00122.2007; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Schmid Holger, 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P164; Shah YM, 2008, GASTROENTEROLOGY, V134, P2036, DOI 10.1053/j.gastro.2008.03.009; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Tanno T., 2010, ADV HEMATOL, V2010; TAYLOR M, 2011, GASTROENTEROLOG 0318, DOI DOI 10.1053/J.GASTRO.2011.03.007; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Weatherall DJ, 1998, BAILLIERE CLIN HAEM, V11, P127, DOI 10.1016/S0950-3536(98)80072-3	46	49	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2011	286	22					19533	19540		10.1074/jbc.M111.238667	http://dx.doi.org/10.1074/jbc.M111.238667			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	769OZ	21498508	Green Published, hybrid			2022-12-25	WOS:000291027700036
J	Chen, JQ; Lee, SK; Abd-Elgaliel, WR; Liang, LF; Galende, EY; Hajjar, RJ; Tung, CH				Chen, Jiqiu; Lee, Seung Koo; Abd-Elgaliel, Wael R.; Liang, Lifan; Galende, Elisa-Yaniz; Hajjar, Roger J.; Tung, Ching-Hsuan			Assessment of Cardiovascular Fibrosis Using Novel Fluorescent Probes	PLOS ONE			English	Article							HEART-FAILURE; DIASTOLIC DYSFUNCTION; GENE-TRANSFER; HUG MODEL; COLLAGEN; HYPERTROPHY; BINDING; MECHANISMS; DISEASE	Cardiovascular fibrosis resulted from pressure overload or ischemia could alter myocardial stiffness and lead to ventricular dysfunction. Fluorescently labeled collagen-binding protein CNA 35, derived from the surface component of Staphylococcus aureus, and a novel synthetic biphenylalanine containing peptide are applied to stain fibrosis associated collagen and myocytes, respectively. Detailed pathological characteristics of cardiovascular fibrosis could be identified clearly in 2 hours. This staining pair requires only simple staining and brief washing, generating less than 10 ml of waste. The image information collected by this novel fluorescent staining pair is compatible with it collected by the traditional Masson's Trichrome and Picrosirius Red staining which are widely used to stain cardiovascular fibrosis and isolated cells.	[Chen, Jiqiu; Liang, Lifan; Galende, Elisa-Yaniz; Hajjar, Roger J.] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Lee, Seung Koo; Abd-Elgaliel, Wael R.; Tung, Ching-Hsuan] Cornell Univ, Methodist Hosp, Weill Med Coll, Dept Radiol,Res Inst, Houston, TX USA	Icahn School of Medicine at Mount Sinai; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Chen, JQ (corresponding author), Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA.	Roger.hajjar@mssm.edu; ctung@tmhs.org	Tung, Ching-Hsuan/AIE-6009-2022; Lee, Seung Koo/GMX-2610-2022; Tung, Ching-Hsuan/AHC-5070-2022	Tung, Ching-Hsuan/0000-0001-6648-6195; Lee, Seung Koo/0000-0001-9279-8176; Tung, Ching-Hsuan/0000-0001-6648-6195	National Institutes of Health [R01HL088434, R01HL093183, P20HL100396, CA135312]; Transatlantic Leducq Foundation; NATIONAL CANCER INSTITUTE [R01CA135312] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL100396, R01HL093183, R01HL088434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transatlantic Leducq Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the National Institutes of Health R01HL088434, R01HL093183, P20HL100396 (RJH), CA135312 (CHT), and the Transatlantic Leducq Foundation (RJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008; Burlew Brad S., 2000, Cardiology Clinics, V18, P435, DOI 10.1016/S0733-8651(05)70154-5; Burlew BS, 2002, HERZ, V27, P92, DOI 10.1007/s00059-002-2354-y; Chen JQ, 2010, AM J PATHOL, V176, P1705, DOI 10.2353/ajpath.2010.090451; Gradman AH, 2006, PROG CARDIOVASC DIS, V48, P326, DOI 10.1016/j.pcad.2006.02.001; Helms BA, 2009, J AM CHEM SOC, V131, P11683, DOI 10.1021/ja902285m; Huq F, 2004, CIRCULATION, V109, P2780, DOI 10.1161/01.CIR.0000131764.62242.96; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; Megens RTA, 2007, MOL IMAGING, V6, P247, DOI 10.2310/7290.2007.00021; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Sanders HMHF, 2009, CONTRAST MEDIA MOL I, V4, P81, DOI 10.1002/cmmi.266; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	19	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19097	10.1371/journal.pone.0019097	http://dx.doi.org/10.1371/journal.pone.0019097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533060	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400057
J	Zhang, Z; Zhang, P; Hu, HY				Zhang, Zhen; Zhang, Peng; Hu, Huaiyu			LARGE Expression Augments the Glycosylation of Glycoproteins in Addition to alpha-Dystroglycan Conferring Laminin Binding	PLOS ONE			English	Article							DYSTROPHIN-ASSOCIATED GLYCOPROTEIN; CHONDROITIN SULFATE PROTEOGLYCAN; CONGENITAL MUSCULAR-DYSTROPHY; HUMAN LARGE GENE; FUNCTIONAL-ANALYSIS; BRAIN; PROTEIN; MUTATIONS; OLIGOSACCHARIDES; GLYCOSYLTRANSFERASE	Mutations in genes encoding glycosyltransferases (and presumed glycosyltransferases) that affect glycosylation and extracellular matrix binding activity of alpha-dystroglycan (alpha-DG) cause congenital muscular dystrophies (CMDs) with central nervous system manifestations. Among the identified genes, LARGE is of particular interest because its overexpression rescues glycosylation defects of a-DG in mutations of not only LARGE but also other CMD-causing genes and restores laminin binding activity of a-DG. It is not known whether LARGE protein glycosylates other proteins in addition to alpha-DG. In this study, we overexpressed LARGE in DG-deficient cells and analyzed glycosylated proteins by Western blot analysis. Surprisingly, overexpression of LARGE in alpha-DG-deficient cells led to glycosylation dependent IIH6C4 and VIA4-1 immunoreactivity, despite the prevailing view that these antibodies only recognize glycosylated alpha-DG. Furthermore, the hyperglycosylated proteins in LARGE-overexpressing cells demonstrated the functional capacity to bind the extracellular matrix molecule laminin and promote laminin assembly at the cell surface, an effect that was blocked by IIH6C4 antibodies. These results indicate that overexpression of LARGE catalyzes the glycosylation of at least one other glycoprotein in addition to alpha-DG, and that this glycosylation(s) promotes laminin binding activity.	[Zhang, Zhen; Zhang, Peng; Hu, Huaiyu] Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Zhang, Z (corresponding author), Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA.	huh@upstate.edu			National Institutes of Health [HD060458, NS066582]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health grants (HD060458 and NS066582 to H. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brown SC, 1999, J CELL SCI, V112, P209; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Chiba A, 1997, J BIOL CHEM, V272, P2156; Currier SC, 2005, AM J MED GENET A, V133A, P53, DOI 10.1002/ajmg.a.30487; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; de Bernabe DBV, 2003, J MED GENET, V40, P845; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINNE J, 1979, J BIOL CHEM, V254, P295; Fujimura K, 2005, BIOCHEM BIOPH RES CO, V329, P1162, DOI 10.1016/j.bbrc.2005.02.082; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673; Hu HY, 2007, J COMP NEUROL, V501, P168, DOI 10.1002/cne.21238; Hu HY, 2011, NEUROSCI LETT, V489, P10, DOI 10.1016/j.neulet.2010.11.056; Hu HY, 2000, J NEUROSCI RES, V61, P480, DOI 10.1002/1097-4547(20000901)61:5<480::AID-JNR2>3.0.CO;2-M; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2010, J BIOL CHEM, V285, P31208, DOI 10.1074/jbc.M110.116343; Kano H, 2002, BIOCHEM BIOPH RES CO, V291, P1283, DOI 10.1006/bbrc.2002.6608; Kim DS, 2004, NEUROLOGY, V62, P1009, DOI 10.1212/01.WNL.0000115386.28769.65; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kogelberg H, 2001, CARBOHYD RES, V331, P393, DOI 10.1016/S0008-6215(01)00051-9; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; NOTO K, 1995, INT IMMUNOL, V7, P835, DOI 10.1093/intimm/7.5.835; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; Smalheiser NR, 1998, J BIOL CHEM, V273, P23698, DOI 10.1074/jbc.273.37.23698; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Zhang WL, 2002, BIOCHEM J, V361, P153, DOI 10.1042/0264-6021:3610153	61	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19080	10.1371/journal.pone.0019080	http://dx.doi.org/10.1371/journal.pone.0019080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533062	Green Published, Green Submitted, gold			2022-12-25	WOS:000289719400056
J	Funato, H; Oda, S; Yokofujita, J; Igarashi, H; Kuroda, M				Funato, Hiromasa; Oda, Satoko; Yokofujita, Junko; Igarashi, Hiroaki; Kuroda, Masaru			Fasting and High-Fat Diet Alter Histone Deacetylase Expression in the Medial Hypothalamus	PLOS ONE			English	Article							MUSCLE DIFFERENTIATION; EPIGENETIC REGULATION; LEPTIN RESISTANCE; INDUCED OBESITY; FOOD-INTAKE; FEMALE RAT; NEURONS; HDAC10; TRANSCRIPTION; REPRODUCTION	Increasing attention is now being given to the epigenetic regulation of animal and human behaviors including the stress response and drug addiction. Epigenetic factors also influence feeding behavior and metabolic phenotypes, such as obesity and insulin sensitivity. In response to fasting and high-fat diets, the medial hypothalamus changes the expression of neuropeptides regulating feeding, metabolism, and reproductive behaviors. Histone deacetylases (HDACs) are involved in the epigenetic control of gene expression and alter behavior in response to a variety of environmental factors. Here, we examined the expression of HDAC family members in the medial hypothalamus of mice in response to either fasting or a high-fat diet. In response to fasting, HDAC3 and -4 expression levels increased while HDAC10 and -11 levels decreased. Four weeks on a high-fat diet resulted in the increased expression of HDAC5 and -8. Moreover, fasting decreased the number of acetylated histone H3- and acetylated histone H4-positive cells in the ventrolateral subdivision of the ventromedial hypothalamus. Therefore, HDACs may be implicated in altered gene expression profiles in the medial hypothalamus under different metabolic states.	[Funato, Hiromasa; Oda, Satoko; Yokofujita, Junko; Igarashi, Hiroaki; Kuroda, Masaru] Toho Univ, Sch Med, Dept Anat, Tokyo, Japan	Toho University	Funato, H (corresponding author), Toho Univ, Sch Med, Dept Anat, Tokyo, Japan.	hiromasa.funato@med.toho-u.ac.jp	Satoko, Oda/J-8508-2016	Funato, Hiromasa/0000-0002-2787-9700	Toho University School of Medicine; Tanita Healthy Weight Community Trust; Ministry of Education, Culture, Sports, Science and Technology of Japan [22590228]	Toho University School of Medicine(Toho University); Tanita Healthy Weight Community Trust; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Project Research from Toho University School of Medicine (H. F.; http://www.med.toho-u.ac.jp/), a Grant-in-Aid for Research from the Tanita Healthy Weight Community Trust (H. F.; http://www.tanita-grant.com/), and a Grant-in-Aid for Scientific Research (C) 22590228 (H. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/english/e-grants/grants.html). These funders gave the authors financial support to proceed with their project which they designed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Crown A, 2007, NEUROENDOCRINOLOGY, V86, P175, DOI 10.1159/000109095; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fischer DD, 2002, J BIOL CHEM, V277, P6656, DOI 10.1074/jbc.M108055200; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453; Jones JE, 2002, PHYSIOL BEHAV, V77, P19, DOI 10.1016/S0031-9384(02)00780-1; Kaelin CB, 2006, MOL ENDOCRINOL, V20, P2591, DOI 10.1210/me.2006-0107; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Meaney MJ, 2010, NAT NEUROSCI, V13, P1313, DOI 10.1038/nn1110-1313; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Northrop LE, 2008, ENDOCRINOLOGY, V149, P836, DOI 10.1210/en.2007-1040; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Siegel A, 1999, NEUROSCI BIOBEHAV R, V23, P359, DOI 10.1016/S0149-7634(98)00040-2; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Woods SC, 2009, CELL METAB, V9, P489, DOI 10.1016/j.cmet.2009.04.007; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	41	67	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18950	10.1371/journal.pone.0018950	http://dx.doi.org/10.1371/journal.pone.0018950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526203	Green Published, gold, Green Submitted			2022-12-25	WOS:000289578600041
J	Jeter, CR; Liu, B; Liu, X; Chen, X; Liu, C; Calhoun-Davis, T; Repass, J; Zaehres, H; Shen, JJ; Tang, DG				Jeter, C. R.; Liu, B.; Liu, X.; Chen, X.; Liu, C.; Calhoun-Davis, T.; Repass, J.; Zaehres, H.; Shen, J. J.; Tang, D. G.			NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation	ONCOGENE			English	Article						Nanog; prostate cancer; cancer stem cells; castration resistance; self-renewal	TUMOR-INITIATING CELLS; GENE-EXPRESSION; PROSPECTIVE IDENTIFICATION; SIDE POPULATION; MARKER NANOG; BREAST; PROLIFERATION; PLURIPOTENCY; PROGRESSION; BINDING	Cancer cell molecular mimicry of stem cells (SC) imbues neoplastic cells with enhanced proliferative and renewal capacities. In support, numerous mediators of SC self-renewal have been evinced to show oncogenic potential. We have recently reported that short-hairpin RNA-mediated knockdown of the embryonic stem cell (ESC) self-renewal gene NANOG significantly reduced the clonogenic and tumorigenic capabilities of various cancer cells. In this study, we sought to test the potential pro-tumorigenic functions of NANOG, particularly, in prostate cancer (PCa). Using qRT-PCR, we first confirmed that PCa cells expressed NANOG mRNA primarily from the NANOGP8 locus on chromosome 15q14. We then constructed a lentiviral promoter reporter in which the -3.8-kb NANOGP8 genomic fragment was used to drive the expression of green fluorescence protein (GFP). We observed that NANOGP8-GFP PCa cells showed cancer stem cell (CSC) characteristics such as enhanced clonal growth and tumor regenerative capacity. To further investigate the functions and mechanisms of NANOG in tumorigenesis, we established tetracycline-inducible NANOG-overexpressing cancer cell lines, including both PCa (Du145 and LNCaP) and breast (MCF-7) cancer cells. NANOG induction promoted drug resistance in MCF-7 cells, tumor regeneration in Du145 cells and, most importantly, castration-resistant tumor development in LNCaP cells. These pro-tumorigenic effects of NANOG were associated with key molecular changes, including an upregulation of molecules such as CXCR4, IGFBP5, CD133 and ALDH1. The present gain-of-function studies, coupled with our recent loss-of-function work, establish the integral role for NANOG in neoplastic processes and shed light on its mechanisms of action. Oncogene (2011) 30, 3833-3845; doi:10.1038/onc.2011.114; published online 18 April 2011	[Jeter, C. R.; Liu, B.; Liu, X.; Chen, X.; Liu, C.; Calhoun-Davis, T.; Repass, J.; Shen, J. J.; Tang, D. G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA; [Liu, B.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Chen, X.; Liu, C.; Tang, D. G.] Grad Sch Biol Sci, Program Mol Carcinogenesis, Houston, TX USA; [Zaehres, H.] Max Planck Inst Mol Biomed, Munster, Germany	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Max Planck Society	Jeter, CR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA.	cjeter@mdanderson.org; dtang@mdanderson.org	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Liu, Xin/0000-0003-0847-182X; Jeter, Collene/0000-0002-9627-4529; Chen, Xin/0000-0002-0566-7678	NIH [R01-ES015888, R21-ES015893, R21-CA150009]; Department of Defense [W81XWH-07-1-0616, W81XWH-08-1-0472]; Elsa Pardee Foundation; Center Grants [CCSG-5 P30 CA016672-34, ES007784]; AUA Foundation; NATIONAL CANCER INSTITUTE [R21CA150009, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784, R01ES015888, R21ES015893] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Elsa Pardee Foundation; Center Grants; AUA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank P Whitney for FACS, N Otto and the Histology Core for help in IHC analysis, J Moore for assistance in animal breeding and experiments, and other members of the Tang laboratory for support and discussions. This work was supported, in part, by grants from NIH (R01-ES015888, R21-ES015893, R21-CA150009), Department of Defense (W81XWH-07-1-0616, W81XWH-08-1-0472) and the Elsa Pardee Foundation (DGT), and by two Center Grants (CCSG-5 P30 CA016672-34 and ES007784). CR Jeter and C Liu were supported in part by fellowships from the AUA Foundation and DOD, respectively.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huss WJ, 2005, CANCER RES, V65, P6640, DOI 10.1158/0008-5472.CAN-04-2548; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li H, 2009, METHODS MOL BIOL, V568, P85, DOI 10.1007/978-1-59745-280-9_7; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Ma TH, 2009, J BIOL CHEM, V284, P16071, DOI 10.1074/jbc.M109.005041; Machida K, 2009, P NATL ACAD SCI USA, V106, P1548, DOI 10.1073/pnas.0807390106; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Medeiros RB, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-59; Meng HM, 2010, CANCER BIOL THER, V9, P295, DOI 10.4161/cbt.9.4.10666; Miyake H, 2000, ENDOCRINOLOGY, V141, P2257, DOI 10.1210/en.141.6.2257; Nickerson T, 2001, CANCER RES, V61, P6276; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Piestun D, 2006, BIOCHEM BIOPH RES CO, V343, P279, DOI 10.1016/j.bbrc.2006.02.152; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Singh SK, 2003, CANCER RES, V63, P5821; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xu C, 2007, PROSTATE, V67, P1621, DOI 10.1002/pros.20655; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang JY, 2005, BIOCHEM BIOPH RES CO, V338, P1098, DOI 10.1016/j.bbrc.2005.10.071; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	48	271	285	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2011	30	36					3833	3845		10.1038/onc.2011.114	http://dx.doi.org/10.1038/onc.2011.114			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	817PV	21499299	Green Accepted			2022-12-25	WOS:000294687200002
J	Lasagna-Reeves, CA; Glabe, CG; Kayed, R				Lasagna-Reeves, Cristian A.; Glabe, Charles G.; Kayed, Rakez			Amyloid-beta Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; PROTEIN AGGREGATION; ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASE; OLIGOMERS IMPLIES; COMMON MECHANISM; PEPTIDE; PATHOGENESIS; MEMBRANES; TOXINS	Annular protofibrils (APFs) represent a new and distinct class of amyloid structures formed by disease-associated proteins. In vitro, these pore-like structures have been implicated in membrane permeabilization and ion homeostasis via pore formation. Still, evidence for their formation and relevance in vivo is lacking. Herein, we report that APFs are in a distinct pathway from fibril formation in vitro and in vivo. In human Alzheimer disease brain samples, amyloid-beta APFs were associated with diffuse plaques, but not compact plaques; moreover, we show the formation of intracellular APFs. Our results together with previous studies suggest that the prevention of amyloid-beta annular protofibril formation could be a relevant target for the prevention of amyloid-beta toxicity in Alzheimer disease.	[Lasagna-Reeves, Cristian A.; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol, George P & Cynthia Woods Mitchell Ctr Neurodegene, Galveston, TX 77555 USA; [Glabe, Charles G.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Irvine	Kayed, R (corresponding author), Univ Texas Med Branch, Dept Neurol, George P & Cynthia Woods Mitchell Ctr Neurodegene, 301 Univ Blvd,Med Res Bldg,Rm 10-138C, Galveston, TX 77555 USA.	rakayed@utmb.edu	Lasagna-Reeves, Cristian/ABE-2001-2021		Alzheimer's Association; Mitchell Center for Neurodegenerative Diseases; Cullen Trust	Alzheimer's Association(Alzheimer's Association); Mitchell Center for Neurodegenerative Diseases; Cullen Trust	This work was supported by grants from the Alzheimer's Association, the Mitchell Center for Neurodegenerative Diseases, and the Cullen Trust.	ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BURDICK D, 1992, J BIOL CHEM, V267, P546; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hafner JH, 2001, PROG BIOPHYS MOL BIO, V77, P73, DOI 10.1016/S0079-6107(01)00011-6; Hardy J, 2005, BIOCHEM SOC T, V33, P578, DOI 10.1042/BST0330578; Jang H, 2010, P NATL ACAD SCI USA, V107, P6538, DOI 10.1073/pnas.0914251107; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kokubo H, 2009, INT J ALZHEIMERS DIS; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0; Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Porat Y, 2003, BIOCHEMISTRY-US, V42, P10971, DOI 10.1021/bi034889i; Pountney DL, 2004, J NEUROCHEM, V90, P502, DOI 10.1111/j.1471-4159.2004.02533.x; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Shafrir Y, 2010, PROTEINS, V78, P3473, DOI 10.1002/prot.22853; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yamaguchi H, 2000, J NEUROPATH EXP NEUR, V59, P723, DOI 10.1093/jnen/59.8.723; Yamamoto N, 2007, BBA-BIOMEMBRANES, V1768, P1128, DOI 10.1016/j.bbamem.2007.01.009; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	40	104	105	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22122	22130		10.1074/jbc.M111.236257	http://dx.doi.org/10.1074/jbc.M111.236257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21507938	hybrid, Green Published			2022-12-25	WOS:000291719900018
J	McLean, JE; Wudzinska, A; Datan, E; Quaglino, D; Zakeri, Z				McLean, Jeffrey E.; Wudzinska, Aleksandra; Datan, Emmanuel; Quaglino, Daniela; Zakeri, Zahra			Flavivirus NS4A-induced Autophagy Protects Cells against Death and Enhances Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; MODOC VIRAL-INFECTIONS; DENGUE VIRUS; NONSTRUCTURAL PROTEINS; NEUROBLASTOMA-CELLS; GOLDEN-HAMSTER; NS4A; NS3; LOCALIZATION	Flaviviruses include the most prevalent and medically challenging viruses. Persistent infection with flaviviruses of epithelial cells and hepatocytes that do not undergo cell death is common. Here, we report that, in epithelial cells, up-regulation of autophagy following flavivirus infection markedly enhances virus replication and that one flavivirus gene, NS4A, uniquely determines the up-regulation of autophagy. Dengue-2 and Modoc (a murine flavivirus) kill primary murine macrophages but protect epithelial cells and fibroblasts against death provoked by several insults. The flavivirus-induced protection derives from the up-regulation of autophagy, as up-regulation of autophagy by starvation or inactivation of mammalian target of rapamycin also protects the cells against insult, whereas inhibition of autophagy via inactivation of PI3K nullifies the protection conferred by flavivirus. Inhibition of autophagy also limits replication of both Dengue-2 and Modoc virus in epithelial cells. Expression of flavivirus NS4A is sufficient to induce PI3K-dependent autophagy and to protect cells against death; expression of other viral genes, including NS2A and NS4B, fails to protect cells against several stressors. Flavivirus NS4A protein induces autophagy in epithelial cells and thus protects them from death during infection. As autophagy is vital to flavivirus replication in these cells, NS4A is therefore also identified as a critical determinant of flavivirus replication.	[McLean, Jeffrey E.; Wudzinska, Aleksandra; Datan, Emmanuel; Zakeri, Zahra] CUNY, Queens Coll, Dept Biol, Flushing, NY 11367 USA; [McLean, Jeffrey E.; Wudzinska, Aleksandra; Datan, Emmanuel; Zakeri, Zahra] CUNY, Grad Ctr, Flushing, NY 11367 USA; [Quaglino, Daniela] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Patol Gen, I-41100 Modena, Italy	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; Universita di Modena e Reggio Emilia	Zakeri, Z (corresponding author), CUNY, Queens Coll, Dept Biol, 65-30 Kissena Blvd, Flushing, NY 11367 USA.	zahra_zakeri@hotmail.com	Quaglino, Daniela/A-9381-2010; Datan, Emmanuel/T-8987-2019	Quaglino, Daniela/0000-0002-4302-5078; Datan, Emmanuel/0000-0001-9820-3233	National Institutes of Health [2T34GM070387-03]; City University of New York (CUNY); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI094351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM070387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City University of New York (CUNY); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health MARC U-STAR Grant 2T34GM070387-03 (to Z. Z.). This work was also supported by Professional Staff Congress-City University of New York (PSC-CUNY) award (to Z. Z.).	BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; CARDIFF RD, 1973, INFECT IMMUN, V7, P809, DOI 10.1128/IAI.7.5.809-816.1973; DAVIS JW, 1974, INFECT IMMUN, V10, P328, DOI 10.1128/IAI.10.2.328-334.1974; DAVIS JW, 1973, APPL MICROBIOL, V26, P344, DOI 10.1128/AEM.26.3.344-348.1973; DAVIS JW, 1974, INFECT IMMUN, V10, P1362, DOI 10.1128/IAI.10.6.1362-1369.1974; Despres P, 1998, J VIROL, V72, P823; Despres P, 1996, J VIROL, V70, P4090; Espina LM, 2003, AM J TROP MED HYG, V68, P48, DOI 10.4269/ajtmh.2003.68.48; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003; GULATI L, 1982, BRIT J EXP PATHOL, V63, P194; HALSTEAD SB, 1989, REV INFECT DIS, V11, P830; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Jan JT, 2000, J VIROL, V74, P8680, DOI 10.1128/JVI.74.18.8680-8691.2000; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Jiang LB, 2009, BIOCHEM BIOPH RES CO, V385, P187, DOI 10.1016/j.bbrc.2009.05.036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Leyssen P, 2001, VIROLOGY, V279, P27, DOI 10.1006/viro.2000.0723; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993; Lin L, 2006, CELL DEATH DIFFER, V13, P141, DOI 10.1038/sj.cdd.4401717; Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999; Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; Morens DM, 2009, PEDIATR INFECT DIS J, V28, P635, DOI 10.1097/INF.0b013e3181afcd5b; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; POGODINA VV, 1981, ACTA VIROL, V25, P337; Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006; Siirin MT, 2007, AM J TROP MED HYG, V76, P299, DOI 10.4269/ajtmh.2007.76.299; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; TAKEGAMI T, 1995, VIRUS GENES, V9, P105, DOI 10.1007/BF01702653; Tanida I, 2010, METHODS MOL BIOL, V648, P193, DOI 10.1007/978-1-60761-756-3_13; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Tonry JH, 2005, AM J TROP MED HYG, V72, P320, DOI 10.4269/ajtmh.2005.72.320; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	43	179	193	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22147	22159		10.1074/jbc.M110.192500	http://dx.doi.org/10.1074/jbc.M110.192500			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21511946	Green Published, hybrid			2022-12-25	WOS:000291719900021
J	Moessinger, C; Kuerschner, L; Spandl, J; Shevchenko, A; Thiele, C				Moessinger, Christine; Kuerschner, Lars; Spandl, Johanna; Shevchenko, Andrej; Thiele, Christoph			Human Lysophosphatidylcholine Acyltransferases 1 and 2 Are Located in Lipid Droplets Where They Catalyze the Formation of Phosphatidylcholine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; ACID-BINDING PROTEIN; ACYL-COA; POSSIBLE INVOLVEMENT; MAMMALIAN-CELLS; II CELLS; MEMBRANE; IDENTIFICATION; BIOSYNTHESIS; CLONING	Phosphatidylcholine (PC) is synthesized by two different pathways, the Lands cycle and the Kennedy pathway. The recently identified key enzymes of the Lands cycle, lysophosphatidylcholine acyltransferase 1 and 2 (LPCAT1 and -2), were reported to localize to the endoplasmic reticulum and to function in lung surfactant production and in inflammation response. Here, we show in various mammalian cell lines that both enzymes additionally localize to lipid droplets (LDs), which consist of a core of neutral lipids surrounded by a monolayer of phospholipid, mainly PC. This dual localization is enabled by the monotopic topology of these enzymes demonstrated in this study. Furthermore, we show that LDs have the ability to locally synthesize PC and that this activity correlates with the LPCAT1 and -2 expression level. This suggests that LPCAT1 and -2 have, in addition to their known function in specialized cells, a ubiquitous role in LD-associated lipid metabolism.	[Moessinger, Christine; Kuerschner, Lars; Spandl, Johanna; Thiele, Christoph] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany; [Moessinger, Christine; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Bonn; Max Planck Society	Thiele, C (corresponding author), Univ Bonn, Life & Med Sci Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	cthiele@uni-bonn.de			Deutsche Forschungsgemeinschaft [TR83]; European Union; German National Academic Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); German National Academic Foundation	This work was supported by Deutsche Forschungsgemeinschaft (Transregio TR83), the European Union Framework 7 Project "LipidomicNet," and the German National Academic Foundation.	Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; Caldas H, 2003, HUM MOL GENET, V12, P2981, DOI 10.1093/hmg/ddg321; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Mansilla F, 2009, J MOL MED, V87, P85, DOI 10.1007/s00109-008-0409-0; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Massey JB, 1997, BIOPHYS J, V72, P1732, DOI 10.1016/S0006-3495(97)78819-2; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Ohashi M, 2003, J BIOL CHEM, V278, P36819, DOI 10.1074/jbc.M301408200; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Ostermeyer AG, 2004, J CELL BIOL, V164, P69, DOI 10.1083/jcb.200303037; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; TAYLOR DC, 1990, ANAL BIOCHEM, V184, P311, DOI 10.1016/0003-2697(90)90686-4; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; VANCURA A, 1992, J BIOL CHEM, V267, P14353; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	68	107	111	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21330	21339		10.1074/jbc.M110.202424	http://dx.doi.org/10.1074/jbc.M110.202424			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21498505	Green Published, hybrid			2022-12-25	WOS:000291464700032
J	Bourquard, T; Bernauer, J; Aze, J; Poupon, A				Bourquard, Thomas; Bernauer, Julie; Aze, Jerome; Poupon, Anne			A Collaborative Filtering Approach for Protein-Protein Docking Scoring Functions	PLOS ONE			English	Article							CAPRI; PRINCIPLES; PROGRESS	A protein-protein docking procedure traditionally consists in two successive tasks: a search algorithm generates a large number of candidate conformations mimicking the complex existing in vivo between two proteins, and a scoring function is used to rank them in order to extract a native-like one. We have already shown that using Voronoi constructions and a well chosen set of parameters, an accurate scoring function could be designed and optimized. However to be able to perform large-scale in silico exploration of the interactome, a near-native solution has to be found in the ten best-ranked solutions. This cannot yet be guaranteed by any of the existing scoring functions. In this work, we introduce a new procedure for conformation ranking. We previously developed a set of scoring functions where learning was performed using a genetic algorithm. These functions were used to assign a rank to each possible conformation. We now have a refined rank using different classifiers (decision trees, rules and support vector machines) in a collaborative filtering scheme. The scoring function newly obtained is evaluated using 10 fold cross-validation, and compared to the functions obtained using either genetic algorithms or collaborative filtering taken separately. This new approach was successfully applied to the CAPRI scoring ensembles. We show that for 10 targets out of 12, we are able to find a near-native conformation in the 10 best ranked solutions. Moreover, for 6 of them, the near-native conformation selected is of high accuracy. Finally, we show that this function dramatically enriches the 100 best-ranking conformations in near-native structures.	[Bourquard, Thomas; Aze, Jerome] Univ Paris 11, Rech Informat Lab, INRIA AMIB, Bioinformat Grp, F-91405 Orsay, France; [Bourquard, Thomas; Bernauer, Julie] Ecole Polytech, Lab Informat LIX, INRIA AMIB, Bioinformat Grp, Palaiseau, France; [Bourquard, Thomas] LORIA, INRIA Nancy Grand Est, Vandoeuvre Les Nancy, France; [Poupon, Anne] INRA, BIOS Grp, UMR85, Unite Physiol Reprod & Comportements, F-37380 Nouzilly, France; [Poupon, Anne] CNRS, UMR6175, Nouzilly, France; [Poupon, Anne] Univ Tours, Tours, France	UDICE-French Research Universities; Universite Paris Saclay; Institut Polytechnique de Paris; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Universite de Tours	Bourquard, T (corresponding author), Univ Paris 11, Rech Informat Lab, INRIA AMIB, Bioinformat Grp, Bat 490, F-91405 Orsay, France.	Anne.Poupon@tours.inra.fr	Bernauer, Julie/M-7518-2014	Bernauer, Julie/0000-0003-2345-995X; Poupon, Anne/0000-0003-0617-0935				Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; [Anonymous], 2009, ADV ARTIFICIAL INTEL; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernauer J, 2007, BIOINFORMATICS, V23, P555, DOI 10.1093/bioinformatics/btl654; Bernauer J, 2005, PHYS BIOL, V2, pS17, DOI 10.1088/1478-3975/2/2/S02; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; Boissonnat JD, 2002, COMP GEOM-THEOR APPL, V22, P5, DOI 10.1016/S0925-7721(01)00054-2; Bourquard T, 2009, 2009 6TH INTERNATIONAL SYMPOSIUM ON VORONOI DIAGRAMS (ISVD 2009), P225, DOI 10.1109/ISVD.2009.11; Chen R, 2003, PROTEINS, V52, P88, DOI 10.1002/prot.10390; COHEN WW, 1995, INT C MACH LEARN, P115; FRANK IHW, 1998, 15 INT C MACH LEARN, P144; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Joachims, 1999, MAKING LARGE SCALE S, P169; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Sanderson Christopher M., 2009, Briefings in Functional Genomics & Proteomics, V8, P1, DOI 10.1093/bfgp/elp003; Scholkopf B., 1998, ADV KERNEL METHODS S; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9	28	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18541	10.1371/journal.pone.0018541	http://dx.doi.org/10.1371/journal.pone.0018541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526112	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800009
J	Kokkinopoulos, I; Shahabi, G; Colman, A; Jeffery, G				Kokkinopoulos, Ioannis; Shahabi, Golnaz; Colman, Alan; Jeffery, Glen			Mature Peripheral RPE Cells Have an Intrinsic Capacity to Proliferate; A Potential Regulatory Mechanism for Age-Related Cell Loss	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; BETA-CATENIN; TIGHT JUNCTIONS; E-CADHERIN; EXPRESSION; P27(KIP1); APOPTOSIS; DEFECTS; CYCLE; MTOR	BACKGROUND: Mammalian peripheral retinal pigmented epithelium (RPE) cells proliferate throughout life, while central cells are senescent. It is thought that some peripheral cells migrate centrally to correct age-related central RPE loss. METHODOLOGY/PRINCIPAL FINDINGS: We ask whether this proliferative capacity is intrinsic to such cells and whether cells located centrally produce diffusible signals imposing senescence upon the former once migrated. We also ask whether there are regional differences in expression patterns of key genes involved in these features between the centre and the periphery in vivo and in vitro. Low density RPE cultures obtained from adult mice revealed significantly greater levels of proliferation when derived from peripheral compared to central tissue, but this significance declined with increasing culture density. Further, exposure to centrally conditioned media had no influence on proliferation in peripheral RPE cell cultures at the concentrations examined. Central cells expressed significantly higher levels of E-Cadherin revealing a tighter cell adhesion than in the peripheral regions. Fluorescence-labelled staining for E-Cadherin, F-actin and ZO-1 in vivo revealed different patterns with significantly increased expression on central RPE cells than those in the periphery or differences in junctional morphology. A range of other genes were investigated both in vivo and in vitro associated with RPE proliferation in order to identify gene expression differences between the centre and the periphery. Specifically, the cell cycle inhibitor p27(Kip1) was significantly elevated in central senescent regions in vivo and mTOR, associated with RPE cell senescence, was significantly elevated in the centre in comparison to the periphery. CONCLUSIONS: These data show that the proliferative capacity of peripheral RPE cells is intrinsic and cell-autonomous in adult mice. These differences between centre and periphery are reflected in distinct patterns in junctional markers. The regional proliferation differences may be inversely dependent to cell-cell contact.	[Kokkinopoulos, Ioannis; Shahabi, Golnaz; Jeffery, Glen] UCL, Inst Ophthalmol, London, England; [Kokkinopoulos, Ioannis] Kings Coll London, Sch Biomed & Hlth Sci Wolfson Ctr Age Related Dis, London WC2R 2LS, England; [Colman, Alan] Singapore Stem Cell Consortium, Singapore, Singapore	University of London; University College London; University of London; King's College London	Kokkinopoulos, I (corresponding author), UCL, Inst Ophthalmol, London, England.	g.jeffery@ucl.ac.uk			Medical Research Council UK [G03000341]; Rosetree Trust; MRC [G0701114] Funding Source: UKRI; Medical Research Council [G0701114] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetree Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an MRC grant [the Medical Research Council UK (G03000341)] and The Rosetree Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams T, 2010, EXP EYE RES, V90, P368, DOI 10.1016/j.exer.2009.10.002; Al-Hussaini H, 2008, MOL VIS, V14, P1784; Amemiya K, 2004, BIOCHEM BIOPH RES CO, V316, P1, DOI 10.1016/j.bbrc.2004.01.172; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Assimakopoulos SF, 2011, EUR J CLIN INVEST, V41, P117, DOI 10.1111/j.1365-2362.2010.02379.x; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Burke JM, 1999, INVEST OPHTH VIS SCI, V40, P2963; CHEN Y, 2010, INVEST OPHTHALMOL VI; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Chiba C, 2006, J COMP NEUROL, V495, P391, DOI 10.1002/cne.20880; Defoe DM, 2007, MOL VIS, V13, P273; Del Priore LV, 2002, INVEST OPHTH VIS SCI, V43, P3312; ELMAN MJ, 1986, OPHTHALMOLOGY, V93, P224; Fischer AJ, 2001, DEV NEUROSCI-BASEL, V23, P268, DOI 10.1159/000048710; Galluzzi L, 2010, AGING-US, V2, P535, DOI 10.18632/aging.100202; Georgiadis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015730; Kiilgaard JF, 2007, INVEST OPHTH VIS SCI, V48, P355, DOI 10.1167/iovs.05-1565; KONARI K, 1995, EXP EYE RES, V61, P99, DOI 10.1016/S0014-4835(95)80063-8; LAI YL, 1986, P SOC EXP BIOL MED, V181, P371; Mann I., 1964, DEV HUMAN EYE; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng TL, 2005, MODERN PATHOL, V18, P68, DOI 10.1038/modpathol.3800272; Parrales A, 2010, J CELL PHYSIOL, V222, P302, DOI 10.1002/jcp.21951; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Steindl-Kuscher K, 2009, INVEST OPHTH VIS SCI, V50, P4471, DOI 10.1167/iovs.08-3139; STREETEN BW, 1969, ARCH OPHTHALMOL-CHIC, V81, P383; Tolmachova T, 2010, INVEST OPHTH VIS SCI, V51, P4913, DOI 10.1167/iovs.09-4892; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; VANDEKERCKHOVE J, 1985, EMBO J, V4, P2815, DOI 10.1002/j.1460-2075.1985.tb04008.x; von Leithner PL, 2010, MOL VIS, V16, P570; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yoshida K, 2004, ANAT EMBRYOL, V208, P145, DOI 10.1007/s00429-004-0382-5; Young R W, 1983, Trans Am Ophthalmol Soc, V81, P193; Yu AL, 2009, INVEST OPHTH VIS SCI, V50, P926, DOI 10.1167/iovs.07-1003; Zygar CA, 2005, DEV BRAIN RES, V154, P91, DOI 10.1016/j.devbrainres.2004.10.009	40	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18921	10.1371/journal.pone.0018921	http://dx.doi.org/10.1371/journal.pone.0018921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526120	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800022
J	Peleg, B; Disanza, A; Scita, G; Gov, N				Peleg, Barak; Disanza, Andrea; Scita, Giorgio; Gov, Nir			Propagating Cell-Membrane Waves Driven by Curved Activators of Actin Polymerization	PLOS ONE			English	Article							PROTEIN; IRSP53; LINKS; CYTOKINESIS; CURVATURE; DYNAMICS; DOMAINS; TUBA	Cells exhibit propagating membrane waves which involve the actin cytoskeleton. One type of such membranal waves are Circular Dorsal Ruffles (CDR) which are related to endocytosis and receptor internalization. Experimentally, CDRs have been associated with membrane bound activators of actin polymerization of concave shape. We present experimental evidence for the localization of convex membrane proteins in these structures, and their insensitivity to inhibition of myosin II contractility in immortalized mouse embryo fibroblasts cell cultures. These observations lead us to propose a theoretical model which explains the formation of these waves due to the interplay between complexes that contain activators of actin polymerization and membrane-bound curved proteins of both types of curvature (concave and convex). Our model predicts that the activity of both types of curved proteins is essential for sustaining propagating waves, which are abolished when one type of curved activator is removed. Within this model waves are initiated when the level of actin polymerization induced by the curved activators is higher than some threshold value, which allows the cell to control CDR formation. We demonstrate that the model can explain many features of CDRs, and give several testable predictions. This work demonstrates the importance of curved membrane proteins in organizing the actin cytoskeleton and cell shape.	[Peleg, Barak; Gov, Nir] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Disanza, Andrea; Scita, Giorgio] FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy; [Scita, Giorgio] Univ Milan, Dept Med Surg & Dent, Milan, Italy	Weizmann Institute of Science; IFOM - FIRC Institute of Molecular Oncology; University of Milan	Peleg, B (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	nir.gov@weizmann.ac.il	Scita, Giorgio/J-9670-2012; GOV, NIR/K-1415-2012	Disanza, Andrea/0000-0001-5101-2907; Scita, Giorgio/0000-0001-7984-1889; GOV, NIR/0000-0001-7774-1139	Alvin and Gertrude Levine Career Development Chair; BSF [2006285]; AIRC (Associazione Italiana Ricerca sul Cancro) [4874, 8678]; PRIN (progetti di ricerca di interesse nazionale); International Association for Cancer Research [AICR 09-0582]	Alvin and Gertrude Levine Career Development Chair; BSF(US-Israel Binational Science Foundation); AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); PRIN (progetti di ricerca di interesse nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); International Association for Cancer Research	N.G. thanks the Alvin and Gertrude Levine Career Development Chair, and the BSF grant No. 2006285 for their support. This research is made possible in part by the historic generosity of the Harold Perlman Family. G.S. and A.D. thank the AIRC (Associazione Italiana Ricerca sul Cancro) grants No. 4874 and 8678 for their support. G.S. thanks the PRIN2007 (progetti di ricerca di interesse nazionale) and the International Association for Cancer Research (AICR 09-0582) for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio E, 2010, EMBO J, V29, P292, DOI 10.1038/emboj.2009.341; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Carlsson AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228102; Chen CH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238101; Coelho Neto J, 2005, EXP CELL RES, V303, P207, DOI 10.1016/j.yexcr.2004.09.002; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Dobereiner H. G., 2006, PHYS REV LETT, V97, P10; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gov N, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011104; Gov NS, 2006, BIOPHYS J, V90, P454, DOI 10.1529/biophysj.105.062224; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Kovacs EM, 2006, J CELL SCI, V119, P2715, DOI 10.1242/jcs.03005; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Sens P, 1998, EUROPHYS LETT, V43, P95, DOI 10.1209/epl/i1998-00325-6; Shlomovitz R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.168103; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Suetsugu S, 2010, J BIOCHEM, V148, P1, DOI 10.1093/jb/mvq049; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Veksler A, 2007, BIOPHYS J, V93, P3798, DOI 10.1529/biophysj.107.113282; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Weiss SM, 2009, CELL HOST MICROBE, V5, P244, DOI 10.1016/j.chom.2009.02.003; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102	32	51	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e18635	10.1371/journal.pone.0018635	http://dx.doi.org/10.1371/journal.pone.0018635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21533032	Green Submitted, Green Published, gold			2022-12-25	WOS:000290014500008
J	Cerezo, M; Cerny, V; Carracedo, A; Salas, A				Cerezo, Maria; Cerny, Viktor; Carracedo, Angel; Salas, Antonio			New Insights into the Lake Chad Basin Population Structure Revealed by High-Throughput Genotyping of Mitochondrial DNA Coding SNPs	PLOS ONE			English	Article							SUB-SAHARAN; GENE FLOW; AFRICAN; ANCESTRY; SEQUENCE; HERITAGE; NETWORK; EASTERN; LEGACY	Background: Located in the Sudan belt, the Chad Basin forms a remarkable ecosystem, where several unique agricultural and pastoral techniques have been developed. Both from an archaeological and a genetic point of view, this region has been interpreted to be the center of a bidirectional corridor connecting West and East Africa, as well as a meeting point for populations coming from North Africa through the Saharan desert. Methodology/Principal Findings: Samples from twelve ethnic groups from the Chad Basin (n = 542) have been high-throughput genotyped for 230 coding region mitochondrial DNA (mtDNA) Single Nucleotide Polymorphisms (mtSNPs) using Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF) mass spectrometry. This set of mtSNPs allowed for much better phylogenetic resolution than previous studies of this geographic region, enabling new insights into its population history. Notable haplogroup (hg) heterogeneity has been observed in the Chad Basin mirroring the different demographic histories of these ethnic groups. As estimated using a Bayesian framework, nomadic populations showed negative growth which was not always correlated to their estimated effective population sizes. Nomads also showed lower diversity values than sedentary groups. Conclusions/Significance: Compared to sedentary population, nomads showed signals of stronger genetic drift occurring in their ancestral populations. These populations, however, retained more haplotype diversity in their hypervariable segments I (HVS-I), but not their mtSNPs, suggesting a more ancestral ethnogenesis. Whereas the nomadic population showed a higher Mediterranean influence signaled mainly by sub-lineages of M1, R0, U6, and U5, the other populations showed a more consistent sub-Saharan pattern. Although lifestyle may have an influence on diversity patterns and hg composition, analysis of molecular variance has not identified these differences. The present study indicates that analysis of mtSNPs at high resolution could be a fast and extensive approach for screening variation in population studies where labor-intensive techniques such as entire genome sequencing remain unfeasible.	[Cerezo, Maria; Carracedo, Angel; Salas, Antonio] Univ Santiago de Compostela, CIBERER, Dept Anat Patolox & Ciencias Forenses, Inst Med Legal,Fac Med,Unidade Xenet, Galicia, Spain; [Cerny, Viktor] Acad Sci Czech Republ, Inst Archaeol, Archaeogenet Lab, Prague, Czech Republic	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Prague	Cerezo, M (corresponding author), Univ Santiago de Compostela, CIBERER, Dept Anat Patolox & Ciencias Forenses, Inst Med Legal,Fac Med,Unidade Xenet, Galicia, Spain.	antonio.salas@usc.es	Carracedo, Angel/D-4257-2012; Cerny, Viktor/G-7842-2014; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012	Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Cerezo Fernandez, Maria/0000-0003-3073-1130	Xunta de Galicia [2008/XA122]; Fundacion de Investigacion Medica Mutua Madrilena; Grant Agency of the Czech Republic [206/08/1587]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This research received support from Xunta de Galicia (Grupos Emerxentes; 2008/XA122), two grants from the Fundacion de Investigacion Medica Mutua Madrilena given to AS, and a Grant Agency of the Czech Republic (Grant no. 206/08/1587) given to VC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Alvarez-Iglesias V, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-26; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Batello C, 2004, FUTURE IS ANCIENT LA; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Beleza S, 2005, HUM GENET, V117, P366, DOI 10.1007/s00439-005-1290-3; Bereir RE, 2007, EUR J HUM GENET, V15, P1183, DOI 10.1038/sj.ejhg.5201892; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Cerezo M, 2009, ELECTROPHORESIS, V30, P3665, DOI 10.1002/elps.200900294; CERNY V, 2009, J PHYS, V138, P439; CERNY V, 2008, J PHYS, V136, P128; Cerny V, 2011, MOL BIOL EVOL, V28, P71, DOI 10.1093/molbev/msq178; COBLE M, 2004, IDENTIFICATION SINGL; Coble MD, 2006, INT J LEGAL MED, V120, P27, DOI 10.1007/s00414-005-0044-z; Elson JL, 2007, AM J HUM GENET, V80, P378, DOI 10.1086/511652; EXCOFFIER L, 1992, GENETICS, V131, P479; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; GERNY V, 2007, ANN HUM GENET, V71, P433; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; GULDEMANN T, 2008, MACROSUDAN BELT IDEN; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mosquera-Miguel A, 2009, FORENSIC SCI INT-GEN, V3, P261, DOI 10.1016/j.fsigen.2009.04.006; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Plaza S, 2004, HUM GENET, V115, P439, DOI 10.1007/s00439-004-1164-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quintana-Murci L, 2008, P NATL ACAD SCI USA, V105, DOI 10.1073/pnas.0711467105; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; RICHARDS M, 2004, STUDIES HONOUR COLIN, P1363; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2004, AM J HUM GENET, V75, P524, DOI 10.1086/423824; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010218; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921	49	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18682	10.1371/journal.pone.0018682	http://dx.doi.org/10.1371/journal.pone.0018682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533064	Green Submitted, gold, Green Published			2022-12-25	WOS:000289719400020
J	Campbell, JH; Burdo, TH; Autissier, P; Bombardier, JP; Westmoreland, SV; Soulas, C; Gonzalez, RG; Ratai, EM; Williams, KC				Campbell, Jennifer H.; Burdo, Tricia H.; Autissier, Patrick; Bombardier, Jeffrey P.; Westmoreland, Susan V.; Soulas, Caroline; Gonzalez, R. Gilberto; Ratai, Eva-Maria; Williams, Kenneth C.			Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; AMYOTROPHIC-LATERAL-SCLEROSIS; PERIVASCULAR MACROPHAGES; NONHUMAN PRIMATE; HIV-INFECTION; CD8(+) LYMPHOCYTES; TYPE-1 INFECTION; T-CELLS; DEMENTIA; DISEASE	Background: Minocycline is a tetracycline antibiotic that has been proposed as a potential conjunctive therapy for HIV-1 associated cognitive disorders. Precise mechanism(s) of minocycline's functions are not well defined. Methods: Fourteen rhesus macaques were SIV infected and neuronal metabolites measured by proton magnetic resonance spectroscopy ((1)H MRS). Seven received minocycline (4 mg/kg) daily starting at day 28 post-infection (pi). Monocyte expansion and activation were assessed by flow cytometry, cell traffic to lymph nodes, CD16 regulation, viral replication, and cytokine production were studied. Results: Minocycline treatment decreased plasma virus and pro-inflammatory CD14+CD16+ and CD14(lo)CD16+ monocytes, and reduced their expression of CD11b, CD163, CD64, CCR2 and HLA-DR. There was reduced recruitment of monocyte/macrophages and productively infected cells in axillary lymph nodes. There was an inverse correlation between brain NAA/Cr (neuronal injury) and circulating CD14+CD16+ and CD14(lo)CD16+ monocytes. Minocycline treatment in vitro reduced SIV replication CD16 expression on activated CD14+CD16+ monocytes, and IL-6 production by monocytes following LPS stimulation. Conclusion: Neuroprotective effects of minocycline are due in part to reduction of activated monocytes, monocyte traffic. Mechanisms for these effects include CD16 regulation, reduced viral replication, and inhibited immune activation.	[Campbell, Jennifer H.; Burdo, Tricia H.; Autissier, Patrick; Soulas, Caroline; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Gonzalez, R. Gilberto; Ratai, Eva-Maria] Harvard Univ, Sch Med, Boston, MA USA; [Bombardier, Jeffrey P.; Westmoreland, Susan V.] New England Reg Primate Res Ctr, Southborough, MA 01772 USA; [Gonzalez, R. Gilberto; Ratai, Eva-Maria] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Gonzalez, R. Gilberto; Ratai, Eva-Maria] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Boston College; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Campbell, JH (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	williauy@bc.edu		Ratai, Eva-Maria/0000-0001-9476-6207	NIH [RO1NS40237, R01NS37654, U19MH081835, R01NS06897, R21NS059331, R01NS050041]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH081835, R25MH080663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059331, R01NS040237, R01NS050041, R01NS037654] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (www.nih.gov) grants RO1NS40237 (KCW), R01NS37654(KCW), U19MH081835 (KCW), R01NS06897 (KCW), R21NS059331 (EMR), and R01NS050041 (RGG). In vivo CD8 T lymphocyte depletion antibodies used in these studies were provided by the NIH Nonhuman Primate Reagent Resource (nhpreagents.bidmc.harvard.edu; R24 RR016001, N01 AI040101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2006, VIROLOGY, V344, P267, DOI 10.1016/j.virol.2005.10.027; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; ARONSON AL, 1980, J AM VET MED ASSOC, V176, P1061; BROGDEN RN, 1975, DRUGS, V9, P251, DOI 10.2165/00003495-197509040-00005; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Burdo TH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000842; Chen-Roetling J, 2009, BIOCHEM BIOPH RES CO, V386, P322, DOI 10.1016/j.bbrc.2009.06.026; Clay CC, 2007, J VIROL, V81, P12040, DOI 10.1128/JVI.00133-07; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; GRANT I, 1987, ANN INTERN MED, V107, P828, DOI 10.7326/0003-4819-107-6-828; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kim WK, 2005, NEUROTOX RES, V8, P107, DOI 10.1007/BF03033823; Kim WK, 2003, J LEUKOCYTE BIOL, V74, P650, DOI 10.1189/jlb.0503207; Kim WK, 2010, J LEUKOCYTE BIOL, V87, P557, DOI 10.1189/jlb.0209082; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; LASSMANN H, 1993, GLIA, V7, P19, DOI 10.1002/glia.440070106; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; McArthur JC, 2004, ARCH NEUROL-CHICAGO, V61, P1687, DOI 10.1001/archneur.61.11.1687; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Otani I, 1999, MICROBES INFECT, V1, P977, DOI 10.1016/S1286-4579(99)80515-2; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Rappaport J, 1999, J LEUKOCYTE BIOL, V65, P458, DOI 10.1002/jlb.65.4.458; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; RINGLER DJ, 1989, AM J PATHOL, V134, P373; SAIVIN S, 1988, CLIN PHARMACOKINET, V15, P355, DOI 10.2165/00003088-198815060-00001; Sakellari D, 2000, J CLIN PERIODONTOL, V27, P53, DOI 10.1034/j.1600-051x.2000.027001053.x; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; SHAN S, 2009, NEUROBIOL AGING; Shiramizu B, 2005, AIDS, V19, P45, DOI 10.1097/00002030-200501030-00005; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Soulas C, 2009, AM J PATHOL, V174, P1808, DOI 10.2353/ajpath.2009.081010; Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Zhao CH, 2007, NEUROBIOL DIS, V26, P36, DOI 10.1016/j.nbd.2006.11.012; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; ZIEGLERHEITBROCK HWL, 1988, HYBRIDOMA, V7, P521, DOI 10.1089/hyb.1988.7.521; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	55	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18688	10.1371/journal.pone.0018688	http://dx.doi.org/10.1371/journal.pone.0018688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494695	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400043
J	Selvais, C; D'Auria, L; Tyteca, D; Perrot, G; Lemoine, P; Troeberg, L; Dedieu, S; Noel, A; Nagase, H; Henriet, P; Courtoy, PJ; Marbaix, E; Emonard, H				Selvais, Charlotte; D'Auria, Ludovic; Tyteca, Donatienne; Perrot, Gwenn; Lemoine, Pascale; Troeberg, Linda; Dedieu, Stephane; Noel, Agnes; Nagase, Hideaki; Henriet, Patrick; Courtoy, Pierre J.; Marbaix, Etienne; Emonard, Herve			Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function	FASEB JOURNAL			English	Article						ADAM; MMP; endocytosis; plasma membrane; raft	EPIDERMAL-GROWTH-FACTOR; LIPID RAFTS; ADAM METALLOPROTEINASES; ENDOCYTIC CLEARANCE; CYTOPLASMIC DOMAIN; HUMAN ENDOMETRIUM; OVARIAN-STEROIDS; PLASMA-MEMBRANE; UP-REGULATION; GELATINASE-A	Low-density lipoprotein receptor-related protein-1 (LRP-1) is a plasma membrane scavenger and signaling receptor, composed of a large ligand-binding subunit (515-kDa alpha-chain) linked to a shorter transmembrane subunit (85-kDa beta-chain). LRP-1 cell-surface level and function are controlled by proteolytic shedding of its ectodomain. Here, we identified ectodomain sheddases in human HT1080 cells and demonstrated regulation of the cleavage by cholesterol by comparing the classical fibroblastoid type with a spontaneous epithelioid variant, enriched similar to 2-fold in cholesterol. Two membrane-associated metalloproteinases were involved in LRP-1 shedding: a disintegrin and metalloproteinase-12 (ADAM-12) and membrane-type 1 matrix metalloproteinase (MT1-MMP). Although both variants expressed similar levels of LRP-1, ADAM-12, MT1-MMP, and specific tissue inhibitor of metalloproteinases-2 (TIMP-2), LRP-1 shedding from epithelioid cells was similar to 4-fold lower than from fibroblastoid cells. Release of the ectodomain was triggered by cholesterol depletion in epithelioid cells and impaired by cholesterol overload in fibroblastoid cells. Modulation of LRP-1 shedding on clearance was reflected by accumulation of gelatinases (MMP-2 and MMP-9) in the medium. We conclude that cholesterol exerts an important control on LRP-1 levels and function at the plasma membrane by modulating shedding of its ectodomain, and therefore represents a novel regulator of extracellular proteolytic activities.-Selvais, C., D'Auria, L., Tyteca, D., Perrot, G, Lemoine, P., Troeberg, L., Dedieu, S., Noel, A., Nagase, H., Henriet, P., Courtoy, P. J., Marbaix, E., Emonard, H. Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function. FASEB J. 25, 2770-2781 (2011). www.fasebj.org	[Selvais, Charlotte; D'Auria, Ludovic; Tyteca, Donatienne; Lemoine, Pascale; Henriet, Patrick; Courtoy, Pierre J.; Marbaix, Etienne] Duve Inst, Cell Biol Lab, B-1200 Brussels, Belgium; [Selvais, Charlotte; D'Auria, Ludovic; Tyteca, Donatienne; Lemoine, Pascale; Henriet, Patrick; Courtoy, Pierre J.; Marbaix, Etienne] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Perrot, Gwenn; Dedieu, Stephane; Emonard, Herve] Univ Reims, Fac Med, Reims, France; [Perrot, Gwenn; Dedieu, Stephane; Emonard, Herve] Univ Reims, Ctr Natl Rech Sci CNRS, Unite Mixte Rech UMR 6237, Reims, France; [Troeberg, Linda; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, London, England; [Noel, Agnes] Univ Liege, Lab Tumor & Dev Biol, Grp Interdisciplinaire Genoprote Appl Canc, Liege, Belgium	Universite Catholique Louvain; Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; Imperial College London; University of Oxford; University of Liege	Marbaix, E (corresponding author), Duve Inst, Cell Biol Lab, UCL-75-41,75 Ave Hippocrate, B-1200 Brussels, Belgium.	etienne.marbaix@uclouvain.be	Emonard, Herve/R-9718-2019; Emonard, Hervé/AAD-5432-2019	/0000-0003-0939-4651; Henriet, Patrick/0000-0003-4602-8888; d'auria, ludovic/0000-0001-6270-7739; Dedieu, Stephane/0000-0003-1447-5640; Noel, Agnes/0000-0002-7670-6179	Centre National de la Recherche Scientifique; Fonds National pour la Sante ACI; U.S. National Institutes of Health [AR40994]; Belgian Fonds de la Recherche Scientifique (FRS/FNRS); Fondation contre le Cancer and the Direction Generale des Technologies, de la Recherche et de l'Energie from the Region Wallonne; Fonds Special de la Recherche of the Universite Catholique de Louvain; Fonds de la Recherche Scientifique Medicale; Concerted Research Actions of Communaute Francaise de Belgique; Interuniversity Attraction Poles Program; Belgian FRS/FNRS-Televie; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fonds National pour la Sante ACI; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian Fonds de la Recherche Scientifique (FRS/FNRS)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer and the Direction Generale des Technologies, de la Recherche et de l'Energie from the Region Wallonne; Fonds Special de la Recherche of the Universite Catholique de Louvain; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Concerted Research Actions of Communaute Francaise de Belgique; Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office); Belgian FRS/FNRS-Televie(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank E. Konradowski and D. Delapiere for excellent technical support, as well as Prof. Mark Rider (de Duve Institute, Universite Catholique de Louvain, Brussels, Belgium) for editorial assistance. The work was supported by grants from Centre National de la Recherche Scientifique, Contrat de Projets Etat-Region 2007-2013, and Fonds National pour la Sante ACI 2008 (Canceropole Grand-Est Project) (to G.P., S.D. and H.E.); by U.S. National Institutes of Health grant AR40994 (to L.T. and H.N.); by the Belgian Fonds de la Recherche Scientifique (FRS/FNRS), the Fondation contre le Cancer and the Direction Generale des Technologies, de la Recherche et de l'Energie from the Region Wallonne (to A.N.); and by Fonds Special de la Recherche of the Universite Catholique de Louvain, Fonds de la Recherche Scientifique Medicale, Concerted Research Actions of Communaute Francaise de Belgique, and Interuniversity Attraction Poles Program (to P. H., P.J.C., and E. M.). C.S. was a recipient of a grant from Belgian FRS/FNRS-Televie. L.D.A. was a recipient of a grant from the Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture. P.H. is a research associate at FRS/FNRS.	Anderegg U, 2009, J INVEST DERMATOL, V129, P1471, DOI 10.1038/jid.2008.323; Atkinson SJ, 2004, FEBS LETT, V566, P65, DOI 10.1016/j.febslet.2004.04.040; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Barnes H, 2003, ONCOGENE, V22, P3589, DOI 10.1038/sj.onc.1206504; Berton A, 2001, J BIOL CHEM, V276, P20458, DOI 10.1074/jbc.M011664200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Ceschin DG, 2009, J CELL BIOCHEM, V106, P372, DOI 10.1002/jcb.22014; Cornet PB, 2005, J CLIN ENDOCR METAB, V90, P1001, DOI 10.1210/jc.2004-1277; Dedieu S, 2008, MOL CELL BIOL, V28, P2980, DOI 10.1128/MCB.02238-07; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Emonard H, 2005, BIOCHIMIE, V87, P369, DOI 10.1016/j.biochi.2004.11.013; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Foca C, 2000, MOL HUM REPROD, V6, P921, DOI 10.1093/molehr/6.10.921; FRISCH SM, 1994, J CELL BIOL, V127, P1085, DOI 10.1083/jcb.127.4.1085; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu Q, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-17; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Okada A, 2008, ARTHRITIS RHEUM-US, V58, P778, DOI 10.1002/art.23262; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Quinn KA, 1999, EXP CELL RES, V251, P433, DOI 10.1006/excr.1999.4590; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Selvais C, 2009, ENDOCRINOLOGY, V150, P3792, DOI 10.1210/en.2009-0015; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Tamaki C, 2007, MOL PHARMACOL, V72, P850, DOI 10.1124/mol.107.036913; Tanaka M, 2004, J BIOL CHEM, V279, P41950, DOI 10.1074/jbc.M400086200; Tanida S, 2004, GASTROENTEROLOGY, V127, P559, DOI 10.1053/j.gastro.2004.05.017; Thevenard J, 2010, INT J CANCER, V126, P1055, DOI 10.1002/ijc.24688; Troeberg L, 2002, BIOCHEMISTRY-US, V41, P15025, DOI 10.1021/bi026454l; Tyteca D, 2010, BBA-BIOMEMBRANES, V1798, P909, DOI 10.1016/j.bbamem.2010.01.021; Vassilev V, 2005, J CLIN ENDOCR METAB, V90, P5848, DOI 10.1210/jc.2005-0762; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Webb DJ, 2000, J CELL SCI, V113, P123; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wu LH, 2005, J CELL BIOCHEM, V96, P1021, DOI 10.1002/jcb.20596	59	63	64	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2770	2781		10.1096/fj.10-169508	http://dx.doi.org/10.1096/fj.10-169508			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21518850	Green Published, Green Submitted			2022-12-25	WOS:000293337800025
J	Kukimoto-Niino, M; Yoshikawa, S; Takagi, T; Ohsawa, N; Tomabechi, Y; Terada, T; Shirouzu, M; Suzuki, A; Lee, S; Yamauchi, T; Okada-Iwabu, M; Iwabu, M; Kadowaki, T; Minokoshi, Y; Yokoyama, S				Kukimoto-Niino, Mutsuko; Yoshikawa, Seiko; Takagi, Tetsuo; Ohsawa, Noboru; Tomabechi, Yuri; Terada, Takaho; Shirouzu, Mikako; Suzuki, Atsushi; Lee, Suni; Yamauchi, Toshimasa; Okada-Iwabu, Miki; Iwabu, Masato; Kadowaki, Takashi; Minokoshi, Yasuhiko; Yokoyama, Shigeyuki			Crystal Structure of the Ca2+/Calmodulin-dependent Protein Kinase Kinase in Complex with the Inhibitor STO-609	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; REGULATORY MECHANISM; CALMODULIN; ACTIVATION; CALCIUM; DOMAIN; PHOSPHORYLATION; LOCALIZATION; RECOGNITION; SEQUENCE	Ca2+/calmodulin (CaM)-dependent protein kinase (CaMK) kinase (CaMKK) is a member of the CaMK cascade that mediates the response to intracellular Ca2+ elevation. CaMKK phosphorylates and activates CaMKI and CaMKIV, which directly activate transcription factors. In this study, we determined the 2.4 angstrom crystal structure of the catalytic kinase domain of the human CaMKK beta isoform complexed with its selective inhibitor, STO-609. The structure revealed that CaMKK beta lacks the alpha D helix and that the equivalent region displays a hydrophobic molecular surface, which may reflect its unique substrate recognition and autoinhibition. Although CaMKK beta lacks the activation loop phosphorylation site, the activation loop is folded in an active-state conformation, which is stabilized by a number of interactions between amino acid residues conserved among the CaMKK isoforms. An in vitro analysis of the kinase activity confirmed the intrinsic activity of the CaMKK beta kinase domain. Structure and sequence analyses of the STO-609-binding site revealed amino acid replacements that may affect the inhibitor binding. Indeed, mutagenesis demonstrated that the CaMKK beta residue Pro(274), which replaces the conserved acidic residue of other protein kinases, is an important determinant for the selective inhibition by STO-609. Therefore, the present structure provides a molecular basis for clarifying the known biochemical properties of CaMKK beta and for designing novel inhibitors targeting CaMKK beta and the related protein kinases.	[Minokoshi, Yasuhiko] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Endocrinol & Metab, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Kukimoto-Niino, Mutsuko; Yoshikawa, Seiko; Takagi, Tetsuo; Ohsawa, Noboru; Tomabechi, Yuri; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yamauchi, Toshimasa; Okada-Iwabu, Miki; Iwabu, Masato; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Tokyo 1130033, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); RIKEN; University of Tokyo; University of Tokyo	Minokoshi, Y (corresponding author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Endocrinol & Metab, Dept Dev Physiol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	minokosh@nips.ac.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Kukimoto-Niino, Mutsuko/C-6704-2017; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Minokoshi, Yasuhiko/0000-0002-7119-4805	RIKEN Structural Genomics/Proteomics Initiative (RSGI); National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science and Technology of Japan	RIKEN Structural Genomics/Proteomics Initiative (RSGI); National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the RIKEN Structural Genomics/Proteomics Initiative (RSGI), the National Project on Protein Structural and Functional Analyses, and the Targeted Proteins Research Program (TPRP), the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Fujimoto T, 2008, BIOCHEMISTRY-US, V47, P4151, DOI 10.1021/bi702528r; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kigawa T., 2007, CELL FREE PROTEIN SY, P83; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Kitani T, 1999, J BIOCHEM-TOKYO, V125, P1022, DOI 10.1093/oxfordjournals.jbchem.a022381; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Okuno S, 2000, J BIOCHEM-TOKYO, V127, P965, DOI 10.1093/oxfordjournals.jbchem.a022712; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Tokumitsu H, 1999, J BIOL CHEM, V274, P15803, DOI 10.1074/jbc.274.22.15803; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	50	29	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22570	22579		10.1074/jbc.M111.251710	http://dx.doi.org/10.1074/jbc.M111.251710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21504895	Green Published, hybrid			2022-12-25	WOS:000291719900064
J	Compton, S; Kim, C; Griner, NB; Potluri, P; Scheffler, IE; Sen, S; Jerry, DJ; Schneider, S; Yadava, N				Compton, Shannon; Kim, Chul; Griner, Nicholas B.; Potluri, Prasanth; Scheffler, Immo E.; Sen, Sabyasachi; Jerry, D. Joseph; Schneider, Sallie; Yadava, Nagendra			Mitochondrial Dysfunction Impairs Tumor Suppressor p53 Expression/Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; SPARE RESPIRATORY CAPACITY; CHINESE-HAMSTER CELLS; COMPLEX-I DEFICIENCY; DNA-BINDING ACTIVITY; WILD-TYPE P53; CANCER-CELLS; OXIDATIVE-PHOSPHORYLATION; ENERGY-METABOLISM; MOLECULAR-GENETICS	Recently, mitochondria have been suggested to act in tumor suppression. However, the underlying mechanisms by which mitochondria suppress tumorigenesis are far from being clear. In this study, we have investigated the link between mitochondrial dysfunction and the tumor suppressor protein p53 using a set of respiration-deficient (Res(-)) mammalian cell mutants with impaired assembly of the oxidative phosphorylation machinery. Our data suggest that normal mitochondrial function is required for gamma-irradiation (gamma IR)-induced cell death, which is mainly a p53-dependent process. The Res(-) cells are protected against gamma IR-induced cell death due to impaired p53 expression/function. We find that the loss of complex I biogenesis in the absence of the MWFE subunit reduces the steady-state level of the p53 protein, although there is no effect on the p53 protein level in the absence of the ESSS subunit that is also essential for complex I assembly. The p53 protein level was also reduced to undetectable levels in Res(-) cells with severely impaired mitochondrial protein synthesis. This suggests that p53 protein expression is differentially regulated depending upon the type of electron transport chain/respiratory chain deficiency. Moreover, irrespective of the differences in the p53 protein expression profile, gamma IR-induced p53 activity is compromised in all Res(-) cells. Using two different conditional systems for complex I assembly, we also show that the effect of mitochondrial dysfunction on p53 expression/function is a reversible phenomenon. We believe that these findings will have major implications in the understanding of cancer development and therapy.	[Compton, Shannon; Kim, Chul; Sen, Sabyasachi; Jerry, D. Joseph; Schneider, Sallie; Yadava, Nagendra] Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA; [Sen, Sabyasachi; Yadava, Nagendra] Tufts Univ, Sch Med, Baystate Med Ctr, Div Endocrinol Diabet & Metab, Springfield, MA 01199 USA; [Yadava, Nagendra] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Griner, Nicholas B.; Sen, Sabyasachi; Jerry, D. Joseph; Schneider, Sallie] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Potluri, Prasanth; Scheffler, Immo E.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California San Diego	Yadava, N (corresponding author), Pioneer Valley Life Sci Inst, 3601 Main St, Springfield, MA 01107 USA.	Nagendra.Yadava@baystatehealth.org		Compton, Shannon/0000-0001-9372-1891	National Institutes of Health [R21NS057224, R01-CA105452, R01-ES015739]; Baystate Health Foundation; Center of Excellence in Apoptosis Research; NATIONAL CANCER INSTITUTE [R01CA105452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baystate Health Foundation; Center of Excellence in Apoptosis Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21NS057224 (to N.Y.) and R01-CA105452, R01-ES015739 (to D.J.J.). This work was also supported in part by funds from a Rays of Hope grant from the Baystate Health Foundation and start-up funds from Center of Excellence in Apoptosis Research.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Acebo P, 2009, TRANSL ONCOL, V2, P138, DOI 10.1593/tlo.09106; Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Au HC, 1999, P NATL ACAD SCI USA, V96, P4354, DOI 10.1073/pnas.96.8.4354; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Blackburn AC, 2004, CANCER RES, V64, P5140, DOI 10.1158/0008-5472.CAN-03-3435; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Broz DK, 2010, CARCINOGENESIS, V31, P1311, DOI 10.1093/carcin/bgp331; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; Chandra D, 2006, CELL, V125, P1333, DOI 10.1016/j.cell.2006.05.026; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Cuezva JM, 2007, J BIOENERG BIOMEMBR, V39, P259, DOI 10.1007/s10863-007-9087-9; Cuezva JM, 2009, BBA-MOL BASIS DIS, V1792, P1145, DOI 10.1016/j.bbadis.2009.01.006; Czarnecka AM, 2010, ONCOL REP, V23, P531, DOI 10.3892/or_00000666; Czarnecka AM, 2010, BREAST CANCER RES TR, V121, P511, DOI 10.1007/s10549-009-0358-5; de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874; DEFRANCESCO L, 1975, J CELL PHYSIOL, V85, P293, DOI 10.1002/jcp.1040850216; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; DITTA G, 1976, SOMAT CELL GENET, V2, P331, DOI 10.1007/BF01538838; DITTA G, 1977, NATURE, V268, P64, DOI 10.1038/268064a0; DONNELLY M, 1976, J CELL PHYSIOL, V89, P39, DOI 10.1002/jcp.1040890105; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Gauger KJ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-11; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Holley AK, 2009, FUTURE ONCOL, V5, P117, DOI 10.2217/14796694.5.1.117; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Johnson-Cadwell LI, 2007, J NEUROCHEM, V101, P1619, DOI 10.1111/j.1471-4159.2007.04516.x; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kulawiec M, 2009, J HUM GENET, V54, P647, DOI 10.1038/jhg.2009.89; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Lu Shaolei, 2008, Endocrinology, V149, P4809, DOI 10.1210/en.2008-0035; Mamelak AJ, 2005, EXP DERMATOL, V14, P336, DOI 10.1111/j.0906-6705.2005.00278.x; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayr JA, 2008, CLIN CANCER RES, V14, P2270, DOI 10.1158/1078-0432.CCR-07-4131; Metcalfe S, 1999, ONCOGENE, V18, P2351, DOI 10.1038/sj.onc.1202559; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Nicholls DG, 2010, ESSAYS BIOCHEM, V47, P25, DOI [10.1042/BSE0470025, 10.1042/bse0470025]; Norris PS, 1997, ONCOGENE, V15, P2241, DOI 10.1038/sj.onc.1201406; Okorokov AL, 1999, MOL CELL BIOL, V19, P7501; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Porcelli AM, 2010, HUM MOL GENET, V19, P1019, DOI 10.1093/hmg/ddp566; Potluri P, 2004, EUR J BIOCHEM, V271, P3265, DOI 10.1111/j.1432-1033.2004.04260.x; Ray AM, 2009, PROSTATE, V69, P956, DOI 10.1002/pros.20943; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Scheffler IE, 2004, BBA-BIOENERGETICS, V1659, P160, DOI 10.1016/j.bbabio.2004.08.002; Scheffler IE, 2001, J BIOENERG BIOMEMBR, V33, P243, DOI 10.1023/A:1010739120891; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Sun WY, 2009, CLIN CANCER RES, V15, P476, DOI 10.1158/1078-0432.CCR-08-0930; Theodoratou E, 2010, CARCINOGENESIS, V31, P296, DOI 10.1093/carcin/bgp237; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; van Waveren C, 2006, CARCINOGENESIS, V27, P409, DOI 10.1093/carcin/bgi242; Verhaegh GW, 1997, MOL CELL BIOL, V17, P5699, DOI 10.1128/MCB.17.10.5699; Verhaegh GW, 1998, MOL CARCINOGEN, V21, P205, DOI 10.1002/(SICI)1098-2744(199803)21:3<205::AID-MC8>3.0.CO;2-K; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013459; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yadava N, 2008, INT J BIOCHEM CELL B, V40, P447, DOI 10.1016/j.biocel.2007.08.015; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; Yadava N, 2002, J BIOL CHEM, V277, P21221, DOI 10.1074/jbc.M202016200; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Zanssen S, 2005, PLOS MED, V2, P1082, DOI 10.1371/journal.pmed.0020401; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104	101	45	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20297	20312		10.1074/jbc.M110.163063	http://dx.doi.org/10.1074/jbc.M110.163063			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502317	Green Published, hybrid			2022-12-25	WOS:000291267600018
J	Kisic, M; Matamoros, T; Nevot, M; Mendieta, J; Martinez-Picado, J; Martinez, MA; Menendez-Arias, L				Kisic, Monica; Matamoros, Tania; Nevot, Maria; Mendieta, Jesus; Martinez-Picado, Javier; Martinez, Miguel A.; Menendez-Arias, Luis			Thymidine Analogue Excision and Discrimination Modulated by Mutational Complexes Including Single Amino Acid Deletions of Asp-67 or Thr-69 in HIV-1 Reverse Transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIGH-LEVEL RESISTANCE; DRUG-RESISTANCE; REPLICATION CAPACITY; NUCLEOTIDE ANALOGS; PRIMER UNBLOCKING; VIRAL REPLICATION; CATALYTIC COMPLEX; CODING REGION; ZIDOVUDINE	Single amino acid deletions in the beta 3-beta 4 hairpin loop of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) have been identified in heavily treated patients. The deletion of Asp-67 together with mutations T69G and K70R (Delta 67 complex) are usually associated with thymidine analog resistance mutations (TAMs) (e. g. M41L, T215Y, etc.) while the deletion of Thr-69 (Delta 69) is rarely found in isolates containing TAMs. Here, we show that the complex Delta 67/T69G/K70R enhances ATP-dependent phosphorolytic activity on primers terminated with 3'-azido-3'-deoxythymidine (AZT) or 2',3'-didehydro-2',3terminated with 3'-azido-3'-deoxythymidine (AZT) or 2',3'-didehydro-2',3'-dideoxythymidine (d4T) both in the presence or absence of TAMs (i.e. M41L/T215Y), while Delta 69 (or the complex S68G/Delta 69/K70G) antagonize the effects of TAMs in ATP-mediated excision. These effects are consistent with AZT susceptibility data obtained with recombinant HIV-1 bearing the relevant RTs. Molecular dynamics studies based on models of wild-type HIV-1 RT and mutant Delta 69, Delta 67/T69G/K70R, and D67N/K70R RTs support a relevant role for Lys/Arg-70 in the excision reaction. In Delta 69 RT, the side chain of Lys-70 locates away from the putative pyrophosphate binding site. Therefore, its participation in interactions required for the excision reaction is unlikely. Our theoretical studies also suggest a role for Lys-219 in thymidine analog excision/discrimination. However, pre-steady-state kinetics revealed only minor differences in selectivity of AZT-triphosphate versus dTTP between deletion-containing RTs and their homologous enzymes having the K219E mutation. K219E reduced both ATP- and pyrophosphate-mediated excision of primers terminated with thymidine analogues, only when introduced in RTs bearing Delta 69 or S68G/Delta 69/K70G, providing further biochemical evidence that explains the lack of association of Delta 69 and TAMs in HIV-1 isolates.	[Kisic, Monica; Matamoros, Tania; Mendieta, Jesus; Menendez-Arias, Luis] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Kisic, Monica; Matamoros, Tania; Mendieta, Jesus; Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Nevot, Maria; Martinez-Picado, Javier; Martinez, Miguel A.] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Lab Retrovirol, Barcelona 08916, Spain; [Martinez-Picado, Javier] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA	Menendez-Arias, L (corresponding author), Ctr Biol Mol Severo Ochoa CSIC UAM, C Nicolas Cabrera,1,Campus Cantoblanco, Madrid 28049, Spain.	lmenendez@cbm.uam.es	Arias, Luis Menendez/N-7447-2016; Menendez Arias, Luis/G-2436-2016; Matamoros, Tania/F-2580-2016; Martinez, Miguel Angel/K-6435-2014; Nevot, Maria/AAC-7839-2022; Martinez-Picado, Javier/G-5507-2012; Mendieta, Jesús/P-4802-2016; Nevot, Maria/E-6187-2016	Arias, Luis Menendez/0000-0002-1251-6640; Matamoros, Tania/0000-0001-9268-0696; Martinez, Miguel Angel/0000-0002-6681-4950; Nevot, Maria/0000-0003-4947-4648; Martinez-Picado, Javier/0000-0002-4916-2129; Mendieta, Jesús/0000-0002-5498-0871; Nevot, Maria/0000-0003-4947-4648; Mendieta, Jesus/0000-0001-9286-2166	Ministry of Science and Innovation of Spain [BIO2010/15542]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [36771/08]; Fondo de Investigacion Sanitaria (through the "Red Tematica de Investigacion Cooperativa en SIDA") [RD06/006]; Fundacion Ramon Areces; Spanish Ministry of Science and Innovation [BFU2010-15194]; European Community; ICREA Funding Source: Custom	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Fondo de Investigacion Sanitaria (through the "Red Tematica de Investigacion Cooperativa en SIDA")(Instituto de Salud Carlos III); Fundacion Ramon Areces; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); ICREA(ICREA)	This work was supported by grants of the Ministry of Science and Innovation of Spain (BIO2010/15542), Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) (Grant 36771/08), Fondo de Investigacion Sanitaria (through the "Red Tematica de Investigacion Cooperativa en SIDA" RD06/006), and an institutional grant from the Fundacion Ramon Areces. Work at Fundacio irsiCaixa was supported by Spanish Ministry of Science and Innovation Grant BFU2010-15194 (to M. A. M.), and by the European Community's Seventh Framework Program (FP7/2007-2013) under the project "Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)."	Betancor G, 2010, ANTIMICROB AGENTS CH, V54, P4799, DOI 10.1128/AAC.00716-10; Boretto J, 2001, ANAL BIOCHEM, V292, P139, DOI 10.1006/abio.2001.5045; Boyer PL, 2004, J VIROL, V78, P9987, DOI 10.1128/JVI.78.18.9987-9997.2004; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Cases-Gonzalez CE, 2007, J MOL BIOL, V365, P298, DOI 10.1016/j.jmb.2006.09.073; Cozzi-Lepri A, 2005, ANTIVIR THER, V10, P791; De Clercq E, 2010, CURR OPIN PHARMACOL, V10, P507, DOI 10.1016/j.coph.2010.04.011; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Eggink D, 2007, ANTIVIR RES, V75, P93, DOI 10.1016/j.antiviral.2007.03.001; Hanna GJ, 2000, J INFECT DIS, V181, P904, DOI 10.1086/315329; Harrigan PR, 1996, J VIROL, V70, P5930, DOI 10.1128/JVI.70.9.5930-5934.1996; Herschhorn A, 2010, CELL MOL LIFE SCI, V67, P2717, DOI 10.1007/s00018-010-0346-2; Hooker DJ, 1996, J VIROL, V70, P8010, DOI 10.1128/JVI.70.11.8010-8018.1996; Hu ZX, 2007, JAIDS-J ACQ IMM DEF, V45, P494, DOI 10.1097/QAI.0b013e31806ada48; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Imamichi T, 2000, J VIROL, V74, P1023, DOI 10.1128/JVI.74.2.1023-1028.2000; Imamichi T, 2001, J VIROL, V75, P3988, DOI 10.1128/JVI.75.8.3988-3992.2001; KATI WM, 1992, J BIOL CHEM, V267, P25988; KELLAM P, 1992, P NATL ACAD SCI USA, V89, P1934, DOI 10.1073/pnas.89.5.1934; KELLAM P, 1994, ANTIMICROB AGENTS CH, V38, P23, DOI 10.1128/AAC.38.1.23; Kisic M, 2008, J MOL BIOL, V382, P327, DOI 10.1016/j.jmb.2008.07.030; LACEY SF, 1994, J VIROL, V68, P3421, DOI 10.1128/JVI.68.5.3421-3424.1994; LARDER BA, 1991, J VIROL, V65, P5232, DOI 10.1128/JVI.65.10.5232-5236.1991; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; MartinHernandez AM, 1997, NUCLEIC ACIDS RES, V25, P1383, DOI 10.1093/nar/25.7.1383; Mas A, 2002, J MOL BIOL, V323, P181, DOI 10.1016/S0022-2836(02)00911-7; Masquelier B, 2001, ANTIMICROB AGENTS CH, V45, P1836, DOI 10.1128/AAC.45.6.1836-1842.2001; Matamoros T, 2005, J MOL BIOL, V349, P451, DOI 10.1016/j.jmb.2005.04.004; Matamoros T, 2009, J BIOL CHEM, V284, P32792, DOI 10.1074/jbc.M109.038885; Mendieta J, 2008, PROTEINS, V71, P565, DOI 10.1002/prot.21711; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Menendez-Arias L, 2006, CURR PHARM DESIGN, V12, P1811, DOI 10.2174/138161206776873608; Menendez-Arias L, 2010, ANTIVIR RES, V85, P210, DOI 10.1016/j.antiviral.2009.07.006; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Naeger LK, 2001, ANTIVIR THER, V6, P115; Ross L, 2000, J HUMAN VIROL, V3, P144; Ross L, 2004, AIDS, V18, P1691, DOI 10.1097/01.aids.0000131355.44834.e4; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Smith AJ, 2006, CURR PHARM DESIGN, V12, P1827, DOI 10.2174/138161206776873572; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; Villena C, 2007, J VIROL, V81, P4713, DOI 10.1128/JVI.02135-06; Winters MA, 2000, J VIROL, V74, P10707, DOI 10.1128/JVI.74.22.10707-10713.2000; Yahi N, 1999, J CLIN MICROBIOL, V37, P4099, DOI 10.1128/JCM.37.12.4099-4106.1999	47	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20615	20624		10.1074/jbc.M111.226100	http://dx.doi.org/10.1074/jbc.M111.226100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21504903	hybrid, Green Published			2022-12-25	WOS:000291267600048
J	Remacle, AG; Shiryaev, SA; Radichev, IA; Rozanov, DV; Stec, B; Strongin, AY				Remacle, Albert G.; Shiryaev, Sergey A.; Radichev, Ilian A.; Rozanov, Dmitri V.; Stec, Boguslaw; Strongin, Alex Y.			Dynamic Interdomain Interactions Contribute to the Inhibition of Matrix Metalloproteinases by Tissue Inhibitors of Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; X-RAY-STRUCTURE; COMPLEX-FORMATION; IV COLLAGENASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; GELATINASE-A; FULL-LENGTH; 1-MATRIX METALLOPROTEINASE; INTEGRIN ALPHA-V-BETA-3	Because of their important function, matrix metalloproteinases (MMPs) are promising drug targets in multiple diseases, including malignancies. The structure of MMPs includes a catalytic domain, a hinge, and a hemopexin domain (PEX), which are followed by a transmembrane and cytoplasmic tail domains or by a glycosylphosphatidylinositol linker in membrane-type MMPs (MT-MMPs). TIMPs-1, -2, -3, and -4 are potent natural regulators of the MMP activity. These are the inhibitory N-terminal and the non-inhibitory C-terminal structural domains in TIMPs. Based on our structural modeling, we hypothesized that steric clashes exist between the non-inhibitory C-terminal domain of TIMPs and the PEX of MMPs. Conversely, a certain mobility of the PEX relative to the catalytic domain is required to avoid these obstacles. Because of its exceedingly poor association constant and, in contrast with TIMP-2, TIMP-1 is inefficient against MT1-MMP. We specifically selected an MT1-MMP . TIMP-1 pair to test our hypothesis, because any improvement of the inhibitory potency would be readily recorded. We characterized the domain-swapped MT1-MMP chimeras in which the PEX of MMP-2 (that forms a complex with TIMP-2) and of MMP-9 (that forms a complex with TIMP-1) replaced the original PEX in the MT1-MMP structure. In contrast with the wild-type MT1-MMP, the diverse proteolytic activities of the swapped-PEX chimeras were then inhibited by both TIMP-1 and TIMP-2. Overall, our studies suggest that the structural parameters of both domains of TIMPs have to be taken into account for their re-engineering to harness the therapeutic in vivo potential of the novel TIMP-based MMP antagonists with constrained selectivity.	[Remacle, Albert G.; Shiryaev, Sergey A.; Radichev, Ilian A.; Rozanov, Dmitri V.; Stec, Boguslaw; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016; Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [CA77470, CA83017]; NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77470 and CA83017 (to A. Y. S.).	Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Choi WS, 2008, J THROMB HAEMOST, V6, P517, DOI 10.1111/j.1538-7836.2007.02871.x; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Edwards DR, 1996, INT J OBESITY, V20, pS9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Gohlke U, 1996, FEBS LETT, V378, P126, DOI 10.1016/0014-5793(95)01435-7; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Hutton M, 1998, BIOCHEMISTRY-US, V37, P10094, DOI 10.1021/bi980616p; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Jiang AX, 2003, J BIOL CHEM, V278, P38765, DOI 10.1074/jbc.M306618200; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Lang R, 2004, J MOL BIOL, V336, P213, DOI 10.1016/j.jmb.2003.12.022; Lee MH, 2010, CANCER LETT, V290, P114, DOI 10.1016/j.canlet.2009.08.029; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 2003, BIOCHEM SOC SYMP, V70, P201, DOI 10.1042/bss0700201; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase Hideaki, 2008, P787, DOI 10.1007/978-0-387-69057-5_37; Nisato RE, 2005, CANCER RES, V65, P9377, DOI 10.1158/0008-5472.CAN-05-1512; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Patterson ML, 2001, FEBS LETT, V503, P158, DOI 10.1016/S0014-5793(01)02723-5; Radichev IA, 2010, J BIOL CHEM, V285, P16076, DOI 10.1074/jbc.M110.107094; Rapti M, 2008, BIOCHEM J, V411, P433, DOI 10.1042/BJ20071430; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shiryaev SA, 2009, J BIOL CHEM, V284, P30615, DOI 10.1074/jbc.M109.041244; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Tuuttila A, 1998, J MOL BIOL, V284, P1133, DOI 10.1006/jmbi.1998.2223; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Williamson RA, 1996, EUR J BIOCHEM, V241, P476, DOI 10.1111/j.1432-1033.1996.00476.x; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616	65	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					21002	21012		10.1074/jbc.M110.200139	http://dx.doi.org/10.1074/jbc.M110.200139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21518756	Green Published, hybrid			2022-12-25	WOS:000291267600084
J	Vila-Brau, A; De Sousa-Coelho, AL; Mayordomo, C; Haro, D; Marrero, PF				Vila-Brau, Anna; Luisa De Sousa-Coelho, Ana; Mayordomo, Cristina; Haro, Diego; Marrero, Pedro F.			Human HMGCS2 Regulates Mitochondrial Fatty Acid Oxidation and FGF21 Expression in HepG2 Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; COA SYNTHASE GENE; 3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE; PPAR-ALPHA; RESPONSIVE ELEMENT; ADAPTIVE RESPONSE; KETONE-BODY; ENZYME; METABOLISM; KETOGENESIS	HMGCS2 (hydroxymethylglutaryl CoA synthase 2), the gene that regulates ketone body production, is barely expressed in cultured cell lines. In this study, we restored HMGCS2 expression and activity in HepG2 cells, thus showing that the wild type enzyme can induce fatty acid beta-oxidation (FAO) and ketogenesis, whereas a catalytically inactive mutant C166A did not generate either process. Peroxisome proliferator-activated receptor (PPAR) alpha expression also induces fatty acid beta-oxidation and endogenous HMGCS2 expression. Interestingly, PPAR alpha-mediated induction was abolished when HMGCS2 expression was down-regulated by RNAi. These results indicate that HMGCS2 expression is both sufficient and necessary to the control of fatty acid oxidation in these cells. Next, we examined the expression pattern of several PPAR alpha target genes in this now "ketogenic" HepG2 cell line. FGF21 (fibroblast growth factor 21) expression was specifically induced by HMGCS2 activity or by the inclusion of the oxidized form of ketone bodies (acetoacetate) in the culture medium. This effect was blunted by SirT1 (sirtuin 1) RNAi, so we propose a SirT1-dependent mechanism for FGF21 induction by acetoacetate. These data suggest a novel feed-forward mechanism by which HMGCS2 could regulate adaptive metabolic responses during fasting. This mechanism could be physiologically relevant, because fasting-mediated induction of liver FGF21 was dependent on SirT1 activity in vivo.	[Marrero, Pedro F.] Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, Sch Pharm, E-08028 Barcelona, Spain; Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain	University of Barcelona; University of Barcelona	Marrero, PF (corresponding author), Univ Barcelona, Fac Farm, Dept Bioquim & Biol Mol, Sch Pharm, Joan XXIII S-N, E-08028 Barcelona, Spain.	pedromarrero@ub.edu	De Sousa Coelho, Ana Luísa/K-1651-2019; Haro, Diego/I-4623-2015; De Sousa-Coelho, Ana Luísa/V-1529-2019; Marrero, Pedro F/I-1919-2015	Haro, Diego/0000-0001-9147-0486; De Sousa-Coelho, Ana Luísa/0000-0002-8451-4302; Mayordomo Tella, Maria Cristina/0000-0003-3245-0818	Spanish Ministerio de Educacion y Ciencia [BFU2007-67322/BMC, SAF2010-15217]; Catalan government (Ajut de Suport als Grups de Recerca de Catalunya) [2005SGR00857, 2009SGR163]; Catalan government; Fundacao para a Ciencia e a Tecnologia through the Portuguese government;  [RCMNC03/08]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Catalan government (Ajut de Suport als Grups de Recerca de Catalunya); Catalan government; Fundacao para a Ciencia e a Tecnologia through the Portuguese government; 	This work was supported by Grants BFU2007-67322/BMC (to P. F. M.) and SAF2010-15217 (to D. H.) from the Spanish Ministerio de Educacion y Ciencia and RCMNC03/08 (to D. H.) and also by funding from the Catalan government (Ajut de Suport als Grups de Recerca de Catalunya Grants 2005SGR00857 and 2009SGR163).; Supported by Scholarship from Catalan government (Ajut al Personal Investigador, FI 2007-2011).; Supported by the Fundacao para a Ciencia e a Tecnologia through the Portuguese government.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barrero MJ, 2003, BIOCHEM J, V369, P721, DOI 10.1042/BJ20020851; Camarero N, 2006, MOL CANCER RES, V4, P645, DOI 10.1158/1541-7786.MCR-05-0267; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Eledrisi MS, 2006, AM J MED SCI, V331, P243, DOI 10.1097/00000441-200605000-00002; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kostiuk MA, 2010, FASEB J, V24, P1914, DOI 10.1096/fj.09-149765; KOUNDAKJIAN PP, 1970, BIOCHEM J, V119, P49, DOI 10.1042/bj1190049; Le May C, 2000, FEBS LETT, V475, P163, DOI 10.1016/S0014-5793(00)01648-3; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; MASCARO C, 1995, ARCH BIOCHEM BIOPHYS, V317, P385, DOI 10.1006/abbi.1995.1178; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Meertens LM, 1998, EMBO J, V17, P6972, DOI 10.1093/emboj/17.23.6972; MISRA I, 1993, J BIOL CHEM, V268, P12129; Napal L, 2005, J MOL BIOL, V354, P751, DOI 10.1016/j.jmb.2005.09.097; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ortiz JA, 1999, BIOCHEM J, V337, P329, DOI 10.1042/0264-6021:3370329; PRIPBUUS C, 1992, EUR J BIOCHEM, V209, P291, DOI 10.1111/j.1432-1033.1992.tb17288.x; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Quant Patti A., 1994, V28, P13; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; ROKOSZ LL, 1994, ARCH BIOCHEM BIOPHYS, V312, P1, DOI 10.1006/abbi.1994.1273; VALERA A, 1994, J BIOL CHEM, V269, P6267; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439	34	89	92	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20423	20430		10.1074/jbc.M111.235044	http://dx.doi.org/10.1074/jbc.M111.235044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502324	hybrid, Green Published			2022-12-25	WOS:000291267600030
J	Zhuang, QY; Li, J; Wu, ZH; Zhang, JG; Sun, W; Li, T; Yan, YJ; Jiang, Y; Zhao, RC; Qiu, GX				Zhuang, Qianyu; Li, Jing; Wu, Zhihong; Zhang, Jianguo; Sun, Wei; Li, Tao; Yan, Yujuan; Jiang, Ying; Zhao, Robert Chunhua; Qiu, Guixing			Differential Proteome Analysis of Bone Marrow Mesenchymal Stem Cells from Adolescent Idiopathic Scoliosis Patients	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GROWTH-RELATED PROTEIN; EHRLICH ASCITES TUMOR; PYRUVATE-KINASE; RETINOIC ACID; HL-60 CELLS; OSTEOGENIC DIFFERENTIATION; MINERAL DENSITY; LEUKEMIA-CELLS; CALCIUM INTAKE	Adolescent idiopathic scoliosis (AIS) is a complex three-dimensional deformity of the spine. The cause and pathogenesis of scoliosis and the accompanying generalized osteopenia remain unclear despite decades of extensive research. In this study, we utilized two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) coupled with mass spectrometry (MS) to analyze the differential proteome of bone marrow mesenchymal stem cells (BM-MSCs) from AIS patients. In total, 41 significantly altered protein spots were detected, of which 34 spots were identified by MALDI-TOF/TOF analysis and found to represent 25 distinct gene products. Among these proteins, five related to bone growth and development, including pyruvate kinase M2, annexin A2, heat shock 27 kDa protein, gamma-actin, and beta-actin, were found to be dysregulated and therefore selected for further validation by Western blot analysis. At the protein level, our results supported the previous hypothesis that decreased osteogenic differentiation ability of MSCs is one of the mechanisms leading to osteopenia in AIS. In summary, we analyzed the differential BM-MSCs proteome of AIS patients for the first time, which may help to elucidate the underlying molecular mechanisms of bone loss in AIS and also increase understanding of the etiology and pathogenesis of AIS.	[Zhuang, Qianyu; Wu, Zhihong; Zhang, Jianguo; Li, Tao; Qiu, Guixing] Beijing Union Med Coll Hosp, Dept Orthoped, Beijing, Peoples R China; [Li, Jing; Zhao, Robert Chunhua] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Excellence Tissue Engn, Beijing 100730, Peoples R China; [Li, Jing; Zhao, Robert Chunhua] Chinese Acad Med Sci, Sch Basic Med, Beijing 100037, Peoples R China; [Li, Jing; Zhao, Robert Chunhua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Wei; Yan, Yujuan; Jiang, Ying] Beijing Inst Radiat Med, State Key Lab Prote, Beijing Proteome Res Ctr, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Academy of Military Medical Sciences - China	Zhuang, QY (corresponding author), Beijing Union Med Coll Hosp, Dept Orthoped, Beijing, Peoples R China.	qiuguixingpumch@gmail.com	wu, zhi/GXH-3041-2022	Qiu, Guixing/0000-0002-4597-9350	National Natural Science Foundation of P.R. China [30700856, 30772191]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of P.R. China (Grant Number: 30700856, 30772191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Uri Michael, 2002, Am J Orthop (Belle Mead NJ), V31, P387; BENNDORF R, 1988, BIOCHEM INT, V17, P225; Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007; BOARD M, 1990, BIOCHEM J, V265, P503, DOI 10.1042/bj2650503; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chai YH, 1999, J NEUROSCI, V19, P10338; Chaufour S, 1996, CELL STRESS CHAPERON, V1, P225, DOI 10.1379/1466-1268(1996)001<0225:TAPACI>2.3.CO;2; Cheng J C, 2001, Spine (Phila Pa 1976), V26, pE19; Cheng JCY, 2000, J BONE MINER RES, V15, P1587, DOI 10.1359/jbmr.2000.15.8.1587; Cheng JCY, 1997, SPINE, V22, P1716, DOI 10.1097/00007632-199708010-00006; Cheung CSK, 2006, SPINE, V31, P330, DOI 10.1097/01.brs.0000197410.92525.10; Cheung KMC, 2008, INT ORTHOP, V32, P729, DOI 10.1007/s00264-007-0393-y; Chu WCW, 2008, SCOLIOSIS SPINAL DIS, V3, DOI 10.1186/1748-7161-3-8; Coillard C, 1996, Eur Spine J, V5, P91, DOI 10.1007/BF00298387; CROMPTON MR, 1988, CELL, V55, P1, DOI 10.1016/0092-8674(88)90002-5; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; GAESTEL M, 1989, EUR J BIOCHEM, V179, P209, DOI 10.1111/j.1432-1033.1989.tb14542.x; GENGE BR, 1989, J BIOL CHEM, V264, P10917; GHOSH P, 1980, SPINE, V5, P310, DOI 10.1097/00007632-198007000-00004; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Gilmore WS, 2004, BIOCHEM SOC T, V32, P1122, DOI 10.1042/BST0321122; Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Hermus JPS, 2007, EUR SPINE J, V16, pS338, DOI 10.1007/s00586-007-0335-9; HEYDARI AR, 1994, EXPERIENTIA, V50, P1092, DOI 10.1007/BF01923466; Hicks JM, 2010, SPINE, V35, pE465, DOI 10.1097/BRS.0b013e3181d1021a; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Ilharreborde B, 2009, J SPINAL DISORD TECH, V22, P530, DOI 10.1097/BSD.0b013e31818d64b7; KANE WJ, 1977, CLIN ORTHOP RELAT R, P43; Kirsch T, 2006, CURR OPIN RHEUMATOL, V18, P174, DOI 10.1097/01.bor.0000209431.59226.46; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Lee WTK, 2005, OSTEOPOROSIS INT, V16, P1024, DOI 10.1007/s00198-004-1792-1; Li D, 2005, PROG BIOCHEM BIOPHYS, V32, P1026; Liang CRMY, 2005, PROTEOMICS, V5, P2258, DOI 10.1002/pmic.200401256; LONCARDUSEK M, 1991, CLIN ORTHOP RELAT R, P278; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; LONSTEIN JE, 1994, LANCET, V344, P1407; Loones MT, 1998, CELL STRESS CHAPERON, V3, P237, DOI 10.1379/1466-1268(1998)003<0237:HACDDE>2.3.CO;2; MACHIDA M, 1993, SPINE, V18, P1609, DOI 10.1097/00007632-199309000-00007; Mansilla E, 2006, TRANSPL P, V38, P967, DOI 10.1016/j.transproceed.2006.02.053; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; MISOL S, 1971, CLIN ORTHOP RELAT R, P122, DOI 10.1097/00003086-197111000-00019; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Negrini S, 2010, SPINE, V35, P1285, DOI 10.1097/BRS.0b013e3181dc48f4; Normanno N, 2005, ENDOCR-RELAT CANCER, V12, P471, DOI 10.1677/erc.1.00956; Ogilvie J, 2010, CURR OPIN PEDIATR, V22, P67, DOI 10.1097/MOP.0b013e32833419ac; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; Park WW, 2009, EUR SPINE J, V18, P1920, DOI 10.1007/s00586-009-1129-z; Pfander D, 2001, AM J PATHOL, V159, P1777, DOI 10.1016/S0002-9440(10)63024-6; REINACHER M, 1981, VIRCHOWS ARCH B, V37, P79, DOI 10.1007/BF02892557; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; SAKIC K, 1992, INT ORTHOP, V16, P207, DOI 10.1007/BF00182695; Sakic K, 1993, Lijec Vjesn, V115, P268; SHAKOORI AR, 1992, J CELL BIOCHEM, V48, P277, DOI 10.1002/jcb.240480308; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; SPECTOR NL, 1994, FEBS LETT, V337, P184, DOI 10.1016/0014-5793(94)80270-X; SPECTOR NL, 1993, J CELL PHYSIOL, V156, P619, DOI 10.1002/jcp.1041560322; SPECTOR NL, 1995, J BIOL CHEM, V270, P1003, DOI 10.1074/jbc.270.3.1003; SPECTOR NL, 1992, J IMMUNOL, V148, P1668; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; STAHL J, 1992, DIFFERENTIATION, V51, P33, DOI 10.1111/j.1432-0436.1992.tb00677.x; SUAREZ F, 1993, J BONE MINER RES, V8, P1201; Suh KT, 2007, EUR SPINE J, V16, P1563, DOI 10.1007/s00586-007-0390-2; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; van Rhijn L W, 2001, Spine (Phila Pa 1976), V26, pE373, DOI 10.1097/00007632-200108150-00021; van Rhijn LW, 2001, ACTA ORTHOP SCAND, V72, P621, DOI 10.1080/000164701317269058; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Wang WJ, 2010, EUR SPINE J, V19, P726, DOI 10.1007/s00586-009-1247-7; Ward K, 2010, AM J MED GENET A, V152A, P1178, DOI 10.1002/ajmg.a.33145; Weinstein S L, 1989, Instr Course Lect, V38, P115; Wever DJ, 1999, EUR SPINE J, V8, P252, DOI 10.1007/s005860050169; Yang ZD, 2009, MED HYPOTHESES, V73, P709, DOI 10.1016/j.mehy.2009.02.046; Yeung HY, 2006, STUD HEALTH TECHNOL, V123, P599; Zhou H, 2010, BIOL BLOOD MARROW TR, V16, P403, DOI 10.1016/j.bbmt.2009.11.006	81	16	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18834	10.1371/journal.pone.0018834	http://dx.doi.org/10.1371/journal.pone.0018834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21526124	gold, Green Published, Green Submitted			2022-12-25	WOS:000290015800014
J	Sabri, A; Hance, T; Leroy, PD; Frere, I; Haubruge, E; Destain, J; Compere, P; Thonart, P				Sabri, Ahmed; Hance, Thierry; Leroy, Pascal D.; Frere, Isabelle; Haubruge, Eric; Destain, Jacqueline; Compere, Philippe; Thonart, Philippe			Placenta-Like Structure of the Aphid Endoparasitic Wasp Aphidius ervi: A Strategy of Optimal Resources Acquisition	PLOS ONE			English	Article							CROCEIPES CRESSON BRACONIDAE; DIAPETIMORPHA-INTROITA; ACYRTHOSIPHON-PISUM; COTESIA-CONGREGATA; BIOLOGICAL-CONTROL; PROTEIN-SYNTHESIS; ARTIFICIAL DIET; HOST REGULATION; TERATOCYTES; HYMENOPTERA	Aphidius ervi (Hymenoptera: Braconidae) is an entomophagous parasitoid known to be an effective parasitoid of several aphid species of economic importance. A reduction of its production cost during mass rearing for inundative release is needed to improve its use in biological control of pests. In these contexts, a careful analysis of its entire development phases within its host is needed. This paper shows that this parasitoid has some characteristics in its embryological development rather complex and different from most other reported insects, which can be phylogenetically very close. First, its yolkless egg allows a high fecundity of the female but force them to hatch from the egg shell rapidly to the host hemocoel. An early cellularisation allowing a rapid differentiation of a serosa membrane seems to confirm this hypothesis. The serosa wraps the developing embryo until the first instar larva stage and invades the host tissues by microvilli projections and form a placenta like structure able to divert host resources and allowing nutrition and respiration of embryo. Such interspecific invasion, at the cellular level, recalls mammal's trophoblasts that anchors maternal uterine wall and underlines the high adaptation of A. ervi to develop in the host body.	[Sabri, Ahmed; Destain, Jacqueline; Thonart, Philippe] Univ Liege, Ctr Wallon Biol Ind, Liege, Belgium; [Hance, Thierry; Frere, Isabelle] Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, Louvain, Belgium; [Leroy, Pascal D.; Haubruge, Eric] Univ Liege Gembloux Agro Bio Tech, Dept Funct & Evolutionary Entomol, Gembloux, Belgium; [Compere, Philippe] Univ Liege, Lab Morphol Ultrastruct, Liege, Belgium	University of Liege; University of Liege	Sabri, A (corresponding author), Univ Liege, Ctr Wallon Biol Ind, Liege, Belgium.	a.sabri@ulg.ac.be		Haubruge, Eric/0000-0002-8138-0476	la Region Wallonne de Belgique [061/6288]	la Region Wallonne de Belgique	This work was supported by "la Region Wallonne de Belgique" convention Waleo2 no061/6288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.T., 1973, P1; BECKAGE NE, 1994, J PARASITOL, V80, P389, DOI 10.2307/3283409; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Cecchettini A, 2001, EUR J CELL BIOL, V80, P458, DOI 10.1078/0171-9335-00179; Consoli FL, 1999, ENTOMOL EXP APPL, V91, P327, DOI 10.1046/j.1570-7458.1999.00499.x; Dahlman Douglas L., 1993, P145; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; DeBuron I, 1997, J INSECT PHYSIOL, V43, P915, DOI 10.1016/S0022-1910(97)00056-5; Digilio MC, 2000, J INSECT PHYSIOL, V46, P1041, DOI 10.1016/S0022-1910(99)00216-4; Digilio MC, 1998, J INSECT PHYSIOL, V44, P779, DOI 10.1016/S0022-1910(98)00010-9; Falabella P, 2000, ENTOMOL EXP APPL, V97, P1, DOI 10.1023/A:1004097427267; Fedoroff S, 2001, PROTOCOLS NEURAL CEL; FERKOVICH SM, 1986, INSECT BIOCHEM, V16, P337, DOI 10.1016/0020-1790(86)90045-4; Ferkovich SM, 1999, BIOCONTROL, V44, P29, DOI 10.1023/A:1009939028766; FRESHNEY R, 2005, CULTURE CELL ANIMAL; Gelman DB, 2000, J INSECT PHYSIOL, V46, P457, DOI 10.1016/S0022-1910(99)00132-8; Giordana B, 2003, J INSECT PHYSIOL, V49, P1115, DOI 10.1016/j.jinsphys.2003.08.010; Giorgi F, 1999, MICRON, V30, P579, DOI 10.1016/S0968-4328(99)00054-2; GONZALEZ D, 1978, ENTOMOPHAGA, V23, P239, DOI 10.1007/BF02373098; Grbic M, 2000, BIOESSAYS, V22, P920, DOI 10.1002/1521-1878(200010)22:10&lt;920::AID-BIES7&gt;3.0.CO;2-Q; Grbic M, 1998, P NATL ACAD SCI USA, V95, P1097, DOI 10.1073/pnas.95.3.1097; GREANY P, 1986, J INSECT PHYSL, V32, P419; GREANY PD, 1984, BIOSCIENCE, V34, P690, DOI 10.2307/1309661; Grenier S., 1994, P181; Grimaldi A, 2006, J INSECT PHYSIOL, V52, P870, DOI 10.1016/j.jinsphys.2006.05.011; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; JOHNSTON DS, 1992, CELL, V68, P201; LERALEC A, 1995, BIOCONTROL, V40, P87; Machida R., 1998, P ARTHROPOD EMBRYOL, V33, P1; Masumoto M, 2006, TISSUE CELL, V38, P159, DOI 10.1016/j.tice.2006.01.004; NORDIN JH, 1990, ARCH INSECT BIOCHEM, V15, P119, DOI 10.1002/arch.940150302; Panfilio KA, 2006, DEV BIOL, V292, P226, DOI 10.1016/j.ydbio.2005.12.028; Panfilio KA, 2008, DEV BIOL, V313, P471, DOI 10.1016/j.ydbio.2007.11.004; Pedata PA, 2003, J INSECT PHYSIOL, V49, P1063, DOI 10.1016/j.jinsphys.2003.08.003; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; PENNACCHIO F, 1994, INT J INSECT MORPHOL, V23, P93, DOI 10.1016/0020-7322(94)90003-5; Rafiqi AM, 2008, P NATL ACAD SCI USA, V105, P234, DOI 10.1073/pnas.0709145105; Rahbe Y, 2002, J INSECT PHYSIOL, V48, P507, DOI 10.1016/S0022-1910(02)00053-7; Speicher BR, 1936, J MORPHOL, V59, P401, DOI 10.1002/jmor.1050590208; Stilmant D, 2008, OECOLOGIA, V156, P905, DOI 10.1007/s00442-008-1036-8; Strand Michael R., 2008, P113, DOI 10.1002/9780470696200.ch6; Suzuki M, 2007, J INSECT PHYSIOL, V53, P1072, DOI 10.1016/j.jinsphys.2007.06.006; Thompson SN, 1999, ANNU REV ENTOMOL, V44, P561, DOI 10.1146/annurev.ento.44.1.561; TILDEN RL, 1987, INSECT BIOCHEM, V17, P783, DOI 10.1016/0020-1790(87)90012-6; TREMBLAY E, 1973, ANNU REV ENTOMOL, V18, P421, DOI 10.1146/annurev.en.18.010173.002225; van der Zee M, 2005, CURR BIOL, V15, P624, DOI 10.1016/j.cub.2005.02.057; VINSON S, 1994, PARASITOID IN VITRO, P49; VINSON S, 1988, ANIM PLANT SCI, V1, P25; Vinson S.B., 1984, Symposia of the Royal Entomological Society of London, V12, P325; VINSON SB, 1981, SEMIOCHEMICALS THEIR, P51; ZEH D, 1989, Q REV BIOL, P147; ZHANG DQ, 1994, INT J INSECT MORPHOL, V23, P173, DOI 10.1016/0020-7322(94)90016-7	53	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18847	10.1371/journal.pone.0018847	http://dx.doi.org/10.1371/journal.pone.0018847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526196	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100029
J	Suen, G; Weimer, PJ; Stevenson, DM; Aylward, FO; Boyum, J; Deneke, J; Drinkwater, C; Ivanova, NN; Mikhailova, N; Chertkov, O; Goodwin, LA; Currie, CR; Mead, D; Brumm, PJ				Suen, Garret; Weimer, Paul J.; Stevenson, David M.; Aylward, Frank O.; Boyum, Julie; Deneke, Jan; Drinkwater, Colleen; Ivanova, Natalia N.; Mikhailova, Natalia; Chertkov, Olga; Goodwin, Lynne A.; Currie, Cameron R.; Mead, David; Brumm, Phillip J.			The Complete Genome Sequence of Fibrobacter succinogenes S85 Reveals a Cellulolytic and Metabolic Specialist	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; RUMINOCOCCUS-FLAVEFACIENS; SYNERGISTIC INTERACTIONS; SIGNATURE SEQUENCES; ENDOGLUCANASE GENE; RUMINAL BACTERIUM; MOLECULAR-CLONING; CELLULASE GENE; ANNOTATION; EXPRESSION	Fibrobacter succinogenes is an important member of the rumen microbial community that converts plant biomass into nutrients usable by its host. This bacterium, which is also one of only two cultivated species in its phylum, is an efficient and prolific degrader of cellulose. Specifically, it has a particularly high activity against crystalline cellulose that requires close physical contact with this substrate. However, unlike other known cellulolytic microbes, it does not degrade cellulose using a cellulosome or by producing high extracellular titers of cellulase enzymes. To better understand the biology of F. succinogenes, we sequenced the genome of the type strain S85 to completion. A total of 3,085 open reading frames were predicted from its 3.84 Mbp genome. Analysis of sequences predicted to encode for carbohydrate-degrading enzymes revealed an unusually high number of genes that were classified into 49 different families of glycoside hydrolases, carbohydrate binding modules (CBMs), carbohydrate esterases, and polysaccharide lyases. Of the 31 identified cellulases, none contain CBMs in families 1, 2, and 3, typically associated with crystalline cellulose degradation. Polysaccharide hydrolysis and utilization assays showed that F. succinogenes was able to hydrolyze a number of polysaccharides, but could only utilize the hydrolytic products of cellulose. This suggests that F. succinogenes uses its array of hemicellulose-degrading enzymes to remove hemicelluloses to gain access to cellulose. This is reflected in its genome, as F. succinogenes lacks many of the genes necessary to transport and metabolize the hydrolytic products of non-cellulose polysaccharides. The F. succinogenes genome reveals a bacterium that specializes in cellulose as its sole energy source, and provides insight into a novel strategy for cellulose degradation.	[Suen, Garret; Aylward, Frank O.; Currie, Cameron R.; Mead, David; Brumm, Phillip J.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Suen, Garret; Aylward, Frank O.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Weimer, Paul J.; Stevenson, David M.] ARS, US Dairy Forage Res Ctr, USDA, Madison, WI USA; [Boyum, Julie; Deneke, Jan; Drinkwater, Colleen; Mead, David] Lucigen Corp, Middleton, WI USA; [Ivanova, Natalia N.; Mikhailova, Natalia; Goodwin, Lynne A.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Chertkov, Olga; Goodwin, Lynne A.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Brumm, Phillip J.] C5 6 Technol, Middleton, WI USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Department of Energy (DOE); United States Department of Energy (DOE); Los Alamos National Laboratory	Suen, G (corresponding author), Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	pbrumm@c56technologies.com	Weimer, Paul James/AAY-6485-2020; Suen, Garret/AAF-2080-2019	Weimer, Paul James/0000-0002-9278-6535; Suen, Garret/0000-0002-6170-711X; MEAD, David/0000-0003-1982-9356; Ivanova, Natalia/0000-0002-5802-9485; Aylward, Frank/0000-0002-1279-4050	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; USDA ARS [3655-41000-005-00D]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); USDA ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Office of Science of the US Department of Energy(United States Department of Energy (DOE))	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494) supporting GS, FOA, CRC, DM, and PJB. This work was also funded by a USDA ARS CRIS project 3655-41000-005-00D supported DMS and PJW. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. All work performed by employees of Lucigen or C5-6 Technologies was performed under and supported by subcontract to the GLBRC. Neither corporation was a funder of the work; no funds of either corporation was used for this research or to support the researchers during performance of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1961, J BACTERIOL, V81, P903, DOI 10.1128/JB.81.6.903-910.1961; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asanuma N, 2000, J GEN APPL MICROBIOL, V46, P119, DOI 10.2323/jgam.46.119; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; BROUSSOLLE V, 1994, FEMS MICROBIOL LETT, V124, P439; BRUMM P, 2010, APPL BIOCHEM BIOTECH, DOI DOI 10.1007/S12010-12010-19070-12015; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CAVICCHIOLI R, 1991, APPL ENVIRON MICROB, V57, P359, DOI 10.1128/AEM.57.2.359-365.1991; Centeno MSJ, 2006, FEMS MICROBIOL LETT, V265, P26, DOI 10.1111/j.1574-6968.2006.00464.x; Cho KK, 2000, ENZYME MICROB TECH, V27, P475, DOI 10.1016/S0141-0229(00)00256-8; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; COSTERTON JW, 1992, INT BIODETER BIODEGR, V30, P123; Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; GONG JH, 1993, J BACTERIOL, V175, P6810, DOI 10.1128/jb.175.21.6810-6821.1993; Gong JH, 1996, CAN J MICROBIOL, V42, P453, DOI 10.1139/m96-062; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Griffiths E, 2001, MICROBIOL-SGM, V147, P2611, DOI 10.1099/00221287-147-9-2611; GROLEAU D, 1981, CAN J MICROBIOL, V27, P517, DOI 10.1139/m81-077; Gupta RS, 2004, CRIT REV MICROBIOL, V30, P123, DOI 10.1080/10408410490435133; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Han C., 2006, P 2006 INT C BIOINF, P141; Han SO, 2003, J BACTERIOL, V185, P2520, DOI 10.1128/JB.185.8.2520-2527.2003; Hashimoto W, 2005, BIOCHEMISTRY-US, V44, P13783, DOI 10.1021/bi050873b; Hashimoto W, 2005, BIOSCI BIOTECH BIOCH, V69, P673, DOI 10.1271/bbb.69.673; HUANG L, 1990, APPL ENVIRON MICROB, V56, P1229, DOI 10.1128/AEM.56.5.1229-1234.1990; HUNGATE RE, 1950, BACTERIOL REV, V14, P1; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iyo AH, 1996, CAN J MICROBIOL, V42, P934, DOI 10.1139/m96-120; IYO AH, 1994, CAN J MICROBIOL, V40, P592, DOI 10.1139/m94-094; Jun HS, 2007, ASIAN AUSTRAL J ANIM, V20, P802, DOI 10.5713/ajas.2007.802; Jun HS, 2003, CAN J MICROBIOL, V49, P171, DOI 10.1139/W03-024; Jun HS, 2007, J BACTERIOL, V189, P6806, DOI 10.1128/JB.00560-07; Kam DK, 2005, CAN J MICROBIOL, V51, P821, DOI [10.1139/w05-074, 10.1139/W05-074]; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Kobayashi Y, 2008, FOLIA MICROBIOL, V53, P195, DOI 10.1007/s12223-008-0024-z; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; KUDO H, 1987, CAN J MICROBIOL, V33, P267, DOI 10.1139/m87-045; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LIN CZ, 1995, APPL ENVIRON MICROB, V61, P1348, DOI 10.1128/AEM.61.4.1348-1351.1995; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Maglione G, 1997, APPL MICROBIOL BIOT, V48, P720, DOI 10.1007/s002530051122; Malburg LM, 1996, APPL ENVIRON MICROB, V62, P898, DOI 10.1128/AEM.62.3.898-906.1996; Malburg SRC, 1997, APPL ENVIRON MICROB, V63, P2449, DOI 10.1128/AEM.63.6.2449-2453.1997; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsui H, 2010, ANAEROBE, V16, P83, DOI 10.1016/j.anaerobe.2009.07.005; MCDERMID KP, 1990, APPL ENVIRON MICROB, V56, P3805, DOI 10.1128/AEM.56.12.3805-3810.1990; MCGAVIN MJ, 1989, J BACTERIOL, V171, P5587, DOI 10.1128/jb.171.10.5587-5595.1989; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; MILLER TL, 1978, ARCH MICROBIOL, V117, P145, DOI 10.1007/BF00402302; Mitsumori M, 1996, FEMS MICROBIOL LETT, V139, P43; MONTGOMERY L, 1988, INT J SYST BACTERIOL, V38, P430, DOI 10.1099/00207713-38-4-430; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; Morrison M, 2009, CURR OPIN BIOTECH, V20, P358, DOI 10.1016/j.copbio.2009.05.004; Nataf Y, 2009, J BACTERIOL, V191, P203, DOI 10.1128/JB.01190-08; Ogata K, 1997, CURR MICROBIOL, V35, P22, DOI 10.1007/s002849900205; Ozcan N, 1996, LETT APPL MICROBIOL, V22, P85, DOI 10.1111/j.1472-765X.1996.tb01114.x; PARADIS FW, 1993, J BACTERIOL, V175, P7666, DOI 10.1128/JB.175.23.7666-7672.1993; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; PURUSHE J, 2010, MICROB ECOL, DOI DOI 10.1007/S00248-00010-09692-00248; Qi M, 2008, J BACTERIOL, V190, P1976, DOI 10.1128/JB.01667-07; Qi M, 2007, APPL ENVIRON MICROB, V73, P6098, DOI 10.1128/AEM.01037-07; Russell J. B., 2002, RUMEN MICROBIOLOGY I; RUSSELL JB, 1985, APPL ENVIRON MICROB, V49, P572, DOI 10.1128/AEM.49.3.572-576.1985; Shi Y, 1996, APPL ENVIRON MICROB, V62, P1084, DOI 10.1128/AEM.62.3.1084-1088.1996; Spiridonov NA, 1999, J BIOL CHEM, V274, P13127, DOI 10.1074/jbc.274.19.13127; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tamaru Y, 2000, J BACTERIOL, V182, P5906, DOI 10.1128/JB.182.20.5906-5910.2000; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TEATHER RM, 1990, J BACTERIOL, V172, P3837, DOI 10.1128/jb.172.7.3837-3841.1990; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Weimer PJ, 1996, J DAIRY SCI, V79, P1496, DOI 10.3168/jds.S0022-0302(96)76509-8; WEIMER PJ, 1991, APPL MICROBIOL BIOT, V36, P178, DOI 10.1007/BF00164416; WEIMER PJ, 1991, APPL ENVIRON MICROB, V57, P3101, DOI 10.1128/AEM.57.11.3101-3106.1991; WEIMER PJ, 1993, ARCH MICROBIOL, V160, P288, DOI 10.1007/BF00292079; WEIMER PJ, 1996, ENZYMATIC DEGRADATIO, P291; WELLS JE, 1995, APPL ENVIRON MICROB, V61, P1757, DOI 10.1128/AEM.61.5.1757-1762.1995; Wilson DB, 2009, CELLULOSE, V16, P723, DOI 10.1007/s10570-009-9326-9; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07; YOSHIDA S, 2010, J BACTERIOL, DOI DOI 10.1128/JB.00503-00510; Yoshida S, 2010, J BACTERIOL, V192, P483, DOI 10.1128/JB.00935-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; [No title captured]	95	141	147	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18814	10.1371/journal.pone.0018814	http://dx.doi.org/10.1371/journal.pone.0018814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526192	Green Submitted, Green Published, gold			2022-12-25	WOS:000289671100023
J	Go, YM; Kang, SM; Roede, JR; Orr, M; Jones, DP				Go, Young-Mi; Kang, Sang-Moo; Roede, James R.; Orr, Michael; Jones, Dean P.			Increased Inflammatory Signaling and Lethality of Influenza H1N1 by Nuclear Thioredoxin-1	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL-SPECIFIC EXPRESSION; RECEPTOR-ACTIVATING FACTOR; DNA-BINDING ACTIVITY; GLUCOCORTICOID-RECEPTOR; REDOX REGULATION; TRANSCRIPTION FACTOR; TRANSGENIC MICE; MITOCHONDRIAL THIOREDOXIN; DIRECT ASSOCIATION	Background: Cell culture studies show that the antioxidant thiol protein, thioredoxin-1 (Trx1), translocates to cell nuclei during stress, facilitates DNA binding of transcription factors NF-kappa B and glucocorticoid receptor (GR) and potentiates signaling in immune cells. Excessive proinflammatory signaling in vivo contributes to immune hyper-responsiveness and disease severity, but no studies have addressed whether nuclear Trx1 mediates such responses. Methodology/Principal Findings: Transgenic mice (Tg) expressing human Trx1 (hTrx1) with added nuclear localization signal (NLS) showed broad tissue expression and nuclear localization. The role of nuclear Trx1 in inflammatory signaling was examined in Tg and wild-type (WT) mice following infection with influenza (H1N1) virus. Results showed that Tg mice had earlier and more extensive NF-kappa B activation, increased TNF-alpha and IL-6 expression, greater weight loss, slower recovery and increased mortality compared to WT. Decreased plasma glutathione (GSH) and oxidized plasma GSH/GSSG redox potential (EhGSSG) following infection in Tg mice showed that the increased nuclear thiol antioxidant caused a paradoxical downstream oxidative stress. An independent test of this nuclear reductive stress showed that glucocorticoid-induced thymocyte apoptosis was increased by NLS-Trx1. Conclusion/Significance: Increased Trx1 in cell nuclei can increase severity of disease responses by potentiation of redoxsensitive transcription factor activation.	[Go, Young-Mi; Roede, James R.; Orr, Michael; Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA	Emory University	Go, YM (corresponding author), Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA.	dpjones@emory.edu			National Institute of Environmental Health Sciences [ES011195, ES009047]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009047, R01ES011195] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences Grants ES011195 and ES009047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; Cifone MG, 1999, BLOOD, V93, P2282, DOI 10.1182/blood.V93.7.2282.407a23_2282_2296; Dai SC, 2009, ARTERIOSCL THROM VAS, V29, P495, DOI 10.1161/ATVBAHA.108.180349; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Gasdaska JR, 1996, BIOCHEM PHARMACOL, V52, P1741, DOI 10.1016/S0006-2952(96)00595-3; Go YM, 2004, J BIOL CHEM, V279, P5837, DOI 10.1074/jbc.M307547200; Go YM, 2007, FREE RADICAL BIO MED, V42, P363, DOI 10.1016/j.freeradbiomed.2006.11.005; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Go YM, 2010, FREE RADICAL BIO MED, V48, P275, DOI 10.1016/j.freeradbiomed.2009.10.050; Goldsack NR, 2003, SEX TRANSM INFECT, V79, P337, DOI 10.1136/sti.79.4.337; GRIPPO JF, 1985, J BIOL CHEM, V260, P93; GRIPPO JF, 1983, J BIOL CHEM, V258, P3658; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Harper R, 2001, AM J RESP CELL MOL, V25, P178, DOI 10.1165/ajrcmb.25.2.4471; Hayashi S, 1997, NUCLEIC ACIDS RES, V25, P4035, DOI 10.1093/nar/25.20.4035; He M, 2008, TOXICOL SCI, V105, P44, DOI 10.1093/toxsci/kfn116; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Jones DP, 2009, FREE RADICAL BIO MED, V47, P1329, DOI 10.1016/j.freeradbiomed.2009.08.021; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kim YC, 2003, ONCOGENE, V22, P1860, DOI 10.1038/sj.onc.1206369; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; Malik G, 2006, ANTIOXID REDOX SIGN, V8, P2101, DOI 10.1089/ars.2006.8.2101; Marques AH, 2009, ANN NY ACAD SCI, V1179, P1, DOI 10.1111/j.1749-6632.2009.04987.x; MATTHEWS JR, 1993, NUCLEIC ACIDS RES, V21, P1727, DOI 10.1093/nar/21.8.1727; Nakamura H, 2002, IMMUNOL LETT, V82, P165, DOI 10.1016/S0165-2478(02)00033-0; Okamoto K, 1999, J BIOL CHEM, V274, P10363, DOI 10.1074/jbc.274.15.10363; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Powis G, 2004, MOL CANCER THER, V3, P647; Psarra AMG, 2009, BIOCHEM J, V422, P521, DOI 10.1042/BJ20090107; Quan FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009161; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Ravi D, 2005, J BIOL CHEM, V280, P40084, DOI 10.1074/jbc.M507192200; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Schroeder P, 2007, ARTERIOSCL THROM VAS, V27, P2325, DOI 10.1161/ATVBAHA.107.149419; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Spielberger JC, 2008, J CELL BIOCHEM, V104, P1879, DOI 10.1002/jcb.21762; Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; Ueno M, 2000, IMMUNOL LETT, V75, P15, DOI 10.1016/S0165-2478(00)00284-4; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; ZACHARCHUK CM, 1990, J IMMUNOL, V145, P4037; Zhang HF, 2007, AM J PATHOL, V170, P1108, DOI 10.2353/ajpath.2007.060960; Zhang X, 2010, HYPERTENSION, V55, P1412, DOI 10.1161/HYPERTENSIONAHA.109.147066	59	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18918	10.1371/journal.pone.0018918	http://dx.doi.org/10.1371/journal.pone.0018918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526215	Green Published, Green Submitted, gold			2022-12-25	WOS:000289578600038
J	Mota, BEF; Gallardo-Romero, N; Trindade, G; Keckler, MS; Karem, K; Carroll, D; Campos, MA; Vieira, LQ; da Fonseca, FG; Ferreira, PCP; Bonjardim, CA; Damon, IK; Kroon, EG				Mota, Bruno E. F.; Gallardo-Romero, Nadia; Trindade, Giliane; Keckler, M. Shannon; Karem, Kevin; Carroll, Darin; Campos, Marco A.; Vieira, Leda Q.; da Fonseca, Flavio G.; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Damon, Inger K.; Kroon, Erna G.			Adverse Events Post Smallpox-Vaccination: Insights from Tail Scarification Infection in Mice with Vaccinia virus	PLOS ONE			English	Article							CELL-DEFICIENT MICE; IMMUNE-RESPONSE; POXVIRUS INFECTION; PROGRESSIVE VACCINIA; ANTIBODY; REPLICATION; INHIBITION; PROTECTION; CLEARANCE; MONKEYPOX	Adverse events upon smallpox vaccination with fully-replicative strains of Vaccinia virus (VACV) comprise an array of clinical manifestations that occur primarily in immunocompromised patients leading to significant host morbidity/mortality. The expansion of immune-suppressed populations and the possible release of Variola virus as a bioterrorist act have given rise to concerns over vaccination complications should more widespread vaccination be reinitiated. Our goal was to evaluate the components of the host immune system that are sufficient to prevent morbidity/mortality in a murine model of tail scarification, which mimics immunological and clinical features of smallpox vaccination in humans. Infection of C57BL/6 wild-type mice led to a strictly localized infection, with complete viral clearance by day 28 p.i. On the other hand, infection of T and B-cell deficient mice (Rag1(-/-)) produced a severe disease, with uncontrolled viral replication at the inoculation site and dissemination to internal organs. Infection of B-cell deficient animals (mu MT) produced no mortality. However, viral clearance in mMT animals was delayed compared to WT animals, with detectable viral titers in tail and internal organs late in infection. Treatment of Rag1(-/-) with rabbit hyperimmune anti-vaccinia serum had a subtle effect on the morbidity/mortality of this strain, but it was effective in reduce viral titers in ovaries. Finally, NUDE athymic mice showed a similar outcome of infection as Rag1(-/-), and passive transfer of WT T cells to Rag1(-/-) animals proved fully effective in preventing morbidity/mortality. These results strongly suggest that both T and B cells are important in the immune response to primary VACV infection in mice, and that T-cells are required to control the infection at the inoculation site and providing help for B-cells to produce antibodies, which help to prevent viral dissemination. These insights might prove helpful to better identify individuals with higher risk of complications after infection with poxvirus.	[Mota, Bruno E. F.; Trindade, Giliane; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Kroon, Erna G.] Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil; [Gallardo-Romero, Nadia; Keckler, M. Shannon; Karem, Kevin; Carroll, Darin; Damon, Inger K.] Ctr Dis Control & Prevent, Poxvirus Program, Atlanta, GA USA; [Campos, Marco A.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Vieira, Leda Q.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [da Fonseca, Flavio G.] Univ Fed Minas Gerais, Dept Microbiol, Lab Virol Comparada, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Centers for Disease Control & Prevention - USA; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Mota, BEF (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Virus Lab, Belo Horizonte, MG, Brazil.	kroone@icb.ufmg.br	Keckler, M. Shannon/S-8970-2019; Vieira, Leda Q/G-7487-2014; Vieira, Leda Quercia/AAD-3424-2019; Campos, Marco Antonio/AAU-6229-2021; Kroon, Erna/V-5444-2019; Campos, Marco A/C-4000-2013; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna Geessien/B-3631-2015; Keckler, M. Shannon/C-3864-2009	Vieira, Leda Quercia/0000-0001-5481-9618; Campos, Marco Antonio/0000-0003-4683-0176; Campos, Marco A/0000-0003-4683-0176; Kroon, Erna Geessien/0000-0003-2721-3826; Mota, Bruno/0000-0003-0348-4875; Keckler, M. Shannon/0000-0002-2275-4730	Brazilian Ministry of Agriculture, Livestock and Supply (MAPA); Brazilian National Council for Scientific and Technological Development; Brazilian Coordination for Improvement of Graduated Personnel; Foundation for Research Development of Minas Gerais; Oak Ridge Institute for Science and Education; CDC	Brazilian Ministry of Agriculture, Livestock and Supply (MAPA); Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Coordination for Improvement of Graduated Personnel; Foundation for Research Development of Minas Gerais; Oak Ridge Institute for Science and Education(General Electric); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by funds from the Brazilian Ministry of Agriculture, Livestock and Supply (MAPA), Brazilian National Council for Scientific and Technological Development (CNPq-http://www.cnpq.br), Brazilian Coordination for Improvement of Graduated Personnel (CAPES-http://www.capes.gov.br), Foundation for Research Development of Minas Gerais (FAPEMIG-http://www.fapemig.br), the Oak Ridge Institute for Science and Education (ORISE-http://www.orise.orau.gov) and CDC intramural funds. GT, MAC, LQV, FGF, PCPF, CAB and EGK are CNPq fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Bray M, 2003, CLIN INFECT DIS, V36, P766, DOI 10.1086/374244; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Freyschmidt EJ, 2007, J ALLERGY CLIN IMMUN, V119, P671, DOI 10.1016/j.jaci.2006.12.645; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Gherardi MM, 2003, J GEN VIROL, V84, P1961, DOI 10.1099/vir.0.19120-0; HARRIS N, 1995, J VIROL, V69, P910, DOI 10.1128/JVI.69.2.910-915.1995; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Jezek Z, 1988, HUMAN MONKEYPOX; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kawakami Y, 2009, J EXP MED, V206, P1219, DOI 10.1084/jem.20082835; Kohno K, 1998, CLIN IMMUNOL IMMUNOP, V86, P11, DOI 10.1006/clin.1997.4475; Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Lustig S, 2009, VACCINE, V27, P1691, DOI 10.1016/j.vaccine.2009.01.038; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mortimer PP, 2003, CLIN MED, V3, P255, DOI 10.7861/clinmedicine.3-3-255; MOSS B, 2001, FUNDAMENTAL VIROLOGY; Mota BEF, 2010, ARCH VIROL, V155, P1139, DOI 10.1007/s00705-010-0675-3; Neyts J, 2004, ANTIMICROB AGENTS CH, V48, P2267, DOI 10.1128/AAC.48.6.2267-2273.2004; Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Perera LP, 2001, P NATL ACAD SCI USA, V98, P5146, DOI 10.1073/pnas.081080298; Puissant-Lubrano B, 2010, J CLIN INVEST, V120, P1636, DOI 10.1172/JCI38506; Ramirez JC, 2002, J GEN VIROL, V83, P1059, DOI 10.1099/0022-1317-83-5-1059; Rolph MS, 1996, VIROLOGY, V217, P470, DOI 10.1006/viro.1996.0141; Saito T, 2009, JAMA-J AM MED ASSOC, V301, P1025, DOI 10.1001/jama.2009.289; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sharon M, 2007, VACCINE, V25, P7743, DOI 10.1016/j.vaccine.2007.09.023; SPRIGGS MK, 1992, P NATL ACAD SCI USA, V89, P6070, DOI 10.1073/pnas.89.13.6070; Tian T, 2009, J INVEST DERMATOL, V129, P70, DOI 10.1038/jid.2008.191; Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74; Worthington M, 2003, CLIN INFECT DIS, V37, P864, DOI 10.1086/377275; Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265; Xu RH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000768	42	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18924	10.1371/journal.pone.0018924	http://dx.doi.org/10.1371/journal.pone.0018924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526210	gold, Green Published, Green Submitted			2022-12-25	WOS:000289578600039
J	Scheeren, FA; van Geelen, CMM; Yasuda, E; Spits, H; Beaumont, T				Scheeren, Ferenc A.; van Geelen, Caroline M. M.; Yasuda, Etsuko; Spits, Hergen; Beaumont, Tim			Antigen-Specific Monoclonal Antibodies Isolated from B Cells Expressing Constitutively Active STAT5	PLOS ONE			English	Article							TERMINAL DIFFERENTIATION; IMMUNOGLOBULIN GENE; INFECTIOUS-DISEASES; BCL-6 EXPRESSION; HODGKIN LYMPHOMA; IL-21; TRANSCRIPTION; CHAIN; PROLIFERATION; MECHANISM	Background: Fully human monoclonal antibodies directed against specific pathogens have a high therapeutic potential, but are difficult to generate. Methodology/Principal Findings: Memory B cells were immortalized by expressing an inducible active mutant of the transcription factor Signal Transducer and Activator of Transcription 5 (STAT5). Active STAT5 inhibits the differentiation of B cells while increasing their replicative life span. We obtained cloned B cell lines, which produced antibodies in the presence of interleukin 21 after turning off STAT5. We used this method to obtain monoclonal antibodies against the model antigen tetanus toxin. Conclusions/Significance: Here we describe a novel and relatively simple method of immortalizing antigen-specific human B cells for isolation of human monoclonal antibodies. These results show that STAT5 overexpression can be employed to isolate antigen specific antibodies from human memory B cells.	[Scheeren, Ferenc A.; van Geelen, Caroline M. M.; Yasuda, Etsuko; Spits, Hergen; Beaumont, Tim] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [van Geelen, Caroline M. M.; Yasuda, Etsuko; Spits, Hergen; Beaumont, Tim] Univ Amsterdam, Acad Med Ctr, AIMM Therapeut, NL-1105 AZ Amsterdam, Netherlands; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Tytgat Inst, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Scheeren, FA (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA.	beaumont@aimmtherapeutics.com	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338; Scheeren, Ferenc/0000-0002-8304-9023	Netherlands Organization for Scientific Research (NWO); AIMM therapeutics	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); AIMM therapeutics	The study was financially supported by the Netherlands Organization for Scientific Research (NWO) and by AIMM therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; BURTON DR, 1994, ADV IMMUNOL, V57, P191, DOI 10.1016/S0065-2776(08)60674-4; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fornek JL, 2006, BLOOD, V107, P1085, DOI 10.1182/blood-2005-07-2871; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; HENDRIKSEN CFM, 1989, J BIOL STAND, V17, P241, DOI 10.1016/0092-1157(89)90016-4; HENDRIKSEN CFM, 1988, J BIOL STAND, V16, P287, DOI 10.1016/0092-1157(88)90017-0; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Lischke A, 1998, J BIOL CHEM, V273, P31222, DOI 10.1074/jbc.273.47.31222; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Scheeren FA, 2008, BLOOD, V111, P4706, DOI 10.1182/blood-2007-08-105643; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; STEINITZ M, 1977, NATURE, V269, P420, DOI 10.1038/269420a0; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Ushmorov A, 2004, BLOOD, V104, P3326, DOI 10.1182/blood-2003-04-1197; Wagner EF, 1998, J IMMUNOL, V161, P1123; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WEZEL AL, 1979, NED TIJDSCHR GENEES, V123, P466; WRAMMERT J, 2008, NATURE; YAMAMURA K, 1986, P NATL ACAD SCI USA, V83, P2152, DOI 10.1073/pnas.83.7.2152; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	44	3	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e17189	10.1371/journal.pone.0017189	http://dx.doi.org/10.1371/journal.pone.0017189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21525985	Green Submitted, gold, Green Published			2022-12-25	WOS:000289578600004
J	Badar, A; DeFreitas, S; McDonnell, JM; Yahya, N; Thakor, D; Razavi, R; Smith, R; Sacks, S; Mullen, GED				Badar, Adam; DeFreitas, Sarah; McDonnell, James M.; Yahya, Norhakim; Thakor, David; Razavi, Reza; Smith, Richard; Sacks, Steven; Mullen, Gregory E. D.			Recombinant Complement Receptor 2 Radiolabeled with [Tc-99m(CO)(3)](+): A Potential New Radiopharmaceutical for Imaging Activated Complement	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; RENAL-TRANSPLANTATION; C3; INJURY; INFLAMMATION; INHIBITOR; ISCHEMIA; PROTEINS; CR2/CD21; VACCINE	We describe the design and synthesis of a new Tc-99m labeled bioconjugate for imaging activated complement, based on Short Consensus Repeats 1 and 2 of Complement Receptor 2 (CR2), the binding domain for C3d. To avoid non specific modification of CR2 and the potential for modifying lysine residues critical to the CR2/C3d contact surface, we engineered a new protein, recombinant CR2 (rCR2), to include the C-terminal sequence VFPLECHHHHHH, a hexahistidine tag (for site-specific radiolabeling with [Tc-99m(CO)(3)(OH2)(3)](+)). The protein was characterized by N-terminal sequencing, SDS-PAGE and size exclusion chromatography. To test the function of the recombinant CR2, binding to C3d was confirmed by enzyme-linked immunosorbent assay (ELISA). The function was further confirmed by binding of rCR2 to C3d(+) red blood cells (RBC) which were generated by deposition of human or rat C3d and analyzed by fluorescence microscopy and flow cytometry. The affinity of rCR2 for C3d(+), in presence of 150 mM NaCl, was measured using surface plasma resonance giving rise to a K-D approximate to 500 nM. Radiolabeling of rCR2 or an inactive mutant of rCR2 (K41E CR2) or an unrelated protein of a similar size (C2A) with [Tc-99m(CO)(3)(OH2)(3)](+) at gave radiochemical yields >95%. Site-specifically radiolabeled rCR2 bound to C3d to C3d(+) RBC. Binding of radiolabeled rCR2 to C3d was inhibited by anti-C3d and the radiolabeled inactive mutant K41E CR2 and C2A did not bind to C3d(+) RBCs. We conclude that rCR2-Tc-99m has excellent radiolabeling, stability and C3d binding characteristics and warrants in vivo evaluation as an activated complement imaging agent.	[Badar, Adam; DeFreitas, Sarah; Smith, Richard; Sacks, Steven; Mullen, Gregory E. D.] Kings Coll London, Guys Hosp, Med Res Council Ctr Transplantat, London WC2R 2LS, England; [Badar, Adam; Thakor, David; Razavi, Reza; Mullen, Gregory E. D.] Kings Coll London, St Thomas Hosp, Div Imaging Sci, London WC2R 2LS, England; [McDonnell, James M.; Yahya, Norhakim] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Badar, A (corresponding author), Kings Coll London, Guys Hosp, Med Res Council Ctr Transplantat, London WC2R 2LS, England.	stephen.sacks@kcl.ac.uk; greg.mullen@kcl.ac.uk		Razavi, Reza/0000-0003-1065-3008; McDonnell, James/0000-0001-9037-2980; Sacks, Steven/0000-0001-6361-9095	King's College London, Division of Imaging Sciences, MRC Centre of Transplantation; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; MRC [G0600892, G0501494] Funding Source: UKRI; Medical Research Council [G1000758, G0600892, G1000758B, G0501494] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	King's College London, Division of Imaging Sciences, MRC Centre of Transplantation; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge financial support from King's College London, Division of Imaging Sciences, MRC Centre of Transplantation, The Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atary JZ, 2010, EUROPACE, V12, P378, DOI 10.1093/europace/eup420; Banz Y, 2007, CARDIOVASC RES, V76, P482, DOI 10.1016/j.cardiores.2007.07.016; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Cai WB, 2007, J NUCL MED, V48, P304; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; Dodd I, 1995, PROTEIN EXPRES PURIF, V6, P727, DOI 10.1006/prep.1995.0003; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; FUJISAKU A, 1989, J BIOL CHEM, V264, P2118; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; HEARSE DJ, 1992, CARDIOVASC RES, V26, P101, DOI 10.1093/cvr/26.2.101; KILGORE KS, 1994, CARDIOVASC RES, V28, P437, DOI 10.1093/cvr/28.4.437; Koning OHJ, 1997, TRANSPLANTATION, V63, P1620, DOI 10.1097/00007890-199706150-00015; KORTHUIS RJ, 1989, AM J PHYSIOL, V256, pH315, DOI 10.1152/ajpheart.1989.256.1.H315; Kovacs JM, 2009, J BIOL CHEM, V284, P9513, DOI 10.1074/jbc.M808404200; Law SKA, 1997, PROTEIN SCI, V6, P263; LITT MR, 1989, CIRCULATION, V80, P1816, DOI 10.1161/01.CIR.80.6.1816; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Pagtalunan ME, 1999, J AM SOC NEPHROL, V10, P366; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Serkova NJ, 2010, RADIOLOGY, V255, P517, DOI 10.1148/radiol.09091134; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Springall T, 2001, NAT MED, V7, P801, DOI 10.1038/89923; Tavare R, 2009, BIOCONJUGATE CHEM, V20, P2071, DOI 10.1021/bc900160j; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Waibel R, 1999, NAT BIOTECHNOL, V17, P897, DOI 10.1038/12890; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wijns W, 2010, EUR HEART J; Zhou WD, 2006, BLOOD, V107, P2461, DOI 10.1182/blood-2005-08-3144	35	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2011	6	4							e18275	10.1371/journal.pone.0018275	http://dx.doi.org/10.1371/journal.pone.0018275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745UM	21494666	Green Published, gold, Green Submitted			2022-12-25	WOS:000289192400013
J	Karpowicz, SJ; Prochnik, SE; Grossman, AR; Merchant, SS				Karpowicz, Steven J.; Prochnik, Simon E.; Grossman, Arthur R.; Merchant, Sabeeha S.			The GreenCut2 Resource, a Phylogenomically Derived Inventory of Proteins Specific to the Plant Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS GENOME REVEALS; I SIGNAL PEPTIDASE; PLASTID EVOLUTION; PROTEOME DATABASE; GENE-EXPRESSION; BZIP PROTEIN; ARABIDOPSIS; CHLOROPLAST; LOCALIZATION; REINHARDTII	The plastid is a defining structure of photosynthetic eukaryotes and houses many plant-specific processes, including the light reactions, carbon fixation, pigment synthesis, and other primary metabolic processes. Identifying proteins associated with catalytic, structural, and regulatory functions that are unique to plastid-containing organisms is necessary to fully define the scope of plant biochemistry. Here, we performed phylogenomics on 20 genomes to compile a new inventory of 597 nucleus-encoded proteins conserved in plants and green algae but not in non-photosynthetic organisms. 286 of these proteins are of known function, whereas 311 are not characterized. This inventory was validated as applicable and relevant to diverse photosynthetic eukaryotes using an additional eight genomes from distantly related plants (including Micromonas, Selaginella, and soybean). Manual curation of the known proteins in the inventory established its importance to plastid biochemistry. To predict functions for the 52% of proteins of unknown function, we used sequence motifs, subcellular localization, co-expression analysis, and RNA abundance data. We demonstrate that 18% of the proteins in the inventory have functions outside the plastid and/or beyond green tissues. Although 32% of proteins in the inventory have homologs in all cyanobacteria, unexpectedly, 30% are eukaryote-specific. Finally, 8% of the proteins of unknown function share no similarity to any characterized protein and are plant lineage-specific. We present this annotated inventory of 597 proteins as a resource for functional analyses of plant-specific biochemistry.	[Karpowicz, Steven J.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Prochnik, Simon E.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Grossman, Arthur R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Carnegie Institution for Science	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	sabeeha@chem.ucla.edu			National Institutes of Health [GM07185]; Ruth L. Kirschstein National Research Service Award; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; departmental Majeti-Alapati Fellowship; National Science Foundation [MCB-095 1094]; United States Department of Energy [DE-FG02-07ER64427, DE-FC02-02ER63421]; Div Of Molecular and Cellular Bioscience [0951094] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); departmental Majeti-Alapati Fellowship; National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM07185, a Ruth L. Kirschstein National Research Service Award (to S.J.K.). This work was also supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231 (to S.E.P.).; Supported in part by a departmental Majeti-Alapati Fellowship.; Supported by National Science Foundation Grant MCB-095 1094 and United States Department of Energy Grant DE-FG02-07ER64427.; Supported by United States Department of Energy Cooperative Agreement DE-FC02-02ER63421 (to David Eisenberg). To whom correspondence should be addressed: Dept. of Chemistry and Biochemistry, UCLA, 607 Charles E. Young Dr. E., Los Angeles, CA 90095-1569. Tel.: 310-825-8300; Fax: 310-206-1035; E-mail: sabeeha@chem.ucla.edu.	Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Adam Z, 2002, TRENDS PLANT SCI, V7, P451, DOI 10.1016/S1360-1385(02)02326-9; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P5029, DOI 10.1093/nar/gkh833; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Belhaj K, 2009, PLANT J, V58, P287, DOI 10.1111/j.1365-313X.2008.03779.x; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Bonsegna S, 2005, ARCH BIOCHEM BIOPHYS, V443, P74, DOI 10.1016/j.abb.2005.09.003; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; CASTRUITA M, 2011, PLANT CELL, DOI DOI 10.1105/TCP.111.084400; Chang CW, 2005, PLANT PHYSIOL, V138, P319, DOI 10.1104/pp.105.059550; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Comas I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S7; Conte MG, 2008, NUCLEIC ACIDS RES, V36, pD991, DOI 10.1093/nar/gkm934; Corami F, 2005, J ENVIRON MONITOR, V7, P1256, DOI 10.1039/b507323p; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Galland N, 2010, EUR J CELL BIOL, V89, P621, DOI 10.1016/j.ejcb.2010.04.001; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610; Gupta RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-24; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HOUTZ RL, 1991, PLANT PHYSIOL, V97, P913, DOI 10.1104/pp.97.3.913; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Inoue K, 1997, J BIOL CHEM, V272, P31747, DOI 10.1074/jbc.272.50.31747; Jancek S, 2008, MOL BIOL EVOL, V25, P2293, DOI 10.1093/molbev/msn168; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kleffmann T, 2006, PLANT CELL PHYSIOL, V47, P432, DOI 10.1093/pcp/pcj005; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Murata N, 2006, J EXP BOT, V57, P235, DOI 10.1093/jxb/erj005; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Okazaki Y, 2009, PLANT CELL, V21, P892, DOI 10.1105/tpc.108.063925; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Park S, 2004, P NATL ACAD SCI USA, V101, P12765, DOI 10.1073/pnas.0402764101; Peers G, 2006, NATURE, V441, P341, DOI 10.1038/nature04630; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Sasaki NV, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap025; Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Shipman RL, 2009, FEBS LETT, V583, P938, DOI 10.1016/j.febslet.2009.02.016; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Souciet JL, 2009, GENOME RES, V19, P1696, DOI 10.1101/gr.091546.109; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Sugimoto K, 2007, FEBS LETT, V581, P4519, DOI 10.1016/j.febslet.2007.08.035; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vaistij FE, 2000, P NATL ACAD SCI USA, V97, P14813, DOI 10.1073/pnas.97.26.14813; van Wijk KJ, 2004, PLANT PHYSIOL BIOCH, V42, P963, DOI 10.1016/j.plaphy.2004.10.015; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Yu B, 2003, PLANT J, V36, P762, DOI 10.1046/j.1365-313X.2003.01918.x; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051; Zhu JH, 2007, MOL CELL BIOL, V27, P5214, DOI 10.1128/MCB.01989-06	90	80	81	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21427	21439		10.1074/jbc.M111.233734	http://dx.doi.org/10.1074/jbc.M111.233734			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21515685	Green Published, hybrid			2022-12-25	WOS:000291464700041
J	Ticu, C; Murataliev, M; Nechifor, R; Wilson, KS				Ticu, Cristina; Murataliev, Marat; Nechifor, Roxana; Wilson, Kevin S.			A Central Interdomain Protein Joint in Elongation Factor G Regulates Antibiotic Sensitivity, GTP Hydrolysis, and Ribosome Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSIDIC ACID RESISTANCE; TRANSFER-RNA TRANSLOCATION; FACTOR EF-G; CRYSTAL-STRUCTURE; STAPHYLOCOCCUS-AUREUS; FACTOR TU; THERMUS-THERMOPHILUS; DOMAIN-III; BINDING; SWITCH	The antibiotic fusidic acid potently inhibits bacterial translation (and cellular growth) by lodging between domains I and III of elongation factor G (EF-G) and preventing release of EF-G from the ribosome. We examined the functions of key amino acid residues near the active site of EF-G that interact with fusidic acid and regulate hydrolysis of GTP. Alanine mutants of these residues spontaneously hydrolyzed GTP in solution, bypassing the normal activating role of the ribosome. A conserved phenylalanine in the switch II element of EF-G was important for suppressing GTP hydrolysis in solution and critical for catalyzing translocation of the ribosome along mRNA. These experimental results reveal the multipurpose roles of an interdomain joint in the heart of an essential translation factor that can both promote and inhibit bacterial translation.	[Wilson, Kevin S.] Oklahoma State Univ, Dept Biochem & Mol Biol, Noble Res Ctr 246, Stillwater, OK 74078 USA; [Ticu, Cristina; Murataliev, Marat; Nechifor, Roxana; Wilson, Kevin S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	Oklahoma State University System; Oklahoma State University - Stillwater; University of Alberta	Wilson, KS (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Noble Res Ctr 246, Stillwater, OK 74078 USA.	kevin.s.wilson@okstate.edu			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Besier S, 2003, MOL MICROBIOL, V47, P463, DOI 10.1046/j.1365-2958.2003.03307.x; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Castanheira M, 2010, ANTIMICROB AGENTS CH, V54, P3614, DOI 10.1128/AAC.01390-09; Chen Y, 2010, FEBS J, V277, P3789, DOI 10.1111/j.1742-4658.2010.07780.x; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Hansson S, 2005, FEBS LETT, V579, P4492, DOI 10.1016/j.febslet.2005.07.016; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Johanson U, 1996, J MOL BIOL, V258, P420, DOI 10.1006/jmbi.1996.0259; JOHANSON U, 1994, GENE, V143, P55, DOI 10.1016/0378-1119(94)90604-1; Lannergard J, 2009, ANTIMICROB AGENTS CH, V53, P2059, DOI 10.1128/AAC.00871-08; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Macvanin M, 2000, MOL MICROBIOL, V37, P98, DOI 10.1046/j.1365-2958.2000.01967.x; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Martemyanov KA, 2001, J BIOL CHEM, V276, P28774, DOI 10.1074/jbc.M102023200; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Nechifor R, 2007, J BIOL CHEM, V282, P36998, DOI 10.1074/jbc.M707179200; Nguyen B, 2010, J MOL BIOL, V397, P1245, DOI 10.1016/j.jmb.2010.02.039; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; ROHRBACH MS, 1976, BIOCHEMISTRY-US, V15, P4565, DOI 10.1021/bi00666a003; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Ticu C, 2009, EMBO J, V28, P2053, DOI 10.1038/emboj.2009.169; Turnidge J, 1999, INT J ANTIMICROB AG, V12, pS23, DOI 10.1016/S0924-8579(98)00071-5; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; WILLIE GR, 1975, BIOCHEMISTRY-US, V14, P1713, DOI 10.1021/bi00679a025; Wilson KS, 2004, J MOL BIOL, V337, P15, DOI 10.1016/j.jmb.2004.01.013; WOLF H, 1974, P NATL ACAD SCI USA, V71, P4910, DOI 10.1073/pnas.71.12.4910	40	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21697	21705		10.1074/jbc.M110.214056	http://dx.doi.org/10.1074/jbc.M110.214056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21531717	hybrid, Green Published			2022-12-25	WOS:000291464700066
J	Zhou, W; Brush, MH; Choy, MS; Shenolikar, S				Zhou, Wei; Brush, Matthew H.; Choy, Meng S.; Shenolikar, Shirish			Association with Endoplasmic Reticulum Promotes Proteasomal Degradation of GADD34 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 2; MESSENGER-RNA TRANSLATION; DNA-DAMAGE; GROWTH ARREST; ALPHA-SUBUNIT; ER STRESS; APOPTOSIS; CELLS; DEPHOSPHORYLATION; ACTIVATION	Stress-induced endogenous and ectopically expressed GADD34 proteins were present both in the cytoplasm and in membranes, with their membrane association showing similar biochemical properties. Deletion of N-terminal sequences in GADD34-GFP proteins highlighted an amphipathic helix, whose hydrophobic surface, specifically valine 25 and leucine 29, mediated endoplasmic reticulum (ER) localization. Substitution of leucines for three arginines on the polar surface indicated that the same helix also mediated the association of GADD34 with mitochondria. Fluorescence protease protection and chemical modification of cysteines substituted in the membrane-binding domain pointed to a monotopic insertion of GADD34 into the outer layer of the ER membrane. Fluorescence recovery after photobleaching showed that ER association retards the mobility of GADD34 in living cells. Both WT GADD34 and the mutant, V25R, effectively scaffolded the alpha-isoform of protein phosphatase-1 (PP1 alpha) and enabled eIF2 alpha dephosphorylation. However, the largely cytosolic V25R protein displayed a reduced rate of proteasomal degradation, and unlike WT GADD34, whose ectopic expression resulted in a dilated or distended ER, V25R did not modify ER morphology. These studies suggested that the association of with ER modulates intracellular trafficking and proteasomal degradation of GADD34, and in turn, its ability to modify ER morphology.	[Zhou, Wei; Choy, Meng S.; Shenolikar, Shirish] Duke NUS Grad Med Sch, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Zhou, Wei; Choy, Meng S.; Shenolikar, Shirish] Duke NUS Grad Med Sch, Signature Res Program Neurosci & Behav Disorders, Singapore 169857, Singapore; [Brush, Matthew H.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Duke University	Shenolikar, S (corresponding author), Duke NUS Grad Med Sch, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	Shirish.Shenolikar@duke-nus.edu.sg		Choy, Meng Shyan/0000-0002-7590-3031	Duke-NUS Graduate Medical School; National Medical Research Council [IRG09nov003]	Duke-NUS Graduate Medical School; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by research funds provided by Duke-NUS Graduate Medical School and an individual research grant (IRG09nov003) from the National Medical Research Council (to S. S.).	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; CHOU J, 1994, P NATL ACAD SCI USA, V91, P5247, DOI 10.1073/pnas.91.12.5247; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Garrido JL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-231; Gill MB, 2009, J NEUROSCI RES, V87, P2047, DOI 10.1002/jnr.22019; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2001, COLD SPRING HARB SYM, V66, P499, DOI 10.1101/sqb.2001.66.499; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Hollander MC, 2001, INT J CANCER, V96, P22, DOI 10.1002/1097-0215(20010220)96:1<22::AID-IJC3>3.0.CO;2-K; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Imai H, 2002, EUR J NEUROSCI, V15, P1929, DOI 10.1046/j.1460-9568.2002.02025.x; JINGAMI H, 1987, J CELL BIOL, V104, P1693, DOI 10.1083/jcb.104.6.1693; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; LORD KA, 1990, CELL GROWTH DIFFER, V1, P637; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Morishima N, 2004, J BIOL CHEM, V279, P50375, DOI 10.1074/jbc.M408493200; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Shnyrova A, 2008, CURR BIOL, V18, pR474, DOI 10.1016/j.cub.2008.04.031; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Yamamoto A, 1996, J CELL SCI, V109, P1727; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361	40	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21687	21696		10.1074/jbc.M110.212787	http://dx.doi.org/10.1074/jbc.M110.212787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21518769	hybrid, Green Published			2022-12-25	WOS:000291464700065
J	Hagglund, MGA; Sreedharan, S; Nilsson, VCO; Shaik, JHA; Almkvist, IM; Backlin, S; Wrange, O; Fredriksson, R				Hagglund, Maria G. A.; Sreedharan, Smitha; Nilsson, Victor C. O.; Shaik, Jafar H. A.; Almkvist, Ingrid M.; Backlin, Sofi; Wrange, Orjan; Fredriksson, Robert			Identification of SLC38A7 (SNAT7) Protein as a Glutamine Transporter Expressed in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; SYSTEM N; NITROGEN-METABOLISM; GLIAL-CELLS; CLONING; LIVER; LOCALIZATION; SUBTYPE; DISTRIBUTIONS; ORGANIZATION	The SLC38 family of transporters has in total 11 members in humans and they encode amino acid transporters called sodium-coupled amino acid transporters (SNAT). To date, five SNATs have been characterized and functionally subdivided into systems A (SLC38A1, SLC38A2, and SLC38A4) and N (SLC38A3 and SLC38A5) showing the highest transport for glutamine and alanine. Here we present identification of a novel glutamine transporter encoded by the Slc38a7 gene, which we propose should be named SNAT7. This transporter has L-glutamine as the preferred substrate but also transports other amino acids with polar side chains, as well as L-histidine and L-alanine. The expression pattern and substrate profile for SLC38A7 shows highest similarity to the known system N transporters. Therefore, we propose that SLC38A7 is a novel member of this system. We used in situ hybridization and immunohistochemistry with a custom-made antibody to show that SLC38A7 is expressed in all neurons, but not in astrocytes, in the mouse brain. SLC38A7 is unique in being the first system N transporter expressed in GABAergic and also other neurons. The preferred substrate and axonal localization of SLC38A7 close to the synaptic cleft indicates that SLC38A7 could have an important function for the reuptake and recycling of glutamate.	[Hagglund, Maria G. A.; Sreedharan, Smitha; Nilsson, Victor C. O.; Shaik, Jafar H. A.; Almkvist, Ingrid M.; Backlin, Sofi; Fredriksson, Robert] Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden; [Wrange, Orjan] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Uppsala University; Karolinska Institutet	Fredriksson, R (corresponding author), Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden.	Robert.Fredriksson@neuro.uu.se	Fredriksson, Robert/AAH-3921-2019	Fredriksson, Robert/0000-0002-2810-3226	Swedish Research Council [VR-NT 2008-3228, VR-M 2008-66X]; Ahlens Foundation; Novo Nordisk Foundation; Goran Gustafsson Foundation; Engkvist Foundation; Magnus Bergvall Foundation; Swedish Cancer Foundation [09-0786]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlens Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Goran Gustafsson Foundation; Engkvist Foundation; Magnus Bergvall Foundation; Swedish Cancer Foundation	This work was supported in part by Swedish Research Council Grant VR-NT 2008-3228 (to R. F.), Ahlens Foundation, The Novo Nordisk Foundation, The Goran Gustafsson Foundation, Engkvist Foundation, and the Magnus Bergvall Foundation.; Supported by Swedish Research Council Grant VR-M 2008-66X and Swedish Cancer Foundation Grant 09-0786.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Armano S, 2002, J BIOL CHEM, V277, P10467, DOI 10.1074/jbc.M110942200; BARKER GA, 1990, EXP PHYSIOL, V75, P3, DOI 10.1113/expphysiol.1990.sp003382; Broer S, 2001, J NEUROCHEM, V77, P705, DOI 10.1046/j.1471-4159.2001.00322.x; Chaudhry FA, 2002, J CELL BIOL, V157, P349, DOI 10.1083/jcb.200201070; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; CHRISTENSEN HN, 1985, J MEMBRANE BIOL, V84, P97, DOI 10.1007/BF01872207; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Conti F, 2006, NEUROCHEM INT, V48, P459, DOI 10.1016/j.neuint.2005.11.016; Cubelos B, 2005, GLIA, V49, P230, DOI 10.1002/glia.20106; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Gelius B, 2001, EXP CELL RES, V265, P319, DOI 10.1006/excr.2001.5184; Gonzalez-Gonzalez IM, 2005, NEUROSCIENCE, V130, P61, DOI 10.1016/j.neuroscience.2004.09.023; Gu SM, 2001, GENOMICS, V74, P262, DOI 10.1006/geno.2001.6567; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Gu SM, 2000, P NATL ACAD SCI USA, V97, P3230, DOI 10.1073/pnas.050318197; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; HAUSSINGER D, 1990, BIOCHEM J, V267, P281; He Lei, 2009, Human Genomics, V3, P195; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; HUBER G, 1984, J NEUROSCI, V4, P151; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Kusuhara H, 2009, DRUG METAB PHARMACOK, V24, P37, DOI 10.2133/dmpk.24.37; LAAKE JH, 1995, J NEUROCHEM, V65, P871; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Nakanishi T, 2001, AM J PHYSIOL-CELL PH, V281, pC1757, DOI 10.1152/ajpcell.2001.281.6.C1757; Newsholme P, 2003, BRAZ J MED BIOL RES, V36, P153, DOI 10.1590/S0100-879X2003000200002; PENG L, 1993, DEV NEUROSCI-BASEL, V15, P367, DOI 10.1159/000111357; Rae C, 2003, J NEUROCHEM, V85, P503, DOI 10.1046/j.1471-4159.2003.01713.x; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Tamarappoo BK, 1997, J NEUROCHEM, V68, P954; Tanaka K, 2005, NEUROSCI LETT, V378, P70, DOI 10.1016/j.neulet.2004.12.030; Umapathy NS, 2008, INVEST OPHTH VIS SCI, V49, P5151, DOI 10.1167/iovs.08-2245; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Watford M, 2000, J NUTR, V130, p983S, DOI 10.1093/jn/130.4.983S; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776	59	85	90	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20500	20511		10.1074/jbc.M110.162404	http://dx.doi.org/10.1074/jbc.M110.162404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21511949	Green Published, hybrid			2022-12-25	WOS:000291267600037
J	Pinto, JR; Yang, SW; Hitz, MP; Parvatiyar, MS; Jones, MA; Liang, JS; Kokta, V; Talajic, M; Tremblay, N; Jaeggi, M; Andelfinger, G; Potter, JD				Pinto, Jose Renato; Yang, Shi Wei; Hitz, Marc-Phillip; Parvatiyar, Michelle S.; Jones, Michelle A.; Liang, Jingsheng; Kokta, Victor; Talajic, Mario; Tremblay, Nicolas; Jaeggi, Michelle; Andelfinger, Gregor; Potter, James D.			Fetal Cardiac Troponin Isoforms Rescue the Increased Ca2+ Sensitivity Produced by a Novel Double Deletion in Cardiac Troponin T Linked to Restrictive Cardiomyopathy A CLINICAL, GENETIC, AND FUNCTIONAL APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MUSCLE-CONTRACTION; FORCE DEVELOPMENT; TRANSGENIC MICE; DILATED CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; HEART-FAILURE; FAILING HEART; MOUSE MODEL; MUTATIONS	A novel double deletion in cardiac troponin T (cTnT) of two highly conserved amino acids (Asn-100 and Glu-101) was found in a restrictive cardiomyopathic (RCM) pediatric patient. Clinical evaluation revealed the presence of left atrial enlargement and marked left ventricle diastolic dysfunction. The explanted heart examined by electron microscopy revealed myofibrillar disarray and mild fibrosis. Pedigree analysis established that this mutation arose de novo. The patient tested negative for six other sarcomeric genes. The single and double recombinant cTnT mutants were generated, and their functional consequences were analyzed in porcine skinned cardiac muscle. In the adult Tn environment (cTnT3 + cardiac troponin I), the single cTnT3-Delta N100 and cTnT3-Delta E101 mutations had opposing effects on the Ca2+ sensitivity of force development compared with WT, whereas the double deletion cTnT3-Delta N100/Delta E101 increased the Ca2+ sensitivity + 0.19 pCa units. In addition, cTnT3-Delta N100/Delta E101 decreased the cooperativity of force development, suggesting alterations in intrafilament protein-protein interactions. In the fetal Tn environment, (cTnT1 + slow skeletal troponin I), the single (cTnT1-Delta N110) and double (cTnT1-Delta N110/Delta E111) deletions did not change the Ca2+ sensitivity compared with control. To recreate the patient's heterozygous genotype, we performed a reconstituted ATPase activity assay. Thin filaments containing 50:50 cTnT3-Delta N100/Delta E101:cTnT3-WT also increased the myofilament Ca2+ sensitivity compared with WT. Co-sedimentation of thin filament proteins indicated that no significant changes occurred in the binding of Tn containing the RCM cTnT mutation to actin-Tm. This report reveals the protective role of Tn fetal isoforms as they rescue the increased Ca2+ sensitivity produced by a cTnT-RCM mutation and may account for the lack of lethality during gestation.	[Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Yang, Shi Wei; Hitz, Marc-Phillip; Kokta, Victor; Tremblay, Nicolas; Jaeggi, Michelle; Andelfinger, Gregor] Univ Montreal, CHU St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Yang, Shi Wei; Hitz, Marc-Phillip; Kokta, Victor; Tremblay, Nicolas; Jaeggi, Michelle; Andelfinger, Gregor] Univ Montreal, CHU St Justine, Dept Biochem, Montreal, PQ H3T 1C5, Canada; [Talajic, Mario] Univ Montreal, Dept Med, Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada	University of Miami; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Room 6083,R-189,1600 NW 10th Ave, Miami, FL 33136 USA.	jdpotter@miami.edu	Tremblay, Nicolas/O-7927-2019; Hitz, Marc/ABD-9495-2021; parvatiyar, michelle/ABH-7542-2020; Hitz, Marc-Phillip/Q-5571-2018; Yang, Wei/HIA-0360-2022; Pinto, Jose Renato/H-2631-2017	Tremblay, Nicolas/0000-0003-4246-7189; Hitz, Marc-Phillip/0000-0001-9894-6897; Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069; Talajic, Mario/0000-0001-8469-4748	National Institutes of Health [HL-042325]; JE King Grant [1KN13-34001]; Sainte Justine Hospital Foundation; American Heart Association; Nussia and Andre Aisenstadt Foundation; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042325, R01HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JE King Grant; Sainte Justine Hospital Foundation; American Heart Association(American Heart Association); Nussia and Andre Aisenstadt Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-042325 (to J. D. P.).; Supported by J&E King Grant 1KN13-34001.; Supported by a grant from the Sainte Justine Hospital Foundation.; Supported by a postdoctoral fellowship from the American Heart Association.; Supported by a Clinician-Scientist Award of the Canadian Institutes of Health Research and the Nussia and Andre Aisenstadt Foundation. To whom correspondence may be addressed: Genetique Cardiovasculaire, CHU Sainte Justine, University of Montreal, 3175, Cote Sainte Catherine, Montreal, Quebec H3T 1C5, Canada. E-mail: gregor.andelfinger@recherche-ste-justine.qc.ca.	Ahmad F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002642; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Ammash NM, 2000, CIRCULATION, V101, P2490, DOI 10.1161/01.CIR.101.21.2490; ANDERSON PAW, 1991, CIRC RES, V69, P1226, DOI 10.1161/01.RES.69.5.1226; ANDERSON PAW, 1995, CIRC RES, V76, P681, DOI 10.1161/01.RES.76.4.681; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Chang AN, 2008, BIOCHEM BIOPH RES CO, V369, P74, DOI 10.1016/j.bbrc.2007.12.081; Chen SC, 2001, J HEART LUNG TRANSPL, V20, P90, DOI 10.1016/S1053-2498(00)00162-5; Chimenti C, 2008, AM J PATHOL, V172, P1482, DOI 10.2353/ajpath.2008.070576; Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Dipchand AI, 2009, J HEART LUNG TRANSPL, V28, P1312, DOI 10.1016/j.healun.2009.05.019; Du J, 2006, ARCH BIOCHEM BIOPHYS, V456, P143, DOI 10.1016/j.abb.2006.08.018; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Eidem BW, 2004, J AM SOC ECHOCARDIOG, V17, P212, DOI 10.1016/j.echo.2003.12.005; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hernandez OM, 2005, J BIOL CHEM, V280, P37183, DOI 10.1074/jbc.M508114200; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; Huang XP, 1999, CIRC RES, V84, P1; Karam Simon, 2008, Congenit Heart Dis, V3, P138, DOI 10.1111/j.1747-0803.2008.00165.x; Kaski JP, 2008, HEART, V94, P1478, DOI 10.1136/hrt.2007.134684; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kostareva A, 2009, INT J CARDIOL, V131, P410, DOI 10.1016/j.ijcard.2007.07.108; Kranias E. G., 2007, V45, P523; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; Menon SC, 2008, CLIN GENET, V74, P445, DOI 10.1111/j.1399-0004.2008.01062.x; Metzger JM, 2003, J BIOL CHEM, V278, P13118, DOI 10.1074/jbc.M212601200; Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Murakami K, 2008, P NATL ACAD SCI USA, V105, P7200, DOI 10.1073/pnas.0801950105; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; Ommen SR, 2000, CIRCULATION, V102, P1788; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Parvatiyar MS, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/350706; Peddy SB, 2006, PEDIATRICS, V117, P1830, DOI 10.1542/peds.2005-2301; Pena JR, 2010, J MOL CELL CARDIOL, V49, P993, DOI 10.1016/j.yjmcc.2010.09.010; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; SASSE S, 1993, CIRC RES, V72, P932, DOI 10.1161/01.RES.72.5.932; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; SOLARO RJ, 1988, CIRC RES, V63, P779, DOI 10.1161/01.RES.63.4.779; Soldin SJ, 2006, CLIN CHIM ACTA, V366, P304, DOI 10.1016/j.cca.2005.11.005; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TOWNSEND PJ, 1995, J MOL CELL CARDIOL, V27, P2223, DOI 10.1016/S0022-2828(95)91587-7; Urboniene D, 2005, CIRC RES, V97, P70, DOI 10.1161/01.RES.0000173849.68636.1e; Varnava AM, 2001, CIRCULATION, V104, P1380, DOI 10.1161/hc3701.095952; Ware SM, 2008, CLIN GENET, V73, P165, DOI 10.1111/j.1399-0004.2007.00939.x; Weller RJ, 2002, AM J CARDIOL, V90, P501, DOI 10.1016/S0002-9149(02)02522-5; Wen YH, 2009, J MOL BIOL, V392, P1158, DOI 10.1016/j.jmb.2009.07.080; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zangwill SD, 2009, J HEART LUNG TRANSPL, V28, P1335, DOI 10.1016/j.healun.2009.06.028	60	12	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20901	20912		10.1074/jbc.M111.234336	http://dx.doi.org/10.1074/jbc.M111.234336			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21502316	Green Published, hybrid			2022-12-25	WOS:000291267600074
J	Gutekunst, M; Oren, M; Weilbacher, A; Dengler, MA; Markwardt, C; Thomale, J; Aulitzky, WE; van der Kuip, H				Gutekunst, Matthias; Oren, Moshe; Weilbacher, Andrea; Dengler, Michael A.; Markwardt, Christiane; Thomale, Juergen; Aulitzky, Walter E.; van der Kuip, Heiko			p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin	PLOS ONE			English	Article							DNA-DAMAGE; INDUCED APOPTOSIS; FAMILY PROTEINS; XPA PROTEIN; SENSITIVITY; GENE; PHOSPHORYLATION; BORTEZOMIB; RESISTANCE; CANCER	Consistent with the excellent clinical results in testicular germ cell tumors (TGCT), most cell lines derived from this cancer show an exquisite sensitivity to Cisplatin. It is well accepted that the high susceptibility of TGCT cells to apoptosis plays a central role in this hypersensitive phenotype. The role of the tumor suppressor p53 in this response, however, remains controversial. Here we show that siRNA-mediated silencing of p53 is sufficient to completely abrogate hypersensitivity not only to Cisplatin but also to non-genotoxic inducers of p53 such as the Mdm2 antagonist Nutlin-3 and the proteasome inhibitor Bortezomib. The close relationship between p53 protein levels and induction of apoptosis is lost upon short-term differentiation, indicating that this predominant pro-apoptotic function of p53 is unique in pluripotent embryonal carcinoma (EC) cells. RNA interference experiments as well as microarray analysis demonstrated a central role of the proapoptotic p53 target gene NOXA in the p53-dependent apoptotic response of these cells. In conclusion, our data indicate that the hypersensitivity of TGCT cells is a result of their unique sensitivity to p53 activation. Furthermore, in the very specific cellular context of germ cell-derived pluripotent EC cells, p53 function appears to be limited to induction of apoptosis.	[Gutekunst, Matthias; Weilbacher, Andrea; Dengler, Michael A.; Markwardt, Christiane; van der Kuip, Heiko] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Gutekunst, Matthias; Weilbacher, Andrea; Dengler, Michael A.; Markwardt, Christiane; van der Kuip, Heiko] Univ Tubingen, Stuttgart, Germany; [Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Thomale, Juergen] Univ Duisburg Essen, Inst Cell Biol, Sch Med, Essen, Germany; [Aulitzky, Walter E.] Robert Bosch Krankenhaus, Dept Internal Med 2, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Weizmann Institute of Science; University of Duisburg Essen; Bosch; Robert Bosch Krankenhaus	Gutekunst, M (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-7000 Stuttgart, Germany.	heiko.van-der-kuip@ikp-stuttgart.de	Dengler, Michael/AFR-3509-2022	Oren, Moshe/0000-0003-4311-7172; Markwardt, Craig/0000-0001-9803-3879; Dengler, Michael/0000-0002-1693-1761	Robert-Bosch foundation [11.5.8000.0083.0, O2A]	Robert-Bosch foundation	This work was supported by the Robert-Bosch foundation (11.5.8000.0083.0 and O2A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Bauer S, 2010, EUR UROL, V57, P679, DOI 10.1016/j.eururo.2009.06.014; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Burger H, 1999, INT J CANCER, V81, P620, DOI 10.1002/(SICI)1097-0215(19990517)81:4<620::AID-IJC19>3.3.CO;2-J; Burger H, 1997, INT J CANCER, V73, P592, DOI 10.1002/(SICI)1097-0215(19971114)73:4<592::AID-IJC22>3.0.CO;2-A; Cepeda V, 2007, ANTI-CANCER AGENT ME, V7, P3, DOI 10.2174/187152007779314044; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Chresta CM, 1996, CANCER RES, V56, P1834; Datta MW, 2001, MODERN PATHOL, V14, P437, DOI 10.1038/modpathol.3880331; di Pietro A, 2005, INT J BIOCHEM CELL B, V37, P2437, DOI 10.1016/j.biocel.2005.06.014; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Gosland M, 1996, PHARMACOTHERAPY, V16, P16; Guillou L, 1996, AM J PATHOL, V149, P1221; Houldsworth J, 1998, ONCOGENE, V16, P2345, DOI 10.1038/sj.onc.1201770; HUDDART RA, 1995, EUR J CANCER, V31A, P739, DOI 10.1016/0959-8049(95)00047-M; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Koberle B, 1997, INT J CANCER, V70, P551, DOI 10.1002/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G; Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3; KOBERLE B, 2010, BIOCH BIOPHYS ACTA; Koberle B, 2008, MOL CARCINOGEN, V47, P580, DOI 10.1002/mc.20418; Li BZ, 2010, CELL CYCLE, V9, P1411, DOI 10.4161/cc.9.7.11255; Lichtig H, 2010, VIROLOGY, V396, P47, DOI 10.1016/j.virol.2009.10.011; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lutzker SG, 1998, APMIS, V106, P85, DOI 10.1111/j.1699-0463.1998.tb01323.x; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Lutzker SG, 2001, ONCOGENE, V20, P2982, DOI 10.1038/sj.onc.1204394; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Masters JRW, 1996, EUR J CANCER, V32A, P1248, DOI 10.1016/0959-8049(96)00033-0; MASTERS JRW, 1993, INT J CANCER, V53, P340, DOI 10.1002/ijc.2910530228; Nakajima Wataru, 2007, Journal of Nippon Medical School, V74, P148, DOI 10.1272/jnms.74.148; PENG HQ, 1993, CANCER RES, V53, P3574; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Skorta I, 2009, CANCER RES, V69, P9337, DOI 10.1158/0008-5472.CAN-09-0548; Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Spierings DCJ, 2004, ONCOGENE, V23, P4862, DOI 10.1038/sj.onc.1207617; Spierings DCJ, 2003, J PATHOL, V200, P137, DOI 10.1002/path.1373; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; van der Kuip H, 2001, BLOOD, V98, P1532, DOI 10.1182/blood.V98.5.1532; Vaziri SAJ, 2009, ANTICANCER RES, V29, P2961; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Welsh C, 2004, INT J CANCER, V110, P352, DOI 10.1002/ijc.20134; Williams SA, 2003, CANCER RES, V63, P7338	55	68	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2011	6	4							e19198	10.1371/journal.pone.0019198	http://dx.doi.org/10.1371/journal.pone.0019198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756ME	21532991	Green Published, gold			2022-12-25	WOS:000290014500025
J	Ai, EK; Poole, DS; Skop, AR				Ai, Erkang; Poole, Daniel S.; Skop, Ahna R.			Long Astral Microtubules and RACK-1 Stabilize Polarity Domains during Maintenance Phase in Caenorhabditis elegans Embryos	PLOS ONE			English	Article							ANTERIOR-POSTERIOR AXIS; C-ELEGANS; PAR PROTEINS; CELL POLARITY; ANTEROPOSTERIOR AXIS; RECYCLING ENDOSOME; ESTABLISHMENT; POLARIZATION; CYTOKINESIS; TRANSPORT	Cell polarity is a very well conserved process important for cell differentiation, cell migration, and embryonic development. After the establishment of distinct cortical domains, polarity cues have to be stabilized and maintained within a fluid and dynamic membrane to achieve proper cell asymmetry. Microtubules have long been thought to deliver the signals required to polarize a cell. While previous studies suggest that microtubules play a key role in the establishment of polarity, the requirement of microtubules during maintenance phase remains unclear. In this study, we show that depletion of Caenorhabditis elegans RACK-1, which leads to short astral microtubules during prometaphase, specifically affects maintenance of cortical PAR domains and Dynamin localization. We then investigated the consequence of knocking down other factors that also abolish astral microtubule elongation during polarity maintenance phase. We found a correlation between short astral microtubules and the instability of PAR-6 and PAR-2 domains during maintenance phase. Our data support a necessary role for astral microtubules in the maintenance phase of cell polarity.	[Ai, Erkang; Poole, Daniel S.; Skop, Ahna R.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Ai, EK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	skop@wisc.edu	Skop, Ahna Renee/X-3305-2019	Skop, Ahna Renee/0000-0003-3522-4939	NSF [MCB-0546398]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL092583] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an NSF CAREER award (MCB-0546398) to A. R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aceto D, 2006, DEV BIOL, V299, P386, DOI 10.1016/j.ydbio.2006.08.002; Ai E, 2009, MOL BIOL CELL, V20, P1629, DOI 10.1091/mbc.E08-09-0917; Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Jenkins N, 2006, SCIENCE, V313, P1298, DOI 10.1126/science.1130291; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Kimura A, 2007, J CELL BIOL, V179, P1347, DOI 10.1083/jcb.200706005; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Labbe JC, 2004, J CELL BIOL, V167, P245, DOI 10.1083/jcb.200406008; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Motegi F, 2006, DEV CELL, V10, P509, DOI 10.1016/j.devcel.2006.03.001; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Murthy K, 2008, J CELL SCI, V121, P2350, DOI 10.1242/jcs.027052; Nakayama Y, 2009, DEV CELL, V16, P889, DOI 10.1016/j.devcel.2009.04.009; Nance J, 2005, BIOESSAYS, V27, P126, DOI 10.1002/bies.20175; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Portereiko MF, 2004, CURR BIOL, V14, P932, DOI 10.1016/j.cub.2004.05.052; Schenk C, 2010, DEVELOPMENT, V137, P1743, DOI 10.1242/dev.040436; Schonegg S, 2007, P NATL ACAD SCI USA, V104, P14976, DOI 10.1073/pnas.0706941104; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Sonneville R, 2004, DEVELOPMENT, V131, P3527, DOI 10.1242/dev.01244; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; Wittmann T, 2001, J CELL SCI, V114, P3795; Zhang HN, 2008, MOL BIOL CELL, V19, P2553, DOI 10.1091/mbc.E07-09-0862	50	9	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19020	10.1371/journal.pone.0019020	http://dx.doi.org/10.1371/journal.pone.0019020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533050	Green Published, gold			2022-12-25	WOS:000289719400050
J	Zimmer, C; Boos, M; Bertrand, F; Robin, JP; Petit, O				Zimmer, Cedric; Boos, Mathieu; Bertrand, Frederic; Robin, Jean-Patrice; Petit, Odile			Behavioural Adjustment in Response to Increased Predation Risk: A Study in Three Duck Species	PLOS ONE			English	Article							VIGILANCE TRADE-OFF; ANAS-CRECCA-CRECCA; ALLOCATION HYPOTHESIS; TEMPORAL VARIATION; FOOD AVAILABILITY; FORAGING ACTIVITY; BODY-MASS; SLEEP; BIRDS; MORTALITY	Predation directly triggers behavioural decisions designed to increase immediate survival. However, these behavioural modifications can have long term costs. There is therefore a trade-off between antipredator behaviours and other activities. This trade-off is generally considered between vigilance and only one other behaviour, thus neglecting potential compensations. In this study, we considered the effect of an increase in predation risk on the diurnal time-budget of three captive duck species during the wintering period. We artificially increased predation risk by disturbing two groups of 14 mallard and teals at different frequencies, and one group of 14 tufted ducks with a radio-controlled stressor. We recorded foraging, vigilance, preening and sleeping durations the week before, during and after disturbance sessions. Disturbed groups were compared to an undisturbed control group. We showed that in all three species, the increase in predation risk resulted in a decrease in foraging and preening and led to an increase in sleeping. It is worth noting that contrary to common observations, vigilance did not increase. However, ducks are known to be vigilant while sleeping. This complex behavioural adjustment therefore seems to be optimal as it may allow ducks to reduce their predation risk. Our results highlight the fact that it is necessary to encompass the whole individual time-budget when studying behavioural modifications under predation risk. Finally, we propose that studies of behavioural time-budget changes under predation risk should be included in the more general framework of the starvation-predation risk trade-off.	[Zimmer, Cedric; Robin, Jean-Patrice; Petit, Odile] Univ Strasbourg, CNRS, Dept Ecol Physiol & Ethol, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Boos, Mathieu] Naturaconst Res Agcy Appl Ecol, Wilshausen, France; [Bertrand, Frederic] Univ Strasbourg, CNRS, Inst Rech Math Avancee, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Zimmer, C (corresponding author), Univ Strasbourg, CNRS, Dept Ecol Physiol & Ethol, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France.	cedric.zimmer@c-strasbourg.fr	Bertrand, Frédéric/ABA-2622-2020; Zimmer, Cédric/C-5654-2011	Bertrand, Frédéric/0000-0002-0837-8281; Zimmer, Cedric/0000-0001-8160-2836	Region Alsace; National Fund for Biological Research on Game and Wildlife Species; CNRS	Region Alsace(Region Grand-Est); National Fund for Biological Research on Game and Wildlife Species; CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was supported by grants from "Region Alsace'' (http://www.region-alsace.eu/), National Fund for Biological Research on Game and Wildlife Species, and CNRS (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AMLANER CJ, 1983, BEHAVIOUR, V87, P85, DOI 10.1163/156853983X00138; Anholt BR, 1998, EVOL ECOL, V12, P729, DOI 10.1023/A:1006589616931; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Arzel C, 2007, CAN J ZOOL, V85, P81, DOI 10.1139/Z06-201; Beale C. M., 2007, INT J COMP PSYCHOL, V20, P111; Belden LK, 2000, ANIM BEHAV, V59, P871, DOI 10.1006/anbe.1999.1398; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Carey C., 1996, AVIAN ENERGETICS NUT; Cresswell W, 2008, IBIS, V150, P209, DOI 10.1111/j.1474-919X.2008.00784.x; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; De Leeuw JJ, 1999, ARDEA, V87, P15; Dekker D, 2003, J RAPTOR RES, V37, P161; del Hoyo J, 2013, HDB BIRDS WORLD; Fernandez-Juricic E, 2007, WATERBIRDS, V30, P554, DOI 10.1675/1524-4695(2007)030[0554:RONBNH]2.0.CO;2; Frid A, 2002, CONSERV ECOL, V6; Fritz H, 2000, ARDEA, V88, P9; Gagliardi A, 2006, WATERBIRDS, V29, P105, DOI 10.1675/1524-4695(2006)29[105:BROWGC]2.0.CO;2; Gauthier-Clerc M, 1998, CAN J ZOOL, V76, P2214, DOI 10.1139/cjz-76-12-2214; Gauthier-Clerc M, 2000, CONDOR, V102, P307, DOI 10.1650/0010-5422(2000)102[0307:SVTOIG]2.0.CO;2; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; JORDE DG, 1984, CONDOR, V86, P258, DOI 10.2307/1366993; Laursen K, 2005, WILDLIFE BIOL, V11, P13, DOI 10.2981/0909-6396(2005)11[13:FAEDOS]2.0.CO;2; LENDREM DW, 1983, ANIM BEHAV, V31, P532, DOI 10.1016/S0003-3472(83)80076-1; LENDREM DW, 1984, ANIM BEHAV, V32, P243, DOI 10.1016/S0003-3472(84)80343-7; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima SL, 2007, ANIM BEHAV, V74, P189, DOI 10.1016/j.anbehav.2006.12.007; Lind J, 2006, J ORNITHOL, V147, P310, DOI 10.1007/s10336-005-0051-3; Lind J, 2005, BEHAV ECOL, V16, P945, DOI 10.1093/beheco/ari075; MacLeod R, 2006, ANIM BEHAV, V71, P523, DOI 10.1016/j.anbehav.2005.04.020; Marsden SJ, 2000, ENVIRON MANAGE, V26, P207, DOI 10.1007/s002670010082; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; MEDDIS R, 1975, ANIM BEHAV, V23, P676, DOI 10.1016/0003-3472(75)90144-X; Mirza RS, 2006, ETHOLOGY, V112, P44, DOI 10.1111/j.1439-0310.2006.01111.x; Murphy Mary E., 1996, P158; NILSSON L, 1970, OIKOS, V21, P145, DOI 10.2307/3543670; Norberg Ulla M., 1996, P199; Nudds RL, 2000, J EXP BIOL, V203, P1561; Owen M, 1990, WATERFOWL ECOLOGY; PAULUS S L, 1988, P135; PEDROLI JC, 1981, RELATIONS ENTRE MOUL; Rattenborg NC, 1999, BEHAV BRAIN RES, V105, P163, DOI 10.1016/S0166-4328(99)00070-4; Rattenborg NC, 1999, NATURE, V397, P397, DOI 10.1038/17037; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Roth TC, 2006, J SLEEP RES, V15, P395, DOI 10.1111/j.1365-2869.2006.00559.x; SARGEANT AB, 1973, AM MIDL NAT, V89, P208, DOI 10.2307/2424149; SARGEANT AB, 1984, WILDL MONOGR, V1; Steer D, 2009, ANIM BEHAV, V78, P1071, DOI 10.1016/j.anbehav.2009.07.024; Tamisier A., 1999, CAMARGUE CANARDS FOU; TAMISIER A, 1972, ALAUDA, V10, P107; TAMISIER A, 1972, ALAUDA, V10, P235; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Zimmer C, 2010, J AVIAN BIOL, V41, P637, DOI 10.1111/j.1600-048X.2010.05110.x	62	12	14	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18977	10.1371/journal.pone.0018977	http://dx.doi.org/10.1371/journal.pone.0018977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533055	gold, Green Published			2022-12-25	WOS:000289719400043
J	Hahn, MA; Wu, XW; Li, AX; Hahn, T; Pfeifer, GP				Hahn, Maria A.; Wu, Xiwei; Li, Arthur X.; Hahn, Torsten; Pfeifer, Gerd P.			Relationship between Gene Body DNA Methylation and Intragenic H3K9me3 and H3K36me3 Chromatin Marks	PLOS ONE			English	Article							HISTONE H3 LYSINE-9; HUMAN CANCER-CELLS; RNA-POLYMERASE-II; ARABIDOPSIS-THALIANA; STEM-CELLS; GENOME; METHYLTRANSFERASE; TRANSCRIPTION; DISTINCT; DNMT1	To elucidate the relationship between intragenic DNA methylation and chromatin marks, we performed epigenetic profiling of chromosome 19 in human bronchial epithelial cells (HBEC) and in the colorectal cancer cell line HCT116 as well as its counterpart with double knockout of DNMT1 and DNMT3B (HCT116-DKO). Analysis of H3K36me3 profiles indicated that this intragenic mark of active genes is associated with two categories of genes: (i) genes with low CpG density and H3K9me3 in the gene body or (ii) genes with high CpG density and DNA methylation in the gene body. We observed that a combination of low CpG density in gene bodies together with H3K9me3 and H3K36me3 occupancy is a specific epigenetic feature of zinc finger (ZNF) genes, which comprise 90% of all genes carrying both histone marks on chromosome 19. For genes with high intragenic CpG density, transcription and H3K36me3 occupancy were not changed in conditions of partial or intensive loss of DNA methylation in gene bodies. siRNA knockdown of SETD2, the major histone methyltransferase responsible for production of H3K36me3, did not reduce DNA methylation in gene bodies. Our study suggests that the H3K36me3 and DNA methylation marks in gene bodies are established largely independently of each other and points to similar functional roles of intragenic DNA methylation and intragenic H3K9me3 for CpG-rich and CpG-poor genes, respectively.	[Hahn, Maria A.; Hahn, Torsten; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA USA; [Wu, Xiwei] City Hope Natl Med Ctr, Dept Mol Med, Beckman Res Inst, Duarte, CA USA; [Li, Arthur X.] City Hope Natl Med Ctr, Dept Informat Sci, Beckman Res Inst, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Hahn, MA (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA USA.	gpfeifer@coh.org			NIH [CA084469, AG036041]; NATIONAL CANCER INSTITUTE [R01CA084469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants CA084469 and AG036041 to GPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DHAYALAN A, 2010, J BIOL CHEM; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He XJ, 2009, GENE DEV, V23, P2717, DOI 10.1101/gad.1851809; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Lohmann F, 2010, STEM CELLS, V28, P201, DOI 10.1002/stem.278; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; RAUCH TA, 2010, METHODS IN PRESS; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	53	96	102	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18844	10.1371/journal.pone.0018844	http://dx.doi.org/10.1371/journal.pone.0018844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526191	Green Submitted, gold, Green Published			2022-12-25	WOS:000289671100028
J	Park, DS; Foottit, R; Maw, E; Hebert, PDN				Park, Doo-Sang; Foottit, Robert; Maw, Eric; Hebert, Paul D. N.			Barcoding Bugs: DNA-Based Identification of the True Bugs (Insecta: Hemiptera: Heteroptera)	PLOS ONE			English	Article								Background: DNA barcoding, the analysis of sequence variation in the 59 region of the mitochondrial cytochrome c oxidase COI) gene, has been shown to provide an efficient method for the identification of species in a wide range of animal taxa. In order to assess the effectiveness of barcodes in the discrimination of Heteroptera, we examined 344 species belonging to 178 genera, drawn from specimens in the Canadian National Collection of Insects. Methodology/Principal Findings: Analysis of the COI gene revealed less than 2% intra-specific divergence in 90% of the taxa examined, while minimum interspecific distances exceeded 3% in 77% of congeneric species pairs. Instances where barcodes fail to distinguish species represented clusters of morphologically similar species, except one case of barcode identity between species in different genera. Several instances of deep intraspecific divergence were detected suggesting possible cryptic species. Conclusions/Significance: Although this analysis encompasses 0.8% of the described global fauna, our results indicate that DNA barcodes will aid the identification of Heteroptera. This advance will be useful in pest management, regulatory and environmental applications and will also reveal species that require further taxonomic research.	[Park, Doo-Sang] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon, South Korea; [Foottit, Robert; Maw, Eric] Agr & Agri Food Canada, Invertebrate Biodivers Natl Environm Hlth Program, Ottawa, ON, Canada; [Foottit, Robert; Maw, Eric] Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Park, Doo-Sang; Hebert, Paul D. N.] Biodivers Inst Ontario, Guelph, ON, Canada	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Agriculture & Agri Food Canada	Park, DS (corresponding author), Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Taejon, South Korea.	Robert.Foottit@agr.gc.ca	Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	NSERC, Genome Canada (through the Ontario Genomics Institute); Agriculture and Agri-Food Canada	NSERC, Genome Canada (through the Ontario Genomics Institute)(Natural Sciences and Engineering Research Council of Canada (NSERC)Genome Canada); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research was supported by funding to the Canadian Barcode of Life Network from NSERC, Genome Canada (through the Ontario Genomics Institute), and by Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Damgaard J, 2008, INSECT SYST EVOL, V39, P107, DOI 10.1163/187631208788784156; Floyd Robin M., 2009, P417, DOI 10.1002/9781444308211.ch17; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Henry Thomas J., 2009, P223, DOI 10.1002/9781444308211.ch10; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jung S, 2011, MOL ECOL RESOUR, V11, P266, DOI 10.1111/j.1755-0998.2010.02945.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Memon N, 2006, SYST ENTOMOL, V31, P703, DOI 10.1111/j.1365-3113.2006.00350.x; Park DS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-423; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaeffer CW, 2000, HETEROPTERA EC IMPOR; Schuh Randall T., 2001, Bulletin of the American Museum of Natural History, V266, P1, DOI 10.1206/0003-0090(2001)266<0001:RONWPF>2.0.CO;2; Schwartz M.D., 1998, MEMOIRS ENTOMOLOGY I, V10, P1	17	128	139	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18749	10.1371/journal.pone.0018749	http://dx.doi.org/10.1371/journal.pone.0018749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750WK	21526211	Green Published, Green Submitted, gold			2022-12-25	WOS:000289578600029
J	Liu, Z; Luo, WR; Zhou, Y; Zhen, Y; Yang, HL; Yu, XL; Ye, YF; Li, X; Wang, H; Jiang, QP; Zhang, YJ; Yao, KT; Fang, WY				Liu, Zhen; Luo, Weiren; Zhou, Ying; Zhen, Yan; Yang, Huiling; Yu, Xiaoli; Ye, Yanfen; Li, Xin; Wang, Hao; Jiang, Qinping; Zhang, Yajie; Yao, Kaitai; Fang, Weiyi			Potential Tumor Suppressor NESG1 as an Unfavorable Prognosis Factor in Nasopharyngeal Carcinoma (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							EXPRESSION; GROWTH; PROLIFERATION; KINASE; ATF-2; CELLS; GENE	Background: Recently we identified nasopharyngeal epithelium specific protein 1 (NESG1) as a potential tumor suppressor in nasopharyngeal carcinoma (NPC). The purpose of this study is to investigate the involvement of NESG1 in tumor progression and prognosis of human NPC. Methodology/Principal Findings: NESG1 protein expression in NPC was examined. Survival analysis was performed using Kaplan-Meier method. The effect of NESG1 on cell proliferation, migration, and invasion were also investigated. Results: NESG1 expression was downregulated in atypical hyperplasia and NPC samples compared to normal and squamous nasopharynx tissues. Reduced protein expression was negatively associated with the status of NPC progression. Patients with lower NESG1 expression had a shorter overall survival and disease-free time than did patients with higher NESG1 expression. Multivariate analysis suggested NESG1 expression as an independent prognostic indicator for NPC patient survival. Proliferation, migration, and invasion ability were significantly increased in cell lines following lentiviral-mediated shRNA suppression of NESG1 expression. Microarray analysis indicated that NESG1 participated in multiple pathways, including MAPK signaling and cell cycle regulation. Finally, DNA methylation microarray examination revealed a lack of hypermethylation at the NESG1 promoter, suggesting other mechanisms are involved in suppressing NESG1 expression in NPC. Conclusion: Our studies are the first to demonstrate that decreased NESG1 expression is an unfavorable prognostic factor for NPC.	[Liu, Zhen; Zhang, Yajie] Guangzhou Med Univ, Dept Pathol, Basic Sch, Guangzhou, Guangdong, Peoples R China; [Liu, Zhen; Luo, Weiren; Zhou, Ying; Zhen, Yan; Yu, Xiaoli; Ye, Yanfen; Li, Xin; Wang, Hao; Yao, Kaitai; Fang, Weiyi] So Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Luo, Weiren] Guangdong Med Coll, Dept Pathol, Dongguan, Peoples R China; [Jiang, Qinping] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Yang, Huiling] Guangdong Med Coll, Sch Pharm, Dongguan, Peoples R China	Guangzhou Medical University; Southern Medical University - China; Guangdong Medical University; Guangzhou Medical University; Guangdong Medical University	Liu, Z (corresponding author), Guangzhou Med Univ, Dept Pathol, Basic Sch, Guangzhou, Guangdong, Peoples R China.	fangweiyi1975@yahoo.com.cn	Ren, Jian/D-3270-2011; Xue, Yu/G-5929-2011; Luo, Weiren/AAI-8364-2020; Liu, Zexian/D-1153-2011	Ren, Jian/0000-0002-4161-1292; Xue, Yu/0000-0002-9403-6869; Luo, Weiren/0000-0002-2762-6332; Liu, Zexian/0000-0001-9698-0610	National Nature Science Fund of China [81071632, 30870973]; Natural Science Fund of Guangdong Province [8451051501000314]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by National Nature Science Fund of China (NO. 81071632 and NO. 30870973)(http://www.nsfc.gov.cn), Natural Science Fund of Guangdong Province (NO. 8451051501000314) (http://www.gdstc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010493; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Dong WJ, 2010, INT J CANCER, V127, P1526, DOI 10.1002/ijc.25161; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Henkens R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-147; Jadeski LC, 2003, INT J CANCER, V106, P496, DOI 10.1002/ijc.11268; Johansen C, 2009, CARCINOGENESIS, V30, P2100, DOI 10.1093/carcin/bgp238; Jonak C, 2011, J DERMATOL SCI, V61, P32, DOI 10.1016/j.jdermsci.2010.10.009; Knippen S, 2009, ANTICANCER RES, V29, P183; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Li ZK, 1999, GENE, V237, P235, DOI 10.1016/S0378-1119(99)00234-6; Liu Z, 2011, INT J CANCER, V128, P2562, DOI 10.1002/ijc.25595; Lung HL, 2010, INT J CANCER, V127, P304, DOI 10.1002/ijc.25047; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Modi H, 2011, LEUKEMIA, V25, P305, DOI 10.1038/leu.2010.257; Poage GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009651; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Recio JA, 2002, ONCOGENE, V21, P1000, DOI 10.1038/sj.onc.1205150; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Ungefroren H, 2007, INT J CANCER, V120, P1641, DOI 10.1002/ijc.22393; Wang SA, 2011, HISTOPATHOLOGY, V58, P217, DOI 10.1111/j.1365-2559.2010.03739.x; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38; Zhou YH, 2008, INT J CANCER, V123, P2065, DOI 10.1002/ijc.23727; Zoumpourlis V, 2000, ONCOGENE, V19, P4011, DOI 10.1038/sj.onc.1203732	31	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2011	6	11							e27887	10.1371/journal.pone.0027887	http://dx.doi.org/10.1371/journal.pone.0027887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KW	22140479	Green Published, Green Submitted, gold			2022-12-25	WOS:000298163400020
J	Perrin, RJ; Craig-Schapiro, R; Malone, JP; Shah, AR; Gilmore, P; Davis, AE; Roe, CM; Peskind, ER; Li, G; Galasko, DR; Clark, CM; Quinn, JF; Kaye, JA; Morris, JC; Holtzman, DM; Townsend, RR; Fagan, AM				Perrin, Richard J.; Craig-Schapiro, Rebecca; Malone, James P.; Shah, Aarti R.; Gilmore, Petra; Davis, Alan E.; Roe, Catherine M.; Peskind, Elaine R.; Li, Ge; Galasko, Douglas R.; Clark, Christopher M.; Quinn, Joseph F.; Kaye, Jeffrey A.; Morris, John C.; Holtzman, David M.; Townsend, R. Reid; Fagan, Anne M.			Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; EPITHELIUM-DERIVED FACTOR; CELL-ADHESION MOLECULE; AMYLOID-BETA-PROTEIN; IMMUNODEFICIENCY-VIRUS ENCEPHALITIS; FRONTOTEMPORAL LOBAR DEGENERATION; SECRETORY GRANULE MEMBRANE; CEREBRAL-ARTERY OCCLUSION; GENOME-WIDE ASSOCIATION; CARBONIC-ANHYDRASE-IV	Background: Ideally, disease modifying therapies for Alzheimer disease (AD) will be applied during the 'preclinical' stage (pathology present with cognition intact) before severe neuronal damage occurs, or upon recognizing very mild cognitive impairment. Developing and judiciously administering such therapies will require biomarker panels to identify early AD pathology, classify disease stage, monitor pathological progression, and predict cognitive decline. To discover such biomarkers, we measured AD-associated changes in the cerebrospinal fluid (CSF) proteome. Methods and Findings: CSF samples from individuals with mild AD (Clinical Dementia Rating [CDR] 1) (n = 24) and cognitively normal controls (CDR 0) (n = 24) were subjected to two-dimensional difference-in-gel electrophoresis. Within 119 differentially-abundant gel features, mass spectrometry (LC-MS/MS) identified 47 proteins. For validation, eleven proteins were re-evaluated by enzyme-linked immunosorbent assays (ELISA). Six of these assays (NrCAM, YKL-40, chromogranin A, carnosinase I, transthyretin, cystatin C) distinguished CDR 1 and CDR 0 groups and were subsequently applied (with tau, p-tau181 and A beta 42 ELISAs) to a larger independent cohort (n = 292) that included individuals with very mild dementia (CDR 0.5). Receiver-operating characteristic curve analyses using stepwise logistic regression yielded optimal biomarker combinations to distinguish CDR 0 from CDR. 0 (tau, YKL-40, NrCAM) and CDR 1 from CDR, 1 (tau, chromogranin A, carnosinase I) with areas under the curve of 0.90 (0.85-0.94 95% confidence interval [CI]) and 0.88 (0.81-0.94 CI), respectively. Conclusions: Four novel CSF biomarkers for AD (NrCAM, YKL-40, chromogranin A, carnosinase I) can improve the diagnostic accuracy of A beta 42 and tau. Together, these six markers describe six clinicopathological stages from cognitive normalcy to mild dementia, including stages defined by increased risk of cognitive decline. Such a panel might improve clinical trial efficiency by guiding subject enrollment and monitoring disease progression. Further studies will be required to validate this panel and evaluate its potential for distinguishing AD from other dementing conditions.	[Perrin, Richard J.] Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA; [Perrin, Richard J.; Morris, John C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Perrin, Richard J.; Roe, Catherine M.; Morris, John C.; Holtzman, David M.; Fagan, Anne M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO USA; [Craig-Schapiro, Rebecca; Shah, Aarti R.; Roe, Catherine M.; Morris, John C.; Holtzman, David M.; Fagan, Anne M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Holtzman, David M.; Townsend, R. Reid] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Holtzman, David M.; Townsend, R. Reid] Washington Univ, Sch Med, Div Metab, St Louis, MO 63110 USA; [Malone, James P.; Gilmore, Petra; Davis, Alan E.; Holtzman, David M.; Townsend, R. Reid] Washington Univ, Sch Med, Prote Ctr, St Louis, MO USA; [Holtzman, David M.; Fagan, Anne M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Peskind, Elaine R.] Univ Washington, Sch Med, Dept Vet Affairs, NW Network,Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [Peskind, Elaine R.; Li, Ge] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Galasko, Douglas R.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Clark, Christopher M.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Clark, Christopher M.] Univ Penn, Rush Alzheimers Dis Ctr, Philadelphia, PA 19104 USA; [Clark, Christopher M.] Avid Radiopharmaceut, Philadelphia, PA USA; [Quinn, Joseph F.; Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Layton Aging & Alzheimers Dis Ctr, Portland, OR USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of Pennsylvania; University of Pennsylvania; Oregon Health & Science University	Perrin, RJ (corresponding author), Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63130 USA.	rperrin@path.wustl.edu	Morris, John C/A-1686-2012	Roe, Catherine/0000-0002-1405-0485; Kaye, Jeffrey/0000-0002-9971-3478; Misko, Thomas/0000-0001-7917-422X; Quinn, Joseph/0000-0001-7305-2256; Kuhn, Max/0000-0003-2402-136X	National Alzheimer's Coordinating Center (NACC) [U01 AG16976, P50 AG05681, P01 AG026276, P50 AG05136, P01 AG03991, P30 NS057105, UL1 RR024992]; W.M. Keck Foundation [P41 RR00954]; Dept. of Veterans Affairs [AG020020, AG23185, AG08017, AG10124, T32 NS007205]; Charles and Joanne Knight Alzheimer Research Initiative; Avid Radiopharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007205, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124, P50AG005681, P30AG008017, P50AG005136, P01AG026276, R01AG023185, K23AG020020, P01AG003991, U01AG016976] Funding Source: NIH RePORTER	National Alzheimer's Coordinating Center (NACC); W.M. Keck Foundation(W.M. Keck Foundation); Dept. of Veterans Affairs(US Department of Veterans Affairs); Charles and Joanne Knight Alzheimer Research Initiative; Avid Radiopharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Alzheimer's Coordinating Center (NACC) Grant U01 AG16976 (A.M.F.); P50 AG05681 (C.M.R., E.A.G.); P01 AG026276 (C.M.R., E.A.G.); P50 AG05136; P01 AG03991(J.C.M.); P30 NS057105 (D.M.H.); UL1 RR024992 (R.R.T.; C.M.R.); W.M. Keck Foundation (R.R.T.); P41 RR00954 (R.R.T); Dept. of Veterans Affairs (E.R.P.); AG020020 (G.L.); AG23185 (D.R.G.); AG08017 (J.F.Q.); AG08017 (J.A.K.); AG10124 (C.M.C); T32 NS007205 (R.J.P.); and the Charles and Joanne Knight Alzheimer Research Initiative (A.M.F.); Avid Radiopharmaceuticals (C.M.C., employment unrelated to this study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Ablonczy Z, 2009, J BIOL CHEM, V284, P30177, DOI 10.1074/jbc.M109.032391; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; Abraham CR, 2000, ANN NY ACAD SCI, V920, P245; Aisa B, 2010, J ALZHEIMERS DIS, V20, P659, DOI 10.3233/JAD-2010-1398; AKIYAMA H, 1991, J NEUROIMMUNOL, V32, P19, DOI 10.1016/0165-5728(91)90067-H; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alder J, 2003, J NEUROSCI, V23, P10800; Antequera D, 2009, NEUROBIOL DIS, V36, P42, DOI 10.1016/j.nbd.2009.06.018; Arun P, 2009, NEUROCHEM INT, V55, P219, DOI 10.1016/j.neuint.2009.03.003; Balion CM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-38; Barnes LL, 2006, NEUROLOGY, V67, P1581, DOI 10.1212/01.wnl.0000242734.16663.09; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Bekirov IH, 2008, HIPPOCAMPUS, V18, P349, DOI 10.1002/hipo.20395; Benfenati F, 2004, J NEUROCHEM, V89, P1260, DOI 10.1111/j.1471-4159.2004.02419.x; Bergamaschini L, 2001, MECH AGEING DEV, V122, P1971, DOI 10.1016/S0047-6374(01)00311-6; BERGGARD I, 1968, J BIOL CHEM, V243, P4095; Bian H, 2008, NEUROLOGY, V70, P1827, DOI 10.1212/01.wnl.0000311445.21321.fc; Bilak MM, 1999, J NEUROPATH EXP NEUR, V58, P719, DOI 10.1097/00005072-199907000-00006; Biroccio A, 2006, PROTEOMICS, V6, P2305, DOI 10.1002/pmic.200500285; BLENNOW K, 1995, DEMENTIA, V6, P306, DOI 10.1159/000106963; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Capo CR, 2008, BIOMETALS, V21, P367, DOI 10.1007/s10534-007-9125-4; Carrette O, 2003, PROTEOMICS, V3, P1486, DOI 10.1002/pmic.200300470; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Castellani RJ, 1999, FREE RADICAL BIO MED, V26, P1508, DOI 10.1016/S0891-5849(99)00016-7; Chauhan VPS, 1999, BIOCHEM BIOPH RES CO, V258, P241, DOI 10.1006/bbrc.1999.0623; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Choe L, 2007, PROTEOMICS, V7, P3651, DOI 10.1002/pmic.200700316; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Choi-Miura N.-H., 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P239, DOI 10.2174/1568016043356327; Choi-Miura NH, 2000, INFLAMM RES, V49, P305, DOI 10.1007/PL00000211; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Costa R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002899; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; D'Aniello A, 2005, NEUROSCI LETT, V388, P49, DOI 10.1016/j.neulet.2005.06.030; Davidsson P, 2002, MOL BRAIN RES, V109, P128, DOI 10.1016/S0169-328X(02)00549-1; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; DeKosky ST, 2003, ANN NEUROL, V53, P81, DOI 10.1002/ana.10414; EBERHARD DA, 1994, AM J PATHOL, V145, P640; Eder U, 1998, J NEURAL TRANSM, V105, P39, DOI 10.1007/s007020050036; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, EMBO MOL MED, V1, P371, DOI 10.1002/emmm.200900048; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Finehout EJ, 2005, DIS MARKERS, V21, P93, DOI 10.1155/2005/806573; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Gao J, 2008, BBA-BIOMEMBRANES, V1778, P1429, DOI 10.1016/j.bbamem.2008.03.013; Gasser MC, 2003, J NEUROCHEM, V85, P662, DOI 10.1046/j.1471-4159.2003.01677.x; Grimmer T, 2009, BIOL PSYCHIAT, V65, P927, DOI 10.1016/j.biopsych.2009.01.027; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Gunzburg MJ, 2007, J BIOL CHEM, V282, P35831, DOI 10.1074/jbc.M706425200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; HARIGAYA Y, 1995, INTERNAL MED, V34, P481, DOI 10.2169/internalmedicine.34.481; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harr SD, 1996, J NEUROCHEM, V66, P2429; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Henion TR, 2005, J NEUROSCI, V25, P1894, DOI 10.1523/JNEUROSCI.4654-04.2005; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hipkiss AR, 2007, J ALZHEIMERS DIS, V11, P229; Hosaka M, 2005, J CELL SCI, V118, P4785, DOI 10.1242/jcs.02608; Hosaka M, 2004, J BIOL CHEM, V279, P3627, DOI 10.1074/jbc.M310104200; Hosaka M, 2010, ENDOCR J, V57, P275, DOI 10.1507/endocrj.K10E-038; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; HOULDEN H, 1995, NEUROSCI LETT, V188, P202, DOI 10.1016/0304-3940(95)11422-S; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Hu Y, 2005, MOL CELL PROTEOMICS, V4, P2000, DOI 10.1074/mcp.M500207-MCP200; Hu Y, 2007, PROTEOM CLIN APPL, V1, P1373, DOI 10.1002/prca.200600999; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Ji LN, 2009, J ALZHEIMERS DIS, V18, P105, DOI 10.3233/JAD-2009-1127; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kaneko K, 2002, J NEUROPATH EXP NEUR, V61, P1069, DOI 10.1093/jnen/61.12.1069; Kapaki E, 2008, ALZ DIS ASSOC DIS, V22, P47, DOI 10.1097/WAD.0b013e3181610fea; KATZAV A, 2009, NEUROBIOL AGING; Kaufmann WA, 1998, EUR J NEUROSCI, V10, P1084, DOI 10.1046/j.1460-9568.1998.00121.x; Kaynar MY, 2005, J CLIN NEUROSCI, V12, P754, DOI 10.1016/j.jocn.2005.06.001; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Kessler H, 2006, J NEURAL TRANSM, V113, P1763, DOI 10.1007/s00702-006-0485-7; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; Koch S, 2001, J LIPID RES, V42, P1143; Kolson DL, 2008, AM J PATHOL, V173, P25, DOI 10.2353/ajpath.2008.080389; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kovacs DM, 2000, EXP GERONTOL, V35, P473, DOI 10.1016/S0531-5565(00)00113-3; Kubota K, 2009, J NEUROCHEM, V110, P496, DOI 10.1111/j.1471-4159.2009.06099.x; Kuncl RW, 2002, J NEUROCHEM, V81, P178, DOI 10.1046/j.1471-4159.2002.00813.x; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LASSMANN H, 1992, NEUROSCIENCE, V46, P1, DOI 10.1016/0306-4522(92)90003-K; Latefi NS, 2009, DEV NEUROBIOL, V69, P518, DOI 10.1002/dneu.20718; Lechner T, 2004, EXP GERONTOL, V39, P101, DOI 10.1016/j.exger.2003.09.018; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; Levin Edward D., 2005, Current Alzheimer Research, V2, P191; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; Li L, 2008, CELL DEATH DIFFER, V15, P879, DOI 10.1038/cdd.2008.8; Liang D, 2009, J BIOL CHEM, V284, P5195, DOI 10.1074/jbc.M806260200; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; LOB HE, HYPERTENSION, V55, P283; Lob HE, 2010, HYPERTENSION, V55, P277, DOI 10.1161/HYPERTENSIONAHA.109.142646; Loeffler DA, 2004, NEUROBIOL AGING, V25, P1001, DOI 10.1016/j.neurobiolaging.2003.11.003; Loeffler DA, 1996, BRAIN RES, V738, P265, DOI 10.1016/S0006-8993(96)00782-2; Lovell MA, 2008, NEUROLOGY, V70, P2212, DOI 10.1212/01.wnl.0000312383.39973.88; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Markesbery WR, 2006, ARCH NEUROL-CHICAGO, V63, P38, DOI 10.1001/archneur.63.1.38; MASAKI T, 1992, J BIOCHEM-TOKYO, V111, P573, DOI 10.1093/oxfordjournals.jbchem.a123799; Massaro AR, 2009, EUR REV MED PHARMACO, V13, P397; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; Misasi Roberta, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P119; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Montine TJ, 1997, AM J PATHOL, V151, P1571; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Murphy B F, 1989, Int Immunol, V1, P551, DOI 10.1093/intimm/1.5.551; Mysore SP, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.001.2007; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Narita M, 1997, J NEUROCHEM, V69, P1904; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; NISSEN MH, 1990, EUR J BIOCHEM, V189, P423, DOI 10.1111/j.1432-1033.1990.tb15505.x; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Ochiai T, 2008, BBA-GEN SUBJECTS, V1780, P1441, DOI 10.1016/j.bbagen.2008.07.010; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Okii N, 2007, ACTA HISTOCHEM CYTOC, V40, P113, DOI 10.1267/ahc.07011; Ostergaard C, 2002, CLIN DIAGN LAB IMMUN, V9, P598, DOI 10.1128/CDLI.9.3.598-604.2002; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Paco S, 2010, CEREB CORTEX, V20, P1386, DOI 10.1093/cercor/bhp202; PALMER RH, 1995, BIOCHEM J, V309, P315, DOI 10.1042/bj3090315; Pan S, 2008, J PROTEOME RES, V7, P720, DOI 10.1021/pr700630x; Park J, 2009, J MOL NEUROSCI, V37, P151, DOI 10.1007/s12031-008-9098-y; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; PERARNAU B, 1990, NATURE, V346, P751, DOI 10.1038/346751a0; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Puche AC, 1997, NEUROREPORT, V8, P3183, DOI 10.1097/00001756-199710200-00001; Ray I, 2000, BRAIN RES, V853, P344, DOI 10.1016/S0006-8993(99)02315-X; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Riemenschneider M, 1998, LANCET, V351, P63, DOI 10.1016/S0140-6736(05)78060-0; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Sanagi T, 2005, NEUROSCI LETT, V380, P105, DOI 10.1016/j.neulet.2005.01.035; Sanagi T, 2008, J NEUROCHEM, V106, P1841, DOI 10.1111/j.1471-4159.2008.05529.x; SCHMIDBAUER JM, 1990, HISTOCHEMISTRY, V94, P427; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; SCHWEDEN J, 1989, BIOCHEM J, V264, P347, DOI 10.1042/bj2640347; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Shin TM, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-16; Shyu WC, 2008, J CLIN INVEST, V118, P133, DOI 10.1172/JCI32723; Sikora J, 2007, ACTA NEUROPATHOL, V113, P163, DOI 10.1007/s00401-006-0148-7; Simonsen AH, 2008, NEUROBIOL AGING, V29, P961, DOI 10.1016/j.neurobiolaging.2007.01.011; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Simonsen AH, 2007, ARCH NEUROL-CHICAGO, V64, P366, DOI 10.1001/archneur.64.3.366; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Snider BJ, 2009, ARCH NEUROL-CHICAGO, V66, P638, DOI 10.1001/archneurol.2009.55; Squitti R, 2009, NEUROLOGY, V72, P50, DOI 10.1212/01.wnl.0000338568.28960.3f; Squitti R, 2008, PRION, V2, P23, DOI 10.4161/pri.2.1.6297; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Steur EJ, 1998, LANCET, V351, P1105, DOI 10.1016/S0140-6736(05)79387-9; Stoltzner SE, 2000, AM J PATHOL, V156, P489, DOI 10.1016/S0002-9440(10)64753-0; Storan MJ, 2004, J COMP NEUROL, V475, P289, DOI 10.1002/cne.20167; Storandt M, 2006, NEUROLOGY, V67, P467, DOI 10.1212/01.wnl.0000228231.26111.6e; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Sun Y, 2005, NEUROSCI LETT, V380, P219, DOI 10.1016/j.neulet.2005.01.038; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; Svichar N, 2009, J NEUROSCI, V29, P3252, DOI 10.1523/JNEUROSCI.0036-09.2009; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Takanohashi A, 2005, GLIA, V51, P266, DOI 10.1002/glia.20203; Tapiola T, 1998, LANCET, V352, P287, DOI 10.1016/S0140-6736(05)60260-7; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Todaro L, 2004, NEUROBIOL DIS, V15, P387, DOI 10.1016/j.nbd.2003.11.014; Tolboom N, 2009, J NUCL MED, V50, P1464, DOI 10.2967/jnumed.109.064360; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; Ueyama T, 2001, J NEUROCHEM, V79, P903, DOI 10.1046/j.1471-4159.2001.00624.x; UMEZAWA Y, 1991, JPN J CLIN ONCOL, V21, P251; VITIELLO A, 1990, SCIENCE, V250, P1423, DOI 10.1126/science.2124002; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Vollbach H, 2005, ANN NEUROL, V58, P436, DOI 10.1002/ana.20593; Vukovic J, 2009, MATRIX BIOL, V28, P406, DOI 10.1016/j.matbio.2009.06.001; Wati H, 2009, BRAIN PATHOL, V19, P48, DOI 10.1111/j.1750-3639.2008.00166.x; WISNIEWSKI T, 1995, AM J PATHOL, V147, P238; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; Woronowicz A, 2008, HIPPOCAMPUS, V18, P1051, DOI 10.1002/hipo.20462; Woronowicz A, 2010, J NEUROSCI RES, V88, P64, DOI 10.1002/jnr.22174; Wright Nathan T, 2009, Curr Chem Biol, V3, P138; WURDIG S, 1991, NEUROSCI LETT, V130, P165, DOI 10.1016/0304-3940(91)90388-A; Yabe T, 2010, CURR MOL MED, V10, P259, DOI 10.2174/156652410791065354; Yamagishi S, 2004, MED HYPOTHESES, V63, P115, DOI 10.1016/j.mehy.2004.02.022; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang J, 2005, J ALZHEIMERS DIS, V7, P125; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236; Zhu XM, 2005, J NEUROCHEM, V95, P1351, DOI 10.1111/j.1471-4159.2005.03460.x; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	230	155	162	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2011	6	1							e16032	10.1371/journal.pone.0016032	http://dx.doi.org/10.1371/journal.pone.0016032			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LX	21264269	gold, Green Published, Green Submitted			2022-12-25	WOS:000286514300004
J	Liu, ZX; Cao, J; Gao, XJ; Ma, Q; Ren, J; Xue, Y				Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian; Ren, Jian; Xue, Yu			GPS-CCD: A Novel Computational Program for the Prediction of Calpain Cleavage Sites	PLOS ONE			English	Article							PHOSPHORYLATION SITES; MEDIATED CLEAVAGE; PEPTIDE LIBRARY; PROTEIN; DATABASE; IDENTIFICATION; APOPTOSIS; SUBSTRATE; AUTOPHAGY; PATHWAY	As one of the most essential post-translational modifications (PTMs) of proteins, proteolysis, especially calpain-mediated cleavage, plays an important role in many biological processes, including cell death/apoptosis, cytoskeletal remodeling, and the cell cycle. Experimental identification of calpain targets with bona fide cleavage sites is fundamental for dissecting the molecular mechanisms and biological roles of calpain cleavage. In contrast to time-consuming and labor-intensive experimental approaches, computational prediction of calpain cleavage sites might more cheaply and readily provide useful information for further experimental investigation. In this work, we constructed a novel software package of GPS-CCD (Calpain Cleavage Detector) for the prediction of calpain cleavage sites, with an accuracy of 89.98%, sensitivity of 60.87% and specificity of 90.07%. With this software, we annotated potential calpain cleavage sites for hundreds of calpain substrates, for which the exact cleavage sites had not been previously determined. In this regard, GPS-CCD 1.0 is considered to be a useful tool for experimentalists. The online service and local packages of GPS-CCD 1.0 were implemented in JAVA and are freely available at: http://ccd.biocuckoo.org/.	[Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu, Zexian; Cao, Jun; Gao, Xinjiao; Ma, Qian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Liu, Zexian; Xue, Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Syst Biol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China; [Ren, Jian] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huazhong University of Science & Technology; Sun Yat Sen University	Liu, ZX (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.	renjian.sysu@gmail.com; xueyu@mail.hust.edu.cn	Ren, Jian/D-3270-2011; Xue, Yu/G-5929-2011; Luo, Weiren/AAI-8364-2020; Liu, Zexian/D-1153-2011	Ren, Jian/0000-0002-4161-1292; Xue, Yu/0000-0002-9403-6869; Luo, Weiren/0000-0002-2762-6332; Liu, Zexian/0000-0001-9698-0610	National Basic Research Program (973 project) [2010CB945400, 2011CB910400]; National Natural Science Foundation of China [90919001, 31071154, 30900835, 30830036, 91019020, 21075045]; Fundamental Research Funds for the Central Universities [HUST: 2010JC049, 2010ZD018, SYSU: 11lgzd11, 11lgjc09]	National Basic Research Program (973 project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Basic Research Program (973 project) (2010CB945400, 2011CB910400), National Natural Science Foundation of China (90919001, 31071154, 30900835, 30830036, 91019020, 21075045), and Fundamental Research Funds for the Central Universities (HUST: 2010JC049, 2010ZD018; SYSU: 11lgzd11, 11lgjc09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Boyd SE, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P372; Chen Q, 2006, J NEUROCHEM, V99, P1133, DOI 10.1111/j.1471-4159.2006.04160.x; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; duVerle David, 2010, V22, P202; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Futai E, 1999, MOL GEN GENET, V260, P559, DOI 10.1007/s004380050929; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Joy J, 2006, BIOL CHEM, V387, P329, DOI 10.1515/BC.2006.044; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Rawlings ND, 2009, LARGE ACCURATE COLLE; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Squier MKT, 1999, J CELL PHYSIOL, V178, P311, DOI 10.1002/(SICI)1097-4652(199903)178:3<311::AID-JCP5>3.3.CO;2-K; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Thomas DA, 2006, PROTEOMICS, V6, P2112, DOI 10.1002/pmic.200500153; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhou FF, 2005, FEBS LETT, V579, P3369, DOI 10.1016/j.febslet.2005.04.076	37	104	112	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19001	10.1371/journal.pone.0019001	http://dx.doi.org/10.1371/journal.pone.0019001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	22140479	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400047
J	Michalik, P; Rittschof, CC				Michalik, Peter; Rittschof, Clare C.			A Comparative Analysis of the Morphology and Evolution of Permanent Sperm Depletion in Spiders	PLOS ONE			English	Article							ORB-WEAVING SPIDER; NEPHILA PLUMIPES ARANEOIDEA; ARGIOPE-BRUENNICHI ARANEAE; MALE COPULATION FREQUENCY; SEXUAL CANNIBALISM; WEB SPIDER; MATING-BEHAVIOR; CLAVIPES ARANEAE; SIZE DIMORPHISM; NATURAL-HISTORY	Once thought to be energetically cheap and easy to produce, empirical work has shown that sperm is a costly and limited resource for males. In some spider species, there is behavioral evidence that sperm are permanently depleted after a single mating. This extreme degree of mating investment appears to co-occur with other reproductive strategies common to spiders, e. g. genital mutilation and sexual cannibalism. Here we corroborate that sperm depletion in the golden orb-web spider Nephila clavipes is permanent by uncovering its mechanistic basis using light and electron microscopy. In addition, we use a phylogeny-based statistical analysis to test the evolutionary relationships between permanent sperm depletion (PSD) and other reproductive strategies in spiders. Male testes do not produce sperm during adulthood, which is unusual in spiders. Instead, spermatogenesis is nearly synchronous and ends before the maturation molt. Testis size decreases as males approach their maturation molt and reaches its lowest point after sperm is transferred into the male copulatory organs (pedipalps). As a consequence, the amount of sperm available to males for mating is limited to the sperm contained in the pedipalps, and once it is used, males lose their ability to fertilize eggs. Our data suggest that PSD has evolved independently at least three times within web-building spiders and is significantly correlated with the evolution of other mating strategies that limit males to monogamy, including genital mutilation and sexual cannibalism. We conclude that PSD may be an energy-saving adaptation in species where males are limited to monogamy. This could be particularly important in web-building spiders where extreme sexual size dimorphism results in large, sedentary females and small, searching males who rarely feed as adults and are vulnerable to starvation. Future work will explore possible energetic benefits and the evolutionary lability of PSD relative to other mate-limiting reproductive behaviors.	[Michalik, Peter] Ernst Moritz Arndt Univ Greifswald, Zoolog Inst & Museum, Greifswald, Germany; [Michalik, Peter] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Rittschof, Clare C.] Univ Florida, Dept Biol, Gainesville, FL USA	Ernst Moritz Arndt Universitat Greifswald; American Museum of Natural History (AMNH); State University System of Florida; University of Florida	Michalik, P (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zoolog Inst & Museum, Greifswald, Germany.	michalik@uni-greifswald.de	Michalik, Peter/E-6757-2010	Michalik, Peter/0000-0003-2459-9153	NSF-DDIG [IOS-0909367]; University of Greifswald	NSF-DDIG(National Science Foundation (NSF)); University of Greifswald	NSF-DDIG Grant No. IOS-0909367. Travel grant by the University of Greifswald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI G, 1990, ACTA ZOOL FENN, V190, P17; Andrade MCB, 2005, INTEGR COMP BIOL, V45, P838, DOI 10.1093/icb/45.5.838; Andrade MCB, 2002, ANIM BEHAV, V63, P857, DOI 10.1006/anbe.2002.2003; Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Bateman PW, 2001, ETHOLOGY, V107, P1087, DOI 10.1046/j.1439-0310.2001.00756.x; Boivin G, 2005, OECOLOGIA, V143, P198, DOI 10.1007/s00442-004-1800-3; Bukowski TC, 2001, ANIM BEHAV, V62, P887, DOI 10.1006/anbe.2001.1834; Bukowski TC, 1997, J ARACHNOL, V25, P307; CHRISTENSON T, 1989, J ARACHNOL, V17, P115; CHRISTENSON TE, 1979, BEHAV ECOL SOCIOBIOL, V5, P87, DOI 10.1007/BF00302697; CHRISTENSON TE, 1985, J COMP PSYCHOL, V99, P160, DOI 10.1037/0735-7036.99.2.160; CHRISTENSON TE, 1988, J COMP PSYCHOL, V102, P312, DOI 10.1037/0735-7036.102.4.312; Coddington JA, 1997, NATURE, V385, P687, DOI 10.1038/385687a0; Corcobado G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-236; Costa FG, 1998, J ARACHNOL, V26, P106; Danielson-Francois AM, 2006, J ARACHNOL, V34, P387, DOI 10.1636/S04-46.1; Danielson-Francois AM, 2005, J INSECT BEHAV, V18, P131, DOI 10.1007/s10905-005-9352-x; DEWSBURY DA, 1983, J COMP PSYCHOL, V97, P34, DOI 10.1037/0735-7036.97.1.34; Eberhard WG, 2004, J ARACHNOL, V32, P545, DOI 10.1636/0161-8202(2004)032[0545:WSSSST]2.0.CO;2; ELGAR MA, 1991, EVOLUTION, V45, P444, DOI 10.1111/j.1558-5646.1991.tb04419.x; Engqvist L, 2006, J EVOLUTION BIOL, V19, P1448, DOI 10.1111/j.1420-9101.2006.01134.x; Foelix R. F., 2011, BIOL SPIDERS; Foellmer MW, 2004, EVOL ECOL RES, V6, P163; FOELLMER MW, 2003, P ROYAL SOC LONDON B; FORSTER LM, 1992, AUST J ZOOL, V40, P1, DOI 10.1071/ZO9920001; Fromhage L, 2003, BEHAV ECOL SOCIOBIOL, V55, P60, DOI 10.1007/s00265-003-0656-6; Fromhage L, 2006, BEHAV ECOL, V17, P353, DOI 10.1093/beheco/arj037; Fromhage L, 2005, EVOLUTION, V59, P1400; GAGE MJG, 1994, FUNCT ECOL, V8, P594, DOI 10.2307/2389920; Herberstein ME, 2005, ETHOLOGY, V111, P1050, DOI 10.1111/j.1439-0310.2005.01114.x; Herberstein ME, 2002, BEHAV ECOL SOCIOBIOL, V51, P440, DOI 10.1007/s00265-002-0460-8; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; HUBER BA, 1995, J ZOOL, V235, P689, DOI 10.1111/j.1469-7998.1995.tb01778.x; Huber Bernhard A., 1998, Bulletin of the British Arachnological Society, V11, P81; Knoflach B, 2000, J NAT HIST, V34, P1639, DOI 10.1080/00222930050117530; Knoflach B, 2001, J ZOOL, V254, P449, DOI 10.1017/S0952836901000954; Knoflach B., 2004, Denisia, P161; Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x; Kuntner M, 2009, J ARACHNOL, V37, P266, DOI 10.1636/St08-67.1; Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x; Lemaitre JF, 2009, ANIM BEHAV, V77, P49, DOI 10.1016/j.anbehav.2008.08.028; Linn CD, 2007, ANIM BEHAV, V74, P481, DOI 10.1016/j.anbehav.2007.02.004; MADDISON WP, 1990, EVOLUTION, V44, P539, DOI 10.2307/2409434; MADDISON WP, 2000, MACCLADE VERSION 4; MADDISON WP, 2010, MESQUITE; Michalik P, 2006, ZOOLOGY, V109, P14, DOI 10.1016/j.zool.2005.09.010; Michalik P, 2006, J MORPHOL, V267, P129, DOI 10.1002/jmor.10226; MICHALIK P, 2006, THESIS ERNST MORITZ; Michalik Peter, 2005, Front Zool, V2, P12, DOI 10.1186/1742-9994-2-12; Michalik P, 2010, AM MUS NOVIT, P1, DOI 10.1206/680.1; Michalik Peter, 2009, Contributions to Natural History (Bern), V12, P959; Michalik P, 2010, TISSUE CELL, V42, P32, DOI 10.1016/j.tice.2009.06.004; Miller JA, 2007, EVOLUTION, V61, P1301, DOI 10.1111/j.1558-5646.2007.00115.x; Molina Y, 2008, ANIM BEHAV, V76, P1327, DOI 10.1016/j.anbehav.2008.04.021; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; MYERS L, 1988, J ARACHNOL, V16, P254; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Nessler SH, 2007, P R SOC B, V274, P2337, DOI 10.1098/rspb.2007.0585; Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074; Nessler S, 2009, BEHAV ECOL SOCIOBIOL, V63, P355, DOI 10.1007/s00265-008-0669-2; Olsson M, 1997, P ROY SOC B-BIOL SCI, V264, P455, DOI 10.1098/rspb.1997.0065; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Radhakrishnan P, 2009, ANIM BEHAV, V78, P839, DOI 10.1016/j.anbehav.2009.07.002; Ramos M, 2004, P NATL ACAD SCI USA, V101, P4883, DOI 10.1073/pnas.0400324101; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Schneider JM, 2005, J ARACHNOL, V33, P663, DOI 10.1636/S03-32.1; Schneider JM, 2006, ANIM BEHAV, V71, P781, DOI 10.1016/j.anbehav.2005.05.012; Schneider JM, 2001, BEHAV ECOL SOCIOBIOL, V49, P410, DOI 10.1007/s002650000307; Schneider JM, 2001, BEHAV ECOL, V12, P547, DOI 10.1093/beheco/12.5.547; Schneider JM, 2008, AUST J ZOOL, V56, P233, DOI 10.1071/ZO08041; SIMMONS LW, 1993, P ROY SOC B-BIOL SCI, V251, P183, DOI 10.1098/rspb.1993.0027; Smith C, 2009, ANIM BEHAV, V77, P1227, DOI 10.1016/j.anbehav.2009.01.027; Snow LSE, 2006, ETHOLOGY, V112, P379, DOI 10.1111/j.1439-0310.2006.01163.x; Snow LSE, 2004, BEHAV ECOL, V15, P785, DOI 10.1093/beheco/arh080; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stoltz JA, 2010, P ROY SOC B-BIOL SCI, V277, P585, DOI 10.1098/rspb.2009.1554; Uhl G, 2010, GENETICA, V138, P75, DOI 10.1007/s10709-009-9388-5; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8	81	69	72	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2011	6	1							e16014	10.1371/journal.pone.0016014	http://dx.doi.org/10.1371/journal.pone.0016014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710LU	21525987	Green Submitted, Green Published, gold			2022-12-25	WOS:000286514000016
J	Campbell, MS; Mullins, JI; Hughes, JP; Celum, C; Wong, KG; Raugi, DN; Sorensen, S; Stoddard, JN; Zhao, H; Deng, WJ; Kahle, E; Panteleeff, D; Baeten, JM; McCutchan, FE; Albert, J; Leitner, T; Wald, A; Corey, L; Lingappa, JR				Campbell, Mary S.; Mullins, James I.; Hughes, James P.; Celum, Connie; Wong, Kim G.; Raugi, Dana N.; Sorensen, Stefanie; Stoddard, Julia N.; Zhao, Hong; Deng, Wenjie; Kahle, Erin; Panteleeff, Dana; Baeten, Jared M.; McCutchan, Francine E.; Albert, Jan; Leitner, Thomas; Wald, Anna; Corey, Lawrence; Lingappa, Jairam R.		Partners Prevention HSV HIV	Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HETEROSEXUAL TRANSMISSION; MOLECULAR EPIDEMIOLOGY; INFECTED INDIVIDUALS; SEQUENCE ALIGNMENT; WEB SERVER; VARIANTS; IDENTIFICATION; PROGRESSION; EVOLUTION	Background: Characterization of viruses in HIV-1 transmission pairs will help identify biological determinants of infectiousness and evaluate candidate interventions to reduce transmission. Although HIV-1 sequencing is frequently used to substantiate linkage between newly HIV-1 infected individuals and their sexual partners in epidemiologic and forensic studies, viral sequencing is seldom applied in HIV-1 prevention trials. The Partners in Prevention HSV/HIV Transmission Study (ClinicalTrials.gov #NCT00194519) was a prospective randomized placebo-controlled trial that enrolled serodiscordant heterosexual couples to determine the efficacy of genital herpes suppression in reducing HIV-1 transmission; as part of the study analysis, HIV-1 sequences were examined for genetic linkage between seroconverters and their enrolled partners. Methodology/Principal Findings: We obtained partial consensus HIV-1 env and gag sequences from blood plasma for 151 transmission pairs and performed deep sequencing of env in some cases. We analyzed sequences with phylogenetic techniques and developed a Bayesian algorithm to evaluate the probability of linkage. For linkage, we required monophyletic clustering between enrolled partners' sequences and a Bayesian posterior probability of >= 50%. Adjudicators classified each seroconversion, finding 108 (71.5%) linked, 40 (26.5%) unlinked, and 3 (2.0%) indeterminate transmissions, with linkage determined by consensus env sequencing in 91 (84%). Male seroconverters had a higher frequency of unlinked transmissions than female seroconverters. The likelihood of transmission from the enrolled partner was related to time on study, with increasing numbers of unlinked transmissions occurring after longer observation periods. Finally, baseline viral load was found to be significantly higher among linked transmitters. Conclusions/Significance: In this first use of HIV-1 sequencing to establish endpoints in a large clinical trial, more than one-fourth of transmissions were unlinked to the enrolled partner, illustrating the relevance of these methods in the design of future HIV-1 prevention trials in serodiscordant couples. A hierarchy of sequencing techniques, analysis methods, and expert adjudication contributed to the linkage determination process.	[Campbell, Mary S.; Mullins, James I.; Celum, Connie; Baeten, Jared M.; Wald, Anna; Corey, Lawrence; Lingappa, Jairam R.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Mullins, James I.; Wong, Kim G.; Raugi, Dana N.; Sorensen, Stefanie; Stoddard, Julia N.; Zhao, Hong; Deng, Wenjie] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.; Corey, Lawrence] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Hughes, James P.] Univ Washington, Sch Med, Dept Biostat, Seattle, WA USA; [Celum, Connie; Kahle, Erin; Panteleeff, Dana; Baeten, Jared M.; Lingappa, Jairam R.] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA USA; [McCutchan, Francine E.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Leitner, Thomas] Los Alamos Natl Lab, Los Alamos, NM USA; [Wald, Anna] Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA USA; [Lingappa, Jairam R.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Wald, Anna; Corey, Lawrence] Fred Hutchinson Canc Inst, Vaccine & Infect Dis Div, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; Karolinska Institutet; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Campbell, MS (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.	jmullins@uw.edu	Corey, Lawrence/AAE-1796-2020; Lingappa, Jairam/N-7760-2017; Wald, Anna/B-6272-2012	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Campbell, Matthew/0000-0002-4469-5209; Were, Edwin/0000-0002-4783-0795; Kapiga, Saidi/0000-0003-1753-4060; , Erin/0000-0001-6060-9852	Bill and Melinda Gates Foundation [26469]; University of Washington Center for AIDS Research (UW CFAR) [AI-27757]; National Institutes of Health [AI029168, AI074424]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, R01AI029168, P30AI027757, R37AI029168, K08AI074424] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP1LM011509] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of Washington Center for AIDS Research (UW CFAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was part of the Partners in Prevention HSV/HIV Transmission Study funded by the Bill and Melinda Gates Foundation (grant ID #26469). Some computational analyses were also supported by a grant through the University of Washington Center for AIDS Research (UW CFAR, AI-27757) Computational Biology Core. National Institutes of Health grants to JPH (AI029168) and MSC (AI074424) provided additional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; ALBERT J, 1993, NATURE, V361, P595, DOI 10.1038/361595b0; Bull M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007122; Bull ME, 2009, J VIROL, V83, P6020, DOI 10.1128/JVI.02664-08; Celum C, N ENGL J MED, V362, P427; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FISCHER W, PLOS ONE, V5; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hahn T, 1999, AIDS RES HUM RETROV, V15, P875, DOI 10.1089/088922299310584; HOLMES EC, 1993, J INFECT DIS, V167, P1411, DOI 10.1093/infdis/167.6.1411; HOLMES EC, 1993, NATURE, V364, P766, DOI 10.1038/364766b0; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Learn G.H., 2003, HIV SEQUENCE COMPEND, P22; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Leitner T., 2000, AIDS REV, V2, P241; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; MADDISON W.P., 2001, MACCLADE ANAL PHYLOG; OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shankarappa R, 1998, VIROLOGY, V241, P251, DOI 10.1006/viro.1997.8996; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; STROMBERG M, 2007, MOSAIK IS SUITE COMP; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Truong HHM, 2002, J ACQ IMMUN DEF SYND, V29, P232, DOI 10.1097/00042560-200203010-00003; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006	42	138	140	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e16986	10.1371/journal.pone.0016986	http://dx.doi.org/10.1371/journal.pone.0016986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399681	Green Published, Green Submitted, gold			2022-12-25	WOS:000287933300004
J	Michelena, P; Deneubourg, JL				Michelena, Pablo; Deneubourg, Jean-Louis			How Group Size Affects Vigilance Dynamics and Time Allocation Patterns: The Key Role of Imitation and Tempo	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; SOCIAL FACILITATION; PUBLIC INFORMATION; SPATIAL POSITION; FLOCK SIZE; BEHAVIOR; MAMMALS; ATTACK; FLIGHT	In the context of social foraging, predator detection has been the subject of numerous studies, which acknowledge the adaptive response of the individual to the trade-off between feeding and vigilance. Typically, animals gain energy by increasing their feeding time and decreasing their vigilance effort with increasing group size, without increasing their risk of predation ('group size effect'). Research on the biological utility of vigilance has prevailed over considerations of the mechanistic rules that link individual decisions to group behavior. With sheep as a model species, we identified how the behaviors of conspecifics affect the individual decisions to switch activity. We highlight a simple mechanism whereby the group size effect on collective vigilance dynamics is shaped by two key features: the magnitude of social amplification and intrinsic differences between foraging and scanning bout durations. Our results highlight a positive correlation between the duration of scanning and foraging bouts at the level of the group. This finding reveals the existence of groups with high and low rates of transition between activies, suggesting individual variations in the transition rate, or 'tempo'. We present a mathematical model based on behavioral rules derived from experiments. Our theoretical predictions show that the system is robust in respect to variations in the propensity to imitate scanning and foraging, yet flexible in respect to differences in the duration of activity bouts. The model shows how individual decisions contribute to collective behavior patterns and how the group, in turn, facilitates individual-level adaptive responses.	[Michelena, Pablo; Deneubourg, Jean-Louis] ULB, Unit Social Ecol, Brussels, Belgium	Universite Libre de Bruxelles	Michelena, P (corresponding author), ULB, Unit Social Ecol, Brussels, Belgium.	Pablo.Michelena@ulb.ac.be	Michalik, Peter/E-6757-2010	Michalik, Peter/0000-0003-2459-9153	Universite libre de Bruxelles (ULB); European Community [IST-2001-35506]	Universite libre de Bruxelles (ULB); European Community(European Commission)	This study was supported by a post doctoral fellow of the Universite libre de Bruxelles (ULB) and the experiments were sponsored by the the LEURRE project of the Future and Emerging Technologies program of the European Community (IST-2001-35506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr DB, 1999, ANIM BEHAV, V58, P831, DOI 10.1006/anbe.1999.1227; Beauchamp G, 2003, BEHAV PROCESS, V63, P111, DOI 10.1016/S0376-6357(03)00002-0; Beauchamp G, 2002, CAN J ZOOL, V80, P1634, DOI 10.1139/Z02-156; Beauchamp G, 2007, ANIM BEHAV, V73, P445, DOI 10.1016/j.anbehav.2006.09.004; BEKOFF M, 1995, ETHOLOGY, V99, P150, DOI 10.1111/j.1439-0310.1995.tb01096.x; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; Blanchard P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1863, DOI 10.1007/s00265-008-0615-3; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Carter AJ, 2009, BEHAV ECOL SOCIOBIOL, V64, P237, DOI 10.1007/s00265-009-0840-4; CLAYTON DA, 1978, Q REV BIOL, V53, P373, DOI 10.1086/410789; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Ebensperger LA, 2006, ETHOLOGY, V112, P879, DOI 10.1111/j.1439-0310.2006.01242.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fernandez-Juricic E, 2008, ETHOLOGY, V114, P105, DOI 10.1111/j.1439-0310.2007.01433.x; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Gautrais J, 2007, ANIM BEHAV, V74, P1443, DOI 10.1016/j.anbehav.2007.02.020; Geist V., 1971, MOUNTAIN SHEEP STUDY; Hilton GM, 1999, BEHAV ECOL, V10, P391, DOI 10.1093/beheco/10.4.391; Jeanson R, 2004, BEHAV ECOL SOCIOBIOL, V55, P388, DOI 10.1007/s00265-003-0716-y; Jewell P.A., 1974, ISLAND SURVIVORS ECO; KAUTZ MA, 1982, J WILDLIFE MANAGE, V46, P704, DOI 10.2307/3808562; Krause J, 2002, LIVING GROUPS; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; LAWRENCE AB, 1984, APPL ANIM BEHAV SCI, V13, P176, DOI 10.1016/0168-1591(84)90075-3; LAZARUS J, 1979, BEHAVIOUR, V71, P127, DOI 10.1163/156853979X00133; LIMA SL, 1995, ANIM BEHAV, V50, P1097, DOI 10.1016/0003-3472(95)80109-X; Meunier H, 2006, BEHAVIOUR, V143, P1511, DOI 10.1163/156853906779366982; Michelena P, 2006, OECOLOGIA, V148, P170, DOI 10.1007/s00442-005-0347-2; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; NICOLIS G, 1971, P NATL ACAD SCI USA, V68, P2102, DOI 10.1073/pnas.68.9.2102; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2007, ANIM BEHAV, V73, P595, DOI 10.1016/j.anbehav.2006.06.007; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; Periquet S, 2010, ANIM BEHAV, V79, P665, DOI 10.1016/j.anbehav.2009.12.016; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Pillot MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014487; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; QUENETTE PY, 1990, ACTA OECOL, V11, P801; QUENETTE PY, 1992, CAN J ZOOL, V70, P1632, DOI 10.1139/z92-226; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Rieucau G, 2009, ANIM BEHAV, V78, P961, DOI 10.1016/j.anbehav.2009.06.023; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Sirot E, 2006, ANIM BEHAV, V72, P373, DOI 10.1016/j.anbehav.2005.10.028; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sumpter D. J. T., 2009, COLLECTIVE ANIMAL BE; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; [No title captured]; [No title captured]	56	69	72	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2011	6	4							e18631	10.1371/journal.pone.0018631	http://dx.doi.org/10.1371/journal.pone.0018631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	750WK	21525987	gold, Green Published, Green Submitted			2022-12-25	WOS:000289578600021
J	Kumar, A; Gao, H; Xu, J; Reuben, J; Yu, DH; Mehta, K				Kumar, Anupam; Gao, Hui; Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil			Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; DRUG-RESISTANT; GLAND CELLS; BREAST; PROLIFERATION; MECHANISMS	Cancer stem cells (CSCs) or tumor initiating cells (TICs) make up only a small fraction of total tumor cell population, but recent evidence suggests that they are responsible for tumor initiation and the maintenance of tumor growth. Whether CSCs/TICs originate from normal stem cells or result from the dedifferentiation of terminally differentiated cells remains unknown. Here we provide evidence that sustained expression of the proinflammatory protein tissue transglutaminase (TG2) confers stem cell like properties in non-transformed and transformed mammary epithelial cells. Sustained expression of TG2 was associated with increase in CD44(high)/CD24(low/-) subpopulation, increased ability of cells to form mammospheres, and acquisition of self-renewal ability. Mammospheres derived from TG2-transfected mammary epithelial cells (MCF10A) differentiated into complex secondary structures when grown in Matrigel cultures. Cells in these secondary structures differentiated into Muc1-positive (luminal marker) and integrin alpha 6-positive (basal marker) cells in response to prolactin treatment. Highly aggressive MDA-231 and drug-resistant MCF-7/RT breast cancer cells, which express high basal levels of TG2, shared many traits with TG2-transfected MCF10A stem cells but unlike MCF10A-derived stem cells they failed to form the secondary structures and to differentiate into Muc1-positive luminal cells when grown in Matrigel culture. Downregulation of TG2 attenuated stem cell properties in both non-transformed and transformed mammary epithelial cells. Taken together, these results suggested a new function for TG2 and revealed a novel mechanism responsible for promoting the stem cell characteristics in adult mammary epithelial cells.	[Kumar, Anupam; Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Gao, Hui; Reuben, James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Xu, Jia; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kumar, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kmehta@mdanderson.org	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Susan G. Komen for the Cure Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from Susan G. Komen for the Cure Foundation (http://ww5.komen.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gamucci T, 2007, BRIT J CANCER, V97, P1040, DOI 10.1038/sj.bjc.6603982; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Lacerda L, 2010, DRUG RESIST UPDATE, V13, P99, DOI 10.1016/j.drup.2010.08.001; Lawson JC, 2009, BREAST CANCER RES TR, V118, P241, DOI 10.1007/s10549-009-0524-9; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; LU S, 1995, J BIOL CHEM, V270, P9748, DOI 10.1074/jbc.270.17.9748; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; SUTO N, 1993, J BIOL CHEM, V268, P7469; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716	31	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20701	10.1371/journal.pone.0020701	http://dx.doi.org/10.1371/journal.pone.0020701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21526230	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500037
J	Kumar, A; Bullard, RL; Patel, P; Paslay, LC; Singh, D; Bienkiewicz, EA; Morgan, SE; Rangachari, V				Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Paslay, Lea C.; Singh, Dipti; Bienkiewicz, Ewa A.; Morgan, Sarah E.; Rangachari, Vijayaraghavan			Non-Esterified Fatty Acids Generate Distinct Low-Molecular Weight Amyloid-beta (A beta 42) Oligomers along Pathway Different from Fibril Formation	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; ALPHA-SYNUCLEIN; IN-VITRO; CONTAINING MEMBRANES; APOLIPOPROTEIN-E; ENDOGENOUS SEED; LIPID-MEMBRANES; TRANSGENIC MICE	Amyloid-beta (A beta) peptide aggregation is known to play a central role in the etiology of Alzheimer's disease (AD). Among various aggregates, low-molecular weight soluble oligomers of A beta are increasingly believed to be the primary neurotoxic agents responsible for memory impairment. Anionic interfaces are known to influence the A beta aggregation process significantly. Here, we report the effects of interfaces formed by medium-chain (C9-C12), saturated non-esterified fatty acids (NEFAs) on A beta 42 aggregation. NEFAs uniquely affected A beta 42 aggregation rates that depended on both the ratio of A beta:NEFA as well the critical micelle concentration (CMC) of the NEFAs. More importantly, irrespective of the kind of NEFA used, we observed that two distinct oligomers, 12-18 mers and 4-5 mers were formed via different pathway of aggregation under specific experimental conditions: (i) 12-18 mers were generated near the CMC in which NEFAs augment the rate of A beta 42 aggregation towards fibril formation, and, (ii) 4-5 mers were formed above the CMC, where NEFAs inhibit fibril formation. The data indicated that both 12-18 mers and 4-5 mers are formed along an alternate pathway called 'off-pathway' that did not result in fibril formation and yet have subtle structural and morphological differences that distinguish their bulk molecular behavior. These observations, (i) reflect the possible mechanism of A beta aggregation in physiological lipid-rich environments, and (ii) reiterate the fact that all oligomeric forms of A beta need not be obligatory intermediates of the fibril formation pathway.	[Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Rangachari, Vijayaraghavan] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Paslay, Lea C.; Singh, Dipti; Morgan, Sarah E.] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA; [Bienkiewicz, Ewa A.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	University of Southern Mississippi; University of Southern Mississippi; State University System of Florida; Florida State University	Kumar, A (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Alzheimer's Association [NIRG-09-132721]; American Heart Association [0535185N]; National Science Foundation [DMR-0213883]; National Center for Research Resources, National Institutes of Health [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by NIRG grant from Alzheimer's Association (NIRG-09-132721) (www.Alz.org) and an American Heart Association SDG award (0535185N) for VR (www.AHA.org). Partial support by the MRSEC program of the National Science Foundation (DMR-0213883) as well as Mississippi INBRE funded by the National Center for Research Resources, National Institutes of Health (award# P20RR016476) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Carpentier YA, 2006, PROSTAG LEUKOTR ESS, V75, P145, DOI 10.1016/j.plefa.2006.05.004; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; EDWARDS K, 1994, BIOCHEMISTRY-US, V33, P13304, DOI 10.1021/bi00249a017; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fletcher TG, 1997, PROTEIN SCI, V6, P666; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Hagihara Y, 2002, BIOCHEMISTRY-US, V41, P1020, DOI 10.1021/bi015693q; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kurganov B, 2004, PEPTIDES, V25, P217, DOI 10.1016/j.peptides.2004.01.001; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; LUZZATI V, 1966, ANN NY ACAD SCI, V137, P409, DOI 10.1111/j.1749-6632.1966.tb50172.x; Ma Z, 2002, MOL MED, V8, P863, DOI 10.1007/BF03402092; Mandal PK, 2004, NEUROCHEM RES, V29, P2273, DOI 10.1007/s11064-004-7036-0; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; MAYES PA, 2000, LANGE MED BOOKS, P268; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MICHAEL R, 2005, BIOCHEMISTRY-US, V44, P165; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Perczel A., 1996, CIRCULAR DICHROISM C, P285; Pillot T, 1996, J BIOL CHEM, V271, P28757, DOI 10.1074/jbc.271.46.28757; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; REISSHUSSON F, 1966, J COLLOID INTERF SCI, V21, P534, DOI 10.1016/0095-8522(66)90051-1; Ross BP, 2004, MOL PHARMACEUT, V1, P233, DOI 10.1021/mp049964d; Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200; Schlame M, 1996, J LIPID RES, V37, P2608; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; SOLFRIZZI V, 2009, AGEING RES REV; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; Waiter MF, 1997, BIOCHEM BIOPH RES CO, V233, P760, DOI 10.1006/bbrc.1997.6547; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Wood SJ, 1996, J BIOL CHEM, V271, P4086; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; Yamamoto N, 2004, FEBS LETT, V569, P135, DOI 10.1016/j.febslet.2004.05.037; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	71	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18759	10.1371/journal.pone.0018759	http://dx.doi.org/10.1371/journal.pone.0018759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526230	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100019
